PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brennan, DJ; O'Connor, DP; Laursen, H; McGee, SF; McCarthy, S; Zagozdzon, R; Rexhepaj, E; Culhane, AC; Martin, FM; Duffy, MJ; Landberg, G; Ryden, L; Hewitt, SM; Kuhar, MJ; Bernards, R; Millikan, RC; Crown, JP; Jirstrom, K; Gallagher, WM				Brennan, D. J.; O'Connor, D. P.; Laursen, H.; McGee, S. F.; McCarthy, S.; Zagozdzon, R.; Rexhepaj, E.; Culhane, A. C.; Martin, F. M.; Duffy, M. J.; Landberg, G.; Ryden, L.; Hewitt, S. M.; Kuhar, M. J.; Bernards, R.; Millikan, R. C.; Crown, J. P.; Jirstrom, K.; Gallagher, W. M.			The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ER alpha, and is an independent prognostic factor in node-negative breast cancer	ONCOGENE			English	Article						cocaine- and amphetamine-regulated transcript; breast cancer; prognosis; estrogen receptor	NERVE GROWTH-FACTOR; ESTROGEN-RECEPTOR; GENE-EXPRESSION; CART PEPTIDES; PHOSPHORYLATION; TAMOXIFEN; PROTEIN; TRIAL; SERINE-118; THERAPY	Personalized medicine requires the identification of unambiguous prognostic and predictive biomarkers to inform therapeutic decisions. Within this context, the management of lymph node-negative breast cancer is the subject of much debate with particular emphasis on the requirement for adjuvant chemotherapy. The identification of prognostic and predictive biomarkers in this group of patients is crucial. Here, we demonstrate by tissue microarray and automated image analysis that the cocaine- and amphetamine-regulated transcript (CART) is expressed in primary and metastatic breast cancer and is an independent poor prognostic factor in estrogen receptor (ER)-positive, lymph node-negative tumors in two separate breast cancer cohorts (n = 690; P = 0.002, 0.013). We also show that CART increases the transcriptional activity of ER alpha in a ligand-independent manner via the mitogen-activated protein kinase pathway and that CART stimulates an autocrine/paracrine loop within tumor cells to amplify the CART signal. Additionally, we demonstrate that CART expression in ER-positive breast cancer cell lines protects against tamoxifen-mediated cell death and that high CART expression predicts disease outcome in tamoxifen-treated patients in vivo in three independent breast cancer cohorts. We believe that CART profiling will help facilitate stratification of lymph node-negative breast cancer patients into high- and low-risk categories and allow for the personalization of therapy. Oncogene (2012) 31, 3483-3494; doi:10.1038/onc.2011.519; published online 5 December 2011	[Brennan, D. J.; O'Connor, D. P.; Laursen, H.; McGee, S. F.; McCarthy, S.; Zagozdzon, R.; Rexhepaj, E.; Martin, F. M.; Gallagher, W. M.] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Culhane, A. C.] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biost & Computat Biol, Boston, MA 02115 USA; [Duffy, M. J.] Univ Coll Dublin, UCD Sch Med & Med Sci, UCD Conway Inst, Dublin 2, Ireland; [Duffy, M. J.] St Vincents Univ Hosp, Dept Pathol & Lab Med, Dublin 4, Ireland; [Landberg, G.] Lund Univ, Skane Univ Hosp, Ctr Mol Pathol, Dept Lab Med, Malmo, Sweden; [Hewitt, S. M.] NCI, Tissue Array Res Program, Pathol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Kuhar, M. J.] Emory Univ, Yerkes Natl Primate Res Ctr, Div Neurosci, Atlanta, GA 30322 USA; [Bernards, R.] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Millikan, R. C.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Crown, J. P.] St Vincents Univ Hosp, Dublin 4, Ireland; [Ryden, L.] Lund Univ, Div Surg, Skane Univ Hosp, Dept Clin Sci, Lund, Sweden; [Jirstrom, K.] Lund Univ, Skane Univ Hosp, Div Pathol, Dept Clin Sci, Lund, Sweden	University College Dublin; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; University College Dublin; University College Dublin; Saint Vincent's University Hospital; Lund University; Skane University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emory University; Netherlands Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; University College Dublin; Saint Vincent's University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Gallagher, WM (corresponding author), Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland.	william.gallagher@ucd.ie	Culhane, Aedin/AAG-8490-2019; Zagozdzon, Radoslaw/K-2141-2012; McCarthy, Sarah/HCI-8963-2022; Duffy, Michael/J-5610-2019; Crown, John/AAL-3367-2020; Zagozdzon, Radoslaw/AAC-4298-2019	Culhane, Aedin/0000-0002-1395-9734; Duffy, Michael/0000-0002-9259-6619; Zagozdzon, Radoslaw/0000-0002-7957-2372; Hewitt, Stephen/0000-0001-8283-1788; Gallagher, William/0000-0002-4307-5999; Brennan, Donal/0000-0002-6747-3342; O'Connor, Darran/0000-0002-8835-1547; Bernards, Rene/0000-0001-8677-3423	Program for Third Level Institutions; Health Research Board of Ireland; Enterprise Ireland; Science Foundation Ireland [08/SRC/B1410]; European Community [224865];  [RR00165]; NATIONAL CANCER INSTITUTE [ZICBC010923, P50CA058223] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010732] Funding Source: NIH RePORTER	Program for Third Level Institutions; Health Research Board of Ireland; Enterprise Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Community(European Commission); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The UCD Conway Institute is funded by the Program for Third Level Institutions, as administered by the Higher Education Authority of Ireland. Funding is acknowledged from the Health Research Board of Ireland, Enterprise Ireland and the Science Foundation Ireland Strategic Research Cluster award to Molecular Therapeutics for Cancer Ireland (08/SRC/B1410). The work of Dr R Zagozdzon has been supported by a Marie Curie International Reintegration Grant no. 224865 within the 7th European Community Framework Program. Dr MJ Kuhar is funded by RR00165.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Adriaenssens E, 2008, CANCER RES, V68, P346, DOI 10.1158/0008-5472.CAN-07-1183; Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; Bech P, 2008, J CLIN ENDOCR METAB, V93, P1246, DOI 10.1210/jc.2007-1946; Borgquist S, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2146; Brennan DJ, 2008, CLIN CANCER RES, V14, P2681, DOI 10.1158/1078-0432.CCR-07-1760; Brennan DJ, 2006, CLIN CANCER RES, V12, P6421, DOI 10.1158/1078-0432.CCR-06-0480; Brennan DJ, 2010, NAT REV CANCER, V10, P605, DOI 10.1038/nrc2902; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chanrion M, 2008, CLIN CANCER RES, V14, P1744, DOI 10.1158/1078-0432.CCR-07-1833; Cheng JW, 2007, ENDOCRINOLOGY, V148, P4634, DOI 10.1210/en.2007-0148; Clarke M, 1998, LANCET, V351, P1451; Dolle L, 2004, CURR CANCER DRUG TAR, V4, P463, DOI 10.2174/1568009043332853; Dominguez G, 2004, MOL BRAIN RES, V126, P22, DOI 10.1016/j.molbrainres.2004.02.027; Dominguez G, 2006, PEPTIDES, V27, P1913, DOI 10.1016/j.peptides.2006.01.025; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Epping MT, 2007, P NATL ACAD SCI USA, V104, P17777, DOI 10.1073/pnas.0702518104; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Jia J, 2008, NEUROPEPTIDES, V42, P653, DOI 10.1016/j.npep.2008.05.006; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Keegan BP, 2006, BREAST CANCER RES TR, V95, P265, DOI 10.1007/s10549-005-9024-8; Koylu EO, 1997, J NEUROENDOCRINOL, V9, P823, DOI 10.1046/j.1365-2826.1997.00651.x; Koylu EO, 2006, PEPTIDES, V27, P1956, DOI 10.1016/j.peptides.2006.03.032; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Lakatos A, 2005, NEUROSCI LETT, V384, P198, DOI 10.1016/j.neulet.2005.04.072; Mantzoros CS, 1999, INT J CANCER, V80, P523, DOI 10.1002/(SICI)1097-0215(19990209)80:4<523::AID-IJC7>3.3.CO;2-3; O'Brien SL, 2007, INT J CANCER, V120, P1434, DOI 10.1002/ijc.22413; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; Ruscica M, 2007, PEPTIDES, V28, P426, DOI 10.1016/j.peptides.2006.08.045; Ryden L, 2005, EUR J CANCER, V41, P256, DOI 10.1016/j.ejca.2004.06.030; Ryden L, 2003, BREAST CANCER RES TR, V82, P147, DOI 10.1023/B:BREA.0000004357.92232.cb; Sen A, 2008, MOL ENDOCRINOL, V22, P2655, DOI 10.1210/me.2008-0077; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; TAYLOR AH, 1990, CANCER RES, V50, P7882; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Yamashita H, 2008, ENDOCR-RELAT CANCER, V15, P755, DOI 10.1677/ERC-08-0078; Zoubir M, 2008, ANN ONCOL, V19, P1402, DOI 10.1093/annonc/mdn151; Zujewski JA, 2008, FUTURE ONCOL, V4, P603, DOI 10.2217/14796694.4.5.603; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	43	7	8	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2012	31	30					3483	3494		10.1038/onc.2011.519	http://dx.doi.org/10.1038/onc.2011.519			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	979UA	22139072	Green Accepted, Green Submitted			2022-12-25	WOS:000306844100001
J	Quinones, MM; Winston, JT; Stromhaug, PE				Quinones, Mariana Morales; Winston, Jared T.; Stromhaug, Per E.			Propeptide of Aminopeptidase 1 Protein Mediates Aggregation and Vesicle Formation in Cytoplasm-to-Vacuole Targeting Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; IN-VIVO; SELECTIVE AUTOPHAGY; CELL-DEATH; ANTIBACTERIAL AUTOPHAGY; ENDOPLASMIC-RETICULUM; QUATERNARY STRUCTURE; MAGNETIC-RESONANCE; ALPHA-MANNOSIDASE; TRANSPORT	Misfolded protein aggregation causes disease and aging; autophagy counteracts this by eliminating damaged components, enabling cells to survive starvation. The cytoplasm-to-vacuole targeting pathway in yeast encompasses the aggregation of the premature form of aminopeptidase 1 (prApe1) in cytosol and its sequestration by autophagic proteins into a vesicle for vacuolar transport. We show that the propeptide of Ape1 is important for aggregation and vesicle formation and that it is sufficient for binding to prApe1 and Atg19. Defective aggregation disrupts vacuolar transport, suggesting that aggregate shape is important in vesicle formation, whereas Atg19 binding is not sufficient for vacuolar transport. Aggregation involves hydrophobicity, whereas Atg19 binding requires additional electrostatic interactions. Ape1 dodecamerization may cluster propeptides into trimeric structures, with sufficient affinity to form propeptide hexamers by binding to other dodecamers, causing aggregation. We show that Ape1 aggregates bind Atg19 and Atg8 in vitro; this could be used as a scaffold for an in vitro assay of autophagosome formation to elucidate the mechanisms of autophagy.	[Quinones, Mariana Morales; Winston, Jared T.; Stromhaug, Per E.] Univ Missouri, Dept Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Stromhaug, PE (corresponding author), SUNY Binghamton, POB 6000, Binghamton, NY 13902 USA.	per@binghamton.edu						Adachi W, 2007, ACTA CRYSTALLOGR F, V63, P200, DOI 10.1107/S1744309107005441; Amar N, 2006, EMBO REP, V7, P635, DOI 10.1038/sj.embor.7400698; Andrei-Selmer C, 2001, J BIOL CHEM, V276, P11606, DOI 10.1074/jbc.M003846200; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Baumeister W, 2000, TRENDS BIOCHEM SCI, V25, P624, DOI 10.1016/S0968-0004(00)01720-5; Beeler T, 1997, BBA-BIOMEMBRANES, V1323, P310, DOI 10.1016/S0005-2736(96)00199-X; Bhatia D, 2009, ANGEW CHEM INT EDIT, V48, P4134, DOI 10.1002/anie.200806000; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Broering JM, 2005, J PHYS CHEM B, V109, P20612, DOI 10.1021/jp053618+; Chang CY, 2007, MOL BIOL CELL, V18, P919, DOI 10.1091/mbc.E06-08-0683; CHANG YH, 1989, J BIOL CHEM, V264, P6979; Collins KD, 2004, METHODS, V34, P300, DOI 10.1016/j.ymeth.2004.03.021; Coury LA, 1999, FEMS MICROBIOL LETT, V179, P327, DOI 10.1111/j.1574-6968.1999.tb08745.x; CROWTHER RA, 1981, J CELL BIOL, V91, P790, DOI 10.1083/jcb.91.3.790; CUEVA R, 1989, FEBS LETT, V259, P125, DOI 10.1016/0014-5793(89)81510-8; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; DAVISSALINAS J, 1995, J NEUROCHEM, V65, P931; Deretic V, 2008, SCI AM, V298, P74, DOI 10.1038/scientificamerican0508-74; Dikic I, 2010, CANCER RES, V70, P3431, DOI 10.1158/0008-5472.CAN-09-4027; EILAM Y, 1982, MICROBIOS, V35, P99; ELSKENS MT, 1991, J GEN MICROBIOL, V137, P637, DOI 10.1099/00221287-137-3-637; Farre JC, 2007, AUTOPHAGY, V3, P230, DOI 10.4161/auto.3905; Fornasari MS, 2004, MOL BIOL EVOL, V21, P97, DOI 10.1093/molbev/msg244; Gonzalez B, 2000, YEAST, V16, P483, DOI 10.1002/(SICI)1097-0061(200004)16:6<483::AID-YEA542>3.0.CO;2-E; GREENFIELD NJ, 1987, BIOCHIM BIOPHYS ACTA, V926, P205, DOI 10.1016/0304-4165(87)90205-4; Haji-Akbari A, 2009, NATURE, V462, P773, DOI 10.1038/nature08641; Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621; Hayward AP, 2009, SEMIN CELL DEV BIOL, V20, P1041, DOI 10.1016/j.semcdb.2009.04.012; Hino T, 2004, ACTA CRYSTALLOGR D, V60, P803, DOI 10.1107/S0907444904003233; Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI [DOI 10.1007/BF01918191, 10.1007/BF01918191]; Huang J, 2011, AUTOPHAGY, V7, P17, DOI 10.4161/auto.7.1.13840; Huang THJ, 2000, J BIOL CHEM, V275, P36436, DOI 10.1074/jbc.M005698200; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Kageyama T, 2009, BIOCHEM BIOPH RES CO, V378, P551, DOI 10.1016/j.bbrc.2008.11.084; Kentsis A, 2004, CURR PROTEIN PEPT SC, V5, P125, DOI 10.2174/1389203043486856; Kim J, 1997, J CELL BIOL, V137, P609, DOI 10.1083/jcb.137.3.609; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kuhn RJ, 2005, ADV VIRUS RES, V64, P263, DOI 10.1016/S0065-3527(05)64008-0; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Liu B, 2010, ACTA PHARMACOL SIN, V31, P1154, DOI 10.1038/aps.2010.118; Lunemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Martinez E, 1997, J MOL BIOL, V267, P1124, DOI 10.1006/jmbi.1997.0925; Mazon MJ, 2007, MOL MICROBIOL, V63, P1069, DOI 10.1111/j.1365-2958.2006.05580.x; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; METZ G, 1977, Z NATURFORSCH C, V32, P929; Milne JLS, 2002, EMBO J, V21, P5587, DOI 10.1093/emboj/cdf574; Moelbert S, 2004, BIOPHYS CHEM, V112, P45, DOI 10.1016/j.bpc.2004.06.012; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Newcomb WW, 1996, J MOL BIOL, V263, P432, DOI 10.1006/jmbi.1996.0587; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Oda MN, 1996, J CELL BIOL, V132, P999, DOI 10.1083/jcb.132.6.999; Okorokov LA, 1997, FEMS MICROBIOL LETT, V146, P39, DOI 10.1016/S0378-1097(96)00437-5; OLZ R, 1993, J BACTERIOL, V175, P2205, DOI 10.1128/JB.175.8.2205-2213.1993; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perez-Jimenez R, 2004, BIOPHYS J, V86, P2414, DOI 10.1016/S0006-3495(04)74298-8; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Raman S, 2006, NANOMED-NANOTECHNOL, V2, P95, DOI 10.1016/j.nano.2006.04.007; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; ROOMANS GM, 1976, J CELL SCI, V21, P119; Schu P, 2008, METHOD ENZYMOL, V451, P67, DOI 10.1016/S0076-6879(08)03206-0; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shahnazari S, 2011, AUTOPHAGY, V7, P331, DOI 10.4161/auto.7.3.14045; Shahnazari S, 2010, CELL HOST MICROBE, V8, P137, DOI 10.1016/j.chom.2010.07.002; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Sunder S, 1996, MOL CELL BIOCHEM, V158, P121; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Theobald U, 1996, BIOTECHNOL TECH, V10, P297; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tunnicliffe HE, 1925, BIOCHEM J, V19, P194, DOI 10.1042/bj0190194; van Eunen K, 2010, FEBS J, V277, P749, DOI 10.1111/j.1742-4658.2009.07524.x; Vrbka L, 2006, J PHYS CHEM B, V110, P7036, DOI 10.1021/jp0567624; Walz J, 1997, MOL CELL, V1, P59, DOI 10.1016/S1097-2765(00)80007-6; Wang T, 2009, J CELL BIOL, V186, P703, DOI 10.1083/jcb.200904090; Watanabe Y, 2010, J BIOL CHEM, V285, P30026, DOI 10.1074/jbc.M110.143545; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035; Yuga M, 2011, J BIOL CHEM, V286, P13704, DOI 10.1074/jbc.M110.173906; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441; Zhou HX, 2005, PROTEINS, V61, P69, DOI 10.1002/prot.20500	88	16	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10121	10133		10.1074/jbc.M111.311696	http://dx.doi.org/10.1074/jbc.M111.311696			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22123825	Green Published, hybrid			2022-12-25	WOS:000302167200044
J	Chen, JR; Zhang, J; Lazarenko, OP; Kang, P; Blackburn, ML; Ronis, MJJ; Badger, TM; Shankar, K				Chen, Jin-Ran; Zhang, Jian; Lazarenko, Oxana P.; Kang, Ping; Blackburn, Michael L.; Ronis, Martin J. J.; Badger, Thomas M.; Shankar, Kartik			Inhibition of fetal bone development through epigenetic down-regulation of HoxA10 in obese rats fed high-fat diet	FASEB JOURNAL			English	Article						osteoblast; methylation; osteogenesis; free fatty acid	VITAMIN-D STATUS; DNA METHYLATION; OSTEOPOROSIS; OSTEOBLASTOGENESIS; ORIGINS; DISEASE; LINEAGE; CELLS; ACIDS; MASS	Epidemiological studies show that maternal obesity during intrauterine and early postnatal life increases the risk of low bone mass and fracture later in life. Here, we show that bone development is inhibited in gestational embryonic day 18.5 (E18.5) embryos from rat dams made obese by feeding a high-fat diet (HFD). Moreover, fetal rat osteogenic calvarial cells (FOCCs) from these obese dams have significantly less potential to develop into mature osteoblasts compared to cells from AIN-93G diet-fed controls. Profiling of transcriptional genes for osteogenesis revealed a profound decrease in the homeodomain-containing factor A10 (HoxA10) in FOCCs from fetuses of HFD-induced obese dams. Significant methylation of the HoxA10 promoter was found in those FOCCs, as well as in mouse ST2 cells treated with a mixture of free fatty acids similar to that found in serum from HFD-induced obese rats. This was accompanied by lower expression of osteogenic markers, but higher levels of PPAR gamma. Control FOCCs depleted of the HoxA10 gene (shRNA) ex vivo behave similarly to cells from fetuses of obese dams; conversely, overexpression of HoxA10 gene in FOCCs from HFD rats exhibit the same phenotype as controls. Treatment of FOCCs from control rats or of ST2 cells with an artificial mixture of free fatty acids significantly down-regulated HoxA10 protein expression, and cells exhibited adipocyte-like properties. These results suggest that maternal obesity impairs fetal skeletal development through down-regulation of the HoxA10 gene, which may lead to an increase in the prevalence of low bone mass in the offspring later in life.-Chen, J.-R., Zhang, J., Lazarenko, O. P., Kang, P., Blackburn, M. L., Ronis, M. J. J., Badger, T. M., Shankar, K. Inhibition of fetal bone development through epigenetic down-regulation of HoxA10 in obese rats fed high-fat diet. FASEB J. 26, 1131-1141 (2012). www.fasebj.org	[Chen, Jin-Ran; Zhang, Jian; Lazarenko, Oxana P.; Kang, Ping; Blackburn, Michael L.; Ronis, Martin J. J.; Badger, Thomas M.; Shankar, Kartik] Arkansas Childrens Nutr Ctr, Little Rock, AR 72202 USA; [Chen, Jin-Ran; Zhang, Jian; Ronis, Martin J. J.; Badger, Thomas M.; Shankar, Kartik] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Lazarenko, Oxana P.; Blackburn, Michael L.; Badger, Thomas M.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Ronis, Martin J. J.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Chen, JR (corresponding author), Arkansas Childrens Nutr Ctr, 15 Childrens Way,Slot 512-20B, Little Rock, AR 72202 USA.	chenjinran@uams.edu		Shankar, Kartik/0000-0002-7964-9026	U.S. Department of Agriculture/Agriculture Research Service [CRIS 6251-51000-006-03s]	U.S. Department of Agriculture/Agriculture Research Service(United States Department of Agriculture (USDA))	This work was supported by U.S. Department of Agriculture/Agriculture Research Service grant CRIS 6251-51000-006-03s to the Arkansas Children's Nutrition Center.	Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bromer JG, 2010, FASEB J, V24, P2273, DOI 10.1096/fj.09-140533; Chen JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013704; Chen JR, 2010, J BONE MINER RES, V25, P2399, DOI 10.1002/jbmr.137; Chen JR, 2010, J BONE MINER RES, V25, P1117, DOI 10.1002/jbmr.7; Cooper C, 2009, ADV EXP MED BIOL, V646, P31, DOI 10.1007/978-1-4020-9173-5_3; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; ELPHICK MC, 1975, J PHYSIOL-LONDON, V252, P29, DOI 10.1113/jphysiol.1975.sp011132; Gicquel C, 2008, BEST PRACT RES CL EN, V22, P1, DOI 10.1016/j.beem.2007.07.009; Gluckman PD, 2007, BIOESSAYS, V29, P145, DOI 10.1002/bies.20522; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Gordon JAR, 2011, CELLS TISSUES ORGANS, V194, P146, DOI 10.1159/000324790; Gordon JAR, 2010, MOL CELL BIOL, V30, P3531, DOI 10.1128/MCB.00889-09; Greco EA, 2010, INT J CLIN PRACT, V64, P817, DOI 10.1111/j.1742-1241.2009.02301.x; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; Hassan MQ, 2009, CELLS TISSUES ORGANS, V189, P122, DOI 10.1159/000151453; Herrera BM, 2011, MATURITAS, V69, P41, DOI 10.1016/j.maturitas.2011.02.018; Hombria JCG, 2003, DIFFERENTIATION, V71, P461, DOI 10.1046/j.1432-0436.2003.7108004.x; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Javaid MK, 2002, BEST PRACT RES CL EN, V16, P349, DOI 10.1053/beem.2002.0199; King JC, 2006, ANNU REV NUTR, V26, P271, DOI 10.1146/annurev.nutr.24.012003.132249; Lanham SA, 2008, OSTEOPOROSIS INT, V19, P157, DOI 10.1007/s00198-007-0448-3; Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788; Liang C, 2009, BIRTH DEFECTS RES B, V86, P362, DOI 10.1002/bdrb.20204; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Mahon P, 2010, J BONE MINER RES, V25, P14, DOI 10.1359/jbmr.090701; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Menegola E, 2001, TERATOLOGY, V64, P125, DOI 10.1002/tera.1055; Premaor MO, 2010, J BONE MINER RES, V25, P292, DOI 10.1359/jbmr.091004; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Shankar K, 2010, ENDOCRINOLOGY, V151, P153, DOI 10.1210/en.2009-0840; Viljakainen HT, 2010, J CLIN ENDOCR METAB, V95, P1749, DOI 10.1210/jc.2009-1391; WONG GL, 1975, P NATL ACAD SCI USA, V72, P3167, DOI 10.1073/pnas.72.8.3167; Zhao LJ, 2008, J BONE MINER RES, V23, P17, DOI 10.1359/JBMR.070813	36	39	40	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2012	26	3					1131	1141		10.1096/fj.11-197822	http://dx.doi.org/10.1096/fj.11-197822			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22131269				2022-12-25	WOS:000300949300017
J	Adelstein, JS; Shehzad, Z; Mennes, M; DeYoung, CG; Zuo, XN; Kelly, C; Margulies, DS; Bloomfield, A; Gray, JR; Castellanos, FX; Milham, MP				Adelstein, Jonathan S.; Shehzad, Zarrar; Mennes, Maarten; DeYoung, Colin G.; Zuo, Xi-Nian; Kelly, Clare; Margulies, Daniel S.; Bloomfield, Aaron; Gray, Jeremy R.; Castellanos, F. Xavier; Milham, Michael P.			Personality Is Reflected in the Brain's Intrinsic Functional Architecture	PLOS ONE			English	Article							TEMPORAL POLE ACTIVITY; RESTING STATE FMRI; ANTERIOR CINGULATE; INDIVIDUAL-DIFFERENCES; NEUROTICISM TRAIT; DECISION-MAKING; WORKING-MEMORY; HUMAN STRIATUM; CORTICAL HUBS; HAPPY FACES	Personality describes persistent human behavioral responses to broad classes of environmental stimuli. Investigating how personality traits are reflected in the brain's functional architecture is challenging, in part due to the difficulty of designing appropriate task probes. Resting-state functional connectivity (RSFC) can detect intrinsic activation patterns without relying on any specific task. Here we use RSFC to investigate the neural correlates of the five-factor personality domains. Based on seed regions placed within two cognitive and affective 'hubs' in the brain-the anterior cingulate and precuneus-each domain of personality predicted RSFC with a unique pattern of brain regions. These patterns corresponded with functional subdivisions responsible for cognitive and affective processing such as motivation, empathy and future-oriented thinking. Neuroticism and Extraversion, the two most widely studied of the five constructs, predicted connectivity between seed regions and the dorsomedial prefrontal cortex and lateral paralimbic regions, respectively. These areas are associated with emotional regulation, self-evaluation and reward, consistent with the trait qualities. Personality traits were mostly associated with functional connections that were inconsistently present across participants. This suggests that although a fundamental, core functional architecture is preserved across individuals, variable connections outside of that core encompass the inter-individual differences in personality that motivate diverse responses.	[Adelstein, Jonathan S.; Mennes, Maarten; Zuo, Xi-Nian; Kelly, Clare; Bloomfield, Aaron; Castellanos, F. Xavier] NYU, Langone Med Ctr, NYU Child Study Ctr, Phyllis Green & Randolph Cowen Inst Pediat Neuros, New York, NY 10012 USA; [Shehzad, Zarrar; Gray, Jeremy R.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [DeYoung, Colin G.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Lab Funct Connectome & Dev, Beijing 100101, Peoples R China; [Margulies, Daniel S.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Margulies, Daniel S.] Univ Berlin, Mind & Brain Inst, Berlin, Germany; [Castellanos, F. Xavier; Milham, Michael P.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA; [Milham, Michael P.] Child Mind Inst, Ctr Developing Brain, New York, NY USA	New York University; NYU Langone Medical Center; Yale University; University of Minnesota System; University of Minnesota Twin Cities; Chinese Academy of Sciences; Institute of Psychology, CAS; Max Planck Society; Nathan Kline Institute for Psychiatric Research	Adelstein, JS (corresponding author), NYU, Langone Med Ctr, NYU Child Study Ctr, Phyllis Green & Randolph Cowen Inst Pediat Neuros, New York, NY 10012 USA.	michael.milham@childmind.org	Zuo, Xi-Nian/A-7273-2009; Castellanos, Francisco Xavier/K-1892-2014; Gray, Jeremy/A-2635-2013; Milham, Michael P./Y-3160-2019; Milham, Michael P/K-9501-2014; Mennes, Maarten/C-9924-2011; Kelly, Clare/H-4629-2016; Margulies, Daniel/L-4719-2016	Zuo, Xi-Nian/0000-0001-9110-585X; Castellanos, Francisco Xavier/0000-0001-9192-9437; Mennes, Maarten/0000-0002-7279-3439; Kelly, Clare/0000-0001-8253-357X; Margulies, Daniel/0000-0002-8880-9204	Howard Hughes Medical Institute; National Institute of Mental Health [R01MH083246, R01MH081218]; National Institute on Drug Abuse [R03DA024775, R01DA016979]; Autism Speaks; National Science and Engineering Research Council of Canada; Startup Foundation for Distinguished Research Professor of Institute for Psychology; Natural Science Foundation of China [Y0CX492S03, 81171409]; Stavros Niarchos Foundation; Leon Levy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081218, R01MH083246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA024775, R01DA016979] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Autism Speaks; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Startup Foundation for Distinguished Research Professor of Institute for Psychology; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Stavros Niarchos Foundation; Leon Levy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the Howard Hughes Medical Institute (to J.S.A.), the National Institute of Mental Health (R01MH083246 and R01MH081218 to F. X. C. and M. P. M.), National Institute on Drug Abuse (R03DA024775, to C. K.; R01DA016979, to F. X. C.) and Autism Speaks, a Post-Graduate Fellowship from the National Science and Engineering Research Council of Canada (to Z.S.), the Startup Foundation for Distinguished Research Professor of Institute for Psychology and the Natural Science Foundation of China (Y0CX492S03 and 81171409 to X-N.Z.) as well as gifts to the New York University Child Study Center from the Stavros Niarchos Foundation, Leon Levy Foundation, and an endowment provided by Phyllis Green and Randolph Cowen. Funders had no role in the design of the study, data analyses or interpretation or presentation of results.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Allemand M, 2008, DEV PSYCHOL, V44, P758, DOI 10.1037/0012-1649.44.3.758; Amin Z, 2004, J RES PERS, V38, P15, DOI 10.1016/j.jrp.2003.09.011; Andersson JLR, 2007, TR07JA2 NONLINEAR RE; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Berquin PC, 1998, NEUROLOGY, V50, P1087, DOI 10.1212/WNL.50.4.1087; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brieger P, 2000, J PERS DISORD, V14, P282, DOI 10.1521/pedi.2000.14.3.282; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bueti D, 2010, NEUROIMAGE, V51, P1168, DOI 10.1016/j.neuroimage.2010.03.023; Canli T, 2004, J PERS, V72, P1105, DOI 10.1111/j.1467-6494.2004.00292.x; Canli T, 2004, BEHAV NEUROSCI, V118, P897, DOI 10.1037/0735-7044.118.5.897; Canli T, 2002, BRAIN COGNITION, V50, P414, DOI 10.1016/S0278-2626(02)00517-1; Canli T, 2001, BEHAV NEUROSCI, V115, P33, DOI 10.1037//0735-7044.115.1.33; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; Cohen MX, 2005, COGNITIVE BRAIN RES, V25, P851, DOI 10.1016/j.cogbrainres.2005.09.018; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; COSTA PT, 1995, J PERS ASSESS, V64, P21, DOI 10.1207/s15327752jpa6401_2; Cox CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012296; Cuijpers P, 2005, PSYCHIAT RES, V133, P229, DOI 10.1016/j.psychres.2004.10.006; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; DeYoung CG, 2005, J PERS, V73, P825, DOI 10.1111/j.1467-6494.2005.00330.x; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; DeYoung CG, 2009, CAMBRIDGE HANDBOOK OF PERSONALITY PSYCHOLOGY, P323; DeYoung CG, 2009, J PERS SOC PSYCHOL, V97, P883, DOI 10.1037/a0016615; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Di Martino A, 2009, AM J PSYCHIAT, V166, P891, DOI 10.1176/appi.ajp.2009.08121894; Digman JM, 1997, J PERS SOC PSYCHOL, V73, P1246, DOI 10.1037/0022-3514.73.6.1246; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Eisenberger NI, 2005, COGN AFFECT BEHAV NE, V5, P169, DOI 10.3758/CABN.5.2.169; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Friedman HS, 2010, J PERS, V78, P179, DOI 10.1111/j.1467-6494.2009.00613.x; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Haas BW, 2007, BEHAV NEUROSCI, V121, P249, DOI 10.1037/0735-7044.121.2.249; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hoptman MJ, 2009, SCHIZOPHR B, V36, P1020; Hopwood CJ, 2009, J PERS DISORD, V23, P466, DOI 10.1521/pedi.2009.23.5.466; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Jang KL, 1998, J PERS SOC PSYCHOL, V74, P1556, DOI 10.1037/0022-3514.74.6.1556; Jausovec N, 2007, INT J PSYCHOPHYSIOL, V66, P215, DOI 10.1016/j.ijpsycho.2007.07.005; Jimura K, 2010, BRAIN RES, V1328, P104, DOI 10.1016/j.brainres.2010.03.016; Jimura K, 2009, NEUROSCI LETT, V453, P45, DOI 10.1016/j.neulet.2009.02.012; John O.P., 2008, PARADIGM SHIFT INTEG, V3rd ed., P114, DOI DOI 10.1016/S0191-8869(97)81000-8; Johnson DL, 1999, AM J PSYCHIAT, V156, P252; Jollant F, 2010, NEUROIMAGE, V51, P1275, DOI 10.1016/j.neuroimage.2010.03.027; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kim SH, 2008, NEUROREPORT, V19, P883, DOI 10.1097/WNR.0b013e328300080f; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Krain AL, 2006, NEUROIMAGE, V32, P477, DOI 10.1016/j.neuroimage.2006.02.047; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Kristensen AS, 2009, J ANXIETY DISORD, V23, P600, DOI 10.1016/j.janxdis.2009.01.009; Kumari V, 2007, BEHAV NEUROSCI, V121, P643, DOI 10.1037/0735-7044.121.4.643; Kunisato Y, 2011, NEUROSCI LETT, V492, P109, DOI 10.1016/j.neulet.2011.01.067; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Marien P, 2009, CORTEX, V45, P527, DOI 10.1016/j.cortex.2007.12.010; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Mobbs D, 2005, P NATL ACAD SCI USA, V102, P16502, DOI 10.1073/pnas.0408457102; Nigg JT, 2002, J PERS SOC PSYCHOL, V83, P451, DOI [10.1037/0022-3514.83.2.451, 10.1037//0022-3514.83.2.451]; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Omura K, 2005, NEUROREPORT, V16, P1905, DOI 10.1097/01.wnr.0000186596.64458.76; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Raichle ME, 2010, SCI AM, V302, P44, DOI 10.1038/scientificamerican0310-44; Read SJ, 2010, PSYCHOL REV, V117, P61, DOI 10.1037/a0018131; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Sabatini E, 2009, BRAIN RES BULL, V79, P258, DOI 10.1016/j.brainresbull.2009.03.001; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Sheng T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012611; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sollberger M, 2009, NEUROPSYCHOLOGIA, V47, P2812, DOI 10.1016/j.neuropsychologia.2009.06.006; Spinhoven P, 2009, GEN HOSP PSYCHIAT, V31, P470, DOI 10.1016/j.genhosppsych.2009.05.002; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Sutin AR, 2009, CEREB CORTEX, V19, P2797, DOI 10.1093/cercor/bhp066; Terracciano A, 2010, MOL PSYCHIATR, V15, P647, DOI 10.1038/mp.2008.113; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tran Y, 2006, INT J PSYCHOPHYSIOL, V60, P215, DOI 10.1016/j.ijpsycho.2005.05.008; Trull TJ, 2005, ANNU REV CLIN PSYCHO, V1, P355, DOI 10.1146/annurev.clinpsy.1.102803.144009; Uliaszek AA, 2009, J RES PERS, V43, P785, DOI 10.1016/j.jrp.2009.05.009; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Woollams AM, 2011, J COGNITIVE NEUROSCI, V23, P992, DOI 10.1162/jocn.2010.21502; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118; Ystad M, 2010, NEUROIMAGE, V52, P379, DOI 10.1016/j.neuroimage.2010.03.062; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	102	192	197	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27633	10.1371/journal.pone.0027633	http://dx.doi.org/10.1371/journal.pone.0027633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863MI	22140453	Green Published, gold			2022-12-25	WOS:000298168100014
J	Lee, BK; Ploner, A; Zhang, ZX; Gryfelt, G; Wikman, A; Reilly, M				Lee, Brian K.; Ploner, Alexander; Zhang, Zhongxing; Gryfelt, Gunilla; Wikman, Agneta; Reilly, Marie			Constructing a Population-Based Research Database from Routine Maternal Screening Records: A Resource for Studying Alloimmunization in Pregnant Women	PLOS ONE			English	Article							RED-CELL ANTIBODIES; ANTI-D; HEMOLYTIC-DISEASE; NEWBORN; FREQUENCY; SWEDEN; FETUS	Background: Although screening for maternal red blood cell antibodies during pregnancy is a standard procedure, the prevalence and clinical consequences of non-anti-D immunization are poorly understood. The objective was to create a national database of maternal antibody screening results that can be linked with population health registers to create a research resource for investigating these issues. Study Design and Methods: Each birth in the Swedish Medical Birth Register was uniquely identified and linked to the text stored in routine maternal antibody screening records in the time window from 9 months prior to 2 weeks after the delivery date. These text records were subjected to a computerized search for specific antibodies using regular expressions. To illustrate the research potential of the resulting database, selected antibody prevalence rates are presented as tables and figures, and the complete data (from more than 60 specific antibodies) presented as online moving graphical displays. Results: More than one million (1,191,761) births with valid screening information from 1982-2002 constitute the study population. Computerized coverage of screening increased steadily over time and varied by region as electronic records were adopted. To ensure data quality, we restricted analysis to birth records in areas and years with a sustained coverage of at least 80%, representing 920,903 births from 572,626 mothers in 17 of the 24 counties in Sweden. During the study period, non-anti-D and anti-D antibodies occurred in 76.8/10,000 and 14.1/10,000 pregnancies respectively, with marked differences between specific antibodies over time. Conclusion: This work demonstrates the feasibility of creating a nationally representative research database from the routine maternal antibody screening records from an extended calendar period. By linkage with population registers of maternal and child health, such data are a valuable resource for addressing important clinical questions, such as the etiological significance of non-anti-D antibodies.	[Lee, Brian K.] Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Ploner, Alexander; Zhang, Zhongxing; Reilly, Marie] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Gryfelt, Gunilla; Wikman, Agneta] Karolinska Inst, Dept Clin Immunol & Transfus Med, Stockholm, Sweden; [Gryfelt, Gunilla; Wikman, Agneta] Karolinska Univ Hosp, Stockholm, Sweden	Drexel University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Lee, BK (corresponding author), Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA.	Marie.Reilly@ki.se		Ploner, Alexander/0000-0002-5042-8326; Wikman, Agneta/0000-0002-8810-7974; Lee, Brian/0000-0002-3635-8034	Swedish Research Council (VR) [60521601, K2007-54X-20327-01-2]	Swedish Research Council (VR)(Swedish Research Council)	The work performed was supported by a grant from the Swedish Research Council (VR) contract number 60521601, project number K2007-54X-20327-01-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameen R, 2005, MED PRIN PRACT, V14, P230, DOI 10.1159/000085740; American College of Obstetricians and Gynecologists, 2006, Obstet Gynecol, V108, P457; Barss VA, 2009, SIGNIFICANCE MINOR R; BASKETT TF, 1986, CAN MED ASSOC J, V134, P1259; BOWELL PJ, 1986, BRIT J OBSTET GYNAEC, V93, P1038, DOI 10.1111/j.1471-0528.1986.tb07828.x; BOWMAN JM, 1983, CAN MED ASSOC J, V129, P343; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Daniels G., 2002, ALLOIMMUNE DISORDERS, P21, DOI DOI 10.1017/CBO9780511527043.004; de Silva M, 2003, VOX SANG, V85, P328; Edgren G, 2006, VOX SANG, V91, P316, DOI 10.1111/j.1423-0410.2006.00817.x; FILBEY D, 1995, ACTA OBSTET GYN SCAN, V74, P687, DOI 10.3109/00016349509021175; Gottvall T, 2008, ACTA OBSTET GYN SCAN, V87, P843, DOI 10.1080/00016340802268880; Gotvall T, 1993, ACTA OBSTET GYN SCAN, V72, P434; Koelewijn JM, 2008, TRANSFUSION, V48, P941, DOI 10.1111/j.1537-2995.2007.01625.x; KORNSTAD L, 1983, ACTA OBSTET GYN SCAN, V62, P431, DOI 10.3109/00016348309154215; Moise KJ, 2008, SEMIN FETAL NEONAT M, V13, P207, DOI 10.1016/j.siny.2008.02.007; Robertson G, 2008, IEEE T VIS COMPUT GR, V14, P1325, DOI 10.1109/TVCG.2008.125; SOLOLA A, 1983, OBSTET GYNECOL, V61, P25; Turchin A, 2006, J AM MED INFORM ASSN, V13, P691, DOI 10.1197/jamia.M2078; Urbaniak SJ, 2000, BLOOD REV, V14, P44, DOI 10.1054/blre.1999.0123	20	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27619	10.1371/journal.pone.0027619	http://dx.doi.org/10.1371/journal.pone.0027619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140452	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100013
J	Thurber, AR; Jones, WJ; Schnabel, K				Thurber, Andrew R.; Jones, William J.; Schnabel, Kareen			Dancing for Food in the Deep Sea: Bacterial Farming by a New Species of Yeti Crab	PLOS ONE			English	Article							MITOCHONDRIAL GENE REARRANGEMENTS; POLYUNSATURATED FATTY-ACIDS; HYDROTHERMAL VENT SHRIMPS; RIFTIA-PACHYPTILA JONES; RIMICARIS-EXOCULATA; WATER MOTION; TUBE WORM; ATLANTIC; CARBON; CRUSTACEA	Vent and seep animals harness chemosynthetic energy to thrive far from the sun's energy. While symbiont-derived energy fuels many taxa, vent crustaceans have remained an enigma; these shrimps, crabs, and barnacles possess a phylogenetically distinct group of chemosynthetic bacterial epibionts, yet the role of these bacteria has remained unclear. We test whether a new species of Yeti crab, which we describe as Kiwa puravida n. sp, farms the epibiotic bacteria that it grows on its chelipeds (claws), chelipeds that the crab waves in fluid escaping from a deep-sea methane seep. Lipid and isotope analyses provide evidence that epibiotic bacteria are the crab's main food source and K. puravida n. sp. has highly-modified setae (hairs) on its 3(rd) maxilliped (a mouth appendage) which it uses to harvest these bacteria. The epsilon-and gamma-proteobacteria that this methane-seep species farms are closely related to hydrothermal-vent decapod epibionts. We hypothesize that this species waves its arm in reducing fluid to increase the productivity of its epibionts by removing boundary layers which may otherwise limit carbon fixation. The discovery of this new species, only the second within a family described in 2005, stresses how much remains undiscovered on our continental margins.	[Thurber, Andrew R.] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA; [Jones, William J.] Univ S Carolina, Environm Genom Core Facil, Columbia, SC 29208 USA; [Schnabel, Kareen] Natl Inst Water & Atmospher Res, Wellington, New Zealand	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Thurber, AR (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA.	athurber@coas.oregonstate.edu		Schnabel, Kareen/0000-0002-9965-9010	National Science Foundation (NSF) [OCE-0242034, OCE-0826254, OCE-0939557]; New Zealand Foundation for Research, Science and Technology [C01X0502]; David & Lucile Packard Foundation; Monterey Bay Aquarium Research Institute; Michael M. Mullin Memorial Fellowship; Sydney E. Frank Foundation; Census of Marine Life - Training Award for New Investigators (TAWNI); Directorate For Geosciences [0826254] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); David & Lucile Packard Foundation(The David & Lucile Packard Foundation); Monterey Bay Aquarium Research Institute; Michael M. Mullin Memorial Fellowship; Sydney E. Frank Foundation; Census of Marine Life - Training Award for New Investigators (TAWNI); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the National Science Foundation (NSF) OCE-0242034, OCE-0826254 and OCE-0939557, the New Zealand Foundation for Research, Science and Technology (project C01X0502), the David & Lucile Packard Foundation, the Monterey Bay Aquarium Research Institute, the Michael M. Mullin Memorial Fellowship, the Sydney E. Frank Foundation, and Census of Marine Life - Training Award for New Investigators (TAWNI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRODSKY LI, 1995, BIOCHEMISTRY-MOSCOW+, V60, P923; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; Cavanaugh CM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P475, DOI 10.1007/0-387-30741-9_18; CHILDRESS JJ, 1986, SCIENCE, V233, P1306, DOI 10.1126/science.233.4770.1306; Colaco A, 2007, MAR ECOL-EVOL PERSP, V28, P15, DOI 10.1111/j.1439-0485.2006.00123.x; Conway N.M., 1994, P158; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Dallwitz MJ, 1997, 408 CSIRO DIV ENT; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENNISON WC, 1988, J EXP MAR BIOL ECOL, V115, P67, DOI 10.1016/0022-0981(88)90190-6; Di Meo CA, 2000, APPL ENVIRON MICROB, V66, P651, DOI 10.1128/AEM.66.2.651-658.2000; Duperron S, 2005, APPL ENVIRON MICROB, V71, P1694, DOI 10.1128/AEM.71.4.1694-1700.2005; Durand L, 2010, FEMS MICROBIOL ECOL, V71, P291, DOI 10.1111/j.1574-6941.2009.00806.x; Ehrlich H., 2010, BIOL MAT MARINE ORIG, V2010, P569; FELBECK H, 1981, SCIENCE, V213, P336, DOI 10.1126/science.213.4505.336; GEBRUK AV, 1993, MAR ECOL PROG SER, V98, P247, DOI 10.3354/meps098247; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P485, DOI 10.1017/S0025315400002186; Goffredi SK, 2008, ENVIRON MICROBIOL, V10, P2623, DOI 10.1111/j.1462-2920.2008.01684.x; Goffredi SK, 2010, ENV MICROBIOL REP, V2, P479, DOI 10.1111/j.1758-2229.2010.00136.x; GROSSMANN S, 1991, MAR ECOL PROG SER, V77, P85, DOI 10.3354/meps077085; Halanych KM, 1998, CAH BIOL MAR, V39, P355; Hickerson MJ, 2000, MOL BIOL EVOL, V17, P639, DOI 10.1093/oxfordjournals.molbev.a026342; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JOKIEL PL, 1978, J EXP MAR BIOL ECOL, V35, P87, DOI 10.1016/0022-0981(78)90092-8; LESSER MP, 1994, J EXP MAR BIOL ECOL, V178, P153, DOI 10.1016/0022-0981(94)90034-5; Lewis T, 2000, J MICROBIOL METH, V43, P107, DOI 10.1016/S0167-7012(00)00217-7; MacAvoy SE, 2002, CHEM GEOL, V185, P1, DOI 10.1016/S0009-2541(01)00394-1; Macpherson E, 2005, ZOOSYSTEMA, V27, P709; MCCAFFREY MA, 1989, ORG GEOCHEM, V14, P61, DOI 10.1016/0146-6380(89)90019-3; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McLaughlin PA, 2007, J CRUSTACEAN BIOL, V27, P97, DOI 10.1651/S-2675.1; Miyake H, 2007, MAR ECOL-EVOL PERSP, V28, P86, DOI 10.1111/j.1439-0485.2006.00115.x; Morrison CL, 2002, P ROY SOC B-BIOL SCI, V269, P345, DOI 10.1098/rspb.2001.1886; Nichols DS, 2003, FEMS MICROBIOL LETT, V219, P1, DOI 10.1016/S0378-1097(02)01200-4; PATTERSON MR, 1991, LIMNOL OCEANOGR, V36, P936, DOI 10.4319/lo.1991.36.5.0936; PAULL CK, 1984, SCIENCE, V226, P965, DOI 10.1126/science.226.4677.965; Petersen JM, 2010, ENVIRON MICROBIOL, V12, P2204, DOI 10.1111/j.1462-2920.2009.02129.x; POLZ MF, 1995, P NATL ACAD SCI USA, V92, P7232, DOI 10.1073/pnas.92.16.7232; Polz MF, 1998, LIMNOL OCEANOGR, V43, P1631, DOI 10.4319/lo.1998.43.7.1631; Pond DW, 1997, MAR ECOL PROG SER, V156, P167, DOI 10.3354/meps156167; Saito H, 2008, J CHROMATOGR A, V1200, P242, DOI 10.1016/j.chroma.2008.05.094; SCHMALJOHANN R, 1990, MAR ECOL PROG SER, V61, P119, DOI 10.3354/meps061119; SEGONZAC M, 1993, CAH BIOL MAR, V34, P535; Southward AJ, 1998, CAH BIOL MAR, V39, P259; Tsuchida S, 2011, J MAR BIOL ASSOC UK, V91, P23, DOI 10.1017/S0025315410001827; Volkman JK, 1998, ORG GEOCHEM, V29, P1163, DOI 10.1016/S0146-6380(98)00062-X; Vrijenhoek RC, 2007, BIOL BULL-US, V212, P180, DOI 10.2307/25066600; Wolff T, 2005, CAH BIOL MAR, V46, P97; Yang JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-257; Zbinden M, 2003, FEMS MICROBIOL ECOL, V46, P23, DOI 10.1016/S0168-6496(03)00176-4	52	62	65	1	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e26243	10.1371/journal.pone.0026243	http://dx.doi.org/10.1371/journal.pone.0026243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140426	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168100003
J	Milani, L; Ghiselli, F; Maurizii, MG; Passamonti, M				Milani, Liliana; Ghiselli, Fabrizio; Maurizii, Maria Gabriella; Passamonti, Marco			Doubly Uniparental Inheritance of Mitochondria As a Model System for Studying Germ Line Formation	PLOS ONE			English	Article							LARGE RIBOSOMAL-RNA; VASA-LIKE GENE; MUSSEL MYTILUS-GALLOPROVINCIALIS; DROSOPHILA POLAR GRANULES; DEPENDENT SEX-RATIO; SPERM MITOCHONDRIA; CHROMATOID BODY; CAENORHABDITIS-ELEGANS; XENOPUS-LAEVIS; ULTRASTRUCTURAL CHARACTERIZATION	Background: Doubly Uniparental Inheritance (DUI) of mitochondria occurs when both mothers and fathers are capable of transmitting mitochondria to their offspring, in contrast to the typical Strictly Maternal Inheritance (SMI). DUI was found in some bivalve molluscs, in which two mitochondrial genomes are inherited, one through eggs, the other through sperm. During male embryo development, spermatozoon mitochondria aggregate in proximity of the first cleavage furrow and end up in the primordial germ cells, while they are dispersed in female embryos. Methodology/Principal Findings: We used MitoTracker, microtubule staining and transmission electron microscopy to examine the mechanisms of this unusual distribution of sperm mitochondria in the DUI species Ruditapes philippinarum. Our results suggest that in male embryos the midbody deriving from the mitotic spindle of the first division concurs in positioning the aggregate of sperm mitochondria. Furthermore, an immunocytochemical analysis showed that the germ line determinant Vasa segregates close to the first cleavage furrow. Conclusions/Significance: In DUI male embryos, spermatozoon mitochondria aggregate in a stable area on the animal-vegetal axis: in organisms with spiral segmentation this zone is not involved in cleavage, so the aggregation is maintained. Moreover, sperm mitochondria reach the same embryonic area in which also germ plasm is transferred. In 2-blastomere embryos, the segregation of sperm mitochondria in the same region with Vasa suggests their contribution in male germ line formation. In DUI male embryos, M-type mitochondria must be recognized by egg factors to be actively transferred in the germ line, where they become dominant replacing the Balbiani body mitochondria. The typical features of germ line assembly point to a common biological mechanism shared by DUI and SMI organisms. Although the molecular dynamics of the segregation of sperm mitochondria in DUI species are unknown, they could be a variation of the mechanism regulating the mitochondrial bottleneck in all metazoans.	[Milani, Liliana; Ghiselli, Fabrizio; Maurizii, Maria Gabriella; Passamonti, Marco] Univ Bologna, Dept Biol Evoluzionist Sperimentale, Bologna, Italy	University of Bologna	Milani, L (corresponding author), Univ Bologna, Dept Biol Evoluzionist Sperimentale, Bologna, Italy.	liliana.milani@unibo.it	Passamonti, Marco/J-7502-2012; Milani, Liliana/B-7063-2015; Ghiselli, Fabrizio/D-2260-2010	Milani, Liliana/0000-0001-5052-2075; Ghiselli, Fabrizio/0000-0002-1680-8616; Passamonti, Marco/0000-0002-6222-8225	University and Research Italian Ministry (MIUR PRIN07) [2007NSHJL8_002]; University of Bologna, [A.31.CANZELSEW]	University and Research Italian Ministry (MIUR PRIN07)(Ministry of Education, Universities and Research (MIUR)); University of Bologna,	This work was supported by the University and Research Italian Ministry (MIUR PRIN07, grant number 2007NSHJL8_002 to MP) and the "Canziani Bequest'' fund (University of Bologna, grant number A.31.CANZELSEW to MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amikura R, 2005, MECH DEVELOP, V122, P1087, DOI 10.1016/j.mod.2005.06.003; Amikura R, 2001, P NATL ACAD SCI USA, V98, P9133, DOI 10.1073/pnas.171286998; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Becalska AN, 2010, DEV BIOL, V340, P528, DOI 10.1016/j.ydbio.2010.02.006; BIELIAVSKY N, 1990, J SUBMICR CYTOL PATH, V22, P445; Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014; Breton S, 2007, TRENDS GENET, V23, P465, DOI 10.1016/j.tig.2007.05.011; Breton S, 2011, MOL BIOL EVOL, V28, P1645, DOI 10.1093/molbev/msq345; Cai S, 2010, CURR BIOL, V20, P880, DOI 10.1016/j.cub.2010.03.067; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Cao LQ, 2004, GENETICS, V166, P883, DOI 10.1534/genetics.166.2.883; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Chuma S, 2009, MOL CELL ENDOCRINOL, V306, P17, DOI 10.1016/j.mce.2008.11.009; Cogswell AT, 2006, GENOME, V49, P799, DOI 10.1139/G06-036; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Davison A, 2006, BIOESSAYS, V28, P642, DOI 10.1002/bies.20424; Devauchelle N, 1990, TAPES PHILIPPINARUM; DING D, 1994, DEV BIOL, V163, P503, DOI 10.1006/dbio.1994.1166; Doucet-Beaupre H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-50; Ebbert Mercedes Ann, 1993, P150; EDDY EM, 1975, INT REV CYTOL, V43, P229; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V320, P592, DOI 10.1016/j.bbrc.2004.06.009; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V315, P897, DOI 10.1016/j.bbrc.2004.01.145; Ghiselli F, 2012, MOL BIOL EVOL, V29, P771, DOI 10.1093/molbev/msr248; Ghiselli F, 2011, MOL BIOL EVOL, V28, P949, DOI 10.1093/molbev/msq271; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gustafson EA, 2010, BIOESSAYS, V32, P626, DOI 10.1002/bies.201000001; HAY B, 1988, DEVELOPMENT, V103, P625; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Hejnol A, 2010, INTEGR COMP BIOL, V50, P695, DOI 10.1093/icb/icq103; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hurst CDD, 1997, INFLUENTIAL PASSENGERS, P125; Iida T, 1998, P NATL ACAD SCI USA, V95, P11274, DOI 10.1073/pnas.95.19.11274; Ikenishi K, 1998, DEV GROWTH DIFFER, V40, P1; ILLMENSEE K, 1976, DEV BIOL, V49, P40, DOI 10.1016/0012-1606(76)90257-8; ISAEVA VV, 2001, RUSS J MAR BIOL, V27, pS8, DOI DOI 10.1023/A:1013842820458; Kakoi S, 2008, ZOOL SCI, V25, P455, DOI 10.2108/zsj.25.455; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Katayama M, 2006, DEV BIOL, V299, P206, DOI 10.1016/j.ydbio.2006.07.022; Kenchington E, 2002, GENETICS, V161, P1579; Kloc M, 2004, CURR TOP DEV BIOL, V59, P1, DOI 10.1016/S0070-2153(04)59001-4; Kloc M, 2005, J CELL SCI, V118, P269, DOI 10.1242/jcs.01637; Kloc M, 2001, INT REV CYTOL, V203, P63; Kloc M, 1998, MECH DEVELOP, V75, P81, DOI 10.1016/S0925-4773(98)00086-0; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Kobayashi S, 1998, CURR BIOL, V8, P1117, DOI 10.1016/S0960-9822(98)70466-X; KOBAYASHI S, 1993, SCIENCE, V260, P1521, DOI 10.1126/science.7684857; Kobayashi T, 2000, MECH DEVELOP, V99, P139, DOI 10.1016/S0925-4773(00)00464-0; Kogo N, 2011, DEV BIOL, V349, P462, DOI 10.1016/j.ydbio.2010.11.021; KOMIYA T, 1994, DEV BIOL, V162, P354, DOI 10.1006/dbio.1994.1093; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Kranz AM, 2010, J EXP ZOOL PART B, V314, P1; Kuznicki KA, 2000, DEVELOPMENT, V127, P2907; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Lerit DA, 2011, CURR BIOL, V21, P439, DOI 10.1016/j.cub.2011.01.073; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Matova N, 2001, DEV BIOL, V231, P291, DOI 10.1006/dbio.2000.0120; Maurizii MG, 2009, DEV GENES EVOL, V219, P361, DOI 10.1007/s00427-009-0295-7; MIGNOTTE F, 1987, BIOL CELL, V60, P97, DOI 10.1111/j.1768-322X.1987.tb00549.x; Milani L, J EXP ZOO B IN PRESS; Mochizuki K, 2001, DEV GENES EVOL, V211, P299, DOI 10.1007/s004270100156; Nakao H, 1999, DEV GENES EVOL, V209, P312, DOI 10.1007/s004270050257; Negri H, 2009, P ROY SOC B-BIOL SCI, V276, P2485, DOI 10.1098/rspb.2009.0324; Notredame C, 2003, BIOINFORMATICS AND GENOMES: CURRENT PERSPECTIVES, P27; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Obata M, 2005, DEV GROWTH DIFFER, V47, P255; Obata M, 2010, DEV GENES EVOL, V220, P139, DOI 10.1007/s00427-010-0335-3; Ogawa M, 1999, ZOOL SCI, V16, P445, DOI 10.2108/zsj.16.445; Parvinen M, 2005, INT J ANDROL, V28, P189, DOI 10.1111/j.1365-2605.2005.00542.x; Passamonti M, 2009, DNA CELL BIOL, V28, P79, DOI 10.1089/dna.2008.0807; Paweletz N, 2001, NAT REV MOL CELL BIO, V2, P72, DOI 10.1038/35048077; Peruquetti RL, 2011, MICRON, V42, P87, DOI 10.1016/j.micron.2010.07.009; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Raz E, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Reunov A, 2000, DEV GROWTH DIFFER, V42, P139; Reunov A, 2006, ZYGOTE, V14, P231, DOI 10.1017/S0967199406003789; Rongo C, 1996, TRENDS GENET, V12, P102, DOI 10.1016/0168-9525(96)81421-1; RUSSELL L, 1978, ANAT REC, V190, P79, DOI 10.1002/ar.1091900108; Saavedra C, 1997, GENETICS, V145, P1073; Saffman EE, 1999, CELL MOL LIFE SCI, V55, P1141, DOI 10.1007/s000180050363; Shang P, 2010, J CELL SCI, V123, P331, DOI 10.1242/jcs.059949; Shitara H, 1998, GENETICS, V148, P851; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Smiraglia DJ, 2008, CANCER BIOL THER, V7, P1182, DOI 10.4161/cbt.7.8.6215; SODERSTROM KO, 1976, CELL TISSUE RES, V168, P335, DOI 10.1007/BF00215311; Sutherland B, 1998, GENETICS, V148, P341; Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582; Sutovsky P, 1996, BIOL REPROD, V55, P1195, DOI 10.1095/biolreprod55.6.1195; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Swartz SZ, 2008, DEV GENES EVOL, V218, P107, DOI 10.1007/s00427-008-0203-6; Theologidis I, 2008, EVOLUTION, V62, P959, DOI 10.1111/j.1558-5646.2008.00329.x; TOURTE M, 1984, EUR J CELL BIOL, V34, P171; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; Tyler SEB, 2006, INT J DEV BIOL, V50, P405, DOI 10.1387/ijdb.052007st; Venetis C, 2006, P R SOC B, V273, P2483, DOI 10.1098/rspb.2006.3607; Volodina N, 2003, DEV DYNAM, V226, P654, DOI 10.1002/dvdy.10275; Williamson A, 1996, ANNU REV CELL DEV BI, V12, P365, DOI 10.1146/annurev.cellbio.12.1.365; Woods FH, 1931, J MORPHOL PHYSIOL, V51, P545, DOI 10.1002/jmor.1050510208; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Zhang YZ, 2008, DEV GROWTH DIFFER, V50, P189, DOI [10.1111/j.1440-169X.2008.00988.x, 10.1111/j.1440-169x.2008.00988.x]; Zhou RR, 2010, CURR GENET, V56, P101, DOI 10.1007/s00294-010-0291-5	108	46	46	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28194	10.1371/journal.pone.0028194	http://dx.doi.org/10.1371/journal.pone.0028194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140544	Green Published, Green Submitted, gold			2022-12-25	WOS:000298166300037
J	Donaire, L; Pedrola, L; de la Rosa, R; Llave, C				Donaire, Livia; Pedrola, Laia; de la Rosa, Raul; Llave, Cesar			High-Throughput Sequencing of RNA Silencing-Associated Small RNAs in Olive (Olea europaea L.)	PLOS ONE			English	Article							TRANS-ACTING SIRNAS; STRESS-RESPONSIVE MICRORNAS; PLANT MICRORNAS; ARABIDOPSIS-THALIANA; POPULUS-TRICHOCARPA; DNA METHYLATION; JUVENILE PERIOD; LAND PLANTS; MIRNA GENES; TARGETS	Small RNAs (sRNAs) of 20 to 25 nucleotides (nt) in length maintain genome integrity and control gene expression in a multitude of developmental and physiological processes. Despite RNA silencing has been primarily studied in model plants, the advent of high-throughput sequencing technologies has enabled profiling of the sRNA component of more than 40 plant species. Here, we used deep sequencing and molecular methods to report the first inventory of sRNAs in olive (Olea europaea L.). sRNA libraries prepared from juvenile and adult shoots revealed that the 24-nt class dominates the sRNA transcriptome and atypically accumulates to levels never seen in other plant species, suggesting an active role of heterochromatin silencing in the maintenance and integrity of its large genome. A total of 18 known miRNA families were identified in the libraries. Also, 5 other sRNAs derived from potential hairpin-like precursors remain as plausible miRNA candidates. RNA blots confirmed miRNA expression and suggested tissue-and/or developmental-specific expression patterns. Target mRNAs of conserved miRNAs were computationally predicted among the olive cDNA collection and experimentally validated through endonucleolytic cleavage assays. Finally, we use expression data to uncover genetic components of the miR156, miR172 and miR390/TAS3-derived trans-acting small interfering RNA (tasiRNA) regulatory nodes, suggesting that these interactive networks controlling developmental transitions are fully operational in olive.	[Donaire, Livia; Llave, Cesar] Spanish Natl Res Council, Dept Environm Biol, Ctr Invest Biol, Madrid, Spain; [Pedrola, Laia] Parc Cient Univ Valencia, Lifesequencing SL, Valencia, Spain; [de la Rosa, Raul] IFAPA, Ctr Alameda Obispo, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Donaire, L (corresponding author), Spanish Natl Res Council, Dept Environm Biol, Ctr Invest Biol, Madrid, Spain.	cesarllave@cib.csic.es	De la Rosa, Raul/AIB-1463-2022; De la Rosa, Raul/B-5755-2008; Donaire, Livia/W-3541-2017; Llave, Cesar/ABF-5827-2021	De la Rosa, Raul/0000-0002-0752-9607; De la Rosa, Raul/0000-0002-0752-9607; Donaire, Livia/0000-0002-5454-2994; Pedrola, Laia/0000-0002-3031-6124	GENOMA ESPANA (Spain)	GENOMA ESPANA (Spain)	This work is part of the OLEAGEN research project that was funded by GENOMA ESPANA (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Baldoni L, 2006, ANN BOT-LONDON, V98, P935, DOI 10.1093/aob/mcl178; Barakat Abdelali, 2007, BMC Genomics, V8, P481, DOI 10.1186/1471-2164-8-481; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; De la Rosa R, 2006, AUST J AGR RES, V57, P477, DOI 10.1071/AR05219; de la Rosa R, 2003, THEOR APPL GENET, V106, P1273, DOI 10.1007/s00122-002-1189-5; Dolgosheina EV, 2008, RNA, V14, P1508, DOI 10.1261/rna.1052008; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Fahlgren N, 2009, RNA, V15, P992, DOI 10.1261/rna.1473809; Garcia D, 2006, CURR BIOL, V16, P933, DOI 10.1016/j.cub.2006.03.064; Gonzalez-Ibeas D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-393; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Jay F, 2010, METHODS MOL BIOL, V592, P183, DOI 10.1007/978-1-60327-005-2_13; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Llave C, 2011, METHODS MOL BIOL, V732, P187, DOI 10.1007/978-1-61779-083-6_14; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; MacLean D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009901; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Martinez-Priego L, 2008, VIROLOGY, V376, P346, DOI 10.1016/j.virol.2008.03.024; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Mica E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-558; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Moreno-Alias I, 2009, TREES-STRUCT FUNCT, V23, P181, DOI 10.1007/s00468-008-0266-z; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Pantaleo V, 2010, VIROLOGY, V408, P49, DOI 10.1016/j.virol.2010.09.001; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.0960-7412.2010.04208.x, 10.1111/j.1365-313X.2010.04208.x]; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; Qiu DY, 2009, GENE, V436, P37, DOI 10.1016/j.gene.2009.01.006; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rubio-Somoza I, 2011, TRENDS PLANT SCI, V16, P258, DOI 10.1016/j.tplants.2011.03.001; Rubio-Somoza I, 2009, CURR OPIN PLANT BIOL, V12, P622, DOI 10.1016/j.pbi.2009.07.003; Santos-Antunes F, 2005, HORTSCIENCE, V40, P1213, DOI 10.21273/HORTSCI.40.5.1213; Shen D, 2009, PLANT SYST EVOL, V283, P125, DOI 10.1007/s00606-009-0221-5; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sunkar R, 2005, NUCLEIC ACIDS RES, V33, P4443, DOI 10.1093/nar/gki758; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; TOUS J, 2005, VARIEDADES OLIVO CUL; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Yakovlev IA, 2010, NEW PHYTOL, V187, P1154, DOI 10.1111/j.1469-8137.2010.03341.x; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	84	49	53	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27916	10.1371/journal.pone.0027916	http://dx.doi.org/10.1371/journal.pone.0027916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140484	Green Submitted, Green Published, gold			2022-12-25	WOS:000298163400022
J	Opina, ACL; Ghaghada, KB; Zhao, PY; Kiefer, G; Annapragada, A; Sherry, AD				Opina, Ana Christina L.; Ghaghada, Ketan B.; Zhao, Piyu; Kiefer, Garry; Annapragada, Ananth; Sherry, A. Dean			TmDOTA-Tetraglycinate Encapsulated Liposomes as pH-Sensitive LipoCEST Agents	PLOS ONE			English	Article							NUCLEAR MAGNETIC-RESONANCE; SATURATION-TRANSFER CEST; CONTRAST AGENTS; LANTHANIDE(III) COMPLEXES; CHOLESTEROL CONTENT; IN-VIVO; EXCHANGE; INVIVO; PERMEABILITY; STABILITY	Lanthanide DOTA-tetraglycinate (LnDOTA-(gly)(4)(-)) complexes contain four magnetically equivalent amide protons that exchange with protons of bulk water. The rate of this base catalyzed exchange process has been measured using chemical exchange saturation transfer (CEST) NMR techniques as a function of solution pH for various paramagnetic LnDOTA-(gly)(4)(-) complexes to evaluate the effects of lanthanide ion size on this process. Complexes with Tb(III), Dy(III), Tm(III) and Yb(III) were chosen because these ions induce large hyperfine shifts in all ligand protons, including the exchanging amide protons. The magnitude of the amide proton CEST exchange signal differed for the four paramagnetic complexes in order, Yb>Tm>Tb>Dy. Although the Dy(III) complex showed the largest hyperfine shift as expected, the combination of favorable chemical shift and amide proton CEST linewidth in the Tm(III) complex was deemed most favorable for future in vivo applications where tissue magnetization effects can interfere. TmDOTA-(gly)(4)(-) at various concentrations was encapsulated in the core interior of liposomes to yield lipoCEST particles for molecular imaging. The resulting nanoparticles showed less than 1% leakage of the agent from the interior over a range of temperatures and pH. The pH versus amide proton CEST curves differed for the free versus encapsulated agents over the acidic pH regions, consistent with a lower proton permeability across the liposomal bilayer for the encapsulated agent. Nevertheless, the resulting lipoCEST nanoparticles amplify the CEST sensitivity by a factor of similar to 10(4) compared to the free, un-encapsulated agent. Such pH sensitive nano-probes could prove useful for pH mapping of liposomes targeted to tumors.	[Opina, Ana Christina L.; Zhao, Piyu; Kiefer, Garry; Sherry, A. Dean] Univ Texas Dallas, Dept Chem, Richardson, TX 75083 USA; [Ghaghada, Ketan B.; Annapragada, Ananth] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX USA; [Sherry, A. Dean] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Southwestern Medical Center Dallas	Opina, ACL (corresponding author), Univ Texas Dallas, Dept Chem, Richardson, TX 75083 USA.	sherry@utdallas.edu	Ghaghada, Ketan/F-6825-2012; Annapragada, Ananth/GOK-1576-2022; Sherry, Dean/P-2348-2018	Sherry, Dean/0000-0001-7150-8301; Annapragada, Ananth/0000-0002-3156-9617	National Institutes of Health [RR-02584, EB-004582, CA-115531]; Robert A. Welch Foundation [AT-584]; NATIONAL CANCER INSTITUTE [U24CA126608, R01CA115531] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB004582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was provided by the National Institutes of Health (RR-02584, EB-004582, and CA-115531) and the Robert A. Welch Foundation (AT-584). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime S, 2005, ANGEW CHEM INT EDIT, V44, P5513, DOI 10.1002/anie.200501473; Aime S, 1998, ANGEW CHEM INT EDIT, V37, P2673, DOI 10.1002/(SICI)1521-3773(19981016)37:19<2673::AID-ANIE2673>3.0.CO;2-#; Aime S, 2002, ANGEW CHEM INT EDIT, V41, P4334, DOI 10.1002/1521-3773(20021115)41:22<4334::AID-ANIE4334>3.0.CO;2-1; Aime S, 2002, MAGN RESON MED, V47, P639, DOI 10.1002/mrm.10106; ALLEN TM, 1994, TRENDS PHARMACOL SCI, V15, P215, DOI 10.1016/0165-6147(94)90314-X; Ayyagari AL, 2006, MAGN RESON MED, V55, P1023, DOI 10.1002/mrm.20846; Baranyai Z, 2005, HELV CHIM ACTA, V88, P604, DOI 10.1002/hlca.200590042; Baranyai Z, 2007, EUR J INORG CHEM, P3639, DOI 10.1002/ejic.200700178; BLEANEY B, 1972, J MAGN RESON, V8, P91, DOI 10.1016/0022-2364(72)90027-3; DEGIER J, 1968, BIOCHIM BIOPHYS ACTA, V150, P666, DOI 10.1016/0005-2736(68)90056-4; ENG J, 1991, MAGNET RESON MED, V17, P304, DOI 10.1002/mrm.1910170203; Ghaghada KB, 2007, AM J NEURORADIOL, V28, P48; GREGORIADIS G, 1979, BIOCHEM BIOPH RES CO, V89, P1287, DOI 10.1016/0006-291X(79)92148-X; KIRBY C, 1980, BIOCHEM J, V186, P591, DOI 10.1042/bj1860591; KLIBANOV AL, 1990, FEBS LETT, V268, P235, DOI 10.1016/0014-5793(90)81016-H; LAUFFER RB, 1987, CHEM REV, V87, P901, DOI 10.1021/cr00081a003; MASSARI S, 1991, BIOCHIM BIOPHYS ACTA, V1067, P131, DOI 10.1016/0005-2736(91)90034-6; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; Sherry AD, 2009, J MAGN RESON IMAGING, V30, P1240, DOI 10.1002/jmri.21966; Terreno E, 2004, INVEST RADIOL, V39, P235, DOI 10.1097/01.rli.0000116607.26372.d0; Ward KM, 2000, MAGN RESON MED, V44, P799, DOI 10.1002/1522-2594(200011)44:5<799::AID-MRM18>3.0.CO;2-S; WOESSNER DE, 1961, J CHEM PHYS, V35, P41, DOI 10.1063/1.1731931; WOLFF SD, 1991, RADIOLOGY, V179, P133, DOI 10.1148/radiology.179.1.2006263; WOLFF SD, 1990, J MAGN RESON, V86, P164, DOI 10.1016/0022-2364(90)90220-4; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Zhang SR, 2001, J AM CHEM SOC, V123, P1517, DOI 10.1021/ja005820q; Zhao JM, 2008, J AM CHEM SOC, V130, P5178, DOI 10.1021/ja710159q; Zheng JZ, 2007, PHARM RES-DORDR, V24, P1193, DOI 10.1007/s11095-006-9220-1	28	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27370	10.1371/journal.pone.0027370	http://dx.doi.org/10.1371/journal.pone.0027370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140438	gold, Green Submitted, Green Published			2022-12-25	WOS:000298163400005
J	Walsh, S; Nygren, J; Ponten, A; Jovinge, S				Walsh, Stuart; Nygren, Jens; Ponten, Annica; Jovinge, Stefan			Myogenic Reprogramming of Bone Marrow Derived Cells in a W(41)Dmd(mdx) Deficient Mouse Model	PLOS ONE			English	Article							STEM-CELL; MUSCLE REGENERATION; MDX MICE; IN-VIVO; HEPATOCYTES; SKELETAL; TRANSPLANTATION; EXPRESSION; DEFECTS; FUSION	Lack of expression of dystrophin leads to degeneration of muscle fibers and infiltration of connective and adipose tissue. Cell transplantation therapy has been proposed as a treatment for intractable muscle degenerative disorders. Several reports have demonstrated the ability of bone-marrow derived cells (BMDC) to contribute to non-haematopoietic tissues including epithelium, heart, liver, skeletal muscle and brain following transplantation by means of fusion and reprogramming. A key issue is the extent to which fusion and reprogramming can occur in vivo, particularly under conditions of myogenic deterioration. To investigate the therapeutic potential of bone marrow transplantation in monogenetic myopathy, green fluorescent protein-positive (GFP(+)) bone marrow cells were transplanted into non-irradiated c-kit receptor - deficient (W-41) mdx mice. This model allows BMDC reconstitution in the absence of irradiation induced myeloablation. We provide the first report of BMDC fusion in a W-41/Dmd(mdx) deficient mouse model. In the absence of irradiation induced injury, few GFP(+) cardiomyocytes and muscle fibres were detected 24 weeks post BMT. It was expected that the frequency of fusion in the hearts of W(41)Dmd(mdx) mice would be similar to frequencies observed in infarcted mice [1]. Although, it is clear from this study that individual cardiomyocytes with monogenetic deficiencies can be rescued by fusion, it is as clear that in the absence of irradiation, the formation of stable and reprogrammed fusion hybrids occurs, with the current techniques, at very low levels in non-irradiated recipients.	[Walsh, Stuart; Ponten, Annica; Jovinge, Stefan] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Lund, Sweden; [Nygren, Jens] Lund Univ, Immunol Unit, Expt Med Res Inst, Lund, Sweden; [Nygren, Jens] Halmstad Univ, Ctr Res Welf Hlth & Sport, Halmstad, Sweden; [Jovinge, Stefan] Univ Lund Hosp, Dept Cardiol, S-22185 Lund, Sweden	Lund University; Lund University; Halmstad University; Lund University; Skane University Hospital	Walsh, S (corresponding author), Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Lund, Sweden.	stefan.jovinge@med.lu.se		Nygren, Jens M/0000-0002-3576-2393	Swedish Foundation for Strategic Research [A3 02:094]; Swedish Research Council [K2010-65X-21408-01-3]; Swedish heart-Lung Foundation [20080850]; Juvenile Diabetes Research Foundation [529-2005-8327]; European Comission [223372]	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish heart-Lung Foundation(Swedish Heart-Lung Foundation); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Comission(European CommissionEuropean Commission Joint Research Centre)	Funding provided by the Center of Excellence grant from the Swedish Foundation for Strategic Research grant number A3 02:094, The Swedish Research Council grant number K2010-65X-21408-01-3, The Swedish heart-Lung Foundation grant number 20080850, The Juvenile Diabetes Research Foundation grant number 529-2005-8327 and the European Comission FP7 Grant 223372 CardioCell Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Amalfitano A, 1996, MUSCLE NERVE, V19, P1549, DOI 10.1002/(SICI)1097-4598(199612)19:12<1549::AID-MUS4>3.0.CO;2-A; Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237; Brazelton TR, 2003, DEV BIOL, V262, P64, DOI 10.1016/S0012-1606(03)00357-9; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Dreyfus PA, 2004, AM J PATHOL, V164, P773, DOI 10.1016/S0002-9440(10)63165-3; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fukada S, 2002, J CELL SCI, V115, P1285; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; LAW DJ, 1993, AM J PATHOL, V142, P1513; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Wang X, 2002, AM J PATHOL, V161, P565, DOI 10.1016/S0002-9440(10)64212-5	21	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27500	10.1371/journal.pone.0027500	http://dx.doi.org/10.1371/journal.pone.0027500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140444	Green Published, gold			2022-12-25	WOS:000298163400007
J	Kasprick, DS; Kish, PE; Junttila, TL; Ward, LA; Bohnsack, BL; Kahana, A				Kasprick, Daniel S.; Kish, Phillip E.; Junttila, Tyler L.; Ward, Lindsay A.; Bohnsack, Brenda L.; Kahana, Alon			Microanatomy of Adult Zebrafish Extraocular Muscles	PLOS ONE			English	Article							NEUROMUSCULAR-JUNCTIONS; FINE STRUCTURE; THROMBOSPONDIN-4; INNERVATION; GENE; MICE; FORM	Binocular vision requires intricate control of eye movement to align overlapping visual fields for fusion in the visual cortex, and each eye is controlled by 6 extraocular muscles (EOMs). Disorders of EOMs are an important cause of symptomatic vision loss. Importantly, EOMs represent specialized skeletal muscles with distinct gene expression profile and susceptibility to neuromuscular disorders. We aim to investigate and describe the anatomy of adult zebrafish extraocular muscles (EOMs) to enable comparison with human EOM anatomy and facilitate the use of zebrafish as a model for EOM research. Using differential interference contrast (DIC), epifluorescence microscopy, and precise sectioning techniques, we evaluate the anatomy of zebrafish EOM origin, muscle course, and insertion on the eye. Immunofluorescence is used to identify components of tendons, basement membrane and neuromuscular junctions (NMJs), and to analyze myofiber characteristics. We find that adult zebrafish EOM insertions on the globe parallel the organization of human EOMs, including the close proximity of specific EOM insertions to one another. However, analysis of EOM origins reveals important differences between human and zebrafish, such as the common rostral origin of both oblique muscles and the caudal origin of the lateral rectus muscles. Thrombospondin 4 marks the EOM tendons in regions that are highly innervated, and laminin marks the basement membrane, enabling evaluation of myofiber size and distribution. The NMJs appear to include both en plaque and en grappe synapses, while NMJ density is much higher in EOMs than in somatic muscles. In conclusion, zebrafish and human EOM anatomy are generally homologous, supporting the use of zebrafish for studying EOM biology. However, anatomic differences exist, revealing divergent evolutionary pressures.	[Kasprick, Daniel S.; Kish, Phillip E.; Junttila, Tyler L.; Ward, Lindsay A.; Bohnsack, Brenda L.; Kahana, Alon] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kasprick, DS (corresponding author), Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	akahana@med.umich.edu	Kish, Phil E/H-6051-2011	Kish, Phillip/0000-0002-1992-3310; Bohnsack, Brenda/0000-0001-8961-6343; Kahana, Alon/0000-0002-5667-2274	Fight for Sight Student Award; Research to Prevent Blindness; National Eye Institute of the National Institutes of Health [K08 EY018689]; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan [P30 EY007003]; National Health Institute-National Center for Research resources [P40 RR012546]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K08EY018689, P30EY007003] Funding Source: NIH RePORTER	Fight for Sight Student Award; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan; National Health Institute-National Center for Research resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by a Fight for Sight Student Award (DSK), Research to Prevent Blindness Career Development Award (AK), Alliance for Vision Research (AK), grant K08 EY018689 (AK) from the National Eye Institute of the National Institutes of Health and a Vision Research Core Award P30 EY007003 to the Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan. The Zebrafish International Resource Center is supported by grant P40 RR012546 from the National Health Institute-National Center for Research resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBER S, 1995, J CELL BIOL, V131, P1083, DOI 10.1083/jcb.131.4.1083; Bohnsack BL, 2011, ARCH OPHTHALMOL; Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; COULY GF, 1992, DEVELOPMENT, V114, P1; Easter SS, 1996, DEV BIOL, V180, P646; Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gullberg G, 1999, CELL MOL LIFE SCI, V56, P442, DOI 10.1007/PL00000616; Harrison AR, 2007, INVEST OPHTH VIS SCI, V48, P3594, DOI 10.1167/iovs.06-1239; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Jaggi GP, 2005, INVEST OPHTH VIS SCI, V46, P2258, DOI 10.1167/iovs.04-1164; Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999; Khanna S, 2004, INVEST OPHTH VIS SCI, V45, P3055, DOI 10.1167/iovs.03-1385; Khanna S, 2003, FASEB J, V17, P1370, DOI 10.1096/fj.02-1108fje; Kjellgren D, 2004, INVEST OPHTH VIS SCI, V45, P4233, DOI 10.1167/iovs.04-0456; KUPFER C, 1960, J PHYSIOL-LONDON, V153, P522, DOI 10.1113/jphysiol.1960.sp006552; Lampe PD, 1998, J CELL BIOL, V143, P1735, DOI 10.1083/jcb.143.6.1735; Newton G, 1999, MAMM GENOME, V10, P1010, DOI 10.1007/s003359901149; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Oh SY, 2001, INVEST OPHTH VIS SCI, V42, P17; Porter JD, 2001, P NATL ACAD SCI USA, V98, P12062, DOI 10.1073/pnas.211257298; PORTER JD, 1995, SURV OPHTHALMOL, V39, P451, DOI 10.1016/S0039-6257(05)80055-4; SADEH M, 1984, J NEUROL SCI, V66, P295, DOI 10.1016/0022-510X(84)90018-2; SAKIMOTO T, 1970, INVEST OPHTH VISUAL, V9, P316; Schilling TF, 1996, DEVELOPMENT, V122, P1417; Spencer R F, 1988, Rev Oculomot Res, V2, P33; ZACKS SI, 1962, J NEUROPATH EXP NEUR, V21, P335, DOI 10.1097/00005072-196207000-00001	29	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27095	10.1371/journal.pone.0027095	http://dx.doi.org/10.1371/journal.pone.0027095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132088	Green Submitted, gold, Green Published			2022-12-25	WOS:000298162000010
J	Wu, S; Koizumi, K; MacRae-Crerar, A; Gallagher, KL				Wu, Shuang; Koizumi, Koji; MacRae-Crerar, Aurora; Gallagher, Kimberly L.			Assessing the Utility of Photoswitchable Fluorescent Proteins for Tracking Intercellular Protein Movement in the Arabidopsis Root	PLOS ONE			English	Article							EPIDERMAL-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MARKER; CAPRICE; PLANTS; EOSFP; LOCALIZATION; ACTIN; SHR	One way in which cells communicate is through the direct transfer of proteins. In plants, many of these proteins are transcription factors, which are made by one cell type and traffic into another. In order to understand how this movement occurs and its role in development, we would like to track this movement in live, intact plants in real-time. Here we examine the utility of the photoconvertible proteins, Dendra2 and (to a lesser extent) EosFP as tags for studying intracellular and intercellular protein movement in the Arabidopsis root. To this end, we made fusions between Dendra2 and six mobile transcription factors. Our results show that Dendra2 is an effective tool for studying protein movement between plant cells. Interestingly, we found that Dendra2 could not simply be swapped into existing constructs that had originally contained GFP. Most of the fusions made in this way failed to produce a fluorescent fusion. In addition we found that the optimal settings for photoconversion of Dendra2 in stably transformed roots were different from what has been published for photoconversion in transient assays in plants or in animal cells. By modifying the confocal setting, we were able to photoconvert Dendra2 in all cell layers in the root. However the efficiency of photoconversion was affected by the position of the cell layer within the root, with more internal tissues requiring more energy. By examining the Dendra2 fusions, we confirmed the mobility of the SHORT-ROOT (SHR) and CAPRICE (CPC) transcription factors between cells and we further discovered that SHR movement in stele and CPC movement in the epidermis are non-directional.	[Wu, Shuang; Koizumi, Koji; MacRae-Crerar, Aurora; Gallagher, Kimberly L.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Wu, S (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	gallagkl@sas.upenn.edu	Wu, Shuang/M-1839-2013		University of Pennsylvania Research Foundation (URF); NSF [0920327]	University of Pennsylvania Research Foundation (URF); NSF(National Science Foundation (NSF))	This research was funded by a University of Pennsylvania Research Foundation (URF) grant and an NSF grant 0920327 awarded to K. L. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2011, J CELL MOL MED, V15, P1458, DOI 10.1111/j.1582-4934.2010.01008.x; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; BENFEY PN, 1989, SCIENCE, V244, P174, DOI 10.1126/science.244.4901.174; Bernhardt C, 2005, DEVELOPMENT, V132, P291, DOI 10.1242/dev.01565; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; DERRICK PM, 1992, PLANT CELL, V4, P1405, DOI 10.1105/tpc.4.11.1405; Deuschle K, 2006, PLANT CELL, V18, P2314, DOI 10.1105/tpc.106.044073; Gallagher KL, 2009, PLANT J, V57, P785, DOI 10.1111/j.1365-313X.2008.03735.x; Gallagher KL, 2004, CURR BIOL, V14, P1847, DOI 10.1016/j.cub.2004.09.081; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Koizumi K, 2011, CURR BIOL, V21, P1559, DOI 10.1016/j.cub.2011.08.013; Koshino-Kimura Y, 2005, PLANT CELL PHYSIOL, V46, P817, DOI 10.1093/pcp/pci096; Kurata T, 2005, DEVELOPMENT, V132, P5387, DOI 10.1242/dev.02139; Lee JY, 2011, TRENDS PLANT SCI, V16, P201, DOI 10.1016/j.tplants.2011.01.004; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Martin K, 2009, PLANT J, V59, P150, DOI 10.1111/j.1365-313X.2009.03850.x; Mathur J, 2010, PLANT PHYSIOL, V154, P1573, DOI 10.1104/pp.110.165431; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Nienhaus GU, 2006, PHOTOCHEM PHOTOBIOL, V82, P351, DOI 10.1562/2005-05-19-RA-533; Prochiantz A, 2011, METHODS MOL BIOL, V683, P249, DOI 10.1007/978-1-60761-919-2_18; Rausin G, 2010, PLANT PHYSIOL, V153, P273, DOI 10.1104/pp.110.154740; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Roslan HA, 2001, PLANT J, V28, P225, DOI 10.1046/j.1365-313X.2001.01146.x; Schenkel M, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-21; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Wada T, 2002, DEVELOPMENT, V129, P5409, DOI 10.1242/dev.00111; Welch D, 2007, GENE DEV, V21, P2196, DOI 10.1101/gad.440307; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wiedenmann J, 2006, EXPERT REV PROTEOMIC, V3, P361, DOI 10.1586/14789450.3.3.361; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Wu S, 2011, CURR OPIN PLANT BIOL, V14, P563, DOI 10.1016/j.pbi.2011.06.006	36	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27536	10.1371/journal.pone.0027536	http://dx.doi.org/10.1371/journal.pone.0027536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132108	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000024
J	Bhat, S; Zhu, X; Patel, RP; Orlando, R; Shimkets, LJ				Bhat, Swapna; Zhu, Xiang; Patel, Ricky P.; Orlando, Ron; Shimkets, Lawrence J.			Identification and Localization of Myxococcus xanthus Porins and Lipoproteins	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; FRUITING BODY MORPHOGENESIS; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; EXTRACELLULAR-MATRIX; CELL-INTERACTIONS; WEB SERVER; PREDICTION; SEQUENCE; SIGNAL	Myxococcus xanthus DK1622 contains inner (IM) and outer membranes (OM) separated by a peptidoglycan layer. Integral membrane, beta-barrel proteins are found exclusively in the OM where they form pores allowing the passage of nutrients, waste products and signals. One porin, Oar, is required for intercellular communication of the C-signal. An oar mutant produces CsgA but is unable to ripple or stimulate csgA mutants to develop suggesting that it is the channel for C-signaling. Six prediction programs were evaluated for their ability to identify beta-barrel proteins. No program was reliable unless the predicted proteins were first parsed using Signal P, Lipo P and TMHMM, after which TMBETA-SVM and TMBETADISC-RBF identified beta-barrel proteins most accurately. 228 beta-barrel proteins were predicted from among 7331 protein coding regions, representing 3.1% of total genes. Sucrose density gradients were used to separate vegetative cell IM and OM fractions, and LC-MS/MS of OM proteins identified 54 beta-barrel proteins. Another class of membrane proteins, the lipoproteins, are anchored in the membrane via a lipid moiety at the N-terminus. 44 OM proteins identified by LC-MS/MS were predicted lipoproteins. Lipoproteins are distributed between the IM, OM and ECM according to an N-terminal sorting sequence that varies among species. Sequence analysis revealed conservation of alanine at the +7 position of mature ECM lipoproteins, lysine at the +2 position of IM lipoproteins, and no noticable conservation within the OM lipoproteins. Site directed mutagenesis and immuno transmission electron microscopy showed that alanine at the +7 position is essential for sorting of the lipoprotein FibA into the ECM. FibA appears at normal levels in the ECM even when a +2 lysine is added to the signal sequence. These results suggest that ECM proteins have a unique method of secretion. It is now possible to target lipoproteins to specific IM, OM and ECM locations by manipulating the amino acid sequence near the +1 cysteine processing site.	[Bhat, Swapna; Patel, Ricky P.; Shimkets, Lawrence J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Zhu, Xiang; Orlando, Ron] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bhat, S (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	shimkets@uga.edu			National Science Foundation [MCB 0742976]	National Science Foundation(National Science Foundation (NSF))	This work was supported by research grant MCB 0742976 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avadhani M, 2006, J BACTERIOL, V188, P8543, DOI 10.1128/JB.01047-06; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; BEHMLANDER RM, 1991, J BACTERIOL, V173, P7810, DOI 10.1128/jb.173.24.7810-7820.1991; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berven FS, 2004, NUCLEIC ACIDS RES, V32, pW394, DOI 10.1093/nar/gkh351; Bos MP, 2007, EMBO REP, V8, P1149, DOI 10.1038/sj.embor.7401092; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Curtis PD, 2007, J BACTERIOL, V189, P7634, DOI 10.1128/JB.01007-07; DOWNARD J, 1993, J BACTERIOL, V175, P7762, DOI 10.1128/JB.175.24.7762-7770.1993; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Garrow AG, 2005, NUCLEIC ACIDS RES, V33, pW188, DOI 10.1093/nar/gki384; Graham RLJ, 2006, J PROTEOME RES, V5, P3145, DOI 10.1021/pr060293g; Gromiha MM, 2005, NUCLEIC ACIDS RES, V33, pW164, DOI 10.1093/nar/gki367; Gumbart J, 2007, BIOPHYS J, V93, P496, DOI 10.1529/biophysj.107.104158; HAGEN DC, 1978, DEV BIOL, V64, P284, DOI 10.1016/0012-1606(78)90079-9; HANCOCK REW, 1978, J BACTERIOL, V136, P381, DOI 10.1128/JB.136.1.381-390.1978; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Johnson JM, 1999, J MOL BIOL, V287, P695, DOI 10.1006/jmbi.1999.2630; Kahnt J, 2010, J PROTEOME RES, V9, P5197, DOI 10.1021/pr1004983; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kearns DB, 2002, J BACTERIOL, V184, P1678, DOI 10.1128/JB.184.6.1678-1684.2002; KIM SK, 1990, SCIENCE, V249, P926, DOI 10.1126/science.2118274; KIM SK, 1990, GENE DEV, V4, P896, DOI 10.1101/gad.4.6.896; KOSKI P, 1990, GENE, V88, P117; Kruse T, 2001, MOL MICROBIOL, V40, P156, DOI 10.1046/j.1365-2958.2001.02365.x; KUNER JM, 1982, J BACTERIOL, V151, P458, DOI 10.1128/JB.151.1.458-461.1982; Letain TE, 1997, MOL MICROBIOL, V24, P271, DOI 10.1046/j.1365-2958.1997.3331703.x; MARTINEZCANAMERO M, 1993, J BACTERIOL, V175, P4756, DOI 10.1128/JB.175.15.4756-4763.1993; Masuda K, 2002, P NATL ACAD SCI USA, V99, P7390, DOI 10.1073/pnas.112085599; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Ou YY, 2008, COMPUT BIOL CHEM, V32, P227, DOI 10.1016/j.compbiolchem.2008.03.002; Park KJ, 2005, BIOINFORMATICS, V21, P4223, DOI 10.1093/bioinformatics/bti697; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; POQUET I, 1993, MOL MICROBIOL, V9, P1061, DOI 10.1111/j.1365-2958.1993.tb01235.x; Postle K, 2007, METHOD ENZYMOL, V422, P245, DOI 10.1016/S0076-6879(06)22012-3; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Punta M, 2007, METHODS, V41, P460, DOI 10.1016/j.ymeth.2006.07.026; REIZER J, 1993, CRIT REV BIOCHEM MOL, V28, P235, DOI 10.3109/10409239309086796; Seydel A, 1999, MOL MICROBIOL, V34, P810, DOI 10.1046/j.1365-2958.1999.01647.x; SHIMKETS LJ, 1982, J BACTERIOL, V152, P451; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; SHIMKETS LJ, 1983, P NATL ACAD SCI-BIOL, V80, P1406, DOI 10.1073/pnas.80.5.1406; Simunovic V, 2003, J BACTERIOL, V185, P5066, DOI 10.1128/JB.185.17.5066-5075.2003; TANAKA SY, 2007, J BIOL CHEM, V282; TOAL DR, 1995, MOL MICROBIOL, V16, P177, DOI 10.1111/j.1365-2958.1995.tb02291.x; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; van den Berg B, 2005, CURR OPIN STRUC BIOL, V15, P401, DOI 10.1016/j.sbi.2005.06.003; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wu SS, 1997, J BACTERIOL, V179, P7748, DOI 10.1128/jb.179.24.7748-7758.1997; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhao JY, 2008, APPL ENVIRON MICROB, V74, P1980, DOI 10.1128/AEM.02143-07	56	41	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27475	10.1371/journal.pone.0027475	http://dx.doi.org/10.1371/journal.pone.0027475			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132103	Green Submitted, gold, Green Published			2022-12-25	WOS:000297792400007
J	Pang, RTK; Liu, WM; Leung, CON; Ye, TM; Kwan, PCK; Lee, KF; Yeung, WSB				Pang, Ronald T. K.; Liu, Wei-Min; Leung, Carmen O. N.; Ye, Tian-Min; Kwan, Peter C. K.; Lee, Kai-Fai; Yeung, William S. B.			miR-135A Regulates Preimplantation Embryo Development through Down-Regulation of E3 Ubiquitin Ligase Seven in Absentia Homolog 1A (SIAH1A) Expression	PLOS ONE			English	Article							MICRORNA EXPRESSION; PROTEASOME PATHWAY; CELL-DEATH; OOCYTE; DEGRADATION; PROTEINS; ACTIVATION; INTERACTS; RNAS; IDENTIFICATION	Background: MicroRNAs (miRNAs) are small non-coding RNA molecules capable of regulating transcription and translation. Previously, a cluster of miRNAs that are specifically expressed in mouse zygotes but not in oocytes or other preimplantation stages embryos are identified by multiplex real-time polymerase chain reaction-based miRNA profiling. The functional role of one of these zygote-specific miRNAs, miR-135a, in preimplantation embryo development was investigated. Methodology/Principal Findings: Microinjection of miR-135a inhibitor suppressed first cell cleavage in more than 30% of the zygotes. Bioinformatics analysis identified E3 Ubiquitin Ligase Seven In Absentia Homolog 1A (Siah1a) as a predicted target of miR-135a. Western blotting and 3'UTR luciferase functional assays demonstrated that miR-135a down-regulated the expression of Siah1 in HeLa cells and in mouse zygotes. Siah1a was expressed in preimplantation embryos and its expression pattern negatively correlated with that of miR-135a. Co-injection of Siah1a-specific antibody with miR-135a inhibitor partially nullified the effect of miR-135a inhibition. Proteasome inhibition by MG-132 revealed that miR-135a regulated proteasomal degradation and potentially controlled the expression of chemokinesin DNA binding protein (Kid). Conclusions/Significance: The present study demonstrated for the first time that zygotic specific miRNA modulates the first cell cleavage through regulating expression of Siah1a.	[Pang, Ronald T. K.; Liu, Wei-Min; Leung, Carmen O. N.; Ye, Tian-Min; Kwan, Peter C. K.; Lee, Kai-Fai; Yeung, William S. B.] Univ Hong Kong, Dept Obstet & Gynaecol, Pokfulam, Hong Kong, Peoples R China; [Pang, Ronald T. K.; Liu, Wei-Min; Lee, Kai-Fai; Yeung, William S. B.] Univ Hong Kong, Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Pang, RTK (corresponding author), Univ Hong Kong, Dept Obstet & Gynaecol, Pokfulam, Hong Kong, Peoples R China.	wsbyeung@hku.hk	Pang, Ronald/B-8039-2013; Lee, Calvin Kai Fai/C-4328-2009	Lee, Calvin Kai Fai/0000-0001-5957-439X	Department of Obstetrics and Gynaecology, The University of Hong Kong	Department of Obstetrics and Gynaecology, The University of Hong Kong(University of Hong Kong)	This work was supported by the general account from the Department of Obstetrics and Gynaecology, The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bowerman B, 2006, DEVELOPMENT, V133, P773, DOI 10.1242/dev.02276; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brooks WS, 2008, J BIOL CHEM, V283, P22304, DOI 10.1074/jbc.M803238200; DELLA NG, 1993, DEVELOPMENT, V117, P1333; DeRenzo C, 2004, TRENDS CELL BIOL, V14, P420, DOI 10.1016/j.tcb.2004.07.005; Dickins RA, 2002, MOL CELL BIOL, V22, P2294, DOI 10.1128/MCB.22.7.2294-2303.2002; Evsikov AV, 2006, GENE DEV, V20, P2713, DOI 10.1101/gad.1471006; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Frew IJ, 2003, MOL CELL BIOL, V23, P9150, DOI 10.1128/MCB.23.24.9150-9161.2003; Frew IJ, 2002, MOL CELL BIOL, V22, P8155, DOI 10.1128/MCB.22.23.8155-8164.2002; Germani A, 2000, ONCOGENE, V19, P5997, DOI 10.1038/sj.onc.1204002; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hardy K, 1997, MOL HUM REPROD, V3, P919, DOI 10.1093/molehr/3.10.919; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnsen SA, 2002, J BIOL CHEM, V277, P30754, DOI 10.1074/jbc.M204812200; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Koscianska E, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-79; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Mtango NR, 2007, PHYSIOL GENOMICS, V31, P1, DOI 10.1152/physiolgenomics.00040.2007; Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Papandile A, 2004, ZYGOTE, V12, P57, DOI 10.1017/S0967199404002588; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Roperch JP, 1999, P NATL ACAD SCI USA, V96, P8070, DOI 10.1073/pnas.96.14.8070; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; Suzumori N, 2003, P NATL ACAD SCI USA, V100, P550, DOI 10.1073/pnas.0234474100; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Viswanathan SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006143; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Xu ZH, 2006, J BIOL CHEM, V281, P303, DOI 10.1074/jbc.M509060200; Yang YH, 2008, DEV DYNAM, V237, P2315, DOI 10.1002/dvdy.21666	56	29	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27878	10.1371/journal.pone.0027878	http://dx.doi.org/10.1371/journal.pone.0027878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132158	gold, Green Published			2022-12-25	WOS:000297792400020
J	Logsdon, NJ; Eberhardt, MK; Allen, CE; Barry, PA; Walter, MR				Logsdon, Naomi J.; Eberhardt, Meghan K.; Allen, Christopher E.; Barry, Peter A.; Walter, Mark R.			Design and Analysis of Rhesus Cytomegalovirus IL-10 Mutants as a Model for Novel Vaccines against Human Cytomegalovirus	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; CRYSTAL-STRUCTURE; INTERLEUKIN-10 RECEPTOR; ENCODED INTERLEUKIN-10; INTERFERON-GAMMA; SOLUBLE IL-10R1; DENDRITIC CELLS; SALIVARY-GLANDS; T-CELLS; VIRUS	Background: Human cytomegalovirus (HCMV) expresses a viral ortholog (CMVIL-10) of human cellular interleukin-10 (cIL-10). Despite only similar to 26% amino acid sequence identity, CMVIL-10 exhibits comparable immunosuppressive activity with cIL-10, attenuates HCMV antiviral immune responses, and contributes to lifelong persistence within infected hosts. The low sequence identity between CMVIL-10 and cIL-10 suggests vaccination with CMVIL-10 may generate antibodies that specifically neutralize CMVIL-10 biological activity, but not the cellular cytokine, cIL-10. However, immunization with functional CMVIL-10 might be detrimental to the host because of its immunosuppressive properties. Methods and Findings: Structural biology was used to engineer biologically inactive mutants of CMVIL-10 that would, upon vaccination, elicit a potent immune response to the wild-type viral cytokine. To test the designed proteins, the mutations were incorporated into the rhesus cytomegalovirus (RhCMV) ortholog of CMVIL-10 (RhCMVIL-10) and used to vaccinate RhCMV-infected rhesus macaques. Immunization with the inactive RhCMVIL-10 mutants stimulated antibodies against wildtype RhCMVIL-10 that neutralized its biological activity, but did not cross-react with rhesus cellular IL-10. Conclusion: This study demonstrates an immunization strategy to neutralize RhCMVIL-10 biological activity using nonfunctional RhCMVIL-10 antigens. The results provide the methodology for targeting CMVIL-10 in vaccine, and therapeutic strategies, to nullify HCMV's ability to (1) skew innate and adaptive immunity, (2) disseminate from the site of primary mucosal infection, and (3) establish a lifelong persistent infection.	[Logsdon, Naomi J.; Allen, Christopher E.; Walter, Mark R.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Eberhardt, Meghan K.; Barry, Peter A.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA	University of Alabama System; University of Alabama Birmingham; University of California System; University of California Davis	Logsdon, NJ (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	walter@uab.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) [R01 AI49342, RO1 AI047300]; National Center for Research Resources (NIH) [RR00169]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047300, R01AI049342] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants R01 AI49342 (to PAB) and RO1 AI047300 (to MRW) from the National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov) of the National Institutes of Health (NIH), and by a grant RR00169 from the National Center for Research Resources (NIH) to the California National Primate Research Center (www.cnprc.ucdavis.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2008, VACCINE, V26, P6013, DOI 10.1016/j.vaccine.2008.07.103; ALTER G, J CLIN INVEST, V120, P1905; Barboza L, 2009, CELL IMMUNOL, V257, P61, DOI 10.1016/j.cellimm.2009.02.008; Biswas PS, 2007, J IMMUNOL, V179, P4520, DOI 10.4049/jimmunol.179.7.4520; BOLPETTI A, BMC IMMUNOL, V11, P27; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; BUENO LL, PLOS ONE, V5, pE9623; Campbell AE, 2008, MED MICROBIOL IMMUN, V197, P205, DOI 10.1007/s00430-008-0077-2; Chang WLW, 2007, J IMMUNOL, V178, P7794, DOI 10.4049/jimmunol.178.12.7794; Chang WL, P NATL ACAD SCI US, V107, P22647; Chang WLW, 2004, J VIROL, V78, P8720, DOI 10.1128/JVI.78.16.8720-8731.2004; Crough T, 2009, CLIN MICROBIOL REV, V22, P76, DOI 10.1128/CMR.00034-08; Cui XH, 2008, VACCINE, V26, P5760, DOI 10.1016/j.vaccine.2008.07.092; CUNNINGHAM C, J GEN VIROL, V91, P605; De La Barrera S, 2004, CLIN EXP IMMUNOL, V138, P128, DOI 10.1111/j.1365-2249.2004.02577.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ejrnaes M, 2007, AUTOIMMUN REV, V6, P267, DOI 10.1016/j.autrev.2006.09.002; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Garrigue I, 2007, J CLIN VIROL, V40, P120, DOI 10.1016/j.jcv.2007.06.015; GRIFFITHS PD, LANCET, V377, P1256; HANSHAW JB, 1971, J INFECT DIS, V123, P555, DOI 10.1093/infdis/123.5.555; Humphreys IR, 2007, J EXP MED, V204, P1217, DOI 10.1084/jem.20062424; Jones BC, 2002, P NATL ACAD SCI USA, V99, P9404, DOI 10.1073/pnas.152147499; JONES M, J IMMUNOL, V185, P3583; Jones M, 2010, J IMMUNOL, V185, P3583, DOI 10.4049/jimmunol.1001535; Josephson K, 2002, STRUCTURE, V10, P981, DOI 10.1016/S0969-2126(02)00791-8; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Josephson K, 2001, ACTA CRYSTALLOGR D, V57, P1908, DOI 10.1107/S0907444901016249; Kaplan DE, 2008, J HEPATOL, V48, P903, DOI 10.1016/j.jhep.2008.01.030; Kedhar Sanjay R, 2007, Herpes, V14, P66; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; LI J, IMMUNOL CELL BIOL, V88, P834; Liu Y, 1997, J IMMUNOL, V158, P604; Lockridge KM, 2000, VIROLOGY, V268, P272, DOI 10.1006/viro.2000.0195; Loomis-Huff JE, 2001, VACCINE, V19, P4865, DOI 10.1016/S0264-410X(01)00232-8; Macagno A, 2010, J VIROL, V84, P1005, DOI 10.1128/JVI.01809-09; MARKS E, PLOS PATHOG, V6; Mocarski ES, 2002, TRENDS MICROBIOL, V10, P332, DOI 10.1016/S0966-842X(02)02393-4; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MOREIRA AP, CELL IMMUNOL, V263, P196; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Perez AB, 2004, J MED VIROL, V73, P230, DOI 10.1002/jmv.20080; Peters N, 2006, IMMUNOL REV, V213, P159, DOI 10.1111/j.1600-065X.2006.00432.x; Plotkin SA, 1999, AM HEART J, V138, pS484, DOI 10.1016/S0002-8703(99)70281-4; Redpath S, 1999, J IMMUNOL, V162, P6701; ROSS SA, J INFECT DIS, V201, P386; SILVERMAN JM, J IMMUNOL, V185, P5011; SONG W, AIDS RES HUM RETROVI, V27, P639; Spencer JV, 2002, J VIROL, V76, P1285, DOI 10.1128/JVI.76.3.1285-1292.2002; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; UBOL S, J INFECT DIS, V201, P923; WALTER MR, 1995, BIOCHEMISTRY-US, V34, P12118, DOI 10.1021/bi00038a004; WELLER TH, 1971, NEW ENGL J MED, V285, P203, DOI 10.1056/NEJM197107222850406; WILSON EB, CURR TOP MICROBIOL I, V350, P39; WINDSOR WT, 1993, BIOCHEMISTRY-US, V32, P8807, DOI 10.1021/bi00085a011; Yamamoto-Tabata T, 2004, J VIROL, V78, P2831, DOI 10.1128/JVI.78.6.2831-2840.2004; Yoon SI, 2005, STRUCTURE, V13, P551, DOI 10.1016/j.str.2005.01.016; YOON SI, STRUCTURE, V18, P638; Yoon SI, 2006, J BIOL CHEM, V281, P35088, DOI 10.1074/jbc.M606791200; YOW MD, 1989, J INFECT DIS, V159, P163, DOI 10.1093/infdis/159.2.163; Yue YJ, 2003, J GEN VIROL, V84, P3371, DOI 10.1099/vir.0.19508-0; Yue YJ, 2008, ADV VIRUS RES, V72, P207, DOI 10.1016/S0065-3527(08)00405-3; ZDANOV A, 1995, STRUCTURE, V3, P591, DOI 10.1016/S0969-2126(01)00193-9	64	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28127	10.1371/journal.pone.0028127	http://dx.doi.org/10.1371/journal.pone.0028127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132227	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789900049
J	Collaco, JM; McGready, J; Green, DM; Naughton, KM; Watson, CP; Shields, T; Bell, SC; Wainwright, CE; Cutting, GR				Collaco, Joseph M.; McGready, John; Green, Deanna M.; Naughton, Kathleen M.; Watson, Christopher P.; Shields, Timothy; Bell, Scott C.; Wainwright, Claire E.; Cutting, Garry R.		ACFBAL Study Grp	Effect of Temperature on Cystic Fibrosis Lung Disease and Infections: A Replicated Cohort Study	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; SOCIOECONOMIC-STATUS; AIR-POLLUTION; CHILDREN; ASSOCIATION; MORTALITY; MANIFESTATIONS; ACQUISITION; PHENOTYPE; SEVERITY	Background: Progressive lung disease accounts for the majority of morbidity and mortality observed in cystic fibrosis (CF). Beyond secondhand smoke exposure and socio-economic status, the effect of specific environmental factors on CF lung function is largely unknown. Methods: Multivariate regression was used to assess correlation between specific environmental factors, the presence of pulmonary pathogens, and variation in lung function using subjects enrolled in the U. S. CF Twin and Sibling Study (CFTSS: n = 1378). Significant associations were tested for replication in the U. S. CF Foundation Patient Registry (CFF: n = 16439), the Australian CF Data Registry (ACFDR: n = 1801), and prospectively ascertained subjects from Australia/New Zealand (ACFBAL: n = 167). Results: In CFTSS subjects, the presence of Pseudomonas aeruginosa (OR = 1.06 per degrees F; p < 0.001) was associated with warmer annual ambient temperatures. This finding was independently replicated in the CFF (1.02; p < 0.001), ACFDR (1.05; p = 0.002), and ACFBAL (1.09; p = 0.003) subjects. Warmer temperatures (20.34 points per degrees F; p = 0.005) and public insurance (-6.43 points; p < 0.001) were associated with lower lung function in the CFTSS subjects. These findings were replicated in the CFF subjects (temperature: -0.31; p < 0.001; insurance: -9.11; p< 0.001) and similar in the ACFDR subjects (temperature: -0.23; p = 0.057). The association between temperature and lung function was minimally influenced by P. aeruginosa. Similarly, the association between temperature and P. aeruginosa was largely independent of lung function. Conclusions: Ambient temperature is associated with prevalence of P. aeruginosa and lung function in four independent samples of CF patients from two continents.	[Collaco, Joseph M.; Green, Deanna M.] Johns Hopkins Univ, Sch Med, Eudowood Div Pediat Resp Sci, Baltimore, MD 21218 USA; [McGready, John] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Naughton, Kathleen M.; Watson, Christopher P.; Cutting, Garry R.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Shields, Timothy] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Bell, Scott C.] Prince Charles Hosp, Brisbane, Qld 4032, Australia; [Bell, Scott C.; Wainwright, Claire E.] Univ Queensland, Brisbane, Qld, Australia; [Wainwright, Claire E.] Royal Childrens Hosp, Brisbane, Qld, Australia	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Prince Charles Hospital; University of Queensland; Royal Children's Hospital Brisbane	Collaco, JM (corresponding author), Johns Hopkins Univ, Sch Med, Eudowood Div Pediat Resp Sci, Baltimore, MD 21218 USA.	mcollac1@jhmi.edu	Bell, Scott/AAJ-4298-2020; Wainwright, Claire E/G-4218-2013; Green, Deanna/HGU-5890-2022	Bell, Scott/0000-0001-8651-7139; Wainwright, Claire E/0000-0001-8389-3809; 	Cystic Fibrosis Foundation [COLLAC09A0]; Flight Attendant Medical Research Institute [CIA_062553]; National Institutes of Health [5R01HL068927-09]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072748, R01HL068927] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Flight Attendant Medical Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Cystic Fibrosis Foundation (COLLAC09A0), the Flight Attendant Medical Research Institute (CIA_062553), and the National Institutes of Health (5R01HL068927-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beydon N, 2002, AM J RESP CRIT CARE, V166, P1099, DOI 10.1164/rccm.200205-421OC; Bloomer BJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037308; CAMPBELL PW, 1992, J PEDIATR-US, V120, P261, DOI 10.1016/S0022-3476(05)80438-X; Cappello S, 2006, BRAZ J MICROBIOL, V37, P205, DOI 10.1590/S1517-83822006000300001; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Collaco JM, 2008, JAMA-J AM MED ASSOC, V299, P417, DOI 10.1001/jama.299.4.417; Collaco JM, 2010, J PEDIATR-US, V157, P802, DOI 10.1016/j.jpeds.2010.05.018; Conibear TCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006289; Curtis JR, 1997, AM J RESP CRIT CARE, V155, P1921, DOI 10.1164/ajrccm.155.6.9196096; Fonseca AP, 2007, FEMS IMMUNOL MED MIC, V51, P505, DOI 10.1111/j.1574-695X.2007.00328.x; Goss CH, 2004, AM J RESP CRIT CARE, V169, P816, DOI 10.1164/rccm.200306-779OC; Green DM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-140; Hallstrand TS, 2004, ANN ALLERG ASTHMA IM, V92, P228, DOI 10.1016/S1081-1206(10)61552-9; HAMOSH A, 1993, NEW ENGL J MED, V329, P1308; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Kenny D. A., 2011, MEDIATION; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; Koch C, 2001, PEDIATR PULM, V31, P1, DOI 10.1002/1099-0496(200101)31:1<1::AID-PPUL1000>3.0.CO;2-T; Kosorok MR, 1998, PEDIATR PULM, V26, P81, DOI 10.1002/(SICI)1099-0496(199808)26:2<81::AID-PPUL2>3.0.CO;2-K; Kulich M, 2005, AM J RESP CRIT CARE, V172, P885, DOI 10.1164/rccm.200410-1335OC; Li ZH, 2005, JAMA-J AM MED ASSOC, V293, P581, DOI 10.1001/jama.293.5.581; LiPuma JJ, 2005, CURR OPIN PULM MED, V11, P528, DOI 10.1097/01.mcp.0000181475.85187.ed; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; McKone EF, 2003, LANCET, V361, P1671, DOI 10.1016/S0140-6736(03)13368-5; Musken M, 2010, MICROBIOL-SGM, V156, P431, DOI 10.1099/mic.0.033290-0; O'Connor GT, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e333; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Roberts S, 2004, ENVIRON RES, V96, P328, DOI 10.1016/j.envres.2004.01.015; Rosenfeld M, 2010, PEDIATR PULM, V45, P934, DOI 10.1002/ppul.21279; RUBIN BK, 1990, NEW ENGL J MED, V323, P782, DOI 10.1056/NEJM199009203231203; Schechter MS, 2009, J PEDIATR-US, V155, P634, DOI 10.1016/j.jpeds.2009.04.059; Schechter MS, 1998, J PEDIATR-US, V132, P260, DOI 10.1016/S0022-3476(98)70442-1; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; SMYTH A, 1994, ARCH DIS CHILD, V71, P353, DOI 10.1136/adc.71.4.353; Stanke F, 2011, J MED GENET, V48, P24, DOI 10.1136/jmg.2010.080937; Stephenson A, 2011, PEDIATR PULM, V46, P376, DOI 10.1002/ppul.21368; *US EPA, 2008, USEPA600R06164F; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC	39	80	81	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27784	10.1371/journal.pone.0027784	http://dx.doi.org/10.1371/journal.pone.0027784			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125624	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789200024
J	McAlpine, SM; Issekutz, TB; Marshall, JS				McAlpine, Sarah M.; Issekutz, Thomas B.; Marshall, Jean S.			Virus stimulation of human mast cells results in the recruitment of CD56(+) T cells by a mechanism dependent on CCR5 ligands	FASEB JOURNAL			English	Article						chemotaxis; chemokines; innate immunity; allergy	CHEMOKINE RECEPTOR EXPRESSION; HEPATITIS-C VIRUS; IMMUNE-RESPONSES; CORD BLOOD; NK CELLS; KEY ROLE; ACTIVATION; REOVIRUS; LYMPHOCYTES; INFECTION	The trafficking of effector cells to sites of infection is crucial for antiviral responses. However, the mechanisms of recruitment of the interferon-gamma-producing and cytotoxic CD56(+) T cells are poorly understood. Human mast cells are sentinel cells found in the skin and airway and produce selected proinflammatory mediators in response to multiple pathogen-associated signals. The role of human mast cell-derived chemokines in T-cell recruitment to virus infection was examined. Supernatants from primary human cord blood-derived mast cells (CBMCs) infected with mammalian reovirus were examined for chemokine production and utilized in chemotaxis assays. Virus-infected CBMCs produced several chemokines, including CCL3, CCL4, and CCL5. Supernatants from reovirus-infected CBMCs selectively induced the chemotaxis of CD8(+) T cells (10 +/- 1%) and CD3(+) CD56(+) T cells (19 +/- 5%). CD56(+) T-cell migration was inhibited by pertussis toxin (65 +/- 9%) and met-RAN-TES (56 +/- 7%), a CCR1/CCR5 antagonist. CD56(+) T cells expressed CCR5, but little CCR1. The depletion of CCL3, CCL4, and CCL5 from reovirus-infected CBMC supernatants significantly (41 +/- 10%) inhibited CD56(+) T-cell chemotaxis. This study demonstrates a novel role for mast cells and CCR5 in CD56(+) T-cell trafficking and suggests that human mast cells enhance immunity to viruses through the selective recruitment of cytotoxic effector cells to virus infection sites. These findings could be exploited to enhance local T-cell responses in chronic viral infection and malignancies at mast cell-rich sites.-McAlpine, S. M., Issekutz, T. B., Marshall, J. S. Virus stimulation of human mast cells results in the recruitment of CD56(+) T cells by a mechanism dependent on CCR5 ligands. FASEB J. 26, 1280-1289 (2012). www.fasebj.org	[McAlpine, Sarah M.; Issekutz, Thomas B.; Marshall, Jean S.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada; [McAlpine, Sarah M.; Issekutz, Thomas B.; Marshall, Jean S.] Dalhousie Univ, Dalhousie Inflammat Grp, Halifax, NS B3H 1X5, Canada; [Issekutz, Thomas B.] Dalhousie Univ, Dept Pediat, Halifax, NS B3H 1X5, Canada; [Issekutz, Thomas B.; Marshall, Jean S.] Dalhousie Univ, Dept Pathol, Halifax, NS B3H 1X5, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	Marshall, JS (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Rm 7C,5850 Coll St, Halifax, NS B3H 1X5, Canada.	jean.marshall@dal.ca	MARSHALL, JEAN/K-4014-2012	Marshall, Jean S./0000-0002-5642-1379; McAlpine, Sarah M/0000-0002-9298-9682; Issekutz, Thomas/0000-0001-5486-9463	Canadian Institutes of Health Research; Canadian Cancer Society Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	The authors thank Dr. Patrick Lee (Dalhousie University) for supplying reovirus for these studies and Dr. Ian Haidl (Dalhousie University) for his experimental advice and revision of the manuscript. This study was supported by grants from the Canadian Institutes of Health Research and the Canadian Cancer Society Research Institute. The authors also thank Yi-Song Wei, Nong Xu, Sarah Roberts, Sarah Bugden, Pamela Gallant and Sandy Edgar for their excellent technical assistance.	Albarran B, 2005, APMIS, V113, P526, DOI 10.1111/j.1600-0463.2005.apm_191.x; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Boisvert J, 2003, J HEPATOL, V38, P67, DOI 10.1016/S0168-8278(02)00328-8; Brainard DM, 2007, J VIROL, V81, P8439, DOI 10.1128/JVI.00199-07; Brown MG, 2009, J LEUKOCYTE BIOL, V85, P71, DOI 10.1189/jlb.0308167; Burke SM, 2008, BLOOD, V111, P5467, DOI 10.1182/blood-2007-10-118547; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; Doherty DG, 1999, J IMMUNOL, V163, P2314; Dunne J, 2001, J IMMUNOL, V167, P3129, DOI 10.4049/jimmunol.167.6.3129; Faint JM, 2001, J IMMUNOL, V167, P212, DOI 10.4049/jimmunol.167.1.212; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Golden-Mason L, 2007, J VIROL, V81, P9292, DOI 10.1128/JVI.00834-07; Gurish MF, 2006, J ALLERGY CLIN IMMUN, V117, P1285, DOI 10.1016/j.jaci.2006.04.017; Hess C, 2004, BLOOD, V104, P3463, DOI 10.1182/blood-2004-03-1067; Jin YD, 1998, HUM IMMUNOL, V59, P352, DOI 10.1016/S0198-8859(98)00030-5; Kato M, 2004, INT ARCH ALLERGY IMM, V134, P37, DOI 10.1159/000077791; Kelly-Rogers J, 2006, HUM IMMUNOL, V67, P863, DOI 10.1016/j.humimm.2006.08.292; King CA, 2000, J VIROL, V74, P7146, DOI 10.1128/JVI.74.15.7146-7150.2000; King CA, 2002, J VIROL, V76, P8408, DOI 10.1128/JVI.76.16.8408-8419.2002; Kohlmeier JE, 2008, IMMUNITY, V29, P101, DOI 10.1016/j.immuni.2008.05.011; Kohlmeier JE, 2009, J IMMUNOL, V183, P4378, DOI 10.4049/jimmunol.0902022; Komatsu K, 2008, CURR EYE RES, V33, P736, DOI 10.1080/02713680802344716; Kulka M, 2004, J ALLERGY CLIN IMMUN, V114, P174, DOI 10.1016/j.jaci.2004.03.049; Maginnis MS, 2008, J VIROL, V82, P3181, DOI 10.1128/JVI.01612-07; Maginnis MS, 2006, J VIROL, V80, P2760, DOI 10.1128/JVI.80.6.2760-2770.2006; Marcato P, 2007, MOL THER, V15, P1522, DOI 10.1038/sj.mt.6300179; McCurdy JD, 2003, J IMMUNOL, V170, P1625, DOI 10.4049/jimmunol.170.4.1625; Metz M, 2007, TRENDS IMMUNOL, V28, P234, DOI 10.1016/j.it.2007.03.003; MOSS J, 1984, J RECEPTOR RES, V4, P459, DOI 10.3109/10799898409042567; Musha N, 1998, CLIN EXP IMMUNOL, V113, P220; Norris S, 1998, J HEPATOL, V28, P84, DOI 10.1016/S0168-8278(98)80206-7; Olynych TJ, 2006, J ALLERGY CLIN IMMUN, V118, P837, DOI 10.1016/j.jaci.2006.06.008; Orinska Z, 2005, BLOOD, V106, P978, DOI 10.1182/blood-2004-07-2656; ORTALDO JR, 1991, CELL IMMUNOL, V136, P486, DOI 10.1016/0008-8749(91)90369-M; PACITTI AF, 1987, J VIROL, V61, P1407, DOI 10.1128/JVI.61.5.1407-1415.1987; PAUL RW, 1989, VIROLOGY, V172, P382, DOI 10.1016/0042-6822(89)90146-3; Proudfoot AEI, 1999, J BIOL CHEM, V274, P32478, DOI 10.1074/jbc.274.45.32478; Saito H, 1996, J IMMUNOL, V157, P343; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Schaller MA, 2008, AM J PATHOL, V172, P386, DOI 10.2353/ajpath.2008.070537; SCHMIDTWOLF IGH, 1994, BRIT J HAEMATOL, V87, P453, DOI 10.1111/j.1365-2141.1994.tb08297.x; St John AL, 2011, P NATL ACAD SCI USA, V108, P9190, DOI 10.1073/pnas.1105079108; Stelekati E, 2009, IMMUNITY, V31, P665, DOI 10.1016/j.immuni.2009.08.022; Takayama E, 2003, IMMUNOLOGY, V108, P211, DOI 10.1046/j.1365-2567.2003.01575.x; Yang LV, 2005, BLOOD, V105, P1127, DOI 10.1182/blood-2004-05-1916; Ye L, 2009, HEPATOLOGY, V49, P753, DOI 10.1002/hep.22715	48	28	28	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2012	26	3					1280	1289		10.1096/fj.11-188979	http://dx.doi.org/10.1096/fj.11-188979			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22125314				2022-12-25	WOS:000300949300030
J	Eapen, A; Ramachandran, A; George, A				Eapen, Asha; Ramachandran, Amsaveni; George, Anne			Dentin Phosphoprotein (DPP) Activates Integrin-mediated Anchorage-dependent Signals in Undifferentiated Mesenchymal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; SIALOPHOSPHOPROTEIN DSPP; RAT DENTIN; EXPRESSION PATTERNS; MATRIX PROTEINS; TYROSINE KINASE; GENE-EXPRESSION; MAP KINASES; IN-VIVO; PHOSPHOPHORYN	Dentin phosphoprotein (DPP), a major noncollagenous protein of the dentin matrix, is a highly acidic protein that binds Ca2+ avidly and is thus linked to matrix mineralization. Here, we demonstrate that the RGD domain in DPP can bind to integrins on the cell surface of undifferentiated mesenchymal stem cells and pulp cells. This coupling generates intracellular signals that are channeled along cytoskeletal filaments and activate the non-receptor tyrosine kinase focal adhesion kinase, which plays a key role in signaling at sites of cellular adhesion. The putative focal adhesion kinase autophosphorylation site Tyr397 is phosphorylated during focal adhesion assembly induced by DPP on the substrate. We further demonstrate that these intracellular signals propagate through the cytoplasm and activate anchorage-dependent ERK signaling. Activated ERK translocates to the nucleus and phosphorylates the transcription factor ELK-1, which in turn coordinates the expression of downstream target genes such as DMP1 and dentin sialoprotein (DSP). These studies suggest a novel paradigm demonstrating that extracellular DPP can induce intracellular signaling that can be propagated to the nucleus and thus alter gene activities.	[Eapen, Asha; Ramachandran, Amsaveni; George, Anne] Univ Illinois, Brodie Tooth Dev Genet & Regenerat Med Res Lab, Dept Oral Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	George, A (corresponding author), Univ Illinois, Brodie Tooth Dev Genet & Regenerat Med Res Lab, Dept Oral Biol, Chicago, IL 60612 USA.	anneg@uic.edu		GEORGE, ANNE/0000-0002-9008-7642	National Institutes of Health [DE 19633]; Brodie Endowment Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brodie Endowment Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 19633. This work was also supported by the Brodie Endowment Fund.	Alvares K, 2006, DEV DYNAM, V235, P2980, DOI 10.1002/dvdy.20935; Aplin AE, 2003, FEBS LETT, V534, P11, DOI 10.1016/S0014-5793(02)03840-1; Aplin AE, 2002, J CELL SCI, V115, P2781; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; Cance WG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.120pe22; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; George A, 1999, CONNECT TISSUE RES, V40, P49, DOI 10.3109/03008209909005277; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Golubovskaya V, 2004, BBA-GENE STRUCT EXPR, V1678, P111, DOI 10.1016/j.bbaexp.2004.03.002; Hao JJ, 2004, BONE, V34, P921, DOI 10.1016/j.bone.2004.01.020; Hart PS, 2007, CELLS TISSUES ORGANS, V186, P70, DOI 10.1159/000102682; He G, 2005, J BIOL CHEM, V280, P33109, DOI 10.1074/jbc.M500159200; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; Hynes RO, 2004, MATRIX BIOL, V23, P333, DOI 10.1016/j.matbio.2004.08.001; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Juliano RL, 2001, METHOD ENZYMOL, V333, P151; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; LINDE A, 1981, BIOCHIM BIOPHYS ACTA, V667, P341, DOI 10.1016/0005-2795(81)90200-2; MacDougall M, 1997, CYTOGENET CELL GENET, V79, P121, DOI 10.1159/000134697; MacDougall M, 2006, AM J MED GENET A, V140A, P2536, DOI 10.1002/ajmg.a.31359; Malik RK, 1996, J BIOL CHEM, V271, P29785, DOI 10.1074/jbc.271.47.29785; Mamali I, 2008, J CELL PHYSIOL, V216, P198, DOI 10.1002/jcp.21390; Mamali I, 2008, J CELL BIOCHEM, V103, P1895, DOI 10.1002/jcb.21580; Ruoslahti E, 1996, TUMOR BIOL, V17, P117, DOI 10.1159/000217975; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; SABSAY B, 1991, BIOCHEM J, V276, P699, DOI 10.1042/bj2760699; SFEIR C, 1995, J BONE MINER RES, V10, P607; Shemesh T, 2005, J PHYS-CONDENS MAT, V17, pS3913, DOI 10.1088/0953-8984/17/47/019; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Staquet MJ, 2006, CELL TISSUE RES, V323, P457, DOI 10.1007/s00441-005-0104-1; STETLERSTEVENSON WG, 1983, BIOCHEMISTRY-US, V22, P4326, DOI 10.1021/bi00287a025; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; Thotakura SR, 2000, J DENT RES, V79, P835, DOI 10.1177/00220345000790030901; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; TURNER CE, 1991, J CELL BIOL, V115, P201, DOI 10.1083/jcb.115.1.201; VEIS A, 1988, CIBA F SYMP, V136, P161; Veis A, 1998, EUR J ORAL SCI, V106, P234, DOI 10.1111/j.1600-0722.1998.tb02181.x; Yamakoshi Y, 2005, J BIOL CHEM, V280, P17472, DOI 10.1074/jbc.M413220200; Yamakoshi Y, 2008, J BIOL CHEM, V283, P14835, DOI 10.1074/jbc.M800633200; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200	49	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5211	5224		10.1074/jbc.M111.290080	http://dx.doi.org/10.1074/jbc.M111.290080			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22134916	Green Published, hybrid			2022-12-25	WOS:000300638000004
J	Fisher, IB; Ostrowski, M; Muthusamy, N				Fisher, Ian B.; Ostrowski, Mike; Muthusamy, Natarajan			Role for Ets-2(Thr-72) Transcription Factor in Stage-specific Thymocyte Development and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE SELECTION; NEGATIVE SELECTION; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; ERK ACTIVATION; KAPPA-B; ETS-2; MICE; PROTEIN; PATHWAY	Interference of Ras signaling deregulates thymocyte development in mouse models. However, the role of Ets-2, a transcription factor that is phosphorylated on a critical threonine residue (Thr-72) by the Ras/MAPK pathway in thymocyte development, has not been defined. Transgenic mice overexpressing a phosphomutant Ets-2 (T72A) in the thymus displayed reduced thymus size associated with a 60-80% reduction in thymocyte populations. The transgenic mice exhibited a 20-fold increase in a c-Kit(+) CD4(+) CD8(+) CD3(-) population and a 5-fold increase in a unique CD5(low) population associated with a partial developmental block at the DN2-DN3 stage of thymocytes. Transgenic thymocytes exhibited increased apoptosis, and overexpression of Bcl-2 rescued the hypocellularity and associated thymocyte developmental block in double transgenic mice. The observed defects in these mice are not dependent on Ets-1 expression. These studies implicate for the first time a stage-specific Ets-1-independent regulatory role for Ets-2 in early thymocyte development and survival.	[Fisher, Ian B.; Ostrowski, Mike; Muthusamy, Natarajan] Ohio State Univ, Ctr Comprehens Canc, Mol Cellular Dev Biol Program, Div Hematol, Columbus, OH 43210 USA; [Muthusamy, Natarajan] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Columbus, OH 43210 USA; [Ostrowski, Mike; Muthusamy, Natarajan] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Muthusamy, Natarajan] Ohio State Univ, Ctr Comprehens Canc, Dept Vet Biosci, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Muthusamy, N (corresponding author), 455E Ohio State Univ Comprehens Canc Ctr, Div Hematol, Dept Internal Med, 410W12th Ave, Columbus, OH 43210 USA.	raj.muthusamy@osumc.edu	Ostrowski, Michael/H-3108-2011	Ostrowski, Michael/0000-0003-2948-6297				Akashi K, 1996, IMMUNITY, V5, P147, DOI 10.1016/S1074-7613(00)80491-4; Akashi K, 1998, P NATL ACAD SCI USA, V95, P2486, DOI 10.1073/pnas.95.5.2486; AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; Anderson MK, 1999, DEVELOPMENT, V126, P3131; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Baker KM, 2003, J BIOL CHEM, V278, P17876, DOI 10.1074/jbc.M209480200; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; Bommhardt U, 2000, J IMMUNOL, V164, P2326, DOI 10.4049/jimmunol.164.5.2326; Cantrell DA, 2002, NAT REV IMMUNOL, V2, P20, DOI 10.1038/nri703; Costello PS, 2004, NAT IMMUNOL, V5, P289, DOI 10.1038/ni1038; Delgado P, 2000, NATURE, V406, P426, DOI 10.1038/35019102; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; Eyquem S, 2004, P NATL ACAD SCI USA, V101, P15712, DOI 10.1073/pnas.0405546101; Ezashi T, 1998, P NATL ACAD SCI USA, V95, P7882, DOI 10.1073/pnas.95.14.7882; Foos G, 2000, ONCOGENE, V19, P5507, DOI 10.1038/sj.onc.1203946; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; FUJIWARA S, 1990, MOL CELL BIOL, V10, P1249, DOI 10.1128/MCB.10.3.1249; FUJIWARA S, 1988, MOL CELL BIOL, V8, P4700, DOI 10.1128/MCB.8.11.4700; Hettmann T, 2000, J IMMUNOL, V165, P5004, DOI 10.4049/jimmunol.165.9.5004; Hettmann T, 1999, J EXP MED, V189, P145, DOI 10.1084/jem.189.1.145; Mariathasan S, 2000, EUR J IMMUNOL, V30, P1060, DOI 10.1002/(SICI)1521-4141(200004)30:4<1060::AID-IMMU1060>3.0.CO;2-2; McCarthy SA, 1997, MOL CELL BIOL, V17, P2401, DOI 10.1128/MCB.17.5.2401; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Na SY, 2003, J IMMUNOL, V171, P1285, DOI 10.4049/jimmunol.171.3.1285; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pivniouk VI, 2000, CURR OPIN IMMUNOL, V12, P173, DOI 10.1016/S0952-7915(99)00068-0; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Smith JL, 2000, MOL CELL BIOL, V20, P8026, DOI 10.1128/MCB.20.21.8026-8034.2000; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STRASSER A, 1994, NATURE, V368, P457, DOI 10.1038/368457a0; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Villalba M, 2000, EUR J IMMUNOL, V30, P1587, DOI 10.1002/1521-4141(200006)30:6<1587::AID-IMMU1587>3.0.CO;2-T; Wei G, 2003, ANTICANCER RES, V23, P2173; Wolvetang EJ, 2003, NEUROBIOL DIS, V14, P349, DOI 10.1016/S0969-9961(03)00107-4; Wolvetang EJ, 2003, HUM MOL GENET, V12, P247, DOI 10.1093/hmg/ddg015; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yang BS, 1996, MOL CELL BIOL, V16, P538; Zabuawala T, 2010, CANCER RES, V70, P1323, DOI 10.1158/0008-5472.CAN-09-1474; Zaldumbide A, 2002, J IMMUNOL, V169, P4873, DOI 10.4049/jimmunol.169.9.4873; Zamisch M, 2009, J EXP MED, V206, P2685, DOI 10.1084/jem.20092024	47	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5199	5210		10.1074/jbc.M111.242602	http://dx.doi.org/10.1074/jbc.M111.242602			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22128184	hybrid, Green Published			2022-12-25	WOS:000300638000003
J	Bovijn, C; Ulrichts, P; De Smet, AS; Catteeuw, D; Beyaert, R; Tavernier, J; Peelman, F				Bovijn, Celia; Ulrichts, Peter; De Smet, Anne-Sophie; Catteeuw, Dominiek; Beyaert, Rudi; Tavernier, Jan; Peelman, Frank			Identification of Interaction Sites for Dimerization and Adapter Recruitment in Toll/Interleukin-1 Receptor (TIR) Domain of Toll-like Receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MULTIPLE SEQUENCE ALIGNMENT; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; INTERACTION TRAP; STRUCTURAL BASIS; PROTEINS; TLR4; ACTIVATION; DIMER	Toll-like receptor signaling requires interactions of the Toll/IL-1 receptor (TIR) domains of the receptor and adapter proteins. Using the mammalian protein-protein interaction trap strategy, homology modeling, and site-directed mutagenesis, we identify the interaction surfaces in the TLR4 TIR domain for the TLR4-TLR4, TLR4-MyD88 adapter-like (MAL), and TLR4-TRIF-related adapter molecule (TRAM) interaction. Two binding sites are equally important for TLR4 dimerization and adapter recruitment. In a model based on the crystal structure of the dimeric TLR10 TIR domain, the first binding site mediates TLR4-TLR4 TIR-TIR interaction. Upon dimerization, two identical second binding sites of the TLR4 TIR domain are juxtaposed and form an extended binding platform for both MAL and TRAM. In our mammalian protein-protein interaction trap assay, MAL and TRAM compete for binding to this platform. Our data suggest that adapter binding can stabilize the TLR4 TIR dimerization.	[Bovijn, Celia; Ulrichts, Peter; De Smet, Anne-Sophie; Catteeuw, Dominiek; Tavernier, Jan; Peelman, Frank] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Beyaert, Rudi] Univ Ghent VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Peelman, F (corresponding author), Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium.	frank.peelman@vib-ugent.be	Beyaert, Rudi/B-2589-2009; Tavernier, Jan/AAG-3636-2019	Beyaert, Rudi/0000-0002-5704-582X	Ugent BOF [01Z03306]; FWO "Krediet aan Navorsers" [1.5.256.08N]	Ugent BOF; FWO "Krediet aan Navorsers"(FWO)	This work was supported by Ugent BOF Grant 01Z03306 and FWO "Krediet aan Navorsers" Grant 1.5.256.08N.	Bartfai T, 2003, P NATL ACAD SCI USA, V100, P7971, DOI 10.1073/pnas.0932746100; Brown V, 2006, EUR J IMMUNOL, V36, P742, DOI 10.1002/eji.200535158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Eyckerman S, 1999, EUR CYTOKINE NETW, V10, P549; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Jenkins KA, 2010, CYTOKINE, V49, P237, DOI 10.1016/j.cyto.2009.01.009; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Monie TP, 2009, IMMUNOL REV, V227, P161, DOI 10.1111/j.1600-065X.2008.00735.x; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Pattyn E, 2008, J VIROL METHODS, V153, P7, DOI 10.1016/j.jviromet.2008.06.021; Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piessevaux J, 2006, J BIOL CHEM, V281, P32953, DOI 10.1074/jbc.M600776200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ronni T, 2003, MOL CELL BIOL, V23, P2543, DOI 10.1128/MCB.23.7.2543-2555.2003; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Takashima K, 2009, BRIT J PHARMACOL, V157, P1250, DOI 10.1111/j.1476-5381.2009.00297.x; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toshchakov VY, 2007, J IMMUNOL, V178, P2655, DOI 10.4049/jimmunol.178.5.2655; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Ulrichts P, 2007, FEBS LETT, V581, P629, DOI 10.1016/j.febslet.2007.01.026; Ulrichts P, 2010, J CELL SCI, V123, P256, DOI 10.1242/jcs.056002; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087	47	51	52	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4088	4098		10.1074/jbc.M111.282350	http://dx.doi.org/10.1074/jbc.M111.282350			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22139835	Green Published, hybrid			2022-12-25	WOS:000300410900042
J	Rooj, AK; McNicholas, CM; Bartoszewski, R; Bebok, Z; Benos, DJ; Fuller, CM				Rooj, Arun K.; McNicholas, Carmel M.; Bartoszewski, Rafal; Bebok, Zsuzsanna; Benos, Dale J.; Fuller, Catherine M.			Glioma-specific Cation Conductance Regulates Migration and Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL ENAC; ION CHANNELS; MEMBRANE DEPOLARIZATION; NA+ CHANNELS; HYBRID-CELLS; K+ CHANNELS; PROLIFERATION; AMILORIDE; EXPRESSION; CANCER	In this study, we have investigated the role of a glioma-specific cation channel assembled from subunits of the Deg/epithelial sodium channel (ENaC) superfamily, in the regulation of migration and cell cycle progression in glioma cells. Channel inhibition by psalmotoxin-1 (PcTX-1) significantly inhibited migration and proliferation of D54-MG glioma cells. Both PcTX-1 and benzamil, an amiloride analog, caused cell cycle arrest of D54-MG cells inG(0)/G(1) phases (by 30 and 40%, respectively) and reduced cell accumulation in S and G(2)/M phases after 24 h of incubation. Both PcTX-1 and benzamil up-regulated expression of cyclin-dependent kinase inhibitor proteins p21(Cip1) and p27(Kip1). Similar results were obtained in U87MG and primary glioblastoma multiforme cells maintained in primary culture and following knockdown of one of the component subunits, ASIC1. In contrast, knocking down delta ENaC, which is not a component of the glioma cation channel complex, had no effect on cyclin-dependent kinase inhibitor expression. Phosphorylation of ERK1/2 was also inhibited by PcTX-1, benzamil, and knockdown of ASIC1 but not delta ENaC in D54MG cells. Our data suggest that a specific cation conductance composed of acid-sensing ion channels and ENaC subunits regulates migration and cell cycle progression in gliomas.	[Rooj, Arun K.; McNicholas, Carmel M.; Benos, Dale J.; Fuller, Catherine M.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Bartoszewski, Rafal; Bebok, Zsuzsanna; Benos, Dale J.; Fuller, Catherine M.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Fuller, CM (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, MCLM 830,1530 3rd Ave S, Birmingham, AL 35294 USA.	cfuller@uab.edu	Bartoszewski, Rafal A/D-6311-2011	Bartoszewski, Rafal A/0000-0002-2864-6757; McNicholas-Bevensee, Carmel/0000-0002-7013-8764	National Institutes of Health [DK37206]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037206, R56DK037206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK37206.	AKAIKE N, 1994, JPN J PHYSIOL, V44, P433, DOI 10.2170/jjphysiol.44.433; Berdiev BK, 2003, J BIOL CHEM, V278, P15023, DOI 10.1074/jbc.M300991200; Bondarava M, 2009, PFLUG ARCH EUR J PHY, V458, P675, DOI 10.1007/s00424-009-0649-z; Bubien JK, 2004, AM J PHYSIOL-CELL PH, V287, pC1282, DOI 10.1152/ajpcell.00077.2004; Bubien JK, 1999, AM J PHYSIOL-CELL PH, V276, pC1405, DOI 10.1152/ajpcell.1999.276.6.C1405; Chifflet S, 2005, AM J PHYSIOL-CELL PH, V288, pC1420, DOI 10.1152/ajpcell.00259.2004; Chioni AM, 2009, INT J BIOCHEM CELL B, V41, P1216, DOI 10.1016/j.biocel.2008.11.001; Cuddapah VA, 2011, AM J PHYSIOL-CELL PH, V301, pC541, DOI 10.1152/ajpcell.00102.2011; del Monaco SM, 2009, J MEMBRANE BIOL, V232, P1, DOI 10.1007/s00232-009-9206-0; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Falin RA, 2007, J GEN PHYSIOL, V130, P313, DOI 10.1085/jgp.200709775; Fanton CP, 2001, J BIOL CHEM, V276, P18871, DOI 10.1074/jbc.M011514200; George J, 2010, INT J BIOCHEM CELL B, V42, P1164, DOI 10.1016/j.biocel.2010.04.002; Ghiani CA, 1999, J NEUROSCI, V19, P5380; Glassmann A, 2011, INT J ONCOL, V39, P1567, DOI 10.3892/ijo.2011.1165; GomezManzano C, 1996, CANCER RES, V56, P694; Grifoni SC, 2008, MICROVASC RES, V75, P202, DOI 10.1016/j.mvr.2007.08.003; Grifoni SC, 2006, AM J PHYSIOL-HEART C, V291, pH3076, DOI 10.1152/ajpheart.00333.2006; Gysin S, 2005, CANCER RES, V65, P4870, DOI 10.1158/0008-5472.CAN-04-2848; Haerteis S, 2009, J BIOL CHEM, V284, P29024, DOI 10.1074/jbc.M109.018945; Herrero-Gonzalez S, 2010, ONCOGENE, V29, P5712, DOI 10.1038/onc.2010.299; Hwang CY, 2009, MOL CELL BIOL, V29, P3379, DOI 10.1128/MCB.01758-08; Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671; Joshi AD, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-17; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kapoor N, 2009, J BIOL CHEM, V284, P24526, DOI 10.1074/jbc.M109.037390; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Komata T, 2003, BRIT J CANCER, V88, P1277, DOI 10.1038/sj.bjc.6600862; Kortylewski M, 2001, BIOCHEM J, V357, P297, DOI 10.1042/0264-6021:3570297; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lopez-Gines C, 2008, NEUROPATHOLOGY, V28, P507, DOI 10.1111/j.1440-1789.2008.00911.x; McLean LA, 2000, AM J PHYSIOL-CELL PH, V278, pC676, DOI 10.1152/ajpcell.2000.278.4.C676; McLendon RE, 2007, ARCH PATHOL LAB MED, V131, P1585; Nakabayashi H, 2011, CANCER SCI, V102, P393, DOI 10.1111/j.1349-7006.2010.01794.x; Nakamura K, 2008, AM J PHYSIOL-HEART C, V294, pH1700, DOI 10.1152/ajpheart.01203.2007; ODONNELL ME, 1982, J CELL PHYSIOL, V113, P405, DOI 10.1002/jcp.1041130308; ODONNELL ME, 1983, J PHARMACOL EXP THER, V226, P368; Prevarskaya N, 2007, BBA-MOL BASIS DIS, V1772, P937, DOI 10.1016/j.bbadis.2007.05.006; Ransom CB, 2001, J NEUROSCI, V21, P7674, DOI 10.1523/JNEUROSCI.21-19-07674.2001; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Ross SB, 2007, AM J PHYSIOL-CELL PH, V293, pC1181, DOI 10.1152/ajpcell.00066.2007; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Soroceanu L, 1999, J NEUROSCI, V19, P5942, DOI 10.1523/JNEUROSCI.19-14-05942.1999; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Ullrich N, 1996, NEUROREPORT, V7, P1020, DOI 10.1097/00001756-199604100-00013; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Vila-Carriles WH, 2006, J BIOL CHEM, V281, P19220, DOI 10.1074/jbc.M603100200; Wang K, 2010, J NEURO-ONCOL, V98, P319, DOI 10.1007/s11060-009-0082-3; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; Xu JH, 2011, J NEURO-ONCOL, V105, P241, DOI 10.1007/s11060-011-0604-7; Yang LM, 2006, J BIOL CHEM, V281, P9859, DOI 10.1074/jbc.M512046200; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	54	64	65	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4053	4065		10.1074/jbc.M111.311688	http://dx.doi.org/10.1074/jbc.M111.311688			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22130665	hybrid, Green Published			2022-12-25	WOS:000300410900039
J	Bultynck, G; Kiviluoto, S; Henke, N; Ivanova, H; Schneider, L; Rybalchenko, V; Luyten, T; Nuyts, K; De Borggraeve, W; Bezprozvanny, I; Parys, JB; De Smedt, H; Missiaen, L; Methner, A				Bultynck, Geert; Kiviluoto, Santeri; Henke, Nadine; Ivanova, Hristina; Schneider, Lars; Rybalchenko, Volodymyr; Luyten, Tomas; Nuyts, Koen; De Borggraeve, Wim; Bezprozvanny, Ilya; Parys, Jan B.; De Smedt, Humbert; Missiaen, Ludwig; Methner, Axel			The C Terminus of Bax Inhibitor-1 Forms a Ca2+-permeable Channel Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; ENDOPLASMIC-RETICULUM STRESS; OXYGEN-GLUCOSE DEPRIVATION; IP3 RECEPTOR; CELL-DEATH; ER-STRESS; ALZHEIMERS-DISEASE; CA2+ HOMEOSTASIS; CALCIUM-RELEASE; FAMILY-MEMBERS	Bax inhibitor-1 (BI-1) is a multitransmembrane domain-spanning endoplasmic reticulum (ER)-located protein that is evolutionarily conserved and protects against apoptosis and ER stress. Furthermore, BI-1 is proposed to modulate ER Ca2+ homeostasis by acting as a Ca2+-leak channel. Based on experimental determination of the BI-1 topology, we propose that its C terminus forms a Ca2+ pore responsible for its Ca2+-leak properties. We utilized a set of C-terminal peptides to screen for Ca2+ leak activity in unidirectional Ca-45(2+)-flux experiments and identified an alpha-helical 20-amino acid peptide causing Ca2+ leak from the ER. The Ca2+ leak was independent of endogenous ER Ca2+-release channels or other Ca2+-leak mechanisms, namely translocons and presenilins. The Ca2+-permeating property of the peptide was confirmed in lipid-bilayer experiments. Using mutant peptides, we identified critical residues responsible for the Ca2+-leak properties of this BI-1 peptide, including a series of critical negatively charged aspartate residues. Using peptides corresponding to the equivalent BI-1 domain from various organisms, we found that the Ca2+-leak properties were conserved among animal, but not plant and yeast orthologs. By mutating one of the critical aspartate residues in the proposed Ca2+-channel pore in full-length BI-1, we found that Asp-213 was essential for BI-1-dependent ER Ca2+ leak. Thus, we elucidated residues critically important for BI-1-mediated Ca2+ leak and its potential channel pore. Remarkably, one of these residues was not conserved among plant and yeast BI-1 orthologs, indicating that the ER Ca2+-leak properties of BI-1 are an added function during evolution.	[Bultynck, Geert; Kiviluoto, Santeri; Ivanova, Hristina; Luyten, Tomas; Parys, Jan B.; De Smedt, Humbert; Missiaen, Ludwig] Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Mol & Cellular Signaling, B-3000 Louvain, Belgium; [Nuyts, Koen; De Borggraeve, Wim] Katholieke Univ Leuven, Dept Mol Design & Synth, B-3000 Louvain, Belgium; [Henke, Nadine; Schneider, Lars; Methner, Axel] Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany; [Rybalchenko, Volodymyr; Bezprozvanny, Ilya] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	KU Leuven; KU Leuven; Heinrich Heine University Dusseldorf; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bultynck, G (corresponding author), Katholieke Univ Leuven, Campus Gasthuisberg O-N-1 Bus 802,Herestr 49, BE-3000 Louvain, Belgium.	geert.bultynck@med.kuleuven.be	Nuyts, Koen/L-9930-2017; De Borggraeve, Wim/AGE-5612-2022; Kiviluoto, Santeri/M-2743-2014	Nuyts, Koen/0000-0003-0387-9965; De Borggraeve, Wim/0000-0001-7813-6192; Kiviluoto, Santeri/0000-0001-5010-5327; Methner, Axel/0000-0002-8774-0057; Rybalchenko, Volodymyr/0000-0003-4092-0779; Nickel, Nadine/0000-0002-0609-0735; Parys, Jan/0000-0002-3591-4967; Bultynck, Geert/0000-0002-5968-4828	Deutsche Forschungsgemeinschaft [ME1922/9-1]; Forschungskommission of the Heinrich Heine-University Dusseldorf; Research Foundation-Flanders (F. W. O.) [G.0604.07N, G.0788.11N, G.0724.09]; Research Council of the K.U. Leuven [GOA/09/012]; OT START [SRT/10/044]; Interuniversity Attraction Poles Program Belgian Science Policy [P6/28]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungskommission of the Heinrich Heine-University Dusseldorf; Research Foundation-Flanders (F. W. O.)(FWO); Research Council of the K.U. Leuven(KU Leuven); OT START; Interuniversity Attraction Poles Program Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by Deutsche Forschungsgemeinschaft Grant ME1922/9-1 and the Forschungskommission of the Heinrich Heine-University Dusseldorf (to A. M.), by Research Foundation-Flanders (F. W. O.) Grants G.0604.07N (to H. D. S.), G.0788.11N (to G. B. and W. D. B.), and G.0724.09 (to L. M.), by the Research Council of the K.U. Leuven via the Concerted Actions program (GOA/09/012) and an OT START (SRT/10/044), and by Interuniversity Attraction Poles Program Belgian Science Policy P6/28 (to H. D. S., J. B. P., and L. M.).	Ahn T, 2010, CELL CALCIUM, V47, P387, DOI 10.1016/j.ceca.2010.02.003; Ahn T, 2009, FEBS J, V276, P2285, DOI 10.1111/j.1742-4658.2009.06956.x; Austin RC, 2009, ANTIOXID REDOX SIGN, V11, P2279, DOI [10.1089/ars.2009.2686, 10.1089/ARS.2009.2686]; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072; Castillo K, 2011, EMBO J, V30, P4465, DOI 10.1038/emboj.2011.318; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cheung KH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000818; D'hondt C, 2011, CELL SIGNAL, V23, P305, DOI 10.1016/j.cellsig.2010.07.018; Decuypere JP, 2010, CELL CALCIUM, V48, P161, DOI 10.1016/j.ceca.2010.08.003; Dohm CP, 2006, J MOL NEUROSCI, V29, P1, DOI 10.1385/JMN:29:1:1; Giorgi C, 2008, CURR MOL MED, V8, P119; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Grzmil M, 2006, J PATHOL, V208, P340, DOI 10.1002/path.1902; Grzmil M, 2003, AM J PATHOL, V163, P543, DOI 10.1016/S0002-9440(10)63682-6; Hemrajani C, 2010, P NATL ACAD SCI USA, V107, P3129, DOI 10.1073/pnas.0911609106; Henke N, 2011, CELL CALCIUM, V50, P251, DOI 10.1016/j.ceca.2011.05.005; Kasri NN, 2006, CELL CALCIUM, V40, P41, DOI 10.1016/j.ceca.2006.03.005; Kasri NN, 2005, MOL PHARMACOL, V68, P241, DOI 10.1124/mol.105.013045; Keddie NS, 2011, CHEM COMMUN, V47, P242, DOI 10.1039/c0cc03003a; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Kim HR, 2009, J CELL SCI, V122, P1126, DOI 10.1242/jcs.038430; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee GH, 2010, ONCOGENE, V29, P2130, DOI 10.1038/onc.2009.491; Lee GH, 2010, MOL CELL BIOL, V30, P1800, DOI 10.1128/MCB.01357-09; Li XY, 2010, CELL BIOL INT, V34, P1099, DOI 10.1042/CBI20090400; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Mackrill JJ, 1996, BIOCHEM J, V318, P871, DOI 10.1042/bj3180871; Madeo F, 2009, MOL CELL, V33, P669, DOI 10.1016/j.molcel.2009.03.002; MISSIAEN L, 1992, NATURE, V357, P599, DOI 10.1038/357599a0; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Oakes SA, 2003, BIOCHEM PHARMACOL, V66, P1335, DOI 10.1016/S0006-2952(03)00482-9; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Romagnoli A., 2007, NOVART FDN SYMP, V287, P131; Romagnoli Anna, 2007, Novartis Found Symp, V287, P122; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; Sammels E, 2010, CELL CALCIUM, V47, P297, DOI 10.1016/j.ceca.2010.02.001; Tanaka R, 2006, CANCER-AM CANCER SOC, V106, P648, DOI 10.1002/cncr.21639; Thomenius MJ, 2003, J CELL SCI, V116, P4493, DOI 10.1242/jcs.00829; Tovey SC, 2006, NAT PROTOC, V1, P259, DOI 10.1038/nprot.2006.40; Westphalen BC, 2005, CELL DEATH DIFFER, V12, P304, DOI 10.1038/sj.cdd.4401547; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Zhang MH, 2010, MOL CELL BIOCHEM, V333, P1, DOI 10.1007/s11010-009-0198-y	51	70	72	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2544	2557		10.1074/jbc.M111.275354	http://dx.doi.org/10.1074/jbc.M111.275354			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22128171	hybrid, Green Published			2022-12-25	WOS:000300292300028
J	Park, JH; Johansson, HE; Aoki, H; Huang, BX; Kim, HY; Ganoza, MC; Park, MH				Park, Jong-Hwan; Johansson, Hans E.; Aoki, Hiroyuki; Huang, Bill X.; Kim, Hee-Yong; Ganoza, M. Clelia; Park, Myung Hee			Post-translational Modification by beta-Lysylation Is Required for Activity of Escherichia coli Elongation Factor P (EF-P)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE-BOND SYNTHESIS; SYNTHESIS INITIATION-FACTORS; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; TRANSLATION ELONGATION; HYPUSINE MODIFICATION; BACILLUS-SUBTILIS; GENE-PRODUCT; EXPRESSION	Bacterial elongation factor P (EF-P) is the ortholog of archaeal and eukaryotic initiation factor 5A (eIF5A). EF-P shares sequence homology and crystal structure with eIF5A, but unlike eIF5A, EF-P does not undergo hypusine modification. Recently, two bacterial genes, yjeA and yjeK, encoding truncated homologs of class II lysyl-tRNA synthetase and of lysine-2,3-aminomutase, respectively, have been implicated in the modification of EF-P to convert a specific lysine to a hypothetical beta-lysyl-lysine. Here we present biochemical evidence for beta-lysyl-lysine modification in Escherichia coli EF-P and for its role in EF-P activity by characterizing native and recombinant EF-P proteins for their modification status and activity in vitro. Mass spectrometric analyses confirmed the lysyl modification at lysine 34 in native and recombinant EF-P proteins. The beta-lysyl-lysine isopeptide was identified in the exhaustive Pronase digests of native EF-P and recombinant EF-P isolated from E. coli coexpressing EF-P, YjeA, and YjeK but not in the digests of proteins derived from the vectors encoding EF-P alone or EF-P together with YjeA, indicating that both enzymes, YjeA and YjeK, are required for beta-lysylation of EF-P. Endogenous EF-P as well as the recombinant EF-P preparation containing beta-lysyl-EF-P stimulated N-formyl-methionyl-puromycin synthesis similar to 4-fold over the preparations containing unmodified EF-P and/or alpha-lysyl-EF-P. The mutant lacking the modification site lysine (K34A) was inactive. This is the first report of biochemical evidence for the beta-lysylation of EF-P in vivo and the requirement for this modification for the activity of EF-P.	[Johansson, Hans E.] Biosearch Technol Inc, Novato, CA 94949 USA; [Park, Jong-Hwan; Park, Myung Hee] NIDCR, Oral & Pharyngeal Canc Branch, Bethesda, MD 20892 USA; [Huang, Bill X.; Kim, Hee-Yong] NIAAA, Lab Mol Signaling, NIH, Bethesda, MD 20892 USA; [Aoki, Hiroyuki; Ganoza, M. Clelia] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Toronto	Johansson, HE (corresponding author), Biosearch Technol Inc, 81 Digital Dr, Novato, CA 94949 USA.	hjohansson@biosearchtech.com; mhpark@nih.gov	Johansson, Hans E./C-5113-2017	Johansson, Hans E./0000-0001-9495-6107; GANOZA MELGAREJO, MICHAEL RICHARD/0000-0003-0196-8104	NIDCR; NIAAA, National Institutes of Health; Carl Trygger Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000284] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAAA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Carl Trygger Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by the Intramural Research Program of NIDCR and NIAAA, National Institutes of Health. This work was also supported in part by a grant from the Carl Trygger Foundation (to H. E. J.).	Ambrogelly A, 2010, FEBS LETT, V584, P3055, DOI 10.1016/j.febslet.2010.05.036; Aoki H, 1997, BIOCHIMIE, V79, P7, DOI 10.1016/S0300-9084(97)87619-5; Aoki H, 1997, J BIOL CHEM, V272, P32254, DOI 10.1074/jbc.272.51.32254; AOKI H, 1991, NUCLEIC ACIDS RES, V19, P6215, DOI 10.1093/nar/19.22.6215; Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Behshad E, 2006, BIOCHEMISTRY-US, V45, P12639, DOI 10.1021/bi061328t; BENNE R, 1978, J BIOL CHEM, V253, P3078; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; BYERS TL, 1992, BIOCHEM J, V287, P717, DOI 10.1042/bj2870717; Chattopadhyay MK, 2008, P NATL ACAD SCI USA, V105, P6554, DOI 10.1073/pnas.0710970105; Chattopadhyay MK, 2009, J BACTERIOL, V191, P5549, DOI 10.1128/JB.00381-09; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; FOLK JE, 1980, J BIOL CHEM, V255, P3695; Ganoza MC, 2002, MICROBIOL MOL BIOL R, V66, P460, DOI 10.1128/MMBR.66.3.460-485.2002; Ganoza MC, 2000, BIOL CHEM, V381, P553, DOI 10.1515/BC.2000.071; GLICK BR, 1979, EUR J BIOCHEM, V97, P23, DOI 10.1111/j.1432-1033.1979.tb13081.x; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; GREEN RH, 1985, BIOCHEM BIOPH RES CO, V126, P792, DOI 10.1016/0006-291X(85)90254-2; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Henderson A, 2011, P NATL ACAD SCI USA, V108, P6415, DOI 10.1073/pnas.1008150108; Jansson BPM, 2000, J BACTERIOL, V182, P1158, DOI 10.1128/JB.182.4.1158-1161.2000; JOE YA, 1995, J BIOL CHEM, V270, P22386, DOI 10.1074/jbc.270.38.22386; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; KEMPER WM, 1976, J BIOL CHEM, V251, P5551; Kim KK, 1998, P NATL ACAD SCI USA, V95, P10419, DOI 10.1073/pnas.95.18.10419; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; Ma FS, 2010, PLANT CELL ENVIRON, V33, P1682, DOI 10.1111/j.1365-3040.2010.02173.x; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Ohashi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2245, DOI 10.1271/bbb.67.2245; Park JH, 2006, P NATL ACAD SCI USA, V103, P51, DOI 10.1073/pnas.0509348102; Park JH, 2011, PROTEIN ENG DES SEL, V24, P301, DOI 10.1093/protein/gzq110; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Tong YF, 2009, PROTEINS, V75, P1040, DOI 10.1002/prot.22378; Umland TC, 2004, J BIOL CHEM, V279, P28697, DOI 10.1074/jbc.M404095200; Xu JY, 2011, PLANT MOL BIOL, V75, P167, DOI 10.1007/s11103-010-9716-2; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Zanelli CF, 2007, AMINO ACIDS, V33, P351, DOI 10.1007/s00726-007-0533-0; Zou SB, 2011, VIRULENCE, V2, P147, DOI 10.4161/viru.2.2.15039	44	46	50	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2579	2590		10.1074/jbc.M111.309633	http://dx.doi.org/10.1074/jbc.M111.309633			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22128152	hybrid, Green Published			2022-12-25	WOS:000300292300031
J	Altun, M; Zhao, B; Velasco, K; Liu, HY; Hassink, G; Paschke, J; Pereira, T; Lindsten, K				Altun, Mikael; Zhao, Bin; Velasco, Kelly; Liu, Haiyin; Hassink, Gerco; Paschke, Julia; Pereira, Teresa; Lindsten, Kristina			Ubiquitin-specific Protease 19 (USP19) Regulates Hypoxia-inducible Factor 1 alpha (HIF-1 alpha) during Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYME; PROLYL HYDROXYLATION; DEGRADATION; SUPPRESSION; STABILITY; MECHANISM; PROTEINS; BINDING; DOMAIN; ALPHA	A proper cellular adaptation to low oxygen levels is essential for processes such as development, growth, metabolism, and angiogenesis. The response to decrease in oxygen supply, referred to as hypoxia, is also involved in numerous human diseases including cancer, inflammatory conditions, and vascular disease. The hypoxia-inducible factor 1-alpha (HIF-1 alpha), a key player in the hypoxic response, is kept under stringent regulation. At normoxia, the levels are kept low as a consequence of the efficient degradation by the ubiquitin-proteasome system, and in response to hypoxia, the degradation is blocked and the accumulating HIF-1 alpha promotes a transcriptional response essential for proper adaptation and survival. Here we show that the ubiquitin-specific protease-19 (USP19) interacts with components of the hypoxia pathway including HIF-1 alpha and rescues it from degradation independent of its catalytic activity. In the absence of USP19, cells fail to mount an appropriate response to hypoxia, indicating an important role for this enzyme in normal or pathological conditions.	[Altun, Mikael; Zhao, Bin; Velasco, Kelly; Liu, Haiyin; Hassink, Gerco; Paschke, Julia; Pereira, Teresa; Lindsten, Kristina] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Altun, Mikael] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Lindsten, K (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Box 285, S-17177 Stockholm, Sweden.	kristina.lindsten@ki.se	Altun, Mikael/AAF-5496-2020; Pereira, Teresa/AAP-8197-2020; Zhao, Bin/F-1055-2018; Altun, Mikael/AAI-9527-2020; Zhao, Bin/ABB-6186-2021	Pereira, Teresa/0000-0001-8654-2385; Zhao, Bin/0000-0001-7065-2416; Altun, Mikael/0000-0002-6937-6124; Zhao, Bin/0000-0001-7065-2416; Velasco, Kelly/0000-0002-9376-6034; Liu, Haiyin/0000-0003-3103-6949	Swedish Research council; Karolinska Institutet; Magn Bergvalls stiftelse; Ake Wibergs Stiftelse; Swedish Cancer Society; ERACOL	Swedish Research council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Magn Bergvalls stiftelse; Ake Wibergs Stiftelse; Swedish Cancer Society(Swedish Cancer Society); ERACOL	This work was supported by grants from the Swedish Research council (to K. L., T. P., and M. A.), Karolinska Institutet (to K. L., B. Z., and M. A.), Magn Bergvalls stiftelse (to K. L.), Ake Wibergs Stiftelse (to K. L.), The Swedish Cancer Society (to T. P.), and ERACOL (to K. V.).	Andre H, 2008, J BIOL CHEM, V283, P29375, DOI 10.1074/jbc.M805919200; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; Combaret L, 2005, AM J PHYSIOL-ENDOC M, V288, pE693, DOI 10.1152/ajpendo.00281.2004; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Heikkila M, 2011, CELL MOL LIFE SCI, V68, P3885, DOI 10.1007/s00018-011-0679-5; Hock A, 2010, INT J BIOCHEM CELL B, V42, P1618, DOI 10.1016/j.biocel.2010.06.011; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hubbi ME, 2011, MOL CELL, V42, P700, DOI 10.1016/j.molcel.2011.03.029; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Li ZB, 2005, EMBO REP, V6, P373, DOI 10.1038/sj.embor.7400377; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Mei YD, 2011, J BIOL CHEM, V286, P35380, DOI 10.1074/jbc.M111.282020; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nakayama K, 2009, MOL CANCER RES, V7, P443, DOI 10.1158/1541-7786.MCR-08-0458; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Ratcliffe PJ, 1998, J EXP BIOL, V201, P1153; Roperch JP, 1999, P NATL ACAD SCI USA, V96, P8070, DOI 10.1073/pnas.96.14.8070; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064	46	59	66	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1962	1969		10.1074/jbc.M111.305615	http://dx.doi.org/10.1074/jbc.M111.305615			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128162	Green Published, hybrid			2022-12-25	WOS:000299321000037
J	Bonitz, T; Alva, V; Saleh, O; Lupas, AN; Heide, L				Bonitz, Tobias; Alva, Vikram; Saleh, Orwah; Lupas, Andrei N.; Heide, Lutz			Evolutionary Relationships of Microbial Aromatic Prenyltransferases	PLOS ONE			English	Article							PROTEIN HOMOLOGY DETECTION; ESCHERICHIA-COLI; STRUCTURAL BASIS; BIOSYNTHESIS; GENE; IDENTIFICATION; DATABASE; SUPERFAMILY; PRENYLATION; EXPRESSION	The linkage of isoprenoid and aromatic moieties, catalyzed by aromatic prenyltransferases (PTases), leads to an impressive diversity of primary and secondary metabolites, including important pharmaceuticals and toxins. A few years ago, a hydroxynaphthalene PTase, NphB, featuring a novel ten-stranded beta-barrel fold was identified in Streptomyces sp. strain CL190. This fold, termed the PT-barrel, is formed of five tandem alpha alpha beta beta structural repeats and remained exclusive to the NphB family until its recent discovery in the DMATS family of indole PTases. Members of these two families exist only in fungi and bacteria, and all of them appear to catalyze the prenylation of aromatic substrates involved in secondary metabolism. Sequence comparisons using PSI-BLAST do not yield matches between these two families, suggesting that they may have converged upon the same fold independently. However, we now provide evidence for a common ancestry for the NphB and DMATS families of PTases. We also identify sequence repeats that coincide with the structural repeats in proteins belonging to these two families. Therefore we propose that the PT-barrel arose by amplification of an ancestral alpha alpha beta beta module. In view of their homology and their similarities in structure and function, we propose to group the NphB and DMATS families together into a single superfamily, the PT-barrel superfamily.	[Bonitz, Tobias; Saleh, Orwah; Heide, Lutz] Univ Tubingen, Inst Pharmaceut, Tubingen, Germany; [Alva, Vikram; Lupas, Andrei N.] Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society	Bonitz, T (corresponding author), Univ Tubingen, Inst Pharmaceut, Tubingen, Germany.	heide@uni-tuebingen.de	Alva, Vikram/D-9378-2010	Alva, Vikram/0000-0003-1188-473X; Heide, Lutz/0000-0001-7809-7453	German Federal Ministry of Education and Research (BMBF GenBioCom)	German Federal Ministry of Education and Research (BMBF GenBioCom)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the German Federal Ministry of Education and Research (BMBF GenBioCom) to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alva V, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-17; Alva V, 2010, PROTEIN SCI, V19, P124, DOI 10.1002/pro.297; ASAI K, 1994, BIOCHEM BIOPH RES CO, V202, P340, DOI 10.1006/bbrc.1994.1933; Awakawa T, 2011, CHEMBIOCHEM, V12, P439, DOI 10.1002/cbic.201000628; Balibar CJ, 2007, NAT CHEM BIOL, V3, P584, DOI 10.1038/nchembio.2007.20; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Brauer L, 2008, CHEMBIOCHEM, V9, P982, DOI 10.1002/cbic.200700575; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Cheng H, 2008, NUCLEIC ACIDS RES, V36, pD211, DOI 10.1093/nar/gkm698; Chooi YH, 2010, CHEM BIOL, V17, P483, DOI 10.1016/j.chembiol.2010.03.015; Copley RR, 2000, J MOL BIOL, V303, P627, DOI 10.1006/jmbi.2000.4152; Dairi T, 2005, J ANTIBIOT, V58, P227, DOI 10.1038/ja.2005.27; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edwards DJ, 2004, J AM CHEM SOC, V126, P11432, DOI 10.1021/ja047876g; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Huang HR, 2005, J BIOL CHEM, V280, P24539, DOI 10.1074/jbc.M504068200; Itoh T, 2010, NAT CHEM, V2, P858, DOI [10.1038/NCHEM.764, 10.1038/nchem.764]; Jost M, 2010, J AM CHEM SOC, V132, P17849, DOI 10.1021/ja106817c; Koeduka T, 2011, PLANT BIOLOGY, V13, P411, DOI 10.1111/j.1438-8677.2010.00409.x; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; Kumano T, 2008, BIOORGAN MED CHEM, V16, P8117, DOI 10.1016/j.bmc.2008.07.052; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li SM, 2009, APPL MICROBIOL BIOT, V84, P631, DOI 10.1007/s00253-009-2128-z; Macone A, 2009, BIOORGAN MED CHEM, V17, P6003, DOI 10.1016/j.bmc.2009.06.061; MELZER M, 1994, BBA-LIPID LIPID MET, V1212, P93, DOI 10.1016/0005-2760(94)90193-7; Metzger U, 2010, J MOL BIOL, V404, P611, DOI 10.1016/j.jmb.2010.09.067; Metzger U, 2009, P NATL ACAD SCI USA, V106, P14309, DOI 10.1073/pnas.0904897106; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; Oster U, 1997, J BIOL CHEM, V272, P9671; Ozaki T, 2009, J ANTIBIOT, V62, P385, DOI 10.1038/ja.2009.48; Pojer F, 2003, P NATL ACAD SCI USA, V100, P2316, DOI 10.1073/pnas.0337708100; Poulter C. Dale, 2006, Phytochemistry Reviews, V5, P17, DOI 10.1007/s11101-005-4887-1; Remmert M, 2010, MOL BIOL EVOL, V27, P1348, DOI 10.1093/molbev/msq017; Sadreyev R, 2003, J MOL BIOL, V326, P317, DOI 10.1016/S0022-2836(02)01371-2; SAIKI K, 1992, BIOCHEM BIOPH RES CO, V189, P1491, DOI 10.1016/0006-291X(92)90243-E; Savidge B, 2002, PLANT PHYSIOL, V129, P321, DOI 10.1104/pp.010747; Schultz AW, 2010, J NAT PROD, V73, P373, DOI 10.1021/np9006876; Shindo K, 2011, BIOSCI BIOTECH BIOCH, V75, P505, DOI 10.1271/bbb.100731; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW137, DOI 10.1093/nar/gkl130; Stec E, 2011, CHEMBIOCHEM, V12, P1724, DOI 10.1002/cbic.201100188; Steffan N, 2009, CURR MED CHEM, V16, P218, DOI 10.2174/092986709787002772; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; Takahashi S, 2010, J BACTERIOL, V192, P2839, DOI 10.1128/JB.01557-09; Tello M, 2008, CELL MOL LIFE SCI, V65, P1459, DOI 10.1007/s00018-008-7579-3; Xiao YL, 2009, MOL BIOSYST, V5, P913, DOI 10.1039/b902370d; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zou HX, 2011, APPL MICROBIOL BIOT, V89, P1443, DOI 10.1007/s00253-010-2956-x	59	62	67	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27336	10.1371/journal.pone.0027336	http://dx.doi.org/10.1371/journal.pone.0027336			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140437	gold, Green Submitted, Green Published			2022-12-25	WOS:000298168100008
J	Nesbitt, SJ; Ksepka, DT; Clarke, JA				Nesbitt, Sterling J.; Ksepka, Daniel T.; Clarke, Julia A.			Podargiform Affinities of the Enigmatic Fluvioviridavis platyrhamphus and the Early Diversification of Strisores ("Caprimulgiformes" plus Apodiformes)	PLOS ONE			English	Article							GREEN RIVER FORMATION; MIDDLE EOCENE; PHYLOGENETIC ANALYSIS; FOSSIL RECORD; AVES; BIRDS; PALEOGENE; MESSEL; MOUSEBIRD; NIGHTJARS	Background: The early Eocene Green River Formation avifauna preserves exceptional exemplars of the earliest unambiguous stem representatives of many extant avian clades. We identify the basal-most member of Podargiformes (extant and fossil stem lineage frogmouths) based on a new specimen of Fluvioviridavis platyrhamphus, a unique neoavian bird from the Fossil Butte Member of the Green River Formation of Wyoming. Extant frogmouths (Podargidae) comprise approximately 13 nocturnal species with an exclusively Australasian distribution. Methodology/Principal Findings: The new specimen was included in a combined phylogenetic analysis of morphological (osteology and soft tissue) and molecular sequence (cytochrome b, c-myc exon 3, and RAG) data sampling species-level taxa from both extant and extinct members of Steatornithidae, Podargidae, Caprimulgidae, Nyctibiidae, Aegothelidae, and Apodiformes (=Strisores). New data from F. platyrhamphus help resolve phylogenetic relationships within Strisores, supporting placement of F. platyrhamphus and the European fossil form Masillapodargus longipes as basal parts of Podargiformes and also supporting a sister taxon relationship between Podargiformes and Steatornithiformes (oilbirds) within Strisores. This relationship is recovered only when fossil taxa are included, reaffirming the potential impact of stem fossil taxa on inferences of phylogenetic relationships. The well-preserved mandible and palate of the new specimen demonstrate that many of the unique characteristics of the skull that characterize the crown frogmouth clade Podargidae arose early in the evolutionary history of the clade, over 50 million years ago. Comparisons with the new specimen also indicate that Eurofluvioviridavis and Fluvioviridavis are not closely related. Conclusions/Significance: Together with the European fossil frogmouth Masillapodargus, Fluvioviridavis shows that Podargiformes had a much wider geographic distribution in the past, whereas extant species are restricted to Australasia. The Eocene record of Strisores from the Green River Formation and Messel Formation indicates most major subclade divergences had already occurred by the early-middle Eocene.	[Nesbitt, Sterling J.; Clarke, Julia A.] Univ Texas Austin, Jackson Sch Geosci, Dept Geol Sci, Austin, TX 78712 USA; [Ksepka, Daniel T.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; [Ksepka, Daniel T.] N Carolina Museum Nat Sci, Dept Paleontol, Raleigh, NC USA	University of Texas System; University of Texas Austin; University of North Carolina; North Carolina State University	Nesbitt, SJ (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Dept Geol Sci, Austin, TX 78712 USA.	nesbitt@jsg.utexas.edu	Ksepka, Daniel/A-2007-2009	Nesbitt, Sterling/0000-0002-7017-1652	National Science Foundation Division of Earth Sciences [0938199, 0719943]; Directorate For Geosciences [0938199] Funding Source: National Science Foundation	National Science Foundation Division of Earth Sciences(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project was supported by the National Science Foundation Division of Earth Sciences (grants 0938199 to JAC and 0719943 to LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird S. F., 1858, REPORTS EXPLORATIONS; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Blondel J, 1998, TRENDS ECOL EVOL, V13, P488, DOI 10.1016/S0169-5347(98)01461-X; Bonaparte C.L.J.L., 1838, NUOVI ANN SCI NATURE, V2, P105; Braun MJ, 2009, MOL PHYLOGENET EVOL, V53, P948, DOI 10.1016/j.ympev.2009.08.025; BRODKORB P, 1970, Contributions to Geology University of Wyoming, V9, P13; Buchheim HP, 1997, GEOLOGICAL SOC AM AB, V29, pA105; Clarke JA, 2009, ZOOL J LINN SOC-LOND, V157, P586, DOI 10.1111/j.1096-3642.2009.00550.x; Cleere N, 2007, IBIS, V149, P271, DOI 10.1111/j.1474-919X.2006.00626.x; CODDINGTON J, 1994, CLADISTICS, V10, P415; Cracraft J, 2004, ASSEMBLING THE TREE OF LIFE, P468; Cushman RAJ, 1999, NPSNRGRDGRDTR9903, V4, P67; Eastman C. R., 1900, Geological Magazine, V(2), P54; Elzanowski A, 2009, J MORPHOLOGY; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Eugster HP, 1998, MODERN ANCIENT LACUS, P1; Fain MG, 2004, EVOLUTION, V58, P2558; Feduccia A., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P101; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; Frakes L. A, 1992, CLIMATE MODES PHANER; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Grande L., 1985, B GEOLOGICAL SURVEY, V63, P1; Grande L, 1994, CONTRIBUTIONS GEOLOG, V30, P13; Grande Lance, 1994, Contributions to Geology University of Wyoming, V30, P33; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HOLYOAK DT, 1999, HDB BIRDS WORLD, V5, P266; Houde P, PAPERS AVIAN PALEONT, P137; Houde PW., 1988, PALEOGNATHOUS BIRDS; James HF, 2005, AUK, V122, P1049, DOI 10.1642/0004-8038(2005)122[1049:PFATRO]2.0.CO;2; Ksepka DT, 2010, ZOOL J LINN SOC-LOND, V160, P685, DOI 10.1111/j.1096-3642.2009.00626.x; Ksepka DT, 2010, J VERTEBR PALEONTOL, V30, P215, DOI 10.1080/02724630903412414; Ksepka DT, 2009, AUK, V126, P245, DOI 10.1525/auk.2009.07178; Ksepka DT, J PALEONTOL IN PRESS; Livezey Bradley C., 2006, Bulletin of Carnegie Museum of Natural History, V37, P1; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; MacGinitie H.D., 1969, U CALIF PUBLS GEOL S, V83, P1; Mathews GM, 1918, BIRDS AUSTR; Mayr G, 2005, BIOL REV, V80, P515, DOI 10.1017/S1464793105006779; Mayr G, 2003, CLADISTICS, V19, P527, DOI [10.1016/j.cladistics.2003.10.003, 10.1111/j.1096-0031.2003.tb00387.x]; Mayr G, 1999, NEUES JAHRB GEOL P M, P312; Mayr G, 2005, CAN J EARTH SCI, V42, P2021, DOI 10.1139/E05-060; Mayr G, 2005, J SYST PALAEONTOL, V3, P359, DOI 10.1017/S1477201905001653; Mayr G, 2004, J VERTEBR PALEONTOL, V24, P366, DOI 10.1671/1970; Mayr G, 2004, J SYST PALAEONTOL, V2, P1; Mayr G, 2004, ACTA PALAEONTOL POL, V49, P211; Mayr G, 2004, SCIENCE, V304, P861, DOI 10.1126/science.1096856; Mayr G, 2003, AUK, V120, P145, DOI 10.1642/0004-8038(2003)120[0145:POETSA]2.0.CO;2; Mayr G, 2002, J ORNITHOL, V143, P82, DOI 10.1007/BF02465461; Mayr G, 1999, J VERTEBR PALEONTOL, V19, P521, DOI 10.1080/02724634.1999.10011162; Mayr G, 2001, ACTA PALAEONTOL POL, V46, P393; Mayr G, 2001, NEUES JAHRB GEOL P-M, P65; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Mayr Gerald, 1998, Courier Forschungsinstitut Senckenberg, V205, P1; Mayr Gerald, 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V3, P207; Mayr G, 2010, J ZOOL SYST EVOL RES, V48, P126, DOI 10.1111/j.1439-0469.2009.00552.x; McGrew PO, 1975, 3 NAT PARK SERV; Mertz D.F., 2005, COUR FORSCH I SENCKE, V255, P67; Morgan-Richards M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-20; MOURER-CHAUVIRE C., 1989, ACT 19 C INT ORN, P2047; Olson S.L., 1985, Avian Biology, V8, P79; Olson S.L., 1987, Documents des Laboratoires de Geologie de la Faculte des Sciences de Lyon, P57; Olson S.L., 1977, Smithsonian Contr. Paleobiol., VNo. 35, P1; Olson SL, 2005, ZOOTAXA, P1; Olson SL, PAPERS AVIAN PALEONT, P127; PETERS D S, 1985, Senckenbergiana Lethaea, V66, P143; Reed EH, 2009, T ROY SOC SOUTH AUST, V133, P30, DOI 10.1080/03721426.2009.10887108; Schweizer MK, 2007, PALEOBIOLOGY, V33, P590, DOI 10.1666/05079.1; Smith ME, 2008, GEOL SOC AM BULL, V120, P54, DOI 10.1130/B26073.1; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Weidig I, 2006, PALAEONT Z, V80, P230, DOI 10.1007/BF02988439; Weidig I, 2010, REC AUST MUS, V62, P29, DOI 10.3853/j.0067-1975.62.2010.1544; [No title captured]	72	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e26350	10.1371/journal.pone.0026350	http://dx.doi.org/10.1371/journal.pone.0026350			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140427	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100004
J	Batts, TD; Machado, HL; Zhang, YQ; Creighton, CJ; Li, Y; Rosen, JM				Batts, Torey D.; Machado, Heather L.; Zhang, Yiqun; Creighton, Chad J.; Li, Yi; Rosen, Jeffrey M.			Stem Cell Antigen-1 (Sca-1) Regulates Mammary Tumor Development and Cell Migration	PLOS ONE			English	Article							BREAST-CANCER; MOUSE MODEL; GROWTH-FACTOR; TGF-BETA; EXPRESSION; TUMORIGENESIS; GLAND; IDENTIFICATION; VISUALIZATION; PROGRESSION	Background: Stem cell antigen-1 (Sca-1 or Ly6A) is a glycosyl phostidylinositol (GPI)-anchored cell surface protein associated with both stem and progenitor activity, as well as tumor initiating-potential. However, at present the functional role for Sca-1 is poorly defined. Methodology/Principal Findings: To investigate the role of Sca-1 in mammary tumorigenesis, we used a mammary cell line derived from a MMTV-Wnt1 mouse mammary tumor that expresses high levels of endogenous Sca-1. Using shRNA knockdown, we demonstrate that Sca-1 expression controls cell proliferation during early tumor progression in mice. Functional limiting dilution transplantations into recipient mice demonstrate that repression of Sca-1 increases the population of tumor propagating cells. In scratch monolayer assays, Sca-1 enhances cell migration. In addition, knockdown of Sca-1 was shown to affect cell adhesion to a number of different extracellular matrix components. Microarray analysis indicates that repression of Sca-1 leads to changes in expression of genes involved in proliferation, cell migration, immune response and cell organization. Conclusions/Significance: Sca-1 exerts marked effects on cellular activity and tumorgenicity both in vitro and in vivo. A better understanding of Sca-1 function may provide insight into the broader role of GPI-anchored cell surface proteins in cancer.	[Batts, Torey D.] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; [Machado, Heather L.; Li, Yi; Rosen, Jeffrey M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Zhang, Yiqun; Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Li, Yi] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Batts, TD (corresponding author), Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA.	jrosen@bcm.edu	Zhang, YiQun/HCI-2427-2022; Li, Yi/A-7635-2009	Li, Yi/0000-0002-9976-518X	National Cancer Institute [CA16303, CA084243-S01]; National Institutes of Health [GM056929]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, U19AI067854] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by a grant from the National Cancer Institute, CA16303 (JMR), a research supplement to promote diversity in health related research CA084243-S01 (TDB) and National Institutes of Health GM056929 (JMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Epting CL, 2008, J CELL PHYSIOL, V217, P250, DOI 10.1002/jcp.21500; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jo M, 2007, ONCOGENE, V26, P2585, DOI 10.1038/sj.onc.1210066; Kafadar KA, 2009, DEV BIOL, V326, P47, DOI 10.1016/j.ydbio.2008.10.036; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Medina D, 1996, J MAMMARY GLAND BIOL, V1, P5, DOI 10.1007/BF02096299; Pond AC, 2010, CANCER RES, V70, P4868, DOI 10.1158/0008-5472.CAN-09-4404; Roarty K, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2244; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schwertfeger KL, 2006, CANCER RES, V66, P5676, DOI 10.1158/0008-5472.CAN-05-3781; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Ulisse S, 2009, CURR CANCER DRUG TAR, V9, P32, DOI 10.2174/156800909787314002; Upadhyay G, 2011, P NATL ACAD SCI USA, V108, P7820, DOI 10.1073/pnas.1103441108; Wang YF, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-84; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Witz IP, 2000, J CELL BIOCHEM, P61; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Yuan H, 2011, CANC PREV R IN PRESS; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	29	26	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27841	10.1371/journal.pone.0027841	http://dx.doi.org/10.1371/journal.pone.0027841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140470	gold, Green Published, Green Submitted			2022-12-25	WOS:000298166300012
J	Guo, W; Song, YB; Yu, FH				Guo, Wei; Song, Yao-Bin; Yu, Fei-Hai			Heterogeneous Light Supply Affects Growth and Biomass Allocation of the Understory Fern Diplopterygium glaucum at High Patch Contrast	PLOS ONE			English	Article							DIVISION-OF-LABOR; CLONAL INTEGRATION; PHYSIOLOGICAL INTEGRATION; FRAGARIA-CHILOENSIS; GLECHOMA-HEDERACEA; ENVIRONMENTAL HETEROGENEITY; RAMETS; HERB; PLASTICITY; FOREST	Spatial heterogeneity in resource supply is common and responses to heterogeneous resource supply have been extensively documented in clonal angiosperms but not in pteridophytes. To test the hypotheses that clonal integration can modify responses of pteridophytes to heterogeneous resource supply and the integration effect is larger at higher patch contrast, we conducted a field experiment with three homogeneous and two heterogeneous light treatments on the rhizomatous, understory fern Diplopterygium glaucum in an evergreen broad-leaved forest in East China. In homogeneous treatments, all D. glaucum ramets in 1.5 mx1.5 m units were subjected to 10, 40 and 100% natural light, respectively. In the heterogeneous treatment of low patch contrast, ramets in the central 0.5 mx0.5 m plots of the units were subjected to 40% natural light and their interconnected ramets in the surrounding area of the units to 100%; in the heterogeneous treatment of high patch contrast, ramets in the central plots were subjected to 10% natural light and those in the surrounding area to 100%. In the homogeneous treatments, biomass and number of living ramets in the central plots decreased and number of dead ramets increased with decreasing light supply. At low contrast heterogeneous light supply did not affect performance or biomass allocation of D. glaucum in the central plots, but at high contrast it increased lamina biomass and number of living ramets older than annual and modified biomass allocation to lamina and rhizome. Thus, clonal integration can affect responses of understory ferns to heterogeneous light supply and ramets in low light patches can be supported by those in high light. The results also suggest that effects of clonal integration depend on the degree of patch contrast and a significant integration effect may be found only under a relatively high patch contrast.	[Guo, Wei; Yu, Fei-Hai] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Song, Yao-Bin] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Botany, CAS	Guo, W (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	feihaiyu@bjfu.edu.cn	Yu, Fei-Hai/O-9395-2016	Yu, Fei-Hai/0000-0001-5007-1745	Fundamental Research Funds for the Central Universities [JC2011-4]; National Science Foundation of China [31070371]; CAS [KZCX2-YW-430]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences)	FHY thanks the support from the Fundamental Research Funds for the Central Universities (Grant JC2011-4), the National Science Foundation of China (Grant 31070371), and the Important Directional Item of CAS Knowledge Innovative Project (KZCX2-YW-430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 1996, VEGETATIO, V122, P83, DOI 10.1007/BF00052818; Alpert P, 1999, OECOLOGIA, V120, P69, DOI 10.1007/s004420050834; Caldwell M.M., 1994, EXPLOITATION ENV HET; CARACO T, 1991, ECOLOGY, V72, P81, DOI 10.2307/1938904; Chen JS, 2006, PLANT ECOL, V183, P147, DOI 10.1007/s11258-005-9013-3; Chen JS, 2010, ACTA OECOL, V36, P23, DOI 10.1016/j.actao.2009.09.006; de Kroon J.M, 1990, CLONAL GROWTH PLANTS; de la Cretaz AL, 2002, RESTOR ECOL, V10, P416, DOI 10.1046/j.1526-100X.2002.02037.x; Ding B-Y, 2001, J ZHEJIANG U, V27, P370; DONG M, 1995, OECOLOGIA, V101, P282, DOI 10.1007/BF00328813; Dong M, 1999, PLANT ECOL, V141, P53, DOI 10.1023/A:1009875000149; Du JA, 2010, FLORA, V205, P399, DOI 10.1016/j.flora.2009.12.018; FRIEDMAN D, 1991, OECOLOGIA, V86, P76, DOI 10.1007/BF00317392; George LO, 1999, ECOLOGY, V80, P833, DOI 10.1890/0012-9658(1999)080[0833:TFUAAE]2.0.CO;2; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; JACKSON RB, 1993, ECOLOGY, V74, P612, DOI 10.2307/1939320; Janecek S, 2008, EVOL ECOL, V22, P325, DOI 10.1007/s10682-007-9203-7; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Kroon H.D., 1997, ECOLOGY EVOLUTION CL; LAU RR, 1988, ECOLOGY, V69, P215, DOI 10.2307/1943177; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Li Yuan-Heng, 2008, Zhiwu Shengtai Xuebao, V32, P1166, DOI 10.3773/j.issn.1005-264x.2008.05.021; Liu J, 2008, PHOTOSYNTHETICA, V46, P299, DOI 10.1007/s11099-008-0054-4; Lu S.G., 2007, PTERIDOLOGY; Nilsson J, 2008, EVOL ECOL, V22, P437, DOI 10.1007/s10682-007-9199-z; Qian C-S, 1959, FLORA REPUBLICAE POP; Railing CA, 2000, AM FERN J, V90, P77, DOI 10.2307/1547416; Roiloa SR, 2006, ANN BOT-LONDON, V98, P1043, DOI 10.1093/aob/mcl185; Roiloa SR, 2007, J ECOL, V95, P397, DOI 10.1111/j.1365-2745.2007.01216.x; Saitoh T, 2002, J ECOL, V90, P78, DOI 10.1046/j.0022-0477.2001.00631.x; SLADE AJ, 1987, J ECOL, V75, P1023, DOI 10.2307/2260311; Stuefer JF, 1996, VEGETATIO, V127, P55, DOI 10.1007/BF00054847; STUEFER JF, 1994, J ECOL, V82, P511, DOI 10.2307/2261260; Van Kleunen M, 2000, J EVOLUTION BIOL, V13, P237; Wang ZW, 2004, ACTA OECOL, V26, P255, DOI 10.1016/j.actao.2004.08.007; Wijesinghe DK, 1999, J ECOL, V87, P860, DOI 10.1046/j.1365-2745.1999.00395.x; Wijesinghe DK, 1996, OIKOS, V77, P137, DOI 10.2307/3545593; Zhang LL, 2009, FLORA, V204, P628, DOI 10.1016/j.flora.2008.09.003; Zhang LL, 2009, FLORA, V204, P182, DOI 10.1016/j.flora.2008.02.001; Zhang XQ, 2006, FLORA, V201, P547, DOI 10.1016/j.flora.2005.12.002	40	23	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27998	10.1371/journal.pone.0027998	http://dx.doi.org/10.1371/journal.pone.0027998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132189	Green Submitted, Green Published, gold			2022-12-25	WOS:000298162000057
J	Puhakka, L; Salo, M; Saaksjarvi, IE				Puhakka, Liisa; Salo, Matti; Saaksjarvi, Ilari E.			Bird Diversity, Birdwatching Tourism and Conservation in Peru: A Geographic Analysis	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; ENVIRONMENTAL SERVICES; ANDES; POPULATION; ECOTOURISM; EASEMENTS; PAYMENTS; IMPACTS; CONTEXT	In the face of the continuing global biodiversity loss, it is important not only to assess the need for conservation, through e. g. gap analyses, but also to seek practical solutions for protecting biodiversity. Environmentally and socially sustainable tourism can be one such solution. We present a method to spatially link data on conservation needs and tourism-based economic opportunities, using bird-related tourism in Peru as an example. Our analysis highlighted areas in Peru where potential for such projects could be particularly high. Several areas within the central and northern Andean regions, as well as within the lowland Amazonian regions of Madre de Dios and Loreto emerge as promising for this type of activity. Mechanisms to implement conservation in these areas include e. g. conservation and ecotourism concessions, private conservation areas, and conservation easements. Some of these mechanisms also offer opportunities for local communities seeking to secure their traditional land ownership and use rights. (Spanish language abstract, Abstract S1).	[Puhakka, Liisa; Salo, Matti; Saaksjarvi, Ilari E.] Univ Turku, Dept Biol, SF-20500 Turku, Finland	University of Turku	Puhakka, L (corresponding author), Univ Turku, Dept Biol, SF-20500 Turku, Finland.	lhpuha@utu.fi	Salo, Matti/D-3292-2011	Salo, Matti/0000-0002-6328-5299	Centre for International Mobility CIMO; Turun Suomalaisen Saastopankin Stipendirahasto; Turun Suomalainen yliopistoseura ry; Kone foundation	Centre for International Mobility CIMO; Turun Suomalaisen Saastopankin Stipendirahasto; Turun Suomalainen yliopistoseura ry; Kone foundation	The work of LP was financed by the Centre for International Mobility CIMO (www.cimo.fi) via the North South Higher Education Programme, as well as by Turun Suomalaisen Saastopankin Stipendirahasto, Turun Suomalainen yliopistoseura ry (http://www.utu.fi/yliopistoseura/) and Kone foundation (http://www.koneensaatio.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo Pratolongo F, 2009, BIRDLIFE CONSERVATIO, V16, P307; Ashley C., 1998, IIED WILDLIFE DEV SE, V11; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Capella JL, 2007, MANUAL INSTRUMENTOS; Christ C, 2003, TOURISM BIODIVERSITY; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Devenish C, 2009, IMPORTANT BIRD AREAS, P456; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Fjeldsa J, 2005, AMBIO, V34, P205, DOI 10.1639/0044-7447(2005)034[0205:ICAACA]2.0.CO;2; Fjeldsa J, 2007, BIODIVERS CONSERV, V16, P2739, DOI 10.1007/s10531-007-9204-4; Fjeldsa J, 2009, ANN MO BOT GARD, V96, P398, DOI 10.3417/2007148; Font X, 2002, TOURISM MANAGE, V23, P197, DOI 10.1016/S0261-5177(01)00084-X; Franke I, 2005, SERIE CONSERVACION B, P471; Hayward MW, 2011, BIODIVERSIT IN PRESS, DOI [10.1007/s10531-10011-10091-10533, DOI 10.1007/S10531-10011-10091-10533]; IUCN and UNEP, 2010, WORLD DAT PROT AR WD; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Kiesecker JM, 2007, FRONT ECOL ENVIRON, V5, P125, DOI 10.1890/1540-9295(2007)5[125:CEICAQ]2.0.CO;2; Korngold G., 2007, SSRN ELECT J, DOI [10.2139/ssrn.1004363, DOI 10.2139/SSRN.1004363]; Kruger O, 2005, BIODIVERS CONSERV, V14, P579, DOI 10.1007/s10531-004-3917-4; Llambi LD, 2005, MT RES DEV, V25, P200, DOI 10.1659/0276-4741(2005)025[0200:PPFBCI]2.0.CO;2; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Merenlender AM, 2004, CONSERV BIOL, V18, P65, DOI 10.1111/j.1523-1739.2004.00401.x; MINCETUR, 2011, PER IND TRIM TUR 200; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nelson A, 2008, CHRISTIAN TRAVEL PLA; O'Hare G, 1999, GEOGR J, V165, P47, DOI 10.2307/3060510; Ohl-Schacherer J, 2008, ENVIRON CONSERV, V35, P14, DOI 10.1017/S0376892908004517; Pagiola S, 2008, ECOL ECON, V65, P712, DOI 10.1016/j.ecolecon.2007.07.033; Plenge M, 2010, LIST BIRDS PERU; Promperu, 2011, PERF TUR EXTR; Puhakka L, 2008, THESIS U TURKU TURKU; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sandbrook CG, 2010, J INT DEV, V22, P124, DOI 10.1002/jid.1507; SCHULENBERG T.S., 2007, BIRDS PERU; Schulenberg TS, 2006, DISTRIBUTION MAPS BI; Schulman L, 2007, BIODIVERS CONSERV, V16, P3011, DOI 10.1007/s10531-007-9158-6; Seidl AF, 2000, ECOL ECON, V33, P1, DOI 10.1016/S0921-8009(99)00146-9; Sekercioglu CH, 2002, ENVIRON CONSERV, V29, P282, DOI 10.1017/S0376892902000206; [SERNANP INEI], 2011, SIST AR NAT PROT EST; [SERNANP INEI], 2011, MAP AR NAT PROT; Valqui T, 2005, PERU EDEN NATURAL AV; Valqui T., 2004, WATCH BIRDS PERU; Walpole MJ, 2000, ANN TOURISM RES, V27, P559, DOI 10.1016/S0160-7383(99)00088-2; Young BF, 2009, AUK, V126, P554, DOI 10.1525/auk.2009.08155	45	18	22	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e26786	10.1371/journal.pone.0026786	http://dx.doi.org/10.1371/journal.pone.0026786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KL	22132078	Green Submitted, Green Published, gold			2022-12-25	WOS:000298162000005
J	Pilon-Thomas, S; Nelson, N; Vohra, N; Jerald, M; Pendleton, L; Szekeres, K; Ghansah, T				Pilon-Thomas, Shari; Nelson, Nadine; Vohra, Nasreen; Jerald, Maya; Pendleton, Laura; Szekeres, Karoly; Ghansah, Tomar			Murine Pancreatic Adenocarcinoma Dampens SHIP-1 Expression and Alters MDSC Homeostasis and Function	PLOS ONE			English	Article							MYELOID SUPPRESSOR-CELLS; INOSITOL PHOSPHATASE; REGULATORY CELLS; CANCER; APOPTOSIS; SURVIVAL; GROWTH; BETA; MICE; PHOSPHORYLATION	Background: Pancreatic cancer is one of the most aggressive cancers, with tumor-induced myeloid-derived suppressor cells (MDSC) contributing to its pathogenesis and ineffective therapies. In response to cytokine/chemokine receptor activation, src homology 2 domain-containing inositol 5'-phosphatase-1 (SHIP-1) influences phosphatidylinositol-3-kinase (PI3K) signaling events, which regulate immunohomeostasis. We hypothesize that factors from murine pancreatic cancer cells cause the down-regulation of SHIP-1 expression, which may potentially contribute to MDSC expansion, and the suppression of CD8(+) T cell immune responses. Therefore, we sought to determine the role of SHIP-1 in solid tumor progression, such as murine pancreatic cancer. Methodology and Principal Findings: Immunocompetent C57BL/6 mice were inoculated with either murine Panc02 cells (tumor-bearing [TB] mice) or Phosphate Buffer Saline (PBS) (control mice). Cytometric Bead Array (CBA) analysis of supernatants of cultured Panc02 detected pro-inflammatory cytokines such as IL-6, IL-10 and MCP-1. TB mice showed a significant increase in serum levels of pro-inflammatory factors IL-6 and MCP-1 measured by CBA. qRT-PCR and Western blot analyses revealed the in vivo down-regulation of SHIP-1 expression in splenocytes from TB mice. Western blot analyses also detected reduced SHIP-1 activity, increased AKT-1 and BAD hyper-phosphorylation and up-regulation of BCL-2 expression in splenocytes from TB mice. In vitro, qRT-PCR and Western blot analyses detected reduced SHIP-1 mRNA and protein expression in control splenocytes co-cultured with Panc02 cells. Flow cytometry results showed significant expansion of MDSC in peripheral blood and splenocytes from TB mice. AutoMACS sorted TB MDSC exhibited hyper-phosphorylation of AKT-1 and over-expression of BCL-2 detected by western blot analysis. TB MDSC significantly suppressed antigen-specific CD8(+) T cell immune responses in vitro. Conclusion/Significance: SHIP-1 may regulate immune development that impacts MDSC expansion and function, contributing to pancreatic tumor progression. Thus, SHIP-1 can be a potential therapeutic target to help restore immunohomeostasis and improve therapeutic responses in patients with pancreatic cancer.	[Pilon-Thomas, Shari; Vohra, Nasreen] H Lee Moffitt Comprehens Canc Ctr & Res Inst, Program Immunol, Tampa, FL 33612 USA; [Nelson, Nadine; Jerald, Maya; Pendleton, Laura; Szekeres, Karoly; Ghansah, Tomar] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Pilon-Thomas, S (corresponding author), H Lee Moffitt Comprehens Canc Ctr & Res Inst, Program Immunol, Tampa, FL 33612 USA.	tghansah@health.usf.edu	Ghansah, Tomar/H-4566-2011; Vohra, Nasreen/AAW-3454-2021	Vohra, Nasreen/0000-0002-6411-3042	American Cancer Society [93-032-13]; NATIONAL CANCER INSTITUTE [P30CA076292, R00CA128825] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Institutional Research Grant # 93-032-13 from the American Cancer Society awarded to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinikula J, 2010, EUR J IMMUNOL, V40, P2599, DOI 10.1002/eji.200940002; Aman MJ, 2000, MOL CELL BIOL, V20, P3576, DOI 10.1128/MCB.20.10.3576-3589.2000; Bae J, 2001, APOPTOSIS, V6, P319, DOI 10.1023/A:1011319901057; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Collazo MM, 2009, BLOOD, V113, P2934, DOI 10.1182/blood-2008-09-181164; CONDE C, 2011, BIOCH PHARM; CORBETT TH, 1984, CANCER RES, V44, P717; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Coultas L, 2003, SEMIN CANCER BIOL, V13, P115, DOI 10.1016/S1044-579X(02)00129-3; Damen JE, 2001, BLOOD, V97, P1343, DOI 10.1182/blood.V97.5.1343; Gabhann JN, 2010, J IMMUNOL, V184, P2314, DOI 10.4049/jimmunol.0902589; Ghansah T, 2004, J IMMUNOL, V173, P7324, DOI 10.4049/jimmunol.173.12.7324; Gloire G, 2007, BIOCHEM SOC T, V35, P277, DOI 10.1042/BST0350277; Hamilton MJ, 2011, EXP HEMATOL, V39, P2, DOI 10.1016/j.exphem.2010.11.002; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Huber M, 1999, PROG BIOPHYS MOL BIO, V71, P423, DOI 10.1016/S0079-6107(98)00049-2; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kerr WG, 2011, ANN NY ACAD SCI, V1217, P1, DOI 10.1111/j.1749-6632.2010.05869.x; Lakhanpal GK, 2010, BLOOD, V116, P428, DOI 10.1182/blood-2009-10-250217; Liu L, 1997, LEUKEMIA, V11, P181, DOI 10.1038/sj.leu.2400559; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Lo TCT, 2009, LEUKEMIA RES, V33, P1562, DOI 10.1016/j.leukres.2009.04.032; Ma K, 2008, CELL SIGNAL, V20, P684, DOI 10.1016/j.cellsig.2007.12.004; Maeda K, 2005, BLOOD, V106, P879, DOI 10.1182/blood-2005-02-0456; Maeda K, 2010, BLOOD, V115, P4699, DOI 10.1182/blood-2009-07-230631; Morse MA, 2009, EXPERT OPIN BIOL TH, V9, P331, DOI 10.1517/14712590802715756 ; Nakamura K, 2004, J EXP MED, V199, P243, DOI 10.1084/jem.20031193; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Ostrand-Rosenberg S, 2010, CANCER IMMUNOL IMMUN, V59, P1593, DOI 10.1007/s00262-010-0855-8; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Paraiso KHT, 2007, J IMMUNOL, V178, P2893, DOI 10.4049/jimmunol.178.5.2893; Parsons CM, 2010, ANTICANCER RES, V30, P3279; Pedersen IM, 2009, EMBO MOL MED, V1, P288, DOI 10.1002/emmm.200900028; Phee H, 2000, J BIOL CHEM, V275, P19090, DOI 10.1074/jbc.M001093200; Pilon-Thomas S, 2010, J IMMUNOL, V184, P3442, DOI 10.4049/jimmunol.0904114; Prasad NK, 2008, CARCINOGENESIS, V29, P25, DOI 10.1093/carcin/bgm213; Prasad NK, 2008, TUMOR BIOL, V29, P330, DOI 10.1159/000172970; Roongapinun S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014174; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Sly LM, 2003, EXP HEMATOL, V31, P1170, DOI 10.1016/j.exphem.2003.09.011; Valderrama-Carvajal H, 2002, NAT CELL BIOL, V4, P963, DOI 10.1038/ncb885; Wang JL, 2000, CANCER RES, V60, P1498; Whiteside TL, 2010, J ALLERGY CLIN IMMUN, V125, pS272, DOI 10.1016/j.jaci.2009.09.045	49	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27729	10.1371/journal.pone.0027729	http://dx.doi.org/10.1371/journal.pone.0027729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132131	Green Submitted, Green Published, gold			2022-12-25	WOS:000297792400013
J	Chikova, A; Grando, SA				Chikova, Anna; Grando, Sergei A.			Naturally Occurring Variants of Human A9 Nicotinic Receptor Differentially Affect Bronchial Cell Proliferation and Transformation	PLOS ONE			English	Article							CONGENITAL MYASTHENIC SYNDROME; ACETYLCHOLINE-RECEPTOR; EPITHELIAL-CELLS; LUNG-CANCER; ALPHA-7-NICOTINIC RECEPTOR; SUSCEPTIBILITY LOCUS; CHOLINERGIC SYSTEM; SUBUNIT; EXPRESSION; ACTIVATION	Isolation of polyadenilated mRNA from human immortalized bronchial epithelial cell line BEP2D revealed the presence of multiple isoforms of RNA coded by the CHRNA9 gene for alpha 9 nicotinic acetylcholine receptor (nAChR). BEP2D cells were homozygous for the rs10009228 polymorphism encoding for N442S amino acid substitution, and also contained mRNA coding for several truncated isoforms of alpha 9 protein. To elucidate the biologic significance of the naturally occurring variants of alpha 9 nAChR, we compared the biologic effects of overexpression of full-length alpha 9 N442 and S442 proteins, and the truncated alpha 9 variant occurring due to a loss of the exon 4 sequence that causes frame shift and early termination of the translation. These as well as control vector were overexpressed in the BEP2D cells that were used in the assays of proliferation rate, spontaneous vs. tobacco nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced cellular transformation, and tumorigenicity in cell culture and mice. Overexpression of the S442 variant significantly increased cellular proliferation, and spontaneous and NNK-induced transformation. The N442 variant significantly decreased cellular transformation, without affecting proliferation rate. Overexpression of the truncated alpha 9 significantly decreased proliferation and suppressed cellular transformation. These results suggested that alpha 9 nAChR plays important roles in regulation of bronchial cell growth by endogenous acetylcholine and exogenous nicotine, and susceptibility to NNK-induced carcinogenic transformation. The biologic activities of alpha 9 nAChR may be regulated at the splicing level, and genetic polymorphisms in CHRNA9 affecting protein levels, amino acid sequence and RNA splicing may influence the risk for lung cancer.	[Chikova, Anna; Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA; [Chikova, Anna] Minist Hlth Russian Federat, DI Ivanovsky Inst Virol, Moscow, Russia; [Grando, Sergei A.] Univ Calif Irvine, Ctr Canc, Irvine, CA 92717 USA; [Grando, Sergei A.] Univ Calif Irvine, Res Inst, Irvine, CA 92717 USA	University of California System; University of California Irvine; Ministry of Health of the Russian Federation; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; University of California System; University of California Irvine; University of California System; University of California Irvine	Chikova, A (corresponding author), Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA.	sgrando@uci.edu			National Institutes of Health (NIH) [ES017009, DE14173]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017009] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (NIH) grants ES017009 and DE14173. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Arredondo J, 2006, J CANCER RES CLIN, V132, P653, DOI 10.1007/s00432-006-0113-9; Baxter SW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000802; Catassi A, 2008, EUR J CANCER, V44, P2296, DOI 10.1016/j.ejca.2008.06.045; CHIKOVA A, LIFE SCI UNPUB; Grozio A, 2008, INT J CANCER, V122, P1911, DOI 10.1002/ijc.23298; Hei TK, 1997, ENVIRON HEALTH PERSP, V105, P1085, DOI 10.2307/3433513; Hiel H, 2000, BRAIN RES, V858, P215, DOI 10.1016/S0006-8993(00)01947-8; Hosie AM, 2001, NEUROSCIENCE, V102, P709, DOI 10.1016/S0306-4522(00)00483-8; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jones AK, 2010, ADV EXP MED BIOL, V683, P25; Lang TM, 2007, MOL CELL BIOL, V27, P5587, DOI 10.1128/MCB.01883-06; Lansdell SJ, 2000, NEUROPHARMACOLOGY, V39, P2604, DOI 10.1016/S0028-3908(00)00111-8; Lee CH, 2010, JNCI-J NATL CANCER I, V102, P1322, DOI 10.1093/jnci/djq300; Masuda A, 2008, HUM MOL GENET, V17, P4022, DOI 10.1093/hmg/ddn305; Maus ADJ, 1998, MOL PHARMACOL, V54, P779, DOI 10.1124/mol.54.5.779; Newland CF, 1995, J PHYSIOL-LONDON, V489, P767, DOI 10.1113/jphysiol.1995.sp021090; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2; Ohno Kinji, 2005, Acta Myol, V24, P50; Paleari L, 2008, SEMIN CANCER BIOL, V18, P211, DOI 10.1016/j.semcancer.2007.12.009; Paleari L, 2009, DRUG DISCOV TODAY, V14, P822, DOI 10.1016/j.drudis.2009.06.016; Paleari L, 2009, AM J RESP CRIT CARE, V179, P1141, DOI 10.1164/rccm.200806-908OC; Proskocil BJ, 2004, ENDOCRINOLOGY, V145, P2498, DOI 10.1210/en.2003-1728; Richard P, 2007, NEUROMUSCULAR DISORD, V17, P409, DOI 10.1016/j.nmd.2007.01.018; Russo P, 2006, CURR MED CHEM, V13, P3493, DOI 10.2174/092986706779026192; Sattelle DB, 2005, BIOESSAYS, V27, P366, DOI 10.1002/bies.20207; Severance EG, 2004, MOL PHARMACOL, V66, P420, DOI 10.1124/mol.104.000059; Shih YL, 2010, J AGR FOOD CHEM, V58, P235, DOI 10.1021/jf9031684; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tian YF, 2011, BRAIN RES, V1381, P228, DOI 10.1016/j.brainres.2011.01.026; Tu SH, 2011, MOL NUTR FOOD RES, V55, P455, DOI 10.1002/mnfr.201000254; Verbitsky M, 2000, NEUROPHARMACOLOGY, V39, P2515, DOI 10.1016/S0028-3908(00)00124-6; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; WILLEY JC, 1991, CANCER RES, V51, P5370; Wu CH, 2011, CLIN CANCER RES, V17, P3533, DOI 10.1158/1078-0432.CCR-10-2434; Xie H, 2007, AM J RESP CELL MOL, V37, P544, DOI 10.1165/rcmb.2007-0058OC; Zia S, 1997, RES COMMUN MOL PATH, V97, P243	37	24	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27978	10.1371/journal.pone.0027978	http://dx.doi.org/10.1371/journal.pone.0027978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125646	Green Published, gold			2022-12-25	WOS:000297789200046
J	Cino, EA; Wong-ekkabut, J; Karttunen, M; Choy, WY				Cino, Elio A.; Wong-ekkabut, Jirasak; Karttunen, Mikko; Choy, Wing-Yiu			Microsecond Molecular Dynamics Simulations of Intrinsically Disordered Proteins Involved in the Oxidative Stress Response	PLOS ONE			English	Article							GROMOS FORCE-FIELD; PROTHYMOSIN-ALPHA; UNSTRUCTURED PROTEINS; RECOGNITION FEATURES; INTERACTION NETWORKS; BINDING; KEAP1; ROLES; BETA; NRF2	Intrinsically disordered proteins (IDPs) are abundant in cells and have central roles in protein-protein interaction networks. Interactions between the IDP Prothymosin alpha (ProT alpha) and the Neh2 domain of Nuclear factor erythroid 2-related factor 2 (Nrf2), with a common binding partner, Kelch-like ECH-associated protein 1(Keap1), are essential for regulating cellular response to oxidative stress. Misregulation of this pathway can lead to neurodegenerative diseases, premature aging and cancer. In order to understand the mechanisms these two disordered proteins employ to bind to Keap1, we performed extensive 0.5-1.0 microsecond atomistic molecular dynamics (MD) simulations and isothermal titration calorimetry experiments to investigate the structure/dynamics of free-state ProT alpha and Neh2 and their thermodynamics of bindings. The results show that in their free states, both ProT alpha and Neh2 have propensities to form bound-state-like beta-turn structures but to different extents. We also found that, for both proteins, residues outside the Keap1-binding motifs may play important roles in stabilizing the bound-state-like structures. Based on our findings, we propose that the binding of disordered ProT alpha and Neh2 to Keap1 occurs synergistically via preformed structural elements (PSEs) and coupled folding and binding, with a heavy bias towards PSEs, particularly for Neh2. Our results provide insights into the molecular mechanisms Neh2 and ProT alpha bind to Keap1, information that is useful for developing therapeutics to enhance the oxidative stress response.	[Cino, Elio A.; Choy, Wing-Yiu] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Wong-ekkabut, Jirasak; Karttunen, Mikko] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada; [Wong-ekkabut, Jirasak] Kasetsart Univ, Fac Sci, Bangkok, Thailand; [Karttunen, Mikko] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Kasetsart University; University of Waterloo	Cino, EA (corresponding author), Univ Western Ontario, Dept Biochem, London, ON, Canada.	mikko.karttunen@uwaterloo.ca; jchoy4@uwo.ca	Choy, Wing-Yiu/O-7608-2017; Wong-ekkabut, Jirasak/GQQ-6677-2022; Karttunen, Mikko/G-4531-2010; Wong-ekkabut, Jirasak/O-7209-2015	Choy, Wing-Yiu/0000-0002-2124-7278; Karttunen, Mikko/0000-0002-8626-3033; Wong-ekkabut, Jirasak/0000-0002-3651-9870	Canadian Institutes of Health Research (CIHR) [74679]; Natural Sciences and Engineering Research Council of Canada; Ontario Early Researcher Award program; SHARCNET (Shared Hierarchical Academic Research Computing Network); SciNet HPC Consortium	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Early Researcher Award program(Ministry of Research and Innovation, Ontario); SHARCNET (Shared Hierarchical Academic Research Computing Network); SciNet HPC Consortium	This work was supported by grants from the Canadian Institutes of Health Research (CIHR; MOP#74679; WYC), the Natural Sciences and Engineering Research Council of Canada (MK) and the Ontario Early Researcher Award program (WYC, MK). An Ontario Graduate Scholarship in Science and Technology (OGSST) was awarded to E. C. Computational resources were provided by SHARCNET (Shared Hierarchical Academic Research Computing Network - www.sharcnet.ca) and the SciNet HPC Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzopardi PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009330; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Baumketner A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3081138; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Bobrovnikova-Marjon E, 2010, ONCOGENE, V29, P3881, DOI 10.1038/onc.2010.153; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen HF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006516; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Cheng YG, 2006, BIOCHEMISTRY-US, V45, P10448, DOI 10.1021/bi060981d; Choy WY, 2001, J MOL BIOL, V308, P1011, DOI 10.1006/jmbi.2001.4750; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; DUNKER AK, 1998, PAC S BIOCOMP, V3, P473; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Gall C, 2007, PROTEIN SCI, V16, P2510, DOI 10.1110/ps.073062707; HARITOS AA, 1984, P NATL ACAD SCI-BIOL, V81, P1008, DOI 10.1073/pnas.81.4.1008; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang W, 2011, J CHEM THEORY COMPUT, V7, P1237, DOI 10.1021/ct100747y; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Karttunen M, 2008, CURR TOP MEMBR, V60, P49, DOI 10.1016/S1063-5823(08)00002-1; Kaszuba K, 2010, J PHYS CHEM B, V114, P8374, DOI 10.1021/jp909971f; Kumar S, 2000, PROTEIN SCI, V9, P10; LEWIS PN, 1973, BIOCHIM BIOPHYS ACTA, V303, P211, DOI 10.1016/0005-2795(73)90350-4; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; MACARTHUR MW, 1993, PROTEINS, V17, P232, DOI 10.1002/prot.340170303; Espinoza-Fonseca LM, 2009, BIOCHEM BIOPH RES CO, V382, P479, DOI 10.1016/j.bbrc.2009.02.151; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Mokhtarzada S, 2011, BIOCHEMISTRY-US, V50, P715, DOI 10.1021/bi101236z; Morar AS, 2001, PROTEIN SCI, V10, P2195, DOI 10.1110/ps.24301; Murzyn K, 2006, BIOINTERPHASES, V1, P98, DOI 10.1116/1.2354573; NI B, 2011, J MOL MODEL IN PRESS; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Padmanabhan B, 2008, ACTA CRYSTALLOGR F, V64, P233, DOI 10.1107/S1744309108004995; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Patra M, 2003, BIOPHYS J, V84, P3636, DOI 10.1016/S0006-3495(03)75094-2; Patra M, 2004, J COMPUT CHEM, V25, P678, DOI 10.1002/jcc.10417; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pineiro A, 2000, PEPTIDES, V21, P1433, DOI 10.1016/S0196-9781(00)00288-6; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; SALMA P, 2009, J INFECT DIS, V5, P126; Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438; Sivakolundu SG, 2005, J MOL BIOL, V353, P1118, DOI 10.1016/j.jmb.2005.08.074; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tsai CJ, 2001, PROTEINS, V44, P418, DOI 10.1002/prot.1107; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Veurink G, 2003, ANN HUM BIOL, V30, P639, DOI 10.1080/03014460310001620144; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Wang YF, 2011, NAT CHEM BIOL, V7, P214, DOI 10.1038/NCHEMBIO.536; Wong-Ekkabut J, 2010, NAT NANOTECHNOL, V5, P555, DOI 10.1038/nnano.2010.152; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Wu KP, 2009, J MOL BIOL, V391, P784, DOI 10.1016/j.jmb.2009.06.063; Yi SL, 2007, BIOCHEMISTRY-US, V46, P13120, DOI 10.1021/bi7014822	81	38	38	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27371	10.1371/journal.pone.0027371	http://dx.doi.org/10.1371/journal.pone.0027371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125611	Green Published, gold			2022-12-25	WOS:000297789200011
J	Kumar, S; Das, M; Hadad, CM; Musier-Forsyth, K				Kumar, Sandeep; Das, Mom; Hadad, Christopher M.; Musier-Forsyth, Karin			Substrate Specificity of Bacterial Prolyl-tRNA Synthetase Editing Domain Is Controlled by a Tunable Hydrophobic Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAEMOPHILUS-INFLUENZAE YBAK; MISCHARGED TRANSFER-RNA; AMINO-ACID; STRUCTURAL BASIS; FORCE-FIELD; PROTEIN; DISCRIMINATION; CYS-TRNA(PRO); RECOGNITION; VALINE	Aminoacyl-tRNA synthetases catalyze the covalent attachment of amino acids onto their cognate tRNAs. High fidelity in this reaction is crucial to the accurate decoding of genetic information and is ensured, in part, by proofreading of the newly synthesized aminoacyl-tRNAs. Prolyl-tRNA synthetases (ProRS) mischarge tRNA(Pro) with alanine or cysteine due to their smaller or similar sizes relative to cognate proline. Mischarged Ala-tRNA(Pro) is hydrolyzed by an editing domain (INS) present in most bacterial ProRSs. In contrast, the INS domain is unable to deacylate Cys-tRNA(Pro), which is hydrolyzed exclusively by a freestanding trans-editing domain known as YbaK. Here, we have used computational and experimental approaches to probe the molecular basis of INS domain alanine specificity. We show that the methyl side chain of alanine binds in a well defined hydrophobic pocket characterized by conserved residues Ile-263, Leu-266, and Lys-279 and partially conserved residue Thr-277 in Escherichia coli ProRS. Site-specific mutation of these residues leads to a significant loss in Ala-tRNA(Pro) hydrolysis, and altering the size of the pocket modulates the substrate specificity. Remarkably, one ProRS INS domain variant displays a complete switch in substrate specificity from alanine to cysteine. The mutually exclusive aminoacyl-tRNA substrate specificities of the WT and engineered INS domains is consistent with the evolution of two distinct editing domains that function to clear Ala-tRNA(Pro) and Cys-tRNA(Pro) in vivo.	[Kumar, Sandeep; Das, Mom; Hadad, Christopher M.; Musier-Forsyth, Karin] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Das, Mom; Musier-Forsyth, Karin] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Kumar, Sandeep; Das, Mom; Musier-Forsyth, Karin] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Musier-Forsyth, K (corresponding author), Ohio State Univ, Dept Chem & Biochem, 100 W 18th Ave, Columbus, OH 43210 USA.	musier@chemistry.ohio-state.edu		Hadad, Christopher/0000-0003-1211-4315; Das, Mom/0000-0002-9436-6809	National Institutes of Health [GM049928]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049928, R01GM049928, R55GM049928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM049928 (to K. M.-F.).	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; An SG, 2004, J BIOL CHEM, V279, P42359, DOI 10.1074/jbc.C400304200; [Anonymous], 2008, AMBER 10; Bates PA, 2001, PROTEINS, P39; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Crepin T, 2006, STRUCTURE, V14, P1511, DOI 10.1016/j.str.2006.08.007; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fersht AR, 1998, SCIENCE, V280, P541, DOI 10.1126/science.280.5363.541; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Jensen JH, 2005, J PHYS CHEM A, V109, P6634, DOI 10.1021/jp051922x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Ling JQ, 2009, MOL CELL, V33, P654, DOI 10.1016/j.molcel.2009.01.031; Mascarenhas A. P., 2009, V22, P155; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Nordin BE, 2002, J BIOL CHEM, V277, P20510, DOI 10.1074/jbc.M202023200; Nureki O, 2001, COLD SPRING HARB SYM, V66, P167, DOI 10.1101/sqb.2001.66.167; Reynolds NM, 2010, NAT REV MICROBIOL, V8, P849, DOI 10.1038/nrmicro2472; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; So BR, 2011, J BIOL CHEM, V286, P31810, DOI 10.1074/jbc.M111.232611; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; Sokabe M, 2009, P NATL ACAD SCI USA, V106, P11028, DOI 10.1073/pnas.0904645106; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Wong FC, 2002, BIOCHEMISTRY-US, V41, P7108, DOI 10.1021/bi012178j; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zhang H, 2000, PROTEINS, V40, P86, DOI 10.1002/(SICI)1097-0134(20000701)40:1<86::AID-PROT100>3.0.CO;2-Y	37	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3175	3184		10.1074/jbc.M111.313619	http://dx.doi.org/10.1074/jbc.M111.313619			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22128149	Green Published, hybrid			2022-12-25	WOS:000300295100023
J	Ohto, U; Usui, K; Ochi, T; Yuki, K; Satow, Y; Shimizu, T				Ohto, Umeharu; Usui, Kimihito; Ochi, Toshinari; Yuki, Kenjiro; Satow, Yoshinori; Shimizu, Toshiyuki			Crystal Structure of Human beta-Galactosidase STRUCTURAL BASIS OF G(M1) GANGLIOSIDOSIS AND MORQUIO B DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GM1 GANGLIOSIDOSIS; GENE-MUTATIONS; GM1-GANGLIOSIDOSIS; PRECURSOR; COMPLEX; FORMS; CLASSIFICATION; PURIFICATION; SPECIFICITY; PROGRAM	G(M1) gangliosidosis and Morquio B are autosomal recessive lysosomal storage diseases associated with a neurodegenerative disorder or dwarfism and skeletal abnormalities, respectively. These diseases are caused by deficiencies in the lysosomal enzyme beta-D-galactosidase (beta-Gal), which lead to accumulations of the beta-Gal substrates, G(M1) ganglioside, and keratan sulfate. beta-Gal is an exoglycosidase that catalyzes the hydrolysis of terminal beta-linked galactose residues. This study shows the crystal structures of human beta-Gal in complex with its catalytic product galactose or with its inhibitor 1-deoxygalactonojirimycin. Human beta-Gal is composed of a catalytic TIM barrel domain followed by beta-domain 1 and beta-domain 2. To gain structural insight into the molecular defects of beta-Gal in the above diseases, the disease-causing mutations were mapped onto the three-dimensional structure. Finally, the possible causes of the diseases are discussed.	[Ohto, Umeharu; Usui, Kimihito; Ochi, Toshinari; Yuki, Kenjiro; Satow, Yoshinori; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Shimizu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shimizu@mol.f.u-tokyo.ac.jp			Targeted Proteins Research Program; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Targeted Proteins Research Program and by grants-in-aid for Scientific Research from Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (to U. O., Y. S., and T. S.).	Aguilar CF, 1997, J MOL BIOL, V271, P789, DOI 10.1006/jmbi.1997.1215; ALPERS DH, 1969, J BIOL CHEM, V244, P1238; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; ASP NG, 1972, ANAL BIOCHEM, V47, P527, DOI 10.1016/0003-2697(72)90147-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunetti-Pierri N, 2008, MOL GENET METAB, V94, P391, DOI 10.1016/j.ymgme.2008.04.012; Caciotti A, 2011, BBA-MOL BASIS DIS, V1812, P782, DOI 10.1016/j.bbadis.2011.03.018; Callahan JW, 1999, BBA-MOL BASIS DIS, V1455, P85, DOI 10.1016/S0925-4439(99)00075-7; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DISTLER JJ, 1973, J BIOL CHEM, V248, P6772; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hidaka M, 2002, J MOL BIOL, V322, P79, DOI 10.1016/S0022-2836(02)00746-5; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HOOGEVEEN AT, 1986, J BIOL CHEM, V261, P5702; HOOGEVEEN AT, 1983, J BIOL CHEM, V258, P2143; HOOGEVEEN AT, 1984, J BIOL CHEM, V259, P1974; HUBBES M, 1992, BIOCHEM J, V285, P827, DOI 10.1042/bj2850827; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; JONES CS, 1984, CAN J BIOCHEM CELL B, V62, P529, DOI 10.1139/o84-070; Juers DH, 1999, PROTEIN SCI, V8, P122; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Maksimainen M, 2011, J STRUCT BIOL, V174, P156, DOI 10.1016/j.jsb.2010.11.024; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; McCarter JD, 1997, J BIOL CHEM, V272, P396; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; MORREAU H, 1989, J BIOL CHEM, V264, P20655; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NORDEN AGW, 1974, J BIOL CHEM, V249, P7969; Okumiya T, 2003, MOL GENET METAB, V78, P51, DOI 10.1016/S1096-7192(02)00199-3; OSHIMA A, 1991, AM J HUM GENET, V49, P1091; OSHIMA A, 1988, BIOCHEM BIOPH RES CO, V157, P238, DOI 10.1016/S0006-291X(88)80038-X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Privitera S, 1998, J BIOL CHEM, V273, P6319, DOI 10.1074/jbc.273.11.6319; REARDON D, 1995, FASEB J, V9, P497, DOI 10.1096/fasebj.9.7.7737457; Rojas AL, 2004, J MOL BIOL, V343, P1281, DOI 10.1016/j.jmb.2004.09.012; Skalova T, 2005, J MOL BIOL, V353, P282, DOI 10.1016/j.jmb.2005.08.028; Suzuki Y., 2001, METABOLIC MOL BASES, P3775; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Usui K., 2011, ACTA CRYS F IN PRESS; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van der Spoel A, 2000, J BIOL CHEM, V275, P10035, DOI 10.1074/jbc.275.14.10035; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; YAMAMOTO Y, 1990, DNA CELL BIOL, V9, P119, DOI 10.1089/dna.1990.9.119; YAMAMOTO Y, 1982, J BIOCHEM, V92, P13, DOI 10.1093/oxfordjournals.jbchem.a133910; YOSHIDA K, 1991, AM J HUM GENET, V49, P435; ZHANG SQ, 1994, BIOCHEM J, V304, P281, DOI 10.1042/bj3040281	49	77	85	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1801	1812		10.1074/jbc.M111.293795	http://dx.doi.org/10.1074/jbc.M111.293795			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128166	Green Published, hybrid			2022-12-25	WOS:000299321000022
J	Peng, HM; Morishima, Y; Pratt, WB; Osawa, Y				Peng, Hwei-Ming; Morishima, Yoshihiro; Pratt, William B.; Osawa, Yoichi			Modulation of Heme/Substrate Binding Cleft of Neuronal Nitric-oxide Synthase (nNOS) Regulates Binding of Hsp90 and Hsp70 Proteins and nNOS Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90/HSP70-BASED CHAPERONE MACHINERY; HEAT-SHOCK-PROTEIN; IN-VITRO; PROTEOLYTIC DEGRADATION; ACTIVATION; HEAT-SHOCK-PROTEIN-90; CALMODULIN; DOMAIN; HEME; VIVO	Like other nitric-oxide synthase (NOS) enzymes, neuronal NOS (nNOS) turnover and activity are regulated by the Hsp90/Hsp70-based chaperone machinery, which regulates signaling proteins by modulating ligand binding clefts (Pratt, W. B., Morishima, Y., and Osawa, Y. (2008) J. Biol. Chem. 283, 22885-22889). We have previously shown that nNOS turnover is due to Hsp70/CHIP-dependent ubiquitination and proteasomal degradation. In this work, we use an intracellular cross-linking approach to study both chaperone binding and nNOS ubiquitination in intact HEK293 cells. Treatment of cells with N-G-nitro-L-arginine, a slowly reversible competitive inhibitor that stabilizes nNOS, decreases both nNOS ubiquitination and binding of Hsp90, Hsp70, and CHIP. Treatment with the calcium ionophore A23187, which increases Ca2+-calmodulin binding to nNOS, increases nNOS ubiquitination and binding of Hsp90, Hsp70, and CHIP in a manner that is specific for changes in the heme/substrate binding cleft. Both Hsp90 and Hsp70 are bound to the expressed nNOS oxygenase domain, which contains the heme/substrate binding cleft, but not to the reductase domain, and binding is increased to an expressed fragment containing both the oxygenase domain and the calmodulin binding site. Overexpression of Hsp70 promotes nNOS ubiquitination and decreases nNOS protein, and overexpression of Hsp90 inhibits nNOS ubiquitination and increases nNOS protein, showing the opposing effects of the two chaperones as they participate in nNOS quality control in the cell. These observations support the notion that changes in the state of the heme/substrate binding cleft affect chaperone binding and thus nNOS ubiquitination.	[Peng, Hwei-Ming; Morishima, Yoshihiro; Pratt, William B.; Osawa, Yoichi] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Osawa, Y (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA.	osawa@umich.edu			National Institutes of Health [GM077430]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077430 (to Y.O.).	ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; Bender AT, 2000, J BIOL CHEM, V275, P17407, DOI 10.1074/jbc.M000155200; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Billecke SS, 2002, J BIOL CHEM, V277, P20504, DOI 10.1074/jbc.M201940200; Brouet A, 2001, J BIOL CHEM, V276, P32663, DOI 10.1074/jbc.M101371200; Citri A, 2002, EMBO J, V21, P2407, DOI 10.1093/emboj/21.10.2407; Clapp KM, 2010, J BIOL CHEM, V285, P33642, DOI 10.1074/jbc.M110.159178; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dunbar AY, 2006, DRUG METAB DISPOS, V34, P1448, DOI 10.1124/dmd.106.009951; Dunbar AY, 2004, MOL PHARMACOL, V66, P964, DOI 10.1124/mol.104.000125; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Ghosh A, 2011, FASEB J, V25, P2049, DOI 10.1096/fj.10-180554; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; Han GC, 2009, J PHARMACOL EXP THER, V329, P850, DOI 10.1124/jpet.108.149112; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Kamada Y, 2005, MOL BRAIN RES, V142, P19, DOI 10.1016/j.molbrainres.2005.09.003; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; MCMILLAN K, 1992, P NATL ACAD SCI USA, V89, P11141, DOI 10.1073/pnas.89.23.11141; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Noguchi S, 2000, J BIOL CHEM, V275, P2376, DOI 10.1074/jbc.275.4.2376; Osawa Y, 2003, J PHARMACOL EXP THER, V304, P493, DOI 10.1124/jpet.102.035055; OSAWA Y, 1989, CHEM RES TOXICOL, V2, P131, DOI 10.1021/tx00009a001; OSAWA Y, 1993, J BIOL CHEM, V268, P2953; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Peng HM, 2009, BIOCHEMISTRY-US, V48, P8483, DOI 10.1021/bi901058g; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Song Y, 2001, BIOCHEM J, V355, P357, DOI 10.1042/0264-6021:3550357; Song Y, 2001, AM J PHYSIOL-CELL PH, V281, pC1819, DOI 10.1152/ajpcell.2001.281.6.C1819; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Takahashi S, 2003, J BIOL CHEM, V278, P30821, DOI 10.1074/jbc.M304471200; Takahashi S, 2003, J BIOL CHEM, V278, P9339, DOI 10.1074/jbc.M212651200; Vuletich JL, 2002, MOL PHARMACOL, V62, P110, DOI 10.1124/mol.62.1.110; Wang AM, 2010, J BIOL CHEM, V285, P15714, DOI 10.1074/jbc.M109.098806; Xu H, 2007, J BIOL CHEM, V282, P37567, DOI 10.1074/jbc.M706464200; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yoshida M, 2003, J BIOL CHEM, V278, P36953, DOI 10.1074/jbc.M305214200; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	44	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1556	1565		10.1074/jbc.M111.323295	http://dx.doi.org/10.1074/jbc.M111.323295			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128174	Green Published, hybrid			2022-12-25	WOS:000299170300069
J	Rodas, C; Klena, JD; Nicklasson, M; Iniguez, V; Sjoling, A				Rodas, Claudia; Klena, John D.; Nicklasson, Matilda; Iniguez, Volga; Sjoling, Asa			Clonal Relatedness of Enterotoxigenic Escherichia coli (ETEC) Strains Expressing LT and CS17 Isolated from Children with Diarrhoea in La Paz, Bolivia	PLOS ONE			English	Article							COLONIZATION FACTORS; DEVELOPING-COUNTRIES; VIRULENCE FACTORS; EVOLUTIONARY; TOXINS; IDENTIFICATION; GENES	Background: Enterotoxigenic Escherichia coli (ETEC) is a major cause of traveller's and infantile diarrhoea in the developing world. ETEC produces two toxins, a heat-stable toxin (known as ST) and a heat-labile toxin (LT) and colonization factors that help the bacteria to attach to epithelial cells. Methodology/Principal Findings: In this study, we characterized a subset of ETEC clinical isolates recovered from Bolivian children under 5 years of age using a combination of multilocus sequence typing (MLST) analysis, virulence typing, serotyping and antimicrobial resistance test patterns in order to determine the genetic background of ETEC strains circulating in Bolivia. We found that strains expressing the heat-labile (LT) enterotoxin and colonization factor CS17 were common and belonged to several MLST sequence types but mainly to sequence type-423 and sequence type-443 (Achtman scheme). To further study the LT/CS17 strains we analysed the nucleotide sequence of the CS17 operon and compared the structure to LT/CS17 ETEC isolates from Bangladesh. Sequence analysis confirmed that all sequence type-423 strains from Bolivia had a single nucleotide polymorphism; SNPbol in the CS17 operon that was also found in some other MLST sequence types from Bolivia but not in strains recovered from Bangladeshi children. The dominant ETEC clone in Bolivia (sequence type-423/SNPbol) was found to persist over multiple years and was associated with severe diarrhoea but these strains were variable with respect to antimicrobial resistance patterns. Conclusion/Significance: The results showed that although the LT/CS17 phenotype is common among ETEC strains in Bolivia, multiple clones, as determined by unique MLST sequence types, populate this phenotype. Our data also appear to suggest that acquisition and loss of antimicrobial resistance in LT-expressing CS17 ETEC clones is more dynamic than acquisition or loss of virulence factors.	[Rodas, Claudia; Nicklasson, Matilda; Sjoling, Asa] Univ Gothenburg, WHO Collaborating Ctr Res Enterotoxigen Escherich, Gothenburg, Sweden; [Rodas, Claudia; Nicklasson, Matilda; Sjoling, Asa] Univ Gothenburg, Dept Microbiol & Immunol, Inst Biomed, Gothenburg, Sweden; [Klena, John D.] US Naval Med Res Unit 3, Clin Trials & Mil Studies Program, Cairo, Egypt; [Rodas, Claudia; Iniguez, Volga] Univ Mayor San Andres, Inst Biol Mol & Biotecnol, Fac Ciencias Puras & Nat, La Paz, Bolivia	University of Gothenburg; University of Gothenburg; Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3); Universidad Mayor de San Andres	Rodas, C (corresponding author), Univ Gothenburg, WHO Collaborating Ctr Res Enterotoxigen Escherich, Gothenburg, Sweden.	asa.sjoling@microbio.gu.se		Sjoling, Asa/0000-0003-1529-1720	Swedish Agency for Research Economic Cooperation (SIDA); Swedish Foundation of International Cooperation in Research and Higher Education (STINT) [YR2009-7022]; Ministerio de Ciencia e Innovacion (Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria) [REIPI-RD06/0008-1018, S09/01273]; Xunta de Galicia [07MRU036261PR, 09TAL007261PR, 2007/000044-0]; Swedish Institute	Swedish Agency for Research Economic Cooperation (SIDA); Swedish Foundation of International Cooperation in Research and Higher Education (STINT); Ministerio de Ciencia e Innovacion (Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Swedish Institute	This study was supported by the Swedish Agency for Research Economic Cooperation (SIDA) (the UMSA-IBMB "Diarrhoeal Disease Project"). Support was also obtained from The Swedish Foundation of International Cooperation in Research and Higher Education (STINT) Institutional Grants for Younger Researchers YR2009-7022, Ministerio de Ciencia e Innovacion (Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria, REIPI-RD06/0008-1018 and PS09/01273) and Xunta de Galicia (07MRU036261PR, 09TAL007261PR, 2007/000044-0). Claudia Rodas acknowledges the financial support from the Swedish Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2005, NUCLEIC ACIDS RES, V1, P33; Anantha RP, 2004, INFECT IMMUN, V72, P7190, DOI 10.1128/IAI.72.12.7190-7201.2004; Armstrong GL, 1996, EPIDEMIOL REV, V18, P29, DOI 10.1093/oxfordjournals.epirev.a017914; Beutin L, 2005, J CLIN MICROBIOL, V43, P1552, DOI 10.1128/JCM.43.4.1552-1563.2005; BLACK RE, 1990, REV INFECT DIS, V12, pS73; Bolin I, 2006, J CLIN MICROBIOL, V44, P3872, DOI 10.1128/JCM.00790-06; CLSI (Clinical and Laboratory Standards Institute), 2008, M27A3 CLSI, V28, P25; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Guinee P. A. M., 1981, Laboratory diagnosis in neonatal calf and pig diarrhoea, P126; GYLES CL, 1977, SCIENCE, V198, P198, DOI 10.1126/science.333581; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Nicklasson M, 2008, MICROB PATHOGENESIS, V44, P246, DOI 10.1016/j.micpath.2007.06.009; Nicklasson M, 2010, EMERG INFECT DIS, V16, P143, DOI 10.3201/eid1601.090979; Olesen B, 2009, J CLIN MICROBIOL, V47, P1857, DOI 10.1128/JCM.00230-09; ORSKOV F, 1976, MED MICROBIOL IMMUN, V162, P73, DOI 10.1007/BF02121318; Pacheco ABF, 1998, J CLIN MICROBIOL, V36, P2099, DOI 10.1128/JCM.36.7.2099-2102.1998; Pacheco ABF, 1997, J CLIN MICROBIOL, V35, P1521, DOI 10.1128/JCM.35.6.1521-1525.1997; Perna NT, 1998, INFECT IMMUN, V98, P23; Qadri F, 2000, J CLIN MICROBIOL, V38, P27; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; RAO MC, 1985, CIBA F SYMP, V112, P74; Rodas C, 2011, BRAZ J INFECT DIS, V15, P132, DOI [10.1016/S1413-8670(11)70158-1, 10.1590/S1413-86702011000200007]; Rodas C, 2009, J CLIN MICROBIOL, V47, P1218, DOI 10.1128/JCM.00316-09; Rodrigues J, 1996, INFECT IMMUN, V64, P2680, DOI 10.1128/IAI.64.7.2680-2686.1996; SACK RB, 1980, J INFECT DIS, V142, P279, DOI 10.1093/infdis/142.2.279; Sjoling A, 2007, J CLIN MICROBIOL, V45, P3295, DOI 10.1128/JCM.00471-07; Steinsland H, 2004, J CLIN MICROBIOL, V42, P3100, DOI 10.1128/JCM.42.7.3100-3107.2004; Steinsland H, 2010, J CLIN MICROBIOL, V48, P2916, DOI 10.1128/JCM.02432-09; Svennerholm AM, 2008, EXPERT REV VACCINES, V7, P795, DOI 10.1586/14760584.7.6.795; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turner KME, 2007, INT J ANTIMICROB AG, V29, P129, DOI 10.1016/j.ijantimicag.2006.11.002; Walker RI, 2007, VACCINE, V25, P2545, DOI 10.1016/j.vaccine.2006.12.028; WHO, 2002, RED RISKS PROM HLTH; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569	36	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e18313	10.1371/journal.pone.0018313	http://dx.doi.org/10.1371/journal.pone.0018313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140423	Green Published, Green Submitted, gold			2022-12-25	WOS:000298166300001
J	Schwerk, N; Brinkmann, F; Soudah, B; Kabesch, M; Hansen, G				Schwerk, Nicolaus; Brinkmann, Folke; Soudah, Bisharah; Kabesch, Michael; Hansen, Gesine			Wheeze in Preschool Age Is Associated with Pulmonary Bacterial Infection and Resolves after Antibiotic Therapy	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE; CHILDHOOD ASTHMA; YOUNG-CHILDREN; BIRTH COHORT; AIRWAY; LIFE; CT	Background: Neonates with airways colonized by Haemophilus influenzae, Streptococcus pneumoniae or Moraxella catarrhalis are at increased risk for recurrent wheeze which may resemble asthma early in life. It is not clear whether chronic colonization by these pathogens is causative for severe persistent wheeze in some preschool children and whether these children might benefit from antibiotic treatment. We assessed the relevance of bacterial colonization and chronic airway infection in preschool children with severe persistent wheezing and evaluated the outcome of long-time antibiotic treatment on the clinical course in such children. Methodology/Principal Findings: Preschool children (n = 42) with severe persistent wheeze but no symptoms of acute pulmonary infection were investigated by bronchoscopy and bronchoalveolar lavage (BAL). Differential cell counts and microbiological and virological analyses were performed on BAL samples. Patients diagnosed with bacterial infection were treated with antibiotics for 2-16 weeks (n = 29). A modified ISAAC questionnaire was used for follow-up assessment of children at least 6 months after bronchoscopy. Of the 42 children with severe wheezing, 34 (81%) showed a neutrophilic inflammation and 20 (59%) of this subgroup had elevated bacterial counts (>= 10(4) colony forming units per milliliter) suggesting infection. Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis were the most frequently isolated species. After treatment with appropriate antibiotics 92% of patients showed a marked improvement of symptoms upon follow-up examination. Conclusions/Significance: Chronic bacterial infections are relevant in a subgroup of preschool children with persistent wheezing and such children benefit significantly from antibiotic therapy.	[Schwerk, Nicolaus; Brinkmann, Folke; Kabesch, Michael; Hansen, Gesine] Univ Childrens Hosp, Hanover Med Sch, Dept Pneumol Allergy & Neonatol, Hannover, Germany; [Soudah, Bisharah] Hannover Med Sch, Inst Pathol, Hannover, Germany	Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School	Schwerk, N (corresponding author), Univ Childrens Hosp, Hanover Med Sch, Dept Pneumol Allergy & Neonatol, Hannover, Germany.	kabesch.michael@mh-hannover.de	schwerk, nicolaus/AAU-5676-2020; Kabesch, Michael/GZM-1583-2022; Brinkmann, Folke/GQA-9081-2022; Kabesch, Michael/AAB-5701-2020	Brinkmann, Folke/0000-0002-4307-4232; 				Aysola RS, 2008, CHEST, V134, P1183, DOI 10.1378/chest.07-2779; Bacharier LB, 2008, ALLERGY, V63, P5, DOI 10.1111/j.1398-9995.2007.01586.x; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Biscardi S, 2004, CLIN INFECT DIS, V38, P1341, DOI 10.1086/392498; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Blasi F, 2007, INT J ANTIMICROB AG, V29, P485, DOI 10.1016/j.ijantimicag.2006.11.029; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; Chan EY, 2005, PEDIATR PULM, V39, P558, DOI 10.1002/ppul.20227; Costabel U, 1997, ATLAS BAL; de Blic J, 2000, EUR RESPIR J, V15, P217; Donnelly D, 2007, THORAX, V62, P80, DOI 10.1136/thx.2006.058933; Gibson PG, 2010, MED J AUSTRALIA, V192, P265, DOI 10.5694/j.1326-5377.2010.tb03504.x; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Lau S, 2003, EUR RESPIR J, V21, P834, DOI 10.1183/09031936.03.00037203; Le Bourgeois M, 2002, CHEST, V122, P791, DOI 10.1378/chest.122.3.791; Marchac V, 2002, AM J ROENTGENOL, V179, P1245, DOI 10.2214/ajr.179.5.1791245; Marchant JM, 2005, COCHRANE DATABASE SY, V19; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Muhlebach MS, 1999, AM J RESP CRIT CARE, V160, P186, DOI 10.1164/ajrccm.160.1.9808096; Najafi N, 2003, PEDIATR PULM, V35, P302, DOI 10.1002/ppul.10266; Saglani S, 2006, EUR RESPIR J, V27, P29, DOI 10.1183/09031936.06.00030605; Tsai SL, 2002, PEDIATR RADIOL, V32, P498, DOI 10.1007/s00247-001-0654-7	24	38	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27913	10.1371/journal.pone.0027913	http://dx.doi.org/10.1371/journal.pone.0027913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140482	Green Published, Green Submitted, gold			2022-12-25	WOS:000298166300017
J	Hoeks, J; de Wilde, J; Hulshof, MFM; van den Berg, SAA; Schaart, G; van Dijk, KW; Smit, E; Mariman, ECM				Hoeks, Joris; de Wilde, Janneke; Hulshof, Martijn F. M.; van den Berg, Sjoerd A. A.; Schaart, Gert; van Dijk, Ko Willems; Smit, Egbert; Mariman, Edwin C. M.			High Fat Diet-Induced Changes in Mouse Muscle Mitochondrial Phospholipids Do Not Impair Mitochondrial Respiration Despite Insulin Resistance	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; ACID-COMPOSITION; OXIDATIVE-PHOSPHORYLATION; MEMBRANE PHOSPHOLIPIDS; C57BL/6J MICE; DYSFUNCTION; METABOLISM; GENES; SENSITIVITY; INCREASES	Background: Type 2 diabetes mellitus and muscle insulin resistance have been associated with reduced capacity of skeletal muscle mitochondria, possibly as a result of increased intake of dietary fat. Here, we examined the hypothesis that a prolonged high-fat diet consumption (HFD) increases the saturation of muscle mitochondrial membrane phospholipids causing impaired mitochondrial oxidative capacity and possibly insulin resistance. Methodology: C57BL/6J mice were fed an 8-week or 20-week low fat diet (10 kcal%; LFD) or HFD (45 kcal%). Skeletal muscle mitochondria were isolated and fatty acid (FA) composition of skeletal muscle mitochondrial phospholipids was analyzed by thin-layer chromatography followed by GC. High-resolution respirometry was used to assess oxidation of pyruvate and fatty acids by mitochondria. Insulin sensitivity was estimated by HOMA-IR. Principal Findings: At 8 weeks, mono-unsaturated FA (16:1n7, 18:1n7 and 18:1n9) were decreased (-4.0%, p<0.001), whereas saturated FA (16:0) were increased (+3.2%, p<0.001) in phospholipids of HFD vs. LFD mitochondria. Interestingly, 20 weeks of HFD descreased mono-unsaturated FA while n-6 poly-unsaturated FA (18:2n6, 20:4n6, 22:5n6) showed a pronounced increase (+4.0%, p<0.001). Despite increased saturation of muscle mitochondrial phospholipids after the 8-week HFD, mitochondrial oxidation of both pyruvate and fatty acids were similar between LFD and HFD mice. After 20 weeks of HFD, the increase in n-6 poly-unsaturated FA was accompanied by enhanced maximal capacity of the electron transport chain (+49%, p=0.002) and a tendency for increased ADP-stimulated respiration, but only when fuelled by a lipid-derived substrate. Insulin sensitivity in HFD mice was reduced at both 8 and 20 weeks. Conclusions/Interpretation: Our findings do not support the concept that prolonged HF feeding leads to increased saturation of skeletal muscle mitochondrial phospholipids resulting in a decrease in mitochondrial fat oxidative capacity and (muscle) insulin resistance.	[Hoeks, Joris; de Wilde, Janneke; Hulshof, Martijn F. M.; van Dijk, Ko Willems; Smit, Egbert; Mariman, Edwin C. M.] Maastricht Univ, Dept Human Biol, NUTRIM Sch Nutr Toxicol & Metab, Med Ctr, Maastricht, Netherlands; [de Wilde, Janneke; Hulshof, Martijn F. M.; van den Berg, Sjoerd A. A.; Smit, Egbert; Mariman, Edwin C. M.] Nutrigen Consortium, Top Inst Food & Nutr, Wageningen, Netherlands; [van den Berg, Sjoerd A. A.; van Dijk, Ko Willems] Univ Med Ctr Leiden, Dept Human Genet, Leiden, Netherlands; [Schaart, Gert] Maastricht Univ, Dept Human Movement Sci, NUTRIM Sch Nutr Toxicol & Metab, Med Ctr, Maastricht, Netherlands; [van Dijk, Ko Willems] Univ Med Ctr Leiden, Dept Internal Med, Leiden, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Top Institute Food & Nutrition; Leiden University; Leiden University Medical Center (LUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Leiden University; Leiden University Medical Center (LUMC)	Hoeks, J (corresponding author), Maastricht Univ, Dept Human Biol, NUTRIM Sch Nutr Toxicol & Metab, Med Ctr, Maastricht, Netherlands.	j.dewilde@maastrichtuniversity.nl	van den Berg, Sjoerd AA/B-1994-2009; van den Berg, Sjoerd A/R-9541-2018; van Dijk, Ko Willems/A-1798-2008; van Dijk, Ko Willems/AAT-4681-2021	van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394; van den Berg, Sjoerd/0000-0001-5937-7505; van den Berg, Sjoerd/0000-0001-8967-376X; Hoeks, Joris/0000-0002-0265-0870	Top Institute Food and Nutrition; Dutch government; Netherlands Organization for Health Research and Development (ZonMw) [9120.6050]; Netherlands Consortium for System Biology	Top Institute Food and Nutrition; Dutch government; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Netherlands Consortium for System Biology	This study was funded by the Top Institute Food and Nutrition, with financial support by the Dutch government. Joris Hoeks was supported by a grant from The Netherlands Organization for Health Research and Development (ZonMw) (Grant No. 9120.6050). Sjoerd van den Berg was supported by the Netherlands Consortium for System Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Brehm A, 2006, DIABETES, V55, P136, DOI 10.2337/diabetes.55.1.136; de Wilde J, 2008, PHYSIOL GENOMICS, V32, P360, DOI 10.1152/physiolgenomics.00219.2007; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; den Hoed M, 2008, J APPL PHYSIOL, V105, P561, DOI 10.1152/japplphysiol.00091.2008; Goyens PLL, 2005, J LIPID RES, V46, P1474, DOI 10.1194/jlr.M400514-JLR200; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Haag M, 2005, MED SCI MONITOR, V11, pRA359; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Haugaard SB, 2006, CLIN ENDOCRINOL, V64, P169, DOI 10.1111/j.1365-2265.2006.02444.x; Hoeks J, 2006, DIABETOLOGIA, V49, P2419, DOI 10.1007/s00125-006-0369-2; Hoeks J, 2008, FEBS LETT, V582, P510, DOI 10.1016/j.febslet.2008.01.013; Hoeks J, 2010, DIABETES, V59, P2117, DOI 10.2337/db10-0519; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Hulbert AJ, 2005, BIOL REV, V80, P155, DOI 10.1017/S1464793104006578; Iossa S, 2002, INT J OBESITY, V26, P65, DOI 10.1038/sj.ijo.0801844; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; Lemieux H, 2008, COMP BIOCHEM PHYS A, V149, P20, DOI 10.1016/j.cbpa.2007.09.015; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nabben M, BIOCH BIOPH IN PRESS; PAN DA, 1994, J NUTR, V124, P1555, DOI 10.1093/jn/124.9.1555; Pan DA, 1995, J CLIN INVEST, V96, P2802, DOI 10.1172/JCI118350; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391; Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schrauwen P, 2010, BBA-MOL CELL BIOL L, V1801, P266, DOI 10.1016/j.bbalip.2009.09.011; Schrauwen-Hinderling VB, 2007, DIABETOLOGIA, V50, P113, DOI 10.1007/s00125-006-0475-1; Shabalina IG, 2010, BBA-BIOENERGETICS, V1797, P968, DOI 10.1016/j.bbabio.2010.02.033; Silva JP, 2005, EMBO J, V24, P4061, DOI 10.1038/sj.emboj.7600866; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Vazquez-Memije ME, 2005, EXP GERONTOL, V40, P482, DOI 10.1016/j.exger.2005.03.006; VESSBY B, 1994, DIABETOLOGIA, V37, P1044, DOI 10.1007/s001250050215	41	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27274	10.1371/journal.pone.0027274	http://dx.doi.org/10.1371/journal.pone.0027274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140436	Green Submitted, gold, Green Published			2022-12-25	WOS:000298163400004
J	Rahman, MM; Kundu, JK; Shin, JW; Na, HK; Surh, YJ				Rahman, Md Mostafizur; Kundu, Joydeb Kumar; Shin, Jun-Wan; Na, Hye-Kyung; Surh, Young-Joon			Docosahexaenoic Acid Inhibits UVB-Induced Activation of NF-kappa B and Expression of COX-2 and NOX-4 in HR-1 Hairless Mouse Skin by Blocking MSK1 Signaling	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; INDUCED OXIDATIVE STRESS; NADPH OXIDASE; CYCLOOXYGENASE-2 EXPRESSION; PROTEIN-KINASE; HUMAN KERATINOCYTES; ROS PRODUCTION; P38 MAPK; IN-VITRO; INFLAMMATION	Exposure to ultraviolet-B (UVB) radiation induces inflammation and photocarcinogenesis in mammalian skin. Docosahexaenoic acid (DHA), a representative omega-3 polyunsaturated fatty acid, has been reported to possess anti-inflammatory and chemopreventive properties. In the present study, we investigated the molecular mechanisms underlying the inhibitory effects of DHA on UVB-induced inflammation in mouse skin. Our study revealed that topical application of DHA prior to UVB irradiation attenuated the expression of cyclooxygenase-2 (COX-2) and NAD(P) H: oxidase-4 (NOX-4) in hairless mouse skin. DHA pretreatment also attenuated UVB-induced DNA binding of nuclear factor-kappaB (NF-kappa B) through the inhibition of phosphorylation of I kappa B kinase-alpha/beta, phosphorylation and degradation of I kappa B alpha and nuclear translocation of p50 and p65. In addition, UVB-induced phosphorylation of p65 at the serine 276 residue was significantly inhibited by topical application of DHA. Irradiation with UVB induced phosphorylation of mitogen and stress-activated kinase-1 (MSK1), extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein (MAP) kinase, and all these events were attenuated by pretreatment with DHA. Blocking ERK and p38 MAP kinase signaling by U0126 and SB203580, respectively, diminished MSK1 phosphorylation in UVB-irradiated mouse skin. Pretreatment with H-89, a pharmacological inhibitor of MSK1, abrogated UVB-induced activation of NF-kappa B and the expression of COX-2 and NOX-4 in mouse skin. In conclusion, topically applied DHA inhibits the UVB-induced activation of NF-kappa B and the expression of COX-2 and NOX-4 by blocking the phosphorylation of MSK1, a kinase downstream of ERK and p38 MAP kinase, in hairless mouse skin.	[Rahman, Md Mostafizur; Kundu, Joydeb Kumar; Shin, Jun-Wan; Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Res Ctr, Seoul, South Korea; [Na, Hye-Kyung] Sungsin Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Surh, Young-Joon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, WCU Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Surh, Young-Joon] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Sungshin Women's University; Seoul National University (SNU); Seoul National University (SNU)	Rahman, MM (corresponding author), Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Res Ctr, Seoul, South Korea.	surh@plaza.snu.ac.kr			World Class University [R31-008-000-10103-0]	World Class University	This work was supported by the World Class University grant (R31-008-000-10103-0) from the National Research Foundation of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An KP, 2002, PHOTOCHEM PHOTOBIOL, V76, P73, DOI 10.1562/0031-8655(2002)076<0073:CEIMAH>2.0.CO;2; An WS, 2009, AM J PHYSIOL-RENAL, V297, pF895, DOI 10.1152/ajprenal.00217.2009; Bachelor MA, 2005, MOL CANCER RES, V3, P90, DOI 10.1158/1541-7786.MCR-04-0065; Beak SM, 2004, BIOCHIMIE, V86, P425, DOI 10.1016/j.biochi.2004.06.010; Chamulitrat W, 2004, J INVEST DERMATOL, V122, P1000, DOI 10.1111/j.0022-202X.2004.22410.x; Chang EJ, 2011, MOL CARCINOGEN, V50, P310, DOI 10.1002/mc.20646; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; de Gruijl FR, 2002, SKIN PHARMACOL APPL, V15, P316, DOI 10.1159/000064535; Dickinson SE, 2011, MOL CARCINOGEN, V50, P469, DOI 10.1002/mc.20734; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; Djordjevic T, 2005, ARTERIOSCL THROM VAS, V25, P519, DOI 10.1161/01.ATV.0000154279.98244.eb; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; Jho David H, 2004, Integr Cancer Ther, V3, P98, DOI 10.1177/1534735404264736; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kaur G, 2011, PROG LIPID RES, V50, P28, DOI 10.1016/j.plipres.2010.07.004; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Kim AL, 2005, J INVEST DERMATOL, V124, P1318, DOI 10.1111/j.0022-202X.2005.23747.x; Kim JK, 2007, FREE RADICAL RES, V41, P603, DOI 10.1080/10715760701209896; Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002; Kundu JK, 2009, J FUNCT FOODS, V1, P98, DOI 10.1016/j.jff.2008.09.016; Lee CF, 2010, CIRC RES, V106, P1489, DOI 10.1161/CIRCRESAHA.109.215392; Lewis DA, 2008, J INVEST DERMATOL, V128, P1022, DOI 10.1038/sj.jid.5701127; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Machida T, 2005, J PHARMACOL SCI, V99, P113, DOI 10.1254/jphs.SC0050099; Manea A, 2010, BIOCHEM BIOPH RES CO, V396, P901, DOI 10.1016/j.bbrc.2010.05.019; Manea A, 2010, ARTERIOSCL THROM VAS, V30, P105, DOI 10.1161/ATVBAHA.109.193896; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Moe KT, 2006, J CELL MOL MED, V10, P231, DOI 10.1111/j.1582-4934.2006.tb00304.x; Mullen A, 2010, J NUTR BIOCHEM, V21, P444, DOI 10.1016/j.jnutbio.2009.02.008; Muller-Decker K, 2002, P NATL ACAD SCI USA, V99, P12483, DOI 10.1073/pnas.192323799; Murakami A, 2007, INT J CANCER, V121, P2357, DOI 10.1002/ijc.23161; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Otkjaer K, 2007, J INVEST DERMATOL, V127, P1326, DOI 10.1038/sj.jid.5700713; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Park S, 2010, J MOL MED, V88, P807, DOI 10.1007/s00109-010-0622-5; Pentland AP, 1999, CARCINOGENESIS, V20, P1939, DOI 10.1093/carcin/20.10.1939; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Richard D, 2009, BIOCHEM BIOPH RES CO, V389, P516, DOI 10.1016/j.bbrc.2009.09.013; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; SERINI S, 2010, J NUTR BIOCH; Sharma SD, 2007, MOL CANCER THER, V6, P995, DOI 10.1158/1535-7163.MCT-06-0661; Shono T, 2008, INT J CANCER, V123, P787, DOI 10.1002/ijc.23569; Sol VVD, 2005, J IMMUNOL, V174, P2825, DOI 10.4049/jimmunol.174.5.2825; Sun YY, 2007, WAVE RANDOM COMPLEX, V17, P1, DOI 10.1080/17455030600791694; Surh YJ, 2005, ARCH PHARM RES, V28, P1, DOI 10.1007/BF02975128; Tiano HF, 2002, CANCER RES, V62, P3395; Tobar N, 2010, BRIT J CANCER, V103, P1040, DOI 10.1038/sj.bjc.6605847; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang R, 2011, INT J CANCER, V128, P2581, DOI 10.1002/ijc.25610; Wang TM, 2011, J NUTR BIOCHEM, V22, P187, DOI 10.1016/j.jnutbio.2010.01.007; Wingler M, 2001, FREE RADICAL BIO MED, V31, P1456, DOI 10.1016/S0891-5849(01)00727-4; Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745; Yan Y, 2006, PHOTOCHEM PHOTOBIOL, V82, P665, DOI 10.1562/2005-08-17-RA-652; Zhao YF, 2006, CARCINOGENESIS, V27, P1692, DOI 10.1093/carcin/bgl037	58	43	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28065	10.1371/journal.pone.0028065	http://dx.doi.org/10.1371/journal.pone.0028065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140508	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163400030
J	Kijima, M; Gardiol, N; Held, W				Kijima, Mika; Gardiol, Noemie; Held, Werner			Natural Killer Cell Mediated Missing-Self Recognition Can Protect Mice from Primary Chronic Myeloid Leukemia In Vivo	PLOS ONE			English	Article							MHC CLASS-I; CHRONIC MYELOGENOUS LEUKEMIA; BONE-MARROW ALLOGRAFTS; VERSUS-HOST-DISEASE; NK CELLS; HEMATOPOIETIC TRANSPLANTS; INHIBITORY RECEPTORS; KIR LIGANDS; T-CELLS; HLA-C	Background: Natural Killer (NK) cells are thought to protect from residual leukemic cells in patients receiving stem cell transplantation. However, multiple retrospective analyses of patient data have yielded conflicting conclusions regarding a putative role of NK cells and the essential NK cell recognition events mediating a protective effect against leukemia. Further, a NK cell mediated protective effect against primary leukemia in vivo has not been shown directly. Methodology/Principal Findings: Here we addressed whether NK cells have the potential to control chronic myeloid leukemia (CML) arising based on the transplantation of BCR-ABL1 oncogene expressing primary bone marrow precursor cells into lethally irradiated recipient mice. These analyses identified missing-self recognition as the only NK cell-mediated recognition strategy, which is able to significantly protect from the development of CML disease in vivo. Conclusion: Our data provide a proof of principle that NK cells can control primary leukemic cells in vivo. Since the presence of NK cells reduced the abundance of leukemia propagating cancer stem cells, the data raise the possibility that NK cell recognition has the potential to cure CML, which may be difficult using small molecule BCR-ABL1 inhibitors. Finally, our findings validate approaches to treat leukemia using antibody-based blockade of self-specific inhibitory MHC class I receptors.	[Kijima, Mika; Gardiol, Noemie; Held, Werner] Univ Lausanne, Ludwig Ctr Canc Res, CH-1066 Epalinges, Switzerland	University of Lausanne	Kijima, M (corresponding author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.	Werner.Held@unil.ch			Swiss Cancer League	Swiss Cancer League	This work was supported in part by a grant from the Swiss Cancer League to W.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Benjamin JE, 2010, CURR OPIN ONCOL, V22, P130, DOI 10.1097/CCO.0b013e328335a559; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Brunstein CG, 2009, BLOOD, V113, P5628, DOI 10.1182/blood-2008-12-197467; Chalifour A, 2009, IMMUNITY, V30, P337, DOI 10.1016/j.immuni.2008.12.019; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Cooley S, 2009, BLOOD, V113, P726, DOI 10.1182/blood-2008-07-171926; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Davies SM, 2002, BLOOD, V100, P3825, DOI 10.1182/blood-2002-04-1197; Dong ZJ, 2009, NAT IMMUNOL, V10, P973, DOI 10.1038/ni.1763; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Gratwohl A, 2009, BEST PRACT RES CL HA, V22, P431, DOI 10.1016/j.beha.2009.05.002; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Hill GR, 1997, BLOOD, V90, P3204, DOI 10.1182/blood.V90.8.3204; Hsu KC, 2006, BIOL BLOOD MARROW TR, V12, P828, DOI 10.1016/j.bbmt.2006.04.008; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Ioannidis V, 2001, J IMMUNOL, V167, P6256, DOI 10.4049/jimmunol.167.11.6256; Joncker NT, 2010, J EXP MED, V207, P2065, DOI 10.1084/jem.20100570; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Leung W, 2004, J IMMUNOL, V172, P644, DOI 10.4049/jimmunol.172.1.644; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Miller JS, 2007, BLOOD, V109, P5058, DOI 10.1182/blood-2007-01-065383; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; MORETTA A, 1995, J EXP MED, V182, P875, DOI 10.1084/jem.182.3.875; MURPHY WJ, 1987, J EXP MED, V166, P1499, DOI 10.1084/jem.166.5.1499; Nakamura MC, 1999, J EXP MED, V189, P493, DOI 10.1084/jem.189.3.493; Ogasawara K, 2005, NAT IMMUNOL; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; Olson JA, 2009, J IMMUNOL, V183, P3219, DOI 10.4049/jimmunol.0804268; Orr MT, 2010, NAT IMMUNOL, V11, P321, DOI 10.1038/ni.1849; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pegram HJ, 2011, LEUKEMIA RES, V35, P14, DOI 10.1016/j.leukres.2010.07.030; Pende D, 2009, BLOOD, V113, P3119, DOI 10.1182/blood-2008-06-164103; Prlic M, 2007, BLOOD, V110, P2024, DOI 10.1182/blood-2007-04-086108; Raziuddin A, 1998, J IMMUNOL, V160, P87; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruggeri L, 1999, BLOOD, V94, P333, DOI 10.1182/blood.V94.1.333.413a31_333_339; Ruggeri L, 2007, CURR OPIN ONCOL, V19, P142, DOI 10.1097/CCO.0b013e3280148a1a; Shami PJ, 2012, LEUKEMIA, V26, P214, DOI 10.1038/leu.2011.217; Sola C, 2009, P NATL ACAD SCI USA, V106, P12879, DOI 10.1073/pnas.0901653106; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Vahlne G, 2010, EUR J IMMUNOL, V40, P813, DOI 10.1002/eji.200939755	48	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27639	10.1371/journal.pone.0027639	http://dx.doi.org/10.1371/journal.pone.0027639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132120	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000031
J	Schouten, LJ; van Dijk, BAC; Lumey, LH; Goldbohm, RA; van den Brandt, PA				Schouten, Leo J.; van Dijk, Boukje A. C.; Lumey, L. H.; Goldbohm, R. Alexandra; van den Brandt, Piet A.			Energy Restriction during Childhood and Early Adulthood and Ovarian Cancer Risk	PLOS ONE			English	Article							1944-1945 DUTCH FAMINE; NETHERLANDS COHORT; COLORECTAL-CANCER; BREAST-CANCER; CALORIC RESTRICTION; EARLY-LIFE; DIET; AGE; SUBSEQUENT; HEIGHT	Dietary energy restriction may protect against cancer. In parts of the Netherlands, mostly in larger cities, periods of chronically impaired nutrition and even severe famine (Hunger Winter 1944-1945) existed during the 1930s and World War II (1940-1945). We studied the association between energy restriction during childhood and early adulthood on the risk of ovarian cancer later in life. In 1986, the Netherlands Cohort Study was initiated. A self-administered questionnaire on dietary habits and other cancer risk factors was completed by 62,573 women aged 55-69 years at baseline. Follow-up for cancer was established by record linkage to the Netherlands Cancer Registry. After 16.3 years of follow-up, 364 invasive epithelial ovarian cancer cases and 2220 subcohort members (sampled from the total cohort directly after baseline) with complete information confounders were available for case-cohort analyses. In multivariable analysis, ovarian cancer risk was lower for participants with an unemployed father during the 1930s (Hazard Ratio (HR), 0.70; 95% Confidence Interval (CI), 0.47-1.06) compared to participants with an employed father as well as for participants living in a city during World War II (HR, 0.69; 95% CI, 0.54-0.90) compared to participants living in the country-side. Residence in a Western City during the famine (Hunger Winter) was not associated with a decreased risk. Our results show a relation between proxy variables for modest energy restriction over a longer period of time during childhood or early adulthood and a reduced ovarian cancer risk.	[Schouten, Leo J.; van den Brandt, Piet A.] Maastricht Univ, Dept Epidemiol, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [van Dijk, Boukje A. C.] Comprehens Canc Ctr Netherlands, Groningen, Netherlands; [Lumey, L. H.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Goldbohm, R. Alexandra] TNO, Dept Life Style, Leiden, Netherlands	Maastricht University; Columbia University; Netherlands Organization Applied Science Research	Schouten, LJ (corresponding author), Maastricht Univ, Dept Epidemiol, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands.	Lj.Schouten@epid.unimaas.nl	Schouten, Leo J/AAB-2275-2019; Schouten, Leo J/G-3713-2012	Schouten, Leo J/0000-0003-3361-7560; van den Brandt, Piet/0000-0001-8781-8099	World Cancer Research Fund-United Kingdom [2003-30]; Netherlands Cancer Society	World Cancer Research Fund-United Kingdom; Netherlands Cancer Society(KWF Kankerbestrijding)	This study has received funding from the World Cancer Research Fund-United Kingdom (grant no. 2003-30) and from the Netherlands Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer HJ, 2008, BRIT J CANCER, V99, P1916, DOI 10.1038/sj.bjc.6604742; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Braem MGM, 2010, AM J EPIDEMIOL, V172, P1181, DOI 10.1093/aje/kwq264; Breunis J, 1946, ANN AM ACAD POLIT SS, V245, P87, DOI 10.1177/000271624624500113; BURGER GCE, 1945, LANCET, V2, P282; Carver DK, 2011, CANCER PREV RES, V4, P562, DOI 10.1158/1940-6207.CAPR-10-0294; COX DR, 1972, J R STAT SOC B, V34, P187; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P717; DENHARTOG AP, 1983, VOEDING, V44, P92; Dirx MJM, 2003, CANCER-AM CANCER SOC, V97, P46, DOI 10.1002/cncr.11052; Dirx MJM, 1999, CANCER CAUSE CONTROL, V10, P189, DOI 10.1023/A:1008821524297; DOLS M. J. L., 1946, Voeding, V6, P193; Elias SG, 2004, J NATL CANCER I, V96, P539, DOI 10.1093/jnci/djh087; Elias SG, 2005, CANCER EPIDEM BIOMAR, V14, P1981, DOI 10.1158/1055-9965.EPI-04-0839; FATHALLA MF, 1971, LANCET, V2, P163; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goldbohm RA, 1994, TIJDSCHR SOC GEZONDH, V72, P80; Hankinson SE, 2006, CANC EPIDEMIOLOGY PR, P1013, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0052; Hughes LAE, 2010, INT J EPIDEMIOL, V39, P1333, DOI 10.1093/ije/dyq062; KASTEIN GW, 1935, NED TIJDSCHR GENEES, V79, P5583; KRITCHEVSKY D, 1995, EUR J CANCER PREV, V4, P445, DOI 10.1097/00008469-199512000-00002; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Loucks AB, 2006, J CLIN ENDOCR METAB, V91, P3158, DOI 10.1210/jc.2006-0570; Mellemkjaer L, 2001, CANCER CAUSE CONTROL, V12, P173, DOI 10.1023/A:1008974414116; Michels KB, 2004, JAMA-J AM MED ASSOC, V291, P1226, DOI 10.1001/jama.291.10.1226; Prentice RL, 2007, JNCI-J NATL CANCER I, V99, P1534, DOI 10.1093/jnci/djm159; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Schouten LJ, 2008, CANCER EPIDEM BIOMAR, V17, P902, DOI 10.1158/1055-9965.EPI-07-2524; Schouten LJ, 2003, AM J EPIDEMIOL, V157, P424, DOI 10.1093/aje/kwf224; Stein Z., 1975, FAMINE HUM DEV DUTCH; Svensson E, 2005, CANCER CAUSE CONTROL, V16, P215, DOI 10.1007/s10552-004-3073-x; Svensson E, 2002, EUR J CANCER PREV, V11, P489, DOI 10.1097/00008469-200210000-00012; Trienekens G, 2000, FOOD SCI POLICY REGU; TROMP MH, 1934, NED TIJDSCHR GENEES, V78, P5388; VANDENBRANDT PA, 1990, INT J EPIDEMIOL, V19, P553; VANDENBRANDT PA, 1990, J CLIN EPIDEMIOL, V43, P285, DOI 10.1016/0895-4356(90)90009-E; VANDERSPUY ZM, 1985, CLIN OBSTET GYNAECOL, V12, P579	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27960	10.1371/journal.pone.0027960	http://dx.doi.org/10.1371/journal.pone.0027960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132180	Green Published, Green Submitted, gold			2022-12-25	WOS:000298162000052
J	Dutra, RC; Leite, DFP; Bento, AF; Manjavachi, MN; Patricio, ES; Figueiredo, CP; Pesquero, JB; Calixto, JB				Dutra, Rafael C.; Leite, Daniela F. P.; Bento, Allisson F.; Manjavachi, Marianne N.; Patricio, Eliziane S.; Figueiredo, Claudia P.; Pesquero, Joao B.; Calixto, Joao B.			The Role of Kinin Receptors in Preventing Neuroinflammation and Its Clinical Severity during Experimental Autoimmune Encephalomyelitis in Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TUMOR BARRIER PERMEABILITY; BLOOD-BRAIN-BARRIER; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; T-CELLS; ALZHEIMERS-DISEASE; DENDRITIC CELLS; T(H)17 CELLS; EXPRESSION	Background: Multiple sclerosis (MS) is a demyelinating and neuroinflammatory disease of the human central nervous system (CNS). The expression of kinins is increased in MS patients, but the underlying mechanisms by which the kinin receptor regulates MS development have not been elucidated. Methodology/Principal Findings: Experimental autoimmune encephalomyelitis (EAE) was induced in female C57BL/6 mice by immunization with MOG(35-55) peptide emulsified in complete Freund's adjuvant and injected with pertussis toxin on day 0 and day 2. Here, we report that blockade of the B1R in the induction phase of EAE markedly suppressed its progression by interfering with the onset of the immune response. Furthermore, B1R antagonist suppressed the production/expression of antigen-specific T(H)1 and T(H)17 cytokines and transcription factors, both in the periphery and in the CNS. In the chronic phase of EAE, the blockade of B1R consistently impaired the clinical progression of EAE. Conversely, administration of the B1R agonist in the acute phase of EAE suppressed disease progression and inhibited the increase in permeability of the blood-brain barrier (BBB) and any further CNS inflammation. Of note, blockade of the B2R only showed a moderate impact on all of the studied parameters of EAE progression. Conclusions/Significance: Our results strongly suggest that kinin receptors, mainly the B1R subtype, play a dual role in EAE progression depending on the phase of treatment through the lymphocytes and glial cell-dependent pathways.	[Dutra, Rafael C.; Leite, Daniela F. P.; Bento, Allisson F.; Manjavachi, Marianne N.; Patricio, Eliziane S.; Figueiredo, Claudia P.; Calixto, Joao B.] Univ Fed Santa Catarina, Dept Pharmacol, Ctr Biol Sci, Florianopolis, SC, Brazil; [Pesquero, Joao B.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Sao Paulo (UNIFESP)	Dutra, RC (corresponding author), Univ Fed Santa Catarina, Dept Pharmacol, Ctr Biol Sci, Florianopolis, SC, Brazil.	calixto@farmaco.ufsc.br	Bento, Allisson/F-5603-2013; Pesquero, Joao/C-1470-2012; Figueiredo, Claudia P/F-8424-2012; Dutra, Rafael C/F-8452-2012	Pesquero, Joao/0000-0002-4507-632X; Dutra, Rafael C/0000-0002-6938-2161; Figueiredo, Claudia/0000-0001-9467-9891; calixto, joao Batista/0000-0003-4041-7153	Conselho Nacional de Desenvolvimento Cientifico eTecnologico (CNPq), Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil; Programa de Apoio aos Nucleos de Excelencia (PRONEX), Brazil; Fundacaode Apoio a Pesquisa Cientifica Tecnologica do Estado de Santa Catarina (FAPESC), Brazil; CNPq; CAPES	Conselho Nacional de Desenvolvimento Cientifico eTecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Apoio aos Nucleos de Excelencia (PRONEX), Brazil; Fundacaode Apoio a Pesquisa Cientifica Tecnologica do Estado de Santa Catarina (FAPESC), Brazil; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico eTecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Programa de Apoio aos Nucleos de Excelencia (PRONEX) and the Fundacaode Apoio a Pesquisa Cientifica Tecnologica do Estado de Santa Catarina (FAPESC), all of Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. R. C. D., A. F. B., and M.M.N. are Ph.D. students in pharmacology receiving grants from CNPq and CAPES, respectively.	Aliberti J, 2003, J IMMUNOL, V170, P5349, DOI 10.4049/jimmunol.170.11.5349; Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; BORKOWSKI JA, 1995, J BIOL CHEM, V270, P13706, DOI 10.1074/jbc.270.23.13706; Calixto JB, 2004, BRIT J PHARMACOL, V143, P803, DOI 10.1038/sj.bjp.0706012; Campos MM, 2006, TRENDS PHARMACOL SCI, V27, P646, DOI 10.1016/j.tips.2006.10.007; Carola V, 2010, GENES BRAIN BEHAV, V9, P379, DOI 10.1111/j.1601-183X.2010.00572.x; COSTA R, 2011, BR J PHARM; Crusio WE, 2009, GENES BRAIN BEHAV, V8, P1, DOI 10.1111/j.1601-183X.2008.00438.x; Crusio WE, 2004, BIOL PSYCHIAT, V56, P381, DOI 10.1016/j.biopsych.2003.12.026; Danielisova V, 2009, CELL MOL NEUROBIOL, V29, P871, DOI 10.1007/s10571-009-9369-3; Dos Santos AC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-49; Dutra RC, 2011, BRIT J PHARMACOL, V163, P358, DOI 10.1111/j.1476-5381.2011.01226.x; Ellestad KK, 2009, J IMMUNOL, V183, P298, DOI 10.4049/jimmunol.0803576; Elliott PJ, 1996, EXP NEUROL, V141, P214, DOI 10.1006/exnr.1996.0156; Emerich DF, 2000, PHARMACEUT RES, V17, P1212, DOI 10.1023/A:1026462629438; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gerlai R, 2001, BEHAV BRAIN RES, V125, P13, DOI 10.1016/S0166-4328(01)00282-0; GERMAIN L, 1988, J NEUROL SCI, V83, P211, DOI 10.1016/0022-510X(88)90069-X; Gobin SJP, 2001, GLIA, V36, P68, DOI 10.1002/glia.1096; Gobel K, 2011, J AUTOIMMUN, V36, P106, DOI 10.1016/j.jaut.2010.11.004; Goverman J, 2009, NAT REV IMMUNOL; Gresack JE, 2010, BEHAV BRAIN RES, V209, P80, DOI 10.1016/j.bbr.2010.01.018; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Juan QL, 2009, NEUROSCI LETT, V450, P172, DOI 10.1016/j.neulet.2008.10.080; Kawakami N, 2005, J IMMUNOL, V175, P69, DOI 10.4049/jimmunol.175.1.69; Khan TK, 2009, NEUROBIOL DIS, V34, P332, DOI 10.1016/j.nbd.2009.02.003; Kim H, 2007, BRAIN RES, V1162, P113, DOI 10.1016/j.brainres.2007.05.072; Kiselycznyk C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00010; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Liu LB, 2008, J NEUROSCI RES, V86, P1153, DOI 10.1002/jnr.21558; Liu YH, 2001, NEUROL RES, V23, P379, DOI 10.1179/016164101101198596; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marceau F, 1998, CLIN REV ALLERG IMMU, V16, P385, DOI 10.1007/BF02737658; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Moldovan IR, 2003, J NEUROIMMUNOL, V141, P132, DOI 10.1016/S0165-5728(03)00221-2; Mycko MA, 2008, EUR J IMMUNOL, V38, P1999, DOI 10.1002/eji.200737661; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Prat A, 2000, J NEUROPATH EXP NEUR, V59, P896, DOI 10.1093/jnen/59.10.896; Prat A, 2005, ARCH NEUROL-CHICAGO, V62, P795, DOI 10.1001/archneur.62.5.795; Prediger RDS, 2008, NEUROSCIENCE, V151, P631, DOI 10.1016/j.neuroscience.2007.11.009; Schulze-Topphoff U, 2009, NAT MED, V15, P788, DOI 10.1038/nm.1980; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Terenyi N, 2009, MOL IMMUNOL, V47, P57, DOI 10.1016/j.molimm.2008.12.026; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; WALKER K, 1995, NEUROCHEM INT, V26, P1, DOI 10.1016/0197-0186(94)00114-A; Walther T, 1998, J BIOL CHEM, V273, P11867, DOI 10.1074/jbc.273.19.11867; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Zhang H, 2007, BRAIN RES, V1144, P33, DOI 10.1016/j.brainres.2007.01.133; Zhang M, 2010, NEUROSCIENCE, V171, P852, DOI 10.1016/j.neuroscience.2010.09.029	55	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27875	10.1371/journal.pone.0027875	http://dx.doi.org/10.1371/journal.pone.0027875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132157	Green Submitted, Green Published, gold			2022-12-25	WOS:000297792400019
J	Ren, G; Blum, G; Verdoes, M; Liu, HG; Syed, S; Edgington, LE; Gheysens, O; Miao, Z; Jiang, H; Gambhir, SS; Bogyo, M; Cheng, Z				Ren, Gang; Blum, Galia; Verdoes, Martijn; Liu, Hongguang; Syed, Salahuddin; Edgington, Laura E.; Gheysens, Olivier; Miao, Zheng; Jiang, Han; Gambhir, Sanjiv Sam; Bogyo, Matthew; Cheng, Zhen			Non-Invasive Imaging of Cysteine Cathepsin Activity in Solid Tumors Using a Cu-64-Labeled Activity-Based Probe	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; PROTEASE ACTIVITY; CANCER; EXPRESSION; MICROENVIRONMENT; PROTEOLYSIS; ACTIVATION; INVASION; TARGET	The papain family of cysteine cathepsins are actively involved in multiple stages of tumorigenesis. Because elevated cathepsin activity can be found in many types of human cancers, they are promising biomarkers that can be used to target radiological contrast agents for tumor detection. However, currently there are no radiological imaging agents available for these important molecular targets. We report here the development of positron emission tomography (PET) radionuclide-labeled probes that target the cysteine cathepsins by formation of an enzyme activity-dependent bond with the active site cysteine. These probes contain an acyloxymethyl ketone (AOMK) functional group that irreversibly labels the active site cysteine of papain family proteases attached to a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) tag for labeling with Cu-64 for PET imaging studies. We performed biodistribution and microPET imaging studies in nude mice bearing subcutaneous tumors expressing various levels of cysteine cathepsin activity and found that the extent of probe uptake by tumors correlated with overall protease activity as measured by biochemical methods. Furthermore, probe signals could be reduced by pre-treatment with a general cathepsin inhibitor. We also found that inclusion of a Cy5 tag on the probe increased tumor uptake relative to probes lacking this fluorogenic dye. Overall, these results demonstrate that small molecule activity-based probes carrying radio-tracers can be used to image protease activity in living subjects.	[Ren, Gang; Liu, Hongguang; Gheysens, Olivier; Miao, Zheng; Jiang, Han; Gambhir, Sanjiv Sam; Bogyo, Matthew; Cheng, Zhen] Stanford Univ, MIPS, Stanford, CA 94305 USA; [Ren, Gang; Liu, Hongguang; Gheysens, Olivier; Miao, Zheng; Jiang, Han; Gambhir, Sanjiv Sam; Cheng, Zhen] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Gambhir, Sanjiv Sam] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Blum, Galia; Verdoes, Martijn; Syed, Salahuddin; Edgington, Laura E.; Bogyo, Matthew] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Bogyo, Matthew] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Ren, Gang; Liu, Hongguang; Gheysens, Olivier; Miao, Zheng; Jiang, Han; Gambhir, Sanjiv Sam; Bogyo, Matthew; Cheng, Zhen] Stanford Univ, Bio X Program, Stanford, CA 94305 USA; [Blum, Galia] Hebrew Univ Jerusalem, Inst Drug Res, Jerusalem, Israel	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Hebrew University of Jerusalem	Ren, G (corresponding author), Stanford Univ, MIPS, Stanford, CA 94305 USA.	sgambhir@stanford.edu; mbogyo@stanford.edu; zcheng@stanford.edu	Verdoes, Martijn/A-4911-2015; Verdoes, Martijn/AAD-5239-2022; Cheng, Zhen/K-2843-2012; miao, zheng/A-8851-2012	Verdoes, Martijn/0000-0001-8753-3528; Verdoes, Martijn/0000-0001-8753-3528; Cheng, Zhen/0000-0001-8177-9463; , Han/0000-0001-7455-3810; Bogyo, Matthew/0000-0003-3753-4412; SYED, SALAHUDDIN/0000-0002-9696-6437; Edgington-Mitchell, Laura/0000-0002-6810-6149	National Institutes of Health (NIH) National Technology Centers for Networks and Pathways [U54 RR020843]; NIH [R01 EB005011]; Susan G. Komen for the Cure [PDF0504576]; National Cancer Institute (NCI) [R24 CA93862]; NCI In Vivo Cellular Molecular Imaging Center (ICMIC) [P50 CA114747]; NATIONAL CANCER INSTITUTE [T32CA009302, P50CA114747] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Technology Centers for Networks and Pathways(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI In Vivo Cellular Molecular Imaging Center (ICMIC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in part, by National Institutes of Health (NIH) National Technology Centers for Networks and Pathways grant U54 RR020843 (MB), NIH grant R01 EB005011 (MB), Susan G. Komen for the Cure grant PDF0504576 (GB), National Cancer Institute (NCI) Small Animal Imaging Resource Program (SAIRP) grant R24 CA93862, and NCI In Vivo Cellular Molecular Imaging Center (ICMIC) grant P50 CA114747 (SSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CJ, 2001, J NUCL MED, V42, P213; Baruch A, 2004, TRENDS CELL BIOL, V14, P29, DOI 10.1016/j.tcb.2003.11.002; Berger Alicia B, 2004, Am J Pharmacogenomics, V4, P371, DOI 10.2165/00129785-200404060-00004; Blum G, 2005, NAT CHEM BIOL, V1, P203, DOI 10.1038/nchembio728; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Bogdanov AA, 2002, NEOPLASIA, V4, P228, DOI 10.1038/sj.neo.7900238; Boswell CA, 2004, J MED CHEM, V47, P1465, DOI 10.1021/jm030383m; Bremer C, 2002, RADIOLOGY, V222, P814, DOI 10.1148/radiol.2223010812; CAMPO E, 1994, AM J PATHOL, V145, P301; Cavallo-Medved D, 2003, CURR TOP DEV BIOL, V54, P313, DOI 10.1016/S0070-2153(03)54013-3; Cheng Z, 2007, BIOCONJUGATE CHEM, V18, P765, DOI 10.1021/bc060306g; D'Orazi G, 2000, J GENE MED, V2, P11; Edgington LE, 2009, NAT MED, V15, P967, DOI 10.1038/nm.1938; Eijan AM, 2003, CANCER, V98, P262, DOI 10.1002/cncr.11493; Figueiredo JL, 2006, INT J CANCER, V118, P2672, DOI 10.1002/ijc.21713; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Joyce JA, 2004, CELL CYCLE, V3, P1516, DOI 10.4161/cc.3.12.1289; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Lee M, 2004, CHEM SOC REV, V33, P401, DOI 10.1039/b209224g; Lim IT, 2004, J AM CHEM SOC, V126, P10271, DOI 10.1021/ja0489240; Mahmood U, 1999, RADIOLOGY, V213, P866, DOI 10.1148/radiology.213.3.r99dc14866; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; Sloane BF, 2006, ANNU REV PHARMACOL, V46, P301, DOI 10.1146/annurev.pharmtox.45.120403.095853; Sloane BF, 2005, SEMIN CANCER BIOL, V15, P149, DOI 10.1016/j.semcancer.2004.08.001; Sun XK, 2004, NUCL MED BIOL, V31, P1051, DOI 10.1016/j.nucmedbio.2004.08.011	31	39	39	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28029	10.1371/journal.pone.0028029	http://dx.doi.org/10.1371/journal.pone.0028029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132198	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789900039
J	Sanford, MR; Demirci, B; Marsden, CD; Lee, Y; Cornel, AJ; Lanzaro, GC				Sanford, Michelle R.; Demirci, Berna; Marsden, Clare D.; Lee, Yoosook; Cornel, Anthony J.; Lanzaro, Gregory C.			Morphological Differentiation May Mediate Mate-Choice between Incipient Species of Anopheles gambiae s.s.	PLOS ONE			English	Article							MOLECULAR-FORMS; REPRODUCTIVE ISOLATION; CHROMOSOMAL FORMS; WEST-AFRICA; WING LENGTH; GENE FLOW; POPULATIONS; COMPLEX; DIPTERA; DIVERGENCE	The M and S molecular forms of Anopheles gambiae s.s. have been considered incipient species for more than ten years, yet the mechanism underlying assortative mating of these incipient species has remained elusive. The discovery of the importance of harmonic convergence of wing beat frequency in mosquito mating and its relation to wing size have laid the foundation for exploring phenotypic divergence in wing size of wild populations of the two forms. In this study, wings from field collected mosquitoes were measured for wing length and wing width from two parts of the sympatric distribution, which differ with respect to the strength of assortative mating. In Mali, where assortative mating is strong, as evidenced by low rates of hybridization, mean wing lengths and wing widths were significantly larger than those from Guinea-Bissau. In addition, mean wing widths in Mali were significantly different between molecular forms. In Guinea-Bissau, assortative mating appears comparatively reduced and wing lengths and widths did not differ significantly between molecular forms. The data presented in this study support the hypothesis that wing beat frequency may mediate assortative mating in the incipient species of A. gambiae and represent the first documentation of a morphological difference between the M and S molecular forms.	[Sanford, Michelle R.; Marsden, Clare D.; Lee, Yoosook; Lanzaro, Gregory C.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Demirci, Berna] Hacettepe Univ, Fac Sci, Ankara, Turkey; [Cornel, Anthony J.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	University of California System; University of California Davis; Hacettepe University; University of California System; University of California Davis	Sanford, MR (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	uranotaenia@gmail.com	Sanford, Michelle/C-9575-2011	Sanford, Michelle/0000-0001-6212-4023; Lee, Yoosook/0000-0002-1392-7177	National Institutes of Health [AI062929, AI078183, AI074550]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074550, R21AI062929, R01AI078183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grants AI062929, AI078183 and AI074550 awarded to GCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Bottecchia M, 2004, J MOL EVOL, V58, P754, DOI 10.1007/s00239-004-2586-y; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415; Cator LJ, 2010, BEHAV ECOL, V21, P1033, DOI 10.1093/beheco/arq087; Cator LJ, 2009, SCIENCE, V323, P1077, DOI 10.1126/science.1166541; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; Diabate A, 2006, J MED ENTOMOL, V43, P480, DOI 10.1603/0022-2585(2006)43[480:MSOTMM]2.0.CO;2; Diabate A, 2007, J MED ENTOMOL, V44, P60, DOI 10.1603/0022-2585(2007)44[60:ETEOPI]2.0.CO;2; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Gibson G, 2010, JARO-J ASSOC RES OTO, V11, P527, DOI 10.1007/s10162-010-0243-2; Gimonneau G, 2012, MED VET ENTOMOL, V26, P9, DOI 10.1111/j.1365-2915.2011.00957.x; Gleason JM, 1998, EVOLUTION, V52, P1493, DOI [10.2307/2411319, 10.1111/j.1558-5646.1998.tb02031.x]; Koella JC, 1996, J MED ENTOMOL, V33, P261, DOI 10.1093/jmedent/33.2.261; Lanzaro GC, 1998, P NATL ACAD SCI USA, V95, P14260, DOI 10.1073/pnas.95.24.14260; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; LEE Y, 2009, MALARIA J, V8, DOI DOI 10.1186/1475-2875-1188-1175; Lee Y, 2009, J MED ENTOMOL, V46, P316, DOI 10.1603/033.046.0216; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; MARSDEN CM, 2011, MOL ECOL IN PRESS; NASCI RS, 1990, J MED ENTOMOL, V27, P716, DOI 10.1093/jmedent/27.4.716; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Peixato AA, 2001, INT J PARASITOL, V31, P635, DOI 10.1016/S0020-7519(01)00149-7; Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040; Slotman MA, 2006, GENETICS, V174, P2081, DOI 10.1534/genetics.106.059949; Souza NA, 2004, J MED ENTOMOL, V41, P906, DOI 10.1603/0022-2585-41.5.906; Taylor C, 2001, GENETICS, V157, P743; Tripet F, 2004, J MED ENTOMOL, V41, P375, DOI 10.1603/0022-2585-41.3.375; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Tripet F, 2007, AM J TROP MED HYG, V76, P81; Tuno N, 2010, J MED ENTOMOL, V47, P28, DOI 10.1603/033.047.0104; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2	40	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27920	10.1371/journal.pone.0027920	http://dx.doi.org/10.1371/journal.pone.0027920			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132169	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789900033
J	Guo, Y; Liu, H; Yang, TL; Li, SYM; Li, SYK; Tian, Q; Liu, YJ; Deng, HW				Guo, Yan; Liu, Hui; Yang, Tie-Lin; Li, Siyang M.; Li, Siyuan K.; Tian, Qing; Liu, Yong-Jun; Deng, Hong-Wen			The Fat Mass and Obesity Associated Gene, FTO, Is Also Associated with Osteoporosis Phenotypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHILDHOOD OBESITY; ADULT OBESITY; POPULATION; BONE; LINKAGE; SAMPLE; INDEX; TOOL; BMI	Obesity and osteoporosis are closely correlated genetically. FTO gene has been consistently identified to be associated with obesity phenotypes. A recent study reported that the mice lacking Fto could result in lower bone mineral density (BMD). Thus, we hypothesize that the FTO gene might be also important for osteoporosis phenotypes. To test for such a hypothesis, we performed an association analyses to investigate the relationship between SNPs in FTO and BMD at both hip and spine. A total of 141 SNPs were tested in two independent Chinese populations (818 and 809 unrelated Han subjects, respectively) and a Caucasian population (2,286 unrelated subjects). Combining the two Chinese samples, we identified 6 SNPs in FTO to be significantly associated with hip BMD after multiple testing adjustments, with the combined P values ranged from 4.99x10(-4) -1.47x10(-4). These 6 SNPs are all located at the intron 8 of FTO and in high linkage disequilibrium. Each copy of the minor allele of each SNP was associated with increased hip BMD values with the effect size (beta) of similar to 0.025 and similar to 0.015 in the Chinese sample 1 and 2, respectively. However, none of these 6 SNPs showed significant association signal in the Caucasian sample, by presenting some extent of ethnic difference. Our findings, together with the prior biological evidence, suggest that the FTO gene might be a new candidate for BMD variation and osteoporosis in Chinese populations.	[Guo, Yan; Yang, Tie-Lin] Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Peoples R China; [Guo, Yan; Yang, Tie-Lin] Xi An Jiao Tong Univ, Inst Mol Genet, Sch Life Sci & Technol, Xian 710049, Peoples R China; [Liu, Hui] Xian Red Cross Hosp, Dept Articular Surg, Xian, Peoples R China; [Li, Siyang M.; Li, Siyuan K.] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Tian, Qing; Liu, Yong-Jun; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Systemat Biomed Res, Shanghai 201800, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; University of Missouri System; University of Missouri Kansas City; Tulane University; University of Shanghai for Science & Technology	Yang, TL (corresponding author), Xi An Jiao Tong Univ, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Peoples R China.	yangtielin@xjtu.edu.cn; hdeng2@tulane.edu	Liu, Yong/GWQ-6163-2022; Guo, Yan/G-8742-2014; Yang, Tie-Lin/G-8365-2014	Guo, Yan/0000-0002-7364-2392; Yang, Tie-Lin/0000-0001-7062-3025; Deng, Hong-Wen/0000-0002-0387-8818	National Natural Science Foundation of China [81000363, 31000554]; PhD. Programs Foundation of Ministry of Education of China [20100201120058]; Fundamental Research Funds for the Central Universities, Shanghai Leading Academic Discipline Project [S30501]; University of Shanghai for Science and Technology; Xi'an Jiaotong University; National Institutes of Health (NIH) [R01 AR050496, R21 AG027110, R01 AG026564, R01 AR057049-01A1, R21 AA015973]; SCOR (Specialized Center of Research) [P50 AR055081]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, P50AR055081, R01AR057049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, R21AG027110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PhD. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities, Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline ProjectFundamental Research Funds for the Central Universities); University of Shanghai for Science and Technology; Xi'an Jiaotong University(Xi'an Jiaotong University); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SCOR (Specialized Center of Research); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from National Natural Science Foundation of China (81000363, 31000554), the PhD. Programs Foundation of Ministry of Education of China (20100201120058), the Fundamental Research Funds for the Central Universities, Shanghai Leading Academic Discipline Project(S30501), and startup funds from University of Shanghai for Science and Technology and Xi'an Jiaotong University. The study was also funded by grants from National Institutes of Health (NIH R01 AR050496, R21 AG027110, R01 AG026564, R01 AR057049-01A1 and R21 AA015973) and a SCOR (Specialized Center of Research) grant (P50 AR055081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Cha SW, 2008, OBESITY, V16, P2185, DOI 10.1038/oby.2008.314; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Deng FY, 2006, OSTEOPOROSIS INT, V17, P119, DOI 10.1007/s00198-005-1930-4; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X; Guo Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000806; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Hubacek JA, 2008, OBESITY, V16, P2764, DOI 10.1038/oby.2008.421; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Toth Edit, 2005, Orvosi Hetilap, V146, P1489; Zhao JH, 2011, OBESITY, V19, P1311, DOI 10.1038/oby.2010.324; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572; Zhao LJ, 2006, HUM GENET, V120, P561, DOI 10.1007/s00439-006-0243-9	25	30	32	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27312	10.1371/journal.pone.0027312	http://dx.doi.org/10.1371/journal.pone.0027312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125610	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789200010
J	Kamath, S; Chavez, AO; Gastaldelli, A; Casiraghi, F; Halff, GA; Abrahamian, GA; Davalli, AM; Bastarrachea, RA; Comuzzie, AG; Guardado-Mendoza, R; Jimenez-Ceja, LM; Mattern, V; Paez, AM; Ricotti, A; Tejero, ME; Higgins, PB; Rodriguez-Sanchez, IP; Tripathy, D; DeFronzo, RA; Dick, EJ; Cline, GW; Folli, F				Kamath, Subhash; Chavez, Alberto O.; Gastaldelli, Amalia; Casiraghi, Francesca; Halff, Glenn A.; Abrahamian, Gregory A.; Davalli, Alberto M.; Bastarrachea, Raul A.; Comuzzie, Anthony G.; Guardado-Mendoza, Rodolfo; Jimenez-Ceja, Lilia M.; Mattern, Vicki; Paez, Ana Maria; Ricotti, Andrea; Tejero, Mary E.; Higgins, Paul B.; Rodriguez-Sanchez, Iram Pablo; Tripathy, Devjit; DeFronzo, Ralph A.; Dick, Edward J., Jr.; Cline, Gary W.; Folli, Franco			Coordinated Defects in Hepatic Long Chain Fatty Acid Metabolism and Triglyceride Accumulation Contribute to Insulin Resistance in Non-Human Primates	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; LIVER-DISEASE; ADIPOSE-TISSUE; DIABETES-MELLITUS; GENE-EXPRESSION; DIETARY-INTAKE; CELL-FUNCTION; STEATOSIS; OBESITY; HUMANS	Non-Alcoholic fatty liver disease (NAFLD) is characterized by accumulation of triglycerides (TG) in hepatocytes, which may also trigger cirrhosis. The mechanisms of NAFLD are not fully understood, but insulin resistance has been proposed as a key determinant. Aims: To determine the TG content and long chain fatty acyl CoA composition profile in liver from obese nondiabetic insulin resistant (IR) and lean insulin sensitive (IS) baboons in relation with hepatic and peripheral insulin sensitivity. Methods: Twenty baboons with varying grades of adiposity were studied. Hepatic (liver) and peripheral (mainly muscle) insulin sensitivity was measured with a euglycemic clamp and QUICKI. Liver biopsies were performed at baseline for TG content and LCFA profile by mass spectrometry, and histological analysis. Findings were correlated with clinical and biochemical markers of adiposity and insulin resistance. Results: Obese IR baboons had elevated liver TG content compared to IS. Furthermore, the concentration of unsaturated (LC-UFA) was greater than saturated (LC-SFA) fatty acyl CoA in the liver. Interestingly, LC-FA UFA and SFA correlated with waist, BMI, insulin, NEFA, TG, QUICKI, but not M/I. Histological findings of NAFLD ranging from focal to diffuse hepatic steatosis were found in obese IR baboons. Conclusion: Liver TG content is closely related with both hepatic and peripheral IR, whereas liver LC-UFA and LC-SFA are closely related only with hepatic IR in non-human primates. Mechanisms leading to the accumulation of TG, LC-UFA and an altered UFA: LC-SFA ratio may play an important role in the pathophysiology of fatty liver disease in humans.	[Kamath, Subhash; Chavez, Alberto O.; Gastaldelli, Amalia; Casiraghi, Francesca; Davalli, Alberto M.; Guardado-Mendoza, Rodolfo; Jimenez-Ceja, Lilia M.; Paez, Ana Maria; Tripathy, Devjit; DeFronzo, Ralph A.; Folli, Franco] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Diabet, San Antonio, TX 78229 USA; [Gastaldelli, Amalia; Ricotti, Andrea] CNR, Inst Clin Physiol, Pisa, Italy; [Halff, Glenn A.; Abrahamian, Gregory A.] Univ Texas Hlth Sci Ctr San Antonio, UT Transplant Ctr, San Antonio, TX 78229 USA; [Davalli, Alberto M.; Folli, Franco] Ist Sci San Raffaele, Diabet & Endocrinol Unit, Dept Internal Med, I-20132 Milan, Italy; [Bastarrachea, Raul A.; Comuzzie, Anthony G.; Mattern, Vicki; Tejero, Mary E.; Higgins, Paul B.; Rodriguez-Sanchez, Iram Pablo; Dick, Edward J., Jr.] SW Natl Primate Res Ctr, Texas Biomed Res Inst, San Antonio, TX USA; [Cline, Gary W.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	University of Texas System; University of Texas Health San Antonio; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Texas System; University of Texas Health San Antonio; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Texas Biomedical Research Institute; Yale University	Kamath, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Diabet, San Antonio, TX 78229 USA.	folli@uthscsa.edu	Gastaldelli, Amalia/H-3319-2014; folli, franco/J-2795-2018; Bastarrachea, Raul/B-5920-2019; Casiraghi, Francesca/GLS-0884-2022; rodriguez-sanchez, iram/F-7838-2012	Gastaldelli, Amalia/0000-0003-2594-1651; folli, franco/0000-0001-9824-5222; Bastarrachea, Raul/0000-0002-4034-3062; Guardado Mendoza, Rodolfo/0000-0002-6491-7577	National Institutes of Health (NIH); USPHS [P30 DK-45735]; National Center for Research Resources of the NIH [P51 RR013986, C06 RR014578, C06 RR013556, C06 RR015456, C06 RR017515]; University of Milan, Italy;  [RO1 DK-080148]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR013556, C06RR014578, P51RR013986, C06RR015456, C06RR017515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080148, P30DK045735] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); National Center for Research Resources of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Milan, Italy; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	FF was supported by RO1 DK-080148. This study was partially supported by the National Institutes of Health (NIH), a grant from the USPHS (P30 DK-45735) and conducted in facilities constructed with support from the Research Facilities Improvement Program under grant numbers P51 RR013986, C06 RR014578, C06 RR013556, C06 RR015456, and C06 RR017515 from the National Center for Research Resources of the NIH. F. C. was supported by a fellowship from the University of Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32; Angulo P, 2007, NUTR REV, V65, pS57, DOI 10.1111/j.1753-4887.2007.tb00329.x; Araya J, 2004, CLIN SCI, V106, P635, DOI 10.1042/CS20030326; ARTURI F, J CLIN ENDOCRINOL ME, V96, pE1640; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bose T, 2009, J MED PRIMATOL, V38, P418, DOI 10.1111/j.1600-0684.2009.00379.x; Bozzetto L, 2011, EUR J CLIN INVEST, V41, P39, DOI 10.1111/j.1365-2362.2010.02372.x; Bueno AA, 2008, PFLUG ARCH EUR J PHY, V455, P701, DOI 10.1007/s00424-007-0330-3; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Chavez AO, 2008, DIABETES, V57, P899, DOI 10.2337/db07-0790; Chavez AO, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-22; Cobbold JFL, 2009, CLIN SCI, V116, P403, DOI 10.1042/CS20080159; Deivanayagam S, 2008, AM J CLIN NUTR, V88, P257, DOI 10.1093/ajcn/88.2.257; Elinav E, 2009, HEPATOLOGY, V49, P278, DOI 10.1002/hep.22584; Erion DM, 2009, CELL METAB, V10, P499, DOI 10.1016/j.cmet.2009.10.007; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fabbrini E, 2009, CURR OPIN CLIN NUTR, V12, P474, DOI 10.1097/MCO.0b013e32832eb587; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Gastaldelli A, 2007, GASTROENTEROLOGY, V133, P496, DOI 10.1053/j.gastro.2007.04.068; GROOP LC, 1989, J CLIN INVEST, V84, P205, DOI 10.1172/JCI114142; Guardado-Mendoza R, 2009, P NATL ACAD SCI USA, V106, P13992, DOI 10.1073/pnas.0906471106; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hwang JH, 2007, AM J PHYSIOL-ENDOC M, V293, pE1663, DOI 10.1152/ajpendo.00590.2006; Kashyap SR, 2009, OBESITY, V17, P1696, DOI 10.1038/oby.2009.89; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Kotronen A, 2010, OBESITY, V18, P937, DOI 10.1038/oby.2009.326; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moore JB, 2010, P NUTR SOC, V69, P211, DOI 10.1017/S0029665110000030; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Nobili V, 2006, HEPATOLOGY, V44, P458, DOI 10.1002/hep.21262; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Perseghin G, 2011, DIABETES CARE, V34, pS367, DOI 10.2337/dc11-s249; Peter A, 2011, AM J PHYSIOL-ENDOC M, V300, pE321, DOI 10.1152/ajpendo.00306.2010; Peter A, 2009, CLIN CHEM, V55, P2113, DOI 10.1373/clinchem.2009.127274; PETTINELLI P, 2011, J CLIN ENDOCRINOL ME; Pischon T, 2003, CIRCULATION, V108, P155, DOI 10.1161/01.CIR.0000079224.46084.C2; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030; Riserus U, 2002, CIRCULATION, V106, P1925, DOI 10.1161/01.CIR.0000033589.15413.48; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Seth D, 2003, AM J PATHOL, V163, P2303, DOI 10.1016/S0002-9440(10)63587-0; Svegliati-Baroni G, 1999, HEPATOLOGY, V29, P1743, DOI 10.1002/hep.510290632; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; van Werven JR, 2010, EUR J RADIOL, V75, pE102, DOI 10.1016/j.ejrad.2009.12.033; Velloso LA, 1996, P NATL ACAD SCI USA, V93, P12490, DOI 10.1073/pnas.93.22.12490; Wendel AA, 2008, J LIPID RES, V49, P98, DOI 10.1194/jlr.M700195-JLR200; WENE JD, 1982, PHYSIOL BEHAV, V28, P569, DOI 10.1016/0031-9384(82)90155-X; ZHANG X, CIRCULATION, V124, P77	57	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27617	10.1371/journal.pone.0027617	http://dx.doi.org/10.1371/journal.pone.0027617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125617	Green Published, gold, Green Submitted			2022-12-25	WOS:000297789200017
J	Bonavia, R; Inda, MM; Vandenberg, S; Cheng, SY; Nagane, M; Hadwiger, P; Tan, P; Sah, DWY; Cavenee, WK; Furnari, FB				Bonavia, R.; Inda, M. M.; Vandenberg, S.; Cheng, S-Y; Nagane, M.; Hadwiger, P.; Tan, P.; Sah, D. W. Y.; Cavenee, W. K.; Furnari, F. B.			EGFRvIII promotes glioma angiogenesis and growth through the NF-kappa B, interleukin-8 pathway	ONCOGENE			English	Article						glioblastoma; EGFR; Delta EGFR; angiogenesis; NF-kappa B; IL-8	SIGNAL-TRANSDUCTION PATHWAYS; TRANSCRIPTION FACTOR AP-1; FACTOR RECEPTOR COMMON; BREAST-CANCER CELLS; IN-VITRO; TYROSINE PHOSPHORYLATION; GLIOBLASTOMA-MULTIFORME; TUMOR-GROWTH; BRAIN-TUMOR; STEM-CELL	Sustaining a high growth rate requires tumors to exploit resources in their microenvironment. One example of this is the extensive angiogenesis that is a typical feature of high-grade gliomas. Here, we show that expression of the constitutively active mutant epidermal growth factor receptor, Delta EGFR (EGFRvIII, EGFR*, de2-7EGFR) is associated with significantly higher expression levels of the pro-angiogenic factor interleukin (IL)-8 in human glioma specimens and glioma stem cells. Furthermore, the ectopic expression of Delta EGFR in different glioma cell lines caused up to 60-fold increases in the secretion of IL-8. Xenografts of these cells exhibit increased neovascularization, which is not elicited by cells overexpressing wildtype (wt) EGFR or DEGFR with an additional kinase domain mutation. Analysis of the regulation of IL-8 by site-directed mutagenesis of its promoter showed that DEGFR regulates its expression through the transcription factors nuclear factor (NF)-kappa B, activator protein 1 (AP-1) and CCAAT/enhancer binding protein (C/EBP). Glioma cells overexpressing Delta EGFR showed constitutive activation and DNA binding of NF-kappa B, overexpression of c-Jun and activation of its upstream kinase c-Jun N-terminal kinase (JNK) and overexpression of C/EBP beta. Selective pharmacological or genetic targeting of the NF-kappa B or AP-1 pathways efficiently blocked promoter activity and secretion of IL-8. Moreover, RNA interference-mediated knock-down of either IL-8 or the NF-kappa B subunit p65, in Delta EGFR-expressing cells attenuated their ability to form tumors and to induce angiogenesis when injected subcutaneously into nude mice. On the contrary, the overexpression of IL-8 in glioma cells lacking Delta EGFR potently enhanced their tumorigenicity and produced highly vascularized tumors, suggesting the importance of this cytokine and its transcription regulators in promoting glioma angiogenesis and tumor growth. Oncogene (2012) 31, 4054-4066; doi: 10.1038/onc.2011.563; published online 5 December 2011	[Bonavia, R.; Inda, M. M.; Cavenee, W. K.; Furnari, F. B.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Bonavia, R.; Vandenberg, S.] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Vandenberg, S.; Cavenee, W. K.; Furnari, F. B.] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; [Cheng, S-Y] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Nagane, M.] Kyorin Univ, Fac Med, Dept Neurosurg, Tokyo, Japan; [Hadwiger, P.; Tan, P.] Alnylam Europe AG, Kulmbach, Germany; [Sah, D. W. Y.] Alnylam Pharmaceut Inc, Cambridge, MA USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kyorin University	Furnari, FB (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	ffurnari@ucsd.edu		Furnari, Frank/0000-0003-1909-4361	Goldhirsh Foundation; NIH [P01-CA95616, RO1CA130966]; Pennsylvania Department of Health; Innovative Research Scholar Award of the Hillman Foundation; Gobierno de Navarra, Spain; American Brain Tumor Association in Honor of Walter Terlik; Federazione Italiana Ricerca Cancro; NATIONAL CANCER INSTITUTE [P01CA095616, R01CA130966] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22591618] Funding Source: KAKEN	Goldhirsh Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; Innovative Research Scholar Award of the Hillman Foundation; Gobierno de Navarra, Spain; American Brain Tumor Association in Honor of Walter Terlik; Federazione Italiana Ricerca Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Donna Harclerode and Donald Pizzo for technical assistance with immunostaining and Dr Cameron Brennan for providing the GBM tumorspheres. This work was supported by an award from the Goldhirsh Foundation (to FBF), and NIH Grant P01-CA95616 (to WKC, FBF), as well as NIH RO1CA130966, a grant with Pennsylvania Department of Health and an Innovative Research Scholar Award of the Hillman Foundation (to SYC). WKC is a fellow of the National Foundation for Cancer Research. MM Inda thanks the Gobierno de Navarra, Spain, and the American Brain Tumor Association in Honor of Walter Terlik for the fellowships received. R Bonavia was supported by a fellowship from Federazione Italiana Ricerca Cancro.	Antonyak MA, 1998, J BIOL CHEM, V273, P2817, DOI 10.1074/jbc.273.5.2817; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Biernat W, 2004, BRAIN PATHOL, V14, P131, DOI 10.1111/j.1750-3639.2004.tb00045.x; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Brew R, 2000, CYTOKINE, V12, P78, DOI 10.1006/cyto.1999.0518; BROWN PH, 1993, ONCOGENE, V8, P877; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Chen DY, 2003, ONCOGENE, V22, P4348, DOI 10.1038/sj.onc.1206532; Feldkamp MM, 1999, INT J CANCER, V81, P118, DOI 10.1002/(SICI)1097-0215(19990331)81:1<118::AID-IJC20>3.3.CO;2-X; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Gille J, 1997, EMBO J, V16, P750, DOI 10.1093/emboj/16.4.750; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; HURTT MR, 1992, J NEUROPATH EXP NEUR, V51, P84, DOI 10.1097/00005072-199201000-00010; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; JAROS E, 1992, BRIT J CANCER, V66, P373, DOI 10.1038/bjc.1992.273; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lal S, 2000, J NEUROSURG, V92, P326, DOI 10.3171/jns.2000.92.2.0326; Le Page C, 2005, PROSTATE, V65, P306, DOI 10.1002/pros.20291; Lee CH, 2007, BIOFACTORS, V29, P19, DOI 10.1002/biof.5520290103; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Magnus N, 2010, BLOOD, V116, P815, DOI 10.1182/blood-2009-10-250639; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Malliri A, 1998, J CELL BIOL, V143, P1087, DOI 10.1083/jcb.143.4.1087; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Nagane M, 1998, P NATL ACAD SCI USA, V95, P5724, DOI 10.1073/pnas.95.10.5724; Narita Y, 2002, CANCER RES, V62, P6764; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Nishikawa Ryo, 2004, Brain Tumor Pathol, V21, P53, DOI 10.1007/BF02484510; Norden AD, 2008, LANCET NEUROL, V7, P1152, DOI 10.1016/S1474-4422(08)70260-6; Petit AMV, 1997, AM J PATHOL, V151, P1523; Prigent SA, 1996, J BIOL CHEM, V271, P25639, DOI 10.1074/jbc.271.41.25639; SCHLEGEL J, 1994, INT J CANCER, V56, P72; Shinojima N, 2003, CANCER RES, V63, P6962; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Takamori H, 2000, PANCREAS, V21, P52, DOI 10.1097/00006676-200007000-00051; Tsukahara T, 1999, J VIROL, V73, P7981, DOI 10.1128/JVI.73.10.7981-7987.1999; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; WANG ZQ, 1991, EMBO J, V10, P2437, DOI 10.1002/j.1460-2075.1991.tb07783.x; Weissenberger J, 2004, ONCOGENE, V23, P3308, DOI 10.1038/sj.onc.1207455; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Yao C, 2007, INT J CANCER, V121, P1949, DOI 10.1002/ijc.22930; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200	57	125	127	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2012	31	36					4054	4066		10.1038/onc.2011.563	http://dx.doi.org/10.1038/onc.2011.563			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	004NQ	22139077	Green Accepted			2022-12-25	WOS:000308688800006
J	Gruninger, RJ; Dobing, S; Smith, AD; Bruder, LM; Selinger, LB; Wieden, HJ; Mosimann, SC				Gruninger, Robert J.; Dobing, Selina; Smith, Adam D.; Bruder, Lisza M.; Selinger, L. Brent; Wieden, Hans-Joachim; Mosimann, Steven C.			Substrate Binding in Protein-tyrosine Phosphatase-like Inositol Polyphosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY CRYSTALLOGRAPHY; MYOINOSITOL HEXAKISPHOSPHATE; STRUCTURAL-ANALYSIS; PHYTASE; HYDROLYSIS; STEREOSPECIFICITY; SPECIFICITY; MECHANISM; PATHWAY; COMPLEX	Protein-tyrosine phosphatase-like inositol polyphosphatases are microbial enzymes that catalyze the stepwise removal of one or more phosphates from highly phosphorylated myo-inositols via a relatively ordered pathway. To understand the substrate specificity and kinetic mechanism of these enzymes we have determined high resolution, single crystal, x-ray crystallographic structures of inactive Selenomonas ruminantium PhyA in complex with myo-inositol hexa-and pentakisphosphate. These structures provide the first glimpse of a myo-inositol polyphosphatase-ligand complex consistent with its known specificity and reveal novel features of the kinetic mechanism. To complement the structural studies, fluorescent binding assays have been developed and demonstrate that the K-d for this enzyme is several orders of magnitude lower than the K-m. Together with rapid kinetics data, these results suggest that the protein tyrosine phosphatase-like inositol polyphosphatases have a two-step, substrate-binding mechanism that facilitates catalysis.	[Gruninger, Robert J.; Dobing, Selina; Smith, Adam D.; Bruder, Lisza M.; Wieden, Hans-Joachim; Mosimann, Steven C.] Univ Lethbridge, Dept Chem & Biochem, Lethbridge, AB T1K 3M4, Canada; [Selinger, L. Brent] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge; University of Lethbridge	Mosimann, SC (corresponding author), 4401 Univ Dr, Lethbridge, AB T1K 3M4, Canada.	steven.mosimann@uleth.ca		Selinger, Leonard/0000-0001-8205-8334	National Science and Engineering Research Council of Canada (NSERC); NSERC	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by National Science and Engineering Research Council of Canada (NSERC) discovery grants (to H.-J.W., L. B. S., and S. C. M.) and NSERC studentships (to R.J.G., S. D., and L.M.B.).	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Caffrey JJ, 1999, FEBS LETT, V442, P99, DOI 10.1016/S0014-5793(98)01636-6; Chatterjee S, 2003, MOL PLANT MICROBE IN, V16, P973, DOI 10.1094/MPMI.2003.16.11.973; Chu HM, 2004, STRUCTURE, V12, P2015, DOI 10.1016/j.str.2004.08.010; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Goodrich J. A., 2007, BINDING KINETICS MOL, P135; Greiner R, 2002, J AGR FOOD CHEM, V50, P6865, DOI 10.1021/jf025620t; Gruninger RJ, 2008, FEBS J, V275, P3783, DOI 10.1111/j.1742-4658.2008.06524.x; Gruninger RJ, 2009, J MOL BIOL, V392, P75, DOI 10.1016/j.jmb.2009.05.079; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Jackson SG, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-80; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Lim D, 2000, NAT STRUCT BIOL, V7, P108; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Majerus PW, 2008, ADV ENZYME REGUL, V48, P10, DOI 10.1016/j.advenzreg.2008.04.001; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mullaney EJ, 2000, ADV APPL MICROBIOL, V47, P157, DOI 10.1016/S0065-2164(00)47004-8; Mullaney EJ, 2003, BIOCHEM BIOPH RES CO, V312, P179, DOI 10.1016/j.bbrc.2003.09.176; Nakashima BA, 2007, MICROB ECOL, V53, P82, DOI 10.1007/s00248-006-9147-4; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Puhl AA, 2008, BIOCHEM CELL BIOL, V86, P322, DOI 10.1139/o08-095; Puhl AA, 2008, INT J BIOCHEM CELL B, V40, P2053, DOI 10.1016/j.biocel.2008.02.003; Puhl AA, 2007, PROTEIN SCI, V16, P1368, DOI 10.1110/ps.062738307; Puhl AA, 2009, APPL MICROBIOL BIOT, V82, P95, DOI 10.1007/s00253-008-1734-5; Rao DECS, 2009, CRIT REV BIOTECHNOL, V29, P182, DOI 10.1080/07388550902919571; Shah N, 2003, BIOCHEMISTRY-US, V42, P13812, DOI 10.1021/bi034742r; STREET IP, 1991, TETRAHEDRON, V47, P5919, DOI 10.1016/S0040-4020(01)86484-X; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Ullah AHJ, 1998, BIOCHEM BIOPH RES CO, V251, P260, DOI 10.1006/bbrc.1998.9456; Ullah AHJ, 2000, BIOCHEM BIOPH RES CO, V275, P279, DOI 10.1006/bbrc.2000.3271; Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zou JY, 1999, STRUCTURE, V7, P1035, DOI 10.1016/S0969-2126(99)80171-3	37	10	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9722	9730		10.1074/jbc.M111.309872	http://dx.doi.org/10.1074/jbc.M111.309872			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22139834	Green Published, hybrid			2022-12-25	WOS:000302167200006
J	Milanese, C; Sager, JJ; Bai, Q; Farrell, TC; Cannon, JR; Greenamyre, JT; Burton, EA				Milanese, Chiara; Sager, Jonathan J.; Bai, Qing; Farrell, Thomas C.; Cannon, Jason R.; Greenamyre, J. Timothy; Burton, Edward A.			Hypokinesia and Reduced Dopamine Levels in Zebrafish Lacking beta- and gamma 1-Synucleins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; ALPHA-SYNUCLEIN; TRANSGENIC ZEBRAFISH; GAMMA-SYNUCLEIN; MICE LACKING; KNOCKOUT MICE; RISK-FACTORS; NEURON LOSS; IN-VIVO; GENE	alpha-Synuclein is strongly implicated in the pathogenesis of Parkinson disease. However, the normal functions of synucleins and how these relate to disease pathogenesis are uncertain. We characterized endogenous zebrafish synucleins in order to develop tractable models to elucidate the physiological roles of synucleins in neurons in vivo. Three zebrafish genes, sncb, sncg1, and sncg2 (encoding beta-, gamma 1-, and gamma 2-synucleins respectively), show extensive phylogenetic conservation with respect to their human paralogues. A zebrafish alpha-synuclein orthologue was not found. Abundant 1.45-kb sncb and 2.7-kb sncg1 mRNAs were detected in the CNS from early development through adulthood and showed overlapping but distinct expression patterns. Both transcripts were detected in catecholaminergic neurons throughout the CNS. Zebrafish lacking beta-, gamma 1-, or both synucleins during early development showed normal CNS and body morphology but exhibited decreased spontaneous motor activity that resolved as gene expression recovered. Zebrafish lacking both beta- and gamma 1-synucleins were more severely hypokinetic than animals lacking one or the other synuclein and showed delayed differentiation of dopaminergic neurons and reduced dopamine levels. Phenotypic abnormalities resulting from loss of endogenous zebrafish synucleins were rescued by expression of human alpha-synuclein. These data demonstrate that synucleins have essential phylogenetically conserved neuronal functions that regulate dopamine homeostasis and spontaneous motor behavior. Zebrafish models will allow further elucidation of the molecular physiology and pathophysiology of synucleins in vivo.	[Milanese, Chiara; Sager, Jonathan J.; Bai, Qing; Farrell, Thomas C.; Cannon, Jason R.; Greenamyre, J. Timothy; Burton, Edward A.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15213 USA; [Milanese, Chiara; Sager, Jonathan J.; Bai, Qing; Farrell, Thomas C.; Cannon, Jason R.; Greenamyre, J. Timothy; Burton, Edward A.] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15213 USA; [Sager, Jonathan J.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15213 USA; [Burton, Edward A.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Milanese, Chiara] Ri MED Fdn, I-90133 Palermo, Italy; [Greenamyre, J. Timothy; Burton, Edward A.] Pittsburgh Vet Affairs Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Geriatric Research Education & Clinical Center	Burton, EA (corresponding author), Univ Pittsburgh, Dept Neurol, 7015 BST-3,3501 5th Ave, Pittsburgh, PA 15213 USA.	eab25@pitt.edu	Cannon, Jason/F-2435-2012; Burton, Edward/AAO-9677-2021; Burton, Edward/ABB-1324-2021; Milanese, Chiara/AAA-9267-2019	Cannon, Jason/0000-0003-1907-4555; Burton, Edward/0000-0002-8072-4636; Milanese, Chiara/0000-0001-8696-2603; Greenamyre, J. Timothy/0000-0003-3468-7878	National Institutes of Health [NS0583691, ES019879]; Pittsburgh Foundation [M2005-0071]; Ri.MED Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES019879, R00ES019879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pittsburgh Foundation; Ri.MED Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS0583691 and ES019879. This work was also supported by Pittsburgh Foundation Grant M2005-0071 and the Ri.MED Foundation.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Anichtchik OV, 2004, J NEUROCHEM, V88, P443, DOI 10.1046/j.1471-4159.2003.02190.x; Anwar S, 2011, J NEUROSCI, V31, P7264, DOI 10.1523/JNEUROSCI.6194-10.2011; Bai Q, 2009, NEUROSCIENCE, V164, P1138, DOI 10.1016/j.neuroscience.2009.09.014; Bai Q, 2007, NUCLEIC ACIDS RES, V35, P6501, DOI 10.1093/nar/gkm608; Bai Q, 2006, BRAIN RES, V1113, P33, DOI 10.1016/j.brainres.2006.07.057; Bai Q, 2011, J COMP NEUROL, V519, P1580, DOI 10.1002/cne.22587; Bai Q, 2009, NEUROSCI LETT, V449, P252, DOI 10.1016/j.neulet.2008.10.101; Bandmann O, 2010, NEUROBIOL DIS, V40, P58, DOI 10.1016/j.nbd.2010.05.017; Bretaud S, 2004, NEUROTOXICOL TERATOL, V26, P857, DOI 10.1016/j.ntt.2004.06.014; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen YC, 2009, DEV DYNAM, V238, P746, DOI 10.1002/dvdy.21877; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Fuchs J, 2008, FASEB J, V22, P1327, DOI 10.1096/fj.07-9348com; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Hayashi S, 2000, MOVEMENT DISORD, V15, P884, DOI 10.1002/1531-8257(200009)15:5<884::AID-MDS1019>3.0.CO;2-8; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lam CS, 2005, EUR J NEUROSCI, V21, P1758, DOI 10.1111/j.1460-9568.2005.03988.x; Lepiller S, 2009, GENE, V445, P58, DOI 10.1016/j.gene.2009.05.016; Liang J, 2008, HUM MOL GENET, V17, P3784, DOI 10.1093/hmg/ddn276; Lo K, 1996, GENE, V182, P13, DOI 10.1016/S0378-1119(96)00438-6; Ma PM, 2003, J COMP NEUROL, V460, P13, DOI 10.1002/cne.10544; McKinley ET, 2005, MOL BRAIN RES, V141, P128, DOI 10.1016/j.molbrainres.2005.08.014; McLean DL, 2009, J NEUROSCI, V29, P13566, DOI 10.1523/JNEUROSCI.3277-09.2009; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Muto A, 2011, P NATL ACAD SCI USA, V108, P5425, DOI 10.1073/pnas.1000887108; Naumann EA, 2010, NAT NEUROSCI, V13, P513, DOI 10.1038/nn.2518; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Panula P, 2010, NEUROBIOL DIS, V40, P46, DOI 10.1016/j.nbd.2010.05.010; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Robertson DC, 2004, J NEUROCHEM, V89, P1126, DOI 10.1111/j.1471-4159.2004.02378.x; Sager JJ, 2010, BRAIN STRUCT FUNCT, V214, P285, DOI 10.1007/s00429-009-0237-1; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Sallinen V, 2010, NEUROBIOL DIS, V40, P93, DOI 10.1016/j.nbd.2010.06.001; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schluter OM, 2003, NEUROSCIENCE, V118, P985, DOI 10.1016/S0306-4522(03)00036-8; Sheng DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000914; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sinha AU, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-82; Specht CG, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-11; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sun ZH, 2008, DEV DYNAM, V237, P2490, DOI 10.1002/dvdy.21569; Thisse C., 2004, ZFIN; Trinh K, 2008, J NEUROSCI, V28, P465, DOI 10.1523/JNEUROSCI.4778-07.2008; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Wider C, 2010, NEURODEGENER DIS, V7, P175, DOI 10.1159/000289232; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Yoshida H, 2006, BIOCHEMISTRY-US, V45, P2599, DOI 10.1021/bi051993m; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	64	59	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					2971	2983		10.1074/jbc.M111.308312	http://dx.doi.org/10.1074/jbc.M111.308312			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22128150	hybrid, Green Published			2022-12-25	WOS:000300295100005
J	Yamagata, K; Li, X; Ikegaki, S; Oneyama, C; Okada, M; Nishita, M; Minami, Y				Yamagata, Kaoru; Li, Xin; Ikegaki, Shunkichi; Oneyama, Chitose; Okada, Masato; Nishita, Michiru; Minami, Yasuhiro			Dissection of Wnt5a-Ror2 Signaling Leading to Matrix Metalloproteinase (MMP-13) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE ROR2; SQUAMOUS-CELL CARCINOMAS; COLLAGENASE-3 MMP-13; GROWTH-FACTOR; TRANSCRIPTION FACTOR; BREAST CARCINOMAS; GENE-EXPRESSION; BETA-CATENIN; RECEPTOR; CANCER	It has been shown that constitutively active Wnt5a-Ror2 signaling in osteosarcoma cell lines plays crucial roles in induced expression of matrix metalloproteinase-13 (MMP-13), required for their invasiveness; however, it remains largely unclear about the molecular basis of MMP-13 gene induction by Wnt5a-Ror2 signaling. Here we show by reporter assay that the activator protein 1 (AP1) (binding site in the promoter region of MMP-13 gene is primarily responsible for its transcriptional activation by Wnt5a-Ror2 signaling in osteosarcoma cell lines SaOS-2 and U2OS. Chromatin immunoprecipitation assays revealed that c-Jun and ATF2 are crucial transcription factors recruited to the AP1-binding site in the MMP-13 gene promoter during Wnt5a-Ror2 signaling in SaOS-2 cells. Using siRNA-mediated suppression or specific inhibitors, we also show that Dishevelled2 (Dvl2) and c-Jun N-terminal kinase are required for MMP-13 gene induction presumably via phosphorylation of c-Jun and ATF2 during Wnt5a-Ror2 signaling in SaOS-2 cells. Interestingly, Dvl2 and Rac1, but not Dvl3, are required for MMP-13 expression in SaOS-2 cells, whereas Dvl3, but not Dvl2 and Rac1, is required for its expression in U2OS cells, indicating the presence of distinct intracellular signaling machineries leading to expression of the same gene, in this case MMP-13 gene in different osteosarcoma cell lines. Moreover, we provide evidence suggesting that Wnt5a-Ror2 signaling might also be required for expression of MMP-13 gene during the development of the cartilaginous tissue.	[Yamagata, Kaoru; Li, Xin; Ikegaki, Shunkichi; Nishita, Michiru; Minami, Yasuhiro] Kobe Univ, Dept Physiol & Cell Biol, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Oneyama, Chitose; Okada, Masato] Osaka Univ, Dept Oncogene Res, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Kobe University; Osaka University	Minami, Y (corresponding author), Kobe Univ, Dept Physiol & Cell Biol, Grad Sch Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	minami@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Tokyo Biochemical Research Foundation; Hyogo Science and Technology Association; Uehara Memorial Foundation; Foundation for Promotion of Cancer Research; Grants-in-Aid for Scientific Research [22790291, 22689009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Biochemical Research Foundation; Hyogo Science and Technology Association; Uehara Memorial Foundation(Uehara Memorial Foundation); Foundation for Promotion of Cancer Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Scientific Research (B), for Young Scientists (B), Scientific Research on Innovative Areas, and for Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and grants from the Tokyo Biochemical Research Foundation, Hyogo Science and Technology Association, Uehara Memorial Foundation, and Foundation for Promotion of Cancer Research.	Airola K, 1999, BRIT J CANCER, V80, P733, DOI 10.1038/sj.bjc.6690417; Airola K, 1997, J INVEST DERMATOL, V109, P225, DOI 10.1111/1523-1747.ep12319441; Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; Borden P, 1996, J BIOL CHEM, V271, P23577, DOI 10.1074/jbc.271.38.23577; Boumah CE, 2009, MOL ENDOCRINOL, V23, P1255, DOI 10.1210/me.2008-0217; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Etoh T, 2000, GUT, V47, P50, DOI 10.1136/gut.47.1.50; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; IOZZO RV, 1995, CANCER RES, V55, P3495; Johansson N, 1999, AM J PATHOL, V154, P469, DOI 10.1016/S0002-9440(10)65293-5; Johansson N, 1997, AM J PATHOL, V151, P499; Kanazawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012228; Kani S, 2004, J BIOL CHEM, V279, P50102, DOI 10.1074/jbc.M409039200; Kobayashi M, 2005, ARTHRITIS RHEUM-US, V52, P128, DOI 10.1002/art.20776; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Morioka K, 2009, CANCER SCI, V100, P1227, DOI 10.1111/j.1349-7006.2009.01165.x; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; Nishita M, 2010, MOL CELL BIOL, V30, P3610, DOI 10.1128/MCB.00177-10; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Ren DY, 2011, GENES CELLS, V16, P304, DOI 10.1111/j.1365-2443.2011.01487.x; Solis-Herruzo JA, 1999, J BIOL CHEM, V274, P30919, DOI 10.1074/jbc.274.43.30919; StahleBackdahl M, 1997, LAB INVEST, V76, P717; Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769; Uria JA, 1998, AM J PATHOL, V153, P91, DOI 10.1016/S0002-9440(10)65549-6; Uria JA, 1997, CANCER RES, V57, P4882; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Witte F, 2010, FASEB J, V24, P2417, DOI 10.1096/fj.09-150615; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Yamada T, 2010, ANTICANCER RES, V30, P2693; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007	44	55	60	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1588	1599		10.1074/jbc.M111.315127	http://dx.doi.org/10.1074/jbc.M111.315127			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128168	hybrid, Green Published			2022-12-25	WOS:000299170300072
J	McTaggart, JS; Lee, S; Iberl, M; Church, C; Cox, RD; Ashcroft, FM				McTaggart, James S.; Lee, Sheena; Iberl, Michaela; Church, Chris; Cox, Roger D.; Ashcroft, Frances M.			FTO Is Expressed in Neurones throughout the Brain and Its Expression Is Unaltered by Fasting	PLOS ONE			English	Article							ENERGY-INTAKE; FOOD-INTAKE; OBESITY GENE; CHILDHOOD; VARIANT; MICE; NEUN	Single-nucleotide polymorphisms in the first intron of the ubiquitously expressed FTO gene are associated with obesity. Although the physiological functions of FTO remain unclear, food intake is often altered when Fto expression levels are manipulated. Furthermore, deletion of FTO from neurones alone has a similar effect on food intake to deletion of FTO in all tissues. These results indicate that FTO expression in the brain is particularly important. Considerable focus has been placed on the dynamic regulation of Fto mRNA expression in the hypothalamus after short-term (16-48 hour) fasting, but results have been controversial. There are no studies that quantify FTO protein levels across the brain, and assess its alteration following short-term fasting. Using immunohistochemistry, we found that FTO protein is widely expressed in mouse brain, and present in the majority of neurones. Using quantitative Western blotting and RT-qPCR we show that FTO protein and mRNA levels in the hypothalamus, cerebellum and rostral brain are relatively uniform, and levels in the brain are higher than in skeletal muscles of the lower limbs. Fasting for 18 hours does not alter the expression pattern, or levels, of FTO protein and mRNA. We further show that the majority of POMC neurones, which are critically involved in food intake regulation, also express FTO, but that the percentage of FTO-positive POMC neurones is not altered by fasting. In summary, we find no evidence that Fto/FTO expression is regulated by short-term (18-hour) fasting. Thus, it is unlikely that the hunger and increased post-fasting food intake caused by such food deprivation is driven by alterations in Fto/FTO expression. The widespread expression of FTO in neurones also suggests that physiological studies of this protein should not be limited to the hypothalamus.	[McTaggart, James S.; Lee, Sheena; Iberl, Michaela; Ashcroft, Frances M.] Henry Wellcome Ctr Gene Funct, OXION Ctr Ion Channel Studies, Dept Physiol Anat & Genet, Oxford, England; [Church, Chris; Cox, Roger D.] MRC Harwell, Harwell, Berks, England	University of Oxford; MRC Harwell	McTaggart, JS (corresponding author), Henry Wellcome Ctr Gene Funct, OXION Ctr Ion Channel Studies, Dept Physiol Anat & Genet, Oxford, England.	frances.ashcroft@dpag.ox.ac.uk		Cox, Roger/0000-0001-7170-5014	Medical Research Council; Wellcome Trust; Royal Society; Medical Research Council [MC_U142661184] Funding Source: researchfish; MRC [MC_U142661184] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the Medical Research Council (JSM and CC held Medical Research Council studentships), Wellcome Trust (OXION support for SL and MI), and the Royal Society (Research Professorship to FMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Agouni A, 2010, BIOCHEM BIOPH RES CO, V401, P104, DOI 10.1016/j.bbrc.2010.09.018; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Guan HP, 2009, J BIOL CHEM, V284, P24644, DOI 10.1074/jbc.M109.034397; HEIZMANN CW, 1982, P NATL ACAD SCI-BIOL, V79, P7243, DOI 10.1073/pnas.79.23.7243; Hodge HC, 1941, J BIOL CHEM, V139, P897; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Jia G, NAT CHEM BIOL; Jikumaru M, 2007, PHYSIOL CHEM PHYS ME, V39, P247; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; MENAHAN LA, 1983, COMP BIOCHEM PHYS B, V74, P859, DOI 10.1016/0305-0491(83)90157-8; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Olszewski PK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-129; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Tanofsky-Kraff M, 2009, AM J CLIN NUTR, V90, P1483, DOI 10.3945/ajcn.2009.28439; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Wang P, 2011, MOL MED, V17, P523, DOI [10.2119/molmed.2010.000134, 10.2119/molmed.2010.00134]; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wardle J, 2008, INT J OBESITY; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Wu Q, 2010, BIOCHEM BIOPH RES CO, V401, P390, DOI 10.1016/j.bbrc.2010.09.064	36	62	64	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27968	10.1371/journal.pone.0027968	http://dx.doi.org/10.1371/journal.pone.0027968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140494	gold, Green Submitted, Green Published			2022-12-25	WOS:000298168100028
J	Zeyrek, FY; Palacpac, N; Yuksel, F; Yagi, M; Honjo, K; Fujita, Y; Arisue, N; Takeo, S; Tanabe, K; Horii, T; Tsuboi, T; Ishii, KJ; Coban, C				Zeyrek, Fadile Yildiz; Palacpac, Nirianne; Yuksel, Fehmi; Yagi, Masanori; Honjo, Kaori; Fujita, Yukiko; Arisue, Nobuko; Takeo, Satoru; Tanabe, Kazuyuki; Horii, Toshihiro; Tsuboi, Takafumi; Ishii, Ken J.; Coban, Cevayir			Serologic Markers in Relation to Parasite Exposure History Help to Estimate Transmission Dynamics of Plasmodium vivax	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; C-TERMINAL REGION; ACQUIRED ANTIBODY-RESPONSES; NEW-GUINEAN CHILDREN; MALARIA TRANSMISSION; IMMUNE-RESPONSES; WHEAT-GERM; FALCIPARUM; INFECTION; TURKEY	Plasmodium vivax infection has been gaining attention because of its re-emergence in several parts of the world. Southeastern Turkey is one of the places in which persistent focal malaria caused exclusively by P. vivax parasites occurs. Although control and elimination studies have been underway for many years, no detailed study has been conducted to understand the mechanisms underlying the ineffective control of malaria in this region. Here, for the first time, using serologic markers we try to extract as much information as possible in this region to get a glimpse of P. vivax transmission. We conducted a sero-immunological study, evaluating antibody responses of individuals living in Sanliurfa to four different P. vivax antigens; three blood-stage antigens (PvMSP1(19), PvAMA1-ecto, and PvSERA4) and one pre-erythrocytic stage antigen (PvCSP). The results suggest that a prior history of malaria infection and age can be determining factors for the levels and sustainability of naturally acquired antibodies. Significantly higher antibody responses to all the studied antigens were observed in blood smear-negative individuals with a prior history of malaria infection. Moreover, these individuals were significantly older than blood smear-negative individuals with no prior history of infection. These data from an area of sole P. vivax-endemic region may have important implications for the global malaria control/elimination programs and vaccine design.	[Zeyrek, Fadile Yildiz; Fujita, Yukiko; Coban, Cevayir] Osaka Univ, Immunol Frontier Res Ctr, Lab Malaria Immunol, Osaka, Japan; [Zeyrek, Fadile Yildiz; Yuksel, Fehmi] Harran Univ Sch Med, Dept Microbiol, Sanliurfa, Turkey; [Palacpac, Nirianne; Yagi, Masanori; Arisue, Nobuko; Horii, Toshihiro] Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Osaka, Japan; [Honjo, Kaori] Osaka Univ, Global Collaborat Ctr, Osaka, Japan; [Takeo, Satoru; Tsuboi, Takafumi] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 790, Japan; [Tanabe, Kazuyuki] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Malariol, Osaka, Japan; [Ishii, Ken J.] Osaka Univ, Lab Vaccine Sci, Immunol Frontier Res Ctr, Osaka, Japan	Osaka University; Harran University; Osaka University; Osaka University; Ehime University; Osaka University; Osaka University	Zeyrek, FY (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Lab Malaria Immunol, Osaka, Japan.	ccoban@biken.osaka-u.ac.jp	Coban, Cevayir/B-2129-2012; Tsuboi, Takafumi/AAK-6145-2021; ZEYREK, FADİLE YILDIZ/AAA-5368-2021; Ishii, Ken J/B-1685-2012; COBAN, Cevayir/P-1928-2019	Ishii, Ken J/0000-0002-6728-3872; COBAN, Cevayir/0000-0002-4467-7799; Tsuboi, Takafumi/0000-0002-7415-1325; Horii, Toshihiro/0000-0002-3000-2045; Palacpac, Nirianne Marie/0000-0003-4098-3972	Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partly supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Grants-in-Aid for Scientific Research on Priority Areas from MEXT (http://www.mext.go.jp/english/) (to KT, TH, TT, KJI and CC). FYZ and CC were supported by the Japan Society for the Promotion of Science (JSPS) fellowship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; Chuangchaiya S, 2010, CLIN EXP IMMUNOL, V160, P233, DOI 10.1111/j.1365-2249.2009.04075.x; Coban C, 2004, INFECT IMMUN, V72, P253, DOI 10.1128/IAI.72.1.253-259.2004; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Culleton R, 2009, J INFECT DIS, V200, P1465, DOI 10.1086/644510; Douglas NM, 2011, CLIN INFECT DIS, V52, P612, DOI 10.1093/cid/ciq249; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fernandez-Becerra C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-29; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; Horii T, 2010, PARASITOL INT, V59, P380, DOI 10.1016/j.parint.2010.05.002; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; John CC, 2005, AM J TROP MED HYG, V73, P222, DOI 10.4269/ajtmh.2005.73.222; Kirchgatter K, 1998, J INFECT DIS, V177, P511, DOI 10.1086/517389; Kochar DK, 2010, AM J TROP MED HYG, V83, P981, DOI 10.4269/ajtmh.2010.09-0633; KRATZ FW, 1956, PUBLIC HEALTH REP, V71, P409, DOI 10.2307/4589425; Lim KJ, 2004, PARASITOL RES, V92, P384, DOI 10.1007/s00436-003-1009-0; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Lin JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018716; Luxemburger C, 1999, LANCET, V354, P162, DOI 10.1016/S0140-6736(05)75295-8; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Mueller I, 2009, VACCINE, V27, P5633, DOI [10.1016/j.vaccine.2009.07.018, 10.1016/j.vaccine.2009.08.112]; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Mufalo BC, 2008, MICROBES INFECT, V10, P1266, DOI 10.1016/j.micinf.2008.07.023; Okech RN, 2006, AM J TROP MED HYG, V74, P191, DOI 10.4269/ajtmh.2006.74.191; Palacpac NMQ, 2006, MOL BIOCHEM PARASIT, V150, P353, DOI 10.1016/j.molbiopara.2006.07.006; Palacpac NMQ, 2011, VACCINE, V29, P5837, DOI 10.1016/j.vaccine.2011.06.052; Rodrigues MHC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-39; Rui E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-192; Snounou G, 2004, TRENDS PARASITOL, V20, P333, DOI 10.1016/j.pt.2004.05.004; Soares IS, 1997, INFECT IMMUN, V65, P1606, DOI 10.1128/IAI.65.5.1606-1614.1997; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; Van den Eede P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016257; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; Wickramarachchi T, 2007, INT J PARASITOL, V37, P199, DOI 10.1016/j.ijpara.2006.09.002; Zeyrek FY, 2008, AM J TROP MED HYG, V78, P729, DOI 10.4269/ajtmh.2008.78.729; Zeyrek FY, 2010, AM J TROP MED HYG, V83, P1230, DOI 10.4269/ajtmh.2010.10-0353; Zeyrek FY, 2006, PARASITE IMMUNOL, V28, P201, DOI 10.1111/j.1365-3024.2006.00822.x	42	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28126	10.1371/journal.pone.0028126	http://dx.doi.org/10.1371/journal.pone.0028126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140521	Green Published, Green Submitted, gold			2022-12-25	WOS:000298166300027
J	Lim, JH; Kim, SY; Park, SY; Lee, SY; Kim, MJ; Han, YJ; Lee, SW; Chung, JH; Kim, MY; Yang, JH; Ryu, HM				Lim, Ji Hyae; Kim, Shin Young; Park, So Yeon; Lee, Shin Yeong; Kim, Mi Jin; Han, You Jung; Lee, Si Won; Chung, Jin Hoon; Kim, Moon Young; Yang, Jae Hyug; Ryu, Hyun Mee			Non-Invasive Epigenetic Detection of Fetal Trisomy 21 in First Trimester Maternal Plasma	PLOS ONE			English	Article							DNA-METHYLATION; PRENATAL-DIAGNOSIS; DOWN-SYNDROME; 1ST-TRIMESTER; PHOSPHODIESTERASE; IDENTIFICATION; AMNIOCENTESIS; EXTRACTION; WORKSHOP; PDE9A	Background: Down syndrome (DS) is the most common known aneuploidy, caused by an extra copy of all or part of chromosome 21. Fetal-specific epigenetic markers have been investigated for non-invasive prenatal detection of fetal DS. The phosphodiesterases gene, PDE9A, located on chromosome 21q22.3, is completely methylated in blood (M-PDE9A) and unmethylated in the placenta (U-PDE9A). Therefore, we estimated the accuracy of non-invasive fetal DS detection during the first trimester of pregnancy using this tissue-specific epigenetic characteristic of PDE9A. Methodology/Principal Findings: A nested, case-control study was conducted using maternal plasma samples collected from 108 pregnant women carrying 18 DS and 90 normal fetuses (each case was matched with 5 controls according to gestational weeks at blood sampling). All pregnancies were singletons at or before 12 weeks of gestation between October 2008 and May 2009. The maternal plasma levels of M-PDE9A and U-PDE9A were measured by quantitative methylation-specific polymerase chain reaction. M-PDE9A and U-PDE9A levels were obtained in all samples and did not differ between male and female fetuses. M-PDE9A levels did not differ between the DS cases and controls (1854.3 vs 2004.5 copies/mL; P = 0.928). U-PDE9A levels were significantly elevated in women with DS fetuses compared with controls (356.8 vs 194.7 copies/mL, P<0.001). The sensitivities of U-PDE9A level and the unmethylation index of PDE9A for non-invasive fetal DS detection were 77.8% and 83.3%, respectively, with a 5% false-positive rate. In the risk assessment for fetal DS, the adjusted odds ratios of U-PDE9A level and UI were 46.2 [95% confidence interval: 7.8-151.6] and 63.7 [95% confidence interval: 23.2-206.7], respectively. Conclusions: Our findings suggest that U-PDE9A level and the unmethylation index of PDE9A may be useful biomarkers for non-invasive fetal DS detection during the first trimester of pregnancy, regardless of fetal gender.	[Lim, Ji Hyae; Kim, Shin Young; Park, So Yeon; Lee, Shin Yeong; Kim, Mi Jin; Ryu, Hyun Mee] Cheil Gen Hosp, Med Res Inst, Med Genet Lab, Seoul, South Korea; [Han, You Jung; Lee, Si Won; Chung, Jin Hoon; Kim, Moon Young; Yang, Jae Hyug; Ryu, Hyun Mee] KwanDong Univ, Coll Med, Womens Healthcare Ctr, Seoul, South Korea; [Han, You Jung; Lee, Si Won; Chung, Jin Hoon; Kim, Moon Young; Yang, Jae Hyug; Ryu, Hyun Mee] Cheil Gen Hosp, Dept Obstet & Gynecol, Seoul, South Korea	Catholic Kwandong University	Lim, JH (corresponding author), Cheil Gen Hosp, Med Res Inst, Med Genet Lab, Seoul, South Korea.	hmryu@yahoo.com	Han, You Jung/W-3659-2019; Kim, Mi Jin/GXH-9639-2022; Lim, Ji Hyae/N-4634-2013	Han, You Jung/0000-0003-4087-9198; CHUNG, JIN HOON/0000-0002-5137-0680; Lim, Ji Hyae/0000-0002-1105-7235	Life Insurance Philanthropy Foundation	Life Insurance Philanthropy Foundation	This study was supported by a research grant from the Life Insurance Philanthropy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Clausen FB, 2007, PRENATAL DIAG, V27, P6, DOI 10.1002/pd.1605; Driscoll DA, 2009, NEW ENGL J MED, V360, P2556, DOI 10.1056/NEJMcp0900134; Farina A, 2003, CLIN CHEM, V49, P239, DOI 10.1373/49.2.239; Fisher DA, 1998, J BIOL CHEM, V273, P15559, DOI 10.1074/jbc.273.25.15559; Guipponi M, 1998, HUM GENET, V103, P386, DOI 10.1007/s004390050838; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; Legler TJ, 2007, PRENATAL DIAG, V27, P824, DOI 10.1002/pd.1783; Li Y, 2004, CLIN CHEM, V50, P1002, DOI 10.1373/clinchem.2003.029835; Lim JH, 2008, OBSTET GYNECOL, V111, P1403, DOI 10.1097/AOG.0b013e3181719b7a; Lim JH, 2012, FASEB J, V26, P250, DOI 10.1096/fj.11-191429; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Papageorgiou EA, 2011, NAT MED, V17, P510, DOI 10.1038/nm.2312; Poon LLM, 2002, CLIN CHEM, V48, P35; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Reddy UM, 2006, OBSTET GYNECOL, V107, P167, DOI 10.1097/01.AOG.0000194186.34664.a9; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Tong YK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015244; Wapner R, 2003, NEW ENGL J MED, V349, P1405, DOI 10.1056/NEJMoa025273	23	16	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27709	10.1371/journal.pone.0027709	http://dx.doi.org/10.1371/journal.pone.0027709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132128	Green Submitted, gold, Green Published			2022-12-25	WOS:000298162000036
J	Xu, ZH; Zhong, SH; Li, XH; Li, WX; Rothstein, SJ; Zhang, SH; Bi, YM; Xie, CX				Xu, Zhenhua; Zhong, Sihui; Li, Xinhai; Li, Wenxue; Rothstein, Steven J.; Zhang, Shihuang; Bi, Yongmei; Xie, Chuanxiao			Genome-Wide Identification of MicroRNAs in Response to Low Nitrate Availability in Maize Leaves and Roots	PLOS ONE			English	Article							GENE-EXPRESSION; UBIQUITIN LIGASE; NITROGEN STRESS; ARABIDOPSIS; REVEALS; PROTEIN; TRANSCRIPTOME; BIOGENESIS; PATTERNS; NETWORK	Background: Nitrate is the major source of nitrogen available for many crop plants and is often the limiting factor for plant growth and agricultural productivity especially for maize. Many studies have been done identifying the transcriptome changes under low nitrate conditions. However, the microRNAs (miRNAs) varied under nitrate limiting conditions in maize has not been reported. MiRNAs play important roles in abiotic stress responses and nutrient deprivation. Methodology/ Principal Findings: In this study, we used the SmartArray (TM) and GeneChip (R) microarray systems to perform a genome-wide search to detect miRNAs responding to the chronic and transient nitrate limiting conditions in maize. Nine miRNA families (miR164, miR169, miR172, miR397, miR398, miR399, miR408, miR528, and miR827) were identified in leaves, and nine miRNA families (miR160, miR167, miR168, miR169, miR319, miR395, miR399, miR408, and miR528) identified in roots. They were verified by real time stem loop RT-PCR, and some with additional time points of nitrate limitation. The miRNAs identified showed overlapping or unique responses to chronic and transient nitrate limitation, as well as tissue specificity. The potential target genes of these miRNAs in maize were identified. The expression of some of these was examined by qRT-PCR. The potential function of these miRNAs in responding to nitrate limitation is described. Conclusions/Significance: Genome-wide miRNAs responding to nitrate limiting conditions in maize leaves and roots were identified. This provides an insight into the timing and tissue specificity of the transcriptional regulation to low nitrate availability in maize. The knowledge gained will help understand the important roles miRNAs play in maize responding to a nitrogen limiting environment and eventually develop strategies for the improvement of maize genetics.	[Xu, Zhenhua; Li, Xinhai; Li, Wenxue; Zhang, Shihuang; Xie, Chuanxiao] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Zhong, Sihui; Rothstein, Steven J.; Bi, Yongmei] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; University of Guelph	Xu, ZH (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	cxxie@caas.net.cn	Rothstein, Steven J/A-4947-2013	Rothstein, Steven J/0000-0003-0737-1878	China Ministry of Science and Technology [2009CB118404]; National Science Foundation of China [30871535]; Natural Sciences and Engineering Research Council of Canada	China Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by a Chinese National "973" program from the China Ministry of Science and Technology (Subprogram of Grant # 2009CB118404), by the National Science Foundation of China (Grant # 30871535) to CXX and by funding from the Natural Sciences and Engineering Research Council of Canada to SJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JF, 2008, PHOTOSYNTHESIS ENERG, P1355; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bi YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-281; Bi YM, 2009, PLANT CELL ENVIRON, V32, P1749, DOI 10.1111/j.1365-3040.2009.02032.x; Cai XN, 2006, J EXP BOT, V57, P2563, DOI 10.1093/jxb/erl022; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Chiou TJ, 2007, PLANT CELL ENVIRON, V30, P323, DOI 10.1111/j.1365-3040.2007.01643.x; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Jian XY, 2010, GENOMICS, V95, P47, DOI 10.1016/j.ygeno.2009.08.017; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kantar M, 2011, PLANTA, DOI [10.1007/s00425-00010-01309-00424, DOI 10.1007/S00425-00010-01309-00424]; Koyama T, 2007, PLANT CELL; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lian XM, 2006, PLANT MOL BIOL, V60, P617, DOI 10.1007/s11103-005-5441-7; Lin SI, 2010, PLANT CELL PHYSIOL, V51, P2119, DOI 10.1093/pcp/pcq170; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Pant BD, 2009, PLANT PHYSIOL, V150, P1541, DOI 10.1104/pp.109.139139; Peng MS, 2007, PLANT MOL BIOL, V65, P775, DOI 10.1007/s11103-007-9241-0; Peng MS, 2007, PLANT J, V50, P320, DOI 10.1111/j.1365-313X.2007.03050.x; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang RC, 2007, PLANT PHYSIOL, V145, P1735, DOI 10.1104/pp.107.108944; Wang YH, 2001, PLANT PHYSIOL, V127, P345, DOI 10.1104/pp.127.1.345; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zimmermann R, 2005, PLANT MOL BIOL, V58, P669, DOI 10.1007/s11103-005-7702-x	58	109	121	4	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28009	10.1371/journal.pone.0028009	http://dx.doi.org/10.1371/journal.pone.0028009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132192	Green Published, Green Submitted, gold			2022-12-25	WOS:000298162000058
J	Schleit, J; Wall, VZ; Simko, M; Kaeberlein, M				Schleit, Jennifer; Wall, Valerie Z.; Simko, Marissa; Kaeberlein, Matt			The MDT-15 Subunit of Mediator Interacts with Dietary Restriction to Modulate Longevity and Fluoranthene Toxicity in Caenorhabditis elegans	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; DNA ADDUCT FORMATION; CALORIC RESTRICTION; METABOLIC-ACTIVATION; BACTERIAL DEPRIVATION; AROMATIC-HYDROCARBONS; STRESS RESISTANCE; GENETIC PATHWAYS; PROTEIN; SIR2	Dietary restriction (DR), the limitation of calorie intake while maintaining proper nutrition, has been found to extend life span and delay the onset of age-associated disease in a wide range of species. Previous studies have suggested that DR can reduce the lethality of environmental toxins. To further examine the role of DR in toxin response, we measured life spans of the nematode Caenorhabditis elegans treated with the mutagenic polyaromatic hydrocarbon, fluoranthene (FLA). FLA is a direct byproduct of combustion, and is one of U. S. Environmental Protection Agency's sixteen priority environmental toxins. Treatment with 5 mu g/ml FLA shortened the life spans of ad libitum fed nematodes, and DR resulted in increased sensitivity to FLA. To determine the role of detoxifying enzymes in the toxicity of FLA, we tested nematodes with mutations in the gene encoding the MDT-15 subunit of mediator, a transcriptional coactivator that regulates genes involved in fatty acid metabolism and detoxification. Mutation of mdt-15 increased the life span of FLA treated animals compared to wild-type animals with no difference observed between DR and ad libitum fed mdt-15 animals. We also examined mutants with altered insulin-IGF-1-like signaling (IIS), which is known to modulate life span and stress resistance in C. elegans independently of DR. Mutation of the genes coding for the insulin-like receptor DAF-2 or the FOXO-family transcription factor DAF16 did not alter the animals' susceptibility to FLA compared to wild type. Taken together, our results suggest that certain compounds have increased toxicity when combined with a DR regimen through increased metabolic activation. This increased metabolic activation appears to be mediated through the MDT-15 transcription factor and is independent of the IIS pathway.	[Schleit, Jennifer; Wall, Valerie Z.; Simko, Marissa; Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Schleit, J (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kaeber@uw.edu		Kaeberlein, Matt/0000-0002-1311-3421	NIH [R01AG031108, ES007032]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH Grant R01AG031108 to MK. JS was supported by the Environmental Pathology/Toxicology Training Grant (NIH Grant ES007032). MK is an Ellison Medical Foundation New Scholar in Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidoo A, 1999, MUTAT RES-FUND MOL M, V430, P155, DOI 10.1016/S0027-5107(99)00197-9; BERG TF, 1994, FOOD CHEM TOXICOL, V32, P45, DOI 10.1016/0278-6915(84)90035-8; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Bruce-Keller AJ, 1999, ANN NEUROL, V45, P8, DOI 10.1002/1531-8249(199901)45:1<8::AID-ART4>3.0.CO;2-V; Chen D, 2007, TRENDS MOL MED, V13, P64, DOI 10.1016/j.molmed.2006.12.004; Chen W, 1996, DRUG CHEM TOXICOL, V19, P21, DOI 10.3109/01480549609002194; Chou MW, 1997, TOXICOL LETT, V92, P21, DOI 10.1016/S0378-4274(97)00029-5; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; DELANEY JR, 2011, AGING CELL; Essumang DK, 2011, B ENVIRON CONTAM TOX, V86, P438, DOI 10.1007/s00128-011-0232-0; Gems D, 2005, MECH AGEING DEV, V126, P381, DOI 10.1016/j.mad.2004.09.001; GRAM TE, 1970, J PHARMACOL EXP THER, V175, P12; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, ANN NY ACAD SCI, V1170, P688, DOI 10.1111/j.1749-6632.2009.04019.x; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HANSON SK, 1978, TOXICOL LETT, V1, P301, DOI 10.1016/0378-4274(78)90011-5; Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x; Harper JM, 2006, MECH AGEING DEV, V127, P687, DOI 10.1016/j.mad.2006.04.002; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Holloszy JO, 2007, EXP GERONTOL, V42, P709, DOI 10.1016/j.exger.2007.03.009; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2007, AGEING RES REV, V6, P128, DOI 10.1016/j.arr.2007.04.001; Kaeberlein M, 2010, BIOESSAYS, V32, P96, DOI 10.1002/bies.200900171; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kennedy BK, 2007, CELL MOL LIFE SCI, V64, P1323, DOI 10.1007/s00018-007-6470-y; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Leiser SF, 2011, AGING CELL, V10, P318, DOI 10.1111/j.1474-9726.2011.00672.x; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Mair W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004535; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; PEGRAM RA, 1989, MECH AGEING DEV, V48, P167, DOI 10.1016/0047-6374(89)90048-1; PESSAYRE D, 1980, BIOCHEM PHARMACOL, V29, P2219, DOI 10.1016/0006-2952(80)90201-4; Platt KL, 2008, MUTAT RES-GEN TOX EN, V650, P96, DOI 10.1016/j.mrgentox.2007.09.011; Raffaghello L, 2008, P NATL ACAD SCI USA, V105, P8215, DOI 10.1073/pnas.0708100105; Ramaiah SK, 2001, DRUG METAB DISPOS, V29, P1088; Ramaiah SK, 1998, TOXICOL SCI, V45, P233, DOI 10.1006/toxs.1998.2511; Rogers AN, 2011, CELL METAB, V14, P55, DOI 10.1016/j.cmet.2011.05.010; Roth GS, 2001, ANN NY ACAD SCI, V928, P305; Seng JE, 1996, ARCH BIOCHEM BIOPHYS, V335, P42, DOI 10.1006/abbi.1996.0480; Shaikh ZA, 1999, TOXICOLOGY, V133, P93, DOI 10.1016/S0300-483X(99)00012-8; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; Smith ED, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-49; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; STRUBELT O, 1981, TOXICOL APPL PHARM, V60, P66, DOI 10.1016/0041-008X(81)90136-8; Sutphin GL, 2008, EXP GERONTOL, V43, P130, DOI 10.1016/j.exger.2007.10.019; SUTPHIN GL, 2009, J VIS EXP; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Taubert S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000021; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; WALKER RM, 1982, CAN J PHYSIOL PHARM, V60, P399, DOI 10.1139/y82-058; WARSHAWSKI D, 1992, ENV HLTH PERSPECT, V107, P317; Weindruch R., 1988, RETARDATION AGING DI; Xue WL, 2005, TOXICOL APPL PHARM, V206, P73, DOI 10.1016/j.taap.2004.11.006	70	7	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28036	10.1371/journal.pone.0028036	http://dx.doi.org/10.1371/journal.pone.0028036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132200	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789900041
J	Carpenter, S; Wilson, A; Barber, J; Veronesi, E; Mellor, P; Venter, G; Gubbins, S				Carpenter, Simon; Wilson, Anthony; Barber, James; Veronesi, Eva; Mellor, Philip; Venter, Gert; Gubbins, Simon			Temperature Dependence of the Extrinsic Incubation Period of Orbiviruses in Culicoides Biting Midges	PLOS ONE			English	Article							EQUINE ENCEPHALOMYELITIS VIRUS; LIFE-HISTORY PARAMETERS; AFRICAN HORSE SICKNESS; BLUETONGUE-VIRUS; VARIIPENNIS DIPTERA; SONORENSIS DIPTERA; VECTORIAL CAPACITY; CERATOPOGONIDAE; TRANSMISSION; INFECTION	Background: The rate at which viruses replicate and disseminate in competent arthropod vectors is limited by the temperature of their environment, and this can be an important determinant of geographical and seasonal limits to their transmission by arthropods in temperate regions. Methodology/Principal Findings: Here, we present a novel statistical methodology for estimating the relationship between temperature and the extrinsic incubation period (EIP) and apply it to both published and novel data on virus replication for three internationally important orbiviruses (African horse sickness virus (AHSV), bluetongue virus (BTV) and epizootic haemorrhagic disease virus (EHDV)) in their Culicoides vectors. Our analyses show that there can be differences in vector competence for different orbiviruses in the same vector species and for the same orbivirus in different vector species. Both the rate of virus replication (approximately 0.017-0.021 per degree-day) and the minimum temperature required for replication (11-13 degrees C), however, were generally consistent for different orbiviruses and across different Culicoides vector species. The estimates obtained in the present study suggest that previous publications have underestimated the replication rate and threshold temperature because the statistical methods they used included an implicit assumption that all negative vectors were infected. Conclusions/Significance: Robust estimates of the temperature dependence of arbovirus replication are essential for building accurate models of transmission and for informing policy decisions about seasonal relaxations to movement restrictions. The methodology developed in this study provides the required robustness and is superior to methods used previously. Importantly, the methods are generic and can readily be applied to other arbovirus-vector systems, as long as the assumptions described in the text are valid.	[Carpenter, Simon; Wilson, Anthony; Barber, James; Veronesi, Eva; Mellor, Philip; Gubbins, Simon] Inst Anim Hlth, Vector Borne Dis Programme, Woking, Surrey, England; [Venter, Gert] ARC Onderstepoort Vet Inst, Pretoria, South Africa; [Venter, Gert] Univ Pretoria, Dept Vet Trop Dis, Onderstepoort, South Africa	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Pretoria	Carpenter, S (corresponding author), Inst Anim Hlth, Vector Borne Dis Programme, Woking, Surrey, England.	simon.carpenter@iah.ac.uk	Carpenter, Simon T/C-2718-2013	Carpenter, Simon T/0000-0001-5775-045X; Gubbins, Simon/0000-0003-0538-4173; Veronesi, Eva/0000-0003-3411-7891; Wilson, Anthony/0000-0002-2000-2914	Biotechnology and Biological Sciences Research Council [BBS/B/00603, BBS/E/I/00001409, BBS/E/I/00001146, BBS/E/I/00001320, BBS/E/I/00001444]; Department for Environment, Food and Rural Affairs [SE4104, SE4209]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001445] Funding Source: researchfish; BBSRC [BBS/E/I/00001320, BBS/E/I/00001445, BBS/E/I/00001409, BBS/E/I/00001444] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council [grant codes BBS/B/00603, BBS/E/I/00001409, BBS/E/I/00001146, BBS/E/I/00001320 and BBS/E/I/00001444] and the Department for Environment, Food and Rural Affairs [grant codes SE4104 and SE4209]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Bellan SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010165; BELLIS GA, 1994, J MED ENTOMOL, V31, P382, DOI 10.1093/jmedent/31.3.382; BOORMAN J, 1987, MED VET ENTOMOL, V1, P211, DOI 10.1111/j.1365-2915.1987.tb00346.x; BOORMAN J, 1974, B ENTOMOL RES, V64, P371, DOI 10.1017/S0007485300031254; Carpenter S, 2008, VET REC, V163, P589, DOI 10.1136/vr.163.20.589; Carpenter S, 2006, J MED ENTOMOL, V43, P73, DOI 10.1603/0022-2585(2006)043[0073:OSTBVO]2.0.CO;2; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Darpel KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017545; FARAN ME, 1987, AM J TROP MED HYG, V37, P403, DOI 10.4269/ajtmh.1987.37.403; FINNEY DJ, 1964, STATISTICAL METHODS, P661; FOSTER NM, 1979, J MED ENTOMOL, V15, P302, DOI 10.1093/jmedent/15.3.302; Fu H, 1999, ARCH VIROL, V144, P747, DOI 10.1007/s007050050540; GARD GP, 1987, STUDIES BLUETONGUE V; Gelman A., 2004, BAYESIAN DATA ANAL; Gerry AC, 2000, J MED ENTOMOL, V37, P675, DOI 10.1603/0022-2585-37.5.675; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; HURLBUT HS, 1966, AM J TROP MED HYG, V15, P989, DOI 10.4269/ajtmh.1966.15.989; JENNINGS DM, 1987, ARCH VIROL, V95, P177, DOI 10.1007/BF01310778; Kato CY, 2007, J VIROL METHODS, V140, P140, DOI 10.1016/j.jviromet.2006.11.009; Kumral NA, 2008, J PEST SCI, V81, P63, DOI 10.1007/s10340-007-0185-6; LECHAUDEL M, 2009, ISHS ACTA HORTICULTU, V880, P175; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P985, DOI 10.1098/rspb.2001.1599; Lysyk TJ, 2007, J MED ENTOMOL, V44, P741, DOI 10.1603/0022-2585(2007)44[741:EOTOLH]2.0.CO;2; Martin Estelle, 2010, BMC Ecology, V10, P8, DOI 10.1186/1472-6785-10-8; Mecham JO, 2006, J VIROL METHODS, V135, P269, DOI 10.1016/j.jviromet.2006.03.002; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; MELLOR PS, 1971, T ROY SOC TROP MED H, V65, P199, DOI 10.1016/0035-9203(71)90218-5; Mellor PS, 2000, J COMP PATHOL, V123, P231, DOI 10.1053/jcpa.2000.0434; MULLENS BA, 1995, MED VET ENTOMOL, V9, P71, DOI 10.1111/j.1365-2915.1995.tb00119.x; Mullens BA, 2004, VETER ITAL SER, V40, P160; Paweska JT, 2002, MED VET ENTOMOL, V16, P10, DOI 10.1046/j.1365-2915.2002.00334.x; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; *R DEV COR TEAM, 2010, COMPUTING; Racloz V, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-42; Roberts GO, 1996, MARKOV CHAIN MONTE C, V57, P45, DOI DOI 10.1007/978-1-4899-4485-6-3; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Scott TW, 1998, AM J TROP MED HYG, V59, P341, DOI 10.4269/ajtmh.1998.59.341; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; SMITH CEG, 1987, AM J TROP MED HYG, V37, pS33, DOI 10.4269/ajtmh.1987.37.33S; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Veronesi E, 2009, VET PARASITOL, V163, P370, DOI 10.1016/j.vetpar.2009.04.031; Veronesi E, 2008, J MED ENTOMOL, V45, P129, DOI 10.1603/0022-2585(2008)45[129:QBVIAC]2.0.CO;2; WECHSLER SJ, 1989, J INVERTEBR PATHOL, V54, P385, DOI 10.1016/0022-2011(89)90123-7; Wellby MP, 1996, B ENTOMOL RES, V86, P715, DOI 10.1017/S0007485300039237; Wilson A, 2007, VET REC, V161, P487, DOI 10.1136/vr.161.14.487; Wilson A, 2009, VET RES, V40, DOI 10.1051/vetres:2008054; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Wittmann EJ, 2002, MED VET ENTOMOL, V16, P147, DOI 10.1046/j.1365-2915.2002.00357.x; Yadin H, 2008, VET REC, V162, P53, DOI 10.1136/vr.162.2.53; Zou L, 2007, ENVIRON MONIT ASSESS, V129, P413, DOI 10.1007/s10661-006-9373-8	53	95	95	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27987	10.1371/journal.pone.0027987	http://dx.doi.org/10.1371/journal.pone.0027987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125649	Green Published, gold, Green Submitted			2022-12-25	WOS:000297789200049
J	Wang, JJ; Yang, DM; Zhang, Y; Shen, J; van der Gast, C; Hahn, MW; Wu, QL				Wang, Jianjun; Yang, Dongmei; Zhang, Yong; Shen, Ji; van der Gast, Christopher; Hahn, Martin W.; Wu, Qinglong			Do Patterns of Bacterial Diversity along Salinity Gradients Differ from Those Observed for Macroorganisms?	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; IN-SITU DETECTION; GEL-ELECTROPHORESIS ANALYSIS; MICROBIAL DIVERSITY; SOLAR SALTERN; BACTERIOPLANKTON COMMUNITY; HYPERSALINE ENVIRONMENTS; OLIGONUCLEOTIDE PROBES; GENETIC DIVERSITY; TIBETAN PLATEAU	It is widely accepted that biodiversity is lower in more extreme environments. In this study, we sought to determine whether this trend, well documented for macroorganisms, also holds at the microbial level for bacteria. We used denaturing gradient gel electrophoresis (DGGE) with phylum-specific primers to quantify the taxon richness (i.e., the DGGE band numbers) of the bacterioplankton communities of 32 pristine Tibetan lakes that represent a broad salinity range (freshwater to hypersaline). For the lakes investigated, salinity was found to be the environmental variable with the strongest influence on the bacterial community composition. We found that the bacterial taxon richness in freshwater habitats increased with increasing salinity up to a value of 1 parts per thousand. In saline systems (systems with >1 parts per thousand salinity), the expected decrease of taxon richness along a gradient of further increasing salinity was not observed. These patterns were consistently observed for two sets of samples taken in two different years. A comparison of 16S rRNA gene clone libraries revealed that the bacterial community of the lake with the highest salinity was characterized by a higher recent accelerated diversification than the community of a freshwater lake, whereas the phylogenetic diversity in the hypersaline lake was lower than that in the freshwater lake. These results suggest that different evolutionary forces may act on bacterial populations in freshwater and hypersaline lakes on the Tibetan Plateau, potentially resulting in different community structures and diversity patterns.	[Wang, Jianjun; Yang, Dongmei; Zhang, Yong; Shen, Ji; Wu, Qinglong] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Peoples R China; [Zhang, Yong] Anhui Normal Univ, Life Sci Coll, Wuhu, Peoples R China; [van der Gast, Christopher] Ctr Ecol & Hydrol, Natl Environm Res Council NERC, Wallingford, Oxon, England; [Hahn, Martin W.] Austrian Acad Sci, Inst Limnol, A-5310 Mondsee, Austria	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Anhui Normal University; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Austrian Academy of Sciences	Wang, JJ (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Peoples R China.	qlwu@niglas.ac.cn	Wu, Qinglong L/B-7625-2011; Hahn, Martin W./B-9998-2008; van der Gast, Christopher/G-1153-2011	Hahn, Martin W./0000-0003-0501-2556; van der Gast, Christopher/0000-0003-1101-4048; Wang, Jianjun/0000-0001-7039-7136	NSFC [30770392, 30970540]; National Basic Research Program of China [2008CB418104]; Natural Environment Research Council [CEH010021] Funding Source: researchfish	NSFC(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by NSFC (grant 30770392, 30970540, http://www.nsfc.gov.cn) and by the National Basic Research Program of China (2008CB418104, http://www.973.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed RMM, 2007, ENVIRON MICROBIOL, V9, P1384, DOI 10.1111/j.1462-2920.2007.01254.x; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Barberan A, 2010, AQUAT MICROB ECOL, V59, P1, DOI 10.3354/ame01389; Beier S, 2011, APPL ENVIRON MICROB, V77, P1101, DOI 10.1128/AEM.01481-10; Ben-Dov E, 2008, FEMS MICROBIOL ECOL, V66, P437, DOI 10.1111/j.1574-6941.2008.00549.x; Benlloch S, 2002, ENVIRON MICROBIOL, V4, P349, DOI 10.1046/j.1462-2920.2002.00306.x; Bernhard AE, 2005, ENVIRON MICROBIOL, V7, P1289, DOI 10.1111/j.1462-2920.2005.00808.x; Brazelton WJ, 2010, P NATL ACAD SCI USA, V107, P1612, DOI 10.1073/pnas.0905369107; Casamayor EO, 2002, ENVIRON MICROBIOL, V4, P338, DOI 10.1046/j.1462-2920.2002.00297.x; CHAO A, 1984, SCAND J STAT, V11, P265; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FELSENSTEIN J, 1995, PHYLIP PHYLOGENY INF; Fordyce JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011781; Foti MJ, 2008, EXTREMOPHILES, V12, P133, DOI 10.1007/s00792-007-0117-7; FRONTIER S, 1985, OCEANOGR MAR BIOL, V23, P253; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Greenberg A.E., 1984, P AWWA WAT QUAL TECH, P11; Hammer U.T., 1986, SALINE LAKE ECOSYSTE; HAMMER UT, 1988, HYDROBIOLOGIA, V158, P101, DOI 10.1007/BF00026269; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hewson I, 2004, APPL ENVIRON MICROB, V70, P3425, DOI 10.1128/AEM.70.6.3425-3433.2004; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Horner-Devine MC, 2003, ECOL LETT, V6, P613; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Jaspers E, 2001, FEMS MICROBIOL ECOL, V36, P153, DOI 10.1016/S0168-6496(01)00129-5; Jiang HC, 2007, ENVIRON MICROBIOL, V9, P2603, DOI 10.1111/j.1462-2920.2007.01377.x; Jones CM, 2010, ISME J, V4, P633, DOI 10.1038/ismej.2009.152; Jungblut AD, 2005, ENVIRON MICROBIOL, V7, P519, DOI 10.1111/j.1462-2920.2005.00717.x; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lefebvre O, 2006, EXTREMOPHILES, V10, P505, DOI 10.1007/s00792-006-0524-1; Leps J, 2003, MULTIVARIATE ANAL EC; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Ludemann H, 2000, SYST APPL MICROBIOL, V23, P582, DOI 10.1016/S0723-2020(00)80033-8; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Martin AP, 2004, EVOLUTION, V58, P946; MARTINEZMURCIA AJ, 1995, FEMS MICROBIOL ECOL, V17, P247, DOI 10.1111/j.1574-6941.1995.tb00149.x; Meier H, 1999, SYST APPL MICROBIOL, V22, P186, DOI 10.1016/S0723-2020(99)80065-4; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neef A, 1998, MICROBIOL-UK, V144, P3257, DOI 10.1099/00221287-144-12-3257; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Overmann J, 1999, ARCH MICROBIOL, V172, P83, DOI 10.1007/s002030050744; Ovreas L, 2003, MICROB ECOL, V46, P291, DOI 10.1007/s00248-003-3006-3; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Purves W. K., 1998, LIFE SCI BIOL; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Remane A., 1934, Verhandlungen der Deutschen Zoologischen Gesellschaft Leipzig, V36, P34; Ricklefs RE, 2007, TRENDS ECOL EVOL, V22, P601, DOI 10.1016/j.tree.2007.06.013; RODRIGUEZVALERA F, 1985, MICROBIAL ECOL, V11, P107, DOI 10.1007/BF02010483; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Sandaa RA, 2003, EXTREMOPHILES, V7, P347, DOI 10.1007/s00792-003-0328-5; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Schapira M, 2009, AQUAT MICROB ECOL, V54, P171, DOI 10.3354/ame01262; Silveira CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017789; Srivastava Ashish Kumar, 2009, Saline Syst, V5, P4, DOI 10.1186/1746-1448-5-4; Verschuren D, 2000, ECOLOGY, V81, P164, DOI 10.1890/0012-9658(2000)081[0164:EODSAS]2.0.CO;2; Wang JJ, 2008, ENVIRON MICROBIOL, V10, P2537, DOI 10.1111/j.1462-2920.2008.01678.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wetzel R., 2001, LIMNOLOGY, V3rd; WILLIAMS WD, 1990, HYDROBIOLOGIA, V197, P257, DOI 10.1007/BF00026955; Williams WD, 1998, HYDROBIOLOGIA, V381, P191, DOI 10.1023/A:1003287826503; Wu QL, 2006, APPL ENVIRON MICROB, V72, P5478, DOI 10.1128/AEM.00767-06; Wu QLL, 2009, MICROB ECOL, V58, P569, DOI 10.1007/s00248-009-9526-8; Xing P, 2009, APPL ENVIRON MICROB, V75, P7017, DOI 10.1128/AEM.01544-09	69	91	95	5	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27597	10.1371/journal.pone.0027597	http://dx.doi.org/10.1371/journal.pone.0027597			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125616	gold, Green Published, Green Accepted			2022-12-25	WOS:000297789200016
J	Olesen, JM; Stefanescu, C; Traveset, A				Olesen, Jens M.; Stefanescu, Constanti; Traveset, Anna			Strong, Long-Term Temporal Dynamics of an Ecological Network	PLOS ONE			English	Article							NESTEDNESS; TIME; METACOMMUNITY; BROADSTONE; ABUNDANCE; SPACE; UK	Nature is organized into complex, dynamical networks of species and their interactions, which may influence diversity and stability. However, network research is, generally, short-term and depict ecological networks as static structures only, devoid of any dynamics. This hampers our understanding of how nature responds to larger disturbances such as changes in climate. In order to remedy this we studied the long-term (12-yrs) dynamics of a flower-visitation network, consisting of flower-visiting butterflies and their nectar plants. Global network properties, i.e. numbers of species and links, as well as connectance, were temporally stable, whereas most species and links showed a strong temporal dynamics. However, species of butterflies and plants varied bimodally in their temporal persistance: Sporadic species, being present only 1-2(-5) years, and stable species, being present (9-)11-12 years, dominated the networks. Temporal persistence and linkage level of species, i.e. number of links to other species, made up two groups of species: Specialists with a highly variable temporal persistence, and temporally stable species with a highly variable linkage level. Turnover of links of specialists was driven by species turnover, whereas turnover of links among generalists took place through rewiring, i.e. by reshuffling existing interactions. However, in spite of this strong internal dynamics of species and links the network appeared overall stable. If this global stability-local instability phenomenon is general, it is a most astonishing feature of ecological networks.	[Olesen, Jens M.] Aarhus Univ, Inst Biosci, Aarhus, Denmark; [Stefanescu, Constanti] Museu Granollers Ciencies Nat, Butterfly Monitoring Scheme, Barcelona, Spain; [Traveset, Anna] Univ Illes Balears, Inst Mediterrani Estudis Avancats, Consejo Super Invest Cient, Esporles, Mallorca, Spain	Aarhus University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears	Olesen, JM (corresponding author), Aarhus Univ, Inst Biosci, Aarhus, Denmark.	jens.olesen@biology.au.dk	Traveset, Anna V/D-7802-2011; Olesen, Jens M/A-3011-2009	Olesen, Jens M/0000-0003-1998-1083; Olesen, Jes/0000-0002-6712-2702	Danish National Research Council; Departament de Medi Ambient i Habitatge de la Generalitat de Catalunya (Catalan Autonomous Government's Ministry of Housing and the Environment); Diputacio de Barcelona-Servei de Parcs Naturals (Barcelona Regional Council's Natural Park Service)	Danish National Research Council(Danmarks Grundforskningsfond); Departament de Medi Ambient i Habitatge de la Generalitat de Catalunya (Catalan Autonomous Government's Ministry of Housing and the Environment); Diputacio de Barcelona-Servei de Parcs Naturals (Barcelona Regional Council's Natural Park Service)	JMO received support for this work from The Danish National Research Council. The Butterfly Counting Project received support from the Departament de Medi Ambient i Habitatge de la Generalitat de Catalunya (Catalan Autonomous Government's Ministry of Housing and the Environment) and Diputacio de Barcelona-Servei de Parcs Naturals (Barcelona Regional Council's Natural Park Service). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Albrecht M, 2010, OIKOS, V119, P1610, DOI 10.1111/j.1600-0706.2010.18376.x; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Azeria ET, 2008, OIKOS, V117, P1006, DOI [10.1111/j.0030-1299.2008.16529.x, 10.1111/j.2008.0030-1299.16529.x]; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Burkle LA, 2011, AM J BOT, V98, P528, DOI 10.3732/ajb.1000391; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; COLLINS SL, 1991, ECOLOGY, V72, P654, DOI 10.2307/2937205; Diaz-Castelazo C, 2010, ECOLOGY, V91, P793, DOI 10.1890/08-1883.1; Goulson D, 1997, ANIM BEHAV, V53, P1009, DOI 10.1006/anbe.1996.0390; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2010, ADV ECOL RES, V42, P1, DOI 10.1016/S0065-2504(10)42001-2; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; POLLARD E, MONITORING BUTTERFLI; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Stefanescu C, 2009, OIKOS, V118, P1109, DOI 10.1111/j.1600-0706.2009.17274.x; TOKESHI M, 1992, RES POPUL ECOL, V34, P249, DOI 10.1007/BF02514796; Tudor O, 2004, BIOL CONSERV, V119, P397, DOI 10.1016/j.biocon.2004.01.002; Vacher C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001740; Woodward G, 2002, FRESHWATER BIOL, V47, P1419, DOI 10.1046/j.1365-2427.2002.00872.x	27	75	77	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e26455	10.1371/journal.pone.0026455	http://dx.doi.org/10.1371/journal.pone.0026455			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22125597	gold, Green Published, Green Submitted			2022-12-25	WOS:000297555800005
J	Li, Y; Wu, J; Song, F; Tang, J; Wang, SJ; Yu, XL; Chen, ZN; Jiang, JL				Li, Yong; Wu, Jiao; Song, Fei; Tang, Juan; Wang, Shi-Jie; Yu, Xiao-Ling; Chen, Zhi-Nan; Jiang, Jian-Li			Extracellular Membrane-proximal Domain of HAb18G/CD147 Binds to Metal Ion-dependent Adhesion Site (MIDAS) Motif of Integrin beta 1 to Modulate Malignant Properties of Hepatoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; CRYSTAL-STRUCTURE; ADENOVIRAL VECTORS; GENE-TRANSFER; GROWTH; CANCER; ALPHA-V-BETA-3; METASTASIS; RECEPTOR; INVOLVEMENT	Several lines of evidence suggest that HAb18G/CD147 interacts with the integrin variants alpha 3 beta 1 and alpha 6 beta 1. However, the mechanism of the interaction remains largely unknown. In this study, mammalian protein-protein interaction trap (MAPPIT), a mammalian two-hybrid method, was used to study the CD147-integrin beta 1 subunit interaction. CD147 in human hepatocellular carcinoma (HCC) cells was interfered with by small hairpin RNA. Nude mouse xenograft model and metastatic model of HCC were used to detect the role of CD147 in carcinogenesis and metastasis. We found that the extracellular membrane-proximal domain of HAb18G/CD147 (I-type domain) binds at the metal ion-dependent adhesion site in the beta A domain of the integrin beta 1 subunit, and Asp(179) in the I-type domain of HAb18G/CD147 plays an important role in the interaction. The levels of the proteins that act downstream of integrin, including focal adhesion kinase (FAK) and phospho-FAK, were decreased, and the cytoskeletal structures of HCC cells were rearranged bearing the HAb18G/CD147 deletion. Simultaneously, the migration and invasion capacities, secretion of matrix metalloproteinases, colony formation rate in vitro, and tumor growth and metastatic potential in vivo were decreased. These results indicate that the interaction of HAb18G/CD147 extracellular I-type domain with the integrin beta 1 metal ion-dependent adhesion site motif activates the downstream FAK signaling pathway, subsequently enhancing the malignant properties of HCC cells.	[Li, Yong; Wu, Jiao; Song, Fei; Tang, Juan; Wang, Shi-Jie; Yu, Xiao-Ling; Chen, Zhi-Nan; Jiang, Jian-Li] Fourth Mil Med Univ, Cell Engn Res Ctr, State Key Lab Canc Biol, Dept Cell Biol, Xian 710032, Peoples R China	Air Force Military Medical University	Chen, ZN (corresponding author), Fourth Mil Med Univ, Cell Engn Res Ctr, State Key Lab Canc Biol, Dept Cell Biol, Xian 710032, Peoples R China.	znchen@fmmu.edu.cn; jiangjl@fmmu.edu.cn	YU, Xiaoling/M-8815-2018	YU, Xiaoling/0000-0001-6035-3906; Chen, Zhi-Nan/0000-0001-5512-4623	National Basic Research Program of China [2009CB521704]; National Science and Technology Major Project [2011ZX09102-001-21, 2012ZX10002017-002]; National Natural Science Foundation of China [81071691, 30970564, 81030058]	National Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2009CB521704, National Science and Technology Major Project Grants 2011ZX09102-001-21 and 2012ZX10002017-002, and National Natural Science Foundation of China Grants 81071691, 30970564, and 81030058.	Arnaout MA, 2002, IMMUNOL REV, V186, P125, DOI 10.1034/j.1600-065X.2002.18612.x; Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S0955-0674(02)00371-X; Berditchevski F, 1997, J BIOL CHEM, V272, P29174, DOI 10.1074/jbc.272.46.29174; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Chen LL, 1998, BIOCHEMISTRY-US, V37, P8743, DOI 10.1021/bi980311a; Chen ZN, 2006, INT J RADIAT ONCOL, V65, P435, DOI 10.1016/j.ijrobp.2005.12.034; Cho JY, 2001, BLOOD, V98, P374, DOI 10.1182/blood.V98.2.374; Curtin KD, 2005, J CELL SCI, V118, P2649, DOI 10.1242/jcs.02408; Dai JY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-337; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Fadool JM, 1996, BIOCHEM BIOPH RES CO, V229, P280, DOI 10.1006/bbrc.1996.1793; Grill J, 2001, CLIN CANCER RES, V7, P641; Iacono KT, 2007, EXP MOL PATHOL, V83, P283, DOI 10.1016/j.yexmp.2007.08.014; Jiang JL, 2001, J BIOL CHEM, V276, P46870, DOI 10.1074/jbc.M108291200; Li PC, 2010, MOL THER, V18, P921, DOI 10.1038/mt.2010.5; Liu S, 2009, BIOCONJUGATE CHEM, V20, P2199, DOI 10.1021/bc900167c; Moreno-Manzano V, 2000, BIOCHEM BIOPH RES CO, V277, P293, DOI 10.1006/bbrc.2000.3654; Mould AP, 2002, J BIOL CHEM, V277, P19800, DOI 10.1074/jbc.M201571200; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tang J, 2008, CELL MOL LIFE SCI, V65, P2933, DOI 10.1007/s00018-008-8315-8; Ulrichts P, 2010, J CELL SCI, V123, P256, DOI 10.1242/jcs.056002; Wesseling JG, 2001, GENE THER, V8, P969, DOI 10.1038/sj.gt.3301473; Witlox AM, 2004, CLIN CANCER RES, V10, P61, DOI 10.1158/1078-0432.CCR-0609-03; Wu H, 2004, GENE THER, V11, P874, DOI 10.1038/sj.gt.3302249; Xiao WW, 2010, MOL CANCER THER, V9, P2714, DOI 10.1158/1535-7163.MCT-10-0308; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xu HY, 2007, CANCER LETT, V247, P336, DOI 10.1016/j.canlet.2006.05.017; Xu J, 2007, MOL CANCER RES, V5, P605, DOI 10.1158/1541-7786.MCR-06-0286; Xu J, 2007, HEPATOLOGY, V45, P269, DOI 10.1002/hep.21465; Yong KT, 2010, PANCREATOLOGY, V10, P553, DOI 10.1159/000283577; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200; Zhao P, 2011, HEPATOLOGY, V54, P2012, DOI 10.1002/hep.24592	34	56	60	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4759	4772		10.1074/jbc.M111.277699	http://dx.doi.org/10.1074/jbc.M111.277699			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22130661	hybrid, Green Published			2022-12-25	WOS:000300608500037
J	Materia, S; Cater, MA; Klomp, LWJ; Mercer, JFB; La Fontaine, S				Materia, Stephanie; Cater, Michael A.; Klomp, Leo W. J.; Mercer, Julian F. B.; La Fontaine, Sharon			Clusterin and COMMD1 Independently Regulate Degradation of the Mammalian Copper ATPases ATP7A and ATP7B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIC MILK MOUSE; P-TYPE ATPASE; WILSON-DISEASE; MENKES DISEASE; TRANSPORTING ATPASE; IN-VIVO; PROTEIN; TRAFFICKING; BINDING; EXPRESSION	ATP7A and ATP7B are copper-transporting P-1B-type ATPases (Cu-ATPases) that are critical for regulating intracellular copper homeostasis. Mutations in the genes encoding ATP7A and ATP7B lead to copper deficiency and copper toxicity disorders, Menkes and Wilson diseases, respectively. Clusterin and COMMD1 were previously identified as interacting partners of these Cu-ATPases. In this study, we confirmed that clusterin and COMMD1 interact to down-regulate both ATP7A and ATP7B. Overexpression and knockdown of clusterin/COMMD1 decreased and increased, respectively, endogenous levels of ATP7A and ATP7B, consistent with a role in facilitating Cu-ATPase degradation. We demonstrate that whereas the clusterin/ATP7B interaction was enhanced by oxidative stress or mutation of ATP7B, the COMMD1/ATP7B interaction did not change under oxidative stress conditions, and only increased with ATP7B mutations that led to its misfolding. Clusterin and COMMD1 facilitated the degradation of ATP7B containing the same Wilson disease-causing C-terminal mutations via different degradation pathways, clusterin via the lysosomal pathway and COMMD1 via the proteasomal pathway. Furthermore, endogenous ATP7B existed in a complex with clusterin and COMMD1, but these interactions were neither competitive nor cooperative and occurred independently of each other. Together these data indicate that clusterin and COMMD1 represent alternative and independent systems regulating Cu-ATPase quality control, and consequently contributing to the maintenance of copper homeostasis.	[Materia, Stephanie; Mercer, Julian F. B.; La Fontaine, Sharon] Deakin Univ, Strateg Res Ctr Mol & Med Res, Burwood, Vic 3125, Australia; [Materia, Stephanie; Mercer, Julian F. B.; La Fontaine, Sharon] Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Burwood, Vic 3125, Australia; [Cater, Michael A.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic 3002, Australia; [Klomp, Leo W. J.] Univ Med Ctr, Lab Metab & Endocrine Dis, NL-3584 EA Utrecht, Netherlands	Deakin University; Deakin University; Peter Maccallum Cancer Center; Utrecht University; Utrecht University Medical Center	La Fontaine, S (corresponding author), 221 Burwood Hwy, Burwood, Vic 3125, Australia.	sharon.lafontaine@deakin.edu.au	La Fontaine, Sharon/G-7113-2018; Mercer, Julian/R-8583-2019	La Fontaine, Sharon/0000-0002-9948-074X; 	National Health and Medical Research Council of Australia (NHMRC); NHMRC [520345]; Dutch Digestive Disease Foundation [WS02-34]; NOW Program [912.04.106]; Netherlands Organisation for Scientific Research-Earth and Life Sciences [817.02.022]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Dutch Digestive Disease Foundation; NOW Program; Netherlands Organisation for Scientific Research-Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC) (to S. L. and J. F. B. M.), NHMRC Biomedical Research Fellowship 520345 (to M. A. C.), Dutch Digestive Disease Foundation Grant WS02-34, NOW Program Grant 912.04.106, and The Netherlands Organisation for Scientific Research-Earth and Life Sciences Grant 817.02.022 (to L. W. J. K.).	[Anonymous], 1995, METABOLIC BASIS INHE; ARONOW BJ, 1993, P NATL ACAD SCI USA, V90, P725, DOI 10.1073/pnas.90.2.725; Bailey RW, 2001, BIOCHEMISTRY-US, V40, P11828, DOI 10.1021/bi010135x; Balantinou E, 2009, FREE RADICAL BIO MED, V46, P1267, DOI 10.1016/j.freeradbiomed.2009.01.025; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Biasio W, 2004, J BIOL CHEM, V279, P5429, DOI 10.1074/jbc.M311155200; Borm B, 2004, J PEDIATR-US, V145, P119, DOI 10.1016/j.jpeds.2004.04.033; Burkhead JL, 2009, J BIOL CHEM, V284, P696, DOI 10.1074/jbc.M804766200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Cater MA, 2006, GASTROENTEROLOGY, V130, P493, DOI 10.1053/j.gastro.2005.10.054; Cater MA, 2004, BIOCHEM J, V380, P805, DOI 10.1042/BJ20031804; Das SK, 2006, NAT CLIN PRACT NEURO, V2, P482, DOI 10.1038/ncpneuro0291; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; De Bie P, 2005, J HERED, V96, P803, DOI 10.1093/jhered/esi110; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; Drevillon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018334; Gouider-Khouja N, 2009, PARKINSONISM RELAT D, V15, pS126, DOI 10.1016/S1353-8020(09)70798-9; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Gupta A, 2011, P NATL ACAD SCI USA, V108, P5390, DOI 10.1073/pnas.1014959108; Horslen S, 2010, J CLIN GASTROENTEROL, V44, P387, DOI 10.1097/MCG.0b013e3181d96ac4; Huang Y, 2008, J BIOL CHEM, V283, P11453, DOI 10.1074/jbc.M708544200; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Ke BX, 2006, AM J PHYSIOL-REG I, V290, pR1460, DOI 10.1152/ajpregu.00806.2005; Ke Y, 2010, AM J PHYSIOL-RENAL, V298, pF1445, DOI 10.1152/ajprenal.00257.2009; Kim BE, 2007, J MED GENET, V44, P641, DOI 10.1136/jmg.2007.049627; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; La Fontaine S, 2001, HUM MOL GENET, V10, P361, DOI 10.1093/hmg/10.4.361; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Maine GN, 2007, CELL MOL LIFE SCI, V64, P1997, DOI 10.1007/s00018-007-7078-y; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Majumdar R, 2000, J NEUROL SCI, V179, P140, DOI 10.1016/S0022-510X(00)00399-3; Materia S, 2011, J BIOL CHEM, V286, P10073, DOI 10.1074/jbc.M110.190546; Miyayama T, 2010, BIOCHEM J, V429, P53, DOI 10.1042/BJ20100223; Moller LB, 2009, BIOCHIMIE, V91, P1273, DOI 10.1016/j.biochi.2009.05.011; Monty JF, 2005, J NUTR, V135, P2762, DOI 10.1093/jn/135.12.2762; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; Payne AS, 1998, P NATL ACAD SCI USA, V95, P10854, DOI 10.1073/pnas.95.18.10854; Pucci S, 2009, ADV CANCER RES, V105, P93, DOI 10.1016/S0065-230X(09)05006-4; Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671; Roelofsen H, 2000, GASTROENTEROLOGY, V119, P782, DOI 10.1053/gast.2000.17834; Sarkar B, 2011, METALLOMICS, V3, P20, DOI 10.1039/c0mt00031k; Senzolo M, 2007, CLIN NEUROL NEUROSUR, V109, P71, DOI 10.1016/j.clineuro.2006.01.008; Sommerhalter M, 2007, J MOL BIOL, V365, P715, DOI 10.1016/j.jmb.2006.10.030; Spee B, 2007, ANIM GENET, V38, P168, DOI 10.1111/j.1365-2052.2007.01580.x; Strausak D, 1999, J BIOL CHEM, V274, P11170, DOI 10.1074/jbc.274.16.11170; Takeshita Y, 2002, J HUM GENET, V47, P543, DOI 10.1007/s100380200082; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Terada K, 1999, FEBS LETT, V448, P53, DOI 10.1016/S0014-5793(99)00319-1; Theophilos MB, 1996, HUM MOL GENET, V5, P1619, DOI 10.1093/hmg/5.10.1619; Thoms HC, 2010, CANCER RES, V70, P139, DOI 10.1158/0008-5472.CAN-09-1397; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; van de Sluis B, 2007, CELL CYCLE, V6, P2091, DOI 10.4161/cc.6.17.4646; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; van den Berghe PVE, 2009, HEPATOLOGY, V50, P1783, DOI 10.1002/hep.23209; Vonk WIM, 2012, CELL MOL LIFE SCI, V69, P149, DOI 10.1007/s00018-011-0743-1; Vonk WIM, 2010, J BIOL CHEM, V285, P28991, DOI 10.1074/jbc.M110.101477; Voskoboinik I, 2001, BIOCHEM BIOPH RES CO, V281, P966, DOI 10.1006/bbrc.2001.4445; Wilson MR, 2008, MOL BIOSYST, V4, P42, DOI 10.1039/b712728f; Wyatt AR, 2011, CELL MOL LIFE SCI, V68, P3919, DOI [10.1007/s00018-011-0684-8, 10.1007/s00018-011-0684-8)]; Zoubeidi A, 2010, MOL CANCER RES, V8, P119, DOI 10.1158/1541-7786.MCR-09-0277	69	57	59	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2485	2499		10.1074/jbc.M111.302216	http://dx.doi.org/10.1074/jbc.M111.302216			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130675	hybrid, Green Published			2022-12-25	WOS:000300292300023
J	Matthews, LA; Jones, DR; Prasad, AA; Duncker, BP; Guarne, A				Matthews, Lindsay A.; Jones, Darryl R.; Prasad, Ajai A.; Duncker, Bernard P.; Guarne, Alba			Saccharomyces cerevisiae Dbf4 Has Unique Fold Necessary for Interaction with Rad53 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; DNA-REPLICATION; S-PHASE; FHA DOMAIN; CHECKPOINT RESPONSE; PROTEIN-KINASE; BRCT DOMAINS; CDC7 KINASE; COMPLEX; BINDING	Dbf4 is a conserved eukaryotic protein that functions as the regulatory subunit of the Dbf4-dependent kinase (DDK) complex. DDK plays essential roles in DNA replication initiation and checkpoint activation. During the replication checkpoint, Saccharomyces cerevisiae Dbf4 is phosphorylated in a Rad53-dependent manner, and this, in turn, inhibits initiation of replication at late origins. We have determined the minimal region of Dbf4 required for the interaction with the checkpoint kinase Rad53 and solved its crystal structure. The core of this fragment of Dbf4 folds as a BRCT domain, but it includes an additional N-terminal helix unique to Dbf4. Mutation of the residues that anchor this helix to the domain core abolish the interaction between Dbf4 and Rad53, indicating that this helix is an integral element of the domain. The structure also reveals that previously characterized Dbf4 mutants with checkpoint phenotypes destabilize the domain, indicating that its structural integrity is essential for the interaction with Rad53. Collectively, these results allow us to propose a model for the association between Dbf4 and Rad53.	[Guarne, Alba] McMaster Univ, Hlth Sci Ctr 4N57A, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Jones, Darryl R.; Prasad, Ajai A.; Duncker, Bernard P.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	McMaster University; University of Waterloo	Guarne, A (corresponding author), McMaster Univ, Hlth Sci Ctr 4N57A, Dept Biochem & Biomed Sci, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	guarnea@mcmaster.ca		Duncker, Bernard/0000-0002-6055-9522	Canadian Institutes of Health Research [MOP 67189]; Natural Sciences and Engineering Research Council [RGPIN 238392]; Canadian Institutes of Health Research; Ontario Graduate Scholarship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by Canadian Institutes of Health Research Grant MOP 67189 (to A. G.) and Natural Sciences and Engineering Research Council Grant RGPIN 238392 (to B. P. D.).; Supported by a doctoral scholarship from the Canadian Institutes of Health Research.; Recipient of an Ontario Graduate Scholarship doctoral award.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Campbell SJ, 2010, STRUCTURE, V18, P167, DOI 10.1016/j.str.2009.12.008; Chen YC, 2010, J BIOL CHEM, V285, P41244, DOI 10.1074/jbc.M110.155242; Cheng LA, 1999, MOL CELL BIOL, V19, P4270; Cormack B, 2002, METHOD ENZYMOL, V350, P199, DOI 10.1016/S0076-6879(02)50964-2; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dohrmann PR, 1999, GENETICS, V151, P965; Duch A, 2011, J BIOL CHEM, V286, P2486, DOI 10.1074/jbc.M110.190843; Duncker BP, 2002, P NATL ACAD SCI USA, V99, P16087, DOI 10.1073/pnas.252093999; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Gabrielse C, 2006, GENETICS, V173, P541, DOI 10.1534/genetics.106.057521; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Harkins V, 2009, GENETICS, V183, P1269, DOI 10.1534/genetics.109.110155; Heffernan TP, 2007, J BIOL CHEM, V282, P9458, DOI 10.1074/jbc.M611292200; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; JACKSON AL, 1993, MOL CELL BIOL, V13, P2899, DOI 10.1128/MCB.13.5.2899; Jones DR, 2010, CELL CYCLE, V9, P2018, DOI 10.4161/cc.9.10.11752; Kihara M, 2000, J BIOL CHEM, V275, P35051, DOI 10.1074/jbc.M003491200; Kim JM, 2003, MUTAT RES-FUND MOL M, V532, P29, DOI 10.1016/j.mrfmmm.2003.08.008; Kobayashi M, 2010, J BIOL CHEM, V285, P10087, DOI 10.1074/jbc.M109.054106; Leung CCY, 2011, CELL CYCLE, V10, P2461, DOI 10.4161/cc.10.15.16312; Lloyd J, 2009, CELL, V139, P100, DOI 10.1016/j.cell.2009.07.043; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Lucca C, 2004, ONCOGENE, V23, P1206, DOI 10.1038/sj.onc.1207199; Marston AL, 2009, CURR BIOL, V19, pR74, DOI 10.1016/j.cub.2008.12.003; Martin-Garcia R, 2011, CELL MOL LIFE SCI, V68, P2907, DOI 10.1007/s00018-010-0596-z; Masai H, 2000, BIOCHEM BIOPH RES CO, V275, P228, DOI 10.1006/bbrc.2000.3281; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Matthews LA, 2009, ACTA CRYSTALLOGR F, V65, P890, DOI 10.1107/S1744309109029376; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller CT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000498; Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; Ogino K, 2001, J BIOL CHEM, V276, P31376, DOI 10.1074/jbc.M102197200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATTERSON M, 1986, MOL CELL BIOL, V6, P1590, DOI 10.1128/MCB.6.5.1590; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pellicioli A, 2005, CURR BIOL, V15, pR769, DOI 10.1016/j.cub.2005.08.057; Pessoa-Brandao L, 2004, GENETICS, V167, P1597, DOI 10.1534/genetics.103.021675; Pike BL, 2004, MOL CELL BIOL, V24, P2779, DOI 10.1128/MCB.24.7.2779-2788.2004; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Varrin AE, 2005, MOL CELL BIOL, V25, P7494, DOI 10.1128/MCB.25.17.7494-7504.2005; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373	53	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2378	2387		10.1074/jbc.M111.233973	http://dx.doi.org/10.1074/jbc.M111.233973			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130670	hybrid, Green Published			2022-12-25	WOS:000300292300013
J	Wang, JC; Chen, L; Ko, CI; Zhang, L; Puga, A; Xia, Y				Wang, Jingcai; Chen, Liang; Ko, Chia-I; Zhang, Lin; Puga, Alvaro; Xia, Ying			Distinct Signaling Properties of Mitogen-activated Protein Kinase Kinases 4 (MKK4) and 7 (MKK7) in Embryonic Stem Cell (ESC) Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; SYNERGISTIC ACTIVATION; CARDIAC-FUNCTION; APOPTOSIS; P38; EXPRESSION; REVEALS; PATHWAY; GROWTH; MICE	Signal transduction pathways are integral components of the developmental regulatory network that guides progressive cell fate determination. MKK4 and MKK7 are upstream kinases of the mitogen-activated protein kinases (MAPKs), responsible for channeling physiological and environmental signals to their cellular responses. Both kinases are essential for survival of mouse embryos, but because of embryonic lethality, their precise developmental roles remain largely unknown. Using gene knock-out mouse ESCs, we studied the roles of MKK4 and MKK7 in differentiation in vitro. While MKK4 and MKK7 were dispensable for ESC self-renewal and pluripotency maintenance, they exhibited unique signaling and functional properties in differentiation. MKK4 and MKK7 complemented each other in activation of the JNK-c-Jun cascades and loss of both led to senescence upon cell differentiation. On the other hand, MKK4 and MKK7 had opposite effects on activation of the p38 cascades during differentiation. Specifically, MKK7 reduced p38 activation, while Mkk7(-/-) ESCs had elevated phosphorylation of MKK4, p38, and ATF2, and increased MEF2C expression. Consequently, Mkk7(-/-) ESCs had higher expression of MHC and MLC and enhanced formation of contractile cardiomyocytes. In contrast, MKK4 was required for p38 activation and Mkk4(-/-) ESCs exhibited diminished p-ATF2 and MEF2C expression, resulting in impaired MHC induction and defective cardiomyocyte differentiation. Exogenous MKK4 expression partially restored the ability of Mkk4(-/-) ESCs to differentiate into cardiomyocytes. Our results uncover complementary and interdependent roles of MKK4 and MKK7 in development, and identify the essential requirement for MKK4 in p38 activation and cardiomyocyte differentiation.	[Wang, Jingcai; Zhang, Lin] So Med Univ, Dept Histol & Embryol, Guangzhou 510515, Guangdong, Peoples R China; [Wang, Jingcai; Chen, Liang; Ko, Chia-I; Puga, Alvaro; Xia, Ying] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45367 USA	Southern Medical University - China; University System of Ohio; University of Cincinnati	Zhang, L (corresponding author), So Med Univ, Dept Histol & Embryol, Guangzhou 510515, Guangdong, Peoples R China.	zlilyzh@126.com; ying.xia@uc.edu	Chen, Liang/G-2990-2013	Chen, Liang/0000-0002-6748-9416	National Institutes of Health [EY15227]; NIEHS [ES006273, P30 ES006096]; Ryan Foundation; National Natural Science Foundation of China [30973129]; program for New Century Excellent Talents in University [NCET-08-0647, NCET-09-0088]; Foundation for Science & Tech Research Project of Guangdong [2009A030200015]; Natural Science Foundation of Guangdong Province [92510515000008]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0731]; NATIONAL EYE INSTITUTE [R01EY015227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006273, P30ES006096, R56ES006273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Ryan Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Foundation for Science & Tech Research Project of Guangdong; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by funding from the National Institutes of Health, Grant EY15227 (to J. W., L. C., and Y. X.), NIEHS ES006273 (to C. K., and A. P.), and NIEHS P30 ES006096 (to J. W., L. C., C. K., A. P., and Y. X.), and Ryan Foundation (to L. C.).; Supported in part by grants from The National Natural Science Foundation of China (No. 30973129) and the program for New Century Excellent Talents in University (No. NCET-08-0647 and NCET-09-0088), Foundation for Science & Tech Research Project of Guangdong (2009A030200015), Key Program of Natural Science Foundation of Guangdong Province (92510515000008), and Program for Changjiang Scholars and Innovative Research Team in University (IRT0731).	Aikawa R, 2002, HYPERTENSION, V39, P233, DOI 10.1161/hy0202.102699; Amura CR, 2005, MOL CELL BIOL, V25, P10791, DOI 10.1128/MCB.25.24.10791-10802.2005; Aouadi M, 2006, STEM CELLS, V24, P1399, DOI 10.1634/stemcells.2005-0398; Asaoka Y, 2010, J BIOCHEM, V148, P393, DOI 10.1093/jb/mvq098; Barruet E, 2011, STEM CELLS DEV, V20, P1233, DOI 10.1089/scd.2010.0213; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Bissonauth V, 2006, DEVELOPMENT, V133, P3429, DOI 10.1242/dev.02526; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Davidson SM, 2000, DEV BIOL, V218, P146, DOI 10.1006/dbio.1999.9596; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Di Felice V, 2009, ANAT REC, V292, P449, DOI 10.1002/ar.20858; Doss MX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r56; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Dworkin S, 2009, STEM CELLS, V27, P1347, DOI 10.1002/stem.56; Eriksson M, 2002, J BIOL CHEM, V277, P15992, DOI 10.1074/jbc.M107340200; Ganiatsas S, 1998, P NATL ACAD SCI USA, V95, P6881, DOI 10.1073/pnas.95.12.6881; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Glise B, 1997, GENE DEV, V11, P1738, DOI 10.1101/gad.11.13.1738; Gribaldo Laura, 2002, Experimental Hematology (Charlottesville), V30, P628, DOI 10.1016/S0301-472X(02)00827-5; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Harvey RP, 1999, SEMIN CELL DEV BIOL, V10, P99, DOI 10.1006/scdb.1998.0277; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hopfl G, 2004, METH MOL B, V254, P79; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kim NY, 2009, ARCH PHARM RES, V32, P737, DOI 10.1007/s12272-009-1513-6; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; Li ZH, 2006, AM J PHYSIOL-HEART C, V291, pH1972, DOI 10.1152/ajpheart.00043.2006; Lim JY, 2005, J MOL CELL CARDIOL, V39, P627, DOI 10.1016/j.yjmcc.2005.06.016; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liu W, 2009, CIRC RES, V104, P905, DOI 10.1161/CIRCRESAHA.108.188292; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; Nishina H, 1999, DEVELOPMENT, V126, P505; Nishitai G, 2004, J BIOL CHEM, V279, P1621, DOI 10.1074/jbc.M310335200; Peng ZM, 2007, J BIOL CHEM, V282, P21487, DOI 10.1074/jbc.M702510200; Rui YN, 2007, DEV CELL, V13, P268, DOI 10.1016/j.devcel.2007.07.006; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Sasaki T, 2001, J EXP MED, V194, P757, DOI 10.1084/jem.194.6.757; Schnekenburger M, 2007, BBA-GENE STRUCT EXPR, V1769, P569, DOI 10.1016/j.bbaexp.2007.07.002; Seo J, 2010, J CELL BIOCHEM, V110, P1022, DOI 10.1002/jcb.22616; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sugden PH, 1998, J MOL MED, V76, P725, DOI 10.1007/s001090050275; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wada T, 2001, J BIOL CHEM, V276, P30892, DOI 10.1074/jbc.M011780200; Wang JY, 2010, FASEB J, V24, P2066, DOI 10.1096/fj.09-142315; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; Xu P, 2010, MOL CELL BIOL, V30, P1329, DOI 10.1128/MCB.00795-09; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Yu AL, 2010, INVEST OPHTH VIS SCI, V51, P5718, DOI 10.1167/iovs.10-5679; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115	61	17	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2787	2797		10.1074/jbc.M111.281915	http://dx.doi.org/10.1074/jbc.M111.281915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130668	Green Published, hybrid			2022-12-25	WOS:000300292300050
J	Demont, Y; Corbet, C; Page, A; Ataman-Onal, Y; Choquet-Kastylevsky, G; Fliniaux, I; Le Bourhis, X; Toillon, RA; Bradshaw, RA; Hondermarck, H				Demont, Yohann; Corbet, Cyril; Page, Adeline; Ataman-Oenal, Yasemin; Choquet-Kastylevsky, Genevieve; Fliniaux, Ingrid; Le Bourhis, Xuefen; Toillon, Robert-Alain; Bradshaw, Ralph A.; Hondermarck, Hubert			Pro-nerve Growth Factor Induces Autocrine Stimulation of Breast Cancer Cell Invasion through Tropomyosin-related Kinase A (TrkA) and Sortilin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTORS; FACTOR PRECURSOR; PROLIFERATION; EXPRESSION; OVEREXPRESSION; DEGRADATION; METASTASIS; APOPTOSIS; SURVIVAL	The precursor of nerve growth factor (proNGF) has been described as a biologically active polypeptide able to induce apoptosis in neuronal cells, via the neurotrophin receptor p75(NTR) and the sortilin receptor. Herein, it is shown that proNGF is produced and secreted by breast cancer cells, stimulating their invasion. Using Western blotting and mass spectrometry, proNGF was detected in a panel of breast cancer cells as well as in their conditioned media. Immunohistochemical analysis indicated an overproduction of proNGF in breast tumors, when compared with benign and normal breast biopsies, and a relationship to lymph node invasion in ductal carcinomas. Interestingly, siRNA against proNGF induced a decrease of breast cancer cell invasion that was restored by the addition of non-cleavable proNGF. The activation of TrkA, Akt, and Src, but not the MAP kinases, was observed. In addition, the proNGF invasive effect was inhibited by the Trk pharmacological inhibitor K252a, a kinase-dead TrkA, and siRNA against TrkA sortilin, neurotensin, whereas siRNA against p75(NTR) and the MAP kinase inhibitor PD98059 had no impact. These data reveal the existence of an autocrine loop stimulated by proNGF and mediated by TrkA and sortilin, with the activation of Akt and Src, for the stimulation of breast cancer cell invasion.	[Demont, Yohann; Corbet, Cyril; Fliniaux, Ingrid; Le Bourhis, Xuefen; Toillon, Robert-Alain; Hondermarck, Hubert] Univ Lille, INSERM Growth Factor Signaling Breast Canc U908, F-59655 Villeneuve Dascq, France; [Page, Adeline] Univ Lille, Mass Spectrometry Facil, IFR 147, F-59655 Villeneuve Dascq, France; [Ataman-Oenal, Yasemin; Choquet-Kastylevsky, Genevieve] BioMerieux, Dept Biomarker Res & Validat, F-69280 Marcy Letoile, France; [Bradshaw, Ralph A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; bioMerieux; University of California System; University of California San Francisco	Hondermarck, H (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia.	hubert.hondermarck@newcastle.edu.au	Toillon, Robert-Alain/Q-2286-2018; Bradshaw, Ralph A/K-1515-2013; Fliniaux, Ingrid/D-9129-2015; Le+Bourhis, Xuefen/AAL-5141-2021	Toillon, Robert-Alain/0000-0001-5483-2118; Fliniaux, Ingrid/0000-0001-6377-5098	Ligue Nationale Contre le Cancer; INSERM; French Ministry for Research and Education; Groupement des Entreprises Francaises pour la Lutte Contre le Cancer (GEFLUC); Region Nord-Pas-de-Calais; Association pour la Recherche sur le Cancer	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministry for Research and Education; Groupement des Entreprises Francaises pour la Lutte Contre le Cancer (GEFLUC); Region Nord-Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by grants from the "Ligue Nationale Contre le Cancer" (Equipe labellisee 2009 and the Comite du Nord), the INSERM, the French Ministry for Research and Education, the Groupement des Entreprises Francaises pour la Lutte Contre le Cancer (GEFLUC), and the "Region Nord-Pas-de-Calais."; Recipient of a fellowship from the "Association pour la Recherche sur le Cancer."	Adriaenssens E, 2008, CANCER RES, V68, P346, DOI 10.1158/0008-5472.CAN-07-1183; Aragona M, 2001, CANCER INVEST, V19, P692, DOI 10.1081/CNV-100106144; Bloom AP, 2011, J PAIN, V12, P698, DOI 10.1016/j.jpain.2010.12.016; Boutilier J, 2008, J BIOL CHEM, V283, P12709, DOI 10.1074/jbc.M710018200; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Chiarenza A, 2001, CANCER RES, V61, P3002; Clewes O, 2008, J NEUROCHEM, V107, P1124, DOI 10.1111/j.1471-4159.2008.05698.x; Davidson B, 2004, BREAST CANCER RES TR, V83, P119, DOI 10.1023/B:BREA.0000010704.17479.8a; Descamps S, 2001, CANCER RES, V61, P4337; Descamps S, 2001, J BIOL CHEM, V276, P17864, DOI 10.1074/jbc.M010499200; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Dolle L, 2003, ONCOGENE, V22, P5592, DOI 10.1038/sj.onc.1206805; El Yazidi-Belkoura I, 2003, J BIOL CHEM, V278, P16952, DOI 10.1074/jbc.M300631200; Feng D, 2010, J MOL BIOL, V396, P967, DOI 10.1016/j.jmb.2009.12.030; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hempstead Barbara L., 2006, Current Alzheimer Research, V3, P19, DOI 10.2174/156720506775697061; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Lagadec C, 2009, ONCOGENE, V28, P1960, DOI 10.1038/onc.2009.61; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Masoudi R, 2009, J BIOL CHEM, V284, P18424, DOI 10.1074/jbc.M109.007104; Matrone C, 2009, P NATL ACAD SCI USA, V106, P11358, DOI 10.1073/pnas.0904998106; Montano X, 2009, ONCOGENE, V28, P3787, DOI 10.1038/onc.2009.143; Naderi A, 2007, CANCER RES, V67, P6725, DOI 10.1158/0008-5472.CAN-06-4394; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pagadala PC, 2006, P NATL ACAD SCI USA, V103, P17939, DOI 10.1073/pnas.0604139103; Pedraza CE, 2005, AM J PATHOL, V166, P533, DOI 10.1016/S0002-9440(10)62275-4; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Romon R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-157; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; Shooter EM, 2001, ANNU REV NEUROSCI, V24, P601, DOI 10.1146/annurev.neuro.24.1.601; Tagliabue E, 2000, J BIOL CHEM, V275, P5388, DOI 10.1074/jbc.275.8.5388; Truzzi F, 2008, J INVEST DERMATOL, V128, P2031, DOI 10.1038/jid.2008.21; Vaegter CB, 2011, NAT NEUROSCI, V14, P54, DOI 10.1038/nn.2689; Vanhecke E, 2011, CLIN CANCER RES, V17, P1741, DOI 10.1158/1078-0432.CCR-10-1890; Verbeke S, 2010, CELL SIGNAL, V22, P1864, DOI 10.1016/j.cellsig.2010.07.014; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670	37	56	62	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1923	1931		10.1074/jbc.M110.211714	http://dx.doi.org/10.1074/jbc.M110.211714			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128158	Green Published, hybrid			2022-12-25	WOS:000299321000033
J	Mankad, P; James, A; Siriwardena, AK; Elliott, AC; Bruce, JIE				Mankad, Parini; James, Andrew; Siriwardena, Ajith K.; Elliott, Austin C.; Bruce, Jason I. E.			Insulin Protects Pancreatic Acinar Cells from Cytosolic Calcium Overload and Inhibition of Plasma Membrane Calcium Pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCED ANESTHETIC REQUIREMENTS; CERULEIN-INDUCED PANCREATITIS; HORMONE-SPECIFIC DEFECT; DIABETIC-RATS; CANCER-CELLS; GLUCOSE-TRANSPORT; EXOCRINE PANCREAS; OXIDATIVE STRESS; HEXOKINASE-II; CA2+ UPTAKE	Acute pancreatitis is a serious and sometimes fatal inflammatory disease of the pancreas without any reliable treatment or imminent cure. In recent years, impaired metabolism and cytosolic Ca2+ ([Ca2+](i)) overload in pancreatic acinar cells have been implicated as the cardinal pathological events common to most forms of pancreatitis, regardless of the precise causative factor. Therefore, restoration of metabolism and protection against cytosolic Ca2+ overload likely represent key therapeutic untapped strategies for the treatment of this disease. The plasma membrane Ca2+-ATPase (PMCA) provides a final common path for cells to "defend" [Ca2+](i) during cellular injury. In this paper, we use fluorescence imaging to show for the first time that insulin treatment, which is protective in animal models and clinical studies of human pancreatitis, directly protects pancreatic acinar cells from oxidant-induced cytosolic Ca2+ overload and inhibition of the PMCA. This protection was independent of oxidative stress or mitochondrial membrane potential but appeared to involve the activation of Akt and an acute metabolic switch from mitochondrial to predominantly glycolytic metabolism. This switch to glycolysis appeared to be sufficient to maintain cellular ATP and thus PMCA activity, thereby preventing Ca2+ overload, even in the face of impaired mitochondrial function.	[Mankad, Parini; James, Andrew; Elliott, Austin C.; Bruce, Jason I. E.] Univ Manchester, Fac Life Sci, Manchester M13 9NT, Lancs, England; [Siriwardena, Ajith K.] Manchester Royal Infirm, Hepatobiliary Surg Unit, Manchester M13 9NT, Lancs, England	University of Manchester; University of Manchester	Bruce, JIE (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9NT, Lancs, England.	jason.bruce@manchester.ac.uk		James, Andrew/0000-0002-2432-5948; Elliott, Austin/0000-0003-3569-9002	Biotechnology and Biological Sciences Research Council New Investigator; Central Manchester Foundation Trust/National Institutes of Health Research Manchester Biological Research Centre; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/C514607/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council New Investigator(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Central Manchester Foundation Trust/National Institutes of Health Research Manchester Biological Research Centre; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council New Investigator Grant (to J. I. E. B.) and a Central Manchester Foundation Trust/National Institutes of Health Research Manchester Biological Research Centre pump priming fund (to A. K. S. and J. I. E. B.). Preliminary accounts of these data have been presented at meetings of the Physiological Society and American Pancreatic Association.; Supported by a Biotechnology and Biological Sciences Research Council Ph.D. studentship.	Baggaley EM, 2008, AM J PHYSIOL-CELL PH, V295, pC1247, DOI 10.1152/ajpcell.00083.2008; Berna MJ, 2009, CELL SIGNAL, V21, P622, DOI 10.1016/j.cellsig.2009.01.003; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; BORTHWICK AC, 1990, BIOCHEM J, V270, P795, DOI 10.1042/bj2700795; Bruce JIE, 2007, AM J PHYSIOL-CELL PH, V293, pC938, DOI 10.1152/ajpcell.00582.2006; Bruce Jason Ie, 2010, World J Biol Chem, V1, P221, DOI 10.4331/wjbc.v1.i7.221; CORVERA S, 1991, J BIOL CHEM, V266, P9271; Dembinski A, 2006, GROWTH HORM IGF RES, V16, P348, DOI 10.1016/j.ghir.2006.09.003; Denton RM, 1996, ADV ENZYME REGUL, V36, P183, DOI 10.1016/0065-2571(95)00020-8; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Dolado I, 2008, CANCER CELL, V14, P427, DOI 10.1016/j.ccr.2008.11.006; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fischer L, 2007, AM J PHYSIOL-GASTR L, V292, pG875, DOI 10.1152/ajpgi.00558.2005; Fischer L, 2004, AM J PHYSIOL-GASTR L, V287, pG1200, DOI 10.1152/ajpgi.00212.2004; Foster FM, 2003, J CELL SCI, V116, P3037, DOI 10.1242/jcs.00609; Gukovskaya AS, 2006, J GASTROEN HEPATOL, V21, pS10, DOI 10.1111/j.1440-1746.2006.04571.x; Gukovsky I, 2004, GASTROENTEROLOGY, V126, P554, DOI 10.1053/j.gastro.2003.11.017; HALLBERG D, 1977, ACTA CHIR SCAND, V143, P451; HARDIN CD, 1993, AM J PHYSIOL, V265, pH1326, DOI 10.1152/ajpheart.1993.265.4.H1326; HARDIN CD, 1992, J GEN PHYSIOL, V99, P21, DOI 10.1085/jgp.99.1.21; Hegyi P, 2000, J PHYSIOLOGY-PARIS, V94, P51, DOI 10.1016/S0928-4257(99)00103-5; Hegyi P, 2004, WORLD J GASTROENTERO, V10, P2003, DOI 10.3748/wjg.v10.i14.2003; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JANICKI PK, 1994, LIFE SCI, V55, pPL359, DOI 10.1016/0024-3205(94)00761-6; JANICKI PK, 1995, LIFE SCI, V56, pPL357, DOI 10.1016/0024-3205(95)00117-O; LEVY J, 1994, METABOLISM, V43, P1055, DOI 10.1016/0026-0495(94)90189-9; LEVY J, 1995, INT J OBESITY, V19, P97; LEVY J, 1994, METABOLISM, V43, P604, DOI 10.1016/0026-0495(94)90203-8; Lupia E, 2004, AM J PATHOL, V165, P2003, DOI 10.1016/S0002-9440(10)63251-8; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; MUALLEM S, 1988, J MEMBRANE BIOL, V102, P153, DOI 10.1007/BF01870453; Odinokova IV, 2008, J GASTROEN HEPATOL, V23, pS25, DOI 10.1111/j.1440-1746.2007.05271.x; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; PAUL RJ, 1989, FASEB J, V3, P2298, DOI 10.1096/fasebj.3.11.2528493; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P1, DOI 10.1007/s10863-007-9070-5; Peter H, 2004, WORLD J GASTROENTERO, V10, P2275; Petersen OH, 2009, CELL CALCIUM, V45, P634, DOI 10.1016/j.ceca.2009.02.005; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Savkovic V, 2004, DIGEST DIS, V22, P239, DOI 10.1159/000082795; Schmidt Maike M, 2009, Front Neuroenergetics, V1, P1, DOI 10.3389/neuro.14.001.2009; Singh VP, 2001, J CLIN INVEST, V108, P1387, DOI 10.1172/JCI200112874; SUZUKI H, 1993, PANCREAS, V8, P465, DOI 10.1097/00006676-199307000-00010; SVENSSON JO, 1975, SCAND J GASTROENTERO, V10, P487; Takacs T, 2001, PHARMACOL RES, V44, P363, DOI 10.1006/phrs.2001.0843; TANNER LI, 1987, J BIOL CHEM, V262, P8975; Tsuang W, 2009, AM J GASTROENTEROL, V104, P984, DOI 10.1038/ajg.2009.27; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Warzecha Z, 2003, J PHYSIOL PHARMACOL, V54, P575; Warzecha Z, 2001, EUR J PHARMACOL, V430, P113, DOI 10.1016/S0014-2999(01)01352-8; Weber CK, 2001, PANCREATOLOGY, V1, P356, DOI 10.1159/000055834; Wu P, 2010, CURR MED CHEM, V17, P4326, DOI 10.2174/092986710793361234; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; Zhou YJ, 2009, LIFE SCI, V85, P670, DOI 10.1016/j.lfs.2009.09.006	58	26	28	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1823	1836		10.1074/jbc.M111.326272	http://dx.doi.org/10.1074/jbc.M111.326272			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128146	Green Published, hybrid			2022-12-25	WOS:000299321000024
J	Sauve, S; Buijs, D; Gingras, G; Aubin, Y				Sauve, Simon; Buijs, Daniel; Gingras, Genevieve; Aubin, Yves			Interactions between the Conserved Hydrophobic Region of the Prion Protein and Dodecylphosphocholine Micelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; MEMBRANE-PROTEINS; PEPTIDE; VISUALIZATION; SPECTROSCOPY; SIMULATIONS; ORIENTATION; RESIDUES; DYNAMICS; SYSTEM	The three-dimensional structure of PrP110-136, a peptide encompassing the conserved hydrophobic region of the human prion protein, has been determined at high resolution in dodecylphosphocholine micelles by NMR. The results support the conclusion that the (PrP)-Pr-Ctm, a transmembrane form of the prion protein, adopts a different conformation than the reported structures of the normal prion protein determined in solution. Paramagnetic relaxation enhancement studies with gadolinium-diethylenetriaminepentaacetic acid indicated that the conserved hydrophobic region peptide is not inserted symmetrically in the micelle, thus suggesting the presence of a guanidium-phosphate ion pair involving the side chain of the terminal arginine and the detergent headgroup. Titration of dodecylphosphocholine into a solution of PrP110-136 revealed the presence of a surface-bound species. In addition, paramagnetic probes located the surface-bound peptide somewhere below the micelle-water interface when using the inserted helix as a positional reference. This localization of the unknown population would allow a similar ion pair interaction.	[Sauve, Simon; Buijs, Daniel; Gingras, Genevieve; Aubin, Yves] Hlth Canada, Ctr Vaccine Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0K9, Canada; [Buijs, Daniel; Aubin, Yves] Carleton Univ, Dept Chem, Ottawa, ON K1S 5B6, Canada	Health Canada; Carleton University	Aubin, Y (corresponding author), 251 Sir Frederick Banting Driveway, Ottawa, ON K1A 0K9, Canada.	yves.aubin@hc-sc.gc.ca			Bovine Sponqiform Encephalopathy initiative of the Government of Canada; National Science and Engineering Research Council	Bovine Sponqiform Encephalopathy initiative of the Government of Canada; National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Bovine Sponqiform Encephalopathy initiative of the Government of Canada.; Supported by a National Science and Engineering Research Council discovery grant. To whom correspondence should be addressed: 251 Sir Frederick Banting Driveway, Ottawa, ON K1A 0K9, Canada. Fax: 613-941-8933; E-mail: yves.aubin@hc-sc.gc.ca.	Baker M, 2010, NAT METHODS, V7, P429, DOI 10.1038/nmeth0610-429; Baron GS, 2003, J BIOL CHEM, V278, P14883, DOI 10.1074/jbc.M210840200; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Chakrabarti O, 2009, TRENDS BIOCHEM SCI, V34, P287, DOI 10.1016/j.tibs.2009.03.001; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; DEFEA KA, 1994, J BIOL CHEM, V269, P16810; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Natale G, 2005, ORG BIOMOL CHEM, V3, P490, DOI 10.1039/b407928k; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Glover KJ, 1999, ANAL BIOCHEM, V272, P270, DOI 10.1006/abio.1999.4182; Glover KJ, 2001, BIOCHEMISTRY-US, V40, P13137, DOI 10.1021/bi011485m; Gobl C, 2010, J PHYS CHEM B, V114, P4717, DOI 10.1021/jp9114089; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Hodak M, 2009, P NATL ACAD SCI USA, V106, P11576, DOI 10.1073/pnas.0903807106; Hornemann S, 2009, J BIOL CHEM, V284, P22713, DOI 10.1074/jbc.M109.000430; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kuwata K, 2003, P NATL ACAD SCI USA, V100, P14790, DOI 10.1073/pnas.2433563100; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Lazaridis T, 2005, J PHYS CHEM B, V109, P15098, DOI 10.1021/jp0516801; Liang BY, 2006, J AM CHEM SOC, V128, P4389, DOI 10.1021/ja0574825; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Moore RA, 2009, CURR OPIN STRUC BIOL, V19, P14, DOI 10.1016/j.sbi.2008.12.007; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Opella SJ, 2004, CHEM REV, V104, P3587, DOI 10.1021/cr0304121; Palladino P, 2010, J FLUORESC, V20, P191, DOI 10.1007/s10895-009-0537-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Stewart RS, 2001, J BIOL CHEM, V276, P2212, DOI 10.1074/jbc.M006763200; Su YC, 2010, BIOCHEMISTRY-US, V49, P6009, DOI 10.1021/bi100642n; Tanford C., 1980, HYDROPHOBIC EFFECT F, V2; Tang M, 2007, J AM CHEM SOC, V129, P11438, DOI 10.1021/ja072511s; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Will R. G., 2004, PRION BIOL DIS, P631; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Wymore T, 1999, J MOL STRUCT, V485, P195, DOI 10.1016/S0022-2860(99)00090-3; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	39	14	14	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1915	1922		10.1074/jbc.M111.279364	http://dx.doi.org/10.1074/jbc.M111.279364			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128151	hybrid, Green Published			2022-12-25	WOS:000299321000032
J	Srivastava, RM; Srivastava, S; Singh, M; Bajpai, VK; Ghosh, JK				Srivastava, Raghvendra M.; Srivastava, Saurabh; Singh, Manish; Bajpai, Virendra Kumar; Ghosh, Jimut Kanti			Consequences of Alteration in Leucine Zipper Sequence of Melittin in Its Neutralization of Lipopolysaccharide-induced Proinflammatory Response in Macrophage Cells and Interaction with Lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE PRODUCTION; NF-KAPPA-B; TARGET GENE-EXPRESSION; GRAM-NEGATIVE BACTERIA; HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDES; ENDOTOXIN NEUTRALIZATION; CATHELICIDIN FAMILY; MEDIATOR GENERATION; CATIONIC PEPTIDES	The bee venom antimicrobial peptide, melittin, besides showing versatile activity against microorganisms also neutralizes lipopolysaccharide (LPS)-induced proinflammatory responses in macrophage cells. However, how the amino acid sequence of melittin contributes in its anti-inflammatory properties is mostly unknown. To determine the importance of the leucine zipper sequence of melittin in its neutralization of LPS-induced inflammatory responses in macrophages and interaction with LPS, anti-inflammatory properties of melittin and its three analogues and their interactions with LPS were studied in detail. Two of these analogues, namely melittin Mut-1 (MM-1) and melittin Mut-2 (MM-2), possess leucine to alanine substitutions in the single and double heptadic leucine residue(s) of melittin, respectively, whereas the third analogue is a scrambled peptide (Mel-SCR) that contains the amino acid composition of melittin with minor rearrangement in its leucine zipper sequence. Although MM-1 partly inhibited the production of proinflammatory cytokines in RAW 264.7 and rat primary macrophage cells in the presence of LPS, MM-2 and Mel-SCR were negligibly active. A progressive decrease in interaction of melittin with LPS, aggregation in LPS, and dissociation of LPS aggregates with alteration in the leucine zipper sequence of melittin was observed. Furthermore, with alteration in the leucine zipper sequence of melittin, these analogues failed to exhibit cellular responses associated with neutralization of LPS-induced inflammatory responses in macrophage cells by melittin. The data indicated a probable important role of the leucine zipper sequence of melittin in neutralizing LPS-induced proinflammatory responses in macrophage cells as well as in its interaction with LPS.	[Srivastava, Raghvendra M.; Srivastava, Saurabh; Ghosh, Jimut Kanti] Cent Drug Res Inst, Mol & Struct Biol Div, Sophisticated Analyt Instrument Facil, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India; [Singh, Manish; Bajpai, Virendra Kumar] Cent Drug Res Inst, Electron Microscopy Unit, Sophisticated Analyt Instrument Facil, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Ghosh, JK (corresponding author), Cent Drug Res Inst, Mol & Struct Biol Div, Sophisticated Analyt Instrument Facil, Council Sci & Ind Res, Chattar Manzil Palace,POB 173, Lucknow 226001, Uttar Pradesh, India.	jighosh@yahoo.com	Srivastava, Raghvendra/F-7211-2017; Srivastava, Saurabh/L-1188-2017	Srivastava, Saurabh/0000-0003-3159-7826; Singh, Manish/0000-0002-9124-1859	Council of Scientific and Industrial Research network [NWP 0005]; Council of Scientific and Industrial Research (CSIR) [NWP 0005]; Council of Scientific and Industrial Research (CSIR), India	Council of Scientific and Industrial Research network; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported in part by Council of Scientific and Industrial Research network project NWP 0005. This is Council of Scientific and Industrial Research-Central Drug Research Institute communication number 8164.; Supported as a project assistant (level 4) position under Council of Scientific and Industrial Research (CSIR), NWP 0005.; Supported by senior research fellowships from Council of Scientific and Industrial Research (CSIR), India.	Afaq F, 2003, ONCOGENE, V22, P1035, DOI 10.1038/sj.onc.1206206; Ahmad A, 2009, BIOCHEMISTRY-US, V48, P10905, DOI 10.1021/bi9009874; Ahmad A, 2009, BBA-BIOMEMBRANES, V1788, P2411, DOI 10.1016/j.bbamem.2009.08.021; Andra J, 2007, BIOCHEM J, V406, P297, DOI 10.1042/BJ20070279; Asthana N, 2004, J BIOL CHEM, V279, P55042, DOI 10.1074/jbc.M408881200; Bhunia A, 2007, BBA-BIOMEMBRANES, V1768, P3282, DOI 10.1016/j.bbamem.2007.07.017; Bhunia A, 2009, J BIOL CHEM, V284, P21991, DOI 10.1074/jbc.M109.013573; Bhunia A, 2009, BIOPOLYMERS, V92, P9, DOI 10.1002/bip.21104; BOLTZNITULESCU G, 1987, J LEUKOCYTE BIOL, V41, P83, DOI 10.1002/jlb.41.1.83; Comalada N, 2003, AM J PHYSIOL-CELL PH, V285, pC1235, DOI 10.1152/ajpcell.00228.2003; DAVID SA, 1992, BIOCHIM BIOPHYS ACTA, V1123, P269, DOI 10.1016/0005-2760(92)90006-H; de Haas CJC, 2000, J IMMUNOL METHODS, V242, P79, DOI 10.1016/S0022-1759(00)00207-6; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Ding L, 2003, BIOCHEMISTRY-US, V42, P12251, DOI 10.1021/bi035130+; Downey J. S., 1998, FRONT BIOSCI, V3, pd468; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Giacometti A, 2002, ANTIMICROB AGENTS CH, V46, P2132, DOI 10.1128/AAC.46.7.2132-2136.2002; Giacometti A, 2006, ANTIMICROB AGENTS CH, V50, P2478, DOI 10.1128/AAC.01553-05; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gough M, 1996, INFECT IMMUN, V64, P4922, DOI 10.1128/IAI.64.12.4922-4927.1996; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Havenga MJE, 2001, ANAL BIOCHEM, V290, P283, DOI 10.1006/abio.2000.4966; HAYTER JB, 1987, J BIOL CHEM, V262, P5100; HIRATA M, 1994, INFECT IMMUN, V62, P1421, DOI 10.1128/IAI.62.4.1421-1426.1994; Japelj B, 2005, J BIOL CHEM, V280, P16955, DOI 10.1074/jbc.M500266200; Kadowaki S, 2004, MOL CELL BIOCHEM, V262, P51, DOI 10.1023/B:MCBI.0000038215.89821.7f; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Li P, 2004, J BIOL CHEM, V279, P50150, DOI 10.1074/jbc.M405606200; Mamani-Matsuda M, 2004, ANTIMICROB AGENTS CH, V48, P924, DOI 10.1128/AAC.48.3.924-929.2004; Mangoni ML, 2008, J BIOL CHEM, V283, P22907, DOI 10.1074/jbc.M800495200; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Pandey BK, 2010, BIOCHEMISTRY-US, V49, P7920, DOI 10.1021/bi100729m; Papo N, 2005, J BIOL CHEM, V280, P10378, DOI 10.1074/jbc.M412865200; Park HJ, 2004, ARTHRITIS RHEUM-US, V50, P3504, DOI 10.1002/art.20626; Park HJ, 2007, BIOCHEM PHARMACOL, V73, P237, DOI 10.1016/j.bcp.2006.09.023; Park HJ, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-7; Pattanaik U, 1996, ANN NY ACAD SCI, V793, P506, DOI 10.1111/j.1749-6632.1996.tb33551.x; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Petruson K, 2005, RHINOLOGY, V43, P18; PIERS KL, 1994, MOL MICROBIOL, V12, P951, DOI 10.1111/j.1365-2958.1994.tb01083.x; Privat C, 1997, LIFE SCI, V61, P1193, DOI 10.1016/S0024-3205(97)00661-9; Reid AB, 2005, J PHARMACOL EXP THER, V312, P509, DOI 10.1124/jpet.104.075945; RIFKIND D, 1966, J BACTERIOL, V92, P815, DOI 10.1128/JB.92.4.815-819.1966; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Schulke S, 2010, MOL IMMUNOL, V48, P341, DOI 10.1016/j.molimm.2010.07.006; Scott MG, 1999, INFECT IMMUN, V67, P6445; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Shaw PJ, 2007, TOXICOL SCI, V100, P259, DOI 10.1093/toxsci/kfm218; Tack BF, 2002, EUR J BIOCHEM, V269, P1181, DOI 10.1046/j.0014-2956.2002.02751.x; Tepel M, 2000, KIDNEY INT, V58, P867, DOI 10.1046/j.1523-1755.2000.00236.x; Tsuzuki H, 2001, J SURG RES, V100, P127, DOI 10.1006/jsre.2001.6227; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Turpin P, 1999, J BIOL CHEM, V274, P6804, DOI 10.1074/jbc.274.10.6804; Vasselon T, 1999, J EXP MED, V190, P509, DOI 10.1084/jem.190.4.509; WU CSC, 1981, BIOCHEMISTRY-US, V20, P566, DOI 10.1021/bi00506a019; Xiao YJ, 2006, FEBS J, V273, P2581, DOI 10.1111/j.1742-4658.2006.05261.x; Yadav SP, 2003, J BIOL CHEM, V278, P51023, DOI 10.1074/jbc.M310052200; Yu Z, 2007, GYNECOL ONCOL, V106, P541, DOI 10.1016/j.ygyno.2007.05.024; Zhu WL, 2007, BBA-BIOMEMBRANES, V1768, P1506, DOI 10.1016/j.bbamem.2007.03.010	65	33	34	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1980	1995		10.1074/jbc.M111.302893	http://dx.doi.org/10.1074/jbc.M111.302893			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128186	Green Published, hybrid			2022-12-25	WOS:000299321000039
J	Gertow, K; Cedervall, J; Jamil, S; Ali, R; Imreh, MP; Gulyas, M; Sandstedt, B; Ahrlund-Richter, L				Gertow, Karin; Cedervall, Jessica; Jamil, Seema; Ali, Rouknuddin; Imreh, Marta P.; Gulyas, Miklos; Sandstedt, Bengt; Ahrlund-Richter, Lars			Early Events in Xenograft Development from the Human Embryonic Stem Cell Line HS181-Resemblance with an Initial Multiple Epiblast Formation	PLOS ONE			English	Article							HUMAN BLASTOCYSTS; ES CELLS; DIFFERENTIATION; TERATOMAS; MICE; CULTURE; SYSTEM; GROWTH; PLURIPOTENCY; IMPLANTATION	Xenografting is widely used for assessing in vivo pluripotency of human stem cell populations. Here, we report on early to late events in the development of mature experimental teratoma from a well-characterized human embryonic stem cell (HESC) line, HS181. The results show an embryonic process, increasingly chaotic. Active proliferation of the stem cell derived cellular progeny was detected already at day 5, and characterized by the appearance of multiple sites of engraftment, with structures of single or pseudostratified columnar epithelium surrounding small cavities. The striking histological resemblance to developing embryonic ectoderm, and the formation of epiblast-like structures was supported by the expression of the markers OCT4, NANOG, SSEA-4 and KLF4, but a lack of REX1. The early neural marker NESTIN was uniformly expressed, while markers linked to gastrulation, such as BMP-4, NODAL or BRACHYURY were not detected. Thus, observations on day 5 indicated differentiation comparable to the most early transient cell populations in human post implantation development. Confirming and expanding on previous findings from HS181 xenografts, these early events were followed by an increasingly chaotic development, incorporated in the formation of a benign teratoma with complex embryonic components. In the mature HS181 teratomas not all types of organs/tissues were detected, indicating a restricted differentiation, and a lack of adequate spatial developmental cues during the further teratoma formation. Uniquely, a kinetic alignment of rare complex structures was made to human embryos at diagnosed gestation stages, showing minor kinetic deviations between HS181 teratoma and the human counterpart.	[Gertow, Karin; Cedervall, Jessica; Jamil, Seema; Imreh, Marta P.; Sandstedt, Bengt; Ahrlund-Richter, Lars] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Ali, Rouknuddin] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Gulyas, Miklos] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Uppsala University	Gertow, K (corresponding author), Ludwig Inst Canc Res Ltd, Stockholm, Sweden.	ahrlund@gmail.com	Ahrlund-Richter, Lars/C-6226-2012	Gulyas, Miklos/0000-0003-4988-6933; Jamil, Seema/0000-0003-4264-7163	Swedish Research Council [K2008-55X-2034-01-3]; Petrus and Augusta Hedlund's stiftelse; Cancer Society in Stockholm [091551]; King Gustaf V Jubilee Fund [094271]; Karolinska Institutet; Higher Education Commission of Pakistan	Swedish Research Council(Swedish Research CouncilEuropean Commission); Petrus and Augusta Hedlund's stiftelse; Cancer Society in Stockholm; King Gustaf V Jubilee Fund; Karolinska Institutet(Karolinska Institutet); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	This work was supported by the Swedish Research Council (K2008-55X-2034-01-3), Petrus and Augusta Hedlund's stiftelse, The Cancer Society in Stockholm (091551), the King Gustaf V Jubilee Fund (094271) and Karolinska Institutet. SJ and RA were supported by stipends from the Higher Education Commission of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Blum B, 2007, STEM CELLS, V25, P1924, DOI 10.1634/stemcells.2007-0073; Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; BRONNERFRASER M, 1991, DEV BIOL, V143, P213, DOI 10.1016/0012-1606(91)90071-A; Cedervall J, 2012, HUMAN STEM IN PRESS; Cooke MJ, 2006, STEM CELLS DEV, V15, P254, DOI 10.1089/scd.2006.15.254; CROY BA, 1990, J REPROD FERTIL, V88, P231, DOI 10.1530/jrf.0.0880231; FREE MJ, 1976, BIOL REPROD, V14, P481, DOI 10.1095/biolreprod14.4.481; Gardner DK, 1998, FERTIL STERIL, V69, P84, DOI 10.1016/S0015-0282(97)00438-X; Gerecht-Nir S, 2004, BIOL REPROD, V71, P2029, DOI 10.1095/biolreprod.104.031930; Gertow K, 2004, STEM CELLS DEV, V13, P421, DOI 10.1089/scd.2004.13.421; Gertow K, 2007, CURR PROTOC STEM CEL; Gertow K, 2007, J CELL BIOCHEM, V100, P1518, DOI 10.1002/jcb.21144; HAUB O, 1991, DEVELOPMENT, V112, P397; HEBERT JM, 1991, DEVELOPMENT, V112, P407; Heins N, 2004, STEM CELLS, V22, P367, DOI 10.1634/stemcells.22-3-367; Hill MA, 2007, CLIN OBSTET GYNECOL, V50, P2, DOI 10.1097/GRF.0b013e31802f119d; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Imreh MP, 2004, STEM CELLS DEV, V13, P337, DOI 10.1089/1547328041797534; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; KEYNES RJ, 1984, NATURE, V310, P786, DOI 10.1038/310786a0; Kruger A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r229; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lensch MW, 2007, NAT BIOTECHNOL, V25, P1211, DOI 10.1038/nbt1107-1211a; Lensch MW, 2007, CELL STEM CELL, V1, P253, DOI 10.1016/j.stem.2007.07.019; MACDOUGALL JR, 1990, CELL IMMUNOL, V130, P106, DOI 10.1016/0008-8749(90)90165-N; Mikkola M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-40; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Prokhorova TA, 2009, STEM CELLS DEV, V18, P47, DOI 10.1089/scd.2007.0266; Przyborski SA, 2005, STEM CELLS, V23, P1242, DOI 10.1634/stemcells.2005-0014; Rathjen J, 1999, J CELL SCI, V112, P601; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; SETCHELL BP, 1964, J PHYSIOL-LONDON, V171, P411, DOI 10.1113/jphysiol.1964.sp007387; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; TARARA R, 1987, ANAT EMBRYOL, V176, P267, DOI 10.1007/BF00310182; TEILLET MA, 1987, DEV BIOL, V120, P329, DOI 10.1016/0012-1606(87)90236-3; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; WIDELITZ RB, 1993, J CELL PHYSIOL, V156, P399, DOI 10.1002/jcp.1041560224; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003	45	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27741	10.1371/journal.pone.0027741	http://dx.doi.org/10.1371/journal.pone.0027741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140465	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100016
J	Wilson, AJ; de Boer, M; Arnott, G; Grimmer, A				Wilson, Alastair J.; de Boer, Marloes; Arnott, Gareth; Grimmer, Andrew			Integrating Personality Research and Animal Contest Theory: Aggressiveness in the Green Swordtail Xiphophorus helleri	PLOS ONE			English	Article							BEHAVIORAL SYNDROMES; FIGHTING ABILITY; FISH; EVOLUTION; DOMINANCE; COMPETITION; ECOLOGY; WINNER; COMBAT; RANK	Aggression occurs when individuals compete over limiting resources. While theoretical studies have long placed a strong emphasis on context-specificity of aggression, there is increasing recognition that consistent behavioural differences exist among individuals, and that aggressiveness may be an important component of individual personality. Though empirical studies tend to focus on one aspect or the other, we suggest there is merit in modelling both within-and among-individual variation in agonistic behaviour simultaneously. Here, we demonstrate how this can be achieved using multivariate linear mixed effect models. Using data from repeated mirror trials and dyadic interactions of male green swordtails, Xiphophorus helleri, we show repeatable components of (co)variation in a suite of agonistic behaviour that is broadly consistent with a major axis of variation in aggressiveness. We also show that observed focal behaviour is dependent on opponent effects, which can themselves be repeatable but were more generally found to be context specific. In particular, our models show that within-individual variation in agonistic behaviour is explained, at least in part, by the relative size of a live opponent as predicted by contest theory. Finally, we suggest several additional applications of the multivariate models demonstrated here. These include testing the recently queried functional equivalence of alternative experimental approaches, (e. g., mirror trials, dyadic interaction tests) for assaying individual aggressiveness.	[Wilson, Alastair J.; de Boer, Marloes; Grimmer, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Arnott, Gareth] Univ Glasgow, Inst Biodivers, Glasgow, Lanark, Scotland	University of Edinburgh; University of Glasgow	Wilson, AJ (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	alastair.wilson@ed.ac.uk	Wilson, Alastair/F-3118-2010	Wilson, Alastair/0000-0002-5045-2051	Biology and Biotechnology Research Council	Biology and Biotechnology Research Council	This work was funded by a Biology and Biotechnology Research Council David Phillips fellowship awarded to AJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnott G, 2011, BIOL LETTERS, V7, P683, DOI 10.1098/rsbl.2011.0328; Arnott G, 2010, BEHAV PROCESS, V84, P750, DOI 10.1016/j.beproc.2010.05.001; Arnott G, 2009, BIOL LETTERS, V5, P762, DOI 10.1098/rsbl.2009.0526; Arnott G, 2009, ANIM BEHAV, V77, P991, DOI 10.1016/j.anbehav.2009.02.010; AUSTAD SN, 1983, ANIM BEHAV, V31, P59, DOI 10.1016/S0003-3472(83)80173-0; BEAUGRAND J, 1991, ANIM BEHAV, V41, P417, DOI 10.1016/S0003-3472(05)80842-5; BEAUGRAND JP, 1985, BEHAV PROCESS, V10, P1, DOI 10.1016/0376-6357(85)90116-0; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Benson KE, 2006, ANIM BEHAV, V71, P129, DOI 10.1016/j.anbehav.2005.05.004; BRADLEY RA, 1952, BIOMETRIKA, V39, P324, DOI 10.1093/biomet/39.3-4.324; Briffa M, 2009, ANIM BEHAV, V77, P759, DOI 10.1016/j.anbehav.2008.11.010; Desjardins JK, 2010, BIOL LETTERS, V6, P744, DOI 10.1098/rsbl.2010.0247; Dochtermann NA, 2010, BEHAV ECOL, V21, P437, DOI 10.1093/beheco/arq021; Dugatkin LA, 1997, BEHAV ECOL, V8, P583, DOI 10.1093/beheco/8.6.583; Dzieweczynski TL, 2010, BEHAV PROCESS, V85, P83, DOI 10.1016/j.beproc.2010.06.011; Earley RL, 2006, BEHAV PROCESS, V73, P290, DOI 10.1016/j.beproc.2006.07.001; Earley RL, 2002, P ROY SOC B-BIOL SCI, V269, P943, DOI 10.1098/rspb.2002.1973; Earley RL, 2000, ETHOLOGY, V106, P743, DOI 10.1046/j.1439-0310.2000.00586.x; Earley RL, 2006, ZEBRAFISH, V3, P287, DOI 10.1089/zeb.2006.3.287; ENQUIST M, 1990, ANIM BEHAV, V40, P1, DOI 10.1016/S0003-3472(05)80660-8; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; Fawcett TW, 2010, P ROY SOC B-BIOL SCI, V277, P1427, DOI 10.1098/rspb.2009.2088; Galwey N.W., 2006, INTRO MIXED MODELLIN; Gibbons JM, 2009, APPL ANIM BEHAV SCI, V121, P1, DOI 10.1016/j.applanim.2009.08.002; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Goulet C, 2001, RELATION DOMIN UNPUB; Hardling R, 2004, AM NAT, V163, P240, DOI 10.1086/381043; Hedeker D., 2006, LONGITUDINAL DATA AN; Higham NJ, 2002, IMA J NUMER ANAL, V22, P329, DOI 10.1093/imanum/22.3.329; Hodge SJ, 2009, BEHAV ECOL, V20, P930, DOI 10.1093/beheco/arp071; Huntingford F.A., 1987, ANIMAL CONFLICT; Johnstone RA, 2001, P NATL ACAD SCI USA, V98, P9177, DOI 10.1073/pnas.161058798; Magellan K, 2010, J ETHOL, V28, P239, DOI 10.1007/s10164-009-0175-7; McGhee KE, 2010, ANIM BEHAV, V79, P497, DOI 10.1016/j.anbehav.2009.11.037; Meyer K, 2008, GENETICS, V180, P1153, DOI 10.1534/genetics.108.090159; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Moretz J, 2005, BEHAV ECOL SOCIOBIOL, V59, P51, DOI 10.1007/s00265-005-0008-9; MORRIS MR, 1995, BEHAV ECOL SOCIOBIOL, V37, P303, DOI 10.1007/BF00174134; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Payne RJH, 1998, ANIM BEHAV, V56, P651, DOI 10.1006/anbe.1998.0835; Peake TM, 2004, LEARN BEHAV, V32, P114; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Prenter J, 2008, ANIMAL BEHAV; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Renison D, 2002, BEHAV ECOL, V13, P462, DOI 10.1093/beheco/13.4.462; Robinson MR, 2007, BIOL LETTERS, V3, P651, DOI 10.1098/rsbl.2007.0278; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Sontirat S., 1984, Kasetsart Journal Natural Sciences, V18, P99; Taylor PW, 2003, ANIM BEHAV, V65, P1195, DOI 10.1006/anbe.2003.2169; Tinbergen, 1951, STUDY INSTINCT; Visscher PM, 2006, TWIN RES HUM GENET, V9, P490, DOI 10.1375/183242706778024928; WARD PI, 1983, BEHAV ECOL SOCIOBIOL, V14, P69, DOI 10.1007/BF00366658; While GM, 2010, HORM BEHAV, V58, P208, DOI 10.1016/j.yhbeh.2010.03.016; Wilson AJ, 2008, J EVOLUTION BIOL, V21, P647, DOI 10.1111/j.1420-9101.2008.01500.x; Wilson AJ, 2011, J EVOLUTION BIOL, V24, P772, DOI 10.1111/j.1420-9101.2010.02212.x; Wilson AJ, 2009, P ROY SOC B-BIOL SCI, V276, P533, DOI 10.1098/rspb.2008.1193	59	50	50	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28024	10.1371/journal.pone.0028024	http://dx.doi.org/10.1371/journal.pone.0028024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140502	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000298168100031
J	Johansson, D; Shannon, O; Rasmussen, M				Johansson, Daniel; Shannon, Oonagh; Rasmussen, Magnus			Platelet and Neutrophil Responses to Gram Positive Pathogens in Patients with Bacteremic Infection	PLOS ONE			English	Article							IMMUNOGLOBULIN-G; CELL FILTRATION; IGG BINDING; P-SELECTIN; ACTIVATION; FIBRINOGEN; AGGREGATION; ROLES; COMPLEMENT; MECHANISMS	Background: Many Gram-positive pathogens aggregate and activate platelets in vitro and this has been proposed to contribute to virulence. Platelets can also form complexes with neutrophils but little is however known about platelet and platelet-neutrophil responses in bacterial infection. Methodology/Principal Findings: We added isolates of Gram-positive bacteria from 38 patients with a bacteremic infection to blood drawn from the same patient. Aggregometry and flow cytometry were used to assess platelet aggregation and to quantify activation of platelets, neutrophils, and platelet-neutrophils complexes (PNCs) induced by the bacteria. Fifteen healthy persons served as controls. Most isolates of Staphylococcus aureus, beta hemolytic streptococci, and Enterococcus faecalis induced aggregation of platelets from their respective hosts, whereas pneumococci failed to do so. S. aureus isolates induced platelet aggregation more rapidly in patients than in controls, whereas platelet activation by S. aureus was lower in patients than in controls. PNCs were more abundant in baseline samples from patients than in healthy controls and most bacterial isolates induced additional PNC formation and neutrophil activation. Conclusion/Significance: We have demonstrated for the first time that bacteria isolated from patients with Gram-positive bacteremia can induce platelet activation and aggregation, PNC formation, and neutrophil activation in the same infected host. This underlines the significance of these interactions during infection, which could be a target for future therapies in sepsis.	[Johansson, Daniel; Shannon, Oonagh; Rasmussen, Magnus] Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden	Lund University	Johansson, D (corresponding author), Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden.	Magnus.Rasmussen@med.lu.se		Shannon, Oonagh/0000-0001-8291-8189; Rasmussen, Magnus/0000-0003-1588-5473	Swedish Society of Medicine; Swedish Government; Swedish Research Council [21112, 7480]; Royal Physiographic Society in Lund; Foundations of Osterlund and Crafoord	Swedish Society of Medicine; Swedish Government; Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society in Lund; Foundations of Osterlund and Crafoord	This study was financed by the Swedish Society of Medicine, the Swedish Government Fund for Clinical Research (ALF), the Swedish Research Council (Project 21112 and 7480), the Royal Physiographic Society in Lund, and the Foundations of Osterlund and Crafoord. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKESSON P, 1990, MOL IMMUNOL, V27, P523, DOI 10.1016/0161-5890(90)90071-7; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; BAYER AS, 1995, INFECT IMMUN, V63, P3634, DOI 10.1128/IAI.63.9.3634-3641.1995; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brandt CM, 2009, CLIN INFECT DIS, V49, P766, DOI 10.1086/605085; Brown KK, 1998, AM J RESP CELL MOL, V18, P100, DOI 10.1165/ajrcmb.18.1.2314; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Evangelista Virgilio, 1996, Blood, V88, P4183; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Fitzgerald JR, 2006, MOL MICROBIOL, V59, P212, DOI 10.1111/j.1365-2958.2005.04922.x; Gafter-Gvili A, 2011, MAYO CLIN PROC, V86, P389, DOI 10.4065/mcp.2010.0705; GAWAZ M, 1995, EUR J CLIN INVEST, V25, P843, DOI 10.1111/j.1365-2362.1995.tb01694.x; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Keane C, 2010, J THROMB HAEMOST, V8, P2757, DOI 10.1111/j.1538-7836.2010.04093.x; Kerrigan SW, 2010, CELL MOL LIFE SCI, V67, P513, DOI 10.1007/s00018-009-0207-z; Kirschenbaum LA, 2002, SHOCK, V17, P508, DOI 10.1097/00024382-200206000-00012; Kirschenbaum LA, 2000, AM J RESP CRIT CARE, V161, P1602, DOI 10.1164/ajrccm.161.5.9902105; KURPIEWSKI GE, 1983, INFECT IMMUN, V39, P704, DOI 10.1128/IAI.39.2.704-708.1983; Loughman A, 2005, MOL MICROBIOL, V57, P804, DOI 10.1111/j.1365-2958.2005.04731.x; Mavrommatis AC, 2000, CRIT CARE MED, V28, P451, DOI 10.1097/00003246-200002000-00027; McNicol A, 2006, THROMB HAEMOSTASIS, V95, P288, DOI 10.1160/TH05-07-0491; Miajlovic H, 2007, INFECT IMMUN, V75, P3335, DOI 10.1128/IAI.01993-06; Papapanagiotou D, 2009, ATHEROSCLEROSIS, V202, P605, DOI 10.1016/j.atherosclerosis.2008.05.035; Peters MJ, 2003, J LEUKOCYTE BIOL, V73, P722, DOI 10.1189/jlb.1002509; Pietrocola G, 2005, BLOOD, V105, P1052, DOI 10.1182/blood-2004-06-2149; Rasmussen M, 2010, MICROBES INFECT, V12, P295, DOI 10.1016/j.micinf.2010.01.005; Rindi S, 2006, EUR J CLIN INVEST, V36, P536, DOI 10.1111/j.1365-2362.2006.01675.x; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Semple JW, 2010, CELL MOL LIFE SCI, V67, P499, DOI 10.1007/s00018-009-0205-1; Sjobring U, 2002, BLOOD, V100, P4470, DOI 10.1182/blood-2002-01-0069; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; SULLAM PM, 1988, INFECT IMMUN, V56, P2907, DOI 10.1128/IAI.56.11.2907-2911.1988; ZIMMERMAN TS, 1975, J CLIN INVEST, V56, P828, DOI 10.1172/JCI108161	35	50	51	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e26928	10.1371/journal.pone.0026928	http://dx.doi.org/10.1371/journal.pone.0026928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140434	Green Published, Green Submitted, gold			2022-12-25	WOS:000298166300003
J	Li, T; Li, YM; Ahn, K; Price, DL; Sisodia, SS; Wong, PC				Li, Tong; Li, Yue-Ming; Ahn, Kwangwook; Price, Donald L.; Sisodia, Sangram S.; Wong, Philip C.			Increased Expression of PS1 Is Sufficient to Elevate the Level and Activity of gamma-Secretase In Vivo	PLOS ONE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; AMYLOID PRECURSOR PROTEIN; GENOME-WIDE ASSOCIATION; A-BETA LEVELS; IDENTIFIES VARIANTS; MISSENSE MUTATIONS; APOLIPOPROTEIN-E; PRESENILIN-1; NICASTRIN; COMPLEX	Increase in the generation and deposition of amyloid-beta (Ab) plays a central role in the development of Alzheimer's Disease (AD). Elevation of the activity of c-secretase, a key enzyme required for the generation for A beta, can thus be a potential risk factor in AD. However, it is not known whether gamma-secretase can be upregulated in vivo. While in vitro studies showed that expression of all four components of gamma-secretase (Nicastrin, Presenilin, Pen-2 and Aph-1) are required for upregulation of gamma-secretase, it remains to be established as to whether this is true in vivo. To investigate whether overexpressing a single component of the gamma-secretase complex is sufficient to elevate its level and activity in the brain, we analyzed transgenic mice expressing either wild type or familial AD (fAD) associated mutant PS1. In contrast to cell culture studies, overexpression of either wild type or mutant PS1 is sufficient to increase levels of Nicastrin and Pen-2, and elevate the level of active gamma-secretase complex, enzymatic activity of gamma-secretase and the deposition of A beta in brains of mice. Importantly, gamma-secretase comprised of mutant PS1 is less active than that of wild type PS1-containing gamma-secretase; however, gamma-secretase comprised of mutant PS1 cleaves at the A beta 42 site of APP-CTFs more efficiently than at the A beta 40 site, resulting in greater accumulation of A beta deposits in the brain. Our data suggest that whereas fAD-linked PS1 mutants cause early onset disease, upregulation of PS1/gamma-secretase activity may be a risk factor for late onset sporadic AD.	[Li, Tong; Price, Donald L.; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Price, Donald L.; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Price, Donald L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Li, Yue-Ming; Ahn, Kwangwook] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Sisodia, Sangram S.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Memorial Sloan Kettering Cancer Center; University of Chicago	Li, T (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	tli1@jhmi.edu	LI, Yue/GRS-8071-2022		National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS45150, P01 NS047308]; National Institute on Aging (NIA) [P50 AG05146]; MetLife Foundation; Frederic J. Pelda Alzheimer's Research Fund; Adler Foundation; Ellison Medical Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047308, R01NS045150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MetLife Foundation; Frederic J. Pelda Alzheimer's Research Fund; Adler Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from National Institute of Neurological Disorders and Stroke (NINDS) (R01 NS45150, and P01 NS047308 to PCW), the National Institute on Aging (NIA) (P50 AG05146 to DLP), MetLife Foundation (to PCW), Frederic J. Pelda Alzheimer's Research Fund (to Division of Neuropathology at Johns Hopkins) (to TL), Adler Foundation (to TL) and Ellison Medical Foundation (to TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kumar VB, J EXP BIOL, V212, P494; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee MK, 1997, NAT MED, V3, P756, DOI 10.1038/nm0797-756; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Li T, 2003, J NEUROSCI, V23, P3272; Li T, 2007, J BIOL CHEM, V282, P32264, DOI 10.1074/jbc.M703649200; Li T, 2007, J NEUROSCI, V27, P10849, DOI 10.1523/JNEUROSCI.2152-07.2007; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Meckler X, 2010, J NEUROSCI, V30, P16160, DOI 10.1523/JNEUROSCI.4436-10.2010; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Vehmas AK, 2001, DNA CELL BIOL, V20, P713, DOI 10.1089/10445490152717578; Wong PC, 2006, BASIC NEUROCHEMISTRY, P781; Xu GL, 2002, ALZ DIS ASSOC DIS, V16, P191, DOI 10.1097/00002093-200207000-00010	51	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28179	10.1371/journal.pone.0028179	http://dx.doi.org/10.1371/journal.pone.0028179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140537	Green Published, Green Submitted, gold			2022-12-25	WOS:000298166300036
J	Kawelke, N; Vasel, M; Sens, C; von Au, A; Dooley, S; Nakchbandi, IA				Kawelke, Nina; Vasel, Matthaeus; Sens, Carla; von Au, Anja; Dooley, Steven; Nakchbandi, Inaam A.			Fibronectin Protects from Excessive Liver Fibrosis by Modulating the Availability of and Responsiveness of Stellate Cells to Active TGF-beta	PLOS ONE			English	Article							SPLICED EDA SEGMENT; HEPATIC FIBROGENESIS; EXTRACELLULAR-MATRIX; EIIIA SEGMENT; GROWTH; EXPRESSION; PLASMA; POLYMERIZATION; ACTIVATION; STABILITY	Fibrotic tissue in the liver is mainly composed of collagen. Fibronectin, which is also present in fibrotic matrices, is required for collagen matrix assembly in vitro. It also modulates the amount of growth factors and their release from the matrix. We therefore examined the effects of the absence of fibronectin on the development of fibrosis in mice. Conditional deletion of fibronectin in the liver using the Mx promoter to drive cre expression resulted in increased collagen production and hence a more pronounced fibrosis in response to dimethylnitrosamine in mice. Exclusive deletion of fibronectin in hepatocytes or normalization of circulating fibronectin in Mx-cKO mice did not affect the development of fibrosis suggesting a role for fibronectin production by other liver cell types. The boosted fibrosis in fibronectin-deficient mice was associated with enhanced stellate cell activation and proliferation, elevated concentrations of active TGF-beta, and increased TGF-beta-mediated signaling. In vitro experiments revealed that collagen-type-I production by fibronectin-deficient hepatic stellate cells stimulated with TGF-beta was more pronounced, and was associated with augmented Smad3-mediated signaling. Interfering with TGF-beta signaling using SB431542 normalized collagen-type-I production in fibronectin-deficient hepatic stellate cells. Furthermore, precoating culture plates with fibronectin, but not collagen, or providing fibronectin fibrils unable to interact with RGD binding integrins via the RGD domain significantly diminished the amount of active TGF-beta in fibronectin-deficient stellate cells and normalized collagen-type-I production in response to TGF-beta stimulation. Thus, excessive stellate cell activation and production of collagen results from increased active TGF-beta and TGF-beta signaling in the absence of fibronectin. In conclusion, our data indicate that fibronectin controls the availability of active TGF-beta in the injured liver, which impacts the severity of the resulting fibrosis. We therefore propose a novel role for locally produced fibronectin in protecting the liver from an excessive TGF-beta-mediated response.	[Kawelke, Nina; Vasel, Matthaeus; Sens, Carla; von Au, Anja; Nakchbandi, Inaam A.] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Kawelke, Nina; Vasel, Matthaeus; Sens, Carla; von Au, Anja; Nakchbandi, Inaam A.] Univ Heidelberg, Inst Immunol, D-6900 Heidelberg, Germany; [Dooley, Steven] Univ Heidelberg, Dept Med 2, D-6800 Mannheim, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Kawelke, N (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	inaam.nakchbandi@urz.uni-heidelberg.de	Dooley, Steven/T-6491-2018	Dooley, Steven/0000-0002-4840-6240	Max-Planck Society; University of Heidelberg	Max-Planck Society(Max Planck Society); University of Heidelberg	This work was funded by the Max-Planck Society and the University of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Akiyama SK., 2001, CURR PROTOC CELL BIO; Bentmann A, 2010, J BONE MINER RES, V25, P706, DOI 10.1359/jbmr.091011; BERG RA, 1982, METHOD ENZYMOL, V82, P372; Constandinou C, 2005, METH MOLEC MED, V117, P237; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Fontana L, 2005, FASEB J, V19, P1798, DOI 10.1096/fj.05-4134com; Fukuda T, 2002, CANCER RES, V62, P5603; Geerts A, 1998, HEPATOLOGY, V27, P590, DOI 10.1002/hep.510270238; Hackl N, 2009, CIRCULATING FI UNPUB; Hackl NJ, 2010, SCAND J GASTROENTERO, V45, P349, DOI 10.3109/00365520903490606; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; JARNAGIN WR, 1994, J CELL BIOL, V127, P2037, DOI 10.1083/jcb.127.6.2037; Kawelke N, 2008, J BONE MINER RES, V23, P1278, DOI 10.1359/JBMR.080313; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; Liu W, 2011, PROTEOMICS, V11, P3556, DOI 10.1002/pmic.201100157; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; Manabe R, 1999, J BIOL CHEM, V274, P5919, DOI 10.1074/jbc.274.9.5919; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Matsui S, 1997, J HEPATOL, V27, P843, DOI 10.1016/S0168-8278(97)80322-4; MATSUURA H, 1985, P NATL ACAD SCI USA, V82, P6517, DOI 10.1073/pnas.82.19.6517; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Moretti FA, 2007, J BIOL CHEM, V282, P28057, DOI 10.1074/jbc.M611315200; Moriya K, 2011, GASTROENTEROLOGY, V140, P1653, DOI 10.1053/j.gastro.2011.02.005; Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100; Niki T, 1996, HEPATOLOGY, V23, P1538, DOI 10.1053/jhep.1996.v23.pm0008675175; Parsons CJ, 2007, J GASTROEN HEPATOL, V22, pS79, DOI 10.1111/j.1440-1746.2006.04659.x; PRITCHARD DJ, 1989, J PATHOL, V158, P253, DOI 10.1002/path.1711580314; PUCHTLER H, 1973, BEITR PATHOL, V150, P174, DOI 10.1016/S0005-8165(73)80016-2; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; STEGEMANN H, 1958, H-S Z PHYSIOL CHEM, V311, P41, DOI 10.1515/bchm2.1958.311.1.41; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Theret N, 1999, HEPATOLOGY, V30, P462, DOI 10.1002/hep.510300236; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wu J, 2000, J GASTROENTEROL, V35, P665, DOI 10.1007/s005350070045; Xu GX, 1997, J PATHOL, V183, P90, DOI 10.1002/(SICI)1096-9896(199709)183:1<90::AID-PATH1105>3.0.CO;2-J; YAMAOKA K, 1993, DIGEST DIS SCI, V38, P1473, DOI 10.1007/BF01308606; Yoshida T, 2004, J EXP MED, V199, P1701, DOI 10.1084/jem.20031675; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161	44	60	61	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28181	10.1371/journal.pone.0028181	http://dx.doi.org/10.1371/journal.pone.0028181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140539	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163400036
J	Tanaka, Y; Kawahashi, K; Katagiri, ZI; Nakayama, Y; Mahajan, M; Kioussis, D				Tanaka, Yujiro; Kawahashi, Koji; Katagiri, Zen-Ichiro; Nakayama, Yasuhiro; Mahajan, Milind; Kioussis, Dimitris			Dual Function of Histone H3 Lysine 36 Methyltransferase ASH1 in Regulation of Hox Gene Expression	PLOS ONE			English	Article							RNA-POLYMERASE-II; TRITHORAX-GROUP PROTEIN; SET DOMAIN; DROSOPHILA-MELANOGASTER; PHOSPHATASE 2A; PHD FINGER; STEM-CELLS; MLL; LEUKEMIA; IDENTIFICATION	Hox genes play important roles in haematopoietic development in mammals. ASH1 is a member of the trithorax group (trxG) that is required for proper expression of Hox genes and is preferentially expressed in haematopoietic stem cells. We have recently reported that ASH1 methylates histone H3 at lysine 36 (K36) but its biological function has remained elusive. Here we show that ASH1 regulates Hox gene expression positively and negatively in a leukemic cell line K562 and is required for myelomonocytic differentiation of murine haematopoietic stem cells. ASH1 binds to endogenous Hox loci in K562 cells and its knockdown causes reduced expression of Hox genes. In addition, ASH1 and MLL1 induce more than 100-fold activation of Hox promoters in HeLa cells if expressed simultaneously but not individually. Notably, ASH1 harbouring a point mutation that kills methyltransferase activity is more efficient than wild type ASH1 in Hox gene activation, indicating that K36 methylation is not a prerequisite for Hox gene expression. Moreover, tethering wild type or catalytically inactive methyltransferase domain of ASH1 to a heterologous promoter causes downregulation or upregulation, respectively, of transcription, supporting a hypothesis that K36 methylation imparts repression. Knockdown of ASH1 in K562 cells in vitro causes increased expression of e-globin gene and reduced expression of myelomonocytic markers GPIIb and GPIIIa, whereas knockdown of ASH1 in murine haematopoietic stem cells in vivo results in decreased number of macrophages and granulocytes, a phenotype similar to that induced by loss of mll1 function. Taken together, our data suggest that ASH1 and MLL1 synergize in activation of Hox genes and thereby regulate development of myelomonocytic lineages from haematopoietic stem cells.	[Tanaka, Yujiro; Kawahashi, Koji; Katagiri, Zen-Ichiro] Tokyo Med & Dent Univ, Med Res Inst, Sch Biomed Sci & Biochem Genet, Tokyo, Japan; [Nakayama, Yasuhiro] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Mahajan, Milind] Yale Univ, Yale Ctr Genome Anal, Orange, CT USA; [Tanaka, Yujiro; Kioussis, Dimitris] Natl Inst Med Res, London NW7 1AA, England	Tokyo Medical & Dental University (TMDU); Yale University; Yale University; MRC National Institute for Medical Research	Tanaka, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Sch Biomed Sci & Biochem Genet, Tokyo, Japan.	ytanaka.bgen@mri.tmd.ac.jp			Japanese Ministry of Culture and Science [20510183, 22116504]	Japanese Ministry of Culture and Science	This study was supported by a Grant-in-Aid to YT from the Japanese Ministry of Culture and Science (grant nos. 20510183 and 22116504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HT, 1997, J BIOL CHEM, V272, P28407, DOI 10.1074/jbc.272.45.28407; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ammosova T, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-47; An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; ANDERSSON LC, 1979, INT J CANCER, V23, P143, DOI 10.1002/ijc.2910230202; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; DiMartino JF, 1999, BRIT J HAEMATOL, V106, P614, DOI 10.1046/j.1365-2141.1999.01439.x; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hess JL, 1997, BLOOD, V90, P1799, DOI 10.1182/blood.V90.5.1799; Ingham PW, 1998, INT J DEV BIOL, V42, P423; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Katsani KR, 2001, GENE DEV, V15, P2197, DOI 10.1101/gad.201901; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; LAJEUNESSE D, 1995, MECH DEVELOP, V53, P123, DOI 10.1016/0925-4773(95)00430-0; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Magli MC, 1997, J CELL PHYSIOL, V173, P168, DOI 10.1002/(SICI)1097-4652(199711)173:2<168::AID-JCP16>3.0.CO;2-C; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Minakuchi M, 2001, EUR J BIOCHEM, V268, P1340, DOI 10.1046/j.1432-1327.2001.02000.x; Nakamura T, 2000, P NATL ACAD SCI USA, V97, P7284, DOI 10.1073/pnas.97.13.7284; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; REEVES R, 1985, NUCLEIC ACIDS RES, V13, P3599, DOI 10.1093/nar/13.10.3599; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Shashikant CS, 1995, DEVELOPMENT, V121, P4339; SHEARN A, 1978, GENETICS, V89, P341; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Tanaka Y, 2008, BIOCHEM BIOPH RES CO, V365, P589, DOI 10.1016/j.bbrc.2007.10.159; Tanaka Y, 2007, GENE, V397, P161, DOI 10.1016/j.gene.2007.04.027; Tripoulas N, 1996, GENETICS, V143, P913; TRIPOULAS NA, 1994, GENETICS, V137, P1027; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	52	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28171	10.1371/journal.pone.0028171	http://dx.doi.org/10.1371/journal.pone.0028171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140534	gold, Green Published, Green Submitted			2022-12-25	WOS:000298163400035
J	Carvalho, A; Osorio, NS; Saraiva, M; Cunha, C; Almeida, AJ; Teixeira-Coelho, M; Ludovico, P; Pedrosa, J; Pitzurra, L; Aversa, F; Romani, L; Castro, AG; Rodrigues, F				Carvalho, Agostinho; Osorio, Nuno S.; Saraiva, Margarida; Cunha, Cristina; Almeida, Agostinho J.; Teixeira-Coelho, Maria; Ludovico, Paula; Pedrosa, Jorge; Pitzurra, Lucia; Aversa, Franco; Romani, Luigina; Castro, Antonio G.; Rodrigues, Fernando			The C Allele of rs5743836 Polymorphism in the Human TLR9 Promoter Links IL-6 and TLR9 Up-Regulation and Confers Increased B-Cell Proliferation	PLOS ONE			English	Article							RECEPTOR GENES; SELF-DNA; DISEASE; SUSCEPTIBILITY; ASSOCIATION; HAPLOTYPES; LYMPHOMA; BINDING	In humans, allelic variants in Toll-like receptors (TLRs) associate with several pathologies. However, the underlying cellular and molecular mechanisms of this association remain largely unknown. Analysis of the human TLR9 promoter revealed that the C allele of the rs5743836 polymorphism generates several regulatory sites, including an IL-6-responding element. Here, we show that, in mononuclear cells carrying the TC genotype of rs5743836, IL-6 up-regulates TLR9 expression, leading to exacerbated cellular responses to CpG, including IL-6 production and B-cell proliferation. Our study uncovers a role for the rs5743836 polymorphism in B-cell biology with implications on TLR9-mediated diseases and on the therapeutic usage of TLR9 agonists/antagonists.	[Carvalho, Agostinho; Osorio, Nuno S.; Saraiva, Margarida; Cunha, Cristina; Almeida, Agostinho J.; Teixeira-Coelho, Maria; Ludovico, Paula; Pedrosa, Jorge; Castro, Antonio G.; Rodrigues, Fernando] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal; [Carvalho, Agostinho; Osorio, Nuno S.; Saraiva, Margarida; Cunha, Cristina; Almeida, Agostinho J.; Teixeira-Coelho, Maria; Ludovico, Paula; Pedrosa, Jorge; Castro, Antonio G.; Rodrigues, Fernando] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Carvalho, Agostinho; Cunha, Cristina; Pitzurra, Lucia; Romani, Luigina] Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy; [Aversa, Franco] Univ Perugia, Div Hematol & Clin Immunol, Dept Clin & Expt Med, I-06100 Perugia, Italy	Universidade do Minho; University of Perugia; University of Perugia	Carvalho, A (corresponding author), Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal.	frodrigues@ecsaude.uminho.pt	Rodrigues, Fernando/T-5299-2018; Osório, Nuno S./D-4773-2013; Cunha, Cristina/AAH-9951-2021; Castro, Gil/T-7584-2018; Osório, Nuno S./AAF-4307-2020; Romani, Luigina/O-9987-2018; Rodrigues, Fernando/A-3123-2011; Pedrosa, Jorge/H-4877-2011; Carvalho, Agostinho/D-2667-2009; Ludovico, Paula/B-4338-2011; Cunha, Cristina/D-2687-2009; Saraiva, Margarida/E-8781-2011	Rodrigues, Fernando/0000-0001-8436-9398; Osório, Nuno S./0000-0003-0949-5399; Cunha, Cristina/0000-0002-6002-5782; Castro, Gil/0000-0002-4684-4183; Osório, Nuno S./0000-0003-0949-5399; Pedrosa, Jorge/0000-0002-8204-4888; Carvalho, Agostinho/0000-0001-8935-8030; Ludovico, Paula/0000-0003-4130-7167; Cunha, Cristina/0000-0002-6002-5782; Saraiva, Margarida/0000-0002-8180-1293; Pitzurra, Lucia/0000-0002-6866-7982; Romani, Luigina/0000-0002-1356-525X; Ramalho Almeida, Agostinho Joao/0000-0002-3367-0540; Aversa, Franco/0000-0002-8871-6817; Teixeira-Coelho, Maria/0000-0003-1435-9332	FCT [PIC/IC/83313/2007]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	A. Carvalho, N.S. Osorio, M. Teixeira-Coelho, A.J. Almeida, M. Saraiva and C. Cunha were financially supported by Fundacao para a Ciencia e Tecnologia (FCT), Portugal. This study was supported by FCT - Grant Number PIC/IC/83313/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Bourke E, 2003, BLOOD, V102, P956, DOI 10.1182/blood-2002-11-3355; Carvalho A, 2008, J INFECT DIS, V197, P618, DOI 10.1086/526500; Carvalho A, 2012, GENES IMMUN, V13, P197, DOI 10.1038/gene.2011.59; Carvalho A, 2009, EXP HEMATOL, V37, P1022, DOI 10.1016/j.exphem.2009.06.004; Deane JA, 2006, J IMMUNOL, V177, P6573, DOI 10.4049/jimmunol.177.10.6573; Duan HO, 2003, J BIOL CHEM, V278, P41270, DOI 10.1074/jbc.M304210200; Gilliet M, 2008, CURR OPIN IMMUNOL, V20, P401, DOI 10.1016/j.coi.2008.06.008; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Jahrsdorfer B, 2005, CLIN CANCER RES, V11, P1490, DOI 10.1158/1078-0432.CCR-04-1890; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lazarus R, 2003, GENOMICS, V81, P85, DOI 10.1016/S0888-7543(02)00022-8; Mollaki V, 2009, J HUM GENET, V54, P655, DOI 10.1038/jhg.2009.90; Ng MTH, 2010, INFECT IMMUN, V78, P1345, DOI 10.1128/IAI.01226-09; Pine SO, 2009, AIDS, V23, P2387, DOI 10.1097/QAD.0b013e328330b489; Takeshita F, 2004, J IMMUNOL, V173, P2552, DOI 10.4049/jimmunol.173.4.2552; Torok HP, 2004, GASTROENTEROLOGY, V127, P365, DOI 10.1053/j.gastro.2004.05.051	19	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28256	10.1371/journal.pone.0028256	http://dx.doi.org/10.1371/journal.pone.0028256			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132241	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000088
J	Corin, K; Baaske, P; Ravel, DB; Song, JY; Brown, E; Wang, XQ; Wienken, CJ; Jerabek-Willemsen, M; Duhr, S; Luo, Y; Braun, D; Zhang, SG				Corin, Karolina; Baaske, Philipp; Ravel, Deepali B.; Song, Junyao; Brown, Emily; Wang, Xiaoqiang; Wienken, Christoph J.; Jerabek-Willemsen, Moran; Duhr, Stefan; Luo, Yuan; Braun, Dieter; Zhang, Shuguang			Designer Lipid-Like Peptides: A Class of Detergents for Studying Functional Olfactory Receptors Using Commercial Cell-Free Systems	PLOS ONE			English	Article							SURFACTANT-LIKE PEPTIDES; PROTEIN-COUPLED RECEPTORS; EXPRESSION SYSTEMS; MEMBRANE-PROTEINS; FORM NANOTUBES; STABILITY; AMPHIPOLS	A crucial bottleneck in membrane protein studies, particularly G-protein coupled receptors, is the notorious difficulty of finding an optimal detergent that can solubilize them and maintain their stability and function. Here we report rapid production of 12 unique mammalian olfactory receptors using short designer lipid-like peptides as detergents. The peptides were able to solubilize and stabilize each receptor. Circular dichroism showed that the purified olfactory receptors had alpha-helical secondary structures. Microscale thermophoresis suggested that the receptors were functional and bound their odorants. Blot intensity measurements indicated that milligram quantities of each olfactory receptor could be produced with at least one peptide detergent. The peptide detergents' capability was comparable to that of the detergent Brij-35. The ability of 10 peptide detergents to functionally solubilize 12 olfactory receptors demonstrates their usefulness as a new class of detergents for olfactory receptors, and possibly other G-protein coupled receptors and membrane proteins.	[Corin, Karolina; Ravel, Deepali B.; Song, Junyao; Brown, Emily; Wang, Xiaoqiang; Zhang, Shuguang] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; [Baaske, Philipp; Duhr, Stefan] NanoTemper Technol GmbH, Munich, Germany; [Wienken, Christoph J.; Jerabek-Willemsen, Moran; Braun, Dieter] Univ Munich, Munich, Germany; [Wang, Xiaoqiang] China Univ Petr E China, Ctr Bioengn & Biotechnol, Qingdao, Shandong, Peoples R China; [Luo, Yuan] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	Massachusetts Institute of Technology (MIT); University of Munich; China University of Petroleum; University System of Maryland; University of Maryland Baltimore	Corin, K (corresponding author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	shuguang@mit.edu		Corin, Karolina/0000-0003-3080-5742; Zhang, Shuguang/0000-0002-3856-3752	Defense Advanced Research Project Agency [DARPA-HR0011-09-C-0012]; MIT	Defense Advanced Research Project Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); MIT	This work is supported in part from Defense Advanced Research Project Agency DARPA-HR0011-09-C-0012 and MIT UROP research funding and MIT Undergraduate Research Opportunity Program (UROP) funding. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baaske P, 2010, ANGEW CHEM INT EDIT, V49, P2238, DOI 10.1002/anie.200903998; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; Corin K, 2011, PLOS ONE IN PRESS; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Endo Y, 2006, CURR OPIN BIOTECH, V17, P373, DOI 10.1016/j.copbio.2006.06.009; Garavito RM, 1996, J BIOENERG BIOMEMBR, V28, P13, DOI 10.1007/BF02150674; Ishihara G, 2005, PROTEIN EXPRES PURIF, V41, P27, DOI 10.1016/j.pep.2005.01.013; Kaiser L, 2008, P NATL ACAD SCI USA, V105, P15726, DOI 10.1073/pnas.0804766105; Khoe U, 2009, LANGMUIR, V25, P4111, DOI 10.1021/la8025232; Kiley P, 2005, PLOS BIOL, V3, P1180, DOI 10.1371/journal.pbio.0030230; Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x; Klammt C, 2007, J STRUCT BIOL, V158, P482, DOI 10.1016/j.jsb.2007.01.006; Matsumoto K, 2009, J PHYS CHEM B, V113, P75, DOI 10.1021/jp8021425; McGregor CL, 2003, NAT BIOTECHNOL, V21, P171, DOI 10.1038/nbt776; Nagai A, 2007, J NANOSCI NANOTECHNO, V7, P2246, DOI 10.1166/jnn.2007.647; Popot JL, 2003, CELL MOL LIFE SCI, V60, P1559, DOI 10.1007/s00018-003-3169-6; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Santoso S, 2002, NANO LETT, V2, P687, DOI 10.1021/n1025563i; Savage DF, 2007, PROTEIN SCI, V16, P966, DOI 10.1110/ps.062696307; SCHAFMEISTER CE, 1993, SCIENCE, V262, P734, DOI 10.1126/science.8235592; SPIRIN AS, 1988, SCIENCE, V242, P1162, DOI 10.1126/science.3055301; Theisen MJ, 2005, BBA-PROTEINS PROTEOM, V1751, P213, DOI 10.1016/j.bbapap.2005.04.011; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599; von Maltzahn G, 2003, LANGMUIR, V19, P4332, DOI 10.1021/la026526+; Wang XQ, 2011, P NATL ACAD SCI USA, V108, P9049, DOI 10.1073/pnas.1018185108; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Yaghmur A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000479; Yeh JI, 2005, BIOCHEMISTRY-US, V44, P16912, DOI 10.1021/bi051357o; Yokoyama S, 2003, CURR OPIN CHEM BIOL, V7, P39, DOI 10.1016/S1367-5931(02)00019-4; Yu SM, 2000, PROTEIN SCI, V9, P2518, DOI 10.1110/ps.9.12.2518; Zhao XJ, 2006, P NATL ACAD SCI USA, V103, P17707, DOI 10.1073/pnas.0607167103	33	43	43	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e25067	10.1371/journal.pone.0025067	http://dx.doi.org/10.1371/journal.pone.0025067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132066	Green Published, Green Submitted, gold			2022-12-25	WOS:000298162000001
J	Tian, Y; Jia, ZC; Wang, J; Huang, ZM; Tang, J; Zheng, YH; Tang, Y; Wang, QH; Tian, ZQ; Yang, D; Zhang, Y; Fu, XL; Song, JX; Liu, SL; van Velkinburgh, JC; Wu, YZ; Ni, B				Tian, Yi; Jia, Zhengcai; Wang, Jun; Huang, Zemin; Tang, Jun; Zheng, Yanhua; Tang, Yan; Wang, Qinghong; Tian, Zhiqiang; Yang, Di; Zhang, Yi; Fu, Xiaolan; Song, Jianxun; Liu, Shunli; van Velkinburgh, Jennifer C.; Wu, Yuzhang; Ni, Bing			Global Mapping of H3K4me1 and H3K4me3 Reveals the Chromatin State-Based Cell Type-Specific Gene Regulation in Human Treg Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; T-CELLS; GENOME-WIDE; HISTONE MODIFICATIONS; FOXP3 EXPRESSION; DNA METHYLATION; SACCHAROMYCES-CEREVISIAE; ACETYLATION; PROMOTERS; LINEAGE	Regulatory T cells (Treg) contribute to the crucial immunological processes of self-tolerance and immune homeostasis. Genomic mechanisms that regulate cell fate decisions leading to Treg or conventional T cells (Tconv) lineages and those underlying Treg function remain to be fully elucidated, especially at the histone modification level. We generated high-resolution genome-wide distribution maps of monomethylated histone H3 lysine 4 (H3K4me1) and trimethylated H3K4 (H3K4me3) in human CD4(+)CD25(+)FOXP3(+) Tregs and CD4(+)CD25(+)FOXP3(-) activated (a) Tconv cells by DNA sequencing-by-synthesis. 2115 H3K4me3 regions corresponded to proximal promoters; in Tregs, the genes associated with these regions included the master regulator FOXP3 and the chemokine (C-C motif) receptor 7 (CCR7). 41024 Treg-specific H3K4me1 regions were identified. The majority of the H3K4me1 regions differing between Treg and aTconv cells were located at promoter-distal sites, and in vitro reporter gene assays were used to evaluate and identify novel enhancer activity. We provide for the first time a comprehensive genome-wide dataset of lineage-specific H3K4me1 and H3K4me3 patterns in Treg and aTconv cells, which may control cell type-specific gene regulation. This basic principle is likely not restricted to the two closely-related T cell populations, but may apply generally to somatic cell lineages in adult organisms.	[Tian, Yi; Jia, Zhengcai; Huang, Zemin; Tang, Jun; Zheng, Yanhua; Tang, Yan; Wang, Qinghong; Tian, Zhiqiang; Yang, Di; Zhang, Yi; Fu, Xiaolan; Liu, Shunli; Wu, Yuzhang; Ni, Bing] Third Mil Med Univ, PLA, Inst Immunol, Chongqing, Peoples R China; [Wang, Jun] Beijing Genom Inst Branch Shenzhen, Shenzhen, Peoples R China; [Song, Jianxun] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA; [van Velkinburgh, Jennifer C.] Initiat Collaboratory BioMed Res, Santa Fe, NM USA	Army Medical University; Beijing Genomics Institute (BGI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Tian, Y (corresponding author), Third Mil Med Univ, PLA, Inst Immunol, Chongqing, Peoples R China.	wuyuzhang@yahoo.com; nibingxi@yahoo.com	Wang, Jun/A-7261-2013; wang, qinghong/M-7969-2017; yang, zheng/HGC-7753-2022; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016; van Velkinburgh, Jennifer/D-7205-2015	Ni, Bing/0000-0002-4297-5346; Wu, Yuzhang/0000-0002-4049-0214; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; van Velkinburgh, Jennifer/0000-0002-4592-2397	Major State Basic Research Development Program of China (973 Program) [2007CB512805, 2007CB512401]; National Natural Science Foundation of China [30771950, 31070798]; Chongqing Science and Technology Committee [2008BB5033]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Committee	This work was supported by grants from the Major State Basic Research Development Program of China (973 Program) (Nos. 2007CB512805 and 2007CB512401), http://www.most.gov.cn/index.htm, the General Program of National Natural Science Foundation of China (No. 30771950, and 31070798), http://www.nsfc.gov.cn/ and the Chongqing Science and Technology Committee (2008BB5033), http://www.ctin.ac.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Araki Y, 2008, J IMMUNOL, V180, P8102, DOI 10.4049/jimmunol.180.12.8102; Arya M, 2005, EXPERT REV MOL DIAGN, V5, P209, DOI 10.1586/14737159.5.2.209; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; HOU JZ, 1995, IMMUNITY, V2, P321, DOI 10.1016/1074-7613(95)90140-X; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	54	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27770	10.1371/journal.pone.0027770	http://dx.doi.org/10.1371/journal.pone.0027770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132139	Green Published, Green Submitted, gold			2022-12-25	WOS:000298162000041
J	van Westen, GJP; Wegner, JK; Geluykens, P; Kwanten, L; Vereycken, I; Peeters, A; IJzerman, AP; van Vlijmen, HWT; Bender, A				van Westen, Gerard J. P.; Wegner, Jorg K.; Geluykens, Peggy; Kwanten, Leen; Vereycken, Inge; Peeters, Anik; IJzerman, Adriaan P.; van Vlijmen, Herman W. T.; Bender, Andreas			Which Compound to Select in Lead Optimization? Prospectively Validated Proteochemometric Models Guide Preclinical Development	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE INHIBITOR; HIV-1 DRUG-RESISTANCE; DRUGGABLE GENOME; ANTIRETROVIRAL THERAPY; MULTIPLE LIGANDS; ACTIVITY-CLIFFS; BINDING-SITE; SIMILARITY; MUTATIONS	In quite a few diseases, drug resistance due to target variability poses a serious problem in pharmacotherapy. This is certainly true for HIV, and hence, it is often unknown which drug is best to use or to develop against an individual HIV strain. In this work we applied 'proteochemometric' modeling of HIV Non-Nucleoside Reverse Transcriptase (NNRTI) inhibitors to support preclinical development by predicting compound performance on multiple mutants in the lead selection stage. Proteochemometric models are based on both small molecule and target properties and can thus capture multi-target activity relationships simultaneously, the targets in this case being a set of 14 HIV Reverse Transcriptase (RT) mutants. We validated our model by experimentally confirming model predictions for 317 untested compound -mutant pairs, with a prediction error comparable with assay variability (RMSE 0.62). Furthermore, dependent on the similarity of a new mutant to the training set, we could predict with high accuracy which compound will be most effective on a sequence with a previously unknown genotype. Hence, our models allow the evaluation of compound performance on untested sequences and the selection of the most promising leads for further preclinical research. The modeling concept is likely to be applicable also to other target families with genetic variability like other viruses or bacteria, or with similar orthologs like GPCRs.	[van Westen, Gerard J. P.; IJzerman, Adriaan P.; van Vlijmen, Herman W. T.; Bender, Andreas] Leiden Amsterdam Ctr Drug Res, Div Med Chem, Leiden, Netherlands; [Wegner, Jorg K.; Geluykens, Peggy; Kwanten, Leen; Vereycken, Inge; Peeters, Anik; van Vlijmen, Herman W. T.] Tibotec BVBA, Beerse, Belgium; [Bender, Andreas] Univ Cambridge, Unilever Ctr Mol Sci Informat, Cambridge, England	Leiden University; Leiden University - Excl LUMC; Johnson & Johnson; University of Cambridge	van Westen, GJP (corresponding author), Leiden Amsterdam Ctr Drug Res, Div Med Chem, Leiden, Netherlands.	ab454@cam.ac.uk	van Westen, Gerard/HHZ-3762-2022; Bender, Andreas/C-6942-2009; van Westen, Gerard JP/D-7432-2011; IJzerman, Ad/ABG-1353-2020; Wegner, Jörg K/C-6598-2009	Bender, Andreas/0000-0002-6683-7546; van Westen, Gerard JP/0000-0003-0717-1817; IJzerman, Ad/0000-0002-1182-2259; Wegner, Jörg K/0000-0002-1852-9434	Tibotec; Dutch Top Institute Pharma (TI Pharma) [D1-105]; Tibotec BVBA; JKW; PG; LK; IV; AP; HWTvV	Tibotec; Dutch Top Institute Pharma (TI Pharma); Tibotec BVBA; JKW; PG(Procter & Gamble); LK; IV; AP; HWTvV	GJPvW is a PhD student funded by Tibotec whose role involved contributing to the experimental data, validation of the results, and providing scientific input into the design of the study (such as the improvement of modeling methods). The performing of the data analysis, and the decision to publish was not influenced in any way by the funders. The authors' collaborators from Tibotec helped in the preparation of the manuscript, however, no situation occurred where the academic partners of the team were not able to publish what was desired. AB and API received funding from Dutch Top Institute Pharma (TI Pharma), project number D1-105, who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The Non-Nucleoside Reverse Transcriptase Inhibitiros Etravirine and Rilpivirine are marketed drugs developed by Tibotec, one of the funders of the current study. GJPvW was funded by Tibotec BVBA and JKW, PG, LK, IV, AP and HWTvV are employees of this company. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ahmed SNS, 2000, HEPATOLOGY, V32, P1078, DOI 10.1053/jhep.2000.19619; Altmann A, 2009, ANTIVIR THER, V14, P273; Altmann A, 2009, J INFECT DIS, V199, P999, DOI 10.1086/597305; Andries K, 2004, ANTIMICROB AGENTS CH, V48, P4680, DOI 10.1128/AAC.48.12.4680-4686.2004; [Anonymous], 1998, NUMBERING POSITIONS; Beerenwinkel N, 2002, P NATL ACAD SCI USA, V99, P8271, DOI 10.1073/pnas.112177799; Beerenwinkel N, 2003, BIOINFORMATICS, V19, pI16, DOI 10.1093/bioinformatics/btg1001; Bender A, 2004, J CHEM INF COMP SCI, V44, P1708, DOI 10.1021/ci0498719; Bender A, 2004, ORG BIOMOL CHEM, V2, P3204, DOI 10.1039/b409813g; Bender A, 2009, J CHEM INF MODEL, V49, P108, DOI 10.1021/ci800249s; Das K, 2008, P NATL ACAD SCI USA, V105, P1466, DOI 10.1073/pnas.0711209105; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Dimitriadou E, 2006, MISC FUNCTION DEP ST; Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758; Faulon JL, 2010, CH CRC MATH COMP BIO, P1, DOI 10.1201/9781420082999; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Garland SL, 2011, CURR TOP MED CHEM, V11, P1870; Glen RC, 2006, IDRUGS, V9, P199; Guha R, 2008, J CHEM INF MODEL, V48, P646, DOI 10.1021/ci7004093; Guillemont J.E.G., 2008, Preparation of HIV inhibiting 5,6-substituted pyrimidines, Patent No. [WO2008080965, 2008080965]; Guillemont JEG, 2007, HIV INHIBITING 5 HYD; Guillemont JEG, 2008, HIV INHIBITING 6 SUB; Guillemont JEG, 2007, HIV INHIBITING 5 AMI; Hambly K, 2006, MOL DIVERS, V10, P273, DOI 10.1007/s11030-006-9035-3; Havlir DV, 1996, J VIROL, V70, P7894, DOI 10.1128/JVI.70.11.7894-7899.1996; Hertogs K, 1998, ANTIMICROB AGENTS CH, V42, P269, DOI 10.1093/jac/42.2.269; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Horvath D, 2009, J CHEM INF MODEL, V49, P1762, DOI 10.1021/ci9000579; Jacoby E, 2006, CHEMOGENEOMICS: KNOWLEDGE-BASED APPROACHES TO DRUG DISCOVERY, P1, DOI 10.1142/9781860948114; Jensen BF, 2007, J MED CHEM, V50, P501, DOI 10.1021/jm060333s; Johnson M. A., 1990, CONCEPTS APPL MOL SI; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Kawashima S, 1999, NUCLEIC ACIDS RES, V27, P368, DOI 10.1093/nar/27.1.368; Lapins M, 2009, J CHEM INF MODEL, V49, P1202, DOI 10.1021/ci800453k; Lapinsh M, 2001, BBA-GEN SUBJECTS, V1525, P180, DOI 10.1016/S0304-4165(00)00187-2; Mancinelli L, 2002, AAPS J, V2, P29; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Medina-Franco JL, 2009, J CHEM INF MODEL, V49, P477, DOI 10.1021/ci800379q; MERLUZZI VJ, 1990, SCIENCE, V250, P1411, DOI 10.1126/science.1701568; Meslamani J, 2011, J CHEM INF MODEL, V51, P1593, DOI 10.1021/ci200166t; Morphy R, 2005, J MED CHEM, V48, P6523, DOI 10.1021/jm058225d; Morphy R, 2007, DRUG DISCOV TODAY, V12, P156, DOI 10.1016/j.drudis.2006.12.006; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Patterson DE, 1996, J MED CHEM, V39, P3049, DOI 10.1021/jm960290n; Pawlotsky JM, 1998, J VIROL, V72, P2795, DOI 10.1128/JVI.72.4.2795-2805.1998; REN JS, 1995, NAT STRUCT BIOL, V2, P293, DOI 10.1038/nsb0495-293; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Scitegic Accelrys Software Inc, 2007, PIP PILOT STUD EDIT; Sisay MT, 2009, J CHEM INF MODEL, V49, P2179, DOI 10.1021/ci900243a; Tropsha A, 2003, QSAR COMB SCI, V22, P69, DOI 10.1002/qsar.200390007; van Westen GJP, 2011, MEDCHEMCOMM, V2, P16, DOI 10.1039/c0md00165a; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vermeiren H, 2007, J VIROL METHODS, V145, P47, DOI 10.1016/j.jviromet.2007.05.009; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Woodcock J, 2007, CLIN PHARMACOL THER, V81, P164, DOI 10.1038/sj.clpt.6100063; WU JC, 1991, BIOCHEMISTRY-US, V30, P2022, DOI 10.1021/bi00222a003; YOUNG SD, 1995, ANTIMICROB AGENTS CH, V39, P2602, DOI 10.1128/AAC.39.12.2602	60	42	44	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27518	10.1371/journal.pone.0027518	http://dx.doi.org/10.1371/journal.pone.0027518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132107	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000023
J	Westereng, B; Ishida, T; Vaaje-Kolstad, G; Wu, M; Eijsink, VGH; Igarashi, K; Samejima, M; Stahlberg, J; Horn, SJ; Sandgren, M				Westereng, Bjorge; Ishida, Takuya; Vaaje-Kolstad, Gustav; Wu, Miao; Eijsink, Vincent G. H.; Igarashi, Kiyohiko; Samejima, Masahiro; Stahlberg, Jerry; Horn, Svein J.; Sandgren, Mats			The Putative Endoglucanase PcGH61D from Phanerochaete chrysosporium Is a Metal-Dependent Oxidative Enzyme that Cleaves Cellulose	PLOS ONE			English	Article							GLYCOSIDE HYDROLASE FAMILY; CELLOBIOSE DEHYDROGENASE	Many fungi growing on plant biomass produce proteins currently classified as glycoside hydrolase family 61 (GH61), some of which are known to act synergistically with cellulases. In this study we show that PcGH61D, the gene product of an open reading frame in the genome of Phanerochaete chrysosporium, is an enzyme that cleaves cellulose using a metal-dependent oxidative mechanism that leads to generation of aldonic acids. The activity of this enzyme and its beneficial effect on the efficiency of classical cellulases are stimulated by the presence of electron donors. Experiments with reduced cellulose confirmed the oxidative nature of the reaction catalyzed by PcGH61D and indicated that the enzyme may be capable of penetrating into the substrate. Considering the abundance of GH61-encoding genes in fungi and genes encoding their functional bacterial homologues currently classified as carbohydrate binding modules family 33 (CBM33), this enzyme activity is likely to turn out as a major determinant of microbial biomass-degrading efficiency.	[Westereng, Bjorge; Vaaje-Kolstad, Gustav; Eijsink, Vincent G. H.; Horn, Svein J.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Ishida, Takuya; Igarashi, Kiyohiko; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo, Japan; [Ishida, Takuya; Wu, Miao; Stahlberg, Jerry; Sandgren, Mats] Swedish Univ Agr Sci, Dept Mol Biol, Uppsala, Sweden	Norwegian University of Life Sciences; University of Tokyo; Swedish University of Agricultural Sciences	Westereng, B (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway.	svein.horn@umb.no; mats.sandgren@slu.se	Igarashi, Kiyohiko/E-6799-2016; Horn, Svein Jarle/C-6258-2008; Westereng, Bjørge/A-1688-2013; Stahlberg, Jerry/D-4163-2013	Igarashi, Kiyohiko/0000-0001-5152-7177; Horn, Svein Jarle/0000-0002-1590-9001; Westereng, Bjørge/0000-0002-5141-7231; Stahlberg, Jerry/0000-0003-4059-8580; Sandgren, Mats/0000-0002-2358-4534; Vaaje-Kolstad, Gustav/0000-0002-3077-8003	internal university and faculty money; Norwegian Research Council [186946, 190965, 193817, 196885]	internal university and faculty money; Norwegian Research Council(Research Council of NorwayEuropean Commission)	The majority of the research work described in the paper was funded by internal university and faculty money granted to the participating research groups. This work was also partly supported by the Norwegian Research Council, grants 186946, 190965, 193817 and 196885. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DOMON B, 1988, BIOCHEMISTRY-US, V27, P1534, DOI 10.1021/bi00405a021; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Herpoel-Gimbert I, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-18; Hori C, 2011, FEMS MICROBIOL LETT, V321, P14, DOI 10.1111/j.1574-6968.2011.02307.x; Igarashi K, 2005, FEBS J, V272, P2869, DOI 10.1111/j.1742-4658.2005.04707.x; Igarashi K, 2008, APPL ENVIRON MICROB, V74, P5628, DOI 10.1128/AEM.00812-08; JOHNSRUD SC, 1985, APPL MICROBIOL BIOT, V21, P320; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Karlsson J, 2001, EUR J BIOCHEM, V268, P6498, DOI 10.1046/j.0014-2956.2001.02605.x; Kawai R, 2003, BIOSCI BIOTECH BIOCH, V67, P1, DOI 10.1271/bbb.67.1; KREMER SM, 1992, EUR J BIOCHEM, V208, P807, DOI 10.1111/j.1432-1033.1992.tb17251.x; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; RAGUZ S, 1992, GENE, V119, P183, DOI 10.1016/0378-1119(92)90270-Y; REESE ET, 1950, J BACTERIOL, V59, P485, DOI 10.1128/JB.59.4.485-497.1950; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vanden Wymelenberg A, 2005, J BIOTECHNOL, V118, P17, DOI 10.1016/j.jbiotec.2005.03.010; Vanden Wymelenberg A, 2002, APPL ENVIRON MICROB, V68, P5765, DOI 10.1128/AEM.68.11.5765-5768.2002; Vanden Wymelenberg A, 2006, FUNGAL GENET BIOL, V43, P343, DOI 10.1016/j.fgb.2006.01.003; Vanden Wymelenberg A, 2009, APPL ENVIRON MICROB, V75, P4058, DOI 10.1128/AEM.00314-09; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; Yoshida M, 2002, FEMS MICROBIOL LETT, V217, P225, DOI 10.1111/j.1574-6968.2002.tb11479.x; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j; Zoia L, 2011, J AGR FOOD CHEM, V59, P829, DOI 10.1021/jf103615e	35	196	206	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27807	10.1371/journal.pone.0027807	http://dx.doi.org/10.1371/journal.pone.0027807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132148	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000298162000045
J	Xu, XB; Steere, RR; Fedorchuk, CA; Pang, JJ; Lee, JY; Lim, JH; Xu, HD; Pan, ZXK; Maggirwar, SB; Li, JD				Xu, Xiangbin; Steere, Rachel R.; Fedorchuk, Christine A.; Pang, Jinjiang; Lee, Ji-Yun; Lim, Jae Hyang; Xu, Haidong; Pan, Zhixing K.; Maggirwar, Sanjay B.; Li, Jian-Dong			Activation of Epidermal Growth Factor Receptor Is Required for NTHi-Induced NF-kappa B-Dependent Inflammation	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; BRONCHIAL EPITHELIAL-CELLS; SIGNALING CASCADE; AIRWAY EPITHELIUM; MUCIN PRODUCTION; OTITIS-MEDIA; EGFR; P38; INTERLEUKIN-8; EXPRESSION	Background: Inflammation is a hallmark of many serious human diseases. Nontypeable Haemophilus influenzae (NTHi) is an important human pathogen causing respiratory tract infections in both adults and children. NTHi infections are characterized by inflammation, which is mainly mediated by nuclear transcription factor-kappa B (NF-kappa B)-dependent production of proinflammatory mediators. Epidermal growth factor receptor (EGFR) has been shown to play important roles in regulating diverse biological processes, including cell growth, differentiation, apoptosis, adhesion, and migration. Its role in regulating NF-kappa B activation and inflammation, however, remains largely unknown. Methodology/Principal Findings: In the present study, we demonstrate that EGFR plays a vital role in NTHi-induced NF-kappa B activation and the subsequent induction of proinflammatory mediators in human middle ear epithelial cells and other cell types. Importantly, we found that AG1478, a specific tyrosine kinase inhibitor of EGFR potently inhibited NTHi-induced inflammatory responses in the middle ears and lungs of mice in vivo. Moreover, we found that MKK3/6-p38 and PI3K/Akt signaling pathways are required for mediating EGFR-dependent NF-kappa B activation and inflammatory responses by NTHi. Conclusions/Significance: Here, we provide direct evidence that EGFR plays a critical role in mediating NTHi-induced NF-kappa B activation and inflammation in vitro and in vivo. Given that EGFR inhibitors have been approved in clinical use for the treatment of cancers, current studies will not only provide novel insights into the molecular mechanisms underlying the regulation of inflammation, but may also lead to the development of novel therapeutic strategies for the treatment of respiratory inflammatory diseases and other inflammatory diseases.	[Xu, Xiangbin; Steere, Rachel R.; Fedorchuk, Christine A.; Lee, Ji-Yun; Lim, Jae Hyang; Xu, Haidong; Maggirwar, Sanjay B.; Li, Jian-Dong] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Pang, Jinjiang] Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Lee, Ji-Yun; Lim, Jae Hyang; Xu, Haidong; Li, Jian-Dong] Georgia State Univ, Dept Biol, Ctr Inflammat Immun & Infect, Atlanta, GA USA; [Pan, Zhixing K.] Univ Toledo, Dept Med Microbiol & Immunol, Med Ctr, Toledo, OH 43606 USA	University of Rochester; University of Rochester; University System of Georgia; Georgia State University; University System of Ohio; University of Toledo	Xu, XB (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	Xiangbin_Xu@urmc.rochester.edu; jdli@gsu.edu		Lim, Jae Hyang/0000-0003-0972-9271; Li, Jian-Dong/0000-0002-5593-050X	National Institutes of Health [DC010048, DC005843, DC004562, AI073374, NS054578, NS066801, AHA 10SDG2630077]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054578, R01NS066801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC010048, R01DC004562, R01DC005843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from National Institutes of Health DC010048 (to X. X.), DC005843, DC004562 and AI073374 (to J.D.L), NS054578, NS066801 (to S.B.M) and AHA 10SDG2630077 (to J.H.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amishima M, 1998, AM J RESP CRIT CARE, V157, P1907, DOI 10.1164/ajrccm.157.6.9609040; Blanchet S, 2004, AM J RESP CELL MOL, V30, P421, DOI 10.1165/rcmb.2003-0281RC; BLUESTONE CD, 1982, NEW ENGL J MED, V306, P1399, DOI 10.1056/NEJM198206103062305; Bonner JC, 2002, AM J PHYSIOL-LUNG C, V283, pL528, DOI 10.1152/ajplung.00126.2002; Burgel PR, 2004, THORAX, V59, P992, DOI 10.1136/thx.2003.018879; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chun YM, 2002, ANN OTO RHINOL LARYN, V111, P507, DOI 10.1177/000348940211100606; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998; Frey MR, 2006, EMBO J, V25, P5683, DOI 10.1038/sj.emboj.7601457; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huang SM, 1999, INVEST NEW DRUG, V17, P259, DOI 10.1023/A:1006384521198; Hur GY, 2007, EXP MOL MED, V39, P367, DOI 10.1038/emm.2007.41; Jeon KI, 2010, P NATL ACAD SCI USA, V107, P9795, DOI 10.1073/pnas.0914414107; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; KUKLINSKA D, 1984, EUR J CLIN MICROBIOL, V3, P249, DOI 10.1007/BF02014895; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Le Page C, 2005, PROSTATE, V65, P306, DOI 10.1002/pros.20291; Mikami F, 2005, J BIOL CHEM, V280, P36185, DOI 10.1074/jbc.M503941200; MURPHY TF, 1992, AM REV RESPIR DIS, V146, P1067, DOI 10.1164/ajrccm/146.4.1067; MURPHY TF, 1987, REV INFECT DIS, V9, P1; Murphy TF, 2000, PEDIATR INFECT DIS J, V19, pS9, DOI 10.1097/00006454-200005001-00003; Nakanaga T, 2007, AM J PHYSIOL-LUNG C, V292, pL1289, DOI 10.1152/ajplung.00356.2006; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Richard KL, 2008, J NEUROSCI, V28, P5784, DOI 10.1523/JNEUROSCI.1146-08.2008; Richter A, 2002, AM J RESP CELL MOL, V27, P85, DOI 10.1165/ajrcmb.27.1.4789; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Tetley Teresa D., 2005, Current Drug Targets - Inflammation and Allergy, V4, P607, DOI 10.2174/156801005774912824; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Vargaftig BB, 2003, AM J PHYSIOL-LUNG C, V285, pL808, DOI 10.1152/ajplung.00377.2002; Wang BN, 2003, INFECT IMMUN, V71, P5523, DOI 10.1128/IAI.71.10.5523-5530.2003; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818; Watanabe T, 2004, P NATL ACAD SCI USA, V101, P3563, DOI 10.1073/pnas.0400557101; Wong WSF, 2005, CURR OPIN PHARMACOL, V5, P264, DOI 10.1016/j.coph.2005.01.009; Xu KM, 2007, CANCER RES, V67, P6121, DOI 10.1158/0008-5472.CAN-07-0141; Yim JJ, 2006, GENES IMMUN, V7, P150, DOI 10.1038/sj.gene.6364274	40	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28216	10.1371/journal.pone.0028216	http://dx.doi.org/10.1371/journal.pone.0028216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132240	gold, Green Submitted, Green Published			2022-12-25	WOS:000298162000087
J	Milano, I; Babbucci, M; Panitz, F; Ogden, R; Nielsen, RO; Taylor, MI; Helyar, SJ; Carvalho, GR; Espineira, M; Atanassova, M; Tinti, F; Maes, GE; Patarnello, T; Bargelloni, L				Milano, Ilaria; Babbucci, Massimiliano; Panitz, Frank; Ogden, Rob; Nielsen, Rasmus O.; Taylor, Martin I.; Helyar, Sarah J.; Carvalho, Gary R.; Espineira, Montserrat; Atanassova, Miroslava; Tinti, Fausto; Maes, Gregory E.; Patarnello, Tomaso; Bargelloni, Luca		FishPopTrace Consortium	Novel Tools for Conservation Genomics: Comparing Two High-Throughput Approaches for SNP Discovery in the Transcriptome of the European Hake	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; MERLUCCIUS-MERLUCCIUS; POPULATION GENOMICS; GENETIC-STRUCTURE; GENERATION; FISHERIES; ECOLOGY; STOCKS; FLOW; BAY	The growing accessibility to genomic resources using next-generation sequencing (NGS) technologies has revolutionized the application of molecular genetic tools to ecology and evolutionary studies in non-model organisms. Here we present the case study of the European hake (Merluccius merluccius), one of the most important demersal resources of European fisheries. Two sequencing platforms, the Roche 454 FLX (454) and the Illumina Genome Analyzer (GAII), were used for Single Nucleotide Polymorphisms (SNPs) discovery in the hake muscle transcriptome. De novo transcriptome assembly into unique contigs, annotation, and in silico SNP detection were carried out in parallel for 454 and GAII sequence data. High-throughput genotyping using the Illumina GoldenGate assay was performed for validating 1,536 putative SNPs. Validation results were analysed to compare the performances of 454 and GAII methods and to evaluate the role of several variables (e.g. sequencing depth, intron-exon structure, sequence quality and annotation). Despite well-known differences in sequence length and throughput, the two approaches showed similar assay conversion rates (approximately 43%) and percentages of polymorphic loci (67.5% and 63.3% for GAII and 454, respectively). Both NGS platforms therefore demonstrated to be suitable for large scale identification of SNPs in transcribed regions of non-model species, although the lack of a reference genome profoundly affects the genotyping success rate. The overall efficiency, however, can be improved using strict quality and filtering criteria for SNP selection (sequence quality, intron-exon structure, target region score).	[Milano, Ilaria; Tinti, Fausto] Univ Bologna, Dept Expt & Evolutionary Biol, Bologna, Italy; [Babbucci, Massimiliano; Patarnello, Tomaso; Bargelloni, Luca] Univ Padua, Dept Publ Hlth Comparat Pathol & Vet Hyg, Legnaro, Italy; [Panitz, Frank; Nielsen, Rasmus O.] Aarhus Univ, Dept Mol Biol & Genet, Fac Sci & Technol, Tjele, Denmark; [Ogden, Rob] Royal Zool Soc Scotland, TRACE Wildlife Forens Network, Edinburgh, Midlothian, Scotland; [Taylor, Martin I.; Helyar, Sarah J.; Carvalho, Gary R.] Univ Bangor, Mol Ecol & Fisheries Genet Lab MEFGL, Sch Biol Sci, Environm Ctr Wales, Bangor, Gwynedd, Wales; [Espineira, Montserrat; Atanassova, Miroslava] ANFACO CECOPECSA, Vigo, Spain; [Maes, Gregory E.] Katholieke Univ Leuven, Lab Anim Divers & Systemat, Louvain, Belgium	University of Bologna; University of Padua; Aarhus University; Bangor University; KU Leuven	Milano, I (corresponding author), Univ Bologna, Dept Expt & Evolutionary Biol, Bologna, Italy.	ilaria.milano2@unibo.it	Taylor, Martin I/B-4298-2013; Tinti, Fausto/D-4847-2012; Panitz, Frank/A-3281-2017; Atanassova, Miroslava/AAE-4547-2020; Maes, Gregory/N-4983-2019; Maes, Gregory/C-5450-2008; Helyar, Sarah/C-4988-2013	Tinti, Fausto/0000-0002-8649-5387; Panitz, Frank/0000-0002-6909-5162; Atanassova, Miroslava/0000-0001-7636-3084; Maes, Gregory/0000-0002-1531-7321; Maes, Gregory/0000-0002-1531-7321; PATARNELLO, Tomaso/0000-0003-1794-5791; Helyar, Sarah/0000-0002-1600-997X; BABBUCCI, MASSIMILIANO/0000-0002-4060-4728	European Community [FP7/2007-2013, KBBE-212399]; MerSnip project; Joint Research Council (JRC)	European Community(European Commission); MerSnip project; Joint Research Council (JRC)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no KBBE-212399 (FishPopTrace). Financial support for GAII sequencing and SNP discovery was provided by the MerSnip project funded by the Joint Research Council (JRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Bluthgen Nils, 2005, Genome Inform, V16, P106; Bonin A, 2008, MOL ECOL, V17, P3583, DOI 10.1111/j.1365-294X.2008.03854.x; CASEY J, 1994, HAKE BIOL FISHERIES, P125; Castillo AGF, 2004, MAR BIOTECHNOL, V6, P299, DOI 10.1007/s10126-004-3027-z; Cimmaruta R, 2005, MOL ECOL, V14, P2577, DOI 10.1111/j.1365-294X.2005.02595.x; Everett MV, 2011, MOL ECOL RESOUR, V11, P93, DOI 10.1111/j.1755-0998.2010.02969.x; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; *FAO, 2010, FAO YB FISH AQU STAT; *FAO, 2010, 12 SESS SCI ADV COMM; FERGUSON A, 1994, REV FISH BIOL FISHER, V4, P379, DOI 10.1007/BF00042911; Ferraresso S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-354; Freamo H, 2011, MOL ECOL RESOUR, V11, P254, DOI 10.1111/j.1755-0998.2010.02952.x; Galindo J, 2010, J EVOLUTION BIOL, V23, P2004, DOI 10.1111/j.1420-9101.2010.02071.x; Garvin MR, 2010, MOL ECOL RESOUR, V10, P915, DOI 10.1111/j.1755-0998.2010.02891.x; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hauser L, 2008, FISH FISH, V9, P473, DOI 10.1111/j.1467-2979.2008.00306.x; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hemmer-Hansen J, 2011, MOL ECOL RESOUR, V11, P71, DOI 10.1111/j.1755-0998.2010.02940.x; Huang WC, 2008, GENOME RES, V18, P1538, DOI 10.1101/gr.076067.108; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Kerstens HHD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-4; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Kraus RHS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-150; Lepoittevin C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011034; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Lundy CJ, 2000, MOL ECOL, V9, P2067, DOI 10.1046/j.1365-294X.2000.01120.x; Lundy CJ, 1999, MOL ECOL, V8, P1889, DOI 10.1046/j.1365-294x.1999.00789.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; MURUA H, 2010, BIOL FISHERIES EUROP, P97; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; OLIVER P, 1994, HAKE BIOL FISHERIES, P181; Panitz F, 2007, BIOINFORMATICS, V23, pI387, DOI 10.1093/bioinformatics/btm192; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Pita A, 2010, THALASSAS, V26, P129; Pita A, 2011, CONT SHELF RES, V31, P376, DOI 10.1016/j.csr.2010.09.010; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Roldan MI, 1998, HEREDITY, V81, P327, DOI 10.1046/j.1365-2540.1998.00383.x; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vera M, 2011, AQUACULTURE, V313, P31, DOI 10.1016/j.aquaculture.2011.01.038; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wenne R, 2007, AQUAT LIVING RESOUR, V20, P241, DOI 10.1051/alr:2007037; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010	64	49	49	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28008	10.1371/journal.pone.0028008	http://dx.doi.org/10.1371/journal.pone.0028008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132191	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000297792400031
J	Wiklund, ED; Gao, S; Hulf, T; Sibbritt, T; Nair, S; Costea, DE; Villadsen, SB; Bakholdt, V; Bramsen, JB; Sorensen, JA; Krogdahl, A; Clark, SJ; Kjems, J				Wiklund, Erik D.; Gao, Shan; Hulf, Toby; Sibbritt, Tennille; Nair, Shalima; Costea, Daniela Elena; Villadsen, Sune B.; Bakholdt, Vivi; Bramsen, Jesper B.; Sorensen, Jens A.; Krogdahl, Annelise; Clark, Susan J.; Kjems, Jorgen			MicroRNA Alterations and Associated Aberrant DNA Methylation Patterns across Multiple Sample Types in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							E-CADHERIN; PROMOTER METHYLATION; CPG METHYLATION; DOWN-REGULATION; MIR-200 FAMILY; FEEDBACK LOOP; CANCER-CELLS; EXPRESSION; HEAD; GENE	Background: MicroRNA (miRNA) expression is broadly altered in cancer, but few studies have investigated miRNA deregulation in oral squamous cell carcinoma (OSCC). Epigenetic mechanisms are involved in the regulation of >30 miRNA genes in a range of tissues, and we aimed to investigate this further in OSCC. Methods: TaqMan (R) qRT-PCR arrays and individual assays were used to profile miRNA expression in a panel of 25 tumors with matched adjacent tissues from patients with OSCC, and 8 control paired oral stroma and epithelium from healthy volunteers. Associated DNA methylation changes of candidate epigenetically deregulated miRNA genes were measured in the same samples using the MassArray (R) mass spectrometry platform. MiRNA expression and DNA methylation changes were also investigated in FACS sorted CD44(high) oral cancer stem cells from primary tumor samples (CSCs), and in oral rinse and saliva from 15 OSCC patients and 7 healthy volunteers. Results: MiRNA expression patterns were consistent in healthy oral epithelium and stroma, but broadly altered in both tumor and adjacent tissue from OSCC patients. MiR-375 is repressed and miR-127 activated in OSCC, and we confirm previous reports of miR-137 hypermethylation in oral cancer. The miR-200 s/miR-205 were epigenetically activated in tumors vs normal tissues, but repressed in the absence of DNA hypermethylation specifically in CD44(high) oral CSCs. Aberrant miR-375 and miR-200a expression and miR-200c-141 methylation could be detected in and distinguish OSCC patient oral rinse and saliva from healthy volunteers, suggesting a potential clinical application for OSCC specific miRNA signatures in oral fluids. Conclusions: MiRNA expression and DNA methylation changes are a common event in OSCC, and we suggest miR-375, miR-127, miR-137, the miR-200 family and miR-205 as promising candidates for future investigations. Although overall activated in OSCC, miR-200/miR-205 suppression in oral CSCs indicate that cell specific silencing of these miRNAs may drive tumor expansion and progression.	[Wiklund, Erik D.; Gao, Shan; Villadsen, Sune B.; Bramsen, Jesper B.; Kjems, Jorgen] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Wiklund, Erik D.; Hulf, Toby; Sibbritt, Tennille; Nair, Shalima; Clark, Susan J.] St Vincents Hosp, Garvan Inst Med Res, Canc Program, Epigenet Grp, Darlinghurst, NSW 2010, Australia; [Costea, Daniela Elena] Univ Bergen, Gade Inst, Sect Pathol, Bergen, Norway; [Bakholdt, Vivi; Sorensen, Jens A.] Odense Univ Hosp, Dept Plast Surg, DK-5000 Odense, Denmark; [Krogdahl, Annelise] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark	Aarhus University; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Bergen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Wiklund, ED (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	shg@mb.au.dk	Costea, Daniela Elena/AAB-9705-2020; Clark, Susan J/U-7365-2019; Kjems, Jorgen/I-3490-2016; Clark, Susan J/B-2272-2008; sørensen, jens ahm/D-6279-2014	Clark, Susan J/0000-0001-5925-5030; Kjems, Jorgen/0000-0003-4128-9317; Clark, Susan J/0000-0001-5925-5030; Costea, Daniela-Elena/0000-0001-7673-0358; Sorensen, Jens Ahm/0000-0003-4903-0094	EU; Danish Medical Research Council [09065615]; Novo Nordisk Foundation; Cure Cancer Australia; New South Wales Cancer Institute; NHMRC	EU(European Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Cure Cancer Australia; New South Wales Cancer Institute; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was partially supported by EU-FP6 Integrated project: Silencing RNAs: Organisers and coordinators of complexity in eukaryotic organisms (SIROCCO) (to EDW, JBB, SBV and JK), the Danish Medical Research Council (No. 09065615) (to SG and JK), The Novo Nordisk Foundation (to JK), Cure Cancer Australia and New South Wales Cancer Institute Fellowships (to TH), and NH&MRC project grants (to SJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2010, SEER CANC STAT REV 1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boldrup L, 2007, J PATHOL, V213, P384, DOI 10.1002/path.2237; BRABLETZ S, 2011, EMBO J; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Cervigne NK, 2009, HUM MOL GENET, V18, P4818, DOI 10.1093/hmg/ddp446; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2001, CANCER RES, V61, P3225; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; Gao S, 2005, J ORAL PATHOL MED, V34, P116, DOI 10.1111/j.1600-0714.2004.00275.x; Gao S, 2004, INT J CANCER, V109, P230, DOI 10.1002/ijc.11592; Gomes CC, 2008, ORAL ONCOL, V44, P910, DOI 10.1016/j.oraloncology.2008.01.002; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hasegawa M, 2002, ONCOGENE, V21, P4231, DOI 10.1038/sj.onc.1205528; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Hinshelwood RA, 2007, CANCER RES, V67, P11517, DOI 10.1158/0008-5472.CAN-07-1284; Hulf T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-54; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Langevin SM, 2010, CARCINOGENESIS, V31, P864, DOI 10.1093/carcin/bgq051; LANGEVIN SM, 2010, MICRORNA 137 PROMOTE; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; LO WL, 2010, J PATHOL; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; MACKENZIE IC, 1979, SCAND J DENT RES, V87, P234; Nakayama S, 2001, INT J CANCER, V93, P667, DOI 10.1002/ijc.1386; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; PISANI P, 1993, INT J CANCER, V55, P891, DOI 10.1002/ijc.2910550604; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rosas SLB, 2001, CANCER RES, V61, P939; Ross JP, 2010, EPIGENOMICS-UK, V2, P245, DOI 10.2217/EPI.10.2; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Weber B, 2007, CELL CYCLE, V6, P1001, DOI 10.4161/cc.6.9.4209; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; WIKLUND ED, 2010, INT J CANC; Williams HK, 2000, J CLIN PATHOL-MOL PA, V53, P165, DOI 10.1136/mp.53.4.165; Wotschofsky Z, 2011, ANAL BIOCHEM, V417, P233, DOI 10.1016/j.ab.2011.06.009	55	116	120	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27840	10.1371/journal.pone.0027840	http://dx.doi.org/10.1371/journal.pone.0027840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132151	gold, Green Published			2022-12-25	WOS:000297792400017
J	Li, XX; LeBlanc, J; Truong, A; Vuthoori, R; Chen, SS; Lustgarten, JL; Roth, B; Allard, J; Ippoliti, A; Presley, LL; Borneman, J; Bigbee, WL; Gopalakrishnan, V; Graeber, TG; Elashoff, D; Braun, J; Goodglick, L				Li, Xiaoxiao; LeBlanc, James; Allison Truong; Vuthoori, Ravi; Chen, Sharon S.; Lustgarten, Jonathan L.; Roth, Bennett; Allard, Jeff; Ippoliti, Andrew; Presley, Laura L.; Borneman, James; Bigbee, William L.; Gopalakrishnan, Vanathi; Graeber, Thomas G.; Elashoff, David; Braun, Jonathan; Goodglick, Lee			A Metaproteomic Approach to Study Human-Microbial Ecosystems at the Mucosal Luminal Interface	PLOS ONE			English	Article							ALKALINE SPHINGOMYELINASE ACTIVITY; ENHANCED LASER-DESORPTION; MASS-SPECTROMETRY; GUT; SERUM; CEA; EXPRESSION; MARKERS; SPECTRA; CELLS	Aberrant interactions between the host and the intestinal bacteria are thought to contribute to the pathogenesis of many digestive diseases. However, studying the complex ecosystem at the human mucosal-luminal interface (MLI) is challenging and requires an integrative systems biology approach. Therefore, we developed a novel method integrating lavage sampling of the human mucosal surface, high-throughput proteomics, and a unique suite of bioinformatic and statistical analyses. Shotgun proteomic analysis of secreted proteins recovered from the MLI confirmed the presence of both human and bacterial components. To profile the MLI metaproteome, we collected 205 mucosal lavage samples from 38 healthy subjects, and subjected them to high-throughput proteomics. The spectral data were subjected to a rigorous data processing pipeline to optimize suitability for quantitation and analysis, and then were evaluated using a set of biostatistical tools. Compared to the mucosal transcriptome, the MLI metaproteome was enriched for extracellular proteins involved in response to stimulus and immune system processes. Analysis of the metaproteome revealed significant individual-related as well as anatomic region-related (biogeographic) features. Quantitative shotgun proteomics established the identity and confirmed the biogeographic association of 49 proteins (including 3 functional protein networks) demarcating the proximal and distal colon. This robust and integrated proteomic approach is thus effective for identifying functional features of the human mucosal ecosystem, and a fresh understanding of the basic biology and disease processes at the MLI.	[Li, Xiaoxiao; Chen, Sharon S.; Graeber, Thomas G.; Braun, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [LeBlanc, James; Allison Truong; Vuthoori, Ravi; Braun, Jonathan; Goodglick, Lee] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Lustgarten, Jonathan L.; Gopalakrishnan, Vanathi] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA USA; [Roth, Bennett; Allard, Jeff] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Digest Dis, Los Angeles, CA 90095 USA; [Ippoliti, Andrew] Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90048 USA; [Presley, Laura L.; Borneman, James] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Bigbee, William L.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Bigbee, William L.] Univ Pittsburgh, Univ Pittsburgh Canc Inst, Pittsburgh, PA USA; [Gopalakrishnan, Vanathi] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Graeber, Thomas G.; Elashoff, David; Braun, Jonathan; Goodglick, Lee] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Elashoff, David] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Riverside; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Li, XX (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	jbraun@mednet.ucla.edu; lgoodglick@mednet.ucla.edu		Graeber, Thomas/0000-0001-8574-9181; Braun, Jonathan/0000-0003-1646-2974; Truong, Allison/0000-0002-9985-1280; Gopalakrishnan, Vanathi/0000-0002-7813-4055	National Institutes of Health (NIH) [DK46763, AI078885]; UCLA AIDS Institute; UCLA Center for AIDS Research NIH [AI28697]; Crohn's and Colitis Foundation of America [156, 1567]; Dr. Ursula Mandel Student Fellowship; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078885, P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA AIDS Institute; UCLA Center for AIDS Research NIH; Crohn's and Colitis Foundation of America; Dr. Ursula Mandel Student Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health (NIH) grants DK46763 (JB) and AI078885 (JB), the UCLA AIDS Institute and the UCLA Center for AIDS Research NIH AI28697 (JB), Crohn's and Colitis Foundation of America grant 156 (LG) and 1567 (JB), and the Dr. Ursula Mandel Student Fellowship (XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivado M, 2007, P NATL ACAD SCI USA, V104, P1307, DOI 10.1073/pnas.0610330104; Aldulaymi B, 2010, ANTICANCER RES, V30, P4755; Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143; Andersson D, 2009, DIGEST DIS SCI, V54, P1440, DOI 10.1007/s10620-008-0509-2; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Baggerly KA, 2004, BIOINFORMATICS, V20, P777, DOI 10.1093/bioinformatics/btg484; Banerjee S, 2009, MUCOSAL IMMUNOL, V2, P220, DOI 10.1038/mi.2009.3; Beisvag V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-470; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Cannataro M, 2007, FUTURE GENER COMP SY, V23, P55, DOI 10.1016/j.future.2006.04.011; Cannataro M, 2005, COMP MED SY, P549, DOI 10.1109/CBMS.2005.87; CANNATARO M, 2005, MS ANAL INTELLIGENT; Carethers JM, 2011, GASTROENTEROLOGY, V141, P411, DOI 10.1053/j.gastro.2011.06.029; Cedres S, 2011, CLIN LUNG CANCER, V12, P172, DOI 10.1016/j.cllc.2011.03.019; Cooley J, 2001, BIOCHEMISTRY-US, V40, P15762, DOI 10.1021/bi0113925; Coombes KR, 2005, PROTEOMICS, V5, P4107, DOI 10.1002/pmic.200401261; Coombes KR, 2003, CLIN CHEM, V49, P1615, DOI 10.1373/49.10.1615; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Di Marzio L, 2005, CANCER EPIDEM BIOMAR, V14, P856, DOI 10.1158/1055-9965.EPI-04-0434; DUAN RD, 1995, BBA-LIPID LIPID MET, V1259, P49, DOI 10.1016/0005-2760(95)00137-2; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fushiki T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-358; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glebov OK, 2003, CANCER EPIDEM BIOMAR, V12, P755; Hertervig E, 1997, CANCER, V79, P448, DOI 10.1002/(SICI)1097-0142(19970201)79:3<448::AID-CNCR4>3.0.CO;2-E; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hoopmann MR, 2007, ANAL CHEM, V79, P5620, DOI 10.1021/ac0700833; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Liebhardt S, 2010, ANTICANCER RES, V30, P1707; Lin XH, 1997, BIOMETRIKA, V84, P309, DOI 10.1093/biomet/84.2.309; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Morris JS, 2005, BIOINFORMATICS, V21, P1764, DOI 10.1093/bioinformatics/bti254; Muenzner P, 2010, SCIENCE, V329, P1197, DOI 10.1126/science.1190892; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Presley LL, 2012, INFLAMM BOWEL DIS, V18, P409, DOI 10.1002/ibd.21793; Presley LL, 2010, APPL ENVIRON MICROB, V76, P936, DOI 10.1128/AEM.01561-09; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Swidsinski A, 2008, GASTROENTEROLOGY, V135, P568, DOI 10.1053/j.gastro.2008.04.017; Topaloglou T, 2006, DRUG DISCOV TODAY, V11, P509, DOI 10.1016/j.drudis.2006.04.011; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Walker WL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-494; Wong JWH, 2005, BIOINFORMATICS, V21, P2088, DOI 10.1093/bioinformatics/bti300; Wu J, 2004, AM J PHYSIOL-GASTR L, V287, pG967, DOI 10.1152/ajpgi.00190.2004; Yasui Y, 2003, BIOSTATISTICS, V4, P449, DOI 10.1093/biostatistics/4.3.449; Yi Y, 2009, BIOMARKERS, V14, P480, DOI 10.3109/13547500903180265; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r	56	60	60	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e26542	10.1371/journal.pone.0026542	http://dx.doi.org/10.1371/journal.pone.0026542			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132074	Green Accepted, gold, Green Published			2022-12-25	WOS:000297789900004
J	Miller, JP; Krueger, S; Heys, JJ; Gedeon, T				Miller, John P.; Krueger, Susan; Heys, Jeffrey J.; Gedeon, Tomas			Quantitative Characterization of the Filiform Mechanosensory Hair Array on the Cricket Cercus	PLOS ONE			English	Article							INFORMATION-THEORETIC ANALYSIS; GIANT INTERNEURON SYSTEM; WIND-RECEPTOR HAIRS; SENSORY SYSTEM; RANGE FRACTIONATION; RESPONSE PROPERTIES; ACHETA-DOMESTICUS; MORPHOLOGY; PHYSIOLOGY; MECHANORECEPTORS	Background: Crickets and other orthopteran insects sense air currents with a pair of abdominal appendages resembling antennae, called cerci. Each cercus in the common house cricket Acheta domesticus is approximately 1 cm long, and is covered with 500 to 750 filiform mechanosensory hairs. The distribution of the hairs on the cerci, as well as the global patterns of their movement vectors, have been characterized semi-quantitatively in studies over the last 40 years, and have been shown to be very stereotypical across different animals in this species. Although the cercal sensory system has been the focus of many studies in the areas of neuroethology, development, biomechanics, sensory function and neural coding, there has not yet been a quantitative study of the functional morphology of the receptor array of this important model system. Methodology/Principal Findings: We present a quantitative characterization of the structural characteristics and functional morphology of the cercal filiform hair array. We demonstrate that the excitatory direction along each hair's movement plane can be identified by features of its socket that are visible at the light-microscopic level, and that the length of the hair associated with each socket can also be estimated accurately from a structural parameter of the socket. We characterize the length and directionality of all hairs on the basal half of a sample of three cerci, and present statistical analyses of the distributions. Conclusions/Significance: The inter-animal variation of several global organizational features is low, consistent with constraints imposed by functional effectiveness and/or developmental processes. Contrary to previous reports, however, we show that the filiform hairs are not re-identifiable in the strict sense.	[Miller, John P.; Krueger, Susan; Heys, Jeffrey J.; Gedeon, Tomas] Montana State Univ, Ctr Computat Biol, Bozeman, MT 59717 USA; [Gedeon, Tomas] Montana State Univ, Dept Math, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Miller, JP (corresponding author), Montana State Univ, Ctr Computat Biol, Bozeman, MT 59717 USA.	jpmillerusa@gmail.com	Miller, John J/GZG-5663-2022		National Science Foundation (NSF) [CMMI-0849433]; National Institutes of Health (NIH) [R01 MH-064416-06]; Direct For Mathematical & Physical Scien [0818785] Funding Source: National Science Foundation; Directorate For Engineering [0849433] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064416] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was financially supported by National Science Foundation (NSF) grant CMMI-0849433 and National Institutes of Health (NIH) grant R01 MH-064416-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACON JP, 1984, J PHYSIOL-LONDON, V352, P601, DOI 10.1113/jphysiol.1984.sp015312; BISCHOF HJ, 1975, J COMP PHYSIOL, V98, P277, DOI 10.1007/BF00656974; Casas J, 2010, ANNU REV ENTOMOL, V55, P505, DOI 10.1146/annurev-ento-112408-085342; CHIBA A, 1992, J EXP BIOL, V164, P205; CUMMINS B, 2011, FRONTIERS S IN PRESS; Cummins B, 2007, J THEOR BIOL, V247, P266, DOI 10.1016/j.jtbi.2007.02.003; Dangles O, 2006, J EXP BIOL, V209, P4363, DOI 10.1242/jeb.02485; Dangles O, 2006, J EXP BIOL, V209, P393, DOI 10.1242/jeb.02000; Dangles O, 2005, J EXP BIOL, V208, P461, DOI 10.1242/jeb.01369; Dangles O, 2008, J COMP PHYSIOL A, V194, P653, DOI 10.1007/s00359-008-0339-x; DUMPERT K, 1977, J COMP PHYSIOL, V122, P9, DOI 10.1007/BF00611245; EDWARDS JS, 1974, PROC R SOC SER B-BIO, V185, P83, DOI 10.1098/rspb.1974.0007; GNATZY W, 1980, CELL TISSUE RES, V213, P441; GNATZY W, 1978, CELL TISSUE RES, V187, P1; GODDE J, 1983, THESIS WESTFALISCHEW; HEILIGENBERG W, 1987, J COMP PHYSIOL A, V161, P621, DOI 10.1007/BF00603665; Heys JJ, 2008, J BIOMECH, V41, P977, DOI 10.1016/j.jbiomech.2007.12.015; HUMPHREY JAC, 1993, PHILOS T R SOC B, V340, P423, DOI 10.1098/rstb.1993.0083; Jacobs GA, 2008, J EXP BIOL, V211, P1819, DOI 10.1242/jeb.016402; KAMPER G, 1990, J COMP PHYSIOL A, V167, P193, DOI 10.1007/BF00188111; Keil T.A., 1984, P477; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; Kumagai T, 1998, J COMP PHYSIOL A, V183, P187, DOI 10.1007/s003590050246; LANDOLFA MA, 1995, J COMP PHYSIOL A, V177, P749; LANDOLFA MA, 1995, J COMP PHYSIOL A, V177, P759; Magal C, 2006, J THEOR BIOL, V241, P459, DOI 10.1016/j.jtbi.2005.12.009; Mulder-Rosi J, 2010, J NEUROPHYSIOL, V103, P1823, DOI 10.1152/jn.00875.2009; MURPHEY RK, 1980, J COMP NEUROL, V191, P53, DOI 10.1002/cne.901910103; MURPHEY RK, 1981, DEV BIOL, V88, P236, DOI 10.1016/0012-1606(81)90167-6; PALKA J, 1977, J COMP PHYSIOL, V119, P267, DOI 10.1007/BF00656638; PALKA J, 1977, J COMP PHYSIOL, V119, P301, DOI 10.1007/BF00656640; Rasband WS, 1997, IMAGEJ; Roddey JC, 1996, J NEUROPHYSIOL, V75, P1365, DOI 10.1152/jn.1996.75.4.1365; SAKAGUCHI DS, 1983, J COMP PHYSIOL, V150, P141, DOI 10.1007/BF00606364; Shimozawa T, 1998, J COMP PHYSIOL A, V183, P171, DOI 10.1007/s003590050245; SHIMOZAWA T, 1984, J COMP PHYSIOL, V155, P485, DOI 10.1007/BF00611913; SHIMOZAWA T, 1984, J COMP PHYSIOL, V155, P495, DOI 10.1007/BF00611914; Steinmann T, 2006, J EXP BIOL, V209, P4398, DOI 10.1242/jeb.02506; STERN C, 1954, AM SCI, V42, P212; Theunissen F, 1996, J NEUROPHYSIOL, V75, P1345, DOI 10.1152/jn.1996.75.4.1345; THEUNISSEN FE, 1991, J NEUROPHYSIOL, V66, P1690, DOI 10.1152/jn.1991.66.5.1690; THURM U, 1983, J SUBMICR CYTOL PATH, V15, P151; TOBIAS M, 1979, J COMP PHYSIOL, V129, P51, DOI 10.1007/BF00679911; WALTHALL WW, 1986, DEV BIOL, V113, P182, DOI 10.1016/0012-1606(86)90121-1	44	28	28	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27873	10.1371/journal.pone.0027873	http://dx.doi.org/10.1371/journal.pone.0027873			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132155	gold, Green Published, Green Submitted			2022-12-25	WOS:000297789900026
J	Murillo-Maldonado, JM; Zeineddine, FB; Stock, R; Thackeray, J; Riesgo-Escovar, JR				Murillo-Maldonado, Juan M.; Zeineddine, Fouad Bou; Stock, Rachel; Thackeray, Justin; Riesgo-Escovar, Juan R.			Insulin Receptor-Mediated Signaling via Phospholipase C-gamma Regulates Growth and Differentiation in Drosophila	PLOS ONE			English	Article							PROTEIN-KINASE-C; EGF RECEPTOR; PLC-GAMMA; CELL; EYE; ACTIVATION; C-GAMMA-1; SEVENLESS; IDENTIFICATION; PROLIFERATION	Coordination between growth and patterning/differentiation is critical if appropriate final organ structure and size is to be achieved. Understanding how these two processes are regulated is therefore a fundamental and as yet incompletely answered question. Here we show through genetic analysis that the phospholipase C-gamma ( PLC-gamma) encoded by small wing (sl) acts as such a link between growth and patterning/differentiation by modulating some MAPK outputs once activated by the insulin pathway; particularly, sl promotes growth and suppresses ectopic differentiation in the developing eye and wing, allowing cells to attain a normal size and differentiate properly. sl mutants have previously been shown to have a combination of both growth and patterning/differentiation phenotypes: small wings, ectopic wing veins, and extra R7 photoreceptor cells. We show here that PLC-gamma activated by the insulin pathway participates broadly and positively during cell growth modulating EGF pathway activity, whereas in cell differentiation PLC-gamma activated by the insulin receptor negatively regulates the EGF pathway. These roles require different SH2 domains of PLC-gamma, and act via classic PLC-gamma signaling and EGF ligand processing. By means of PLC-gamma, the insulin receptor therefore modulates differentiation as well as growth. Overall, our results provide evidence that PLC-gamma acts during development at a time when growth ends and differentiation begins, and is important for proper coordination of these two processes.	[Murillo-Maldonado, Juan M.; Riesgo-Escovar, Juan R.] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Queretaro, Mexico; [Zeineddine, Fouad Bou; Stock, Rachel; Thackeray, Justin] Clark Univ, Dept Biol, Worcester, MA 01610 USA	Universidad Nacional Autonoma de Mexico; Clark University	Murillo-Maldonado, JM (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Campus Juriquilla, Queretaro, Mexico.	juanriesgo@prodigy.net.mx	Zeineddine, Fouad Bou/AAK-3791-2020	Zeineddine, Fouad Bou/0000-0002-5386-0579; Murillo-Maldonado, Juan Manuel/0000-0003-2019-7106	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [81864, 46133]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) de la Universidad Nacional Autonoma de Mexico (UNAM) [IN201707]; National Institutes of Heath (NIH)	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) de la Universidad Nacional Autonoma de Mexico (UNAM)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); National Institutes of Heath (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT) (grants # 81864 and 46133), Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) de la Universidad Nacional Autonoma de Mexico (UNAM) to JRR.-E(IN201707) and by the National Institutes of Heath (NIH) awarded to J.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Betson M, 2007, GENETICS, V176, P2201, DOI 10.1534/genetics.107.072967; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Buckley CT, 2004, J BIOL CHEM, V279, P41807, DOI 10.1074/jbc.M407851200; Chattopadhyay A, 1999, J BIOL CHEM, V274, P26091, DOI 10.1074/jbc.274.37.26091; Chen P, 1996, MOL BIOL CELL, V7, P871, DOI 10.1091/mbc.7.6.871; CHOE CU, 2006, SCI STKE, pRE15; Choi JH, 2007, ADV ENZYME REGUL, V47, P104, DOI 10.1016/j.advenzreg.2006.12.010; Crozatier M, 2004, TRENDS GENET, V20, P498, DOI 10.1016/j.tig.2004.07.013; Day SJ, 2000, DEVELOPMENT, V127, P2977; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P569; EMORI Y, 1994, J BIOL CHEM, V269, P19474; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Kayali AG, 1998, J BIOL CHEM, V273, P13808, DOI 10.1074/jbc.273.22.13808; KOLODKIN AL, 1994, DEVELOPMENT, V120, P1731; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Mankidy R, 2003, GENETICS, V164, P553; Marenda DR, 2006, DEVELOPMENT, V133, P43, DOI 10.1242/dev.02168; MARENGERE LEM, 1992, J BIOL CHEM, V267, P22779; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; McNeill H, 2008, GENETICS, V179, P843, DOI 10.1534/genetics.107.083097; Mollereau B, 2005, DEV DYNAM, V232, P585, DOI 10.1002/dvdy.20271; Patterson RL, 2005, TRENDS BIOCHEM SCI, V30, P688, DOI 10.1016/j.tibs.2005.10.005; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Raabe T, 1996, CELL, V85, P911, DOI 10.1016/S0092-8674(00)81274-X; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Schlesinger A, 2004, DEV CELL, V7, P535, DOI 10.1016/j.devcel.2004.09.001; SEEDORF K, 1995, J BIOL CHEM, V270, P18953, DOI 10.1074/jbc.270.32.18953; SMITH MR, 1994, P NATL ACAD SCI USA, V91, P6554, DOI 10.1073/pnas.91.14.6554; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Thackeray JR, 1998, DEVELOPMENT, V125, P5033; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; Walker JA, 2006, GENE DEV, V20, P3311, DOI 10.1101/gad.1466806; Werz C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000596; Wolff T, 2000, DROSOPHILA PROTOCOLS, P229; XU T, 1993, DEVELOPMENT, V117, P1223; Ye KQ, 2002, NATURE, V415, P541, DOI 10.1038/415541a; Zhu L, 2001, CURR OPIN GENET DEV, V11, P91, DOI 10.1016/S0959-437X(00)00162-3	46	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28067	10.1371/journal.pone.0028067	http://dx.doi.org/10.1371/journal.pone.0028067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132213	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789900045
J	Pujades-Rodriguez, M; Dantony, E; Pinoges, L; Ecochard, R; Etard, JF; Carrillo-Casas, E; Szumilin, E				Pujades-Rodriguez, Mar; Dantony, Emmanuelle; Pinoges, Loretxu; Ecochard, Rene; Etard, Jean-Francois; Carrillo-Casas, Esther; Szumilin, Elisabeth		AIDS Working Grp Med Sans	Toxicity Associated with Stavudine Dose Reduction from 40 to 30 mg in First-Line Antiretroviral Therapy	PLOS ONE			English	Article							DISTAL SENSORY POLYNEUROPATHY; BODY-COMPOSITION; HIV-INFECTION; RISK-FACTORS; NEUROPATHY; LIPODYSTROPHY; TENOFOVIR; REGIMENS; COHORT; TRIAL	Background: To compare the incidence and timing of toxicity associated with the use of a reduced dose of stavudine from 40 to 30 mg in first-line antiretroviral therapy (ART) for HIV treatment and to investigate associated risk factors. Methods: Multicohort study including 23 HIV programs in resource-limited countries. Adults enrolled between January 2005 and December 2009. Four-year rates of all-cause and stavudine-specific toxicity were estimated. Multilevel mixed-effect Poisson and accelerated failure models were used to investigate factors associated with toxicity and timing of diagnosis. Findings: A total of 48,785 patients contributed 62,505 person-years of follow-up. Rate of all-cause toxicity was 7.80 (95%CI 7.59-8.03) per 100 person-years, but varied greatly across sites (range 0.41-21.76). Patients treated with stavudine 40 mg had higher rates of toxicity (adjusted rate ratio [aRR] 1.18, 95%CI 1.06-1.30 during the first year of ART; and 1.51, 95%CI 1.32-1.71 during the second year). Women, older age, initial advanced clinical stage, and low CD4 count were associated with increased toxicity rate ratios. Timing of lipodystrophy and peripheral neuropathy diagnosis were 12% and 13% shorter, respectively, in patients treated with stavudine 40 mg than in those receiving 30 mg stavudine dose (P = 0.03 and 0.07, respectively). Insterpretation: Higher rates of drug-related toxicity were reported in patients receiving stavudine 40 mg compared with 30 mg, and the time to toxicity diagnosis was shorter in patients treated with the higher dose. Higher rates of toxicity were observed during the first two years of ART.	[Pujades-Rodriguez, Mar; Pinoges, Loretxu; Etard, Jean-Francois] Epictr, Dept Clin Res, Paris, France; [Dantony, Emmanuelle; Ecochard, Rene] Hosp Civils Lyon, Serv Biostat, Lyon, France; [Dantony, Emmanuelle; Ecochard, Rene] Ctr Natl Rech Sci, Unite Mixte Rech 5558, Villeurbanne, France; [Dantony, Emmanuelle; Ecochard, Rene] Univ Lyon, Serv Biostat, Lyon, France; [Etard, Jean-Francois] Inst Rech Dev, Unite Mixte Int 233, Montpellier, France; [Carrillo-Casas, Esther] MSF AIDS Working Grp, Dept Med, Amsterdam, Netherlands; [Szumilin, Elisabeth] MSF AIDS Working Grp, Dept Med, Paris, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Institut de Recherche pour le Developpement (IRD); Doctors Without Borders; Doctors Without Borders; Sanofi-Aventis; Sanofi France	Pujades-Rodriguez, M (corresponding author), Epictr, Dept Clin Res, Paris, France.	mar.pujades@epicentre.msf.org	Pujades-Rodriguez, Mar/G-4388-2014; Pujades-Rodriguez, Mar/T-1129-2018; Etard, Jean François/A-9630-2008; Etard, Jean-Francois/V-4865-2019	Pujades-Rodriguez, Mar/0000-0002-7778-3520; Pujades-Rodriguez, Mar/0000-0002-1375-1028; Etard, Jean François/0000-0002-4873-0788; Etard, Jean-Francois/0000-0002-4873-0788; Dantony, Emmanuelle/0000-0001-5143-0666	World Health Organization through the Gates Foundation pharmacovigilance initiative; Medecins Sans Frontieres (MSF); MSF AIDS Working Group	World Health Organization through the Gates Foundation pharmacovigilance initiative; Medecins Sans Frontieres (MSF); MSF AIDS Working Group	Funding to perform this work was given by the World Health Organization through the Gates Foundation pharmacovigilance initiative, and Medecins Sans Frontieres (MSF). The World Health Organization and the Gates Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MSF staff participated in data collection (through their work in routine projects in collaboration with the Ministry of Health) and preparation of the manuscript (ECC and ES are members of the medical department of MSF). The other authors work for Epicentre, which is a non-profit organisation created by MSF to conduct operational research/evaluations in MSF-supported projects to improve the quality of care provided and evaluate activities/strategies.; The authors thank Micheline Diepart, Chris Duncombe and Marco Vitoria from the World Health Organization for their support to this work; the ministries of health of the countries and the MSF field teams for their daily work and effort to provide care to the patients and for data collection; the members of the MSF AIDS Working Group for their advice and support; and the Epicentre FUCHIA team for their support in data collection and data quality maintenance. We also thank Oliver Yun for his editorial work.	Ait-Mohand H, 2008, HIV MED, V9, P738, DOI 10.1111/j.1468-1293.2008.00616.x; ANDERSON RE, 1995, J INFECT DIS, V171, pS118, DOI 10.1093/infdis/171.Supplement_2.S118; Boulassel MR, 2006, J MED VIROL, V78, P1158, DOI 10.1002/jmv.20676; BROWNE MJ, 1993, J INFECT DIS, V167, P21, DOI 10.1093/infdis/167.1.21; Childs EA, 1999, NEUROLOGY, V52, P607, DOI 10.1212/WNL.52.3.607; Evans SR, 2011, AIDS, V25, P919, DOI 10.1097/QAD.0b013e328345889d; HANVANICH M, 2003, ANTIVIR THER, V8; Hill A, 2007, EXPERT OPIN PHARMACO, V8, P679, DOI 10.1517/14656566.8.5.679; Keswani SC, 2002, AIDS, V16, P2105, DOI 10.1097/00002030-200211080-00002; Lichtenstein KA, 2005, CLIN INFECT DIS, V40, P148, DOI 10.1086/426076; Lopez OL, 2004, EUR J NEUROL, V11, P97, DOI 10.1046/j.1351-5101.2003.00713.x; McComsey GA, 2008, CLIN INFECT DIS, V46, P1290, DOI 10.1086/529384; Mercier S, 2009, JAIDS-J ACQ IMM DEF, V51, P224, DOI 10.1097/QAI.0b013e31819c16f4; Milinkovic A, 2007, ANTIVIR THER, V12, P407; Nolan D, 2003, AIDS, V17, P1329, DOI 10.1097/00002030-200306130-00007; PETERSEN EA, 1995, J INFECT DIS, V171, pS131, DOI 10.1093/infdis/171.Supplement_2.S131; Pujades-Rodriguez M, 2010, JAMA-J AM MED ASSOC, V304, P303, DOI 10.1001/jama.2010.980; Pujari SN, 2005, JAIDS-J ACQ IMM DEF, V39, P199; RIBERA E, 2011, RANDOMIZED STUDY COM; Robinson-Papp J, 2010, PAIN, V151, P732, DOI 10.1016/j.pain.2010.08.045; Rosen S, 2008, JAIDS-J ACQ IMM DEF, V48, P334, DOI 10.1097/QAI.0b013e31817ae5ef; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Sanchez-Conde M, 2005, HIV CLIN TRIALS, V6, P197, DOI 10.1310/ED57-EU48-RK6A-E5U0; Schifitto G, 2002, NEUROLOGY, V58, P1764, DOI 10.1212/WNL.58.12.1764; Simpson DM, 2006, NEUROLOGY, V66, P1679, DOI 10.1212/01.wnl.0000218303.48113.5d; Simpson DM, 1998, AIDS, V12, P2425, DOI 10.1097/00002030-199818000-00011; Skopelitis EE, 2006, INT J STD AIDS, V17, P467, DOI 10.1258/095646206777689062; Tagliati M, 1999, ARCH NEUROL-CHICAGO, V56, P84, DOI 10.1001/archneur.56.1.84; Vivithanaporn P, 2010, NEUROLOGY, V75, P1150, DOI 10.1212/WNL.0b013e3181f4d5bb; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; *WHO, ADD 2006 WHO GUID AN; WOLF E, 2004, LOW DOSE STAVUDINE L	32	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28112	10.1371/journal.pone.0028112	http://dx.doi.org/10.1371/journal.pone.0028112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132226	Green Published, gold, Green Submitted			2022-12-25	WOS:000297789900048
J	Roshandel, D; Thomson, W; Pye, SR; Boonen, S; Borghs, H; Vanderschueren, D; Huhtaniemi, IT; Adams, JE; Ward, KA; Bartfai, G; Casanueva, FF; Finn, JD; Forti, G; Giwercman, A; Han, TS; Kula, K; Lean, ME; Pendleton, N; Punab, M; Wu, FC; Holliday, KL; O'Neill, TW				Roshandel, Delnaz; Thomson, Wendy; Pye, Stephen R.; Boonen, Steven; Borghs, Herman; Vanderschueren, Dirk; Huhtaniemi, Ilpo T.; Adams, Judith E.; Ward, Kate A.; Bartfai, Gyorgy; Casanueva, Felipe F.; Finn, Joseph D.; Forti, Gianni; Giwercman, Aleksander; Han, Thang S.; Kula, Krzysztof; Lean, Michael E.; Pendleton, Neil; Punab, Margus; Wu, Frederick C.; Holliday, Kate L.; O'Neill, Terence W.		EMAS Study Grp	Polymorphisms in Genes Involved in the NF-kappa B Signalling Pathway Are Associated with Bone Mineral Density, Geometry and Turnover in Men	PLOS ONE			English	Article							OSTEOPOROTIC FRACTURES; RISK; BMD; DETERMINANTS; WOMEN; TWIN; HIP	Introduction: In this study, we aimed to investigate the association between single nucleotide polymorphisms (SNPs) within two genes involved in the NF-kappa B cascade (GPR177 and MAP3K14) and bone mineral density (BMD) assessed at different skeletal sites, radial geometric parameters and bone turnover. Methods: Ten GPR177 SNPs previously associated with BMD with genome-wide significance and twelve tag SNPs (r(2) >= 0.8) within MAP3K14 (+/-10 kb) were genotyped in 2359 men aged 40-79 years recruited from 8 centres for participation in the European Male Aging Study (EMAS). Measurement of bone turnover markers (PINP and CTX-I) in the serum and quantitative ultrasound (QUS) at the calcaneus were performed in all centres. Dual energy X-ray absorptiometry (DXA), at the lumbar spine and hip, and peripheral quantitative computed tomography (pQCT), at the distal and midshaft radius, were performed in a subsample (2 centres). Linear regression was used to test for association between the SNPs and bone measures under an additive genetic model adjusting for study centre. Results: We validated the associations between SNPs in GPR177 and BMD(a) previously reported and also observed evidence of pleiotrophic effects on density and geometry. Rs2772300 in GPR177 was associated with increased total hip and LS BMD(a), increased total and cortical vBMD at the radius and increased cortical area, thickness and stress strain index. We also found evidence of association with BMD(a), vBMD, geometric parameters and CTX-I for SNPs in MAP3K14. None of the GPR177 and MAP3K14 SNPs were associated with calcaneal estimated BMD measured by QUS. Conclusion: Our findings suggest that SNPs in GPR177 and MAP3K14 involved in the NF-kappa B signalling pathway influence bone mineral density, geometry and turnover in a population-based cohort of middle aged and elderly men. This adds to the understanding of the role of genetic variation in this pathway in determining bone health.	[Roshandel, Delnaz; Thomson, Wendy; Pye, Stephen R.; Finn, Joseph D.; Holliday, Kate L.; O'Neill, Terence W.] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Boonen, Steven; Borghs, Herman] Katholieke Univ Leuven, Leuven Univ, Div Geriatr Med, Louvain, Belgium; [Vanderschueren, Dirk] Katholieke Univ Leuven, Dept Androl & Endocrinol, Louvain, Belgium; [Huhtaniemi, Ilpo T.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Ward, Kate A.] Elsie Widdowson Lab, MRC Human Nutr Res, Cambridge, England; [Bartfai, Gyorgy] Albert Szent Gyorgyi Med Univ, Dept Obstet Gynaecol & Androl, H-6701 Szeged, Hungary; [Casanueva, Felipe F.] Univ Santiago de Compostela, CIBER Fisiopatol Obesidad & Nutr CB06 03, Inst Salud Carlos III, Dept Med,CHUS, Santiago De Compostela, Spain; [Forti, Gianni] Univ Florence, Androl Unit, Dept Clin Physiopathol, Florence, Italy; [Giwercman, Aleksander] Lund Univ, Scanian Androl Ctr, Dept Urol, Malmo Univ Hosp, Lund, Sweden; [Han, Thang S.] Royal Free Hosp, Royal Free & Univ Coll Hosp Med Sch, Dept Endocrinol, London, England; [Kula, Krzysztof] Med Univ Lodz, Dept Androl & Reprod Endocrinol, Lodz, Poland; [Lean, Michael E.] Univ Glasgow, Dept Human Nutr, Glasgow, Lanark, Scotland; [Pendleton, Neil] Univ Manchester, Hope Hosp, Manchester Acad Hlth Sci Ctr, Salford M6 8HD, Lancs, England; [Punab, Margus] Tartu Univ Clin, Androl Unit, United Labs, Tartu, Estonia; [Wu, Frederick C.] Univ Manchester, Manchester Royal Infirm, Dept Endocrinol, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England	University of Manchester; KU Leuven; KU Leuven; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Szeged University; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Complexo Hospitalario Universitario de Santiago de Compostela; Instituto de Salud Carlos III; Universidade de Santiago de Compostela; University of Florence; Lund University; Skane University Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Medical University Lodz; University of Glasgow; University of Manchester; University of Tartu; University of Manchester	Roshandel, D (corresponding author), Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	Kate.Holliday@manchester.ac.uk	Pye, Stephen R/D-9236-2011; Pendleton, Neil/F-2333-2015	Pye, Stephen R/0000-0002-7263-2897; Pendleton, Neil/0000-0003-0794-2386; Roshandel, Delnaz/0000-0002-4902-8587; Punab, Margus/0000-0001-9601-6311; vanderschueren, dirk/0000-0003-1395-0104; Thomson, Wendy/0000-0002-9022-5179; Ward, Kate/0000-0001-7034-6750; Han, Thang/0000-0003-2570-0938; O'Neill, Terence/0000-0002-8896-4677	Commission of the European Communities [QLK6-CT-2001-00258]; Arthritis Research UK; University Hospitals Leuven, Belgium	Commission of the European Communities(European Commission); Arthritis Research UK(Versus Arthritis); University Hospitals Leuven, Belgium	The European Male Ageing Study (EMAS) is funded by the Commission of the European Communities Fifth Framework Programme "Quality of Life and Management of Living Resources'' Grant QLK6-CT-2001-00258 and supported by funding from the Arthritis Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The EMAS principal investigator is Professor Frederick Wu, MD, Dept of Endocrinology, Manchester Royal Infirmary, UK. The authors wish to thank the men who participated in the eight countries, the research/nursing staff in the eight centres: C Pott, Manchester, E Wouters, Leuven, M Nilsson, Malmo, M del Mar Fernandez, Santiago de Compostela, M Jedrzejowska, Lodz, H-M Tabo, Tartu, A Heredi, Szeged for their data collection and C Moseley, Manchester for data entry and project coordination. Dr. Vanderschueren is a senior clinical investigator supported by the Clinical Research Fund of the University Hospitals Leuven, Belgium. Dr. Boonen is a senior clinical investigator of the Fund for Scientific Research-Flanders, Belgium (F.W.O.-Vlaanderen). Dr. Boonen is holder of the Leuven University Chair in Metabolic Bone Diseases.	Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Consensus Development Conference, 1993, AM J MED, V94, P646; Cummings SR, 2006, J BONE MINER RES, V21, P1550, DOI 10.1359/JBMR.060708; Dargent-Molina P, 1999, OSTEOPOROSIS INT, V9, P188, DOI 10.1007/s001980050134; FLICKER L, 1995, J BONE MINER RES, V10, P1607; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183; KRALL EA, 1993, J BONE MINER RES, V8, P1; Lee DM, 2009, INT J ANDROL, V32, P11, DOI 10.1111/j.1365-2605.2008.00879.x; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reid DM, 2006, OSTEOPOROSIS INT, V17, P125, DOI 10.1007/s00198-005-1936-y; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Roshandel D, 2010, J BONE MINER RES, V25, P1830, DOI 10.1002/jbmr.78; Soysa NS, 2009, BIOCHEM BIOPH RES CO, V378, P1, DOI 10.1016/j.bbrc.2008.10.146; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Videman T, 2007, J BONE MINER RES, V22, P1455, DOI 10.1359/JBMR.070606; Ward KA, 2005, CALCIFIED TISSUE INT, V77, P275, DOI 10.1007/s00223-005-0031-x; Ward KA, 2005, BONE, V36, P1012, DOI 10.1016/j.bone.2005.03.001	25	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28031	10.1371/journal.pone.0028031	http://dx.doi.org/10.1371/journal.pone.0028031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132199	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000297789900040
J	Thomas, B; Suhadev, M; Mani, J; Ganapathy, BG; Armugam, A; Faizunnisha, F; Chelliah, M; Wares, F				Thomas, Beena; Suhadev, Mohanarani; Mani, Jamuna; Ganapathy, B. Gopala; Armugam, Asaithambi; Faizunnisha, F.; Chelliah, Mohanasundari; Wares, Fraser			Feasibility of an Alcohol Intervention Programme for TB Patients with Alcohol Use Disorder (AUD) - A Qualitative Study from Chennai, South India	PLOS ONE			English	Article							RISK-FACTORS; TUBERCULOSIS PATIENTS; FAILURE; DEFAULT; HEALTH; DEATH	Background: The negative influences of alcohol on TB management with regard to delays in seeking care as well as non compliance for treatment has been well documented. This study is part of a larger study on the prevalence of AUD (Alcohol Use Disorder) among TB patients which revealed that almost a quarter of TB patients who consumed alcohol could be classified as those who had AUD. However there is dearth of any effective alcohol intervention programme for TB patients with Alcohol Use Disorder (AUD). Methodology: This qualitative study using the ecological system model was done to gain insights into the perceived effect of alcohol use on TB treatment and perceived necessity of an intervention programme for TB patients with AUD. We used purposive sampling to select 44 men from 73 TB patients with an AUDIT score >8. Focus group discussions (FGDs) and interviews were conducted with TB patients with AUD, their family members and health providers. Results: TB patients with AUD report excessive alcohol intake as one of the reasons for their vulnerability for TB. Peer pressure has been reported by many as the main reason for alcohol consumption. The influences of alcohol use on TB treatment has been elaborated especially with regard to the fears around the adverse effects of alcohol on TB drugs and the fear of being reprimanded by health providers. The need for alcohol intervention programs was expressed by the TB patients, their families and health providers. Suggestions for the intervention programmes included individual and group sessions, involvement of family members, audiovisual aids and the importance of sensitization by health staff. Conclusions: The findings call for urgent need based interventions which need to be pilot tested with a randomized control trial to bring out a model intervention programme for TB patients with AUD.	[Thomas, Beena; Suhadev, Mohanarani; Mani, Jamuna; Ganapathy, B. Gopala; Armugam, Asaithambi; Faizunnisha, F.; Chelliah, Mohanasundari] TB Res Ctr, Madras, Tamil Nadu, India; [Wares, Fraser] Off WHO Representat India, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); World Health Organization	Thomas, B (corresponding author), TB Res Ctr, Madras, Tamil Nadu, India.	beenaelli09@gmail.com			World Health Organisation; United States agency for International development	World Health Organisation(World Health Organization); United States agency for International development(United States Agency for International Development (USAID))	The study was supported in part by World Health Organisation with financial assistance provided by the United States agency for International development under Model DOTS project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babor TF., 2001, ALCOHOL USE DISORDER; Das SK, 2006, NATL MED J INDIA, V19, P94; Flynn JL, 1996, ANN NY ACAD SCI, V795, P137, DOI 10.1111/j.1749-6632.1996.tb52662.x; Ganapathy Sudha, 2008, Indian J Tuberc, V55, P9; Happel Kyle I, 2005, Proc Am Thorac Soc, V2, P428, DOI 10.1513/pats.200507-065JS; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Jacobson JM, 1992, ALCOHOL HEALTH RES W, V16, P39; Jaggarajamma K, 2008, Indian J Tuberc, V55, P179; Jaggarajamma K, 2007, Indian J Tuberc, V54, P130; Jakubowiak WM, 2007, INT J TUBERC LUNG D, V11, P46; Kolappan C, 2007, INT J TUBERC LUNG D, V11, P999; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Long NH, 1999, SOC SCI MED, V49, P815, DOI 10.1016/S0277-9536(99)00171-9; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; MUNIYANDI M, 2009, 1 INT C ALC HIV IND; de Albuquerque MDPM, 2007, CAD SAUDE PUBLICA, V23, P1573, DOI 10.1590/S0102-311X2007000700008; Rajeswari R, 2005, SOC SCI MED, V60, P1845, DOI 10.1016/j.socscimed.2004.08.024; Reddy KS, 2002, AM J HEALTH BEHAV, V26, P173, DOI 10.5993/AJHB.26.3.2; REHM J, 2009, SYSTEMATIC REVIEWBMC, V9, P450; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; SAXENA S, 1999, ALCOHOL PUBLIC HLTH, P37; SIVARAM S, 2007, J URBAN HEALTH, V84, P4; *STOP TB PARTN SEC, 2001, HUM RIGHTS APPR TUB; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Suhadev M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019485; Szabo G, 1997, ALCOHOL HEALTH RES W, V21, P39; Szabo G, 1997, ALCOHOL HEALTH RES W, V21, P30; TRINI AM, 2009, EUR J PUBLIC HEALTH, V19, P16; Zhang P, 2002, FRONT BIOSCI-LANDMRK, V7, pD1314	29	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27752	10.1371/journal.pone.0027752	http://dx.doi.org/10.1371/journal.pone.0027752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	858IO	22132134	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000297789900018
J	Chang, YF; Lee-Chang, JS; Harris, KY; Sinha-Hikim, AP; Rao, MK				Chang, Yao-Fu; Lee-Chang, Jennifer S.; Harris, Krystle Y.; Sinha-Hikim, Amiya P.; Rao, Manjeet K.			Role of beta-Catenin in Post-Meiotic Male Germ Cell Differentiation	PLOS ONE			English	Article							PROTEIN-KINASE KINASE; APICAL ECTOPLASMIC SPECIALIZATION; MULLERIAN DUCT REGRESSION; DOUBLE MUTANT MICE; E-CADHERIN; ADHERENS JUNCTIONS; C-JUN; MOUSE TESTIS; ENDOPLASMIC-RETICULUM; ENDOTHELIAL-CELLS	Though roles of beta-catenin signaling during testis development have been well established, relatively little is known about its role in postnatal testicular physiology. Even less is known about its role in post-meiotic germ cell development and differentiation. Here, we report that beta-catenin is highly expressed in post-meiotic germ cells and plays an important role during spermiogenesis in mice. Spermatid-specific deletion of beta-catenin resulted in significantly reduced sperm count, increased germ cell apoptosis and impaired fertility. In addition, ultrastructural studies show that the loss of beta-catenin in post-meiotic germ cells led to acrosomal defects, anomalous release of immature spermatids and disruption of adherens junctions between Sertoli cells and elongating spermatids (apical ectoplasmic specialization; ES). These defects are likely due to altered expression of several genes reportedly involved in Sertoli cell-germ cell adhesion and germ cell differentiation, as revealed by gene expression analysis. Taken together, our results suggest that beta-catenin is an important molecular link that integrates Sertoli cell-germ cell adhesion with the signaling events essential for post-meiotic germ cell development and maturation. Since beta-catenin is also highly expressed in the Sertoli cells, we propose that binding of germ cell beta-catenin complex to beta-catenin complex on Sertoli cell at the apical ES surface triggers a signaling cascade that regulates post-meiotic germ cell differentiation.	[Chang, Yao-Fu; Lee-Chang, Jennifer S.; Harris, Krystle Y.; Rao, Manjeet K.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Rao, Manjeet K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Sinha-Hikim, Amiya P.] Charles R Drew Univ Med & Sci, Div Endocrinol Metab & Mol Med, Los Angeles, CA 90059 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Charles R. Drew University of Medicine & Science	Chang, YF (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA.	raom@uthscsa.edu			National Institute of Child Health & Human Development, National Institutes of Health [HD057118]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057118] Funding Source: NIH RePORTER	National Institute of Child Health & Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by National Institute of Child Health & Human Development (HD057118), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar MA, 2009, MOL BIOL CELL, V20, P1705, DOI 10.1091/mbc.E08-03-0282; Allard S, 2000, DEVELOPMENT, V127, P3349; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Brault V, 2001, DEVELOPMENT, V128, P1253; Braun RE, 1998, SEMIN CELL DEV BIOL, V9, P483, DOI 10.1006/scdb.1998.0226; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Cai H, 2008, CARDIOVASC RES, V77, P30, DOI 10.1093/cvr/cvm010; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chang E, 2011, BLOOD, V117, P2527, DOI 10.1182/blood-2010-08-302281; Chang H, 2008, DEVELOPMENT, V135, P1875, DOI 10.1242/dev.018572; Chang YF, 2011, BIOTECHNIQUES, V51, P341, DOI 10.2144/000113764; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Desai BS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-19; Foltz IN, 1998, J BIOL CHEM, V273, P9344, DOI 10.1074/jbc.273.15.9344; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Fucini RV, 2002, MOL BIOL CELL, V13, P621, DOI 10.1091/mbc.01-11-0547; Fukamachi K, 2002, J BIOL CHEM, V277, P43549, DOI 10.1074/jbc.C200502200; Gamell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016477; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Guo XM, 2009, TRAFFIC, V10, P1350, DOI 10.1111/j.1600-0854.2009.00950.x; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hasegawa M, 1997, RADIAT RES, V147, P457, DOI 10.2307/3579503; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Holland PM, 1997, J BIOL CHEM, V272, P24994, DOI 10.1074/jbc.272.40.24994; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Hyenne V, 2007, REPRODUCTION, V133, P563, DOI 10.1530/REP-06-0271; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kimura T, 2006, DEV BIOL, V300, P545, DOI 10.1016/j.ydbio.2006.06.038; Kobayashi A, 2011, DEVELOPMENT, V138, P1967, DOI 10.1242/dev.056143; Koksal IT, 2006, PATHOL ONCOL RES, V12, P13, DOI 10.1007/BF02893426; KOSOWER NS, 1992, J ANDROL, V13, P342; Kumar TR, 2001, ENDOCRINOLOGY, V142, P3512, DOI 10.1210/en.142.8.3512; Lee JH, 2005, ARCH ANDROLOGY, V51, P271, DOI 10.1080/014850190923387; Lee MH, 2011, FASEB J, V25, P613, DOI 10.1096/fj.10-161380; Lee NPY, 2003, BIOL REPROD, V68, P489, DOI 10.1095/biolreprod.102.005793; Luna A, 2002, MOL BIOL CELL, V13, P866, DOI 10.1091/mbc.01-12-0579; MEISTRICH ML, 1993, EUR UROL, V23, P136; Moriguchi T, 1999, J BIOL CHEM, V274, P30957, DOI 10.1074/jbc.274.43.30957; Mruk DD, 2004, TRENDS ENDOCRIN MET, V15, P439, DOI 10.1016/j.tem.2004.09.009; Mueller S, 2003, BIOL REPROD, V69, P1330, DOI 10.1095/biolreprod.102.014670; O'Bryan MK, 2008, DEV BIOL, V316, P359, DOI 10.1016/j.ydbio.2008.01.042; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; PESCHON JJ, 1987, P NATL ACAD SCI USA, V84, P5316, DOI 10.1073/pnas.84.15.5316; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Rao MK, 2006, GENE DEV, V20, P147, DOI 10.1101/gad1367806; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; RUSSELL LD, 1980, TISSUE CELL, V12, P263, DOI 10.1016/0040-8166(80)90005-1; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Shirley CR, 2004, BIOL REPROD, V71, P1220, DOI 10.1095/biolreprod.104.029363; Singh S, 2003, J BIOL CHEM, V278, P36410, DOI 10.1074/jbc.M306428200; SINHAHIKIM AP, 1993, ENDOCRINOLOGY, V133, P2161, DOI 10.1210/en.133.5.2161; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Tanuma N, 2009, ONCOGENE, V28, P752, DOI 10.1038/onc.2008.431; Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335; Tauriello DVF, 2010, CELL CYCLE, V9, P3700, DOI 10.4161/cc.9.18.13204; Theard D, 2007, MOL BIOL CELL, V18, P2313, DOI 10.1091/mbc.E06-11-1040; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Vasudevan SA, 2005, BIOCHEM BIOPH RES CO, V330, P511, DOI 10.1016/j.bbrc.2005.03.028; Wang Q, 2001, J IMMUNOL, V166, P6877, DOI 10.4049/jimmunol.166.11.6877; Wine RN, 1999, J ANDROL, V20, P198; Wolski KM, 2005, J ANDROL, V26, P354, DOI 10.2164/jandrol.04142; Wong EWP, 2008, P NATL ACAD SCI USA, V105, P9657, DOI 10.1073/pnas.0801527105; Wong EWP, 2009, INT REV CEL MOL BIO, V278, P309, DOI 10.1016/S1937-6448(09)78007-4; Xia WL, 2005, J CELL PHYSIOL, V205, P141, DOI 10.1002/jcp.20377; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Yamauchi J, 1999, J BIOL CHEM, V274, P1957, DOI 10.1074/jbc.274.4.1957; Yan HHN, 2008, P NATL ACAD SCI USA, V105, P8950, DOI 10.1073/pnas.0711264105; Yan HHN, 2006, J BIOL CHEM, V281, P17286, DOI 10.1074/jbc.M513218200; Yu W, 2007, ONCOGENE, V26, P1178, DOI 10.1038/sj.onc.1209899; Zhang JH, 2007, BIOTECHNIQUES, V42, P281, DOI 10.2144/000112429; Zhao M, 2001, MOL CELL BIOL, V21, P7243, DOI 10.1128/MCB.21.21.7243-7255.2001; Zhao M, 2007, DEV BIOL, V304, P848, DOI 10.1016/j.ydbio.2007.01.005; Zou HY, 2007, FEBS LETT, V581, P196, DOI 10.1016/j.febslet.2006.12.012	78	32	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e28039	10.1371/journal.pone.0028039	http://dx.doi.org/10.1371/journal.pone.0028039			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125654	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789200054
J	Kurth, P; Preiss, A; Kovall, RA; Maier, D				Kurth, Patricia; Preiss, Anette; Kovall, Rhett A.; Maier, Dieter			Molecular Analysis of the Notch Repressor-Complex in Drosophila: Characterization of Potential Hairless Binding Sites on Suppressor of Hairless	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; WINGLESS EXPRESSION; SIGNALING PATHWAY; CELL FATES; ACTIVATION; RECEPTOR; GENES; TRANSCRIPTION; RECRUITMENT; ANTAGONIST	The Notch signalling pathway mediates cell-cell communication in a wide variety of organisms. The major components, as well as the basic mechanisms of Notch signal transduction, are remarkably well conserved amongst vertebrates and invertebrates. Notch signalling results in transcriptional activation of Notch target genes, which is mediated by an activator complex composed of the DNA binding protein CSL, the intracellular domain of the Notch receptor, and the transcriptional coactivator Mastermind. In the absence of active signalling, CSL represses transcription from Notch target genes by the recruitment of corepressors. The Notch activator complex is extremely well conserved and has been studied in great detail. However, Notch repressor complexes are far less understood. In Drosophila melanogaster, the CSL protein is termed Suppressor of Hairless [Su(H)]. Su(H) functions as a transcriptional repressor by binding Hairless, the major antagonist of Notch signalling in Drosophila, which in turn recruits two general corepressors - Groucho and C-terminal binding protein CtBP. Recently, we determined that the C-terminal domain (CTD) of Su(H) binds Hairless and identified a single site in Hairless, which is essential for contacting Su(H). Here we present additional biochemical and in vivo studies aimed at mapping the residues in Su(H) that contact Hairless. Focusing on surface exposed residues in the CTD, we identified two sites that affect Hairless binding in biochemical assays. Mutation of these sites neither affects binding to DNA nor to Notch. Subsequently, these Su(H) mutants were found to function normally in cellular and in vivo assays using transgenic flies. However, these experiments rely on Su(H) overexpression, which does not allow for detection of quantitative or subtle differences in activity. We discuss the implications of our results.	[Kurth, Patricia; Preiss, Anette; Maier, Dieter] Univ Hohenheim, Inst Genet 240, D-7000 Stuttgart, Germany; [Kovall, Rhett A.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH USA	University Hohenheim; University System of Ohio; University of Cincinnati	Kurth, P (corresponding author), Univ Hohenheim, Inst Genet 240, D-7000 Stuttgart, Germany.	dieter.maier@uni-hohenheim.de			National Institutes of Health (NIH) [CA120199]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA120199] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a National Institutes of Health (NIH) grant CA120199 (http://www.nih.gov) and a Leukemia and Lymphoma Society award (http://www.leukemia-lymphoma.org) to RAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Barolo S, 2002, GENE DEV, V16, P1964, DOI 10.1101/gad.987402; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bray S, 2005, DEV CELL, V8, P279, DOI 10.1016/j.devcel.2004.11.020; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; DiazBenjumea FJ, 1995, DEVELOPMENT, V121, P4215; Eastman DS, 1997, MOL CELL BIOL, V17, P5620, DOI 10.1128/MCB.17.9.5620; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Friedmann DR, 2008, J BIOL CHEM, V283, P14781, DOI 10.1074/jbc.M709501200; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Furriols M, 2000, DEV BIOL, V227, P520, DOI 10.1006/dbio.2000.9923; Gho M, 1996, DEVELOPMENT, V122, P1673; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hay BA, 1997, P NATL ACAD SCI USA, V94, P5195, DOI 10.1073/pnas.94.10.5195; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Maier D, 1999, MECH DEVELOP, V89, P195, DOI 10.1016/S0925-4773(99)00208-7; Maier D, 2002, P NATL ACAD SCI USA, V99, P15480, DOI 10.1073/pnas.242596699; Maier D, 2006, HEREDITAS, V143, P212, DOI 10.1111/j.2007.0018-0661.01971.x; Maier D, 2011, MOL BIOL CELL, V22, P3242, DOI 10.1091/mbc.E11-05-0420; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Matsuno K, 1997, DEVELOPMENT, V124, P4265; Morel V, 2001, CURR BIOL, V11, P789, DOI 10.1016/S0960-9822(01)00224-X; Muller D, 2006, J CELL SCI, V119, P250, DOI 10.1242/jcs.02743; Muller D, 2005, GENETICS, V171, P1137, DOI 10.1534/genetics.105.044453; Nagel AC, 2005, MOL CELL BIOL, V25, P10433, DOI 10.1128/MCB.25.23.10433-10441.2005; Nagel AC, 2011, HEREDITAS, V148, P77, DOI 10.1111/j.1601-5223.2011.02221.x; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Perea D, 2009, DEV BIOL, V328, P445, DOI 10.1016/j.ydbio.2009.02.002; Protzer CE, 2008, J CELL SCI, V121, P3167, DOI 10.1242/jcs.035014; Rodriguez DD, 2002, DEVELOPMENT, V129, P3995; RULIFSON EJ, 1995, DEVELOPMENT, V121, P2813; SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433; Terriente J, 2008, DEV BIOL, V320, P102, DOI 10.1016/j.ydbio.2008.04.028; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; Wech I, 2005, CELL DEATH DIFFER, V12, P145, DOI 10.1038/sj.cdd.4401538; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Yu SY, 2002, DEVELOPMENT, V129, P3269	46	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27986	10.1371/journal.pone.0027986	http://dx.doi.org/10.1371/journal.pone.0027986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125648	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789200048
J	Puttker, T; Bueno, AA; de Barros, CD; Sommer, S; Pardini, R				Puettker, Thomas; Bueno, Adriana A.; de Barros, Camila dos Santos; Sommer, Simone; Pardini, Renata			Immigration Rates in Fragmented Landscapes - Empirical Evidence for the Importance of Habitat Amount for Species Persistence	PLOS ONE			English	Article							GRACILINANUS-MICROTARSUS MARSUPIALIA; PATCH ISOLATION METRICS; POPULATION-DYNAMICS; ATLANTIC FOREST; EXTINCTION THRESHOLDS; ANIMAL MOVEMENT; SMALL MAMMALS; RECAPTURE; SURVIVAL; DIDELPHIDAE	Background: The total amount of native vegetation is an important property of fragmented landscapes and is known to exert a strong influence on population and metapopulation dynamics. As the relationship between habitat loss and local patch and gap characteristics is strongly non-linear, theoretical models predict that immigration rates should decrease dramatically at low levels of remaining native vegetation cover, leading to patch-area effects and the existence of species extinction thresholds across fragmented landscapes with different proportions of remaining native vegetation. Although empirical patterns of species distribution and richness give support to these models, direct measurements of immigration rates across fragmented landscapes are still lacking. Methodology/Principal Findings: Using the Brazilian Atlantic forest marsupial Gray Slender Mouse Opossum (Marmosops Incanus) as a model species and estimating demographic parameters of populations in patches situated in three landscapes differing in the total amount of remaining forest, we tested the hypotheses that patch-area effects on population density are apparent only at intermediate levels of forest cover, and that immigration rates into forest patches are defined primarily by landscape context surrounding patches. As expected, we observed a positive patch-area effect on M. incanus density only within the landscape with intermediate forest cover. Density was independent of patch size in the most forested landscape and the species was absent from the most deforested landscape. Specifically, the mean estimated numbers of immigrants into small patches were lower in the landscape with intermediate forest cover compared to the most forested landscape. Conclusions/Significance: Our results reveal the crucial importance of the total amount of remaining native vegetation for species persistence in fragmented landscapes, and specifically as to the role of variable immigration rates in providing the underlying mechanism that drives both patch-area effects and species extinction thresholds.	[Puettker, Thomas; Bueno, Adriana A.; Pardini, Renata] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [de Barros, Camila dos Santos] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil; [Puettker, Thomas; Sommer, Simone] Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Genet, Berlin, Germany	Universidade de Sao Paulo; Universidade de Sao Paulo; Leibniz Institut fur Zoo und Wildtierforschung	Puttker, T (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil.	thomaspuettker@gmx.de	Püttker, Thomas/K-9069-2013; Pardini, Renata/C-4095-2012; Barros, Camila/C-2011-2012; Puettker, Thomas/HGU-5522-2022	Püttker, Thomas/0000-0003-0605-1442; Pardini, Renata/0000-0002-3769-8401; Barros, Camila/0000-0003-3063-8358; 	German Federal Ministry of Education and Research (BMBF Germany) [01 LB 0202]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [690144/01-6]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [05/56555-4]; Natural Environment Research Council [NE/F01614X/1] Funding Source: researchfish; NERC [NE/F01614X/1] Funding Source: UKRI	German Federal Ministry of Education and Research (BMBF Germany)(Federal Ministry of Education & Research (BMBF)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the German Federal Ministry of Education and Research (BMBF Germany; http://www.bmbf.de/) (01 LB 0202); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; http://www.cnpq.br/) (690144/01-6); and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; http://www.fapesp.br/) (05/56555-4). This study is part of the BIOCASP project (Biodiversity Conservation in Fragmented Landscapes on the Atlantic Plateau of Sao Paulo, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aars J, 1999, OIKOS, V85, P204, DOI 10.2307/3546487; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Andreassen HP, 1998, J ANIM ECOL, V67, P941, DOI 10.1046/j.1365-2656.1998.6760941.x; Andren H, 1996, OIKOS, V76, P235, DOI 10.2307/3546195; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Banks SC, 2005, MOL ECOL, V14, P1667, DOI 10.1111/j.1365-294X.2005.02525.x; Beck H, 2004, OIKOS, V106, P27, DOI 10.1111/j.0030-1299.2004.12864.x; Bender DJ, 2003, LANDSCAPE ECOL, V18, P17, DOI 10.1023/A:1022937226820; Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; BERNARDO LRR, 2010, THESIS FEDERAL U RIO, P76; Bowman J, 2002, CONSERV ECOL, V6; Briscoe DA., 2002, INTRO CONSERVATION G, DOI [10.1017/CBO9780511808999, DOI 10.1017/CBO9780511808999]; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Chiarello AG, 2000, CONSERV BIOL, V14, P1649, DOI 10.1046/j.1523-1739.2000.99071.x; Coffman CJ, 2001, OIKOS, V93, P3, DOI 10.1034/j.1600-0706.2001.930101.x; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; FAHRIG L, 1988, THEOR POPUL BIOL, V34, P194, DOI 10.1016/0040-5809(88)90042-1; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Fernandes FR, 2010, J TROP ECOL, V26, P185, DOI 10.1017/S0266467409990526; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Forero-Medina G, 2009, J TROP ECOL, V25, P53, DOI 10.1017/S0266467408005543; Gaggiotti Oscar E., 2004, P337, DOI 10.1016/B978-012323448-3/50016-7; Gardner JL, 2007, BIOL CONSERV, V135, P473, DOI 10.1016/j.biocon.2006.10.040; Gentile R, 2004, MAMMALIA, V68, P109, DOI 10.1515/mamm.2004.012; Gruber B, 2008, OECOLOGIA, V154, P679, DOI 10.1007/s00442-007-0866-0; Hanski I., 2004, ECOLOGY GENETICS EVO, P696; Hanski I, 2011, AMBIO, V40, P248, DOI 10.1007/s13280-011-0147-3; HARRISON S, 1991, BIOL J LINN SOC, V42, P73, DOI 10.1111/j.1095-8312.1991.tb00552.x; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; Johannesen E, 2000, ECOL LETT, V3, P48, DOI 10.1046/j.1461-0248.2000.00119.x; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kendall WL, 1997, ECOLOGY, V78, P563; KENDALL WL, 1992, WILDLIFE 2001 : POPULATIONS, P31; LANDE R, 1987, AM NAT, V130, P624, DOI 10.1086/284734; Lindenmayer DB, 2007, OIKOS, V116, P1220, DOI 10.1111/j.2007.0030-1299.15683.x; Lira PK, 2007, J TROP ECOL, V23, P427, DOI 10.1017/S0266467407004142; Macedo Joana, 2006, Mastozool. neotrop., V13, P133; Martins EG, 2006, MAMM BIOL, V71, P304, DOI 10.1016/j.mambio.2006.03.001; Martins EG, 2006, J TROP ECOL, V22, P461, DOI 10.1017/S0266467406003269; Metzger JP, 2010, NAT CONSERVACAO, V8, P92, DOI 10.4322/natcon.00801017; Metzger JP, 2010, SCIENCE, V329, P276, DOI 10.1126/science.329.5989.276-b; Meyer-Lucht Y, 2010, CONSERV GENET, V11, P2001, DOI 10.1007/s10592-010-0093-9; MEYERLUCHT Y, 2008, BMC GENET, V9, DOI DOI 10.1186/1471-2156-1189-1139; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; PARADIS E, 1995, J ANIM ECOL, V64, P579, DOI 10.2307/5801; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Pradel R, 1996, BIOMETRICS, V52, P703, DOI 10.2307/2532908; PUTTKER T, 2008, BMC ECOL, V8, DOI DOI 10.1186/1472-6785-1188-1189; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ruiz-Gutierrez V, 2008, ECOL APPL, V18, P838, DOI 10.1890/07-1090.1; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Smith JE, 2006, OIKOS, V112, P209; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Stoll P, 2009, J ANIM ECOL, V78, P236, DOI 10.1111/j.1365-2656.2008.01478.x; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Thomas CD, 1999, J ANIM ECOL, V68, P647, DOI 10.1046/j.1365-2656.1999.00330.x; Tischendorf L, 2003, LANDSCAPE ECOL, V18, P41, DOI 10.1023/A:1022908109982; Umetsu F, 2007, LANDSCAPE ECOL, V22, P517, DOI 10.1007/s10980-006-9041-y; Umetsu F, 2006, J MAMMAL, V87, P757, DOI 10.1644/05-MAMM-A-285R2.1; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; With KA, 1999, LANDSCAPE ECOL, V14, P73, DOI 10.1023/A:1008030215600; With KA, 1999, CONSERV BIOL, V13, P314, DOI 10.1046/j.1523-1739.1999.013002314.x; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035	69	34	36	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27963	10.1371/journal.pone.0027963	http://dx.doi.org/10.1371/journal.pone.0027963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125643	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789200043
J	Wang, QD; Zhang, M; Ning, G; Gu, WQ; Su, TW; Xu, M; Li, B; Wang, WQ				Wang, Qidi; Zhang, Min; Ning, Guang; Gu, Weiqiong; Su, Tingwei; Xu, Min; Li, Biao; Wang, Weiqing			Brown Adipose Tissue in Humans Is Activated by Elevated Plasma Catecholamines Levels and Is Inversely Related to Central Obesity	PLOS ONE			English	Article							F-18-FDG PET/CT; ADULT HUMANS; PHEOCHROMOCYTOMA; FAT; ADIPOCYTES; MICE; HYPERLIPIDEMIA; THERMOGENESIS; LIPOLYSIS; PATIENT	Background: Recent studies have shown that adult human possess active brown adipose tissue (BAT), which might be important in controlling obesity. It is known that beta-adrenoceptor-UCP1 system regulates BAT in rodent, but its influence in adult humans remains to be shown. The present study is to determine whether BAT activity can be independently stimulated by elevated catecholamines levels in adult human, and whether it is associated with their adiposity. Methodology/Principal Findings: We studied 14 patients with pheochromocytoma and 14 normal subjects who had performed both (18)F-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) and plasma total metanephrine (TMN) measurements during 2007-2010. The BAT detection rate and the mean BAT activity were significantly higher in patients with elevated TMN levels (Group A: 6/8 and 6.7 +/- 2.1 SUVmean.g/ml) than patients with normal TMN concentrations (Group B:0/6 and 0.4 +/- 0.04 SUVmean.g/ml) and normal subjects (Group C:0/14 and 0.4 +/- 0.03 SUVmean.g/ml). BAT activities were positively correlated with TMN levels (R = 0.83, p < 0.0001) and were inversely related to body mass index (R = -0.47, p = 0.010), visceral fat areas (R = -0.39, p = 0.044), visceral/total fat areas (R = -0.52, p = 0.0043) and waist circumferences (R = -0.43, p = 0.019). Robust regression revealed that TMN (R = 0.81, p < 0.0001) and waist circumferences (R = -0.009, p = 0.009) were the two independent predictors of BAT activities. Conclusions/Significance: Brown adipose tissue activity in adult human can be activated by elevated plasma TMN levels, such as in the case of patients with pheochromocytoma, and is negatively associated with central adiposity.	[Wang, Qidi; Ning, Guang; Gu, Weiqiong; Su, Tingwei; Xu, Min; Wang, Weiqing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Endocrine Tumors, Chinese Hlth Minist,Rui Jin Hosp, Shanghai 200030, Peoples R China; [Wang, Qidi; Ning, Guang; Gu, Weiqiong; Su, Tingwei; Xu, Min; Wang, Weiqing] Shanghai Jiao Tong Univ, Sch Med, Key Lab Endocrine & Metab Dis, Chinese Hlth Minist,Rui Jin Hosp, Shanghai 200030, Peoples R China; [Wang, Qidi; Ning, Guang; Gu, Weiqiong; Su, Tingwei; Xu, Min; Wang, Weiqing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Clin Ctr Endocrine & Metab Dis, E Inst Shanghai Univ,Rui Jin Hosp, Shanghai 200030, Peoples R China; [Wang, Qidi; Ning, Guang; Gu, Weiqiong; Su, Tingwei; Xu, Min; Wang, Weiqing] Shanghai Jiao Tong Univ, Sch Med, Div Endocrinol & Metab, E Inst Shanghai Univ,Rui Jin Hosp, Shanghai 200030, Peoples R China; [Zhang, Min; Li, Biao] Shanghai Jiao Tong Univ, Sch Med, Dept Nucl Med, Rui Jin Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, QD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Endocrine Tumors, Chinese Hlth Minist,Rui Jin Hosp, Shanghai 200030, Peoples R China.	wqingw@hotmail.com		Wang, Qinhu/0000-0003-1251-073X; Shan, Weixing/0000-0001-7286-4041	National Key Technologies Research and Development Program [2008ZX09312-0191200]; Chinese National Natural Science Foundation [30725037, 81030011]; Key Project of Shanghai Science and Technology [09DZ1950200]; National Natural Science Foundation of China [81070616]; Shanghai Pujiang Program [10PJ1407400]	National Key Technologies Research and Development Program(National Key Technology R&D Program); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Project of Shanghai Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This study was supported by the grants from the National Key Technologies Research and Development Program (2008ZX09312-0191200), the Chinese National Natural Science Foundation (30725037 and 81030011), the Key Project of Shanghai Science and Technology (09DZ1950200), the National Natural Science Foundation of China (No. 81070616), and Shanghai Pujiang Program (10PJ1407400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R., 2008, SAGE U PAPER SERIES; Arch JRS, 1996, INT J OBESITY, V20, P191; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; COPPACK SW, 1994, J LIPID RES, V35, P177; COUSIN B, 1992, J CELL SCI, V103, P931; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Daniels SR, 2000, AM J EPIDEMIOL, V152, P1179, DOI 10.1093/aje/152.12.1179; DULLOO AG, 1984, CAN J PHYSIOL PHARM, V62, P235, DOI 10.1139/y84-035; Fruhbeck G, 2009, TRENDS PHARMACOL SCI, V30, P387, DOI 10.1016/j.tips.2009.05.003; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hadi M, 2007, J NUCL MED, V48, P1077, DOI 10.2967/jnumed.106.035915; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Inokuma K, 2006, AM J PHYSIOL-ENDOC M, V290, pE1014, DOI 10.1152/ajpendo.00105.2005; Yamaga LYI, 2008, EUR J NUCL MED MOL I, V35, P446, DOI 10.1007/s00259-007-0538-7; KAJIMURA S, CELL METAB, V11, P257; Kuji I, 2008, ANN NUCL MED, V22, P231, DOI 10.1007/s12149-007-0096-x; Large V, 1998, DIABETES METAB, V24, P409; LEAN MEJ, 1986, INT J OBESITY, V10, P219; LENDERS JWM, 1993, CLIN CHEM, V39, P97; Lenders JWM, 2002, JAMA-J AM MED ASSOC, V287, P1427, DOI 10.1001/jama.287.11.1427; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lofgren P, 2005, DIABETOLOGIA, V48, P2334, DOI 10.1007/s00125-005-1961-6; LONCAR D, 1991, CELL TISSUE RES, V266, P149, DOI 10.1007/BF00678721; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lowell BB, 2003, J BIOL CHEM, V278, P29385, DOI 10.1074/jbc.R300011200; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Menke A, 2007, OBESITY, V15, P785, DOI 10.1038/oby.2007.593; Omachi A, 2008, RES VET SCI, V85, P214, DOI 10.1016/j.rvsc.2007.11.003; RICQUIER D, 1982, J CLIN ENDOCR METAB, V54, P803; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283; 2005, GE MED SYSTEMS VOLUM, P399	35	97	101	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2011	6	6							e21006	10.1371/journal.pone.0021006	http://dx.doi.org/10.1371/journal.pone.0021006			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782BY	22140518	Green Published, Green Submitted, gold			2022-12-25	WOS:000291983800017
J	Kuo, CJ; Bell, H; Hsieh, CL; Ptak, CP; Chang, YF				Kuo, Chih-Jung; Bell, Hannah; Hsieh, Ching-Lin; Ptak, Christopher P.; Chang, Yung-Fu			Novel Mycobacteria Antigen 85 Complex Binding Motif on Fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE PROTEIN; STAPHYLOCOCCUS-AUREUS; ATTACHMENT PROTEIN; BACTERIAL ADHERENCE; PROTECTIVE EFFICACY; CRYSTAL-STRUCTURE; SECRETED PROTEIN; CALCIUM BINDS; TUBERCULOSIS; ADHESIN	The members of the antigen 85 protein family (Ag85), consisting of members Ag85A, Ag85B, and Ag85C, are the predominantly secreted proteins of mycobacteria and possess the ability to specifically interact with fibronectin (Fn). Because Fn-binding proteins are likely to be important virulence factors of Mycobacterium spp., Ag85 may contribute to the adherence, invasion, and dissemination of organisms in host tissue. In this study, we reported the Fn binding affinity of Ag85A, Ag85B, and Ag85C from Mycobacterium avium subsp. paratuberculosis (MAP) (K-D values were determined from 33.6 to 68.4 nM) and mapped the Ag85-binding motifs of Fn. Fn14, a type III module located on the heparin-binding domain II (Hep-2) of Fn, was discovered to interact with Ag85 from MAP. The peptide inhibition assay subsequently demonstrated that a peptide consisting of residues 17-26 from Fn14 ((17)SLLVSWQPPR(26), termed P17-26) could interfere with Ag85B binding to Fn (73.3% reduction). In addition, single alanine substitutions along the sequence of P17-26 revealed that the key residues involved in Ag85-Fn binding likely contribute through hydrophobic and charge interactions. Moreover, binding of Ag85 on Fn siRNA-transfected Caco2 cells was dramatically reduced (44.6%), implying the physiological significance of the Ag85-Fn interaction between mycobacteria and host cells during infection. Our results indicate that Ag85 binds to Fn at a novel motif and plays a critical role in mycobacteria adherence to host cells by initiating infection. Ag85 might serve as an important colonization factor potentially contributing to mycobacterial virulence.	[Kuo, Chih-Jung; Bell, Hannah; Hsieh, Ching-Lin; Chang, Yung-Fu] Cornell Univ, Dept Populat Med & Diagnost Sci, Coll Vet Med, Ithaca, NY 14853 USA; [Ptak, Christopher P.] Cornell Univ, Dept Mol Med, Coll Vet Med, Ithaca, NY 14853 USA	Cornell University; Cornell University	Chang, YF (corresponding author), Cornell Univ, Dept Populat Med & Diagnost Sci, Coll Vet Med, Ithaca, NY 14853 USA.	yc42@cornell.edu	Ptak, Christopher/AAP-7763-2021; Hsieh, Ching-Lin/ABA-6461-2021; Ptak, Christopher/I-3126-2012; Hsieh, Ching-Lin/K-4139-2018	Ptak, Christopher/0000-0003-2752-0367; Ptak, Christopher/0000-0003-2752-0367; Kuo, Chih-Jung/0000-0002-4988-5124; Hsieh, Ching-Lin/0000-0002-3665-5717	Agriculture and Food Research Initiative, United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2008-55620-18710, 2009-65119-05993]; National Research Initiative, United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2008-35204-04626]; Biotechnology Research and Development Corporation (BRDC); Animal Formula Fund [NY-478455, NY-478437]	Agriculture and Food Research Initiative, United States Department of Agriculture Cooperative State Research, Education, and Extension Service; National Research Initiative, United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Biotechnology Research and Development Corporation (BRDC); Animal Formula Fund	This work was supported by Agriculture and Food Research Initiative, United States Department of Agriculture Cooperative State Research, Education, and Extension Service Grant 2008-55620-18710 (Johne's Disease Integrated Program), the National Research Initiative, United States Department of Agriculture Cooperative State Research, Education, and Extension Service Grant 2008-35204-04626, the Agriculture and Food Research Initiative, United States Department of Agriculture Cooperative State Research, Education, and Extension Service Grant 2009-65119-05993, the Biotechnology Research and Development Corporation (BRDC), and the Animal Formula Fund Grant NY-478455 and NY-478437.	AMBLER RP, 1968, BIOCHEM J, V108, P893, DOI 10.1042/bj1080893; Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; Baldwin S. L., 1999, Tubercle and Lung Disease, V79, P251, DOI 10.1054/tuld.1998.0196; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Chessa D, 2008, MOL MICROBIOL, V68, P573, DOI 10.1111/j.1365-2958.2008.06185.x; COCITO C, 1994, CLIN MICROBIOL REV, V7, P328, DOI 10.1128/CMR.7.3.328-345.1994; Dabo SM, 2006, INFECT IMMUN, V74, P2513, DOI 10.1128/IAI.74.5.2513-2521.2006; Denis O, 1997, INFECT IMMUN, V65, P676, DOI 10.1128/IAI.65.2.676-684.1997; Hermon-Taylor J, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-15; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; JANICKI BW, 1971, AM REV RESPIR DIS, V104, P602; Janvilisri T, 2010, J INFECT DIS, V202, P282, DOI 10.1086/653484; Joh D, 1998, EUR J BIOCHEM, V258, P897, DOI 10.1046/j.1432-1327.1998.2580897.x; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; JOHNE HA, 1895, DTSCH Z TIERMED PATH, V21, P438; Kamath AT, 1999, INFECT IMMUN, V67, P1702; Kingsley RA, 2004, MOL MICROBIOL, V52, P345, DOI 10.1111/j.1365-2958.2004.03995.x; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin YP, 2011, J BIOL CHEM, V286, P3957, DOI 10.1074/jbc.M110.184523; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Mempel M, 2002, BRIT J DERMATOL, V146, P943, DOI 10.1046/j.1365-2133.2002.04752.x; NAGAI S, 1991, INFECT IMMUN, V59, P372, DOI 10.1128/IAI.59.1.372-382.1991; Naito M, 2000, BIOCHEM J, V347, P725, DOI 10.1042/0264-6021:3470725; Naito M, 1998, J BIOL CHEM, V273, P2905, DOI 10.1074/jbc.273.5.2905; National Animal Health Monitoring System, 1997, JOHN DIS US DAIR OP; OHARA N, 1995, SCAND J IMMUNOL, V41, P433, DOI 10.1111/j.1365-3083.1995.tb03589.x; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Peacock SJ, 1999, MICROBIOL-SGM, V145, P3477, DOI 10.1099/00221287-145-12-3477; PEAKE P, 1993, INFECT IMMUN, V61, P4828, DOI 10.1128/IAI.61.11.4828-4834.1993; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POTTS JR, 1994, CURR OPIN CELL BIOL, V6, P648, DOI 10.1016/0955-0674(94)90090-6; Probert WS, 2001, INFECT IMMUN, V69, P4129, DOI 10.1128/IAI.69.6.4129-4133.2001; RATLIFF TL, 1993, INFECT IMMUN, V61, P1889, DOI 10.1128/IAI.61.5.1889-1894.1993; Ronning DR, 2004, J BIOL CHEM, V279, P36771, DOI 10.1074/jbc.M400811200; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Sanki AK, 2009, MOL BIOSYST, V5, P945, DOI 10.1039/b902284h; Santos R, 2001, MOL PLANT MICROBE IN, V14, P758, DOI 10.1094/MPMI.2001.14.6.758; SCHOREY JS, 1995, INFECT IMMUN, V63, P2652, DOI 10.1128/IAI.63.7.2652-2657.1995; Schorey JS, 1996, MOL MICROBIOL, V21, P321, DOI 10.1046/j.1365-2958.1996.6381353.x; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Secott TE, 2001, INFECT IMMUN, V69, P2075, DOI 10.1128/IAI.69.4.2075-2082.2001; Sharma A, 1999, EMBO J, V18, P1468, DOI 10.1093/emboj/18.6.1468; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Tung JY, 2010, J BIOL CHEM, V285, P3245, DOI 10.1074/jbc.M109.006320; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; Vazquez V, 2011, J BIOL CHEM, V286, P29797, DOI 10.1074/jbc.M110.214981; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992; Xu QJ, 2004, J BIOL CHEM, V279, P4269, DOI 10.1074/jbc.M311586200; Zhao WC, 1999, J BIOL CHEM, V274, P4521, DOI 10.1074/jbc.274.8.4521	55	32	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1892	1902		10.1074/jbc.M111.298687	http://dx.doi.org/10.1074/jbc.M111.298687			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128161	Green Published, hybrid			2022-12-25	WOS:000299321000030
J	Pfister, AS; Tanneberger, K; Schambony, A; Behrens, J				Pfister, Astrid S.; Tanneberger, Kristina; Schambony, Alexandra; Behrens, Juergen			Amer2 Protein Is a Novel Negative Regulator of Wnt/beta-Catenin Signaling Involved in Neuroectodermal Patterning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; FUNCTIONAL INTERACTION; GENE FAMILY; WILMS-TUMOR; XENOPUS; EXPRESSION; APC; WTX; TRANSCRIPTION; MEMBRANE	Wnt/beta-catenin signaling is negatively controlled by the adenomatous polyposis coli (APC) tumor suppressor, which induces proteasomal degradation of beta-catenin as part of the beta-catenin destruction complex. Amer2 (APC membrane recruitment 2; FAM123A) is a direct interaction partner of APC, related to the tumor suppressor Amer1/WTX, but its function in Wnt signaling is not known. Here, we show that Amer2 recruits APC to the plasma membrane by binding to phosphatidylinositol 4,5-bispho-sphate lipids via lysine-rich motifs and that APC links beta-catenin and the destruction complex components axin and conductin to Amer2. Knockdown of Amer2 increased Wnt target gene expression and reporter activity in cell lines, and overexpression reduced reporter activity, which required membrane association of Amer2. In Xenopus embryos, Amer2 is expressed mainly in the dorsal neuroectoderm and neural tissues. Down-regulation of Amer2 by specific morpholino oligonucleotides altered neuroectodermal patterning, which could be rescued by expression of a dominant-negative mutant of Lef1 that interferes with beta-catenin-dependent transcription. Our data characterize Amer2 for the first time as a negative regulator of Wnt signaling both in cell lines and in vivo and define Amer proteins as a novel family of Wnt pathway regulators.	[Pfister, Astrid S.; Tanneberger, Kristina; Behrens, Juergen] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany; [Schambony, Alexandra] Univ Erlangen Nurnberg, Dept Biol, D-91058 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Behrens, J (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, Gluckstr 6, D-91054 Erlangen, Germany.	jbehrens@molmed.uni-erlangen.de		Schambony, Alexandra/0000-0001-8771-5487	Deutsche Forschungsgemeinschaft [Be1550/6-1, SCHA965/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Be1550/6-1 (to J. B.) and SCHA965/6-1 (to A. S.).	Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Boutet A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-280; BRADLEY LC, 1993, MECH DEVELOP, V40, P73, DOI 10.1016/0925-4773(93)90089-G; Casarosa S, 1997, MECH DEVELOP, V61, P187, DOI 10.1016/S0925-4773(96)00640-5; Comai G, 2010, DEV DYNAM, V239, P1867, DOI 10.1002/dvdy.22313; Conacci-Sorrell ME, 2002, GENE DEV, V16, P2058, DOI 10.1101/gad.227502; De Robertis EM, 1997, COLD SPRING HARB SYM, V62, P169; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Hamada F, 2002, NAT CELL BIOL, V4, P208, DOI 10.1038/ncb755; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; Jenkins ZA, 2009, NAT GENET, V41, P95, DOI 10.1038/ng.270; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kohler EM, 2008, HUM MOL GENET, V17, P1978, DOI 10.1093/hmg/ddn095; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Michiue T, 2004, DEV DYNAM, V230, P79, DOI 10.1002/dvdy.20037; Moisan A, 2011, DEV CELL, V20, P583, DOI 10.1016/j.devcel.2011.03.013; Polakis P, 2000, GENE DEV, V14, P1837; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Tanneberger K, 2011, J BIOL CHEM, V286, P19204, DOI 10.1074/jbc.M111.224881; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Unterseher F, 2004, EMBO J, V23, P3259, DOI 10.1038/sj.emboj.7600332; Yamamoto Y, 2003, HEPATOLOGY, V37, P528, DOI 10.1053/jhep.2003.50029; Zhou ZF, 2011, P NATL ACAD SCI USA, V108, P6626, DOI 10.1073/pnas.1018514108	31	18	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1734	1741		10.1074/jbc.M111.308650	http://dx.doi.org/10.1074/jbc.M111.308650			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128170	Green Published, hybrid			2022-12-25	WOS:000299321000016
J	Usukura, E; Suzuki, T; Furuike, S; Soga, N; Saita, E; Hisabori, T; Kinosita, K; Yoshida, M				Usukura, Eiji; Suzuki, Toshiharu; Furuike, Shou; Soga, Naoki; Saita, Ei-ichiro; Hisabori, Toru; Kinosita, Kazuhiko, Jr.; Yoshida, Masasuke			Torque Generation and Utilization in Motor Enzyme F0F1-ATP Synthase HALF-TORQUE F-1 WITH SHORT-SIZED PUSHROD HELIX AND REDUCED ATP SYNTHESIS BY HALF-TORQUE F0F1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; PROTON MOTIVE FORCE; BETA-SUBUNIT; CATALYTIC SUBUNITS; FOF1-ATP SYNTHASE; ROTARY MECHANISM; EPSILON-SUBUNIT; F-1-ATPASE; ROTATION; RESOLUTION	ATP synthase (F0F1) is made of two motors, a proton-driven motor (F-0) and an ATP-driven motor (F-1), connected by a common rotary shaft, and catalyzes proton flow-driven ATP synthesis and ATP-driven proton pumping. In F-1, the central gamma subunit rotates inside the alpha(3)beta(3) ring. Here we report structural features of F-1 responsible for torque generation and the catalytic ability of the low-torque F0F1. (i) Deletion of one or two turns in the alpha-helix in the C-terminal domain of catalytic beta subunit at the rotor/stator contact region generates mutant F(1)s, termed F-1(1/2)s, that rotate with about half of the normal torque. This helix would support the helix-loop-helix structure acting as a solid "pushrod" to push the rotor gamma subunit, but the short helix in F-1(1/2) s would fail to accomplish this task. (ii) Three different half-torque F0F1(1/2)s were purified and reconstituted into proteoliposomes. They carry out ATP-driven proton pumping and build up the same small transmembrane Delta pH, indicating that the final Delta pH is directly related to the amount of torque. (iii) The half-torque F0F1(1/2)s can catalyze ATP synthesis, although slowly. The rate of synthesis varies widely among the three F0F1(1/2)s, which suggests that the rate reflects subtle conformational variations of individual mutants.	[Yoshida, Masasuke] Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 6038555, Japan; [Usukura, Eiji; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; [Suzuki, Toshiharu; Saita, Ei-ichiro; Hisabori, Toru; Yoshida, Masasuke] Japan Sci & Technol Agcy JST, Int Cooperat Res Project ICORP, ATP Synth Regulat Project, Tokyo 1350064, Japan; [Furuike, Shou] Osaka Med Coll, Dept Phys, Takatsuki, Osaka 5698686, Japan; [Soga, Naoki; Kinosita, Kazuhiko, Jr.] Waseda Univ, Dept Phys, Shinjuku Ku, Tokyo 1710033, Japan	Kyoto Sangyo University; Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Osaka Medical College; Waseda University	Yoshida, M (corresponding author), Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 6038555, Japan.	masasuke.yoshida@cc.kyoto-su.ac.jp	Hisabori, Toru/E-5205-2014	Hisabori, Toru/0000-0003-2046-0277	Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [21000011] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the ATP synthesis Regulation Project (ICORP) through Japan Science and Technology Agency (to M.Y.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; Boyer PD, 2002, J BIOL CHEM, V277, P39045, DOI 10.1074/jbc.X200001200; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Furuike S, 2008, BIOPHYS J, V95, P761, DOI 10.1529/biophysj.107.123307; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Hara KY, 2000, J BIOL CHEM, V275, P14260, DOI 10.1074/jbc.275.19.14260; Hayashi K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218103; Hossain MD, 2008, BIOPHYS J, V95, P4837, DOI 10.1529/biophysj.108.140061; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; Kohori A, 2011, BIOPHYS J, V101, P188, DOI 10.1016/j.bpj.2011.05.008; Konno H, 2004, BIOCHEM BIOPH RES CO, V318, P17, DOI 10.1016/j.bbrc.2004.03.179; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; Mnatsakanyan N, 2011, J BIOL CHEM, V286, P29788, DOI 10.1074/jbc.M111.254730; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Oster G, 2003, TRENDS CELL BIOL, V13, P114, DOI 10.1016/S0962-8924(03)00004-7; Panke O, 2001, BIOPHYS J, V81, P1220, DOI 10.1016/S0006-3495(01)75780-3; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Soga N, 2011, FEBS J, V278, P2647, DOI 10.1111/j.1742-4658.2011.08191.x; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	40	35	35	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1884	1891		10.1074/jbc.M111.305938	http://dx.doi.org/10.1074/jbc.M111.305938			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128167	hybrid, Green Published			2022-12-25	WOS:000299321000029
J	Veshnyakova, A; Piontek, J; Protze, J; Waziri, N; Heise, I; Krause, G				Veshnyakova, Anna; Piontek, Joerg; Protze, Jonas; Waziri, Negar; Heise, Ivonne; Krause, Gerd			Mechanism of Clostridium perfringens Enterotoxin Interaction with Claudin-3/-4 Protein Suggests Structural Modifications of the Toxin to Target Specific Claudins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL FRAGMENT; PORE-FORMING TOXINS; TIGHT JUNCTION; BARRIER; CANCER; IDENTIFICATION; DETERMINANTS; METASTASIS; MODULATOR; DOMAIN	Claudins (Cld) are essential constituents of tight junctions. Domain I of Clostridium perfringens enterotoxin (cCPE) binds to the second extracellular loop (ECL2) of a subset of claudins, e. g. Cld3/4 and influences tight junction formation. We aimed to identify interacting interfaces and to alter claudin specificity of cCPE. Mutagenesis, binding assays, and molecular modeling were performed. Mutation-guided ECL2 docking of Cld3/4 onto the crystal structure of cCPE revealed a common orientation of the proposed ECL2 helix-turn-helix motif in the binding cavity of cCPE: residues Leu(150)/Leu(151) of Cld3/4 bind similarly to a hydrophobic pit formed by Tyr(306), Tyr(310), and Tyr(312) of cCPE, and Pro(152)/Ala(153) of Cld3/4 is proposed to bind to a second pit close to Leu(223), Leu(254), and Leu(315). However, sequence variation in ECL2 of these claudins is likely responsible for slightly different conformation in the turn region, which is in line with different cCPE interaction modes of Cld3 and Cld4. Substitutions of other so far not characterized cCPE residues lining the pocket revealed two spatially separated groups of residues (Leu(223), Asp(225), and Arg(227) and Leu(254), lle(258), and Asp(284)), which are involved in binding to Cld3 and Cld4, albeit differently. Involvement of Asn(148) of Cld3 in cCPE binding was confirmed, whereas no evidence for involvement of Lys(156) or Arg(157) was found. We show structure-based alteration of cCPE generating claudin binders, which interact subtype-specific preferentially either with Cld3 or with Cld4. The obtained mutants and mechanistic insights will advance the design of cCPE-based modulators to target specific claudin subtypes related either to paracellular barriers that impede drug delivery or to tumors.	[Veshnyakova, Anna; Piontek, Joerg; Protze, Jonas; Waziri, Negar; Heise, Ivonne; Krause, Gerd] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Piontek, J (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	piontek@fmp-berlin.de	Piontek, Joerg/K-6305-2013; Protze, Jonas/ABB-9737-2020	Piontek, Joerg/0000-0002-0880-8915; Protze, Jonas/0000-0002-1506-9831	Deutsche Forschungsgemeinschaft [KR 1273/3-2, PI 837/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants KR 1273/3-2 and PI 837/2-1.	Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; Briggs DC, 2011, J MOL BIOL, V413, P138, DOI 10.1016/j.jmb.2011.07.066; Casagrande F, 2011, CANCER-AM CANCER SOC, V117, P5519, DOI 10.1002/cncr.26215; Ebihara C, 2006, J PHARMACOL EXP THER, V316, P255, DOI 10.1124/jpet.105.093351; Escudero-Esparza A, 2011, FRONT BIOSCI-LANDMRK, V16, P1069, DOI 10.2741/3736; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Harada M, 2007, BIOCHEM PHARMACOL, V73, P206, DOI 10.1016/j.bcp.2006.10.002; Kakutani H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016611; Katahira J, 1997, J BIOL CHEM, V272, P26652, DOI 10.1074/jbc.272.42.26652; Kimura J, 2010, J BIOL CHEM, V285, P401, DOI 10.1074/jbc.M109.051417; Kitadokoro K, 2011, J BIOL CHEM, V286, P19549, DOI 10.1074/jbc.M111.228478; KokaiKun JF, 1997, INFECT IMMUN, V65, P1014, DOI 10.1128/IAI.65.3.1014-1022.1997; Kominsky SL, 2007, CANCER RES, V67, P7977, DOI 10.1158/0008-5472.CAN-07-1314; Kondoh M, 2006, BIOL PHARM BULL, V29, P1783, DOI 10.1248/bpb.29.1783; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Krause G, 2009, ANN NY ACAD SCI, V1165, P34, DOI 10.1111/j.1749-6632.2009.04057.x; McClane BA, 2001, TOXICON, V39, P1781, DOI 10.1016/S0041-0101(01)00164-7; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ouban A, 2010, HISTOL HISTOPATHOL, V25, P83, DOI 10.14670/HH-25.83; Piehl C, 2010, CELL MOL LIFE SCI, V67, P2131, DOI 10.1007/s00018-010-0332-8; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Piontek J, 2011, CELL MOL LIFE SCI, V68, P3903, DOI 10.1007/s00018-011-0680-z; Robertson SL, 2010, INFECT IMMUN, V78, P505, DOI 10.1128/IAI.00778-09; Saeki R, 2009, MOL PHARMACOL, V76, P918, DOI 10.1124/mol.109.058412; Smedley JG, 2007, INFECT IMMUN, V75, P2381, DOI 10.1128/IAI.01737-06; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Takahashi A, 2011, CURR MED CHEM, V18, P1861, DOI 10.2174/092986711795496809; Takahashi A, 2008, BIOCHEM PHARMACOL, V75, P1639, DOI 10.1016/j.bcp.2007.12.016; Turksen K, 2011, BBA-REV CANCER, V1816, P73, DOI 10.1016/j.bbcan.2011.04.001; Van Itallie CM, 2008, J BIOL CHEM, V283, P268, DOI 10.1074/jbc.M708066200; Veshnyakova A, 2010, TOXINS, V2, P1336, DOI 10.3390/toxins2061336; Walther W, 2012, GENE THER, V19, P494, DOI 10.1038/gt.2011.136; Winkler L, 2009, J BIOL CHEM, V284, P18863, DOI 10.1074/jbc.M109.008623; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154; Zhang JJ, 2010, P NATL ACAD SCI USA, V107, P1425, DOI 10.1073/pnas.0911996107	37	67	68	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1698	1708		10.1074/jbc.M111.312165	http://dx.doi.org/10.1074/jbc.M111.312165			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128179	Green Published, hybrid			2022-12-25	WOS:000299321000013
J	Soto-Cardalda, A; Fakas, S; Pascual, F; Choi, HS; Carman, GM				Soto-Cardalda, Anibal; Fakas, Stylianos; Pascual, Florencia; Choi, Hyeon-Son; Carman, George M.			Phosphatidate Phosphatase Plays Role in Zinc-mediated Regulation of Phospholipid Synthesis in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLSERINE SYNTHASE; TRANSCRIPTIONAL ACTIVATOR; TRANSPORTER PROTEIN; GENETIC-REGULATION; ESCHERICHIA-COLI; CHOLINE KINASE; LIPIN HOMOLOG; BIOSYNTHESIS	In the yeast Saccharomyces cerevisiae, the synthesis of phospholipids is coordinately regulated by mechanisms that control the homeostasis of the essential mineral zinc (Carman, G. M., and Han, G. S. (2007) Regulation of phospholipid synthesis in Saccharomyces cerevisiae by zinc depletion. Biochim. Biophys. Acta 1771, 322-330; Eide, D. J. (2009) Homeostatic and adaptive responses to zinc deficiency in Saccharomyces cerevisiae. J. Biol. Chem. 284, 18565-18569). The synthesis of phosphatidylcholine is balanced by the repression of CDP-diacylglycerol pathway enzymes and the induction of Kennedy pathway enzymes. PAH1-encoded phosphatidate phosphatase catalyzes the penultimate step in triacylglycerol synthesis, and the diacylglycerol generated in the reaction may also be used for phosphatidylcholine synthesis via the Kennedy pathway. In this work, we showed that the expression of PAH1-encoded phosphatidate phosphatase was induced by zinc deficiency through a mechanism that involved interaction of the Zap1p zinc-responsive transcription factor with putative upstream activating sequence zinc-responsive elements in the PAH1 promoter. The pah1 Delta mutation resulted in the derepression of the CHO1-encoded phosphatidylserine synthase (CDP-diacylglycerol pathway enzyme) and loss of the zinc-mediated regulation of the enzyme. Loss of phosphatidate phosphatase also resulted in the derepression of the CKI1-encoded choline kinase (Kennedy pathway enzyme) but decreased the synthesis of phosphatidylcholine when cells were deficient of zinc. This result confirmed the role phosphatidate phosphatase plays in phosphatidylcholine synthesis via the Kennedy pathway.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu	Fakas, Stylianos/R-9908-2019; Fakas, Stylianos/AAQ-7594-2020	Fakas, Stylianos/0000-0001-8692-1326; Fakas, Stylianos/0000-0001-8692-1326	National Institutes of Health from the USPHS [GM-28140, GM-75378]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, F31GM075378, R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health from the USPHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-28140 (to G. M. C.) and GM-75378 (to A. S.-C.) from the USPHS.	BAILIS AM, 1992, NUCLEIC ACIDS RES, V20, P1411, DOI 10.1093/nar/20.6.1411; BAILIS AM, 1987, MOL CELL BIOL, V7, P167, DOI 10.1128/MCB.7.1.167; Bird A, 2000, J BIOL CHEM, V275, P16160, DOI 10.1074/jbc.M000664200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2007, BBA-MOL CELL BIOL L, V1771, P322, DOI 10.1016/j.bbalip.2006.05.006; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1992, METHOD ENZYMOL, V209, P298; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; CRAVEN GR, 1965, J BIOL CHEM, V240, P2468; Devirgiliis C, 2004, BIOCHEM BIOPH RES CO, V323, P58, DOI 10.1016/j.bbrc.2004.08.051; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Eide DJ, 2003, J NUTR, V133, p1532S, DOI 10.1093/jn/133.5.1532S; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Furneisen JM, 2000, BBA-MOL CELL BIOL L, V1484, P71, DOI 10.1016/S1388-1981(99)00202-4; Gaspar ML, 2007, BBA-MOL CELL BIOL L, V1771, P241, DOI 10.1016/j.bbalip.2006.06.011; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Habeler G, 2002, NUCLEIC ACIDS RES, V30, P80, DOI 10.1093/nar/30.1.80; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; Han SH, 2005, J BIOL CHEM, V280, P29017, DOI 10.1074/jbc.M505881200; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kersting MC, 2006, J BIOL CHEM, V281, P13110, DOI 10.1074/jbc.M601612200; Kim KH, 1998, J BIOL CHEM, V273, P6844, DOI 10.1074/jbc.273.12.6844; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; LAMPING E, 1994, GENETICS, V137, P55; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MacDiarmid CW, 2003, J BIOL CHEM, V278, P15065, DOI 10.1074/jbc.M300568200; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Miyabe S, 2001, BIOCHEM BIOPH RES CO, V282, P79, DOI 10.1006/bbrc.2001.4522; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; NIKAWA J, 1993, MOL MICROBIOL, V10, P955, DOI 10.1111/j.1365-2958.1993.tb00967.x; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oshiro J, 2003, BBA-MOL CELL BIOL L, V1635, P1, DOI 10.1016/j.bbalip.2003.10.002; Oshiro J, 2000, J BIOL CHEM, V275, P40887, DOI 10.1074/jbc.M008144200; POOLE MA, 1986, J BACTERIOL, V168, P668, DOI 10.1128/jb.168.2.668-672.1986; PORTER TJ, 1992, METHOD ENZYMOL, V209, P134; RATTRAY JBM, 1975, BACTERIOL REV, V39, P197, DOI 10.1128/MMBR.39.3.197-231.1975; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; SCHWABE JWR, 1994, NAT STRUCT BIOL, V1, P345, DOI 10.1038/nsb0694-345; Soto A, 2008, J BIOL CHEM, V283, P10079, DOI 10.1074/jbc.M800502200; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; Waters BM, 2002, J BIOL CHEM, V277, P33749, DOI 10.1074/jbc.M206214200; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zhao H, 1996, J BIOL CHEM, V271, P23203, DOI 10.1074/jbc.271.38.23203; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	74	36	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					968	977		10.1074/jbc.M111.313130	http://dx.doi.org/10.1074/jbc.M111.313130			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128164	hybrid, Green Published			2022-12-25	WOS:000299170300015
J	Goshima, G				Goshima, Gohta			Identification of a TPX2-Like Microtubule-Associated Protein in Drosophila	PLOS ONE			English	Article							SPINDLE-POLE ORGANIZATION; CELL-CYCLE PROGRESSION; XENOPUS EGG EXTRACTS; AURORA-A KINASE; MITOTIC SPINDLE; MAMMALIAN-CELLS; IMPORTIN-ALPHA; S2 CELLS; TPX2; LOCALIZATION	Chromosome segregation during mitosis and meiosis relies on the spindle and the functions of numerous microtubule-associated proteins (MAPs). One of the best-studied spindle MAPs is the highly conserved TPX2, which has been reported to have characteristic intracellular dynamics and molecular activities, such as nuclear localisation in interphase, poleward movement in the metaphase spindle, microtubule nucleation, microtubule stabilisation, microtubule bundling, Aurora A kinase activation, kinesin-5 binding, and kinesin-12 recruitment. This protein has been shown to be essential for spindle formation in every cell type analysed so far. However, as yet, TPX2 homologues have not been found in the Drosophila genome. In this study, I found that the Drosophila protein Ssp1/Mei-38 has significant homology to TPX2. Sequence conservation was limited to the putative spindle microtubule-associated region of TPX2, and intriguingly, D-TPX2 (Ssp1/Mei-38) lacks Aurora A- and kinesin-5-binding domains, which are highly conserved in other animal and plant species, including many insects such as ants and bees. D-TPX2 uniformly localised to kinetochore microtubule-enriched regions of the metaphase spindle in the S2 cell line, and it had microtubule binding and bundling activities in vitro. In comparison with other systems, the contribution of D-TPX2 to cell division seems to be minor; live cell imaging of microtubules and chromosomes after RNAi knockdown identified significant delay in chromosome congression in only 18% of the cells. Thus, while this conserved spindle protein is present in Drosophila, other mechanisms may largely compensate for its spindle assembly and chromosome segregation functions.	Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Goshima, G (corresponding author), Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	goshima@bio.nagoya-u.ac.jp			Japan Society for the Promotion of Science; Naito Foundation; Inoue Foundation; Uehara Foundation; Asahi Glass Foundation; Human Frontier Science Program (HFSP)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Inoue Foundation(Inoue Research Award for Young Scientists); Uehara Foundation(Uehara Memorial Foundation); Asahi Glass Foundation; Human Frontier Science Program (HFSP)(Human Frontier Science Program)	This work was supported by the Next Generation grant (Japan Society for the Promotion of Science), the Naito Foundation, the Inoue Foundation, the Uehara Foundation, the Asahi Glass Foundation, and the Human Frontier Science Program (HFSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER BS, 1972, GENETICS, V71, P255; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bettencourt-Dias M, 2009, METHODS MOL BIOL, V545, P39, DOI 10.1007/978-1-60327-993-2_3; Bieling P, 2010, METHOD CELL BIOL, V95, P555, DOI 10.1016/S0091-679X(10)95028-0; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Brunet S, 2004, MOL BIOL CELL, V15, P5318, DOI 10.1091/mbc.E04-05-0385; Brunet S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003338; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Eckerdt F, 2008, CURR BIOL, V18, P519, DOI 10.1016/j.cub.2008.02.077; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Goshima G, 2005, MOL BIOL CELL, V16, P3896, DOI 10.1091/mbc.E05-02-0118; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Goshima G, 2010, ANNU REV CELL DEV BI, V26, P21, DOI 10.1146/annurev-cellbio-100109-104006; Goshima G, 2010, METHOD CELL BIOL, V97, P259, DOI 10.1016/S0091-679X(10)97015-5; Goshima G, 2010, CURR OPIN CELL BIOL, V22, P44, DOI 10.1016/j.ceb.2009.11.012; Groen AC, 2009, MOL BIOL CELL, V20, P2766, DOI 10.1091/mbc.E09-01-0043; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Li WJ, 2011, J CELL BIOL, V193, P973, DOI 10.1083/jcb.201101108; Ma N, 2011, J CELL BIOL, V195, P87, DOI 10.1083/jcb.201106149; Manning AL, 2007, CURR BIOL, V17, P260, DOI 10.1016/j.cub.2006.11.071; Ozlu N, 2005, DEV CELL, V9, P237, DOI 10.1016/j.devcel.2005.07.002; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Tsai MY, 2005, CURR BIOL, V15, P2156, DOI 10.1016/j.cub.2005.10.054; Tulu US, 2006, CURR BIOL, V16, P536, DOI 10.1016/j.cub.2006.01.060; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Vos JW, 2008, PLANT CELL, V20, P2783, DOI 10.1105/tpc.107.056796; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Wu CJ, 2008, GENETICS, V180, P61, DOI 10.1534/genetics.108.091140; Zhang G, 2009, J CELL SCI, V122, P535, DOI 10.1242/jcs.040352	40	33	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28120	10.1371/journal.pone.0028120	http://dx.doi.org/10.1371/journal.pone.0028120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140519	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100038
J	Gao, CH; Xue, YF; Ma, YH				Gao, Chenghua; Xue, Yanfen; Ma, Yanhe			Protoplast Transformation of Recalcitrant Alkaliphilic Bacillus sp with Methylated Plasmid DNA and a Developed Hard Agar Regeneration Medium	PLOS ONE			English	Article							SUBTILIS PROTOPLASTS; GENETIC-TRANSFORMATION; ESCHERICHIA-COLI; PSEUDOFIRMUS OF4; RESTRICTION; EFFICIENCY; ENZYMES; EXPRESSION; BACTERIA; CLONING	Among the diverse alkaliphilic Bacillus strains, only a little have been reported to be genetically transformed. In this study, an efficient protoplast transformation procedure was developed for recalcitrant alkaliphilic Bacillus sp. N16-5. The procedure involved polyethylene glycol-induced DNA uptake by the protoplasts and subsequent protoplast regeneration with a developed hard agar regeneration medium. An in vivo methylation strategy was introduced to methylate the exogenous plasmid DNA for improving the transformation efficiency. The transformation efficiency reached to 1.1x10(5) transformants per mu g plasmid DNA with methylated plasmid pHCMC04 and the developed hard agar regeneration medium. This procedure might also be applicable to the genetic transformation of other Bacillus strains.	[Gao, Chenghua; Xue, Yanfen; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Gao, Chenghua] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, CH (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	mayanhe@im.ac.cn	MA, YAN/HHN-2912-2022		National Basic Research Program of China (973 Project) [2011CBA00805]; Natural Science Foundation of China [30621005]	National Basic Research Program of China (973 Project)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Project, #2011CBA00805) and Natural Science Foundation of China (30621005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAMATSU T, 1982, AGR BIOL CHEM TOKYO, V46, P1617, DOI 10.1080/00021369.1982.10865298; AONO R, 1991, AGR BIOL CHEM TOKYO, V55, P2643, DOI 10.1080/00021369.1991.10871027; Berndt C, 2003, MICROBIOL-SGM, V149, P895, DOI 10.1099/mic.0.26033-0; BHATT YB, 1987, LETT APPL MICROBIOL, V4, P77, DOI 10.1111/j.1472-765X.1987.tb01587.x; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; BOURNE N, 1986, J GEN MICROBIOL, V132, P251; CHANG S, 1979, MOL GEN GENET, V168, P111, DOI 10.1007/BF00267940; CLIVE D, 1970, J GEN MICROBIOL, V61, P233, DOI 10.1099/00221287-61-2-233; DUNN RM, 1987, ARCH MICROBIOL, V146, P323, DOI 10.1007/BF00410929; ElhaI J, 1997, J BACTERIOL, V179, P1998, DOI 10.1128/jb.179.6.1998-2005.1997; Fujinami S, 2010, ENVIRON TECHNOL, V31, P845, DOI 10.1080/09593331003762807; GARDENER S, 1984, J GEN MICROBIOL, V130, P731; Gilmour R, 2000, J BACTERIOL, V182, P5969, DOI 10.1128/JB.182.21.5969-5981.2000; HAIMA P, 1987, MOL GEN GENET, V209, P335, DOI 10.1007/BF00329663; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Horikoshi K, 1999, MICROBIOL MOL BIOL R, V63, P735, DOI 10.1128/MMBR.63.4.735-750.1999; HORIKOSHI K, 1971, AGR BIOL CHEM TOKYO, V35, P1407, DOI 10.1080/00021369.1971.10860094; IMANAKA T, 1982, J BACTERIOL, V149, P824, DOI 10.1128/JB.149.3.824-830.1982; Ito M, 1997, J BACTERIOL, V179, P3851, DOI 10.1128/jb.179.12.3851-3857.1997; Ito M, 2001, BIOSCI BIOTECH BIOCH, V65, P2773, DOI 10.1271/bbb.65.2773; Ito S, 1998, EXTREMOPHILES, V2, P185, DOI 10.1007/s007920050059; KIMURA H, 1994, BIOSCI BIOTECH BIOCH, V58, P1002, DOI 10.1271/bbb.58.1002; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; KUDO T, 1990, J BACTERIOL, V172, P7282, DOI 10.1128/jb.172.12.7282-7283.1990; LANDMAN OE, 1963, J MOL BIOL, V7, P721, DOI 10.1016/S0022-2836(63)80119-9; LANDMAN OE, 1968, J BACTERIOL, V96, P2154, DOI 10.1128/JB.96.6.2154-2170.1968; LEENHOUTS KJ, 1989, APPL ENVIRON MICROB, V55, P394, DOI 10.1128/AEM.55.2.394-400.1989; Li G, 2010, J MICROBIOL BIOTECHN, V20, P670, DOI 10.4014/jmb.0911.11019; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Ma YH, 2004, EXTREMOPHILES, V8, P447, DOI 10.1007/s00792-004-0405-4; MALLONEE DH, 1989, APPL ENVIRON MICROB, V55, P2517, DOI 10.1128/AEM.55.10.2517-2521.1989; MERCENIER A, 1988, BIOCHIMIE, V70, P503, DOI 10.1016/0300-9084(88)90086-7; MERMELSTEIN LD, 1993, APPL ENVIRON MICROB, V59, P1077, DOI 10.1128/AEM.59.4.1077-1081.1993; Nguyen HD, 2005, PLASMID, V54, P241, DOI 10.1016/j.plasmid.2005.05.001; NIEISEN P, 1995, MICROBIOLOGY, V141, P1745; Nikolajewa S, 2005, NUCLEIC ACIDS RES, V33, P2726, DOI 10.1093/nar/gki575; NIMI O, 1983, BIOTECHNOL LETT, V5, P709, DOI 10.1007/BF01386367; PAAVILAINEN S, 1994, J FERMENT BIOENG, V78, P217, DOI 10.1016/0922-338X(94)90293-3; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; PUYET A, 1987, FEMS MICROBIOL LETT, V40, P1; Sambrook J, 2001, MOL CLONING LAB MANU; SULLIVAN MA, 1984, GENE, V29, P21, DOI 10.1016/0378-1119(84)90161-6; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Wallace JG, 2011, LETT APPL MICROBIOL, V52, P430, DOI 10.1111/j.1472-765X.2011.03017.x; WHITEHEAD PR, 1985, ARCH MICROBIOL, V141, P70, DOI 10.1007/BF00446742; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; Yasui K, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn884; YUAN R, 1981, ANNU REV BIOCHEM, V50, P285, DOI 10.1146/annurev.bi.50.070181.001441; Zhang GM, 2010, BIOTECHNOL LETT, V32, P1915, DOI 10.1007/s10529-010-0372-z	49	13	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28148	10.1371/journal.pone.0028148	http://dx.doi.org/10.1371/journal.pone.0028148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132233	gold, Green Published, Green Submitted			2022-12-25	WOS:000298162000082
J	Shi, Q; Liu, XY; Bai, YY; Cui, CJ; Li, J; Li, YS; Hu, SS; Wei, YJ				Shi, Qiang; Liu, Xiaoyan; Bai, Yuanyuan; Cui, Chuanjue; Li, Jun; Li, Yishi; Hu, Shengshou; Wei, Yingjie			In Vitro Effects of Pirfenidone on Cardiac Fibroblasts: Proliferation, Myofibroblast Differentiation, Migration and Cytokine Secretion	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; EXPERIMENTAL MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR ENLARGEMENT; HEART-FAILURE; MATRIX-METALLOPROTEINASE; CELL-PROLIFERATION; PHENOTYPIC MODULATION; COLLAGEN PRODUCTION; PULMONARY-FIBROSIS; TISSUE INHIBITORS	Cardiac fibroblasts (CFs) are the primary cell type responsible for cardiac fibrosis during pathological myocardial remodeling. Several studies have illustrated that pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone) attenuates cardiac fibrosis in different animal models. However, the effects of pirfenidone on cardiac fibroblast behavior have not been examined. In this study, we investigated whether pirfenidone directly modulates cardiac fibroblast behavior that is important in myocardial remodeling such as proliferation, myofibroblast differentiation, migration and cytokine secretion. Fibroblasts were isolated from neonatal rat hearts and bioassays were performed to determine the effects of pirfenidone on fibroblast function. We demonstrated that treatment of CFs with pirfenidone resulted in decreased proliferation, and attenuated fibroblast alpha-smooth muscle actin expression and collagen contractility. Boyden chamber assay illustrated that pirfenidone inhibited fibroblast migration ability, probably by decreasing the ratio of matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1. Furthermore, pirfenidone attenuated the synthesis and secretion of transforming growth factor-beta 1 but elevated that of interleukin-10. These direct and pleiotropic effects of pirfenidone on cardiac fibroblasts point to its potential use in the treatment of adverse myocardial remodeling.	[Shi, Qiang; Liu, Xiaoyan; Bai, Yuanyuan; Cui, Chuanjue; Li, Jun; Li, Yishi; Hu, Shengshou; Wei, Yingjie] Chinese Acad Med Sci, Peking Union Med Coll, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College	Shi, Q (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis,Fuwai Hosp, Beijing 100730, Peoples R China.	shengshouhu@yahoo.com; weiyingjiefw@126.com			National 973 Program [2010CB529505]; National Natural Science Foundation of China [81170206]; National Science and Technology Major Project [2008ZX09312-018]	National 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project	This study was supported by research grants from the National 973 Program (2010CB529505 to SSH), the National Natural Science Foundation of China (81170206 to YJW) and by the National Science and Technology Major Project (2008ZX09312-018 to YSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Burghardt I, 2007, BIOCHEM BIOPH RES CO, V354, P542, DOI 10.1016/j.bbrc.2007.01.012; Card JW, 2003, TOXICOL SCI, V75, P169, DOI 10.1093/toxsci/kfg167; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Di Sario A, 2002, J HEPATOL, V37, P584, DOI 10.1016/S0168-8278(02)00245-3; Dosanjh AK, 1998, TRANSPLANT P, V30, P1910, DOI 10.1016/S0041-1345(98)00478-3; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; EGHBALI M, 1992, BASIC RES CARDIOL, V87, P183; Frangogiannis NG, 2006, CURR MED CHEM, V13, P1877, DOI 10.2174/092986706777585086; Garcia L, 2002, J HEPATOL, V37, P797, DOI 10.1016/S0168-8278(02)00272-6; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hewitson TD, 2001, J NEPHROL, V14, P453; Iyer SN, 1999, J PHARMACOL EXP THER, V291, P367; IYER SN, 1995, J LAB CLIN MED, V125, P779; Kakugawa T, 2004, EUR RESPIR J, V24, P57, DOI 10.1183/09031936.04.00120803; Kaneko M, 1998, CLIN EXP IMMUNOL, V113, P72, DOI 10.1046/j.1365-2249.1998.00618.x; Lan L, 2008, TRANSPL INT, V21, P581, DOI 10.1111/j.1432-2277.2008.00652.x; Lee BS, 1998, J CLIN ENDOCR METAB, V83, P219, DOI 10.1210/jc.83.1.219; Lee KW, 2006, CIRCULATION, V114, P1703, DOI 10.1161/CIRCULATIONAHA.106.624320; Leh S, 2005, NEPHROL DIAL TRANSPL, V20, P71, DOI 10.1093/ndt/gfh562; Li YY, 1998, CIRCULATION, V98, P1728, DOI 10.1161/01.CIR.98.17.1728; Li ZW, 2010, FEBS J, V277, P3688, DOI 10.1111/j.1742-4658.2010.07770.x; Lijnen P, 2003, METHOD FIND EXP CLIN, V25, P79, DOI 10.1358/mf.2003.25.2.723680; Lin XC, 2009, INVEST OPHTH VIS SCI, V50, P3763, DOI 10.1167/iovs.08-2815; Lu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012963; Miric G, 2001, BRIT J PHARMACOL, V133, P687, DOI 10.1038/sj.bjp.0704131; Mirkovic S, 2002, BRIT J PHARMACOL, V135, P961, DOI 10.1038/sj.bjp.0704539; Mu W, 2005, J AM SOC NEPHROL, V16, P3651, DOI 10.1681/ASN.2005030297; Nakayama S, 2008, LIFE SCI, V82, P210, DOI 10.1016/j.lfs.2007.11.003; Nakazato H, 2002, EUR J PHARMACOL, V446, P177, DOI 10.1016/S0014-2999(02)01758-2; Nguyen DT, 2010, HEART RHYTHM, V7, P1438, DOI 10.1016/j.hrthm.2010.04.030; Oku H, 2002, EUR J PHARMACOL, V446, P167, DOI 10.1016/S0014-2999(02)01757-0; Oku H, 2008, EUR J PHARMACOL, V590, P400, DOI 10.1016/j.ejphar.2008.06.046; Peterson JT, 2001, CIRCULATION, V103, P2303; Petrov V V, 2000, J Renin Angiotensin Aldosterone Syst, V1, P342, DOI 10.3317/jraas.2000.064; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Porter KE, 2002, J VASC SURG, V36, P150, DOI 10.1067/mva.2002.122029; Rohde LE, 1999, CIRCULATION, V99, P3063, DOI 10.1161/01.CIR.99.23.3063; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Shihab FS, 2002, AM J TRANSPLANT, V2, P111, DOI 10.1034/j.1600-6143.2002.020201.x; Shimizu T, 1998, KIDNEY INT, V54, P99, DOI 10.1046/j.1523-1755.1998.00962.x; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8; Tada S, 2001, CLIN EXP PHARMACOL P, V28, P522, DOI 10.1046/j.1440-1681.2001.03481.x; Towbin JA, 2007, NEW ENGL J MED, V357, P1767, DOI 10.1056/NEJMcibr075397; Visner GA, 2009, TRANSPLANTATION, V88, P330, DOI 10.1097/TP.0b013e3181ae3392; WANG Y, 2011, PHYTOMEDICI IN PRESS; Wei YJ, 2011, J CELL MOL MED, V15, P773, DOI 10.1111/j.1582-4934.2010.01049.x; Wilson EM, 2002, J CARD FAIL, V8, P390, DOI 10.1054/jcaf.2002.129659; Wilson MS, 2007, J CLIN INVEST, V117, P2941, DOI 10.1172/JCI31546	54	72	76	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28134	10.1371/journal.pone.0028134	http://dx.doi.org/10.1371/journal.pone.0028134			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132230	Green Submitted, Green Published, gold			2022-12-25	WOS:000298162000079
J	Byarugaba, DK; Ducatez, MF; Erima, B; Mworozi, EA; Millard, M; Kibuuka, H; Lukwago, L; Bwogi, J; Kaira, BB; Mimbe, D; Schnabel, DC; Krauss, S; Darnell, D; Webby, RJ; Webster, RG; Wabwire-Mangen, F				Byarugaba, Denis K.; Ducatez, Mariette F.; Erima, Bernard; Mworozi, Edison A.; Millard, Monica; Kibuuka, Hannah; Lukwago, Luswa; Bwogi, Josephine; Kaira, Blanche B.; Mimbe, Derrick; Schnabel, David C.; Krauss, Scott; Darnell, Daniel; Webby, Richard J.; Webster, Robert G.; Wabwire-Mangen, Fred			Molecular Epidemiology of Influenza A/H3N2 Viruses Circulating in Uganda	PLOS ONE			English	Article							A VIRUSES; A(H1N1) VIRUSES; EVOLUTION; PROTEIN; NEURAMINIDASE; AMPLIFICATION; ADAPTATION; GENOME; H1N1; GENE	The increasing availability of complete influenza virus genomes is deepening our understanding of influenza evolutionary dynamics and facilitating the selection of vaccine strains. However, only one complete African influenza virus sequence is available in the public domain. Here we present a complete genome analysis of 59 influenza A/H3N2 viruses isolated from humans in Uganda during the 2008 and 2009 season. Isolates were recovered from hospital-based sentinel surveillance for influenza-like illnesses and their whole genome sequenced. The viruses circulating during these two seasons clearly differed from each other phylogenetically. They showed a slow evolution away from the 2009/10 recommended vaccine strain (A/Brisbane/10/07), instead clustering with the 2010/11 recommended vaccine strain (A/Perth/16/09) in the A/Victoria/208/09 clade, as observed in other global regions. All of the isolates carried the adamantane resistance marker S31N in the M2 gene and carried several markers of enhanced transmission; as expected, none carried any marker of neuraminidase inhibitor resistance. The hemagglutinin gene of the 2009 isolates differed from that of the 2008 isolates in antigenic sites A, B, D, and to a lesser extent, C and E indicating evidence of an early phylogenetic shift from the 2008 to 2009 viruses. The internal genes of the 2009 isolates were similar to those of one 2008 isolate, A/Uganda/MUWRP-050/2008. Another 2008 isolate had a truncated PB1-F2 protein. Whole genome sequencing can enhance surveillance of future seasonal changes in the viral genome which is crucial to ensure that selected vaccine strains are protective against the strains circulating in Eastern Africa. This data provides an important baseline for this surveillance. Overall the influenza virus activity in Uganda appears to mirror that observed in other regions of the southern hemisphere.	[Byarugaba, Denis K.] Makerere Univ, Fac Vet Med, Kampala, Uganda; [Byarugaba, Denis K.; Erima, Bernard; Millard, Monica; Kibuuka, Hannah; Kaira, Blanche B.; Mimbe, Derrick; Wabwire-Mangen, Fred] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Ducatez, Mariette F.; Krauss, Scott; Darnell, Daniel; Webby, Richard J.; Webster, Robert G.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Mworozi, Edison A.] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Lukwago, Luswa] Minist Hlth, Kampala, Uganda; [Bwogi, Josephine] Uganda Virus Res Inst, Entebbe, Uganda; [Schnabel, David C.] USA, Res Unit, Nairobi, Kenya	Makerere University; Makerere University; St Jude Children's Research Hospital; Makerere University; Uganda Virus Research Institute	Byarugaba, DK (corresponding author), Makerere Univ, Fac Vet Med, Kampala, Uganda.	dkb@vetmed.mak.ac.ug	Bwogi, Josephine/AGJ-4829-2022; Webby, Richard J/N-5657-2018	Bwogi, Josephine/0000-0001-6975-7106; Byarugaba, Denis K./0000-0002-4175-5659	US Department of Defense's Global Emerging Infections Surveillance and Response System (DoD-GEIS) [W81XWH-06-C-0414]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200700005C]; American Lebanese Syrian Associated Charities (ALSAC)	US Department of Defense's Global Emerging Infections Surveillance and Response System (DoD-GEIS)(United States Department of Defense); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC))	The sample collection and virus isolation of this study was supported by the US Department of Defense's Global Emerging Infections Surveillance and Response System (DoD-GEIS) through Contract No. W81XWH-06-C-0414. The sequencing of the isolates was supported by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services Contract No. HHSN266200700005C; and the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CF, 2009, ARCH MED RES, V40, P643, DOI 10.1016/j.arcmed.2009.10.007; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Bokhari SH, 2010, IEEE ACM T COMPUT BI, V7, P288, DOI 10.1109/TCBB.2008.73; Bulimo WD, 2008, INFLUENZA OTHER RESP, V2, P107, DOI 10.1111/j.1750-2659.2008.00044.x; Chan CH, 2006, J VIROL METHODS, V136, P38, DOI 10.1016/j.jviromet.2006.03.027; Conenello GM, 2007, CELL HOST MICROBE, V2, P207, DOI 10.1016/j.chom.2007.09.010; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Falagas ME, 2011, EPIDEMIOL INFECT, V139, P27, DOI 10.1017/S0950268810002037; Fereidouni SR, 2009, VET MICROBIOL, V135, P253, DOI 10.1016/j.vetmic.2008.09.077; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Fricke WF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000217; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hanon E, 2009, Bull Mem Acad R Med Belg, V164, P283; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lee N, 2010, ANN INTERN MED, V152, P618, DOI 10.7326/0003-4819-152-9-201005040-00021; Lin JH, 2008, J MED VIROL, V80, P316, DOI 10.1002/jmv.21074; MCGREGOR IA, 1979, BRIT MED BULL, V35, P15, DOI 10.1093/oxfordjournals.bmb.a071535; McHardy AC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000566; Memoli MJ, 2008, DRUG DISCOV TODAY, V13, P590, DOI 10.1016/j.drudis.2008.03.024; Memoli MJ, 2009, J INFECT DIS, V200, P1232, DOI 10.1086/605893; Njouom R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-56; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Schoub Barry D, 2010, Expert Rev Respir Med, V4, P167, DOI 10.1586/ers.10.10; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Thippamom N, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-185; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	32	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27803	10.1371/journal.pone.0027803	http://dx.doi.org/10.1371/journal.pone.0027803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132146	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789900022
J	Muzaffar, M; Ahmad, A				Muzaffar, Mahvish; Ahmad, Atta			The Mechanism of Enhanced Insulin Amyloid Fibril Formation by NaCl Is Better Explained by a Conformational Change Model	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; PROTEIN AGGREGATION; MONOMERIC INSULIN; EARLY EVENTS; X-RAY; BEHAVIOR; PATHWAY; CATION; CHAIN; SITE	The high propensity of insulin to fibrillate causes severe biomedical and biotechnological complications. Insulin fibrillation studies attain significant importance considering the prevalence of diabetes and the requirement of functional insulin in each dose. Although studied since the early years of the 20(th) century, elucidation of the mechanism of insulin fibrillation has not been understood completely. We have previously, through several studies, shown that insulin hexamer dissociates into monomer that undergoes partial unfolding before converting into mature fibrils. In this study we have established that NaCl enhances insulin fibrillation mainly due to subtle structural changes and is not a mere salt effect. We have carried out studies both in the presence and absence of urea and Gdn. HCl and compared the relationship between conformation of insulin induced by urea and Gdn. HCl with respect to NaCl at both pH 7.4 (hexamer) and pH 2 (monomer). Fibril formation was followed with a Thioflavin T assay and structural changes were monitored by circular dichroism and size-exclusion chromatography. The results show salt-insulin interactions are difficult to classify as commonly accepted Debye-Huckel or Hofmeister series interactions but instead a strong correlation between the association states and conformational states of insulin and their propensity to fibrillate is evident.	[Muzaffar, Mahvish] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Muzaffar, M (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	ahmadatt@umich.edu		Ahmad, Atta/0000-0002-6968-192X; Muzaffar, Mahvish/0000-0002-2619-7724	University of Michigan COPE	University of Michigan COPE	This article was made available as Open Access with the support of the University of Michigan COPE Fund, http://lib.umich.edu/cope. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel JJ, 1926, P NATL ACAD SCI USA, V12, P132, DOI 10.1073/pnas.12.2.132; Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Ahmad A, 2004, J BIOL CHEM, V279, P14999, DOI 10.1074/jbc.M313134200; Ahmad A, 2003, BIOCHEMISTRY-US, V42, P11404, DOI 10.1021/bi034868o; Ahmad A, 2001, BIOCHEMISTRY-US, V40, P1945, DOI 10.1021/bi001933a; Ahmad A., 2009, BIOCHIM BIOPHYS ACTA, V1794, P1536; Ahmad A, 2010, INT J BIOL MACROMOL, V46, P275, DOI 10.1016/j.ijbiomac.2009.12.017; Albert SG, 2007, DIABETES RES CLIN PR, V75, P374, DOI 10.1016/j.diabres.2006.07.013; Apetri AC, 2003, J BIOL CHEM, V278, P22187, DOI 10.1074/jbc.M302130200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; BEYCHOK S, 1965, P NATL ACAD SCI USA, V53, P999, DOI 10.1073/pnas.53.5.999; Blake C, 1996, STRUCTURE, V4, P989, DOI 10.1016/S0969-2126(96)00104-9; Blatherwick NR, 1927, J BIOL CHEM, V72, P57; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1997, PROTEINS, V27, P507, DOI 10.1002/(SICI)1097-0134(199704)27:4<507::AID-PROT4>3.3.CO;2-H; Brange J, 1993, Pharm Biotechnol, V5, P315; BURKE MJ, 1972, BIOCHEMISTRY-US, V11, P2435, DOI 10.1021/bi00763a008; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369; DeBolle X, 1997, BIOCHEM J, V323, P409; Debye P, 1923, PHYS Z, V24, P185; DISCHE FE, 1988, DIABETOLOGIA, V31, P158, DOI 10.1007/BF00276849; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Ferrari D, 2001, BIOPOLYMERS, V62, P249, DOI 10.1002/bip.1020; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Gibson TJ, 2006, PROTEIN SCI, V15, P1133, DOI 10.1110/ps.051879606; GJERDE DT, 1980, J CHROMATOGR, V187, P35, DOI 10.1016/S0021-9673(00)87871-1; GLENNER GG, 1981, PROG HISTOCHEM CYTOC, V13, P1; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; GREGOR HP, 1955, J AM CHEM SOC, V77, P2713, DOI 10.1021/ja01615a011; GURSKY O, 1992, BIOPHYS J, V61, P604, DOI 10.1016/S0006-3495(92)81865-9; Hasegawa K, 2003, BIOCHEM BIOPH RES CO, V304, P101, DOI 10.1016/S0006-291X(03)00543-6; Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI [DOI 10.1007/BF01918191, 10.1007/BF01918191]; HOHENESTER E, 1994, BIOCHEMISTRY-US, V33, P13561, DOI 10.1021/bi00250a008; Hong DP, 2006, BIOCHEMISTRY-US, V45, P9342, DOI 10.1021/bi0604936; Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200; Huang K, 2006, BIOCHEMISTRY-US, V45, P10278, DOI 10.1021/bi060879g; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Klement K, 2007, J MOL BIOL, V373, P1321, DOI 10.1016/j.jmb.2007.08.068; KLOSTERMEYER H, 1966, ANGEW CHEM INT EDIT, V5, P807, DOI 10.1002/anie.196608071; Krogh A, 1928, BIOCHEM J, V22, P1231, DOI 10.1042/bj0221231; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; Li J, 2002, NEUROTOXICOLOGY, V23, P553, DOI 10.1016/S0161-813X(02)00066-9; MILLICAN RL, 1994, BIOCHEMISTRY-US, V33, P1116, DOI 10.1021/bi00171a010; Munishkina LA, 2003, BIOCHEMISTRY-US, V42, P2720, DOI 10.1021/bi027166s; Munishkina LA, 2004, BIOCHEMISTRY-US, V43, P3289, DOI 10.1021/bi034938r; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nielsen L, 2001, J PHARM SCI-US, V90, P29, DOI 10.1002/1520-6017(200101)90:1<29::AID-JPS4>3.0.CO;2-4; PACE CN, 1988, BIOCHEMISTRY-US, V27, P3242, DOI 10.1021/bi00409a018; Pedersen JS, 2006, BIOPHYS J, V90, P4181, DOI 10.1529/biophysj.105.070912; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Roher AE, 2000, BBA-MOL BASIS DIS, V1502, P31, DOI 10.1016/S0925-4439(00)00030-2; Sahoo S, 2003, DIAGN CYTOPATHOL, V28, P325, DOI 10.1002/dc.10296; Scrocchi LA, 2002, J MOL BIOL, V318, P697, DOI 10.1016/S0022-2836(02)00164-X; Shikama Y, 2010, INTERNAL MED, V49, P397, DOI 10.2169/internalmedicine.49.2633; Singh LR, 2009, J BIOSCIENCES, V34, P321, DOI 10.1007/s12038-009-0036-0; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; SLUZKY V, 1992, BIOTECHNOL BIOENG, V40, P895, DOI 10.1002/bit.260400805; Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3; Souillac PO, 2002, J BIOL CHEM, V277, P12666, DOI 10.1074/jbc.M109229200; STORKEL S, 1983, LAB INVEST, V48, P108; Strickland E H, 1974, CRC Crit Rev Biochem, V2, P113, DOI 10.3109/10409237409105445; Swift B, 2002, DIABETIC MED, V19, P881, DOI 10.1046/j.1464-5491.2002.07581.x; Tito P, 2000, J MOL BIOL, V303, P267, DOI 10.1006/jmbi.2000.4142; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Waugh DF, 1944, J AM CHEM SOC, V66, P663, DOI 10.1021/ja01232a516; WAUGH DF, 1953, J AM CHEM SOC, V75, P2592, DOI 10.1021/ja01107a013; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yeh V, 2010, PROTEIN SCI, V19, P47, DOI 10.1002/pro.281; Yumlu S, 2009, HUM PATHOL, V40, P1655, DOI 10.1016/j.humpath.2009.02.019	81	44	52	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27906	10.1371/journal.pone.0027906	http://dx.doi.org/10.1371/journal.pone.0027906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132167	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789900031
J	Varga, Z; Juhasz, T; Matta, C; Fodor, J; Katona, E; Bartok, A; Olah, T; Sebe, A; Csernoch, L; Panyi, G; Zakany, R				Varga, Zoltan; Juhasz, Tamas; Matta, Csaba; Fodor, Janos; Katona, Eva; Bartok, Adam; Olah, Tamas; Sebe, Attila; Csernoch, Laszlo; Panyi, Gyorgy; Zakany, Roza			Switch of Voltage-Gated K+ Channel Expression in the Plasma Membrane of Chondrogenic Cells Affects Cytosolic Ca2+-Oscillations and Cartilage Formation	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; ION CHANNELS; CALCIUM OSCILLATIONS; SODIUM-CHANNELS; PROLIFERATION; GROWTH; KV1.5; DIFFERENTIATION; INACTIVATION; CHONDROCYTES	Background: Understanding the key elements of signaling of chondroprogenitor cells at the earliest steps of differentiation may substantially improve our opportunities for the application of mesenchymal stem cells in cartilage tissue engineering, which is a promising approach of regenerative therapy of joint diseases. Ion channels, membrane potential and Ca2+-signaling are important regulators of cell proliferation and differentiation. Our aim was to identify such plasma membrane ion channels involved in signaling during chondrogenesis, which may serve as specific molecular targets for influencing chondrogenic differentiation and ultimately cartilage formation. Methodology/Principal Findings: Using patch-clamp, RT-PCR and Western-blot experiments, we found that chondrogenic cells in primary micromass cell cultures obtained from embryonic chicken limb buds expressed voltage-gated Na(V)1.4, K(V)1.1, K(V)1.3 and K(V)4.1 channels, although K(V)1.3 was not detectable in the plasma membrane. Tetrodotoxin (TTX), the inhibitor of Na(V)1.4 channels, had no effect on cartilage formation. In contrast, presence of 20 mM of the K+ channel blocker tetraethylammonium (TEA) during the time-window of the final commitment of chondrogenic cells reduced K-V currents (to 27+/-3% of control), cell proliferation (thymidine incorporation: to 39+/-4.4% of control), expression of cartilage-specific genes and consequently, cartilage formation (metachromasia: to 18.0+/-6.4% of control) and also depolarized the membrane potential (by 9.3+/-2.1 mV). High-frequency Ca2+-oscillations were also suppressed by 10 mM TEA (confocal microscopy: frequency to 8.5+/-2.6% of the control). Peak expression of TEA-sensitive K(V)1.1 in the plasma membrane overlapped with this period. Application of TEA to differentiated chondrocytes, mainly expressing the TEA-insensitive K(V)4.1 did not affect cartilage formation. Conclusions/Significance: These data demonstrate that the differentiation and proliferation of chondrogenic cells depend on rapid Ca2+-oscillations, which are modulated by K-V-driven membrane potential changes. K(V)1.1 function seems especially critical during the final commitment period. We show the critical role of voltage-gated cation channels in the differentiation of non-excitable cells with potential therapeutic use.	[Varga, Zoltan; Bartok, Adam; Sebe, Attila; Panyi, Gyorgy] Univ Debrecen, Dept Biophys & Cell Biol, H-4012 Debrecen, Hungary; [Varga, Zoltan; Juhasz, Tamas; Matta, Csaba; Fodor, Janos; Katona, Eva; Bartok, Adam; Olah, Tamas; Sebe, Attila; Csernoch, Laszlo; Panyi, Gyorgy; Zakany, Roza] Hlth Sci Ctr, Debrecen, Hungary; [Juhasz, Tamas; Matta, Csaba; Katona, Eva; Zakany, Roza] Univ Debrecen, Dept Anat Histol & Embryol, H-4012 Debrecen, Hungary; [Fodor, Janos; Olah, Tamas; Csernoch, Laszlo] Univ Debrecen, Dept Physiol, H-4012 Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen	Varga, Z (corresponding author), Univ Debrecen, Dept Biophys & Cell Biol, H-4012 Debrecen, Hungary.	panyi@med.unideb.hu	Matta, Csaba/C-7066-2017; Juhasz, Tamas/M-6878-2019; Bartok, Adam/AAE-9780-2019; Panyi, Gyorgy/H-4406-2013	Matta, Csaba/0000-0002-9678-7420; Juhasz, Tamas/0000-0003-0489-5676; Olah, Tamas/0000-0002-3834-6272; Katona, Eva/0000-0002-8166-1438; Panyi, Gyorgy/0000-0001-6227-3301; Csernoch, Laszlo/0000-0002-2446-1456	Hungarian National Science Fund [OTKA K75604, OTKA-CNK 80709, OTKA CK 78179]; Hungarian Ministry of Education [K-2009-TAMOP-4.2.2-08/1/2008-0019, TAMOP-4.2.1/B-09/1/KONV-2010-007]; Bolyai fellowship;  [ETT 022/09];  [ETT 345/09]	Hungarian National Science Fund; Hungarian Ministry of Education; Bolyai fellowship(Hungarian Academy of Sciences); ; 	This work was supported by the Hungarian National Science Fund (OTKA K75604, OTKA-CNK 80709 and OTKA CK 78179), the Hungarian Ministry of Education (K-2009-TAMOP-4.2.2-08/1/2008-0019 and TAMOP-4.2.1/B-09/1/KONV-2010-007) and grants ETT 022/09, ETT 345/09 and a Bolyai fellowship to ZV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett-Jolley R, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00135; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; Carrithers MD, 2007, J IMMUNOL, V178, P7822, DOI 10.4049/jimmunol.178.12.7822; Centeno CJ, 2008, PAIN PHYSICIAN, V11, P343; Craner MJ, 2005, GLIA, V49, P220, DOI 10.1002/glia.20112; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.physiol.55.1.427; Fodor J, 2009, CELL CALCIUM, V45, P421, DOI 10.1016/j.ceca.2009.02.004; Fraser SP, 2004, FEBS LETT, V569, P191, DOI 10.1016/j.febslet.2004.05.063; FREYRIA AM, 2011, INJURY IN PRESS, DOI DOI 10.1016/J.INJURY.2011.05.035; Galle J, 2010, CURR MED CHEM, V17, P2274, DOI 10.2174/092986710791331095; GRANDOLFO M, 1992, BIOCHEM BIOPH RES CO, V182, P1429, DOI 10.1016/0006-291X(92)91893-U; GRANDOLFO M, 1990, CALCIFIED TISSUE INT, V47, P302, DOI 10.1007/BF02555913; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Guo ZX, 2010, NEUROSCI LETT, V478, P156, DOI 10.1016/j.neulet.2010.05.007; Hardingham TE, 2006, J ANAT, V209, P469, DOI 10.1111/j.1469-7580.2006.00630.x; Helmlinger G, 1996, J VASC RES, V33, P360, DOI 10.1159/000159164; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Jow F, 2004, P NATL ACAD SCI USA, V101, P15535, DOI 10.1073/pnas.0402081101; Juretic N, 2007, J CELL PHYSIOL, V210, P819, DOI 10.1002/jcp.20902; Kawano S, 2006, CELL CALCIUM, V39, P313, DOI 10.1016/j.ceca.2005.11.008; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; LEONARD RJ, 1992, P NATL ACAD SCI USA, V89, P10094, DOI 10.1073/pnas.89.21.10094; LEWIS R, 2011, J CELL PHYSL; LONG KJ, 1994, BIOCHEM BIOPH RES CO, V201, P776, DOI 10.1006/bbrc.1994.1768; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Matta C, 2008, CELL CALCIUM, V44, P310, DOI 10.1016/j.ceca.2007.12.010; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Mobasheri A, 2005, AM J PHYSIOL-REG I, V289, pR172, DOI 10.1152/ajpregu.00710.2004; Mobasheri A, 2010, J CELL PHYSIOL, V223, P511, DOI 10.1002/jcp.22075; Mouw JK, 2007, BIOMECH MODEL MECHAN, V6, P33, DOI 10.1007/s10237-006-0034-1; Muramatsu S, 2007, J BIOL CHEM, V282, P32158, DOI 10.1074/jbc.M706158200; Nesti LJ, 2007, J CELL BIOCHEM, V101, P348, DOI 10.1002/jcb.21180; Ng SY, 2010, J CELL PHYSIOL, V224, P165, DOI 10.1002/jcp.22113; O'Grady SM, 2005, INT J BIOCHEM CELL B, V37, P1578, DOI 10.1016/j.biocel.2005.04.002; PAK MD, 1991, P NATL ACAD SCI USA, V88, P4386, DOI 10.1073/pnas.88.10.4386; Panyi G, 2004, IMMUNOL LETT, V92, P55, DOI 10.1016/j.imlet.2003.11.020; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Pingguan-Murphy B, 2006, J CELL PHYSIOL, V209, P389, DOI 10.1002/jcp.20747; Salter DM, 2004, BIORHEOLOGY, V41, P273; Szabo I, 2005, J BIOL CHEM, V280, P12790, DOI 10.1074/jbc.M413548200; Tsuga K, 2002, J MEMBRANE BIOL, V185, P75, DOI 10.1007/s00232-001-0112-3; Vicente R, 2008, J BIOL CHEM, V283, P8756, DOI 10.1074/jbc.M708223200; Vicente R, 2006, J BIOL CHEM, V281, P37675, DOI 10.1074/jbc.M605617200; WALSH KB, 1992, AM J PHYSIOL, V262, pC1335, DOI 10.1152/ajpcell.1992.262.5.C1335; Wilson JR, 2004, J PHYSIOL-LONDON, V557, P93, DOI 10.1113/jphysiol.2003.058883; WILTINK A, 1994, CALCIFIED TISSUE INT, V54, P278, DOI 10.1007/BF00295951; Wohlrab D, 2001, J Orthop Sci, V6, P155, DOI 10.1007/s007760100064; Wray S, 2010, PHYSIOL REV, V90, P113, DOI 10.1152/physrev.00018.2008; Wu QQ, 2000, EXP CELL RES, V256, P383, DOI 10.1006/excr.2000.4847; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zenisek D, 2001, J NEUROSCI, V21, P4543, DOI 10.1523/JNEUROSCI.21-13-04543.2001; Zsiros E, 2009, J IMMUNOL, V183, P4483, DOI 10.4049/jimmunol.0803003	54	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27957	10.1371/journal.pone.0027957	http://dx.doi.org/10.1371/journal.pone.0027957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132179	Green Published, gold, Green Submitted			2022-12-25	WOS:000297789900037
J	Ko, SH; Nauta, A; Morrison, SD; Zhou, HY; Zimmermann, A; Gurtner, GC; Ding, S; Longaker, MT				Ko, Sae Hee; Nauta, Allison; Morrison, Shane D.; Zhou, Hongyan; Zimmermann, Andrew; Gurtner, Geoffrey C.; Ding, Sheng; Longaker, Michael T.			Antimycotic Ciclopirox Olamine in the Diabetic Environment Promotes Angiogenesis and Enhances Wound Healing	PLOS ONE			English	Article							VEGF EXPRESSION; HYPOXIA; HIF-1-ALPHA; ULCERS; OXYGEN; FOOT; ONYCHOMYCOSIS; IMPAIRMENTS; INDUCTION; TISSUE	Diabetic wounds remain a major medical challenge with often disappointing outcomes despite the best available care. An impaired response to tissue hypoxia and insufficient angiogenesis are major factors responsible for poor healing in diabetic wounds. Here we show that the antimycotic drug ciclopirox olamine (CPX) can induce therapeutic angiogenesis in diabetic wounds. Treatment with CPX in vitro led to upregulation of multiple angiogenic genes and increased availability of HIF-1 alpha. Using an excisional wound splinting model in diabetic mice, we showed that serial topical treatment with CPX enhanced wound healing compared to vehicle control treatment, with significantly accelerated wound closure, increased angiogenesis, and increased dermal cellularity. These findings offer a promising new topical pharmacologic therapy for the treatment of diabetic wounds.	[Ko, Sae Hee; Nauta, Allison; Morrison, Shane D.; Zimmermann, Andrew; Gurtner, Geoffrey C.; Longaker, Michael T.] Stanford Univ, Sch Med, Dept Surg, Hagey Lab Regenerat Med,Div Plast & Reconstruct S, Stanford, CA 94305 USA; [Ko, Sae Hee] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Nauta, Allison] Georgetown Univ, Sch Med, Dept Surg, Washington, DC USA; [Zhou, Hongyan] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA; [Gurtner, Geoffrey C.; Longaker, Michael T.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Georgetown University; University of California System; University of California San Francisco; The J David Gladstone Institutes; Stanford University	Ko, SH (corresponding author), Stanford Univ, Sch Med, Dept Surg, Hagey Lab Regenerat Med,Div Plast & Reconstruct S, Stanford, CA 94305 USA.	longaker@stanford.edu	zhou, hongyan/B-3689-2011	zhou, hongyan/0000-0001-5919-7715; Morrison, Shane/0000-0003-3868-3532	Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; NIH/NIDDK [DK074095-07]; American College of Surgeons; National Institutes of Health; Howard Hughes Medical Institute; Beckman Medical Scholars grant at Stanford; California Institute for Regenerative Medicine; NICHD; NHLBI; NEI; NIMH/NIH; Prostate Cancer Foundation; Gladstone Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074095] Funding Source: NIH RePORTER	Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American College of Surgeons; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Beckman Medical Scholars grant at Stanford; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Prostate Cancer Foundation; Gladstone Institute(University of California System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge the support of the Oak Foundation and the Hagey Laboratory for Pediatric Regenerative Medicine (MTL, GCG, SHK, ACN, ASZ, and SDM), NIH/NIDDK R01/R56 grant DK074095-07 (GCG), The American College of Surgeons Residents Research Scholarship and the National Institutes of Health Loan Repayment Program (SHK), the Howard Hughes Medical Institute Research Fellowship and Beckman Medical Scholars grant at Stanford (SDM), and the California Institute for Regenerative Medicine, NICHD, NHLBI, NEI, NIMH/NIH, Prostate Cancer Foundation, and the Gladstone Institute (SD, HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DG, 1998, DIABETES CARE, V21, P855, DOI 10.2337/diacare.21.5.855; Beer HD, 1997, J INVEST DERMATOL, V109, P132, DOI 10.1111/1523-1747.ep12319188; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Brenner MA, 2007, J AM PODIAT MED ASSN, V97, P195, DOI 10.7547/0970195; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Covello KL, 2004, CURR TOP DEV BIOL, V62, P37; Cross KJ, 2003, SURG CLIN N AM, V83, P531, DOI 10.1016/S0039-6109(02)00202-5; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; Eberhard Y, 2009, BLOOD, V114, P3064, DOI 10.1182/blood-2009-03-209965; Fang RC, 2010, WOUND REPAIR REGEN, V18, P605, DOI 10.1111/j.1524-475X.2010.00634.x; Frykberg R G, 1999, Adv Wound Care, V12, P139; Fung ML, 2007, OPEN CARDIOVASC MED, V1, P1, DOI 10.2174/1874192400701010001; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Hinchliffe RJ, 2008, DIABETES-METAB RES, V24, pS119, DOI 10.1002/dmrr.825; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Jeffcoate WJ, 2006, DIABETES CARE, V29, P1784, DOI 10.2337/dc06-0306; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Linden T, 2003, FASEB J, V17, P761, DOI 10.1096/fj.02-0586fje; Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024; Mayser P, 2009, AM J CLIN DERMATOL, V10, P211, DOI 10.2165/00128071-200910040-00001; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Oyibo SO, 2001, DIABETIC MED, V18, P133, DOI 10.1046/j.1464-5491.2001.00422.x; Seluanov A., 2010, J VIS EXP; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Subissi A, 2010, DRUGS, V70, P2133, DOI 10.2165/11538110-000000000-00000; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; Wieman TJ, 1998, DIABETES CARE, V21, P822, DOI 10.2337/diacare.21.5.822; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	35	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27844	10.1371/journal.pone.0027844	http://dx.doi.org/10.1371/journal.pone.0027844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125629	Green Published, gold			2022-12-25	WOS:000297789200029
J	Qaisar, R; Renaud, G; Morine, K; Barton, ER; Sweeney, HL; Larsson, L				Qaisar, Rizwan; Renaud, Guillaume; Morine, Kevin; Barton, Elisabeth R.; Sweeney, H. Lee; Larsson, Lars			Is functional hypertrophy and specific force coupled with the addition of myonuclei at the single muscle fiber level?	FASEB JOURNAL			English	Article						IGF-1; myosin; myostatin	SATELLITE CELL-PROLIFERATION; RAT SOLEUS MUSCLE; GROWTH-FACTOR-I; EXPRESSION; MYOSIN; SLOW; MASS; CONTRACTILE; INHIBITION; ACTIVATION	Muscle force is typically proportional to muscle size, resulting in constant force normalized to muscle fiber cross-sectional area (specific force). Mice overexpressing insulin-like growth factor-1 (IGF-1) exhibit a proportional gain in muscle force and size, but not the myostatin-deficient mice. In an attempt to explore the role of the cytoplasmic volume supported by individual myonuclei [myonuclear domain (MND) size] on functional capacity of skeletal muscle, we have investigated specific force in relation to MND and the content of the molecular motor protein, myosin, at the single muscle fiber level from myostatin-knockout (Mstn(-/-)) and IGF1-overexpressing (mIgf1(-/-)) mice. We hypothesize that the addition of extra myonuclei is a prerequisite for maintenance of specific force during muscle hypertrophy. A novel algorithm was used to measure individual MNDs in 3 dimensions along the length of single muscle fibers from the fast-twitch extensor digitorum longus and the slow-twitch soleus muscle. A significant effect of the size of individual MNDs in hypertrophic muscle fibers on both specific force and myosin content was observed. This effect was muscle cell type specific and suggested there is a critical volume individual myonuclei can support efficiently. The large MNDs found in fast muscles of Mstn(-/)-mice were correlated with the decrement in specific force and myosin content in Mstn(-/)-muscles. Thus, myostatin inhibition may not be able to maintain the appropriate MND for optimal function.-Qaisar, R., Renaud, G., Morine, K., Barton, E. R., Sweeney, H. L., Larsson, L. Is functional hypertrophy and specific force coupled with the addition of myonuclei at the single muscle fiber level? FASEB J. 26, 1077-1085 (2012). www.fasebj.org	[Qaisar, Rizwan; Renaud, Guillaume; Larsson, Lars] Uppsala Univ, Dept Neurosci, SE-75185 Uppsala, Sweden; [Morine, Kevin; Sweeney, H. Lee] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Barton, Elisabeth R.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Larsson, Lars] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA	Uppsala University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Larsson, L (corresponding author), Uppsala Univ, Dept Neurosci, SE-75185 Uppsala, Sweden.	lars.larsson@neurofys.uu.se	Larsson, Lars/AAY-1347-2021	Larsson, Lars/0000-0003-3722-035X; Qaisar, Rizwan/0000-0001-8485-7172	Swedish Research Council [8651]; European Commission [CT-223756, COST CM1001]; King Gustaf V and Queen Victoria's Foundation; Association Francaise contre les Myopathies; Higher Education Commission (HEC) of Pakistan; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); King Gustaf V and Queen Victoria's Foundation; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors are grateful to Yvette Hedstrom, Rebeca Corpeno, and Ann-Marie Gustafson for excellent technical assistance and to Dr. Julien Ochala for invaluable help and support during experiments and constructive criticism of the manuscript. This study was supported by grants from the Swedish Research Council (8651), the European Commission (MyoAge, EC Fp7 CT-223756 and COST CM1001), King Gustaf V and Queen Victoria's Foundation, and Association Francaise contre les Myopathies to L. L., and the Higher Education Commission (HEC) of Pakistan to R.Q.	ALLEN DL, 1995, J APPL PHYSIOL, V78, P1969, DOI 10.1152/jappl.1995.78.5.1969; ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Amthor H, 2009, P NATL ACAD SCI USA, V106, P7479, DOI 10.1073/pnas.0811129106; Barton-Davis ER, 1999, ACTA PHYSIOL SCAND, V167, P301; Bruusgaard JC, 2006, J APPL PHYSIOL, V100, P2024, DOI 10.1152/japplphysiol.00913.2005; Bruusgaard JC, 2003, J PHYSIOL-LONDON, V551, P467, DOI 10.1113/jphysiol.2003.045328; Colombini B, 2009, J MUSCLE RES CELL M, V30, P199, DOI 10.1007/s10974-009-9187-8; Cristea A, 2011, SARCOPENIA-AGE-RELATED MUSCLE WASTING AND WEAKNESS: MECHANISMS AND TREATMENTS, P55, DOI 10.1007/978-90-481-9713-2_4; Cristea A, 2010, AGING CELL, V9, P685, DOI 10.1111/j.1474-9726.2010.00594.x; Del Prete Z, 2008, ANN BIOMED ENG, V36, P1281, DOI 10.1007/s10439-008-9496-x; DODSON MV, 1985, ENDOCRINOLOGY, V117, P2357, DOI 10.1210/endo-117-6-2357; DONOGHUE MJ, 1991, J CELL BIOL, V115, P423, DOI 10.1083/jcb.115.2.423; Dubowitz V., 1985, MUSCLE BIOPSY PRACTI; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Frontera WR, 1997, MUSCLE NERVE, V20, P948, DOI 10.1002/(SICI)1097-4598(199708)20:8<948::AID-MUS3>3.0.CO;2-6; Gonzalez E, 2003, J PHYSIOL-LONDON, V552, P833, DOI 10.1113/jphysiol.2003.048165; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; HANZLIKOVA V, 1975, CELL TISSUE RES, V160, P411; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; LEWIS SEM, 1984, BIOCHEM J, V217, P517, DOI 10.1042/bj2170517; Liu JX, 2009, EXP PHYSIOL, V94, P117, DOI 10.1113/expphysiol.2008.043877; Martyn DA, 2007, BIOPHYS J, V92, P4379, DOI 10.1529/biophysj.106.096768; Matsakas A, 2009, NEUROMUSCULAR DISORD, V19, P489, DOI 10.1016/j.nmd.2009.06.367; McCarthy JJ, 2007, J APPL PHYSIOL, V103, P1102; McCarthy JJ, 2007, J APPL PHYSIOL, V103, P1100, DOI 10.1152/japplphysiol.00101.2007a; MCDONALD KS, 1995, J APPL PHYSIOL, V79, P1796, DOI 10.1152/jappl.1995.79.5.1796; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Morine KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009176; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; MOSS RL, 1979, J PHYSIOL-LONDON, V292, P177, DOI 10.1113/jphysiol.1979.sp012845; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Paul AC, 2002, J CELL BIOL, V156, P751, DOI 10.1083/jcb.200105147; Quinn LS, 2007, AM J PHYSIOL-ENDOC M, V293, pE1538, DOI 10.1152/ajpendo.00160.2007; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; Seow CY, 1997, J PHYSIOL-LONDON, V501, P149, DOI 10.1111/j.1469-7793.1997.149bo.x; SNOW MH, 1990, ANAT REC, V227, P437, DOI 10.1002/ar.1092270407; Thompson LV, 2006, J APPL PHYSIOL, V101, P1581, DOI 10.1152/japplphysiol.00426.2006; TSENG BS, 1994, CELL TISSUE RES, V275, P39, DOI 10.1007/BF00305374; Wada KI, 2003, JPN J PHYSIOL, V53, P145; Watt KI, 2010, MUSCLE NERVE, V41, P624, DOI 10.1002/mus.21573; Welle S, 2006, AM J PHYSIOL-ENDOC M, V290, pE409, DOI 10.1152/ajpendo.00433.2005; Welle S, 2007, AM J PHYSIOL-ENDOC M, V292, pE985, DOI 10.1152/ajpendo.00531.2006; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2	46	47	47	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1077	1085		10.1096/fj.11-192195	http://dx.doi.org/10.1096/fj.11-192195			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22125316	Green Submitted, Green Published			2022-12-25	WOS:000300949300012
J	Han, S; Bahmanyar, S; Zhang, PX; Grishin, N; Oegema, K; Crooke, R; Graham, M; Reue, K; Dixon, JE; Goodman, JM				Han, Sungwon; Bahmanyar, Shirin; Zhang, Peixiang; Grishin, Nick; Oegema, Karen; Crooke, Roseann; Graham, Mark; Reue, Karen; Dixon, Jack E.; Goodman, Joel M.			Nuclear Envelope Phosphatase 1-Regulatory Subunit 1 (Formerly TMEM188) Is the Metazoan Spo7p Ortholog and Functions in the Lipin Activation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; DIACYLGLYCEROL KINASES; CAENORHABDITIS-ELEGANS; ENDOPLASMIC-RETICULUM; YEAST; PROTEIN; GENE; MEMBRANE; PHOSPHORYLATION; MUTATIONS	Lipin-1 catalyzes the formation of diacylglycerol from phosphatidicacid. Lipin-1 mutations cause lipodystrophy in mice and acute myopathy in humans. It is heavily phosphorylated, and the yeast ortholog Pah1p becomes membrane-associated and active upon dephosphorylation by the Nem1p-Spo7p membrane complex. A mammalian ortholog of Nem1p is the C-terminal domain nuclear envelope phosphatase 1 (CTDNEP1, formerly "dullard"), but its Spo7p-like partner is unknown, and the need for its existence is debated. Here, we identify the metazoan ortholog of Spo7p, TMEM188, renamed nuclear envelope phosphatase 1-regulatory subunit 1 (NEP1-R1). CTDNEP1 and NEP1-R1 together complement a nem1 Delta spo7 Delta strain to block endoplasmic reticulum proliferation and restore triacylglycerol levels and lipid droplet number. The two human orthologs are in a complex in cells, and the amount of CTDNEP1 is increased in the presence of NEP1-R1. In the Caenorhabditis elegans embryo, expression of nematode CTDNEP1 and NEP1-R1, as well as lipin-1, is required for normal nuclear membrane breakdown after zygote formation. Theexpression pattern of NEP1-R1 and CTDNEP1 in human and mouse tissues closely mirrors that of lipin-1. CTDNEP1 can dephosphorylate lipins-1a, -1b, and -2 in human cells only in the presence of NEP1-R1. The nuclear fraction of lipin-1b is increased when CTD-NEP1 and NEP1-R1 are co-expressed. Therefore, NEP1-R1 is functionally conserved from yeast to humans and functions in the lipin activation pathway.	[Han, Sungwon; Goodman, Joel M.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Grishin, Nick] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Bahmanyar, Shirin; Oegema, Karen] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cell & Mol Med, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Zhang, Peixiang; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Crooke, Roseann; Graham, Mark] ISIS Pharmaceut Inc, Carlsbad, CA 92008 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Isis Pharmaceuticals Inc	Goodman, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	joel.goodman@utsouthwestern.edu	Han, Sungwon/B-8115-2012	Han, Sungwon/0000-0002-4097-856X	National Institutes of Health [GM094575, HL90553, DK18849, DK18024, GM084210]; Jan and Bob Bullock Endowment; Welch Foundation [I-1506]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018024, R37DK018024, R01DK018849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084210, R01GM094575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jan and Bob Bullock Endowment; Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM094575, HL90553 (to K. R.), DK18849 and DK18024 (to J. E. D.), and GM084210 (to J. M. G.). This work was also supported by The Jan and Bob Bullock Endowment (to S. H.) and The Welch Foundation I-1506 (to N. G.),	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Cai JJ, 2009, BBA-MOL CELL BIOL L, V1791, P942, DOI 10.1016/j.bbalip.2009.02.010; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; ESPOSITO MS, 1969, GENETICS, V61, P79; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Ferguson PJ, 2005, J MED GENET, V42, P551, DOI 10.1136/jmg.2005.030759; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gorjanacz M, 2009, J CELL SCI, V122, P1963, DOI 10.1242/jcs.044750; Goto K, 2008, TOHOKU J EXP MED, V214, P199, DOI 10.1620/tjem.214.199; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Knapek K, 2010, MOL CELL BIOL, V30, P4492, DOI 10.1128/MCB.00229-10; Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; Michot C, 2010, HUM MUTAT, V31, pE1564, DOI 10.1002/humu.21282; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Oegema K., 2005, WORMBOOK C ELEGANS, DOI 10.1895/wormbook.1.72.1; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Reue K, 2000, J LIPID RES, V41, P1067; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Satow R, 2002, BIOCHEM BIOPH RES CO, V295, P85, DOI 10.1016/S0006-291X(02)00641-1; SCHLAME M, 1993, J BIOL CHEM, V268, P74; SCHLAME M, 1993, EUR J BIOCHEM, V212, P727, DOI 10.1111/j.1432-1033.1993.tb17711.x; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Skinner JR, 2009, J BIOL CHEM, V284, P30941, DOI 10.1074/jbc.M109.013995; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wang Y, 2009, NUCLEIC ACIDS RES, V37, P3522, DOI 10.1093/nar/gkp212; WEINER MP, 1994, PCR METH APPL, V4, pS131; Wu R, 2011, BIOCHEMISTRY-US, V50, P3045, DOI 10.1021/bi200336b; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhong XP, 2008, IMMUNOL REV, V224, P249, DOI 10.1111/j.1600-065X.2008.00647.x	63	59	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3123	3137		10.1074/jbc.M111.324350	http://dx.doi.org/10.1074/jbc.M111.324350			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22134922	Green Published, hybrid			2022-12-25	WOS:000300295100018
J	Strozecka, J; Chrusciel, E; Gorna, E; Szymanska, A; Zietkiewicz, S; Liberek, K				Strozecka, Joanna; Chrusciel, Elzbieta; Gorna, Emilia; Szymanska, Aneta; Zietkiewicz, Szymon; Liberek, Krzysztof			Importance of N- and C-terminal Regions of IbpA, Escherichia coli Small Heat Shock Protein, for Chaperone Function and Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTICHAPERONE NETWORK; CRYSTAL-STRUCTURE; COMPETENT STATE; DISAGGREGATION; SUBSTRATE; BINDING; AGGREGATION; EFFICIENT; HSP26; CLPB	Small heat shock proteins are ubiquitous molecular chaperones that, during cellular stress, bind to misfolded proteins and maintain them in a refolding competent state. Two members of the small heat shock protein family, IbpA and IbpB, are present in Escherichia coli. Despite 48% sequence identity, the proteins have distinct activities in promoting protein disaggregation. Cooperation between IbpA and IbpB is crucial for prevention of the irreversible aggregation of proteins. In this study, we investigated the importance of the N- and C-terminal regions of IbpA for self-oligomerization and chaperone functions. Deletion of either the N- or C-terminal region of IbpA resulted in a defect in the IbpA fibril formation process. The deletions also impaired IbpA chaperone function, defined as the ability to stabilize, in cooperation with IbpB, protein aggregates in a disaggregation-competent state. Our results show that the defect in chaperone function, observed in truncated versions of IbpA, is due to the inability of these proteins to interact with substrate proteins and consequently to change the properties of aggregates. At the same time, these versions of IbpA interact with IbpB similarly to the wild type protein. Competition experiments performed with the pC peptide, which corresponds to the IbpA C terminus, suggested the importance of IbpA intermolecular interactions in the stabilization of aggregates in a state competent for disaggregation. Our results suggest that these interactions are not only dependent on the universally conserved IEI motif but also on arginine 133 neighboring the IEI motif. IbpA mutated at arginine 133 to alanine lacked chaperone activity.	[Strozecka, Joanna; Chrusciel, Elzbieta; Zietkiewicz, Szymon; Liberek, Krzysztof] Univ Gdansk, Dept Mol & Cellular Biol, Intercollegiate Fac Biotechnol, PL-80822 Gdansk, Poland; [Gorna, Emilia; Szymanska, Aneta] Univ Gdansk, Fac Chem, PL-80852 Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Liberek, K (corresponding author), Univ Gdansk, Dept Mol & Cellular Biol, Intercollegiate Fac Biotechnol, Kladki 24, PL-80822 Gdansk, Poland.	liberek@biotech.ug.gda.pl	Ziętkiewicz, Szymon/L-5259-2014; Liberek, Krzysztof/F-5812-2011; Szymanska, Aneta/AAZ-2783-2021	Szymanska, Aneta/0000-0002-8664-2041; Zietkiewicz, Szymon/0000-0002-3435-4603; Ilowska, Emilia/0000-0002-5774-3644; Chrusciel, Elzbieta/0000-0001-9621-2013; Liberek, Krzysztof/0000-0002-7532-9279	Polish Ministry of Science and Higher Education [N N301 197239]; TEAM/2009/-13/5 program	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); TEAM/2009/-13/5 program	This work was supported by Polish Ministry of Science and Higher Education Grant N N301 197239.; Supported by the TEAM/2009/-13/5 program.	ALLEN SP, 1992, J BACTERIOL, V174, P6938, DOI 10.1128/JB.174.21.6938-6947.1992; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CHUANG SE, 1993, GENE, V134, P1, DOI 10.1016/0378-1119(93)90167-2; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Giese KC, 2004, J BIOL CHEM, V279, P32674, DOI 10.1074/jbc.M404455200; Haslbeck M, 2002, CELL MOL LIFE SCI, V59, P1649, DOI 10.1007/PL00012492; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Jiao WW, 2005, J MOL BIOL, V347, P871, DOI 10.1016/j.jmb.2005.01.029; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kitagawa M, 2002, EUR J BIOCHEM, V269, P2907, DOI 10.1046/j.1432-1033.2002.02958.x; Kuczynska-Wisnik D, 2002, MICROBIOL-SGM, V148, P1757, DOI 10.1099/00221287-148-6-1757; Laskowska E, 1996, BIOCHIMIE, V78, P117, DOI 10.1016/0300-9084(96)82643-5; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; Matuszewska M, 2005, J BIOL CHEM, V280, P12292, DOI 10.1074/jbc.M412706200; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Ratajczak E, 2010, FEBS LETT, V584, P2253, DOI 10.1016/j.febslet.2010.04.060; Ratajczak E, 2009, J MOL BIOL, V386, P178, DOI 10.1016/j.jmb.2008.12.009; Shearstone JR, 1999, J BIOL CHEM, V274, P9937, DOI 10.1074/jbc.274.15.9937; Stromer T, 2004, J BIOL CHEM, V279, P11222, DOI 10.1074/jbc.M310149200; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; WOO KM, 1992, J BIOL CHEM, V267, P20429; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x	36	28	29	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2843	2853		10.1074/jbc.M111.273847	http://dx.doi.org/10.1074/jbc.M111.273847			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139842	hybrid, Green Published			2022-12-25	WOS:000300292300056
J	Cippitelli, A; Astarita, G; Duranti, A; Caprioli, G; Ubaldi, M; Stopponi, S; Kallupi, M; Sagratini, G; de Fonseca, FR; Piomelli, D; Ciccocioppo, R				Cippitelli, Andrea; Astarita, Giuseppe; Duranti, Andrea; Caprioli, Giovanni; Ubaldi, Massimo; Stopponi, Serena; Kallupi, Marsida; Sagratini, Gianni; Rodriguez de Fonseca, Fernando; Piomelli, Daniele; Ciccocioppo, Roberto			Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; CORTICOTROPIN-RELEASING FACTOR; BRAIN REWARD FUNCTION; AMIDE HYDROLASE FAAH; ELEVATED PLUS-MAZE; CANNABINOID SYSTEM; LOCOMOTOR-ACTIVITY; RESTRAINT STRESS; TURNOVER RATE; RATS	Evidence shows that the endocannabinoid system modulates the addictive properties of nicotine. In the present study, we hypothesized that spontaneous withdrawal resulting from removal of chronically implanted transdermal nicotine patches is regulated by the endocannabinoid system. A 7-day nicotine dependence procedure (5.2 mg/rat/day) elicited occurrence of reliable nicotine abstinence symptoms in Wistar rats. Somatic and affective withdrawal signs were observed at 16 and 34 hours following removal of nicotine patches, respectively. Further behavioral manifestations including decrease in locomotor activity and increased weight gain also occurred during withdrawal. Expression of spontaneous nicotine withdrawal was accompanied by fluctuation in levels of the endocannabinoid anandamide (AEA) in several brain structures including the amygdala, the hippocampus, the hypothalamus and the prefrontal cortex. Conversely, levels of 2-arachidonoyl-sn-glycerol were not significantly altered. Pharmacological inhibition of fatty acid amide hydrolase (FAAH), the enzyme responsible for the intracellular degradation of AEA, by URB597 (0.1 and 0.3 mg/kg, i.p.), reduced withdrawal-induced anxiety as assessed by the elevated plus maze test and the shock-probe defensive burying paradigm, but did not prevent the occurrence of somatic signs. Together, the results indicate that pharmacological strategies aimed at enhancing endocannabinoid signaling may offer therapeutic advantages to treat the negative affective state produced by nicotine withdrawal, which is critical for the maintenance of tobacco use.	[Cippitelli, Andrea; Ubaldi, Massimo; Stopponi, Serena; Kallupi, Marsida; Piomelli, Daniele; Ciccocioppo, Roberto] Univ Camerino, Sch Pharm, Pharmacol Unit, I-62032 Camerino, Italy; [Astarita, Giuseppe; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Duranti, Andrea] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Duranti, Andrea] Univ Urbino Carlo Bo, Technol Unit, Urbino, Italy; [Caprioli, Giovanni; Sagratini, Gianni] Univ Camerino, Sch Pharm, Med Chem Unit, I-62032 Camerino, Italy; [Rodriguez de Fonseca, Fernando] Hosp Carlos Haya de Malaga, Fdn IMABIS, Malaga, Spain; [Piomelli, Daniele] Italian Inst Technol, Genoa, Italy	University of Camerino; University of California System; University of California Irvine; University of Urbino; University of Urbino; University of Camerino; FIMABIS; Istituto Italiano di Tecnologia - IIT	Cippitelli, A (corresponding author), Univ Camerino, Sch Pharm, Pharmacol Unit, I-62032 Camerino, Italy.	andrea.cippitelli@unicam.it	Caprioli, Giovanni/H-4143-2019; Kallupi, Marsida/AAP-6084-2020; Astarita, Giuseppe/AAD-1239-2019; Sagratini, Gianni/A-2264-2015; DE FONSECA, FERNANDO RODRIGUEZ/E-9767-2012; Astarita, Giuseppe/N-7346-2014	Caprioli, Giovanni/0000-0002-5530-877X; Kallupi, Marsida/0000-0002-8688-709X; Sagratini, Gianni/0000-0001-6231-8709; Ubaldi, Massimo/0000-0002-4089-2483; Astarita, Giuseppe/0000-0001-6700-301X	University of Camerino, Italy; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA031387] Funding Source: NIH RePORTER	University of Camerino, Italy; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Financial support was from the University of Camerino, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquas E, 2000, EUR J PHARMACOL, V401, P179, DOI 10.1016/S0014-2999(00)00403-9; Bura SA, 2010, EUR NEUROPSYCHOPHARM, V20, P369, DOI 10.1016/j.euroneuro.2010.02.003; Balerio GN, 2006, PSYCHOPHARMACOLOGY, V184, P504, DOI 10.1007/s00213-005-0251-9; Balerio GN, 2004, EUR J NEUROSCI, V20, P2737, DOI 10.1111/j.1460-9568.2004.03714.x; Berrendero F, 2005, J NEUROSCI, V25, P1103, DOI 10.1523/JNEUROSCI.3008-04.2005; Bruijnzeel AW, 2007, NEUROPSYCHOPHARMACOL, V32, P955, DOI 10.1038/sj.npp.1301192; Cannich A, 2004, LEARN MEMORY, V11, P625, DOI 10.1101/lm.77904; Castane A, 2005, PHARMACOL BIOCHEM BE, V81, P381, DOI 10.1016/j.pbb.2005.01.025; Castane A, 2002, NEUROPHARMACOLOGY, V43, P857, DOI 10.1016/S0028-3908(02)00118-1; Cippitelli A, 2008, PSYCHOPHARMACOLOGY, V198, P449, DOI 10.1007/s00213-008-1104-0; Cohen C, 2005, PHARMACOL BIOCHEM BE, V81, P387, DOI 10.1016/j.pbb.2005.01.024; Damaj MI, 2003, J PHARMACOL EXP THER, V307, P526, DOI 10.1124/jpet.103.054908; De Boer SF, 2003, EUR J PHARMACOL, V463, P145, DOI 10.1016/S0014-2999(03)01278-0; de Fonseca FR, 2005, ALCOHOL ALCOHOLISM, V40, P2, DOI 10.1093/alcalc/agh110; deFonseca FR, 1997, SCIENCE, V276, P2050, DOI 10.1126/science.276.5321.2050; Del Arco I, 2002, EUR J PHARMACOL, V454, P103, DOI 10.1016/S0014-2999(02)02483-4; Epping-Jordan MP, 1998, NATURE, V393, P76, DOI 10.1038/30001; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Forget B, 2005, PSYCHOPHARMACOLOGY, V181, P722, DOI 10.1007/s00213-005-0015-6; Forget B, 2009, PSYCHOPHARMACOLOGY, V205, P613, DOI 10.1007/s00213-009-1569-5; George O, 2007, P NATL ACAD SCI USA, V104, P17198, DOI 10.1073/pnas.0707585104; Giuffrida A, 2000, ANAL BIOCHEM, V280, P87, DOI 10.1006/abio.2000.4509; Gonzalez S, 2002, BRAIN RES, V954, P73, DOI 10.1016/S0006-8993(02)03344-9; Haller J, 2009, PSYCHOPHARMACOLOGY, V204, P607, DOI 10.1007/s00213-009-1494-7; HELTON DR, 1993, PSYCHOPHARMACOLOGY, V113, P205, DOI 10.1007/BF02245698; Helton DR, 1997, NEUROPHARMACOLOGY, V36, P1511, DOI 10.1016/S0028-3908(97)00170-6; Hildebrand BE, 1997, PSYCHOPHARMACOLOGY, V129, P348, DOI 10.1007/s002130050200; Hughes JR, 2007, NICOTINE TOB RES, V9, P329, DOI 10.1080/14622200701188927; HUGHES JR, 1991, ARCH GEN PSYCHIAT, V48, P52; Irvine EE, 2001, PHARMACOL BIOCHEM BE, V68, P319, DOI 10.1016/S0091-3057(00)00449-4; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kenny PJ, 2001, PHARMACOL BIOCHEM BE, V70, P531, DOI 10.1016/S0091-3057(01)00651-7; Le Foll B, 2004, NEUROREPORT, V15, P2139, DOI 10.1097/00001756-200409150-00028; LEVIN ED, 1987, PHYSIOL BEHAV, V39, P441, DOI 10.1016/0031-9384(87)90370-2; Lisboa SF, 2008, EUR J PHARMACOL, V593, P73, DOI 10.1016/j.ejphar.2008.07.032; Maldonado R, 2010, CURR DRUG TARGETS, V11, P440, DOI 10.2174/138945010790980358; Malin DH, 2001, PHARMACOL BIOCHEM BE, V70, P551, DOI 10.1016/S0091-3057(01)00699-2; MALIN DH, 1992, PHARMACOL BIOCHEM BE, V43, P779, DOI 10.1016/0091-3057(92)90408-8; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Merritt LL, 2008, J PHARMACOL EXP THER, V326, P483, DOI 10.1124/jpet.108.138321; Miksys S, 2000, BIOCHEM PHARMACOL, V59, P1501, DOI 10.1016/S0006-2952(00)00281-1; Mor M, 2004, J MED CHEM, V47, P4998, DOI 10.1021/jm031140x; Moreira FA, 2008, NEUROPHARMACOLOGY, V54, P141, DOI 10.1016/j.neuropharm.2007.07.005; O'Dell LE, 2007, J PHARMACOL EXP THER, V320, P180, DOI 10.1124/jpet.106.105270; Panagis G, 2000, SYNAPSE, V35, P15, DOI 10.1002/(SICI)1098-2396(200001)35:1<15::AID-SYN3>3.0.CO;2-C; Patel S, 2005, EUR J NEUROSCI, V21, P1057, DOI 10.1111/j.1460-9568.2005.03916.x; Patel S, 2006, J PHARMACOL EXP THER, V318, P304, DOI 10.1124/jpet.106.101287; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Picciotto MR, 2000, NEUROPSYCHOPHARMACOL, V22, P451, DOI 10.1016/S0893-133X(99)00146-3; PICH EM, 1995, J NEUROSCI, V15, P5439; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; POMERLEAU OF, 1986, PSYCHOPHARMACOL BULL, V22, P865; REVUELTA AV, 1978, N-S ARCH PHARMACOL, V304, P107, DOI 10.1007/BF00495546; Richter RM, 1999, SYNAPSE, V32, P254, DOI 10.1002/(SICI)1098-2396(19990615)32:4<254::AID-SYN2>3.0.CO;2-H; RISNER ME, 1983, J PHARMACOL EXP THER, V224, P319; Sarnyai Z, 2001, PHARMACOL REV, V53, P209; Scherma M, 2008, NEUROPHARMACOLOGY, V54, P129, DOI 10.1016/j.neuropharm.2007.08.011; SCHNEIDER NG, 1984, ADDICT BEHAV, V9, P149, DOI 10.1016/0306-4603(84)90052-2; Semba J, 2004, PSYCHONEUROENDOCRINO, V29, P215, DOI 10.1016/S0306-4530(03)00024-6; Slawecki CJ, 2003, PHARMACOL BIOCHEM BE, V75, P355, DOI 10.1016/S0091-3057(03)00093-5; Slawecki CJ, 2002, DEV BRAIN RES, V138, P15, DOI 10.1016/S0165-3806(02)00455-8; Solinas M, 2007, J PHARMACOL EXP THER, V321, P1127, DOI 10.1124/jpet.106.116830; Stella N, 2001, EUR J PHARMACOL, V425, P189, DOI 10.1016/S0014-2999(01)01182-7; Suzuki T, 1999, EUR J PHARMACOL, V369, P159, DOI 10.1016/S0014-2999(99)00086-2; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; TREIT D, 1981, PHARMACOL BIOCHEM BE, V15, P619, DOI 10.1016/0091-3057(81)90219-7; TRIPATHI HL, 1987, ALCOHOL DRUG RES, V7, P525; Tzavara ET, 2002, EUR J NEUROSCI, V16, P149, DOI 10.1046/j.1460-9568.2002.02061.x; Viveros Maria-Paz, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/52908; Watkins SS, 2000, J PHARMACOL EXP THER, V292, P1053; Winders SE, 1998, PSYCHOPHARMACOLOGY, V137, P383, DOI 10.1007/s002130050634; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	73	51	52	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28142	10.1371/journal.pone.0028142	http://dx.doi.org/10.1371/journal.pone.0028142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140525	gold, Green Published			2022-12-25	WOS:000298168100040
J	Kitamura, K; Fujiyoshi, K; Yamane, J; Toyota, F; Hikishima, K; Nomura, T; Funakoshi, H; Nakamura, T; Aoki, M; Toyama, Y; Okano, H; Nakamura, M				Kitamura, Kazuya; Fujiyoshi, Kanehiro; Yamane, Jun-ichi; Toyota, Fumika; Hikishima, Keigo; Nomura, Tatsuji; Funakoshi, Hiroshi; Nakamura, Toshikazu; Aoki, Masashi; Toyama, Yoshiaki; Okano, Hideyuki; Nakamura, Masaya			Human Hepatocyte Growth Factor Promotes Functional Recovery in Primates after Spinal Cord Injury	PLOS ONE			English	Article							DISYNAPTIC PYRAMIDAL EXCITATION; CORTICOSPINAL TRACT; NEUROTROPHIC FACTOR; PROPRIOSPINAL NEURONS; UNILATERAL SECTION; CERVICAL LEVEL; MACAQUE MONKEY; MOTOR CORTEX; FORELIMB MOTONEURONS; HAND REPRESENTATION	Many therapeutic interventions for spinal cord injury (SCI) using neurotrophic factors have focused on reducing the area damaged by secondary, post-injury degeneration, to promote functional recovery. Hepatocyte growth factor (HGF), which is a potent mitogen for mature hepatocytes and a mediator of the inflammatory responses to tissue injury, was recently highlighted as a potent neurotrophic factor in the central nervous system. We previously reported that introducing exogenous HGF into the injured rodent spinal cord using a herpes simplex virus-1 vector significantly reduces the area of damaged tissue and promotes functional recovery. However, that study did not examine the therapeutic effects of administering HGF after injury, which is the most critical issue for clinical application. To translate this strategy to human treatment, we induced a contusive cervical SCI in the common marmoset, a primate, and then administered recombinant human HGF (rhHGF) intrathecally. Motor function was assessed using an original open field scoring system focusing on manual function, including reach-and-grasp performance and hand placement in walking. The intrathecal rhHGF preserved the corticospinal fibers and myelinated areas, thereby promoting functional recovery. In vivo magnetic resonance imaging showed significant preservation of the intact spinal cord parenchyma. rhHGF-treatment did not give rise to an abnormal outgrowth of calcitonin gene related peptide positive fibers compared to the control group, indicating that this treatment did not induce or exacerbate allodynia. This is the first study to report the efficacy of rhHGF for treating SCI in non-human primates. In addition, this is the first presentation of a novel scale for assessing neurological motor performance in non-human primates after contusive cervical SCI.	[Kitamura, Kazuya; Fujiyoshi, Kanehiro; Yamane, Jun-ichi; Toyama, Yoshiaki; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo, Japan; [Kitamura, Kazuya; Hikishima, Keigo; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Kitamura, Kazuya] Hiratsuka City Hosp, Dept Orthoped Surg, Hiratsuka, Kanagawa, Japan; [Toyota, Fumika; Hikishima, Keigo; Nomura, Tatsuji] Cent Inst Expt Anim, Miyamae Ku, Kawasaki, Kanagawa, Japan; [Funakoshi, Hiroshi] Asahikawa Med Univ, Ctr Adv Res & Educ, Asahikawa, Hokkaido, Japan; [Nakamura, Toshikazu] Osaka Univ, Kringle Pharma Joint Res Div Regenerat Drug Disco, Ctr Adv Sci & Innovat, Osaka, Japan; [Aoki, Masashi] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan	Keio University; Keio University; Asahikawa Medical College; Osaka University; Tohoku University	Kitamura, K (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo, Japan.	hidokano@a2.keio.jp; masa@a8.keio.jp	Okano, Hideyuki/I-7584-2019; Hikishima, Keigo/L-1202-2013; Toyama, Yoshiaki/K-5743-2013; Nakamura, Masaya/K-4111-2013; Hikishima, Keigo/AAP-9586-2020	Hikishima, Keigo/0000-0003-1133-1297; Hikishima, Keigo/0000-0003-1133-1297	JSPS; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); MEXT	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Grants-in-Aid for Scientific Research from JSPS and the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), the Project for Realization of Regenerative Medicine and Support for the Core Institutes for iPS Cell Research from MEXT, and by a grant-in-aid for the Global COE program from MEXT to Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstermark B, 1999, J NEUROPHYSIOL, V82, P3580, DOI 10.1152/jn.1999.82.6.3580; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Belci M, 2004, SPINAL CORD, V42, P417, DOI 10.1038/sj.sc.3101613; BERNARD CG, 1953, EXPERIENTIA, V9, P111, DOI 10.1007/BF02178344; Blesch A, 2001, J COMP NEUROL, V436, P399, DOI 10.1002/cne.1076; BORTOFF GA, 1993, J NEUROSCI, V13, P5105, DOI 10.1523/JNEUROSCI.13-12-05105.1993; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Casella GTB, 2002, EXP NEUROL, V173, P63, DOI 10.1006/exnr.2001.7827; Caton A, 2000, DEVELOPMENT, V127, P1751; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Date I, 2004, J NEUROSCI RES, V78, P442, DOI 10.1002/jnr.20263; Davidson AG, 2007, J NEUROSCI, V27, P8053, DOI 10.1523/JNEUROSCI.0040-07.2007; Davidson AG, 2006, EXP BRAIN RES, V173, P25, DOI 10.1007/s00221-006-0374-1; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Fujiyoshi K, 2007, J NEUROSCI, V27, P11991, DOI 10.1523/JNEUROSCI.3354-07.2007; Funakoshi H, 2011, CURR SIGNAL TRANSD T, V6, P156, DOI 10.2174/157436211795659982; GELFAN S., 1964, PROGR BRAIN RES, V11, P238; Glaser J, 2004, J NEUROSCI RES, V77, P701, DOI 10.1002/jnr.20204; Grill R, 1997, J NEUROSCI, V17, P5560; Guizar-Sahagun G, 2005, NEUROSCIENCE, V130, P639, DOI 10.1016/j.neuroscience.2004.09.056; Hamanoue M, 1996, J NEUROSCI RES, V43, P554, DOI 10.1002/(SICI)1097-4547(19960301)43:5<554::AID-JNR5>3.0.CO;2-H; HEFFNER R, 1975, BRAIN BEHAV EVOLUT, V12, P161, DOI 10.1159/000124401; HEFFNER RS, 1983, BRAIN BEHAV EVOLUT, V23, P165, DOI 10.1159/000121494; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; HONDA S, 1995, MOL BRAIN RES, V32, P197, DOI 10.1016/0169-328X(95)00075-4; ILLERT M, 1978, EXP BRAIN RES, V33, P101; Isa T, 2006, J NEUROPHYSIOL, V95, P3674, DOI 10.1152/jn.00103.2005; Isa T, 2007, PHYSIOLOGY, V22, P145, DOI 10.1152/physiol.00045.2006; Ishigaki A, 2007, J NEUROPATH EXP NEUR, V66, P1037, DOI 10.1097/nen.0b013e318159886b; Iwanami A, 2005, J NEUROSCI RES, V80, P172, DOI 10.1002/jnr.20435; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924; Kitamura K, 2007, J NEUROSCI RES, V85, P2332, DOI 10.1002/jnr.21372; Lemon RN, 2004, PROG BRAIN RES, V143, P263, DOI 10.1016/S0079-6123(03)43026-4; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Liu L J, 1999, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V13, P295; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Maina F, 1999, NAT NEUROSCI, V2, P213, DOI 10.1038/6310; MANSFIELD K, 2004, WHITE PAPER COMPLETE; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Miyazawa T, 1998, J CEREBR BLOOD F MET, V18, P345, DOI 10.1097/00004647-199804000-00001; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Nishimura Y, 2007, SCIENCE, V318, P1150, DOI 10.1126/science.1147243; Nishimura Y, 2009, BRAIN, V132, P709, DOI 10.1093/brain/awn338; Nowak DD, 2009, J AM ACAD ORTHOP SUR, V17, P756, DOI 10.5435/00124635-200912000-00004; PALMER E, 1992, J PHYSIOL-LONDON, V449, P429, DOI 10.1113/jphysiol.1992.sp019094; Pettersson LG, 1997, NEUROSCI RES, V29, P241, DOI 10.1016/S0168-0102(97)00093-X; Pettersson LG, 2002, EUR J NEUROSCI, V16, P1349, DOI 10.1046/j.1460-9568.2002.02203.x; Phillips C G, 1977, Monogr Physiol Soc, pv; RALSTON DD, 1985, J COMP NEUROL, V242, P325, DOI 10.1002/cne.902420303; Rouiller EM, 1996, EUR J NEUROSCI, V8, P1055, DOI 10.1111/j.1460-9568.1996.tb01592.x; Sasaki S, 2004, J NEUROPHYSIOL, V92, P3142, DOI 10.1152/jn.00342.2004; Schmidlin E, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-56; Schmidlin E, 2004, BRAIN RES, V1017, P172, DOI 10.1016/j.brainres.2004.05.036; SHAPOVALOV AI, 1975, REV PHYSIOL BIOCH P, V72, P1, DOI 10.1007/BFb0031545; Shimamura M, 2006, HYPERTENSION, V47, P742, DOI 10.1161/01.HYP.0000208598.57687.3e; TERASHIMA T, 1994, J COMP NEUROL, V340, P469, DOI 10.1002/cne.903400403; Tuszynski MH, 1996, EXP NEUROL, V137, P157, DOI 10.1006/exnr.1996.0016; TUSZYNSKI MH, 1994, EXP NEUROL, V126, P1, DOI 10.1006/exnr.1994.1037; Wannier T, 2005, J NEUROTRAUM, V22, P703, DOI 10.1089/neu.2005.22.703	64	62	71	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27706	10.1371/journal.pone.0027706	http://dx.doi.org/10.1371/journal.pone.0027706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140459	Green Submitted, Green Published, gold			2022-12-25	WOS:000298166300010
J	Matthews, B; Hausch, S; Winter, C; Suttle, CA; Shurin, JB				Matthews, Blake; Hausch, Stephen; Winter, Christian; Suttle, Curtis A.; Shurin, Jonathan B.			Contrasting Ecosystem-Effects of Morphologically Similar Copepods	PLOS ONE			English	Article							ADAPTIVE DIVERGENCE; DIAPTOMID COPEPODS; SPECIES COMPLEX; DIVERSIFICATION; EVOLUTION; BIODIVERSITY; POPULATIONS; RATES; CONSEQUENCES; INDIVIDUALS	Organisms alter the biotic and abiotic conditions of ecosystems. They can modulate the availability of resources to other species (ecosystem engineering) and shape selection pressures on other organisms (niche construction). Very little is known about how the engineering effects of organisms vary among and within species, and, as a result, the ecosystem consequences of species diversification and phenotypic evolution are poorly understood. Here, using a common gardening experiment, we test whether morphologically similar species and populations of Diaptomidae copepods (Leptodiaptomus ashlandi, Hesperodiaptomus franciscanus, Skistodiaptomus oregonensis) have similar or different effects on the structure and function of freshwater ecosystems. We found that copepod species had contrasting effects on algal biomass, ammonium concentrations, and sedimentation rates, and that copepod populations had contrasting effects on prokaryote abundance, sedimentation rates, and gross primary productivity. The average size of ecosystem-effect contrasts between species was similar to those between populations, and was comparable to those between fish species and populations measured in previous common gardening experiments. Our results suggest that subtle morphological variation among and within species can cause multifarious and divergent ecosystem-effects. We conclude that using morphological trait variation to assess the functional similarity of organisms may underestimate the importance of species and population diversity for ecosystem functioning.	[Matthews, Blake] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Ctr Ecol Evolut & Biogeochem, Kastanienbaum, Luzern, Switzerland; [Hausch, Stephen] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Winter, Christian] Univ Vienna, Dept Marine Biol, Vienna, Austria; [Suttle, Curtis A.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V5Z 1M9, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Bot, Vancouver, BC V5Z 1M9, Canada; [Shurin, Jonathan B.] Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Calgary; University of Vienna; University of British Columbia; University of British Columbia; University of British Columbia; University of California System; University of California San Diego	Matthews, B (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Ctr Ecol Evolut & Biogeochem, Kastanienbaum, Luzern, Switzerland.	blake.matthews@eawag.ch	Suttle, Curtis A/C-3150-2008; Matthews, Blake/B-5608-2009; suttle, c/N-1144-2019	Suttle, Curtis A/0000-0002-0372-0033; Matthews, Blake/0000-0001-9089-704X; suttle, c/0000-0002-0372-0033; Winter, Christian/0000-0001-6327-0209	Natural Sciences and Engineering Research Council of Canada; Tula Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Tula Foundation	All authors were supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca). CAS and CW were additionally supported by the Tula Foundation (http://www.tula.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly D, 2009, P NATL ACAD SCI USA, V106, P19699, DOI 10.1073/pnas.0901635106; Adams DC, 2009, P ROY SOC B-BIOL SCI, V276, P2729, DOI 10.1098/rspb.2009.0543; ANDERSON RS, 1967, CAN J ZOOLOG, V45, P1043, DOI 10.1139/z67-113; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Bailey JK, 2009, NEW PHYTOL, V184, P746, DOI 10.1111/j.1469-8137.2009.03081.x; Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107; BELL G, 1993, OECOLOGIA, V96, P114, DOI 10.1007/BF00318038; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; CARTER JCH, 1980, CAN J ZOOL, V58, P1355, DOI 10.1139/z80-188; Chase JM, 2009, ECOL LETT, V12, P1210, DOI 10.1111/j.1461-0248.2009.01362.x; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; Daleo P, 2007, ECOL LETT, V10, P902, DOI 10.1111/j.1461-0248.2007.01082.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; GANZ HH, 1995, MAR BIOL, V123, P821, DOI 10.1007/BF00349126; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; JACOBY CA, 1983, MAR BIOL, V76, P77, DOI 10.1007/BF00393058; Johnson MTJ, 2009, PHILOS T R SOC B, V364, P1593, DOI 10.1098/rstb.2008.0334; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; Kozak KH, 2006, P ROY SOC B-BIOL SCI, V273, P539, DOI 10.1098/rspb.2005.3326; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; LAVIN PA, 1986, CAN J FISH AQUAT SCI, V43, P2455, DOI 10.1139/f86-305; Lee CE, 2000, EVOLUTION, V54, P2014, DOI 10.1111/j.0014-3820.2000.tb01245.x; Lee CE, 2002, HYDROBIOLOGIA, V480, P111, DOI 10.1023/A:1021293203512; Leibold MA, 2010, ECOL LETT, V13, P1290, DOI 10.1111/j.1461-0248.2010.01523.x; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Lund OT, 1979, HDB COMMON METHODS L; MARSH CD, 1907, T WISC ACAD SCI, V15, P381; Marszalek MA, 2009, HYDROBIOLOGIA, V624, P61, DOI 10.1007/s10750-008-9666-8; Matthews B, 2005, LIMNOL OCEANOGR, V50, P1404, DOI 10.4319/lo.2005.50.5.1404; Matthews B, 2011, ECOL LETT, V14, P690, DOI 10.1111/j.1461-0248.2011.01627.x; McIntyre PB, 2008, ECOLOGY, V89, P2335, DOI 10.1890/07-1552.1; McPeek MA, 2000, ECOLOGY, V81, P904; McPeek MA, 2008, AM NAT, V171, pE158, DOI 10.1086/587076; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; ODUM E P, 1971, P574; Olff H, 2009, PHILOS T R SOC B, V364, P1755, DOI 10.1098/rstb.2008.0222; Palkovacs EP, 2009, PHILOS T R SOC B, V364, P1617, DOI 10.1098/rstb.2009.0016; Palkovacs EP, 2009, ECOLOGY, V90, P300, DOI 10.1890/08-1673.1; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Robinson BW, 2000, BEHAVIOUR, V137, P865, DOI 10.1163/156853900502501; Sandercock GA, 1994, INTRO KEY FRESHWATER; Sanders RW, 1996, LIMNOL OCEANOGR, V41, P1295, DOI 10.4319/lo.1996.41.6.1295; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; Tabachnick B. G., 2001, USING MULTIVARIATE S; Taylor BW, 2007, J N AM BENTHOL SOC, V26, P167, DOI 10.1899/0887-3593(2007)26[167:ITFAMM]2.0.CO;2; Terborgh J., 2010, TROPHIC CASCADES PRE; Thum RA, 2008, HYDROBIOLOGIA, V614, P197, DOI 10.1007/s10750-008-9506-x; Thum RA, 2009, BIOL J LINN SOC, V96, P150, DOI 10.1111/j.1095-8312.2008.01105.x; Torke B, 2001, HYDROBIOLOGIA, V453, P351, DOI 10.1023/A:1013185916287; Turner JT, 2004, ZOOL STUD, V43, P255; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Webb CT, 2010, ECOL LETT, V13, P267, DOI 10.1111/j.1461-0248.2010.01444.x; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Wilson M. S., 1953, Smithsonian Miscellaneous Collections, V122, P1; Wright JP, 2006, BIOSCIENCE, V56, P203, DOI 10.1641/0006-3568(2006)056[0203:TCOOAE]2.0.CO;2	64	16	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e26700	10.1371/journal.pone.0026700	http://dx.doi.org/10.1371/journal.pone.0026700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140432	Green Published, Green Submitted, gold			2022-12-25	WOS:000298166300002
J	Erlandsson, J; McQuaid, CD; Skold, M				Erlandsson, Johan; McQuaid, Christopher D.; Skold, Martin			Patchiness and Co-Existence of Indigenous and Invasive Mussels at Small Spatial Scales: The Interaction of Facilitation and Competition	PLOS ONE			English	Article							MYTILUS-GALLOPROVINCIALIS; PERNA-PERNA; INTERTIDAL MUSSELS; ATTACHMENT STRENGTH; HABITAT SEGREGATION; PACIFIC COAST; WAVE ACTION; MECHANISMS; SETTLEMENT; MORTALITY	Ecological theory predicts that two species with similar requirements will fail to show long-term co-existence in situations where shared resources are limiting, especially at spatial scales that are small relative to the size of the organisms. Two species of intertidal mussels, the indigenous Perna perna and the invasive Mytilus galloprovincialis, form mixed beds on the south coast of South Africa in a situation that has been stable for several generations of these species, even though these populations are often limited by the availability of space. We examined the spatial structure of these species where they coexist at small spatial scales in the absence of apparent environmental heterogeneity at two sites, testing: whether conspecific aggregation of mussels can occur (using spatial Monte-Carlo tests); the degree of patchiness (using Korcak B patchiness exponent), and whether there was a relationship between percent cover and patchiness. We found that under certain circumstances there is non-random conspecific aggregation, but that in other circumstances there may be random distribution (i.e. the two species are mixed), so that spatial patterns are context-dependent. The relative cover of the species differed between sites, and within each site, the species with higher cover showed low Korcak B values (indicating low patchiness, i.e. the existence of fewer, larger patches), while the less abundant species showed the reverse, i.e. high patchiness. This relationship did not hold for either species within sites. We conclude that co-existence between these mussels is possible, even at small spatial scales because each species is an ecological engineer and, while they have been shown to compete for space, this is preceded by initial facilitation. We suggest that a patchy pattern of co-existence is possible because of a balance between direct (competitive) and indirect (facilitative) interactions.	[Erlandsson, Johan] Novia Univ Appl Sci, Abo Akad Univ, ARONIA Coastal Zone Res Team, Ekenas, Finland; [McQuaid, Christopher D.] Rhodes Univ, Dept Zool & Entomol, Coastal Res Grp, ZA-6140 Grahamstown, South Africa; [Skold, Martin] Stockholm Univ, Dept Math, S-10691 Stockholm, Sweden	Abo Akademi University; Novia University of Applied Sciences; Rhodes University; Stockholm University	Erlandsson, J (corresponding author), Novia Univ Appl Sci, Abo Akad Univ, ARONIA Coastal Zone Res Team, Ekenas, Finland.	jerlands@abo.fi	Sköld, Martin/C-8525-2012; McQuaid, Christopher/AAT-3725-2020	McQuaid, Christopher/0000-0002-3473-8308; Skold, Martin/0000-0001-7053-9667	Hellmuth Hertz Foundation; Royal Swedish Academy of Sciences; Stint Foundation, Sweden; Rhodes University, South Africa; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	Hellmuth Hertz Foundation; Royal Swedish Academy of Sciences; Stint Foundation, Sweden; Rhodes University, South Africa; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation	This study was funded by the Hellmuth Hertz Foundation, The Royal Swedish Academy of Sciences (www.kva.se), Stint Foundation, Sweden, and Rhodes University (www.ru.ac.za), South Africa (to JE). This work is also based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation (to CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2002, P ROY SOC B-BIOL SCI, V269, P2541, DOI 10.1098/rspb.2002.2181; Amarasekare P, 2001, AM NAT, V158, P572, DOI 10.1086/323586; [Anonymous], 1932, STAT METHODS RES WOR; Bell JJ, 2008, MAR ECOL PROG SER, V368, P127, DOI 10.3354/meps07637; BERTNESS MD, 1985, OECOLOGIA, V67, P192, DOI 10.1007/BF00384283; Bownes S, 2008, AFR J MAR SCI, V30, P233, DOI 10.2989/AJMS.2008.30.2.3.553; Bownes S., 2005, THESIS RHODES U GRAH; Bownes SJ, 2006, J EXP MAR BIOL ECOL, V338, P140, DOI 10.1016/j.jembe.2006.07.006; Bownes SJ, 2010, MAR BIOL, V157, P1799, DOI 10.1007/s00227-010-1452-2; Bownes SJ, 2009, MAR BIOL, V156, P991, DOI 10.1007/s00227-009-1143-z; BRANCH GM, 1984, OCEANOGR MAR BIOL, V22, P429; Branch GM., 2010, 2 OCEANS GUIDE MARIN; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Carson HS, 2010, CURR BIOL, V20, P1926, DOI 10.1016/j.cub.2010.09.057; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Cole VJ, 2010, ECOLOGY, V91, P3549, DOI 10.1890/09-2152.1; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Dale MR., 2000, SPATIAL PATTERN ANAL; DYE AH, 1992, NETH J SEA RES, V30, P209, DOI 10.1016/0077-7579(92)90059-N; Erlandsson J, 2006, MAR ECOL PROG SER, V320, P169, DOI 10.3354/meps320169; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Geange SW, 2009, ECOLOGY, V90, P2868, DOI 10.1890/08-0630.1; Harris JM, 1998, S AFR J ZOOL, V33, P1; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; Hastings HM, 1993, FRACTALS USERS GUIDE; Hewitt JE, 1996, MAR ECOL PROG SER, V135, P57, DOI 10.3354/meps135057; Hill JM, 2006, MAR ECOL PROG SER, V318, P63, DOI 10.3354/meps318063; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; Imre AR, 2011, ECOL INDIC, V11, P1134, DOI 10.1016/j.ecolind.2010.12.013; Kohler S, 2009, ESTUAR COAST SHELF S, V84, P361, DOI 10.1016/j.ecss.2009.03.035; Kostylev V, 2001, MAR BIOL, V139, P497, DOI 10.1007/s002270100597; LASIAK TA, 1995, MAR ECOL PROG SER, V120, P147, DOI 10.3354/meps120147; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; MCDONALD JH, 1988, MAR BIOL, V99, P111, DOI 10.1007/BF00644984; McQuaid CD, 2000, MAR BIOL, V137, P925, DOI 10.1007/s002270000398; McQuaid CD, 2010, J EXP MAR BIOL ECOL, V384, P119, DOI 10.1016/j.jembe.2010.01.005; Nicastro KR, 2010, BIOL INVASIONS, V12, P2165, DOI 10.1007/s10530-009-9619-9; Nicastro KR, 2008, MAR ECOL PROG SER, V372, P119, DOI 10.3354/meps07671; Nicastro Katy R., 2010, BMC Ecology, V10, P17, DOI 10.1186/1472-6785-10-17; Peralta P, 2000, INT J REMOTE SENS, V21, P2555, DOI 10.1080/01431160050110179; Plass-Johnson JG, 2010, MAR ECOL PROG SER, V411, P149, DOI 10.3354/meps08681; Quinn GP, 2003, EXPT DESIGN DATA ANA; QUINN JF, 1982, OECOLOGIA, V54, P129, DOI 10.1007/BF00541119; Rawson PD, 1999, MAR BIOL, V134, P201, DOI 10.1007/s002270050538; Ricciardi A, 2004, ECOL LETT, V7, P781, DOI 10.1111/j.1461-0248.2004.00642.x; Rius M, 2006, MAR BIOL, V150, P69, DOI 10.1007/s00227-006-0322-4; Rius M, 2009, BASIC APPL ECOL, V10, P607, DOI 10.1016/j.baae.2009.03.008; Robinson TB, 2005, AFR J MAR SCI, V27, P297, DOI 10.2989/18142320509504088; Stachowicz JJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P41; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; van de Koppel J, 2005, AM NAT, V165, pE66; van de Koppel J, 2008, SCIENCE, V322, P739, DOI 10.1126/science.1163952; von der Meden CEO, 2010, MAR ECOL PROG SER, V411, P161, DOI 10.3354/meps08642; von der Meden CEO, 2008, MAR ECOL PROG SER, V372, P135, DOI 10.3354/meps07731; Weerman EJ, 2011, ECOLOGY, V92, P487, DOI 10.1890/10-0270.1; Zardi GI, 2007, MAR ECOL PROG SER, V334, P155, DOI 10.3354/meps334155; Zardi GI, 2006, MAR BIOL, V150, P79, DOI 10.1007/s00227-006-0328-y	58	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e26958	10.1371/journal.pone.0026958	http://dx.doi.org/10.1371/journal.pone.0026958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132084	Green Published, Green Submitted, gold			2022-12-25	WOS:000297792400003
J	Sperka, T; Geissler, KJ; Merkel, U; Scholl, I; Rubio, I; Herrlich, P; Morrison, HL				Sperka, Tobias; Geissler, Katja J.; Merkel, Ulrike; Scholl, Ingmar; Rubio, Ignacio; Herrlich, Peter; Morrison, Helen L.			Activation of Ras Requires the ERM-Dependent Link of Actin to the Plasma Membrane	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; NUCLEOTIDE EXCHANGE; HISTONE DOMAIN; SRF ACTIVITY; IN-VITRO; CD44; SEVENLESS; GROWTH; SON; PROTEINS	Background: Receptor tyrosine kinases (RTKs) participate in a multitude of signaling pathways, some of them via the small G-protein Ras. An important component in the activation of Ras is Son of sevenless (SOS), which catalyzes the nucleotide exchange on Ras. Principal Findings: We can now demonstrate that the activation of Ras requires, in addition, the essential participation of ezrin, radixin and/or moesin (ERM), a family of actin-binding proteins, and of actin. Disrupting either the interaction of the ERM proteins with co-receptors, down-regulation of ERM proteins by siRNA, expression of dominant-negative mutants of the ERM proteins or disruption of F-actin, abolishes growth factor-induced Ras activation. Ezrin/actin catalyzes the formation of a multiprotein complex consisting of RTK, co-receptor, Grb2, SOS and Ras. We also identify binding sites for both Ras and SOS on ezrin; mutations of these binding sites destroy the interactions and inhibit Ras activation. Finally, we show that the formation of the ezrin-dependent complex is necessary to enhance the catalytic activity of SOS and thereby Ras activation. Conclusions: Taking these findings together, we propose that the ERM proteins are novel scaffolds at the level of SOS activity control, which is relevant for both normal Ras function and dysfunction known to occur in several human cancers.	[Sperka, Tobias; Geissler, Katja J.; Merkel, Ulrike; Scholl, Ingmar; Morrison, Helen L.] Fritz Lipmann Inst FLI, Morrison Lab, Leibniz Inst Age Res, Jena, Germany; [Sperka, Tobias; Herrlich, Peter] Fritz Lipmann Inst FLI, Herrlich Lab, Leibniz Inst Age Res, Jena, Germany; [Rubio, Ignacio] Univ Jena, Inst Mol Cell Biol, Ctr Mol Biomed, Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena	Sperka, T (corresponding author), Fritz Lipmann Inst FLI, Morrison Lab, Leibniz Inst Age Res, Jena, Germany.	helen@fli-leibniz.de	Morrison, Helen/F-9748-2014; Sperka, Tobias/E-2659-2017; Morrison, Helen/B-3984-2017	Morrison, Helen/0000-0003-4938-1409; Morrison, Helen/0000-0003-4938-1409	Krebshilfe [107089]; Deutsche Forschungsgemeinschaft [He551/10.3]; DFG [SFB604]	Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	The authors had three grants that funded this work: 1) Krebshilfe 107089 www.krebshilfe.de, 2) Deutsche Forschungsgemeinschaft (He551/10.3), 3) SFB604 Multi functional signalling proteins (from DFG) www.dfg.de/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiatari I, 2010, J CELL MOL MED, V14, P1166, DOI 10.1111/j.1582-4934.2009.00772.x; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Giordano S, 1997, P NATL ACAD SCI USA, V94, P13868, DOI 10.1073/pnas.94.25.13868; Grimsley CM, 2006, J BIOL CHEM, V281, P5928, DOI 10.1074/jbc.M510647200; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Gureasko J, 2010, P NATL ACAD SCI USA, V107, P3430, DOI 10.1073/pnas.0913915107; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hunter KW, 2004, TRENDS MOL MED, V10, P201, DOI 10.1016/j.molmed.2004.03.001; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Klominek J, 1998, CLIN EXP METASTAS, V16, P529, DOI 10.1023/A:1006542301794; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; MCKERNAN RM, 1990, J NEUROCHEM, V54, P924, DOI 10.1111/j.1471-4159.1990.tb02339.x; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; PORFIRI E, 1994, J BIOL CHEM, V269, P22672; RAABE T, 2002, SCI STKE, pPE28; Rubio I, 2000, CURR BIOL, V10, P1225, DOI 10.1016/S0960-9822(00)00731-4; Saleh HS, 2009, J MOL BIOL, V385, P1015, DOI 10.1016/j.jmb.2008.11.051; SHEETZ MJ, 1988, J BIOL CHEM, V263, P19210; Sherman L, 1998, GENE DEV, V12, P1058, DOI 10.1101/gad.12.7.1058; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Takahashi K, 1998, ONCOGENE, V16, P3279, DOI 10.1038/sj.onc.1201874; TOMOZAWA Y, 1978, P NATL ACAD SCI USA, V75, P6305, DOI 10.1073/pnas.75.12.6305; Treisman R, 1998, COLD SPRING HARB SYM, V63, P643, DOI 10.1101/sqb.1998.63.643; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Valastyan S, 2009, GENE DEV, V23, P2592, DOI 10.1101/gad.1832709; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Yadav KK, 2010, P NATL ACAD SCI USA, V107, P3436, DOI 10.1073/pnas.0914315107; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	43	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27511	10.1371/journal.pone.0027511	http://dx.doi.org/10.1371/journal.pone.0027511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132106	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789900012
J	Schlee, W; Kleinjung, T; Hiller, W; Goebel, G; Kolassa, IT; Langguth, B				Schlee, Winfried; Kleinjung, Tobias; Hiller, Wolfgang; Goebel, Gerhard; Kolassa, Iris-Tatjana; Langguth, Berthold			Does Tinnitus Distress Depend on Age of Onset?	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HEARING-LOSS; PLASTICITY; SEVERITY; LOUDNESS	Objectives: Tinnitus is the perception of a sound in the absence of any physical source of it. About 5-15% of the population report hearing such a tinnitus and about 1-2% suffer from their tinnitus leading to anxiety, sleep disorders or depression. It is currently not completely understood why some people feel distressed by their tinnitus, while others don't. Several studies indicate that the amount of tinnitus distress is associated with many factors including comorbid anxiety, comorbid depression, personality, the psychosocial situation, the amount of the related hearing loss and the loudness of the tinnitus. Furthermore, theoretical considerations suggest an impact of the age at tinnitus onset influencing tinnitus distress. Methods: Based on a sample of 755 normal hearing tinnitus patients we tested this assumption. All participants answered a questionnaire on the amount of tinnitus distress together with a large variety of clinical and demographic data. Results: Patients with an earlier onset of tinnitus suffer significantly less than patients with an onset later in life. Furthermore, patients with a later onset of tinnitus describe their course of tinnitus distress as more abrupt and distressing right from the beginning. Conclusion: We argue that a decline of compensatory brain plasticity in older age accounts for this age-dependent tinnitus decompensation.	[Schlee, Winfried; Kolassa, Iris-Tatjana] Univ Ulm, Dept Clin & Biol Psychol, Ulm, Germany; [Kleinjung, Tobias] Univ Zurich, Dept Otorhinolaryngol, Zurich, Switzerland; [Kleinjung, Tobias; Langguth, Berthold] Univ Regensburg, Interdisciplinary Tinnitus Clin, Regensburg, Germany; [Hiller, Wolfgang] Johannes Gutenberg Univ Mainz, Dept Clin Psychol, Regensburg, Germany; [Goebel, Gerhard] Med Psychomat Hosp, Schoen Clin Roseneck, Prien Am Chiemsee, Germany; [Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany	Ulm University; University of Zurich; University of Regensburg; Johannes Gutenberg University of Mainz; University of Regensburg	Schlee, W (corresponding author), Univ Ulm, Dept Clin & Biol Psychol, Ulm, Germany.	Winfried.Schlee@uni-ulm.de	Schlee, Winfried/C-8983-2011; Kleinjung, Tobias/AAJ-3141-2020; Langguth, Berthold/AAP-2638-2021; Kolassa, Iris Tatjana/Y-3032-2018	Schlee, Winfried/0000-0001-7942-1788; Kleinjung, Tobias/0000-0003-3867-234X; 				Andersson G, 2006, ACTA OTO-LARYNGOL, V126, P39, DOI 10.1080/03655230600895226; Crocetti A, 2009, OTOLARYNG HEAD NECK, V140, P403, DOI 10.1016/j.otohns.2008.11.036; De Ridder D, 2005, OTOL NEUROTOL, V26, P616, DOI 10.1097/01.mao.0000178146.91139.3c; De Ridder D, 2010, NEUROSURGERY, V66, P656, DOI 10.1227/01.NEU.0000366110.87836.53; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Freitas C, 2011, FRONT AGING NEUROSCI, V3, DOI [10.3389/fnagi.2011.00005, 10.3389/fnagi.2011.00006]; GOEBEL G, 1994, HNO, V42, P166; Goh JO, 2009, RESTOR NEUROL NEUROS, V27, P391, DOI 10.3233/RNN-2009-0493; HALLIWELL RS, 1986, TEX AES MISC PUBL, P1; Hiller W, 2004, INT J AUDIOL, V43, P600, DOI 10.1080/14992020400050077; Hiller W, 2007, AUDIOL NEURO-OTOL, V12, P391, DOI 10.1159/000106482; Hiller W, 2006, ARCH OTOLARYNGOL, V132, P1323, DOI 10.1001/archotol.132.12.1323; Hoffman H., 2004, TINNITUS THEORY MANA, P16; Khedr EM, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.127712; Kleinjung T, 2007, OTOLARYNG HEAD NECK, V137, P589, DOI 10.1016/j.otohns.2006.12.007; Langguth B, 2007, PROG BRAIN RES, V166, P221, DOI 10.1016/S0079-6123(07)66020-8; Moller AR, 2007, PROG BRAIN RES, V166, P37, DOI 10.1016/S0079-6123(07)66003-8; Pilgramm M., 1999, P 6 INT TINN SEM CAM, P7; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Savastano M, 2008, EUR ARCH OTO-RHINO-L, V265, P1295, DOI 10.1007/s00405-008-0630-z; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Shargorodsky J, 2010, JAMA-J AM MED ASSOC, V304, P772, DOI 10.1001/jama.2010.1124; Vanneste S, 2011, CLIN NEUROPHYSIOL, V122, P578, DOI 10.1016/j.clinph.2010.07.022; Weisz N, 2007, PROG BRAIN RES, V166, P61, DOI 10.1016/S0079-6123(07)66006-3; Zollig J, 2009, RESTOR NEUROL NEUROS, V27, P421, DOI 10.3233/RNN-2009-0513	25	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27379	10.1371/journal.pone.0027379	http://dx.doi.org/10.1371/journal.pone.0027379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125612	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000297789200012
J	Phiri, HT; Bridges, DJ; Glover, SJ; van Mourik, JA; de Laat, B; M'baya, B; Taylor, TE; Seydel, KB; Molyneux, ME; Faragher, EB; Craig, AG; Bunn, JEG				Phiri, Happy T.; Bridges, Daniel J.; Glover, Simon J.; van Mourik, Jan A.; de Laat, Bas; M'baya, Bridon; Taylor, Terrie E.; Seydel, Karl B.; Molyneux, Malcolm E.; Faragher, E. Brian; Craig, Alister G.; Bunn, James E. G.			Elevated Plasma Von Willebrand Factor and Propeptide Levels in Malawian Children with Malaria	PLOS ONE			English	Article							VONWILLEBRAND-FACTOR; QUANTITATIVE-ANALYSIS; FALCIPARUM-MALARIA; CEREBRAL MALARIA; FACTOR ANTIGEN; SECRETION; PROPOLYPEPTIDE; RELEASE	Background: In spite of the significant mortality associated with Plasmodium falciparum infection, the mechanisms underlying severe disease remain poorly understood. We have previously shown evidence of endothelial activation in Ghanaian children with malaria, indicated by elevated plasma levels of both von Willebrand factor (VWF) and its propeptide. In the current prospective study of children in Malawi with retinopathy confirmed cerebral malaria, we compared these markers with uncomplicated malaria, non malarial febrile illness and controls. Methods and Findings: Children with cerebral malaria, mild malaria and controls without malaria were recruited into the study. All comatose patients were examined by direct and indirect ophthalmoscopy. Plasma VWF and propeptide levels were measured by ELISA. Median VWF and propeptide levels were significantly higher in patients with uncomplicated malaria than in children with non-malarial febrile illness of comparable severity, in whom levels were higher than in non-febrile controls. Median concentrations of both markers were higher in cerebral malaria than in uncomplicated malaria, and were similar in patients with and without retinopathy. Levels of both VWF and propeptide fell significantly 48 hours after commencing therapy and were normal one month later. Conclusions: In children with malaria plasma VWF and propeptide levels are markedly elevated in both cerebral and mild paediatric malaria, with levels matching disease severity, and these normalize upon recovery. High levels of both markers also occur in retinopathy-negative 'cerebral malaria' cases, many of whom are thought to be suffering from diseases other than malaria, indicating that further studies of these markers will be required to determine their sensitivity and specificity.	[Phiri, Happy T.; Bridges, Daniel J.; Molyneux, Malcolm E.] Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Glover, Simon J.; Taylor, Terrie E.; Seydel, Karl B.] Univ Malawi, Coll Med, Blantyre Malaria Project, Blantyre, Malawi; [van Mourik, Jan A.; de Laat, Bas] Sanquin, Dept Plasma Prot, Amsterdam, Netherlands; [van Mourik, Jan A.; de Laat, Bas] Sanquin, Dept Blood Coagulat, Amsterdam, Netherlands; [M'baya, Bridon] Malawi Blood Transfus Serv, Blantyre, Malawi; [Taylor, Terrie E.; Seydel, Karl B.] Michigan State Univ, Coll Osteopath Med, Dept Internal Med, E Lansing, MI 48824 USA; [Molyneux, Malcolm E.; Faragher, E. Brian; Craig, Alister G.; Bunn, James E. G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of Malawi; University of Malawi; Michigan State University; Michigan State University College of Osteopathic Medicine; Liverpool School of Tropical Medicine; University of Liverpool	Phiri, HT (corresponding author), Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	jegbunn@liv.ac.uk		Craig, Alister/0000-0003-0914-6164	Wellcome Trust [WT081345MA]; Bill and Melinda Gates Foundation; Netherlands Heart Foundation [2006T053]	Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was funded by the Wellcome Trust (grant WT081345MA) (http://www.wellcome.ac.uk). Dr. Happy Phiri was funded through a re-entry grant from the Bill and Melinda Gates Foundation (www.gatesfoundation.org). Bas de Laat is a Fellow of the Netherlands Heart Foundation (grant no. 2006T053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arman M, 2007, AM J TROP MED HYG, V77, P943, DOI 10.4269/ajtmh.2007.77.943; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Beare NAV, 2006, AM J TROP MED HYG, V75, P790, DOI 10.4269/ajtmh.2006.75.790; Borchiellini A, 1996, BLOOD, V88, P2951, DOI 10.1182/blood.V88.8.2951.bloodjournal8882951; Bridges DJ, 2010, BLOOD, V115, P1472, DOI 10.1182/blood-2009-07-235150; Conroy AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015291; de Mast Q, 2007, J INFECT DIS, V196, P622, DOI 10.1086/519844; Erdman LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017440; ETTLING M, 1994, TROP MED PARASITOL, V45, P57; Hannah MJ, 2005, J BIOL CHEM, V280, P22827, DOI 10.1074/jbc.M412547200; Hollestelle MJ, 2006, BRIT J HAEMATOL, V133, P562, DOI 10.1111/j.1365-2141.2006.06067.x; KRISHNA S, 1994, T ROY SOC TROP MED H, V88, P67, DOI 10.1016/0035-9203(94)90504-5; Larkin D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000349; MAYADAS TN, 1991, ANN NY ACAD SCI, V614, P153, DOI 10.1111/j.1749-6632.1991.tb43700.x; MOLYNEUX ME, 1989, Q J MED, V71, P441; Newton CRJC, 1998, AM J TROP MED HYG, V58, P673, DOI 10.4269/ajtmh.1998.58.673; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Rosenberg JB, 2002, BLOOD, V100, P1699, DOI 10.1182/blood-2002-03-0789; RUBIN DB, 1990, J CLIN INVEST, V86, P474, DOI 10.1172/JCI114733; RUGGERI ZM, 1993, FASEB J, V7, P308, DOI 10.1096/fasebj.7.2.8440408; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sadler JE, 2002, SCIENCE, V297, P1128, DOI 10.1126/science.1075452; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; STEL HV, 1985, BLOOD, V65, P85; Sulo J, 2002, LANCET, V360, P1136, DOI 10.1016/S0140-6736(02)11198-6; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; van Mourik JA, 1999, BLOOD, V94, P179, DOI 10.1182/blood.V94.1.179.413k18_179_185; van Mourik JA, 2001, THROMB HAEMOSTASIS, V86, P164; Vischer UM, 1997, THROMB HAEMOSTASIS, V77, P387; WAGNER DD, 1987, P NATL ACAD SCI USA, V84, P1955, DOI 10.1073/pnas.84.7.1955; Wassmer SC, 2004, J INFECT DIS, V189, P180, DOI 10.1086/380761; WHITE NJ, 1985, LANCET, V1, P776; WISE RJ, 1988, CELL, V52, P229, DOI 10.1016/0092-8674(88)90511-9; Zeigler ZR, 1996, AM J HEMATOL, V53, P213	34	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e25626	10.1371/journal.pone.0025626	http://dx.doi.org/10.1371/journal.pone.0025626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22125593	Green Published, gold, Green Accepted			2022-12-25	WOS:000297555800002
J	Liu, W; Lindberg, J; Sui, G; Luo, J; Egevad, L; Li, T; Xie, C; Wan, M; Kim, ST; Wang, Z; Turner, AR; Zhang, Z; Feng, J; Yan, Y; Sun, J; Bova, GS; Ewing, CM; Yan, G; Gielzak, M; Cramer, SD; Vessella, RL; Zheng, SL; Gronberg, H; Isaacs, WB; Xu, J				Liu, W.; Lindberg, J.; Sui, G.; Luo, J.; Egevad, L.; Li, T.; Xie, C.; Wan, M.; Kim, S-T; Wang, Z.; Turner, A. R.; Zhang, Z.; Feng, J.; Yan, Y.; Sun, J.; Bova, G. S.; Ewing, C. M.; Yan, G.; Gielzak, M.; Cramer, S. D.; Vessella, R. L.; Zheng, S. L.; Gronberg, H.; Isaacs, W. B.; Xu, J.			Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer	ONCOGENE			English	Article						CHD1; homozygous deletion; prostate cancer	COPY NUMBER ANALYSIS; HUMAN LUNG-CANCER; ANDROGEN RECEPTOR; RNAI TECHNOLOGY; STEM-CELLS; CHROMATIN; GENE; EXPRESSION; MUTATIONS; PATHWAY	A clearer definition of the molecular determinants that drive the development and progression of prostate cancer (PCa) is urgently needed. Efforts to map recurrent somatic deletions in the tumor genome, especially homozygous deletions (HODs), have provided important positional information in the search for cancer-causing genes. Analyzing HODs in the tumors of 244 patients from two independent cohorts and 22 PCa xenografts using high-resolution single-nucleotide polymorphism arrays, herein we report the identification of CHD1, a chromatin remodeler, as one of the most frequently homozygously deleted genes in PCa, second only to PTEN in this regard. The HODs observed in CHD1, including deletions affecting only internal exons of CHD1, were found to completely extinguish the expression of mRNA of this gene in PCa xenografts. Loss of this chromatin remodeler in clinical specimens is significantly associated with an increased number of additional chromosomal deletions, both hemi- and homozygous, especially on 2q, 5q and 6q. Together with the deletions observed in HEK293 cells stably transfected with CHD1 small hairpin RNA, these data suggest a causal relationship. Downregulation of Chd1 in mouse prostate epithelial cells caused dramatic morphological changes indicative of increased invasiveness, but did not result in transformation. Indicating a new role of CHD1, these findings collectively suggest that distinct CHD1 associated alterations of genomic structure evolve during and are required for the development of PCa. Oncogene (2012) 31, 3939-3948; doi:10.1038/onc.2011.554; published online 5 December 2011	[Luo, J.; Ewing, C. M.; Yan, G.; Gielzak, M.; Isaacs, W. B.] Johns Hopkins Med Inst, Brady Urol Inst, Baltimore, MD 21287 USA; [Liu, W.; Li, T.; Xie, C.; Kim, S-T; Wang, Z.; Turner, A. R.; Zhang, Z.; Feng, J.; Sun, J.; Zheng, S. L.; Xu, J.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC 27157 USA; [Liu, W.; Li, T.; Xie, C.; Kim, S-T; Wang, Z.; Turner, A. R.; Zhang, Z.; Feng, J.; Sun, J.; Zheng, S. L.; Xu, J.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom & Personalized Med Res, Winston Salem, NC USA; [Lindberg, J.; Gronberg, H.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Sui, G.; Wan, M.; Cramer, S. D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Egevad, L.] Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden; [Yan, Y.; Xu, J.] Van Andel Res Inst, Ctr Genet Epidemiol & Prevent, Grand Rapids, MI USA; [Bova, G. S.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Vessella, R. L.] Univ Washington, Dept Urol, Seattle, WA 98195 USA	Johns Hopkins University; Johns Hopkins Medicine; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Karolinska Institutet; Wake Forest University; Wake Forest Baptist Medical Center; Karolinska Institutet; Karolinska University Hospital; Van Andel Institute; Johns Hopkins University; Johns Hopkins Medicine; University of Washington; University of Washington Seattle	Isaacs, WB (corresponding author), Johns Hopkins Med Inst, Brady Urol Inst, Marburg 115,600 N Wolfe St, Baltimore, MD 21287 USA.	wisaacs@jhmi.edu; jxu@wfubmc.edu	Kim, Seong-Tae/E-4474-2017; Lindberg, Johan/F-4104-2011; LI, TAO/AAL-5932-2020	Kim, Seong-Tae/0000-0001-7436-1405; LI, TAO/0000-0001-7343-9688; Lindberg, Johan/0000-0003-3610-6774; Egevad, Lars/0000-0001-8531-222X; Bova, George/0000-0003-1639-3104	National Institutes of Health [CA135008, CA133066, CA119069, CA131338, 133009]; NATIONAL CANCER INSTITUTE [R01CA131338, R01CA129418, R01CA133009, R01CA133066, R01CA112517, R01CA135008, R01CA119069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study is partially supported by the National Institutes of Health Grants CA135008 and CA133066 (to W Liu and WB Isaacs), CA119069 (to J Xu), CA131338 and 133009 (to SL Zheng and WB Isaacs). We thank Tamara Adams for editing the manuscript. The support of William T Gerrard, Mario Duhon, Jennifer and John Chalsty and P Kevin Jaffe (to WBI) is gratefully acknowledged.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Avvakumov N, 2011, MOL CELL, V41, P502, DOI 10.1016/j.molcel.2011.02.013; Barclay WW, 2008, STEM CELLS, V26, P600, DOI 10.1634/stemcells.2007-0309; Barclay WW, 2005, PROSTATE, V63, P291, DOI 10.1002/pros.20193; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Cengiz B, 2007, ORAL ONCOL, V43, P241, DOI 10.1016/j.oraloncology.2006.03.004; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Deng Z, 2009, ONCOGENE, V28, P3746, DOI 10.1038/onc.2009.231; Deng ZY, 2007, MOL CELL BIOL, V27, P3780, DOI 10.1128/MCB.01761-06; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding Z, 2011, NATURE, V466, P869; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Kohno T, 2010, GENE CHROMOSOME CANC, V49, P342, DOI 10.1002/gcc.20746; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Liu W, 2007, CLIN CANCER RES, V13, P5028, DOI 10.1158/1078-0432.CCR-07-0300; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Lu YJ, 2010, GENE CHROMOSOME CANC, V49, P412, DOI 10.1002/gcc.20752; McDaniel IE, 2008, GENETICS, V178, P583, DOI 10.1534/genetics.107.079038; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Nancarrow DJ, 2008, CANCER RES, V68, P4163, DOI 10.1158/0008-5472.CAN-07-6710; Rahrmann EP, 2009, CANCER RES, V69, P4388, DOI 10.1158/0008-5472.CAN-08-3901; Robbins CM, 2011, GENOME RES, V21, P47, DOI 10.1101/gr.107961.110; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Sims RJ, 2009, NATURE, V460, P802, DOI 10.1038/460802a; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; STOKES DG, 1995, MOL CELL BIOL, V15, P2745; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Sui G, 2005, METH MOL B, V309, P205; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270	41	69	69	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	35					3939	3948		10.1038/onc.2011.554	http://dx.doi.org/10.1038/onc.2011.554			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	999VJ	22139082	Green Accepted			2022-12-25	WOS:000308342800003
J	Wang, S; Xu, L; Jonas, JB; Wang, YX; You, QS; Yang, H				Wang, Shuang; Xu, Liang; Jonas, Jost B.; Wang, Ya Xing; You, Qi Sheng; Yang, Hua			Dyslipidemia and Eye Diseases in the Adult Chinese Population: The Beijing Eye Study	PLOS ONE			English	Article							AGE-RELATED MACULOPATHY; RETINAL VEIN OCCLUSION; RISK-FACTORS; MACULAR DEGENERATION; INTRAOCULAR-PRESSURE; CHOLESTEROL LEVELS; CARDIOVASCULAR-DISEASE; PARAPAPILLARY ATROPHY; JAPANESE POPULATION; BLOOD-PRESSURE	To determine associations between dyslipidemia and ocular diseases, the population-based Beijing Eye Study 2006 examined 3251 subjects (age >= 45 years) who underwent a detailed ophthalmic examination and biochemical blood analysis. Dyslipidemia was defined as any of the following: hypercholesterolemia (total cholesterol concentration >= 5.72 mmol/L ( 220 mg/dL)) or hypertriglyceridemia ( triglyceride concentration >= 1.70 mmol/L (150 mg/dL)) or low high-density lipoprotein-cholesterol (HDL-C concentration <= 0.91 mmol/L (35 mg/dL)). Biochemical blood examinations were available for 2945 (90.6%) subjects. After adjustment for age, gender, habitation region, body mass index, self reported income, blood glucose concentration, diastolic blood pressure and smoking, dyslipidemia was significantly associated with higher intraocular pressure (P<0.001) and beta zone of parapapillary atrophy ( P = 0.03). Dyslipidemia was not significantly associated with the prevalence of glaucoma (P = 0.99), retinal vein occlusions (P = 0.92), diabetic retinopathy (P = 0.49), presence of retinal vascular abnormalities such as focal or general arteriolar narrowing, age-related macular degeneration (P = 0.27), nuclear cataract (P = 0.14), cortical cataract (P = 0.93), and subcapsular cataract (P = 0.67). The results make one conclude that, controlled for systemic and socioeconomic parameters, dyslipidemia was not associated with common ophthalmic disorders including glaucoma and age-related macular degeneration.	[Wang, Shuang; Xu, Liang; Jonas, Jost B.; Wang, Ya Xing; You, Qi Sheng; Yang, Hua] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Wang, S (corresponding author), Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China.	xlbio@yahoo.cn	You, Qisheng/AAG-7153-2020; wang, YA XING/K-9671-2016; You, Qisheng/A-3619-2014	You, Qisheng/0000-0003-0743-7320; wang, YA XING/0000-0003-2749-7793; You, Qisheng/0000-0003-0743-7320				[Anonymous], 1991, Ophthalmology, V98, P786; Cheung N, 2008, INVEST OPHTH VIS SCI, V49, P4297, DOI 10.1167/iovs.08-1826; Chowdhury T, 2002, EYE, V16, P689, DOI 10.1038/sj.eye.6700205; Davis MD, 1998, INVEST OPHTH VIS SCI, V39, P233; Douglas IJ, 2007, OPHTHALMOLOGY, V114, P1164, DOI 10.1016/j.ophtha.2006.09.018; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; GlacetBernard A, 1996, OPHTHALMOLOGY, V103, P551, DOI 10.1016/S0161-6420(96)30653-2; Gupta A, 2004, AM J OPHTHALMOL, V137, P675, DOI 10.1016/j.ajo.2003.11.017; He J, 2004, CIRCULATION, V110, P405, DOI 10.1161/01.CIR.0000136583.52681.0D; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Jeganathan VSE, 2008, AM J OPHTHALMOL, V146, P954, DOI 10.1016/j.ajo.2008.07.006; Jia W P, 2002, Obes Rev, V3, P157; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P2942; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P908; Kaiserman N, 2009, CURR EYE RES, V34, P304, DOI 10.1080/02713680902741670; Kassoff A, 2001, AM J OPHTHALMOL, V131, P167; Keen H, 2001, DIABETOLOGIA, V44, pS22, DOI 10.1007/PL00002935; Klein BE, BR J OPHTHALMOL, V89, P284; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Leung H, 2005, EYE, V19, P861, DOI 10.1038/sj.eye.6701668; Li YH, 2002, NUTR METAB CARDIOVAS, V12, P118; Li YB, 2006, AM J OPHTHALMOL, V142, P788, DOI 10.1016/j.ajo.2006.06.001; Liu WW, 2007, OPHTHALMOLOGY, V114, P1795, DOI 10.1016/j.ophtha.2007.03.010; Maguire MG, 2009, OPHTHALMOLOGY, V116, P2381, DOI 10.1016/j.ophtha.2009.06.055; McGwin G, 2006, ARCH OPHTHALMOL-CHIC, V124, P33, DOI 10.1001/archopht.124.1.33; McGwin G, 2005, OPHTHALMOLOGY, V112, P488, DOI 10.1016/j.ophtha.2004.10.027; McGwin G, 2003, BRIT J OPHTHALMOL, V87, P1121, DOI 10.1136/bjo.87.9.1121; Memarzadeh F, 2008, AM J OPHTHALMOL, V146, P69, DOI 10.1016/j.ajo.2008.03.015; Mitchell P, 2005, AM J OPHTHALMOL, V140, P131, DOI 10.1016/j.ajo.2004.12.088; Miyazaki M, 2005, INVEST OPHTH VIS SCI, V46, P1907, DOI 10.1167/iovs.04-0923; Miyazaki M, 2003, BRIT J OPHTHALMOL, V87, P469, DOI 10.1136/bjo.87.4.469; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; O'Mahoney PRA, 2008, ARCH OPHTHALMOL-CHIC, V126, P692, DOI 10.1001/archopht.126.5.692; Paunksnis A, 2005, EUR J OPHTHALMOL, V15, P255, DOI 10.1177/112067210501500213; Reddy KS, 1998, CIRCULATION, V97, P596; Rodgers A, 1998, LANCET, V352, P1801; Smeeth L, 2005, BRIT J OPHTHALMOL, V89, P1171, DOI 10.1136/bjo.2004.064477; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; VANHERICK W, 1969, AM J OPHTHALMOL, V68, P626, DOI 10.1016/0002-9394(69)91241-0; Wachter A, 2004, OPHTHALMOLOGE, V101, P50, DOI 10.1007/s00347-003-0868-1; Wang S, 2006, OPHTHALMOLOGY, V113, P1752, DOI 10.1016/j.ophtha.2006.05.019; Xu L, 2008, EXP CLIN ENDOCR DIAB, V116, P69, DOI 10.1055/s-2007-985381; Xu L, 2008, AM J HYPERTENS, V21, P1117, DOI 10.1038/ajh.2008.247; Xu L, 2008, GRAEF ARCH CLIN EXP, V246, P923, DOI 10.1007/s00417-008-0773-z; Xu L, 2007, AM J OPHTHALMOL, V144, P541, DOI 10.1016/j.ajo.2007.05.038; Xu L, 2007, AM J OPHTHALMOL, V144, P461, DOI 10.1016/j.ajo.2007.05.013; Yasuda M, 2009, OPHTHALMOLOGY, V116, P2135, DOI 10.1016/j.ophtha.2009.04.017	49	89	92	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2012	7	3							e26871	10.1371/journal.pone.0026871	http://dx.doi.org/10.1371/journal.pone.0026871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943KB	22128290	Green Submitted, Green Published, gold			2022-12-25	WOS:000304118900001
J	Aliprantis, AO; Stolina, M; Kostenuik, PJ; Poliachik, SL; Warner, SE; Bain, SD; Gross, TS				Aliprantis, Antonios O.; Stolina, Marina; Kostenuik, Paul J.; Poliachik, Sandra L.; Warner, Sarah E.; Bain, Steven D.; Gross, Ted S.			Transient muscle paralysis degrades bone via rapid osteoclastogenesis	FASEB JOURNAL			English	Article						homeostasis; botulinum toxin A; NFATc1; RANKL	GENE-RELATED PEPTIDE; SPINAL-CORD-INJURY; BOTULINUM TOXIN INJECTION; KAPPA-B LIGAND; SYMPATHETIC INNERVATION; RECEPTOR ACTIVATOR; GROWING RABBITS; OSTEOPOROSIS; MICE; RAT	A unilateral injection of botulinum toxin A (BTxA) in the calf induces paralysis and profound loss of ipsalateral trabecular bone within days. However, the cellular mechanism underlying acute muscle paralysis-induced bone loss (MPIBL) is poorly understood. We hypothesized that MPIBL arises via rapid and extensive osteoclastogenesis. We performed a series of in vivo experiments to explore this thesis. First, we observed elevated levels of the proosteoclastogenic cytokine receptor activator for nuclear factor-kappa B ligand (RANKL) within the proximal tibia metaphysis at 7 d after muscle paralysis (+113%, P<0.02). Accordingly, osteoclast numbers were increased 122% compared with the contralateral limb at 5 d after paralysis (P=0.04) and MPIBL was completely blocked by treatment with human recombinant osteoprotegerin (hrOPG). Further, conditional deletion of nuclear factor of activated T-cells c1 (NFATc1), the master regulator of osteoclastogenesis, completely inhibited trabecular bone loss (-2.2 +/- 11.9%, P<0.01). All experiments included negative control assessments of contralateral limbs and/or within-animal pre-and postintervention imaging. In summary, transient muscle paralysis induced acute RANKL-mediated osteoclastogenesis resulting in profound local bone resorption. Elucidation of the pathways that initiate osteoclastogenesis after paralysis may identify novel targets to inhibit bone loss and prevent fractures.-Aliprantis, A. O., Stolina, M., Kostenuik, P. J., Poliachik, S. L., Warner, S. E., Bain, S. D., Gross, T. S. Transient muscle paralysis degrades bone via rapid osteoclastogenesis. FASEB J. 26, 1110-1118 (2012). www.fasebj.org	[Poliachik, Sandra L.; Warner, Sarah E.; Bain, Steven D.; Gross, Ted S.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98104 USA; [Aliprantis, Antonios O.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol,Dept Med, Boston, MA 02115 USA; [Aliprantis, Antonios O.] Harvard Univ, Sch Publ Hlth, Dept Infect Dis & Immunol, Boston, MA 02115 USA; [Stolina, Marina; Kostenuik, Paul J.] Amgen Inc, Metab Disorders, Thousand Oaks, CA 91320 USA	University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Amgen	Gross, TS (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Box 359798,325 9th Ave, Seattle, WA 98104 USA.	tgross@u.washington.edu			Burroughs Wellcome Fund Career Award for Medical Scientists; U.S. National Institute of Arthritis and Metabolic Diseases [K08-AR-54859, AR-45665, AR-60304]; Amgen; Sigvard T. Hansen, Jr. Endowed Chair; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060304, R01AR045665, K08AR054859] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); U.S. National Institute of Arthritis and Metabolic Diseases; Amgen(Amgen); Sigvard T. Hansen, Jr. Endowed Chair; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in part, by a Burroughs Wellcome Fund Career Award for Medical Scientists (to A.O.A.), U.S. National Institute of Arthritis and Metabolic Diseases grants K08-AR-54859 (to A.O.A.), AR-45665 (to T. S. G.), and AR-60304 (to T. S. G.); a grant from Amgen (to T. S. G.); and the Sigvard T. Hansen, Jr. Endowed Chair (T. S. G.). A.O.A., S. L. P., S. E. W., and S. D. B. report no conflicts of interest. T. S. G. received funding from Amgen that, in part, supported this work. M. S. and P.J.K. are employees of Amgen and have equity ownership in Amgen. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Arthritis and Metabolic Diseases or the U.S. National Institutes of Health.	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Ausk B. J., 2011, 56 ANN M ORTH RES SO, P2260; Ausk BJ, 2012, BONE, V50, P14, DOI 10.1016/j.bone.2011.08.028; Bain S. D., 2009, J BONE MINER RES, V24, pS96; Blouin S, 2007, OSTEOPOROSIS INT, V18, P85, DOI 10.1007/s00198-006-0197-8; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Castro MJ, 1999, J APPL PHYSIOL, V86, P350, DOI 10.1152/jappl.1999.86.1.350; Chenu C, 2005, JOINT BONE SPINE, V72, P481, DOI 10.1016/j.jbspin.2005.10.007; Cooper C, 2010, OSTEOPOROSIS INT, V21, P425, DOI 10.1007/s00198-010-1251-0; Cornish J, 1999, J BONE MINER RES, V14, P1302, DOI 10.1359/jbmr.1999.14.8.1302; Frost HM, 1999, AM J HUM BIOL, V11, P437; Garland DE, 2008, J SPINAL CORD MED, V31, P543, DOI 10.1080/10790268.2008.11753650; Geusens P, 2009, CLIN INTERV AGING, V4, P241; Goto Tetsuya, 2001, Medical Electron Microscopy, V34, P77; Gracia-Marco L, 2011, EUR J APPL PHYSIOL, V111, P2671, DOI 10.1007/s00421-011-1897-0; HAMBLETON P, 1992, J NEUROL, V239, P16, DOI 10.1007/BF00839205; Hansen RB, 2007, SCAND J UROL NEPHROL, V41, P115, DOI 10.1080/00365590600991383; Imai S, 1997, J BONE MINER RES, V12, P1018, DOI 10.1359/jbmr.1997.12.7.1018; JAWORSKI ZFG, 1981, J ANAT, V133, P397; Judex S, 2004, J BONE MINER RES, V19, P607, DOI 10.1359/JBMR.040110; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kostenuik PJ, 2004, BONE, V34, P656, DOI 10.1016/j.bone.2003.12.006; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kwon TG, 2007, J ORAL MAXIL SURG, V65, P1530, DOI 10.1016/j.joms.2006.10.059; Lang AM, 2003, ARCH PHYS MED REHAB, V84, pS69, DOI 10.1053/apmr.2003.50121; Larson CM, 2000, J PEDIATR ORTHOPED, V20, P71, DOI 10.1097/00004694-200001000-00016; Lewis SJG, 2001, ACTA NEUROL SCAND, V103, P320, DOI 10.1034/j.1600-0404.2001.103005320.x; Libouban H, 2008, MICRON, V39, P998, DOI 10.1016/j.micron.2007.09.006; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; MANNI E, 1989, DOC OPHTHALMOL, V72, P189, DOI 10.1007/BF00156709; Manske SL, 2010, BONE, V46, P24, DOI 10.1016/j.bone.2009.10.016; Marenzana M, 2007, BONE, V41, P206, DOI 10.1016/j.bone.2007.04.184; Min H, 2000, J EXP MED, V192, P463, DOI 10.1084/jem.192.4.463; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Mori T, 1999, BIOCHEM BIOPH RES CO, V262, P418, DOI 10.1006/bbrc.1999.1220; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Ominsky MS, 2007, OSTEOPOROSIS INT, V18, P1073, DOI 10.1007/s00198-007-0363-7; Parfitt AM, 1983, BONE HISTOMORPHOMETR; Poliachik SL, 2010, BONE, V46, P18, DOI 10.1016/j.bone.2009.10.025; Prasad J., 2011, 33 AM SOC BON MIN RE; Rantalainen T, 2011, BONE, V48, P786, DOI 10.1016/j.bone.2010.11.013; Rauch F., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P264; Rauch F, 2004, BONE, V34, P771, DOI 10.1016/j.bone.2004.01.022; Rucci N, 2007, J CELL BIOCHEM, V100, P464, DOI 10.1002/jcb.21059; Sambrook PN, 2003, J BONE MINER RES, V18, P919, DOI 10.1359/jbmr.2003.18.5.919; Saxena R, 2011, J BONE MINER METAB, V29, P111, DOI 10.1007/s00774-010-0201-4; Sayer AA, 2008, J NUTR HEALTH AGING, V12, P427, DOI 10.1007/BF02982703; Serre CM, 1999, BONE, V25, P623, DOI 10.1016/S8756-3282(99)00215-X; SHAW NJ, 1994, ARCH DIS CHILD, V71, P235, DOI 10.1136/adc.71.3.235; Shiotani A, 2001, J ELECTRON MICROSC, V50, P365, DOI 10.1093/jmicro/50.4.365; Sievanen H., ARCH BIOCH BIOPHYS, V503, P146; Singh JA, 2010, THER ADV MUSCULOSKEL, V2, P105, DOI 10.1177/1759720X09357113; Sitara D, 2010, IMMUNOL REV, V233, P286, DOI 10.1111/j.0105-2896.2009.00849.x; Stolina M, 2005, J BONE MINER RES, V20, P1756, DOI 10.1359/JBMR.050601; Takahashi N, 2003, METH MOLEC MED, V80, P129; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Tang-Liu DDS, 2003, TOXICON, V42, P461, DOI 10.1016/S0041-0101(03)00196-X; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Togari A, 2002, MICROSC RES TECHNIQ, V58, P77, DOI 10.1002/jemt.10121; Udagawa N, 1999, BONE, V25, P517, DOI 10.1016/S8756-3282(99)00210-0; Usas A, 2007, BIOMATERIALS, V28, P5401, DOI 10.1016/j.biomaterials.2007.09.008; Vickerman L, 2011, DEV BIOL, V350, P323, DOI 10.1016/j.ydbio.2010.11.031; Vignery A, 1996, BONE, V18, P331, DOI 10.1016/8756-3282(96)00017-8; Warner SE, 2006, BONE, V38, P257, DOI 10.1016/j.bone.2005.08.009; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Wright DE, 2002, J NEUROBIOL, V50, P198, DOI 10.1002/neu.10024; Yoshinaga Y, 2007, J PERIODONTAL RES, V42, P402, DOI 10.1111/j.1600-0765.2007.00960.x; ZAIDI M, 1987, J ENDOCRINOL, V115, P511, DOI 10.1677/joe.0.1150511; ZANCHETTA JR, 1995, BONE, V16, pS393, DOI 10.1016/S8756-3282(95)80505-2	74	29	30	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1110	1118		10.1096/fj.11-196642	http://dx.doi.org/10.1096/fj.11-196642			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22125315	Green Published			2022-12-25	WOS:000300949300015
J	Contois, LW; Nugent, DP; Caron, JM; Cretu, A; Tweedie, E; Akalu, A; Liebes, L; Friesel, R; Rosen, C; Vary, C; Brooks, PC				Contois, Liangru W.; Nugent, Desiree P.; Caron, Jennifer M.; Cretu, Alexandra; Tweedie, Eric; Akalu, Abebe; Liebes, Leonard; Friesel, Robert; Rosen, Clifford; Vary, Calvin; Brooks, Peter C.			Insulin-like Growth Factor Binding Protein-4 Differentially Inhibits Growth Factor-induced Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN TYPE-IV; ENDOTHELIAL-CELL SURVIVAL; HUMANIZED ANTIBODY D93; SMOOTH-MUSCLE-CELLS; P38 MAP KINASE; TUMOR-GROWTH; EXTRACELLULAR-MATRIX; TRANSGENIC MICE; BLOOD-VESSELS; IN-VIVO	An in-depth understanding of the molecular and cellular complexity of angiogenesis continues to advance as new stimulators and inhibitors of blood vessel formation are uncovered. Gaining a more complete understanding of the response of blood vessels to both stimulatory and inhibitory molecules will likely contribute to more effective strategies to control pathological angiogenesis. Here, we provide evidence that endothelial cell interactions with structurally altered collagen type IV may suppress the expression of insulin-like growth factor binding protein-4 (IGFBP-4), a well documented inhibitor of the IGF-1/IGF-1R signaling axis. We report for the first time that IGFBP-4 differentially inhibits angiogenesis induced by distinct growth factor signaling pathways as IGFBP-4 inhibited FGF-2- and IGF-1-stimulated angiogenesis but failed to inhibit VEGF-induced angiogenesis. The resistance of VEGF-stimulated angiogenesis to IGFBP-4 inhibition appears to depend on sustained activation of p38 MAPK as blocking its activity restored the anti-angiogenic effects of IGFBP-4 on VEGF-induced blood vessel growth in vivo. These novel findings provide new insight into how blood vessels respond to endogenous inhibitors during angiogenesis stimulated by distinct growth factor signaling pathways.	[Contois, Liangru W.; Nugent, Desiree P.; Caron, Jennifer M.; Tweedie, Eric; Friesel, Robert; Rosen, Clifford; Vary, Calvin; Brooks, Peter C.] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA; [Cretu, Alexandra] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Akalu, Abebe; Liebes, Leonard] NYU, Sch Med, Dept Med, New York, NY 10016 USA	Maine Medical Center; University of Pennsylvania; New York University	Brooks, PC (corresponding author), Maine Med Ctr Res Inst, Ctr Mol Med, 81 Res Dr, Scarborough, ME 04074 USA.	brookp1@mmc.org			National Institutes of Health [CA91645, HL65301]; Protein, Nucleic Acid Analysis, and Cell Imaging Core [HL083151, P20RR15555]; Bioinformatic Core [P20 RR181789]; National Centre for Research Resources [P20RR15555]; Maine Medical Center; NATIONAL CANCER INSTITUTE [R01CA091645] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015555] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065301, R01HL083151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein, Nucleic Acid Analysis, and Cell Imaging Core; Bioinformatic Core; National Centre for Research Resources; Maine Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA91645 (to P. C. B.), Grant HL65301 (to R. F.), Grants HL083151 and P20RR15555 (Protein, Nucleic Acid Analysis, and Cell Imaging Core) (to C. P. H. V.), and Grant P20 RR181789 (Bioinformatic Core) (to D. M. Wojchowski). This work was also supported by National Centre for Research Resources Grant P20RR15555 and sub-project to PCB (to R. F.) and by institutional support from the Maine Medical Center.	Akaht A, 2007, CANCER RES, V67, P4353, DOI 10.1158/0008-5472.CAN-06-0482; Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; Brooks PC, 1999, METH MOL B, V129, P257; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Cheresh DA, 2008, ONCOGENE, V27, P6285, DOI 10.1038/onc.2008.304; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; Cretu A, 2007, CLIN CANCER RES, V13, P3068, DOI 10.1158/1078-0432.CCR-06-2342; Damon SE, 1998, ENDOCRINOLOGY, V139, P3456, DOI 10.1210/en.139.8.3456; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Duan C, 2002, J ENDOCRINOL, V175, P41, DOI 10.1677/joe.0.1750041; Duan CM, 1998, J BIOL CHEM, V273, P16836, DOI 10.1074/jbc.273.27.16836; Durai R, 2007, INT J ONCOL, V30, P883; Durai R, 2006, INT J ONCOL, V28, P1317; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Freimark B, 2007, MOL IMMUNOL, V44, P3741, DOI 10.1016/j.molimm.2007.03.027; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Gee E, 2010, J CELL PHYSIOL, V222, P120, DOI 10.1002/jcp.21924; Hangai M, 2002, AM J PATHOL, V161, P1429, DOI 10.1016/S0002-9440(10)64418-5; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Jo N, 2006, MOL VIS, V12, P1243; Laursen LS, 2007, MOL ENDOCRINOL, V21, P1246, DOI 10.1210/me.2006-0522; Leong KG, 2002, MOL CELL BIOL, V22, P2830, DOI 10.1128/MCB.22.8.2830-2841.2002; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; Matsumoto T, 2002, J CELL BIOL, V156, P149, DOI 10.1083/jcb.200103096; Moreno MJ, 2006, GLIA, V53, P845, DOI 10.1002/glia.20345; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Nagarajan R, 2007, BIOCHEMISTRY-US, V46, P192, DOI 10.1021/bi061706u; Noonan DM, 2008, CANCER METAST REV, V27, P31, DOI 10.1007/s10555-007-9108-5; Odaka C, 2005, J IMMUNOL, V174, P846, DOI 10.4049/jimmunol.174.2.846; Pernasetti F, 2006, INT J ONCOL, V29, P1371; Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051; Pozzi A, 2009, WIRES SYST BIOL MED, V1, P254, DOI 10.1002/wsbm.7; Rajashekhar G, 2011, J CELL PHYSIOL, V226, P800, DOI 10.1002/jcp.22404; Rini BI, 2005, J CLIN ONCOL, V23, P1028, DOI 10.1200/JCO.2005.01.186; Robert F., 2010, ASCO ANN M; Ryan AJ, 2009, BRIT J CANCER, V101, P278, DOI 10.1038/sj.bjc.6605141; Sanz L, 2003, TRENDS MOL MED, V9, P256, DOI 10.1016/S1471-4914(03)00070-4; Ueno K, 2011, INT J CANCER, V129, P2360, DOI 10.1002/ijc.25899; Wang JW, 1998, ENDOCRINOLOGY, V139, P2605, DOI 10.1210/en.139.5.2605; Xie HL, 2010, J DIGEST DIS, V11, P167, DOI 10.1111/j.1751-2980.2010.00432.x; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yu JZ, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-70; Zheng B, 1998, J BIOL CHEM, V273, P8994, DOI 10.1074/jbc.273.15.8994; Zhou R, 2004, J MOL ENDOCRINOL, V32, P349, DOI 10.1677/jme.0.0320349	47	31	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1779	1789		10.1074/jbc.M111.267732	http://dx.doi.org/10.1074/jbc.M111.267732			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22134921	hybrid, Green Published			2022-12-25	WOS:000299321000020
J	Mehla, R; Bivalkar-Mehla, S; Chauhan, A				Mehla, Rajeev; Bivalkar-Mehla, Shalmali; Chauhan, Ashok			A Flavonoid, Luteolin, Cripples HIV-1 by Abrogation of Tat Function	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CARBOXYL-TERMINAL DOMAIN; LOW-LEVEL VIREMIA; GENE-EXPRESSION; ANTIRETROVIRAL THERAPY; QUANTITATIVE ASSAY; AP-1 ACTIVATION; CELL-CYCLE; SUBTYPE-B; T-CELLS	Despite the effectiveness of combination antiretroviral treatment (cART) against HIV-1, evidence indicates that residual infection persists in different cell types. Intensification of cART does not decrease the residual viral load or immune activation. cART restricts the synthesis of infectious virus but does not curtail HIV-1 transcription and translation from either the integrated or unintegrated viral genomes in infected cells. All treated patients with full viral suppression actually have low-level viremia. More than 60% of treated individuals also develop minor HIV-1-associated neurocognitive deficits (HAND) due to residual virus and immune activation. Thus, new therapeutic agents are needed to curtail HIV-1 transcription and residual virus. In this study, luteolin, a dietary supplement, profoundly reduced HIV-1 infection in reporter cells and primary lymphocytes. HIV-1inhibition by luteolin was independent of viral entry, as shown by the fact that wild-type and VSV-pseudotyped HIV-1 infections were similarly inhibited. Luteolin was unable to inhibit viral reverse transcription. Luteolin had antiviral activity in a latent HIV-1 reactivation model and effectively ablated both clade-B- and -C -Tat-driven LTR transactivation in reporter assays but had no effect on Tat expression and its sub-cellular localization. We conclude that luteolin confers anti-HIV-1 activity at the Tat functional level. Given its biosafety profile and ability to cross the blood-brain barrier, luteolin may serve as a base flavonoid to develop potent anti-HIV-1 derivatives to complement cART.	[Mehla, Rajeev; Bivalkar-Mehla, Shalmali; Chauhan, Ashok] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Chauhan, Ashok] Univ S Carolina, Sch Med, Dept Pharmacol Physiol & Neurosci, Columbia, SC USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Mehla, R (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Ashok.Chauhan@uscmed.sc.edu			National Institutes of Health (NIH) [RO1 NS 050064]; University of South Carolina School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050064] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Carolina School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the National Institutes of Health (NIH) grant RO1 NS 050064 (AC) and internal funding from the University of South Carolina School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 1998, MOL PHARMACOL, V53, P1097; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Boesch-Saadatmandi C, 2011, J NUTR BIOCHEM, V22, P293, DOI 10.1016/j.jnutbio.2010.02.008; Brower ET, 2010, BIOCHEMISTRY-US, V49, P2359, DOI 10.1021/bi1000933; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chauhan A, 2003, J BIOL CHEM, V278, P13512, DOI 10.1074/jbc.M209381200; Chauhan A, 2007, FASEB J, V21, P777, DOI 10.1096/fj.06-7054com; Chauhan A, 2007, J CONTROL RELEASE, V117, P148, DOI 10.1016/j.jconrel.2006.10.031; Chen CY, 2007, LIFE SCI, V81, P1602, DOI 10.1016/j.lfs.2007.09.028; Chen HQ, 2008, NEUROSCI LETT, V448, P175, DOI 10.1016/j.neulet.2008.10.046; Choi EM, 2010, FOOD CHEM TOXICOL, V48, P2607, DOI 10.1016/j.fct.2010.06.029; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Col E, 2001, J BIOL CHEM, V276, P28179, DOI 10.1074/jbc.M101385200; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; Desfosses Y, 2005, J VIROL, V79, P9180, DOI 10.1128/JVI.79.14.9180-9191.2005; Dinoso JB, 2008, CLIN INFECT DIS, V47, P102, DOI 10.1086/588791; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Gates MA, 2007, INT J CANCER, V121, P2225, DOI 10.1002/ijc.22790; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Guendel I, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-114; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hamy F, 2000, CHEM BIOL, V7, P669, DOI 10.1016/S1074-5521(00)00012-0; Hatano H, 2010, AIDS, V24, P2528, DOI 10.1097/QAD.0b013e32833dba03; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hempel J, 1999, NAHRUNG, V43, P201, DOI [10.1002/(SICI)1521-3803(19990601)43:3&lt;201::AID-FOOD201&gt;3.0.CO;2-1, 10.1002/(SICI)1521-3803(19990601)43:3<201::AID-FOOD201>3.3.CO;2-T]; Hwang S, 2003, J BIOL CHEM, V278, P39092, DOI 10.1074/jbc.M301749200; Isel C, 1999, J MOL BIOL, V290, P929, DOI 10.1006/jmbi.1999.2933; Jang S, 2008, P NATL ACAD SCI USA, V105, P7534, DOI 10.1073/pnas.0802865105; Kandathil AJ, 2009, BIOINFORMATION, V4, P237, DOI 10.6026/97320630004237; Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kim YK, 2002, MOL CELL BIOL, V22, P4622, DOI 10.1128/MCB.22.13.4622-4637.2002; Kurosu T, 2002, MICROBIOL IMMUNOL, V46, P787, DOI 10.1111/j.1348-0421.2002.tb02766.x; Letang E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016946; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Lin PH, 2011, J VIROL, V85, P9114, DOI 10.1128/JVI.00175-11; Liu R, 2011, MOLECULES, V16, P2084, DOI 10.3390/molecules16032084; Mannioui A, 2004, VIROLOGY, V329, P77, DOI 10.1016/j.virol.2004.08.022; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Noroozi M, 1998, AM J CLIN NUTR, V67, P1210, DOI 10.1093/ajcn/67.6.1210; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Ozdener H, 2005, J BIOSCIENCES, V30, P391, DOI 10.1007/BF02703676; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; Richter S, 2004, ANTIMICROB AGENTS CH, V48, P1895, DOI 10.1128/AAC.48.5.1895-1899.2004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seelinger G, 2008, PLANTA MED, V74, P1667, DOI 10.1055/s-0028-1088314; Shafer RW, 2008, AIDS REV, V10, P67; Shahriar R, 2009, ANTIMICROB AGENTS CH, V53, P4869, DOI 10.1128/AAC.00592-09; Spivak AM, 2011, AIDS RES HUM RETROVI; Stauber RH, 1998, VIROLOGY, V252, P126, DOI 10.1006/viro.1998.9400; Tewtrakul S, 2003, PHYTOTHER RES, V17, P232, DOI 10.1002/ptr.1111; Tilton JC, 2010, J VIROL, V84, P10863, DOI 10.1128/JVI.01109-10; Tilton JC, 2010, AIDS RES HUM RETROV, V26, P13, DOI 10.1089/aid.2009.0132; Vijaykumar TS, 2008, VIROLOGY, V381, P1, DOI 10.1016/j.virol.2008.07.039; VRIJSEN R, 1988, J GEN VIROL, V69, P1749, DOI 10.1099/0022-1317-69-7-1749; Wang D, 2001, J VIROL, V75, P7266, DOI 10.1128/JVI.75.16.7266-7279.2001; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wruck CJ, 2007, J NEURAL TRANSM-SUPP, P57; Xu HX, 2000, BIOL PHARM BULL, V23, P1072, DOI 10.1248/bpb.23.1072; Yamamoto N, 2006, VIRUS GENES, V32, P105, DOI 10.1007/s11262-005-5851-2; Yi L, 2004, J VIROL, V78, P11334, DOI 10.1128/JVI.78.20.11334-11339.2004; Yoo DR, 2009, CANCER LETT, V282, P48, DOI 10.1016/j.canlet.2009.02.051; Yuan DK, 2007, BIOORGAN MED CHEM, V15, P265, DOI 10.1016/j.bmc.2006.09.062; Zhang RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015620; Zhao G, 2010, NEUROBIOL AGING 0409; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	76	43	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27915	10.1371/journal.pone.0027915	http://dx.doi.org/10.1371/journal.pone.0027915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140483	gold, Green Published, Green Submitted			2022-12-25	WOS:000298168100024
J	del Giudice, EM; Grandone, A; Cirillo, G; Santoro, N; Amato, A; Brienza, C; Savarese, P; Marzuillo, P; Perrone, L				del Giudice, Emanuele Miraglia; Grandone, Anna; Cirillo, Grazia; Santoro, Nicola; Amato, Alessandra; Brienza, Carmine; Savarese, Piera; Marzuillo, Pierluigi; Perrone, Laura			The Association of PNPLA3 Variants with Liver Enzymes in Childhood Obesity Is Driven by the Interaction with Abdominal Fat	PLOS ONE			English	Article							TO-HEIGHT RATIO; INSULIN SENSITIVITY INDEXES; DOMAIN-CONTAINING 3; WAIST CIRCUMFERENCE; DISEASE; CHILDREN; I148M; SEVERITY; RISK; GENE	Background and Aims: A polymorphism in adiponutrin/ patatin-like phospholipase-3 gene (PNPLA3), rs738409 C->G, encoding for the I148M variant, is the strongest genetic determinant of liver fat and ALT levels in adulthood and childhood obesity. Aims of this study were i) to analyse in a large group of obese children the role of the interaction of not-genetic factors such as BMI, waist circumference (W/Hr) and insulin resistance (HOMA-IR) in exposing the association between the I148M polymorphism and ALT levels and ii) to stratify the individual risk of these children to have liver injury on the basis of this gene-environment interaction. Methods: 1048 Italian obese children were investigated. Anthropometric, clinical and metabolic data were collected and the PNPLA3 I148M variant genotyped. Results: Children carrying the 148M allele showed higher ALT and AST levels (p = 0.000006 and p = 0.0002, respectively). Relationships between BMI-SDS, HOMA-IR and W/Hr with ALT were analysed in function of the different PNPLA3 genotypes. Children 148M homozygous showed a stronger correlation between ALT and W/Hr than those carrying the other genotypes (p: 0.0045) and, therefore, 148M homozygotes with high extent of abdominal fat (W/Hr above 0.62) had the highest OR (4.9, 95% C. I. 3.2-7.8, p = 0.00001) to develop pathologic ALT. Conclusions: We have i) showed for the first time that the magnitude of the association of PNPLA3 with liver enzymes is driven by the size of abdominal fat and ii) stratified the individual risk to develop liver damage on the basis of the interaction between the PNPLA3 genotype and abdominal fat.	[del Giudice, Emanuele Miraglia; Grandone, Anna; Cirillo, Grazia; Amato, Alessandra; Brienza, Carmine; Savarese, Piera; Marzuillo, Pierluigi; Perrone, Laura] Univ Naples 2, Dept Pediat, Naples, Italy; [Santoro, Nicola] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA	Universita della Campania Vanvitelli; Yale University	del Giudice, EM (corresponding author), Univ Naples 2, Dept Pediat, Naples, Italy.	emanuele.miraglia@unina2.it	Marzuillo, Pierluigi/J-7447-2018; del Giudice, Emanuele Muraglia/AAC-2824-2019; Santoro, Nicola/A-4897-2014	Marzuillo, Pierluigi/0000-0003-4682-0170; Santoro, Nicola/0000-0001-6437-4173; GRANDONE, Anna/0000-0002-6343-4768; Perrone, Laura/0000-0002-8647-3938				ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Baumeister SE, 2008, GASTROENTEROLOGY, V134, P85, DOI 10.1053/j.gastro.2007.10.024; Browning JD, 2010, HEPATOLOGY, V52, P1189, DOI 10.1002/hep.23946; Chandalia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000812; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Day C P, 2004, Clin Liver Dis, V8, P673, DOI 10.1016/j.cld.2004.04.001; Day CP, 2006, GASTROENTEROLOGY, V130, P207, DOI 10.1053/j.gastro.2005.11.017; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Hara Mitsuhiko, 2002, J Atheroscler Thromb, V9, P127; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; Kantartzis K, 2009, DIABETES, V58, P2616, DOI 10.2337/db09-0279; Lohman TG, 1988, ANTROPOMETRIC STANDA; Maffeis C, 2008, J PEDIATR-US, V152, P207, DOI 10.1016/j.jpeds.2007.09.021; Manco M, 2008, GUT, V57, P1283, DOI 10.1136/gut.2007.142919; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; Pare G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000981; Roberts Eve A, 2007, Clin Liver Dis, V11, P155, DOI 10.1016/j.cld.2007.02.008; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Romeo S, 2010, INT J OBESITY, V34, P190, DOI 10.1038/ijo.2009.216; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2010, J HEPATOL, V53, P335, DOI 10.1016/j.jhep.2010.02.034; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Santoro N, 2010, HEPATOLOGY, V52, P1281, DOI 10.1002/hep.23832; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Speliotes EK, 2010, HEPATOLOGY, V52, P904, DOI 10.1002/hep.23768; Strauss RS, 2000, J PEDIATR-US, V136, P727, DOI 10.1016/S0022-3476(00)24645-3; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Valenti L, 2010, HEPATOLOGY, V52, P1274, DOI 10.1002/hep.23823; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; van der Poorten D, 2008, HEPATOLOGY, V48, P449, DOI 10.1002/hep.22350; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Yeckel CW, 2004, J CLIN ENDOCR METAB, V89, P1096, DOI 10.1210/jc.2003-031503; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zou CB, 2007, NAT MED, V13, P1078, DOI 10.1038/nm1625	40	66	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27933	10.1371/journal.pone.0027933	http://dx.doi.org/10.1371/journal.pone.0027933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140488	gold, Green Published, Green Submitted			2022-12-25	WOS:000298163400025
J	Wang, Y; Choi, JY; Roh, JY; Liu, Q; Tao, XY; Park, JB; Kim, JS; Je, YH				Wang, Yong; Choi, Jae Young; Roh, Jong Yul; Liu, Qin; Tao, Xue Ying; Park, Jong Bin; Kim, Jae Su; Je, Yeon Ho			Genomic Sequence Analysis of Granulovirus Isolated from the Tobacco Cutworm, Spodoptera litura	PLOS ONE			English	Article							BOMBYX-MORI-NUCLEOPOLYHEDROVIRUS; NUCLEAR-POLYHEDROSIS-VIRUS; OCCLUSION-DERIVED VIRUS; OPEN READING FRAMES; PHYLOGENETIC ANALYSIS; BACULOVIRUS GENE; PERITROPHIC MEMBRANE; TRICHOPLUSIA-NI; APOPTOSIS; BRO	Background: Spodoptera litura is a noctuid moth that is considered an agricultural pest. The larvae feed on a wide range of plants and have been recorded on plants from 40 plant families (mostly dicotyledons). It is a major pest of many crops. To better understand Spodoptera litura granulovirus (SpliGV), the nucleotide sequence of the SpliGV DNA genome was determined and analyzed. Methodology/Principal Findings: The genome of the SpliGV was completely sequenced. The nucleotide sequence of the SpliGV genome was 124,121 bp long with 61.2% A+T content and contained 133 putative open reading frames (ORFs) of 150 or more nucleotides. The 133 putative ORFs covered 86.3% of the genome. Among these, 31 ORFs were conserved in most completely sequenced baculovirus genomes, 38 were granulovirus (GV)-specific, and 64 were present in some nucleopolyhedroviruses (NPVs) and/or GVs. We proved that 9 of the ORFs were SpliGV specific. Conclusions/Significance: The genome of SpliGV is 124,121 bp in size. One hundred thirty-three ORFs that putatively encode proteins of 50 or more amino acid residues with minimal overlap were determined. No chitinase or cathepsin genes, which are involved in the liquefaction of the infected host, were found in the SpliGV genome, explaining why SpliGV-infected insects do not degrade in a typical manner. The DNA photolyase gene was first found in the genus Granulovirus. When phylogenic relationships were analyzed, the SpliGV was most closely related to Trichoplusia ni granulovirus (TnGV) and Xestia c-nigrum granulovirus (XecnGV), which belong to the Type I-granuloviruses (Type I-GV).	[Wang, Yong; Choi, Jae Young; Roh, Jong Yul; Liu, Qin; Tao, Xue Ying; Park, Jong Bin; Je, Yeon Ho] Seoul Natl Univ, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul, South Korea; [Kim, Jae Su] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Wang, Y (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China.	btrus@snu.ac.kr	Tao, XueYing/ABG-6993-2021; Kim, Jae Su/L-2194-2013; Choi, Jae Young/G-1731-2010	Tao, XueYing/0000-0002-6539-4659; 	Next-Generation BioGreen 21 Program [PJ008036]; Rural Development Administration, Republic of Korea; Brain Korea 21 project	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Brain Korea 21 project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ008036), Rural Development Administration, Republic of Korea. YW, QL, XYT, and JBP were supported by 2nd stage of the Brain Korea 21 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armes NJ, 1997, PESTIC SCI, V50, P240, DOI 10.1002/(SICI)1096-9063(199707)50:3&lt;240::AID-PS579&gt;3.0.CO;2-9; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bideshi DK, 2003, J GEN VIROL, V84, P2531, DOI 10.1099/vir.0.19256-0; BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; Braunagel SC, 2007, CURR DRUG TARGETS, V8, P1084, DOI 10.2174/138945007782151315; Bulach DM, 1999, J INVERTEBR PATHOL, V73, P59, DOI 10.1006/jipa.1998.4797; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; DERKSEN ACG, 1988, VIROLOGY, V167, P242, DOI 10.1016/0042-6822(88)90074-8; Du QS, 1999, J VIROL, V73, P1278, DOI 10.1128/JVI.73.2.1278-1285.1999; Escasa SR, 2006, J GEN VIROL, V87, P1917, DOI 10.1099/vir.0.81792-0; Fang MG, 2009, J VIROL, V83, P12569, DOI 10.1128/JVI.01141-09; Faulkner P, 1997, J GEN VIROL, V78, P3091, DOI 10.1099/0022-1317-78-12-3091; Federici B.A., 1997, BACULOVIRUSES VIRUSE, P33, DOI [10.1007/978-1-4899-1834-5_3, DOI 10.1007/978-1-4899-1834-5_3]; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Friesen PD, 1997, BACULOVIRUSES, P141; Gomi S, 1999, J GEN VIROL, V80, P1323, DOI 10.1099/0022-1317-80-5-1323; Haas AL, 1996, BIOCHEMISTRY-US, V35, P5385, DOI 10.1021/bi9524981; Haas-Stapleton EJ, 2004, J VIROL, V78, P6786, DOI 10.1128/JVI.78.13.6786-6791.2004; Harrison RL, 2008, VIRUS GENES, V36, P565, DOI 10.1007/s11262-008-0218-0; HASHIMOTO Y, 1991, J GEN VIROL, V72, P2645, DOI 10.1099/0022-1317-72-11-2645; Hashimoto Y, 2000, VIROLOGY, V275, P358, DOI 10.1006/viro.2000.0530; Hay S, 2002, J GEN VIROL, V83, P1547, DOI 10.1099/0022-1317-83-7-1547; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; IJkel WFJ, 1999, J GEN VIROL, V80, P3289, DOI 10.1099/0022-1317-80-12-3289; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Kang WK, 2003, ARCH VIROL, V148, P99, DOI 10.1007/s00705-002-0902-7; Kang WK, 2006, VIROLOGY, V350, P184, DOI 10.1016/j.virol.2006.01.008; Kang WY, 1999, J VIROL, V73, P10339, DOI 10.1128/JVI.73.12.10339-10345.1999; Kikhno I, 2002, J GEN VIROL, V83, P3013, DOI 10.1099/0022-1317-83-12-3013; Kuzio J, 1999, VIROLOGY, V253, P17, DOI 10.1006/viro.1998.9469; Lange M, 2003, VIROLOGY, V317, P220, DOI 10.1016/S0042-6822(03)00515-4; Lu A, 1997, BACULOVIRUSES, P193; LU A, 1997, BACULOVIRUSES, P171; Luque T, 2001, J GEN VIROL, V82, P2531, DOI 10.1099/0022-1317-82-10-2531; MARTIGNONI ME, 1981, MICROBIAL CONTROL PE, P879; MURPHY FA, 1995, ARCH VIROL, P1; Nakai M, 2003, VIROLOGY, V316, P171, DOI 10.1016/j.virol.2003.08.002; Ohkawa T, 2005, J VIROL, V79, P15258, DOI 10.1128/JVI.79.24.15258-15264.2005; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; OREILLY DR, 1997, BACULOVIRUSES, P267; Pang Y, 2001, VIROLOGY, V287, P391, DOI 10.1006/viro.2001.1056; Pei ZF, 2002, J BIOL CHEM, V277, P48677, DOI 10.1074/jbc.M208810200; Pijlman GP, 2003, J GEN VIROL, V84, P2041, DOI 10.1099/vir.0.19133-0; Rapp JC, 1998, J VIROL, V72, P10197, DOI 10.1128/JVI.72.12.10197-10206.1998; Rashidan KK, 2004, J BIOCHEM MOL BIOL, V37, P206; Reilly LM, 1996, VIROLOGY, V218, P243, DOI 10.1006/viro.1996.0185; ROELVINK PW, 1995, J GEN VIROL, V76, P2693, DOI 10.1099/0022-1317-76-11-2693; ROHRMANN GF, 1992, J GEN VIROL, V73, P749, DOI 10.1099/0022-1317-73-4-749; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; SALAMA H S, 1971, Zeitschrift fuer Angewandte Entomologie, V67, P261; Shim Hee Jin, 2009, Journal of Asia-Pacific Entomology, V12, P217, DOI 10.1016/j.aspen.2009.04.001; Solovyev VV, 1999, NUCLEIC ACIDS RES, V27, P248, DOI 10.1093/nar/27.1.248; SWFFORD DL, 2003, PAUP PHYLOGENETIC AN; TANADA Y, 1973, J INVERTEBR PATHOL, V21, P31, DOI 10.1016/0022-2011(73)90110-9; THEILMANN DA, 2005, VIRUS TAXONOMY, P177; TOMALSKI MD, 1991, VIROLOGY, V184, P149, DOI 10.1016/0042-6822(91)90831-U; van Oers MM, 2008, DNA REPAIR, V7, P1309, DOI 10.1016/j.dnarep.2008.04.013; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; van Regenmortel M.H.V., 2000, VIRUS TAXONOMY 7 REP; VanOers MM, 1997, J INVERTEBR PATHOL, V70, P1, DOI 10.1006/jipa.1997.4675; Vucic D, 1997, P NATL ACAD SCI USA, V94, P10183, DOI 10.1073/pnas.94.19.10183; Wang P, 1998, J INVERTEBR PATHOL, V72, P57, DOI 10.1006/jipa.1998.4759; Wang Y, 2008, J MICROBIOL, V46, P704, DOI 10.1007/s12275-008-0133-z; Wormleaton S, 2003, VIROLOGY, V311, P350, DOI 10.1016/S0042-6822(03)00149-1; ZANOTTO PMD, 1993, J INVERTEBR PATHOL, V62, P147, DOI 10.1006/jipa.1993.1090; Zemskov EA, 2000, J VIROL, V74, P6784, DOI 10.1128/JVI.74.15.6784-6789.2000; Zhang XX, 2005, VIRUS RES, V113, P36, DOI 10.1016/j.virusres.2005.04.013; Zoog SJ, 2002, EMBO J, V21, P5130	72	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28163	10.1371/journal.pone.0028163	http://dx.doi.org/10.1371/journal.pone.0028163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132235	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000083
J	Cruz, C; Cairrao, E; Silvestre, S; Breitenfeld, L; Almeida, P; Queiroz, JA				Cruz, Carla; Cairrao, Elisa; Silvestre, Samuel; Breitenfeld, Luiza; Almeida, Paulo; Queiroz, Joao A.			Targeting of Mitochondria-Endoplasmic Reticulum by Fluorescent Macrocyclic Compounds	PLOS ONE			English	Article							COMPLEX; LOCALIZATION; PROBES; MECHANISM; SENSORS	Background: Useful probes of the intracellular environment that target a specific organelle in order to allow direct observation of the changes in these regions is of high current interest. Macrocyclic ligands have already revealed themselves as important selective hosts in some biological applications, forming stable and specific complexes. Therefore, in this paper, several macrocyclic ligands are evaluated as potential molecular probes. Methodology: Four polyammonium macrocycles and one macrotricyclic bearing pyridine and phenanthroline chromophores have been synthesised and evaluated as molecular probes. The cytotoxicity of the compounds has been analyzed using human breast cancer cells (MCF-7), non-cancerous human dermal fibroblasts (NHDF) and human adult dermal skin fibroblasts from a breast cancer patient (P14). All the compounds showed low toxicity at concentrations ranging from 10 nM to 10 mu M, except for [32]phen(2)N(4) which proved to be highly cytotoxic for MCF-7 cells. Flow cytometry studies evidenced that the percentage of apoptotic and necrotic MCF-7 and NHDF cells induced by the compounds is considerably low. Also, flow cytometry analysis showed that some compounds seem to modify the mitochondrial membrane potential (MMP) of the cells. Fluorescence microscopy evidenced that compounds easily cross the plasma membrane (5 min) and accumulated into the mitochondria, as confirmed by co-localization with MitoTracker Green (TM). The fluorescence images also evidenced an intact mitochondria structure after 48 h. Moreover, reticular staining suggestive of endoplasmic reticulum (ER) localization, in addition to the mitochondrial one, has been found by confocal microscopy. Conclusion: Our study reveals that compounds Me-2[28]py(2)N(6), cryptphen, [16]phenN(2), [30]phen(2)N(6), have low toxicity and localize in mitochondria and ER. The ability of these compounds for translocating the cellular membrane (5 min) without special conditioning of the cells or derivatization of the probe, the time-dependent localization (48 h) and the cellular viability provide a proof-of-concept towards their use as promising probes towards biomedical studies.	[Cruz, Carla; Cairrao, Elisa; Silvestre, Samuel; Breitenfeld, Luiza; Almeida, Paulo; Queiroz, Joao A.] Univ Beira Interior, CICS UBI Ctr Invest Ciencias Saude, Covilha, Portugal	Universidade da Beira Interior	Cruz, C (corresponding author), Univ Beira Interior, CICS UBI Ctr Invest Ciencias Saude, Covilha, Portugal.	carlacruz@fcsaude.ubi.pt	Queiroz, João A/L-3104-2014; Almeida, Paulo J S/S-5375-2016; Cruz, Carla/I-7806-2013; Silvestre, Samuel/A-4822-2017; Cairrão, Elisa/AAB-1164-2020; Granadeiro, Luiza Breitenfeld/P-1852-2015; ALMEIDA, PAULO/A-1600-2014	Queiroz, João A/0000-0002-3096-8325; Almeida, Paulo J S/0000-0003-0110-4795; Cruz, Carla/0000-0001-6630-1242; Silvestre, Samuel/0000-0003-4297-5108; Cairrão, Elisa/0000-0002-4823-5701; Granadeiro, Luiza Breitenfeld/0000-0001-8550-1645; ALMEIDA, PAULO/0000-0003-0110-4795	FCT [SFRH/BPD/46934/2008, SFRH/BPD/41612/2007]; COST Action [MP0802, COST-STSM-MP0802-5023]; Fundacao para a Ciencia e a Tecnologia, Portugal; POCTI; FEDER [PTDC/QUI-QUI/100896/2008, PTDC/EBB-BIO/114320/2009]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); COST Action(European Cooperation in Science and Technology (COST)); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); POCTI; FEDER(European Commission)	Carla Cruz and Samuel Silvestre acknowledge post-doctoral grants from FCT SFRH/BPD/46934/2008 and SFRH/BPD/41612/2007, respectively. Carla Cruz also acknowledges to COST Action MP0802 entitled "Self-assembled guanosine structures for molecular electronic devices" for the Short Term Scientific Mission with reference code COST-STSM-MP0802-5023. The authors are also grateful to Fundacao para a Ciencia e a Tecnologia, Portugal, POCTI and FEDER for financial support projects PTDC/QUI-QUI/100896/2008 and PTDC/EBB-BIO/114320/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRITO MO, 2008, NATURE, V456, P605; CHANDLER CJ, 1981, J HETEROCYCLIC CHEM, V18, P599, DOI 10.1002/jhet.5570180332; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Cruz C, 2003, DALTON T, P3172, DOI 10.1039/b304381a; Cruz C, 2009, CHEM-EUR J, V15, P3277, DOI 10.1002/chem.200800993; Diaz G, 2001, IUBMB LIFE, V51, P121, DOI 10.1080/15216540152122139; Domaille DW, 2008, NAT CHEM BIOL, V4, P168, DOI 10.1038/nchembio.69; English AR, 2009, CURR OPIN CELL BIOL, V21, P596, DOI 10.1016/j.ceb.2009.04.004; Festy F, 2007, MOL BIOSYST, V3, P381, DOI 10.1039/b617204k; Freshney R.I., 2005, CULTURE ANIMAL CELLS, DOI [10.1002/0471747599.CAC022, DOI 10.1002/0471747599.CAC022]; Georgiades SN, 2010, ANGEW CHEM INT EDIT, V49, P4020, DOI 10.1002/anie.200906363; Gill MR, 2009, NAT CHEM, V1, P662, DOI [10.1038/nchem.406, 10.1038/NCHEM.406]; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Gokel GW, 2004, CHEM REV, V104, P2723, DOI 10.1021/cr020080k; Hettiarachchi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010514; Hilderbrand SA, 2007, CHEM COMMUN, P2747, DOI 10.1039/b703764c; Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200; Kielar F, 2008, CHEM COMMUN, P2435, DOI 10.1039/b803864c; Kurtoglu M, 2009, MOL NUTR FOOD RES, V53, P68, DOI 10.1002/mnfr.200700457; Lavis LD, 2008, ACS CHEM BIOL, V3, P142, DOI 10.1021/cb700248m; Law GL, 2009, CHEM COMMUN, P7321, DOI 10.1039/b920222f; Lebiedzinska M, 2009, INT J BIOCHEM CELL B, V41, P1805, DOI 10.1016/j.biocel.2009.02.017; Manning HC, 2006, BIOCONJUGATE CHEM, V17, P735, DOI 10.1021/bc060020b; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Monchaud D., 2010, J NUCL ACIDS, P1; Montgomery CP, 2009, ACCOUNTS CHEM RES, V42, P925, DOI 10.1021/ar800174z; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murray BS, 2008, ORG BIOMOL CHEM, V6, P2085, DOI 10.1039/b803895c; Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/NCHEM.217, 10.1038/nchem.217]; New EJ, 2010, CHEM SCI, V1, P111, DOI 10.1039/c0sc00105h; New EJ, 2010, CURR OPIN CHEM BIOL, V14, P238, DOI 10.1016/j.cbpa.2009.10.003; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Scorrano L, 1999, J BIOL CHEM, V274, P24657, DOI 10.1074/jbc.274.35.24657; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; Wolfbeis OS, 2005, J MATER CHEM, V15, P2657, DOI 10.1039/b501536g	36	12	12	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27078	10.1371/journal.pone.0027078	http://dx.doi.org/10.1371/journal.pone.0027078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132086	Green Submitted, gold, Green Published			2022-12-25	WOS:000297789900008
J	Levit, A; Yarnitzky, T; Wiener, A; Meidan, R; Niv, MY				Levit, Anat; Yarnitzky, Talia; Wiener, Ayana; Meidan, Rina; Niv, Masha Y.			Modeling of Human Prokineticin Receptors: Interactions with Novel Small-Molecule Binders and Potential Off-Target Drugs	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ENDOTHELIAL GROWTH-FACTOR; MELANIN-CONCENTRATING HORMONE; X-RAY CRYSTALLOGRAPHY; LIGAND-BINDING SITE; CRYSTAL-STRUCTURE; HOMOLOGY MODELS; IDENTIFICATION; DOCKING; CELLS	Background and Motivation: The Prokineticin receptor (PKR) 1 and 2 subtypes are novel members of family A GPCRs, which exhibit an unusually high degree of sequence similarity. Prokineticins (PKs), their cognate ligands, are small secreted proteins of similar to 80 amino acids; however, non-peptidic low-molecular weight antagonists have also been identified. PKs and their receptors play important roles under various physiological conditions such as maintaining circadian rhythm and pain perception, as well as regulating angiogenesis and modulating immunity. Identifying binding sites for known antagonists and for additional potential binders will facilitate studying and regulating these novel receptors. Blocking PKRs may serve as a therapeutic tool for various diseases, including acute pain, inflammation and cancer. Methods and Results: Ligand-based pharmacophore models were derived from known antagonists, and virtual screening performed on the DrugBank dataset identified potential human PKR (hPKR) ligands with novel scaffolds. Interestingly, these included several HIV protease inhibitors for which endothelial cell dysfunction is a documented side effect. Our results suggest that the side effects might be due to inhibition of the PKR signaling pathway. Docking of known binders to a 3D homology model of hPKR1 is in agreement with the well-established canonical TM-bundle binding site of family A GPCRs. Furthermore, the docking results highlight residues that may form specific contacts with the ligands. These contacts provide structural explanation for the importance of several chemical features that were obtained from the structure-activity analysis of known binders. With the exception of a single loop residue that might be perused in the future for obtaining subtype-specific regulation, the results suggest an identical TM-bundle binding site for hPKR1 and hPKR2. In addition, analysis of the intracellular regions highlights variable regions that may provide subtype specificity.	[Levit, Anat; Yarnitzky, Talia; Wiener, Ayana; Niv, Masha Y.] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Levit, Anat; Meidan, Rina] Hebrew Univ Jerusalem, Dept Anim Sci, Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Niv, Masha Y.] Hebrew Univ Jerusalem, Fritz Haber Ctr Mol Dynam, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Levit, A (corresponding author), Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Fac Agr Food & Environm, IL-76100 Rehovot, Israel.	niv@agri.huji.ac.il	Niv, Masha/AAL-1123-2020	Niv, Masha/0000-0001-8275-8795	Niedersachsen-Israeli Research cooperation fund; Israeli Science Foundation; Canadian Friends of the Hebrew University; Smith excellence fellowship for PhD students	Niedersachsen-Israeli Research cooperation fund; Israeli Science Foundation(Israel Science Foundation); Canadian Friends of the Hebrew University; Smith excellence fellowship for PhD students	The study was funded in part by the Niedersachsen-Israeli Research cooperation fund to MYN and the Israeli Science Foundation to RM. AL is supported by the Johanna Friedlaender memorial award for excellence from the Canadian Friends of the Hebrew University and by the Smith excellence fellowship for PhD students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2011, ANNU REV PHARMACOL, V51, P117, DOI 10.1146/annurev-pharmtox-010510-100553; Balboni G, 2008, J MED CHEM, V51, P7635, DOI 10.1021/jm800854e; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barnum D, 1996, J CHEM INF COMP SCI, V36, P563, DOI 10.1021/ci950273r; Battersby S, 2004, J CLIN ENDOCR METAB, V89, P2463, DOI 10.1210/jc.2003-032012; BHOGAL N, 1994, J BIOL CHEM, V269, P27269; Bissantz C, 2003, PROTEINS, V50, P5, DOI 10.1002/prot.10237; Bohm Hans-Joachim, 2004, Drug Discov Today Technol, V1, P217, DOI 10.1016/j.ddtec.2004.10.009; Boyd M, 2007, EXPERT OPIN PHARMACO, V8, P957, DOI 10.1517/14656566.8.7.957; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bullock CM, 2004, MOL PHARMACOL, V65, P582, DOI 10.1124/mol.65.3.582; Bywater RP, 2005, J MOL RECOGNIT, V18, P60, DOI 10.1002/jmr.685; CARLSSON J, 2011, NAT CHEM BIOL; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COATS SJ, 2009, Patent No. 20090163505; COATS SJ, 2008, Patent No. 20080045535; Coetsee M, 2008, BIOCHEMISTRY-US, V47, P10305, DOI 10.1021/bi800911z; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Eira M, 2006, BRAZ J MED BIOL RES, V39, P1065, DOI 10.1590/S0100-879X2006000800009; Gloriam DE, 2009, J MED CHEM, V52, P4429, DOI 10.1021/jm900319e; Guilini C, 2010, AM J PHYSIOL-HEART C, V298, pH844, DOI 10.1152/ajpheart.00898.2009; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Hernandez M, 2009, NUCLEIC ACIDS RES, V37, pW413, DOI 10.1093/nar/gkp281; Holmberg SD, 2004, NEW ENGL J MED, V350, P730, DOI 10.1056/NEJM200402123500719; Hoogerwerf WA, 2006, NEUROGASTROENT MOTIL, V18, P455, DOI 10.1111/j.1365-2982.2006.00776.x; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Ivanov AA, 2009, J MED CHEM, V52, P3284, DOI 10.1021/jm801533x; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kaser A, 2003, EMBO REP, V4, P469, DOI 10.1038/sj.embor.embor830; Katritch V, 2009, J MOL RECOGNIT, V22, P307, DOI 10.1002/jmr.949; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kisliouk T, 2005, ENDOCRINOLOGY, V146, P3950, DOI 10.1210/en.2005-0297; Kisliouk T, 2003, J CLIN ENDOCR METAB, V88, P3700, DOI 10.1210/jc.2003-030492; Krammer A, 2005, J MOL GRAPH MODEL, V23, P395, DOI 10.1016/j.jmgm.2004.11.007; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lazareno S, 2000, MOL PHARMACOL, V58, P194, DOI 10.1124/mol.58.1.194; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; LEONG SR, 1994, J BIOL CHEM, V269, P19343; Levit A., 2011, METHODS MOL IN PRESS; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Lin R, 2002, J BIOL CHEM, V277, P8724, DOI 10.1074/jbc.M110594200; Novoa EM, 2010, J CHEM THEORY COMPUT, V6, P2547, DOI 10.1021/ct100246y; Martin C, 2011, ENDOCR REV, V32, P225, DOI 10.1210/er.2010-0007; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; McRobb FM, 2010, J CHEM INF MODEL, V50, P626, DOI 10.1021/ci900444q; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; MOBAREC JCR, 2009, J MED CHEM; Monnier C, 2009, HUM MOL GENET, V18, P75, DOI 10.1093/hmg/ddn318; Nebigil CG, 2009, TRENDS CARDIOVAS MED, V19, P55, DOI 10.1016/j.tcm.2009.04.007; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Phatak SS, 2010, J CHEM INF MODEL, V50, P2119, DOI 10.1021/ci100285f; Ralbovsky JL, 2009, BIOORG MED CHEM LETT, V19, P2661, DOI 10.1016/j.bmcl.2009.03.157; Rognan D, 2010, MOL INFORM, V29, P176, DOI 10.1002/minf.200900081; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ryu GM, 2009, NUCLEIC ACIDS RES, V37, P1297, DOI 10.1093/nar/gkn1008; Sela I, 2010, CURR TOP MED CHEM, V10, P638, DOI 10.2174/156802610791111498; Senderowitz H, 2009, CURR PHARM DESIGN, V15, P4049, DOI 10.2174/138161209789824821; Shankar SS, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.06.005; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Soga T, 2002, BBA-GENE STRUCT EXPR, V1579, P173, DOI 10.1016/S0167-4781(02)00546-8; Sprang SR, 2011, NATURE, V469, P172, DOI 10.1038/469172a; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; THOMPSON WJ, 2007, Patent No. 2007067511; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Vilar S, 2011, J MOL GRAPH MODEL, V29, P614, DOI 10.1016/j.jmgm.2010.11.005; Vitale RM, 2004, PROTEINS, V56, P430, DOI 10.1002/prot.20125; Vitale RM, 2003, CHEMBIOCHEM, V4, P73, DOI 10.1002/cbic.200390017; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Wang XW, 2009, AM J PATHOL, V174, P771, DOI 10.2353/ajpath.2009.080157; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; YAMANO Y, 1995, J BIOL CHEM, V270, P14024, DOI 10.1074/jbc.270.23.14024; Yang SY, 2010, DRUG DISCOV TODAY, V15, P444, DOI 10.1016/j.drudis.2010.03.013; Yarnitzky T, 2010, CURR OPIN DRUG DISC, V13, P317; Zhou Q. -Y., 2008, V46, P181, DOI 10.1007/400_2007_053	88	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27990	10.1371/journal.pone.0027990	http://dx.doi.org/10.1371/journal.pone.0027990			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132188	gold, Green Published, Green Submitted			2022-12-25	WOS:000297789900038
J	Nalwadda, G; Tumwesigye, NM; Faxelid, E; Byamugisha, J; Mirembe, F				Nalwadda, Gorrette; Tumwesigye, Nazarius M.; Faxelid, Elisabeth; Byamugisha, Josaphat; Mirembe, Florence			Quality of Care in Contraceptive Services Provided to Young People in Two Ugandan Districts: A Simulated Client Study	PLOS ONE			English	Article							PROVISION; IMPACT	Background: Low and inconsistent use of contraceptives by young people contributes to unintended pregnancies. This study assessed quality of contraceptive services for young people aged 15-24 in two rural districts in Uganda. Methods: Five female and two male simulated clients (SCs) interacted with 128 providers at public, private not-for-profit (PNFP), and private for profit (PFP) health facilities. After consultations, SCs were interviewed using a structured questionnaire. Six aspects of quality of care (client's needs, choice of contraceptive methods, information given to users, client-provider interpersonal relations, constellation of services, and continuity mechanisms) were assessed. Descriptive statistics and factor analysis were performed. Results: Means and categorized quality scores for all aspects of quality were low in both public and private facilities. The lowest quality scores were observed in PFP, and medium scores in PNFP facilities. The choice of contraceptive methods and interpersonal relations quality scores were slightly higher in public facilities. Needs assessment scores were highest in PNFP facilities. All facilities were classified as having low scores for appropriate constellation of services. Information given to users was suboptimal and providers promoted specific contraceptive methods. Minority of providers offered preferred method of choice and showed respect for privacy. Conclusions: The quality of contraceptive services provided to young people was low. Concurrent quality improvements and strengthening of health systems are needed.	[Nalwadda, Gorrette] Makerere Univ, Coll Hlth Sci, Sch Hlth Sci, Dept Nursing, Kampala, Uganda; [Tumwesigye, Nazarius M.] Makerere Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda; [Nalwadda, Gorrette; Faxelid, Elisabeth] Karolinska Inst, Div Global Hlth, Dept Publ Hlth Sci, Stockholm, Sweden; [Nalwadda, Gorrette; Byamugisha, Josaphat; Mirembe, Florence] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Obstet & Gynecol, Kampala, Uganda	Makerere University; Makerere University; Karolinska Institutet; Makerere University	Nalwadda, G (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Hlth Sci, Dept Nursing, Kampala, Uganda.	gnalwadda@gmail.con	Byamugisha, Josaphat/AAL-5776-2020	Byamugisha, Josaphat/0000-0002-3438-9662; Tumwesigye, Nazarius Mbona/0000-0001-7085-8780	Swedish International Development Aid (Sida)	Swedish International Development Aid (Sida)	This article is based on research funded by Swedish International Development Aid (Sida). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha S, 2010, STUD FAMILY PLANN, V41, P205, DOI 10.1111/j.1728-4465.2010.00244.x; ALIZADEH SM, 2007, EUR J CONTRACEPT REP, V12; [Anonymous], UG DEM HLTH SURV 200; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Bertrand J., 1994, HDB INDICATORS FAMIL; Bessinger RE, 2001, INT FAM PLAN PERSPEC, V27, P63, DOI 10.2307/2673816; BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669; BUTLER PA, 2004, RES FAMILY PLANNING, P7; Chin-Quee DS, 2006, STUD FAMILY PLANN, V37, P99, DOI 10.1111/j.1728-4465.2006.00089.x; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Dehlendorf C, 2010, CONTRACEPTION, V81, P292, DOI 10.1016/j.contraception.2009.11.006; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Hubacher D, 2008, CONTRACEPTION, V78, P73, DOI 10.1016/j.contraception.2008.03.002; Huezo C, 1993, Adv Contracept, V9, P129, DOI 10.1007/BF01990143; HUNTINGTON D, 1993, STUD FAMILY PLANN, V24, P187, DOI 10.2307/2939233; Khan SM., 2008, UNMET NEED DEMAND FA; Kipp Walter, 2007, Int J Adolesc Med Health, V19, P383; Koenig MA, 1997, STUD FAMILY PLANN, V28, P278, DOI 10.2307/2137859; *MIT DISTR LOC GOV, 2008, 5 YEAR 2007 2012 ORP; *MOH, 2010, UG NAT HLTH POL, V2; Mugisha JF, 2008, J FAM PLAN REPROD H, V34, P37, DOI 10.1783/147118908783332230; Nalwadda G, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-220; Nalwadda G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-530; RamaRao S, 2003, INT FAM PLAN PERSPEC, V29, P76, DOI 10.2307/3181061; SENDEROWITZ J, 1992, GROWING BIOSOCIAL GA; Singh S, 2005, INT FAM PLAN PERSPEC, V31, P183, DOI 10.1363/3118305; Smith C, 1997, QUAL HEALTH CARE, V6, P59, DOI 10.1136/qshc.6.2.59; Steele F, 1999, STUD FAMILY PLANN, V30, P28, DOI 10.1111/j.1728-4465.1999.00028.x; *UBOS, 2002, 2002 UG POPN HOUS CE	30	22	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27908	10.1371/journal.pone.0027908	http://dx.doi.org/10.1371/journal.pone.0027908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	858IO	22132168	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789900032
J	Chaston, JM; Suen, G; Tucker, SL; Andersen, AW; Bhasin, A; Bode, E; Bode, HB; Brachmann, AO; Cowles, CE; Cowles, KN; Darby, C; de Leon, L; Drace, K; Du, ZJ; Givaudan, A; Tran, EEH; Jewell, KA; Knack, JJ; Krasomil-Osterfeld, KC; Kukor, R; Lanois, A; Latreille, P; Leimgruber, NK; Lipke, CM; Liu, RY; Lu, XJ; Martens, EC; Marri, PR; Medigue, C; Menard, ML; Miller, NM; Morales-Soto, N; Norton, S; Ogier, JC; Orchard, SS; Park, D; Park, Y; Qurollo, BA; Sugar, DR; Richards, GR; Rouy, Z; Slominski, B; Slominski, K; Snyder, H; Tjaden, BC; van der Hoeven, R; Welch, RD; Wheeler, C; Xiang, BS; Barbazuk, B; Gaudriault, S; Goodner, B; Slater, SC; Forst, S; Goldman, BS; Goodrich-Blair, H				Chaston, John M.; Suen, Garret; Tucker, Sarah L.; Andersen, Aaron W.; Bhasin, Archna; Bode, Edna; Bode, Helge B.; Brachmann, Alexander O.; Cowles, Charles E.; Cowles, Kimberly N.; Darby, Creg; de Leon, Limaris; Drace, Kevin; Du, Zijin; Givaudan, Alain; Tran, Erin E. Herbert; Jewell, Kelsea A.; Knack, Jennifer J.; Krasomil-Osterfeld, Karina C.; Kukor, Ryan; Lanois, Anne; Latreille, Phil; Leimgruber, Nancy K.; Lipke, Carolyn M.; Liu, Renyi; Lu, Xiaojun; Martens, Eric C.; Marri, Pradeep R.; Medigue, Claudine; Menard, Megan L.; Miller, Nancy M.; Morales-Soto, Nydia; Norton, Stacie; Ogier, Jean-Claude; Orchard, Samantha S.; Park, Dongjin; Park, Youngjin; Qurollo, Barbara A.; Sugar, Darby Renneckar; Richards, Gregory R.; Rouy, Zoe; Slominski, Brad; Slominski, Kathryn; Snyder, Holly; Tjaden, Brian C.; van der Hoeven, Ransome; Welch, Roy D.; Wheeler, Cathy; Xiang, Bosong; Barbazuk, Brad; Gaudriault, Sophie; Goodner, Brad; Slater, Steven C.; Forst, Steven; Goldman, Barry S.; Goodrich-Blair, Heidi			The Entomopathogenic Bacterial Endosymbionts Xenorhabdus and Photorhabdus: Convergent Lifestyles from Divergent Genomes	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; HETERORHABDITIS-BACTERIOPHORA; ACHROMOBACTER NEMATOPHILUS; ANTIBIOTIC PRODUCTION; INSECTICIDAL ACTIVITY; FUNDAMENTAL UNITS; OXIDATIVE STRESS; REACTIVE OXYGEN; PA-IL; GENE	Members of the genus Xenorhabdus are entomopathogenic bacteria that associate with nematodes. The nematode-bacteria pair infects and kills insects, with both partners contributing to insect pathogenesis and the bacteria providing nutrition to the nematode from available insect-derived nutrients. The nematode provides the bacteria with protection from predators, access to nutrients, and a mechanism of dispersal. Members of the bacterial genus Photorhabdus also associate with nematodes to kill insects, and both genera of bacteria provide similar services to their different nematode hosts through unique physiological and metabolic mechanisms. We posited that these differences would be reflected in their respective genomes. To test this, we sequenced to completion the genomes of Xenorhabdus nematophila ATCC 19061 and Xenorhabdus bovienii SS-2004. As expected, both Xenorhabdus genomes encode many anti-insecticidal compounds, commensurate with their entomopathogenic lifestyle. Despite the similarities in lifestyle between Xenorhabdus and Photorhabdus bacteria, a comparative analysis of the Xenorhabdus, Photorhabdus luminescens, and P. asymbiotica genomes suggests genomic divergence. These findings indicate that evolutionary changes shaped by symbiotic interactions can follow different routes to achieve similar end points.	[Chaston, John M.; Suen, Garret; Andersen, Aaron W.; Cowles, Charles E.; Cowles, Kimberly N.; de Leon, Limaris; Tran, Erin E. Herbert; Jewell, Kelsea A.; Knack, Jennifer J.; Kukor, Ryan; Lipke, Carolyn M.; Lu, Xiaojun; Menard, Megan L.; Orchard, Samantha S.; Park, Youngjin; Sugar, Darby Renneckar; Richards, Gregory R.; Slominski, Brad; Slominski, Kathryn; Goodrich-Blair, Heidi] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Tucker, Sarah L.; Du, Zijin; Krasomil-Osterfeld, Karina C.; Latreille, Phil; Leimgruber, Nancy K.; Miller, Nancy M.; Norton, Stacie; Qurollo, Barbara A.; Xiang, Bosong; Goldman, Barry S.] Monsanto Co, St Louis, MO USA; [Bhasin, Archna] Valdosta State Univ, Dept Biol, Valdosta, GA USA; [Bode, Edna; Bode, Helge B.; Brachmann, Alexander O.] Goethe Univ Frankfurt, Inst Mol Biowissensch, Frankfurt, Germany; [Darby, Creg] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Drace, Kevin] Mercer Univ, Dept Biol, Macon, GA 31207 USA; [Givaudan, Alain; Lanois, Anne; Ogier, Jean-Claude; Gaudriault, Sophie] Univ Montpellier 2, Inst Natl Rech Agron, Montpellier, France; [Givaudan, Alain; Lanois, Anne; Ogier, Jean-Claude; Gaudriault, Sophie] Univ Montpellier, F-34059 Montpellier, France; [Liu, Renyi; Marri, Pradeep R.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Martens, Eric C.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Medigue, Claudine; Rouy, Zoe] CNRS, Inst Genom, Commissariat Energie Atom,UMR 8030, Direct Sci Vivant,Lab Anal Bioinformat Genom & Me, Evry, France; [Morales-Soto, Nydia; Park, Dongjin; Snyder, Holly; van der Hoeven, Ransome; Forst, Steven] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Tjaden, Brian C.] Wellesley Coll, Dept Comp Sci, Wellesley, MA 02181 USA; [Welch, Roy D.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Wheeler, Cathy; Goodner, Brad] Hiram Coll, Dept Biol, Hiram, OH USA; [Barbazuk, Brad] Univ Florida, Dept Biol, Gainesville, FL USA; [Slater, Steven C.] DOE Great Lakes Bioenergy Res Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Monsanto; University System of Georgia; Valdosta State University; Goethe University Frankfurt; University of California System; University of California San Francisco; Mercer University; INRAE; Universite de Montpellier; Universite de Montpellier; University of Arizona; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; CEA; University of Wisconsin System; University of Wisconsin Milwaukee; Wellesley College; Syracuse University; Hiram College; State University System of Florida; University of Florida; United States Department of Energy (DOE)	Chaston, JM (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	barry.s.goldman@monsanto.com; hgblair@bact.wisc.edu	Liu, Renyi/H-7013-2012; Suen, Garret/AAF-2080-2019; Bode, Helge B/F-7022-2014; , Gaudriault/AAK-9152-2021; Jewell, Kelsea/AGG-9303-2022	Suen, Garret/0000-0002-6170-711X; Bode, Helge B/0000-0001-6048-5909; , Gaudriault/0000-0003-2789-4959; van der Hoeven, Ransome/0000-0001-9686-832X; Drace, Kevin/0000-0002-5511-9207; Knack, Jennifer/0000-0003-1252-1092; Welch, Roy/0000-0002-9946-108X; Barbazuk, William/0000-0002-0909-4563; Brachmann, Alexander/0000-0002-9878-9550; Qurollo, Barbara/0000-0002-9849-2511; Goodrich-Blair, Heidi/0000-0003-1934-2636	United States Department of Agriculture [2004-35600-14181]; National Institutes of Health (NIH) National Research Service [T32]; Microbes in Health and Disease [AI55397]; Cellular and Molecular Parasitology [AI007414]; Molecular Biosciences [G07215]; National Science Foundation (NSF); University of Wisconsin-Madison; NSF [0552809, IOS-0950873, IOS-0920631]; NIH [F32 GM072342]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055397, T32AI007414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM072342] Funding Source: NIH RePORTER	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health (NIH) National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microbes in Health and Disease; Cellular and Molecular Parasitology; Molecular Biosciences; National Science Foundation (NSF)(National Science Foundation (NSF)); University of Wisconsin-Madison; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the United States Department of Agriculture Grant 2004-35600-14181. National Institutes of Health (NIH) National Research Service Award T32 support was provided to JC and CL (AI55397 "Microbes in Health and Disease"); CC and EHT (AI007414 "Cellular and Molecular Parasitology"); and SO, KC and GR (G07215, "Molecular Biosciences"). JC was also supported by a National Science Foundation (NSF) Graduate Research Fellowship and EM and CC were supported by the University of Wisconsin-Madison Ira L. Baldwin and Louis and Elsa Thomsen Distinguished Predoctoral Fellowships respectively. LdL was funded by the NSF Research Experience for Microbiology Project 0552809. AB was supported by the NIH grant F32 GM072342. Work in the HG-B lab was supported by grants from the NSF (IOS-0950873 and IOS-0920631). The funders listed above had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also funded by the Monsanto Company whose role, through the employment of ST, ZD, KK-O, PL, NM, SN, BX, B.Goldman, NL and BQ, involved performing the experiments and analyzing the data.	Adams BJ, 2006, BIOL CONTROL, V37, P32, DOI 10.1016/j.biocontrol.2005.11.008; Akhurst R. J., 1990, Entomopathogenic nematodes in biological control., P75; AKHURST RJ, 1982, J GEN MICROBIOL, V128, P3061; AKHURST RJ, 1983, INT J SYST BACTERIOL, V33, P38, DOI 10.1099/00207713-33-1-38; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013154; An RS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-433; Aquilini E, 2010, J BACTERIOL, V192, P4413, DOI 10.1128/JB.00494-10; Ardissone S, 2011, J BACTERIOL, V193, P2218, DOI 10.1128/JB.01260-10; Bennett HPJ, 2005, J BACTERIOL, V187, P77, DOI 10.1128/JB.187.1.77-84.2005; BIRD AF, 1983, INT J PARASITOL, V13, P599, DOI 10.1016/S0020-7519(83)80032-0; Blackburn M, 1998, APPL ENVIRON MICROB, V64, P3036; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brillard J, 2002, J BACTERIOL, V184, P3871, DOI 10.1128/JB.184.14.3871-3878.2002; Brillard J, 2001, APPL ENVIRON MICROB, V67, P2515, DOI 10.1128/AEM.67.6.2515-2525.2001; Brugirard-Ricaud K, 2005, CELL MICROBIOL, V7, P363, DOI 10.1111/j.1462-5822.2004.00466.x; Brugirard-Ricaud K, 2004, J BACTERIOL, V186, P4376, DOI 10.1128/JB.186.13.4376-4381.2004; Caldas C, 2002, APPL ENVIRON MICROB, V68, P1297, DOI 10.1128/AEM.68.3.1297-1304.2002; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Chalabaev S, 2007, PROTEOMICS, V7, P4499, DOI 10.1002/pmic.200700609; Chandra H, 2008, ENVIRON MICROBIOL, V10, P1285, DOI 10.1111/j.1462-2920.2007.01542.x; Chasteen TG, 2009, FEMS MICROBIOL REV, V33, P820, DOI 10.1111/j.1574-6976.2009.00177.x; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Ciche TA, 2008, APPL ENVIRON MICROB, V74, P2275, DOI 10.1128/AEM.02646-07; Clarke DJ, 2008, CELL MICROBIOL, V10, P2159, DOI 10.1111/j.1462-5822.2008.01209.x; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; Cowles KN, 2007, CELL MICROBIOL, V9, P1311, DOI 10.1111/j.1462-5822.2006.00873.x; Cowles KN, 2005, CELL MICROBIOL, V7, P209, DOI 10.1111/j.1462-5822.2004.00448.x; Davidson GS, 2001, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2001, PROCEEDINGS, P23, DOI 10.1109/INFVIS.2001.963275; Derzelle S, 2004, J BACTERIOL, V186, P1270, DOI 10.1128/JB.186.5.1270-1279.2004; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; DUNPHY GB, 1988, J GEN MICROBIOL, V134, P1017; Easom CA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-45; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 2000, GENOME BIOL, V1; Eleftherianos I, 2007, P NATL ACAD SCI USA, V104, P2419, DOI 10.1073/pnas.0610525104; Eleftherianos I, 2006, DEV COMP IMMUNOL, V30, P1099, DOI 10.1016/j.dci.2006.02.008; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FELENSTEIN J, 1989, CLADISTOCS, V5; Ffrench-Constant R, 2006, ADV APPL MICROBIOL, V58, P169, DOI 10.1016/S0065-2164(06)58005-5; Fodor A., 2010, Journal of Microbiology and Antimicrobials, V2, P36; Forst Steven, 2002, P57, DOI 10.1079/9780851995670.0057; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Furgani G, 2008, J APPL MICROBIOL, V104, P745, DOI 10.1111/j.1365-2672.2007.03613.x; Gendlina I, 2007, MOL MICROBIOL, V64, P1214, DOI 10.1111/j.1365-2958.2007.05729.x; Giannoulis P, 2007, J INVERTEBR PATHOL, V94, P20, DOI 10.1016/j.jip.2006.08.010; Goodrich-Blair H, 2007, CURR OPIN MICROBIOL, V10, P225, DOI 10.1016/j.mib.2007.05.006; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Gribaldo S, 2009, RES MICROBIOL, V160, P513, DOI 10.1016/j.resmic.2009.07.006; Griffin CT, 2001, PARASITOLOGY, V122, P181, DOI 10.1017/S003118200100717X; Gupta RS, 2002, THEOR POPUL BIOL, V61, P423, DOI 10.1006/tpbi.2002.1589; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Herbert EE, 2007, APPL ENVIRON MICROB, V73, P7826, DOI 10.1128/AEM.01586-07; Herbert EE, 2007, NAT REV MICROBIOL, V5, P634, DOI 10.1038/nrmicro1706; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ji DJ, 2004, J INSECT PHYSIOL, V50, P489, DOI 10.1016/j.jinsphys.2004.03.005; Joyce SA, 2008, ANGEW CHEM INT EDIT, V47, P1942, DOI 10.1002/anie.200705148; Khandelwal P, 2003, APPL ENVIRON MICROB, V69, P2032, DOI 10.1128/AEM.69.4.2032-2037.2003; Kirkeby S, 2006, MICROB PATHOGENESIS, V40, P191, DOI 10.1016/j.micpath.2006.01.006; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lanois A, 2008, MOL MICROBIOL, V68, P516, DOI 10.1111/j.1365-2958.2008.06168.x; Latreille P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-321; Lyzen R, 2005, ARCH MICROBIOL, V183, P203, DOI 10.1007/s00203-005-0764-y; Martens EC, 2003, J BACTERIOL, V185, P3147, DOI 10.1128/JB.185.10.3147-3154.2003; Morales-Soto N, 2011, J BACTERIOL, V193, P3624, DOI 10.1128/JB.00092-11; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ogier JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-568; Ohno S., 1970, EVOLUTION GENE DUPLI; Ohta M, 2006, DEV COMP IMMUNOL, V30, P867, DOI 10.1016/j.dci.2005.12.005; Park D, 2006, MOL MICROBIOL, V61, P1397, DOI 10.1111/j.1365-2958.2006.05320.x; Park D, 2009, MOL MICROBIOL, V73, P938, DOI 10.1111/j.1365-2958.2009.06817.x; Park Y, 2007, CELL MICROBIOL, V9, P645, DOI 10.1111/j.1462-5822.2006.00815.x; POINAR GO, 1967, J INVERTEBR PATHOL, V9, P510, DOI 10.1016/0022-2011(67)90131-0; POINAR GO, 1966, NEMATOLOGICA, V12, P105, DOI 10.1163/187529266X00068; POINAR GO, 1993, FUND APPL NEMATOL, V16, P333; POPIEL I, 1989, PARASITOLOGY, V99, P77, DOI 10.1017/S0031182000061047; Rebiere-Huet J, 2004, CAN J MICROBIOL, V50, P303, DOI 10.1139/W04-015; Reimer D, 2009, CHEMBIOCHEM, V10, P1997, DOI 10.1002/cbic.200900187; Richards GR, 2008, J BACTERIOL, V190, P4870, DOI 10.1128/JB.00358-08; Richards GR, 2010, APPL ENVIRON MICROB, V76, P221, DOI 10.1128/AEM.01715-09; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Sergeant M, 2006, APPL ENVIRON MICROB, V72, P5895, DOI 10.1128/AEM.00217-06; Sharma S, 2002, FEMS MICROBIOL LETT, V214, P241, DOI 10.1111/j.1574-6968.2002.tb11354.x; Shrestha S, 2007, J INVERTEBR PATHOL, V96, P64, DOI 10.1016/j.jip.2007.02.009; Singh J, 2008, J BACTERIOL, V190, P3877, DOI 10.1128/JB.00209-08; Snyder H, 2007, APPL ENVIRON MICROB, V73, P5338, DOI 10.1128/AEM.02947-06; Somvanshi VS, 2010, MOL MICROBIOL, V77, P1021, DOI 10.1111/j.1365-2958.2010.07270.x; Spiridonov SE, 2004, RUSS J NEMATOL, V12, P85; Spratt BG, 2006, PHILOS T R SOC B, V361, P1897, DOI 10.1098/rstb.2006.1929; Srinivasan BS, 2005, NAT BIOTECHNOL, V23, P691, DOI 10.1038/nbt1098; Suen G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000743; Suyama M, 2001, TRENDS GENET, V17, P10, DOI 10.1016/S0168-9525(00)02159-4; Szpilewska H, 2003, CURR MICROBIOL, V47, P379, DOI 10.1007/s00284-002-4024-y; Tan L, 2001, APPL ENVIRON MICROB, V67, P5010, DOI 10.1128/AEM.67.11.5010-5016.2001; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; THOMAS GM, 1979, INT J SYST BACTERIOL, V29, P352, DOI 10.1099/00207713-29-4-352; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Vigneux F, 2007, J BIOL CHEM, V282, P9571, DOI 10.1074/jbc.M604301200; Vivas EI, 2001, J BACTERIOL, V183, P4687, DOI 10.1128/JB.183.16.4687-4693.2001; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3; Watson RJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-177; Webster John M., 2002, P99, DOI 10.1079/9780851995670.0099; Weiske J, 1999, NITRIC OXIDE-BIOL CH, V3, P123, DOI 10.1006/niox.1999.0215; Wilkinson P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-302; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wu HW, 2010, GENOMICS, V96, P27, DOI 10.1016/j.ygeno.2010.03.007; Wu LC, 2003, ANN SURG, V238, P754, DOI 10.1097/01.sla.0000094551.88143.f8; Yoshida H, 2008, GLYCOBIOLOGY, V18, P1094, DOI 10.1093/glycob/cwn094	122	130	138	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27909	10.1371/journal.pone.0027909	http://dx.doi.org/10.1371/journal.pone.0027909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125637	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789200037
J	Naruse, K; Sato, J; Funakubo, M; Hata, M; Nakamura, N; Kobayashi, Y; Kamiya, H; Shibata, T; Kondo, M; Himeno, T; Matsubara, T; Oiso, Y; Nakamura, J				Naruse, Keiko; Sato, Jun; Funakubo, Megumi; Hata, Masaki; Nakamura, Nobuhisa; Kobayashi, Yasuko; Kamiya, Hideki; Shibata, Taiga; Kondo, Masaki; Himeno, Tatsuhito; Matsubara, Tatsuaki; Oiso, Yutaka; Nakamura, Jiro			Transplantation of Bone Marrow-Derived Mononuclear Cells Improves Mechanical Hyperalgesia, Cold Allodynia and Nerve Function in Diabetic Neuropathy	PLOS ONE			English	Article							ISOSORBIDE DINITRATE SPRAY; FIBROBLAST-GROWTH-FACTOR; AUTOLOGOUS TRANSPLANTATION; THERAPEUTIC ANGIOGENESIS; PERIPHERAL NEUROPATHY; ISCHEMIC-MYOCARDIUM; SENSORY NEUROPATHY; PROGENITOR CELLS; LIMB ISCHEMIA; BLOOD-FLOW	Relief from painful diabetic neuropathy is an important clinical issue. We have previously shown that the transplantation of cultured endothelial progenitor cells or mesenchymal stem cells ameliorated diabetic neuropathy in rats. In this study, we investigated whether transplantation of freshly isolated bone marrow-derived mononuclear cells (BM-MNCs) alleviates neuropathic pain in the early stage of streptozotocin-induced diabetic rats. Two weeks after STZ injection, BM-MNCs or vehicle saline were injected into the unilateral hind limb muscles. Mechanical hyperalgesia and cold allodynia in SD rats were measured as the number of foot withdrawals to von Frey hair stimulation and acetone application, respectively. Two weeks after the BM-MNC transplantation, sciatic motor nerve conduction velocity (MNCV), sensory nerve conduction velocity (SNCV), sciatic nerve blood flow (SNBF), mRNA expressions and histology were assessed. The BM-MNC transplantation significantly ameliorated mechanical hyperalgesia and cold allodynia in the BM-MNC-injected side. Furthermore, the slowed MNCV/SNCV and decreased SNBF in diabetic rats were improved in the BM-MNC-injected side. BM-MNC transplantation improved the decreased mRNA expression of NT-3 and number of microvessels in the hind limb muscles. There was no distinct effect of BM-MNC transplantation on the intraepidermal nerve fiber density. These results suggest that autologous transplantation of BM-MNCs could be a novel strategy for the treatment of painful diabetic neuropathy.	[Naruse, Keiko; Nakamura, Nobuhisa; Kobayashi, Yasuko; Matsubara, Tatsuaki] Aichi Gakuin Univ, Sch Dent, Dept Internal Med, Nagoya, Aichi 464, Japan; [Sato, Jun; Funakubo, Megumi] Nagoya Univ, Environm Med Res Inst, Futurist Environm Simulat Ctr, Nagoya, Aichi 464, Japan; [Hata, Masaki] Aichi Gakuin Univ, Sch Dent, Dept Removable Prosthodont, Nagoya, Aichi 464, Japan; [Kamiya, Hideki; Nakamura, Jiro] Aichi Med Univ, Ctr Diabet, Nagakute, Aichi 48011, Japan; [Shibata, Taiga; Kondo, Masaki; Himeno, Tatsuhito; Oiso, Yutaka] Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Nagoya, Aichi 4648601, Japan	Aichi Gakuin University; Nagoya University; Aichi Gakuin University; Aichi Medical University; Nagoya University	Naruse, K (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Internal Med, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	narusek@dpc.agu.ac.jp	Himeno, Tatsuhito/AAM-1134-2020; Himeno, Tatsuhito/AAF-6413-2021; Nakamura, Jiro/L-3693-2019	Himeno, Tatsuhito/0000-0001-8561-7605; Himeno, Tatsuhito/0000-0002-5677-1125	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [18613019]; MEXT of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported in part by the Grant-in-Aid for Scientific Research (18613019) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and in part by the "Strategic Research AGU-Platform Formation (2008-2012)" Project for Private Universities: matching fund subsidy from MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KJ, 1988, NATURE, V332, P360, DOI 10.1038/332360a0; Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Bril V, 2011, NEUROLOGY, V76, P1758, DOI 10.1212/WNL.0b013e3182166ebe; Calcutt NA, 2004, DIABETOLOGIA, V47, P718, DOI 10.1007/s00125-004-1354-2; Cameron NE, 2001, FREE RADICAL BIO MED, V31, P125, DOI 10.1016/S0891-5849(01)00564-0; CHOI Y, 1994, PAIN, V59, P369, DOI 10.1016/0304-3959(94)90023-X; CUMMINGS BJ, 1992, BRAIN RES, V591, P271, DOI 10.1016/0006-8993(92)91707-L; Dobretsov M, 2003, BRAIN RES, V960, P174, DOI 10.1016/S0006-8993(02)03828-3; DYCK PJ, 1976, NEUROLOGY, V26, P466, DOI 10.1212/WNL.26.5.466; Eaton SEM, 2003, DIABETOLOGIA, V46, P934, DOI 10.1007/s00125-003-1127-3; Fuchs D, 2010, PAIN, V151, P496, DOI 10.1016/j.pain.2010.08.010; Hasegawa T, 2006, EXP NEUROL, V199, P274, DOI 10.1016/j.expneurol.2005.11.001; Hotta N, 1996, DIABETES, V45, P361, DOI 10.2337/diabetes.45.3.361; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ilnytska O, 2006, DIABETES, V55, P1686, DOI 10.2337/db06-0067; Inkster ME, 2007, EUR J PHARMACOL, V561, P63, DOI 10.1016/j.ejphar.2006.12.029; Jarvis MF, 2000, EUR J PHARMACOL, V388, P29, DOI 10.1016/S0014-2999(99)00865-1; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kamiya H, 2004, ANN NEUROL, V56, P827, DOI 10.1002/ana.20295; Kang S, 2010, PAIN, V148, P128, DOI 10.1016/j.pain.2009.10.031; Kapur D, 2003, DIABETES-METAB RES, V19, pS9, DOI 10.1002/dmrr.359; Khan GM, 2002, NEUROSCIENCE, V114, P291, DOI 10.1016/S0306-4522(02)00372-X; Kim H, 2009, STEM CELLS, V27, P1686, DOI 10.1002/stem.87; Lachtermacher S, 2011, STEM CELL REV; Latham JR, 2009, DIABETES, V58, P2656, DOI 10.2337/db08-1763; Lauria G, 2005, J PERIPHER NERV SYST, V10, P202, DOI 10.1111/j.1085-9489.2005.0010210.x; Li F, 2006, NEUROBIOL DIS, V22, P669, DOI 10.1016/j.nbd.2006.01.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malmberg AB, 2004, PAIN, V111, P360, DOI 10.1016/j.pain.2004.07.017; MARIN P, 1994, DIABETES CARE, V17, P382, DOI 10.2337/diacare.17.5.382; Motukuru V, 2008, J VASC SURG, V48, p53S, DOI 10.1016/j.jvs.2008.09.005; Nakae M, 2006, DIABETES, V55, P1470, DOI 10.2337/db05-1160; Naruse K, 2005, DIABETES, V54, P1823, DOI 10.2337/diabetes.54.6.1823; Obrosova IG, 2009, NEUROTHERAPEUTICS, V6, P638, DOI 10.1016/j.nurt.2009.07.004; Quattrini C, 2007, DIABETES CARE, V30, P655, DOI 10.2337/dc06-2154; Rayman G, 2003, DIABETES CARE, V26, P2697, DOI 10.2337/diacare.26.9.2697-a; Schachinger V, 2009, EUR J HEART FAIL, V11, P973, DOI 10.1093/eurjhf/hfp113; Schratzberger P, 2001, J CLIN INVEST, V107, P1083, DOI 10.1172/JCI12188; Shibata T, 2008, DIABETES, V57, P3099, DOI 10.2337/db08-0031; Suzuki Y, 2002, PAIN, V99, P475, DOI 10.1016/S0304-3959(02)00244-0; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Tesfaye S, 2011, J DIABETES INVEST, V2, P33, DOI 10.1111/j.2040-1124.2010.00083.x; Tse HF, 2007, EUR J HEART FAIL, V9, P747, DOI 10.1016/j.ejheart.2007.03.008; Van Damme An, 2002, Current Gene Therapy, V2, P195; Villetti G, 2003, J PHARMACOL EXP THER, V306, P804, DOI 10.1124/jpet.103.050039; Wilson-Gerwing TD, 2008, EXP NEUROL, V213, P303, DOI 10.1016/j.expneurol.2008.06.002; Yagihashi S, 2011, J DIABETES INVEST, V2, P18, DOI 10.1111/j.2040-1124.2010.00070.x; Yuen KCJ, 2002, DIABETES CARE, V25, P1699, DOI 10.2337/diacare.25.10.1699; Zhuang HX, 1996, EXP NEUROL, V140, P198, DOI 10.1006/exnr.1996.0129; Ziegler D, 2008, DIABETES CARE, V31, pS255, DOI 10.2337/dc08-s263	50	49	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27458	10.1371/journal.pone.0027458	http://dx.doi.org/10.1371/journal.pone.0027458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125614	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789200014
J	Zielonka, J; Zielonka, M; Sikora, A; Adamus, J; Joseph, J; Hardy, M; Ouari, O; Dranka, BP; Kalyanaraman, B				Zielonka, Jacek; Zielonka, Monika; Sikora, Adam; Adamus, Jan; Joseph, Joy; Hardy, Micael; Ouari, Olivier; Dranka, Brian P.; Kalyanaraman, Balaraman			Global Profiling of Reactive Oxygen and Nitrogen Species in Biological Systems HIGH-THROUGHPUT REAL-TIME ANALYSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; NITRIC-OXIDE; INTRACELLULAR SUPEROXIDE; MEDIATED OXIDATION; CYTOCHROME-C; HYDROETHIDINE; PEROXYNITRITE; FLUORESCENCE; PRODUCT; HPLC	Herein we describe a high-throughput fluorescence and HPLC-based methodology for global profiling of reactive oxygen and nitrogen species (ROS/RNS) in biological systems. The combined use of HPLC and fluorescence detection is key to successful implementation and validation of this methodology. Included here are methods to specifically detect and quantitate the products formed from interaction between the ROS/RNS species and the fluorogenic probes, as follows: superoxide using hydroethidine, peroxynitrite using boronate-based probes, nitric oxide-derived nitrosating species with 4,5-diaminofluorescein, and hydrogen peroxide and other oxidants using 10-acetyl-3,7-dihydroxyphenoxazine (Amplex (R) Red) with and without horseradish peroxidase, respectively. In this study, we demonstrate real-time monitoring of ROS/RNS in activated macrophages using high-throughput fluorescence and HPLC methods. This global profiling approach, simultaneous detection of multiple ROS/RNS products of fluorescent probes, developed in this study will be useful in unraveling the complex role of ROS/RNS in redox regulation, cell signaling, and cellular oxidative processes and in high-throughput screening of anti-inflammatory antioxidants.	[Dranka, Brian P.; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Dranka, Brian P.; Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Rad Res Ctr, Milwaukee, WI 53226 USA; [Sikora, Adam; Adamus, Jan] Tech Univ Lodz, Inst Appl Radiat Chem, PL-90924 Lodz, Poland; [Hardy, Micael; Ouari, Olivier] Univ Aix Marseille, Lab Chim Prov, UMR 6264, F-13397 Marseille 20, France; [Hardy, Micael; Ouari, Olivier] CNRS, F-13397 Marseille 20, France	Medical College of Wisconsin; Medical College of Wisconsin; Lodz University of Technology; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Kalyanaraman, B (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	balarama@mcw.edu	Hardy, micael/ABF-3357-2020; Zielonka, Jacek/N-9546-2014; Sikora, Adam B/I-2756-2014; Dranka, Brian/B-8701-2016	Hardy, micael/0000-0003-2976-7785; Zielonka, Jacek/0000-0002-2524-0145; Sikora, Adam B/0000-0002-4962-8945; Dranka, Brian/0000-0002-1377-377X; Ouari, Olivier/0000-0003-4320-4313	National Institutes of Health [R01 HL063119]; Foundation for Polish Science (FNP) within European Union; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Polish Science (FNP) within European Union; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL063119 (to B. K.).; Supported by a grant from the Foundation for Polish Science (FNP) within the "Homing Plus" program supported by the European Union within the European Regional Development Fund, through the Innovative Economy Program.	Bonini MG, 2006, FREE RADICAL BIO MED, V40, P968, DOI 10.1016/j.freeradbiomed.2005.10.042; Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271; Burkitt MJ, 2001, BIOCHEM BIOPH RES CO, V282, P329, DOI 10.1006/bbrc.2001.4578; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Folkes LK, 2009, ARCH BIOCHEM BIOPHYS, V484, P122, DOI 10.1016/j.abb.2008.10.014; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Groeger AL, 2010, MOL INTERV, V10, P39, DOI 10.1124/mi.10.1.7; Gutscher M, 2008, NAT METHODS, V5, P553, DOI [10.1038/nmeth.1212, 10.1038/NMETH.1212]; HOGG N, 1994, ARCH BIOCHEM BIOPHYS, V314, P153, DOI 10.1006/abbi.1994.1423; Maghzal GJ, 2007, FREE RADICAL BIO MED, V43, P1095, DOI 10.1016/j.freeradbiomed.2007.06.023; Miller EW, 2005, J AM CHEM SOC, V127, P16652, DOI 10.1021/ja054474f; Mishin V, 2010, FREE RADICAL BIO MED, V48, P1485, DOI 10.1016/j.freeradbiomed.2010.02.030; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Quijano C, 1997, BIOCHEM J, V322, P167, DOI 10.1042/bj3220167; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Ridnour LA, 2004, BIOL CHEM, V385, P1, DOI 10.1515/BC.2004.001; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Sikora A, 2011, CHEM RES TOXICOL, V24, P687, DOI 10.1021/tx100439a; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Thomas S, 2007, FREE RADICAL BIO MED, V42, P1049, DOI 10.1016/j.freeradbiomed.2007.01.005; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Zhang HW, 1997, ARCH BIOCHEM BIOPHYS, V339, P183, DOI 10.1006/abbi.1996.9863; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zielonka J, 2008, FREE RADICAL BIO MED, V44, P835, DOI 10.1016/j.freeradbiomed.2007.11.013; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zielonka J, 2006, ARCH BIOCHEM BIOPHYS, V456, P39, DOI 10.1016/j.abb.2006.09.031; Zielonka J, 2006, FREE RADICAL BIO MED, V41, P1050, DOI 10.1016/j.freeradbiomed.2006.04.017; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031	33	127	135	3	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					2984	2995		10.1074/jbc.M111.309062	http://dx.doi.org/10.1074/jbc.M111.309062			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22139901	hybrid, Green Published			2022-12-25	WOS:000300295100006
J	Uyama, T; Ichi, I; Kono, N; Inoue, A; Tsuboi, K; Jin, XH; Araki, N; Aoki, J; Arai, H; Ueda, N				Uyama, Toru; Ichi, Ikuyo; Kono, Nozomu; Inoue, Asuka; Tsuboi, Kazuhito; Jin, Xing-Hua; Araki, Nobukazu; Aoki, Junken; Arai, Hiroyuki; Ueda, Natsuo			Regulation of Peroxisomal Lipid Metabolism by Catalytic Activity of Tumor Suppressor H-rev107	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; PLASMALOGEN BIOSYNTHESIS; BIOGENESIS DISORDERS; MASS-SPECTROMETRY; GENE; CLONING; IDENTIFICATION; BIOCHEMISTRY; SYNTHASE; MUTANT	H-rev107 is a mammalian protein belonging to the HRAS-like suppressor family. Although the protein was originally found as a tumor suppressor, currently it is receiving considerable attention as a regulator of adipocyte lipolysis. We recently revealed that purified recombinant H-rev107 has phospholipase A(1/2) activity, releasing free fatty acids from glycerophospholipids with a preference for esterolysis at the sn-1 position. In the present study, we constitutively expressed H-rev107 in cloned HEK293 cells to examine its biological function in living cells. Initially, the cells accumulated free fatty acids. We also found a remarkable decrease in the levels of ether-type lipids, including plasmalogen and ether-type triglyceride, with a concomitant increase in fatty alcohols, substrates for the biosynthesis of ether-type lipids. Considering that peroxisomes are involved in the ether-type lipid biosynthesis, we next focused on peroxisomes and found that the peroxisomal markers 70-kDa peroxisomal membrane protein and catalase were abnormally distributed in the transfected cells. These biochemical and morphological abnormalities were not seen in HEK293 cells stably expressing a catalytically inactive mutant of H-rev107. When H-rev107 or its fusion protein with enhanced green fluorescence protein was transiently expressed in mammalian cells, both proteins were associated with peroxisomes in some of the observed cells. These results suggest that H-rev107 interferes with the biosynthesis of ether-type lipids and is responsible for the dysfunction of peroxisomes in H-rev107-expressing cells.	[Uyama, Toru; Tsuboi, Kazuhito; Jin, Xing-Hua; Ueda, Natsuo] Kagawa Univ, Sch Med, Dept Biochem, Miki, Kagawa 7610793, Japan; [Araki, Nobukazu] Kagawa Univ, Sch Med, Dept Histol & Cell Biol, Miki, Kagawa 7610793, Japan; [Ichi, Ikuyo; Kono, Nozomu; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Kono, Nozomu; Arai, Hiroyuki] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Inoue, Asuka; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan	Kagawa University; Kagawa University; University of Tokyo; Japan Science & Technology Agency (JST); Tohoku University	Ueda, N (corresponding author), Kagawa Univ, Sch Med, Dept Biochem, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	nueda@med.kagawa-u.ac.jp	KONO, nozomu/AAM-3178-2020; Jin, Xinghua/K-1142-2015	Jin, Xinghua/0000-0002-8883-5234; Aoki, Junken/0000-0001-9435-1896; Araki, Nobukazu/0000-0001-6160-210X	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Kagawa University Faculty of Medicine; Kagawa University; Ichiro Kanehara Foundation; Sumitomo Foundation; Uehara Memorial Foundation; Core Research for Evolutional Science and Technology (CREST); Grants-in-Aid for Scientific Research [23227004, 23617004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kagawa University Faculty of Medicine; Kagawa University; Ichiro Kanehara Foundation; Sumitomo Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. U.) and the Japan Society for the Promotion of Science (to N. U.). This work was also supported by grants from the Kagawa University Faculty of Medicine Specially Promoted Research Fund 2010 (to T. U.), the Fund for Kagawa University Young Scientists 2011 (to T. U.), the Ichiro Kanehara Foundation (to T. U.), the Sumitomo Foundation (to T. U.), the Uehara Memorial Foundation (to T. U.), and Core Research for Evolutional Science and Technology (CREST) (to N. K. and H. A.).	Araki N, 2003, J CELL SCI, V116, P247, DOI 10.1242/jcs.00235; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1374, DOI 10.1016/j.bbamcr.2006.09.012; Girzalsky W, 2010, BBA-MOL CELL RES, V1803, P724, DOI 10.1016/j.bbamcr.2010.01.002; HAJNAL A, 1994, ONCOGENE, V9, P479; Honsho M, 2008, BBA-MOL CELL RES, V1783, P1857, DOI 10.1016/j.bbamcr.2008.05.018; Honsho M, 2010, J BIOL CHEM, V285, P8537, DOI 10.1074/jbc.M109.083311; Hsu FF, 2003, J MASS SPECTROM, V38, P752, DOI 10.1002/jms.491; Hummasti S, 2008, J LIPID RES, V49, P2535, DOI 10.1194/jlr.M800269-JLR200; Islinger M, 2010, BBA-MOL CELL RES, V1803, P881, DOI 10.1016/j.bbamcr.2010.03.013; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Jin XH, 2009, BBA-MOL CELL BIOL L, V1791, P32, DOI 10.1016/j.bbalip.2008.09.006; Kanzawa N, 2009, P NATL ACAD SCI USA, V106, P17711, DOI 10.1073/pnas.0904762106; KERWIN JL, 1994, J LIPID RES, V35, P1102; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lotz K, 2005, INT J CANCER, V116, P894, DOI 10.1002/ijc.21127; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Nagan N, 1997, P NATL ACAD SCI USA, V94, P4475, DOI 10.1073/pnas.94.9.4475; Nagan N, 1998, BIOCHEM J, V332, P273, DOI 10.1042/bj3320273; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; OSUMI T, 1978, J BIOCHEM, V83, P1361, DOI 10.1093/oxfordjournals.jbchem.a132044; Ren XB, 2010, FEBS LETT, V584, P4222, DOI 10.1016/j.febslet.2010.09.015; Sers C, 1997, J CELL BIOL, V136, P935, DOI 10.1083/jcb.136.4.935; Shyu RY, 2008, AMINO ACIDS, V35, P129, DOI 10.1007/s00726-007-0612-2; South ST, 1999, J CELL BIOL, V144, P255, DOI 10.1083/jcb.144.2.255; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Ueda N, 2010, BBA-MOL CELL BIOL L, V1801, P1274, DOI 10.1016/j.bbalip.2010.08.010; Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200; Van Veldhoven PP, 2010, J LIPID RES, V51, P2863, DOI 10.1194/jlr.R005959; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; Yamasaki M, 1999, J BIOL CHEM, V274, P35293, DOI 10.1074/jbc.274.50.35293; Yan MD, 2005, CURR OPIN CELL BIOL, V17, P376, DOI 10.1016/j.ceb.2005.06.003	37	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2706	2718		10.1074/jbc.M111.267575	http://dx.doi.org/10.1074/jbc.M111.267575			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22134920	Green Published, hybrid			2022-12-25	WOS:000300292300042
J	Lewis, WG; Robinson, LS; Perry, J; Bick, JL; Peipert, JF; Allsworth, JE; Lewis, AL				Lewis, Warren G.; Robinson, Lloyd S.; Perry, Justin; Bick, Jennifer L.; Peipert, Jeffrey F.; Allsworth, Jenifer E.; Lewis, Amanda L.			Hydrolysis of Secreted Sialoglycoprotein Immunoglobulin A (IgA) in ex Vivo and Biochemical Models of Bacterial Vaginosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-BIRTH-WEIGHT; PRETERM DELIVERY; IMMUNE EXCLUSION; PREGNANT-WOMEN; INFECTION; SIALIDASE; COMPONENT; RISK; METRONIDAZOLE; ENDOMETRITIS	Bacterial vaginosis (BV) is a common polymicrobial imbalance of the vaginal flora associated with a wide variety of obstetric and gynecologic complications including serious infections and preterm birth. As evidenced by high recurrence rates following treatment, interventions for BV are still lacking. Several hydrolytic activities, including glycosidases and proteases, have been previously correlated with BV and have been hypothesized to degrade host sialoglycoproteins that participate in mucosal immune functions. Sialidase activity is most predictive of BV status and correlates strongly with adverse health outcomes. Here we combine clinical specimens with biochemical approaches to investigate secretory immunoglobulin A (SIgA) as a substrate of BV-associated glycosidases and proteases. We show that BV clinical specimens hydrolyze sialic acid from SIgA, but not in the presence of the sialidase inhibitor dehydro-deoxysialic acid. The collective action of BV-associated glycosidases exposes underlying mannose residues of SIgA, most apparent on the heavily N-glycosylated secretory component of the antibody. Terminal sialic acid residues on SIgA protect underlying carbohydrate residues from exposure and hydrolysis by exoglycosidases (galactosidase and hexosaminidase). It is known that both IgG and SIgA are present in the human reproductive tract. We show that the IgG heavy chain is more susceptible to proteolysis than its IgA counterpart. Gentle partial deglycosylation of the SIgA secretory component enhanced susceptibility to proteolysis. Together, these data support a model of BV in which SIgA is subject to stepwise exodeglycosylation and enhanced proteolysis, likely compromising the ability of the	[Lewis, Warren G.] Washington Univ, Dept Med, Ctr Womens Infect Dis Res, Sch Med, St Louis, MO 63110 USA; [Robinson, Lloyd S.; Perry, Justin; Lewis, Amanda L.] Washington Univ, Dept Mol Microbiol, Ctr Womens Infect Dis Res, Sch Med, St Louis, MO 63110 USA; [Bick, Jennifer L.; Peipert, Jeffrey F.; Allsworth, Jenifer E.; Lewis, Amanda L.] Washington Univ, Dept Obstet & Gynecol, Ctr Womens Infect Dis Res, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Lewis, AL (corresponding author), 660 S Euclid Ave,Campus Box 8230, St Louis, MO 63110 USA.	allewis@wustl.edu	Lewis, Warren G/W-4369-2019; Allsworth, Jenifer/J-2475-2019	Lewis, Warren G/0000-0003-1210-6403; Allsworth, Jenifer/0000-0001-6559-8638; Lewis, Amanda/0000-0001-6195-3030	March of Dimes; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000450] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by an anonymous donation to the Choice project (to J. F. P.), and laboratory analysis was funded (in part) by a Basil O'Connor Award from the March of Dimes (to A. L. L.).	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; BAENZIGER J, 1974, J BIOL CHEM, V249, P7260; Bonner A, 2009, J BIOL CHEM, V284, P5077, DOI 10.1074/jbc.M807529200; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Bradshaw CS, 2005, J CLIN MICROBIOL, V43, P1304, DOI 10.1128/JCM.43.3.1304-1308.2005; BRISELDEN AM, 1992, J CLIN MICROBIOL, V30, P663, DOI 10.1128/JCM.30.3.663-666.1992; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; Cauci S, 2005, AM J OBSTET GYNECOL, V192, P489, DOI 10.1016/j.ajog.2004.07.023; Cauci S, 2002, J INFECT DIS, V185, P1614, DOI 10.1086/340417; Cauci S, 1998, J INFECT DIS, V178, P1698, DOI 10.1086/314505; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Daele J, 2000, Acta Otorhinolaryngol Belg, V54, P373; Deshpande N, 2010, J PROTEOME RES, V9, P1063, DOI 10.1021/pr900956x; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Donders GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/j.1471-0528.2009.02237.x; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hitti J, 2001, OBSTET GYNECOL, V97, P211, DOI 10.1016/S0029-7844(00)01146-7; KERR MA, 1990, BIOCHEM J, V271, P285, DOI 10.1042/bj2710285; Kilian M, 1996, APMIS, V104, P321, DOI 10.1111/j.1699-0463.1996.tb00724.x; LARSSON PG, 1992, INT J STD AIDS, V3, P239, DOI 10.1177/095646249200300402; Lewis AL, 2009, P NATL ACAD SCI USA, V106, P13552, DOI 10.1073/pnas.0902431106; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; LINDH E, 1975, J IMMUNOL, V114, P284; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; McDonald HM, 2007, COCHRANE DB SYST REV; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; MONCLA BJ, 1990, J CLIN MICROBIOL, V28, P422, DOI 10.1128/JCM.28.3.422-425.1990; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Olmsted SS, 2003, SEX TRANSM DIS, V30, P257, DOI 10.1097/00007435-200303000-00016; Perrier C, 2006, J BIOL CHEM, V281, P14280, DOI 10.1074/jbc.M512958200; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rezeberga D, 2008, ACTA OBSTET GYN SCAN, V87, P360, DOI 10.1080/00016340801936487; Royle L, 2002, ANAL BIOCHEM, V304, P70, DOI 10.1006/abio.2002.5619; Royle L, 2003, J BIOL CHEM, V278, P20140, DOI 10.1074/jbc.M301436200; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Simcox R, 2007, AUST NZ J OBSTET GYN, V47, P368, DOI 10.1111/j.1479-828X.2007.00759.x; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; STOKES CR, 1975, NATURE, V255, P745, DOI 10.1038/255745a0; Svare JA, 2006, BJOG-INT J OBSTET GY, V113, P1419, DOI 10.1111/j.1471-0528.2006.01087.x; Tanaka M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/470803; van Egmond M, 2001, TRENDS IMMUNOL, V22, P205, DOI 10.1016/S1471-4906(01)01873-7; Varki A., 2009, SIALIC ACIDS ESSENTI; WATTS DH, 1990, OBSTET GYNECOL, V75, P52; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Wiesenfeld HC, 2002, OBSTET GYNECOL, V100, P456, DOI 10.1016/S0029-7844(02)02118-X; Wiggins R, 2002, INT J STD AIDS, V13, P755, DOI 10.1258/095646202320753709; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x; Zhang Xin, 2002, Zhonghua Fu Chan Ke Za Zhi, V37, P588	53	48	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2079	2089		10.1074/jbc.M111.278135	http://dx.doi.org/10.1074/jbc.M111.278135			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22134918	hybrid, Green Published			2022-12-25	WOS:000299321000048
J	Hannemann, J; Meyer-Staeckling, S; Kemming, D; Alpers, I; Joosse, SA; Pospisil, H; Kurtz, S; Gorndt, J; Puschel, K; Riethdorf, S; Pantel, K; Brandt, B				Hannemann, Juliane; Meyer-Staeckling, Soenke; Kemming, Dirk; Alpers, Iris; Joosse, Simon A.; Pospisil, Heike; Kurtz, Stefan; Goerndt, Jennifer; Pueschel, Klaus; Riethdorf, Sabine; Pantel, Klaus; Brandt, Burkhard			Quantitative High-Resolution Genomic Analysis of Single Cancer Cells	PLOS ONE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; BREAST-CANCER; LUNG-CANCER; EGFR GENE; ARRAY CGH; THERAPY	During cancer progression, specific genomic aberrations arise that can determine the scope of the disease and can be used as predictive or prognostic markers. The detection of specific gene amplifications or deletions in single blood-borne or disseminated tumour cells that may give rise to the development of metastases is of great clinical interest but technically challenging. In this study, we present a method for quantitative high-resolution genomic analysis of single cells. Cells were isolated under permanent microscopic control followed by high-fidelity whole genome amplification and subsequent analyses by fine tiling array-CGH and qPCR. The assay was applied to single breast cancer cells to analyze the chromosomal region centred by the therapeutical relevant EGFR gene. This method allows precise quantitative analysis of copy number variations in single cell diagnostics.	[Hannemann, Juliane; Meyer-Staeckling, Soenke; Kemming, Dirk; Alpers, Iris; Joosse, Simon A.; Riethdorf, Sabine; Pantel, Klaus; Brandt, Burkhard] Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany; [Pospisil, Heike; Kurtz, Stefan] Univ Hamburg, Ctr Bioinformat, Hamburg, Germany; [Pospisil, Heike] Univ Appl Sci Wildau, Wildau, Germany; [Goerndt, Jennifer; Pueschel, Klaus] Univ Hamburg, Dept Legal Med, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University of Applied Sciences Wildau; University of Hamburg	Hannemann, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany.	Burkhard.Brandt@uksh.de	Pospisil, Heike/G-7377-2016; Joosse, Simon/ABC-2470-2020	Joosse, Simon/0000-0002-4296-5615; Brandt, Burkhard/0000-0003-3681-3049	Bundesministerium Fur Bildung Und Forschung (BMBF) [FKZ: 01ES0724]	Bundesministerium Fur Bildung Und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by Bundesministerium Fur Bildung Und Forschung (BMBF FKZ: 01ES0724, http://www.bmbf.de/de/1398.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulos K, 2008, CURR CANCER DRUG TAR, V8, P431, DOI 10.2174/156800908785133213; Agelopoulos K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-78; Allison M, 2010, NAT BIOTECHNOL, V28, P117, DOI 10.1038/nbt0210-117; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dienstmann R, 2011, ONCOTARGET, V2, P165; Duncan CG, 2010, ONCOTARGET, V1, P265, DOI 10.18632/oncotarget.137; Eilers PHC, 2005, BIOINFORMATICS, V21, P1146, DOI 10.1093/bioinformatics/bti148; Fuhrmann C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn101; Hirsch FR, 2009, LANCET ONCOL, V10, P432, DOI 10.1016/S1470-2045(09)70110-X; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Morrison BJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2111; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Tidow N, 2003, CANCER RES, V63, P1172; Zhang ZF, 2010, ONCOTARGET, V1, P497	22	31	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e26362	10.1371/journal.pone.0026362	http://dx.doi.org/10.1371/journal.pone.0026362			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140428	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100005
J	Wirsing, A; Senkel, S; Klein-Hitpass, L; Ryffel, GU				Wirsing, Andrea; Senkel, Sabine; Klein-Hitpass, Ludger; Ryffel, Gerhart U.			A Systematic Analysis of the 3 ' UTR of HNF4A mRNA Reveals an Interplay of Regulatory Elements Including miRNA Target Sites	PLOS ONE			English	Article							NUCLEAR FACTOR 4-ALPHA; TRANSCRIPTION FACTORS; GENE-EXPRESSION; CELL-PROLIFERATION; DOWN-REGULATION; UNTRANSLATED REGIONS; P2 PROMOTER; MICRORNAS; HNF4-ALPHA; CARCINOMA	Dysfunction of hepatocyte nuclear factor 4 alpha (HNF4 alpha) has been linked to maturity onset diabetes of the young (MODY1), diabetes type II and possibly to renal cell carcinoma (RCC). Whereas diabetes causing mutations are well known, there are no HNF4A mutations found in RCC. Since so far analyses have been constricted to the promoter and open reading frame of HNF4A, we performed a systematic analysis of the human HNF4A 3'UTR. We identified a short (1724 nt) and long (3180 nt) 3'UTR that are much longer than the open reading frame and conferred a repressive effect in luciferase reporter assays in HEK293 and INS-1 cells. By dissecting the 3'UTR into several pieces, we located two distinct elements of about 400 nt conferring a highly repressive effect. These negative elements A and B are counteracted by a balancer element of 39 nt located within the 59 end of the HNF4A 3'UTR. Dicer knock-down experiments implied that the HNF4A 3'UTR is regulated by miRNAs. More detailed analysis showed that miR-34 alpha and miR-21 both overexpressed in RCC cooperate in downregulation of the HNF4A mRNA. One of the identified miR-34 alpha binding sites is destroyed by SNP rs11574744. The identification of several regulatory elements within the HNF4A 3'UTR justifies the analysis of the 3'UTR sequence to explore the dysfunction of HNF4 alpha in diabetes and RCC.	[Wirsing, Andrea; Senkel, Sabine; Klein-Hitpass, Ludger; Ryffel, Gerhart U.] Univ Duisburg Essen, Univ Klinikum Essen, Inst Zellbiol Tumorforsch, Essen, Germany	University of Duisburg Essen	Wirsing, A (corresponding author), Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne Tumour Biol Branch, Melbourne, Vic, Australia.	gerhart.ryffel@uni-due.de			Deutsche Forschungsgemeinschaft [Ry5/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Ry5/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asslaber D, 2010, BLOOD, V115, P4191, DOI 10.1182/blood-2009-07-234823; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Bolotin E, 2010, TRANSCRIPTION FACTOR; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chiba H, 2005, EXP CELL RES, V302, P11, DOI 10.1016/j.yexcr.2004.08.014; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Cok SJ, 2001, J BIOL CHEM, V276, P23179, DOI 10.1074/jbc.M008461200; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dutta KK, 2007, CANCER SCI, V98, P1845, DOI 10.1111/j.1349-7006.2007.00619.x; Erdmann S, 2007, BIOL CHEM, V388, P91, DOI 10.1515/BC.2007.011; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Gautreau D, 1997, DEVELOPMENT, V124, P5013; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Grigo K, 2008, BIOL CHEM, V389, P179, DOI 10.1515/BC.2008.011; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grzybowska EA, 2001, BIOCHEM BIOPH RES CO, V288, P291, DOI 10.1006/bbrc.2001.5738; Gupta RK, 2004, TRENDS MOL MED, V10, P521, DOI 10.1016/j.molmed.2004.09.004; Harries LW, 2008, DIABETES, V57, P1745, DOI 10.2337/db07-1742; Hatzis P, 2006, MOL CELL BIOL, V26, P7017, DOI 10.1128/MCB.00297-06; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Huang JM, 2009, EXP CELL RES, V315, P1200, DOI 10.1016/j.yexcr.2009.01.004; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kolfschoten IGM, 2009, DIABETES OBES METAB, V11, P118, DOI 10.1111/j.1463-1326.2009.01118.x; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Kort EJ, 2008, CANCER RES, V68, P4034, DOI 10.1158/0008-5472.CAN-08-0592; Lausen J, 2000, NUCLEIC ACIDS RES, V28, P430, DOI 10.1093/nar/28.2.430; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lenburg ME, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-31; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Love-Gregory L, 2007, CURR OPIN CLIN NUTR, V10, P397, DOI 10.1097/MCO.0b013e3281e3888d; Lucas B, 2005, ONCOGENE, V24, P6418, DOI 10.1038/sj.onc.1208794; MACDONALD PM, 1990, DEVELOPMENT, V110, P161; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Moncini S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-111; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Nakhei H, 1998, NUCLEIC ACIDS RES, V26, P497, DOI 10.1093/nar/26.2.497; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rajewsky N, 2006, NAT STRUCT MOL BIOL, V13, P754, DOI 10.1038/nsmb0906-754; Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Scheper W, 1996, BIOCHEM J, V318, P195, DOI 10.1042/bj3180195; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; SEEGER MA, 1990, EMBO J, V9, P2977, DOI 10.1002/j.1460-2075.1990.tb07490.x; Sel S, 1996, CANCER LETT, V101, P205, DOI 10.1016/0304-3835(96)04136-5; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; Spizzo R, 2009, CELL, V137, P586, DOI 10.1016/j.cell.2009.04.040; Sun GH, 2010, NUCLEIC ACIDS RES, V38, P239, DOI 10.1093/nar/gkp870; Takagi S, 2010, J BIOL CHEM, V285, P4415, DOI 10.1074/jbc.M109.085431; Tang XQ, 2008, BBA-GENE REGUL MECH, V1779, P697, DOI 10.1016/j.bbagrm.2008.06.010; Thomas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh144; Thomas H, 2001, HUM MOL GENET, V10, P2089, DOI 10.1093/hmg/10.19.2089; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wirsing A, 2010, DIABETIC MED, V27, P631, DOI 10.1111/j.1464-5491.2010.03003.x; Yin C, 2008, HEPATOLOGY, V48, P1528, DOI 10.1002/hep.22510; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	78	33	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27438	10.1371/journal.pone.0027438	http://dx.doi.org/10.1371/journal.pone.0027438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140441	Green Submitted, gold, Green Published			2022-12-25	WOS:000298168100010
J	Won, JH; Ehret, G; Chakravarti, A; Olshen, RA				Won, Joong-Ho; Ehret, Georg; Chakravarti, Aravinda; Olshen, Richard A.			SNPs and Other Features as They Predispose to Complex Disease: Genome-Wide Predictive Analysis of a Quantitative Phenotype for Hypertension	PLOS ONE			English	Article							MEAN ARTERIAL-PRESSURE; FALSE DISCOVERY RATE; BLOOD-PRESSURE; ASSOCIATION; TRAITS; GENE; SUSCEPTIBILITY; COMPONENTS; RISK	Though recently they have fallen into some disrepute, genome-wide association studies (GWAS) have been formulated and applied to understanding essential hypertension. The principal goal here is to use data gathered in a GWAS to gauge the extent to which SNPs and their interactions with other features can be combined to predict mean arterial blood pressure (MAP) in 3138 pre-menopausal and naturally post-menopausal white women. More precisely, we quantify the extent to which data as described permit prediction of MAP beyond what is possible from traditional risk factors such as blood cholesterol levels and glucose levels. Of course, these traditional risk factors are genetic, though typically not explicitly so. In all, there were 44 such risk factors/clinical variables measured and 377,790 single nucleotide polymorphisms (SNPs) genotyped. Data for women we studied are from first visit measurements taken as part of the Atherosclerotic Risk in Communities (ARIC) study. We begin by assessing non-SNP features in their abilities to predict MAP, employing a novel regression technique with two stages, first the discovery of main effects and next discovery of their interactions. The long list of SNPs genotyped is reduced to a manageable list for combining with non-SNP features in prediction. We adapted Efron's local false discovery rate to produce this reduced list. Selected non-SNP and SNP features and their interactions are used to predict MAP using adaptive linear regression. We quantify quality of prediction by an estimated coefficient of determination (R-2). We compare the accuracy of prediction with and without information from SNPs.	[Won, Joong-Ho] VA Cooperat Studies Program, Mountain View, CA USA; [Won, Joong-Ho; Olshen, Richard A.] Stanford Univ, Div Biostat, Stanford, CA 94305 USA; [Ehret, Georg; Chakravarti, Aravinda] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Ehret, Georg] Univ Hosp Geneva, Div Cardiol, Geneva, Switzerland; [Chakravarti, Aravinda] Johns Hopkins Univ, Dept Epidemiol & Med, Baltimore, MD USA	Stanford University; Johns Hopkins University; University of Geneva; Johns Hopkins University	Won, JH (corresponding author), VA Cooperat Studies Program, Mountain View, CA USA.	olshen@stanford.edu	EHRET, Georg B/A-9532-2009; Won, Joong-Ho/GPF-9286-2022	EHRET, Georg B/0000-0002-5730-0675; 	United States National Institutes of Health (NIH) [R01 HL086694]; MERIT [R37EB02784]; Stanford Medical School; National Heart, Lung and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367, R37HL051021, R01HL086694, U10HL054512]; National Human Genome Research Institute [U01HG004402]; NIH [HHSN268200625226C]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015, N01HC055022, N01HC055018, N01HC055020, N01HC055019, N01HC055021, N01HC055016] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087641, R01HL059367, R37HL051021, R42HL055018, R01HL086694, U10HL054512, R41HL055018, R41HL055019] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB002784] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MERIT; Stanford Medical School; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	JHW and RAO were supported by the United States National Institutes of Health (NIH) grant R01 HL086694 and MERIT Award R37EB02784. JHW was also supported by the Dean's postdoctoral fellowship from the Stanford Medical School. The Atherosclerosis Risk in Communities Study is a collaborative study supported by National Heart, Lung and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021 and N01-HC-55022, and grants R01HL087641, R01HL59367, R37HL051021, R01HL086694 and U10HL054512; National Human Genome Research Institute contract U01HG004402; and NIH contract HHSN268200625226C. Infrastructure was supported in part by Grant Number UL1RR025005, a component of the NIH and the NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BREIMAN L., 1984, CRC PRESS; Chang YPC, 2007, AM J HUM GENET, V80, P253, DOI 10.1086/510918; Chen X, 2007, P NATL ACAD SCI USA, V104, P19199, DOI 10.1073/pnas.0709868104; de Andrade M, 1999, GENET EPIDEMIOL, V17, P64, DOI 10.1002/(SICI)1098-2272(1999)17:1<64::AID-GEPI5>3.0.CO;2-M; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Efron B., 2010, LARGE SCALE INFERENC; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; Franklin SS, 2009, CIRCULATION, V119, P243, DOI 10.1161/CIRCULATIONAHA.108.797936; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Huang J, 2004, P NATL ACAD SCI USA, V101, P10529, DOI 10.1073/pnas.0403794101; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Koivukoski L, 2004, HUM MOL GENET, V13, P2325, DOI 10.1093/hmg/ddh237; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mitchell GF, 2005, CIRCULATION, V112, P194, DOI 10.1161/CIRCULATIONAHA.104.530675; MORGAN JN, 1963, J AM STAT ASSOC, V58, P415, DOI 10.2307/2283276; Pandey JP, 2010, SCIENCE, V329, P1148, DOI 10.1126/science.329.5996.1148; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Strandberg TE, 2002, J HYPERTENS, V20, P399, DOI 10.1097/00004872-200203000-00014; Sun WG, 2007, J AM STAT ASSOC, V102, P901, DOI 10.1198/016214507000000545; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Wang MH, 2009, STAT BIOPHARM RES, V1, P424, DOI 10.1198/sbr.2009.0046; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zhang H, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-6824-1	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27891	10.1371/journal.pone.0027891	http://dx.doi.org/10.1371/journal.pone.0027891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140480	gold, Green Submitted, Green Published			2022-12-25	WOS:000298168100023
J	Hu, LB; Li, LK; Xie, HB; Gu, YL; Peng, T				Hu, Longbo; Li, Leike; Xie, Hongbin; Gu, Yanli; Peng, Tao			The Golgi Localization of GOLPH2 (GP73/GOLM1) Is Determined by the Transmembrane and Cytoplamic Sequences	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; LIVER-DISEASE; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; GP73; RETENTION; EXPRESSION; DOMAINS; BETA-1,4-GALACTOSYLTRANSFERASE; ALPHA-2,6-SIALYLTRANSFERASE	Golgi phosphoprotein 2 (GOLPH2) is a resident Golgi type-II membrane protein upregulated in liver disease. Given that GOLPH2 traffics through endosomes and can be secreted into the circulation, it is a promising serum marker for liver diseases. The structure of GOLPH2 and the functions of its different protein domains are not known. In the current study, we investigated the structural determinants for Golgi localization using a panel of GOLPH2 truncation mutants. The Golgi localization of GOLPH2 was not affected by the deletion of the C-terminal part of the protein. A truncated mutant containing the N-terminal portion (the cytoplasmic tail and transmembrane domain (TMD)) localized to the Golgi. Sequential deletion analysis of the N-terminal indicated that the TMD with a positively charged residue in the cytoplasmic N-terminal tail were sufficient to support Golgi localization. We also showed that both endogenous and secreted GOLPH2 exist as a disulfide-bonded dimer, and the coiled-coil domain was sufficient for dimerization. This structural knowledge is important for the understanding the pathogenic role of GOLPH2 in liver diseases, and the development of GOLPH2-based hepatocellular cancer diagnostic methods.	[Hu, Longbo; Li, Leike; Xie, Hongbin; Gu, Yanli; Peng, Tao] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Li, Leike; Peng, Tao] Univ Sci & Technol China, Hefei 230026, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Hu, LB (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	peng_tao@gibh.ac.cn	hu, longbo/S-7060-2018	hu, longbo/0000-0002-3495-6268; Peng, Tao/0000-0001-5260-7128; Li, Leike/0000-0002-1379-1396	National Science Foundation [309701647]; National Basic Research Program (973) [2009CB522306]	National Science Foundation(National Science Foundation (NSF)); National Basic Research Program (973)(National Basic Research Program of China)	This work was supported by National Science Foundation (309701647); National Basic Research Program (973) (Grant No. 2009CB522306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachert C, 2007, TRAFFIC, V8, P1415, DOI 10.1111/j.1600-0854.2007.00621.x; Bulbarelli A, 2002, J CELL SCI, V115, P1689; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Giannelli G, 2006, DIGEST LIVER DIS, V38, P854, DOI 10.1016/j.dld.2006.05.007; Gu YL, 2009, ANN CLIN BIOCHEM, V46, P38, DOI 10.1258/acb.2008.008088; He YX, 2010, J BIOL CHEM, V285, P4603, DOI 10.1074/jbc.M109.044180; Iftikhar R, 2004, AM J GASTROENTEROL, V99, P1087, DOI 10.1111/j.1572-0241.2004.30572.x; Kladney RD, 2002, HEPATOLOGY, V35, P1431, DOI 10.1053/jhep.2002.32525; Kladney RD, 2000, GENE, V249, P53, DOI 10.1016/S0378-1119(00)00136-0; Linstedt AD, 1997, MOL BIOL CELL, V8, P1073, DOI 10.1091/mbc.8.6.1073; Lundbaek JA, 2003, BIOPHYS J, V84, P2080, DOI 10.1016/S0006-3495(03)75015-2; Maitra A, 2004, AM J GASTROENTEROL, V99, P1096, DOI 10.1111/j.1572-0241.2004.40410.x; Marrero JA, 2005, J HEPATOL, V43, P1007, DOI 10.1016/j.jhep.2005.05.028; MASIBAY AS, 1993, J BIOL CHEM, V268, P9908; Munro S, 1998, TRENDS CELL BIOL, V8, P11, DOI 10.1016/S0962-8924(97)01197-5; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; NILSSON T, 1993, J CELL BIOL, V120, P5, DOI 10.1083/jcb.120.1.5; Norton PA, 2007, J CELL BIOCH; Nufer O, 2003, J CELL SCI, V116, P4429, DOI 10.1242/jcs.00759; Puri S, 2002, TRAFFIC, V3, P641, DOI 10.1034/j.1600-0854.2002.30906.x; Ronchi P, 2008, J CELL BIOL, V181, P105, DOI 10.1083/jcb.200710093; WONG SH, 1992, J CELL BIOL, V117, P245, DOI 10.1083/jcb.117.2.245; Wright LM, 2009, INT J CLIN EXP PATHO, V2, P34; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; Zhang P, 2009, TOXICON, V53, P309, DOI 10.1016/j.toxicon.2008.12.006; Zhou Y, 2011, MOL BIOL REP, V38, P1457, DOI 10.1007/s11033-010-0251-7	27	12	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28207	10.1371/journal.pone.0028207	http://dx.doi.org/10.1371/journal.pone.0028207			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140547	gold, Green Published, Green Submitted			2022-12-25	WOS:000298166300038
J	Kastrati, I; Edirisinghe, PD; Hemachandra, LPMP; Chandrasena, ER; Choi, J; Wang, YT; Bolton, JL; Thatcher, GRJ				Kastrati, Irida; Edirisinghe, Praneeth D.; Hemachandra, L-P-Madhubani P.; Chandrasena, Esala R.; Choi, Jaewoo; Wang, Yue-Ting; Bolton, Judy L.; Thatcher, Gregory R. J.			Raloxifene and Desmethylarzoxifene Block Estrogen-Induced Malignant Transformation of Human Breast Epithelial Cells	PLOS ONE			English	Article							ANCHORAGE-INDEPENDENT GROWTH; NUCLEIC ACID ADDUCTS; RECEPTOR MODULATORS; DNA-DAMAGE; EQUINE ESTROGEN; DEPURINATING N3ADENINE; METABOLIC-ACTIVATION; POSTMENOPAUSAL WOMEN; CATECHOL ESTROGENS; N7GUANINE ADDUCTS	There is association between exposure to estrogens and the development and progression of hormone-dependent gynecological cancers. Chemical carcinogenesis by catechol estrogens derived from oxidative metabolism is thought to contribute to breast cancer, yet exact mechanisms remain elusive. Malignant transformation was studied in MCF-10A human mammary epithelial cells, since estrogens are not proliferative in this cell line. The human and equine estrogen components of estrogen replacement therapy (ERT) and their catechol metabolites were studied, along with the influence of co-administration of selective estrogen receptor modulators (SERMs), raloxifene and desmethyl-arzoxifene (DMA), and histone deacetylase inhibitors. Transformation was induced by human estrogens, and selectively by the 4-OH catechol metabolite, and to a lesser extent by an equine estrogen metabolite. The observed estrogen-induced upregulation of CYP450 1B1 in estrogen receptor negative MCF-10A cells, was compatible with a causal role for 4-OH catechol estrogens, as was attenuated transformation by CYP450 inhibitors. Estrogen-induced malignant transformation was blocked by SERMs correlating with a reduction in formation of nucleobase catechol estrogen (NCE) adducts and formation of 8-oxo-dG. NCE adducts can be formed consequent to DNA abasic site formation, but NCE adducts were also observed on incubation of estrogen quinones with free nucleotides. These results suggest that NCE adducts may be a biomarker for cellular electrophilic stress, which together with 8-oxo-dG as a biomarker of oxidative stress correlate with malignant transformation induced by estrogen oxidative metabolites. The observed attenuation of transformation by SERMs correlated with these biomarkers and may also be of clinical significance in breast cancer chemoprevention.	[Kastrati, Irida; Edirisinghe, Praneeth D.; Hemachandra, L-P-Madhubani P.; Chandrasena, Esala R.; Choi, Jaewoo; Wang, Yue-Ting; Bolton, Judy L.; Thatcher, Gregory R. J.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kastrati, I (corresponding author), Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA.	thatcher@uic.edu	Kastrati, Irida/L-4641-2019	Kastrati, Irida/0000-0002-8086-1411; Hemachandra, L P Madhubhani/0000-0001-7756-6190	University of Illinois at Chicago (UIC) Graduate College; National Institutes of Health [R01 CA130037, R01 CA102590]; NATIONAL CANCER INSTITUTE [R01CA102590, R01CA130037] Funding Source: NIH RePORTER	University of Illinois at Chicago (UIC) Graduate College; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the University of Illinois at Chicago (UIC) Graduate College Deiss Award in Biomedical Research to Irida Kastrati, UIC Graduate College fellowship, by National Institutes of Health grants R01 CA130037 (JLB) and R01 CA102590 (GRJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABULHAJJ YJ, 1986, J STEROID BIOCHEM, V25, P245, DOI 10.1016/0022-4731(86)90423-1; Akanni A, 1997, CHEM RES TOXICOL, V10, P477, DOI 10.1021/tx960204m; Akanni A, 1999, CHEM RES TOXICOL, V12, P1247, DOI 10.1021/tx9900932; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; BASOLO F, 1991, MOL CARCINOGEN, V4, P25, DOI 10.1002/mc.2940040106; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Bicaku E, 2008, CANCER RES, V68, P1513, DOI 10.1158/0008-5472.CAN-07-2822; Cavalieri EL, 1997, P NATL ACAD SCI USA, V94, P10937, DOI 10.1073/pnas.94.20.10937; Chen YM, 2000, CHEM RES TOXICOL, V13, P342, DOI 10.1021/tx990186j; Chen ZH, 2005, TOXICOL APPL PHARM, V208, P46, DOI 10.1016/j.taap.2005.01.010; Chen ZH, 2004, CARCINOGENESIS, V25, P2005, DOI 10.1093/carcin/bgh183; Conzen SD, 2003, CANCER J, V9, P4, DOI 10.1097/00130404-200301000-00003; Cosman F, 1999, ENDOCR REV, V20, P418, DOI 10.1210/er.20.3.418; Cuendet M, 2004, MUTAT RES-FUND MOL M, V550, P109, DOI 10.1016/j.mrfmmm.2004.02.005; Cummings SR, 2010, J BONE MINER RES; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Duong V, 2008, MOL CANCER RES, V6, P1908, DOI 10.1158/1541-7786.MCR-08-0299; DWIVEDY I, 1992, CHEM RES TOXICOL, V5, P828, DOI 10.1021/tx00030a016; Fernandez SV, 2006, INT J CANCER, V118, P1862, DOI 10.1002/ijc.21590; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; HAN XL, 1995, CARCINOGENESIS, V16, P2571, DOI 10.1093/carcin/16.10.2571; Hodges-Gallagher L, 2007, BREAST CANCER RES TR, V105, P297, DOI 10.1007/s10549-006-9459-6; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Lareef MH, 2005, INT J ONCOL, V26, P423; LI JJ, 1987, FED PROC, V46, P1858; Liby K, 2006, CLIN CANCER RES, V12, P5902, DOI 10.1158/1078-0432.CCR-06-1119; Liehr JG, 2000, ENDOCR REV, V21, P40, DOI 10.1210/er.21.1.40; LIEHR JG, 1986, J STEROID BIOCHEM, V24, P353, DOI 10.1016/0022-4731(86)90080-4; Liu H, 2005, CHEM RES TOXICOL, V18, P162, DOI 10.1021/tx049776u; Liu H, 2007, CHEM RES TOXICOL, V20, P1676, DOI 10.1021/tx7001367; Lu F, 2007, J STEROID BIOCHEM, V105, P150, DOI 10.1016/j.jsbmb.2006.12.102; Lu F, 2008, CANCER PREV RES, V1, P135, DOI 10.1158/1940-6207.CAPR-08-0037; MACMAHON B, 1960, J NATL CANCER I, V24, P733, DOI 10.1093/jnci/24.3.733; Marchion DC, 2009, MOL CANCER THER, V8, P794, DOI 10.1158/1535-7163.MCT-08-0985; MILLER EC, 1981, CANCER, V47, P1055, DOI 10.1002/1097-0142(19810301)47:5+<1055::AID-CNCR2820471302>3.0.CO;2-3; Osborne CK, 2000, J CLIN ONCOL, V18, P3172, DOI 10.1200/JCO.2000.18.17.3172; Park JH, 2009, DNA REPAIR, V8, P29, DOI 10.1016/j.dnarep.2008.08.011; Park SA, 2009, CANCER RES, V69, P2416, DOI 10.1158/0008-5472.CAN-08-2177; Qin ZH, 2007, J MED CHEM, V50, P2682, DOI 10.1021/jm070079j; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Russo J, 2002, J STEROID BIOCHEM, V80, P149, DOI 10.1016/S0960-0760(01)00183-2; Russo J, 2003, J STEROID BIOCHEM, V87, P1, DOI 10.1016/S0960-0760(03)00390-X; Saeed M, 2007, CHEM-BIOL INTERACT, V165, P175, DOI 10.1016/j.cbi.2006.12.007; Saeed M, 2007, INT J CANCER, V120, P1821, DOI 10.1002/ijc.22399; Saeed M, 2009, INT J CANCER, V124, P1276, DOI 10.1002/ijc.24113; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shen L, 1998, CHEM RES TOXICOL, V11, P94, DOI 10.1021/tx970181r; Shen L, 1997, CARCINOGENESIS, V18, P1093, DOI 10.1093/carcin/18.5.1093; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Singh R, 2003, RAPID COMMUN MASS SP, V17, P126, DOI 10.1002/rcm.883; SOULE HD, 1990, CANCER RES, V50, P6075; Stack DE, 1996, CHEM RES TOXICOL, V9, P851, DOI 10.1021/tx960002q; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; TAIT L, 1990, CANCER RES, V50, P6087; Wang ZC, 2009, J BIOL CHEM, V284, P8624, DOI 10.1074/jbc.M807860200; Yu BL, 2007, MOL CANCER THER, V6, P2418, DOI 10.1158/1535-7163.MCT-07-0268; Yu BL, 2009, BIOCONJUGATE CHEM, V20, P728, DOI 10.1021/bc800435m; Zahid M, 2006, CHEM RES TOXICOL, V19, P164, DOI 10.1021/tx050229y; Zahid M, 2011, FREE RADICAL BIO MED, V50, P78, DOI 10.1016/j.freeradbiomed.2010.10.662; Zhang F, 2001, CHEM RES TOXICOL, V14, P1654, DOI 10.1021/tx010158c; Zhang FG, 1999, CHEM RES TOXICOL, V12, P204, DOI 10.1021/tx980217v; Zhu BT, 1996, J BIOL CHEM, V271, P1357, DOI 10.1074/jbc.271.3.1357; ZHU BT, 1994, ENDOCRINOLOGY, V135, P1772, DOI 10.1210/en.135.5.1772	65	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27876	10.1371/journal.pone.0027876	http://dx.doi.org/10.1371/journal.pone.0027876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140478	gold, Green Submitted, Green Published			2022-12-25	WOS:000298166300016
J	Abbate, A; Salloum, FN; Van Tassell, BW; Vecile, E; Toldo, S; Seropian, I; Mezzaroma, E; Dobrina, A				Abbate, Antonio; Salloum, Fadi N.; Van Tassell, Benjamin W.; Vecile, Elena; Toldo, Stefano; Seropian, Ignacio; Mezzaroma, Eleonora; Dobrina, Aldo			Alterations in the Interleukin-1/Interleukin-1 Receptor Antagonist Balance Modulate Cardiac Remodeling following Myocardial Infarction in the Mouse	PLOS ONE			English	Article							INTERLEUKIN-1; APOPTOSIS; IL-1; CASPASE-1	Background: Healing after acute myocardial infarction (AMI) is characterized by an intense inflammatory response and increased Interleukin-1 (IL-1) tissue activity. Genetically engineered mice lacking the IL-1 receptor (IL-1R1-/-, not responsive to IL-1) or the IL-1 receptor antagonist (IL-1Ra, enhanced response to IL-1) have an altered IL-1/IL-1Ra balance that we hypothesize modulates infarct healing and cardiac remodeling after AMI. Methods: IL-1R1-/- and IL-1Ra-/- male mice and their correspondent wild-types (WT) were subjected to permanent coronary artery ligation or sham surgery. Infarct size (trichrome scar size), apoptotic cell death (TUNEL) and left ventricular (LV) dimensions and function (echocardiography) were measured prior to and 7 days after surgery. Results: When compared with the corresponding WT, IL-1R1-/- mice had significantly smaller infarcts (-25%), less cardiomyocyte apoptosis (-50%), and reduced LV enlargement (LV end-diastolic diameter increase [LVEDD], -20%) and dysfunction (LV ejection fraction [LVEF] decrease, -50%), whereas IL-1Ra-/- mice had significantly larger infarcts (+75%), more apoptosis (5-fold increase), and more severe LV enlargement (LVEDD increase, +30%) and dysfunction (LVEF decrease, +70%)(all P values <0.05). Conclusions: An imbalance in IL-1/IL-1Ra signaling at the IL-1R1 level modulates the severity of cardiac remodeling after AMI in the mouse, with reduced IL-1R1 signaling providing protection and unopposed IL-1R1 signaling providing harm.	[Abbate, Antonio; Salloum, Fadi N.; Toldo, Stefano; Seropian, Ignacio; Mezzaroma, Eleonora] Virginia Commonwealth Univ, Victoria Johnson Res Lab, Richmond, VA 23284 USA; [Abbate, Antonio; Salloum, Fadi N.; Toldo, Stefano; Seropian, Ignacio; Mezzaroma, Eleonora] Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA USA; [Van Tassell, Benjamin W.; Mezzaroma, Eleonora] Virginia Commonwealth Univ, Sch Pharm, Richmond, VA USA; [Vecile, Elena; Dobrina, Aldo] Univ Trieste, Dept Physiol & Pathol, Trieste, Italy	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Trieste	Abbate, A (corresponding author), Virginia Commonwealth Univ, Victoria Johnson Res Lab, Richmond, VA 23284 USA.	aabbate@mcvh-vcu.edu	Salloum, Fadi N/C-2391-2008; Abbate, Antonio/G-8805-2016; Abbate, Antonio/E-3405-2014	Salloum, Fadi N/0000-0002-8947-9315; Abbate, Antonio/0000-0002-1930-785X; Seropian, Ignacio Miguel/0000-0002-6823-4001; Toldo, Stefano/0000-0002-1588-4019; Dobrina, Aldo/0000-0002-8393-1796	American Heart Association;  [KL2RR031989-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058, KL2TR000057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031989] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by an American Heart Association Beginning Grant-in-Aid (Mid-Atlantic Affiliate) to Dr. Abbate. Dr. Salloum is supported by an American Heart Association Scientist Development Grant. Dr. Van Tassell is supported by an institutional KL2RR031989-01. The funding sources had no role in determining the study design nor did they participate in data analysis or reporting.	Abbate A, 2008, AM J CARDIOL, V102, P658, DOI 10.1016/j.amjcard.2008.05.007; Abbate A, 2008, EUR HEART J, V29, P1795, DOI 10.1093/eurheartj/ehn281; Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Abbate A, 2010, EUR J HEART FAIL, V12, P319, DOI 10.1093/eurjhf/hfq017; Abbate A, 2010, AM J CARDIOL, V105, P1371, DOI 10.1016/j.amjcard.2009.12.059; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974; DINARELLO CA, 1987, J IMMUNOL, V139, P1902; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Frantz S, 2003, J MOL CELL CARDIOL, V35, P685, DOI 10.1016/S0022-2828(03)00113-5; Hausenloy DJ, 2010, BASIC RES CARDIOL, V105, P677, DOI 10.1007/s00395-010-0121-4; Heusch G, 2009, CIRCULATION, V120, P1822, DOI 10.1161/CIRCULATIONAHA.109.888784; Hirsch E, 1996, P NATL ACAD SCI USA, V93, P11008, DOI 10.1073/pnas.93.20.11008; Hoffman HM, 2010, CURR ALLERGY ASTHM R, V10, P229, DOI 10.1007/s11882-010-0109-z; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Hwang MW, 2001, J AM COLL CARDIOL, V38, P1546, DOI 10.1016/S0735-1097(01)01591-1; Ing DJ, 1999, CIRC RES, V84, P21; Labow M, 1997, J IMMUNOL, V159, P2452; Merkle S, 2007, CIRC RES, V100, P645, DOI 10.1161/01.RES.0000260203.55077.61; Nicklin MJH, 2000, J EXP MED, V191, P303, DOI 10.1084/jem.191.2.303; SEKIYAMA KD, 1994, CLIN EXP IMMUNOL, V98, P71; Suzuki K, 2001, CIRCULATION, V104, pI308; Syed FM, 2005, CIRC RES, V96, P1103, DOI 10.1161/01.RES.0000166925.45995.ed; Toldo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018102; van den Borne SWM, 2009, CARDIOVASC RES, V84, P273, DOI 10.1093/cvr/cvp207; Van Tassell BW, 2010, J CARDIOVASC PHARM, V55, P117, DOI 10.1097/FJC.0b013e3181c87e53	27	49	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27923	10.1371/journal.pone.0027923	http://dx.doi.org/10.1371/journal.pone.0027923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140485	gold, Green Submitted, Green Published			2022-12-25	WOS:000298163400023
J	Hartney, T; Birari, R; Venkataraman, S; Villegas, L; Martinez, M; Black, SM; Stenmark, KR; Nozik-Grayck, E				Hartney, Tanya; Birari, Rahul; Venkataraman, Sujatha; Villegas, Leah; Martinez, Maylyn; Black, Stephen M.; Stenmark, Kurt R.; Nozik-Grayck, Eva			Xanthine Oxidase-Derived ROS Upregulate Egr-1 via ERK1/2 in PA Smooth Muscle Cells; Model to Test Impact of Extracellular ROS in Chronic Hypoxia	PLOS ONE			English	Article							EARLY GROWTH RESPONSE-1; SUPEROXIDE DISMUTASE EXPRESSION; PULMONARY EC-SOD; HYPERTENSION; ARTERY; EXPOSURE; LUNG; PROLIFERATION; CONTRIBUTES; ACTIVATION	Exposure of newborn calves to chronic hypoxia causes pulmonary artery (PA) hypertension and remodeling. Previous studies showed that the redox-sensitive transcription factor, early growth response-1 (Egr-1), is upregulated in the PA of chronically hypoxic calves and regulates cell proliferation. Furthermore, we established in mice a correlation between hypoxic induction of Egr-1 and reduced activity of extracellular superoxide dismutase (EC-SOD), an antioxidant that scavenges extracellular superoxide. We now hypothesize that loss of EC-SOD in chronically hypoxic calves leads to extracellular superoxide-mediated upregulation of Egr-1. To validate our hypothesis and identify the signaling pathways involved, we utilized PA tissue from normoxic and chronically hypoxic calves and cultured calf and human PA smooth muscle cells (PASMC). Total SOD activity was low in the PA tissue, and only the extracellular SOD component decreased with hypoxia. PA tissue of hypoxic calves showed increased oxidative stress and increased Egr-1 mRNA. To mimic the in vivo hypoxia-induced extracellular oxidant imbalance, cultured calf PASMC were treated with xanthine oxidase (XO), which generates extracellular superoxide and hydrogen peroxide. We found that 1) XO increased Egr-1 mRNA and protein, 2) XO induced the phosphorylation of ERK1/2 and, 3) pretreatment with an ERK1/2 inhibitor prevented induction of Egr-1 by XO. siRNA knock-down of EC-SOD in human PASMC also upregulated Egr-1 mRNA and protein, activated ERK1/2, and enhanced SMC proliferation and reduced apoptosis. We conclude that an oxidant/antioxidant imbalance arising from loss of EC-SOD in the PA with chronic hypoxia induces Egr-1 via activation of ERK1/2 and contributes to pulmonary vascular remodeling.	[Hartney, Tanya; Birari, Rahul; Venkataraman, Sujatha; Villegas, Leah; Martinez, Maylyn; Stenmark, Kurt R.; Nozik-Grayck, Eva] Univ Colorado Denver, Dept Pediat, Aurora, CO USA; [Villegas, Leah; Stenmark, Kurt R.; Nozik-Grayck, Eva] Univ Colorado Denver, Cardiovasc Pulm Res Lab, Aurora, CO USA; [Black, Stephen M.] Georgia Hlth Sci Univ, Augusta, GA USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University System of Georgia; Augusta University	Hartney, T (corresponding author), Univ Colorado Denver, Dept Pediat, Aurora, CO USA.	Eva.Grayck@ucdenver.edu	stenmark, kurt/AFI-6776-2022; stenmark, kurt/AAH-3124-2022; Nozik, Eva/AAP-5395-2020		National Institutes of Health [5RO1-HL086680-04, 5PO1-HL014985-37]; March of Dimes [6-FY06-316]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL014985, R01HL086680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants 5RO1-HL086680-04 (EN-G) and 5PO1-HL014985-37 (KS) and March of Dimes research grant #6-FY06-316 (EN-G). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aggeli IKS, 2010, PHYSIOL RES, V59, P443, DOI 10.33549/physiolres.931806; ANDERSON ME, 1985, HDB METHODS OXYGEN R; Banks MF, 2005, J APPL PHYSIOL, V98, P732, DOI 10.1152/japplphysiol.00821.2004; BEERS RF, 1952, J BIOL CHEM, V195, P133; Buettner GR, 2006, FREE RADICAL BIO MED, V41, P1338, DOI 10.1016/j.freeradbiomed.2006.07.015; Das M, 2008, CARDIOVASC RES, V78, P440, DOI 10.1093/cvr/cvn014; Durmowicz AG, 1996, AM J RESP CELL MOL, V14, P569, DOI 10.1165/ajrcmb.14.6.8652185; Fattman CL, 2001, FREE RADICAL BIO MED, V31, P1198, DOI 10.1016/S0891-5849(01)00699-2; Frid MG, 2009, AM J PHYSIOL-LUNG C, V297, pL1059, DOI 10.1152/ajplung.90611.2008; Frid MG, 1997, CIRC RES, V81, P940; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; Gerasimovskaya EV, 2002, J BIOL CHEM, V277, P44638, DOI 10.1074/jbc.M203012200; Giles BL, 2002, AM J PHYSIOL-LUNG C, V283, pL549, DOI 10.1152/ajplung.00018.2002; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Hasan RN, 2008, CIRC RES, V102, P42, DOI 10.1161/CIRCRESAHA.107.155143; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Hoshikawa Y, 2001, J APPL PHYSIOL, V90, P1299, DOI 10.1152/jappl.2001.90.4.1299; HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3; Jankov RP, 2008, AM J PHYSIOL-LUNG C, V294, pL233, DOI 10.1152/ajplung.00166.2007; Jin NJ, 2000, AM J RESP CELL MOL, V23, P593, DOI 10.1165/ajrcmb.23.5.3921; Kamezaki F, 2008, AM J RESP CRIT CARE, V177, P219, DOI 10.1164/rccm.200702-264OC; Kelley EE, 2006, FREE RADICAL BIO MED, V40, P952, DOI 10.1016/j.freeradbiomed.2005.11.008; Kelley EE, 2010, FREE RADICAL BIO MED, V48, P493, DOI 10.1016/j.freeradbiomed.2009.11.012; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Li CJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1297, DOI 10.1152/ajplung.00194.2006; Li M, 2009, ANN BIOMED ENG, V37, P1082, DOI 10.1007/s10439-009-9684-3; Liu JQ, 2006, AM J PHYSIOL-LUNG C, V290, pL2, DOI 10.1152/ajplung.00135.2005; Mamo LB, 2004, AM J RESP CRIT CARE, V170, P313, DOI 10.1164/rccm.200309-1282OC; Nozik-Grayck E, 2000, AM J PHYSIOL-LUNG C, V279, pL977, DOI 10.1152/ajplung.2000.279.5.L977; Nozik-Grayck E, 2003, AM J PHYSIOL-HEART C, V285, pH2327, DOI 10.1152/ajpheart.00507.2003; Nozik-Grayck E, 2008, AM J PHYSIOL-LUNG C, V295, pL422, DOI 10.1152/ajplung.90293.2008; Oury TD, 2002, AM J PHYSIOL-LUNG C, V283, pL777, DOI 10.1152/ajplung.00011.2002; Oury TD, 1996, FREE RADICAL BIO MED, V20, P957, DOI 10.1016/0891-5849(95)02222-8; Sharma S, 2007, AM J PHYSL LUNG CELL; Stanic B, 2010, ARTERIOSCL THROM VAS, V30, P2234, DOI 10.1161/ATVBAHA.110.207639; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Tan RJ, 2004, J APPL PHYSIOL, V97, P2006, DOI 10.1152/japplphysiol.00480.2004; Van Rheen Z, 2011, AM J RESP CELL MOL, V44, P500, DOI 10.1165/rcmb.2010-0065OC; Wu XQ, 2010, ARTERIOSCL THROM VAS, V30, P471, DOI 10.1161/ATVBAHA.109.184259; Yan SF, 1999, ARTERIOSCL THROM VAS, V19, P2029, DOI 10.1161/01.ATV.19.9.2029; Yan SF, 2000, J APPL PHYSIOL, V88, P2303, DOI 10.1152/jappl.2000.88.6.2303; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030; Yu HW, 2010, BIOCHEM BIOPH RES CO, V396, P451, DOI 10.1016/j.bbrc.2010.04.115	44	54	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27531	10.1371/journal.pone.0027531	http://dx.doi.org/10.1371/journal.pone.0027531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140445	Green Submitted, Green Published, gold			2022-12-25	WOS:000298163400008
J	Jiao, QJ; Zhang, YK; Li, LN; Shen, HB				Jiao, Qing-Ju; Zhang, Yan-Kai; Li, Lu-Ning; Shen, Hong-Bin			BinTree Seeking: A Novel Approach to Mine Both Bi-Sparse and Cohesive Modules in Protein Interaction Networks	PLOS ONE			English	Article							COMMUNITY STRUCTURE; GENE ONTOLOGY; MODELS; MODULARITY; CYTOSCAPE	Modern science of networks has brought significant advances to our understanding of complex systems biology. As a representative model of systems biology, Protein Interaction Networks (PINs) are characterized by a remarkable modular structures, reflecting functional associations between their components. Many methods were proposed to capture cohesive modules so that there is a higher density of edges within modules than those across them. Recent studies reveal that cohesively interacting modules of proteins is not a universal organizing principle in PINs, which has opened up new avenues for revisiting functional modules in PINs. In this paper, functional clusters in PINs are found to be able to form unorthodox structures defined as bi-sparse module. In contrast to the traditional cohesive module, the nodes in the bi-sparse module are sparsely connected internally and densely connected with other bi-sparse or cohesive modules. We present a novel protocol called the BinTree Seeking (BTS) for mining both bi-sparse and cohesive modules in PINs based on Edge Density of Module (EDM) and matrix theory. BTS detects modules by depicting links and nodes rather than nodes alone and its derivation procedure is totally performed on adjacency matrix of networks. The number of modules in a PIN can be automatically determined in the proposed BTS approach. BTS is tested on three real PINs and the results demonstrate that functional modules in PINs are not dominantly cohesive but can be sparse. BTS software and the supporting information are available at: www.csbio.sjtu.edu.cn/bioinf/BTS/.	[Jiao, Qing-Ju; Shen, Hong-Bin] Shanghai Jiao Tong Univ, Dept Automat, Shanghai 200030, Peoples R China; [Jiao, Qing-Ju; Shen, Hong-Bin] Minist Educ China, Key Lab Syst Control & Informat Proc, Shanghai, Peoples R China; [Zhang, Yan-Kai; Li, Lu-Ning] Shanghai Jiao Tong Univ, Dept Phys, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Ministry of Education, China; Shanghai Jiao Tong University	Jiao, QJ (corresponding author), Shanghai Jiao Tong Univ, Dept Automat, Shanghai 200030, Peoples R China.	hbshen@sjtu.edu.cn			National Natural Science Foundation of China [61175024]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201048]; Shanghai Pujiang Program; Shanghai Municipal Education Commission [10ZZ17]; special foundation for innovation program of Shanghai Jiao Tong University [Z-030-010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); special foundation for innovation program of Shanghai Jiao Tong University	This work was supported by National Natural Science Foundation of China (Grant No. 61175024), A Foundation for the Author of National Excellent Doctoral Dissertation of PR China (Grant No. 201048), Shanghai Pujiang Program, Innovation Program of Shanghai Municipal Education Commission (10ZZ17), a special foundation for innovation program of Shanghai Jiao Tong University (Z-030-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Bu DB, 2003, NUCLEIC ACIDS RES, V31, P2443, DOI 10.1093/nar/gkg340; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Han DS, 2004, NUCLEIC ACIDS RES, V32, P6312, DOI 10.1093/nar/gkh972; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hwang W, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-24; Jung SH, 2010, BIOINFORMATICS, V26, P385, DOI 10.1093/bioinformatics/btp668; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lorrain F., 1971, J MATH SOCIOL, V1, P49, DOI [10.1080/0022250x.1971.9989788, DOI 10.1080/0022250X.1971.9989788, 10.1080/0022250X.1971.9989788]; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Newman MEJ, 2007, P NATL ACAD SCI USA, V104, P9564, DOI 10.1073/pnas.0610537104; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pinkert S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000659; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reichardt J, 2007, EUR PHYS J B, V60, P217, DOI 10.1140/epjb/e2007-00340-y; Reichardt J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.015102; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Wang Z, 2007, PLOS COMPUT BIOL, V3, P1011, DOI 10.1371/journal.pcbi.0030107; Ye ZQ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046115	38	79	80	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27646	10.1371/journal.pone.0027646	http://dx.doi.org/10.1371/journal.pone.0027646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140454	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163400010
J	Punnen, S; Hardin, J; Cheng, I; Klein, EA; Witte, JS				Punnen, Sanoj; Hardin, Jill; Cheng, Iona; Klein, Eric A.; Witte, John S.			Impact of Meat Consumption, Preparation, and Mutagens on Aggressive Prostate Cancer	PLOS ONE			English	Article							DIETARY PATTERNS; RISK; FAT; MUTAGENS/CARCINOGENS; CARCINOGENICITY; PREVENTION; EXPRESSION; WHITES; HEALTH; PHIP	Background: The association between meat consumption and prostate cancer remains unclear, perhaps reflecting heterogeneity in the types of tumors studied and the method of meat preparation-which can impact the production of carcinogens. Methods: We address both issues in this case-control study focused on aggressive prostate cancer (470 cases and 512 controls), where men reported not only their meat intake but also their meat preparation and doneness level on a semi-quantitative food-frequency questionnaire. Associations between overall and grilled meat consumption, doneness level, ensuing carcinogens and aggressive prostate cancer were assessed using multivariate logistic regression. Results: Higher consumption of any ground beef or processed meats were positively associated with aggressive prostate cancer, with ground beef showing the strongest association (OR = 2.30, 95% CI: 1.39-3.81; P-trend = 0.002). This association primarily reflected intake of grilled or barbequed meat, with more well-done meat conferring a higher risk of aggressive prostate cancer. Comparing high and low consumptions of well/very well cooked ground beef to no consumption gave OR's of 2.04 (95% CI: 1.41-2.96) and 1.51 (95% CI: 1.06-2.14), respectively. In contrast, consumption of rare/medium cooked ground beef was not associated with aggressive prostate cancer. Looking at meat mutagens produced by cooking at high temperatures, we detected an increased risk with 2-amino-3,8-Dimethylimidazo-[4,5-f]Quinolaxine (MelQx) and 2-amino-3,4,8-trimethylimidazo(4,5-f) qunioxaline (DiMelQx), when comparing the highest to lowest quartiles of intake: OR = 1.69 (95% CI: 1.08-2.64; P-trend = 0.02) and OR = 1.53 (95% CI: 1.00-2.35; P-trend = 0.005), respectively. Discussion: Higher intake of well-done grilled or barbequed red meat and ensuing carcinogens could increase the risk of aggressive prostate cancer.	[Punnen, Sanoj; Witte, John S.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Hardin, Jill; Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Hardin, Jill; Witte, John S.] Univ Calif San Francisco, Inst Human Genet, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Cheng, Iona] Univ Hawaii, Program Epidemiol, Ctr Canc, Honolulu, HI 96822 USA; [Klein, Eric A.] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA; [Klein, Eric A.] Taussig Canc Inst, Cleveland, OH USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Cancer Research Center of Hawaii; University of Hawaii System; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Punnen, S (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA.	wittej@humgen.ucsf.edu			NIH [CA88164, CA127298]; NATIONAL CANCER INSTITUTE [R01CA088164, U01CA127298] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to acknowledge support from the NIH grants CA88164 and CA127298. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 1998, BRIT J CANCER, V78, P1361, DOI 10.1038/bjc.1998.685; Alexander DD, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-50; American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Amin M, 2008, CUAJ-CAN UROL ASSOC, V2, P510; Archer CL, 2000, CANCER LETT, V155, P55, DOI 10.1016/S0304-3835(00)00413-4; Chan JM, 2006, CANCER CAUSE CONTROL, V17, P199, DOI 10.1007/s10552-005-0413-4; Colli JL, 2006, UROL ONCOL-SEMIN ORI, V24, P184, DOI 10.1016/j.urolonc.2005.05.023; Cross AJ, 2004, ENVIRON MOL MUTAGEN, V44, P44, DOI 10.1002/em.20030; Cross AJ, 2005, CANCER RES, V65, P11779, DOI 10.1158/0008-5472.CAN-05-2191; Crowe FL, 2008, AM J CLIN NUTR, V87, P1405, DOI 10.1093/ajcn/87.5.1405; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P1571, DOI 10.1093/jnci/85.19.1571; Hayes RB, 1999, CANCER EPIDEM BIOMAR, V8, P25; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kazerouni N, 2001, FOOD CHEM TOXICOL, V39, P423, DOI 10.1016/S0278-6915(00)00158-7; Koutros S, 2008, CANCER EPIDEM BIOMAR, V17, P80, DOI 10.1158/1055-9965.EPI-07-0392; Koutros S, 2009, CANCER RES, V69, P1877, DOI 10.1158/0008-5472.CAN-08-2447; Ma RWL, 2009, J HUM NUTR DIET, V22, P187, DOI 10.1111/j.1365-277X.2009.00946.x; Michaud DS, 2001, CANCER CAUSE CONTROL, V12, P557, DOI 10.1023/A:1011256201044; Mori M, 2009, MOL NUTR FOOD RES, V53, P191, DOI 10.1002/mnfr.200800285; Park SY, 2007, INT J CANCER, V121, P1339, DOI 10.1002/ijc.22805; Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6; Richman EL, 2010, AM J CLIN NUTR, V91, P712, DOI 10.3945/ajcn.2009.28474; Rodriguez C, 2006, CANCER EPIDEM BIOMAR, V15, P211, DOI 10.1158/1055-9965.EPI-05-0614; Rohrmann S, 2007, CANCER CAUSE CONTROL, V18, P41, DOI 10.1007/s10552-006-0082-y; Sander A, 2011, CANCER CAUSE CONTROL, V22, P109, DOI 10.1007/s10552-010-9680-9; Satia-Abouta J, 2003, AM J EPIDEMIOL, V158, P951, DOI 10.1093/aje/kwg248; Sharma S, 2010, CANCER EPIDEM BIOMAR, V19, P1866, DOI 10.1158/1055-9965.EPI-10-0231; Shirai T, 1999, CANCER LETT, V143, P217, DOI 10.1016/S0304-3835(99)00128-7; Sinha R, 2002, MUTAT RES-FUND MOL M, V506, P197, DOI 10.1016/S0027-5107(02)00166-5; Sinha R, 2009, AM J EPIDEMIOL, V170, P1165, DOI 10.1093/aje/kwp280; Sugimura T, 2004, CANCER SCI, V95, P290, DOI 10.1111/j.1349-7006.2004.tb03205.x; Tang DL, 2007, CANCER EPIDEM BIOMAR, V16, P803, DOI 10.1158/1055-9965.EPI-06-0973; Tseng M, 2004, CANCER EPIDEM BIOMAR, V13, P71, DOI 10.1158/1055-9965.EPI-03-0076; Venkateswaran V, 2010, NAT REV UROL, V7, P442, DOI 10.1038/nrurol.2010.102; Walker M, 2005, INT J CANCER, V116, P592, DOI 10.1002/ijc.21112; Williams JA, 2000, CARCINOGENESIS, V21, P1683, DOI 10.1093/carcin/21.9.1683; Wu K, 2006, CANCER EPIDEM BIOMAR, V15, P167, DOI 10.1158/1055-9965.EPI-05-0100; Zheng W, 2009, NUTR CANCER, V61, P437, DOI 10.1080/01635580802710741	38	28	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27711	10.1371/journal.pone.0027711	http://dx.doi.org/10.1371/journal.pone.0027711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132129	Green Submitted, gold, Green Published			2022-12-25	WOS:000298162000037
J	Fanibunda, SE; Modi, DN; Gokral, JS; Bandivdekar, AH				Fanibunda, Sashaina E.; Modi, Deepak N.; Gokral, Jyotsna S.; Bandivdekar, Atmaram H.			HIV gp120 Binds to Mannose Receptor on Vaginal Epithelial Cells and Induces Production of Matrix Metalloproteinases	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; PARTICLES BEARING; MOLECULAR-BASIS; INFECTION; TRANSMISSION; PROTEINS; MODEL; ENTRY; NONOXYNOL-9	Background: During sexual transmission of HIV in women, the virus breaches the multi-layered CD4 negative stratified squamous epithelial barrier of the vagina, to infect the sub-epithelial CD4 positive immune cells. However the mechanisms by which HIV gains entry into the sub-epithelial zone is hitherto unknown. We have previously reported human mannose receptor (hMR) as a CD4 independent receptor playing a role in HIV transmission on human spermatozoa. The current study was undertaken to investigate the expression of hMR in vaginal epithelial cells, its HIV gp120 binding potential, affinity constants and the induction of matrix metalloproteinases (MMPs) downstream of HIV gp120 binding to hMR. Principal Findings: Human vaginal epithelial cells and the immortalized vaginal epithelial cell line Vk2/E6E7 were used in this study. hMR mRNA and protein were expressed in vaginal epithelial cells and cell line, with a molecular weight of 155 kDa. HIV gp120 bound to vaginal proteins with high affinity, (Kd = 1.2 +/- 0.2 nM for vaginal cells, 1.4 +/- 0.2 nM for cell line) and the hMR antagonist mannan dose dependently inhibited this binding. Both HIV gp120 binding and hMR exhibited identical patterns of localization in the epithelial cells by immunofluorescence. HIV gp120 bound to immunopurified hMR and affinity constants were 2.9 +/- 0.4 nM and 3.2 +/- 0.6 nM for vaginal cells and Vk2/E6E7 cell line respectively. HIV gp120 induced an increase in MMP-9 mRNA expression and activity by zymography, which could be inhibited by an anti-hMR antibody. Conclusion: hMR expressed by vaginal epithelial cells has high affinity for HIV gp120 and this binding induces production of MMPs. We propose that the induction of MMPs in response to HIV gp120 may lead to degradation of tight junction proteins and the extracellular matrix proteins in the vaginal epithelium and basement membrane, leading to weakening of the epithelial barrier; thereby facilitating transport of HIV across the vaginal epithelium.	[Fanibunda, Sashaina E.; Bandivdekar, Atmaram H.] Indian Council Med Res, Dept Biochem, Natl Inst Res Reprod Hlth, Bombay, Maharashtra, India; [Modi, Deepak N.] Indian Council Med Res, Mol & Cellular Biol Lab, Natl Inst Res Reprod Hlth, Bombay, Maharashtra, India; [Gokral, Jyotsna S.] Indian Council Med Res, Div Clin Res, Natl Inst Res Reprod Hlth, Bombay, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH)	Fanibunda, SE (corresponding author), Indian Council Med Res, Dept Biochem, Natl Inst Res Reprod Hlth, Bombay, Maharashtra, India.	batmaram@hotmail.com		Modi, Deepak/0000-0002-4230-4219	Indian Council of Medical Research, Government of India [NIRRH/M/33/11]; Indian Council of Medical Research, Government of India	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	This work (NIRRH/M/33/11) was funded by grants from the Indian Council of Medical Research, Government of India. We are grateful to the Indian Council of Medical Research, Government of India for the Senior Research Fellowship to SEF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2010, J INFECT DIS, V202, P333, DOI 10.1086/653620; Blaskewicz CD, 2011, BIOL REPROD, V85, P97, DOI 10.1095/biolreprod.110.090423; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Collins KB, 2000, NAT MED, V6, P475, DOI 10.1038/74743; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; Cummins NW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024876; Fanibunda SE, 2008, JAIDS-J ACQ IMM DEF, V48, P389, DOI 10.1097/QAI.0b013e318179a0fb; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Giebel SJ, 2005, LAB INVEST, V85, P597, DOI 10.1038/labinvest.3700251; Godbole G, 2011, FERTIL STERIL, V95, P1278, DOI 10.1016/j.fertnstert.2010.09.045; Greenhead P, 2000, J VIROL, V74, P5577, DOI 10.1128/JVI.74.12.5577-5586.2000; Hicar MD, 2010, JAIDS-J ACQ IMM DEF, V54, P223, DOI 10.1097/QAI.0b013e3181dc98a3; Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Hladik F, 2010, ANTIVIR RES, V88, pS3, DOI 10.1016/j.antiviral.2010.09.011; Hope T.J., 2008, MICR 2008 C NEW DELH; Horbul JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022638; Kaushic C, 2011, AM J REPROD IMMUNOL, V65, P253, DOI 10.1111/j.1600-0897.2010.00965.x; KELL PD, 1992, J ROY SOC MED, V85, P706; KELLY DE, 1984, BAILEYS TXB MICROSCO, P113; Kottilil S, 2006, J IMMUNOL, V176, P1107, DOI 10.4049/jimmunol.176.2.1107; Kuznetsov YG, 2003, J VIROL, V77, P11896, DOI 10.1128/JVI.77.22.11896-11909.2003; Lai J, 2009, J BIOL CHEM, V284, P11027, DOI 10.1074/jbc.M809698200; LENNARTZ MR, 1987, J BIOL CHEM, V262, P9942; Lin G, 2007, CURR HIV RES, V5, P514, DOI 10.2174/157016207782418489; Liu Y, 2004, J VIROL, V78, P4120, DOI 10.1128/JVI.78.8.4120-4133.2004; Lopez-Herrera A, 2005, BBA-MOL BASIS DIS, V1741, P55, DOI 10.1016/j.bbadis.2004.12.001; Mastroianni CM, 2007, TRENDS MOL MED, V13, P449, DOI 10.1016/j.molmed.2007.09.001; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; MILLER CJ, 1992, J MED PRIMATOL, V21, P64; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Misse D, 2001, BLOOD, V98, P541, DOI 10.1182/blood.V98.3.541; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; OBRIEN WA, 1994, J VIROL, V68, P5264, DOI 10.1128/JVI.68.8.5264-5269.1994; Parren PWHI, 1997, NAT MED, V3, P366, DOI 10.1038/nm0497-366d; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PYLE SW, 1987, AIDS RES HUM RETROV, V3, P387, DOI 10.1089/aid.1987.3.387; Qiu LB, 2011, TOXICOLOGY, V285, P31, DOI 10.1016/j.tox.2011.03.019; Reijerkerk A, 2006, FASEB J, V20, P2550, DOI 10.1096/fj.06-6099fje; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; Salle B, 2010, J INFECT DIS, V202, P337, DOI 10.1086/653619; SCHNEIDER J, 1986, J GEN VIROL, V67, P2533, DOI 10.1099/0022-1317-67-11-2533; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Steele C, 2002, INFECT IMMUN, V70, P577, DOI 10.1128/IAI.70.2.577-583.2002; Stoddard E, 2007, J IMMUNOL, V179, P3126, DOI 10.4049/jimmunol.179.5.3126; Trifonova RT, 2009, ANTIMICROB AGENTS CH, V53, P1490, DOI 10.1128/AAC.01152-08; Trujillo JR, 2007, P NATL ACAD SCI USA, V104, P5097, DOI 10.1073/pnas.0611263104; UNAIDS, UNAIDS REP GLOB AIDS; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; WILEMAN TE, 1986, P NATL ACAD SCI USA, V83, P2501, DOI 10.1073/pnas.83.8.2501; Wu WB, 2003, EXP CELL RES, V288, P143, DOI 10.1016/S0014-4827(03)00183-6; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2005, J VIROL, V79, P12132, DOI 10.1128/JVI.79.19.12132-12147.2005; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zalenskaya IA, 2011, AM J REPROD IMMUNOL, V65, P569, DOI 10.1111/j.1600-0897.2010.00964.x	62	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28014	10.1371/journal.pone.0028014	http://dx.doi.org/10.1371/journal.pone.0028014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132194	Green Submitted, Green Published, gold			2022-12-25	WOS:000297792400032
J	Maguire, JJ; Kirby, HR; Mead, EJ; Kuc, RE; de Tassigny, XD; Colledge, WH; Davenport, AP				Maguire, Janet J.; Kirby, Helen R.; Mead, Emma J.; Kuc, Rhoda E.; de Tassigny, Xavier d'Anglemont; Colledge, William H.; Davenport, Anthony P.			Inotropic Action of the Puberty Hormone Kisspeptin in Rat, Mouse and Human: Cardiovascular Distribution and Characteristics of the Kisspeptin Receptor	PLOS ONE			English	Article							METASTASIS SUPPRESSOR GENE; PROTEIN-COUPLED RECEPTOR; ORPHAN-RECEPTOR; UROTENSIN-II; KISS-1; GPR54; LOCALIZATION; PEPTIDE; CELLS; ACTIVATION	Kisspeptins, the ligands of the kisspeptin receptor known for its roles in reproduction and cancer, are also vasoconstrictor peptides in atherosclerosis-prone human aorta and coronary artery. The aim of this study was to further investigate the cardiovascular localisation and function of the kisspeptins and their receptor in human compared to rat and mouse heart. Immunohistochemistry and radioligand binding techniques were employed to investigate kisspeptin receptor localisation, density and pharmacological characteristics in cardiac tissues from all three species. Radioimmunoassay was used to detect kisspeptin peptide levels in human normal heart and to identify any pathological changes in myocardium from patients transplanted for cardiomyopathy or ischaemic heart disease. The cardiac function of kisspeptin receptor was studied in isolated human, rat and mouse paced atria, with a role for the receptor confirmed using mice with targeted disruption of Kiss1r. The data demonstrated that kisspeptin receptor-like immunoreactivity localised to endothelial and smooth muscle cells of intramyocardial blood vessels and to myocytes in human and rodent tissue. [I-125]KP-14 bound saturably, with subnanomolar affinity to human and rodent myocardium (K-D = 0.12 nM, human; K-D = 0.44 nM, rat). Positive inotropic effects of kisspeptin were observed in rat, human and mouse. No response was observed in mice with targeted disruption of Kiss1r. In human heart a decrease in cardiac kisspeptin level was detected in ischaemic heart disease. Kisspeptin and its receptor are expressed in the human, rat and mouse heart and kisspeptins possess potent positive inotropic activity. The cardiovascular actions of the kisspeptins may contribute to the role of these peptides in pregnancy but the consequences of receptor activation must be considered if kisspeptin receptor agonists are developed for use in the treatment of reproductive disorders or cancer.	[Maguire, Janet J.; Kirby, Helen R.; Mead, Emma J.; Kuc, Rhoda E.; Davenport, Anthony P.] Univ Cambridge, Clin Pharmacol Unit, Cambridge, England; [de Tassigny, Xavier d'Anglemont; Colledge, William H.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge; University of Cambridge	Maguire, JJ (corresponding author), Univ Cambridge, Clin Pharmacol Unit, Cambridge, England.	jjm1003@medschl.cam.ac.uk	Colledge, William/X-4976-2019; Maguire, Janet J/Z-2180-2019; Davenport, Anthony Peter/A-5773-2008	Colledge, William/0000-0002-9603-4429; Maguire, Janet J/0000-0002-9254-7040; Hargreaves, Emma/0000-0001-7887-2018; Davenport, Anthony Peter/0000-0002-2096-3117	Medical Research Council; British Heart Foundation;  [PS/02/001];  [PG/09/050/27734]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); ; 	This work was supported by grants from the Medical Research Council (http://www.mrc.ac.uk) and the British Heart Foundation (http://www.bhf.org.uk). (Grant numbers PS/02/001 and PG/09/050/27734.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD M, 1995, J PHARMACOL EXP THER, V274, P577; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Castellano JM, 2010, BRAIN RES, V1364, P129, DOI 10.1016/j.brainres.2010.08.057; Clarkson J, 2008, J NEUROSCI, V28, P8691, DOI 10.1523/JNEUROSCI.1775-08.2008; Clements MK, 2001, BIOCHEM BIOPH RES CO, V284, P1189, DOI 10.1006/bbrc.2001.5098; Crown A, 2007, NEUROENDOCRINOLOGY, V86, P175, DOI 10.1159/000109095; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; DAVENPORT AP, 1989, J CARDIOVASC PHARM, V13, pS166, DOI 10.1097/00005344-198900135-00045; DAVENPORT AP, 2005, RECEPTOR BINDING TEC, P155; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; de Tassigny XD, 2010, PHYSIOLOGY, V25, P207, DOI 10.1152/physiol.00009.2010; Dhillo WS, 2005, J CLIN ENDOCR METAB, V90, P6609, DOI 10.1210/jc.2005-1468; Ewert TJ, 2008, NEUROSCI LETT, V436, P163, DOI 10.1016/j.neulet.2008.03.012; Farina A, 2006, PRENATAL DIAG, V26, P1115, DOI 10.1002/pd.1562; Franceschini I, 2006, NEUROSCI LETT, V401, P225, DOI 10.1016/j.neulet.2006.03.039; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Hameed S, 2011, J ENDOCRINOL, V208, P97, DOI 10.1677/JOE-10-0265; Horikoshi Y, 2003, J CLIN ENDOCR METAB, V88, P914, DOI 10.1210/jc.2002-021235; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Katugampola SD, 2001, BRIT J PHARMACOL, V132, P1255, DOI 10.1038/sj.bjp.0703939; KATZ R, 1978, CIRCULATION, V58, P434, DOI 10.1161/01.CIR.58.3.434; Kinoshita M, 2005, ENDOCRINOLOGY, V146, P4431, DOI 10.1210/en.2005-0195; Kirby HR, 2010, PHARMACOL REV, V62, P565, DOI 10.1124/pr.110.002774; Kleinz MJ, 2006, CARDIOVASC RES, V69, P227, DOI 10.1016/j.cardiores.2005.09.001; Konyi A, 2010, REGUL PEPTIDES, V159, P9, DOI 10.1016/j.regpep.2009.07.009; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Kutzleb C, 2005, CURR PROTEIN PEPT SC, V6, P265, DOI 10.2174/1389203054065419; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Lee YR, 2009, ENDOCRINOLOGY, V150, P2837, DOI 10.1210/en.2008-1679; Maguire JJ, 2009, HYPERTENSION, V54, P598, DOI 10.1161/HYPERTENSIONAHA.109.134619; Maguire JJ, 2000, BRIT J PHARMACOL, V131, P441, DOI 10.1038/sj.bjp.0703601; Mead EJ, 2007, ENDOCRINOLOGY, V148, P140, DOI 10.1210/en.2006-0818; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; MOLENAAR P, 1993, CIRC RES, V72, P526, DOI 10.1161/01.RES.72.3.526; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Navenot JM, 2009, MOL PHARMACOL, V75, P1300, DOI 10.1124/mol.109.055095; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Potter EK, 2005, NEUROPEPTIDES, V39, P345, DOI 10.1016/j.npep.2004.12.006; Qiao Chong, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P585; Ramaesh T, 2010, ENDOCRINOLOGY, V151, P5927, DOI 10.1210/en.2010-0565; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Russell FD, 2001, BRIT J PHARMACOL, V132, P5, DOI 10.1038/sj.bjp.0703811; Samson WK, 2000, BRAIN RES, V858, P19, DOI 10.1016/S0006-8993(99)02451-8; Sawyer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014671; Seminara SB, 2008, J NEUROENDOCRINOL, V20, P727, DOI 10.1111/j.1365-2826.2008.01731.x; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Takino T, 2003, ONCOGENE, V22, P4617, DOI 10.1038/sj.onc.1206542; Thompson EL, 2004, J NEUROENDOCRINOL, V16, P850, DOI 10.1111/j.1365-2826.2004.01240.x; Wu M, 2009, P NATL ACAD SCI USA, V106, P17217, DOI 10.1073/pnas.0908200106; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Yoshioka K, 2008, LIFE SCI, V83, P332, DOI 10.1016/j.lfs.2008.06.018	55	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27601	10.1371/journal.pone.0027601	http://dx.doi.org/10.1371/journal.pone.0027601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132116	Green Published, Green Submitted, gold			2022-12-25	WOS:000297792400010
J	Ratner, ES; Keane, FK; Lindner, R; Tassi, RA; Paranjape, T; Glasgow, M; Nallur, S; Deng, Y; Lu, L; Steele, L; Sand, S; Muller, RU; Bignotti, E; Bellone, S; Boeke, M; Yao, X; Pecorelli, S; Ravaggi, A; Katsaros, D; Zelterman, D; Cristea, MC; Yu, H; Rutherford, TJ; Weitzel, JN; Neuhausen, SL; Schwartz, PE; Slack, FJ; Santin, AD; Weidhaas, JB				Ratner, E. S.; Keane, F. K.; Lindner, R.; Tassi, R. A.; Paranjape, T.; Glasgow, M.; Nallur, S.; Deng, Y.; Lu, L.; Steele, L.; Sand, S.; Muller, R-U; Bignotti, E.; Bellone, S.; Boeke, M.; Yao, X.; Pecorelli, S.; Ravaggi, A.; Katsaros, D.; Zelterman, D.; Cristea, M. C.; Yu, H.; Rutherford, T. J.; Weitzel, J. N.; Neuhausen, S. L.; Schwartz, P. E.; Slack, F. J.; Santin, A. D.; Weidhaas, J. B.			A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer	ONCOGENE			English	Article						platinum resistance; KRAS variant; ovarian cancer; outcome	LET-7 MICRORNA-BINDING; 3'-UNTRANSLATED REGION; EXPRESSION; CARBOPLATIN; PACLITAXEL; SURVIVAL; MODELS; MARKER; SITE	Germline variants in the 30 untranslated region (3'UTR) of cancer genes disrupting microRNA (miRNA) regulation have recently been associated with cancer risk. A variant in the 3'UTR of the KRAS oncogene, referred to as the KRAS variant, is associated with both cancer risk and altered tumor biology. Here, we test the hypothesis that the KRAS variant can act as a biomarker of outcome in epithelial ovarian cancer (EOC), and investigate the cause of altered outcome in KRAS variant-positive EOC patients. As this variant seems to be associated with tumor biology, we additionally test the hypothesis that this variant can be directly targeted to impact cell survival. EOC patients with complete clinical data were genotyped for the KRAS variant and analyzed for outcome (n = 536), response to neoadjuvant chemotherapy (n = 25) and platinum resistance (n = 306). Outcome was separately analyzed for women with known BRCA mutations (n = 79). Gene expression was analyzed on a subset of tumors with available tissue. Cell lines were used to confirm altered sensitivity to chemotherapy associated with the KRAS variant. Finally, the KRAS variant was directly targeted through small-interfering RNA/miRNA oligonucleotides in cell lines and survival was measured. Postmenopausal EOC patients with the KRAS variant were significantly more likely to die of ovarian cancer by multivariate analysis (hazard ratio 1.67, 95% confidence interval: 1.09-2.57, P = 0.019, n = 279). Perhaps explaining this finding, EOC patients with the KRAS variant were significantly more likely to be platinum resistant (odds ratio 3.18, confidence interval: 1.31-7.72, P = 0.0106, n = 291). In addition, direct targeting of the KRAS variant led to a significant reduction in EOC cell growth and survival in vitro. These findings confirm the importance of the KRAS variant in EOC, and indicate that the KRAS variant is a biomarker of poor outcome in EOC likely due to platinum resistance. In addition, this study supports the hypothesis that these tumors have continued dependence on such 3'UTR lesions, and that direct targeting may be a viable future treatment approach.	[Weidhaas, J. B.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Ratner, E. S.; Bellone, S.; Rutherford, T. J.; Schwartz, P. E.; Santin, A. D.] Yale Univ, Dept Gynecol Oncol, New Haven, CT 06520 USA; [Lindner, R.] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Tassi, R. A.; Bignotti, E.; Pecorelli, S.; Ravaggi, A.] Univ Brescia, Div Gynecol Oncol, Angelo Nocivelli Inst Mol Med, Brescia, Italy; [Deng, Y.; Lu, L.; Yao, X.; Zelterman, D.; Yu, H.] Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; [Steele, L.; Neuhausen, S. L.] Beckman Res Inst City Hope, Dept Populat Sci, Duarte, CA USA; [Sand, S.; Weitzel, J. N.] City Hope Natl Med Ctr, Div Clin Canc Genet, Duarte, CA USA; [Muller, R-U] Univ Cologne, Dept Med, Div Renal, D-50931 Cologne, Germany; [Muller, R-U] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Katsaros, D.] Univ Turin, Dept Gynecol Oncol, Turin, Italy; [Cristea, M. C.] City Hope Natl Med Ctr, Dept Med Oncol, Duarte, CA USA; [Slack, F. J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University; Yale University; Ruprecht Karls University Heidelberg; University of Brescia; Yale University; City of Hope; Beckman Research Institute of City of Hope; City of Hope; University of Cologne; University of Cologne; University of Turin; City of Hope; Yale University	Weidhaas, JB (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.	joanne.weidhaas@yale.edu	Müller, Roman-Ulrich/AAK-3493-2021; Ravaggi, Antonella/K-5585-2016	Müller, Roman-Ulrich/0000-0001-6910-0745; Ravaggi, Antonella/0000-0003-4661-9979; Bellone, Stefania/0000-0001-5909-5292; Sand, Sharon/0000-0002-9390-5583; Weidhaas, Joanne/0000-0002-5096-3281; Slack, Frank/0000-0001-8263-0409; Zelterman, Daniel/0000-0003-0711-8688	Women's Reproductive Health Research (WRHR) Career Development Program grant [5K12HD047018-08]; Mary Kay Foundation; NCI [CA131301-01A1, RC4CA153828]; K08 grant [CA124484]; Morris and Horowitz Families Endowed Professorship; NIH [R01CA74415]; Markel Foundation; Shannon Family Foundation; Segesta family; Office of the Director, National Institutes of Health;  [R01CA122728]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047018] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA122728, R01CA131301, K08CA124484, R01CA074415, RC4CA153828, R01CA157749] Funding Source: NIH RePORTER	Women's Reproductive Health Research (WRHR) Career Development Program grant; Mary Kay Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); K08 grant; Morris and Horowitz Families Endowed Professorship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Markel Foundation; Shannon Family Foundation; Segesta family; Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank JL and his group for supplying the cell line-associated chemosensitivity data. We appreciate Greg Wilhoite for performing the TaqMan assay and Josef Herzog for processing samples for the City of Hope. We also appreciate Discovery to Cure at Yale University for samples and Jeff Boyd for supplying the BG1 cell line for targeting studies. ER was supported by a Women's Reproductive Health Research (WRHR) Career Development Program grant (5K12HD047018-08). FS and JW were supported by a Mary Kay Foundation Grant, and an R01 from the NCI (CA131301-01A1). JW also was supported by a K08 grant (CA124484). AS was supported by R01CA122728. SLN is partially supported by the Morris and Horowitz Families Endowed Professorship and NIH R01CA74415. JNW and SS are supported by RC4CA153828 from the National Cancer Institute and the Office of the Director, National Institutes of Health, and also by funding from the Markel Foundation. We also appreciate support from the Shannon Family Foundation, the Segesta family and donations made in memory of Jennifer Casey.	ACS, 2010, CANC FACTS FIG 2010, P1; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Christensen BC, 2009, CARCINOGENESIS, V30, P1003, DOI 10.1093/carcin/bgp099; COX DR, 1972, J R STAT SOC B, V34, P187; Cox DR., 1970, ANAL BINARY DATA; Eitan R, 2009, GYNECOL ONCOL, V114, P253, DOI 10.1016/j.ygyno.2009.04.024; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Graziano F, 2010, PHARMACOGENOMICS J, V10, P458, DOI 10.1038/tpj.2010.9; Helland A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018064; Herzog TJ, 2006, NAT CLIN PRACT ONCOL, V3, P604, DOI 10.1038/ncponc0637; Hollestelle A, 2011, BREAST CANCER RES TR, V128, P79, DOI 10.1007/s10549-010-1080-z; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Lu L, 2007, CANCER RES, V67, P10117, DOI 10.1158/0008-5472.CAN-07-2544; Lu L, 2011, GYNECOL ONCOL, V122, P366, DOI 10.1016/j.ygyno.2011.04.033; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mezzanzanica D, 2010, INT J BIOCHEM CELL B, V42, P1262, DOI 10.1016/j.biocel.2009.12.017; Paranjape T, 2011, LANCET ONCOL, V12, P377, DOI 10.1016/S1470-2045(11)70044-4; Parmar MKB, 2003, LANCET, V361, P2099; Peters D, 2005, MOL CANCER THER, V4, P1605, DOI 10.1158/1535-7163.MCT-04-0311; Pfisterer J, 2006, J CLIN ONCOL, V24, P4699, DOI 10.1200/JCO.2006.06.0913; Pharoah PDP, 2011, CLIN CANCER RES, V17, P3742, DOI 10.1158/1078-0432.CCR-10-3405; Ratner E, 2010, CANCER RES, V70, P6509, DOI 10.1158/0008-5472.CAN-10-0689; Salzman DW, 2011, NAT MED, V17, P934, DOI 10.1038/nm0811-934; Sasaki H, 2011, J THORAC ONCOL, V6, P15, DOI 10.1097/JTO.0b013e31820594f0; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; van Jaarsveld MTM, 2010, INT J BIOCHEM CELL B, V42, P1282, DOI 10.1016/j.biocel.2010.01.014; Youn CK, 2004, CANCER RES, V64, P4849, DOI 10.1158/0008-5472.CAN-04-0348; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	33	55	56	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	42					4559	4566		10.1038/onc.2011.539	http://dx.doi.org/10.1038/onc.2011.539			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	022SH	22139083	Green Accepted, Green Submitted			2022-12-25	WOS:000309982100007
J	Issoglio, FM; Carrizo, ME; Romero, JM; Curtino, JA				Issoglio, Federico M.; Carrizo, Maria E.; Romero, Jorge M.; Curtino, Juan A.			Mechanisms of Monomeric and Dimeric Glycogenin Autoglucosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS; INITIATOR; PROTEOGLYCOGEN; SUBUNIT; RETINA	Initiation of glucose polymerization by glycogenin autoglucosylation at Tyr-194 is required to prime de novo biosynthesis of glycogen. It has been proposed that the synthesis of the primer proceeds by intersubunit glucosylation of dimeric glycogenin, even though it has not been demonstrated that this mechanism is responsible for the described polymerization extent of 12 glucoses produced by the dimer. We reported previously the intramonomer glucosylation capability of glycogenin without determining the extent of autoglucopolymerization. Here, we show that the maximum specific autoglucosylation extent (MSAE) produced by the non-glucosylated glycogenin monomer is 13.3 +/- 1.9 glucose units, similar to the 12.5 +/- 1.4 glucose units measured for the dimer. The mechanism and capacity of the dimeric enzyme to carry out full glucopolymerization were also evaluated by construction of heterodimers able to glucosylate exclusively by intrasubunit or intersubunit reaction mechanisms. The MSAE of non-glucosylated glycogenin produced by dimer intrasubunit glucosylation was 16% of that produced by the monomer. However, partially glucosylated glycogenin was able to almost complete its autoglucosylation by the dimer intrasubunit mechanism. The MSAE produced by heterodimer intersubunit glucosylation was 60% of that produced by the wild-type dimer. We conclude that both intrasubunit and intersubunit reaction mechanisms are necessary for the dimeric enzyme to acquire maximum autoglucosylation. The full glucopolymerization capacity of monomeric glycogenin indicates that the enzyme is able to synthesize the glycogen primer without the need for prior dimerization.	[Issoglio, Federico M.; Carrizo, Maria E.; Romero, Jorge M.; Curtino, Juan A.] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, CIQUIBIC, CONICET,Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Curtino, JA (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, CIQUIBIC, CONICET,Dept Quim Biol,Fac Ciencias Quim, Haya de la Torre S-N,X5000HUA, RA-5000 Cordoba, Argentina.	jcurtino@dqb.fcq.unc.edu.ar		Carrizo, Maria Elena/0000-0003-0501-8894; Issoglio, Federico/0000-0001-9225-7855	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT); Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba (SECyT-UNC)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fondo para la Investigacion Cientifica y Tecnologica (FONCyT)(FONCyT); Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba (SECyT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT))	This work was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), the Fondo para la Investigacion Cientifica y Tecnologica (FONCyT), and the Secretaria de Ciencia y Tecnica-Universidad Nacional de Cordoba (SECyT-UNC).	AON MA, 1984, EUR J BIOCHEM, V140, P557, DOI 10.1111/j.1432-1033.1984.tb08138.x; AON MA, 1985, BIOCHEM J, V229, P269, DOI 10.1042/bj2290269; Bazan S, 2005, GLYCOBIOLOGY, V15, pC14, DOI 10.1093/glycob/cwi093; Bazan S, 2008, BIOCHEM BIOPH RES CO, V371, P328, DOI 10.1016/j.bbrc.2008.04.076; Carrizo ME, 1997, GLYCOBIOLOGY, V7, P571, DOI 10.1093/glycob/7.4.571; CHENG C, 1995, MOL CELL BIOL, V15, P6632; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gibbons BJ, 2002, J MOL BIOL, V319, P463, DOI 10.1016/S0022-2836(02)00305-4; Hurley TD, 2005, J BIOL CHEM, V280, P23892, DOI 10.1074/jbc.M502344200; Hurley TD, 2006, BIOCHEM BIOPH RES CO, V348, P374, DOI 10.1016/j.bbrc.2006.07.106; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kennedy L., 1985, MEMBRANES MUSCLE, P65; KRISMAN CR, 1975, EUR J BIOCHEM, V52, P117, DOI 10.1111/j.1432-1033.1975.tb03979.x; Leslie AGW, 1992, PROTEIN CRYSTALLOGR, V26, P27; Lin A, 1999, ARCH BIOCHEM BIOPHYS, V363, P163, DOI 10.1006/abbi.1998.1073; MIOZZO MC, 1989, BIOCHEM J, V260, P287, DOI 10.1042/bj2600287; Moslemi AR, 2010, NEW ENGL J MED, V362, P1203, DOI 10.1056/NEJMoa0900661; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PITCHER J, 1987, EUR J BIOCHEM, V169, P497, DOI 10.1111/j.1432-1033.1987.tb13637.x; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; SKURAT AV, 1993, J BIOL CHEM, V268, P14701; SMYTHE C, 1988, EMBO J, V7, P2681, DOI 10.1002/j.1460-2075.1988.tb03121.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	24	11	11	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1955	1961		10.1074/jbc.M111.287813	http://dx.doi.org/10.1074/jbc.M111.287813			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128147	Green Published, hybrid			2022-12-25	WOS:000299321000036
J	White, R; Gonsior, C; Bauer, NM; Kramer-Albers, EM; Luhmann, HJ; Trotter, J				White, Robin; Gonsior, Constantin; Bauer, Nina M.; Kraemer-Albers, Eva-Maria; Luhmann, Heiko J.; Trotter, Jacqueline			Heterogeneous Nuclear Ribonucleoprotein (hnRNP) F Is a Novel Component of Oligodendroglial RNA Transport Granules Contributing to Regulation of Myelin Basic Protein (MBP) Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FYN TYROSINE KINASE; A2 RESPONSE ELEMENT; MESSENGER-RNAS; CNS MYELINATION; INITIAL EVENTS; DEFICIENT MICE; IN-VITRO; DIFFERENTIATION; EXPRESSION; TRANSLATION	Myelin basic protein (MBP) is a major component of central nervous system (CNS) myelin. The absence of MBP results in the loss of almost all compact myelin in the CNS. MBP mRNA is sorted into RNA granules that are transported to the periphery of oligodendrocytes in a translationally inactive state. A central mediator of this transport process is the trans-acting factor heterogeneous nuclear ribonucleoprotein (hnRNP) A2 that binds to the cis-acting A2-response element in the 3' UTR of MBP mRNA. Recently, we found that activation of the Src family nonreceptor tyrosine kinase Fyn in oligodendrocytes leads to phosphorylation of hnRNP A2 and to increased translation of MBP mRNA. Here, we identify the RNA-binding protein hnRNP F as a novel component of MBP mRNA transport granules. It is associated with hnRNP A2 andMBPmRNAin cytoplasmic granular structures and is involved in post-transcriptional regulation of MBP expression. Fyn kinase activity results in phosphorylation of hnRNP F in the cytoplasm and its release from MBP mRNA and RNA granules. Our results define hnRNP F as a regulatory element of MBP expression in oligodendrocytes and imply an important function of hnRNP F in the control of myelin synthesis.	[White, Robin; Bauer, Nina M.; Luhmann, Heiko J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol & Pathophysiol, D-55128 Mainz, Germany; [Gonsior, Constantin; Kraemer-Albers, Eva-Maria; Trotter, Jacqueline] Johannes Gutenberg Univ Mainz, Dept Biol, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	White, R (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol & Pathophysiol, Duesbergweg 6, D-55128 Mainz, Germany.	white@uni-mainz.de; trotter@uni-mainz.de	Eva-Maria, Kraemer-Albers/AAP-8805-2020; Luhmann, Heiko J./N-8797-2019	Eva-Maria, Kraemer-Albers/0000-0001-7994-1185; Luhmann, Heiko J./0000-0002-7934-8661	Deutsche Forschungsgemeinschaft SPP Glia-Synapse; European Union; Deutsche Forschungsgemeinschaft [GRK 1044]	Deutsche Forschungsgemeinschaft SPP Glia-Synapse(German Research Foundation (DFG)); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft SPP Glia-Synapse, European Union FP6 Signalling and Traffic, and Deutsche Forschungsgemeinschaft Grant GRK 1044.	Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; Aggarwal S, 2011, DEV CELL, V21, P445, DOI 10.1016/j.devcel.2011.08.001; Arthur PK, 2009, J BIOL CHEM, V284, P19982, DOI 10.1074/jbc.M109.009928; Boccaccio GL, 2000, J NEUROSCI RES, V62, P473, DOI 10.1002/1097-4547(20001115)62:4<473::AID-JNR1>3.0.CO;2-F; Bugiani M, 2010, J NEUROPATH EXP NEUR, V69, P987, DOI 10.1097/NEN.0b013e3181f2eafa; Carson JH, 2005, BIOL CELL, V97, P51; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Fitzner D, 2006, EMBO J, V25, P5037, DOI 10.1038/sj.emboj.7601376; Francone VP, 2007, J NEUROSCI, V27, P7654, DOI 10.1523/JNEUROSCI.0203-07.2007; Gao YZ, 2008, MOL BIOL CELL, V19, P2311, DOI 10.1091/mbc.E07-09-0914; Goto J, 2004, CELL MOL NEUROBIOL, V24, P149, DOI 10.1023/B:CEMN.0000012720.71630.14; Goto J, 2008, MOL CELL NEUROSCI, V38, P203, DOI 10.1016/j.mcn.2008.02.009; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Han SP, 2010, TRAFFIC, V11, P886, DOI 10.1111/j.1600-0854.2010.01072.x; Hatfield JT, 2002, GENE, V295, P33, DOI 10.1016/S0378-1119(02)00800-4; Homchaudhuri L, 2009, BIOCHEMISTRY-US, V48, P2385, DOI 10.1021/bi8022587; Honore B, 2004, EXP CELL RES, V294, P199, DOI 10.1016/j.yexcr.2003.11.011; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kalifa Y, 2006, DEV CELL, V10, P291, DOI 10.1016/j.devcel.2006.01.001; Klein C, 2002, J NEUROSCI, V22, P698, DOI 10.1523/JNEUROSCI.22-03-00698.2002; Kosturko LD, 2006, MOL BIOL CELL, V17, P3521, DOI 10.1091/mbc.E05-10-0946; Kramer-Albers EM, 2006, J NEUROSCI, V26, P11743, DOI 10.1523/JNEUROSCI.3581-06.2006; Kramer-Albers EM, 2011, CELL MOL LIFE SCI, V68, P2003, DOI 10.1007/s00018-010-0616-z; Labauge P, 2007, REV NEUROL-FRANCE, V163, P793, DOI 10.1016/S0035-3787(07)91461-7; Laursen LS, 2011, J CELL BIOL, V192, P797, DOI 10.1083/jcb.201007014; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Maggipinto M, 2004, J NEUROSCI RES, V75, P614, DOI 10.1002/jnr.20014; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Nakahara J, 2003, DEV CELL, V4, P841, DOI 10.1016/S1534-5807(03)00155-2; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; POPKO B, 1987, CELL, V48, P713, DOI 10.1016/0092-8674(87)90249-2; READHEAD C, 1990, BEHAV GENET, V20, P213, DOI 10.1007/BF01067791; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; Song K. Y., 2011, CELL MOL LI IN PRESS; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; TROTTER J, 1989, J NEUROSCI RES, V22, P369, DOI 10.1002/jnr.490220402; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Umemori H, 1999, J NEUROSCI, V19, P1393; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wang EM, 2007, NUCLEIC ACIDS RES, V35, P4164, DOI 10.1093/nar/gkm387; Wang EM, 2009, J BIOL CHEM, V284, P11194, DOI 10.1074/jbc.M809373200; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164	50	42	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1742	1754		10.1074/jbc.M111.235010	http://dx.doi.org/10.1074/jbc.M111.235010			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128153	hybrid, Green Published			2022-12-25	WOS:000299321000017
J	Adams, MN; Christensen, ME; He, YW; Waterhouse, NJ; Hooper, JD				Adams, Mark N.; Christensen, Melinda E.; He, Yaowu; Waterhouse, Nigel J.; Hooper, John D.			The Role of Palmitoylation in Signalling, Cellular Trafficking and Plasma Membrane Localization of Protease-Activated Receptor-2	PLOS ONE			English	Article							ARRESTIN-DEPENDENT ENDOCYTOSIS; 4TH CYTOPLASMIC LOOP; COUPLED RECEPTOR; BETA(1)-ADRENERGIC RECEPTOR; VASOPRESSIN RECEPTOR; FLUORESCENT PROTEIN; ERK1/2 ACTIVATION; MOLECULAR-CLONING; HELIX 8; PHOSPHORYLATION	Protease-activated receptor-2 (PAR2) is a G protein coupled receptor (GPCR) activated by proteolytic cleavage of its amino terminal domain by trypsin-like serine proteases. This irreversible activation mechanism leads to rapid receptor desensitization by internalisation and degradation. We have explored the role of palmitoylation, the post-translational addition of palmitate, in PAR2 signalling, trafficking, cell surface expression and desensitization. Experiments using the palmitoylation inhibitor 2-bromopalmitate indicated that palmitate addition is important in trafficking of PAR2 endogenously expressed by prostate cancer cell lines. This was supported by palmitate labelling using two approaches, which showed that PAR2 stably expressed by CHO-K1 cells is palmitoylated and that palmitoylation occurs on cysteine 361. Palmitoylation is required for optimal PAR2 signalling as Ca(2+) flux assays indicated that in response to trypsin agonism, palmitoylation deficient PAR2 is similar to 9 fold less potent than wildtype receptor with a reduction of about 33% in the maximum signal induced via the mutant receptor. Confocal microscopy, flow cytometry and cell surface biotinylation analyses demonstrated that palmitoylation is required for efficient cell surface expression of PAR2. We also show that receptor palmitoylation occurs within the Golgi apparatus and is required for efficient agonist-induced rab11a-mediated trafficking of PAR2 to the cell surface. Palmitoylation is also required for receptor desensitization, as agonist-induced beta-arrestin recruitment and receptor endocytosis and degradation were markedly reduced in CHO-PAR2-C361A cells compared with CHO-PAR2 cells. These data provide new insights on the life cycle of PAR2 and demonstrate that palmitoylation is critical for efficient signalling, trafficking, cell surface localization and degradation of this receptor.	[Adams, Mark N.; Christensen, Melinda E.; He, Yaowu; Waterhouse, Nigel J.; Hooper, John D.] Mater Med Res Inst, Brisbane, Qld, Australia; [Adams, Mark N.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia	Mater Research; Queensland University of Technology (QUT)	Adams, MN (corresponding author), Mater Med Res Inst, Aubigny Pl, Brisbane, Qld, Australia.	jhooper@mmri.mater.org.au	Hooper, John/C-1481-2016; Adams, Mark/AAE-1209-2021; Waterhouse, Nigel/I-9813-2016	Hooper, John/0000-0003-1054-8486; Adams, Mark/0000-0003-1906-5018; HE, Yaowu/0000-0002-7828-263X	National Health and Medical Research Council [614206]; Cancer Council Queensland; Australian Post-Graduate Award; Australian Research Council [FT0991446]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); Australian Post-Graduate Award(Australian Government); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council grant #614206 and a Cancer Council Queensland grant (J. D. H.), an Australian Post-Graduate Award (M. N. A.) and an Australian Research Council Future Fellowship #FT0991446 (N. J. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Ahn KH, 2010, BIOCHEMISTRY-US, V49, P502, DOI 10.1021/bi901619r; Anavi-Goffer S, 2007, J BIOL CHEM, V282, P25100, DOI 10.1074/jbc.M703388200; Blanpain C, 2001, J BIOL CHEM, V276, P23795, DOI 10.1074/jbc.M100583200; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Botham A, 2011, BIOCHEM J, V438, P359, DOI 10.1042/BJ20101958; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Camerer E, DEV CELL, V18, P25; Charest PG, 2003, J BIOL CHEM, V278, P41541, DOI 10.1074/jbc.M306589200; CHAVRIER P, 1990, MOL CELL BIOL, V10, P6578, DOI 10.1128/MCB.10.12.6578; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Fukushima Y, 2001, BBA-MOL CELL RES, V1539, P181, DOI 10.1016/S0167-4889(01)00104-5; Gehret AU, 2010, MOL PHARMACOL, V77, P288, DOI 10.1124/mol.109.059733; Grimsey N, 2011, IUBMB LIFE, V63, P403, DOI 10.1002/iub.442; Groarke DA, 2001, MOL PHARMACOL, V59, P375, DOI 10.1124/mol.59.2.375; Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692; Hawtin SR, 2001, J BIOL CHEM, V276, P38139; He YW, 2008, J BIOL CHEM, V283, P24000, DOI 10.1074/jbc.M803361200; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; MAGEE AI, 1985, EMBO J, V4, P1137, DOI 10.1002/j.1460-2075.1985.tb03751.x; Marin EP, 2000, J BIOL CHEM, V275, P1930, DOI 10.1074/jbc.275.3.1930; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; MOFFETT S, 1993, EMBO J, V12, P349, DOI 10.1002/j.1460-2075.1993.tb05663.x; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; NG GYK, 1994, EUR J PHARM-MOLEC PH, V267, P7, DOI 10.1016/0922-4106(94)90219-4; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Petaja-Repo UE, 2006, J BIOL CHEM, V281, P15780, DOI 10.1074/jbc.M602267200; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17032; Ponimaskin E, 2005, MOL PHARMACOL, V67, P1434, DOI 10.1124/mol.104.008748; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Reid HM, 2010, J BIOL CHEM, V285, P18709, DOI 10.1074/jbc.M110.106476; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Sadeghi HM, 1997, MOL PHARMACOL, V52, P21, DOI 10.1124/mol.52.1.21; Schulein R, 1996, BIOCHEM J, V313, P611, DOI 10.1042/bj3130611; Sevigny LM, 2011, P NATL ACAD SCI USA, V108, P8491, DOI 10.1073/pnas.1017091108; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sharma C, 2008, MOL BIOL CELL, V19, P3415, DOI 10.1091/mbc.E07-11-1164; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Storrie B, 1998, BBA-MOL CELL RES, V1404, P127, DOI 10.1016/S0167-4889(98)00053-6; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Tanaka K, 1998, ENDOCRINOLOGY, V139, P803, DOI 10.1210/en.139.2.803; Ulloa-Aguirre A, 2007, MOL CELL ENDOCRINOL, V260, P153, DOI 10.1016/j.mce.2005.11.050; Vergnolle N, 2005, GUT, V54, P867, DOI 10.1136/gut.2004.048876; Vergnolle N, 1999, BRIT J PHARMACOL, V127, P1083, DOI 10.1038/sj.bjp.0702634; Vergnolle N, 2001, NAT MED, V7, P821, DOI 10.1038/89945; Versteeg HH, 2008, CANCER RES, V68, P7219, DOI 10.1158/0008-5472.CAN-08-0419; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; ZHU HY, 1995, MOL ENDOCRINOL, V9, P141, DOI 10.1210/me.9.2.141; Zuckerman DM, 2011, J BIOL CHEM, V286, P19014, DOI 10.1074/jbc.M110.189977	78	35	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28018	10.1371/journal.pone.0028018	http://dx.doi.org/10.1371/journal.pone.0028018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140500	Green Submitted, Green Published, gold			2022-12-25	WOS:000298166300021
J	Wang, XW; Nath, A; Yang, XR; Portis, A; Walton, SP; Chan, C				Wang, Xuewei; Nath, Aritro; Yang, Xuerui; Portis, Amanda; Walton, S. Patrick; Chan, Christina			Synergy Analysis Reveals Association between Insulin Signaling and Desmoplakin Expression in Palmitate Treated HepG2 Cells	PLOS ONE			English	Article							FATTY LIVER-DISEASE; CARDIOVASCULAR-DISEASE; SKELETAL-MUSCLE; PROTEIN-KINASE; BINDING PROTEINS; CROSS-TALK; ACID; IDENTIFICATION; RESISTANCE; IDENTIFY	The regulation of complex cellular activities in palmitate treated HepG2 cells, and the ensuing cytotoxic phenotype, involves cooperative interactions between genes. While previous approaches have largely focused on identifying individual target genes, elucidating interacting genes has thus far remained elusive. We applied the concept of information synergy to reconstruct a "gene-cooperativity" network for palmititate-induced cytotoxicity in liver cells. Our approach integrated gene expression data with metabolic profiles to select a subset of genes for network reconstruction. Subsequent analysis of the network revealed insulin signaling as the most significantly enriched pathway, and desmoplakin (DSP) as its top neighbor. We determined that palmitate significantly reduces DSP expression, and treatment with insulin restores the lost expression of DSP. Insulin resistance is a common pathological feature of fatty liver and related ailments, whereas loss of DSP has been noted in liver carcinoma. Reduced DSP expression can lead to loss of cell-cell adhesion via desmosomes, and disrupt the keratin intermediate filament network. Our findings suggest that DSP expression may be perturbed by palmitate and, along with insulin resistance, may play a role in palmitate induced cytotoxicity, and serve as potential targets for further studies on non-alcoholic fatty liver disease (NAFLD).	[Wang, Xuewei; Yang, Xuerui; Portis, Amanda; Walton, S. Patrick; Chan, Christina] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Nath, Aritro; Chan, Christina] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Yang, Xuerui; Chan, Christina] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Chan, Christina] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Wang, XW (corresponding author), Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.	krischan@egr.msu.edu	Nath, Aritro/AAV-8720-2020; wang, xuewei/C-7773-2009	Nath, Aritro/0000-0002-3225-4203; Yang, Xuerui/0000-0002-7731-2147; Wang, Xuewei/0000-0003-3679-7421; Walton, S. Patrick/0000-0003-1708-8603	National Institutes of Health (NIH) [R01GM079688-01, R21RR024439]; National Science Foundation (NSF) [CBET 0941055, CBET 1049127]; MSU Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079688] Funding Source: NIH RePORTER; Directorate For Engineering [1049127] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); MSU Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported in part by the National Institutes of Health (NIH) (R01GM079688-01 and R21RR024439), the National Science Foundation (NSF) (CBET 0941055 and CBET 1049127), and the MSU Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008509; Amemiya-Kudo M, 2005, J BIOL CHEM, V280, P34577, DOI 10.1074/jbc.M506718200; Anastassiou D, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100124; Anderson Abraham A, 2009, Pathogenetics, V2, P1, DOI 10.1186/1755-8417-2-1; Angulo P, 2007, NUTR REV, V65, pS57, DOI 10.1111/j.1753-4887.2007.tb00329.x; ARDEN KC, 1995, GENOMICS, V25, P743, DOI 10.1016/0888-7543(95)80023-F; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Buffa L, 2008, EUR J CELL BIOL, V87, P197, DOI 10.1016/j.ejcb.2007.11.003; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Cao Y, 2007, HISTOPATHOLOGY, V51, P528, DOI 10.1111/j.1365-2559.2007.02820.x; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Ceddia RB, 2005, INT J OBESITY, V29, P1175, DOI 10.1038/sj.ijo.0803025; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; Chong MP, 2004, BIOCHEM BIOPH RES CO, V322, P535, DOI 10.1016/j.bbrc.2004.07.150; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Dettling M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r88; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Dyck DJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE600, DOI 10.1152/ajpendo.2001.281.3.E600; Edens MA, 2009, OBES REV, V10, P412, DOI 10.1111/j.1467-789X.2009.00594.x; Ekinci FJ, 1999, BRAIN RES, V850, P207, DOI 10.1016/S0006-8993(99)02146-0; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Franch-Marro X, 2008, J CELL SCI, V121, P1587, DOI 10.1242/jcs.015958; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Han Sheng-fang, 2007, Yingyong Shengtai Xuebao, V18, P2462; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; HOBBS RP, 2010, FASEB J; HUANG L, 2010, EXP CELL RES; Jonkman MF, 2005, AM J HUM GENET, V77, P653, DOI 10.1086/496901; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Letiges M, 2002, MOL ENDOCRINOL, V16, P847, DOI 10.1210/me.16.4.847; Li Z, 2008, BIOTECHNOL PROGR, V24, P29, DOI 10.1021/bp070120b; Li Z, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-21; Li Z, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-202; Lorch JH, 2004, J BIOL CHEM, V279, P37191, DOI 10.1074/jbc.M405123200; Mattar SG, 2005, ANN SURG, V242, P610, DOI 10.1097/01.sla.0000179652.07502.3f; Musso G, 2003, HEPATOLOGY, V37, P909, DOI 10.1053/jhep.2003.50132; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Polakis P, 2000, GENE DEV, V14, P1837; Prada PO, 2009, DIABETES, V58, P2910, DOI 10.2337/db08-0506; Rampazzo A, 2002, AM J HUM GENET, V71, P1200, DOI 10.1086/344208; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Rong R, 2003, NAT NEUROSCI, V6, P1153, DOI 10.1038/nn1134; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Shiraishi Y, 2004, J COMP NEUROL, V473, P582, DOI 10.1002/cne.20116; Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004; Smidt K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005684; Smith JJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb1400157; Smith J, 2008, J BIOL CHEM, V283, P13578, DOI 10.1074/jbc.M800008200; Srivastava S, 2008, BIOTECHNOL BIOENG, V99, P399, DOI 10.1002/bit.21568; Srivastava S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-364; Storz P, 1999, EUR J BIOCHEM, V266, P17, DOI 10.1046/j.1432-1327.1999.00809.x; Sumi K, 2007, MOL CELL BIOL, V27, P4248, DOI 10.1128/MCB.01894-06; Swagell CD, 2005, BIOCHEM BIOPH RES CO, V328, P432, DOI 10.1016/j.bbrc.2004.12.188; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Targher G, 2010, J HEPATOL, V53, P713, DOI 10.1016/j.jhep.2010.04.030; TOPPING DL, 1972, BIOCHEM J, V126, P295, DOI 10.1042/bj1260295; Tsang MYC, 2004, NITRIC OXIDE-BIOL CH, V10, P11, DOI 10.1016/j.niox.2004.01.005; Uzumcu A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.032904; Vinken M, 2006, CRIT REV TOXICOL, V36, P299, DOI 10.1080/10408440600599273; Wang XW, 2008, CURR OPIN BIOTECH, V19, P482, DOI 10.1016/j.copbio.2008.07.011; Watkinson J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-10; Whittock NV, 2002, J INVEST DERMATOL, V118, P232, DOI 10.1046/j.0022-202x.2001.01664.x; Yang XR, 2010, MOL BIOL CELL, V21, P3449, DOI 10.1091/mbc.E10-06-0481; Yang XR, 2009, ARTECH HSE METH BIOE, P75; Yang XR, 2009, BIOINFORMATICS, V25, P2236, DOI 10.1093/bioinformatics/btp376; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Zelber-Sagil S, 2007, J HEPATOL, V47, P711, DOI 10.1016/j.jhep.2007.06.020; Zhang JG, 2008, AM J HUM GENET, V83, P269, DOI 10.1016/j.ajhg.2008.07.009; Zhou Q, 2007, ENDOCRINOLOGY, V148, P5696, DOI 10.1210/en.2007-0183	84	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28138	10.1371/journal.pone.0028138	http://dx.doi.org/10.1371/journal.pone.0028138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132232	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000081
J	Martinez, J; Lisa, S; Sanchez, R; Kowalczyk, W; Zurita, E; Teixido, M; Giralt, E; Andreu, D; Avila, J; Gasset, M				Martinez, Javier; Lisa, Silvia; Sanchez, Rosa; Kowalczyk, Wioleta; Zurita, Esther; Teixido, Meritxell; Giralt, Ernest; Andreu, David; Avila, Jesus; Gasset, Maria			Selenomethionine Incorporation into Amyloid Sequences Regulates Fibrillogenesis and Toxicity	PLOS ONE			English	Article							SOLID-PHASE SYNTHESIS; PRION PROTEIN; OXIDATIVE STRESS; METHIONINE; DISEASE; AGGREGATION; PEPTIDES; NEUROTOXICITY; SELENIUM; POLYMORPHISM	Background: The capacity of a polypeptide chain to engage in an amyloid formation process and cause a conformational disease is contained in its sequence. Some of the sequences undergoing fibrillation contain critical methionine (Met) residues which in vivo can be synthetically substituted by selenomethionine (SeM) and alter their properties. Methodology/Principal Findings: Using peptide synthesis, biophysical techniques and cell viability determinations we have studied the effect of the substitution of methionine (Met) by selenomethionine (SeM) on the fibrillogenesis and toxic properties of A beta 40 and HuPrP(106-140). We have found that the effects display site-specificity and vary from inhibition of fibrillation and decreased toxicity ([SeM35]A beta 40, [SeM129]HuPrP(106-140) and [SeM134]HuPrP(106-140)), retarded assembly, modulation of polymer shape and retention of toxicity ([SeM112]HuPrP(106-140) to absence of effects ([SeM109]HuPrP(106-140)). Conclusions/Significance: This work provides direct evidence that the substitution of Met by SeM in proamyloid sequences has a major impact on their self-assembly and toxic properties, suggesting that the SeM pool can play a major role in dictating the allowance and efficiency of a polypeptide chain to undergo toxic polymerization.	[Martinez, Javier; Lisa, Silvia; Sanchez, Rosa; Gasset, Maria] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain; [Kowalczyk, Wioleta; Andreu, David] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Barcelona, Spain; [Zurita, Esther; Teixido, Meritxell; Giralt, Ernest] Inst Res Biomed, Barcelona, Spain; [Giralt, Ernest] Univ Barcelona, Dept Organ Chem, Barcelona, Spain; [Avila, Jesus] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Pompeu Fabra University; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Martinez, J (corresponding author), CSIC, Inst Quim Fis Rocasolano, Madrid, Spain.	mgasset@iqfr.csic.es	Andreu, David/I-4359-2014; Avila, Jesus/I-2610-2015; Gasset, Maria/K-4339-2012; Kowalczyk, Wioleta/F-5904-2014; Gasset, Maria/I-2050-2014; teixido, meritxell/I-3282-2015; giralt, ernest/N-1669-2014	Andreu, David/0000-0002-6317-6666; Avila, Jesus/0000-0002-6288-0571; Gasset, Maria/0000-0001-6436-4055; Gasset, Maria/0000-0001-6436-4055; teixido, meritxell/0000-0002-7825-3695; giralt, ernest/0000-0001-8381-1797; Martinez, Javier/0000-0002-0104-5652; Kowalczyk, Wioleta/0000-0001-5180-594X	Spanish Ministry of Science and Innovation [BFU2009-07975, BIO2008-04487-CO3-02, BIO2008-00799]; Fundacion Cien-Fundacion Reina Sofia; Generalitat de Catalunya (XRB and Grups Consolidats)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Cien-Fundacion Reina Sofia; Generalitat de Catalunya (XRB and Grups Consolidats)(Generalitat de Catalunya)	This work was supported in part by gra'ts BFU2009-07975 (MG), BIO2008-04487-CO3-02 (DA) and BIO2008-00799 (EG) from the Spanish Ministry of Science and Innovation, from the Fundacion Cien-Fundacion Reina Sofia, and from Generalitat de Catalunya (XRB and Grups Consolidats). Wioleta Kowalczyk is supported by a Juan de la Cierva fellowship from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Apostol MI, 2010, J BIOL CHEM, V285, P29671, DOI 10.1074/jbc.C110.158303; Baskakov I, 2005, FEBS LETT, V579, P2589, DOI 10.1016/j.febslet.2005.03.075; Bergstrom AL, 2007, BBA-PROTEINS PROTEOM, V1774, P1118, DOI 10.1016/j.bbapap.2007.06.016; BISHOP MF, 1984, BIOPHYS J, V46, P631, DOI 10.1016/S0006-3495(84)84062-X; Bitan G, 2003, J AM CHEM SOC, V125, P15359, DOI 10.1021/ja0349296; Budisa N, 1998, EUR J BIOCHEM, V253, P1, DOI 10.1046/j.1432-1327.1998.2530001.x; Butterfield DA, 2005, BBA-PROTEINS PROTEOM, V1703, P149, DOI 10.1016/j.bbapap.2004.10.014; Butterfield DA, 2004, NEUROBIOL AGING, V25, P563, DOI 10.1016/j.neurobiolaging.2003.12.027; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clementi ME, 2005, FEBS LETT, V579, P2913, DOI 10.1016/j.febslet.2005.04.041; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Dettin M, 1997, J PEPT RES, V49, P103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Fioriti L, 2007, J NEUROSCI, V27, P1576, DOI 10.1523/JNEUROSCI.5145-06.2007; Garcia-Martin F, 2006, J COMB CHEM, V8, P213, DOI 10.1021/cc0600019; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Gassner NC, 1999, J MOL BIOL, V294, P17, DOI 10.1006/jmbi.1999.3220; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Green KM, 2008, J GEN VIROL, V89, P598, DOI 10.1099/vir.0.83168-0; GRIFFITHS NM, 1976, BRIT J NUTR, V35, P373, DOI 10.1079/BJN19760043; Grillo-Bosch D, 2011, J PEPT SCI, V17, P32, DOI 10.1002/psc.1293; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haigh CL, 2009, CELL RES, V19, P1062, DOI 10.1038/cr.2009.86; Hakansson K, 2000, ACTA CRYSTALLOGR D, V56, P924, DOI 10.1107/S0907444900006375; Itkin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018250; Johansson AS, 2007, NEUROREPORT, V18, P559, DOI 10.1097/WNR.0b013e3280b07c21; Krause RJ, 2009, BIOCHEM PHARMACOL, V77, P134, DOI 10.1016/j.bcp.2008.09.022; Le DT, 2008, BIOCHEMISTRY-US, V47, P6685, DOI 10.1021/bi800422s; Lee S, 2010, EMBO J, V29, P251, DOI 10.1038/emboj.2009.333; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020244; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lisa S, 2010, CELL MOL LIFE SCI, V67, P2825, DOI 10.1007/s00018-010-0363-1; Maiti P, 2011, BIOCHEM J, V433, P323, DOI 10.1042/BJ20101391; Maji SK, 2009, FEBS LETT, V583, P2610, DOI 10.1016/j.febslet.2009.07.003; Makarava N, 2009, J BIOL CHEM, V284, P14386, DOI 10.1074/jbc.M900533200; McCann JC, 2011, FASEB J, V25, P1793, DOI 10.1096/fj.11-180885; MEPLAN C, 2011, J TRACE ELEMENTS MED, V255, P511; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Ostapchenko VG, 2010, J MOL BIOL, V400, P908, DOI 10.1016/j.jmb.2010.05.051; Palmblad M, 2002, J BIOL CHEM, V277, P19506, DOI 10.1074/jbc.M112218200; Parchi P, 2011, ACTA NEUROPATHOL, V121, P91, DOI 10.1007/s00401-010-0779-6; Petchanikow C, 2001, FEBS LETT, V509, P451, DOI 10.1016/S0014-5793(01)03147-7; Rayman MP, 2008, BRIT J NUTR, V100, P254, DOI 10.1017/S0007114508939830; Salmona M, 2003, J BIOL CHEM, V278, P48146, DOI 10.1074/jbc.M307295200; Sanchez L, 2011, J AM CHEM SOC, V133, P6505, DOI 10.1021/ja1117123; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schrauzer GN, 2000, J NUTR, V130, P1653, DOI 10.1093/jn/130.7.1653; Shahar A, 2010, MOVEMENT DISORD, V25, P1909, DOI 10.1002/mds.23218; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Smith JL, 1998, STRUCT FOLD DES, V6, P815, DOI 10.1016/S0969-2126(98)00083-5; Sohma Y, 2005, J PEPT SCI, V11, P441, DOI 10.1002/psc.649; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Wernimont AK, 2003, J BIOL INORG CHEM, V8, P185, DOI 10.1007/s00775-002-0404-9; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Yamniuk AP, 2009, BIOPHYS J, V96, P1495, DOI 10.1016/j.bpj.2008.10.060; Yokoyama S, 2003, CURR OPIN CHEM BIOL, V7, P39, DOI 10.1016/S1367-5931(02)00019-4	61	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27999	10.1371/journal.pone.0027999	http://dx.doi.org/10.1371/journal.pone.0027999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132190	Green Published, gold			2022-12-25	WOS:000297792400030
J	Feng, H; Beck, J; Nassal, M; Hu, KH				Feng, Hui; Beck, Juergen; Nassal, Michael; Hu, Kang-hong			A SELEX-Screened Aptamer of Human Hepatitis B Virus RNA Encapsidation Signal Suppresses Viral Replication	PLOS ONE			English	Article							HEPADNAVIRUS REVERSE-TRANSCRIPTASE; STEM-LOOP STRUCTURE; IN-VITRO; DNA-SYNTHESIS; TERMINAL PROTEIN; CELL-LINE; POLYMERASE; BINDING; ACTIVATION; INITIATION	Background: The specific interaction between hepatitis B virus (HBV) polymerase (P protein) and the e RNA stem-loop on pregenomic (pg) RNA is crucial for viral replication. It triggers both pgRNA packaging and reverse transcription and thus represents an attractive antiviral target. RNA decoys mimicking e in P protein binding but not supporting replication might represent novel HBV inhibitors. However, because generation of recombinant enzymatically active HBV polymerase is notoriously difficult, such decoys have as yet not been identified. Methodology/Principal Findings: Here we used a SELEX approach, based on a new in vitro reconstitution system exploiting a recombinant truncated HBV P protein (miniP), to identify potential e decoys in two large e RNA pools with randomized upper stem. Selection of strongly P protein binding RNAs correlated with an unexpected strong enrichment of A residues. Two aptamers, S6 and S9, displayed particularly high affinity and specificity for miniP in vitro, yet did not support viral replication when part of a complete HBV genome. Introducing S9 RNA into transiently HBV producing HepG2 cells strongly suppressed pgRNA packaging and DNA synthesis, indicating the S9 RNA can indeed act as an e decoy that competitively inhibits P protein binding to the authentic e signal on pgRNA. Conclusions/Significance: This study demonstrates the first successful identification of human HBV e aptamers by an in vitro SELEX approach. Effective suppression of HBV replication by the S9 aptamer provides proof-of-principle for the ability of e decoy RNAs to interfere with viral P-e complex formation and suggests that S9-like RNAs may further be developed into useful therapeutics against chronic hepatitis B.	[Feng, Hui; Hu, Kang-hong] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Beck, Juergen; Nassal, Michael] Univ Hosp Freiburg, Freiburg, Germany	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; University of Freiburg	Feng, H (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	hukgh@wh.iov.cn	Nassal, Michael/U-4529-2019; Hu, Kanghong/AAL-3011-2020	Nassal, Michael/0000-0003-2204-9158; Beck, Jurgen/0000-0001-8794-9320	National Nature Science Foundations of China [30870131]; Chinese Academy of Sciences [0802021SA1]	National Nature Science Foundations of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	The work was supported by grants from the National Nature Science Foundations of China (30870131) and the program of Chinese Academy of Sciences (0802021SA1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTENSCHLAGER R, 1992, EMBO J, V11, P3413, DOI 10.1002/j.1460-2075.1992.tb05420.x; Barton JL, 2009, NUCLEIC ACIDS RES, V37, P6818, DOI 10.1093/nar/gkp728; BEASLEY RP, 1981, LANCET, V2, P1129; Beck J, 2003, J BIOL CHEM, V278, P36128, DOI 10.1074/jbc.M301069200; Beck J, 1998, MOL CELL BIOL, V18, P6265, DOI 10.1128/MCB.18.11.6265; Beck J, 1997, J VIROL, V71, P4971, DOI 10.1128/JVI.71.7.4971-4980.1997; Beck J, 2011, J VIROL, V85, P7742, DOI 10.1128/JVI.00482-11; Blumberg BS, 1997, P NATL ACAD SCI USA, V94, P7121, DOI 10.1073/pnas.94.14.7121; Cao XX, 2009, NUCLEIC ACIDS RES, V37, P4621, DOI 10.1093/nar/gkp489; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Flodell S, 2002, NUCLEIC ACIDS RES, V30, P4803, DOI 10.1093/nar/gkf603; Flodell S, 2006, NUCLEIC ACIDS RES, V34, P4449, DOI 10.1093/nar/gkl582; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Glebe D, 2007, WORLD J GASTROENTERO, V13, P8, DOI 10.3748/wjg.v13.i1.8; Gopinath SCB, 2006, J GEN VIROL, V87, P479, DOI 10.1099/vir.0.81508-0; Hicke BJ, 2000, J CLIN INVEST, V106, P923, DOI 10.1172/JCI11324; HIRSCH RC, 1991, J VIROL, V65, P3309, DOI 10.1128/JVI.65.6.3309-3316.1991; HIRSCH RC, 1990, NATURE, V344, P552, DOI 10.1038/344552a0; Hu JM, 2006, J VIROL, V80, P2141, DOI 10.1128/JVI.80.5.2141-2150.2006; Hu JM, 2004, J VIROL, V78, P13122, DOI 10.1128/JVI.78.23.13122-13131.2004; Hu JM, 1997, EMBO J, V16, P59, DOI 10.1093/emboj/16.1.59; Hu JM, 2002, J VIROL, V76, P269, DOI 10.1128/JVI.76.1.269-279.2002; Hu KH, 2004, NUCLEIC ACIDS RES, V32, P4377, DOI 10.1093/nar/gkh772; JUNKERNIEPMANN M, 1990, EMBO J, V9, P3389, DOI 10.1002/j.1460-2075.1990.tb07540.x; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kim HY, 2004, VIROLOGY, V322, P22, DOI 10.1016/j.virol.2004.01.009; KNAUS T, 1993, NUCLEIC ACIDS RES, V21, P3967, DOI 10.1093/nar/21.17.3967; Lee SM, 2003, VIRUS GENES, V27, P227, DOI 10.1023/A:1026339731001; MABIT H, 1994, J GEN VIROL, V75, P2681, DOI 10.1099/0022-1317-75-10-2681; Myslinski E, 2001, NUCLEIC ACIDS RES, V29, P2502, DOI 10.1093/nar/29.12.2502; Nassal M, 1996, J VIROL, V70, P2764, DOI 10.1128/JVI.70.5.2764-2773.1996; Nassal M, 1993, Trends Microbiol, V1, P221, DOI 10.1016/0966-842X(93)90136-F; Nassal M, 1999, INTERVIROLOGY, V42, P100, DOI 10.1159/000024970; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Pestourie C, 2005, BIOCHIMIE, V87, P921, DOI 10.1016/j.biochi.2005.04.013; POLLACK JR, 1993, J VIROL, V67, P3254, DOI 10.1128/JVI.67.6.3254-3263.1993; POLLACK JR, 1994, J VIROL, V68, P5579, DOI 10.1128/JVI.68.9.5579-5587.1994; Schaaf SG, 1999, J BIOL CHEM, V274, P37787, DOI 10.1074/jbc.274.53.37787; Scherer LJ, 2011, HUM MOL GENET, V20, pR100, DOI 10.1093/hmg/ddr160; SCHMID B, 2011, J VIROL; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Stahl M, 2007, J VIROL, V81, P13354, DOI 10.1128/JVI.01196-07; Stahl M, 2007, NUCLEIC ACIDS RES, V35, P6124, DOI 10.1093/nar/gkm628; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Sun DX, 2010, J HEPATOL, V52, P817, DOI 10.1016/j.jhep.2009.10.038; Thiel KW, 2009, OLIGONUCLEOTIDES, V19, P209, DOI 10.1089/oli.2009.0199; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; WANG GH, 1992, CELL, V71, P663, DOI 10.1016/0092-8674(92)90599-8; Wang XT, 2003, J VIROL, V77, P4471, DOI 10.1128/JVI.77.8.4471-4480.2003; Ying CX, 2007, P NATL ACAD SCI USA, V104, P8526, DOI 10.1073/pnas.0609883104; Zhao R, 2011, WORLD J GASTROENTERO, V17, P1152, DOI 10.3748/wjg.v17.i9.1152; Zhou JH, 2009, NUCLEIC ACIDS RES, V37, P3094, DOI 10.1093/nar/gkp185; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	70	77	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27862	10.1371/journal.pone.0027862	http://dx.doi.org/10.1371/journal.pone.0027862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125633	gold, Green Published, Green Submitted			2022-12-25	WOS:000297789200033
J	Aktipis, CA; Kwan, VSY; Johnson, KA; Neuberg, SL; Maley, CC				Aktipis, C. Athena; Kwan, Virginia S. Y.; Johnson, Kathryn A.; Neuberg, Steven L.; Maley, Carlo C.			Overlooking Evolution: A Systematic Analysis of Cancer Relapse and Therapeutic Resistance Research	PLOS ONE			English	Article							GENE AMPLIFICATION; IMATINIB RESISTANCE; ACQUIRED-RESISTANCE; BARRETTS-ESOPHAGUS; IN-SITU; CELL; PROGRESSION; MUTATIONS; HETEROGENEITY; CHEMOTHERAPY	Cancer therapy selects for cancer cells resistant to treatment, a process that is fundamentally evolutionary. To what extent, however, is the evolutionary perspective employed in research on therapeutic resistance and relapse? We analyzed 6,228 papers on therapeutic resistance and/or relapse in cancers and found that the use of evolution terms in abstracts has remained at about 1% since the 1980s. However, detailed coding of 22 recent papers revealed a higher proportion of papers using evolutionary methods or evolutionary theory, although this number is still less than 10%. Despite the fact that relapse and therapeutic resistance is essentially an evolutionary process, it appears that this framework has not permeated research. This represents an unrealized opportunity for advances in research on therapeutic resistance.	[Aktipis, C. Athena; Kwan, Virginia S. Y.; Johnson, Kathryn A.; Neuberg, Steven L.] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA; [Aktipis, C. Athena; Maley, Carlo C.] Univ Calif San Francisco, Ctr Evolut & Canc, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	Arizona State University; Arizona State University-Tempe; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Aktipis, CA (corresponding author), Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA.	aktipis@asu.edu			Center for Evolution and Cancer at the Helen Diller Family Comprehensive Cancer Center at University of California San Francisco; National Institutes of Health [F32 CA144331, R01 CA140657, R03 CA137811, P01 CA91955, R01 CA119224]; American Cancer Society [117209-RSG-09-163-01-CNE]; NATIONAL CANCER INSTITUTE [R03CA137811, R01CA140657, R01CA119224, F32CA144331, P01CA091955] Funding Source: NIH RePORTER	Center for Evolution and Cancer at the Helen Diller Family Comprehensive Cancer Center at University of California San Francisco; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research has been supported by the Center for Evolution and Cancer at the Helen Diller Family Comprehensive Cancer Center at University of California San Francisco, as well as National Institutes of Health grants F32 CA144331, R01 CA140657, R03 CA137811, P01 CA91955, and R01 CA119224 as well as the Landon American Association of Cancer Research Innovator Award for Cancer Prevention and Research Scholar Grant #117209-RSG-09-163-01-CNE from the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2000, AM STAT, V54, P280, DOI 10.2307/2685779; Agulnik M, 2006, J CLIN ONCOL, V24, P4801, DOI 10.1200/JCO.2005.03.4496; AKTIPIS CA, 2010, EVOL MED REV; Antonovics J, 2007, PLOS BIOL, V5, P137, DOI 10.1371/journal.pbio.0050030; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Cai WJ, 2010, RADIOTHER ONCOL, V96, P104, DOI 10.1016/j.radonc.2010.04.029; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; CARMAN MD, 1984, J CLIN ONCOL, V2, P16, DOI 10.1200/JCO.1984.2.1.16; Castro MAA, 2008, NUCLEIC ACIDS RES, V36, P6269, DOI 10.1093/nar/gkn636; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Chen LL, 2004, CANCER RES, V64, P5913, DOI 10.1158/0008-5472.CAN-04-0085; Choo BA, 2010, J CLIN ONCOL, V28, pE271, DOI 10.1200/JCO.2009.26.4168; Coley HM, 2008, CANCER TREAT REV, V34, P378, DOI 10.1016/j.ctrv.2008.01.007; Conrado-Abrao F, 2010, INTERACT CARDIOV TH, V11, P328, DOI 10.1510/icvts.2010.240606; Demacq C, 2010, CLIN CHIM ACTA, V411, P1335, DOI 10.1016/j.cca.2010.05.025; Diefenbach CSM, 2010, CURR OPIN ONCOL, V22, P419, DOI 10.1097/CCO.0b013e32833d58f2; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Fuchsjager MH, 2010, INT J RADIAT ONCOL, V78, P743, DOI 10.1016/j.ijrobp.2009.08.040; Gelman Susan., 2003, THE ESSENTIAL CHILD; Gonzalez-Garcia I, 2002, P NATL ACAD SCI USA, V99, P13085, DOI 10.1073/pnas.202139299; Grau E, 2010, J CANCER RES CLIN, V136, P1415, DOI 10.1007/s00432-010-0796-9; Harada T, 2002, CANCER RES, V62, P835; Heng HHQ, 2006, J CELL PHYSIOL, V208, P461, DOI 10.1002/jcp.20685; HORNS RC, 1984, J CLIN ONCOL, V2, P2, DOI 10.1200/JCO.1984.2.1.2; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kreuzer KA, 2003, ANN HEMATOL, V82, P284, DOI 10.1007/s00277-003-0644-y; Kuiper RP, 2010, LEUKEMIA, V24, P1258, DOI 10.1038/leu.2010.87; Le Scodan R, 2010, INT J RADIAT ONCOL, V78, P328, DOI 10.1016/j.ijrobp.2009.07.1735; Lorch A, 2010, J UROLOGY, V184, P168, DOI 10.1016/j.juro.2010.03.017; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Mallik MK, 2010, J THEOR BIOL, V266, P496, DOI 10.1016/j.jtbi.2010.07.009; Markopoulos CJ, 2010, CANCER METAST REV, V29, P581, DOI 10.1007/s10555-010-9248-x; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Merlo LMF, 2010, CANCER PREV RES, V3, P1388, DOI 10.1158/1940-6207.CAPR-10-0108; Mitra A, 2010, BRIT J CANCER, V103, P1229, DOI 10.1038/sj.bjc.6605849; MURPHY DS, 1995, J NATL CANCER I, V87, P1694, DOI 10.1093/jnci/87.22.1694; Nakamura J, 2010, INT J CANCER, V127, P1158, DOI 10.1002/ijc.25129; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nesse RM, 2010, P NATL ACAD SCI USA, V107, P1800, DOI 10.1073/pnas.0906224106; Noetzel E, 2010, ONCOGENE, V29, P4814, DOI 10.1038/onc.2010.229; NOWELL P C, 1962, Blut, V8, P65; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; PEREZREGADERA J, 2010, AM J CLIN ONCOL; Porrata LF, 2010, LEUKEMIA, V24, P1343, DOI 10.1038/leu.2010.108; Reid BJ, 1996, EUR J CANCER PREV, V5, P57, DOI 10.1097/00008469-199612002-00009; Roche-Lestienne C, 2003, SEMIN HEMATOL, V40, P80, DOI 10.1053/shem.2003.50046; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Sanchez BC, 2010, EUR J CANCER, V46, P1580, DOI 10.1016/j.ejca.2010.03.014; SCHIMKE RT, 1984, CANCER RES, V44, P1735; Servoll E, 2010, SCAND J UROL NEPHROL, V44, P217, DOI 10.3109/00365591003720283; Shah NP, 2007, J CLIN INVEST, V117, P2562, DOI 10.1172/JCI30890; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shtulman A, 2006, COGNITIVE PSYCHOL, V52, P170, DOI 10.1016/j.cogpsych.2005.10.001; Shtulman A, 2008, COGNITIVE SCI, V32, P1049, DOI 10.1080/03640210801897864; Tamborini E, 2004, GASTROENTEROLOGY, V127, P294, DOI 10.1053/j.gastro.2004.02.021; Taplin ME, 1999, CANCER RES, V59, P2511; Thirlwell C, 2010, GASTROENTEROLOGY, V138, P1441, DOI 10.1053/j.gastro.2010.01.033; TRENT JM, 1984, J CLIN ONCOL, V2, P8, DOI 10.1200/JCO.1984.2.1.8; Tsao JL, 2000, P NATL ACAD SCI USA, V97, P1236, DOI 10.1073/pnas.97.3.1236; Vangsted AJ, 2010, EUR J HAEMATOL, V85, P209, DOI 10.1111/j.1600-0609.2010.01465.x; Vanneste BGL, 2010, LUNG CANCER, V70, P218, DOI 10.1016/j.lungcan.2010.08.008; Varley KE, 2009, NUCLEIC ACIDS RES, V37, P4603, DOI 10.1093/nar/gkp457; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang TL, 2004, P NATL ACAD SCI USA, V101, P3089, DOI 10.1073/pnas.0308716101; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yegin ZA, 2010, TRANSFUS APHER SCI, V42, P239, DOI 10.1016/j.transci.2010.03.011	70	64	70	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e26100	10.1371/journal.pone.0026100	http://dx.doi.org/10.1371/journal.pone.0026100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22125594	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555800003
J	Hirota, T; Saeki, H; Tomita, K; Tanaka, S; Ebe, K; Sakashita, M; Yamada, T; Fujieda, S; Miyatake, A; Doi, S; Enomoto, T; Hizawa, N; Sakamoto, T; Masuko, H; Sasaki, T; Ebihara, T; Amagai, M; Esaki, H; Takeuchi, S; Furue, M; Noguchi, E; Kamatani, N; Nakamura, Y; Kubo, M; Tamari, M				Hirota, Tomomitsu; Saeki, Hidehisa; Tomita, Kaori; Tanaka, Shota; Ebe, Kouji; Sakashita, Masafumi; Yamada, Takechiyo; Fujieda, Shigeharu; Miyatake, Akihiko; Doi, Satoru; Enomoto, Tadao; Hizawa, Nobuyuki; Sakamoto, Tohru; Masuko, Hironori; Sasaki, Takashi; Ebihara, Tamotsu; Amagai, Masayuki; Esaki, Hitokazu; Takeuchi, Satoshi; Furue, Masutaka; Noguchi, Emiko; Kamatani, Naoyuki; Nakamura, Yusuke; Kubo, Michiaki; Tamari, Mayumi			Variants of C-C Motif Chemokine 22 (CCL22) Are Associated with Susceptibility to Atopic Dermatitis: Case-Control Studies	PLOS ONE			English	Article							MACROPHAGE-DERIVED CHEMOKINE; DENDRITIC CELLS; IN-VIVO; TH2; KERATINOCYTES; INFLAMMATION; EXPRESSION; DISEASE; THYMUS; IL-13	Atopic dermatitis (AD) is a common inflammatory skin disease caused by multiple genetic and environmental factors. AD is characterized by the local infiltration of T helper type 2 (Th2) cells. Recent clinical studies have shown important roles of the Th2 chemokines, CCL22 and CCL17 in the pathogenesis of AD. To investigate whether polymorphisms of the CCL22 gene affect the susceptibility to AD, we conducted association studies and functional studies of the related variants. We first resequenced the CCL22 gene and found a total of 39 SNPs. We selected seven tag SNPs in the CCL22 gene, and conducted association studies using two independent Japanese populations (1(st) population, 916 cases and 1,032 controls; 2(nd) population 1,034 cases and 1,004 controls). After the association results were combined by inverse variance method, we observed a significant association at rs4359426 (meta-analysis, combined P = 9.6 x 10(-6); OR, 0.74; 95% CI, 0.65-0.85). Functional analysis revealed that the risk allele of rs4359426 contributed to higher expression levels of CCL22 mRNA. We further examined the allelic differences in the binding of nuclear proteins by electrophoretic mobility shift assay. The signal intensity of the DNA-protein complex derived from the G allele of rs223821, which was in absolute LD with rs4359426, was higher than that from the A allele. Although further functional analyses are needed, it is likely that related variants play a role in susceptibility to AD in a gain-of-function manner. Our findings provide a new insight into the etiology and pathogenesis of AD.	[Saeki, Hidehisa] Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Tomita, Kaori; Sakashita, Masafumi; Yamada, Takechiyo; Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Div Otorhinolaryngol Head & Neck Surg, Dept Sensory & Locomotor Med, Fukui 910, Japan; [Tanaka, Shota] Univ Yamanashi, Dept Otorhinolaryngol Head & Neck Surg, Fac Med, Tamaho, Yamanashi, Japan; [Ebe, Kouji] Takao Hosp, Kyoto, Japan; [Miyatake, Akihiko] Miyatake Asthma Clin, Osaka, Japan; [Doi, Satoru] Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Pediat Allergy, Osaka, Japan; [Enomoto, Tadao] Nonprofit Org NPO Japan Hlth Promot Supporting Ne, Wakayama, Japan; [Hizawa, Nobuyuki; Sakamoto, Tohru; Masuko, Hironori] Univ Tsukuba, Div Resp Med, Inst Clin Med, Ibaraki, Japan; [Sasaki, Takashi; Ebihara, Tamotsu; Amagai, Masayuki] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Esaki, Hitokazu; Takeuchi, Satoshi; Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka 812, Japan; [Noguchi, Emiko] Univ Tsukuba, Dept Med Genet, Grad Sch Comprehens Human Sci, Ibaraki, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Tokyo, Japan	Jikei University; University of Fukui; University of Yamanashi; Osaka Prefectural Medical Center Respiratory & Allergic Diseases; University of Tsukuba; Keio University; Kyushu University; University of Tsukuba; University of Tokyo		tamari@src.riken.jp	Kubo, Michiaki/N-7947-2015; Amagai, Masayuki/K-5325-2013; Tamari, Mayumi/N-5378-2015; Sasaki, Takashi/AAD-1461-2019	Amagai, Masayuki/0000-0003-3314-7052; Esaki, Hitokazu/0000-0002-3716-520X; Sakamoto, Tohru/0000-0002-8876-1466; Sasaki, Takashi/0000-0002-6275-046X	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare, Japan; Rotary Club of Osaka-Midosuji District in Japan; Grants-in-Aid for Scientific Research [22591896, 22590834, 22791583, 221S0001, 23791204] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Rotary Club of Osaka-Midosuji District in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology and from the Ministry of Health, Labour and Welfare, Japan. This work was conducted as part of the BioBank Japan Project. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank all the patients for participating in the study as well as the collaborating physicians for collecting samples. We also thank the members of BioBank Japan and the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study and M. T. Shimizu, H. Sekiguchi, A. I. Jodo, N. Kawaraichi and the technical staff of the Center for Genomic Medicine for providing technical assistance. We thank K. Barrymore for proof reading this document.	Andrew DP, 1998, J IMMUNOL, V161, P5027; Fiset PO, 2006, J ALLERGY CLIN IMMUN, V118, P287, DOI 10.1016/j.jaci.2006.03.046; Flytlie HA, 2010, CYTOKINE, V49, P24, DOI 10.1016/j.cyto.2009.10.005; Fonacier LS, 2010, J ALLERGY CLIN IMMUN, V125, pS138, DOI 10.1016/j.jaci.2009.05.039; FUJITA H, 2011, J ALLERGY C IN PRESS; Guttman-Yassky E, 2007, J ALLERGY CLIN IMMUN, V119, P1210, DOI 10.1016/j.jaci.2007.03.006; Guttman-Yassky E, 2009, J ALLERGY CLIN IMMUN, V124, P1235, DOI 10.1016/j.jaci.2009.09.031; Hamid Q, 1996, J ALLERGY CLIN IMMUN, V98, P225, DOI 10.1016/S0091-6749(96)70246-4; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hashimoto S, 2006, J DERMATOL SCI, V44, P93, DOI 10.1016/j.jdermsci.2006.08.004; Horikawa T, 2002, INT IMMUNOL, V14, P767, DOI 10.1093/intimm/dxf044; Jahnz-Rozyk K, 2005, ALLERGY, V60, P685, DOI 10.1111/j.1398-9995.2005.00774.x; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Onouchi Y, 2010, HUM MOL GENET, V19, P2898, DOI 10.1093/hmg/ddq176; Perros F, 2009, ALLERGY, V64, P995, DOI 10.1111/j.1398-9995.2009.02095.x; Purwar R, 2006, J INVEST DERMATOL, V126, P1043, DOI 10.1038/sj.jid.5700085; Sekiya T, 2003, IMMUNOGENETICS, V54, P742, DOI 10.1007/s00251-002-0520-2; Shimada Y, 2004, J DERMATOL SCI, V34, P201, DOI 10.1016/j.jdermsci.2004.01.001; Shimizu M, 2005, HUM MOL GENET, V14, P2919, DOI 10.1093/hmg/ddi323; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Tsunemi Y, 2004, ACTA DERM-VENEREOL, V84, P187, DOI 10.1080/00015550410025859; Vulcano M, 2001, EUR J IMMUNOL, V31, P812, DOI 10.1002/1521-4141(200103)31:3<812::AID-IMMU812>3.0.CO;2-L; Watanabe M, 2008, J IMMUNOL, V181, P5653, DOI 10.4049/jimmunol.181.8.5653; Yamashita U, 2002, CRIT REV IMMUNOL, V22, P105	25	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e26987	10.1371/journal.pone.0026987	http://dx.doi.org/10.1371/journal.pone.0026987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22125604	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555800014
J	Jurczak, MJ; Lee, AH; Jornayvaz, FR; Lee, HY; Birkenfeld, AL; Guigni, BA; Kahn, M; Samuel, VT; Glimcher, LH; Shulman, GI				Jurczak, Michael J.; Lee, Ann-Hwee; Jornayvaz, Francois R.; Lee, Hui-Young; Birkenfeld, Andreas L.; Guigni, Blas A.; Kahn, Mario; Samuel, Varman T.; Glimcher, Laurie H.; Shulman, Gerald I.			Dissociation of Inositol-requiring Enzyme (IRE1 alpha)-mediated c-Jun N-terminal Kinase Activation from Hepatic Insulin Resistance in Conditional X-box-binding Protein-1 (XBP1) Knock-out Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; FATTY LIVER-DISEASE; DIET-INDUCED OBESITY; GLUCOSE-HOMEOSTASIS; ER STRESS; RECEPTOR SUBSTRATE-1; TRANSCRIPTION FACTOR; ENERGY-EXPENDITURE; MESSENGER-RNA; STEATOSIS	Hepatic insulin resistance has been attributed to both increased endoplasmic reticulum (ER) stress and accumulation of intracellular lipids, specifically diacylglycerol (DAG). The ER stress response protein, X-box-binding protein-1 (XBP1), was recently shown to regulate hepatic lipogenesis, suggesting that hepatic insulin resistance in models of ER stress may result from defective lipid storage, as opposed to ER-specific stress signals. Studies were designed to dissociate liver lipid accumulation and activation of ER stress signaling pathways, which would allow us to delineate the individual contributions of ER stress and hepatic lipid content to the pathogenesis of hepatic insulin resistance. Conditional XBP1 knock-out (XBP1 Delta) and control mice were fed fructose chow for 1 week. Determinants of whole-body energy balance, weight, and composition were determined. Hepatic lipids including triglyceride, DAGs, and ceramide were measured, alongside markers of ER stress. Whole-body and tissue-specific insulin sensitivity were determined by hyperinsulinemic-euglycemic clamp studies. Hepatic ER stress signaling was increased in fructose chow-fed XBP1 Delta mice as reflected by increased phosphorylated eIF2 alpha, HSPA5 mRNA, and a 2-fold increase in hepatic JNK activity. Despite JNK activation, XBP1 Delta displayed increased hepatic insulin sensitivity during hyperinsulinemic-euglycemic clamp studies, which was associated with increased insulin-stimulated IRS2 tyrosine phosphorylation, reduced hepatic DAG content, and reduced PKC epsilon activity. These studies demonstrate that ER stress and IRE1 alpha-mediated JNK activation can be disassociated from hepatic insulin resistance and support the hypothesis that hepatic insulin resistance in models of ER stress may be secondary to ER stress modulation of hepatic lipogenesis.	[Jurczak, Michael J.; Lee, Hui-Young; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06536 USA; [Jornayvaz, Francois R.; Birkenfeld, Andreas L.; Guigni, Blas A.; Kahn, Mario; Samuel, Varman T.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06536 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA; [Lee, Ann-Hwee; Glimcher, Laurie H.] Harvard Univ, Sch Med, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Glimcher, Laurie H.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, TAC S269,POB 9812, New Haven, CT 06536 USA.	gerald.shulman@yale.edu	Birkenfeld, Andreas L./U-3954-2019; Jornayvaz, François/AAL-2134-2020; Shulman, Gerald I./P-7176-2019	Birkenfeld, Andreas L./0000-0003-1407-9023; Shulman, Gerald I./0000-0003-1529-5668; Jurczak, Michael/0000-0002-6335-6915; Guigni, Blas/0000-0002-9667-8195; Jornayvaz, Francois/0000-0001-9425-3137; Lee, Hui-Young/0000-0002-3464-6382	United States Public Health Service [R01 DK-40936, P30 DK-45735, U24 DK-059635, DK-082448]; American Heart Foundation; Swiss National Science Foundation [PASMP3-132563]; German Research Science Foundation [Bi1292/4-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK040936, R01DK082448, U24DK059635] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Heart Foundation(American Heart Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by United States Public Health Service Grants R01 DK-40936, P30 DK-45735, U24 DK-059635, and DK-082448 (to L. H. G.), the American Heart Foundation (to A.-H. L.), Swiss National Science Foundation Grant PASMP3-132563 (to F. R. J.), and German Research Science Foundation Grant Bi1292/4-1 (to A. L. B.).	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Deevska GM, 2009, J BIOL CHEM, V284, P8359, DOI 10.1074/jbc.M807800200; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Han MS, 2009, DIABETES, V58, P329, DOI 10.2337/db08-0080; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010; Jurczak MJ, 2011, DIABETES, V60, P890, DOI 10.2337/db10-1328; Kim JK, 2001, J CLIN INVEST, V108, P153, DOI 10.1172/JCI10294; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sabio G, 2010, MOL CELL BIOL, V30, P106, DOI 10.1128/MCB.01162-09; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Sreejayan N, 2008, OBESITY, V16, P1331, DOI 10.1038/oby.2008.217; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Whitmarsh AJ, 2001, METHOD ENZYMOL, V332, P319; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Ye RS, 2010, DIABETES, V59, P6, DOI 10.2337/db09-0755; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; YOUN JH, 1993, DIABETES, V42, P757, DOI 10.2337/diabetes.42.5.757; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293	54	121	124	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2558	2567		10.1074/jbc.M111.316760	http://dx.doi.org/10.1074/jbc.M111.316760			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22128176	hybrid, Green Published			2022-12-25	WOS:000300292300029
J	Skizim, NJ; Ananyev, GM; Krishnan, A; Dismukes, GC				Skizim, Nicholas J.; Ananyev, Gennady M.; Krishnan, Anagha; Dismukes, G. Charles			Metabolic Pathways for Photobiological Hydrogen Production by Nitrogenase- and Hydrogenase-containing Unicellular Cyanobacteria Cyanothece	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAIN ATCC 51142; DIAZOTROPHIC CYANOBACTERIUM; FIXING CYANOBACTERIA; H-2 PHOTOPRODUCTION; FIXATION; FLUX; CAPACITY; CHAIN; RATES; N-2	Current biotechnological interest in nitrogen-fixing cyanobacteria stems from their robust respiration and capacity to produce hydrogen. Here we quantify both dark-and light-induced H-2 effluxes by Cyanothece sp. Miami BG 043511 and establish their respective origins. Dark, anoxic H-2 production occurs via hydrogenase utilizing reductant from glycolytic catabolism of carbohydrates (autofermentation). Photo-H-2 is shown to occur via nitrogenase and requires illumination of PSI, whereas production of O-2 by co-illumination of PSII is inhibitory to nitrogenase above a threshold pO(2). Carbohydrate also serves as the major source of reductant for the PSI pathway mediated via nonphotochemical reduction of the plastoquinone pool by NADH dehydrogenases type-1 and type-2 (NDH-1 and NDH-2). Redirection of this reductant flux exclusively through the proton-coupled NDH-1 by inhibition of NDH-2 with flavone increases the photo-H-2 production rate by 2-fold (at the expense of the dark-H-2 rate), due to production of additional ATP (via the proton gradient). Comparison of photobiological hydrogen rates, yields, and energy conversion efficiencies reveals opportunities for improvement.	[Skizim, Nicholas J.; Ananyev, Gennady M.; Krishnan, Anagha; Dismukes, G. Charles] Rutgers State Univ, Dept Chem & Chem Biol, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Skizim, Nicholas J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Rutgers State University New Brunswick; Princeton University	Dismukes, GC (corresponding author), 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	dismukes@rci.rutgers.edu	Dismukes, Gerard C/I-4905-2012	Dismukes, Gerard C/0000-0003-0155-0541	United States Department of Energy [DE-PS02-07ER07-13]; Air Force Office of Scientific Research [AFOSR-MURI-FA9550-05-1-0365]	United States Department of Energy(United States Department of Energy (DOE)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by United States Department of Energy Genomes to Life program Grant DE-PS02-07ER07-13 and Air Force Office of Scientific Research Grant AFOSR-MURI-FA9550-05-1-0365.	Ananyev G, 2008, APPL ENVIRON MICROB, V74, P6102, DOI 10.1128/AEM.01078-08; Bandyopadhyay A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1139; Barney BM, 2004, J BIOL CHEM, V279, P53621, DOI 10.1074/jbc.M410247200; Battchikova N, 2011, BBA-BIOENERGETICS, V1807, P935, DOI 10.1016/j.bbabio.2010.10.017; Bennette NB, 2011, ANAL CHEM, V83, P3808, DOI 10.1021/ac200108a; Borodin VB, 2002, MAR BIOL, V140, P455, DOI 10.1007/s00227-001-0721-5; Bothe H, 2010, MICROBIOL MOL BIOL R, V74, P529, DOI 10.1128/MMBR.00033-10; Burgdorf T, 2005, J BACTERIOL, V187, P3122, DOI 10.1128/JB.187.9.3122-3132.2005; Carrieri D, 2008, INT J HYDROGEN ENERG, V33, P2014, DOI 10.1016/j.ijhydene.2008.02.022; Carrieri D, 2010, APPL ENVIRON MICROB, V76, P6455, DOI 10.1128/AEM.00975-10; Cooley JW, 2001, J BACTERIOL, V183, P4251, DOI 10.1128/JB.183.14.4251-4258.2001; DANON A, 1974, P NATL ACAD SCI USA, V71, P1234, DOI 10.1073/pnas.71.4.1234; Dutta D, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-36; Falkowski P. G., 1997, AQUATIC PHOTOSYNTHES, pviii; GALLON JR, 1992, NEW PHYTOL, V122, P571; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Howitt CA, 1999, J BACTERIOL, V181, P3994, DOI 10.1128/JB.181.13.3994-4003.1999; James B., 2009, SR56046674 US DEP EN, P207; Klamt S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100191; Koebmann BJ, 2002, J BACTERIOL, V184, P3909, DOI 10.1128/JB.184.14.3909-3916.2002; Laurinavichene TV, 2008, J BIOTECHNOL, V134, P275, DOI 10.1016/j.jbiotec.2008.01.006; Ludwig M, 2006, J MOL EVOL, V63, P758, DOI 10.1007/s00239-006-0001-6; Maroti J, 2010, APPL ENVIRON MICROB, V76, P5113, DOI 10.1128/AEM.00351-10; Masukawa H, 2007, APPL ENVIRON MICROB, V73, P7562, DOI 10.1128/AEM.01160-07; McKinlay JB, 2010, CURR OPIN BIOTECH, V21, P244, DOI 10.1016/j.copbio.2010.02.012; McNeely K, 2010, APPL ENVIRON MICROB, V76, P5032, DOI 10.1128/AEM.00862-10; Min HT, 2010, APPL ENVIRON MICROB, V76, P7641, DOI 10.1128/AEM.01456-10; Min HT, 2010, APPL ENVIRON MICROB, V76, P4293, DOI 10.1128/AEM.00146-10; MITSUI A, 1986, NATURE, V323, P720, DOI 10.1038/323720a0; MITSUI A, 1987, PHYSIOL PLANTARUM, V69, P1, DOI 10.1111/j.1399-3054.1987.tb01938.x; MITSUI A, 1995, CURR MICROBIOL, V30, P1, DOI 10.1007/BF00294515; Nixon P. J., 2006, CHLORORESPIRATORY PA, P237; Peschek GA, 2004, PHYSIOL PLANTARUM, V120, P358, DOI 10.1111/j.1399-3054.2004.00274.x; REDDY KJ, 1993, J BACTERIOL, V175, P1284, DOI 10.1128/JB.175.5.1284-1292.1993; Schneegurt MA, 2000, J PHYCOL, V36, P107, DOI 10.1046/j.1529-8817.2000.99152.x; SCHNEEGURT MA, 1994, J BACTERIOL, V176, P1586, DOI 10.1128/jb.176.6.1586-1597.1994; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; SUDA S, 1992, ARCH MICROBIOL, V158, P1, DOI 10.1007/BF00249056; Toepel J, 2008, J BACTERIOL, V190, P3904, DOI 10.1128/JB.00206-08; Tsygankov AA, 2007, APPL BIOCHEM MICRO+, V43, P250, DOI 10.1134/S0003683807030040; VANDEROOST J, 1989, NUCLEIC ACIDS RES, V17, P10098; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	44	26	26	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2777	2786		10.1074/jbc.M111.302125	http://dx.doi.org/10.1074/jbc.M111.302125			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22128188	Green Published, hybrid			2022-12-25	WOS:000300292300049
J	Dudok, JJ; Groffen, AJA; Toonen, RFT; Verhage, M				Dudok, Jacobus J.; Groffen, Alexander J. A.; Toonen, Ruud F. T.; Verhage, Matthijs			Deletion of Munc18-1 in 5-HT Neurons Results in Rapid Degeneration of the 5-HT System and Early Postnatal Lethality	PLOS ONE			English	Article							SEROTONIN NEURONS; REGULATED SECRETION; BRAIN-SEROTONIN; KNOCKOUT MICE; ABSENCE; INNERVATION	The serotonin (5-HT) system densely innervates many brain areas and is important for proper brain development. To specifically ablate the 5-HT system we generated mutant mice carrying a floxed Munc18-1 gene and Cre recombinase driven by the 5-HT-specific serotonin reuptake transporter (SERT) promoter. The majority of mutant mice died within a few days after birth. Immunohistochemical analysis of brains of these mice showed that initially 5-HT neurons are formed and the cortex is innervated with 5-HT projections. From embryonic day 16 onwards, however, 5-HT neurons started to degenerate and at postnatal day 2 hardly any 5-HT projections were present in the cortex. The 5-HT system of mice heterozygous for the floxed Munc18-1 allele was indistinguishable from control mice. These data show that deletion of Munc18-1 in 5-HT neurons results in rapid degeneration of the 5-HT system and suggests that the 5-HT system is important for postnatal survival.	[Dudok, Jacobus J.; Groffen, Alexander J. A.; Toonen, Ruud F. T.; Verhage, Matthijs] Vrije Univ Amsterdam, Dept Funct Genom, CNCR, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Dudok, JJ (corresponding author), Netherlands Inst Neurosci, Dept Neuromed Genet, Amsterdam, Netherlands.	matthijs.verhage@cncr.vu.nl	Groffen, A.J.A./C-1118-2009	Groffen, A.J.A./0000-0003-0046-4027; Dudok, Jacobus/0000-0002-7407-2491; Toonen, Ruud/0000-0002-9900-4233; verhage, matthijs/0000-0002-6085-7503	Dutch Organization for Scientific Research (Zon-MW Pionier) [MW-PIO900-01-001]	Dutch Organization for Scientific Research (Zon-MW Pionier)	This work was supported by the Dutch Organization for Scientific Research (Zon-MW Pionier MW-PIO900-01-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; BENNETTCLARKE CA, 1995, BRAIN RES, V702, P255, DOI 10.1016/0006-8993(95)00867-5; Bunin MA, 1998, J NEUROSCI, V18, P4854; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Donovan SL, 2002, J NEUROSCI, V22, P3543; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Heeroma JH, 2004, EUR J NEUROSCI, V20, P623, DOI 10.1111/j.1460-9568.2004.03503.x; Heeroma JH, 2003, NEUROSCIENCE, V120, P733, DOI 10.1016/S0306-4522(03)00258-6; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; Hodges MR, 2009, J NEUROSCI, V29, P10341, DOI 10.1523/JNEUROSCI.1963-09.2009; Hohmann CF, 2007, BRAIN RES, V1139, P163, DOI 10.1016/j.brainres.2006.12.095; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Korteweg N, 2004, EUR J NEUROSCI, V19, P2944, DOI 10.1111/j.0953-816X.2004.03383.x; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; Narboux-Neme N, 2008, NEUROPHARMACOLOGY, V55, P994, DOI 10.1016/j.neuropharm.2008.08.020; RIDET JL, 1993, NEUROSCIENCE, V52, P143, DOI 10.1016/0306-4522(93)90189-M; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	24	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28137	10.1371/journal.pone.0028137	http://dx.doi.org/10.1371/journal.pone.0028137			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140524	Green Published, Green Submitted, gold			2022-12-25	WOS:000298166300028
J	Perez-Losada, M; Breinholt, JW; Porto, PG; Aira, M; Dominguez, J				Perez-Losada, Marcos; Breinholt, Jesse W.; Porto, Pablo G.; Aira, Manuel; Dominguez, Jorge			An Earthworm Riddle: Systematics and Phylogeography of the Spanish Lumbricid Postandrilus	PLOS ONE			English	Article							SPECIES DELIMITATION; DNA; OLIGOCHAETA; EVOLUTION; MITOCHONDRIAL; POPULATION; DIVERGENCE; INFERENCE; SELECTION; MODELS	Backgroud: As currently defined, the genus Postandrilus Qui and Bouche, 1998, (Lumbricidae) includes six earthworm species, five occurring in Majorca (Baleares Islands, western Mediterranean) and another in Galicia (NW Spain). This disjunct and restricted distribution raises some interesting phylogeographic questions: (1) Is Postandrilus distribution the result of the separation of the Baleares-Kabylies (BK) microplate from the proto-Iberian Peninsula in the Late Oligocene (30-28 Mya) - vicariant hypothesis? (2) Did Postandrilus diversify in Spain and then colonize the Baleares during the Messinian salinity crisis (MSC) 5.96-5.33 Mya - dispersal hypothesis? (3) Is the distribution the result of a two-step process - vicariance with subsequent dispersal? Methodology/Principal Findings: To answer these questions and assess Postandrilus evolutionary relationships and systematics, we collected all of the six Postandrilus species (46 specimens - 16 locations) and used Aporrectodea morenoe and three Prosellodrilus and two Cataladrilus species as the outgroup. Regions of the nuclear 28S rDNA and mitochondrial 16S rDNA, 12S rDNA, ND1, COII and tRNA genes (4,666 bp) were sequenced and analyzed using maximum likelihood and Bayesian methods of phylogenetic and divergence time estimation. The resulting trees revealed six new Postandrilus species in Majorca that clustered with the other five species already described. This Majorcan clade was sister to an Iberian clade including A. morenoe (outgroup) and Postandrilus bertae. Our phylogeny and divergence time estimates indicated that the split between the Iberian and Majorcan Postandrilus clades took place 30.1 Mya, in concordance with the break of the BK microplate from the proto-Iberian Peninsula, and that the present Majorcan clade diversified 5.7 Mya, during the MSC. Conclusions: Postandrilus is highly diverse including multiple cryptic species in Majorca. The genus is not monophyletic and invalid as currently defined. Postandrilus is of vicariant origin and its radiation began in the Late Oligocene.	[Perez-Losada, Marcos] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet CIBIO, Vairao, Portugal; [Breinholt, Jesse W.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Porto, Pablo G.; Aira, Manuel; Dominguez, Jorge] Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Spain	Universidade do Porto; Brigham Young University; Universidade de Vigo	Perez-Losada, M (corresponding author), Univ Porto, Ctr Invest Biodiversidade & Recursos Genet CIBIO, Campus Agr Vairao, Vairao, Portugal.	mlosada323@gmail.com	Domínguez, Jorge/T-7647-2019; Aira, Manuel/B-4506-2016; Domínguez, Jorge/M-2046-2014; Breinholt, Jesse/K-6252-2019; Breinholt, Jesse/F-4330-2014; Perez-Losada, Marcos/I-4407-2013	Domínguez, Jorge/0000-0002-4313-8582; Aira, Manuel/0000-0002-2513-4609; Domínguez, Jorge/0000-0002-4313-8582; Breinholt, Jesse/0000-0002-3867-2430; Breinholt, Jesse/0000-0002-3867-2430; Perez-Losada, Marcos/0000-0002-2585-4657	Spanish Ministerio de Ciencia e Innovacion [CTM2009-08477]; Xunta de Galicia [GCR2008/073]; Xunta de Galicia (Spain); Ministerio de Educacion y Ciencia (Spain)	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Xunta de Galicia (Spain)(Xunta de Galicia); Ministerio de Educacion y Ciencia (Spain)(Spanish Government)	This study was financially supported by the Spanish Ministerio de Ciencia e Innovacion (CTM2009-08477) and by the Xunta de Galicia (GCR2008/073). MA was financially supported by a Parga Pondal fellowship from the Xunta de Galicia (Spain). PGP was financially supported by a predoctoral fellowship from the Ministerio de Educacion y Ciencia (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ W, 1974, NATURE, V248, P309, DOI 10.1038/248309a0; Blakemore RJ, 2007, SERIES SEARCHABLE TE, P1; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Chang CH, 2005, PEDOBIOLOGIA, V49, P591, DOI 10.1016/j.pedobi.2005.07.002; Chang CH, 2009, PEDOBIOLOGIA, V52, P171, DOI 10.1016/j.pedobi.2008.08.002; Chang CH, 2008, MOL PHYLOGENET EVOL, V49, P958, DOI 10.1016/j.ympev.2008.08.025; Dawson AG, 1992, ICE AGE EARTH LATE Q; Diaz Cosin D.J., 1986, Revue d'Ecologie et de Biologie du Sol, V22, P507; Diaz Cosin DJ, 1985, MEGADRILOGICA, V4, P131; Drummond A. J., 2009, TRACER MCMC TRACE AN; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards C.A., 1996, BIOL ECOLOGY EARTHWO, V3rd; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garcia-Castellanos D, 2009, NATURE, V462, P778, DOI 10.1038/nature08555; Huang J, 2007, PEDOBIOLOGIA, V51, P301, DOI 10.1016/j.pedobi.2007.05.003; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Briones MJI, 2009, SOIL BIOL BIOCHEM, V41, P2257, DOI 10.1016/j.soilbio.2009.07.008; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; King RA, 2008, MOL ECOL, V17, P4684, DOI 10.1111/j.1365-294X.2008.03931.x; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Krijgsman W, 2002, EARTH PLANET SC LETT, V205, P1, DOI 10.1016/S0012-821X(02)01008-7; LEE K. E., 1959, NEW ZEALAND DEPT SCI AND INDUST REA BULL, V130, P1; Marshall JC, 2006, EVOLUTION, V60, P1050; MEIJER J, 1972, PEDOBIOLOGIA, V12, P409; Meulenkamp JE, 2003, PALAEOGEOGR PALAEOCL, V196, P209, DOI 10.1016/S0031-0182(03)00319-5; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Minamiya Y, 2009, EUR J SOIL BIOL, V45, P423, DOI 10.1016/j.ejsobi.2009.06.004; Novo M, 2011, MOL PHYLOGENET EVOL, V61, P125, DOI 10.1016/j.ympev.2011.05.018; Novo M, 2010, MOL PHYLOGENET EVOL, V56, P507, DOI 10.1016/j.ympev.2010.04.010; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Perez-Losada M, 2005, PEDOBIOLOGIA, V49, P317, DOI 10.1016/j.pedobi.2005.02.004; Perez-Losada M, 2004, SYST BIOL, V53, P244, DOI 10.1080/10635150490423458; Perez-Losada M, 2011, EUR J SOIL BIO UNPUB; Perez-Losada M, 2009, MOL PHYLOGENET EVOL, V52, P293, DOI 10.1016/j.ympev.2009.04.003; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Qiu J-P, 1998, DOC PEDOZOOLOGIQ INT, V4, P65; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenbaum G., 2002, J VIRTUAL EXPLORER, V8, P107, DOI DOI 10.3809/JVIRTEX.2002.00053; Rouchy JM, 2006, SEDIMENT GEOL, V188, P35, DOI 10.1016/j.sedgeo.2006.02.005; Sei M, 2007, MOL ECOL, V16, P3313, DOI 10.1111/j.1365-294X.2007.03384.x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Thomas JA, 2006, P NATL ACAD SCI USA, V103, P7366, DOI 10.1073/pnas.0510251103; Thomas JA, 2010, MOL BIOL EVOL, V27, P1173, DOI 10.1093/molbev/msq009; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wiens JJ, 1998, SYST BIOL, V47, P568, DOI 10.1080/106351598260581; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878	55	35	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28153	10.1371/journal.pone.0028153	http://dx.doi.org/10.1371/journal.pone.0028153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140529	Green Submitted, Green Published, gold			2022-12-25	WOS:000298166300032
J	Mielcarek, M; Benn, CL; Franklin, SA; Smith, DL; Woodman, B; Marks, PA; Bates, GP				Mielcarek, Michal; Benn, Caroline L.; Franklin, Sophie A.; Smith, Donna L.; Woodman, Ben; Marks, Paul A.; Bates, Gillian P.			SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; NEURONAL INTRANUCLEAR INCLUSIONS; SUBEROYLANILIDE HYDROXAMIC ACID; NEUROTROPHIC FACTOR; EXPRESSION; TRANSCRIPTION; PATHOGENESIS; UNDERLIES; TRIALS	Huntington's disease (HD) is a progressive neurological disorder for which there are no disease-modifying treatments. Transcriptional dysregulation is a major molecular feature of HD, which significantly contributes to disease progression. Therefore, the development of histone deacetylase (HDAC) inhibitors as therapeutics for HD has been energetically pursued. Suberoylanilide hydroxamic acid (SAHA) - a class I HDAC as well an HDAC6 inhibitor, improved motor impairment in the R6/2 mouse model of HD. Recently it has been found that SAHA can also promote the degradation of HDAC4 and possibly other class IIa HDACs at the protein level in various cancer cell lines. To elucidate whether SAHA is a potent modifier of HDAC protein levels in vivo, we performed two independent mouse trials. Both WT and R6/2 mice were chronically treated with SAHA and vehicle. We found that prolonged SAHA treatment causes the degradation of HDAC4 in cortex and brain stem, but not hippocampus, without affecting its transcript levels in vivo. Similarly, SAHA also decreased HDAC2 levels without modifying the expression of its mRNA. Consistent with our previous data, SAHA treatment diminishes Hdac7 transcript levels in both wild type and R6/2 brains and unexpectedly was found to decrease Hdac11 in R6/2 but not wild type. We investigated the effects of SAHA administration on well-characterised molecular readouts of disease progression. We found that SAHA reduces SDS-insoluble aggregate load in the cortex and brain stem but not in the hippocampus of the R6/2 brains, and that this was accompanied by restoration of Bdnf cortical transcript levels.	[Mielcarek, Michal; Franklin, Sophie A.; Smith, Donna L.; Woodman, Ben; Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Benn, Caroline L.] Pfizer Inc, Neusentis, Cambridge, England; [Marks, Paul A.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, Sloan Kettering Inst Canc Res, New York, NY 10021 USA	University of London; King's College London; Pfizer; Memorial Sloan Kettering Cancer Center	Mielcarek, M (corresponding author), Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England.	gillian.bates@kcl.ac.uk	Mielcarek, Michal/M-6302-2018; Bates, Gillian P/E-1146-2012	Mielcarek, Michal/0000-0002-9874-6753; Bates, Gillian P/0000-0002-4041-6305	CHDI Foundation	CHDI Foundation	This work was funded by the CHDI Foundation, a privately-funded non-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. For this study, the CHDI Foundation assisted with the analysis of SAHA stability, purity and pharmacokinetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; BATES G, 2002, HUNTINGTONS DIS; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Benn CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005747; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Chen H, 2011, J CELL BIOCH; Codd R, 2009, INT J BIOCHEM CELL B, V41, P736, DOI 10.1016/j.biocel.2008.05.026; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dokmanovic M, 2007, MOL CANCER THER, V6, P2525, DOI 10.1158/1535-7163.MCT-07-0251; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Hughes RE, 2001, P NATL ACAD SCI USA, V98, P13201, DOI 10.1073/pnas.191498198; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Novak MJU, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3109; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Richon VM, 1998, P NATL ACAD SCI USA, V95, P3003, DOI 10.1073/pnas.95.6.3003; Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Scognamiglio A, 2008, BBA-MOL CELL RES, V1783, P2030, DOI 10.1016/j.bbamcr.2008.07.007; Silvestroni A, 2009, NEUROREPORT, V20, P1098, DOI 10.1097/WNR.0b013e32832e34ee; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Takahashi T, 2010, J MOL CELL BIOL, V2, P180, DOI 10.1093/jmcb/mjq005; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Wu XF, 2008, INT J NEUROPSYCHOPH, V11, P1123, DOI 10.1017/S1461145708009024; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	42	122	128	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27746	10.1371/journal.pone.0027746	http://dx.doi.org/10.1371/journal.pone.0027746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140466	gold, Green Submitted, Green Published			2022-12-25	WOS:000298163400018
J	Downar, J; Bhatt, M; Montague, PR				Downar, Jonathan; Bhatt, Meghana; Montague, P. Read			Neural Correlates of Effective Learning in Experienced Medical Decision-Makers	PLOS ONE			English	Article							HUMAN BRAIN; PREDICTION ERRORS; HUMAN STRIATUM; PSYCHOSIS; RESPONSES; REWARD; SENSITIVITY; OXYGENATION; CONTRAST; CORTEX	Accurate associative learning is often hindered by confirmation bias and success-chasing, which together can conspire to produce or solidify false beliefs in the decision-maker. We performed functional magnetic resonance imaging in 35 experienced physicians, while they learned to choose between two treatments in a series of virtual patient encounters. We estimated a learning model for each subject based on their observed behavior and this model divided clearly into high performers and low performers. The high performers showed small, but equal learning rates for both successes (positive outcomes) and failures (no response to the drug). In contrast, low performers showed very large and asymmetric learning rates, learning significantly more from successes than failures; a tendency that led to sub-optimal treatment choices. Consistently with these behavioral findings, high performers showed larger, more sustained BOLD responses to failed vs. successful outcomes in the dorsolateral prefrontal cortex and inferior parietal lobule while low performers displayed the opposite response profile. Furthermore, participants' learning asymmetry correlated with anticipatory activation in the nucleus accumbens at trial onset, well before outcome presentation. Subjects with anticipatory activation in the nucleus accumbens showed more success-chasing during learning. These results suggest that high performers' brains achieve better outcomes by attending to informative failures during training, rather than chasing the reward value of successes. The differential brain activations between high and low performers could potentially be developed into biomarkers to identify efficient learners on novel decision tasks, in medical or other contexts.	[Downar, Jonathan] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Downar, Jonathan] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada; [Bhatt, Meghana] City Hope Hosp, Beckman Res Inst, Duarte, CA USA; [Montague, P. Read] Virginia Tech, Human Neuroimaging Lab, Caril Res Inst, Roanoke, VA USA; [Montague, P. Read] Virginia Tech, Dept Phys, Roanoke, VA USA; [Montague, P. Read] UCL, Wellcome Trust Ctr Neuroimaging, London, England	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; City of Hope; Beckman Research Institute of City of Hope; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of London; University College London	Downar, J (corresponding author), Univ Toronto, Dept Psychiat, Toronto, ON, Canada.	read@vt.edu	Downar, Jonathan/I-9002-2016	Downar, Jonathan/0000-0002-5140-174X; Lauwereyns, Jan/0000-0003-0551-2550	National Institutes of Health [1 RC4 AG039067, R01 DA11723-02, 2R01 MH085496-05A2]; The Kane Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC4AG039067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Kane Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by the following grants: National Institutes of Health grant # 1 RC4 AG039067, National Institutes of Health grant # R01 DA11723-02, National Institutes of Health grant # 2R01 MH085496-05A2 The Kane Foundation Fellowship. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 1988, LANCET, V2, P349; Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Corlett PR, 2006, ARCH GEN PSYCHIAT, V63, P611, DOI 10.1001/archpsyc.63.6.611; Corlett PR, 2004, NEURON, V44, P877, DOI 10.1016/j.neuron.2004.11.022; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Downar J, 2001, NEUROIMAGE, V14, P1256, DOI 10.1006/nimg.2001.0946; Fletcher PC, 2001, NAT NEUROSCI, V4, P1043, DOI 10.1038/nn733; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Murray GK, 2010, SCHIZOPHRENIA BULL, V36, P465, DOI 10.1093/schbul/sbq005; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Popper K. R., 1934, LOGIC SCI DISCOVERY; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Rodriguez PF, 2006, HUM BRAIN MAPP, V27, P306, DOI 10.1002/hbm.20186; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; SKINNER BF, 1948, J EXP PSYCHOL, V38, P168, DOI 10.1037//0096-3445.121.3.273; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Wason P., 1966, NEW HORIZONS PSYCHOL	28	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27768	10.1371/journal.pone.0027768	http://dx.doi.org/10.1371/journal.pone.0027768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132137	Green Published, Green Submitted, gold			2022-12-25	WOS:000298162000039
J	Pan, S; Chen, R; Stevens, T; Bronner, MP; May, D; Tamura, Y; McIntosh, MW; Brentnall, TA				Pan, Sheng; Chen, Ru; Stevens, Tyler; Bronner, Mary P.; May, Damon; Tamura, Yasuko; McIntosh, Martin W.; Brentnall, Teresa A.			Proteomics Portrait of Archival Lesions of Chronic Pancreatitis	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUES; TANDEM MASS-SPECTROMETRY; SPLENIC VEIN-THROMBOSIS; EXTRACELLULAR-MATRIX; BIOMARKER DISCOVERY; STATISTICAL-MODEL; CANCER-TISSUE; PROTEINS; ADENOCARCINOMA; CELLS	Chronic pancreatitis is a chronic inflammatory disorder of the pancreas. The etiology is multi-fold, but all lead to progressive scarring and loss of pancreatic function. Early diagnosis is difficult; and the understanding of the molecular events that underlie this progressive disease is limited. In this study, we investigated differential proteins associated with mild and severe chronic pancreatitis in comparison with normal pancreas and pancreatic cancer. Paraffin-embedded formalin-fixed tissues from five well-characterized specimens each of normal pancreas (NL), mild chronic pancreatitis (MCP), severe chronic pancreatitis (SCP) and pancreatic ductal adenocarcinoma (PDAC) were subjected to proteomic analysis using a "label-free" comparative approach. Our results show that the numbers of differential proteins increase substantially with the disease severity, from mild to severe chronic pancreatitis, while the number of dysregulated proteins is highest in pancreatic adenocarcinoma. Important functional groups and biological processes associated with chronic pancreatitis and cancer include acinar cell secretory proteins, pancreatic fibrosis/stellate cell activation, glycoproteins, and inflammatory proteins. Three differential proteins were selected for verification by immunohistochemistry, including collagen 14A1, lumican and versican. Further canonical pathway analysis revealed that acute phase response signal, prothrombin activation pathway, and pancreatic fibrosis/pancreatic stellate cell activation pathway were the most significant pathways involved in chronic pancreatitis, while pathways relating to metabolism were the most significant pathways in pancreatic adenocarcinoma. Our study reveals a group of differentially expressed proteins and the related pathways that may shed light on the pathogenesis of chronic pancreatitis and the common molecular events associated with chronic pancreatitis and pancreatic adenocarcinoma.	[Pan, Sheng; Chen, Ru; Tamura, Yasuko; Brentnall, Teresa A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Stevens, Tyler] Cleveland Clin Fdn, Inst Digest Dis, Cleveland, OH 44195 USA; [Bronner, Mary P.] Univ Utah, Dept Anat Pathol, Salt Lake City, UT USA; [May, Damon; McIntosh, Martin W.] Fred Hutchinson Canc Res Ctr, Mol Diagnost Program, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Cleveland Clinic Foundation; Utah System of Higher Education; University of Utah; Fred Hutchinson Cancer Center	Pan, S (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	shengp@medicine.washington.edu; teribr@u.washington.edu		May, Damon/0000-0001-6902-3153	National Institutes of Health [R01CA107209, K25CA137222, K07CA116296, R01DK081368, R21CA149772]; NATIONAL CANCER INSTITUTE [R01CA107209, K07CA116296, R21CA149772, K25CA137222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part with federal funds from the National Institutes of Health under grants R01CA107209, K25CA137222, K07CA116296, R01DK081368 and R21CA149772, and gifts from the Canary Foundation and Gene and Mary Ann Walters Pancreatic Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis MF, 2009, PROTEOMICS, V9, P3815, DOI 10.1002/pmic.200800971; Agarwal AK, 2008, AM J SURG, V196, P149, DOI 10.1016/j.amjsurg.2007.07.039; Albashir S, 2010, AM J GASTROENTEROL, V105, P2498, DOI 10.1038/ajg.2010.274; Ammann RW, 1996, GASTROENTEROLOGY, V111, P224, DOI 10.1053/gast.1996.v111.pm8698203; Balgley BM, 2009, J PROTEOME RES, V8, P917, DOI 10.1021/pr800503u; Bellew M, 2006, BIOINFORMATICS, V22, P1902, DOI 10.1093/bioinformatics/btl276; BHUIYA FA, 2010, EMERGENCY DEP VISITS, P1; Blonder J, 2009, CLIN LAB MED, V29, P101, DOI 10.1016/j.cll.2009.01.006; Chen JH, 2009, HEPATOB PANCREAT DIS, V8, P193; Chen R, 2005, MOL CELL PROTEOMICS, V4, P523, DOI 10.1074/mcp.R500004-MCP200; Chen R, 2005, GASTROENTEROLOGY, V129, P1187, DOI 10.1053/j.gastro.2005.08.001; Chen R, 2007, PROTEOM CLIN APPL, V1, P1582, DOI 10.1002/prca.200700414; Chen R, 2007, MOL CELL PROTEOMICS, V6, P1331, DOI 10.1074/mcp.M700072-MCP200; Chen R, 2006, PROTEOMICS, V6, P3871, DOI 10.1002/pmic.200500702; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; Cui YZ, 2009, PANCREATOLOGY, V9, P89, DOI 10.1159/000178879; Cui YZ, 2009, INT J CANCER, V124, P1614, DOI 10.1002/ijc.24163; Dai L, 2010, J PROTEOME RES, V9, P3394, DOI 10.1021/pr100231m; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Esposito I, 2001, HUM PATHOL, V32, P1174, DOI 10.1053/hupa.2001.28947; Everhart JE, 2009, GASTROENTEROLOGY, V136, P1134, DOI 10.1053/j.gastro.2009.02.038; Friess H, 2001, ANN SURG, V234, P769, DOI 10.1097/00000658-200112000-00008; Grantzdorffer I, 2008, PANCREAS, V36, P329, DOI 10.1097/MPA.0b013e31815cc452; GREENBERGER NJ, 2008, MED HARRISONS PRIN E, V17, pCH307; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Hood BL, 2006, PROTEOMICS, V6, P4106, DOI 10.1002/pmic.200600016; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang SI, 2007, ONCOGENE, V26, P65, DOI 10.1038/sj.onc.1209755; Ishiwata T, 2007, ONCOL REP, V18, P537; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Koninger J, 2004, BIOCHEM BIOPH RES CO, V322, P943, DOI 10.1016/j.bbrc.2004.08.008; Kudo Y, 2007, HISTOL HISTOPATHOL, V22, P1167, DOI 10.14670/HH-22.1167; Lohr M, 2004, PANCREATOLOGY, V4, P67, DOI 10.1159/000077212; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Malka D, 2002, GUT, V51, P849, DOI 10.1136/gut.51.6.849; MAY D, 2008, J PROTEOME RES; May D, 2007, J PROTEOME RES, V6, P2685, DOI 10.1021/pr070146y; May D, 2011, J PROTEOME RES, V10, P200, DOI 10.1021/pr100574p; Mikuriya K, 2007, INT J ONCOL, V30, P849; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ozaki N, 2009, MOL CANCER RES, V7, P1572, DOI 10.1158/1541-7786.MCR-08-0567; PAN S, 2011, J PROTEOME RES; Pan S, 2009, ELECTROPHORESIS, V30, P1132, DOI 10.1002/elps.200800752; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; PING LY, 2002, J PATHOL, V196, P324; Rosty C, 2003, AM J SURG PATHOL, V27, P1495, DOI 10.1097/00000478-200312000-00001; Scarlett CJ, 2006, GASTROENTEROLOGY, V130, P1670, DOI 10.1053/j.gastro.2006.02.036; Shimizu K, 2008, J GASTROENTEROL, V43, P823, DOI 10.1007/s00535-008-2249-7; Shimosegawa T, 2009, CLIN GASTROENTEROL H, V7, pS23, DOI 10.1016/j.cgh.2009.07.042; Spanler BWM, 2008, EUR J GASTROEN HEPAT, V20, P653, DOI 10.1097/MEG.0b013e3282f52f83; Sprung RW, 2009, MOL CELL PROTEOMICS, V8, P1988, DOI 10.1074/mcp.M800518-MCP200; Van Acker GJD, 2002, AM J PHYSIOL-GASTR L, V283, pG794, DOI 10.1152/ajpgi.00363.2001; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; Vimalachandran D, 2004, EXPERT REV PROTEOMIC, V1, P493, DOI 10.1586/14789450.1.4.493; Wang Pei, 2006, Pac Symp Biocomput, P315; Weber SM, 2003, WORLD J SURG, V27, P1271, DOI 10.1007/s00268-003-7247-6	60	41	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27574	10.1371/journal.pone.0027574	http://dx.doi.org/10.1371/journal.pone.0027574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132114	Green Submitted, Green Published, gold			2022-12-25	WOS:000298162000027
J	Zhou, ZY; Wagar, N; Devos, JR; Rottinghaus, E; Diallo, K; Nguyen, DB; Bassey, O; Ugbena, R; Wadonda-Kabondo, N; McConnell, MS; Zulu, I; Chilima, B; Nkengasong, J; Yang, CF				Zhou, Zhiyong; Wagar, Nick; Devos, Joshua R.; Rottinghaus, Erin; Diallo, Karidia; Nguyen, Duc B.; Bassey, Orji; Ugbena, Richard; Wadonda-Kabondo, Nellie; McConnell, Michelle S.; Zulu, Isaac; Chilima, Benson; Nkengasong, John; Yang, Chunfu			Optimization of a Low Cost and Broadly Sensitive Genotyping Assay for HIV-1 Drug Resistance Surveillance and Monitoring in Resource-Limited Settings	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DRIED BLOOD SPOTS; WORLD-HEALTH-ORGANIZATION; SEQUENCE-BASED ANALYSIS; ANTIRETROVIRAL TREATMENT; SUBTYPE-A; MUTATIONS; PERFORMANCE; SYSTEM; PLASMA	Commercially available HIV-1 drug resistance (HIVDR) genotyping assays are expensive and have limitations in detecting non-B subtypes and circulating recombinant forms that are co-circulating in resource-limited settings (RLS). This study aimed to optimize a low cost and broadly sensitive in-house assay in detecting HIVDR mutations in the protease (PR) and reverse transcriptase (RT) regions of pol gene. The overall plasma genotyping sensitivity was 95.8% (N = 96). Compared to the original in-house assay and two commercially available genotyping systems, TRUGENE (R) and ViroSeq (R), the optimized in-house assay showed a nucleotide sequence concordance of 99.3%, 99.6% and 99.1%, respectively. The optimized in-house assay was more sensitive in detecting mixture bases than the original in-house (N=87, P<0.001) and TRUGENE (R) and ViroSeq (R) assays. When the optimized in-house assay was applied to genotype samples collected for HIVDR surveys (N = 230), all 72 (100%) plasma and 69 (95.8%) of the matched dried blood spots (DBS) in the Vietnam transmitted HIVDR survey were genotyped and nucleotide sequence concordance was 98.8%; Testing of treatment-experienced patient plasmas with viral load (VL) >= and < 3 log10 copies/ml from the Nigeria and Malawi surveys yielded 100% (N=46) and 78.6% (N = 14) genotyping rates, respectively. Furthermore, all 18 matched DBS stored at room temperature from the Nigeria survey were genotyped. Phylogenetic analysis of the 236 sequences revealed that 43.6% were CRF01_AE, 25.9% subtype C, 13.1% CRF02_AG, 5.1% subtype G, 4.2% subtype B, 2.5% subtype A, 2.1% each subtype F and unclassifiable, 0.4% each CRF06_CPX, CRF07_BC and CRF09_CPX. Conclusions: The optimized in-house assay is broadly sensitive in genotyping HIV-1 group M viral strains and more sensitive than the original in-house, TRUGENE (R) and ViroSeq (R) in detecting mixed viral populations. The broad sensitivity and substantial reagent cost saving make this assay more accessible for RLS where HIVDR surveillance is recommended to minimize the development and transmission of HIVDR.	[Zhou, Zhiyong; Wagar, Nick; Devos, Joshua R.; Rottinghaus, Erin; Diallo, Karidia; McConnell, Michelle S.; Nkengasong, John; Yang, Chunfu] Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA 30333 USA; [Nguyen, Duc B.] Dept Hlth & Human Serv US CDC, Hanoi, Vietnam; [Bassey, Orji; Ugbena, Richard] CDC GAP, Abuja, Nigeria; [Wadonda-Kabondo, Nellie; Chilima, Benson] Malawi Minist Hlth, Community Hlth Sci Unit, Lilongwe, Malawi; [McConnell, Michelle S.] Thailand Minist Publ Hlth US CDC Collaborat, Nonthaburi, Thailand; [Zulu, Isaac] Global AIDS Program CDC Zambia, Lusaka, Zambia	Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand	Zhou, ZY (corresponding author), Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA 30333 USA.	cxy0@cdc.gov	Yang, Chunfu/G-6890-2013		American Public Health Laboratory (APHL); CDC	American Public Health Laboratory (APHL); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Dr. Erin Rottinghaus is a recipient of the 2009-2011 Emerging Infectious Disease (EID) Fellowship program sponsored by American Public Health Laboratory (APHL) and CDC. The authors thank Dr. Guoqing Zhang, a recipient of APHL/CDC 2011 International EID program for statistical assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegaz WE, 2008, ANTIVIR THER, V13, P89; Aghokeng AF, 2011, J CLIN MICROBIOL, V49, P1635, DOI 10.1128/JCM.01478-10; Beddows S, 2003, J MED VIROL, V70, P337, DOI 10.1002/jmv.10401; BENNETT DE, 2008, PLOS ONE S2, V13, pE4724; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2006, CURR OPIN INFECT DIS, V19, P607, DOI 10.1097/QCO.0b013e3280109ff1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bertagnolio S, 2010, AIDS REV, V12, P195; Bertognolio S, 2008, ANTIVIR THER, V13, P49; Buckton AJ, 2008, CURR OPIN INFECT DIS, V21, P653, DOI 10.1097/QCO.0b013e3283186d1a; Chen JHK, 2007, J CLIN VIROL, V39, P125, DOI 10.1016/j.jcv.2007.03.008; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Eshleman SH, 2005, J CLIN MICROBIOL, V43, P813, DOI 10.1128/JCM.43.2.813-817.2005; Eshleman SH, 2004, J CLIN MICROBIOL, V42, P2711, DOI 10.1128/JCM.42.6.2711-2717.2004; Eshleman SH, 2004, JAIDS-J ACQ IMM DEF, V35, P126, DOI 10.1097/00126334-200402010-00004; Eshleman SH, 2003, BIOTECHNIQUES, V35, P614, DOI 10.2144/03353dd05; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Fontaine E, 2001, J ACQ IMMUN DEF SYND, V28, P254, DOI 10.1097/00042560-200111010-00008; Galli RA, 2003, J CLIN MICROBIOL, V41, P2900, DOI 10.1128/JCM.41.7.2900-2907.2003; Garcia-Lerma JG, 2009, J ANTIMICROB CHEMOTH, V64, P33, DOI 10.1093/jac/dkp150; Garrido C, 2008, J ANTIMICROB CHEMOTH, V61, P694, DOI 10.1093/jac/dkm515; Geretti AM, 2007, CURR OPIN INFECT DIS, V20, P22, DOI 10.1097/QCO.0b013e328013caff; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; GOODENOW M, 1989, J ACQ IMMUN DEF SYND, V2, P344; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hallack R, 2008, J CLIN VIROL, V41, P283, DOI 10.1016/j.jcv.2007.12.011; Harrigan PR, 2002, 14 INT AIDS C BARC S; Hearps AC, 2010, CURR HIV RES, V8, P134, DOI 10.2174/157016210790442740; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Hirsch MS, 2003, CLIN INFECT DIS, V37, P113, DOI 10.1086/375597; Jagodzinski LL, 2003, J CLIN MICROBIOL, V41, P998, DOI 10.1128/JCM.41.3.998-1003.2003; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Jordan MR, 2008, ANTIVIR THER, V13, P15; Kijak GH, 2002, J VIROL, V76, P7000, DOI 10.1128/JVI.76.14.7000-7009.2002; Lira R, 2010, ARCH VIROL, V155, P1117, DOI 10.1007/s00705-010-0696-y; Masciotra S, 2007, AIDS, V21, P2503, DOI 10.1097/QAD.0b013e3281c618db; MCCONNELL M, 2010, 17 C RETR OPP INF PO, P243; McNulty A, 2007, J CLIN MICROBIOL, V45, P517, DOI 10.1128/JCM.02016-06; Mracna M, 2001, J CLIN MICROBIOL, V39, P4323, DOI 10.1128/JCM.39.12.4323-4327.2001; Parkin NT, 2009, ANTIVIR THER, V14, pA162; Saravanan S, 2009, J VIROL METHODS, V159, P211, DOI 10.1016/j.jviromet.2009.03.021; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291, DOI 10.1128/JCM.37.7.2291-2296.1999; Shafer RW, 2001, J CLIN MICROBIOL, V39, P1522, DOI 10.1128/JCM.39.4.1522-1529.2001; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Stringer JSA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000233; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wallis CL, 2010, J VIROL METHODS, V163, P505, DOI 10.1016/j.jviromet.2009.11.011; World Health Organization, 2010, WHO HIVRESNET HIV DR; World Health Organization, 2010, WHO MAN HIV DRUG RES; Yang CF, 2010, J CLIN MICROBIOL, V48, P3158, DOI 10.1128/JCM.00564-10; Youngpairoj AS, 2008, J ANTIMICROB CHEMOTH, V61, P1217, DOI 10.1093/jac/dkn100	52	80	88	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28184	10.1371/journal.pone.0028184	http://dx.doi.org/10.1371/journal.pone.0028184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132237	gold, Green Published, Green Submitted			2022-12-25	WOS:000298162000084
J	Wang, L; Xu, T; Lei, WW; Liu, DM; Li, YJ; Xuan, RJ; Ma, JJ				Wang, Lan; Xu, Tuan; Lei, Wen-wen; Liu, Dong-mei; Li, Ying-jun; Xuan, Rui-jing; Ma, Jing-jin			Cadmium-Induced Oxidative Stress and Apoptotic Changes in the Testis of Freshwater Crab, Sinopotamon henanense	PLOS ONE			English	Article							INDUCED TESTICULAR DAMAGE; DIPHENYL DISELENIDE; LIPID-PEROXIDATION; VITAMIN-E; RAT; CELLS; ACID; ACCUMULATION; MITOCHONDRIA; TESTOSTERONE	Cadmium (Cd), one of the most toxic environmental and industrial pollutants, is known to exert gonadotoxic and spermiotoxic effects. In the present study, we examined the toxic effect of Cd on the testis of freshwater crab, Sinopotamon henanense. Crabs were exposed to different Cd concentrations (from 0 to 116.00 mg.L-1) for 7 d. Oxidative stress and apoptotic changes in the testes were detected. The activities of SOD, GPx and CAT initially increased and subsequently decreased with increasing Cd concentrations, which was accompanied with the increase in malondialdehyde (MDA) and H2O2 content in a concentration-dependent manner. Typical morphological characteristic and physiological changes of apoptosis were observed using a variety of methods (HE staining, AO/EB double fluorescent staining, Transmission Electron Microscope observation and DNA fragmentation analysis), and the activities of caspase-3 and caspase-9 were increased in a concentration-dependent manner after Cd exposure. These results led to the conclusion that Cd could induced oxidative damage as well as apoptosis in the testis, and the apoptotic processes may be mediated via mitochondria-dependent apoptosis pathway by regulating the activities of caspase-3 and caspase-9.	[Wang, Lan; Xu, Tuan; Lei, Wen-wen; Liu, Dong-mei; Li, Ying-jun; Xuan, Rui-jing; Ma, Jing-jin] Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China	Shanxi University	Wang, L (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China.	lanwang@sxu.edu.cn	xu, tuan/AAL-4781-2021		National Natural Science Foundation of China [30870267]; Natural Sciences Foundation of Shanxi Province [2008011069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province)	This work was supported by National Natural Science Foundation of China (no. 30870267, to Lan Wang) and the Natural Sciences Foundation of Shanxi Province (no. 2008011069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI A, 1978, BIOL REPROD, V18, P579, DOI 10.1095/biolreprod18.4.579; *ATSDR, 1997, TOX PROF CADM DRAFT; Aydilek N, 2004, ANDROLOGIA, V36, P277, DOI 10.1111/j.1439-0272.2004.00618.x; AYRES RU, 1992, P NATL ACAD SCI USA, V89, P815, DOI 10.1073/pnas.89.3.815; Baskic D, 2006, CELL BIOL INT, V30, P924, DOI 10.1016/j.cellbi.2006.06.016; [闭向阳 Bi Xiangyang], 2005, [环境化学, Environmental Chemistry], V24, P260; Blanco A, 2007, ENVIRON TOXICOL PHAR, V23, P96, DOI 10.1016/j.etap.2006.07.008; Blottner S, 1999, REPROD TOXICOL, V13, P261, DOI 10.1016/S0890-6238(99)00014-3; Bridges CC, 2005, TOXICOL APPL PHARM, V204, P274, DOI 10.1016/j.taap.2004.09.007; BULLOCK G, 1993, EXP HEMATOL, V21, P1640; [成杭新 Cheng hangxin], 2008, [地学前缘, Earth Science Frontiers], V15, P167; [成杭新 Cheng hangxin], 2008, [地学前缘, Earth Science Frontiers], V15, P203; Deiana L, 1999, FREE RADICAL RES, V31, P237, DOI 10.1080/10715769900300801; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; El-Ashmawy IM, 1999, TOXICOL APPL PHARM, V161, P34, DOI 10.1006/taap.1999.8785; El-Maraghy SA, 2001, J BIOCHEM MOL TOXIC, V15, P207, DOI 10.1002/jbt.18.abs; Filipic M, 2006, HUM EXP TOXICOL, V25, P67, DOI 10.1191/0960327106ht590oa; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; Haouem S, 2008, EXP TOXICOL PATHOL, V59, P307, DOI 10.1016/j.etp.2007.10.002; Hetts SW, 1998, JAMA-J AM MED ASSOC, V279, P300, DOI 10.1001/jama.279.4.300; Ji YL, 2010, REPROD TOXICOL, V29, P176, DOI 10.1016/j.reprotox.2009.10.014; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Kim J, 2006, J TOXICOL ENV HEAL A, V69, P1181, DOI 10.1080/15287390600631144; KOIZUMI T, 1992, J TOXICOL ENV HEALTH, V37, P25, DOI 10.1080/15287399209531654; Lasfer M, 2008, CELL BIOL TOXICOL, V24, P55, DOI 10.1007/s10565-007-9015-0; [李静 Li Jing], 2010, [环境科学学报, Acta Scientiae Circumstantiae], V30, P2277; LOHMANN RD, 1993, BIOCHEM BIOPH RES CO, V190, P1097, DOI 10.1006/bbrc.1993.1162; MANCA D, 1991, TOXICOLOGY, V67, P303, DOI 10.1016/0300-483X(91)90030-5; MCGAHON AJ, 1995, METHOD CELL BIOL, V46, P153; Messaoudi I, 2010, EXP TOXICOL PATHOL, V62, P281, DOI 10.1016/j.etp.2009.04.004; Migliarini B, 2005, GEN COMP ENDOCR, V142, P241, DOI 10.1016/j.ygcen.2004.12.012; Murugesan P, 2005, FREE RADICAL RES, V39, P1259, DOI 10.1080/10715760500308154; NISHIKIMI M, 1975, BIOCHEM BIOPH RES CO, V63, P463, DOI 10.1016/0006-291X(75)90710-X; Ognjanovic BI, 2010, REPROD TOXICOL, V29, P191, DOI 10.1016/j.reprotox.2009.11.009; Oh SH, 2006, TOXICOL APPL PHARM, V212, P212, DOI 10.1016/j.taap.2005.07.018; Parikh V, 2003, J PSYCHIATR RES, V37, P43, DOI 10.1016/S0022-3956(02)00048-1; Pathak N, 2006, TOXICOLOGY, V220, P26, DOI 10.1016/j.tox.2005.11.027; Pathak N, 2006, TOXICOL LETT, V165, P121, DOI 10.1016/j.toxlet.2006.02.004; Pignatti C, 2004, AMINO ACIDS, V27, P359, DOI 10.1007/s00726-004-0115-3; Qian YF, 2008, CELL BIOL INT, V32, P304, DOI 10.1016/j.cellbi.2007.10.004; Reinecke AJ, 2003, WATER AIR SOIL POLL, V145, P395, DOI 10.1023/A:1023602121272; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Santamaria A, 1997, TOXICOL LETT, V93, P117, DOI 10.1016/S0378-4274(97)00082-9; Santos FW, 2006, REPROD TOXICOL, V22, P546, DOI 10.1016/j.reprotox.2005.12.009; Santos FW, 2005, FOOD CHEM TOXICOL, V43, P1723, DOI 10.1016/j.fct.2005.05.015; Santos FW, 2004, TOXICOL LETT, V152, P255, DOI 10.1016/j.toxlet.2004.05.009; Schuwerack PMM, 2001, ECOTOXICOLOGY, V10, P159, DOI 10.1023/A:1016689810391; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; Shaikh ZA, 1999, TOXICOL APPL PHARM, V154, P256, DOI 10.1006/taap.1998.8586; Stohs Sidney J., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P201; SUGITA M, 1995, ENVIRON RES, V68, P31, DOI 10.1006/enrs.1995.1005; Thompson J, 2008, REPROD TOXICOL, V25, P304, DOI 10.1016/j.reprotox.2008.02.001; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Waalkes MP, 1997, TOXICOL APPL PHARM, V142, P40, DOI 10.1006/taap.1996.8005; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Walker N I, 1988, Methods Achiev Exp Pathol, V13, P18; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang Lan, 2002, Acta Zoologica Sinica, V48, P677; [夏锦霞 XIA Jin-xia], 2009, [吉林大学学报. 地球科学版, Journal of Jilin University. Earth Science Edition], V39, P305; Xie H, 2007, APOPTOSIS, V12, P247, DOI 10.1007/s10495-006-0489-7; Xu CY, 1996, TOXICOLOGY, V107, P1, DOI 10.1016/0300-483X(95)03195-L; Xu LC, 2001, BIOMED ENVIRON SCI, V14, P312; Yadav N, 2008, FOOD CHEM TOXICOL, V46, P494, DOI 10.1016/j.fct.2007.08.035; Yan Bo, 2007, Acta Zoologica Sinica, V53, P1121; Yang JM, 2003, REPROD TOXICOL, V17, P553, DOI 10.1016/S0890-6238(03)00100-X; Ye JL, 2007, ENVIRON TOXICOL PHAR, V24, P45, DOI 10.1016/j.etap.2007.01.007; Zhang LC, 1996, CHEM ELEMENT WATER E; [赵传冬 Zhao Chuandong], 2008, [地学前缘, Earth Science Frontiers], V15, P179; ZIELINSKAPSUJA B, 1979, INT J ANDROL, V2, P150, DOI 10.1111/j.1365-2605.1979.tb00048.x	70	35	50	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27853	10.1371/journal.pone.0027853	http://dx.doi.org/10.1371/journal.pone.0027853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132153	Green Submitted, Green Published, gold			2022-12-25	WOS:000297792400018
J	Lustoza, ACDM; Palma, LM; Facanha, AR; Okorokov, LA; Okorokova-Facanha, AL				Lustoza, Ana Cristina D. M.; Palma, Livia M.; Facanha, Arnoldo R.; Okorokov, Lev A.; Okorokova-Facanha, Anna L.			P-5A-Type ATPase Cta4p Is Essential for Ca2+ Transport in the Endoplasmic Reticulum of Schizosaccharomyces pombe	PLOS ONE			English	Article							P-TYPE ATPASE; UNFOLDED PROTEIN RESPONSE; YEAST SECRETORY PATHWAY; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CALCINEURIN; CALCIUM; HOMEOSTASIS	This study establishes the role of P-5A-type Cta4 ATPase in Ca2+ sequestration in the endoplasmic reticulum by detecting an ATP-dependent, vanadate-sensitive and FCCP insensitive Ca-45(2+)-transport in fission yeast membranes isolated by cellular fractionation. Specifically, the Ca2+-ATPase transport activity was decreased in ER membranes isolated from cells lacking a cta4(+) gene. Furthermore, a disruption of cta4(+) resulted in 6-fold increase of intracellular Ca2+ levels, sensitivity towards accumulation of misfolded proteins in ER and ER stress, stimulation of the calcineurin phosphatase activity and vacuolar Ca2+ pumping. These data provide compelling biochemical evidence for a P-5A-type Cta4 ATPase as an essential component of Ca2+ transport system and signaling network which regulate, in conjunction with calcineurin, the ER functionality in fission yeast.	[Lustoza, Ana Cristina D. M.; Palma, Livia M.; Okorokov, Lev A.; Okorokova-Facanha, Anna L.] Univ Estadual Norte Fluminense, Lab Fisiol & Bioquim Microrganismos, Ctr Biociencias & Biotecnol, Rio De Janeiro, Brazil; [Facanha, Arnoldo R.] Univ Estadual Norte Fluminense, Lab Biol Celular & Tecidual, Ctr Biociencias & Biotecnol, Rio De Janeiro, Brazil	Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense	Lustoza, ACDM (corresponding author), Univ Estadual Norte Fluminense, Lab Fisiol & Bioquim Microrganismos, Ctr Biociencias & Biotecnol, Rio De Janeiro, Brazil.	anna@uenf.br	Facanha, Arnoldo Rocha/A-2833-2008	Okorokov, Lev/0000-0002-8469-0701; Rocha Facanha, Arnoldo/0000-0002-5641-6852; Okorokova-Facanha, Anna/0000-0002-6856-7711	CNPq (Conselho Nacional de Pesquisa e Desenvolvimento); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro); CAPES (Coordenacao de Aperfeicoamento de Pessoal no Nivel Superior)	CNPq (Conselho Nacional de Pesquisa e Desenvolvimento)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal no Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CNPq (Conselho Nacional de Pesquisa e Desenvolvimento) and FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro). ACDML and LMP received a PhD fellowship from CAPES (Coordenacao de Aperfeicoamento de Pessoal no Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEIJON C, 1989, P NATL ACAD SCI USA, V86, P6935, DOI 10.1073/pnas.86.18.6935; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Benko Z, 2004, MOL GENET GENOMICS, V271, P161, DOI 10.1007/s00438-003-0967-3; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; BUSH DS, 1995, ANNU REV PLANT PHYS, V46, P95, DOI 10.1146/annurev.pp.46.060195.000523; Carafoli E, 2000, CURR OPIN CHEM BIOL, V4, P152, DOI 10.1016/S1367-5931(99)00069-1; Catty P, 1997, FEBS LETT, V409, P325, DOI 10.1016/S0014-5793(97)00446-8; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; Cortes JCG, 2004, EUKARYOT CELL, V3, P1124, DOI 10.1128/EC.3.5.1124-1135.2004; Cronin SR, 2002, J CELL BIOL, V157, P1017, DOI 10.1083/jcb.200203052; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Facanha ALO, 2002, J CELL BIOL, V157, P1029, DOI 10.1083/jcb.200111012; Furune T, 2008, GENES GENET SYST, V83, P373, DOI 10.1266/ggs.83.373; Groenendyk J, 2004, MOL CELLS, V17, P383; Jakobsen MK, 2005, GENE DEV, V19, P2757, DOI 10.1101/gad.357305; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Martin DC, 2011, J BIOL CHEM, V286, P10744, DOI 10.1074/jbc.M110.177451; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Okorokov LA, 1998, FEMS MICROBIOL LETT, V162, P83, DOI 10.1111/j.1574-6968.1998.tb12982.x; Okorokov LA, 2001, FEBS LETT, V505, P321, DOI 10.1016/S0014-5793(01)02852-6; Okorokova-Facanha AL, 2003, CURR GENET, V43, P273, DOI 10.1007/s00294-003-0395-2; Pimpl P, 2006, PLANT CELL, V18, P198, DOI 10.1105/tpc.105.036665; Poulsen LR, 2008, CELL MOL LIFE SCI, V65, P3119, DOI 10.1007/s00018-008-8341-6; PRICE BD, 1992, J CELL PHYSIOL, V152, P545, DOI 10.1002/jcp.1041520314; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SAMARAO SS, 2009, BIOCHIM BIOPHYS ACTA, V2, P303; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sorensen DM, 2010, BBA-BIOENERGETICS, V1797, P846, DOI 10.1016/j.bbabio.2010.04.010; Sugiura R, 2002, GENES CELLS, V7, P619, DOI 10.1046/j.1365-2443.2002.00557.x; Suzuki C, 1999, MOL MICROBIOL, V32, P813, DOI 10.1046/j.1365-2958.1999.01400.x; Suzuki C, 2001, BIOSCI BIOTECH BIOCH, V65, P2405, DOI 10.1271/bbb.65.2405; Thever MD, 2009, J MEMBRANE BIOL, V229, P115, DOI 10.1007/s00232-009-9176-2; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	43	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27843	10.1371/journal.pone.0027843	http://dx.doi.org/10.1371/journal.pone.0027843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132152	Green Submitted, gold, Green Published			2022-12-25	WOS:000297789900025
J	Zhang, F; Hui, C				Zhang, Feng; Hui, Cang			Eco-Evolutionary Feedback and the Invasion of Cooperation in Prisoner's Dilemma Games	PLOS ONE			English	Article							HABITAT SATURATION; POSITIVE INTERACTIONS; POPULATION-DYNAMICS; DELAYED DISPERSAL; NATAL DISPERSAL; KIN SELECTION; RECIPROCITY; MODELS; FACILITATION; COMMUNITIES	Unveiling the origin and forms of cooperation in nature poses profound challenges in evolutionary ecology. The prisoner's dilemma game is an important metaphor for studying the evolution of cooperation. We here classified potential mechanisms for cooperation evolution into schemes of frequency-and density-dependent selection, and focused on the density-dependent selection in the ecological prisoner's dilemma games. We found that, although assortative encounter is still the necessary condition in ecological games for cooperation evolution, a harsh environment, indicated by a high mortality, can foster the invasion of cooperation. The Hamilton rule provides a fundamental condition for the evolution of cooperation by ensuring an enhanced relatedness between players in low-density populations. Incorporating ecological dynamics into evolutionary games opens up a much wider window for the evolution of cooperation, and exhibits a variety of complex behaviors of dynamics, such as limit and heteroclinic cycles. An alternative evolutionary, or rather succession, sequence was proposed that cooperation first appears in harsh environments, followed by the invasion of defection, which leads to a common catastrophe. The rise of cooperation (and altruism), thus, could be much easier in the density-dependent ecological games than in the classic frequency-dependent evolutionary games.	[Zhang, Feng; Hui, Cang] Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, Matieland, South Africa	Stellenbosch University	Zhang, F (corresponding author), Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, Matieland, South Africa.	fzhang@sun.ac.za	Hui, Cang/A-1781-2008	Hui, Cang/0000-0002-3660-8160	NRF; DST-NRF Centre of Excellence for Invasion Biology at Stellenbosch University	NRF; DST-NRF Centre of Excellence for Invasion Biology at Stellenbosch University	This work was supported by the NRF Blue Sky and Incentive Research Programme (http://www.nrf.ac.za/index.php) and the DST-NRF Centre of Excellence for Invasion Biology at Stellenbosch University (http://academic.sun.ac.za/cib/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2008, EVOLUTION, V62, P1335, DOI 10.1111/j.1558-5646.2008.00369.x; Allee W. C., 1931, ANIMAL AGGREGATIONS; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Baglione V, 2005, J ANIM ECOL, V74, P842, DOI 10.1111/j.1365-2656.2005.00983.x; Banks SC, 2011, P ROY SOC B-BIOL SCI, V278, P2768, DOI 10.1098/rspb.2010.2657; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brockhurst MA, 2007, CURR BIOL, V17, P761, DOI 10.1016/j.cub.2007.02.057; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; BROWN JL, 1994, AM NAT, V143, P435, DOI 10.1086/285612; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Dale S, 2010, IBIS, V152, P292, DOI 10.1111/j.1474-919X.2010.01019.x; Doebeli M, 2004, SCIENCE, V306, P859, DOI 10.1126/science.1101456; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Doebeli M, 1997, P NATL ACAD SCI USA, V94, P5167, DOI 10.1073/pnas.94.10.5167; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; Frank S. A., 1998, FDN SOCIAL EVOLUTION, DOI DOI 10.1515/9780691206820; Gardner A, 2011, J EVOLUTION BIOL, V24, P1020, DOI 10.1111/j.1420-9101.2011.02236.x; Gardner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000752; Hamilton MJ, 2009, P NATL ACAD SCI USA, V106, P12255, DOI 10.1073/pnas.0905708106; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hanski I., 1999, METAPOPULATION ECOLO; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauert C, 2008, THEOR POPUL BIOL, V73, P257, DOI 10.1016/j.tpb.2007.11.007; Hauert C, 2006, P R SOC B, V273, P2565, DOI 10.1098/rspb.2006.3600; HAUSER MD, 1992, P NATL ACAD SCI USA, V89, P12137, DOI 10.1073/pnas.89.24.12137; HEMELRIJK CK, 1990, ANIM BEHAV, V39, P1013, DOI 10.1016/S0003-3472(05)80775-4; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Hui C, 2005, ECOL MODEL, V184, P397, DOI 10.1016/j.ecolmodel.2004.11.004; Kokko H, 2002, AM NAT, V160, P468, DOI 10.1086/342074; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Krams I, 2010, P ROY SOC B-BIOL SCI, V277, P513, DOI 10.1098/rspb.2009.1614; Langer P, 2008, J THEOR BIOL, V250, P634, DOI 10.1016/j.jtbi.2007.11.002; Le Galliard JF, 2003, EVOLUTION, V57, P1; Lehmann L., 2010, PHIL T R SOC B, V365, P1; Lehmann L, 2006, EVOLUTION, V60, P1137; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lion S, 2009, J EVOLUTION BIOL, V22, P1487, DOI 10.1111/j.1420-9101.2009.01769.x; Lion S, 2010, EVOLUTION, V64, P1594, DOI 10.1111/j.1558-5646.2009.00933.x; LOMBARDO MP, 1990, ETHOL SOCIOBIOL, V11, P521, DOI 10.1016/0162-3095(90)90025-2; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak Martin A., 2007, P7; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; Peer K, 2007, BEHAV ECOL SOCIOBIOL, V61, P729, DOI 10.1007/s00265-006-0303-0; Pepper JW, 2000, J THEOR BIOL, V206, P355, DOI 10.1006/jtbi.2000.2132; PIERCE NE, 1987, BEHAV ECOL SOCIOBIOL, V21, P237, DOI 10.1007/BF00292505; Rankin DJ, 2007, J EVOLUTION BIOL, V20, P173, DOI 10.1111/j.1420-9101.2006.01211.x; Rankin DJ, 2009, EVOLUTION, V63, P1913, DOI 10.1111/j.1558-5646.2009.00656.x; Ross-Gillespie A, 2009, EVOLUTION, V63, P2315, DOI 10.1111/j.1558-5646.2009.00723.x; Schino G, 2010, ECOL LETT, V13, P45, DOI 10.1111/j.1461-0248.2009.01396.x; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; SELLA G, 1985, ANIM BEHAV, V33, P938, DOI 10.1016/S0003-3472(85)80028-2; Semmann D, 2003, NATURE, V425, P390, DOI 10.1038/nature01986; Sharp SP, 2008, P ROY SOC B-BIOL SCI, V275, P2125, DOI 10.1098/rspb.2008.0398; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Baalen M, 1998, J THEOR BIOL, V193, P631, DOI 10.1006/jtbi.1998.0730; Verdu M, 2009, J ECOL, V97, P1171, DOI 10.1111/j.1365-2745.2009.01565.x; Wakano JY, 2009, P NATL ACAD SCI USA, V106, P7910, DOI 10.1073/pnas.0812644106; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143; Zhang F, 2005, ECOL RES, V20, P461, DOI 10.1007/s11284-005-0072-7; Zhang F, 2010, EVOL ECOL RES, V12, P23	71	23	25	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27523	10.1371/journal.pone.0027523	http://dx.doi.org/10.1371/journal.pone.0027523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125615	Green Submitted, gold, Green Published			2022-12-25	WOS:000297789200015
J	Balli, D; Ren, X; Chou, FS; Cross, E; Zhang, Y; Kalinichenko, VV; Kalin, TV				Balli, D.; Ren, X.; Chou, F-S; Cross, E.; Zhang, Y.; Kalinichenko, V. V.; Kalin, T. V.			Foxm1 transcription factor is required for macrophage migration during lung inflammation and tumor formation	ONCOGENE			English	Article						Forkhead transcription factor FoxM1; transgenic mice; macrophages; lung cancer; monocyte migration; tumor microenvironment	BUTYLATED HYDROXYTOLUENE; EPITHELIAL-CELLS; CIGARETTE-SMOKE; CANCER; MICE; FORKHEAD; EXPRESSION; PROGRESSION; ROLES; TUMORIGENESIS	Macrophages have a key role in tumor-associated pulmonary inflammation that supports the proliferation of tumor cells and promotes lung tumor growth. Although increased numbers of tumor-associated macrophages are linked to poor prognosis in lung cancer patients, little is known regarding the transcriptional mechanisms controlling recruitment of macrophages during lung tumorigenesis. Forkhead Box m1 (Foxm1) transcription factor is induced in multiple cell types within tumor lesions and its increased expression is associated with poor prognosis in patients with lung adenocarcinomas. To determine the role of Foxm1 in recruitment of tumor-associated macrophages, a mouse line with macrophage-specific Foxm1 deletion was generated (macFoxm1(-/-)). Lung tumorigenesis was induced using a 3-methylcholanthrene/butylated hydroxytoluene (BHT; 3,5-di-t-butyl-4-hydroxytoluene) tumor initiation/promotion protocol. Ablation of Foxm1 in macrophages reduced the number and size of lung tumors in macFoxm1(-/-) mice. Decreased tumorigenesis was associated with diminished proliferation of tumor cells and decreased recruitment of macrophages during the early stages of tumor formation. The expression levels of the pro-inflammatory genes iNOS, Cox-2, interleukin-1b (IL-1b) and IL-6, as well as the migration-related genes macrophage inflammatory protein-1 (MIP-1 alpha), MIP-2 and MMP-12, were decreased in macrophages isolated from macFoxm1(-/-) mice. Migration of Foxm1-deficient macrophages was reduced in vitro. The chemokine receptors responsible for monocyte recruitment to the lung, CX(3)CR1 and CXCR4, were decreased in Foxm1-deficient monocytes. In co-transfection experiments, Foxm1 directly bound to and transcriptionally activated the CX(3)CR1 promoter. Adoptive transfer of wild-type monocytes to macFoxm1(-/-) mice restored BHT-induced pulmonary inflammation to the levels observed in control mice. Expression of Foxm1 in macrophages is required for pulmonary inflammation, recruitment of macrophages into tumor sites and lung tumor growth. Oncogene (2012) 31, 3875-3888; doi:10.1038/onc.2011.549; published online 5 December 2011	[Balli, D.; Ren, X.; Cross, E.; Zhang, Y.; Kalinichenko, V. V.; Kalin, T. V.] Cincinnati Childrens Hosp Res Fdn, Div Pulm Biol, Perinatal Inst, Cincinnati, OH 45229 USA; [Chou, F-S] Cincinnati Childrens Hosp, Div Expt Hematol & Canc Biol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center	Kalin, TV (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Pulm Biol, Perinatal Inst, 3333 Burnet Ave,MLC 7009, Cincinnati, OH 45229 USA.	Tatiana.kalin@cchmc.org	Ren, Xiaomeng/U-1751-2019	Chou, Fu-Sheng/0000-0002-5770-0580	American Cancer Society, Ohio Division; Concern Foundation [84794]; Department of Defense [PC080478]; NIH [R01 CA142724, R01 HL84151]; NATIONAL CANCER INSTITUTE [R01CA142724] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084151] Funding Source: NIH RePORTER	American Cancer Society, Ohio Division(American Cancer Society); Concern Foundation; Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We dedicate this work to the memory of Dr Robert H Costa, a pioneer in the discovery and characterization of Forkhead transcription factors. We thank Dr Jeff Whitsett, Dr Sheila Bell and Dr Craig Bolte for critical reading of the manuscript, and Shirin Akhter, Jon Snyder and Alyssa Sproles for technical assistance. This work was supported by a Research Grant from the American Cancer Society, Ohio Division (TVK); a Grant from Concern Foundation 84794 (TVK); Department of Defense Award PC080478 (TVK); and NIH Grants R01 CA142724 (TVK) and R01 HL84151 (VVK).	ADAMSON IYR, 1977, LAB INVEST, V36, P26; Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Arenberg DA, 2000, CANCER IMMUNOL IMMUN, V49, P63, DOI 10.1007/s002620050603; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Balli D, 2011, CANCER RES, V71, P40, DOI 10.1158/0008-5472.CAN-10-2004; Baron JA, 2000, ANNU REV MED, V51, P511, DOI 10.1146/annurev.med.51.1.511; Bauer AK, 2001, TOXICOLOGY, V169, P1, DOI 10.1016/S0300-483X(01)00475-9; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Blaine SA, 2005, CARCINOGENESIS, V26, P209, DOI 10.1093/carcin/bgh302; Borsig L, 2002, P NATL ACAD SCI USA, V99, P2193, DOI 10.1073/pnas.261704098; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Costa RH, 2005, CURR OPIN GENET DEV, V15, P42, DOI 10.1016/j.gde.2004.12.007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; Faux SP, 2009, BIOMARKERS, V14, P90, DOI 10.1080/13547500902965047; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Heist RS, 2006, CLIN CANCER RES, V12, P5448, DOI 10.1158/1078-0432.CCR-06-0262; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kanwar JR, 2009, CURR MED CHEM, V16, P2373, DOI 10.2174/092986709788682155; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Kim IM, 2005, J BIOL CHEM, V280, P22278, DOI 10.1074/jbc.M500936200; Kleiner DE, 1999, CANCER CHEMOTH PHARM, V43, pS42, DOI 10.1007/s002800051097; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Lala PK, 2001, LANCET ONCOL, V2, P149, DOI 10.1016/S1470-2045(00)00256-4; Malkinson AM, 1997, CANCER RES, V57, P2832; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MARINO AA, 1972, P SOC EXP BIOL MED, V140, P122, DOI 10.3181/00379727-140-36407; Meyer AM, 2006, AM J PHYSIOL-LUNG C, V290, pL1260, DOI 10.1152/ajplung.00182.2005; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nenan S, 2005, MEM I OSWALDO CRUZ, V100, P167, DOI 10.1590/S0074-02762005000900028; Porta C, 2009, IMMUNOBIOLOGY, V214, P761, DOI 10.1016/j.imbio.2009.06.014; Ren XM, 2010, MOL CELL BIOL, V30, P5381, DOI 10.1128/MCB.00876-10; Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186; Srivastava M, 2005, J IMMUNOL, V175, P1884, DOI 10.4049/jimmunol.175.3.1884; THOMPSON JA, 1987, DRUG METAB DISPOS, V15, P833; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Wang IC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006609; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Westcott DJ, 2009, J EXP MED, V206, P3143, DOI 10.1084/jem.20091333; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Zhang JL, 2010, INT J CLIN EXP MED, V3, P233; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154	48	55	58	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	34					3875	3888		10.1038/onc.2011.549	http://dx.doi.org/10.1038/onc.2011.549			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	994IV	22139074	Green Accepted, Bronze			2022-12-25	WOS:000307925000005
J	Zheng, BS; Yang, W; Zhao, XY; Wang, YG; Lou, ZY; Rao, ZH; Feng, Y				Zheng, Baisong; Yang, Wen; Zhao, Xinyu; Wang, Yuguo; Lou, Zhiyong; Rao, Zihe; Feng, Yan			Crystal Structure of Hyperthermophilic Endo-beta-1,4-glucanase IMPLICATIONS FOR CATALYTIC MECHANISM AND THERMOSTABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; 3-DIMENSIONAL STRUCTURE; ERWINIA-CHRYSANTHEMI; BETA-GALACTOSIDASE; ACTIVE-SITE; CELLULASE; FAMILY; SEQUENCE; CLASSIFICATION; IDENTIFICATION	Endo-beta-1,4-glucanase from thermophilic Fervidobacterium nodosum Rt17-B1 (FnCel5A), a new member of glycosyl hydrolase family 5, is highly thermostable and exhibits the highest activity on carboxymethylcellulose among the reported homologues. To understand the structural basis for the thermostability and catalytic mechanism, we report here the crystal structures of FnCel5A and the complex with glucose at atomic resolution. FnCel5A exhibited a (beta/alpha)(8)-barrel structure typical of clan GH-A of the glycoside hydrolase families with a large and deep catalytic pocket located in the C-terminal end of the beta-strands that may permit substrate access. A comparison of the structure of FnCel5A with related structures from thermopile Clostridium thermocellum, mesophile Clostridium cellulolyticum, and psychrophile Pseudoalteromonas haloplanktis showed significant differences in intramolecular interactions (salt bridges and hydrogen bonds) that may account for the difference in their thermostabilities. The substrate complex structure in combination with a mutagenesis analysis of the catalytic residues implicates a distinctive catalytic module Glu(167)-His(226)-Glu(283), which suggests that the histidine may function as an intermediate for the electron transfer network between the typical Glu-Glu catalytic module. Further investigation suggested that the aromatic residues Trp(61), Trp(204), Phe(231), and Trp(240) as well as polar residues Asn(51), His(127), Tyr(228), and His(235) in the active site not only participated in substrate binding but also provided a unique microenvironment suitable for catalysis. These results provide substantial insight into the unique characteristics of FnCel5A for catalysis and adaptation to extreme temperature.	[Yang, Wen; Lou, Zhiyong; Rao, Zihe] Tsinghua Univ, Sch Med, Struct Biol Lab, Beijing 100084, Peoples R China; [Feng, Yan] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Zheng, Baisong; Zhao, Xinyu; Wang, Yuguo; Feng, Yan] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China	Tsinghua University; Shanghai Jiao Tong University; Jilin University	Rao, ZH (corresponding author), Tsinghua Univ, Sch Med, Struct Biol Lab, Beijing 100084, Peoples R China.	raozh@xtal.tsinghua.edu.cn; yfeng2009@mail.sjtu.edu.cn	YANG, WEN/A-1993-2014; Rao, Zihe/HCH-6944-2022		National Basic Research Program of China (973 Program); Natural Science Foundation of China; Science and Technology Commission of the Shanghai Municipality	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of the Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Basic Research Program of China (973 Program), Natural Science Foundation of China, and Science and Technology Commission of the Shanghai Municipality.	BAIRD SD, 1990, BIOCHEM BIOPH RES CO, V169, P1035, DOI 10.1016/0006-291X(90)91998-8; BARRAS F, 1992, FEBS LETT, V300, P145, DOI 10.1016/0014-5793(92)80183-H; BARRETT T, 1995, STRUCTURE, V3, P951, DOI 10.1016/S0969-2126(01)00229-5; BORTOLIGERMAN I, 1995, J MOL BIOL, V246, P82, DOI 10.1006/jmbi.1994.0068; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; Chang MCY, 2007, CURR OPIN CHEM BIOL, V11, P677, DOI 10.1016/j.cbpa.2007.08.039; CLARKE AJ, 1985, EUR J BIOCHEM, V149, P233, DOI 10.1111/j.1432-1033.1985.tb08917.x; DAGGETT V, 1993, J MOL BIOL, V232, P600, DOI 10.1006/jmbi.1993.1414; DEREWENDA U, 1994, J BIOL CHEM, V269, P20811; DOMINGUEZ R, 1995, NAT STRUCT BIOL, V2, P569, DOI 10.1038/nsb0795-569; Dominguez R, 1996, J MOL BIOL, V257, P1042, DOI 10.1006/jmbi.1996.0222; DOMINGUEZ R, 1994, PROTEINS, V19, P158, DOI 10.1002/prot.340190209; DUCROS V, 1995, STRUCTURE, V3, P939, DOI 10.1016/S0969-2126(01)00228-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HARRIS GW, 1994, STRUCTURE, V2, P1107, DOI 10.1016/S0969-2126(94)00112-X; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; JENKINS J, 1995, FEBS LETT, V362, P281, DOI 10.1016/0014-5793(95)00252-5; KIM JM, 1987, APPL ENVIRON MICROB, V53, P2656, DOI 10.1128/AEM.53.11.2656-2659.1987; LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; PY B, 1991, PROTEIN ENG, V4, P325, DOI 10.1093/protein/4.3.325; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; RUSSELL RJM, 1994, STRUCTURE, V2, P1157, DOI 10.1016/S0969-2126(94)00118-9; Sadeghi M, 2006, BIOPHYS CHEM, V119, P256, DOI 10.1016/j.bpc.2005.09.018; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SOGAARD M, 1993, J BIOL CHEM, V268, P22480; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TOMME P, 1989, FEBS LETT, V243, P239, DOI 10.1016/0014-5793(89)80136-X; VARGHESE JN, 1994, P NATL ACAD SCI USA, V91, P2785, DOI 10.1073/pnas.91.7.2785; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Violot S, 2005, J MOL BIOL, V348, P1211, DOI 10.1016/j.jmb.2005.03.026; Wang YG, 2010, J MOL CATAL B-ENZYM, V66, P294, DOI 10.1016/j.molcatb.2010.06.006; WHITE A, 1994, BIOCHEMISTRY-US, V33, P12546, DOI 10.1021/bi00208a003; WIESMANN C, 1995, STRUCTURE, V3, P961, DOI 10.1016/S0969-2126(01)00230-1; WITHERS SG, 1990, J AM CHEM SOC, V112, P5887, DOI 10.1021/ja00171a043; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zhaxybayeva O, 2009, P NATL ACAD SCI USA, V106, P5865, DOI 10.1073/pnas.0901260106; Zheng BS, 2009, ACTA CRYSTALLOGR F, V65, P219, DOI 10.1107/S1744309109001316	48	27	29	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8336	8346		10.1074/jbc.M111.266346	http://dx.doi.org/10.1074/jbc.M111.266346			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22128157	Green Published, hybrid			2022-12-25	WOS:000301349400048
J	Barajas-Espinosa, A; Ni, NC; Yan, D; Zarini, S; Murphy, RC; Funk, CD				Barajas-Espinosa, Alma; Ni, Nathan C.; Yan, Dong; Zarini, Simona; Murphy, Robert C.; Funk, Colin D.			The cysteinyl leukotriene 2 receptor mediates retinal edema and pathological neovascularization in a murine model of oxygen-induced retinopathy	FASEB JOURNAL			English	Article						inflammation; pericyte	VASCULAR-PERMEABILITY; MOUSE MODEL; RAT RETINA; 5-LIPOXYGENASE; PERICYTES; EXPRESSION; CYSLT(1); CELLS; DEGENERATION; CAPILLARIES	Leukotrienes have been implicated in the pathogenesis of degenerative diabetic retinopathy, with research focusing primarily on leukotriene B4, with little attention devoted to the cysteinyl leukotrienes (cysLTs), which act through cysLT receptors (CysLT1R and CysLT2R). We demonstrate here the presence of CysLT2R in pericytes and endothelial cells of superficial retinal vasculature using an indirect assay by assessment of beta-galactosidase expression in CysLT2R-knockout (KO) mice. Retinal damage was induced in KO and wild-type (WT) mice using an established oxygen-induced retinopathy (OIR) model. CysLT2R expression following OIR was intensely upregulated compared to sham-treated controls. Staining with Griffonia simplicifolia lectin revealed enhanced tissue damage (as assessed by vasoobliteration/ vasoproliferation) in KO mice compared to WT controls, yet the opposite was true with respect to retinal edema. However, vascular endothelial growth factor receptor 1 (VEGFR1) transcripts were increased by OIR similarly with respect to genotype. Intravitreal application of exogenous cysLTs elicited greater vasculature leakage (assessed ex vivo) in eyes from WT mice compared to KO mice. While mRNA encoding enzymes for various components of the leukotriene cascade were detected in sham-and OIR-treated retinas, only prostaglandins and hydroxyeicosatetraenoic acids, but not leukotrienes, were detected in A23187-treated retina preparations. Together, these results implicate the CysLT2R in the progression of ischemic retinopathy.-Barajas-Espi-nosa, A., Ni, N. C., Yan, D., Zarini, S., Murphy, R. C., Funk, C. D. The cysteinyl leukotriene 2 receptor mediates retinal edema and pathological neovascularization in a murine model of oxygen-induced retinopathy. FASEB J. 26, 1100-1109 (2012). www.fasebj.org	[Barajas-Espinosa, Alma; Ni, Nathan C.; Yan, Dong; Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Zarini, Simona; Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO USA	Queens University - Canada; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Funk, CD (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St,433 Botterell Hall, Kingston, ON K7L 3N6, Canada.	funkc@queensu.ca	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515; Zarini, Simona/0000-0002-7460-3299; Funk, Colin/0000-0001-7029-4233	CIHR [MOP-68930]; Canada Research Chairs program; Heart and Stroke Foundation of Ontario; CONACyT	CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors thank Tim St Amand and Laurel Ballantyne for their help with retina tissue processing, staining, and animal care; Dr. Lois Smith (Department of Ophthalmology, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA) for the SWIFT software; and Dr. Satoshi Ishii (University of Tokyo, Tokyo, Japan) for supplying the CysLT<INF>2</INF>R-KO embryos. This work is supported by CIHR grant MOP-68930, Canada Research Chairs program, Heart and Stroke Foundation of Ontario Career Investigator Award (C. D. F.), and a CONACyT International Fellowship Award (A.B.-E.).	Al-Shabrawey M, 2011, DIABETES, V60, P614, DOI 10.2337/db10-0008; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; ASHTON N, 1954, BRIT J OPHTHALMOL, V38, P433, DOI 10.1136/bjo.38.7.433; Barajas-Espinosa A, 2011, AM J PATHOL, V178, P2682, DOI 10.1016/j.ajpath.2011.02.041; BAZAN NG, 1987, J NEUROSCI RES, V18, P591, DOI 10.1002/jnr.490180412; Chan-Ling T, 2004, AM J PATHOL, V165, P1301, DOI 10.1016/S0002-9440(10)63389-5; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Chen J, 2011, CURR OPIN PEDIATR, V23, P173, DOI 10.1097/MOP.0b013e3283423f35; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Claxton S, 2003, EXP EYE RES, V77, P305, DOI 10.1016/S0014-4835(03)00153-2; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887; DEOLIVEIRA F, 1966, BRIT J OPHTHALMOL, V50, P134, DOI 10.1136/bjo.50.3.134; Finkensieper A, 2010, CARDIOVASC RES, V86, P37, DOI 10.1093/cvr/cvp385; FUNK CD, 1989, P NATL ACAD SCI USA, V86, P2592, DOI 10.1073/pnas.86.8.2592; Gubitosi-Klug RA, 2008, DIABETES, V57, P1387, DOI 10.2337/db07-1217; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Hui YQ, 2004, CIRCULATION, V110, P3360, DOI 10.1161/01.CIR.0000147775.50954.AA; Kataoka K, 2011, INVEST OPHTH VIS SCI, V52, P1431, DOI 10.1167/iovs.10-5798; Kaur C, 2008, PROG RETIN EYE RES, V27, P622, DOI 10.1016/j.preteyeres.2008.09.003; Lee KS, 2004, J ALLERGY CLIN IMMUN, V114, P1093, DOI 10.1016/j.jaci.2004.07.039; Lynch KR, 1999, NATURE, V399, P789; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; Marmor MF, 1999, DOC OPHTHALMOL, V97, P239, DOI 10.1023/A:1002192829817; McMurdo L, 1998, J PHARMACOL EXP THER, V285, P1255; Moos MPW, 2008, FASEB J, V22, P4352, DOI 10.1096/fj.08-113274; Ni NC, 2011, J PHARMACOL EXP THER, V339, P768, DOI 10.1124/jpet.111.186031; Peters-Golden M, 2001, FEBS LETT, V487, P323, DOI 10.1016/S0014-5793(00)02374-7; Poeckel D, 2009, J BIOL CHEM, V284, P21077, DOI 10.1074/jbc.M109.000901; REINBOTH JJ, 1995, CURR EYE RES, V14, P1001, DOI 10.3109/02713689508998521; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; SCHONFELD W, 1988, IMMUNOLOGY, V65, P529; Sheng WW, 2006, BIOCHEM BIOPH RES CO, V346, P19, DOI 10.1016/j.bbrc.2006.05.023; Shih SC, 2003, J CLIN INVEST, V112, P50, DOI 10.1172/JCI200317808; Silverman W. A., 1980, RETROLENTAL FIBROPLA; SKALLI O, 1989, J HISTOCHEM CYTOCHEM, V37, P315, DOI 10.1177/37.3.2918221; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 2002, ACTA PAEDIATR, V91, P26, DOI 10.1080/08035250260095771; Stahl A, 2010, AM J PATHOL, V177, P2715, DOI 10.2353/ajpath.2010.100526; SZABO ME, 1991, INVEST OPHTH VIS SCI, V32, P1471; Talahalli R, 2010, INVEST OPHTH VIS SCI, V51, P1699, DOI 10.1167/iovs.09-3557; Terry TL., 1942, AM J OPHTHALMOL, V25, P203, DOI DOI 10.1016/S0002-9394(42)92088-9; TSOPANOGLOU NE, 1994, EUR J PHARMACOL, V258, P151, DOI 10.1016/0014-2999(94)90068-X; Ulyatt C, 2011, BIOCHEM BIOPH RES CO, V404, P774, DOI 10.1016/j.bbrc.2010.12.057; WILLIAMSON JR, 1980, MICROVASC RES, V20, P233, DOI 10.1016/0026-2862(80)90010-2; Yuan YM, 2009, J PHARMACOL SCI, V109, P285, DOI 10.1254/jphs.08321FP	48	18	18	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1100	1109		10.1096/fj.11-195792	http://dx.doi.org/10.1096/fj.11-195792			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22131271				2022-12-25	WOS:000300949300014
J	Simiele, F; Recchiuti, A; Mattoscio, D; De Luca, A; Cianci, E; Franchi, S; Gatta, V; Parolari, A; Werba, JP; Camera, M; Favaloro, B; Romano, M				Simiele, Felice; Recchiuti, Antonio; Mattoscio, Domenico; De Luca, Antonella; Cianci, Eleonora; Franchi, Sara; Gatta, Valentina; Parolari, Alessandro; Werba, Jose Pablo; Camera, Marina; Favaloro, Bartolo; Romano, Mario			Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity	FASEB JOURNAL			English	Article						lipoxin A(4) receptor; inflammation; Sp1; polymorphism; methylation	FORMYL-PEPTIDE RECEPTOR; LIPOXIN A(4) RECEPTOR; ACUTE INFLAMMATORY RESPONSES; 5-LIPOXYGENASE PROMOTER; 15-EPI-LIPOXIN A(4); LEUKOTRIENE B-4; SEVERE ASTHMA; UP-REGULATION; ASPIRIN; EXPRESSION	Lipoxin (LX) A(4), a main endogenous stop-signal of inflammation, activates the G-protein-coupled receptor FPR2/ALX, which triggers potent anti-inflammatory signaling in vivo. Thus, the regulation of FPR2/ALX expression may have pathophysiological and therapeutic relevance. Here, we mapped a nucleotide sequence with strong FPR2/ALX promoter activity. Chromatin immuno-precipitation revealed specificity protein 1 (Sp1) binding to the core promoter. Site-directed mutagenesis of the Sp1 cis-acting element and Sp1 overexpression established that this transcription factor is key for maximal promoter activity, which is instead suppressed by DNA methylation. LXA4 enhanced FPR2/ALX promoter activity (+74%) and mRNA expression (+87.5%) in MDA-MB231 cells. A single nucleotide mutation (A/G) was detected in the core promoter of one subject with history of cardiovascular disease and of his two daughters. This mutation reduced by similar to 35-90% the promoter activity in vitro. Moreover, neutrophils from individuals carrying the A/G variant displayed similar to 10- and 3-fold reduction in FPR2/ALX mRNA and protein, respectively, compared with cells from their relatives or healthy volunteers expressing the wild-type allele. These results uncover FPR2/ALX transcriptional regulation and provide the first evidence of mutations that affect FPR2/ALX transcription, thus opening new opportunities for the understanding of the LXA4-FPR2/ALX axis in human disease-Simiele, F., Recchiuti, A., Mattoscio, D., De Luca, A., Cianci, E., Franchi, S., Gatta, V., Parolari, A., Werba, J. P., Camera, M., Favaloro, B., Romano, M. Transcriptional regulation of the human FPR2/ALX gene: Evidence of a heritable genetic variant that impairs promoter activity. FASEB J. 26, 1323-1333 (2012). www.fasebj.org	[Romano, Mario] G DAnnunzio Uni Fdn, Dept Biomed Sci, Ctr Excellence Aging, CeSI, I-66013 Chieti, Italy; [Cianci, Eleonora] G DAnnunzio Uni Fdn, Dept Med & Aging Sci, Ctr Excellence Aging, I-66013 Chieti, Italy; [Franchi, Sara; Gatta, Valentina] G DAnnunzio Uni Fdn, Dept Oral Sci Nano & Biotechnol, Ctr Excellence Aging, I-66013 Chieti, Italy; [Parolari, Alessandro; Werba, Jose Pablo; Camera, Marina] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Camera, Marina] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Parolari, Alessandro] Univ Milan, Dept Cardiovasc Sci, Milan, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; IRCCS Centro Cardiologico Monzino; University of Milan; University of Milan	Romano, M (corresponding author), G DAnnunzio Uni Fdn, Dept Biomed Sci, Ctr Excellence Aging, CeSI, Via Colle Ara, I-66013 Chieti, Italy.	mromano@unich.it	Camera, Marina/AAC-4741-2022; Mattoscio, Domenico/K-1411-2018; Romano, Mario/I-7986-2012; Recchiuti, Antonio/K-7670-2016; Gatta, Valentina/G-5765-2014; Werba, José Pablo/AAC-8973-2019; PAROLARI, ALESSANDRO/AAB-1763-2021	Mattoscio, Domenico/0000-0002-2149-2855; Romano, Mario/0000-0001-8512-1458; Recchiuti, Antonio/0000-0002-1409-5261; Werba, José Pablo/0000-0001-7188-1157; PAROLARI, ALESSANDRO/0000-0002-6954-0422; GATTA, Valentina/0000-0002-9999-5823	Italian Foundation for Cystic Fibrosis Research [FFC 15/2007]; EU	Italian Foundation for Cystic Fibrosis Research; EU(European Commission)	The authors thank investigators and personnel of the Polimorfismi Genici in Ambito Cardiovascolare (POGEAC) Study Group (F. Alamanni, M. Amato, M. Brambilla, P. Canzano, G. Polvani, G. Pompilio, L. Rossetti, and M. Zanobini, Centro Cardiologico Monzino IRCCS; and E. Tremoli, Universita degli Studi di Milano and Centro Cardiologico Monzino IRCCS) and the Functional Genomic Unit (Chieti, Italy) for recruiting subjects and collecting DNA samples for this study. The authors thank the Heart Surgeons of the Centro Cardiologico Monzino IRCSS for patient selection and Irene Recchia, Veronica Cecilia Mari, Antonella Pompei, and Cesidio Giuliani for technical support. A special thanks to Dr. Dieter Steinhilber for helpful discussion and valuable advice. This work was supported by grant FFC 15/2007 from the Italian Foundation for Cystic Fibrosis Research and from the EU VI framework program, EICOSANOX (to M. R). A European patent application relative to data reported in this manuscript has been filed (11425283.6). The authors declare no conflicts of interest.	BAO L, 1992, Genomics, V13, P437, DOI 10.1016/0888-7543(92)90265-T; Birnbaum Y, 2006, CIRCULATION, V114, P929, DOI 10.1161/CIRCULATIONAHA.106.629907; Bonnans C, 2006, AM J PATHOL, V168, P1064, DOI 10.2353/ajpath.2006.051056; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; BOYUM A, 1968, J CLIN LAB INVEST S, V97, P77; Chan MMY, 2010, J IMMUNOL, V184, P6418, DOI 10.4049/jimmunol.0903816; Chiang N, 2003, BRIT J PHARMACOL, V139, P89, DOI 10.1038/sj.bjp.0705220; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; Devchand PR, 2003, FASEB J, V17, P652, DOI 10.1096/fj.02-0770com; Drazen JM, 1999, NAT GENET, V22, P168, DOI 10.1038/9680; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; FIORE S, 1994, J EXP MED, V180, P253, DOI 10.1084/jem.180.1.253; Gronert K, 1998, J EXP MED, V187, P1285, DOI 10.1084/jem.187.8.1285; Hecht I, 2009, J PHARMACOL EXP THER, V328, P426, DOI 10.1124/jpet.108.145821; HOSHIKO S, 1990, P NATL ACAD SCI USA, V87, P9073, DOI 10.1073/pnas.87.23.9073; Kato K, 2000, J EXP MED, V192, P413, DOI 10.1084/jem.192.3.413; Katryniok C., BIOCHIM BIOPHYS ACTA, V1801, P49; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Levy BD, 2005, AM J RESP CRIT CARE, V172, P824, DOI 10.1164/rccm.200410-1413OC; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Morris T, 2010, P NATL ACAD SCI USA, V107, P8842, DOI 10.1073/pnas.1000373107; Morris T, 2009, J IMMUNOL, V183, P2089, DOI 10.4049/jimmunol.0900477; MURPHY PM, 1992, J BIOL CHEM, V267, P7637; Ndlovu M. N., TRENDS BIOCH SCI, V36, P381; PEREZ HD, 1992, GENE, V118, P303, DOI 10.1016/0378-1119(92)90208-7; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Planaguma A, 2010, MUCOSAL IMMUNOL, V3, P270, DOI 10.1038/mi.2009.141; Planaguma A, 2008, AM J RESP CRIT CARE, V178, P574, DOI 10.1164/rccm.200801-061OC; Qiu H, 2006, P NATL ACAD SCI USA, V103, P6913, DOI 10.1073/pnas.0602208103; ROMANO M, 1993, BIOCHEM J, V296, P127, DOI 10.1042/bj2960127; Romano M, 2007, THESCIENTIFICWORLDJO, V7, P1393, DOI 10.1100/tsw.2007.186; Romano M, 2010, THESCIENTIFICWORLDJO, V10, P1048, DOI 10.1100/tsw.2010.113; Sawmynaden P, 2006, BIOCHEM BIOPH RES CO, V349, P1351, DOI 10.1016/j.bbrc.2006.08.179; Schnur N, 2007, BBA-MOL CELL BIOL L, V1771, P1271, DOI 10.1016/j.bbalip.2007.08.003; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; SERHAN CN, 1984, BIOCHEM BIOPH RES CO, V118, P943, DOI 10.1016/0006-291X(84)91486-4; Silverman ES, 1998, AM J RESP CELL MOL, V19, P316, DOI 10.1165/ajrcmb.19.2.3154; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Takano T, 1997, J EXP MED, V185, P1693, DOI 10.1084/jem.185.9.1693; YE RD, 1992, BIOCHEM BIOPH RES CO, V184, P582, DOI 10.1016/0006-291X(92)90629-Y; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	44	50	51	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1323	1333		10.1096/fj.11-198069	http://dx.doi.org/10.1096/fj.11-198069			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22131270				2022-12-25	WOS:000300949300034
J	Hu, SQ; Ye, JS; Zong, YY; Sun, CC; Liu, DH; Wu, YP; Song, T; Zhang, GY				Hu, Shu-Qun; Ye, Jun-Song; Zong, Yan-Yan; Sun, Chang-Cheng; Liu, Dong-Hai; Wu, Yong-Ping; Song, Tao; Zhang, Guang-Yi			S-Nitrosylation of Mixed Lineage Kinase 3 Contributes to Its Activation after Cerebral Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL NITRIC-OXIDE; RAT HIPPOCAMPUS; PROTEIN-KINASE; TUMOR-SUPPRESSOR; APOPTOSIS; MECHANISM; SYNTHASE; RECEPTOR; PATHWAY; INJURY	Previous studies in our laboratory have shown that mixed lineage kinase 3 (MLK3) can be activated following global ischemia. In addition, other laboratories have reported that the activation of MLK3 may be linked to the accumulation of free radicals. However, the mechanism of MLK3 activation remains incompletely understood. We report here that MLK3, overexpressed in HEK293 cells, is S-nitrosylated (forming SNO-MLK3) via a reaction with S-nitrosoglutathione, an exogenous nitric oxide (NO) donor, at one critical cysteine residue (Cys-688). We further show that the S-nitrosylation of MLK3 contributes to its dimerization and activation. We also investigated whether the activation of MLK3 is associated with S-nitrosylation following rat brain is chemia/reperfusion. Our results show that the administration of 7-nitroindazole, an inhibitor of neuronal NO synthase (nNOS), or nNOS antisense oligodeoxy-nucleotides diminished the S-nitrosylation of MLK3 and inhibited its activation induced by cerebral ischemia/reperfusion. In contrast, 2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine (an inhibitor of inducible NO synthase) or nNOS missense oligode-oxynucleotides did not affect the S-nitrosylation of MLK3. In addition, treatment with sodium nitroprusside (an exogenous NO donor) and S-nitrosoglutathione or MK801, an antagonist of the N-methyl-D-aspartate receptor, also diminished the S-nitrosylation and activation of MLK3 induced by cerebral ischemia/reperfusion. The activation of MLK3 facilitated its downstream protein kinase kinase 4/7 (MKK4/7)-JNK signaling module and both nuclear and non-nuclear apoptosis pathways. These data suggest that the activation of MLK3 during the early stages of ischemia/reperfusion is modulated by S-nitrosylation and provides a potential new approach for stroke therapy whereby the post-translational modification machinery is targeted.	[Hu, Shu-Qun; Ye, Jun-Song; Zong, Yan-Yan; Sun, Chang-Cheng; Liu, Dong-Hai; Zhang, Guang-Yi] Xuzhou Med Coll, Jiangsu Key Lab Brain Dis Bioinformat, Xuzhou 221002, Jiangsu, Peoples R China; [Hu, Shu-Qun; Ye, Jun-Song; Zong, Yan-Yan; Sun, Chang-Cheng; Liu, Dong-Hai; Zhang, Guang-Yi] Xuzhou Med Coll, Res Ctr Biochem & Mol Biol, Xuzhou 221002, Jiangsu, Peoples R China; [Wu, Yong-Ping] Xuzhou Med Coll, Jiangsu Key Lab Anesthesiol, Xuzhou 221002, Jiangsu, Peoples R China; [Song, Tao] China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang 110001, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University; China Medical University	Zhang, GY (corresponding author), Xuzhou Med Coll, Jiangsu Key Lab Brain Dis Bioinformat, Xuzhou 221002, Jiangsu, Peoples R China.	gyzhang@xzmc.edu.cn		Song, Tao/0000-0002-6438-1100	National Natural Science Foundation of China [30870543, 90608015]; Natural Science Foundation of Jiangsu [BK2010171]; Jiangsu Educational Science Foundation [10KJA310053]; Xuzhou Medical College Science Foundation [2010KJZ12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Jiangsu Educational Science Foundation; Xuzhou Medical College Science Foundation	This work was supported by Project of National Natural Science Foundation of China Grants 30870543 and 90608015, Natural Science Foundation of Jiangsu Grant BK2010171, Jiangsu Educational Science Foundation Grant 10KJA310053, and Xuzhou Medical College Science Foundation Grant 2010KJZ12.	Almeida A, 1999, BRAIN RES, V816, P580, DOI 10.1016/S0006-8993(98)01240-2; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Choi Dennis W., 1995, Trends in Neurosciences, V18, P58, DOI 10.1016/0166-2236(95)93870-4; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Derakhshan B, 2007, CARDIOVASC RES, V75, P210, DOI 10.1016/j.cardiores.2007.04.023; GALLO KA, 1994, J BIOL CHEM, V269, P15092; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Gu ZL, 2001, NEUROREPORT, V12, P897, DOI 10.1097/00001756-200104170-00006; HEWETT SJ, 1994, NEURON, V13, P487, DOI 10.1016/0896-6273(94)90362-X; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Leung IWL, 1998, J BIOL CHEM, V273, P32408, DOI 10.1074/jbc.273.49.32408; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lipton SA, 1998, CELL CALCIUM, V23, P165, DOI 10.1016/S0143-4160(98)90115-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Park HS, 2000, P NATL ACAD SCI USA, V97, P14382, DOI 10.1073/pnas.97.26.14382; Park HS, 2004, J BIOL CHEM, V279, P7584, DOI 10.1074/jbc.M304183200; Parratt JR, 1998, J ANTIMICROB CHEMOTH, V41, P31, DOI 10.1093/jac/41.suppl_1.31; Pei DS, 2008, J NEUROCHEM, V106, P1952, DOI 10.1111/j.1471-4159.2008.05531.x; Pei DS, 2009, NEUROCHEM RES, V34, P1507, DOI 10.1007/s11064-009-9938-3; Pei DS, 2004, NEUROSCI LETT, V367, P71, DOI 10.1016/j.neulet.2004.05.082; Pi XC, 2009, P NATL ACAD SCI USA, V106, P5675, DOI 10.1073/pnas.0809568106; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Rahman MA, 2010, J BIOL CHEM, V285, P3806, DOI 10.1074/jbc.M109.059782; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Song Y. J., 2005, ACTA ACAD MED XUZHOU, V25, P385; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Tenneti L, 1997, NEUROSCI LETT, V236, P139, DOI 10.1016/S0304-3940(97)00780-5; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Tian H, 2003, NEUROSCI RES, V47, P47, DOI 10.1016/S0168-0102(03)00186-X; Tsang AHK, 2009, P NATL ACAD SCI USA, V106, P4900, DOI 10.1073/pnas.0810595106; Vazquez F, 2000, BBA-REV CANCER, V1470, pM21, DOI 10.1016/S0304-419X(99)00032-3; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Yu HM, 2008, NEUROSCIENCE, V155, P1120, DOI 10.1016/j.neuroscience.2008.03.061; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200; Zhang QX, 2007, BIOCHEMISTRY-US, V46, P4006, DOI 10.1021/bi0615386; ZORUMSKI CF, 1993, PHARMACOL THERAPEUT, V59, P145, DOI 10.1016/0163-7258(93)90043-D	38	41	45	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2364	2377		10.1074/jbc.M111.227124	http://dx.doi.org/10.1074/jbc.M111.227124			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22123824	Green Published, hybrid			2022-12-25	WOS:000300292300012
J	Freville, A; Landrieu, I; Garcia-Gimeno, MA; Vicogne, J; Montbarbon, M; Bertin, B; Verger, A; Kalamou, H; Sanz, P; Werkmeister, E; Pierrot, C; Khalife, J				Freville, Aline; Landrieu, Isabelle; Adelaida Garcia-Gimeno, M.; Vicogne, Jerome; Montbarbon, Muriel; Bertin, Benjamin; Verger, Alexis; Kalamou, Hadidjatou; Sanz, Pascual; Werkmeister, Elisabeth; Pierrot, Christine; Khalife, Jamal			Plasmodium falciparum Inhibitor-3 Homolog Increases Protein Phosphatase Type 1 Activity and Is Essential for Parasitic Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH REPEAT PROTEIN; SACCHAROMYCES-CEREVISIAE; MALARIA PARASITE; STRUCTURAL BASIS; SERINE/THREONINE PHOSPHATASE; DISORDERED PROTEIN; POTENT INHIBITOR; PP1 PHOSPHATASE; CHEMICAL-SHIFTS; EMERGING ROLES	Growing evidence indicates that the protein regulators governing protein phosphatase 1 (PP1) activity have crucial functions because their deletion drastically affects cell growth and division. PP1 has been found to be essential in Plasmodium falciparum, but little is known about its regulators. In this study, we have identified a homolog of Inhibitor-3 of PP1, named PfI3. NMR analysis shows that PfI3 belongs to the disordered protein family. High affinity interaction of PfI3 and PfPP1 is demonstrated in vitro using several methods, with an apparent dissociation constant K-D of 100 nM. We further show that the conserved (KVVRW45)-K-41 motif is crucial for this interaction as the replacement of the Trp(45) by an Ala(45) severely decreases the binding to PfPP1. Surprisingly, PfI3 was unable to rescue a yeast strain deficient in I3 (Ypi1). This lack of functional orthology was supported as functional assays in vitro have revealed that PfI3, unlike yeast I3 and human I3, increases PfPP1 activity. Reverse genetic approaches suggest an essential role of PfI3 in the growth and/or survival of blood stage parasites because attempts to obtain knockout parasites were unsuccessful, although the locus of PfI3 is accessible. The main localization of a GFP-tagged PfI3 in the nucleus of all blood stage parasites is compatible with a regulatory role of PfI3 on the activity of nuclear PfPP1.	[Freville, Aline; Montbarbon, Muriel; Bertin, Benjamin; Kalamou, Hadidjatou; Pierrot, Christine; Khalife, Jamal] Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, Inserm U1019,CNRS UMR 8204, F-59019 Lille, France; [Landrieu, Isabelle] Univ Sci & Technol Lille, Struct & Funct Glycobiol Unit, CNRS UMR8576, F-59655 Villeneuve Dascq, France; [Adelaida Garcia-Gimeno, M.; Sanz, Pascual] CSIC, Inst Biomed Valencia, Valencia 46010, Spain; [Adelaida Garcia-Gimeno, M.; Sanz, Pascual] Ctr Invest Biomed Red Enfermedades Raras, Valencia 46010, Spain; [Verger, Alexis] Univ Lille 2, Univ Lille 1, IRI Inst Rech Interdisciplinaire CNRS USR3078, F-59658 Villeneuve Dascq, France; [Vicogne, Jerome; Werkmeister, Elisabeth] Inst Pasteur, Inst Biol Lille, BICeL IFR142, UMR8161, F-59019 Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Khalife, J (corresponding author), Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, Inserm U1019,CNRS UMR 8204, 1 Rue Prof Calmette, F-59019 Lille, France.	jamal.khalife@pasteur-lille.fr	Khalife, Jamal/AAZ-2833-2020; WERKMEISTER, Elisabeth/GLQ-7361-2022; García-Gimeno, María Adelaida/K-9855-2014; Sanz, Pascual/K-2751-2014; Landrieu, Isabelle/AAF-8495-2019; Bertin, Benjamin/M-8300-2016	García-Gimeno, María Adelaida/0000-0002-6483-3912; Sanz, Pascual/0000-0002-2399-4103; Landrieu, Isabelle/0000-0002-4883-2637; Pierrot, Christine/0000-0002-6835-6789; FREVILLE, Aline/0000-0002-0982-5688; Vicogne, Jerome/0000-0001-8360-7497; Bertin, Benjamin/0000-0002-9160-3717; Khalife, Jamal/0000-0002-4359-8976; verger, alexis/0000-0002-0299-2344	Inserm; Institut Pasteur de Lille; Universite Lille Nord de France; TGE RMN THC, France [FR-3050]; Region Nord; CNRS; Pasteur Institute of Lille; European Community (FEDER); French Research Ministry; University of Sciences and Technologies of Lille I	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Pasteur de Lille; Universite Lille Nord de France; TGE RMN THC, France; Region Nord(Region Hauts-de-France); CNRS(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute of Lille; European Community (FEDER)(European Commission); French Research Ministry(Ministry of Research, France); University of Sciences and Technologies of Lille I	This work was supported in part by Inserm, Institut Pasteur de Lille, Universite Lille Nord de France, and TGE RMN THC Grant FR-3050, France.; We thank Drs. Edith Browaeys, Katia Cailliau, Guy Lippens, and Jean-Michel Wieruszeski for helpful discussions; Dr. Raymond Pierce for the critical reading of the manuscript, and Claude Godin and Herve Drobecq for technical assistance. The NMR facilities were funded by the Region Nord, CNRS, Pasteur Institute of Lille, European Community (FEDER), French Research Ministry, and the University of Sciences and Technologies of Lille I.	AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; Baker SH, 1997, GENETICS, V145, P615; Ben Mamoun C, 1998, J BIOL CHEM, V273, P11241, DOI 10.1074/jbc.273.18.11241; Bennett D, 2005, BIOCHEM SOC T, V33, P1444, DOI 10.1042/BST0331444; Berndt N., 1999, FRONT BIOSCI, V4, pD22, DOI DOI 10.2741/BERNDT;PMID:9872729; Bharucha JP, 2008, MOL BIOL CELL, V19, P1032, DOI 10.1091/mbc.E07-05-0499; Bhattacharyya MK, 2002, INT J PARASITOL, V32, P739, DOI 10.1016/S0020-7519(02)00007-3; Blisnick T, 2006, CELL MICROBIOL, V8, P591, DOI 10.1111/j.1462-5822.2005.00650.x; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Brady MJ, 2001, RECENT PROG HORM RES, V56, P157, DOI 10.1210/rp.56.1.157; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chen F, 2007, CURR BIOL, V17, P293, DOI 10.1016/j.cub.2007.01.068; Cheng AY, 2000, J BIOL CHEM, V275, P34744, DOI 10.1074/jbc.M006210200; Daher W, 2006, MOL MICROBIOL, V60, P578, DOI 10.1111/j.1365-2958.2006.05119.x; Daher W, 2006, BIOCHEM J, V395, P433, DOI 10.1042/BJ20051597; Daher W, 2007, EUKARYOT CELL, V6, P1606, DOI 10.1128/EC.00260-07; Dancheck B, 2008, BIOCHEMISTRY-US, V47, P12346, DOI 10.1021/bi801308y; de Koning-Ward TF, 2009, TRENDS PARASITOL, V25, P4, DOI 10.1016/j.pt.2008.09.009; De Wulf P, 2009, CURR OPIN CELL BIOL, V21, P806, DOI 10.1016/j.ceb.2009.08.003; Dobson S, 2001, MOL BIOCHEM PARASIT, V115, P29, DOI 10.1016/S0166-6851(01)00260-2; Dobson S, 1999, MOL BIOCHEM PARASIT, V99, P167, DOI 10.1016/S0166-6851(99)00010-9; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Fardilha M, 2010, CURR MED CHEM, V17, P3996, DOI 10.2174/092986710793205363; Garcia-Gimeno MA, 2003, J BIOL CHEM, V278, P47744, DOI 10.1074/jbc.M306157200; GINSBURG H, 1987, ANN PARASIT HUM COMP, V62, P418, DOI 10.1051/parasite/1987625418; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hirano K, 1996, FEBS LETT, V389, P191, DOI 10.1016/0014-5793(96)00577-7; HONKANEN RE, 1990, J BIOL CHEM, V265, P19401; Huang H, 2000, J BIOMOL NMR, V17, P359, DOI 10.1023/A:1008355428294; Huang HB, 2007, PROTEINS, V68, P779, DOI 10.1002/prot.21438; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; Ishii K, 1996, EMBO J, V15, P6629, DOI 10.1002/j.1460-2075.1996.tb01053.x; Kuhn Y, 2010, TRAFFIC, V11, P236, DOI 10.1111/j.1600-0854.2009.01018.x; Landsverk HB, 2005, BIOCHEM J, V390, P709, DOI 10.1042/BJ20050678; Lee JH, 2010, J BIOL CHEM, V285, P24466, DOI 10.1074/jbc.M110.109801; Lesage B, 2007, BIOCHEMISTRY-US, V46, P8909, DOI 10.1021/bi7003119; Li JL, 1998, MOL BIOCHEM PARASIT, V95, P287, DOI 10.1016/S0166-6851(98)00106-6; Li JL, 1997, EUR J BIOCHEM, V249, P98, DOI 10.1111/j.1432-1033.1997.t01-2-00098.x; Lin TH, 2004, J BIOMOL NMR, V28, P413, DOI 10.1023/B:JNMR.0000015358.20495.b8; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Marsh JA, 2010, STRUCTURE, V18, P1094, DOI 10.1016/j.str.2010.05.015; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; OHKURA H, 1991, CELL, V64, P149, DOI 10.1016/0092-8674(91)90216-L; OHTA T, 1994, CANCER RES, V54, P6402; Oliver C.J., 1998, FRONT BIOSCI, V3, P961; Pedelini L, 2007, J BIOL CHEM, V282, P3282, DOI 10.1074/jbc.M607171200; Pinheiro AS, 2011, J AM CHEM SOC, V133, P73, DOI 10.1021/ja107810r; Ragusa MJ, 2010, NAT STRUCT MOL BIOL, V17, P459, DOI 10.1038/nsmb.1786; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rose MD., 1990, METHODS YEAST GENETI; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Song WJ, 1998, EMBO J, V17, P5757, DOI 10.1093/emboj/17.19.5757; Sugiyama H, 1997, ONCOGENE, V15, P443, DOI 10.1038/sj.onc.1201207; Takemiya A, 2009, PLANT PHYSIOL, V150, P144, DOI 10.1104/pp.109.135335; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Thompson LJ, 1997, J BIOL CHEM, V272, P29693, DOI 10.1074/jbc.272.47.29693; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TU JL, 1995, EMBO J, V14, P5939, DOI 10.1002/j.1460-2075.1995.tb00282.x; UMLAS J, 1971, AM J TROP MED HYG, V20, P527, DOI 10.4269/ajtmh.1971.20.527; VERNES A, 1984, AM J TROP MED HYG, V33, P197, DOI 10.4269/ajtmh.1984.33.197; Vojtek A., 1997, YEAST 2 HYBRID SYSTE, P26; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; WARD GE, 1994, EXP PARASITOL, V79, P480, DOI 10.1006/expr.1994.1109; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Yokoyama D, 1998, BIOCHEM BIOPH RES CO, V247, P18, DOI 10.1006/bbrc.1998.8730; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055; Zhang J, 1998, BIOCHEMISTRY-US, V37, P16728, DOI 10.1021/bi981169g; Zhang LF, 2008, BIOCHEM BIOPH RES CO, V377, P710, DOI 10.1016/j.bbrc.2008.10.062	77	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1306	1321		10.1074/jbc.M111.276865	http://dx.doi.org/10.1074/jbc.M111.276865			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128182	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000299170300046
J	Mochel, F; Durant, B; Meng, XL; O'Callaghan, J; Yu, H; Brouillet, E; Wheeler, VC; Humbert, S; Schiffmann, R; Durr, A				Mochel, Fanny; Durant, Brandon; Meng, Xingli; O'Callaghan, James; Yu, Hua; Brouillet, Emmanuel; Wheeler, Vanessa C.; Humbert, Sandrine; Schiffmann, Raphael; Durr, Alexandra			Early Alterations of Brain Cellular Energy Homeostasis in Huntington Disease Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAG REPEAT INSTABILITY; CREATINE-KINASE; CLINICAL SYMPTOMS; MOUSE MODEL; MITOCHONDRIAL; MICE; THERAPY; DEFICIT; PHOSPHORYLATION; METABOLISM	Brain energy deficit has been a suggested cause of Huntington disease (HD), but ATP depletion has not reliably been shown in preclinical models, possibly because of the immediate post-mortem changes in cellular energy metabolism. To examine a potential role of a low energy state in HD, we measured, for the first time in a neurodegenerative model, brain levels of high energy phosphates using microwave fixation, which instantaneously inactivates brain enzymatic activities and preserves in vivo levels of analytes. We studied HD transgenic R6/2 mice at ages 4, 8, and 12 weeks. We found significantly increased creatine and phosphocreatine, present as early as 4 weeks for phosphocreatine, preceding motor system deficits and decreased ATP levels in striatum, hippocampus, and frontal cortex of R6/2 mice. ATP and phosphocreatine concentrations were inversely correlated with the number of CAG repeats. Conversely, in mice injected with 3-nitroproprionic acid, an acute model of brain energy deficit, both ATP and phosphocreatine were significantly reduced. Increased creatine and phosphocreatine in R6/2 mice was associated with decreased guanidinoacetate N-methyltransferase and creatine kinase, both at the protein and RNA levels, and increased phosphorylated AMP-dependent protein kinase (pAMPK) over AMPK ratio. In addition, in 4-month-old knock-in Hdh(Q111/+) mice, the earliest metabolic alterations consisted of increased phosphocreatine in the frontal cortex and increased the pAMPK/AMPK ratio. Altogether, this study provides the first direct evidence of chronic alteration in homeostasis of high energy phosphates in HD models in the earliest stages of the disease, indicating possible reduced utilization of the brain phosphocreatine pool.	[Mochel, Fanny] Hop La Pitie Salpetriere, Brain & Spine Inst, INSERM UMR S975, F-75013 Paris, France; [Mochel, Fanny; Durr, Alexandra] Hop La Pitie Salpetriere, AP HP, Dept Genet, F-75013 Paris, France; [Mochel, Fanny] Univ Paris 06, F-75005 Paris, France; [Mochel, Fanny; Durant, Brandon; Meng, Xingli] Baylor Res Inst, Inst Metab Dis, Dallas, TX 75226 USA; [O'Callaghan, James] NIOSH, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA; [Yu, Hua; Humbert, Sandrine; Schiffmann, Raphael] INSERM U1005, Inst Curie, CNRS UMR3306, F-91405 Orsay, France; [Brouillet, Emmanuel] CEA, URA CEA CNRS 2210, Serv MIRCen, F-92265 Fontenay Aux Roses, France; [Wheeler, Vanessa C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Baylor Scott & White Health; Baylor University Medical Center; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Massachusetts General Hospital	Mochel, F (corresponding author), Hop La Pitie Salpetriere, Brain & Spine Inst, INSERM UMR S975, F-75013 Paris, France.	fanny.mochel@upmc.fr	Humbert, Sandrine/S-2981-2016; Brouillet, Emmanuel/B-4784-2014; Durant, Brandon/HCH-8003-2022	Brouillet, Emmanuel/0000-0001-6322-7403; Durant, Brandon/0000-0003-3028-6161; Humbert, Sandrine/0000-0002-9501-2658	National Institutes of Health [NS32765, NS049206]; CHDI Foundation, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032765, R01NS049206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Foundation, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS32765 and NS049206 (to V. C. W.). This work was also supported by the CHDI Foundation, Inc.	Andreassen OA, 2001, J NEUROCHEM, V77, P383, DOI 10.1046/j.1471-4159.2001.00188.x; BEAL MF, 1994, CURR OPIN NEUROL, V7, P542, DOI 10.1097/00019052-199412000-00012; Braissant O, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-9; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; CHAN P, 1991, J NEUROCHEM, V57, P348, DOI 10.1111/j.1471-4159.1991.tb02134.x; Ciarmiello A, 2006, J NUCL MED, V47, P215; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dedeoglu A, 2003, J NEUROCHEM, V85, P1359, DOI 10.1046/j.1471-4159.2003.01706.x; Delaney SM, 1996, J NEUROSCI METH, V64, P151, DOI 10.1016/0165-0270(95)00119-0; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; Ferrante Robert J., 2000, Journal of Neuroscience, V20, P4389; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; in 't Zandt HJA, 2004, J NEUROCHEM, V90, P1321, DOI 10.1111/j.1471-4159.2004.02599.x; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kim J, 2010, BBA-MOL BASIS DIS, V1802, P673, DOI 10.1016/j.bbadis.2010.05.001; Lee JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023647; Lin YS, 2011, J CLIN INVEST, V121, P1519, DOI 10.1172/JCI43220; LOWRY OH, 1964, J BIOL CHEM, V239, P18; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Matthews RT, 1998, J NEUROSCI, V18, P156; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Mochel F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000647; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; O'Callaghan JP, 2004, J NEUROSCI METH, V135, P159, DOI 10.1016/j.jneumeth.2003.12.006; Olah J, 2008, FEBS J, V275, P4740, DOI 10.1111/j.1742-4658.2008.06612.x; Powers WJ, 2007, P NATL ACAD SCI USA, V104, P2945, DOI 10.1073/pnas.0609833104; Rudenko O, 2009, BEHAV BRAIN RES, V203, P188, DOI 10.1016/j.bbr.2009.04.034; Saks V, 1998, MOL CELL BIOCHEM, V184, P291, DOI 10.1023/A:1006828106322; Scharf MT, 2008, J NEUROCHEM, V105, P833, DOI 10.1111/j.1471-4159.2007.05182.x; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Steeghs K, 1997, CELL, V89, P93, DOI 10.1016/S0092-8674(00)80186-5; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Tabrizi SJ, 2005, NEUROLOGY, V64, P1655, DOI 10.1212/01.WNL.0000160388.96242.77; Thu DCV, 2010, BRAIN, V133, P1094, DOI 10.1093/brain/awq047; Tkac I, 2007, J NEUROCHEM, V100, P1397, DOI 10.1111/j.1471-4159.2006.04323.x; van der Burg JMM, 2008, NEUROBIOL DIS, V29, P41, DOI 10.1016/j.nbd.2007.07.029; Verbessem P, 2003, NEUROLOGY, V61, P925, DOI 10.1212/01.WNL.0000090629.40891.4B; Weiss RG, 2002, FASEB J, V16, P613, DOI 10.1096/fj.01-0462fje; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Williams JH, 2008, ANAL BIOCHEM, V372, P135, DOI 10.1016/j.ab.2007.09.020; Yang LC, 2009, J NEUROCHEM, V109, P1427, DOI 10.1111/j.1471-4159.2009.06074.x; Zhang SF, 2011, NEURODEGENER DIS, V8, P194, DOI 10.1159/000321681	47	93	94	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1361	1370		10.1074/jbc.M111.309849	http://dx.doi.org/10.1074/jbc.M111.309849			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22123819	Green Published, hybrid			2022-12-25	WOS:000299170300050
J	Ye, ZJ; Go, GW; Singh, R; Liu, WZ; Keramati, AR; Mani, A				Ye, Zhi-jia; Go, Gwang-Woong; Singh, Rajvir; Liu, Wenzhong; Keramati, Ali Reza; Mani, Arya			LRP6 Protein Regulates Low Density Lipoprotein (LDL) Receptor-mediated LDL Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERCHOLESTEROLEMIA; MEMBRANE-PROTEIN; ADAPTER PROTEIN; COATED PITS; INTERNALIZATION; CHOLESTEROL; CAVEOLIN-1; GENE; ATHEROSCLEROSIS; IDENTIFICATION	Genetic variations in LRP6 gene are associated with high serum LDL cholesterol levels. We have previously shown that LDL clearance in peripheral B-lymphocytes of the LRP6(R611C) mutation carriers is significantly impaired. In this study we have examined the role of wild type LRP6 (LRP6(WT)) and LRP6(R611C) in LDL receptor (LDLR)-mediated LDL uptake. LDL binding and uptake were increased when LRP6(WT) was overexpressed and modestly reduced when it was knocked down in LDLR-deficient CHO (ldlA7) cells. These findings implicated LRP6 in LDLR-independent cellular LDL binding and uptake. However, LRP6 knockdown in wild type CHO cells resulted in a much greater decline in LDL binding and uptake compared with CHO-ldlA7 cells, suggesting impaired function of the LDLR. LDLR internalization was severely diminished when LRP6 was knocked down and was restored after LRP6 was reintroduced. Further analysis revealed that LRP6(WT) forms a complex with LDLR, clathrin, and ARH and undergoes a clathrin-mediated internalization after stimulation with LDL. LDLR and LRP6 internalizations as well as LDL uptake were all impaired in CHO-k1 cells expressing LRP6(R611C). These studies identify LRP6 as a critical modulator of receptor-mediated LDL endocytosis and introduce a mechanism by which variation in LRP6 may contribute to high serum LDL levels.	[Ye, Zhi-jia; Go, Gwang-Woong; Singh, Rajvir; Liu, Wenzhong; Keramati, Ali Reza; Mani, Arya] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Ye, Zhi-jia; Go, Gwang-Woong; Singh, Rajvir; Liu, Wenzhong; Keramati, Ali Reza; Mani, Arya] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Ye, Zhi-jia] Third Mil Med Univ, Coll Prevent Med, Chongqing 400038, Peoples R China	Yale University; Yale University; Army Medical University	Mani, A (corresponding author), 333 Cedar St, New Haven, CT 06510 USA.	arya.mani@yale.edu	Go, Gwang-woong/H-2733-2013; SINGH, RAJVIR/C-8191-2012	Keramati, Ali/0000-0002-8728-1508	National Institutes of Health [R01HL094784-01, R01HL094574-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094784, R01HL094574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL094784-01 and R01HL094574-03.	BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Carozzi AJ, 2000, TRAFFIC, V1, P326, DOI 10.1034/j.1600-0854.2000.010406.x; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Fernandez-Hernando C, 2010, AM J PATHOL, V177, P998, DOI 10.2353/ajpath.2010.091287; Fernandez-Hernando C, 2009, CELL METAB, V10, P48, DOI 10.1016/j.cmet.2009.06.003; Fire E, 1997, J BIOL CHEM, V272, P29538, DOI 10.1074/jbc.272.47.29538; Garuti R, 2005, J BIOL CHEM, V280, P40996, DOI 10.1074/jbc.M509394200; GOLDSTEIN JL, 1973, P NATL ACAD SCI USA, V70, P2804, DOI 10.1073/pnas.70.10.2804; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOBBS HH, 1989, J CLIN INVEST, V84, P656, DOI 10.1172/JCI114212; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu WZ, 2008, CIRC RES, V103, P1280, DOI 10.1161/CIRCRESAHA.108.183863; Loeffler B, 2007, J LIPID RES, V48, P288, DOI 10.1194/jlr.M600292-JLR200; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; NESTEROV A, 1995, J BIOL CHEM, V270, P6320, DOI 10.1074/jbc.270.11.6320; Rahilly-Tierney Catherine R, 2009, Prev Cardiol, V12, P80, DOI 10.1111/j.1751-7141.2008.00018.x; RUSSELL DW, 1986, COLD SPRING HARB SYM, V51, P811, DOI 10.1101/SQB.1986.051.01.094; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; Tiscornia G, 2006, NAT PROTOC, V1, P234, DOI 10.1038/nprot.2006.36; Tomaszewski M, 2009, ARTERIOSCL THROM VAS, V29, P1316, DOI 10.1161/ATVBAHA.109.185355; Varma R, 2005, AM J CARDIOL, V95, P269, DOI 10.1016/j.amjcard.2004.08.095; Vincent V, 1997, J BIOL CHEM, V272, P7062, DOI 10.1074/jbc.272.11.7062; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Yokomori H, 2009, LIVER INT, V29, P266, DOI 10.1111/j.1478-3231.2008.01891.x; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273	28	48	51	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1335	1344		10.1074/jbc.M111.295287	http://dx.doi.org/10.1074/jbc.M111.295287			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128165	Green Published, hybrid			2022-12-25	WOS:000299170300048
J	Shim, BS; Choi, YK; Yun, CH; Lee, EG; Jeon, YS; Park, SM; Cheon, IS; Joo, DH; Cho, CH; Song, MS; Seo, SU; Byun, YH; Park, HJ; Poo, H; Seong, BL; Kim, JO; Nguyen, HH; Stadler, K; Kim, DW; Hong, KJ; Czerkinsky, C; Song, MK				Shim, Byoung-Shik; Choi, Young Ki; Yun, Cheol-Heui; Lee, Eu-Gene; Jeon, Yoon Seong; Park, Sung-Moo; Cheon, In Su; Joo, Dong-Hyun; Cho, Chung Hwan; Song, Min-Suk; Seo, Sang-Uk; Byun, Young-Ho; Park, Hae-Jung; Poo, Haryoung; Seong, Baik Lin; Kim, Jae Ouk; Nguyen, Huan Huu; Stadler, Konrad; Kim, Dong Wook; Hong, Kee-Jong; Czerkinsky, Cecil; Song, Man Ki			Sublingual Immunization with M2-Based Vaccine Induces Broad Protective Immunity against Influenza	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEIN; ANTIGENIC PEPTIDE VACCINE; MONOCLONAL-ANTIBODY; H5N1 INFLUENZA; EXTRACELLULAR DOMAIN; VIRUS-INFECTION; M2; MUCOSAL; MICE; ECTODOMAIN	Background: The ectodomain of matrix protein 2 (M2e) of influenza A virus is a rationale target antigen candidate for the development of a universal vaccine against influenza as M2e undergoes little sequence variation amongst human influenza A strains. Vaccine-induced M2e-specific antibodies (Abs) have been shown to display significant cross-protective activity in animal models. M2e-based vaccine constructs have been shown to be more protective when administered by the intranasal (i.n.) route than after parenteral injection. However, i.n. administration of vaccines poses rare but serious safety issues associated with retrograde passage of inhaled antigens and adjuvants through the olfactory epithelium. In this study, we examined whether the sublingual (s.l.) route could serve as a safe and effective alternative mucosal delivery route for administering a prototype M2e-based vaccine. The mechanism whereby s.l. immunization with M2e vaccine candidate induces broad protection against infection with different influenza virus subtypes was explored. Methods and Results: A recombinant M2 protein with three tandem copies of the M2e (3M2eC) was expressed in Escherichia coli. Parenteral immunizations of mice with 3M2eC induced high levels of M2e-specific serum Abs but failed to provide complete protection against lethal challenge with influenza virus. In contrast, s.l. immunization with 3M2eC was superior for inducing protection in mice. In the latter animals, protection was associated with specific Ab responses in the lungs. Conclusions: The results demonstrate that s.l. immunization with 3M2eC vaccine induced airway mucosal immune responses along with broad cross-protective immunity to influenza. These findings may contribute to the understanding of the M2-based vaccine approach to control epidemic and pandemic influenza infections.	[Shim, Byoung-Shik; Lee, Eu-Gene; Jeon, Yoon Seong; Park, Sung-Moo; Cheon, In Su; Joo, Dong-Hyun; Cho, Chung Hwan; Seo, Sang-Uk; Park, Hae-Jung; Kim, Jae Ouk; Nguyen, Huan Huu; Stadler, Konrad; Czerkinsky, Cecil; Song, Man Ki] Int Vaccine Inst, Div Sci Lab, Seoul, South Korea; [Shim, Byoung-Shik; Yun, Cheol-Heui; Cheon, In Su; Cho, Chung Hwan] Seoul Natl Univ, Dept Agr Biotechnol, Res Inst Agr & Life Sci, Ctr Agr Biomat, Seoul, South Korea; [Choi, Young Ki; Song, Min-Suk] Chungbuk Natl Univ, Coll Med, Cheongju, South Korea; [Choi, Young Ki; Song, Min-Suk] Chungbuk Natl Univ, Med Res Inst, Cheongju, South Korea; [Byun, Young-Ho; Seong, Baik Lin] Yonsei Univ, Dept Biotechnol, Coll Engn, Seoul 120749, South Korea; [Poo, Haryoung] Korean Res Inst Biosci & Biotechnol, Taejon, South Korea; [Kim, Dong Wook] Hanyang Univ, Dept Pharm, Coll Pharm, Kyeonggi Do, South Korea; [Hong, Kee-Jong] Korea Natl Inst Hlth, Div Influenza Viruses, Osong, South Korea	International Vaccine Institute; Seoul National University (SNU); Chungbuk National University; Chungbuk National University; Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Hanyang University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH)	Shim, BS (corresponding author), Int Vaccine Inst, Div Sci Lab, Seoul, South Korea.	mksong@ivi.int	CZERKINSKY, CECIL/G-6520-2015; YUN, Cheol-Heui/AAR-2775-2020	YUN, Cheol-Heui/0000-0002-0041-2887	Korea Research Council of Fundamental Science and Technology; Korea Research Institute for Bioscience and Biotechnology (KRIBB) [KGM0821113]; government of the Republic of Korea; government of the Kuwait; government of the Sweden (Swedish International Development Cooperation Agency [SIDA])	Korea Research Council of Fundamental Science and Technology; Korea Research Institute for Bioscience and Biotechnology (KRIBB); government of the Republic of Korea(Korean Government); government of the Kuwait; government of the Sweden (Swedish International Development Cooperation Agency [SIDA])	This work was supported by a Top Brand Project grant from Korea Research Council of Fundamental Science and Technology and Korea Research Institute for Bioscience and Biotechnology (KRIBB) Initiative program (KGM0821113). The International Vaccine Institute is supported in part by grants from the governments of the Republic of Korea, Kuwait, and Sweden (Swedish International Development Cooperation Agency [SIDA]). The funders had no roles in the study design, in the data analysis, or in the preparation of the manuscript.	ADA GL, 1986, CURR TOP MICROBIOL, V128, P1; Armstrong ME, 2005, J INFECT DIS, V192, P1628, DOI 10.1086/491739; Bessa J, 2008, EUR J IMMUNOL, V38, P114, DOI 10.1002/eji.200636959; BLACK RA, 1993, J GEN VIROL, V74, P143, DOI 10.1099/0022-1317-74-1-143; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; DAWOOD FS, 2009, NEW ENGL J MED, V361, P1; De Filette M, 2006, VACCINE, V24, P544, DOI 10.1016/j.vaccine.2005.08.061; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Ernst WA, 2006, VACCINE, V24, P5158, DOI 10.1016/j.vaccine.2006.04.008; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Feng JQ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-102; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Frace AM, 1999, VACCINE, V17, P2237, DOI 10.1016/S0264-410X(99)00005-5; Fu TM, 2009, VIROLOGY, V385, P218, DOI 10.1016/j.virol.2008.11.035; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Kitikoon P, 2009, VACCINE, V28, P523, DOI 10.1016/j.vaccine.2009.09.130; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Lemiale F, 2003, J VIROL, V77, P10078, DOI 10.1128/JVI.77.18.10078-10087.2003; Liu WL, 2003, FEMS IMMUNOL MED MIC, V35, P141, DOI 10.1016/S0928-8244(03)00009-9; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Mozdzanowska K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-118; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Okuda K, 2001, VACCINE, V19, P3681, DOI 10.1016/S0264-410X(01)00078-0; Oshitani H, 2008, EMERG INFECT DIS, V14, P875, DOI 10.3201/eid1406.070839; Rao SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009812; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; SLEPUSHKIN VA, 1995, VACCINE, V13, P1399, DOI 10.1016/0264-410X(95)92777-Y; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Song MS, 2009, J VIROL, V83, P12325, DOI 10.1128/JVI.01373-09; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Takeda M, 2002, J VIROL, V76, P1391, DOI 10.1128/JVI.76.3.1391-1399.2002; Tissot AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009809; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Wang RF, 2008, ANTIVIR RES, V80, P168, DOI 10.1016/j.antiviral.2008.06.002; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zhao GY, 2010, VACCINE, V28, P7233, DOI 10.1016/j.vaccine.2010.08.049; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-9	48	59	62	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27953	10.1371/journal.pone.0027953	http://dx.doi.org/10.1371/journal.pone.0027953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140491	Green Submitted, Green Published, gold			2022-12-25	WOS:000298168100027
J	Ansari, A; Hasan, Z; Dawood, G; Hussain, R				Ansari, Ambreen; Hasan, Zahra; Dawood, Ghaffar; Hussain, Rabia			Differential Combination of Cytokine and Interferon- gamma+874 T/A Polymorphisms Determines Disease Severity in Pulmonary Tuberculosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; GENE POLYMORPHISMS; MYCOBACTERIUM-TUBERCULOSIS; SUSCEPTIBILITY; ASSOCIATION; IFNG+874T/A; RECEPTOR	Background: Mycobacterium tuberculosis infects nearly 1/3 of the world population and this reservoir forms the largest pool from which new cases arise. Among the cytokines, IFN-gamma is a key determinant in protection against tuberculosis. Single nucleotide polymorphisms (SNPs) in IFN-gamma gene (+874 T/A) which determine TT high ((hi)), AA low ((lo)) and TA intermediate ((int)) responder phenotypes have shown variable associations with tuberculosis disease outcome in different ethnic populations. The objective of the current study was to analyze IFN-gamma gene combinations with other IFN-gamma regulating cytokine genes (IL-10, TNF -alpha, IL-6) to see the effect of gene-combinations on disease severity outcome in pulmonary tuberculosis. Methods and Findings: Study groups comprised of pulmonary TB patients stratified according to lung tissue involvement into mild (Pmd = 74) or advance (Pad = 23) lung disease and compared with healthy controls (TBNA = 166). Genotype analysis was carried out using amplification refractory mutation system-PCR (ARMS-PCR). IFN-gamma gene (+874 T/A) functional SNP combinations in TNF alpha (-308 G/A), IL-10 (-1082 A/G) and IL-6 (-174 G/C) were analyzed. Single gene analysis (Pearson chi(2)) showed a dominant association of IFN-gamma TThi genotype (p = 0.001) and T allele (p = 0.001) with mild disease. IFN-gamma(lo) -IL-10(lo) genotype combination was associated with advanced disease (p = 0.002). IFN-gamma(hi) -IL-6(hi) combination was associated with mild disease (p = 0.0005) while IFN-gamma(lo) -IL-6(int) was associated with protection against both forms of pulmonary disease (p = 0.002). Conclusion: Our results show that a limited number of IFN-gamma gene combinations with other cytokine functional SNPs determine the outcome of disease severity in tuberculosis.	[Ansari, Ambreen; Hasan, Zahra; Hussain, Rabia] Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan; [Dawood, Ghaffar] Masoomeen Trust Hosp, Karachi, Pakistan	Aga Khan University	Ansari, A (corresponding author), Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan.	rabia.hussain@aku.edu	Hasan, Zahra/F-5111-2015; Hasan, Zahra/AAF-2191-2020; Hussain, Rabia/E-9982-2015	Hasan, Zahra/0000-0001-7580-372X; 	Higher Education Commission of Pakistan [20-796/R]; Government of Pakistan [D/07]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Government of Pakistan	This work was funded by the Higher Education Commission of Pakistan Grant No 20-796/R and D/07 Government of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-70; Ansari A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004778; Bagheri M, 2006, TRANSFUSION MED, V16, P192, DOI 10.1111/j.1365-3148.2006.00666.x; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; Casanova JL, 2007, EMBO J, V26, P915, DOI 10.1038/sj.emboj.7601558; Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131; COMSTOCK GW, 1982, AM REV RESPIR DIS, V125, P8; Cooke GS, 2006, AM J RESP CRIT CARE, V174, P339, DOI 10.1164/rccm.200601-088OC; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; CROFTON J, 1990, CROFTON DOUGLAS RESP, P395; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Dupuis S, 2000, IMMUNOL REV, V178, P129, DOI 10.1034/j.1600-065X.2000.17810.x; Etokebe GE, 2006, SCAND J IMMUNOL, V63, P136, DOI 10.1111/j.1365-3083.2005.01716.x; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Hashemi M, 2011, Prague Med Rep, V112, P38; Henao MI, 2006, TUBERCULOSIS, V86, P11, DOI 10.1016/j.tube.2005.03.001; HOWARD M, 1992, IMMUNOL TODAY, V13, P198, DOI 10.1016/0167-5699(92)90153-X; Hussain R, 2011, J CLIN IMMUNOL, V31, P913, DOI 10.1007/s10875-011-9566-y; Hussain R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007444; Jamil B, 2007, TUBERCULOSIS, V87, P279, DOI 10.1016/j.tube.2007.03.004; Jouanguy E, 2000, J CLIN INVEST, V105, P1429, DOI 10.1172/JCI9166; Kaufmann SHE, 2005, J EXP MED, V201, P1693, DOI 10.1084/jem.20050842; Keane J, 2005, RHEUMATOLOGY, V44, P714, DOI 10.1093/rheumatology/keh567; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Kumar V, 2008, NATL MED J INDIA, V21, P120; Leandro ACCS, 2009, BRAZ J MED BIOL RES, V42, P312, DOI 10.1590/S0100-879X2009000400002; Lio D, 2002, EUR J IMMUNOGENET, V29, P371, DOI 10.1046/j.1365-2370.2002.00327.x; Lopez-Maderuelo D, 2003, AM J RESP CRIT CARE, V167, P970, DOI 10.1164/rccm.200205-438BC; Maher D., 1997, Treatment of tuberculosis: guidelines for national programmes. Second edition., P1; Mansouri D, 2005, EUR J PEDIATR, V164, P753, DOI 10.1007/s00431-005-1689-9; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; Moller M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-154; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Pacheco AG, 2008, HUM GENET, V123, P477, DOI 10.1007/s00439-008-0497-5; Rossouw M, 2003, LANCET, V361, P1871, DOI 10.1016/S0140-6736(03)13491-5; Sallakci N, 2007, TUBERCULOSIS, V87, P225, DOI 10.1016/j.tube.2006.10.002; Santos AR, 2000, INT J LEPROSY, V68, P325; Selvaraj P, 2008, CYTOKINE, V43, P26, DOI 10.1016/j.cyto.2008.04.011; Vallinoto ACR, 2010, HUM IMMUNOL, V71, P692, DOI 10.1016/j.humimm.2010.03.008; Velez DR, 2009, HUM GENET, V126, P643, DOI 10.1007/s00439-009-0713-y; WHO, 2009, WHO TECH REP SER, V958, P1; World Health Organization, 2009, GLOB TUB CONTR EP ST; Zhang J, 2011, INT J TUBERC LUNG D, V15, P594, DOI 10.5588/ijtld.09.0703	48	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27848	10.1371/journal.pone.0027848	http://dx.doi.org/10.1371/journal.pone.0027848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140472	Green Published, gold, Green Submitted			2022-12-25	WOS:000298166300013
J	Karki, S; Chakrabarti, P; Huang, GR; Wang, H; Farmer, SR; Kandror, KV				Karki, Shakun; Chakrabarti, Partha; Huang, Guanrong; Wang, Hong; Farmer, Stephen R.; Kandror, Konstantin V.			The Multi-Level Action of Fatty Acids on Adiponectin Production by Fat Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE; NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; LIPOPROTEIN-LIPASE; 3T3-L1 ADIPOCYTES; LYSOSOMAL TRAFFICKING; ENDOCRINE ORGAN; TNF-ALPHA; ER STRESS	Current epidemics of diabetes mellitus is largely caused by wide spread obesity. The best-established connection between obesity and insulin resistance is the elevated and/or dysregulated levels of circulating free fatty acids that cause and aggravate insulin resistance, type 2 diabetes, cardiovascular disease and other hazardous metabolic conditions. Here, we investigated the effect of a major dietary saturated fatty acid, palmitate, on the insulin-sensitizing adipokine adiponectin produced by cultured adipocytes. We have found that palmitate rapidly inhibits transcription of the adiponectin gene and the release of adiponectin from adipocytes. Adiponectin gene expression is controlled primarily by PPAR gamma and C/EBP alpha. Using mouse embryonic fibroblasts from C/EBP alpha-null mice, we have determined that the latter transcription factor may not solely mediate the inhibitory effect of palmitate on adiponectin transcription leaving PPAR gamma as a likely target of palmitate. In agreement with this model, palmitate increases phosphorylation of PPAR gamma on Ser273, and substitution of PPAR gamma for the unphosphorylated mutant Ser273Ala blocks the effect of palmitate on adiponectin transcription. The inhibitory effect of palmitate on adiponectin gene expression requires its intracellular metabolism via the acyl-CoA synthetase 1-mediated pathway. In addition, we found that palmitate stimulates degradation of intracellular adiponectin by lysosomes, and the lysosomal inhibitor, chloroquine, suppressed the effect of palmitate on adiponectin release from adipocytes. We present evidence suggesting that the intracellular sorting receptor, sortilin, plays an important role in targeting of adiponectin to lysosomes. Thus, palmitate not only decreases adiponectin expression at the level of transcription but may also stimulate lysosomal degradation of newly synthesized adiponectin.	[Karki, Shakun; Chakrabarti, Partha; Huang, Guanrong; Wang, Hong; Farmer, Stephen R.; Kandror, Konstantin V.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Karki, S (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.	kkandror@bu.edu		Farmer, Stephen/0000-0003-2483-2795; Kandror, Konstantin/0000-0002-8601-9313	National Institutes of Health (NIH) [DK51586, DK58825, DK52057, DK56736];  [T32HL007969-07]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052057, R01DK056736, R01DK051586, R56DK051586, R01DK052057, R56DK058825, R01DK058825] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grants from the National Institutes of Health (NIH) DK51586 and DK58825 to S.R.F., DK52057 and DK56736 to K.V.K. and by cardiovascular training grant T32HL007969-07 to S. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2008, MOL ENDOCRINOL, V22, P1023, DOI 10.1210/me.2007-0529; Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; APPEL B, 1992, AM J PHYSIOL, V262, pE695, DOI 10.1152/ajpendo.1992.262.5.E695; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bradley RL, 2008, OBESITY, V16, P938, DOI 10.1038/oby.2008.39; Bueno AA, 2008, PFLUG ARCH EUR J PHY, V455, P701, DOI 10.1007/s00424-007-0330-3; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; Deguil J, 2011, TRAFFIC, V12, P349, DOI 10.1111/j.1600-0854.2010.01150.x; Evans SF, 2011, J BIOL CHEM, V286, P29556, DOI 10.1074/jbc.M111.219675; Fernandez-Real JM, 2005, CLIN CHEM, V51, P603, DOI 10.1373/clinchem.2004.041350; GORDON ES, 1960, AM J CLIN NUTR, V8, P740, DOI 10.1093/ajcn/8.5.740; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Halberg N, 2009, DIABETES, V58, P1961, DOI 10.2337/db08-1750; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; JENSEN MD, 1989, J CLIN INVEST, V83, P1168, DOI 10.1172/JCI113997; Jiao P, 2011, OBESITY, V19, P483, DOI 10.1038/oby.2010.200; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kwon S, 2011, J BIOL CHEM, V286, P21876, DOI 10.1074/jbc.M111.228262; Lavoie F, 2009, J CLIN ENDOCR METAB, V94, P998, DOI 10.1210/jc.2008-1021; Lee MJ, 2006, J LIPID RES, V47, P1984, DOI 10.1194/jlr.M600065-JLR200; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; Liu ML, 2010, BIOCHEM J, V425, P41, DOI 10.1042/BJ20091045; Lobo S, 2009, J BIOL CHEM, V284, P18347, DOI 10.1074/jbc.M109.017244; Loo LH, 2009, J CELL BIOL, V187, P375, DOI 10.1083/jcb.200904140; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Ni XY, 2006, TRAFFIC, V7, P889, DOI 10.1111/j.1600-0854.2006.00429.x; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; OLIVECRONA T, 1987, J BIOL CHEM, V262, P10748; do Nascimento CMO, 2009, AN ACAD BRAS CIENC, V81, P453, DOI 10.1590/S0001-37652009000300010; Peng G, 2011, ENDOCRINOLOGY, V152, P2206, DOI 10.1210/en.2010-1369; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Qiang L, 2007, MOL CELL BIOL, V27, P4698, DOI 10.1128/MCB.02279-06; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Ruan H, 2003, J BIOL CHEM, V278, P47585, DOI 10.1074/jbc.M305257200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; SEMB H, 1987, BIOCHIM BIOPHYS ACTA, V921, P104, DOI 10.1016/0005-2760(87)90176-7; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Stryjecki C, 2011, EUR J CLIN NUTR, V65, P285, DOI 10.1038/ejcn.2010.277; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; VANNIER C, 1989, J BIOL CHEM, V264, P13206; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Xi L, 2007, BRIT J PHARMACOL, V151, P610, DOI 10.1038/sj.bjp.0707276; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhou LJ, 2010, DIABETES, V59, P2809, DOI 10.2337/db10-0412; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	56	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28146	10.1371/journal.pone.0028146	http://dx.doi.org/10.1371/journal.pone.0028146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140527	Green Published, Green Submitted, gold			2022-12-25	WOS:000298166300030
J	Chersi, F; Ferrari, PF; Fogassi, L				Chersi, Fabian; Ferrari, Pier Francesco; Fogassi, Leonardo			Neuronal Chains for Actions in the Parietal Lobe: A Computational Model	PLOS ONE			English	Article							VENTRAL PREMOTOR; FUNCTIONAL-ORGANIZATION; MACAQUE MONKEY; CORTEX; BEHAVIOR; MOTOR; REPRESENTATION; CONNECTIONS; PROPAGATION; GENERATION	The inferior part of the parietal lobe (IPL) is known to play a very important role in sensorimotor integration. Neurons in this region code goal-related motor acts performed with the mouth, with the hand and with the arm. It has been demonstrated that most IPL motor neurons coding a specific motor act (e.g., grasping) show markedly different activation patterns according to the final goal of the action sequence in which the act is embedded (grasping for eating or grasping for placing). Some of these neurons (parietal mirror neurons) show a similar selectivity also during the observation of the same action sequences when executed by others. Thus, it appears that the neuronal response occurring during the execution and the observation of a specific grasping act codes not only the executed motor act, but also the agent's final goal (intention). In this work we present a biologically inspired neural network architecture that models mechanisms of motor sequences execution and recognition. In this network, pools composed of motor and mirror neurons that encode motor acts of a sequence are arranged in form of action goal-specific neuronal chains. The execution and the recognition of actions is achieved through the propagation of activity bursts along specific chains modulated by visual and somatosensory inputs. The implemented spiking neuron network is able to reproduce the results found in neurophysiological recordings of parietal neurons during task performance and provides a biologically plausible implementation of the action selection and recognition process. Finally, the present paper proposes a mechanism for the formation of new neural chains by linking together in a sequential manner neurons that represent subsequent motor acts, thus producing goal-directed sequences.	[Chersi, Fabian] CNR, Inst Sci & Technol Cognit, Rome, Italy; [Chersi, Fabian; Ferrari, Pier Francesco; Fogassi, Leonardo] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Ferrari, Pier Francesco] Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy; [Fogassi, Leonardo] Univ Parma, Dept Psychol, I-43100 Parma, Italy; [Ferrari, Pier Francesco; Fogassi, Leonardo] Italian Inst Technol RTM, Parma, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Parma; University of Parma; University of Parma; Istituto Italiano di Tecnologia - IIT	Chersi, F (corresponding author), CNR, Inst Sci & Technol Cognit, Rome, Italy.	fabian.chersi@nemo.unipr.it	Ferrari, Pier Francesco/G-5547-2017; FOGASSI, Leonardo/K-3541-2018	FOGASSI, Leonardo/0000-0003-3348-039X	Italian Space Agency (ASI) [PR-DCMC-GO-1B1125-003]; Italian MIUR [2006052343, 2008J7YFNR002]; Italian Institute of Technology; European project "Goal-Leaders" [FP7 270108]	Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI)); Italian MIUR(Ministry of Education, Universities and Research (MIUR)); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); European project "Goal-Leaders"	This work was supported by the Italian Space Agency (ASI) PR-DCMC-GO-1B1125-003, by the Italian MIUR 2006052343 and 2008J7YFNR002, by the Italian Institute of Technology program (Motor cognition), and by the European project FP7 270108 "Goal-Leaders". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abeles M., 1982, LOCAL CORTICAL CIRCU; Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; AMIT DJ, 1988, P NATL ACAD SCI USA, V85, P2141, DOI 10.1073/pnas.85.7.2141; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BIENENSTOCK E, 1995, NETWORK-COMP NEURAL, V6, P179, DOI 10.1088/0954-898X/6/2/004; Bonini L, 2011, J NEUROSCI, V31, P5876, DOI 10.1523/JNEUROSCI.5186-10.2011; Bonini L, 2010, CEREB CORTEX, V20, P1372, DOI 10.1093/cercor/bhp200; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Chersi F, 2005, SOC NEUROSCI ABS, V412, P8; Colby CL, 1998, NEURON, V20, P15, DOI 10.1016/S0896-6273(00)80429-8; Deco G, 2005, J COGNITIVE NEUROSCI, V17, P294, DOI 10.1162/0898929053124875; Destexhe A, 1996, METHODS NEURONAL MOD; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; FAUGIERGRIMAUD S, 1978, NEUROPSYCHOLOGIA, V16, P151, DOI 10.1016/0028-3932(78)90103-3; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; Fogassi L, 2005, CURR OPIN NEUROBIOL, V15, P626, DOI 10.1016/j.conb.2005.10.015; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2002, ATTENTION PERFORM, V19, P334; Gonzalez-Burgos G, 2004, CEREB CORTEX, V14, P530, DOI 10.1093/cercor/bhh015; Gregoriou GG, 2005, NEUROIMAGE, V27, P442, DOI 10.1016/j.neuroimage.2005.02.038; HYVARINEN J, 1982, PHYSIOL REV, V62, P1060, DOI 10.1152/physrev.1982.62.3.1060; HYVARINEN J, 1981, BRAIN RES, V206, P287, DOI 10.1016/0006-8993(81)90533-3; Ijspeert AJ, 1999, LECT NOTES ARTIF INT, V1674, P195; Ijspeert AJ, 1999, ADAPT BEHAV, V7, P151, DOI 10.1177/105971239900700202; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; JAHR CE, 1990, J NEUROSCI, V10, P3178; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Kepecs A, 2002, BIOL CYBERN, V87, P446, DOI 10.1007/s00422-002-0358-6; KLEINFELD D, 1986, P NATL ACAD SCI USA, V83, P9469, DOI 10.1073/pnas.83.24.9469; Kraskov A, 2009, NEURON, V64, P922, DOI 10.1016/j.neuron.2009.12.010; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Lucke J, 2004, NEURAL COMPUT, V16, P501, DOI 10.1162/089976604772744893; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; PERRETT DI, 1989, J EXP BIOL, V146, P87; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Reyes AD, 2003, NAT NEUROSCI, V6, P593, DOI 10.1038/nn1056; Rigotti M, 2006, SOC NEUROSCIENCE ABS, V569, P14; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti Giacomo, 2006, Novartis Found Symp, V270, P129; Rosenbaum DA, 2007, HUM MOVEMENT SCI, V26, P525, DOI 10.1016/j.humov.2007.04.001; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; Rushworth MFS, 1997, EXP BRAIN RES, V117, P292, DOI 10.1007/s002210050224; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Tuckwell H. C., 1988, INTRO THEORETICAL NE, V1; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; WANG DL, 1990, P IEEE, V78, P1536, DOI 10.1109/5.58329; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	62	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27652	10.1371/journal.pone.0027652	http://dx.doi.org/10.1371/journal.pone.0027652			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140455	gold, Green Published, Green Submitted			2022-12-25	WOS:000298163400011
J	Kogot, JM; Zhang, YT; Moore, SJ; Pagano, P; Stratis-Cullum, DN; Chang-Yen, D; Turewicz, M; Pellegrino, PM; de Fusco, A; Soh, HT; Stagliano, NE				Kogot, Joshua M.; Zhang, Yanting; Moore, Stephen J.; Pagano, Paul; Stratis-Cullum, Dimitra N.; Chang-Yen, David; Turewicz, Marek; Pellegrino, Paul M.; de Fusco, Andre; Soh, H. Tom; Stagliano, Nancy E.			Screening of Peptide Libraries against Protective Antigen of Bacillus anthracis in a Disposable Microfluidic Cartridge	PLOS ONE			English	Article							SURFACE DISPLAY; AFFINITY; PROTEINS; CELLS; MICROARRAYS; ENRICHMENT; ANTIBODY; SCAFFOLD; SELECT	Bacterial surface peptide display has gained popularity as a method of affinity reagent generation for a wide variety of applications ranging from drug discovery to pathogen detection. In order to isolate the bacterial clones that express peptides with high affinities to the target molecule, multiple rounds of manual magnetic activated cell sorting ( MACS) followed by multiple rounds of fluorescence activated cell sorting (FACS) are conventionally used. Although such manual methods are effective, alternative means of library screening which improve the reproducibility, reduce the cost, reduce cross contamination, and minimize exposure to hazardous target materials are highly desired for practical application. Toward this end, we report the first semi-automated system demonstrating the potential for screening bacterially displayed peptides using disposable microfluidic cartridges. The Micro-Magnetic Separation platform (MMS) is capable of screening a bacterial library containing 3610 10 members in 15 minutes and requires minimal operator training. Using this system, we report the isolation of twenty-four distinct peptide ligands that bind to the protective antigen (PA) of Bacilus anthracis in three rounds of selection. A consensus motif WXCFTC was found using the MMS and was also found in one of the PA binders isolated by the conventional MACS/FACS approach. We compared MMS and MACS rare cell recovery over cell populations ranging from 0.1% to 0.0000001% and found that both magnetic sorting methods could recover cells down to 0.0000001% initial cell population, with the MMS having overall lower standard deviation of cell recovery. We believe the MMS system offers a compelling approach towards highly efficient, semi-automated screening of molecular libraries that is at least equal to manual magnetic sorting methods and produced, for the first time, 15-mer peptide binders to PA protein that exhibit better affinity and specificity than peptides isolated using conventional MACS/FACS.	[Kogot, Joshua M.; Stratis-Cullum, Dimitra N.; Pellegrino, Paul M.] USA, Res Lab, Sensors & Electron Devices Directorate, Adelphi, MD USA; [Zhang, Yanting; Pagano, Paul; Chang-Yen, David; Turewicz, Marek; de Fusco, Andre] Cynvenio Biosyst Inc, Westlake Village, CA USA; [Moore, Stephen J.; Stagliano, Nancy E.] CytomX Therapeut LLC, Santa Barbara, CA USA; [Soh, H. Tom] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); University of California System; University of California Santa Barbara	Kogot, JM (corresponding author), USA, Res Lab, Sensors & Electron Devices Directorate, Adelphi, MD USA.	dimitra.n.stratis-cullum.civ@mail.mil	Stratis-Cullum, Dimitra/F-9363-2013	Stratis-Cullum, Dimitra/0000-0002-4832-6945	U.S. Army, through the Institute of Collaborative Biology at University of California Santa Barbara [DAAD19-03-D-0004]; U.S. Department of Energy; U.S. Army Research Laboratory; Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense [BRCALL08-Per3-P-2-0028]	U.S. Army, through the Institute of Collaborative Biology at University of California Santa Barbara; U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported in part by the U.S. Army, through the Institute of Collaborative Biology at University of California Santa Barbara, under grant DAAD19-03-D-0004, in part by an appointment to the Internship/Research Participation Program for the U.S. Army Research Laboratory administered by the Oak Ridge Institute for Science and Education through an agreement between the U.S. Department of Energy and the U.S. Army Research Laboratory, and in part by the Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense (Grant no. BRCALL08-Per3-P-2-0028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessette PH, 2007, ANAL CHEM, V79, P2174, DOI 10.1021/ac0616916; Bessette PH, 2004, PROTEIN ENG DES SEL, V17, P731, DOI 10.1093/protein/gzh084; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bupp K, 2002, MOL THER, V5, P329, DOI 10.1006/mthe.2002.0546; Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107; Christmann A, 1999, PROTEIN ENG, V12, P797, DOI 10.1093/protein/12.9.797; Dane KY, 2009, MOL CANCER THER, V8, P1312, DOI 10.1158/1535-7163.MCT-08-1105; Daugherty PS, 2000, J IMMUNOL METHODS, V243, P211, DOI 10.1016/S0022-1759(00)00236-2; Georgiou G, 1997, NAT BIOTECHNOL, V15, P29, DOI 10.1038/nbt0197-29; Hu XY, 2005, P NATL ACAD SCI USA, V102, P15757, DOI 10.1073/pnas.0507719102; Kenrick SA, 2010, PROTEIN ENG DES SEL, V23, P9, DOI 10.1093/protein/gzp065; Kodadek T, 2001, CHEM BIOL, V8, P105, DOI 10.1016/S1074-5521(00)90067-X; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Krivacic RT, 2004, P NATL ACAD SCI USA, V101, P10501, DOI 10.1073/pnas.0404036101; Lara O, 2004, EXP HEMATOL, V32, P891, DOI 10.1016/j.exphem.2004.07.007; Leary JF, 2005, CYTOM PART A, V67A, P76, DOI 10.1002/cyto.a.20160; Levin AM, 2006, MOL BIOSYST, V2, P49, DOI 10.1039/b511782h; Little LE, 2011, BIOMATERIALS, V32, P1484, DOI 10.1016/j.biomaterials.2010.10.032; MacBeath G, 2001, NAT BIOTECHNOL, V19, P828, DOI 10.1038/nbt0901-828; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Nixon Andrew E., 2002, Current Pharmaceutical Biotechnology, V3, P1; Rice JJ, 2008, PROTEIN ENG DES SEL, V21, P435, DOI 10.1093/protein/gzn020; Rice JJ, 2006, PROTEIN SCI, V15, P825, DOI 10.1110/ps.051897806; Siegel RW, 2004, J IMMUNOL METHODS, V286, P141, DOI 10.1016/j.jim.2004.01.005; Thomas JM, 2009, PROTEIN SCI, V18, P2053, DOI 10.1002/pro.217; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Xu Y, 2009, ANAL CHEM, V81, P7436, DOI 10.1021/ac9012072; Yan H, 2009, J ZHEJIANG UNIV-SC B, V10, P928, DOI 10.1631/jzus.B0920205; Yeung YA, 2002, BIOTECHNOL PROGR, V18, P212, DOI 10.1021/bp010186l	29	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e26925	10.1371/journal.pone.0026925	http://dx.doi.org/10.1371/journal.pone.0026925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140433	Green Published, gold			2022-12-25	WOS:000298163400003
J	Leder, K; Foo, J; Skaggs, B; Gorre, M; Sawyers, CL; Michor, F				Leder, Kevin; Foo, Jasmine; Skaggs, Brian; Gorre, Mercedes; Sawyers, Charles L.; Michor, Franziska			Fitness Conferred by BCR-ABL Kinase Domain Mutations Determines the Risk of Pre-Existing Resistance in Chronic Myeloid Leukemia	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; DRUG-RESISTANCE; TYROSINE KINASE; CHRONIC-PHASE; IMATINIB; MODEL; EVOLUTION; CANCER; MECHANISMS; STRATEGIES	Chronic myeloid leukemia (CML) is the first human malignancy to be successfully treated with a small molecule inhibitor, imatinib, targeting a mutant oncoprotein (BCR-ABL). Despite its successes, acquired resistance to imatinib leads to reduced drug efficacy and frequent progression of disease. Understanding the characteristics of pre-existing resistant cells is important for evaluating the benefits of first-line combination therapy with second generation inhibitors. However, due to limitations of assay sensitivity, determining the existence and characteristics of resistant cell clones at the start of therapy is difficult. Here we combined a mathematical modeling approach using branching processes with experimental data on the fitness changes (i.e., changes in net reproductive rate) conferred by BCR-ABL kinase domain mutations to investigate the likelihood, composition, and diversity of pre-existing resistance. Furthermore, we studied the impact of these factors on the response to tyrosine kinase inhibitors. Our approach predicts that in most patients, there is at most one resistant clone present at the time of diagnosis of their disease. Interestingly, patients are no more likely to harbor the most aggressive, pan-resistant T315I mutation than any other resistance mutation; however, T315I cells on average establish larger-sized clones at the time of diagnosis. We established that for patients diagnosed late, the relative benefit of combination therapy over monotherapy with imatinib is significant, while this benefit is modest for patients with a typically early diagnosis time. These findings, after pre-clinical validation, will have implications for the clinical management of CML: we recommend that patients with advanced-phase disease be treated with combination therapy with at least two tyrosine kinase inhibitors.	[Leder, Kevin] Univ Minnesota, Program Ind & Syst Engn, Minneapolis, MN 55455 USA; [Foo, Jasmine] Univ Minnesota, Sch Math, Minneapolis, MN 55455 USA; [Skaggs, Brian] David Geffen Univ Calif Los Angeles, Sch Med, Div Rheumatol, Los Angeles, CA USA; [Gorre, Mercedes] Combimatrix, Irvine, CA USA; [Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Leder, K (corresponding author), Univ Minnesota, Program Ind & Syst Engn, Minneapolis, MN 55455 USA.	michor@jimmy.harvard.edu	Sawyers, Charles/G-5327-2016		NCI (National Cancer Institute) [U54CA143798]; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR059095] Funding Source: NIH RePORTER	NCI (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported through NCI (National Cancer Institute) grant U54CA143798. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerer WP, 2001, J MATH BIOL, V42, P145, DOI 10.1007/s002850000053; Chanock SJ, 2007, NAT GENET, V39, P283, DOI 10.1038/ng0307-283; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; COLDMAN AJ, 1986, B MATH BIOL, V48, P279, DOI 10.1016/S0092-8240(86)90028-5; Dewanji A, 2005, MATH BIOSCI, V197, P140, DOI 10.1016/j.mbs.2005.07.003; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Durrett R, 2010, THEOR POPUL BIOL, V77, P42, DOI 10.1016/j.tpb.2009.10.008; FOKAS AS, 1991, CANCER RES, V51, P2084; Foo J, 2009, PLOS COMPUTATIONAL B; Frank SA, 2003, J THEOR BIOL, V223, P405, DOI 10.1016/S0022-5193(03)00117-6; Gambacorti-Passerini CB, 2003, LANCET ONCOL, V4, P75, DOI 10.1016/S1470-2045(03)00979-3; Gibbons D, 2011, CANCER IN PRESS; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Haeno H, 2007, GENETICS, V177, P2209, DOI 10.1534/genetics.107.078915; HARNEVO LE, 1992, CANCER CHEMOTH PHARM, V30, P469, DOI 10.1007/BF00685599; Hochhaus A, 2004, LEUKEMIA, V18, P1321, DOI 10.1038/sj.leu.2403426; Hochhaus A, 2006, ANN ONCOL, V17, pX274, DOI 10.1093/annonc/mdl273; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; ICHIMARU M, 1991, J RADIAT RES, V32, P14, DOI 10.1269/jrr.32.SUPPLEMENT2_14; Iwasa Y, 2006, GENETICS, V172, P2557, DOI 10.1534/genetics.105.049791; Jabbour E, 2006, TARGET ONCOL, V1, P186, DOI 10.1007/s11523-006-0032-3; Kim PS, 2008, B MATH BIOL, V70, P1994, DOI 10.1007/s11538-008-9336-z; Kim PS, 2008, B MATH BIOL, V70, P728, DOI 10.1007/s11538-007-9276-z; Komarova N, 2006, J THEOR BIOL, V239, P351, DOI 10.1016/j.jtbi.2005.08.003; Komarova NL, 2007, THEOR POPUL BIOL, V72, P523, DOI 10.1016/j.tpb.2007.08.003; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Luria SE, 1943, GENETICS, V28, P491; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; NOWELL PC, 1960, CANCER RES, V20, P462; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Pierce A, 2002, ONCOGENE, V21, P3068, DOI 10.1038/sj.onc.1205424; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Roeder I, 2006, NATURE MED, V12; SESHADRI R, 1987, CANCER RES, V47, P407; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Skaggs BJ, 2006, P NATL ACAD SCI USA, V103, P19466, DOI 10.1073/pnas.0609239103	42	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27682	10.1371/journal.pone.0027682	http://dx.doi.org/10.1371/journal.pone.0027682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140458	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163400012
J	Mukhopadhyay, P; Reddy, MK; Singla-Pareek, SL; Sopory, SK				Mukhopadhyay, Pradipto; Reddy, Malireddy K.; Singla-Pareek, Sneh Lata; Sopory, Sudhir K.			Transcriptional Downregulation of Rice rpL32 Gene under Abiotic Stress Is Associated with Removal of Transcription Factors within the Promoter Region	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN GENES; CELL NUCLEAR ANTIGEN; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; CIS-ELEMENTS; S6 KINASE; EXPRESSION; ORGANIZATION; IDENTIFICATION; BINDING	Background: The regulation of ribosomal proteins in plants under stress conditions has not been well studied. Although a few reports have shown stress-specific post-transcriptional and translational mechanisms involved in downregulation of ribosomal proteins yet stress-responsive transcriptional regulation of ribosomal proteins is largely unknown in plants. Methodology/Principal Findings: In the present work, transcriptional regulation of genes encoding rice 60S ribosomal protein L32 (rpL32) in response to salt stress has been studied. Northern and RT-PCR analyses showed a significant downregulation of rpL32 transcripts under abiotic stress conditions in rice. Of the four rpL32 genes in rice genome, the gene on chromosome 8 (rpL32_8.1) showed a higher degree of stress-responsive downregulation in salt sensitive rice variety than in tolerant one and its expression reverted to its original level upon withdrawal of stress. The nuclear run-on and promoter: reporter assays revealed that the downregulation of this gene is transcriptional and originates within the promoter region. Using in vivo footprinting and electrophoretic mobility shift assay (EMSA), cis-elements in the promoter of rpL32_8.1 showing reduced binding to proteins in shoots of salt stressed rice seedlings were identified. Conclusions: The present work is one of the few reports on study of stress downregulated genes. The data revealed that rpL32 gene is transcriptionally downregulated under abiotic stress in rice and that this transcriptional downregulation is associated with the removal of transcription factors from specific promoter elements.	[Mukhopadhyay, Pradipto; Reddy, Malireddy K.; Singla-Pareek, Sneh Lata; Sopory, Sudhir K.] Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Mukhopadhyay, P (corresponding author), Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, Delhi, India.	sopory@icgeb.res.in			Department of Biotechnology [BT/PR2965/AGR/155-III/2002]; Government of India; International Centre for Genetic Engineering and Biotechnology; University Grant Commission (UGC), Government of India	Department of Biotechnology; Government of India; International Centre for Genetic Engineering and Biotechnology; University Grant Commission (UGC), Government of India(University Grants Commission, India)	This work has been supported by grants from the Department of Biotechnology (grant number BT/PR2965/AGR/155-III/2002), Government of India and internal grants from International Centre for Genetic Engineering and Biotechnology. PM is thankful to University Grant Commission (UGC), Government of India for providing research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey-Serres J, 1998, LOOK BEYOND TRANSCRIPTION, P125; Barakat A, 2001, PLANT PHYSIOL, V127, P398, DOI 10.1104/pp.010265; BELTRANPENA E, 1995, PLANT MOL BIOL, V28, P327, DOI 10.1007/BF00020251; Brosche M, 1999, BBA-GENE STRUCT EXPR, V1445, P342, DOI 10.1016/S0167-4781(99)00050-0; Busk PK, 2002, PLANT MOL BIOL REP, V20, P287, DOI 10.1007/BF02782464; Folta KM, 2006, NAT PROTOC, V1, P3094, DOI 10.1038/nprot.2006.471; GAO JW, 1994, PLANT MOL BIOL, V25, P761, DOI 10.1007/BF00028872; Giannino D, 2000, MOL GEN GENET, V263, P201, DOI 10.1007/s004380051161; He XY, 2000, J BIOL CHEM, V275, P11799, DOI 10.1074/jbc.275.16.11799; Hirose N, 1999, PLANT PHYSIOL, V121, P805, DOI 10.1104/pp.121.3.805; Jing W, 2006, FEBS LETT, V580, P1827, DOI 10.1016/j.febslet.2006.02.040; Kanazawa A, 2000, PLANT MOL BIOL REP, V18, P377, DOI 10.1007/BF02825066; Kawaguchi R, 2004, PLANT J, V38, P823, DOI 10.1111/j.1365-313X.2004.02090.x; Kim KY, 2004, J EXP BOT, V55, P1153, DOI 10.1093/jxb/erh125; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; KOSUGI S, 1995, PLANT J, V7, P877, DOI 10.1046/j.1365-313X.1995.07060877.x; Kosugi S, 1997, PLANT CELL, V9, P1607, DOI 10.1105/tpc.9.9.1607; Kosugi S, 2002, PLANT J, V30, P337, DOI 10.1046/j.1365-313X.2002.01294.x; L_auchli A., 2007, ADV MOL BREEDING DRO, P1, DOI DOI 10.1007/978-1-4020-5578-2_1; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; LARKIN JC, 1989, GENE DEV, V3, P500, DOI 10.1101/gad.3.4.500; Liu XN, 2003, AM J BOT, V90, P526, DOI 10.3732/ajb.90.4.526; Ludwig A, 2001, PLANTA, V212, P792, DOI 10.1007/s004250000427; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Planta RJ, 1998, YEAST, V14, P471, DOI 10.1002/(SICI)1097-0061(19980330)14:5<471::AID-YEA241>3.0.CO;2-U; Richards RA, 1996, PLANT GROWTH REGUL, V20, P157, DOI 10.1007/BF00024012; Rogalski M, 2008, PLANT CELL, V20, P2221, DOI 10.1105/tpc.108.060392; Saez-Vasquez J, 2000, PLANT SCI, V156, P35, DOI 10.1016/S0168-9452(00)00229-6; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Singer MS, 1998, GENETICS, V150, P613; Tatematsu K, 2005, PLANT PHYSIOL, V138, P757, DOI 10.1104/pp.104.057984; Tester M, 2005, PLANT PHYSIOL, V137, P791, DOI 10.1104/pp.104.900138; Tremousaygue D, 2003, PLANT J, V33, P957, DOI 10.1046/j.1365-313X.2003.01682.x; Turck F, 2004, PLANT PHYSIOL, V134, P1527, DOI 10.1104/pp.103.035873; Ueda A, 2006, ABIOTIC STRESS TOLERANCE IN PLANTS: TOWARD THE IMPROVEMENT OF GLOBAL ENVIRONMENT AND FOOD, P31, DOI 10.1007/1-4020-4389-9_2; WANNER LA, 1991, PLANT CELL, V3, P1289, DOI 10.1105/tpc.3.12.1289; WILLIAMS ME, 1995, PLANT J, V8, P65, DOI 10.1046/j.1365-313X.1995.08010065.x; Wu JZ, 1995, GENOME, V38, P1189, DOI 10.1139/g95-157; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xiong LM, 2001, PHYSIOL PLANTARUM, V112, P152, DOI 10.1034/j.1399-3054.2001.1120202.x; Yamamoto YY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-67; Yoshida S., 1976, LAB MANUAL PHYSL STU; Yu XD, 1998, PLANT PHYSIOL, V116, P1091, DOI 10.1104/pp.116.3.1091	46	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28058	10.1371/journal.pone.0028058	http://dx.doi.org/10.1371/journal.pone.0028058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132208	Green Published, Green Submitted, gold			2022-12-25	WOS:000298162000063
J	Prabhakaran, V; Rypma, B; Narayanan, NS; Meier, TB; Austin, BP; Nair, VA; Naing, L; Thomas, LE; Gabrieli, JDE				Prabhakaran, Vivek; Rypma, Bart; Narayanan, Nandakumar S.; Meier, Timothy B.; Austin, Benjamin P.; Nair, Veena A.; Naing, Lin; Thomas, Lisa E.; Gabrieli, John D. E.			Capacity-Speed Relationships in Prefrontal Cortex	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; GENERAL INTELLIGENCE; CORTICAL ACTIVITY; AGE-DIFFERENCES; ADULT AGE; INFORMATION; SPAN; MAINTENANCE; PERFORMANCE; STRATEGIES	Working memory (WM) capacity and WM processing speed are simple cognitive measures that underlie human performance in complex processes such as reasoning and language comprehension. These cognitive measures have shown to be interrelated in behavioral studies, yet the neural mechanism behind this interdependence has not been elucidated. We have carried out two functional MRI studies to separately identify brain regions involved in capacity and speed. Experiment 1, using a block-design WM verbal task, identified increased WM capacity with increased activity in right prefrontal regions, and Experiment 2, using a single-trial WM verbal task, identified increased WM processing speed with increased activity in similar regions. Our results suggest that right prefrontal areas may be a common region interlinking these two cognitive measures. Moreover, an overlap analysis with regions associated with binding or chunking suggest that this strategic memory consolidation process may be the mechanism interlinking WM capacity and WM speed.	[Prabhakaran, Vivek; Meier, Timothy B.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53715 USA; [Prabhakaran, Vivek; Naing, Lin] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Rypma, Bart] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX 75230 USA; [Narayanan, Nandakumar S.] Yale Univ, Dept Neurol, New Haven, CT USA; [Austin, Benjamin P.] Univ Wisconsin, Cardiovasc Res Ctr, Madison, WI USA; [Thomas, Lisa E.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Thomas, Lisa E.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Gabrieli, John D. E.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Dallas; Yale University; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Prabhakaran, V (corresponding author), Univ Wisconsin, Neurosci Training Program, Madison, WI 53715 USA.	vprabhakaran@uwhealth.org	Nair, Veena A/E-4037-2013; Vasudevan, prabhakaran/C-7240-2012; Gabrieli, John/AAJ-2869-2020	prabhakaran, vivek/0000-0002-1974-3125; NAIR, VEENA/0000-0002-5666-3239; Narayanan, Nandakumar/0000-0002-0427-0003	National Center for Research Resources (NCRR), National Institutes of Health (NIH) [UL1RR025011]; NIH [RO1 DC05375]; Coulter Foundation; NIH NIMH [RC1MH090912-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH090912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005375] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coulter Foundation; NIH NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by grants UL1RR025011 from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources (NCRR), National Institutes of Health (NIH), NIH RO1 DC05375, Coulter Foundation, and RC1MH090912-01 NIH NIMH Challenge Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barch DM, 2005, ANNU REV CLIN PSYCHO, V1, P321, DOI 10.1146/annurev.clinpsy.1.102803.143959; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Bor D, 2007, CEREB CORTEX, V17, P778, DOI 10.1093/cercor/bhk035; CAVANAGH JP, 1972, PSYCHOL REV, V79, P525, DOI 10.1037/h0033482; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; Fleck MS, 2006, CEREB CORTEX, V16, P1623, DOI 10.1093/cercor/bhj097; Glover GH, 1996, MAGNET RESON MED, V35, P299, DOI 10.1002/mrm.1910350306; Kail R, 1997, J EXP CHILD PSYCHOL, V64, P67, DOI 10.1006/jecp.1996.2337; Kail R, 1994, ACTA PSYCHOL, V86; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Mitchell KJ, 2000, PSYCHOL AGING, V15, P527, DOI 10.1037//0882-7974.15.3.527; Owen AM, 1997, NEUROPSYCHOLOGIA, V35, P519, DOI 10.1016/S0028-3932(96)00101-7; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Petrides Michael, 1994, Current Opinion in Neurobiology, V4, P207, DOI 10.1016/0959-4388(94)90074-4; Philipose LE, 2007, BEHAV NEUROL, V18, P37, DOI 10.1155/2007/396946; Phillips S, 2002, NEUROIMAGE, V17, P1031, DOI 10.1006/nimg.2002.1190; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Rajah MN, 2008, NEUROPSYCHOLOGIA, V46, P1088, DOI 10.1016/j.neuropsychologia.2007.10.023; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Rypma B, 2003, COGNITIVE BRAIN RES, V16, P162, DOI 10.1016/S0926-6410(02)00247-1; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Rypma B, 2001, PSYCHOL AGING, V16, P371, DOI 10.1037//0882-7974.16.3.371; SALTHOUSE TA, 1991, PSYCHOL AGING, V6, P118, DOI 10.1037/0882-7974.6.1.118; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Talairach J, 1988, CO PLANAR STEREOTAXI; Theios J, 1973, PSYCHOL LEARN MOTIV, P44; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; Vernon PA, 1987, A JENSEN CONSENSUS C	39	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27504	10.1371/journal.pone.0027504	http://dx.doi.org/10.1371/journal.pone.0027504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KL	22132105	Green Published, gold			2022-12-25	WOS:000298162000022
J	Meng, R; Tang, HY; Westfall, J; London, D; Cao, JH; Mousa, SA; Luidens, M; Hercbergs, A; Davis, FB; Davis, PJ; Lin, HY				Meng, Ran; Tang, Heng-Yuan; Westfall, Jennifer; London, David; Cao, James H.; Mousa, Shaker A.; Luidens, Mary; Hercbergs, Aleck; Davis, Faith B.; Davis, Paul J.; Lin, Hung-Yun			Crosstalk between Integrin alpha v beta 3 and Estrogen Receptor-alpha Is Involved in Thyroid Hormone-Induced Proliferation in Human Lung Carcinoma Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; THYROXINE VS. 3,5,3'-TRIIODO-L-THYRONINE; ENDOTHELIAL GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; TETRAIODOTHYROACETIC ACID; SERINE PHOSPHORYLATION; SURFACE RECEPTOR; GLIOMA-CELLS; CANCER CELLS; MAP KINASE	A cell surface receptor for thyroid hormone that activates extracellular regulated kinase (ERK) 1/2 has been identified on integrin alpha v beta 3. We have examined the actions of thyroid hormone initiated at the integrin on human NCI-H522 non-small cell lung carcinoma and NCI-H510A small cell lung cancer cells. At a physiologic total hormone concentration (10(-7) M), T(4) significantly increased proliferating cell nuclear antigen (PCNA) abundance in these cell lines, as did 3, 5, 39-triiodo-L-thyronine (T(3)) at a supraphysiologic concentration. Neutralizing antibody to integrin alpha v beta 3 and an integrin-binding Arg-GlyAsp (RGD) peptide blocked thyroid hormone-induced PCNA expression. Tetraiodothyroacetic acid (tetrac) lacks thyroid hormone function but inhibits binding of T(4) and T(3) to the integrin receptor; tetrac eliminated thyroid hormone-induced lung cancer cell proliferation and ERK1/2 activation. In these estrogen receptor-alpha (ER alpha)-positive lung cancer cells, thyroid hormone (T(4)>T(3)) caused phosphorylation of ER alpha; the specific ER alpha antagonist ICI 182,780 blocked T(4)-induced, but not T(3)-induced ERK1/2 activation, as well as ER alpha phosphorylation, proliferating-cell nuclear antigen (PCNA) expression and hormone-dependent thymidine uptake by tumor cells. Thus, in ER alpha-positive human lung cancer cells, the proliferative action of thyroid hormone initiated at the plasma membrane is at least in part mediated by ER alpha. In summary, thyroid hormone may be one of several endogenous factors capable of supporting proliferation of lung cancer cells. Activity as an inhibitor of lung cancer cell proliferation induced at the integrin receptor makes tetrac a novel anti-proliferative agent.	[Meng, Ran; Tang, Heng-Yuan; Westfall, Jennifer; London, David; Cao, James H.; Luidens, Mary; Davis, Faith B.; Davis, Paul J.; Lin, Hung-Yun] Ordway Signal Transduct, Albany, NY 12208 USA; [Meng, Ran; Mousa, Shaker A.; Davis, Paul J.; Lin, Hung-Yun] Albany Coll Pharm, Pharmaceut Res Inst, Albany, NY USA; [Luidens, Mary; Davis, Paul J.] Albany Med Coll, Albany, NY 12208 USA; [Hercbergs, Aleck] Cleveland Clin, Cleveland, OH 44106 USA; [Mousa, Shaker A.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia	Albany College of Pharmacy & Health Sciences; Albany Medical College; Cleveland Clinic Foundation; King Saud University	Meng, R (corresponding author), Ordway Signal Transduct, Albany, NY 12208 USA.	ordwayst@gmail.com	Mousa, Shaker A/A-7151-2017	Mousa, Shaker A/0000-0002-9294-015X; Doering, Jennifer/0000-0001-8749-774X	Charitable Leadership Foundation	Charitable Leadership Foundation	This work was supported in part by the Charitable Leadership Foundation and an endowment established at the Ordway Research Institute by M. Frank and Margaret C. Rudy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmadani S, 2008, AM J PHYSIOL-HEART C, V295, pH69, DOI 10.1152/ajpheart.00341.2008; Bergh JJ, 2005, ENDOCRINOLOGY, V146, P2864, DOI 10.1210/en.2005-0102; Bhargava M, 2009, AM J PHYSIOL-CELL PH, V296, pC977, DOI 10.1152/ajpcell.00116.2009; Byzova TV, 2000, EXP CELL RES, V254, P299, DOI 10.1006/excr.1999.4765; Cai Weibo, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P407, DOI 10.2174/187152006778226530; Cao X, 2005, MOL ENDOCRINOL, V19, P102, DOI 10.1210/me.2004-0093; Chaban VV, 2004, ENDOCRINOLOGY, V145, P3788, DOI 10.1210/en.2004-0149; Chattergoon NN, 2007, J ENDOCRINOL, V192, pR1, DOI 10.1677/JOE-06-0114; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Cody V, 2007, STEROIDS, V72, P165, DOI 10.1016/j.steroids.2006.11.008; Davis FB, 2006, CANCER RES, V66, P7270, DOI 10.1158/0008-5472.CAN-05-4365; Davis FB, 2004, CIRC RES, V94, P1500, DOI 10.1161/01.RES.0000130784.90237.4a; Davis PJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE1238, DOI 10.1152/ajpendo.00480.2009; Davis PJ, 2000, J BIOL CHEM, V275, P38032, DOI 10.1074/jbc.M002560200; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Di Fulvio M, 2000, J ENDOCRINOL, V166, P173, DOI 10.1677/joe.0.1660173; FRANCAVILLA A, 1994, HEPATOLOGY, V20, P1237, DOI 10.1002/hep.1840200521; Garcia-Silva S, 2002, TOXICOLOGY, V181, P179, DOI 10.1016/S0300-483X(02)00277-9; Lin C, 2011, CARCINOGENESIS, V32, P19, DOI 10.1093/carcin/bgq212; Lin HY, 2008, CARCINOGENESIS, V29, P62, DOI 10.1093/carcin/bgm239; Lin HY, 2007, STEROIDS, V72, P180, DOI 10.1016/j.steroids.2006.11.014; Lin HY, 2009, AM J PHYSIOL-CELL PH, V296, pC980, DOI 10.1152/ajpcell.00305.2008; Lin HY, 2003, BIOCHEMISTRY-US, V42, P7571, DOI 10.1021/bi0273967; LIN HY, 2007, THYROID S1, V17, pS129; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Malik R, 2003, HEPATOLOGY, V37, P79, DOI 10.1053/jhep.2003.50001; Moreno M, 2008, THYROID, V18, P239, DOI 10.1089/thy.2007.0248; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Mousa SA, 2008, ANGIOGENESIS, V11, P183, DOI 10.1007/s10456-007-9088-7; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Rebbaa A, 2008, ANGIOGENESIS, V11, P269, DOI 10.1007/s10456-008-9110-8; Shih A, 2004, ENDOCRINOLOGY, V145, P1708, DOI 10.1210/en.2003-0742; Shih A, 2001, BIOCHEMISTRY-US, V40, P2870, DOI 10.1021/bi001978b; Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9; Tang HY, 2004, ENDOCRINOLOGY, V145, P3265, DOI 10.1210/en.2004-0308; Woodfield GW, 2009, CLIN CANCER RES, V15, P3672, DOI 10.1158/1078-0432.CCR-08-2343; Yen PM, 2006, ENDOCRINOLOGY, V147, P1598, DOI 10.1210/en.2006-0074	37	71	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27547	10.1371/journal.pone.0027547	http://dx.doi.org/10.1371/journal.pone.0027547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132110	Green Published, Green Submitted, gold			2022-12-25	WOS:000297792400008
J	Taegtmeyer, M; MacPherson, P; Jones, K; Hopkins, M; Moorcroft, J; Lalloo, DG; Chawla, A				Taegtmeyer, Miriam; MacPherson, Peter; Jones, Kathy; Hopkins, Mark; Moorcroft, Jay; Lalloo, David G.; Chawla, Anu			Programmatic Evaluation of a Combined Antigen and Antibody Test for Rapid HIV Diagnosis in a Community and Sexual Health Clinic Screening Programme	PLOS ONE			English	Article							CARE; SERVICES; POINT	Background: A substantial proportion of HIV-infected individuals in the UK are unaware of their status and late presentations continue, especially in low prevalence areas. Fourth generation antigen/antibody rapid test kits could facilitate earlier diagnosis of HIV in non-clinical settings but lack data on performance under programmatic conditions. Methods and Findings: We evaluated the performance of Determine HIV-1/2 Ag/Ab Combo Test (Determine Combo), a rapid test with indicators for both HIV antibodies and p24 antigen, in participants recruited from community outreach and hospital-based sexual health clinics. HIV infection was confirmed using laboratory enzyme-linked immunosorbent assay (EIA), Line Immuno Assay (LIA) and quantitative polymerase chain reaction (PCR). In total, 953 people underwent HIV testing. HIV antibody (Ab) prevalence was 1.8% (17/953). Four false positive rapid tests were identified: two antibody and two p24 antigen (Ag) reactions. Of participants diagnosed as HIV Ab positive, 2/17 (12%) were recent seroconverters based on clinical history and HIV antibody avidity test results. However, none of these were detected by the p24 antigen component of the rapid test kit. There were no other true positive p24 Ag tests. Conclusion: These data lend support to an increasing body of evidence suggesting that 4th generation rapid HIV tests have little additional benefit over 3rd generation HIV kits for routine screening in low prevalence settings and have high rates of false positives. In order to optimally combine community-based case-finding among hard-to-reach groups with reliable and early diagnosis 3rd generation kits should be primarily used with laboratory testing of individuals thought to be at risk of acute HIV infection. A more reliable point of care diagnostic is required for the accurate detection of acute HIV infection under programmatic conditions.	[Taegtmeyer, Miriam; MacPherson, Peter; Lalloo, David G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [MacPherson, Peter] Univ Liverpool, Wellcome Trust Trop Ctr, Liverpool L3 5QA, Merseyside, England; [Jones, Kathy] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool Ctr Sexual Hlth, Liverpool, Merseyside, England; [Hopkins, Mark; Moorcroft, Jay; Chawla, Anu] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool Specialist Virol Ctr, Liverpool, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital	Taegtmeyer, M (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	miriamt@liverpool.ac.uk	MacPherson, Peter/AHD-2477-2022	MacPherson, Peter/0000-0002-0329-9613; Taegtmeyer, Miriam/0000-0002-5377-2536; Lalloo, David/0000-0001-7680-2200	Gilead UK; Ireland Fellowship Programme	Gilead UK(Gilead Sciences); Ireland Fellowship Programme	This project was funded by the Gilead UK and Ireland Fellowship Programme 2009. Additionally 200 Determine test kits were donated by Inverness Medicine for use in the Liverpool Centre for Sexual Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, MMWR Recomm Rep, V45, P1; Beelaert G, 2010, J VIROL METHODS, V168, P218, DOI 10.1016/j.jviromet.2010.06.002; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; *BRIT HIV ASS HIV, 2008, UK NAT GUID HIV TEST; Burns FM, 2008, AIDS, V22, P115, DOI 10.1097/QAD.0b013e3282f1d4b6; Fox J, 2011, SEX TRANSM INFECT, V87, P178, DOI 10.1136/sti.2010.042564; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; *HLTH PROT AG UK, 2009, HIV UK 2009 REP; *HLTH PROT AG UK, 2008, DIAGN HIV PREV STRAT; *INV MED INN INC, 2010, DET HIV 1 2 AG AB CO; MacPherson P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-419; Marum E, 2006, JAMA-J AM MED ASSOC, V296, P859, DOI 10.1001/jama.296.7.859; Mavedzenge S, 2011, HIV SELF TESTING HLT; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Miller WC, 2011, 18 C RETR OPP INF BO; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; PILCHER CD, 2009, 18 C RETR OPP INF MO; Pilcher CD, 2010, J INFECT DIS, V201, pS7, DOI 10.1086/650393; Prost A, 2009, SEX TRANSM INFECT, V85, P326, DOI 10.1136/sti.2008.033233; Sudarshi D, 2007, SEX TRANSM INFECT, V84, P14, DOI 10.1136/sti.2007.026963; Surah S, 2009, INT J STD AIDS, V20, P168, DOI 10.1258/ijsa.2008.008220; Thomas S, 2009, HIV MED, V10, P44; Weber B, 2006, CLIN LAB, V52, P463; Weber B, 2002, J CLIN VIROL, V25, P357, DOI 10.1016/S1386-6532(02)00013-6; World Health Organization, 2007, GUID PROV IN HIV TES	25	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28019	10.1371/journal.pone.0028019	http://dx.doi.org/10.1371/journal.pone.0028019			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132195	Green Accepted, gold, Green Published			2022-12-25	WOS:000297792400033
J	Davies, JM; Carroll, ML; Li, HZ; Poh, AM; Kirkegard, D; Towers, M; Upham, JW				Davies, Janet M.; Carroll, Melanie L.; Li, Hongzhuo; Poh, Alisa M.; Kirkegard, Darren; Towers, Michelle; Upham, John W.			Budesonide and Formoterol Reduce Early Innate Anti-Viral Immune Responses In Vitro	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; ASTHMA EXACERBATIONS; EXPERIMENTAL-INFECTION; BETA(2) AGONISTS; VIRAL-INFECTIONS; RELIEVER THERAPY; ATOPIC ASTHMA; RHINOVIRUS; RELEASE	Asthma is a chronic inflammatory airways disease in which respiratory viral infections frequently trigger exacerbations. Current treatment of asthma with combinations of inhaled corticosteroids and long acting beta2 agonists improves asthma control and reduces exacerbations but what impact this might have on innate anti-viral immunity is unclear. We investigated the in vitro effects of asthma drugs on innate anti-viral immunity. Peripheral blood mononuclear cells (PBMC) from healthy and asthmatic donors were cultured for 24 hours with the Toll-like receptor 7 agonist, imiquimod, or rhinovirus 16 (RV16) in the presence of budesonide and/or formoterol. Production of proinflammatory cytokines and expression of anti-viral intracellular signalling molecules were measured by ELISA and RT-PCR respectively. In PBMC from healthy donors, budesonide alone inhibited IP-10 and IL-6 production induced by imiquimod in a concentration-dependent manner and the degree of inhibition was amplified when budesonide and formoterol were used in combination. Formoterol alone had little effect on these parameters, except at high concentrations (10(-6) M) when IL-6 production increased. In RV16 stimulated PBMC, the combination of budesonide and formoterol inhibited IFN alpha and IP-10 production in asthmatic as well as healthy donors. Combination of budesonide and formoterol also inhibited RV16-stimulated expression of the type I IFN induced genes myxovirus protein A and 2', 5' oligoadenylate synthetise. Notably, RV16 stimulated lower levels of type Myxovirus A and oligoadenylate synthase in PBMC of asthmatics than control donors. These in vitro studies demonstrate that combinations of drugs commonly used in asthma therapy inhibit both early pro-inflammatory cytokines and key aspects of the type I IFN pathway. These findings suggest that budesonide and formoterol curtail excessive inflammation induced by rhinovirus infections in patients with asthma, but whether this inhibits viral clearance in vivo remains to be determined.	[Davies, Janet M.; Carroll, Melanie L.; Li, Hongzhuo; Poh, Alisa M.; Kirkegard, Darren; Towers, Michelle; Upham, John W.] Univ Queensland, Princess Alexandra Hosp, Sch Med, Lung & Allergy Res Ctr,Clin Div, Woolloongabba, Qld, Australia; [Towers, Michelle; Upham, John W.] Princess Alexandra Hosp, Dept Resp Med, Woolloongabba, Qld 4102, Australia	University of Queensland	Davies, JM (corresponding author), Univ Queensland, Princess Alexandra Hosp, Sch Med, Lung & Allergy Res Ctr,Clin Div, Woolloongabba, Qld, Australia.	j.davies2@uq.edu.au	Davies, Janet/C-7989-2009; Upham, John/F-4420-2010	Davies, Janet/0000-0002-6378-4119; Upham, John/0000-0002-0017-3433	Office of Health and Medical Research, Queensland Health; Asthma Foundation of Queensland	Office of Health and Medical Research, Queensland Health; Asthma Foundation of Queensland	Supported by grants from the Office of Health and Medical Research, Queensland Health and the Asthma Foundation of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks GD, 2003, AM J RESP CRIT CARE, V168, P1091, DOI 10.1164/rccm.200306-737OC; Bufe A, 2002, INT ARCH ALLERGY IMM, V127, P82, DOI 10.1159/000048173; Buhl R, 2007, CURR MED RES OPIN, V23, P1867, DOI 10.1185/030079907X210769; Cakebread JA, 2011, J ALLERGY CLIN IMMUN, V127, P1148, DOI 10.1016/j.jaci.2011.01.023; Carroll ML, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-184; Cates CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007313.pub2; Chapman KR, 2010, THORAX, V65, P747, DOI 10.1136/thx.2009.128504; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Denburg Judah A., 2000, Journal of Allergy and Clinical Immunology, V106, pS242; Edwards MR, 2007, J BIOL CHEM, V282, P15366, DOI 10.1074/jbc.M701325200; Edwards MR, 2006, AM J RESP CELL MOL, V34, P616, DOI 10.1165/rcmb.2005-0385OC; Gehlhar K, 2006, CLIN EXP ALLERGY, V36, P331, DOI 10.1111/j.1365-2222.2006.02450.x; Gibson SJ, 2002, CELL IMMUNOL, V218, P74, DOI 10.1016/S0008-8749(02)00517-8; Grunberg K, 2001, AM J RESP CRIT CARE, V164, P1816; Holgate ST, 2005, AM J RESP CRIT CARE, V172, P941, DOI 10.1164/rccm.2507007; Holt PG, 2011, CHEST, V139, P1165, DOI 10.1378/chest.10-2397; Hung CH, 2008, EUR RESPIR J, V31, P1313, DOI 10.1183/09031936.00121406; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; Kohlmeier JE, 2010, IMMUNITY, V33, P96, DOI 10.1016/j.immuni.2010.06.016; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; LEMANSKE RF, 1989, J CLIN INVEST, V83, P1, DOI 10.1172/JCI113843; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; McCormack PL, 2007, DRUGS, V67, P2407, DOI 10.2165/00003495-200767160-00007; Message SD, 2004, J LEUKOCYTE BIOL, V75, P5, DOI 10.1189/jlb.0703315; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Pang LH, 2000, AM J RESP CELL MOL, V23, P79, DOI 10.1165/ajrcmb.23.1.3985; Papadopoulos NG, 2011, ALLERGY, V66, P458, DOI 10.1111/j.1398-9995.2010.02505.x; Papadopoulos NG, 2002, THORAX, V57, P328, DOI 10.1136/thorax.57.4.328; Papadopoulos NG, 2002, CLIN EXP ALLERGY, V32, P537, DOI 10.1046/j.0954-7894.2002.01313.x; Parry DE, 2000, J ALLERGY CLIN IMMUN, V105, P692, DOI 10.1067/mai.2000.104785; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roponen M, 2010, EUR RESPIR J, V35, P64, DOI 10.1183/09031936.00172008; Roth M, 2002, LANCET, V360, P1293, DOI 10.1016/S0140-6736(02)11319-5; Sanders SP, 2001, AM J RESP CELL MOL, V24, P317, DOI 10.1165/ajrcmb.24.3.4131; Simon HU, 2003, ALLERGY, V58, P1250, DOI 10.1046/j.1398-9995.2003.00424.x; Skevaki CL, 2009, CLIN EXP ALLERGY, V39, P1700, DOI 10.1111/j.1365-2222.2009.03307.x; SUBAUSTE MC, 1995, J CLIN INVEST, V96, P549, DOI 10.1172/JCI118067; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Todorova L, 2006, AM J RESP CELL MOL, V34, P92, DOI 10.1165/rcmb.2005-0048OC; Upham JW, 2009, J ALLERGY CLIN IMMUN, V124, P707, DOI 10.1016/j.jaci.2009.07.009; van Elden LJR, 2008, J CLIN VIROL, V41, P116, DOI 10.1016/j.jcv.2007.10.028; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; Wark PAB, 2009, RESPIROLOGY, V14, P180, DOI 10.1111/j.1440-1843.2009.01480.x; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262	48	33	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27898	10.1371/journal.pone.0027898	http://dx.doi.org/10.1371/journal.pone.0027898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125636	gold, Green Published			2022-12-25	WOS:000297789200036
J	Ezzat, K; Helmfors, H; Tudoran, O; Juks, C; Lindberg, S; Padari, K; El-Andaloussi, S; Pooga, M; Langel, U				Ezzat, Kariem; Helmfors, Henrik; Tudoran, Oana; Juks, Carmen; Lindberg, Staffan; Padari, Kaert; El-Andaloussi, Samir; Pooga, Margus; Langel, Ulo			Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides	FASEB JOURNAL			English	Article						drug delivery; splice correction; cellular uptake	PHOSPHOROTHIOATE-STIMULATED UPTAKE; ARGININE-RICH PEPTIDES; SERUM-FREE MEDIUM; IN-VITRO; SURFACE RECEPTOR; NUCLEIC-ACIDS; PLASMID DNA; DELIVERY; TRANSFECTION; COMPLEXES	Cell-penetrating peptides (CPPs) are short cationic peptides that penetrate cells by interacting with the negatively charged plasma membrane; however, the detailed uptake mechanism is not clear. In contrary to the conventional mode of action of CPPs, we show here that a CPP, PepFect14 (PF14), forms negatively charged nanocomplexes with oligonucleotides and their uptake is mediated by class-A scavenger receptors (SCARAs). Specific inhibitory ligands of SCARAs, such as fucoidin, polyinosinic acid, and dextran sulfate, totally inhibit the activity of PF14-oligonucleotide nanocomplexes in the HeLa pLuc705 splice-correction cell model, while nonspecific, chemically related molecules do not. Furthermore, RNA interference (RNAi) knockdown of SCARA subtypes (SCARA3 and SCARA5) that are expressed in this cell line led to a significant reduction of the activity to < 50%. In line with this, immunostaining shows prevalent colocalization of the nanocomplexes with the receptors, and electron microscopy images show no binding or internalization of the nanocomplexes in the presence of the inhibitory ligands. Interestingly, naked oligonucleotides also colocalize with SCARAs when used at high concentrations. These results demonstrate the involvement of SCARA3 and SCARA5 in the uptake of PF14-oligonucleotide nanocomplexes and suggest for the first time that some CPP-based systems function through scavenger receptors, which could yield novel possibilities to understand and improve the transfection by CPPs.-Ezzat, K., Helmfors, H., Tudoran, O., Juks, C., Lindberg, S., Padari, K., El-Andaloussi, S., Pooga, M., Langel, U. Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides. FASEB J. 26, 1172-1180 (2012). www.fasebj.org	[Ezzat, Kariem; Helmfors, Henrik; Lindberg, Staffan; Langel, Ulo] Stockholm Univ, Dept Neurochem, S-10691 Stockholm, Sweden; [Tudoran, Oana] Chiricuta Canc Inst, Dept Funct Genom & Expt Pathol, Cluj Napoca, Romania; [Juks, Carmen; Padari, Kaert; Pooga, Margus] Univ Tartu, Inst Mol & Cell Biol, Dept Dev Biol, EE-50090 Tartu, Estonia; [Langel, Ulo] Univ Tartu, Inst Technol, Mol Biotechnol Lab, EE-50090 Tartu, Estonia; [El-Andaloussi, Samir] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [El-Andaloussi, Samir] Karolinska Inst, Dept Lab Med, Huddinge, Sweden	Stockholm University; Oncology Institute Prof. Dr. Ion Chiricuta; University of Tartu; University of Tartu; University of Oxford; Karolinska Institutet	Ezzat, K (corresponding author), Stockholm Univ, Dept Neurochem, 21A Svante Arrhenius Vag, S-10691 Stockholm, Sweden.	kariem@neurochem.su.se	Pooga, Margus/A-8575-2011; Ezzat, Kariem/O-6593-2019; Ezzat, Kariem/D-1436-2015	Pooga, Margus/0000-0003-4532-4087; Ezzat, Kariem/0000-0003-4186-0675; Helmfors, Henrik/0000-0001-9912-4887; Langel, Ulo/0000-0001-6107-0844; Lindberg, Staffan/0000-0001-7746-8574	Swedish Research Council (VR-NT); SSF (Sweden-Japan); Center for Biomembrane Research, Stockholm; European Union; Estonian Science Foundation (ESF) [7058]; Estonian government [SF0180027s08, 0180019s11]	Swedish Research Council (VR-NT)(Swedish Research Council); SSF (Sweden-Japan)(Swedish Foundation for Strategic Research); Center for Biomembrane Research, Stockholm; European Union(European Commission); Estonian Science Foundation (ESF); Estonian government	The authors thank all the contributing funding agencies. This work was supported by the Swedish Research Council (VR-NT); by SSF (Sweden-Japan); by the Center for Biomembrane Research, Stockholm; by the European Union through the European Regional Development Fund through the Center of Excellence in Chemical Biology, Estonia: by the Estonian Science Foundation (ESF; grant 7058); and by the targeted financing grants SF0180027s08 and 0180019s11 from the Estonian government.	Andaloussi SEL, 2011, NUCLEIC ACIDS RES, V39, P3972, DOI 10.1093/nar/gkq1299; Deshayes S, 2008, ADV DRUG DELIVER REV, V60, P537, DOI 10.1016/j.addr.2007.09.005; Detzer A, 2009, CURR TOP MED CHEM, V9, P1109, DOI 10.2174/156802609789630884; DeWitte-Orr SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000829; Ezzat K, 2011, NUCLEIC ACIDS RES, V39, P5284, DOI 10.1093/nar/gkr072; Ezzat K, 2010, CURR PHARM DESIGN, V16, P1167, DOI 10.2174/138161210790963832; Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l; Han HJ, 1998, HUM MOL GENET, V7, P1039, DOI 10.1093/hmg/7.6.1039; Jarver P, 2010, TRENDS PHARMACOL SCI, V31, P528, DOI 10.1016/j.tips.2010.07.006; Kang SH, 1998, BIOCHEMISTRY-US, V37, P6235, DOI 10.1021/bi980300h; Koller E, 2011, NUCLEIC ACIDS RES, V39, P4795, DOI 10.1093/nar/gkr089; Lehto T, 2011, MOL THER, V19, P1457, DOI 10.1038/mt.2011.10; Lehto T, 2010, J CONTROL RELEASE, V141, P42, DOI 10.1016/j.jconrel.2009.08.028; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Mae M, 2009, EXPERT OPIN DRUG DEL, V6, P1195, DOI 10.1517/17425240903213688; Mae M, 2009, J CONTROL RELEASE, V134, P221, DOI 10.1016/j.jconrel.2008.11.025; Mescalchin A, 2007, EXPERT OPIN BIOL TH, V7, P1531, DOI 10.1517/14712598.7.10.1531; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; Nagayama S, 2007, INT J PHARMACEUT, V329, P192, DOI 10.1016/j.ijpharm.2006.08.025; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Oskolkov N, 2011, INT J PEPT RES THER, V17, P147, DOI 10.1007/s10989-011-9252-1; Overhoff M, 2005, EMBO REP, V6, P1176, DOI 10.1038/sj.embor.7400535; Patel PC, 2010, BIOCONJUGATE CHEM, V21, P2250, DOI 10.1021/bc1002423; PEARSON AM, 1993, J BIOL CHEM, V268, P3546; Peiser L, 2001, MICROBES INFECT, V3, P149, DOI 10.1016/S1286-4579(00)01362-9; Platt N, 1998, CHEM BIOL, V5, pR193, DOI 10.1016/S1074-5521(98)90156-9; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; Pluddemann A, 2009, J INNATE IMMUN, V1, P153, DOI 10.1159/000155227; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Sewell KL, 2002, J PHARMACOL EXP THER, V303, P1334, DOI 10.1124/jpet.102.036749; Sobal G, 2002, J RECEPT SIGNAL TR R, V22, P459, DOI 10.1081/RRS-120014614; Son KK, 2000, BBA-BIOMEMBRANES, V1468, P6, DOI 10.1016/S0005-2736(00)00311-4; Son KK, 2000, BBA-BIOMEMBRANES, V1468, P11, DOI 10.1016/S0005-2736(00)00312-6; Son KK, 2001, BBA-BIOMEMBRANES, V1511, P201, DOI 10.1016/S0005-2736(01)00297-8; Son KK, 2000, BBA-BIOMEMBRANES, V1466, P11, DOI 10.1016/S0005-2736(00)00176-0; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; Takagi H, 2002, J CELL SCI, V115, P3309; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Verdurmen WPR, 2011, TRENDS PHARMACOL SCI, V32, P116, DOI 10.1016/j.tips.2010.11.005; Yacyshyn BR, 2002, GUT, V51, P30, DOI 10.1136/gut.51.1.30; Yanyan JY, 2006, J BIOL CHEM, V281, P11834, DOI 10.1074/jbc.M507599200	43	108	110	0	40	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1172	1180		10.1096/fj.11-191536	http://dx.doi.org/10.1096/fj.11-191536			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22138034				2022-12-25	WOS:000300949300020
J	Cardinale, A; Racaniello, M; Saladini, S; De Chiara, G; Mollinari, C; de Stefano, MC; Pocchiari, M; Garaci, E; Merlo, D				Cardinale, Alessio; Racaniello, Mauro; Saladini, Serena; De Chiara, Giovanna; Mollinari, Cristiana; de Stefano, Maria Chiara; Pocchiari, Maurizio; Garaci, Enrico; Merlo, Daniela			Sublethal Doses of beta-Amyloid Peptide Abrogate DNA-dependent Protein Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; INCREASED OXIDATIVE DAMAGE; SUBSTANTIA-NIGRA NEURONS; DOUBLE-STRAND BREAKS; ALZHEIMERS-DISEASE; CATALYTIC SUBUNIT; HYDROGEN-PEROXIDE; IN-VITRO; TOPOISOMERASE-II; POLY(ADP-RIBOSE) POLYMERASE-1	Accumulation of DNA damage and deficiency in DNA repair potentially contribute to the progressive neuronal loss in neurodegenerative disorders, including Alzheimer disease (AD). In multicellular eukaryotes, double strand breaks (DSBs), the most lethal form of DNA damage, are mainly repaired by the nonhomologous end joining pathway, which relies on DNA-PK complex activity. Both the presence of DSBs and a decreased end joining activity have been reported in AD brains, but the molecular player causing DNA repair dysfunction is still undetermined. beta-Amyloid (A beta), a potential proximate effector of neurotoxicity in AD, might exert cytotoxic effects by reactive oxygen species generation and oxidative stress induction, which may then cause DNA damage. Here, we show that in PC12 cells sublethal concentrations of aggregated A beta (25-35) inhibit DNA-PK kinase activity, compromising DSB repair and sensitizing cells to nonlethal oxidative injury. The inhibition of DNA-PK activity is associated with down-regulation of the catalytic subunit DNA-PK (DNA-PKcs) protein levels, caused by oxidative stress and reversed by antioxidant treatment. Moreover, we show that sublethal doses of A beta(1-42) oligomers enter the nucleus of PC12 cells, accumulate as insoluble oligomeric species, and reduce DNA-PK kinase activity, although in the absence of oxidative stress. Overall, these findings suggest that A beta mediates inhibition of the DNA-PK-dependent nonhomologous end joining pathway contributing to the accumulation of DSBs that, if not efficiently repaired, may lead to the neuronal loss observed in AD.	[Racaniello, Mauro; De Chiara, Giovanna; Mollinari, Cristiana; de Stefano, Maria Chiara; Pocchiari, Maurizio; Merlo, Daniela] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Cardinale, Alessio; Racaniello, Mauro; Saladini, Serena; Merlo, Daniela] Ist Ricovero & Cura Carattere Sci San Raffaele Pi, I-00166 Rome, Italy; [Mollinari, Cristiana] CNR, Ist Farmacol Traslaz, I-00133 Rome, Italy; [Garaci, Enrico] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy	Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); University of Rome Tor Vergata	Merlo, D (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	daniela.merlo@iss.it	GARACI, ENRICO/AAB-3349-2021; De Chiara, Giovanna/AAJ-7843-2021; de Stefano, Maria Chiara/N-6492-2017; Merlo, Daniela/K-7986-2016; Pocchiari, Maurizio/J-8443-2018; Mollinari, Cristiana/K-4131-2016	De Chiara, Giovanna/0000-0002-2219-6097; de Stefano, Maria Chiara/0000-0002-0770-1411; Merlo, Daniela/0000-0003-4240-5762; Pocchiari, Maurizio/0000-0002-7269-2486; Mollinari, Cristiana/0000-0001-8112-5427	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health.	Adamec E, 1999, BRAIN RES, V849, P67, DOI 10.1016/S0006-8993(99)02004-1; Amador FC, 2004, NEUROTOXICOL TERATOL, V26, P387, DOI 10.1016/j.ntt.2003.12.007; Banath JP, 2003, CANCER RES, V63, P4347; Barzilai A, 2007, ANTIOXID REDOX SIGN, V9, P211, DOI 10.1089/ars.2007.9.211; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; BOERRIGTER METI, 1992, J GERONTOL, V47, pB177, DOI 10.1093/geronj/47.6.B177; Bogdanov M, 2000, FREE RADICAL BIO MED, V29, P652, DOI 10.1016/S0891-5849(00)00349-X; Boldogh I, 2003, TOXICOLOGY, V193, P137, DOI 10.1016/j.tox.2003.08.013; Buckig A, 2002, HISTOCHEM CELL BIOL, V118, P353, DOI 10.1007/s00418-002-0459-2; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Butterfield DA, 2002, PEPTIDES, V23, P1299, DOI 10.1016/S0196-9781(02)00066-9; CASCIOLAROSEN LA, 1995, J EXP MED, V182, P1625, DOI 10.1084/jem.182.6.1625; Cecarini V, 2008, BRAIN RES, V1209, P8, DOI 10.1016/j.brainres.2008.03.003; Chakravarthy BR, 1999, J NEUROCHEM, V72, P933, DOI 10.1046/j.1471-4159.1999.0720933.x; CHAUHAN A, 1993, BRAIN RES, V629, P47, DOI 10.1016/0006-8993(93)90479-7; Chen L, 2009, INT J BIOCHEM CELL B, V41, P1284, DOI 10.1016/j.biocel.2008.10.029; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Culmsee C, 2001, MOL BRAIN RES, V87, P257, DOI 10.1016/S0169-328X(01)00008-0; Daido S, 2005, CANCER RES, V65, P4368, DOI 10.1158/0008-5472.CAN-04-4202; Diaz JC, 2009, P NATL ACAD SCI USA, V106, P3348, DOI 10.1073/pnas.0813355106; Douglas P, 2001, J BIOL CHEM, V276, P18992, DOI 10.1074/jbc.M011703200; Enokido Y, 2010, J CELL BIOL, V189, P425, DOI 10.1083/jcb.200905138; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Giuliano P, 2003, HUM MOL GENET, V12, P2301, DOI 10.1093/hmg/ddg242; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hegde ML, 2004, J MOL NEUROSCI, V22, P19, DOI 10.1385/JMN:22:1-2:19; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; IIMOTO DS, 1990, BRAIN RES, V507, P273, DOI 10.1016/0006-8993(90)90282-G; IVERSEN LL, 1995, BIOCHEM J, V311, P1; Johnstone EM, 1996, BIOCHEM BIOPH RES CO, V220, P710, DOI 10.1006/bbrc.1996.0469; Kikuchi H, 2002, ACTA NEUROPATHOL, V103, P408, DOI 10.1007/s00401-001-0480-x; Kisby GE, 1997, NEUROREPORT, V8, P1337, DOI 10.1097/00001756-199704140-00004; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lu HR, 2005, MOL PHARMACOL, V68, P983, DOI 10.1124/mol.105.011544; Lucassen PJ, 1997, J NEUROPATH EXP NEUR, V56, P887, DOI 10.1097/00005072-199708000-00007; Martinez-Senac MD, 1999, EUR J BIOCHEM, V265, P744, DOI 10.1046/j.1432-1327.1999.00775.x; McConnell KR, 1997, J IMMUNOL, V158, P2083; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Merlo D, 2005, CELL DEATH DIFFER, V12, P307, DOI 10.1038/sj.cdd.4401572; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; MULLAART E, 1990, NEUROBIOL AGING, V11, P169, DOI 10.1016/0197-4580(90)90542-8; Neema M, 2005, HIPPOCAMPUS, V15, P1057, DOI 10.1002/hipo.20123; Nouspikel T, 2003, BIOESSAYS, V25, P168, DOI 10.1002/bies.10227; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Olsen BB, 2010, ONCOGENE, V29, P6016, DOI 10.1038/onc.2010.337; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Qi ML, 2007, NAT CELL BIOL, V9, P402, DOI 10.1038/ncb1553; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rashidian J, 2005, P NATL ACAD SCI USA, V102, P14080, DOI 10.1073/pnas.0500099102; ROBBINS JH, 1985, J NEUROL NEUROSUR PS, V48, P916, DOI 10.1136/jnnp.48.9.916; ROBISON SH, 1987, ANN NEUROL, V21, P250, DOI 10.1002/ana.410210306; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Shackelford DA, 2006, NEUROBIOL AGING, V27, P596, DOI 10.1016/j.neurobiolaging.2005.03.009; Shackelford DA, 1999, J NEUROSCI, V19, P4727; Shao L, 2010, EMBO MOL MED, V2, P415, DOI 10.1002/emmm.201000096; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; Shimura-Miura H, 1999, ANN NEUROL, V46, P920, DOI 10.1002/1531-8249(199912)46:6<920::AID-ANA17>3.0.CO;2-R; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Simpson JE, 2010, NEUROPATH APPL NEURO, V36, P25, DOI 10.1111/j.1365-2990.2009.01030.x; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Stadelmann C, 1998, J NEUROPATH EXP NEUR, V57, P456, DOI 10.1097/00005072-199805000-00009; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Tseng BP, 2008, NEUROBIOL AGING, V29, P1607, DOI 10.1016/j.neurobiolaging.2007.04.014; Varadarajan S, 2001, J AM CHEM SOC, V123, P5625, DOI 10.1021/ja010452r; Veuger SJ, 2003, CANCER RES, V63, P6008; Vintem APB, 2009, NEUROTOXICOL TERATOL, V31, P85, DOI 10.1016/j.ntt.2008.11.001; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weissman L, 2007, NEUROSCIENCE, V145, P1318, DOI 10.1016/j.neuroscience.2006.08.061; Weissman L, 2007, NUCLEIC ACIDS RES, V35, P5545, DOI 10.1093/nar/gkm605; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275	94	37	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2618	2631		10.1074/jbc.M111.276550	http://dx.doi.org/10.1074/jbc.M111.276550			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139836	Green Published, hybrid			2022-12-25	WOS:000300292300035
J	Lee, KW; Maeng, JS; Choi, JY; Lee, YR; Hwang, CY; Park, SS; Park, HK; Chung, BH; Lee, SG; Kim, YS; Jeon, H; Eom, SH; Kang, C; Kim, DH; Kwon, KS				Lee, Keun Woo; Maeng, Jin-Soo; Choi, Jeong Yi; Lee, Yu Ran; Hwang, Chae Young; Park, Sung Sup; Park, Hyun Kyu; Chung, Bong Hyun; Lee, Seung-Goo; Kim, Yeon-Soo; Jeon, Hyesung; Eom, Soo Hyun; Kang, ChulHee; Kim, Do Han; Kwon, Ki-Sun			Role of Junctin Protein Interactions in Cellular Dynamics of Calsequestrin Polymer upon Calcium Perturbation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CALSEQUESTRIN; RYANODINE RECEPTOR; BINDING-PROTEIN; RELEASE CHANNEL; VENTRICULAR-TACHYCARDIA; CARDIAC MYOCYTES; CA2+ RELEASE; CASQ2; CONTRACTILITY; TRIADIN	Calsequestrin (CSQ), the major intrasarcoplasmic reticulum calcium storage protein, undergoes dynamic polymerization and depolymerization in a Ca2+-dependent manner. However, no direct evidence of CSQ depolymerization in vivo with physiological relevance has been obtained. In the present study, live cell imaging analysis facilitated characterization of the in vivo dynamics of the macromolecular CSQ structure. CSQ2 appeared as speckles in the presence of normal sarcoplasmic reticulum (SR) Ca2+ that were decondensed upon Ca2+ depletion. Moreover, CSQ2decondensation occurred only in the stoichiometric presence of junctin (JNT). When expressed alone, CSQ2 speckles remained unchanged, even after Ca2+ depletion. FRET analysis revealed constant interactions between CSQ2 and JNT, regardless of the SR Ca2+ concentration, implying that JNT is an essential component of the CSQ scaffold. In vitro solubility assay, electron microscopy, and atomic force microscopy studies using purified recombinant proteins confirmed Ca2+ and JNT-dependent disassembly of the CSQ2 polymer. Accordingly, we conclude that reversible polymerization and depolymerization of CSQ are critical in SR Ca2+ homeostasis.	[Lee, Keun Woo; Choi, Jeong Yi; Lee, Yu Ran; Hwang, Chae Young; Park, Sung Sup; Kwon, Ki-Sun] Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Lab Cell Signaling, Taejon 305806, South Korea; [Park, Hyun Kyu; Chung, Bong Hyun] Korea Res Inst Biosci & Biotechnol, Bionanotechnol Res Ctr, Taejon 305806, South Korea; [Lee, Seung-Goo] Korea Res Inst Biosci & Biotechnol, Ind Biotechnol & Bioenergy Res Ctr, Taejon 305806, South Korea; [Maeng, Jin-Soo] KFRI, Bionanotechnol Res Ctr, Gyeonggi Do 463746, South Korea; [Kim, Yeon-Soo] Inje Univ, Dept Smart Foods & Drugs, Seoul 100032, South Korea; [Kim, Yeon-Soo] Inje Univ, Indang Inst Mol Biol, Seoul 100032, South Korea; [Jeon, Hyesung] Korea Inst Sci & Technol, Biomed Res Ctr, Seoul 136791, South Korea; [Eom, Soo Hyun; Kim, Do Han] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea; [Kang, ChulHee] Washington State Univ, Dept Chem, Pullman, WA 99163 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Inje University; Inje University; Korea Institute of Science & Technology (KIST); Gwangju Institute of Science & Technology (GIST); Washington State University	Kwon, KS (corresponding author), Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Lab Cell Signaling, 125 Gwahangno, Taejon 305806, South Korea.	kwonks@kribb.re.kr	Lee, Seung-Goo/AAS-1613-2021; Lee, Seung-Goo/AAR-9823-2021	Lee, Seung-Goo/0000-0003-4539-9812; Kang, ChulHee/0000-0002-0693-7860	Ministry of Education, Science and Technology [2011-0002141, 2011-0030134, 2011-0027762]; Systems Biology Infrastructure Gwangju Institute of Science and Technology	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Systems Biology Infrastructure Gwangju Institute of Science and Technology	This work was supported by grants from the Ministry of Education, Science and Technology (Grants 2011-0002141, 2011-0030134, and 2011-0027762) (to K. S. K.) and a grant from the Systems Biology Infrastructure Gwangju Institute of Science and Technology (to S. H. E., H. J., and D. H. K.).	AARON BMB, 1984, J BIOL CHEM, V259, P1876; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Beard NA, 2009, EUR BIOPHYS J BIOPHY, V39, P27, DOI 10.1007/s00249-009-0449-6; Canato M, 2010, P NATL ACAD SCI USA, V107, P22326, DOI 10.1073/pnas.1009168108; CHEN SRW, 1994, J BIOL CHEM, V269, P22698; COZENS B, 1984, J BIOL CHEM, V259, P6248; di Barletta MR, 2006, CIRCULATION, V114, P1012, DOI 10.1161/CIRCULATIONAHA.106.623793; Duke AM, 2010, J BIOL CHEM, V285, P25645, DOI 10.1074/jbc.M110.104976; Fan GC, 2007, BIOCHEM BIOPH RES CO, V352, P617, DOI 10.1016/j.bbrc.2006.11.093; FRANZINIARMSTRONG C, 1987, J CELL BIOL, V105, P49, DOI 10.1083/jcb.105.1.49; Gatti G, 1997, MOL BIOL CELL, V8, P1789, DOI 10.1091/mbc.8.9.1789; Gergs U, 2007, AM J PHYSIOL-HEART C, V293, pH728, DOI 10.1152/ajpheart.01187.2006; Glover L, 2001, BBA-BIOMEMBRANES, V1515, P120, DOI 10.1016/S0005-2736(01)00406-0; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; HE ZP, 1993, J BIOL CHEM, V268, P24635; Hong CS, 2002, FASEB J, V16, P1310, DOI 10.1096/fj.01-0908fje; IKEMOTO N, 1974, J BIOL CHEM, V249, P2357; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; Jones LR, 1995, J BIOL CHEM, V270, P30787, DOI 10.1074/jbc.270.51.30787; Kiarash A, 2004, CARDIOVASC RES, V63, P264, DOI 10.1016/j.cardiores.2004.04.001; Kirchhefer U, 2003, CARDIOVASC RES, V59, P369, DOI 10.1016/S0008-6363(03)00432-2; Kirchhof P, 2007, J MOL CELL CARDIOL, V42, P962, DOI 10.1016/j.yjmcc.2007.02.012; Knollmann BC, 2009, J PHYSIOL-LONDON, V587, P3081, DOI 10.1113/jphysiol.2009.172098; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; Lahat H, 2001, AM J HUM GENET, V69, P1378, DOI 10.1086/324565; Launikonis BS, 2006, P NATL ACAD SCI USA, V103, P2982, DOI 10.1073/pnas.0511252103; Lee EH, 2004, J BIOL CHEM, V279, P26481, DOI 10.1074/jbc.M309574200; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; Maguire PB, 1997, BIOCHEM BIOPH RES CO, V240, P721, DOI 10.1006/bbrc.1997.7729; MITCHELL RD, 1988, J BIOL CHEM, V263, P1376; MOORE GA, 1987, FEBS LETT, V224, P331, DOI 10.1016/0014-5793(87)80479-9; OHNISHI M, 1987, BIOCHEMISTRY-US, V26, P7458, DOI 10.1021/bi00397a039; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Postma AV, 2002, CIRC RES, V91, pE21, DOI 10.1161/01.RES.0000038886.18992.6B; Pritchard TJ, 2009, J PHYSIOL-LONDON, V587, P3125, DOI 10.1113/jphysiol.2009.172171; SCOTT BT, 1988, J BIOL CHEM, V263, P8958; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; TANAKA M, 1986, ARCH BIOCHEM BIOPHYS, V251, P369, DOI 10.1016/0003-9861(86)90084-6; Terentyev D, 2008, BIOPHYS J, V95, P2037, DOI 10.1529/biophysj.107.128249; Terentyev D, 2006, CIRC RES, V98, P1151, DOI 10.1161/01.RES.0000220647.93982.08; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; Wang Y, 2006, J BIOL CHEM, V281, P15572, DOI 10.1074/jbc.M600090200; Wei L, 2006, BIOPHYS J, V91, P1288, DOI 10.1529/biophysj.106.082610; Yuan QQ, 2007, CIRCULATION, V115, P300, DOI 10.1161/CIRCULATIONAHA.106.654699; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zhang L, 2001, J MOL CELL CARDIOL, V33, P233, DOI 10.1006/jmcc.2000.1295	51	25	25	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1679	1687		10.1074/jbc.M111.254045	http://dx.doi.org/10.1074/jbc.M111.254045			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22123818	Green Published, hybrid			2022-12-25	WOS:000299321000011
J	Martins, CIM; Silva, PIM; Conceicao, LEC; Costas, B; Hoglund, E; Overli, O; Schrama, JW				Martins, Catarina I. M.; Silva, Patricia I. M.; Conceicao, Luis E. C.; Costas, Benjamin; Hoglund, Erik; Overli, Oyvind; Schrama, Johan W.			Linking Fearfulness and Coping Styles in Fish	PLOS ONE			English	Article							GUPPY POECILIA-RETICULATA; RAINBOW-TROUT; STRESS RESPONSIVENESS; ONCORHYNCHUS-MYKISS; PERSONALITY-TRAITS; INVESTIGATING FEAR; PLASMA-CORTISOL; NILE TILAPIA; BEHAVIOR; NEUROENDOCRINE	Consistent individual differences in cognitive appraisal and emotional reactivity, including fearfulness, are important personality traits in humans, non-human mammals, and birds. Comparative studies on teleost fishes support the existence of coping styles and behavioral syndromes also in poikilothermic animals. The functionalist approach to emotions hold that emotions have evolved to ensure appropriate behavioral responses to dangerous or rewarding stimuli. Little information is however available on how evolutionary widespread these putative links between personality and the expression of emotional or affective states such as fear are. Here we disclose that individual variation in coping style predicts fear responses in Nile tilapia Oreochromis niloticus, using the principle of avoidance learning. Fish previously screened for coping style were given the possibility to escape a signalled aversive stimulus. Fearful individuals showed a range of typically reactive traits such as slow recovery of feed intake in a novel environment, neophobia, and high post-stress cortisol levels. Hence, emotional reactivity and appraisal would appear to be an essential component of animal personality in species distributed throughout the vertebrate subphylum.	[Martins, Catarina I. M.; Silva, Patricia I. M.; Conceicao, Luis E. C.; Costas, Benjamin] Univ Algarve, Ctr Ciencias Mar CCMAR, Faro, Portugal; [Martins, Catarina I. M.; Schrama, Johan W.] Wageningen Univ, Aquaculture & Fisheries Grp, Wageningen, Netherlands; [Costas, Benjamin] Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental C, P-4100 Oporto, Portugal; [Silva, Patricia I. M.; Hoglund, Erik] Danish Tech Univ, Inst Aquat Resources, Aquaculture Sect, N Sea Ctr, Hirtshals, Denmark; [Silva, Patricia I. M.; Overli, Oyvind] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway	Universidade do Algarve; Wageningen University & Research; Universidade do Porto; Technical University of Denmark; Norwegian University of Life Sciences	Martins, CIM (corresponding author), Univ Algarve, Ctr Ciencias Mar CCMAR, Faro, Portugal.	cimartins@ualg.pt	Costas, Benjamín/F-9350-2010; Conceicao, Luis E.C./H-6257-2011	Costas, Benjamín/0000-0003-3758-0849; Conceicao, Luis E.C./0000-0001-6102-2068; Schrama, Johan/0000-0001-7156-8806	Foundation for Science and Technology, Portugal [SFRH/BPD/42015/2007, SFRH/BD/38697/2007, SFRH/BD/44103/2008]	Foundation for Science and Technology, Portugal(Portuguese Foundation for Science and Technology)	This research was supported by the following grants provided by the Foundation for Science and Technology, Portugal (to CM: SFRH/BPD/42015/2007, to BC: SFRH/BD/38697/2007 and to PS: SFRH/BD/44103/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto RE, 2007, PHYSIOL BEHAV, V92, P867, DOI 10.1016/j.physbeh.2007.06.013; Bell AM, 2007, NATURE, V447, P539, DOI 10.1038/447539a; Braithwaite Victoria A., 2006, Fish Physiology, V24, P1; Brown C, 2005, ANIM BEHAV, V70, P1003, DOI 10.1016/j.anbehav.2004.12.022; Budaev SV, 1998, J COMP PSYCHOL, V112, P92, DOI 10.1037/0735-7036.112.1.92; Budaev SV, 1997, J COMP PSYCHOL, V111, P399, DOI 10.1037/0735-7036.111.4.399; Cabanac M, 2009, BEHAV BRAIN RES, V198, P267, DOI 10.1016/j.bbr.2008.11.028; Chandroo KP, 2004, FISH FISH, V5, P281, DOI 10.1111/j.1467-2679.2004.00163.x; Chandroo KP, 2004, APPL ANIM BEHAV SCI, V86, P225, DOI 10.1016/j.applanim.2004.02.004; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; Dadda M, 2007, PHYSIOL BEHAV, V92, P764, DOI 10.1016/j.physbeh.2007.06.001; Dadda M, 2010, BEHAV BRAIN RES, V206, P208, DOI 10.1016/j.bbr.2009.09.019; Ruiz-Gomez MD, 2011, PHYSIOL BEHAV, V102, P317, DOI 10.1016/j.physbeh.2010.11.023; Frijda NH, 1986, EMOTIONS, P56; Frost AJ, 2007, P ROY SOC B-BIOL SCI, V274, P333, DOI 10.1098/rspb.2006.3751; Garamszegi LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002647; Irwin S, 1999, COMP BIOCHEM PHYS C, V124, P27, DOI 10.1016/S0742-8413(99)00043-2; Izard C. E., 1991, PSYCHOL EMOTIONS; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Kristiansen TS, 2007, APPL ANIM BEHAV SCI, V104, P236, DOI 10.1016/j.applanim.2006.09.007; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; MacKenzie S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005314; Martins CIM, 2011, APPL ANIM BEHAV SCI, V130, P135, DOI 10.1016/j.applanim.2010.12.007; Martins CIM, 2009, AQUACULTURE, V298, P43, DOI 10.1016/j.aquaculture.2009.09.030; McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; Moreira PSA, 2004, J FISH BIOL, V64, P961, DOI 10.1111/j.1095-8649.2004.00362.x; Silva PIM, 2010, APPL ANIM BEHAV SCI, V124, P75, DOI 10.1016/j.applanim.2010.01.008; Overli O, 2006, PHYSIOL BEHAV, V87, P506, DOI 10.1016/j.physbeh.2005.11.012; Overli O, 2005, INTEGR COMP BIOL, V45, P463, DOI 10.1093/icb/45.3.463; Overli O, 2002, J EXP BIOL, V205, P391; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004; Pineles SL, 2009, PERS INDIV DIFFER, V46, P48, DOI 10.1016/j.paid.2008.09.003; Portavella M, 2005, EUR J NEUROSCI, V21, P2800, DOI 10.1111/j.1460-9568.2005.04114.x; Portavella M, 2004, J NEUROSCI, V24, P2335, DOI 10.1523/JNEUROSCI.4930-03.2004; Pottinger TG, 1999, GEN COMP ENDOCR, V116, P122, DOI 10.1006/gcen.1999.7355; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Rodriguez F., 2006, FISH COGN BEHAV, V9, P243, DOI [10.1002/9780470996058.ch13, DOI 10.1002/9780470996058.CH13]; Romero LM, 2009, HORM BEHAV, V55, P375, DOI 10.1016/j.yhbeh.2008.12.009; Rose JD, 2007, DIS AQUAT ORGAN, V75, P139, DOI 10.3354/dao075139; Rose JD, 2002, REV FISH SCI, V10, P1, DOI 10.1080/20026491051668; Rothbart MK, 1998, SCHOOL PSYCHOL REV, V27, P479; Schjolden J, 2007, BRAIN BEHAV EVOLUT, V70, P227, DOI 10.1159/000105486; Schulkin J, 2005, TRENDS NEUROSCI, V28, P629, DOI 10.1016/j.tins.2005.09.009; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sneddon L, 2007, COMP BIOCHEM PHYS A, V146, pS78, DOI 10.1016/j.cbpa.2007.01.092; Steimer T, 2003, STRESS, V6, P87, DOI 10.1080/1025389031000111320; Steimer T, 1997, BEHAV GENET, V27, P503, DOI 10.1023/A:1021448713665; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Thomas RJ, 2010, BEHAV ECOL, V21, P669, DOI 10.1093/beheco/arq037; Tong EMW, 2010, J PERS, V78, DOI 10.1111/j.1467-6494.2010.00620.x; van Oers K, 2004, P ROY SOC B-BIOL SCI, V271, P65, DOI 10.1098/rspb.2003.2518; Whittle S, 2006, NEUROSCI BIOBEHAV R, V30, P511, DOI 10.1016/j.neubiorev.2005.09.003; Wingfield JC, 2003, ANIM BEHAV, V66, P807, DOI 10.1006/anbe.2003.2298; Yue S, 2004, APPL ANIM BEHAV SCI, V87, P343, DOI 10.1016/j.applanim.2004.01.004; Yue S, 2008, J APPL ANIM WELF SCI, V11, P14, DOI 10.1080/10888700701729106	58	41	42	4	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28084	10.1371/journal.pone.0028084	http://dx.doi.org/10.1371/journal.pone.0028084			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140511	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168100034
J	Park, WJ; Kothapalli, KSD; Lawrence, P; Brenna, JT				Park, Woo Jung; Kothapalli, Kumar S. D.; Lawrence, Peter; Brenna, J. Thomas			FADS2 Function Loss at the Cancer Hotspot 11q13 Locus Diverts Lipid Signaling Precursor Synthesis to Unusual Eicosanoid Fatty Acids	PLOS ONE			English	Article							METHYL-ESTERS; LOCALIZATION; DESATURASES; PATHWAY; CLONING; CELLS; GENE; N-6	Background: Genes coding for the fatty acid desaturases (FADS1, 2, 3) localized at the cancer genomic hotspot 11q13 locus are required for the biosynthesis of 20 carbon polyunsaturated fatty acids (PUFA) that are direct eicosanoid precursors. In several cancer cell lines, FADS2 encoded Delta 6 and Delta 8 desaturation is not functional. Methodology/Principal Findings: Analyzing MCF7 cell fatty acids with detailed structural mass spectrometry, we show that in the absence of FADS2 activity, the FADS1 product Delta 5-desaturase operates to produce 5,11,14-20:3 and 5,11,14,17-20:4. These PUFA are missing the 8-9 double bond of the eicosanoid signaling precursors arachidonic acid (5,8,11,14-20:4) and eicosapentaenoic acid (5,8,11,14,17-20:5). Heterologous expression of FADS2 restores Delta 6 and Delta 8-desaturase activity and normal eicosanoid precursor synthesis. Conclusions/Significance: The loss of FADS2-encoded activities in cancer cells shuts down normal PUFA biosynthesis, deleting the endogenous supply of eicosanoid and downstream docosanoid precursors, and replacing them with unusual butylene-interrupted fatty acids. If recapitulated in vivo, the normal eicosanoid and docosanoid cell signaling milieu would be depleted and altered due to reduction and substitution of normal substrates with unusual substrates, with unpredictable consequences for cellular communication.	[Park, Woo Jung; Kothapalli, Kumar S. D.; Lawrence, Peter; Brenna, J. Thomas] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University	Park, WJ (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	ksk25@cornell.edu; jtb4@cornell.edu		Brenna, James Thomas/0000-0001-9494-4245				Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chung CC, 2011, HUM MOL GENET, V20, P2869, DOI 10.1093/hmg/ddr189; Diau GY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-11; DUNBAR LM, 1975, J BIOL CHEM, V250, P1152; GARCES R, 1993, ANAL BIOCHEM, V211, P139, DOI 10.1006/abio.1993.1244; GRAMMATIKOS SI, 1994, BRIT J CANCER, V70, P219, DOI 10.1038/bjc.1994.283; GRAMMATIKOS SI, 1994, ANN NY ACAD SCI, V745, P92; Koreth J, 1999, J PATHOL, V187, P28, DOI 10.1002/(SICI)1096-9896(199901)187:1<28::AID-PATH166>3.0.CO;2-R; Lattka E, 2010, CLIN NUTR, V29, P277, DOI 10.1016/j.clnu.2009.11.005; Rosa-Rosa JM, 2009, BREAST CANCER RES TR, V118, P151, DOI 10.1007/s10549-009-0317-1; Marks F, 2000, EUR J CANCER, V36, P314, DOI 10.1016/S0959-8049(99)00318-4; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Merino DM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-63; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; NEGRINI M, 1994, CANCER RES, V54, P1331; Panigrahy D, 2010, CANCER METAST REV, V29, P723, DOI 10.1007/s10555-010-9264-x; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Serhan CN, 2005, CURR OPIN CLIN NUTR, V8, P115, DOI 10.1097/00075197-200503000-00003; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Srivatsan ES, 2002, ONCOGENE, V21, P5631, DOI 10.1038/sj.onc.1205698; Van Pelt CK, 1999, ANAL CHEM, V71, P1981, DOI 10.1021/ac981387f; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; WEI YF, 1985, PROSTAGLANDINS, V29, P537, DOI 10.1016/0090-6980(85)90078-4	23	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28186	10.1371/journal.pone.0028186	http://dx.doi.org/10.1371/journal.pone.0028186			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140540	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100046
J	Liu, F; Struchalin, MV; van Duijn, K; Hofman, A; Uitterlinden, AG; van Duijn, C; Aulchenko, YS; Kayser, M				Liu, Fan; Struchalin, Maksim V.; van Duijn, Kate; Hofman, Albert; Uitterlinden, Andre G.; van Duijn, Cornelia; Aulchenko, Yurii S.; Kayser, Manfred			Detecting Low Frequent Loss-of-Function Alleles in Genome Wide Association Studies with Red Hair Color as Example	PLOS ONE			English	Article							HEREDITARY HYPOPHOSPHATEMIC RICKETS; COMPOUND HETEROZYGOUS MUTATIONS; COMPLEX DISEASES; COMMON DISEASES; GENE; VARIANTS; HYPERCALCIURIA; IDENTIFICATION; DETERMINANTS; EUROPEANS	Multiple loss-of-function (LOF) alleles at the same gene may influence a phenotype not only in the homozygote state when alleles are considered individually, but also in the compound heterozygote (CH) state. Such LOF alleles typically have low frequencies and moderate to large effects. Detecting such variants is of interest to the genetics community, and relevant statistical methods for detecting and quantifying their effects are sorely needed. We present a collapsed double heterozygosity (CDH) test to detect the presence of multiple LOF alleles at a gene. When causal SNPs are available, which may be the case in next generation genome sequencing studies, this CDH test has overwhelmingly higher power than single SNP analysis. When causal SNPs are not directly available such as in current GWA settings, we show the CDH test has higher power than standard single SNP analysis if tagging SNPs are in linkage disequilibrium with the underlying causal SNPs to at least a moderate degree (r(2)>0.1). The test is implemented for genome-wide analysis in the publically available software package GenABEL which is based on a sliding window approach. We provide the proof of principle by conducting a genome-wide CDH analysis of red hair color, a trait known to be influenced by multiple loss-of-function alleles, in a total of 7,732 Dutch individuals with hair color ascertained. The association signals at the MC1R gene locus from CDH were uniformly more significant than traditional GWA analyses (the most significant P for CDH = 3.11x10(-142) vs. P for rs258322 = 1.33x10(-66)). The CDH test will contribute towards finding rare LOF variants in GWAS and sequencing studies.	[Liu, Fan; van Duijn, Kate; Kayser, Manfred] Erasmus MC, Dept Forens Mol Biol, Rotterdam, Netherlands; [Struchalin, Maksim V.; Hofman, Albert; Uitterlinden, Andre G.; van Duijn, Cornelia; Aulchenko, Yurii S.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Liu, F (corresponding author), Erasmus MC, Dept Forens Mol Biol, Rotterdam, Netherlands.	f.liu@erasmusmc.nl	Liu, Fan/B-8833-2013; Aulchenko, Yurii/M-8270-2013	Liu, Fan/0000-0001-9241-8161; Aulchenko, Yurii/0000-0002-7899-1575; Van Duijn, Cornelia/0000-0002-2374-9204	Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) [050-060-810]; Forensic Genomics Consortium Netherlands (FGCN); Netherlands Forensic Institute; Research Institute for Diseases in the Elderly (RIDE) [014-93-015]; NWO [175.010.2005.011, 911-03-012]; Erasmus University Medical Center; Erasmus University Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); RIDE; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports of the Netherlands; European Commission (DG XII); Municipality of Rotterdam	Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Forensic Genomics Consortium Netherlands (FGCN); Netherlands Forensic Institute; Research Institute for Diseases in the Elderly (RIDE); NWO(Netherlands Organization for Scientific Research (NWO)); Erasmus University Medical Center; Erasmus University Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); RIDE; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports of the Netherlands; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam	This study is supported by the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) (nr. 050-060-810) within the framework of the Forensic Genomics Consortium Netherlands (FGCN), the Netherlands Forensic Institute and the Research Institute for Diseases in the Elderly (RIDE) (nr. 014-93-015). The generation and management of GWAS genotype data for the Rotterdam Study (RS-I, RS-II) was supported by a NWO investments grant (nr. 175.010.2005.011, 911-03-012). The Rotterdam Study is funded by the Erasmus University Medical Center, the Erasmus University Rotterdam, the Netherlands Organization for the Health Research and Development (ZonMw), the RIDE, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports of the Netherlands, the European Commission (DG XII), and the Municipality of Rotterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2010, HUM MUTAT, V31, P1090, DOI 10.1002/humu.21326; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Beaumont Kimberley A, 2008, Hum Mutat, V29, pE88, DOI 10.1002/humu.20788; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Bezzina CR, 2001, CARDIOVASC RES, V49, P257, DOI 10.1016/S0008-6363(00)00272-8; Borg K, 2009, HUM MUTAT, V30, pE831, DOI 10.1002/humu.21063; Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Estrada K, 2009, HUM MOL GENET, V18, P3516, DOI 10.1093/hmg/ddp296; Evans DM, 2008, EUR J HUM GENET, V16, P718, DOI 10.1038/sj.ejhg.5202011; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gitelman H J, 1966, Trans Assoc Am Physicians, V79, P221; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hampson G, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-12; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hofman A, 2009, EUR J EPIDEMIOL; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hong J, 2009, ENDOCRINE, V35, P151, DOI 10.1007/s12020-009-9145-7; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; IEIRI T, 1991, J CLIN INVEST, V88, P1901, DOI 10.1172/JCI115513; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Liu F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000934; Lorenz-Depiereux B, 2006, AM J HUM GENET, V78, P193, DOI 10.1086/499410; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Singleton AB, 2010, TRENDS GENET, V26, P438, DOI 10.1016/j.tig.2010.07.004; Song K. N. M., 2011, PHARMACOGENOMICS J; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Vanakker OM, 2007, J INVEST DERMATOL, V127, P581, DOI 10.1038/sj.jid.5700610; Via M, 2010, GENOME MED, V2, DOI 10.1186/gm124; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Wang RR, 2011, INT J MOL MED, V28, P41, DOI 10.3892/ijmm.2011.642	45	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28145	10.1371/journal.pone.0028145	http://dx.doi.org/10.1371/journal.pone.0028145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140526	Green Published, gold, Green Submitted			2022-12-25	WOS:000298166300029
J	Fu, SJ; Fei, Q; Jiang, H; Chuai, SN; Shi, S; Xiong, W; Jiang, L; Lu, C; Atadja, P; Li, E; Shou, JY				Fu, Shijun; Fei, Qi; Jiang, Hua; Chuai, Shannon; Shi, Song; Xiong, Wen; Jiang, Lei; Lu, Chris; Atadja, Peter; Li, En; Shou, Jianyong			Involvement of Histone Acetylation of Sox17 and Foxa2 Promoters during Mouse Definitive Endoderm Differentiation Revealed by MicroRNA Profiling	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BETA-CATENIN; EFFICIENT DIFFERENTIATION; EXPRESSION; HEPATOCYTES; SIGNATURE	Generation of hepatocyte from embryonic stem cells (ESCs) holds great promise for hepatocyte replacement therapy to treat liver diseases. Achieving high efficiency of directed differentiation of ESCs to hepatocyte is of critical importance. Previously, Wnt3a has been reported to promote Activin A-induced human definitive endoderm (DE) differentiation, the early stage of hepatocyte differentiation. However, the underlying molecular mechanisms are not clear. Growing evidence demonstrated that microRNAs (miRNAs) are key regulators involved in various important biological processes including the regulation of stem cell differentiation. In the present study, we profiled genome wide miRNA expression during Wnt3a and Activin A induced mouse DE differentiation. We uncovered distinct miRNA expression patterns during DE differentiation with the identification of a subset of miRNAs whose expression is synergistically regulated by Wnt3a/Activin A treatment at different stages of DE differentiation. Forced expression of a pool of such synergistically regulated miRNAs alone could partially promote DE differentiation, indicating a regulatory role of them. Using TargetScan and GeneGO pathway analyses, the synergistically regulated miRNAs are predicted to regulate key pathways involved in DE differentiation; among them includes the regulation of histone acetylation. Consistently, Wnt3a and Activin A treatment increased global histone acetylation which can be partially mimicked by over expression of the pooled miRNAs. Chromatin IP (ChIP) experiments demonstrated that the promoter regions of Sox17 and Foxa2 are subjected to histone acetylation regulation. Administration of Hdac inhibitors greatly augmented DE differentiation. Our data uncovered a novel epigenetic mechanism of Wnt3a and Activin A induced DE differentiation, whereby the treatment of growth factors induced histone acetylation at least in part by the regulation of miRNA expression.	[Fu, Shijun; Fei, Qi; Jiang, Hua; Chuai, Shannon; Shi, Song; Xiong, Wen; Jiang, Lei; Lu, Chris; Atadja, Peter; Li, En; Shou, Jianyong] China Novartis Inst BioMed Res, Shanghai, Peoples R China	Novartis	Fu, SJ (corresponding author), China Novartis Inst BioMed Res, Shanghai, Peoples R China.	jianyong.shou@novartis.com		Shou, Jianyong/0000-0002-3752-7215	educational office in Novartis Institutes for BioMedical Research	educational office in Novartis Institutes for BioMedical Research	The project is supported by a post-doc program from the educational office in Novartis Institutes for BioMedical Research. The educational office had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avnit-Sagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005033; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Bonifacio LN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012519; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chen YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-264; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Duan YY, 2010, STEM CELLS, V28, P674, DOI 10.1002/stem.315; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Fu SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-369; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hansson M, 2009, DEV BIOL, V330, P286, DOI 10.1016/j.ydbio.2009.03.026; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hinton A, 2010, STEM CELLS DEV, V19, P797, DOI 10.1089/scd.2009.0224; Hosseinkhani M, 2007, BIOCHEM BIOPH RES CO, V356, P386, DOI 10.1016/j.bbrc.2007.02.151; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Jang JS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-144; Karantzali E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r65; Lakshmipathy U, 2007, STEM CELLS DEV, V16, P1003, DOI 10.1089/scd.2007.0026; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li M, 2005, DEV CELL, V9, P415, DOI 10.1016/j.devcel.2005.08.002; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Liu Y, 2004, DEV BIOL, V270, P411, DOI 10.1016/j.ydbio.2004.03.017; Lowe LA, 2001, DEVELOPMENT, V128, P1831; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; Miro JM, 2006, J HEPATOL, V44, pS140, DOI 10.1016/j.jhep.2005.11.028; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Neves A, 2007, DEVELOPMENT, V134, P4459, DOI 10.1242/dev.008680; Simion A, 2010, BIOCHEM BIOPH RES CO, V391, P293, DOI 10.1016/j.bbrc.2009.11.052; Soto-Gutierrez A, 2007, NAT PROTOC, V2, P347, DOI 10.1038/nprot.2007.18; Stainier DYR, 2002, GENE DEV, V16, P893, DOI 10.1101/gad.974902; Turovets N, 2011, DIFFERENTIATION 0207, V7; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Vincent SD, 2003, GENE DEV, V17, P1646, DOI 10.1101/gad.1100503; Viswanathan SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006143; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Yao X, 2010, CHINESE MED J-PEKING, V123, P734, DOI 10.3760/cma.j.issn.0366-6999.2010.06.018; ZHANG H, 2010, DEV BIOL; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	45	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27965	10.1371/journal.pone.0027965	http://dx.doi.org/10.1371/journal.pone.0027965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132182	gold, Green Published, Green Submitted			2022-12-25	WOS:000298162000053
J	Sharma, N; Kumar, R; Renaux, B; Saifeddine, M; Nishikawa, S; Mihara, K; Ramachandran, R; Hollenberg, MD; Rancourt, DE				Sharma, Navneet; Kumar, Rajeev; Renaux, Bernard; Saifeddine, Mahmoud; Nishikawa, Sandra; Mihara, Koichiro; Ramachandran, Rithwik; Hollenberg, Morley D.; Rancourt, Derrick E.			Implantation Serine Proteinase 1 Exhibits Mixed Substrate Specificity that Silences Signaling via Proteinase-Activated Receptors	PLOS ONE			English	Article							PHAGE-DISPLAY; EMBRYO IMPLANTATION; EXPRESSION; PROMISCUITY; MECHANISM; PREGNANCY; TRYPTASE; MICE; ISP2; PROGESTERONE	Implantation S1 family serine proteinases (ISPs) are tryptases involved in embryo hatching and uterine implantation in the mouse. The two different ISP proteins (ISP1 and ISP2) have been detected in both pre- and post-implantation embryo tissue. To date, native ISP obtained from uterus and blastocyst tissues has been isolated only as an active hetero-dimer that exhibits trypsin-like substrate specificity. We hypothesised that in isolation, ISP1 might have a unique substrate specificity that could relate to its role when expressed alone in individual tissues. Thus, we isolated recombinant ISP1 expressed in Pichia pastoris and evaluated its substrate specificity. Using several chromogenic substrates and serine proteinase inhibitors, we demonstrate that ISP1 exhibits trypsin-like substrate specificity, having a preference for lysine over arginine at the P1 position. Phage display peptide mimetics revealed an expanded but mixed substrate specificity of ISP1, including chymotryptic and elastase activity. Based upon targets observed using phage display, we hypothesised that ISP1 might signal to cells by cleaving and activating proteinase-activated receptors (PARs) and therefore assessed PARs 1, 2 and 4 as potential ISP1 targets. We observed that ISP1 silenced enzyme-triggered PAR signaling by receptor-disarming. This PAR-disarming action of ISP1 may be important for embryo development and implantation.	[Sharma, Navneet; Kumar, Rajeev; Nishikawa, Sandra; Rancourt, Derrick E.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Renaux, Bernard; Saifeddine, Mahmoud; Mihara, Koichiro; Ramachandran, Rithwik; Hollenberg, Morley D.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Hollenberg, Morley D.] Univ Calgary, Fac Med, Dept Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Sharma, N (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	navsharm@ucalgary.ca	Hollenberg, Morley/AFV-6966-2022; Ramachandran, Rithwik/N-7815-2015	Ramachandran, Rithwik/0000-0001-9557-9905	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Operating Grants awarded to DR and MH, who contributed equally to this project. DR is an AHFMR Senior Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington AK, 1996, BIOCHEMISTRY-US, V35, P13511, DOI 10.1021/bi960042t; Bell JK, 2003, NAT STRUCT BIOL, V10, P527, DOI 10.1038/nsb944; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Even-Ram SC, 2003, J PATHOL, V200, P47, DOI 10.1002/path.1338; Felber LM, 2005, BIOL CHEM, V386, P291, DOI 10.1515/BC.2005.035; Fukuoka Y, 2007, INT IMMUNOPHARMACOL, V7, P1900, DOI 10.1016/j.intimp.2007.07.007; Griswold KE, 2006, J MOL BIOL, V364, P400, DOI 10.1016/j.jmb.2006.09.012; Hague S., 2002, Angiogenesis, V5, P93, DOI 10.1023/A:1021510723157; Hawthorne S, 2004, ANAL BIOCHEM, V326, P273, DOI 10.1016/j.ab.2003.12.002; Hirota Y, 2005, J CLIN ENDOCR METAB, V90, P1662, DOI 10.1210/jc.2004-0726; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Huang ZP, 2004, REPROD FERT DEVELOP, V16, P379, DOI 10.1071/RD03102; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; Jahan I, 2007, ONCOL REP, V17, P345; Karlson L, 2002, J BIOL CHEM, V277, P18579, DOI 10.1074/jbc.M110356200; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Krikun G, 2008, ANN NY ACAD SCI, V1127, P101, DOI 10.1196/annals.1434.008; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Mitchell SE, 2005, REPROD FERT DEVELOP, V17, P693, DOI 10.1071/RD05032; Nath A, 2008, BIOCHEMISTRY-US, V47, P157, DOI 10.1021/bi701448p; O'Brien M, 2008, BIOL REPROD, V78, P20, DOI 10.1095/biolreprod.107.062182; O'Sullivan CM, 2004, MOL REPROD DEV, V69, P252, DOI 10.1002/mrd.20169; O'Sullivan CM, 2004, MOL REPROD DEV, V69, P126, DOI 10.1002/mrd.20115; O'Sullivan CM, 2002, MOL REPROD DEV, V62, P328, DOI 10.1002/mrd.10142; O'Sullivan CM, 2001, REPRODUCTION, V122, P235, DOI 10.1530/rep.0.1220235; O'Sullivan CM, 2001, REPRODUCTION, V122, P61, DOI 10.1530/rep.0.1220061; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Pan ZY, 2006, BIOORG MED CHEM LETT, V16, P2882, DOI 10.1016/j.bmcl.2006.03.012; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; Sharma N, 2008, BIOL CHEM, V389, P1097, DOI 10.1515/BC.2008.118; Sharma N, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-61; Shintani Y, 2001, BRIT J PHARMACOL, V133, P1276, DOI 10.1038/sj.bjp.0704206; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Sun ZG, 2007, CONTRACEPTION, V76, P250, DOI 10.1016/j.contraception.2007.05.084; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005	43	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27888	10.1371/journal.pone.0027888	http://dx.doi.org/10.1371/journal.pone.0027888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132161	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000047
J	Strong, TC; Kaur, G; Thomas, JH				Strong, Taylor C.; Kaur, Gurvinder; Thomas, Jeffrey H.			Mutations in the Catalytic Loop HRD Motif Alter the Activity and Function of Drosophila Src64	PLOS ONE			English	Article							TYROSINE KINASE; CRYSTAL-STRUCTURE; ACTIN ORGANIZATION; STRUCTURAL BASIS; PROTEIN-KINASES; FAMILY; ACTIVATION; DOMAIN; CELLULARIZATION; MORPHOGENESIS	The catalytic loop HRD motif is found in most protein kinases and these amino acids are predicted to perform functions in catalysis, transition to, and stabilization of the active conformation of the kinase domain. We have identified mutations in a Drosophila src gene, src64, that alter the three HRD amino acids. We have analyzed the mutants for both biochemical activity and biological function during development. Mutation of the aspartate to asparagine eliminates biological function in cytoskeletal processes and severely reduces fertility, supporting the amino acid's critical role in enzymatic activity. The arginine to cysteine mutation has little to no effect on kinase activity or cytoskeletal reorganization, suggesting that the HRD arginine may not be critical for coordinating phosphotyrosine in the active conformation. The histidine to leucine mutant retains some kinase activity and biological function, suggesting that this amino acid may have a biochemical function in the active kinase that is independent of its side chain hydrogen bonding interactions in the active site. We also describe the phenotypic effects of other mutations in the SH2 and tyrosine kinase domains of src64, and we compare them to the phenotypic effects of the src64 null allele.	[Strong, Taylor C.; Kaur, Gurvinder; Thomas, Jeffrey H.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Strong, TC (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.	jeffrey.thomas@ttuhsc.edu		Thomas, Jeffrey H./0000-0003-4748-9045	American Heart Association, South Central [09BGIA2260616]; Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center	American Heart Association, South Central(American Heart Association); Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center	This work was supported by American Heart Association, South Central Affiliate Beginning Grant-in-Aid 09BGIA2260616 and start-up funds from the Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Barrett CP, 2005, J BIOL CHEM, V280, P13993, DOI 10.1074/jbc.M407371200; Breitenlechner CB, 2005, J MOL BIOL, V353, P222, DOI 10.1016/j.jmb.2005.08.023; Broome MA, 1996, J BIOL CHEM, V271, P16798, DOI 10.1074/jbc.271.28.16798; Bukhtiyarova M, 2007, BIOCHEMISTRY-US, V46, P5687, DOI 10.1021/bi0622221; COLE PA, 1995, J BIOL CHEM, V270, P22105, DOI 10.1074/jbc.270.38.22105; Collier LS, 2004, GENETICS, V167, P783, DOI 10.1534/genetics.103.024992; Cooper JL, 2008, FLY, V2, P300, DOI 10.4161/fly.7366; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Dodson GS, 1998, DEVELOPMENT, V125, P2883; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; FULLILOVE SL, 1971, DEV BIOL, V26, P560, DOI 10.1016/0012-1606(71)90141-2; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; Guarnieri DJ, 1998, MOL CELL, V1, P831, DOI 10.1016/S1097-2765(00)80082-9; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Harrison SC, 2003, CELL, V112, P737, DOI 10.1016/S0092-8674(03)00196-X; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kelso RJ, 2002, J CELL BIOL, V156, P703, DOI 10.1083/jcb.200110063; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; Lecuit T, 2000, J CELL BIOL, V150, P849, DOI 10.1083/jcb.150.4.849; Mazumdar A, 2002, BIOESSAYS, V24, P1012, DOI 10.1002/bies.10184; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; O'Reilly AM, 2006, DEVELOPMENT, V133, P2627, DOI 10.1242/dev.02423; Ozkirimli E, 2006, PROTEIN SCI, V15, P1051, DOI 10.1110/ps.051999206; Ozkirimli E, 2008, PROTEIN SCI, V17, P1871, DOI 10.1110/ps.037457.108; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; ROBINSON DN, 1994, DEVELOPMENT, V120, P2015; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Roulier EM, 1998, MOL CELL, V1, P819, DOI 10.1016/S1097-2765(00)80081-7; Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440; SCHEJTER ED, 1993, ANNU REV CELL BIOL, V9, P67, DOI 10.1146/annurev.cellbio.9.1.67; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; SENFTEN M, 1995, ONCOGENE, V10, P199; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Skamnaki VT, 1999, BIOCHEMISTRY-US, V38, P14718, DOI 10.1021/bi991454f; Sokac AM, 2008, J CELL SCI, V121, P1815, DOI 10.1242/jcs.025171; Sokac AM, 2008, DEV CELL, V14, P775, DOI 10.1016/j.devcel.2008.02.014; Strong TC, 2011, GENESIS, V49, P912, DOI 10.1002/dvg.20783; Takahashi M, 2005, DEVELOPMENT, V132, P2547, DOI 10.1242/dev.01850; Tateno M, 2000, SCIENCE, V287, P324, DOI 10.1126/science.287.5451.324; Ten Eyck LF, 2008, BBA-PROTEINS PROTEOM, V1784, P238, DOI 10.1016/j.bbapap.2007.11.002; Thomas JH, 2004, DEVELOPMENT, V131, P863, DOI 10.1242/dev.00989; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tilney LG, 1996, J CELL BIOL, V133, P61, DOI 10.1083/jcb.133.1.61; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Vidal M, 2007, CANCER RES, V67, P10278, DOI 10.1158/0008-5472.CAN-07-1376; WARN RM, 1990, J CELL SCI, V96, P35; Wieschaus E., 1998, DROSOPHILA PRACTICAL, P179; Williams DM, 2002, J AM CHEM SOC, V124, P5956, DOI 10.1021/ja025993a; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; YOUNG PE, 1991, DEVELOPMENT, V111, P1	62	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28100	10.1371/journal.pone.0028100	http://dx.doi.org/10.1371/journal.pone.0028100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132220	gold, Green Published, Green Submitted			2022-12-25	WOS:000298162000071
J	Kim, SN; Doo, AR; Park, JY; Bae, H; Chae, Y; Shim, I; Lee, H; Moon, W; Lee, H; Park, HJ				Kim, Seung-Nam; Doo, Ah-Reum; Park, Ji-Yeun; Bae, Hyungjin; Chae, Younbyoung; Shim, Insop; Lee, Hyangsook; Moon, Woongjoon; Lee, Hyejung; Park, Hi-Joon			Acupuncture Enhances the Synaptic Dopamine Availability to Improve Motor Function in a Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							INDUCED ROTATIONAL BEHAVIOR; ELECTROACUPUNCTURE STIMULATION; MESSENGER-RNA; EXERCISE; DEFICITS	Parkinson's disease (PD) is caused by the selective loss of dopaminergic neurons in the substantia nigra (SN) and the depletion of striatal dopamine (DA). Acupuncture, as an alternative therapy for PD, has beneficial effects in both PD patients and PD animal models, although the underlying mechanisms therein remain uncertain. The present study investigated whether acupuncture treatment affected dopamine neurotransmission in a PD mouse model using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). We found that acupuncture treatment at acupoint GB34 improved motor function with accompanying dopaminergic neuron protection against MPTP but did not restore striatal dopamine depletion. Instead, acupuncture treatment increased dopamine release that in turn, may lead to the enhancement of dopamine availability in the synaptic cleft. Moreover, acupuncture treatment mitigated MPTP-induced abnormal postsynaptic changes, suggesting that acupuncture treatment may increase postsynaptic dopamine neurotransmission and facilitate the normalization of basal ganglia activity. These results suggest that the acupuncture-induced enhancement of synaptic dopamine availability may play a critical role in motor function improvement against MPTP.	[Kim, Seung-Nam; Doo, Ah-Reum; Park, Ji-Yeun; Bae, Hyungjin; Chae, Younbyoung; Shim, Insop; Lee, Hyangsook; Moon, Woongjoon; Lee, Hyejung; Park, Hi-Joon] Kyung Hee Univ, Acupuncture & Meridian Sci Res Ctr, Seoul, South Korea; [Kim, Seung-Nam] Kyung Hee Univ, Dept Oriental Med Sci, Seoul, South Korea	Kyung Hee University; Kyung Hee University	Kim, SN (corresponding author), Kyung Hee Univ, Acupuncture & Meridian Sci Res Ctr, Seoul, South Korea.	wm9306@naver.com; acufind@khu.ac.kr	Park, Hi-Joon/AAG-1196-2021; LEE, HYANGSOOK/D-2070-2017; Chae, Younbyoung/AAM-1243-2020	LEE, HYANGSOOK/0000-0002-1107-9389; Shim, Insop/0000-0002-8014-9782; Chae, Younbyoung/0000-0001-6787-2215; Park, Hi-Joon/0000-0002-0538-2664	National Research Foundation of Korea (NRF); Korea government (MEST) [2010-0008834, 2005-0049404]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) [2010-0008834 and 2005-0049404]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 1999, NEUROBIOL DIS, V6, P461, DOI 10.1006/nbdi.1999.0259; Antonini A, 2009, LANCET NEUROL, V8, P929, DOI 10.1016/S1474-4422(09)70225-X; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hirsch EC, 1998, MOVEMENT DISORD, V13, P39; Hirsch EC, 1998, ANN NEUROL, V44, pS115, DOI 10.1002/ana.410440717; Jeon S, 2008, PROTEOMICS, V8, P4822, DOI 10.1002/pmic.200700955; Jeun SS, 2005, AM J CHINESE MED, V33, P573, DOI 10.1142/S0192415X0500317X; Jia J, 2010, BEHAV NEUROSCI, V124, P305, DOI 10.1037/a0018931; Jia J, 2009, BEHAV BRAIN RES, V205, P214, DOI 10.1016/j.bbr.2009.06.024; Kang JM, 2007, BRAIN RES, V1131, P211, DOI 10.1016/j.brainres.2006.10.089; Keith B.J., 2008, MOUSE BRAIN STEREOTA; Kim ST, 2010, J PHYSIOL SCI, V60, P27, DOI 10.1007/s12576-009-0061-7; KIM SN, 2011, INT J NEURO IN PRESS; Liang XB, 2003, NEUROREPORT, V14, P1177, DOI 10.1097/00001756-200306110-00015; LIANGYUE D, 2004, CHINESE ACUPUNCTURE; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; MOURADIAN MM, 1987, CLIN NEUROPHARMACOL, V10, P351, DOI 10.1097/00002826-198708000-00005; Na BJ, 2009, NEUROSCI LETT, V464, P1, DOI 10.1016/j.neulet.2009.08.009; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; Park HJ, 2003, EXP NEUROL, V180, P92, DOI 10.1016/S0014-4886(02)00031-6; Petzinger GM, 2007, J NEUROSCI, V27, P5291, DOI 10.1523/JNEUROSCI.1069-07.2007; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; ROBERTSON GS, 1989, J NEUROSCI, V9, P3326; Rozas G, 1997, BRAIN RES PROTOC, V2, P75, DOI 10.1016/S1385-299X(97)00034-2; Rozas G, 1998, J NEUROSCI METH, V83, P165, DOI 10.1016/S0165-0270(98)00078-8; Santini E, 2008, FEBS J, V275, P1392, DOI 10.1111/j.1742-4658.2008.06296.x; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Tseng JL, 1997, J NEUROSCI, V17, P325, DOI 10.1523/JNEUROSCI.17-01-00325.1997; Vuckovic MG, 2008, NEUROBIOL DIS, V32, P319, DOI 10.1016/j.nbd.2008.07.015; World Health Organization, 2008, WHO STAND AC POINT L, P226; Yin CS, 2008, RES VET SCI, V84, P159, DOI 10.1016/j.rvsc.2007.04.004; Yu YP, 2010, BRAIN RES, V1336, P58, DOI 10.1016/j.brainres.2010.04.020	36	60	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27566	10.1371/journal.pone.0027566	http://dx.doi.org/10.1371/journal.pone.0027566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132113	Green Published, Green Submitted, gold			2022-12-25	WOS:000297792400009
J	Shan, Q; Han, L; Lynch, JW				Shan, Qiang; Han, Lu; Lynch, Joseph W.			beta Subunit M2-M3 Loop Conformational Changes Are Uncoupled from alpha 1 beta Glycine Receptor Channel Gating: Implications for Human Hereditary Hyperekplexia	PLOS ONE			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; LIGAND-BINDING DOMAIN; X-RAY-STRUCTURE; AGONIST BINDING; GABA(A) RECEPTOR; CHLORIDE CHANNEL; K+ CHANNEL; OPEN STATE; M2 DOMAIN	Hereditary hyperekplexia, or startle disease, is a neuromotor disorder caused mainly by mutations that either prevent the surface expression of, or modify the function of, the human heteromeric alpha 1 beta glycine receptor (GlyR) chloride channel. There is as yet no explanation as to why hyperekplexia mutations that modify channel function are almost exclusively located in the alpha 1 to the exclusion of b subunit. The majority of these mutations are identified in the M2-M3 loop of the alpha 1 subunit. Here we demonstrate that alpha 1 beta GlyR channel function is less sensitive to hyperekplexia-mimicking mutations introduced into the M2-M3 loop of the b than into the alpha 1 subunit. This suggests that the M2-M3 loop of the a subunit dominates the b subunit in gating the alpha 1 beta GlyR channel. A further attempt to determine the possible mechanism underlying this phenomenon by using the voltage-clamp fluorometry technique revealed that agonist-induced conformational changes in the b subunit M2-M3 loop were uncoupled from alpha 1 beta GlyR channel gating. This is in contrast to the a subunit, where the M2-M3 loop conformational changes were shown to be directly coupled to alpha 1 beta GlyR channel gating. Finally, based on analysis of alpha 1 beta chimeric receptors, we demonstrate that the structural components responsible for this are distributed throughout the b subunit, implying that the b subunit has evolved without the functional constraint of a normal gating pathway within it. Our study provides a possible explanation of why hereditary hyperekplexia-causing mutations that modify alpha 1 beta GlyR channel function are almost exclusively located in the alpha 1 to the exclusion of the b subunit.	[Shan, Qiang; Han, Lu; Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Shan, Q (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	qshan@yahoo.com	Lynch, Joseph/C-8636-2009		National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a research grant from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beato M, 2004, J NEUROSCI, V24, P895, DOI 10.1523/JNEUROSCI.4420-03.2004; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Breitinger HG, 2002, CHEMBIOCHEM, V3, P1043, DOI 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO;2-7; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Gandhi CS, 2005, TRENDS NEUROSCI, V28, P472, DOI 10.1016/j.tins.2005.07.005; Gentet LJ, 2002, J PHYSIOL-LONDON, V544, P97, DOI 10.1113/jphysiol.2001.015321; Grewer C, 1999, BIOPHYS J, V77, P727, DOI 10.1016/S0006-3495(99)76927-4; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lewis TM, 2003, J PHYSIOL-LONDON, V549, P361, DOI 10.1113/jphysiol.2002.037796; Lewis TM, 1998, J PHYSIOL-LONDON, V507, P25, DOI 10.1111/j.1469-7793.1998.025bu.x; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Lynch JW, 2001, J NEUROSCI, V21, P2589, DOI 10.1523/JNEUROSCI.21-08-02589.2001; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Macdonald RL, 2004, BIOCHEM PHARMACOL, V68, P1497, DOI 10.1016/j.bcp.2004.07.029; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Shan Q, 2003, J NEUROCHEM, V86, P498, DOI 10.1046/j.1471-4159.2003.01872.x; Shan Q, 2001, J NEUROCHEM, V76, P1109, DOI 10.1046/j.1471-4159.2001.00124.x; Shan QA, 2010, J NEUROSCI METH, V193, P86, DOI 10.1016/j.jneumeth.2010.08.033; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Tsunoyama K, 1998, MOL BIOL EVOL, V15, P518, DOI 10.1093/oxfordjournals.molbev.a025951; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vogel N, 2009, J BIOL CHEM, V284, P36128, DOI 10.1074/jbc.M109.043448; Wang QA, 2010, J BIOL CHEM, V285, P40373, DOI 10.1074/jbc.M110.161513; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9	47	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28105	10.1371/journal.pone.0028105	http://dx.doi.org/10.1371/journal.pone.0028105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132222	Green Published, gold			2022-12-25	WOS:000297792400038
J	Yin, YB; Huang, JL; Gu, XG; Bar-Peled, M; Xu, Y				Yin, Yanbin; Huang, Jinling; Gu, Xiaogang; Bar-Peled, Maor; Xu, Ying			Evolution of Plant Nucleotide-Sugar Interconversion Enzymes	PLOS ONE			English	Article							CELL-WALL POLYSACCHARIDE; HORIZONTAL GENE-TRANSFER; HIDDEN MARKOV-MODELS; DE-NOVO SYNTHESIS; GDP-L-FUCOSE; ARABIDOPSIS-THALIANA; MAXIMUM-LIKELIHOOD; FUNCTIONAL CLONING; CELLULOSE SYNTHASE; GENOME SEQUENCE	Nucleotide-diphospho-sugars (NDP-sugars) are the building blocks of diverse polysaccharides and glycoconjugates in all organisms. In plants, 11 families of NDP-sugar interconversion enzymes (NSEs) have been identified, each of which interconverts one NDP-sugar to another. While the functions of these enzyme families have been characterized in various plants, very little is known about their evolution and origin. Our phylogenetic analyses indicate that all the 11 plant NSE families are distantly related and most of them originated from different progenitor genes, which have already diverged in ancient prokaryotes. For instance, all NSE families are found in the lower land plant mosses and most of them are also found in aquatic algae, implicating that they have already evolved to be capable of synthesizing all the 11 different NDP-sugars. Particularly interesting is that the evolution of RHM (UDP-L-rhamnose synthase) manifests the fusion of genes of three enzymatic activities in early eukaryotes in a rather intriguing manner. The plant NRS/ER (nucleotide-rhamnose synthase/epimerase-reductase), on the other hand, evolved much later from the ancient plant RHMs through losing the N-terminal domain. Based on these findings, an evolutionary model is proposed to explain the origin and evolution of different NSE families. For instance, the UGlcAE (UDP-D-glucuronic acid 4-epimerase) family is suggested to have evolved from some chlamydial bacteria. Our data also show considerably higher sequence diversity among NSE-like genes in modern prokaryotes, consistent with the higher sugar diversity found in prokaryotes. All the NSE families are widely found in plants and algae containing carbohydrate-rich cell walls, while sporadically found in animals, fungi and other eukaryotes, which do not have or have cell walls with distinct compositions. Results of this study were shown to be highly useful for identifying unknown genes for further experimental characterization to determine their functions in the synthesis of diverse glycosylated molecules.	[Yin, Yanbin; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Yin, Yanbin; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Gu, Xiaogang; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Huang, Jinling] E Carolina Univ, Dept Biol, Greenville, NC USA; [Yin, Yanbin; Gu, Xiaogang; Bar-Peled, Maor; Xu, Ying] BioEnergy Sci Ctr, Oak Ridge, TN USA; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Jilin, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of North Carolina; East Carolina University; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); Jilin University	Yin, YB (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA.	peled@ccrc.uga.edu; xyn@bmb.uga.edu	Yin, Yanbin/C-9788-2010; Yin, Yanbin/AAH-2665-2020; Huang, Jinling/ABI-6699-2020	Yin, Yanbin/0000-0001-7667-881X; Yin, Yanbin/0000-0001-7667-881X; Huang, Jinling/0000-0003-4893-4171	U.S. Department of Energy [DE-PS02-06ER64304]; National Science Foundation [DEB-0830024, IOS-0453664]; Office of Biological and Environmental Research in the DOE Office of Science; Direct For Biological Sciences [0830024] Funding Source: National Science Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study is supported by the U.S. Department of Energy (grant # DE-PS02-06ER64304) and the National Science Foundation (DEB-0830024, IOS-0453664). The BioEnergy Science Center (BESC) is supported by the Office of Biological and Environmental Research in the DOE Office of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS B, 2007, GENETIC INFORM EUCAR, P26; Bar-Peled C., 2008, BIOMASS RECALCITRANC, V94-187, P94, DOI DOI 10.1002/9781444305418.CH5; Bar-Peled M, 2011, ANNU REV PLANT BIOL, V62, P127, DOI 10.1146/annurev-arplant-042110-103918; Bashton M, 2002, J MOL BIOL, V315, P927, DOI 10.1006/jmbi.2001.5288; Battistuzzi FU, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-44; Bonin CP, 2000, PLANT J, V21, P445, DOI 10.1046/j.1365-313x.2000.00698.x; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Brown JR, 2003, NAT REV GENET, V4, P121, DOI 10.1038/nrg1000; Burget EG, 2003, PLANT CELL, V15, P523, DOI 10.1105/tpc.008425; Cavalier-Smith T, 2006, PHILOS T R SOC B, V361, P969, DOI 10.1098/rstb.2006.1842; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; de Duve C, 2007, NAT REV GENET, V8, P395, DOI 10.1038/nrg2071; Dong QF, 2005, PLANT PHYSIOL, V139, P610, DOI 10.1104/pp.104.059212; Dong SL, 2009, J BACTERIOL, V191, P7094, DOI 10.1128/JB.01050-09; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; FEINGOLD DS, 1982, PLANT CARBOHYDRATES, P3; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; GU X, 2010, MICROBIOLOGY, V157, P260; Gu XG, 2004, PLANT PHYSIOL, V136, P4256, DOI 10.1104/pp.104.052365; Gu XG, 2010, J BIOL CHEM, V285, P9030, DOI 10.1074/jbc.M109.066803; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guyett P, 2009, CARBOHYD RES, V344, P1072, DOI 10.1016/j.carres.2009.03.026; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; Herget S, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-35; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Huang JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r99; Huang JL, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r109; Kallberg Y, 2010, FEBS J, V277, P2375, DOI 10.1111/j.1742-4658.2010.07656.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kotake T, 2007, BIOSCI BIOTECH BIOCH, V71, P761, DOI 10.1271/bbb.60605; Kotake T, 2009, BIOCHEM J, V424, P169, DOI 10.1042/BJ20091025; Li Q, 2003, MICROBIOL-SGM, V149, P2463, DOI 10.1099/mic.0.26382-0; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; Michel G, 2010, NEW PHYTOL, V188, P67, DOI 10.1111/j.1469-8137.2010.03345.x; Molhoj M, 2003, PLANT J, V35, P693, DOI 10.1046/j.1365-313X.2003.01841.x; Niklas KJ, 2004, BIOSCIENCE, V54, P831, DOI 10.1641/0006-3568(2004)054[0831:TCWTBT]2.0.CO;2; Nobles DR, 2001, PLANT PHYSIOL, V127, P529, DOI 10.1104/pp.010557; Oka T, 2007, J BIOL CHEM, V282, P5389, DOI 10.1074/jbc.M610196200; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Popper ZA, 2010, PLANT PHYSIOL, V153, P373, DOI 10.1104/pp.110.158055; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rautengarten C, 2011, PLANT CELL, V23, P1373, DOI 10.1105/tpc.111.083931; Reiter WD, 2001, PLANT MOL BIOL, V47, P95, DOI 10.1023/A:1010671129803; Reiter WD, 2008, CURR OPIN PLANT BIOL, V11, P236, DOI 10.1016/j.pbi.2008.03.009; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Royo J, 2000, TRENDS GENET, V16, P432, DOI 10.1016/S0168-9525(00)02102-8; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Seifert GJ, 2002, CURR BIOL, V12, P1840, DOI 10.1016/S0960-9822(02)01260-5; Seitz B, 2000, PLANT J, V21, P537, DOI 10.1046/j.1365-313x.2000.00696.x; Selosse MA, 2001, TRENDS ECOL EVOL, V16, P135, DOI 10.1016/S0169-5347(00)02084-X; Sharples SC, 2007, PLANT J, V52, P252, DOI 10.1111/j.1365-313X.2007.03225.x; Sorensen I, 2010, PLANT PHYSIOL, V153, P366, DOI 10.1104/pp.110.154427; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tenhaken R, 1996, PLANT PHYSIOL, V112, P1127, DOI 10.1104/pp.112.3.1127; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Usadel B, 2004, PLANT PHYSIOL, V134, P286, DOI 10.1104/pp.103.034314; Watt G, 2004, PLANT PHYSIOL, V134, P1337, DOI 10.1104/pp.103.037192; Western TL, 2004, PLANT PHYSIOL, V134, P296, DOI 10.1104/pp.103.035519; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Yang T, 2009, J BIOL CHEM, V284, P21526, DOI 10.1074/jbc.M109.014761; Yin YB, 2010, PLANT PHYSIOL, V153, P1729, DOI 10.1104/pp.110.154229; Yin YB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-99; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	70	42	45	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27995	10.1371/journal.pone.0027995	http://dx.doi.org/10.1371/journal.pone.0027995			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125650	gold, Green Submitted, Green Published			2022-12-25	WOS:000297789200050
J	Zhu, KJ; Lv, YM; Yin, XY; Wang, ZX; Sun, LD; He, SM; Cheng, H; Hu, DY; Zhang, Z; Li, Y; Zuo, XB; Zhou, YW; Yang, S; Fan, X; Zhang, XJ; Zhang, FY				Zhu, Kun-Ju; Lv, Yong-Mei; Yin, Xian-Yong; Wang, Zai-Xing; Sun, Liang-Dan; He, Su-Min; Cheng, Hui; Hu, Da-Yan; Zhang, Zheng; Li, Yang; Zuo, Xian-Bo; Zhou, You-Wen; Yang, Sen; Fan, Xing; Zhang, Xue-Jun; Zhang, Feng-Yu			Psoriasis Regression Analysis of MHC Loci Identifies Shared Genetic Variants with Vitiligo	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY VARIANTS; POLYMORPHISM; VULGARIS; HLA-DQA2; IEX-1; HLA; POU5F1; RISK; MAP	Psoriasis is a common inflammatory skin disease with genetic components of both immune system and the epidermis. PSOR1 locus ( 6q21) has been strongly associated with psoriasis; however, it is difficult to identify additional independent association due to strong linkage disequilibrium in the MHC region. We performed stepwise regression analyses of more than 3,000 SNPs in the MHC region genotyped using Human 610-Quad (Illumina) in 1,139 cases with psoriasis and 1,132 controls of Han Chinese population to search for additional independent association. With four regression models obtained, two SNPs rs9468925 in HLA-C/HLA-B and rs2858881 in HLA-DQA2 were repeatedly selected in all models, suggesting that multiple loci outside PSOR1 locus were associated with psoriasis. More importantly we find that rs9468925 in HLA-C/HLA-B is associated with both psoriasis and vitiligo, providing first important evidence that two major skin diseases share a common genetic locus in the MHC, and a basis for elucidating the molecular mechanism of skin disorders.	[Zhu, Kun-Ju; Lv, Yong-Mei; Yin, Xian-Yong; Wang, Zai-Xing; Sun, Liang-Dan; He, Su-Min; Cheng, Hui; Hu, Da-Yan; Zhang, Zheng; Li, Yang; Zuo, Xian-Bo; Zhou, You-Wen; Yang, Sen; Fan, Xing; Zhang, Xue-Jun; Zhang, Feng-Yu] Anhui Med Univ, Inst Dermatol, Hefei, Anhui, Peoples R China; [Zhu, Kun-Ju; Lv, Yong-Mei; Yin, Xian-Yong; Wang, Zai-Xing; Sun, Liang-Dan; He, Su-Min; Cheng, Hui; Hu, Da-Yan; Zhang, Zheng; Li, Yang; Zuo, Xian-Bo; Zhou, You-Wen; Yang, Sen; Fan, Xing; Zhang, Xue-Jun; Zhang, Feng-Yu] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Zhu, Kun-Ju; Lv, Yong-Mei; Yin, Xian-Yong; Wang, Zai-Xing; Sun, Liang-Dan; He, Su-Min; Cheng, Hui; Hu, Da-Yan; Zhang, Zheng; Li, Yang; Zuo, Xian-Bo; Zhou, You-Wen; Yang, Sen; Fan, Xing; Zhang, Xue-Jun; Zhang, Feng-Yu] State Key Lab Incubat Base Dermatol, Hefei, Anhui, Peoples R China; [Zhou, You-Wen] Univ British Columbia, State Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada	Anhui Medical University; Anhui Medical University; University of British Columbia	Zhu, KJ (corresponding author), Anhui Med Univ, Inst Dermatol, Hefei, Anhui, Peoples R China.	ms_fanxing@yahoo.com.cn; ayzxj@vip.sina.com; fengyzhang@hotmail.com	Chen, Gang/G-2722-2010; Zhang, Fengyu/M-1396-2019; Zhu, Kunju/AAN-5264-2020	Zhang, Fengyu/0000-0001-8504-0770; Zhu, Kunju/0000-0002-3649-209X	National Natural Science Foundation of China [30971644, 30800610, 3100528, 8100692, 81072461, 30771942]; Anhui Provincial Special Scientific Program [2007-7]; High-Tech Research and Development Program of China (863 Plan) [2007AA02Z161]; Natural Science Foundation of China [30530670]; National Basic Research Program of China (973 Plan) [2007B516801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Special Scientific Program; High-Tech Research and Development Program of China (863 Plan)(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Plan)(National Basic Research Program of China)	This research was primarily supported by the General Program of National Natural Science Foundation of China (Funding No: 30971644, 30800610); and also by Anhui Provincial Special Scientific Program (2007-7), The High-Tech Research and Development Program of China (863 Plan) (2007AA02Z161), the Key Project of Natural Science Foundation of China (30530670), National Basic Research Program of China (973 Plan) (2007B516801), the General Program of National Natural Science Foundation of China (Funding No: 3100528, 8100692, 81072461, 30771942). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asumalahti K, 2002, HUM MOL GENET, V11, P589, DOI 10.1093/hmg/11.5.589; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burden AD, 1998, J INVEST DERMATOL, V110, P958, DOI 10.1046/j.1523-1747.1998.00213.x; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Capon F, 2004, DERMATOL CLIN, V22, P339, DOI 10.1016/S0733-8635(03)00125-6; Castiblanco J, 2008, HUM IMMUNOL, V69, P45, DOI 10.1016/j.humimm.2007.11.008; Chanda Pritam, 2009, BMC Proc, V3 Suppl 7, pS72; Chang YT, 2006, BRIT J DERMATOL, V155, P663, DOI 10.1111/j.1365-2133.2006.07420.x; Chang YT, 2007, J DERMATOL SCI, V46, P153, DOI 10.1016/j.jdermsci.2007.01.003; Choi HB, 2000, TISSUE ANTIGENS, V56, P548, DOI 10.1034/j.1399-0039.2000.560609.x; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Elder JT, 2001, ARCH DERMATOL, V137, P1447; Epstein MP, 2007, AM J HUM GENET, V80, P921, DOI 10.1086/516842; Feldmann KA, 2001, HISTOCHEM CELL BIOL, V115, P489; Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Gonzalez S, 2000, J INVEST DERMATOL, V115, P824, DOI 10.1046/j.1523-1747.2000.00133.x; Gonzalez S, 2001, HUM IMMUNOL, V62, P632, DOI 10.1016/S0198-8859(01)00242-7; Greetham D, 2007, HUM MOL GENET, V16, P3027, DOI 10.1093/hmg/ddm261; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Huang YH, 2002, ONCOGENE, V21, P6819, DOI 10.1038/sj.onc.1205854; Jin Y, 2010, NAT GENET, V42, P576, DOI 10.1038/ng.602; Kim S, 2010, BRIT J CANCER, V102, P436, DOI 10.1038/sj.bjc.6605516; Krueger JG, 2005, ANN RHEUM DIS, V64, P30, DOI 10.1136/ard.2004.031120; Kumar R, 1998, BIOCHEM BIOPH RES CO, V253, P336, DOI 10.1006/bbrc.1998.9692; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Moller E, 2008, J PATHOL, V215, P78, DOI 10.1002/path.2327; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Quan C, 2010, NAT GENET, V42, P614, DOI 10.1038/ng.603; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Roberson EDO, 2010, TRENDS GENET, V26, P415, DOI 10.1016/j.tig.2010.06.006; ROWE JR, 1990, HUM IMMUNOL, V29, P256, DOI 10.1016/0198-8859(90)90039-R; Rudy GB, 1997, J IMMUNOL, V158, P2116; Sagoo GS, 2004, J INVEST DERMATOL, V122, P1401, DOI 10.1111/j.0022-202X.2004.22607.x; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Suomela S, 2007, ACTA DERM-VENEREOL, V87, P127, DOI 10.2340/00015555-0184; Tiala I, 2008, HUM MOL GENET, V17, P1043, DOI 10.1093/hmg/ddm377; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Ujike H, 2001, NEUROSCI LETT, V301, P41, DOI 10.1016/S0304-3940(01)01602-0; Wei J, 2000, NAT GENET, V25, P376, DOI 10.1038/78044; YU LP, 1991, J IMMUNOL, V147, P4393; Zhang XJ, 2002, INT J DERMATOL, V41, P663, DOI 10.1046/j.1365-4362.2002.01596.x; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310	49	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e23089	10.1371/journal.pone.0023089	http://dx.doi.org/10.1371/journal.pone.0023089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125590	gold, Green Published, Green Submitted			2022-12-25	WOS:000297789200001
J	Smith, SM; Wunder, MB; Norris, DA; Shellman, YG				Smith, Shilo M.; Wunder, Michael B.; Norris, David A.; Shellman, Yiqun G.			A Simple Protocol for Using a LDH-Based Cytotoxicity Assay to Assess the Effects of Death and Growth Inhibition at the Same Time	PLOS ONE			English	Article							TETRAZOLIUM FORMAZAN ASSAY; CELL-LINES; APOPTOSIS; VIABILITY; CULTURE; MTT	Analyzing the effects on cell growth inhibition and/or cell death has been an important component of biological research. The MTS assay and LDH-based cytotoxicity assays are two of the most commonly used methods for this purpose. However, data here showed that MTS cell proliferation assay could not distinguish the effects of cell death or cell growth inhibition. In addition, the original LDH-based cytotoxicity protocol grossly underestimated the proportion of dead cells in conditions with growth inhibition. To overcome the limitation, we present here a simple modified LDH-based cytotoxicity protocol by adding additional condition-specific controls. This modified protocol thus can provide more accurate measurement of killing effects in addition to the measurement of overall effects, especially in conditions with growth inhibition. In summary, we present here a simple, modified cytotoxicity assay, which can determine the overall effects, percentage of cell killing and growth inhibition in one 96-well based assay. This is a viable option for primary screening for many laboratories, and could be adapted for high throughput screening.	[Smith, Shilo M.; Norris, David A.; Shellman, Yiqun G.] Univ Colorado Denver, Dept Dermatol, Sch Med, Aurora, CO USA; [Wunder, Michael B.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Norris, David A.] Dept Vet Affairs Med Ctr, Dermatol Sect, Denver, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Denver	Smith, SM (corresponding author), Univ Colorado Denver, Dept Dermatol, Sch Med, Aurora, CO USA.	Shilo.Smith@UCDenver.edu; Yiqun.Shellman@UCDenver.edu		Shellman, Yiqun/0000-0003-0598-5753	National Institute of Arthritis and Musculoskeletal and Skin (NIAMS) [R01AR26427-18]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR026427] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institute of Arthritis and Musculoskeletal and Skin (NIAMS) grant R01AR26427-18 to Dr. Norris and by a Veterans Administration merit grant to Dr. Norris from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-218; BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; BUTTKE TM, 1993, J IMMUNOL METHODS, V157, P233, DOI 10.1016/0022-1759(93)90092-L; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; KEPP O, 2011, NAT REV DRUG DI 0302, P221; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Zeng FY, 2009, CANCER LETT, V284, P157, DOI 10.1016/j.canlet.2009.04.016	13	107	107	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e26908	10.1371/journal.pone.0026908	http://dx.doi.org/10.1371/journal.pone.0026908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22125603	gold, Green Submitted, Green Published			2022-12-25	WOS:000297555800011
J	Geutjes, EJ; Bajpe, PK; Bernards, R				Geutjes, E-J; Bajpe, P. K.; Bernards, R.			Targeting the epigenome for treatment of cancer	ONCOGENE			English	Review						cancer epigenetics; epigenetic therapy; DNA methylation; histone modifications; nucleosome remodelling	HISTONE-DEACETYLASE INHIBITOR; TUMOR-SUPPRESSOR GENE; PHASE-II TRIAL; POLYCOMB-GROUP PROTEIN; CHROMATIN-REMODELING FACTOR; SUBEROYLANILIDE HYDROXAMIC ACID; DEMETHYLASE JMJD3 CONTRIBUTES; TRANSITIONAL-CELL CARCINOMA; CONVENTIONAL CARE REGIMENS; MESSENGER-RNA EXPRESSION	Cancer genome analyses have revealed that the enzymes involved in epigenetic gene regulation are frequently deregulated in cancer. Here we describe the enzymes that control the epigenetic state of the cell, how they are affected in cancer and how this knowledge can be exploited to treat cancer with a new arsenal of selective therapies. Oncogene (2012) 31, 3827-3844; doi: 10.1038/onc.2011.552; published online 5 December 2011	[Bernards, R.] Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Bernards, R.] Netherlands Canc Inst, Canc Genom Ctr, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl		Bernards, Rene/0000-0001-8677-3423				Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Andersen JB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001338; Nguyen AT, 2011, BLOOD, V117, P6912, DOI 10.1182/blood-2011-02-334359; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Aribi A, 2007, CANCER-AM CANCER SOC, V109, P713, DOI 10.1002/cncr.22457; Arif M, 2010, CHEM BIOL, V17, P903, DOI 10.1016/j.chembiol.2010.06.014; Arisan S, 2005, UROL INT, V75, P252, DOI 10.1159/000087804; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bea S, 2001, CANCER RES, V61, P2409; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Berdasco M, 2009, P NATL ACAD SCI USA, V106, P21830, DOI 10.1073/pnas.0906831106; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Biegel JA, 2000, CLIN CANCER RES, V6, P2759; Biegel JA, 2000, GENE CHROMOSOME CANC, V28, P31, DOI 10.1002/(SICI)1098-2264(200005)28:1<31::AID-GCC4>3.0.CO;2-Y; Biegel Jaclyn A., 2002, Cancer Research, V62, P323; Biegel Jaclyn A, 2004, Curr Oncol Rep, V6, P445, DOI 10.1007/s11912-004-0075-5; Blum KA, 2009, BRIT J HAEMATOL, V147, P507, DOI 10.1111/j.1365-2141.2009.07881.x; Blum W, 2007, J CLIN ONCOL, V25, P3884, DOI 10.1200/JCO.2006.09.4169; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Boumber Y, 2011, ONCOLOGY-NY, V25, P220; Bradley D, 2009, CANCER-AM CANCER SOC, V115, P5541, DOI 10.1002/cncr.24597; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Braiteh F, 2008, CLIN CANCER RES, V14, P6296, DOI 10.1158/1078-0432.CCR-08-1247; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2008, ONCOGENE, V27, P460, DOI 10.1038/sj.onc.1210664; Buszczak M, 2009, SCIENCE, V323, P248, DOI 10.1126/science.1165678; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chadwick RB, 2000, P NATL ACAD SCI USA, V97, P2662, DOI 10.1073/pnas.040579497; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Choi JH, 2001, JPN J CANCER RES, V92, P1300, DOI 10.1111/j.1349-7006.2001.tb02153.x; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Coste A, 2006, EMBO J, V25, P2453, DOI 10.1038/sj.emboj.7601106; Crump M, 2008, ANN ONCOL, V19, P964, DOI 10.1093/annonc/mdn031; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Datta J, 2009, CANCER RES, V69, P4277, DOI 10.1158/0008-5472.CAN-08-3669; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Dickinson M, 2009, BRIT J HAEMATOL, V147, P97, DOI 10.1111/j.1365-2141.2009.07837.x; Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; Eliazer S, 2011, P NATL ACAD SCI USA, V108, P7064, DOI 10.1073/pnas.1015874108; Eliseeva ED, 2007, MOL CANCER THER, V6, P2391, DOI 10.1158/1535-7163.MCT-07-0159; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Esteller M, 1999, AM J PATHOL, V155, P1767, DOI 10.1016/S0002-9440(10)65492-2; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Fenaux P, 2010, J CLIN ONCOL, V28, P562, DOI 10.1200/JCO.2009.23.8329; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Frescas D, 2008, CELL CYCLE, V7, P3539, DOI 10.4161/cc.7.22.7062; Fujita T, 2008, JNCI-J NATL CANCER I, V100, P940, DOI 10.1093/jnci/djn176; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; Galanis E, 2009, J CLIN ONCOL, V27, P2052, DOI 10.1200/JCO.2008.19.0694; Garcia-Manero G, 2006, BLOOD, V108, P3271, DOI 10.1182/blood-2006-03-009142; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Geutjes EJ, 2011, BREAST CANC RES TREA; Giaccone G, 2011, J CLIN ONCOL, V29, P2052, DOI 10.1200/JCO.2010.32.4467; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514; Glaros S, 2008, CANCER RES, V68, P3689, DOI 10.1158/0008-5472.CAN-07-6652; Gore SD, 2006, CANCER RES, V66, P6361, DOI 10.1158/0008-5472.CAN-06-0080; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Grand F, 1999, CANCER RES, V59, P3870; Griffiths DS, 2011, NAT CELL BIOL, V13, P13, DOI 10.1038/ncb2135; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Hamada S, 2010, J MED CHEM, V53, P5629, DOI 10.1021/jm1003655; Hauschild A, 2008, MELANOMA RES, V18, P274, DOI 10.1097/CMR.0b013e328307c248; He LS, 1998, CANCER RES, V58, P4238; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Huang Y, 2011, BREAST CANC RES TREA; Huang Y, 2007, P NATL ACAD SCI USA, V104, P8023, DOI 10.1073/pnas.0700720104; Huang Y, 2009, CLIN CANCER RES, V15, P7217, DOI 10.1158/1078-0432.CCR-09-1293; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Issa JPJ, 2005, J CLIN ONCOL, V23, P3948, DOI 10.1200/JCO.2005.11.981; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jackson EM, 2009, CLIN CANCER RES, V15, P1923, DOI 10.1158/1078-0432.CCR-08-2091; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jaju RJ, 2001, BLOOD, V98, P1264, DOI 10.1182/blood.V98.4.1264; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Jin Ke Long, 2008, J Gynecol Oncol, V19, P185, DOI 10.3802/jgo.2008.19.3.185; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kaminskas E, 2005, CLIN CANCER RES, V11, P3604, DOI 10.1158/1078-0432.CCR-04-2135; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kilpivaara O, 2008, LEUKEMIA, V22, P1813, DOI 10.1038/leu.2008.229; Kirschbaum M, 2011, J CLIN ONCOL, V29, P1198, DOI 10.1200/JCO.2010.32.1398; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Kitabayashi I, 2001, LEUKEMIA, V15, P89, DOI 10.1038/sj.leu.2401983; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Kuck D, 2010, MOL CANCER THER, V9, P3015, DOI 10.1158/1535-7163.MCT-10-0609; Kung AL, 2000, GENE DEV, V14, P272; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Lahusen T, 2009, BREAST CANCER RES TR, V116, P225, DOI 10.1007/s10549-009-0405-2; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Lavau C, 2000, EMBO J, V19, P4655, DOI 10.1093/emboj/19.17.4655; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Liu G, 2009, ONCOGENE, V28, P4491, DOI 10.1038/onc.2009.297; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Luu TH, 2008, CLIN CANCER RES, V14, P7138, DOI 10.1158/1078-0432.CCR-08-0122; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marschalek R, 2011, BRIT J HAEMATOL, V152, P141, DOI 10.1111/j.1365-2141.2010.08459.x; Matsukawa Y, 2006, CANCER SCI, V97, P484, DOI 10.1111/j.1349-7006.2006.00203.x; McGarvey KM, 2008, CANCER RES, V68, P5753, DOI 10.1158/0008-5472.CAN-08-0700; Medina PP, 2004, GENE CHROMOSOME CANC, V41, P170, DOI 10.1002/gcc.20068; Mesa RA, 2011, CANCER-AM CANCER SOC, V117, P4869, DOI 10.1002/cncr.26129; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Miller CT, 2003, CLIN CANCER RES, V9, P4819; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Modesitt SC, 2008, GYNECOL ONCOL, V109, P182, DOI 10.1016/j.ygyno.2008.01.009; Molife LR, 2010, ANN ONCOL, V21, P109, DOI 10.1093/annonc/mdp270; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mulero-Navarro S, 2008, EPIGENETICS-US, V3, P210, DOI 10.4161/epi.3.4.6610; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Namdar M, 2010, P NATL ACAD SCI USA, V107, P20003, DOI 10.1073/pnas.1013754107; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Niesvizky R, 2011, CANCER-AM CANCER SOC, V117, P336, DOI 10.1002/cncr.25584; Niu X, 2012, ONCOGENE, V31, P776, DOI 10.1038/onc.2011.266; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Nowell PC, 2002, SEMIN CANCER BIOL, V12, P261, DOI 10.1016/S1044-579X(02)00012-3; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; Oki Y, 2008, BLOOD, V111, P2382, DOI 10.1182/blood-2007-07-103960; Otterson GA, 2010, J THORAC ONCOL, V5, P1644, DOI 10.1097/JTO.0b013e3181ec1713; Palakurthy RK, 2009, MOL CELL, V36, P219, DOI 10.1016/j.molcel.2009.10.009; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Piekarz RL, 2009, CLIN CANCER RES, V15, P3918, DOI 10.1158/1078-0432.CCR-08-2788; Quintas-Cardama A, 2008, LEUKEMIA, V22, P965, DOI 10.1038/leu.2008.91; Quintas-Cardama A, 2010, NAT REV CLIN ONCOL, V7, P433, DOI 10.1038/nrclinonc.2010.87; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rahman N, 2005, CURR OPIN GENET DEV, V15, P227, DOI 10.1016/j.gde.2005.04.007; Ramalingam SS, 2009, J THORAC ONCOL, V4, P97, DOI 10.1097/JTO.0b013e318191520c; Raman JD, 2005, CLIN CANCER RES, V11, P8570, DOI 10.1158/1078-0432.CCR-05-1047; Rambaldi A, 2010, BRIT J HAEMATOL, V150, P446, DOI 10.1111/j.1365-2141.2010.08266.x; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reisman DN, 2003, CANCER RES, V63, P560; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Rodriguez-Nieto S, 2011, HUM MUTAT, V32, pE1999, DOI 10.1002/humu.21415; Roesch A, 2005, MODERN PATHOL, V18, P1249, DOI 10.1038/modpathol.3800413; Rousseau-Merck MF, 1999, CANCER RES, V59, P3152; Rubio-Moscardo F, 2005, BLOOD, V105, P4445, DOI 10.1182/blood-2004-10-3907; Rui LX, 2010, CANCER CELL, V18, P590, DOI 10.1016/j.ccr.2010.11.013; Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646; Sakakura C, 2000, INT J CANCER, V89, P217; Santos FPS, 2010, BLOOD, V115, P1131, DOI 10.1182/blood-2009-10-246363; Schaefer EW, 2009, HAEMATOL-HEMATOL J, V94, P1375, DOI 10.3324/haematol.2009.009217; Schrump DS, 2008, CLIN CANCER RES, V14, P188, DOI 10.1158/1078-0432.CCR-07-0135; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; Sonpavde G, 2007, CLIN GENITOURIN CANC, V5, P457, DOI 10.3816/CGC.2007.n.036; Stadler WM, 2006, CLIN GENITOURIN CANC, V5, P57, DOI 10.3816/CGC.2006.n.018; Stathis A, 2011, CLIN CANCER RES, V17, P1582, DOI 10.1158/1078-0432.CCR-10-1893; Steele-Perkins G, 2001, GENE DEV, V15, P2250, DOI 10.1101/gad.870101; Steine EJ, 2011, J CLIN INVEST, V121, P1748, DOI 10.1172/JCI43169; Sudo T, 2005, BRIT J CANCER, V92, P1754, DOI 10.1038/sj.bjc.6602531; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Traynor AM, 2009, J THORAC ONCOL, V4, P522, DOI 10.1097/JTO.0b013e3181952478; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; van der Knaap JA, 2010, MOL CELL BIOL, V30, P736, DOI 10.1128/MCB.01121-09; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Vansteenkiste J, 2008, INVEST NEW DRUG, V26, P483, DOI 10.1007/s10637-008-9131-6; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Voso MT, 2009, CLIN CANCER RES, V15, P5002, DOI 10.1158/1078-0432.CCR-09-0494; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang JK, 2010, GENE DEV, V24, P327, DOI 10.1101/gad.1882610; Wang L, 2011, SCIENCE, V333, P765, DOI 10.1126/science.1201662; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wartman LD, 2011, J CLIN INVEST, V121, P1445, DOI 10.1172/JCI45284; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; Weichert W, 2008, LANCET ONCOL, V9, P139, DOI 10.1016/S1470-2045(08)70004-4; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Weikert S, 2005, INT J MOL MED, V16, P349; Whitehead RP, 2009, INVEST NEW DRUG, V27, P469, DOI 10.1007/s10637-008-9190-8; Whittaker SJ, 2010, J CLIN ONCOL, V28, P4485, DOI 10.1200/JCO.2010.28.9066; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wijermans PW, 2008, LEUKEMIA RES, V32, P587, DOI 10.1016/j.leukres.2007.08.004; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Woyach JA, 2009, J CLIN ENDOCR METAB, V94, P164, DOI 10.1210/jc.2008-1631; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamamichi N, 2005, ONCOGENE, V24, P5471, DOI 10.1038/sj.onc.1208716; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Yang ZQ, 2000, CANCER RES, V60, P4735; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Yoo CB, 2007, CANCER RES, V67, P6400, DOI 10.1158/0008-5472.CAN-07-0251; Yuge M, 2000, CANCER GENET CYTOGEN, V122, P37, DOI 10.1016/S0165-4608(00)00274-0; Zeng JP, 2010, GASTROENTEROLOGY, V138, P981, DOI 10.1053/j.gastro.2009.10.004; Zhang ZH, 2005, BREAST CANCER RES TR, V94, P11, DOI 10.1007/s10549-005-6001-1; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371; Zhu WG, 2001, CANCER RES, V61, P1327; Zimmermann S, 2007, CANCER RES, V67, P9047, DOI 10.1158/0008-5472.CAN-07-0312; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	257	45	47	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	34					3827	3844		10.1038/onc.2011.552	http://dx.doi.org/10.1038/onc.2011.552			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	994IV	22139071				2022-12-25	WOS:000307925000001
J	Wu, S; Lin, Y; Xu, D; Chen, J; Shu, M; Zhou, Y; Zhu, W; Su, X; Zhou, Y; Qiu, P; Yan, G				Wu, S.; Lin, Y.; Xu, D.; Chen, J.; Shu, M.; Zhou, Y.; Zhu, W.; Su, X.; Zhou, Y.; Qiu, P.; Yan, G.			MiR-135a functions as a selective killer of malignant glioma	ONCOGENE			English	Article						malignant glioma; microRNA; apoptosis; nucleic-acid drug	PROSTATE-CANCER CELLS; GENE-EXPRESSION; SELF-RENEWAL; APOPTOSIS; MICRORNAS; MOUSE; IDENTIFICATION; PROLIFERATION; DISRUPTION; ACTIVATION	Glioma is the most common and fatal primary brain tumor. Thus far, therapeutic strategies to efficiently and specifically antagonize glioma are limited and poorly developed. Here we report that glia-enriched miR-135a, a microRNA that is dramatically downregulated in malignant glioma and correlated with the pathological grading, is capable of inducing mitochondria-dependent apoptosis of malignant glioma by regulating various genes including STAT6, SMAD5 and BMPR2, as well as affecting the signaling pathway downstream. Moreover, this lethal effect is selectively towards malignant glioma cells, but not neurons and glial cells, through a novel mechanism. Our findings suggest an important role of miR-135a in glioma etiology and provide a potential candidate for malignant glioma therapy. Oncogene (2012) 31, 3866-3874; doi:10.1038/onc.2011.551; published online 5 December 2011	[Wu, S.; Lin, Y.; Xu, D.; Chen, J.; Shu, M.; Zhou, Y.; Zhu, W.; Su, X.; Zhou, Y.; Qiu, P.; Yan, G.] Sun Yat Sen Univ, Dept Pharmacol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University	Yan, G (corresponding author), Sun Yat Sen Univ, Dept Pharmacol, Zhongshan Sch Med, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	ygm@mail.sysu.edu.cn		Lin, Yuan/0000-0002-7152-0965; Wu, Sihan/0000-0001-8329-7492	Key program, National Natural Science Foundation of China [30830111]; Guangzhou Scientific and Technological program [2008Z1-E561]; Guangdong Natural Science Foundation [S2011040004371]	Key program, National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Scientific and Technological program; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by Key program, National Natural Science Foundation of China (No. 30830111), Guangzhou Scientific and Technological program (No. 2008Z1-E561) and Guangdong Natural Science Foundation (No. S2011040004371).	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Beduneau A, 2007, BIOMATERIALS, V28, P4947, DOI 10.1016/j.biomaterials.2007.06.011; Bomben VC, 2010, GLIA, V58, P1145, DOI 10.1002/glia.20994; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kumar B, 2001, IN VITRO CELL DEV-AN, V37, P259; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li KKW, 2009, HUM PATHOL, V40, P1234, DOI 10.1016/j.humpath.2009.02.003; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lim M, 2010, LAB INVEST, V90, P222, DOI 10.1038/labinvest.2009.128; Liu ZP, 2009, BBA-MOL CELL RES, V1793, P1819, DOI 10.1016/j.bbamcr.2009.09.012; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Masuda A, 2001, J BIOL CHEM, V276, P26107, DOI 10.1074/jbc.M011475200; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Nahreini P, 2003, CELL MOL NEUROBIOL, V23, P27, DOI 10.1023/A:1022541017085; Navarro A, 2009, BLOOD, V114, P2945, DOI 10.1182/blood-2009-02-204842; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Rebholz-Schuhmann D, 2007, BIOINFORMATICS, V23, pE237, DOI 10.1093/bioinformatics/btl302; Ritchie W, 2010, BIOINFORMATICS, V26, P223, DOI 10.1093/bioinformatics/btp649; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Sun YX, 2005, EXP CELL RES, V306, P85, DOI 10.1016/j.yexcr.2005.02.012; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wurster AL, 2002, J BIOL CHEM, V277, P27169, DOI 10.1074/jbc.M201207200; Yang SX, 2006, CANCER RES, V66, P4285, DOI 10.1158/0008-5472.CAN-05-4456; Yang YL, 2000, CELL RES, V10, P169, DOI 10.1038/sj.cr.7290046; Zhang WJ, 2008, CYTOKINE, V42, P39, DOI 10.1016/j.cyto.2008.01.016; Zhang Y, 2009, J MOL MED, V87, P43, DOI 10.1007/s00109-008-0403-6	38	71	75	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	34					3866	3874		10.1038/onc.2011.551	http://dx.doi.org/10.1038/onc.2011.551			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	994IV	22139076				2022-12-25	WOS:000307925000004
J	Tchigvintsev, A; Singer, A; Brown, G; Flick, R; Evdokimova, E; Tan, KM; Gonzalez, CF; Savchenko, A; Yakunin, AF				Tchigvintsev, Anatoli; Singer, Alexander; Brown, Greg; Flick, Robert; Evdokimova, Elena; Tan, Kemin; Gonzalez, Claudio F.; Savchenko, Alexei; Yakunin, Alexander F.			Biochemical and Structural Studies of Uncharacterized Protein PA0743 from Pseudomonas aeruginosa Revealed NAD(+)-dependent L-Serine Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLMALONATE-SEMIALDEHYDE DEHYDROGENASE; BETA-HYDROXYACID DEHYDROGENASES; 3-HYDROXYISOBUTYRATE DEHYDROGENASE; ESCHERICHIA-COLI; VALINE METABOLISM; CRYSTAL-STRUCTURE; PURIFICATION; MODEL; REFINEMENT; ACID	The beta-hydroxyacid dehydrogenases form a large family of ubiquitous enzymes that catalyze oxidation of various beta-hydroxy acid substrates to corresponding semialdehydes. Several known enzymes include beta-hydroxyisobutyrate dehydrogenase, 6-phosphogluconate dehydrogenase, 2-(hydroxymethyl)glutarate dehydrogenase, and phenylserine dehydrogenase, but the vast majority of beta-hydroxyacid dehydrogenases remain uncharacterized. Here, we demonstrate that the predicted beta-hydroxyisobutyrate dehydrogenase PA0743 from Pseudomonas aeruginosa catalyzes an NAD(+)-dependent oxidation of L-serine and methyl-L-serine but exhibits low activity against beta-hydroxyisobutyrate. Two crystal structures of PA0743 were solved at 2.2-2.3-angstrom resolution and revealed an N-terminal Rossmann fold domain connected by a long alpha-helix to the C-terminal all-alpha domain. The PA0743 apostructure showed the presence of additional density modeled as HEPES bound in the interdomain cleft close to the predicted catalytic Lys-171, revealing the molecular details of the PA0743 substrate-binding site. The structure of the PA0743-NAD(+) complex demonstrated that the opposite side of the enzyme active site accommodates the cofactor, which is also bound near Lys-171. Site-directed mutagenesis of PA0743 emphasized the critical role of four amino acid residues in catalysis including the primary catalytic residue Lys-171. Our results provide further insight into the molecular mechanisms of substrate selectivity and activity of beta-hydroxyacid dehydrogenases.	[Tchigvintsev, Anatoli; Singer, Alexander; Brown, Greg; Flick, Robert; Evdokimova, Elena; Savchenko, Alexei; Yakunin, Alexander F.] Univ Toronto, Banting & Best Dept Med Res, Dept Chem Engn & Appl Chem, Toronto, ON M5G 1L6, Canada; [Tan, Kemin] Argonne Natl Lab, Midw Ctr Struct Genom, Biosci Div, Argonne, IL 60439 USA; [Gonzalez, Claudio F.] Univ Florida, Genet Inst, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Tan, Kemin] Struct Biol Ctr, Argonne, IL 60439 USA	University of Toronto; United States Department of Energy (DOE); Argonne National Laboratory; State University System of Florida; University of Florida	Yakunin, AF (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Dept Chem Engn & Appl Chem, 112 Coll St, Toronto, ON M5G 1L6, Canada.	a.iakounine@utoronto.ca	Yakunin, Alexander/J-1519-2014	Yakunin, Alexander/0000-0003-0813-6490	National Institutes of Health from the Protein Structure Initiative [GM074942]; Government of Canada through Genome Canada; Ontario Genomics Institute [2009-OGI-ABC-1405]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942, U54GM094585] Funding Source: NIH RePORTER	National Institutes of Health from the Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074942 from the Protein Structure Initiative (to the Midwest Center for Structural Genomics). This work was also supported by the Government of Canada through Genome Canada and Ontario Genomics Institute Grant 2009-OGI-ABC-1405.	ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; Afonine P. V., 2005, CONTRIBUTION DARESBU; Anthon GE, 2004, J AGR FOOD CHEM, V52, P3749, DOI 10.1021/jf035284w; Carius Y, 2010, J BIOL CHEM, V285, P20006, DOI 10.1074/jbc.M110.113738; Chen YY, 2010, J STRUCT BIOL, V169, P25, DOI 10.1016/j.jsb.2009.08.006; Chowdhury EK, 1996, BIOSCI BIOTECH BIOCH, V60, P2043, DOI 10.1271/bbb.60.2043; Chowdhury EK, 1997, BIOSCI BIOTECH BIOCH, V61, P152, DOI 10.1271/bbb.61.152; Ciulli A, 2007, J BIOL CHEM, V282, P8487, DOI 10.1074/jbc.M611171200; CONGDON PJ, 1981, J INHERIT METAB DIS, V4, P79, DOI 10.1007/BF02263600; Cowtan K., 1994, CRYSTALLOGRAPHY, V31, P34; DeLaBarre B, 2000, NAT STRUCT BIOL, V7, P238; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujisawa H, 2003, BBA-PROTEINS PROTEOM, V1645, P89, DOI 10.1016/S1570-9639(02)00533-2; GOODWIN GW, 1989, J BIOL CHEM, V264, P14965; Gutteridge A, 2005, TRENDS BIOCHEM SCI, V30, P622, DOI 10.1016/j.tibs.2005.09.006; HASEGAWA J, 1981, AGR BIOL CHEM TOKYO, V45, P2805, DOI 10.1080/00021369.1981.10864958; HAWES JW, 1995, BIOCHEMISTRY-US, V34, P4231, DOI 10.1021/bi00013a012; Hawes JW, 1996, FEBS LETT, V389, P263, DOI 10.1016/0014-5793(96)00597-2; Heering HA, 1997, J AM CHEM SOC, V119, P11628, DOI 10.1021/ja9723242; HEPTINST.J, 1970, BIOCHEM J, V117, P563, DOI 10.1042/bj1170563; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Keune H., 1976, EUR J APPL MICROBIOL, V2, P2175; Kimber MS, 2003, PROTEINS, V51, P562, DOI 10.1002/prot.10340; KO FJ, 1991, PEDIATR RES, V30, P322, DOI 10.1203/00006450-199110000-00006; LANDAAS S, 1975, CLIN CHIM ACTA, V64, P143, DOI 10.1016/0009-8981(75)90196-5; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LETTO J, 1986, BIOCHEM J, V240, P909, DOI 10.1042/bj2400909; Lokanath NK, 2005, J MOL BIOL, V352, P905, DOI 10.1016/j.jmb.2005.07.068; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Njau RK, 2001, CHEM-BIOL INTERACT, V130, P785, DOI 10.1016/S0009-2797(00)00234-9; Njau RK, 2000, J BIOL CHEM, V275, P38780, DOI 10.1074/jbc.M007432200; Otwinowski Z, 1991, P CCP4 STUD WEEK IS, P80; PACKDIBAMRUNG K, 1993, J BIOCHEM, V114, P930, DOI 10.1093/oxfordjournals.jbchem.a124279; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Reitz S, 2008, J MOL BIOL, V382, P802, DOI 10.1016/j.jmb.2008.07.050; ROBINSON WG, 1957, J BIOL CHEM, V225, P511; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; ROUGRAFF PM, 1989, J BIOL CHEM, V264, P5899; ROUGRAFF PM, 1988, J BIOL CHEM, V263, P327; Saito N, 2009, J BIOL CHEM, V284, P16442, DOI 10.1074/jbc.M109.002089; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Smith E.L., 1975, ENZYMES, P293, DOI DOI 10.1016/S1874-6047(08)60213-9; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; STEELE MI, 1992, J BIOL CHEM, V267, P13585; van Maris AJA, 2004, METAB ENG, V6, P245, DOI 10.1016/j.ymben.2004.05.001; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WONG HC, 1979, J BACTERIOL, V140, P240, DOI 10.1128/JB.140.1.240-245.1979; Yamazawa R, 2011, J BIOCHEM, V149, P701, DOI 10.1093/jb/mvr024; Yao TR, 2010, APPL BIOCHEM BIOTECH, V160, P694, DOI 10.1007/s12010-009-8685-x; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X	55	19	21	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1874	1883		10.1074/jbc.M111.294561	http://dx.doi.org/10.1074/jbc.M111.294561			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128181	hybrid, Green Published			2022-12-25	WOS:000299321000028
J	Das, C; Ghosh, TS; Mande, SS				Das, Chandrani; Ghosh, Tarini Shankar; Mande, Sharmila S.			Computational Analysis of the ESX-1 Region of Mycobacterium tuberculosis: Insights into the Mechanism of Type VII Secretion System	PLOS ONE			English	Article							VIRULENCE FACTORS; CALMETTE-GUERIN; GENE-CLUSTER; IDENTIFICATION; ESAT-6; PREDICTION; PROTEINS; RD1; COMPLEX; PATHOGENESIS	Type VII secretion system (T7SS) is a recent discovery in bacterial secretion systems. First identified in Mycobacterium tuberculosis, this secretion system has later been reported in organisms belonging to the Actinomycetales order and even to distant phyla like Firmicutes. The genome of M. tuberculosis H37Rv contains five gene clusters that have evolved through gene duplication events and include components of the T7SS secretion machinery. These clusters are called ESAT-6 secretion system (ESX) 1 through 5. Out of these, ESX-1 has been the most widely studied region because of its pathological importance. In spite of this, the overall mechanism of protein translocation through ESX-1 secretion machinery is not clearly understood. Specifically, the structural components contributing to the translocation through the mycomembrane have not been characterized yet. In this study, we have carried out a comprehensive in silico analysis of the genes known to be involved in ESX-1 secretion pathway and identified putative proteins having high probability to be associated with this particular pathway. Our study includes analysis of phylogenetic profiles, identification of domains, transmembrane helices, 3D folds, signal peptides and prediction of protein-protein associations. Based on our analysis, we could assign probable novel functions to a few of the ESX-1 components. Additionally, we have identified a few proteins with probable role in the initial activation and formation of mycomembrane translocon of ESX-1 secretion machinery. We also propose a probable working model of T7SS involving ESX-1 secretion pathway.	[Das, Chandrani; Ghosh, Tarini Shankar; Mande, Sharmila S.] Tata Consultancy Serv Ltd, Tata Consultancy ServicesInnovat Labs, Biosci R&D Div, Hyderabad, Andhra Pradesh, India	Tata Sons; Tata Consultancy Services Limited (TCS)	Das, C (corresponding author), Tata Consultancy Serv Ltd, Tata Consultancy ServicesInnovat Labs, Biosci R&D Div, Hyderabad, Andhra Pradesh, India.	sharmila@atc.tcs.com	Ghosh, Tarini/AAW-5456-2020	Ghosh, Tarini/0000-0001-9570-0365				Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Champion PAD, 2009, MOL MICROBIOL, V73, P950, DOI 10.1111/j.1365-2958.2009.06821.x; Correa NE, 2005, J BACTERIOL, V187, P6324, DOI 10.1128/JB.187.18.6324-6332.2005; Daugelat S, 2003, MICROBES INFECT, V5, P1082, DOI 10.1016/S1286-4579(03)00205-3; Dell Anne, 2010, Int J Microbiol, V2010, P148178, DOI 10.1155/2010/148178; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Fung E, 2001, EMBO J, V20, P4901, DOI 10.1093/emboj/20.17.4901; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HO PS, 1994, P NATL ACAD SCI USA, V91, P9549, DOI 10.1073/pnas.91.20.9549; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Kostakioti M, 2005, J BACTERIOL, V187, P4306, DOI 10.1128/JB.187.13.4306-4314.2005; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Liu XQ, 2004, INFECT IMMUN, V72, P2574, DOI 10.1128/IAI.72.5.2574-2581.2004; MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x; Mah N, 2010, MICROBIOL-SGM, V156, P2506, DOI 10.1099/mic.0.040089-0; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Millson SH, 2008, BIOCHEM J, V413, P261, DOI 10.1042/BJ20080105; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rajan I, 2007, BIOINFORMATICS, V23, P2672, DOI 10.1093/bioinformatics/btm405; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; RICH A, 1984, ANNU REV BIOCHEM, V53, P791, DOI 10.1146/annurev.bi.53.070184.004043; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Servant Florence, 2002, Brief Bioinform, V3, P246, DOI 10.1093/bib/3.3.246; Shrivastava S, 2010, J BIOSCIENCES, V35, P351, DOI 10.1007/s12038-010-0040-4; Shrivastava S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002955; Siroy A, 2008, J BIOL CHEM, V283, P17827, DOI 10.1074/jbc.M800866200; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Teutschbein J, 2009, MICROBIOL RES, V164, P253, DOI 10.1016/j.micres.2006.11.016; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Pittius NG, 2001, GENOME BIOL, V2	61	27	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27980	10.1371/journal.pone.0027980	http://dx.doi.org/10.1371/journal.pone.0027980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140496	Green Submitted, gold, Green Published			2022-12-25	WOS:000298168100029
J	Milano, G; Bianciardi, P; Rochemont, V; Vassalli, G; von Segesser, LK; Corno, AF; Guazzi, M; Samaja, M				Milano, Giuseppina; Bianciardi, Paola; Rochemont, Viviane; Vassalli, Giuseppe; von Segesser, Ludwig K.; Corno, Antonio F.; Guazzi, Marco; Samaja, Michele			Phosphodiesterase-5 Inhibition Mimics Intermittent Reoxygenation and Improves Cardioprotection in the Hypoxic Myocardium	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; K-ATP CHANNEL; NITRIC-OXIDE; NA+/CA2+ EXCHANGE; IN-VIVO; SILDENAFIL; APOPTOSIS; ERYTHROPOIETIN; CARDIOMYOCYTES; DYSFUNCTION	Although chronic hypoxia is a claimed myocardial risk factor reducing tolerance to ischemia/reperfusion (I/R), intermittent reoxygenation has beneficial effects and enhances heart tolerance to I/R. Aim of the study: To test the hypothesis that, by mimicking intermittent reoxygenation, selective inhibition of phosphodiesterase-5 activity improves ischemia tolerance during hypoxia. Adult male Sprague-Dawley rats were exposed to hypoxia for 15 days (10% O-2) and treated with placebo, sildenafil (1.4 mg/kg/day, i. p.), intermittent reoxygenation (1 h/day exposure to room air) or both. Controls were normoxic hearts. To assess tolerance to I/R all hearts were subjected to 30-min regional ischemia by left anterior descending coronary artery ligation followed by 3 h-reperfusion. Whereas hypoxia depressed tolerance to I/R, both sildenafil and intermittent reoxygenation reduced the infarct size without exhibiting cumulative effects. The changes in myocardial cGMP, apoptosis (DNA fragmentation), caspase-3 activity (alternative marker for cardiomyocyte apoptosis), eNOS phosphorylation and Akt activity paralleled the changes in cardioprotection. However, the level of plasma nitrates and nitrites was higher in the sildenafil+intermittent reoxygenation than sildenafil and intermittent reoxygenation groups, whereas total eNOS and Akt proteins were unchanged throughout. Conclusions: Sildenafil administration has the potential to mimic the cardioprotective effects led by intermittent reoxygenation, thereby opening the possibility to treat patients unable to be reoxygenated through a pharmacological modulation of NO-dependent mechanisms.	[Milano, Giuseppina; Rochemont, Viviane; Vassalli, Giuseppe; von Segesser, Ludwig K.] CHU Vaudois, CH-1011 Lausanne, Switzerland; [Milano, Giuseppina; Guazzi, Marco] IRCSS, Lab Biol Vasc & Med Regenerativa, Ctr Cardiol Monzino, Milan, Italy; [Bianciardi, Paola; Samaja, Michele] Univ Milan, Dept Med Surg & Dent, Milan, Italy; [Vassalli, Giuseppe] Fdn Cardioctr Ticino, Lugano, Switzerland; [Corno, Antonio F.] Prince Salman Heart Ctr, Riyadh, Saudi Arabia	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); IRCCS Centro Cardiologico Monzino; University of Milan	Milano, G (corresponding author), CHU Vaudois, CH-1011 Lausanne, Switzerland.	giuseppina.milano@chuv.ch	Samaja, Michele/N-3499-2013; Guazzi, Marco/J-3165-2016	Samaja, Michele/0000-0002-0705-340X; Guazzi, Marco/0000-0002-8456-609X; Milano, Giuseppina/0000-0002-5560-4667	Swiss National Science Foundation [FN 310000-110058/1]; Italian Ministry of University and Research	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants from the Swiss National Science Foundation (FN 310000-110058/1) and from the Italian Ministry of University and Research (PRIN 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldashev AA, 2005, THORAX, V60, P683, DOI 10.1136/thx.2005.041954; Allen BS, 1997, ANN THORAC SURG, V64, P1381, DOI 10.1016/S0003-4975(97)00905-3; Baker JE, 2001, J MOL CELL CARDIOL, V33, P331, DOI 10.1006/jmcc.2000.1305; Bianciardi P, 2006, BIOCHEM BIOPH RES CO, V342, P875, DOI 10.1016/j.bbrc.2006.02.042; Bolli R, 2007, AM J PHYSIOL-HEART C, V292, pH19, DOI 10.1152/ajpheart.00712.2006; Boolell M, 1996, Int J Impot Res, V8, P47; Caretti A, 2008, EXP BIOL MED, V233, P1222, DOI 10.3181/0802-RM-73; Chen L, 2006, AM J PHYSIOL-CELL PH, V290, pC1221, DOI 10.1152/ajpcell.00526.2005; Corno AF, 2004, J THORAC CARDIOV SUR, V127, P1301, DOI 10.1016/j.jtcvs.2003.06.012; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Das A, 2006, J BIOL CHEM, V281, P38644, DOI 10.1074/jbc.M606142200; Das S, 2002, DRUG EXP CLIN RES, V28, P213; Fantacci M, 2006, P NATL ACAD SCI USA, V103, P17531, DOI 10.1073/pnas.0608814103; Fisher PW, 2005, CIRCULATION, V111, P1601, DOI 10.1161/01.CIR.0000160359.49478.C2; Fitzpatrick CM, 2005, AM J PHYSIOL-HEART C, V288, pH62, DOI 10.1152/ajpheart.00701.2004; Forkel J, 2004, AM J PHYSIOL-HEART C, V286, pH545, DOI 10.1152/ajpheart.00022.2003; Ghofrani HA, 2002, LANCET, V360, P895, DOI 10.1016/S0140-6736(02)11024-5; Ghofrani HA, 2006, NAT REV DRUG DISCOV, V5, P689, DOI 10.1038/nrd2030; Guazzi M, 2007, J AM COLL CARDIOL, V50, P2136, DOI 10.1016/j.jacc.2007.07.078; Guazzi M, 2007, CURR MED CHEM, V14, P2181; Jackson G, 1999, AM J CARDIOL, V83, p13C; Kukreja RC, 2005, VASC PHARMACOL, V42, P219, DOI 10.1016/j.vph.2005.02.010; Kukreja RC, 2004, J MOL CELL CARDIOL, V36, P165, DOI 10.1016/j.yjmcc.2003.11.001; Liu LP, 2004, CANCER BIOL THER, V3, P492, DOI 10.4161/cbt.3.6.1010; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Milano G, 2004, EXP BIOL MED, V229, P1196, DOI 10.1177/153537020422901115; Milano G, 2002, EXP BIOL MED, V227, P389, DOI 10.1177/153537020222700604; Milano G, 2007, AM J PHYSIOL-HEART C, V292, pH1828, DOI 10.1152/ajpheart.01117.2006; Milano G, 2010, EUR J CARDIO-THORAC, V37, P942, DOI 10.1016/j.ejcts.2009.10.030; Milano G, 2010, EXP BIOL MED, V235, P401, DOI 10.1258/ebm.2009.009153; Morel S, 2006, BASIC RES CARDIOL, V101, P336, DOI 10.1007/s00395-006-0596-1; Ockaili R, 2002, AM J PHYSIOL-HEART C, V283, pH1263, DOI 10.1152/ajpheart.00324.2002; Park AM, 2007, ANTIOXID REDOX SIGN, V9, P723, DOI 10.1089/ars.2007.1460; Richalet JP, 2005, AM J RESP CRIT CARE, V171, P275, DOI 10.1164/rccm.200406-804OC; Ripamonti M, 2006, ELECTROPHORESIS, V27, P3897, DOI 10.1002/elps.200600104; Salloum F, 2003, CIRC RES, V92, P595, DOI 10.1161/01.RES.0000066853.09821.98; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Shi Y, 2004, BASIC RES CARDIOL, V99, P173, DOI 10.1007/s00395-004-0455-x; Shi Y, 2002, CIRC RES, V91, P300, DOI 10.1161/01.RES.0000031799.12850.1E; Tarricone E, 2008, CELL STRESS CHAPERON, V13, P483, DOI 10.1007/s12192-008-0048-y; Webster KA, 2005, J MOL CELL CARDIOL, V38, P35, DOI 10.1016/j.yjmcc.2004.11.007; Yeung HM, 2007, AM J PHYSIOL-CELL PH, V292, pC2046, DOI 10.1152/ajpcell.00458.2006	42	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27910	10.1371/journal.pone.0027910	http://dx.doi.org/10.1371/journal.pone.0027910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140481	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163400021
J	Bhomkar, P; Materi, W; Wishart, DS				Bhomkar, Prasanna; Materi, Wayne; Wishart, David S.			The Bacterial Nanorecorder: Engineering E. coli to Function as a Chemical Recording Device	PLOS ONE			English	Article							ESCHERICHIA-COLI; CELL-DIVISION; OPTIMIZATION; BISTABILITY; EXPRESSION; PLACEMENT; INHIBITOR; MINC; SITE	Synthetic biology is an emerging branch of molecular biology that uses synthetic genetic constructs to create man-made cells or organisms that are capable of performing novel and/or useful applications. Using a synthetic chemically sensitive genetic toggle switch to activate appropriate fluorescent protein indicators (GFP, RFP) and a cell division inhibitor (minC), we have created a novel E. coli strain that can be used as a highly specific, yet simple and inexpensive chemical recording device. This biological "nanorecorder" can be used to determine both the type and the time at which a brief chemical exposure event has occurred. In particular, we show that the short-term exposure (15-30 min) of cells harboring this synthetic genetic circuit to small molecule signals (anhydrotetracycline or IPTG) triggered long-term and uniform cell elongation, with cell length being directly proportional to the time elapsed following a brief chemical exposure. This work demonstrates that facile modification of an existing genetic toggle switch can be exploited to generate a robust, biologically-based "nanorecorder" that could potentially be adapted to detect, respond and record a wide range of chemical stimuli that may vary over time and space.	[Bhomkar, Prasanna; Materi, Wayne; Wishart, David S.] Natl Inst Nanotechnol, Edmonton, AB, Canada; [Wishart, David S.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Wishart, David S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	National Research Council Canada; University of Alberta; University of Alberta	Bhomkar, P (corresponding author), Natl Inst Nanotechnol, Edmonton, AB, Canada.	bhomkar@ualberta.ca	Wishart, David Scott/ABI-3181-2020	Wishart, David S/0000-0002-3207-2434	National Research Council of Canada; Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council (NSERC)	National Research Council of Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	National Research Council of Canada, The Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Arends SJR, 2004, J BACTERIOL, V186, P880, DOI 10.1128/JB.186.3.880-884.2004; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1990, P NATL ACAD SCI USA, V87, P1129, DOI 10.1073/pnas.87.3.1129; DEBOER PAJ, 1988, J BACTERIOL, V170, P2106, DOI 10.1128/jb.170.5.2106-2112.1988; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Fritz Georg, 2007, Syst Synth Biol, V1, P89, DOI 10.1007/s11693-007-9006-8; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ham TS, 2006, BIOTECHNOL BIOENG, V94, P1, DOI 10.1002/bit.20916; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Pfleger BF, 2005, BIOTECHNOL BIOENG, V92, P553, DOI 10.1002/bit.20630; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Sambrook J, 2001, MOL CLONING LAB MANU; Stupak E E, 2010, Genetika, V46, P610; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Weber W, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp014; Wu CH, 2009, BIOTECHNOL PROGR, V25, P898, DOI 10.1002/btpr.203	29	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27559	10.1371/journal.pone.0027559	http://dx.doi.org/10.1371/journal.pone.0027559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132112	gold, Green Published, Green Submitted			2022-12-25	WOS:000298162000026
J	Van Otterloo, J; Richards, JL; Seib, K; Weiss, P; Omer, SB				Van Otterloo, Joshua; Richards, Jennifer L.; Seib, Katherine; Weiss, Paul; Omer, Saad B.			Gift Card Incentives and Non-Response Bias in a Survey of Vaccine Providers: The Role of Geographic and Demographic Factors	PLOS ONE			English	Article							RESPONSE RATES; PHYSICIAN RESPONSE; MAIL SURVEY	This study investigates the effects of non-response bias in a 2010 postal survey assessing experiences with H1N1 influenza vaccine administration among a diverse sample of providers (N = 765) in Washington state. Though we garnered a high response rate (80.9%) by using evidence-based survey design elements, including intensive follow-up and a gift card incentive from Target, non-response bias could exist if there were differences between respondents and non-respondents. We investigated differences between the two groups for seven variables: road distance to the nearest Target store, practice type, previous administration of vaccines, region, urbanicity, size of practice, and Vaccines for Children (VFC) program enrollment. We also examined the effect of non-response bias on survey estimates. Statistically significant differences between respondents and non-respondents were found for four variables: miles to the nearest Target store, type of medical practice, whether the practice routinely administered additional vaccines besides H1N1, and urbanicity. Practices were more likely to respond if they were from a small town or rural area (OR = 7.68, 95% CI = 1.44-40.88), were a non-traditional vaccine provider type (OR = 2.08, 95% CI = 1.06-4.08) or a pediatric provider type (OR = 4.03, 95% CI = 1.36-11.96), or administered additional vaccines besides H1N1 (OR = 1.80, 95% CI = 1.03-3.15). Of particular interest, for each ten mile increase in road distance from the nearest Target store, the likelihood of provider response decreased (OR = 0.73, 95% CI = 0.60-0.89). Of those variables associated with response, only small town or rural practice location was associated with a survey estimate of interest, suggesting that non-response bias had a minimal effect on survey estimates. These findings show that gift card incentives alongside survey design elements and follow-up can achieve high response rates. However, there is evidence that practices farther from the nearest place to redeem gift cards may be less likely to respond to the survey.	[Van Otterloo, Joshua; Richards, Jennifer L.; Seib, Katherine; Weiss, Paul; Omer, Saad B.] Emory Univ, Preparedness & Emergency Response Res Ctr, Atlanta, GA 30322 USA; [Seib, Katherine; Omer, Saad B.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Emory University; Emory University; Rollins School Public Health	Van Otterloo, J (corresponding author), Emory Univ, Preparedness & Emergency Response Res Ctr, Atlanta, GA 30322 USA.	jvanott@emory.edu	Omer, Saad B/K-1182-2012	Omer, Saad B/0000-0002-5383-3474; Beauregard, Jennifer/0000-0003-2587-5148	Centers for Disease Control and Prevention (CDC) [5P01TP000300]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052460] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by a grant from the Centers for Disease Control and Prevention (CDC), grant # 5P01TP000300, to the Emory Preparedness and Emergency Response Research Center, Emory University (Atlanta, GA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; BARTON J, 1980, AM J PUBLIC HEALTH, V70, P823, DOI 10.2105/AJPH.70.8.823; Bjertnaes OA, 2008, EVAL HEALTH PROF, V31, P65, DOI 10.1177/0163278707311874; Burritt C, 2009, BLOOMBERG NEWS  0102; Cull WL, 2005, HEALTH SERV RES, V40, P213, DOI 10.1111/j.1475-6773.2005.00350.x; Delnevo CD, 2004, AM J PREV MED, V26, P234, DOI 10.1016/j.amepre.2003.12.013; Field TS, 2002, MED CARE, V40, P596, DOI 10.1097/00005650-200207000-00006; Hammett TM., 2007, NATL SURVEY INFECT D; Hansen Richard A, 2007, Res Social Adm Pharm, V3, P249, DOI 10.1016/j.sapharm.2006.10.001; Kasprzyk D, 2001, EVAL HEALTH PROF, V24, P3, DOI 10.1177/01632780122034740; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Liu ST, 2011, MATERN CHILD HLTH J, V15, P527, DOI 10.1007/s10995-010-0609-4; McFarlane E, 2007, EVAL HEALTH PROF, V30, P170, DOI 10.1177/0163278707300632; Parashos P, 2005, COMMUNITY DENT ORAL, V33, P9, DOI 10.1111/j.1600-0528.2004.00181.x; Rural Health Research Center, 2004, RUCA DAT ZIP COD RUC; VanGeest JB, 2007, EVAL HEALTH PROF, V30, P303, DOI 10.1177/0163278707307899; Washington State Department of Health, 2005, EM PREP RESP PUBL HL	17	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28108	10.1371/journal.pone.0028108	http://dx.doi.org/10.1371/journal.pone.0028108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KL	22132224	Green Published, gold			2022-12-25	WOS:000298162000074
J	Bob, P; Jasova, D; Raboch, J				Bob, Petr; Jasova, Denisa; Raboch, Jiri			Subclinical Epileptiform Process in Patients with Unipolar Depression and Its Indirect Psychophysiological Manifestations	PLOS ONE			English	Article							STRESS; SYMPTOMS; SENSITIZATION; DISSOCIATION; AMYGDALA; ILLNESS	Background: According to recent clinical findings epileptiform activity in temporolimbic structures may cause and other psychiatric symptoms that may occur independently of any seizure in patient's history. In addition in patients subclinical seizure-like activity with indirect clinical manifestations likely may occur in a form of various forms cognitive, affective, memory, sensory, behavioral and somatic symptoms (the so-called complex partial seizure-like symptoms). A typical characteristic of epileptiform changes is increased neural synchrony related to spreading epileptiform activity between hemispheres even in subclinical conditions i.e. without seizures. These findings suggest hypothesis that measures reflecting a level of synchronization and information transfer between hemispheres could spreading of epileptiform activity and might be related to complex partial seizure-like symptoms. Methods and Findings: Suitable data for such analysis may provide various physiological signals reflecting brain as for example bilateral electrodermal activity (EDA) that is closely related to limbic modulation influences. With purpose we have performed measurement and analysis of bilateral EDA and compared the results with measures of complex partial seizure-like symptoms, depression and actually experienced stress in 44 patients with depression and 35 healthy controls. The results in unipolar depressive patients show that during rest conditions the with higher level of complex partial seizure like symptoms (CPSI) display increased level of EDA transinformation (PTI) calculated between left and right EDA records (Spearman correlation between CPSI and PTI is r = 0.43, p = 0.004). Conclusions: The result may present potentially useful clinical finding suggesting that increased EDA transinformation (PTI) could indirectly indicate increased neural synchrony as a possible indicator of epileptiform activity in unipolar patients treated by serotoninergic antidepresants.	[Bob, Petr] Charles Univ Prague, Dept Psychiat, Fac Med 1, Ctr Neuropsychiat Res Traumat Stress, Prague, Czech Republic; Charles Univ Prague, UHSL, Fac Med 1, Ctr Neuropsychiat Res Traumat Stress, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague	Bob, P (corresponding author), Charles Univ Prague, Dept Psychiat, Fac Med 1, Ctr Neuropsychiat Res Traumat Stress, Prague, Czech Republic.	petrbob@netscape.net	raboch, jiri/N-7445-2017; Bob, Petr/E-3414-2012	raboch, jiri/0000-0001-6667-1497; 	Czech Ministry of Education [1M06039];  [MSM0021620849];  [MSM0021622404];  [SVV262508]	Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); ; ; 	This work was supported by research grants MSM0021620849, MSM0021622404, and SVV262508 and support of research project of Center for Neuropsychiatric Research of Traumatic Stress 1M06039 by Czech Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM PSYCH ASS, 1994, AM PSYCH ASS DSM 4 D; Baumgartner C, 2001, EPILEPTIC DISORD, V3, P103; Beck AT, 1996, PSYCHOL ASSESS; Bob P, 2003, INT J NEUROSCI, V113, P903, DOI 10.1080/00207450390220376; Bob P., 2008, ACTIV NERV SUPER, V50, P9; Bob P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018678; Bob P, 2010, PSYCHOL REP, V107, P685, DOI 10.2466/02.15.16.PR0.107.6.685-696; Bob P, 2010, PROG NEURO-PSYCHOPH, V34, P143, DOI 10.1016/j.pnpbp.2009.10.015; Caldji C, 2003, NEUROPSYCHOPHARMACOL, V28, P1950, DOI 10.1038/sj.npp.1300237; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; Devinsky Orrin, 2004, Epilepsy Curr, V4, P43, DOI 10.1111/j.1535-7597.2004.42001.x; Furmark T, 1997, NEUROREPORT, V8, P3957, DOI 10.1097/00001756-199712220-00021; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Kantz H., 1997, NONLINEAR TIME SERIE; Keller MB, 2003, JAMA-J AM MED ASSOC, V289, P3152, DOI 10.1001/jama.289.23.3152; Kraus JE, 2000, J NEUROPSYCH CLIN N, V12, P328, DOI 10.1176/appi.neuropsych.12.3.328; Lambertz M, 2000, J AUTONOM NERV SYST, V78, P141, DOI 10.1016/S0165-1838(99)00072-7; Landmark CJ, 2008, CNS DRUGS, V22, P27; Mangina CA, 1996, INT J PSYCHOPHYSIOL, V22, P1, DOI 10.1016/0167-8760(96)00022-0; McIntyre DC, 2008, EPILEPSIA, V49, P23, DOI 10.1111/j.1528-1167.2008.01507.x; Monroe SM, 2005, PSYCHOL REV, V112, P417, DOI 10.1037/0033-295X.112.2.417; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; POH MZ, 2010, C P IEEE ENG MED BIO, P4415; Post R M, 1988, Adv Exp Med Biol, V245, P441; POST RM, 1992, AM J PSYCHIAT, V149, P999; ROBERTS RJ, 1992, EPILEPSY RES, V13, P167, DOI 10.1016/0920-1211(92)90073-3; Roca V, 2002, J NEUROPSYCH CLIN N, V14, P185, DOI 10.1176/appi.neuropsych.14.2.185; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SILBERMAN EK, 1985, BRIT J PSYCHIAT, V146, P81, DOI 10.1192/bjp.146.1.81; Teicher MH, 2003, NEUROSCI BIOBEHAV R, V27, P33, DOI 10.1016/S0149-7634(03)00007-1; Varney N R, 1993, Ann Clin Psychiatry, V5, P117, DOI 10.3109/10401239309148973; Weinand Martin E, 2006, Pathophysiology, V13, P233, DOI 10.1016/j.pathophys.2006.08.002; Weinand ME, 2001, EPILEPSY RES, V44, P33, DOI 10.1016/S0920-1211(00)00205-9	33	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28041	10.1371/journal.pone.0028041	http://dx.doi.org/10.1371/journal.pone.0028041			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132204	gold, Green Submitted, Green Published			2022-12-25	WOS:000297792400035
J	Miyama, A; Saito, Y; Yamanaka, K; Hayashi, K; Hamakubo, T; Noguchi, N				Miyama, Akiko; Saito, Yoshiro; Yamanaka, Kazunori; Hayashi, Kojiro; Hamakubo, Takao; Noguchi, Noriko			Oxidation of DJ-1 Induced by 6-Hydroxydopamine Decreasing Intracellular Glutathione	PLOS ONE			English	Article							NEURONAL CELL-DEATH; PARKINSONS-DISEASE; HYDROGEN-PEROXIDE; RELATIVE IMPORTANCE; ALPHA-SYNUCLEIN; OXIDIZED DJ-1; STRESS; NEUROTOXICITY; TOXICITY; QUINONE	DJ-1, the causative gene of a familial form of Parkinson's disease (PD), has been reported to undergo preferential oxidation of the cysteine residue at position 106 (Cys-106) under oxidative stress; however, details of the molecular mechanisms are not well known. In the present study, mechanisms of DJ-1 oxidation induced by 6-hydroxydopamine (6-OHDA) were investigated by using SH-SY5Y cells. The treatment of these cells with 6-OHDA caused an obvious acidic spot sift of DJ-1 due to its oxidation. However, when catalase, which is an hydrogen peroxide (H2O2)-removing enzyme, was added during the treatment, it failed to prevent the oxidation induced by 6-OHDA, suggesting that electrophilic p-quinone formed from 6-OHDA, but not H2O2, was responsible for the DJ-1 oxidation. Benzoquinone, another electrophilic p-quinone, also induced DJ-1 oxidation. The intracellular glutathione (GSH) levels were significantly decreased by 6-OHDA, irrespective of the presence or absence of catalase. The inhibition of GSH synthesis by buthionine sulfoximine resulted in a decrease in GSH levels and enhancement of DJ-1 oxidation. The pretreatment of cells with N-acetyl-cysteine prevented the loss of intracellular GSH and subsequently DJ-1 oxidation induced by 6-OHDA. Collectively, these results suggest that electrophilic p-quinone formed from 6-OHDA induces DJ-1 oxidation by decreasing intracellular GSH.	[Miyama, Akiko; Saito, Yoshiro; Yamanaka, Kazunori; Hayashi, Kojiro; Noguchi, Noriko] Doshisha Univ, Fac Med & Life Sci, Dept Med Life Syst, Kyoto 602, Japan; [Hamakubo, Takao] Univ Tokyo, Lab Syst Biol & Med, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo, Japan	Doshisha University; University of Tokyo	Miyama, A (corresponding author), Doshisha Univ, Fac Med & Life Sci, Dept Med Life Syst, Kyoto 602, Japan.	ysaito@mail.doshisha.ac.jp; nnoguchi@mail.doshisha.ac.jp	Saito, Yoshiro/H-4597-2019	Saito, Yoshiro/0000-0002-0559-5889	Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in part, by the Academic Frontier Research Project on "New Frontier of Biomedical Engineering Research'' of the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akazawa YO, 2010, NEUROSCI LETT, V483, P201, DOI 10.1016/j.neulet.2010.08.007; Akazawa YO, 2010, FREE RADICAL RES, V44, P410, DOI 10.3109/10715760903536349; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; COHEN G, 1974, J BIOL CHEM, V249, P2447; Cornwell DG, 2003, LIPIDS, V38, P973, DOI 10.1007/s11745-003-1151-4; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; GANT TW, 1988, CHEM-BIOL INTERACT, V65, P157, DOI 10.1016/0009-2797(88)90052-X; GEE P, 1989, FREE RADICAL BIO MED, V6, P271, DOI 10.1016/0891-5849(89)90054-3; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Izumi Y, 2005, J NEUROSCI RES, V79, P849, DOI 10.1002/jnr.20382; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Khanna S, 2003, J BIOL CHEM, V278, P43508, DOI 10.1074/jbc.M307075200; Khanna S, 2010, J NEUROCHEM, V112, P1249, DOI 10.1111/j.1471-4159.2009.06550.x; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LIANG YO, 1977, J MED CHEM, V20, P581, DOI 10.1021/jm00214a026; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Mitsumoto A, 2001, FREE RADICAL RES, V35, P301, DOI 10.1080/10715760100300831; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; Saito Y, 2007, FREE RADICAL BIO MED, V42, P675, DOI 10.1016/j.freeradbiomed.2006.12.004; Saito Y, 2006, FREE RADICAL RES, V40, P619, DOI 10.1080/10715760600632552; Saito Y, 2010, FREE RADICAL BIO MED, V49, P1542, DOI 10.1016/j.freeradbiomed.2010.08.016; Saito Y, 2009, NEUROSCI LETT, V465, P1, DOI 10.1016/j.neulet.2009.08.074; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Shimizu E, 2002, NEUROPHARMACOLOGY, V43, P434, DOI 10.1016/S0028-3908(02)00108-9; Sie H, 1991, AM J MED, V9, P31, DOI DOI 10.1016/0002-9343(91)90281-2; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Soto-Otero R, 2000, J NEUROCHEM, V74, P1605, DOI 10.1046/j.1471-4159.2000.0741605.x; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Toppo S, 2009, BBA-GEN SUBJECTS, V1790, P1486, DOI 10.1016/j.bbagen.2009.04.007; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103; WILSON MA, ANTIOXID REDOX SIGNA, V15, P111; WOLF PS, 1994, METHOD ENZYMOL, V233, P182; Yamanaka K, 2011, J BIOL CHEM, V286, P24666, DOI 10.1074/jbc.M111.236273; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	42	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27883	10.1371/journal.pone.0027883	http://dx.doi.org/10.1371/journal.pone.0027883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132160	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789900029
J	Nunes, SS; Rekapally, H; Chang, CC; Hoying, JB				Nunes, Sara S.; Rekapally, Harish; Chang, Carlos C.; Hoying, James B.			Vessel Arterial-Venous Plasticity in Adult Neovascularization	PLOS ONE			English	Article							VEIN GRAFT ADAPTATION; ENDOTHELIAL-CELLS; CARDIOVASCULAR DEVELOPMENT; VASCULAR MORPHOGENESIS; SMOOTH-MUSCLE; EPHRIN-B2; ANGIOGENESIS; EXPRESSION; DIFFERENTIATION; VEGF	Objective: Proper arterial and venous specification is a hallmark of functional vascular networks. While arterial-venous identity is genetically pre-determined during embryo development, it is unknown whether an analogous pre-specification occurs in adult neovascularization. Our goal is to determine whether vessel arterial-venous specification in adult neovascularization is pre-determined by the identity of the originating vessels. Methods and Results: We assessed identity specification during neovascularization by implanting isolated microvessels of arterial identity from both mice and rats and assessing the identity outcomes of the resulting, newly formed vasculature. These microvessels of arterial identity spontaneously formed a stereotypical, perfused microcirculation comprised of the full complement of microvessel types intrinsic to a mature microvasculature. Changes in microvessel identity occurred during sprouting angiogenesis, with neovessels displaying an ambiguous arterial-venous phenotype associated with reduced EphrinB2 phosphorylation. Conclusions: Our findings indicate that microvessel arterial-venous identity in adult neovascularization is not necessarily pre-determined and that adult microvessels display a considerable level of phenotypic plasticity during neovascularization. In addition, we show that vessels of arterial identity also hold the potential to undergo sprouting angiogenesis.	[Nunes, Sara S.] Univ Louisville, Cardiovasc Innovat Inst, Louisville, KY 40292 USA; Jewish Hosp St Marys Hlth Care, Louisville, KY USA	University of Louisville	Nunes, SS (corresponding author), Univ Louisville, Cardiovasc Innovat Inst, Louisville, KY 40292 USA.	sara.vasconcelos@utoronto.ca	Nunes, Sara S./G-9096-2012; Nunes, Sara/GVS-8426-2022	Nunes, Sara/0000-0003-4795-6061; S Nunes Vasconcelos, Sara/0000-0003-0906-7204	National Institutes of Health [EB007556]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007556] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health [http://www.nih.gov grant number EB007556] to JBH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Aitsebaomo J, 2008, CIRC RES, V103, P929, DOI 10.1161/CIRCRESAHA.108.184937; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Buschmann I, 2010, DEVELOPMENT, V137, P2187, DOI 10.1242/dev.045351; Chang CC, 2010, TISSUE ENG PT A, V16, P795, DOI [10.1089/ten.tea.2009.0370, 10.1089/ten.TEA.2009.0370]; Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; dela Paz NG, 2009, CELL TISSUE RES, V335, P5, DOI 10.1007/s00441-008-0706-5; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Hayashi S, 2005, CIRCULATION, V111, P2210, DOI 10.1161/01.CIR.0000163566.07427.73; Hellberg C, 2010, RECENT RESULTS CANC, V180, P103, DOI 10.1007/978-3-540-78281-0_7; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kudo FA, 2007, ARTERIOSCL THROM VAS, V27, P1562, DOI 10.1161/ATVBAHA.107.143032; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Kume T, 2010, HISTOL HISTOPATHOL, V25, P637, DOI 10.14670/HH-25.637; Lamont RE, 2006, SCI STKE, DOI [10.1126/stke.3552006pe39, DOI 10.1126/STKE.3552006PE39]; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Masumura T, 2009, ARTERIOSCL THROM VAS, V29, P2125, DOI 10.1161/ATVBAHA.109.193185; Moyon D, 2001, DEVELOPMENT, V128, P3359; Muto A, 2010, CIRC J, V74, P1501, DOI 10.1253/circj.CJ-10-0495; Nunes SS, 2010, MICROCIRCULATION, V17, P557, DOI 10.1111/j.1549-8719.2010.00052.x; Nunes SS, 2010, MICROVASC RES, V79, P10, DOI 10.1016/j.mvr.2009.10.001; Obi S, 2009, J APPL PHYSIOL, V106, P203, DOI 10.1152/japplphysiol.00197.2008; Rocha SF, 2009, ANGIOGENESIS, V12, P139, DOI 10.1007/s10456-009-9132-x; Salvucci O, 2009, BLOOD, V114, P1707, DOI 10.1182/blood-2008-12-192294; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Shepherd BR, 2007, TISSUE ENG, V13, P2871, DOI 10.1089/ten.2007.0025; Shepherd BR, 2004, ARTERIOSCL THROM VAS, V24, P898, DOI 10.1161/01.ATV.0000124103.86943.1e; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Skalak Thomas C., 1996, Microcirculation (Philadelphia), V3, P143, DOI 10.3109/10739689609148284; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Taylor AC, 2007, MICROCIRCULATION, V14, P253, DOI 10.1080/10739680601141829; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Weinstein BM, 2002, COLD SPRING HARB SYM, V67, P155, DOI 10.1101/sqb.2002.67.155; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511	46	23	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27332	10.1371/journal.pone.0027332	http://dx.doi.org/10.1371/journal.pone.0027332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132096	gold, Green Submitted, Green Published			2022-12-25	WOS:000297789900011
J	Han, FJ; Liang, PZ; Wang, FF; Zeng, LY; Zhang, BL				Han, Fujun; Liang, Peizhou; Wang, Feifei; Zeng, Lingyun; Zhang, Biliang			Automated Analysis of Time-Lapse Imaging of Nuclear Translocation by Retrospective Strategy and Its Application to STAT1 in HeLa Cells	PLOS ONE			English	Article							LIVING CELLS; RECEPTOR; MICROSCOPY; PROTEIN; SEGMENTATION; COMPARTMENTS; CYTOMETRY; RESPONSES; TRACKING; COMPLEX	Cell-based image analysis of time-lapse imaging is mainly challenged by faint fluorescence and dim boundaries of cellular structures of interest. To resolve these bottlenecks, a novel method was developed based on "retrospective" analysis for cells undergoing minor morphological changes during time-lapse imaging. We fixed and stained the cells with a nuclear dye at the end of the experiment, and processed the time-lapse images using the binary masks obtained by segmenting the nuclear-stained image. This automated method also identifies cells that move during the time-lapse imaging, which is a factor that could influence the kinetics measured for target proteins that are present mostly in the cytoplasm. We then validated the method by measuring interferon gamma (IFN gamma) induced signal transducers and activators of transcription 1 (STAT1) nuclear translocation in living HeLa cells. For the first time, automated large-scale analysis of nuclear translocation in living cells was achieved by our novel method. The responses of the cells to IFN gamma exhibited a significant drift across the population, but common features of the responses led us to propose a three-stage model of STAT1 import. The simplicity and automation of this method should enable its application in a broad spectrum of time-lapse studies of nuclear-cytoplasmic translocation.	[Han, Fujun; Liang, Peizhou; Wang, Feifei; Zhang, Biliang] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Lab RNA Chem Biol, Guangzhou, Guangdong, Peoples R China; [Han, Fujun] Peoples Liberat Army 458 Hosp, Dept Otorhinolaryngol, Guangzhou, Guangdong, Peoples R China; [Zeng, Lingyun] Peoples Liberat Army 458 Hosp, Dept Neuroendocrine, Guangzhou, Guangdong, Peoples R China; [Zhang, Biliang] Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Han, Fujun] Univ Walk, Sch Biochem, Bristol, Avon, England	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; University of Bristol	Han, FJ (corresponding author), Univ Walk, Sch Biochem, Bristol, Avon, England.	fujun.han@bristol.ac.uk; zhang_biliang@gibh.org			National Natural Science Foundation of China [30870535, 90913017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (No. 30870535 and 90913017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Introduced Innovative R&D Team Program of Guangdong Province (Gene Silencing Technology and Therapeutics).	An SJ, 2006, TOXICOL SCI, V90, P326, DOI 10.1093/toxsci/kfj109; Berger P, 2005, RADIOLOGY, V235, P1055, DOI 10.1148/radiol.2353040121; BORST H, 1979, J HISTOCHEM CYTOCHEM, V27, P180, DOI 10.1177/27.1.374573; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; Darzynkiewicz Z, 2011, MUTAGENESIS, V26, P153, DOI 10.1093/mutage/geq069; Dewan MAA, 2011, IEEE T BIO-MED ENG, V58, P1637, DOI 10.1109/TBME.2011.2109001; Dorval T, 2010, J BIOMOL SCREEN, V15, P847, DOI 10.1177/1087057110374993; Dzyubachyk O, 2010, BIOINFORMATICS, V26, P2424, DOI 10.1093/bioinformatics/btq434; Han FJ, 2008, ACTA BIOCH BIOPH SIN, V40, P934, DOI 10.1111/j.1745-7270.2008.00480.x; Hartig SM, 2011, METHODS MOL BIOL, V776, P313, DOI 10.1007/978-1-61779-243-4_18; HOLLAND PW, 1977, COMMUN STAT A-THEOR, V6, P813, DOI 10.1080/03610927708827533; Johnson HM, 1998, P SOC EXP BIOL MED, V218, P149; Jones T.R., 2008, MICROSCOPIC IMAGE AN, P209; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kaltreider RC, 2001, ENVIRON HEALTH PERSP, V109, P245, DOI 10.1289/ehp.01109245; Kodiha M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.137pl2; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; Koster M, 1999, EUR J BIOCHEM, V260, P137, DOI 10.1046/j.1432-1327.1999.00149.x; Krause CD, 2006, CELL RES, V16, P55, DOI 10.1038/sj.cr.7310008; Laffers W, 2006, CYTOM PART A, V69A, P127, DOI 10.1002/cyto.a.20216; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Mullassery D, 2008, ESSAYS BIOCHEM, V45, P121, DOI 10.1042/BSE0450121; Mysore SP, 2010, J NEUROSCI, V30, P1727, DOI 10.1523/JNEUROSCI.3740-09.2010; Nicolas FJ, 2004, J CELL SCI, V117, P4113, DOI 10.1242/jcs.01289; Otsu N., 1979, EEE T SYSTREMS MAN C, V9, P62; Shen HL, 2006, CHEMOMETR INTELL LAB, V82, P276, DOI 10.1016/j.chemolab.2005.07.007; Shen H, 2006, J R SOC INTERFACE, V3, P787, DOI 10.1098/rsif.2006.0137; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Starkuviene V, 2007, BRIT J PHARMACOL, V152, P62, DOI 10.1038/sj.bjp.0707346; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Tvarusko W, 1999, P NATL ACAD SCI USA, V96, P7950, DOI 10.1073/pnas.96.14.7950; WU AJ, 1994, J CELL PHYSIOL, V161, P217, DOI 10.1002/jcp.1041610205; Zhou XB, 2009, IEEE T INF TECHNOL B, V13, P152, DOI 10.1109/TITB.2008.2007098	36	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27454	10.1371/journal.pone.0027454	http://dx.doi.org/10.1371/journal.pone.0027454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125613	Green Published, gold, Green Submitted			2022-12-25	WOS:000297789200013
J	Hartman, ML; Kornfeld, H				Hartman, Michelle L.; Kornfeld, Hardy			Interactions between Naive and Infected Macrophages Reduce Mycobacterium tuberculosis Viability	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HUMAN MONOCYTES/MACROPHAGES; ALVEOLAR MACROPHAGES; APOPTOSIS; AUTOPHAGY; RECEPTORS; MECHANISMS; EXPRESSION; PHAGOSOMES; IL-1-BETA	A high intracellular bacillary load of Mycobacterium tuberculosis in macrophages induces an atypical lysosomal cell death with early features of apoptosis that progress to necrosis within hours. Unlike classical apoptosis, this cell death mode does not appear to diminish M. tuberculosis viability. We previously reported that culturing heavily infected macrophages with naive macrophages produced an antimicrobial effect, but only if naive macrophages were added during the pre-necrotic phase of M. tuberculosis-induced cell death. In the present study we investigated the mechanism of antimicrobial activity in co-cultures, anticipating that efferocytosis of bacilli in apoptotic bodies would be required. Confocal microscopy revealed frustrated phagocytosis of M. tuberculosis-infected macrophages with no evidence that significant numbers of bacilli were transferred to the naive macrophages. The antimicrobial effect of naive macrophages was retained when they were separated from infected macrophages in transwells, and conditioned co-culture supernatants transferred antimicrobial activity to cultures of infected macrophages alone. Antimicrobial activity in macrophage co-cultures was abrogated when the naive population was deficient in IL-1 receptor or when the infected population was deficient in inducible nitric oxide synthase. The participation of nitric oxide suggested a conventional antimicrobial mechanism requiring delivery of bacilli to a late endosomal compartment. Using macrophages expressing GFP-LC3 we observed the induction of autophagy specifically by a high intracellular load of M. tuberculosis. Bacilli were identified in LC3-positive compartments and LC3-positive compartments were confirmed to be acidified and LAMP1 positive. Thus, the antimicrobial effect of naive macrophages acting on M. tuberculosis in heavily-infected macrophages is contact-independent. Interleukin-1 provides an afferent signal that induces an as yet unidentified small molecule which promotes nitric oxide-dependent antimicrobial activity against bacilli in autolysosomes of heavily infected macrophages. This cooperative, innate antimicrobial interaction may limit the maximal growth rate of M. tuberculosis prior to the expression of adaptive immunity in pulmonary tuberculosis.	[Hartman, Michelle L.; Kornfeld, Hardy] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Hartman, ML (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	hardy.kornfeld@umassmed.edu	Kornfeld, Hardy/AAS-2903-2021		National Institutes of Health [RO1 HL064664]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant RO1 HL064664. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; Biswas D, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-35; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; FLESCH IEA, 1991, INFECT IMMUN, V59, P3213, DOI 10.1128/IAI.59.9.3213-3218.1991; Fratazzi C, 1999, J LEUKOCYTE BIOL, V66, P763, DOI 10.1002/jlb.66.5.763; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; HENSON PM, 1971, J IMMUNOL, V107, P1547; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Lee J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018367; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Miller BH, 2004, INFECT IMMUN, V72, P2872, DOI 10.1128/IAI.72.5.2872-2878.2004; Morello S, 2006, J IMMUNOL, V177, P7173, DOI 10.4049/jimmunol.177.10.7173; Nozaki Y, 1997, INFECT IMMUN, V65, P3644, DOI 10.1128/IAI.65.9.3644-3647.1997; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Placido R, 2006, CELL IMMUNOL, V244, P10, DOI 10.1016/j.cellimm.2007.02.001; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; ROBERSON SM, 1988, CELL IMMUNOL, V116, P341, DOI 10.1016/0008-8749(88)90236-5; Sawant KV, 2010, MICROBES INFECT, V12, P828, DOI 10.1016/j.micinf.2010.05.009; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Vallerskog T, 2010, J IMMUNOL, V184, P6275, DOI 10.4049/jimmunol.1000304; Vergne I, 2006, AUTOPHAGY, V2, P175, DOI 10.4161/auto.2830	33	22	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27972	10.1371/journal.pone.0027972	http://dx.doi.org/10.1371/journal.pone.0027972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125644	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789200044
J	Sato, W; Kochiyama, T; Uono, S; Matsuda, K; Usui, K; Inoue, Y; Toichi, M				Sato, Wataru; Kochiyama, Takanori; Uono, Shota; Matsuda, Kazumi; Usui, Keiko; Inoue, Yushi; Toichi, Motomi			Rapid Amygdala Gamma Oscillations in Response to Eye Gaze	PLOS ONE			English	Article							ATTENTIONAL SHIFT; RANDOM-FIELD; PERCEPTION; MECHANISMS; INFERENCE; AUTISM	Background: The eye gaze of other individuals conveys important social information and can trigger multiple psychological activities; some of which, such as emotional reactions and attention orienting, occur very rapidly. Although some neuroscientific evidence has suggested that the amygdala may be involved in such rapid gaze processing, no evidence has been reported concerning the speed at which the amygdala responds to eye gaze. Methodology/Principal Findings: To investigate this issue, we recorded electrical activity within the amygdala of six subjects using intracranial electrodes. Subjects observed images of eyes and mosaics pointing in averted and straight directions. The amygdala showed higher gamma-band oscillations for eye gaze than for mosaics, which peaked at 200 ms regardless of the direction of the gaze. Conclusion: These results indicate that the human amygdala rapidly processes eye gaze.	[Sato, Wataru; Kochiyama, Takanori] Kyoto Univ, Hakubi Project, Inuyama, Aichi, Japan; [Uono, Shota; Toichi, Motomi] Kyoto Univ, Fac Human Hlth Sci, Kyoto, Japan; [Matsuda, Kazumi; Usui, Keiko; Inoue, Yushi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Shizuoka, Shizuoka, Japan	Kyoto University; Kyoto University	Sato, W (corresponding author), Kyoto Univ, Hakubi Project, Inuyama, Aichi, Japan.	sato@pri.kyoto-u.ac.jp	Sato, Wataru/E-7503-2017	Sato, Wataru/0000-0002-5335-1272; Kochiyama, Takanori/0000-0002-4023-0674; Uono, Shota/0000-0003-0547-0522	Benesse Corporation	Benesse Corporation	This study was supported by funds from the Benesse Corporation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Akiyama T, 2007, CEREB CORTEX, V17, P2593, DOI 10.1093/cercor/bhl166; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Argyle M., 1976, GAZE MUTUAL GAZE; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; JONES EG, 1976, BRAIN RES, V104, P142, DOI 10.1016/0006-8993(76)90654-5; Kawashima R, 1999, BRAIN, V122, P779, DOI 10.1093/brain/122.4.779; Kilner JM, 2005, NEUROSCI LETT, V374, P174, DOI 10.1016/j.neulet.2004.10.052; Kovach CK, 2011, NEUROIMAGE, V54, P213, DOI 10.1016/j.neuroimage.2010.08.002; Lachaux JP, 2003, J PHYSIOLOGY-PARIS, V97, P613, DOI 10.1016/j.jphysparis.2004.01.018; Larsen A, 2009, SCAND J PSYCHOL, V50, P526, DOI 10.1111/j.1467-9450.2009.00782.x; Menon V, 1996, ELECTROEN CLIN NEURO, V98, P89, DOI 10.1016/0013-4694(95)00206-5; Mihara T, 2001, EPILEPSY SURG, P613; Nation K, 2008, DEV PSYCHOPATHOL, V20, P79, DOI 10.1017/S0954579408000047; Okada T, 2008, SOC COGN AFFECT NEUR, V3, P80, DOI 10.1093/scan/nsm027; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pare D, 2003, PROG NEUROBIOL, V70, P409, DOI 10.1016/S0301-0082(03)00104-7; Sato W, 2004, NEUROIMAGE, V22, P1006, DOI 10.1016/j.neuroimage.2004.02.030; Sato W, 2007, EXP BRAIN RES, V183, P87, DOI 10.1007/s00221-007-1025-x; Sato W, 2011, NEUROPSYCHOLOGIA, V49, P612, DOI 10.1016/j.neuropsychologia.2010.12.025; Sato W, 2009, NEUROIMAGE, V45, P984, DOI 10.1016/j.neuroimage.2008.12.052; STROM JC, 1979, PERS SOC PSYCHOL B, V5, P114, DOI 10.1177/014616727900500125; vonGrunau M, 1995, PERCEPTION, V24, P1297, DOI 10.1068/p241297; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Wicker B, 1998, NEUROIMAGE, V8, P221, DOI 10.1006/nimg.1998.0357; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; YOUNG AW, 1995, BRAIN, V118, P15, DOI 10.1093/brain/118.1.15	31	17	17	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28188	10.1371/journal.pone.0028188	http://dx.doi.org/10.1371/journal.pone.0028188			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863MI	22140541	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100047
J	Clark, AT; Rykken, JJ; Farrell, BD				Clark, Adam T.; Rykken, Jessica J.; Farrell, Brian D.			The Effects of Biogeography on Ant Diversity and Activity on the Boston Harbor Islands, Massachusetts, USA	PLOS ONE			English	Article							EXPERIMENTAL ZOOGEOGRAPHY; ASSEMBLY RULES; COMMUNITIES; POPULATION; COLONIZATION; BIODIVERSITY; DISTURBANCE; HABITAT	Many studies have examined how island biogeography affects diversity on the scale of island systems. In this study, we address how diversity varies over very short periods of time on individual islands. To do this, we compile an inventory of the ants living in the Boston Harbor Islands National Recreation Area, Boston, Massachusetts, USA using data from a five-year All Taxa Biodiversity Inventory of the region's arthropods. Consistent with the classical theory of island biogeography, species richness increased with island size, decreased with island isolation, and remained relatively constant over time. Additionally, our inventory finds that almost half of the known Massachusetts ant fauna can be collected in the BHI, and identifies four new species records for Massachusetts, including one new to the United States, Myrmica scabrinodis. We find that the number of species actually active on islands depended greatly on the timescale under consideration. The species that could be detected during any given week of sampling could by no means account for total island species richness, even when correcting for sampling effort. Though we consistently collected the same number of species over any given week of sampling, the identities of those species varied greatly between weeks. This variation does not result from local immigration and extinction of species, nor from seasonally-driven changes in the abundance of individual species, but rather from weekly changes in the distribution and activity of foraging ants. This variation can be upwards of 50% of ant species per week. This suggests that numerous ant species on the BHI share the same physical space at different times. This temporal partitioning could well explain such unexpectedly high ant diversity in an isolated, urban site.	[Clark, Adam T.] Harvard Univ, Cambridge, MA 02138 USA; [Rykken, Jessica J.; Farrell, Brian D.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Farrell, Brian D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Clark, AT (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	adam.tclark@post.harvard.edu	Clark, Adam/AAC-1039-2022; Clark, Adam Thomas/S-7544-2017	Clark, Adam/0000-0002-8843-3278; Clark, Adam Thomas/0000-0002-8843-3278	Harvard Forest REU; National Park Service; Green Fund; Stone Foundation; University's Center for the Environment, Herchel Smith Summer Undergraduate Research Fellowship; Museum of Comparative Zoolog	Harvard Forest REU; National Park Service; Green Fund; Stone Foundation; University's Center for the Environment, Herchel Smith Summer Undergraduate Research Fellowship; Museum of Comparative Zoolog	Public Funding: Harvard Forest REU, the National Park Service. Private Funding: Green Fund, the Stone Foundation. Harvard University internal grants: University's Center for the Environment, Herchel Smith Summer Undergraduate Research Fellowship, Museum of Comparative Zoology's Grants in aid of Undergraduate Research, and Undergraduate Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN AN, 1995, J BIOGEOGR, V22, P15, DOI 10.2307/2846070; Baselga A, 2010, ECOLOGY, V91, P1974, DOI 10.1890/09-0320.1; Bossert WH, 2010, STOCHASTIC FINITE ST; CHAO A, 1984, SCAND J STAT, V11, P265; Chase J.M., 2009, ECOLOGICAL NICHES LI; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; Coovert GA, 2005, B OHIO BIOL SURVEY N, V15, p[vi, 1]; Dunn RR, 2007, BIOL J LINN SOC, V91, P191, DOI 10.1111/j.1095-8312.2007.00783.x; Ellison AM, 2010, ECOLOGY, V91, P1962, DOI 10.1890/09-1692.1; Gause GF, 1932, J EXP BIOL, V9, P389; GOLDSTEIN EL, 1975, EVOLUTION, V29, P750, DOI 10.1111/j.1558-5646.1975.tb00869.x; Gotelli NJ, 2010, OECOLOGIA, V162, P463, DOI 10.1007/s00442-009-1474-y; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gotelli NJ, 2002, OIKOS, V99, P591, DOI 10.1034/j.1600-0706.2002.11734.x; Groden E, 2005, J ECON ENTOMOL, V98, P1774, DOI 10.1603/0022-0493-98.6.1774; HAVEL JE, 1987, HYDROBIOLOGIA, V150, P273, DOI 10.1007/BF00008708; Holldobler B., 1990, pi; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; Hurd P, 2001, G TEST; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Kaspari Michael, 2000, P89; Kaspari Michael, 2000, P9; Lach L., 2009, ANT ECOLOGY; LEVIN SA, 1974, AM NAT, V108, P207, DOI 10.1086/282900; Lomolino MV, 2001, J BIOGEOGR, V28, P431, DOI 10.1046/j.1365-2699.2001.00550.x; Long JD, 2009, ECOLOGY, V90, P863, DOI 10.1890/08-1337.1; Losos JB, THEORY ISLAND BIOGEO; MacArthur R.H., 1972, pvii; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; MassGIS, 2010, MASSGIS; McGlynn TP, 2004, OIKOS, V106, P611, DOI 10.1111/j.0030-1299.2004.13135.x; Molles M, CONCEPTS APPL; National Weather Service, 1999, US STAT TERR; Niemel? J., 1999, URBAN ECOSYST, V3, P57, DOI [10.1023/A:1009595932440, DOI 10.1023/A:1009595932440]; Osborn F, 1999, STUD NEOTROP FAUNA E, V34, P59, DOI 10.1076/snfe.34.1.59.8918; Pereira HM, 2006, ECOLOGY, V87, P1877, DOI 10.1890/0012-9658(2006)87[1877:MBDICL]2.0.CO;2; Pratt SC, 2005, ANIM BEHAV, V70, P1023, DOI 10.1016/j.anbehav.2005.01.022; Pratt SC, 2005, BEHAV ECOL, V16, P488, DOI 10.1093/beheco/ari020; R Development Core Team, 2006, R LANG ENV STAT COMP; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Rizali A, 2010, J BIOGEOGR, V37, P229, DOI 10.1111/j.1365-2699.2009.02194.x; Rosenzweig ML, 2003, CONSERV BIOL, V17, P864, DOI 10.1046/j.1523-1739.2003.01281.x; ROSENZWEIG ML, 1999, ADV ECOLOGICAL THEOR, P249; ROSENZWEIG ML, SPECIES DIVERSITY SP; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Sanders NJ, 2007, J BIOGEOGR, V34, P1632, DOI 10.1111/j.1365-2699.2007.01714.x; Schoereder JH, 2004, AUSTRAL ECOL, V29, P391, DOI 10.1111/j.1442-9993.2004.01378.x; SIMBERLOFF D, 1976, ECOLOGY, V57, P629, DOI 10.2307/1936179; SIMBERLOFF DS, 1969, ECOLOGY, V50, P278, DOI 10.2307/1934856; Suarez AV, 1998, ECOLOGY, V79, P2041, DOI 10.1890/0012-9658(1998)079[2041:EOFAIO]2.0.CO;2; Tilman D, 2011, AM NAT, V178, P355, DOI 10.1086/661245; Turner IIBL, 1990, EARTH TRANSFORMED HU; Venegas SA, 1996, GEOPHYS RES LETT, V23, P2673, DOI 10.1029/96GL02373; Wilkie KTR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013146; Williams MR, 2009, J BIOGEOGR, V36, P1994, DOI 10.1111/j.1365-2699.2009.02110.x; Wilsey BJ, 2010, ECOLOGY, V91, P1984, DOI 10.1890/09-0351.1; Wilson E.O., 1987, Conservation Biology, V1, P344, DOI 10.1111/j.1523-1739.1987.tb00055.x; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; Wilson EO, 1967, THEORY ISLAND BIOGEO; WRIGHT S, 1945, P NATL ACAD SCI USA, V31, P382, DOI 10.1073/pnas.31.12.382	61	12	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28045	10.1371/journal.pone.0028045	http://dx.doi.org/10.1371/journal.pone.0028045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140504	Green Submitted, gold, Green Published			2022-12-25	WOS:000298166300024
J	Lampert, TJ; Coleman, KD; Hennessey, TM				Lampert, Thomas J.; Coleman, Kevin D.; Hennessey, Todd M.			A Knockout Mutation of a Constitutive GPCR in Tetrahymena Decreases Both G-Protein Activity and Chemoattraction	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; COUPLED RECEPTOR GPR1; GTP-GAMMA-S; GENE-EXPRESSION; ALPHA-SUBUNIT; BIOELECTRIC CONTROL; STIMULATED BINDING; SWIMMING BEHAVIOR; CRYSTAL-STRUCTURE; INVERSE AGONISTS	Although G-protein coupled receptors (GPCRs) are a common element in many chemosensory transduction pathways in eukaryotic cells, no GPCR or regulated G-protein activity has yet been shown in any ciliate. To study the possible role for a GPCR in the chemoresponses of the ciliate Tetrahymena, we have generated a number of macronuclear gene knockouts of putative GPCRs found in the Tetrahymena Genome database. One of these knockout mutants, called G6, is a complete knockout of a gene that we call GPCR6 (TTHERM_00925490). Based on sequence comparisons, the Gpcr6p protein belongs to the Rhodopsin Family of GPCRs. Notably, Gpcr6p shares highest amino acid sequence homologies to GPCRs from Paramecium and several plants. One of the phenotypes of the G6 mutant is a decreased responsiveness to the depolarizing ions Ba2+ and K+, suggesting a decrease in basal excitability (decrease in Ca2+ channel activity). The other major phenotype of G6 is a loss of chemoattraction to lysophosphatidic acid (LPA) and proteose peptone (PP), two known chemoattractants in Tetrahymena. Using microsomal [S-35]GTP gamma S binding assays, we found that wild-type (CU427) have a prominent basal G-protein activity. This activity is decreased to the same level by pertussis toxin (a G-protein inhibitor), addition of chemoattractants, or the G6 mutant. Since the basal G-protein activity is decreased by the GPCR6 knockout, it is likely that this gene codes for a constitutively active GPCR in Tetrahymena. We propose that chemoattractants like LPA and PP cause attraction in Tetrahymena by decreasing the basal G-protein stimulating activity of Gpcr6p. This leads to decreased excitability in wild-type and longer runs of smooth forward swimming (less interrupted by direction changes) towards the attractant. Therefore, these attractants may work as inverse agonists through the constitutively active Gpcr6p coupled to a pertussis-sensitive G-protein.	[Lampert, Thomas J.; Coleman, Kevin D.; Hennessey, Todd M.] SUNY Buffalo, Dept Biol Sci, Amherst, NY 14221 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lampert, TJ (corresponding author), SUNY Buffalo, Dept Biol Sci, Amherst, NY 14221 USA.	thennes@buffalo.edu			NSF [MCB-0445362]	NSF(National Science Foundation (NSF))	This work was supported by the NSF [grant number MCB-0445362] to T. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; ADLER J, 1987, ANN NY ACAD SCI, V510, P95; ASANO T, 1984, BIOCHEMISTRY-US, V23, P5460, DOI 10.1021/bi00318a013; Bell WE, 2007, J EXP BIOL, V210, P357, DOI 10.1242/jeb.02642; BERNAL J, 1991, J EXP BIOL, V155, P505; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; CassidyHanley D, 1997, GENETICS, V146, P135; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Couty JP, 2009, J PHARMACOL EXP THER, V329, P1142, DOI 10.1124/jpet.108.147686; De Ondarza J, 2003, J EUKARYOT MICROBIOL, V50, P349; Deber CM, 2001, PROTEIN SCI, V10, P212, DOI 10.1110/ps.30301; Deng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018605; Drummond AJ, 2010, GENEIOUS V5 3; Dyer M, 2000, MOL BIOCHEM PARASIT, V110, P435, DOI 10.1016/S0166-6851(00)00312-1; ECKERT R, 1972, SCIENCE, V176, P473, DOI 10.1126/science.176.4034.473; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; FABCZAK H, 1993, J PHOTOCH PHOTOBIO B, V21, P47, DOI 10.1016/1011-1344(93)80163-4; FRANCIS JT, 1995, J EUKARYOT MICROBIOL, V42, P78, DOI 10.1111/j.1550-7408.1995.tb01544.x; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; GAERTIG J, 1994, NUCLEIC ACIDS RES, V22, P5391, DOI 10.1093/nar/22.24.5391; Gronlien HK, 2010, J EXP BIOL, V213, P3980, DOI 10.1242/jeb.042903; Gudi S, 1998, P NATL ACAD SCI USA, V95, P2515, DOI 10.1073/pnas.95.5.2515; Hai B, 1997, P NATL ACAD SCI USA, V94, P1310, DOI 10.1073/pnas.94.4.1310; HANYU N, 1986, EMBO J, V5, P1307, DOI 10.1002/j.1460-2075.1986.tb04360.x; HELLUNGLARSEN P, 1986, BIOL BULL, V170, P357, DOI 10.2307/1541847; Hennessey TM, 2000, METHODS CELL BIOL, V62, P363; Hennessey Todd M, 2005, Purinergic Signal, V1, P101, DOI 10.1007/s11302-005-6213-1; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; JOHNSON RL, 1993, GENE DEV, V7, P273, DOI 10.1101/gad.7.2.273; Jones JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001446; Koppelhus U, 2001, METH MOL B, V161, P101; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuruvilla HG, 1997, J EUKARYOT MICROBIOL, V44, P263, DOI 10.1111/j.1550-7408.1997.tb05710.x; Lampert TJ, 2011, CELL BIOL INT, V35, P519, DOI 10.1042/CBI20100320; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEICK V, 1994, J EUKARYOT MICROBIOL, V41, P546, DOI 10.1111/j.1550-7408.1994.tb01515.x; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Leurs R, 2003, INT CONGR SER, V1249, P131, DOI 10.1016/S0531-5131(03)00608-3; Levoye A, 2006, EMBO REP, V7, P1094, DOI 10.1038/sj.embor.7400838; Lin WZ, 2009, PROTEIN ENG DES SEL, V22, P699, DOI 10.1093/protein/gzp057; Lunn CA, 2008, BRIT J PHARMACOL, V153, P226, DOI 10.1038/sj.bjp.0707480; MACHEMER H, 1977, FORTS ZOOL, V24, P195; Maidan MM, 2005, BIOCHEM SOC T, V33, P291, DOI 10.1042/BST0330291; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Marino MJ, 2001, J EUKARYOT MICROBIOL, V48, P527, DOI 10.1111/j.1550-7408.2001.tb00188.x; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Nilson SE, 2010, PLANT PHYSIOL, V152, P2067, DOI 10.1104/pp.109.148262; NODA K, 1994, J BIOL CHEM, V269, P6743; ONIMARU H, 1980, P JPN ACAD B-PHYS, V56, P538, DOI 10.2183/pjab.56.538; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Papasaikas PK, 2004, NUCLEIC ACIDS RES, V32, pW380, DOI 10.1093/nar/gkh431; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; RENAUD FL, 1995, J EUKARYOT MICROBIOL, V42, P205, DOI 10.1111/j.1550-7408.1995.tb01566.x; Risk JM, 2009, PLANT PHYSIOL, V150, P6, DOI 10.1104/pp.109.135749; Rodgers LF, 2008, J EUKARYOT MICROBIOL, V55, P27, DOI 10.1111/j.1550-7408.2007.00300.x; Rohrer DK, 1998, PHYSIOL REV, V78, P35, DOI 10.1152/physrev.1998.78.1.35; SAIMI Y, 1987, ANNU REV GENET, V21, P47, DOI 10.1146/annurev.genet.21.1.47; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SCHEIN SJ, 1976, GENETICS, V84, P453; Schenk PW, 2001, BIOCHEM BIOPH RES CO, V282, P765, DOI 10.1006/bbrc.2001.4649; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Shang YH, 2002, P NATL ACAD SCI USA, V99, P3734, DOI 10.1073/pnas.052016199; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; SNAARJAGALSKA BE, 1988, FEBS LETT, V232, P148, DOI 10.1016/0014-5793(88)80405-8; Suwa M, 2011, PHARMACEUTICALS, V4, P652, DOI 10.3390/ph4040652; TAKAHASHI M, 1992, DEV GENET, V13, P174, DOI 10.1002/dvg.1020130212; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; TIBERI M, 1994, J BIOL CHEM, V269, P27925; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; UI M, 1990, ADP RIBOSYLATING TOX, P45; van Es S, 1999, CELL MOL LIFE SCI, V55, P1341, DOI 10.1007/s000180050374; VANHOUTEN J, 1978, J COMP PHYSIOL, V127, P167, DOI 10.1007/BF01352301; Welton RM, 2000, GENETICS, V156, P513; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xue CY, 2008, FEMS MICROBIOL REV, V32, P1010, DOI 10.1111/j.1574-6976.2008.00131.x; Zhang W, 2011, J EXP BOT, V62, P2371, DOI 10.1093/jxb/erq424	80	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28022	10.1371/journal.pone.0028022	http://dx.doi.org/10.1371/journal.pone.0028022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140501	Green Submitted, gold, Green Published			2022-12-25	WOS:000298166300022
J	Chen, YS; Wu, MJ; Huang, CY; Lin, SC; Chuang, TH; Yu, CC; Lo, JF				Chen, Yu-Syuan; Wu, Meng-Ju; Huang, Chih-Yang; Lin, Shu-Chun; Chuang, Tsung-Hsien; Yu, Cheng-Chia; Lo, Jeng-Fan			CD133/Src Axis Mediates Tumor Initiating Property and Epithelial-Mesenchymal Transition of Head and Neck Cancer	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; STEM-CELLS; ACTIVATION; IDENTIFICATION; PHOSPHORYLATION; SUBPOPULATION; EXPRESSION; CAPACITY; PROMOTES	Background: Head and Neck squamous cell carcinoma (HNSCC) is a human lethal cancer with clinical, pathological, phenotypical and biological heterogeneity. Caner initiating cells (CICs), which are responsible for tumor growth and coupled with gain of epithelial-mesenchymal transition (EMT), have been identified. Previously, we enriched a subpopulation of head and neck cancer initiating cells (HN-CICs) with up-regulation of CD133 and enhancement of EMT. Others demonstrate that Src kinase interacts with and phosphorylates the cytoplasmic domain of CD133. However, the physiological function of CD133/Src signaling in HNSCCs has not been uncovered. Methodology/Principal Finding: Herein, we determined the critical role of CD133/Src axis modulating stemness, EMT and tumorigenicity of HNSCC and HN-CICs. Initially, down-regulation of CD133 significantly reduced the self-renewal ability and expression of stemness genes, and promoted the differentiation and apoptotic capability of HN-CICs. Additionally, knockdown of CD133 in HN-CICs also lessened both in vitro malignant properties including cell migration/cell invasiveness/anchorage independent growth, and in vivo tumor growth by nude mice xenotransplantation assay. In opposite, overexpression of CD133 enhanced the stemness properties and tumorigenic ability of HNSCCs. Lastly, up-regulation of CD133 increased phosphorylation of Src coupled with EMT transformation in HNSCCs, on the contrary, silence of CD133 or treatment of Src inhibitor inversely abrogated above phenotypic effects, which were induced by CD133 up-regulation in HNSCCs or HN-CICs. Conclusion/Significance: Our results suggested that CD133/Src signaling is a regulatory switch to gain of EMT and of stemness properties in HNSCC. Finally, CD133/Src axis might be a potential therapeutic target for HNSCC by eliminating HN-CICs.	[Chen, Yu-Syuan; Wu, Meng-Ju; Lin, Shu-Chun; Yu, Cheng-Chia; Lo, Jeng-Fan] Natl Yang Ming Univ, Inst Oral Biol, Taipei 112, Taiwan; [Huang, Chih-Yang; Lo, Jeng-Fan] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Huang, Chih-Yang; Lo, Jeng-Fan] China Med Univ, Inst Med Sci, Taichung, Taiwan; [Huang, Chih-Yang] China Med Univ, Inst Basic Med Sci, Taichung, Taiwan; [Huang, Chih-Yang] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Chuang, Tsung-Hsien] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan, Miaoli County, Taiwan; [Yu, Cheng-Chia] Chung Shan Med Univ, Inst Oral Biol & Biomat Sci, Taichung, Taiwan; [Yu, Cheng-Chia] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Yu, Cheng-Chia] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Lo, Jeng-Fan] Natl Yang Ming Univ, Dept Dent, Taipei 112, Taiwan; [Lo, Jeng-Fan] Taipei Vet Gen Hosp, Dept Dent, Taipei, Taiwan	National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; National Health Research Institutes - Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Chen, YS (corresponding author), Natl Yang Ming Univ, Inst Oral Biol, Taipei 112, Taiwan.	ccyu@csmu.edu.tw; jflo@ym.edu.tw	Wu, Meng-Ju/AAY-9410-2021; Wu, Meng-Ju/AAY-9406-2021; Lo, Jeng-Fan/ABB-2820-2020; Lo, Jeng-Fan/AAE-9626-2020; Chuang, Tsung-Hsien/F-9679-2010; Yuang, Chih-Yang/O-5111-2015	Wu, Meng-Ju/0000-0001-6847-7065; Lo, Jeng-Fan/0000-0001-7188-9140; Lo, Jeng-Fan/0000-0001-7188-9140; 	National Science Council [NSC95N444, NSC97N456, NSC99N024, NSC100-2314-B-040-001]; Taipei Veterans General Hospital [V97ER2018, V98ER2018]; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan) [97ACD113, 97ACT302, 98ACT302]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Yang-Ming University (Ministry of Education, Aim for the Top University Plan)(Ministry of Education, Taiwan)	This study is supported by research grants from National Science Council (NSC95N444, NSC97N456, NSC99N024 and NSC100-2314-B-040-001), Taipei Veterans General Hospital (V97ER2018 and V98ER2018) and National Yang-Ming University (Ministry of Education, Aim for the Top University Plan: 97ACD113, 97ACT302 and 98ACT302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Beier D, 2008, BRAIN PATHOL, V18, P370, DOI 10.1111/j.1750-3639.2008.00130.x; Boivin D, 2009, BIOCHEMISTRY-US, V48, P3998, DOI 10.1021/bi900159d; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Chu P, 2009, INT J CANCER, V124, P1312, DOI 10.1002/ijc.24061; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; Dong L, 2010, NEUROSCI LETT, V484, P210, DOI 10.1016/j.neulet.2010.08.057; Elsaba TMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010714; Fujimoto M, 2000, IMMUNITY, V13, P47, DOI 10.1016/S1074-7613(00)00007-8; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Harper LJ, 2007, J ORAL PATHOL MED, V36, P594, DOI 10.1111/j.1600-0714.2007.00617.x; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kelly SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010035; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lo JF, 2011, CANCER RES, V71, P1912, DOI 10.1158/0008-5472.CAN-10-2350; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsumoto K, 2009, CANCER RES, V69, P7160, DOI 10.1158/0008-5472.CAN-09-1289; Mazumdar J, 2009, J CELL MOL MED; McCord AM, 2009, MOL CANCER RES, V7, P489, DOI 10.1158/1541-7786.MCR-08-0360; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Nagaharu K, 2011, AM J PATHOL, V178, P754, DOI 10.1016/j.ajpath.2010.10.015; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Rappa G, 2008, STEM CELLS, V26, P3008, DOI 10.1634/stemcells.2008-0601; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Sun X, MOL CANC, V9, P17; Tabu K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-39; Takahashi K, 1989, J JPN STOMATOL SOC, V38, P20, DOI DOI 10.11277/stomatology1952.38.20; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang Q, 2009, HISTOPATHOLOGY, V55, P284, DOI 10.1111/j.1365-2559.2009.03378.x; Wu MJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-283; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yang SC, 2003, J ORAL PATHOL MED, V32, P600, DOI 10.1034/j.1600-0714.2003.00199.x; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhang Q, 2009, CANC LETT; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137; Zito G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003544	59	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28053	10.1371/journal.pone.0028053	http://dx.doi.org/10.1371/journal.pone.0028053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140506	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163400029
J	He, JQ; Vu, DM; Hunt, G; Chugh, A; Bhatnagar, A; Bolli, R				He, Jia-Qiang; Duc Minh Vu; Hunt, Greg; Chugh, Atul; Bhatnagar, Aruni; Bolli, Roberto			Human Cardiac Stem Cells Isolated from Atrial Appendages Stably Express c-kit	PLOS ONE			English	Article							PROGENITOR CELLS; MAST-CELLS; HEART; IDENTIFICATION; DIFFERENTIATE; MULTIPOTENT; MYOCARDIUM; EXPANSION; PROLIFERATION; FIBROBLASTS	The in vivo studies of myocardial infarct using c-kit(+)/Lin(-) cardiac stem cells (CSCs) are still in the early stage with margin or no beneficial effects for cardiac function. One of the potential reasons may be related to the absence of fully understanding the properties of these cells both in vitro and in vivo. In the present study, we aimed to systematically examine how CSCs adapted to in vitro cell processes and whether there is any cell contamination after long-term culture. Human CSCs were enzymatically isolated from the atrial appendages of patients. The fixed tissue sections, freshly isolated or cultured CSCs were then used for identification of c-kit(+)/Lin(-) cells, detection of cell contamination, or differentiation of cardiac lineages. By specific antibody staining, we demonstrated that tissue sections from atrial appendages contained less than 0.036% c-kit(+)/Lin(-) cells. For the first time, we noted that without magnetic activated cell sorting ( MACS), the percentages of c-kit(+)/Lin(-) cells gradually increased up to similar to 40% during continuously culture between passage 2 to 8, but could not exceed.80% unless c-kit MACS was carried out. The resulting c-kit(+)/Lin(-) cells were negative for CD34, CD45, CD133, and Lin markers, but positive for KDR and CD31 in few patients after c-kit MACS. Lin depletion seemed unnecessary for enrichment of c-kit(+)/Lin(-) cell population. Following induced differentiation, c-kit(+)/Lin(-) CSCs demonstrated strong differentiation towards cardiomyocytes but less towards smooth and endothelial cells. We concluded that by using an enzymatic dissociation method, a large number, or higher percentage, of relative pure human CSCs with stable expression of c-kit(+) could be obtained from atrial appendage specimens within,4 weeks following c-kit MACS without Lin depletion. This simple but cost-effective approach can be used to obtain enough numbers of stably-expressed c-kit(+)/Lin(-) cells for clinical trials in repairing myocardial infarction.	[He, Jia-Qiang; Duc Minh Vu; Hunt, Greg; Chugh, Atul; Bhatnagar, Aruni; Bolli, Roberto] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA	University of Louisville	He, JQ (corresponding author), Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA.	rbolli@louisville.edu	Chugh, Atul R/M-9667-2018; Bolli, Roberto/A-6870-2010		National Institutes of Health [5P20RR024489, 5P01HL078825]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health 5P20RR024489 (to AB/JQH) and 5P01HL078825 (to RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72; Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; Bailey B, 2009, REGEN MED, V4, P823, DOI [10.2217/rme.09.51, 10.2217/RME.09.51]; Barile Lucio, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS9, DOI 10.1038/ncpcardio0738; Barile L, 2007, PROG CARDIOVASC DIS, V50, P31, DOI 10.1016/j.pcad.2007.03.005; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli P, 2010, ANN NY ACAD SCI, V1211, P113, DOI 10.1111/j.1749-6632.2010.05814.x; Bollini S, 2011, J MOL CELL CARDIOL, V50, P296, DOI 10.1016/j.yjmcc.2010.07.006; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Chimenti I, 2009, P NATL ACAD SCI USA, V106, pE78, DOI 10.1073/pnas.0903261106; Cottage CT, 2010, CIRC RES, V106, P891, DOI 10.1161/CIRCRESAHA.109.208629; D'Alessandro DA, 2009, CIRC RES, V105, P1128, DOI 10.1161/CIRCRESAHA.109.207266; D'Amario D, 2011, CIRC RES, V108, P857, DOI 10.1161/CIRCRESAHA.111.241380; Davis DR, 2010, J MOL CELL CARDIOL, V49, P312, DOI 10.1016/j.yjmcc.2010.02.019; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; Ellison Georgina M, 2010, Front Biosci (Schol Ed), V2, P641; ESTERRE P, 1992, CELL MOL BIOL, V38, P297; Fajtova M, 2010, NEOPLASMA, V57, P392, DOI 10.4149/neo_2010_05_392; Genovese A, 2010, CHEM IMMUNOL ALLERGY, V95, P98, DOI 10.1159/000315945; Gittenberger-de Groot AC, 2010, J CELL MOL MED, V14, P1056, DOI 10.1111/j.1582-4934.2010.01077.x; Guan K, 2007, J MOL CELL CARDIOL, V43, P377, DOI 10.1016/j.yjmcc.2007.07.056; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; Itzhaki-Alfia A, 2009, CIRCULATION, V120, P2559, DOI 10.1161/CIRCULATIONAHA.109.849588; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Kashiwakura I, 2003, BRIT J HAEMATOL, V122, P479, DOI 10.1046/j.1365-2141.2003.04444.x; KATAYAMA N, 1993, BLOOD, V82, P2353; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kostin S, 2009, J CELL MOL MED, V13, P295, DOI 10.1111/j.1582-4934.2008.00668.x; Kuhn EN, 2010, J CELL PHYSIOL, V225, P321, DOI 10.1002/jcp.22281; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Lovell MJ, 2010, HEART, V96, P1531, DOI 10.1136/hrt.2009.192385; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; Matsuura K, 2005, J BIOL CHEM, V280, P9088, DOI 10.1074/jbc.M413042200; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Meuser-Batista M, 2008, TISSUE CELL, V40, P309, DOI 10.1016/j.tice.2008.02.006; Miettinen M, 2005, APPL IMMUNOHISTO M M, V13, P205, DOI 10.1097/01.pai.0000173054.83414.22; Mishra R, 2011, CIRCULATION, V123, P364, DOI 10.1161/CIRCULATIONAHA.110.971622; Monsel G, 2010, ONCOGENE, V29, P227, DOI 10.1038/onc.2009.320; Mouquet F, 2005, CIRC RES, V97, P1090, DOI 10.1161/01.RES.0000194330.66545.f5; MUTA K, 1995, BLOOD, V86, P572, DOI 10.1182/blood.V86.2.572.bloodjournal862572; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; ORLIC D, 1993, BLOOD, V82, P762, DOI 10.1182/blood.V82.3.762.bloodjournal823762; Orlic D, 2001, ANN NY ACAD SCI, V938, P221; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Pfister O, 2008, CIRC RES, V103, P825, DOI 10.1161/CIRCRESAHA.108.174615; Reid AC, 2007, IMMUNOL REV, V217, P123, DOI 10.1111/j.1600-065X.2007.00514.x; RONNOVJESSEN L, 1992, J HISTOCHEM CYTOCHEM, V40, P475, DOI 10.1177/40.4.1552184; Rota M, 2006, CIRC RES, V99, P42, DOI 10.1161/01.RES.0000231289.63468.08; Sandstedt J, 2010, BASIC RES CARDIOL, V105, P545, DOI 10.1007/s00395-010-0088-1; SINGER KH, 1989, J INVEST DERMATOL, V92, P166, DOI 10.1111/1523-1747.ep12276685; Smith RR, 2008, HEART RHYTHM, V5, P880, DOI 10.1016/j.hrthm.2008.02.011; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Smith RR, 2008, HEART RHYTHM, V5, P749, DOI 10.1016/j.hrthm.2008.02.010; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; SPERR WR, 1994, BLOOD, V84, P3876, DOI 10.1182/blood.V84.11.3876.bloodjournal84113876; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; van Vliet Patrick, 2007, Expert Rev Cardiovasc Ther, V5, P33, DOI 10.1586/14779072.5.1.33; Wu JC, 2010, J NUCL MED, V51, p128S, DOI 10.2967/jnumed.109.068239; Yeoh JSG, 2007, MECH AGEING DEV, V128, P17, DOI 10.1016/j.mad.2006.11.005; Zeisberg EM, 2010, CIRC RES, V107, P1304, DOI 10.1161/CIRCRESAHA.110.231910; Zhou Y, 2010, J HISTOCHEM CYTOCHEM, V58, P309, DOI 10.1369/jhc.2009.955146	71	73	78	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27719	10.1371/journal.pone.0027719	http://dx.doi.org/10.1371/journal.pone.0027719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140461	Green Submitted, Green Published, gold			2022-12-25	WOS:000298163400014
J	Rauf, Z; O'Brien, E; Stampalija, T; Ilioniu, FP; Lavender, T; Alfirevic, Z				Rauf, Zubair; O'Brien, Ediri; Stampalija, Tamara; Ilioniu, Florin P.; Lavender, Tina; Alfirevic, Zarko			Home Labour Induction with Retrievable Prostaglandin Pessary and Continuous Telemetric Trans-Abdominal Fetal ECG Monitoring	PLOS ONE			English	Article							TRIAL	Objective: To evaluate the feasibility of continuous telemetric trans-abdominal fetal electrocardiogram (a-fECG) in women undergoing labour induction at home. Study Design: Low risk women with singleton term pregnancy undergoing labour induction with retrievable, slow-release dinoprostone pessaries (n = 70) were allowed home for up to 24 hours, while a-fECG and uterine activity were monitored in hospital via wireless technology. Semi-structured diaries were analysed using a combined descriptive and interpretive approach. Results: 62/70 women (89%) had successful home monitoring; 8 women (11%) were recalled because of signal loss. Home monitoring lasted between 2-22 hours (median 10 hours). Good quality signal was achieved most of the time (86%, SD 10%). 3 women were recalled back to hospital for suspicious a-fECG. In 2 cases suspicious a-fECG persisted, requiring Caesarean section after recall to hospital. 48/51 women who returned the diary coped well (94%); 46/51 were satisfied with home monitoring (90%). Conclusions: Continuous telemetric trans-abdominal fetal ECG monitoring of ambulatory women undergoing labour induction is feasible and acceptable to women.	[Rauf, Zubair; Stampalija, Tamara; Ilioniu, Florin P.; Alfirevic, Zarko] Univ Liverpool, Liverpool Womens Hosp, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [O'Brien, Ediri; Lavender, Tina] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England	University of Liverpool; University of Manchester	Rauf, Z (corresponding author), Univ Liverpool, Liverpool Womens Hosp, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England.	zarko@liv.ac.uk	Stampalija, Tamara/K-4900-2014; Lavender, Tina/B-1211-2011	Lavender, Tina/0000-0003-1473-4956; stampalija, tamara/0000-0002-9080-3848	Ferring Pharmaceuticals; Monica Healthcare Ltd	Ferring Pharmaceuticals(Ferring Pharmaceuticals); Monica Healthcare Ltd	This study was supported by an unrestricted educational grant to the University of Liverpool provided jointly by Ferring Pharmaceuticals and Monica Healthcare Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists (ACOG), 2009, ACOG PRACT B, V107; Austin SC, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.014; Biem Sandra R D, 2003, J Obstet Gynaecol Can, V25, P23; Boers KE, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c7087; Bollapragada SS, 2009, BJOG-INT J OBSTET GY, V116, P1185, DOI 10.1111/j.1471-0528.2009.02216.x; Carter B, 2004, DEMYSTIFYING QUALITA; Dowswell T, 2010, COCHRANE DB SYST REV, V8; Kelly AJ, 2009, COCHRANE DB SYST REV, V4; Kelly AJ, 2009, COCHRANE DB SYST REV, V2; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; Reid M, 2011, MIDWIFERY, V27, P30, DOI 10.1016/j.midw.2009.11.003; Shetty A, 2005, EUR J OBSTET GYN R B, V123, P56, DOI 10.1016/j.ejogrb.2005.03.004; Witkop CT, 2009, OBSTET GYNECOL, V113, P206, DOI 10.1097/AOG.0b013e31818db36f	13	31	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28129	10.1371/journal.pone.0028129	http://dx.doi.org/10.1371/journal.pone.0028129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140522	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163400034
J	Cantarel, BL; Erickson, AR; VerBerkmoes, NC; Erickson, BK; Carey, PA; Pan, CL; Shah, M; Mongodin, EF; Jansson, JK; Fraser-Liggett, CM; Hettich, RL				Cantarel, Brandi L.; Erickson, Alison R.; VerBerkmoes, Nathan C.; Erickson, Brian K.; Carey, Patricia A.; Pan, Chongle; Shah, Manesh; Mongodin, Emmanuel F.; Jansson, Janet K.; Fraser-Liggett, Claire M.; Hettich, Robert L.			Strategies for Metagenomic-Guided Whole-Community Proteomics of Complex Microbial Environments	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; PROTEIN IDENTIFICATION; GUT MICROBIOTA; GENE; SEQUENCES; GENOME; METAPROTEOMICS; VERSATILE; SOFTWARE; DATABASE	Accurate protein identification in large-scale proteomics experiments relies upon a detailed, accurate protein catalogue, which is derived from predictions of open reading frames based on genome sequence data. Integration of mass spectrometry-based proteomics data with computational proteome predictions from environmental metagenomic sequences has been challenging because of the variable overlap between proteomic datasets and corresponding short-read nucleotide sequence data. In this study, we have benchmarked several strategies for increasing microbial peptide spectral matching in metaproteomic datasets using protein predictions generated from matched metagenomic sequences from the same human fecal samples. Additionally, we investigated the impact of mass spectrometry-based filters (high mass accuracy, delta correlation), and de novo peptide sequencing on the number and robustness of peptide-spectrum assignments in these complex datasets. In summary, we find that high mass accuracy peptide measurements searched against non-assembled reads from DNA sequencing of the same samples significantly increased identifiable proteins without sacrificing accuracy.	[Cantarel, Brandi L.; Mongodin, Emmanuel F.; Fraser-Liggett, Claire M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Erickson, Alison R.; VerBerkmoes, Nathan C.; Erickson, Brian K.; Carey, Patricia A.; Pan, Chongle; Shah, Manesh; Hettich, Robert L.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN USA; [Erickson, Alison R.; Erickson, Brian K.] Univ Tennessee, Grad Sch Genome Sci & Technol, Knoxville, TN USA; [Jansson, Janet K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Dept Ecol, Berkeley, CA 94720 USA	University System of Maryland; University of Maryland Baltimore; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Cantarel, BL (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	hettichrl@ornl.gov	Jansson, Janet/H-5478-2018; Mongodin, Emmanuel/AAF-1850-2020; Cantarel, Brandi/ABF-5756-2020; Hettich, Robert L/N-1458-2016; Pan, Chongle/C-6960-2008	Jansson, Janet/0000-0002-5487-4315; Mongodin, Emmanuel/0000-0003-3833-7437; Cantarel, Brandi/0000-0003-4126-4478; Hettich, Robert L/0000-0001-7708-786X; Pan, Chongle/0000-0003-2860-0334; Fraser, Claire/0000-0003-1462-2428; Erickson, Brian/0000-0002-1150-5042	National Institutes of Health [UH2DK83991]; Crohn's and Collitis Foundation of America [2458]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Collitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by the National Institutes of Health, Human Microbiome Project, grant UH2DK83991. A portion of the metagenome sequencing was also supported in part by a grant entitled "Metagenomic and metaproteomic analysis of the human gut microbiota in Crohn's disease" (reference # 2458) from the Crohn's and Collitis Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Callister SJ, 2010, ENVIRON SCI TECHNOL, V44, P8897, DOI 10.1021/es101029f; Castellana NE, 2008, P NATL ACAD SCI USA, V105, P21034, DOI 10.1073/pnas.0811066106; Chourey K, 2010, J PROTEOME RES, V9, P6615, DOI 10.1021/pr100787q; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Everley PA, 2007, MOL CELL PROTEOMICS, V6, P1771, DOI 10.1074/mcp.M700057-MCP200; Fermin D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r35; Frank A, 2005, ANAL CHEM, V77, P964, DOI 10.1021/ac048788h; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hoff KJ, 2009, NUCLEIC ACIDS RES, V37, pW101, DOI 10.1093/nar/gkp327; Hsieh EJ, 2010, J PROTEOME RES, V9, P1138, DOI 10.1021/pr900816a; Kim S, 2009, MOL CELL PROTEOMICS, V8, P53, DOI 10.1074/mcp.M800103-MCP200; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196; Mackey AJ, 2002, MOL CELL PROTEOMICS, V1, P139, DOI 10.1074/mcp.M100004-MCP200; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Pearson W R, 2000, Methods Mol Biol, V132, P185; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; RAVEL J, 2010, P NATL ACAD SCI US; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; SOWELL SM, 2010, ISME J; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Thompson MR, 2008, ANAL CHEM, V80, P9517, DOI 10.1021/ac801707s; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; VerBerkmoes NC, 2006, J PROTEOME RES, V5, P287, DOI 10.1021/pr0503230; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Wilkins MJ, 2009, APPL ENVIRON MICROB, V75, P6591, DOI 10.1128/AEM.01064-09; Wilmes P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001778; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	40	46	47	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27173	10.1371/journal.pone.0027173	http://dx.doi.org/10.1371/journal.pone.0027173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132090	gold, Green Submitted, Green Published			2022-12-25	WOS:000298162000011
J	Carvalho, FC; Soares, SG; Tamarozzi, MB; Rego, EM; Roque-Barreira, MC				Carvalho, Fernanda Caroline; Soares, Sandro Gomes; Tamarozzi, Mirela Barros; Rego, Eduardo Magalhaes; Roque-Barreira, Maria-Cristina			The Recognition of N-Glycans by the Lectin ArtinM Mediates Cell Death of a Human Myeloid Leukemia Cell Line	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACETYLGLUCOSAMINYLTRANSFERASE-V; ARTOCARPUS-INTEGRIFOLIA; BINDING SPECIFICITY; ARSENIC TRIOXIDE; NB4 CELLS; KM PLUS; KM+; AUTOPHAGY; CANCER	ArtinM, a D-mannose-binding lectin from Artocarpus heterophyllus (jackfruit), interacts with N-glycosylated receptors on the surface of several cells of hematopoietic origin, triggering cell migration, degranulation, and cytokine release. Because malignant transformation is often associated with altered expression of cell surface glycans, we evaluated the interaction of ArtinM with human myelocytic leukemia cells and investigated cellular responses to lectin binding. The intensity of ArtinM binding varied across 3 leukemia cell lines: NB4>K562>U937. The binding, which was directly related to cell growth suppression, was inhibited in the presence of Man alpha 1-3(Man alpha 1-6)Man beta 1, and was reverted in underglycosylated NB4 cells. ArtinM interaction with NB4 cells induced cell death (IC50 = 10 mu g/mL), as indicated by cell surface exposure of phosphatidylserine and disruption of mitochondrial membrane potential unassociated with caspase activation or DNA fragmentation. Moreover, ArtinM treatment of NB4 cells strongly induced reactive oxygen species generation and autophagy, as indicated by the detection of acidic vesicular organelles in the treated cells. NB4 cell death was attributed to ArtinM recognition of the trimannosyl core of N-glycans containing a beta 1,6-GlcNAc branch linked to alpha 1,6-mannose. This modification correlated with higher levels of N-acetylglucosaminyltransferase V transcripts in NB4 cells than in K562 or U937 cells. Our results provide new insights into the potential of N-glycans containing a beta 1,6-GlcNAc branch linked to alpha 1,6-mannose as a novel target for anti-leukemia treatment.	[Carvalho, Fernanda Caroline; Roque-Barreira, Maria-Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Sao Paulo, Brazil; [Soares, Sandro Gomes; Tamarozzi, Mirela Barros] Invent Biotecnol Ltda, Sao Paulo, Brazil; [Rego, Eduardo Magalhaes] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Carvalho, FC (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Sao Paulo, Brazil.	mcrbarre@fmrp.usp.br	Rego, Eduardo M/A-1058-2012; Roque-Barreira, Maria-Cristina/A-4552-2008; Gomes Soares, Sandro/AGA-3968-2022; Soares, Sandro/O-7114-2016; Rego, Eduardo M./Y-5572-2019; Soares, Sandro/B-3601-2008; Rego, Eduardo/AFS-7973-2022	Rego, Eduardo M/0000-0003-1567-4086; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Gomes Soares, Sandro/0000-0001-7205-2510; Soares, Sandro/0000-0001-7205-2510; Rego, Eduardo M./0000-0003-1567-4086; Rego, Eduardo/0000-0003-1567-4086	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [06/60642-2, 09/3032-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, fellowship 06/60642-2), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). FCC received a scholarship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 09/3032-5). As a company, Invent Biotecnologia encourages its employees to submit manuscripts to journals. Besides this role, the company and the funders did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel A, 2009, INT J CANCER, V125, P991, DOI 10.1002/ijc.24500; Brinck U, 1998, ACTA ANAT, V161, P219; Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; Chahud F, 2009, INT J EXP PATHOL, V90, P166, DOI 10.1111/j.1365-2613.2008.00626.x; Chen L, 1998, ONCOGENE, V17, P2087, DOI 10.1038/sj.onc.1202124; Chen YJ, 2009, AUTOPHAGY, V5, P173, DOI 10.4161/auto.5.2.7360; Coltri KC, 2008, AM J PATHOL, V173, P423, DOI 10.2353/ajpath.2008.080126; Degos L, 2003, BRIT J HAEMATOL, V122, P539, DOI 10.1046/j.1365-2141.2003.04460.x; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Ganiko L, 2005, BBA-GEN SUBJECTS, V1721, P152, DOI 10.1016/j.bbagen.2004.10.012; Goussetis DJ, 2010, J BIOL CHEM, V285, P29989, DOI 10.1074/jbc.M109.090530; Guo HB, 2000, J CANCER RES CLIN, V126, P263, DOI 10.1007/s004320050341; He LZ, 2001, J CLIN INVEST, V108, P1321, DOI 10.1172/JCI200111537; Jeyaprakash AA, 2004, J MOL BIOL, V338, P757, DOI 10.1016/j.jmb.2004.03.040; Kim YS, 2009, PROTEIN PEPTIDE LETT, V16, P499, DOI 10.2174/092986609788167798; LANOTTE M, 1991, BLOOD, V77, P1080; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Litynska A, 2001, MELANOMA RES, V11, P205, DOI 10.1097/00008390-200106000-00001; Liu AH, 1998, CELL BIOL INT, V22, P545, DOI 10.1006/cbir.1998.0293; Liu JJ, 2006, J BIOMED SCI, V13, P813, DOI 10.1007/s11373-006-9110-x; LOEWENSTEIN WR, 1979, BIOCHIM BIOPHYS ACTA, V560, P1, DOI 10.1016/0304-419X(79)90002-7; Lowenberg B, 2003, NEW ENGL J MED, V349, P743, DOI 10.1056/NEJMoa025406; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Mateo W, 2002, BLOOD, V100, P2882, DOI 10.1182/blood-2001-12-0217; MISQUITH S, 1994, J BIOL CHEM, V269, P30393; Moreno AN, 2003, INT ARCH ALLERGY IMM, V132, P221, DOI 10.1159/000074303; Murayama T, 1997, INT J CANCER, V70, P575, DOI 10.1002/(SICI)1097-0215(19970304)70:5<575::AID-IJC14>3.3.CO;2-3; Naeem A, 2007, CURR PROTEIN PEPT SC, V8, P261, DOI 10.2174/138920307780831811; Nakamura-Tsuruta S, 2008, FEBS J, V275, P1227, DOI 10.1111/j.1742-4658.2008.06282.x; Numata C, 1998, BIOL PHARM BULL, V21, P214; Ohba H, 2004, TOXICOL APPL PHARM, V195, P182, DOI 10.1016/j.taap.2003.11.018; Ohyama C, 2004, GLYCOBIOLOGY, V14, P671, DOI 10.1093/glycob/cwh071; Panunto-Castelo A, 2001, GLYCOBIOLOGY, V11, P1035, DOI 10.1093/glycob/11.12.1035; Pereira-Da-Silva G, 2006, BBA-GEN SUBJECTS, V1760, P86, DOI 10.1016/j.bbagen.2005.09.011; Pereira-Da-Silva G, 2008, IMMUNOL LETT, V119, P114, DOI 10.1016/j.imlet.2008.06.002; Queiroz AFS, 2009, CANCER CHEMOTH PHARM, V63, P1023, DOI 10.1007/s00280-008-0825-4; Ren YL, 2011, MED ONCOL, V28, P231, DOI 10.1007/s12032-010-9430-6; Roue G, 2003, BIOCHIMIE, V85, P741, DOI 10.1016/S0300-9084(03)00129-9; SANTOSDEOLIVEIRA R, 1994, J IMMUNOL, V153, P1798; Saumet A, 2005, BLOOD, V106, P658, DOI 10.1182/blood-2004-09-3585; Segalla S, 2003, MOL CELL BIOL, V23, P8795, DOI 10.1128/MCB.23.23.8795-8808.2003; Shih CM, 2003, J CELL BIOCHEM, V89, P335, DOI 10.1002/jcb.10488; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Suzuki O, 2007, ONCOL REP, V17, P775; Taniguchi N, 1999, BBA-MOL BASIS DIS, V1455, P287, DOI 10.1016/S0925-4439(99)00066-6; Teixeira CR, 2006, VACCINE, V24, P3001, DOI 10.1016/j.vaccine.2005.11.067; Toledo KA, 2009, IMMUNOL LETT, V123, P14, DOI 10.1016/j.imlet.2009.01.009; Yang N, 2005, J BIOCHEM, V138, P145, DOI 10.1093/jb/mvi109	49	25	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27892	10.1371/journal.pone.0027892	http://dx.doi.org/10.1371/journal.pone.0027892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132163	Green Published, Green Submitted, gold			2022-12-25	WOS:000298162000048
J	Reperant, LA; van de Bildt, MWG; van Amerongen, G; Buehler, DM; Osterhaus, ADME; Jenni-Eiermann, S; Piersma, T; Kuiken, T				Reperant, Leslie A.; van de Bildt, Marco W. G.; van Amerongen, Geert; Buehler, Debbie M.; Osterhaus, Albert D. M. E.; Jenni-Eiermann, Susi; Piersma, Theunis; Kuiken, Thijs			Highly Pathogenic Avian Influenza Virus H5N1 Infection in a Long-Distance Migrant Shorebird under Migratory and Non-Migratory States	PLOS ONE			English	Article							CONSTITUTIVE IMMUNE FUNCTION; COST-BENEFIT-ANALYSIS; BASE-LINE; HEMAGGLUTINATION ASSAY; CALIDRIS-CANUTUS; ASIAN LINEAGE; ORGAN SIZE; CORTICOSTERONE; BIRDS; STRESS	Corticosterone regulates physiological changes preparing wild birds for migration. It also modulates the immune system and may lead to increased susceptibility to infection, with implications for the spread of pathogens, including highly pathogenic avian influenza virus (HPAIV) H5N1. The red knot (Calidris canutus islandica) displays migratory changes in captivity and was used as a model to assess the effect of high plasma concentration of corticosterone on HPAIV H5N1 infection. We inoculated knots during pre-migration (N = 6), fueling (N = 5), migration (N = 9) and post-migration periods (N = 6). Knots from all groups shed similar viral titers for up to 5 days post-inoculation (dpi), peaking at 1 to 3 dpi. Lesions of acute encephalitis, associated with virus replication in neurons, were seen in 1 to 2 knots per group, leading to neurological disease and death at 5 to 11 dpi. Therefore, the risk of HPAIV H5N1 infection in wild birds and of potential transmission between wild birds and poultry may be similar at different times of the year, irrespective of wild birds' migratory status. However, in knots inoculated during the migration period, viral shedding levels positively correlated with pre-inoculation plasma concentration of corticosterone. Of these, knots that did not become productively infected had lower plasma concentration of corticosterone. Conversely, elevated plasma concentration of corticosterone did not result in an increased probability to develop clinical disease. These results suggest that birds with elevated plasma concentration of corticosterone at the time of migration (ready to migrate) may be more susceptible to acquisition of infection and shed higher viral titers-before the onset of clinical disease-than birds with low concentration of corticosterone (not ready for take-off). Yet, they may not be more prone to the development of clinical disease. Therefore, assuming no effect of subclinical infection on the likelihood of migratory take-off, this may favor the spread of HPAIV H5N1 by migratory birds over long distances.	[Reperant, Leslie A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Reperant, Leslie A.; van de Bildt, Marco W. G.; van Amerongen, Geert; Osterhaus, Albert D. M. E.; Kuiken, Thijs] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Buehler, Debbie M.; Piersma, Theunis] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands; [Jenni-Eiermann, Susi] Swiss Ornithol Inst, Sempach, Switzerland; [Piersma, Theunis] Royal Netherlands Inst Sea Res, Texel, Netherlands	Princeton University; Erasmus University Rotterdam; Erasmus MC; University of Groningen; Swiss Ornithological Institute; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Reperant, LA (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	t.kuiken@erasmusmc.nl	Buehler, Deborah/ABB-2088-2021; Piersma, Theunis/D-1871-2012	Buehler, Deborah/0000-0003-3669-6364; Jenni-Eiermann, Susanne/0000-0002-0610-3428; Reperant, Leslie/0000-0002-7212-1595; Piersma, Theunis/0000-0001-9668-466X; Osterhaus, Albert/0000-0002-6074-1172; Kuiken, Thijs/0000-0001-5501-9049	European Commission [044490]; Dutch Ministry of Economic Affairs; Royal Netherlands Institute for Sea Research	European Commission(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Royal Netherlands Institute for Sea Research	This study was supported by European Commission grant no. 044490, "New-FluBird," by the Program "Impulse Veterinary Avian Influenza Research in the Netherlands" of the Dutch Ministry of Economic Affairs, and by an operating grant of Royal Netherlands Institute for Sea Research to TP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Apanius V, 1998, ADV STUD BEHAV, V27, P133; APPLEGATE J E, 1970, Journal of Wildlife Diseases, V6, P443; APPLEGATE J E, 1971, Journal of Wildlife Diseases, V7, P37; Brojer C, 2009, J VET DIAGN INVEST, V21, P579, DOI 10.1177/104063870902100501; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Buehler DM, 2008, PHYSIOL BIOCHEM ZOOL, V81, P673, DOI 10.1086/588591; Buehler DM, 2009, PHYSIOL BIOCHEM ZOOL, V82, P561, DOI 10.1086/603635; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; Campbell TW, 1995, AVIAN HEMATOLOGY CYT; FREEMAN GH, 1951, BIOMETRIKA, V38, P141, DOI 10.2307/2332323; Garvin MC, 2006, J PARASITOL, V92, P659, DOI 10.1645/GE-759R.1; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; Guglielmo CG, 2010, INTEGR COMP BIOL, V50, P336, DOI 10.1093/icb/icq097; Gylfe A, 2000, NATURE, V403, P724, DOI 10.1038/35001663; Hall JS, 2011, INFLUENZA OTHER RESP, V5, P365, DOI 10.1111/j.1750-2659.2011.00238.x; Holberton RL, 1999, GEN COMP ENDOCR, V116, P49, DOI 10.1006/gcen.1999.7336; Jenni L, 1998, J AVIAN BIOL, V29, P521, DOI 10.2307/3677171; Jenni-Eiermann S, 2002, ZOOLOGY, V105, P239, DOI 10.1078/0944-2006-00066; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Kalthoff D, 2008, PLOS ONE, V4, DOI 10.1371/journal.pone.0006170; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; MEIER AH, 1964, GEN COMP ENDOCR, V4, P584, DOI 10.1016/0016-6480(64)90067-X; Mendes L, 2006, J EXP BIOL, V209, P284, DOI 10.1242/jeb.02015; Mueller C, 2006, GEN COMP ENDOCR, V148, P163, DOI 10.1016/j.ygcen.2006.02.012; MUNRO C, 1984, J ENDOCRINOL, V101, P41, DOI 10.1677/joe.0.1010041; MUNRO CJ, 1988, NONRADIOMETRIC ASSAY, P289; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Piersma T, 1998, J AVIAN BIOL, V29, P97, DOI 10.2307/3677186; Piersma T, 2000, GEN COMP ENDOCR, V120, P118, DOI 10.1006/gcen.2000.7543; Piersma T, 2003, J EXP BIOL, V206, P3361, DOI 10.1242/jeb.00545; Piersma T, 2002, NATURWISSENSCHAFTEN, V89, P278, DOI 10.1007/s00114-002-0325-z; Piersma T, 1999, PHYSIOL BIOCHEM ZOOL, V72, P405, DOI 10.1086/316680; Piersma T, 1998, J AVIAN BIOL, V29, P511, DOI 10.2307/3677170; Piersma T, 2011, J EXP BIOL, V214, P295, DOI 10.1242/jeb.046748; Reneerkens J, 2002, PHYSIOL BIOCHEM ZOOL, V75, P200, DOI 10.1086/340853; Reneerkens J, 2002, J EXP ZOOL, V293, P81, DOI 10.1002/jez.10113; Reperant LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000854; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Schekkerman H, 2003, OECOLOGIA, V134, P332, DOI 10.1007/s00442-002-1124-0; SCHWABL H, 2004, J COMP PHYSIOL B, V161, P576; Suarez DL, 2000, DEV COMP IMMUNOL, V24, P269, DOI 10.1016/S0145-305X(99)00078-6; Teifke JP, 2007, VET PATHOL, V44, P137, DOI 10.1354/vp.44-2-137; USGS, 2011, REF REP HIGHL PATH A; van Gils JA, 2003, J EXP BIOL, V206, P3369, DOI 10.1242/jeb.00546; Vezina F, 2006, J EXP BIOL, V209, P3141, DOI 10.1242/jeb.02338; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319; Weber TP, 1996, J AVIAN BIOL, V27, P215, DOI 10.2307/3677225; 2010, AVIAN INFLUENZA POUL	55	13	17	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27814	10.1371/journal.pone.0027814	http://dx.doi.org/10.1371/journal.pone.0027814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132150	Green Published, Green Submitted, gold			2022-12-25	WOS:000297792400016
J	Siegel, MP; Kruse, SE; Knowels, G; Salmon, A; Beyer, R; Xie, H; Van Remmen, H; Smith, SR; Marcinek, DJ				Siegel, Michael P.; Kruse, Shane E.; Knowels, Gary; Salmon, Adam; Beyer, Richard; Xie, Hui; Van Remmen, Holly; Smith, Steven R.; Marcinek, David J.			Reduced Coupling of Oxidative Phosphorylation In Vivo Precedes Electron Transport Chain Defects Due to Mild Oxidative Stress in Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; MITOCHONDRIAL BIOGENESIS; UNCOUPLING PROTEINS; ADENYLATE KINASE; GENE-EXPRESSION; NEURODEGENERATION; PERFORMANCE; APOPTOSIS; ACID	Oxidative stress and mitochondrial function are at the core of many degenerative conditions. However, the interaction between oxidative stress and in vivo mitochondrial function is unclear. We used both pharmacological (2 week paraquat (PQ) treatment of wild type mice) and transgenic (mice lacking Cu, Zn-superoxide dismutase (SOD1(-/-))) models to test the effect of oxidative stress on in vivo mitochondrial function in skeletal muscle. Magnetic resonance and optical spectroscopy were used to measure mitochondrial ATP and oxygen fluxes and cell energetic state. In both models of oxidative stress, coupling of oxidative phosphorylation was significantly lower (lower P/O) at rest in vivo in skeletal muscle and was dose-dependent in the PQ model. Despite this reduction in efficiency, in vivo mitochondrial phosphorylation capacity (ATPmax) was maintained in both models, and ex vivo mitochondrial respiration in permeabilized muscle fibers was unchanged following PQ treatment. In association with the reduced P/O, PQ treatment led to a dose-dependent reduction in PCr/ATP ratio and increased phosphorylation of AMPK. These results indicate that oxidative stress uncouples oxidative phosphorylation in vivo and results in energetic stress in the absence of defects in the mitochondrial electron transport chain.	[Siegel, Michael P.; Marcinek, David J.] Univ Washington, Sch Med, Dept Bioengn, Seattle, WA 98195 USA; [Kruse, Shane E.; Knowels, Gary; Marcinek, David J.] Univ Washington, Sch Med, Dept Radiol, Seattle, WA 98195 USA; [Beyer, Richard] Univ Washington, Sch Med, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Xie, Hui; Smith, Steven R.] Florida Hosp, Sanford Burnham Med Res Inst, Translat Res Inst Metab & Diabet, Winter Pk, FL USA; [Salmon, Adam; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Winter Park; Sanford Burnham Prebys Medical Discovery Institute; University of Texas System; University of Texas Health San Antonio	Siegel, MP (corresponding author), Univ Washington, Sch Med, Dept Bioengn, Seattle, WA 98195 USA.	dmarc@uw.edu	kruse, shane/L-8717-2014; Smith, Steven/HDM-9496-2022	kruse, shane/0000-0001-6344-0650; Salmon, Adam/0000-0002-1475-7843; Siegel, Michael/0000-0003-4263-3220; Smith, Steven/0000-0002-5098-8147; Marcinek, David/0000-0001-5187-2149	Ellison Medical Foundation; NIH [AG022385, AG036606, AG028455, AG030226]; NORC Center [DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036606, R01AG028455, K01AG022385, R01AG030226] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NORC Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a New Scholar Award in Aging from The Ellison Medical Foundation (http://www.ellisonfoundation.org/), NIH grants AG022385, AG036606, AG028455 and AG030226, and NORC Center Grant DK072476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; ANDERSON EJ, 2009, J CLIN INVEST; Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Calabrese V, 2001, NEUROCHEM RES, V26, P739, DOI 10.1023/A:1010955807739; Carreras MC, 2007, AM J PHYSIOL-CELL PH, V292, pC1569, DOI 10.1152/ajpcell.00248.2006; Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x; Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; DREW R, 1979, TOXICOL APPL PHARM, V48, P479, DOI 10.1016/0041-008X(79)90431-9; Du ZX, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-56; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Echtay KS, 2005, BIOFACTORS, V24, P119, DOI 10.1002/biof.5520240114; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Franco AA, 1999, FREE RADICAL BIO MED, V27, P1122, DOI 10.1016/S0891-5849(99)00166-5; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; GOLDING EM, 1995, J EXP BIOL, V198, P1775; Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142; Han ES, 2008, PHYSIOL GENOMICS, V34, P112, DOI 10.1152/physiolgenomics.00239.2007; HEINEMAN FW, 1990, MAGNET RESON MED, V13, P490, DOI 10.1002/mrm.1910130316; Hinerfeld D, 2004, J NEUROCHEM, V88, P657, DOI 10.1046/j.1471-4159.2003.02195.x; Koh HJ, 2010, P NATL ACAD SCI USA, V107, P15541, DOI 10.1073/pnas.1008131107; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kushmerick MJ, 1998, COMP BIOCHEM PHYS B, V120, P109, DOI 10.1016/S0305-0491(98)00026-1; Kwon YH, 2009, FASEB J, V23; Lee JY, 2010, FASEB J, V24; Marcinek DJ, 2005, J PHYSIOL-LONDON, V569, P467, DOI 10.1113/jphysiol.2005.097782; Marcinek DJ, 2004, AM J PHYSIOL-CELL PH, V286, pC457, DOI 10.1152/ajpcell.00237.2003; Marcinek DJ, 2003, AM J PHYSIOL-HEART C, V285, pH1900, DOI 10.1152/ajpheart.00192.2003; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; PARKER N, 2008, BIOCH J; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200; RISTOW M, 2009, P NATL ACAD SCI US; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Schenkman KA, 1997, J APPL PHYSIOL, V82, P86, DOI 10.1152/jappl.1997.82.1.86; Schenkman KA, 2001, AM J PHYSIOL-HEART C, V281, pH2463, DOI 10.1152/ajpheart.2001.281.6.H2463; SKULACHEV VP, 2006, APOPTOSIS; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Taylor D J, 1983, Mol Biol Med, V1, P77; Toime LJ, 2010, FREE RADICAL BIO MED, V49, P606, DOI 10.1016/j.freeradbiomed.2010.05.010; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; WANG H, 2010, DIABETES; WISEMAN RW, 1992, ANAL BIOCHEM, V204, P383, DOI 10.1016/0003-2697(92)90255-6; YFANTI C, MED SCI SPORTS EXERC, V42, P1388; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	55	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e26963	10.1371/journal.pone.0026963	http://dx.doi.org/10.1371/journal.pone.0026963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132085	Green Submitted, Green Published, gold			2022-12-25	WOS:000297792400004
J	Latch, EK; Boarman, WI; Walde, A; Fleischer, RC				Latch, Emily K.; Boarman, William I.; Walde, Andrew; Fleischer, Robert C.			Fine-Scale Analysis Reveals Cryptic Landscape Genetic Structure in Desert Tortoises	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION ANALYSIS; PARTIAL MANTEL TESTS; FALSE DISCOVERY RATE; POPULATION-STRUCTURE; GOPHERUS-AGASSIZII; PHYLOGEOGRAPHIC PATTERNS; MICROSATELLITE LOCI; MITOCHONDRIAL-DNA; COMPUTER-PROGRAM; FLOW	Characterizing the effects of landscape features on genetic variation is essential for understanding how landscapes shape patterns of gene flow and spatial genetic structure of populations. Most landscape genetics studies have focused on patterns of gene flow at a regional scale. However, the genetic structure of populations at a local scale may be influenced by a unique suite of landscape variables that have little bearing on connectivity patterns observed at broader spatial scales. We investigated fine-scale spatial patterns of genetic variation and gene flow in relation to features of the landscape in desert tortoise (Gopherus agassizii), using 859 tortoises genotyped at 16 microsatellite loci with associated data on geographic location, sex, elevation, slope, and soil type, and spatial relationship to putative barriers (power lines, roads). We used spatially explicit and non-explicit Bayesian clustering algorithms to partition the sample into discrete clusters, and characterize the relationships between genetic distance and ecological variables to identify factors with the greatest influence on gene flow at a local scale. Desert tortoises exhibit weak genetic structure at a local scale, and we identified two subpopulations across the study area. Although genetic differentiation between the subpopulations was low, our landscape genetic analysis identified both natural (slope) and anthropogenic (roads) landscape variables that have significantly influenced gene flow within this local population. We show that desert tortoise movements at a local scale are influenced by features of the landscape, and that these features are different than those that influence gene flow at larger scales. Our findings are important for desert tortoise conservation and management, particularly in light of recent translocation efforts in the region. More generally, our results indicate that recent landscape changes can affect gene flow at a local scale and that their effects can be detected almost immediately.	[Latch, Emily K.] Univ Wisconsin, Dept Biol Sci, Behav & Mol Ecol Res Grp, Milwaukee, WI 53201 USA; [Latch, Emily K.; Fleischer, Robert C.] Smithsonian Inst, Natl Zool Pk, Ctr Conservat & Evolutionary Genet, Washington, DC 20008 USA; [Boarman, William I.] Conservat Sci Res & Consulting, Spring Valley, VA USA; [Walde, Andrew] Walde Res & Environm Consulting, Atascadero, CA USA	University of Wisconsin System; University of Wisconsin Milwaukee; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Latch, EK (corresponding author), Univ Wisconsin, Dept Biol Sci, Behav & Mol Ecol Res Grp, POB 413, Milwaukee, WI 53201 USA.	latch@uwm.edu			United States Department of Defense [W9124J-0-c-0011]	United States Department of Defense(United States Department of Defense)	The United States Department of Defense funded this work through a grant to the ITS Corporation, reference code W9124J-0-c-0011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERRY KH, 1986, HERPETOLOGICA, V42, P113; Berry Kristin H., 2002, Chelonian Conservation and Biology, V4, P249; Boarman W.I., 2002, THREATS DESERT TORTO; Boarman W.I., 1996, TRANSPORTATION WILDL, P169; BOARMAN WI, 1993, P 1992 DES TORT COUN, P126; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Britten HB, 1997, COPEIA, P523; BURY RB, 1977, US FISH WILDL SERV W, V8, P1; Castellano S, 2002, EVOLUTION, V56, P1871; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Corander J, 2003, GENETICS, V163, P367; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Edwards T, 2004, CONSERV GENET, V5, P485, DOI 10.1023/B:COGE.0000041031.58192.7c; Edwards T, 2003, MOL ECOL NOTES, V3, P589, DOI 10.1046/j.1471-8286.2003.00521.x; Epperson BK, 2004, THEOR POPUL BIOL, V65, P227, DOI 10.1016/j.tpb.2003.11.003; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; Frantz AC, 2010, HEREDITY, V104, P493, DOI 10.1038/hdy.2009.136; Frantz AC, 2010, MOL ECOL, V19, P1663, DOI 10.1111/j.1365-294X.2010.04605.x; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Gauffre B, 2008, MOL ECOL, V17, P4619, DOI 10.1111/j.1365-294X.2008.03950.x; Gerlach G, 2000, CONSERV BIOL, V14, P1066, DOI 10.1046/j.1523-1739.2000.98519.x; GERMANO DJ, 1993, AM MIDL NAT, V129, P319, DOI 10.2307/2426513; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; Grandmaison DD, 2010, J HERPETOL, V44, P581, DOI 10.1670/08-291.1; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Hagerty BE, 2008, MOL ECOL RESOUR, V8, P1149, DOI 10.1111/j.1755-0998.2008.02208.x; Hagerty BE, 2011, LANDSCAPE ECOL, V26, P267, DOI 10.1007/s10980-010-9550-6; Hagerty BE, 2010, CONSERV GENET, V11, P1795, DOI 10.1007/s10592-010-0073-0; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; LAMB T, 1989, EVOLUTION, V43, P76, DOI 10.1111/j.1558-5646.1989.tb04208.x; Lamb Trip, 2002, P67; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Latch EK, 2008, J HERED, V99, P265, DOI 10.1093/jhered/esn009; Lee-Yaw JA, 2009, MOL ECOL, V18, P1863, DOI 10.1111/j.1365-294X.2009.04152.x; LIGHTFOOT DC, 1991, AM MIDL NAT, V125, P310, DOI 10.2307/2426235; Lovich Jeffrey E., 2000, Chelonian Conservation and Biology, V3, P714; Lowe WH, 2006, ECOLOGY, V87, P334, DOI 10.1890/05-0232; Luckenbach R.A., 1982, U S FISH AND WILDLIFE SERVICE WILDLIFE RESEARCH REPORT, V12, P1; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Marlow, 1979, THESIS U CALIFORNIA; Murphy RW, 2007, CHELONIAN CONSERV BI, V6, P229, DOI 10.2744/1071-8443(2007)6[229:AGAOTR]2.0.CO;2; Murphy RW, 2011, ZOOKEYS, P39, DOI 10.3897/zookeys.113.1353; NAGY KA, 1986, HERPETOLOGICA, V42, P73; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Oftedal Olav T., 2002, Chelonian Conservation and Biology, V4, P341; Paetkau D, 1998, CONSERV BIOL, V12, P418, DOI 10.1046/j.1523-1739.1998.96457.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; PEAKALL R, 1995, MOL ECOL, V4, P135, DOI 10.1111/j.1365-294X.1995.tb00203.x; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Raufaste N, 2001, EVOLUTION, V55, P1703, DOI 10.1111/j.0014-3820.2001.tb00689.x; Richards-Zawacki CL, 2009, DIVERS DISTRIB, V15, P796, DOI 10.1111/j.1472-4642.2009.00582.x; Riedle JD, 2010, J HERPETOL, V44, P164; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Rousset F, 2002, EVOLUTION, V56, P1874; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; Schwartz TS, 2003, MOL ECOL NOTES, V3, P283, DOI 10.1046/j.1471-8286.2003.00428.x; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; STEBBINS RC, 1974, AM BIOL TEACH, V36, P203, DOI 10.2307/4444747; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Tracy C.R., 2004, DESERT TORTOISE RECO; U.S. Fish and Wildlife Service, 1990, FED REG, V55, P12178; USFWS, 2008, REV REC PLA IN PRESS; USFWS (U.S. Fish and Wildlife Service), 1994, DES TORT MOJ POP REC; VASEK F C, 1975, Madrono, V23, P114; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Walde AD, 2009, SOUTHWEST NAT, V54, P375, DOI 10.1894/MH-41.1; Walker FM, 2008, MOL ECOL, V17, P1361, DOI 10.1111/j.1365-294X.2008.03670.x; Wang IJ, 2010, MOL ECOL, V19, P447, DOI 10.1111/j.1365-294X.2009.04465.x; Wang IJ, 2009, MOL ECOL, V18, P3847, DOI 10.1111/j.1365-294X.2009.04338.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wiens John A., 2001, P96	88	28	28	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27794	10.1371/journal.pone.0027794	http://dx.doi.org/10.1371/journal.pone.0027794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132143	gold, Green Published			2022-12-25	WOS:000297789900020
J	Chaykovska, L; von Websky, K; Rahnenfuhrer, J; Alter, M; Heiden, S; Fuchs, H; Runge, F; Klein, T; Hocher, B				Chaykovska, Lyubov; von Websky, Karoline; Rahnenfuehrer, Jan; Alter, Markus; Heiden, Susi; Fuchs, Holger; Runge, Frank; Klein, Thomas; Hocher, Berthold			Effects of DPP-4 Inhibitors on the Heart in a Rat Model of Uremic Cardiomyopathy	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; DIPEPTIDYL-PEPTIDASE-IV; GLUCAGON-LIKE PEPTIDE-1; CYSTATIN-C; CARDIOVASCULAR-DISEASE; DPP4-DEFICIENT RATS; DOUBLE-BLIND; PHARMACOKINETICS; FIBROSIS; GLP-1	Background: Uremic cardiomyopathy contributes substantially to mortality in chronic kidney disease (CKD) patients. Glucagon-like peptide-1 (GLP-1) may improve cardiac function, but is mainly degraded by dipeptidyl peptidase-4 (DPP-4). Methodology/Principal Findings: In a rat model of chronic renal failure, 5/6-nephrectomized [5/6N] rats were treated orally with DPP-4 inhibitors (linagliptin, sitagliptin, alogliptin) or placebo once daily for 4 days from 8 weeks after surgery, to identify the most appropriate treatment for cardiac dysfunction associated with CKD. Linagliptin showed no significant change in blood level AUC(0-infinity) in 5/6N rats, but sitagliptin and alogliptin had significantly higher AUC(0-infinity) values; 41% and 28% (p=0.0001 and p=0.0324), respectively. No correlation of markers of renal tubular and glomerular function with AUC was observed for linagliptin, which required no dose adjustment in uremic rats. Linagliptin 7 mu mol/kg caused a 2-fold increase in GLP-1 (AUC 201.0 ng/l*h) in 5/6N rats compared with sham-treated rats (AUC 108.6 ng/l*h) (p=0.01). The mRNA levels of heart tissue fibrosis markers were all significantly increased in 5/6N vs control rats and reduced/normalized by linagliptin. Conclusions/Significance: DPP-4 inhibition increases plasma GLP-1 levels, particularly in uremia, and reduces expression of cardiac mRNA levels of matrix proteins and B-type natriuretic peptides (BNP). Linagliptin may offer a unique approach for treating uremic cardiomyopathy in CKD patients, with no need for dose-adjustment.	[Chaykovska, Lyubov; von Websky, Karoline; Rahnenfuehrer, Jan; Alter, Markus; Heiden, Susi; Hocher, Berthold] Charite, Inst Pharmacol & Toxicol, Cardiovasc Res Ctr, D-13353 Berlin, Germany; [Chaykovska, Lyubov; von Websky, Karoline; Rahnenfuehrer, Jan; Alter, Markus; Heiden, Susi; Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Alter, Markus] Charite, Med Klin Endokrinol & Nephrol, D-13353 Berlin, Germany; [Fuchs, Holger; Runge, Frank; Klein, Thomas] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Boehringer Ingelheim	Chaykovska, L (corresponding author), Charite, Inst Pharmacol & Toxicol, Cardiovasc Res Ctr, D-13353 Berlin, Germany.	hocher@uni-potsdam.de	Hocher, Berthold/AAC-3510-2020	Heiden, Susi/0000-0001-8993-7120; Hocher, Berthold/0000-0001-8143-0579; Fuchs, Holger/0000-0002-9507-5501; Chaykovska, Lyubov/0000-0002-6250-4007	Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany; Boehringer Ingelheim Pharma GmbH	Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany(Boehringer Ingelheim); Boehringer Ingelheim Pharma GmbH(Boehringer Ingelheim)	This study was supported by Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany, who played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This study was supported by Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany, who played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. Boehringer Ingelheim Pharma GmbH financially supported the study. Holger Fuchs, Frank Runge, and Thomas Klein are research staff of Boehringer Ingelheim Pharma GmbH & Co. Boehringer Ingelheim Pharma GmbH holds the patent of linagliptin (patent number: WO 2004/018468) and developed this compound. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Amann K, 1998, J AM SOC NEPHROL, V9, P1018; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; ARONSON JK, 1988, EUR J CLIN PHARMACOL, V35, P1, DOI 10.1007/BF00555499; Bergman AJ, 2006, CLIN THER, V28, P55, DOI 10.1016/j.clinthera.2006.01.015; Best JH, 2011, DIABETES CARE, V34, P90, DOI 10.2337/dc10-1393; Blech S, 2010, DRUG METAB DISPOS, V38, P667, DOI 10.1124/dmd.109.031476; Boerrigter G, 2007, AM J PHYSIOL-REG I, V292, pR897, DOI 10.1152/ajpregu.00569.2006; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grieve DJ, 2009, BRIT J PHARMACOL, V157, P1340, DOI 10.1111/j.1476-5381.2009.00376.x; Heise T, 2009, DIABETES OBES METAB, V11, P786, DOI 10.1111/j.1463-1326.2009.01046.x; Herman GA, 2005, CLIN PHARMACOL THER, V78, P675, DOI 10.1016/j.clpt.2005.09.002; Horiba N, 2004, KIDNEY INT, V66, P29, DOI 10.1111/j.1523-1755.2004.00704.x; Kalk P, 2007, BRIT J PHARMACOL, V151, P1025, DOI 10.1038/sj.bjp.0707319; Kalk P, 2006, BRIT J PHARMACOL, V148, P853, DOI 10.1038/sj.bjp.0706792; Kirino Y, 2009, J ENDOCRINOL, V200, P53, DOI 10.1677/JOE-08-0424; Ku HC, 2010, N-S ARCH PHARMACOL, V382, P463, DOI 10.1007/s00210-010-0559-9; Kujal P, 2008, Cesk Fysiol, V57, P104; Lindsay MM, 2002, HYPERTENSION, V40, P136, DOI 10.1161/01.HYP.0000024573.17293.23; MALL G, 1990, NEPHROL DIAL TRANSPL, V5, P39, DOI 10.1093/ndt/5.1.39; Masuda Satohiro, 2003, Drug Metab Pharmacokinet, V18, P91, DOI 10.2133/dmpk.18.91; Meier JJ, 2004, DIABETES, V53, P654, DOI 10.2337/diabetes.53.3.654; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; National Institute of Diabetes and Digestive and Kidney Diseases, 2006, US REN DAT SYST USRD; Ossum A, 2009, PHARMACOL RES, V60, P411, DOI 10.1016/j.phrs.2009.06.004; Pfisterer M, 2009, JAMA-J AM MED ASSOC, V301, P383, DOI 10.1001/jama.2009.2; Pucci L, 2007, CLIN CHEM, V53, P480, DOI 10.1373/clinchem.2006.076042; Rabkin R, 2008, J AM SOC NEPHROL, V19, P1774, DOI 10.1681/ASN.2007121386; Rigalleau V, 2008, DIABETES METAB, V34, P482, DOI 10.1016/j.diabet.2008.03.004; Rozen S, 2000, Methods Mol Biol, V132, P365; Scheen AJ, 2010, DIABETES OBES METAB, V12, P648, DOI 10.1111/j.1463-1326.2010.01212.x; Senkel S, 2005, BBA-GENE STRUCT EXPR, V1731, P179, DOI 10.1016/j.bbaexp.2005.10.003; Shvarts V, 2008, Klin Med (Mosk), V86, P12; Tian J, 2009, HYPERTENSION, V54, P1313, DOI 10.1161/HYPERTENSIONAHA.109.140038; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Tyralla K, 2003, KIDNEY INT, V63, pS80, DOI 10.1046/j.1523-1755.63.s84.1.x; Vignon-Zellweger N, 2011, J HYPERTENS, V29, P961, DOI 10.1097/HJH.0b013e3283450770; WEIR GC, 1989, DIABETES, V38, P338, DOI 10.2337/diabetes.38.3.338; Willems D, 2009, CLIN BIOCHEM, V42, P108, DOI 10.1016/j.clinbiochem.2008.10.002; Yan XX, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-70	40	69	89	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27861	10.1371/journal.pone.0027861	http://dx.doi.org/10.1371/journal.pone.0027861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125632	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789200032
J	Evans, DJ; Owlarn, S; Romero, BT; Chen, C; Aboobaker, AA				Evans, Deborah J.; Owlarn, Suthira; Romero, Belen Tejada; Chen, Chen; Aboobaker, A. Aziz			Combining Classical and Molecular Approaches Elaborates on the Complexity of Mechanisms Underpinning Anterior Regeneration	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PLANARIAN REGENERATION; STEM-CELLS; BLASTEMA FORMATION; GENE-EXPRESSION; POLARITY; IDENTITY; MITOSIS; HEAD	The current model of planarian anterior regeneration evokes the establishment of low levels of Wnt signalling at anterior wounds, promoting anterior polarity and subsequent elaboration of anterior fate through the action of the TALE class homeodomain PREP. The classical observation that decapitations positioned anteriorly will regenerate heads more rapidly than posteriorly positioned decapitations was among the first to lead to the proposal of gradients along an anteroposterior (AP) axis in a developmental context. An explicit understanding of this phenomenon is not included in the current model of anterior regeneration. This raises the question what the underlying molecular and cellular basis of this temporal gradient is, whether it can be explained by current models and whether understanding the gradient will shed light on regenerative events. Differences in anterior regeneration rate are established very early after amputation and this gradient is dependent on the activity of Hedgehog (Hh) signalling. Animals induced to produce two tails by either Smed-APC-1(RNAi) or Smed-ptc(RNAi) lose anterior fate but form previously described ectopic anterior brain structures. Later these animals form peripharyngeal brain structures, which in Smed-ptc(RNAi) grow out of the body establishing a new A/P axis. Combining double amputation and hydroxyurea treatment with RNAi experiments indicates that early ectopic brain structures are formed by uncommitted stem cells that have progressed through S-phase of the cell cycle at the time of amputation. Our results elaborate on the current simplistic model of both AP axis and brain regeneration. We find evidence of a gradient of hedgehog signalling that promotes posterior fate and temporarily inhibits anterior regeneration. Our data supports a model for anterior brain regeneration with distinct early and later phases of regeneration. Together these insights start to delineate the interplay between discrete existing, new, and then later homeostatic signals in AP axis regeneration.	[Evans, Deborah J.; Owlarn, Suthira; Romero, Belen Tejada; Chen, Chen; Aboobaker, A. Aziz] Univ Nottingham, Queens Med Ctr, Ctr Genet & Genom, Nottingham NG7 2RD, England	University of Nottingham	Evans, DJ (corresponding author), Univ Nottingham, Queens Med Ctr, Ctr Genet & Genom, Nottingham NG7 2RD, England.	Aziz.Aboobaker@nottingham.ac.uk		Aboobaker, Aziz/0000-0003-4902-5797; Owlarn, Suthira/0000-0002-3258-1415	Biotechnology and Biological Sciences Research Council [BB/E01030X/1]; Medical Research Council [G0601133]; BBSRC [BB/E01030X/1] Funding Source: UKRI; MRC [G0601133] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by project grants from the Biotechnology and Biological Sciences Research Council (BB/E01030X/1) andthe Medical Research Council (G0601133) to AAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOOBAKER AA, 2011, TRENDS CELL BIOL; Adell T, 2009, DEVELOPMENT, V136, P905, DOI 10.1242/dev.033761; Agata K, 2008, PHILOS T R SOC B, V363, P2071, DOI 10.1098/rstb.2008.2260; Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; BAGUNA J, 1976, J EXP ZOOL, V195, P65, DOI 10.1002/jez.1401950107; Blackstone NW, 2006, J EXP ZOOL PART B, V306B, P1, DOI 10.1002/jez.b.21085; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; BRONDSTED HV, 1969, INT SERIES MONOGRAPH, V42; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Cebria F, 2002, MECH DEVELOP, V116, P199, DOI 10.1016/S0925-4773(02)00134-X; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Child CM, 1911, J EXP ZOOL, V10, P265, DOI 10.1002/jez.1400100304; CHILD CM, 1941, PROBLEMS PATTERNS DE; De Robertis EM, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3127pe21; Felix DA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000915; Gonzalez-Estevez C, 2009, INT J DEV BIOL, V53, P493, DOI 10.1387/ijdb.082825cg; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Gurley KA, 2010, DEV BIOL, V347, P24, DOI 10.1016/j.ydbio.2010.08.007; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; IGLESIAS M, 2011, DEV BIOL; Iglesias M, 2008, DEVELOPMENT, V135, P1215, DOI 10.1242/dev.020289; Morgan TH, 1900, ARCH ENTWICKLUNG ORG, V10, P58, DOI 10.1007/BF02156347; Morgan TH, 1904, AM NAT, V38, P502; Morgan TH, 1898, ARCH ENTW MECH ORG, V7, P364; MORGAN TM, 1905, J EXPT ZOOLOGY, V2, P496; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Oviedo NJ, 2010, DEV BIOL, V339, P188, DOI 10.1016/j.ydbio.2009.12.012; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; RANDOLPH H, 1892, J MORPHOL, V7, P317, DOI DOI 10.1002/JMOR.1050070304; Reddien PW, 2011, TRENDS GENET, V27, P277, DOI 10.1016/j.tig.2011.04.004; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; SALO E, 1984, J EMBRYOL EXP MORPH, V83, P63; SIVICKIS P. B., 1931, ARCH ZOOL ITAL, V16, P430; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; Yazawa S, 2009, P NATL ACAD SCI USA, V106, P22329, DOI 10.1073/pnas.0907464106	40	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27927	10.1371/journal.pone.0027927	http://dx.doi.org/10.1371/journal.pone.0027927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125640	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789200040
J	Muehlich, S; Hampl, V; Khalid, S; Singer, S; Frank, N; Breuhahn, K; Gudermann, T; Prywes, R				Muehlich, S.; Hampl, V.; Khalid, S.; Singer, S.; Frank, N.; Breuhahn, K.; Gudermann, T.; Prywes, R.			The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1	ONCOGENE			English	Article						DLC1; MKL1; MKL2; MRTF; Rho; SRF	SERUM RESPONSE FACTOR; TISSUE GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; HUMAN HEPATOCARCINOGENESIS; ACTIN CYTOSKELETON; CELL-MIGRATION; TARGET GENES; METASTASIS; SRF; PROGRESSION	Deleted in Liver Cancer 1 (DLC1) is a tumor suppressor whose allele is lost in 50% of liver, breast, lung and 70% of colon cancers. Here, we show that the transcriptional coactivators Megakaryoblastic Leukemia 1 and 2 (MKL1/2) are constitutively localized to the nucleus in hepatocellular and mammary carcinoma cells that lack DLC1. Moreover, DLC1 loss and MKL1 nuclear localization correlate in primary human hepatocellular carcinoma. Nuclear accumulation of MKL1 in DLC1 deficient cancer cells is accomplished by activation of the RhoA/actin signaling pathway and concomitant impairment of MKL1 phosphorylation, which results in constitutive activation of MKL1/2 target genes. We provide evidence that MKL1/2 mediates cancerous transformation in DLC1-deficient hepatocellular and mammary carcinoma cells. Depletion of MKL1/2 suppresses cell migration, cell proliferation and anchorage-independent cell growth induced by DLC1 loss. Oncogene (2012) 31, 3913-3923; doi:10.1038/onc.2011.560; published online 5 December 2011	[Muehlich, S.; Hampl, V.; Khalid, S.; Frank, N.; Gudermann, T.] Univ Munich, Walther Straub Inst Pharmacol & Toxicol, D-80336 Munich, Germany; [Singer, S.; Breuhahn, K.] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Prywes, R.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	University of Munich; Ruprecht Karls University Heidelberg; Columbia University	Muehlich, S (corresponding author), Univ Munich, Walther Straub Inst Pharmacol & Toxicol, Goethestr 33, D-80336 Munich, Germany.	susanne.muehlich@lrz.uni-muenchen.de		Breuhahn, Kai/0000-0002-2462-1229	German Research Foundation (DFG) [MU 2737/2-1]; National Cancer Institute [CA050329]; NATIONAL CANCER INSTITUTE [R01CA050329] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Scott Lowe for the DLC1 knockdown hepatocytes and Dr Monilola Olayioye for DLC1 vectors. Breast carcinoma cell lines were kindly provided by Dr Ramon Parsons. This work was funded by grant MU 2737/2-1 from the German Research Foundation (DFG) to SM and grant CA050329 from the National Cancer Institute to RP.	Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Gollob JA, 2006, SEMIN ONCOL, V33, P392, DOI 10.1053/j.seminoncol.2006.04.002; Goodison S, 2005, CANCER RES, V65, P6042, DOI 10.1158/0008-5472.CAN-04-3043; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; Heering J, 2009, EXP CELL RES, V315, P2505, DOI 10.1016/j.yexcr.2009.05.022; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Knoll B, 2010, BIOL CHEM, V391, P591, DOI 10.1515/BC.2010.061; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Lahoz A, 2008, GENE DEV, V22, P1724, DOI 10.1101/gad.1691408; Lee SM, 2010, J BIOL CHEM, V285, P22036, DOI 10.1074/jbc.M110.108878; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mazzocca A, 2010, HEPATOLOGY, V51, P523, DOI 10.1002/hep.23285; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morin P, 2009, EUR J CELL BIOL, V88, P495, DOI 10.1016/j.ejcb.2009.04.005; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Muehlich S, 2007, AM J PHYSIOL-CELL PH, V292, pC1732, DOI 10.1152/ajpcell.00552.2006; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Porter KE, 2004, CARDIOVASC RES, V61, P745, DOI 10.1016/j.cardiores.2003.11.032; Prange W, 2003, J PATHOL, V201, P250, DOI 10.1002/path.1448; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Singer S, 2007, HEPATOLOGY, V46, P759, DOI 10.1002/hep.21736; Truong H, 2009, CELL ADHES MIGR, V3, P179, DOI 10.4161/cam.3.2.8036; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Xie D, 2001, CANCER RES, V61, P8917; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yuan BZ, 1998, CANCER RES, V58, P2196	37	38	38	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	35					3913	3923		10.1038/onc.2011.560	http://dx.doi.org/10.1038/onc.2011.560			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	999VJ	22139079				2022-12-25	WOS:000308342800001
J	Podar, D; Scherer, J; Noordally, Z; Herzyk, P; Nies, D; Sanders, D				Podar, Dorina; Scherer, Judith; Noordally, Zeenat; Herzyk, Pawel; Nies, Dietrich; Sanders, Dale			Metal Selectivity Determinants in a Family of Transition Metal Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFUSION FACILITATOR FAMILY; ZINC TRANSPORTER; ARABIDOPSIS-THALIANA; SUBSTRATE-SPECIFICITY; THLASPI-GOESINGENSE; ANTIPORT MECHANISM; VACUOLAR MEMBRANE; CDF FAMILY; TOLERANCE; PROTEIN	Metal tolerance proteins (MTPs) are plant members of the cation diffusion facilitator (CDF) transporter family involved in cellular metal homeostasis. Members of the CDF family are ubiquitously found in all living entities and show principal selectivity for Zn2+, Mn2+, and Fe2+. Little is known regarding metal selectivity determinants of CDFs. We identified a novel cereal member of CDFs in barley, termed HvMTP1, that localizes to the vacuolar membrane. Unlike its close relative AtMTP1, which is highly selective for Zn2+, HvMTP1 exhibits selectivity for both Zn2+ and Co2+ as assessed by its ability to suppress yeast mutant phenotypes for both metals. Expression of HvMTP1/AtMTP1 chimeras in yeast revealed a five-residue sequence within the AtMTP1 N-segment of the His-rich intracytoplasmic loop that confines specificity to Zn2+. Furthermore, mutants of AtMTP1 generated through random mutagenesis revealed residues embedded within transmembrane domain 3 that additionally specify the high degree of Zn2+ selectivity. We propose that the His-rich loop, which might play a role as a zinc chaperone, determines the identity of the metal ions that are transported. The residues within transmembrane domain 3 can also influence metal selectivity, possibly through conformational changes induced at the cation transport site located within the membrane or at the cytoplasmic C-terminal domain.	[Podar, Dorina] Univ Babes Bolyai, Fac Biol Geol, Cluj Napoca 400084, Romania; [Podar, Dorina; Noordally, Zeenat; Sanders, Dale] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Sanders, Dale] John Innes Ctr, Norwich NR4 7UH, Norfolk, England; [Scherer, Judith; Nies, Dietrich] Univ Halle, Inst Mikrobiol, D-06120 Halle, Germany; [Herzyk, Pawel] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland	Babes Bolyai University from Cluj; University of York - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Martin Luther University Halle Wittenberg; University of Glasgow	Podar, D (corresponding author), Univ Babes Bolyai, Fac Biol Geol, Cluj Napoca 400084, Romania.	dorina.podar@gmail.com	Podar, Dorina/B-8702-2012; Podar, Dorina/AAK-3437-2021; Nies, Dietrich H/H-4143-2011	Podar, Dorina/0000-0002-0955-7425; Podar, Dorina/0000-0002-0955-7425; Noordally, Zeenat/0000-0003-2817-1330	European Union; CNCSIS-UEFISCSU [PN II_PD_424/2010]; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0651, BBS/E/J/000C0662] Funding Source: researchfish; BBSRC [BBS/E/J/000C0662, BBS/E/J/000C0651] Funding Source: UKRI	European Union(European Commission); CNCSIS-UEFISCSU(Consiliul National al Cercetarii Stiintifice (CNCS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Framework Programme 6 "PHIME" and CNCSIS-UEFISCSU, PN II_PD_424/2010.	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Arrivault S, 2006, PLANT J, V46, P861, DOI 10.1111/j.1365-313X.2006.02746.x; Auld DS, 2008, CELL MOL LIFE SCI, V65, P3961, DOI 10.1007/s00018-008-8593-1; Bhutta ZA, 2000, AM J CLIN NUTR, V72, P1516; Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; Blindauer CA, 2010, METALLOMICS, V2, P510, DOI 10.1039/c004880a; Brown CK, 1998, J PROTEIN CHEM, V17, P855, DOI 10.1023/A:1020790604887; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Cherezov V, 2008, STRUCTURE, V16, P1378, DOI 10.1016/j.str.2008.05.014; Desbrosses-Fonrouge AG, 2005, FEBS LETT, V579, P4165, DOI 10.1016/j.febslet.2005.06.046; Drager DB, 2004, PLANT J, V39, P425, DOI 10.1111/j.1365-313X.2004.02143.x; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Guffanti AA, 2002, MOL MICROBIOL, V45, P145, DOI 10.1046/j.1365-2958.2002.02998.x; Haney CJ, 2005, J IND MICROBIOL BIOT, V32, P215, DOI 10.1007/s10295-005-0224-3; Higuchi T, 2009, PROTEINS, V76, P768, DOI 10.1002/prot.22444; Kawachi M, 2008, J BIOL CHEM, V283, P8374, DOI 10.1074/jbc.M707646200; Kim D, 2004, PLANT J, V39, P237, DOI 10.1111/j.1365-313X.2004.02126.x; Kobae Y, 2004, PLANT CELL PHYSIOL, V45, P1749, DOI 10.1093/pcp/pci015; Lin HL, 2009, BIOCHEM J, V422, P273, DOI 10.1042/BJ20090853; Lin HL, 2008, J BIOL CHEM, V283, P33865, DOI 10.1074/jbc.M804377200; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Muthukumar B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-32; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Peiter E, 2007, P NATL ACAD SCI USA, V104, P8532, DOI 10.1073/pnas.0609507104; Persans MW, 2001, P NATL ACAD SCI USA, V98, P9995, DOI 10.1073/pnas.171039798; PRASAD AS, 1963, J LAB CLIN MED, V61, P537; Shingu Y, 2005, BIOCHEM BIOPH RES CO, V331, P675, DOI 10.1016/j.bbrc.2005.04.010; Tauris B, 2009, J EXP BOT, V60, P1333, DOI 10.1093/jxb/erp023; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Yuan LY, 2012, PLANT CELL REP, V31, P67, DOI 10.1007/s00299-011-1140-9; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	38	72	77	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3185	3196		10.1074/jbc.M111.305649	http://dx.doi.org/10.1074/jbc.M111.305649			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22139846	Green Published, hybrid			2022-12-25	WOS:000300295100024
J	Govaert, J; Pellis, M; Deschacht, N; Vincke, C; Conrath, K; Muyldermans, S; Saerens, D				Govaert, Jochen; Pellis, Mireille; Deschacht, Nick; Vincke, Cecile; Conrath, Katja; Muyldermans, Serge; Saerens, Dirk			Dual Beneficial Effect of Interloop Disulfide Bond for Single Domain Antibody Fragments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN ANTIBODIES; ANTIGEN-BINDING; MOLECULAR CONVERGENCE; CRYSTAL-STRUCTURE; LIGHT-CHAINS; V-REGION; PROTEIN; MATURATION; SHARK; VHH	The antigen-binding fragment of functional heavy chain antibodies (HCAbs) in camelids comprises a single domain, named the variable domain of heavy chain of HCAbs (VHH). The VHH harbors remarkable amino acid substitutions in the framework region-2 to generate an antigen-binding domain that functions in the absence of a light chain partner. The substitutions provide a more hydrophilic, hence more soluble, character to the VHH but decrease the intrinsic stability of the domain. Here we investigate the functional role of an additional hallmark of dromedary VHHs, i.e. the extra disulfide bond between the first and third antigen-binding loops. After substituting the cysteines forming this interloop cystine by all 20 amino acids, we selected and characterized several VHHs that retain antigen binding capacity. Although VHH domains can function in the absence of an interloop disulfide bond, we demonstrate that its presence constitutes a net advantage. First, the disulfide bond stabilizes the domain and counteracts the destabilization by the framework region-2 hallmark amino acids. Second, the disulfide bond rigidifies the long third antigen-binding loop, leading to a stronger antigen interaction. This dual beneficial effect explains the in vivo antibody maturation process favoring VHH domains with an interloop disulfide bond.	[Muyldermans, Serge] Vrije Univ Brussel, Cellular & Mol Immunol Lab, VIB Dept Struct Biol, B-1050 Brussels, Belgium; VIB, Dept Biol Struct, B-1050 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Muyldermans, S (corresponding author), Vrije Univ Brussel, Cellular & Mol Immunol Lab, VIB Dept Struct Biol, Pl Laan 2, B-1050 Brussels, Belgium.	svmuylde@vub.ac.be	Muyldermans, Serge/AAC-7374-2019; Saerens, Dirk/B-9162-2008; Muyldermans, Serge V/C-6418-2016; Vincke, Cecile/C-6590-2016	Muyldermans, Serge/0000-0002-3678-3575; Muyldermans, Serge V/0000-0002-3678-3575; Saerens, Dirk/0000-0001-8894-8039; Vincke, Cecile/0000-0003-0681-7444	VIB; Fonds voor wetenschappelijk onderzoek-Vlaanderen (FWO-Vlaanderen); Vrije Universiteit Brussel (Onderzoeksraad and Geconcerteerde Onderzoeks Acties); Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen (IWT-Vlaanderen)	VIB; Fonds voor wetenschappelijk onderzoek-Vlaanderen (FWO-Vlaanderen)(FWO); Vrije Universiteit Brussel (Onderzoeksraad and Geconcerteerde Onderzoeks Acties); Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported in part by the VIB, Fonds voor wetenschappelijk onderzoek-Vlaanderen (FWO-Vlaanderen), and Vrije Universiteit Brussel (Onderzoeksraad and Geconcerteerde Onderzoeks Acties).; Supported by the Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen (IWT-Vlaanderen).	Abkevich VI, 2000, J MOL BIOL, V300, P975, DOI 10.1006/jmbi.2000.3893; Baral TN, 2006, NAT MED, V12, P580, DOI 10.1038/nm1395; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Clarke J, 2000, PROTEIN SCI, V9, P2394, DOI 10.1110/ps.9.12.2394; Conrath K, 2005, J MOL BIOL, V350, P112, DOI 10.1016/j.jmb.2005.04.050; Conrath KE, 2003, DEV COMP IMMUNOL, V27, P87, DOI 10.1016/S0145-305X(02)00071-X; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Davies J, 1996, PROTEIN ENG, V9, P531, DOI 10.1093/protein/9.6.531; De Genst E, 2004, J BIOL CHEM, V279, P53593, DOI 10.1074/jbc.M407843200; De Genst E, 2002, J BIOL CHEM, V277, P29897, DOI 10.1074/jbc.M202359200; Decanniere K, 2000, J MOL BIOL, V300, P83, DOI 10.1006/jmbi.2000.3839; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Johansson J, 2002, J IMMUNOL, V168, P5155, DOI 10.4049/jimmunol.168.10.5155; Jones JM, 2004, IMMUNOL REV, V200, P233, DOI 10.1111/j.0105-2896.2004.00168.x; Kabat E. A., 1991, SEQUENCES PROTEINS I; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Lefranc MP, 2004, MOL IMMUNOL, V40, P647, DOI 10.1016/j.molimm.2003.09.006; LESK AM, 1982, J MOL BIOL, V160, P325, DOI 10.1016/0022-2836(82)90179-6; Li ZQ, 2004, GENE DEV, V18, P1, DOI 10.1101/gad.1161904; Lipovsek D, 2007, J MOL BIOL, V368, P1024, DOI 10.1016/j.jmb.2007.02.029; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nguyen VK, 1998, J MOL BIOL, V275, P413, DOI 10.1006/jmbi.1997.1477; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; Nuttall S. D., 2000, Current Pharmaceutical Biotechnology, V1, P253, DOI 10.2174/1389201003378906; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Roux KH, 1998, P NATL ACAD SCI USA, V95, P11804, DOI 10.1073/pnas.95.20.11804; Saerens D, 2004, J BIOL CHEM, V279, P51965, DOI 10.1074/jbc.M409292200; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022; Saerens D, 2008, J IMMUNOL METHODS, V329, P138, DOI 10.1016/j.jim.2007.10.005; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Scholz O, 2000, EUR J BIOCHEM, V267, P1565, DOI 10.1046/j.1432-1327.2000.01170.x; Serruys B, 2010, J GEN VIROL, V91, P643, DOI 10.1099/vir.0.016063-0; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Stanfield RL, 2007, J MOL BIOL, V367, P358, DOI 10.1016/j.jmb.2006.12.045; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Tsai CH, 2007, CURR PROTEIN PEPT SC, V8, P243, DOI 10.2174/138920307780831848; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Welker E, 2001, BIOCHEMISTRY-US, V40, P9059, DOI 10.1021/bi010409g; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	50	96	102	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1970	1979		10.1074/jbc.M111.242818	http://dx.doi.org/10.1074/jbc.M111.242818			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128183	Green Published, hybrid			2022-12-25	WOS:000299321000038
J	Sokolowska, I; Woods, AG; Gawinowicz, MA; Roy, U; Darie, CC				Sokolowska, Izabela; Woods, Alisa G.; Gawinowicz, Mary Ann; Roy, Urmi; Darie, Costel C.			Identification of Potential Tumor Differentiation Factor (TDF) Receptor from Steroid-responsive and Steroid-resistant Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITELLINE ENVELOPE PROTEINS; HEAT-SHOCK PROTEINS; FACTOR PROCOAGULANT ACTIVITY; FAST INTERACTION REFINEMENT; RAINBOW-TROUT EGG; BLUE NATIVE PAGE; ENDOPLASMIC-RETICULUM; ESTROGEN-RECEPTOR; MASS-SPECTROMETRY; PROSTATE-CANCER	Tumor differentiation factor (TDF) is a recently discovered protein, produced by the pituitary gland and secreted into the bloodstream. TDF and TDF-P1, a 20-amino acid peptide selected from the open reading frame of TDF, induce differentiation in human breast and prostate cancer cells but not in other cells. TDF protein has no identified site of action or receptor, and its mechanism of action is unknown. Here, we used TDF-P1 to purify and identify potential TDF receptor (TDF-R) candidates from MCF7 steroid-responsive breast cancer cells and non-breast HeLa cancerous cells using affinity purification chromatography (AP), and mass spectrometry (MS). We identified four candidate proteins from the 70-kDa heat shock protein (HSP70) family in MCF7 cells. Experiments in non-breast HeLa cancerous cells did not identify any TDF-R candidates. AP and MS experiments were validated by AP and Western blotting (WB). We additionally looked for TDF-R in steroid-resistant BT-549 cells and human dermal fibroblasts (HDF-a) using AP and WB. TDF-P1 interacts with potential TDF-R candidates from MCF7 and BT-549 breast cells but not from HeLa or HDF-a cells. Immunofluorescence (IF) experiments identified GRP78, a TDF-R candidate, at the cell surface of MCF7, BT-549 breast cells, and HeLa cells but not HDF-a cells. IF of other HSP70 proteins demonstrated labeling on all four cell types. These results point toward GRP78 and HSP70 proteins as strong TDF-R candidates and suggest that TDF interacts with its receptor, exclusively on breast cells, through a steroid-independent pathway.	[Sokolowska, Izabela; Woods, Alisa G.; Roy, Urmi; Darie, Costel C.] Clarkson Univ, Dept Chem & Biomol Sci, Biochem & Prote Grp, Potsdam, NY 13699 USA; [Gawinowicz, Mary Ann] Columbia Univ, Coll Phys & Surg, Prot Core Facil, New York, NY 10032 USA	Clarkson University; Columbia University	Darie, CC (corresponding author), Clarkson Univ, Dept Chem & Biomol Sci, Biochem & Prote Grp, 8 Clarkson Ave, Potsdam, NY 13699 USA.	cdarie@clarkson.edu	Roy, Urmi/ABG-3629-2020; Darie, Costel/F-1274-2011	Roy, Urmi/0000-0003-0928-0574; Darie, Costel C./0000-0001-6402-2311	Clarkson University; United States Army Research Office through the Defense University Research Instrumentation Program [W911NF-11-1-0304]	Clarkson University; United States Army Research Office through the Defense University Research Instrumentation Program	This work was supported in part by a start-up grant provided by Clarkson University (to C. C. D.) and by support from the United States Army Research Office through the Defense University Research Instrumentation Program (DURIP Grant W911NF-11-1-0304).	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Al-Hashimi AA, 2010, J BIOL CHEM, V285, P28912, DOI 10.1074/jbc.M110.119107; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Awad W, 2008, P NATL ACAD SCI USA, V105, P1164, DOI 10.1073/pnas.0702132105; BRABANT G, 1993, CANCER RES, V53, P4987; Calvert Meredith E, 2003, Reprod Biol Endocrinol, V1, P27, DOI 10.1186/1477-7827-1-27; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; Darie CC, 2004, BIOCHEMISTRY-US, V43, P7459, DOI 10.1021/bi0495937; Darie CC, 2005, J BIOL CHEM, V280, P37585, DOI 10.1074/jbc.M506709200; Darie CC, 2005, FEBS J, V272, P2705, DOI 10.1111/j.1742-4658.2005.04685.x; Darie CC, 2008, NATO SCI PEACE SEC A, P3, DOI 10.1007/978-1-4020-8811-7_1; Darie CC, 2008, NATO SCI PEACE SEC A, P23, DOI 10.1007/978-1-4020-8811-7_2; Darie CC, 2008, BBA-PROTEINS PROTEOM, V1784, P385, DOI 10.1016/j.bbapap.2007.10.011; Darie CC, 2011, PROTEOMICS, V11, P4514, DOI 10.1002/pmic.201000819; DeLeeuw WJF, 1997, J PATHOL, V183, P404, DOI 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; Delpino A, 1998, MOL MEMBR BIOL, V15, P21, DOI 10.3109/09687689809027514; Didelot C, 2007, CURR MED CHEM, V14, P2839, DOI 10.2174/092986707782360079; Dul JL, 2001, J CELL BIOL, V152, P705, DOI 10.1083/jcb.152.4.705; EDELMAN GM, 1991, ANNU REV BIOCHEM, V60, P155, DOI 10.1146/annurev.bi.60.070191.001103; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Graner MW, 2009, CANCER SCI, V100, P1870, DOI 10.1111/j.1349-7006.2009.01269.x; Hafker T, 1998, MICROBIOL-UK, V144, P37, DOI 10.1099/00221287-144-1-37; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Jang JH, 2003, PROTEOMICS, V3, P1947, DOI 10.1002/pmic.200300563; Jensen MR, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1996; Jiang HF, 2007, BBA-MOL CELL BIOL L, V1771, P66, DOI 10.1016/j.bbalip.2006.10.004; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Jorgensen MM, 2000, J BIOL CHEM, V275, P33861, DOI 10.1074/jbc.M004663200; Katanasaka Y, 2010, INT J CANCER, V127, P2685, DOI 10.1002/ijc.25276; Kelber JA, 2009, ONCOGENE, V28, P2324, DOI 10.1038/onc.2009.97; Lanneau D, 2007, PRION, V1, P53, DOI 10.4161/pri.1.1.4059; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Liu Y, 2007, MOL PHARMACEUT, V4, P435, DOI 10.1021/mp060122j; Macias AT, 2011, J MED CHEM, V54, P4034, DOI 10.1021/jm101625x; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Misra UK, 2011, J BIOL CHEM, V286, P1248, DOI 10.1074/jbc.M110.129767; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; Nair SC, 1996, CELL STRESS CHAPERON, V1, P237, DOI 10.1379/1466-1268(1996)001<0237:APOMCI>2.3.CO;2; NEMOTO T, 1992, J STEROID BIOCHEM, V42, P803, DOI 10.1016/0960-0760(92)90088-Z; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Nilsson S, 2002, CRIT REV EUKAR GENE, V12, P237, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i4.10; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; PFEFFER U, 1995, CANCER RES, V55, P2158; Platica M, 2004, P NATL ACAD SCI USA, V101, P1560, DOI 10.1073/pnas.0307829100; PLATICA M, 1992, ENDOCRINOLOGY, V131, P2573, DOI 10.1210/en.131.6.2573; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Rauschert N, 2008, LAB INVEST, V88, P375, DOI 10.1038/labinvest.2008.2; RAY DB, 1981, ENDOCRINOLOGY, V108, P573, DOI 10.1210/endo-108-2-573; Saba JA, 2007, J PROTEOME RES, V6, P2211, DOI 10.1021/pr070031u; SANCHEZ ER, 1990, BIOCHEMISTRY-US, V29, P5145, DOI 10.1021/bi00473a021; Sato M, 2010, ADV GENET, V69, P97, DOI 10.1016/S0065-2660(10)69006-2; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schwarze S, 2010, CANCER BIOL THER, V9, P153, DOI 10.4161/cbt.9.2.10760; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shida M, 2010, ACTA CRYSTALLOGR D, V66, P223, DOI 10.1107/S0907444909053979; Solit DB, 2006, CURR TOP MED CHEM, V6, P1205, DOI 10.2174/156802606777812068; SOMMERS CL, 1991, CELL GROWTH DIFFER, V2, P365; Spellman DS, 2008, MOL CELL PROTEOMICS, V7, P1067, DOI 10.1074/mcp.M700387-MCP200; THEAN ET, 1990, BRIT J CANCER, V61, P773, DOI 10.1038/bjc.1990.173; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P742, DOI 10.1021/bi00147a029; Vladusic EA, 2000, ONCOL REP, V7, P157; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Watson LM, 2003, J BIOL CHEM, V278, P17438, DOI 10.1074/jbc.M301006200; Wolfson H, 2002, LECT NOTES COMPUTER; Zhang LH, 2011, BRAIN RES, V1371, P23, DOI 10.1016/j.brainres.2010.11.063; Zhang LH, 2010, J CELL BIOCHEM, V110, P1299, DOI 10.1002/jcb.22679; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	78	40	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1719	1733		10.1074/jbc.M111.284091	http://dx.doi.org/10.1074/jbc.M111.284091			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22130669	Green Published, hybrid			2022-12-25	WOS:000299321000015
J	Wilhelm, M; Kukekov, NV; Schmit, TL; Biagas, KV; Sproul, AA; Gire, S; Maes, ME; Xu, ZH; Greene, LA				Wilhelm, Michael; Kukekov, Nickolay V.; Schmit, Travis L.; Biagas, Katherine V.; Sproul, Andrew A.; Gire, Stephen; Maes, Margaret E.; Xu, Zhiheng; Greene, Lloyd A.			Sh3rf2/POSHER Protein Promotes Cell Survival by Ring-mediated Proteasomal Degradation of the c-Jun N-terminal Kinase Scaffold POSH (Plenty of SH3s) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JNK ACTIVATION; SYMPATHETIC NEURONS; PEPTIDE INHIBITOR; CEREBRAL-ISCHEMIA; APOPTOSIS; DEATH; PATHWAY; STRESS; IDENTIFICATION; EXCITOTOXICITY	We report that Sh3rf2, a homologue of the pro-apoptotic scaffold POSH (Plenty of SH3s), acts as an anti-apoptotic regulator for the c-Jun N-terminal kinase (JNK) pathway. siRNA-mediated knockdown of Sh3rf2 promotes apoptosis of neuronal PC12 cells, cultured cortical neurons, and C6 glioma cells. This death appears to result from activation of JNK signaling. Loss of Sh3rf2 triggers activation of JNK and its target c-Jun. Also, apoptosis promoted by Sh3rf2 knockdown is inhibited by dominant-negative c-Jun as well as by a JNK inhibitor. Investigation of the mechanism by which Sh3rf2 regulates cell survival implicates POSH, a scaffold required for activation of pro-apoptotic JNK/c-Jun signaling. In cells lacking POSH, Sh3rf2 knockdown is unable to activate JNK. We further find that Sh3rf2 binds POSH to reduce its levels by a mechanism that requires the RING domains of both proteins and that appears to involve proteasomal POSH degradation. Conversely, knockdown of Sh3rf2 promotes the stabilization of POSH protein and activation of JNK signaling. Finally, we show that endogenous Sh3rf2 protein rapidly decreases following several different apoptotic stimuli and that knockdown of Sh3rf2 activates the proapoptotic JNK pathway in neuronal cells. These findings support a model in which Sh3rf2 promotes proteasomal degradation of pro-apoptotic POSH in healthy cells and in which apoptotic stimuli lead to rapid loss of Sh3rf2 expression, and consequently to stabilization of POSH and JNK activation and cell death. On the basis of these observations, we propose the alter-native name POSHER (POSH-eliminating RING protein) for the Sh3rf2 protein.	[Wilhelm, Michael; Schmit, Travis L.; Maes, Margaret E.] Univ Wisconsin Madison, Dept Pediat, Madison, WI 53792 USA; [Wilhelm, Michael; Biagas, Katherine V.; Gire, Stephen] Columbia Univ Hlth Sci, Dept Pediat, New York, NY 10032 USA; [Kukekov, Nickolay V.; Sproul, Andrew A.; Xu, Zhiheng; Greene, Lloyd A.] Columbia Univ Hlth Sci, Dept Pathol & Cell Biol, New York, NY 10032 USA	University of Wisconsin System; University of Wisconsin Madison; Columbia University; Columbia University	Wilhelm, M (corresponding author), Univ Wisconsin Madison, Dept Pediat, H4-411 CSC,600 Highland Ave, Madison, WI 53792 USA.	mwilhelm@pediatrics.wisc.edu		Biagas, Katherine/0000-0002-4669-703X; Sproul, Andrew/0000-0001-6972-1592; Xu, Zhiheng/0000-0002-4809-2851; Maes, Margaret/0000-0001-9642-1085	National Institutes of Health [5RO1NS033689, 5PO1 NS38370]; National Basic Research Program of China 973 Program [2006CB504100/2006CB500701]; National Institutes of Health NICHD [K12-HD00850]; Child Health Research Career Development Award [K12-HD043389-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850, P30HD003352] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD043389] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033689, P50NS038370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China 973 Program(National Basic Research Program of China); National Institutes of Health NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Child Health Research Career Development Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5RO1NS033689 and 5PO1 NS38370 (to L. A. G.) and National Basic Research Program of China 973 Program number 2006CB504100/2006CB500701 (to Z. X.).; Supported by the Pediatric Scientist Development Program, National Institutes of Health NICHD Grant K12-HD00850 and Child Health Research Career Development Award K12-HD043389-02.	Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Bruckner SR, 2001, J NEUROCHEM, V78, P298, DOI 10.1046/j.1471-4159.2001.00400.x; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHOI KY, 1994, CELL, V78, P499; Choi WS, 1999, J NEUROSCI RES, V57, P86, DOI 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dong ZH, 2005, MOL BRAIN RES, V134, P282, DOI 10.1016/j.molbrainres.2004.10.039; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Kim GH, 2006, CELL SIGNAL, V18, P553, DOI 10.1016/j.cellsig.2005.05.026; Kuan CY, 2005, CNS NEUROL DISORD-DR, V4, P63, DOI 10.2174/1568007053005145; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kukekov NV, 2006, J BIOL CHEM, V281, P15517, DOI 10.1074/jbc.M601056200; Maroney AC, 1999, J NEUROCHEM, V73, P1901; Pirianov G, 2007, J CEREBR BLOOD F MET, V27, P1022, DOI 10.1038/sj.jcbfm.9600413; Tapon N, 1998, EMBO J, V17, P1395, DOI 10.1093/emboj/17.5.1395; Troy CM, 2001, J NEUROCHEM, V77, P157, DOI 10.1046/j.1471-4159.2001.00218.x; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Wang J, 2003, J NEUROSCI, V23, P8596; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Wilhelm M, 2007, DEV NEUROSCI-BASEL, V29, P355, DOI 10.1159/000105476; Wilhelm M, 2007, J BIOL CHEM, V282, P1288, DOI 10.1074/jbc.M607038200; Xu ZH, 2005, MOL CELL BIOL, V25, P9949, DOI 10.1128/MCB.25.22.9949-9959.2005; Xu ZH, 2006, J BIOL CHEM, V281, P303, DOI 10.1074/jbc.M509060200; Xu ZH, 2003, EMBO J, V22, P252, DOI 10.1093/emboj/cdg021; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Zhang QG, 2005, J NEUROCHEM, V95, P784, DOI 10.1111/j.1471-4159.2005.03435.x	29	23	29	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2247	2256		10.1074/jbc.M111.269431	http://dx.doi.org/10.1074/jbc.M111.269431			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128169	Green Published, hybrid			2022-12-25	WOS:000299321000062
J	Dennison, SM; Sutherland, LL; Jaeger, FH; Anasti, KM; Parks, R; Stewart, S; Bowman, C; Xia, SM; Zhang, RJ; Shen, XY; Scearce, RM; Ofek, G; Yang, YP; Kwong, PD; Santra, S; Liao, HX; Tomaras, G; Letvin, NL; Chen, B; Alam, SM; Haynes, BF				Dennison, S. Moses; Sutherland, Laura L.; Jaeger, Frederick H.; Anasti, Kara M.; Parks, Robert; Stewart, Shelley; Bowman, Cindy; Xia, Shi-Mao; Zhang, Ruijun; Shen, Xiaoying; Scearce, Richard M.; Ofek, Gilad; Yang, Yongping; Kwong, Peter D.; Santra, Sampa; Liao, Hua-Xin; Tomaras, Georgia; Letvin, Norman L.; Chen, Bing; Alam, S. Munir; Haynes, Barton F.			Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; BROADLY NEUTRALIZING ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES; AUTOREACTIVE B-CELLS; SURFACE-ANTIGEN; VACCINE DESIGN; 2F5 EPITOPE; MEMBRANE; ENVELOPE	A component to the problem of inducing broad neutralizing HIV-1 gp41 membrane proximal external region (MPER) antibodies is the need to focus the antibody response to the transiently exposed MPER pre-hairpin intermediate neutralization epitope. Here we describe a HIV-1 envelope (Env) gp140 oligomer prime followed by MPER peptide-liposomes boost strategy for eliciting serum antibody responses in rhesus macaques that bind to a gp41 fusion intermediate protein. This Env-liposome immunization strategy induced antibodies to the 2F5 neutralizing epitope (664)DKW residues, and these antibodies preferentially bound to a gp41 fusion intermediate construct as well as to MPER scaffolds stabilized in the 2F5-bound conformation. However, no serum lipid binding activity was observed nor was serum neutralizing activity for HIV-1 pseudoviruses present. Nonetheless, the Env-liposome prime-boost immunization strategy induced antibodies that recognized a gp41 fusion intermediate protein and was successful in focusing the antibody response to the desired epitope.	[Dennison, S. Moses; Sutherland, Laura L.; Jaeger, Frederick H.; Anasti, Kara M.; Parks, Robert; Stewart, Shelley; Bowman, Cindy; Xia, Shi-Mao; Zhang, Ruijun; Shen, Xiaoying; Scearce, Richard M.; Liao, Hua-Xin; Tomaras, Georgia; Alam, S. Munir; Haynes, Barton F.] Duke Univ, Sch Med, Human Vaccine Inst, Durham, NC 27710 USA; [Santra, Sampa; Letvin, Norman L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Childrens Hosp,Dept Med, Boston, MA 02215 USA; [Chen, Bing] Harvard Univ, Childrens Hosp, Sch Med, Div Mol Med, Boston, MA 02115 USA; [Ofek, Gilad; Yang, Yongping; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	Duke University; Harvard University; Beth Israel Deaconess Medical Center; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dennison, SM (corresponding author), Duke Univ, Sch Med, Human Vaccine Inst, Durham, NC 27710 USA.	alam0004@mc.duke.edu; hayne002@mc.duke.edu	Tomaras, Georgia/J-5041-2016; Zhang, RUIJUN/AAD-6887-2021; Alam, S. Munir/AAC-6711-2019	Zhang, RUIJUN/0000-0001-6785-9619; 	Bill & Melinda Gates Foundation [38643]; Center for HIV/AIDS Vaccine Immunology (CHAVI) from the NIH, NIAID [AI067854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, U01AI067854, U19AI067854, ZIAAI005022] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Center for HIV/AIDS Vaccine Immunology (CHAVI) from the NIH, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was conducted as part of the Collaboration for AIDS Vaccine Discovery (CAVD) with support from the Bill & Melinda Gates Foundation to BFH (38643) and from the Center for HIV/AIDS Vaccine Immunology (CHAVI) AI067854 from the NIH, NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; Biron Z, 2005, BIOCHEMISTRY-US, V44, P13602, DOI 10.1021/bi0509245; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chakrabarti BK, 2005, VACCINE, V23, P3434, DOI 10.1016/j.vaccine.2005.01.099; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; Dennison SM, 2011, J VIROL, V85, P1340, DOI 10.1128/JVI.01680-10; Dennison SM, 2009, J VIROL, V83, P10211, DOI 10.1128/JVI.00571-09; Eckhart L, 1996, J GEN VIROL, V77, P2001, DOI 10.1099/0022-1317-77-9-2001; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Frey G, 2010, NAT STRUCT MOL BIOL, V17, P1486, DOI 10.1038/nsmb.1950; Gorny MK, 2000, J VIROL, V74, P6186, DOI 10.1128/JVI.74.13.6186-6192.2000; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Guenaga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016074; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Herlands RA, 2008, IMMUNITY, V29, P249, DOI 10.1016/j.immuni.2008.06.009; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hinz A, 2009, VIROLOGY, V390, P221, DOI 10.1016/j.virol.2009.05.015; Ho J, 2005, VACCINE, V23, P1559, DOI 10.1016/j.vaccine.2004.09.037; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Liang XP, 1999, VACCINE, V17, P2862, DOI 10.1016/S0264-410X(99)00125-5; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Matyas GR, 2009, AIDS, V23, P2069, DOI 10.1097/QAD.0b013e32832faea5; McGaughey GB, 2003, BIOCHEMISTRY-US, V42, P3214, DOI 10.1021/bi026952u; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Morris L., 2011, PLOS ONE IN PRESS; Munoz-Barroso I, 1999, J VIROL, V73, P6089; Nicely NI, 2010, NAT STRUCT MOL BIOL, V17, P1492, DOI 10.1038/nsmb.1944; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Phogat S, 2008, VIROLOGY, V373, P72, DOI 10.1016/j.virol.2007.11.005; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; Shen XY, 2010, P NATL ACAD SCI USA, V107, P5972, DOI 10.1073/pnas.0912381107; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tran TT, 2003, CLIN IMMUNOL, V109, P278, DOI 10.1016/j.clim.2003.08.012; Uccellini MB, 2008, J IMMUNOL, V181, P5875, DOI 10.4049/jimmunol.181.9.5875; Verkoczy L, 2011, CURR OPIN IMMUNOL, V23, P383, DOI 10.1016/j.coi.2011.04.003; Verkoczy L, 2010, P NATL ACAD SCI USA, V107, P181, DOI 10.1073/pnas.0912914107; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018233; Watson DS, 2009, VACCINE, V27, P4672, DOI 10.1016/j.vaccine.2009.05.059; Ye L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014813; Yuan W, 2009, AIDS RES HUM RETROV, V25, P319, DOI 10.1089/aid.2008.0213; Zhang HT, 2004, J VIROL, V78, P8342, DOI 10.1128/jvi.78.15.8342-8348.2004	53	58	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27824	10.1371/journal.pone.0027824	http://dx.doi.org/10.1371/journal.pone.0027824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140469	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100019
J	de Amorim, IFG; da Silva, SM; Figueiredo, MM; Moura, EP; de Castro, RS; Lima, TKD; Gontijo, ND; Michalick, MSM; Gollob, KJ; Tafuri, WL				Gontijo de Amorim, Izabela Ferreira; da Silva, Sydnei Magno; Figueiredo, Maria Marta; Moura, Eliane Perlatto; de Castro, Rodrigo Soares; de Souza Lima, Tatjana Keesen; Gontijo, Nelder de Figueiredo; Marques Michalick, Marilene Suzan; Gollob, Kenneth John; Tafuri, Wagner Luiz			Toll Receptors Type-2 and CR3 Expression of Canine Monocytes and Its Correlation with Immunohistochemistry and Xenodiagnosis in Visceral Leishmaniasis	PLOS ONE			English	Article							LUTZOMYIA-LONGIPALPIS; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORS; ASYMPTOMATIC DOGS; IMMUNE-RESPONSES; MACROPHAGES; INFECTION; INFANTUM; CHAGASI; TOLL-LIKE-RECEPTOR-2; RECOGNITION	The aim of the present study was to investigate TLR2 expression in peripheral blood monocytes from dogs naturally infected with Leishmania (Leishmania) infantum to determine whether it correlates with CD11b/CD18 (CR3) expression, and to evaluate the potential of dogs as sources of infection using phlebotomine xenodiagnosis. Forty eight dogs were serologically diagnosed with L. infantum infection by indirect immunofluorescence antibody test (IFAT) and enzyme linked immunosorbent assay (ELISA). Parasitological exams from bone-marrow aspirates were positive by PCR analysis. All dogs were clinical defined as symptomatic. Ear skin tissue samples were obtained for immunohistochemistry (IHQ) analysis. The potential of these dogs as a source of infection using phlebotomine xenodiagnosis (XENO) was evaluated. Flow cytometry was carried out on peripheral blood mononuclear cells using superficial receptors including CD14, CD11b, TLR2 and MHCII. IHQ ear skin tissue parasite load and XENO where done where we found a strict correlation (r = 0.5373). Dogs with higher expression of MFI of CD11b inside CD14 monocytes were represented by dogs without parasite ear tissue load that were unable to infect phlebotomines (IHQ(-)/XENO-). Dogs with lower expression of MFI of CD11b inside CD14 monocytes were represented by dogs with parasite ear tissue load and able to infect phlebotomines (IHQ(+)/XENO+) (p = 0,0032). Comparable results were obtained for MFI of MHCII (p = 0.0054). In addition, considering the population frequency of CD11b(+)TLR2(+) and CD11b(+)MHCII(+), higher values were obtained from dogs with IHQ(-)/XENO- than dogs with IHQ(+)/XENO+ (p = 0.01; p = 0.0048, respectively). These data, together with the TLR2 and NO assays results (CD11b(+)TLR2(+) and NO with higher values for dogs with IHQ(-)/XENO- than dogs with IHQ(+)/XENO+), led to the conclusion that IHQ(-)/XENO- dogs are more resistant or could modulate the cellular immune response essential for Leishmania tissue clearance.	[Gontijo de Amorim, Izabela Ferreira; Figueiredo, Maria Marta; de Castro, Rodrigo Soares; Tafuri, Wagner Luiz] Univ Fed Minas Gerais, Escola Med, Dept Patol Geral, Belo Horizonte, MG, Brazil; [da Silva, Sydnei Magno; Gontijo, Nelder de Figueiredo; Marques Michalick, Marilene Suzan] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Moura, Eliane Perlatto] Univ Fed Minas Gerais, Escola Med, Dept Parasitol, Belo Horizonte, MG, Brazil; [de Souza Lima, Tatjana Keesen; Gollob, Kenneth John] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	de Amorim, IFG (corresponding author), Univ Fed Minas Gerais, Escola Med, Dept Patol Geral, Belo Horizonte, MG, Brazil.	wagnertafuri@gmail.com	Gollob, Kenneth J/GPX-8434-2022; DoenÃas Tropicais, Inct/K-2308-2013; Gollob, Kenneth J/C-1341-2008; Gontijo, Nelder F/D-2539-2013; Silva, Sydnei/K-4089-2012	Gollob, Kenneth J/0000-0003-4184-3867; Gontijo, Nelder F/0000-0003-3357-2497; Silva, Sydnei/0000-0003-3154-5663; Tafuri, Wagner Luiz/0000-0002-7556-0737; FERREIRA GONTIJO DE AMORIM, IZABELA/0000-0003-3660-4167	Fundacao de Amparo e Pesquisa do Estado de Minas Gerais (FAPEMIG) [DS-AQP 00068-08, CBB00219/09]; Pro-reitoria de Pesquisa (PRPq), Universidade Federal de Minas Gerais, UFMG, Minas Gerais State, Brazil [Edital 07/2010]	Fundacao de Amparo e Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Pro-reitoria de Pesquisa (PRPq), Universidade Federal de Minas Gerais, UFMG, Minas Gerais State, Brazil	This study was supported by Fundacao de Amparo e Pesquisa do Estado de Minas Gerais (FAPEMIG CDS-AQP 00068-08 and FAPEMIG CBB00219/09) and Pro-reitoria de Pesquisa (PRPq-Edital 07/2010), Universidade Federal de Minas Gerais, UFMG, Minas Gerais State, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020; Amusategui I, 2003, EUR J EPIDEMIOL, V18, P147, DOI 10.1023/A:1023090929302; Bazzocchi C, 2005, VET IMMUNOL IMMUNOP, V104, P15, DOI 10.1016/j.vetimm.2004.08.023; Becker I, 2003, MOL BIOCHEM PARASIT, V130, P65, DOI 10.1016/S0166-6851(03)00160-9; Bretagne S, 2001, CLIN DIAGN LAB IMMUN, V8, P828, DOI 10.1128/CDLI.8.4.828-831.2001; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Carpenter S, 2007, CELL MICROBIOL, V9, P1891, DOI 10.1111/j.1462-5822.2007.00965.x; Carter CR, 2009, INFECT IMMUN, V77, P5668, DOI 10.1128/IAI.00802-08; Chandra D, 2008, CLIN EXP IMMUNOL, V154, P224, DOI 10.1111/j.1365-2249.2008.03741.x; Ciaramella P, 2005, VET J, V169, P465, DOI 10.1016/j.tvjl.2004.03.009; Ciaramella P, 1997, VET REC, V141, P539, DOI 10.1136/vr.141.21.539; Ciaramella P, 2002, PLATELETS, V13, P331; da Costa-Val AP, 2007, VET J, V174, P636, DOI 10.1016/j.tvjl.2006.11.006; da Silva SM, 2010, VET PARASITOL, V174, P150, DOI 10.1016/j.vetpar.2010.08.005; da Silva SM, 2009, VET PARASITOL, V166, P159, DOI 10.1016/j.vetpar.2009.08.011; De Almeida MC, 2003, INT J PARASITOL, V33, P153, DOI 10.1016/S0020-7519(02)00266-7; de Amorim IFG, 2010, VET PARASITOL, V173, P55, DOI 10.1016/j.vetpar.2010.06.021; de Veer MJ, 2003, EUR J IMMUNOL, V33, P2822, DOI 10.1002/eji.200324128; do Rosario EY, 2005, MEM I OSWALDO CRUZ, V100, P197, DOI 10.1590/S0074-02762005000200015; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Engwerda CR, 2004, TRENDS PARASITOL, V20, P524, DOI 10.1016/j.pt.2004.08.009; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Figueiredo MM, 2010, HISTOL HISTOPATHOL, V25, P877, DOI 10.14670/HH-25.877; Flandin JF, 2006, EUR J IMMUNOL, V36, P411, DOI 10.1002/eji.200535079; Giunchetti RC, 2006, J COMP PATHOL, V135, P100, DOI 10.1016/j.jcpa.2006.06.005; Giunchetti RC, 2008, RES VET SCI, V84, P269, DOI 10.1016/j.rvsc.2007.04.020; Goncalves R, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-39; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guarga JL, 2000, ACTA TROP, V77, P203, DOI 10.1016/S0001-706X(00)00141-8; Guerra CS, 2010, INT J EXP PATHOL, V91, P451, DOI 10.1111/j.1365-2613.2010.00717.x; Hawn TR, 2002, MICROBES INFECT, V4, P763, DOI 10.1016/S1286-4579(02)01596-4; Ishii M, 2006, VET IMMUNOL IMMUNOP, V110, P87, DOI 10.1016/j.vetimm.2005.09.007; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kavoosi G, 2010, EXP PARASITOL, V124, P214, DOI 10.1016/j.exppara.2009.09.017; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Koutinas AF, 1999, J AM ANIM HOSP ASSOC, V35, P376, DOI 10.5326/15473317-35-5-376; Lage RS, 2007, VET IMMUNOL IMMUNOP, V115, P135, DOI 10.1016/j.vetimm.2006.10.001; Lima WG, 2007, VET IMMUNOL IMMUNOP, V117, P129, DOI 10.1016/j.vetimm.2007.02.012; Lima WG, 2004, ACTA TROP, V92, P43, DOI 10.1016/j.actatropica.2004.04.007; Marth T, 1997, J EXP MED, V185, P1987, DOI 10.1084/jem.185.11.1987; MAUEL J, 1991, J LEUKOCYTE BIOL, V49, P73, DOI 10.1002/jlb.49.1.73; Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9; Melo FA, 2009, INT J EXP PATHOL, V90, P538, DOI 10.1111/j.1365-2613.2009.00681.x; Michalsky EM, 2007, VET PARASITOL, V147, P67, DOI 10.1016/j.vetpar.2007.03.004; Mosser David M., 1993, Seminars in Cell Biology, V4, P315, DOI 10.1006/scel.1993.1038; MOSSER DM, 1987, NATURE, V327, P329, DOI 10.1038/327329b0; PIARROUX R, 1993, AM J TROP MED HYG, V49, P364, DOI 10.4269/ajtmh.1993.49.364; Reis AB, 2009, VET IMMUNOL IMMUNOP, V128, P87, DOI 10.1016/j.vetimm.2008.10.307; Ribeiro RR, 2008, ANTIMICROB AGENTS CH, V52, P2564, DOI 10.1128/AAC.00223-08; Sampaio Weverton M, 2007, BMC Vet Res, V3, P11, DOI 10.1186/1746-6148-3-11; Sanchez MA, 2004, AM J TROP MED HYG, V70, P618, DOI 10.4269/ajtmh.2004.70.618; Silvestre R, 2009, IMMUNOLOGY, V128, P484, DOI 10.1111/j.1365-2567.2009.03132.x; Strauss-Ayali D, 2007, VET RES, V38, P547, DOI 10.1051/vetres:2007015; Tafuri WL, 2004, J IMMUNOL METHODS, V292, P17, DOI 10.1016/j.jim.2004.05.009; Takeda K, 2001, JPN J INFECT DIS, V54, P209; Teixeira MJ, 2006, TRENDS PARASITOL, V22, P32, DOI 10.1016/j.pt.2005.11.010; Travi BL, 2001, AM J TROP MED HYG, V64, P119, DOI 10.4269/ajtmh.2001.64.119; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Tuon FF, 2008, INFECT IMMUN, V76, P866, DOI 10.1128/IAI.01090-07; Vercosa BLA, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-45; VOLLER A, 1978, Ricerca in Clinica e in Laboratorio, V8, P289; Xavier SC, 2006, BMC VET RES, V2, P17, DOI [10.1186/1746-6148-2-17, DOI 10.1186/1746-6148-2-17]; Zafra R, 2008, VET IMMUNOL IMMUNOP, V123, P353, DOI 10.1016/j.vetimm.2008.02.022	64	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27679	10.1371/journal.pone.0027679	http://dx.doi.org/10.1371/journal.pone.0027679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140456	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100015
J	Goodin, DS; Jones, J; Li, D; Traboulsee, A; Reder, AT; Beckmann, K; Konieczny, A; Knappertz, V				Goodin, Douglas S.; Jones, Jason; Li, David; Traboulsee, Anthony; Reder, Anthony T.; Beckmann, Karola; Konieczny, Andreas; Knappertz, Volker		16-Year Long-Term Follow-Up Study	Establishing Long-Term Efficacy in Chronic Disease: Use of Recursive Partitioning and Propensity Score Adjustment to Estimate Outcome in MS	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; REMITTING MULTIPLE-SCLEROSIS; INTERFERON BETA-1A; DOUBLE-BLIND; MULTICENTER; STRATIFICATION; NATALIZUMAB; DISABILITY	Context: Establishing the long-term benefit of therapy in chronic diseases has been challenging. Long-term studies require non-randomized designs and, thus, are often confounded by biases. For example, although disease-modifying therapy in MS has a convincing benefit on several short-term outcome-measures in randomized trials, its impact on long-term function remains uncertain. Objective: Data from the 16-year Long-Term Follow-up study of interferon-beta-1b is used to assess the relationship between drug-exposure and long-term disability in MS patients. Design/Setting: To mitigate the bias of outcome-dependent exposure variation in non-randomized long-term studies, drug-exposure was measured as the medication-possession-ratio, adjusted up or down according to multiple different weighting-schemes based on MS severity and MS duration at treatment initiation. A recursive-partitioning algorithm assessed whether exposure (using any weighing scheme) affected long-term outcome. The optimal cut-point that was used to define "high'' or "low'' exposure-groups was chosen by the algorithm. Subsequent to verification of an exposure-impact that included all predictor variables, the two groups were compared using a weighted propensity-stratified analysis in order to mitigate any treatment-selection bias that may have been present. Finally, multiple sensitivity-analyses were undertaken using different definitions of long-term outcome and different assumptions about the data. Main Outcome Measure: Long-Term Disability. Results: In these analyses, the same weighting-scheme was consistently selected by the recursive-partitioning algorithm. This scheme reduced (down-weighted) the effectiveness of drug exposure as either disease duration or disability at treatment-onset increased. Applying this scheme and using propensity-stratification to further mitigate bias, high-exposure had a consistently better clinical outcome compared to low-exposure (Cox proportional hazard ratio = 0.30-0.42; p < 0.0001). Conclusions: Early initiation and sustained use of interferon-beta-1b has a beneficial impact on long-term outcome in MS. Our analysis strategy provides a methodological framework for bias-mitigation in the analysis of non-randomized clinical data.	[Goodin, Douglas S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Jones, Jason] Intermt Healthcare, Salt Lake City, UT USA; [Li, David; Traboulsee, Anthony] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Reder, Anthony T.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Beckmann, Karola] Bayer Schering Pharma AG, Berlin, Germany; [Konieczny, Andreas] Lampe Konieczny & Co, Berlin, Germany; [Knappertz, Volker] Bayer HealthCare, Montville, NJ USA	University of California System; University of California San Francisco; Intermountain Healthcare; Intermountain Medical Center; University of British Columbia; University of Chicago; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals	Goodin, DS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	douglas.goodin@ucsf.edu	Traboulsee, Anthony L/AAB-2051-2020	Traboulsee, Anthony/0000-0002-0351-9639	Bayer HealthCare	Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	The 16-yrfollow-up study was designed by the steering committee (DG, Dl, AT, AR) which also included the neurologist representative from Bayer HealthCare (VK). Data collection was done by the participating centers and was collated by the CRO (Parexl) overseen by the consultant (AK), both funded by Bayer HealthCare. The statistical analysis was performed by (JJ), a consultant paid by Bayer HealthCare and was independently confirmed by (KB), a statistician working in the department of Biostatistics at Bayer HealthCAre. The decision to publish was made by the steering committee members (DG, Dl, AT, AR). The primary manuscript was written by (DG), although this was modified substantially according to the input received from each member of the author panel.	[Anonymous], 2008, PARTY PACKAGE; BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; CIAMPI A, 1988, COMPUT METH PROG BIO, V26, P239, DOI 10.1016/0169-2607(88)90004-1; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Durelli L, 2002, LANCET, V359, P1453, DOI 10.1016/S0140-6736(02)08430-1; Ebers G, 1999, NEUROLOGY, V53, P679; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Ebers GC, 2009, CLIN THER, V31, P1724, DOI 10.1016/j.clinthera.2009.08.003; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; Frohman EM, 2006, ARCH NEUROL-CHICAGO, V63, P614, DOI 10.1001/archneur.63.4.614; Giovannoni G, 2010, NEW ENGL J MED, V362, P416, DOI 10.1056/NEJMoa0902533; Goodin DS, 2009, MULT SCLER, V15, P1175, DOI 10.1177/1352458509107007; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; Goodin DS, 2011, RELATIONSHIP E UNPUB; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; Kappos L, 2006, NEUROLOGY, V67, P1242, DOI 10.1212/01.wnl.0000237641.33768.8d; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Mikol DD, 2008, LANCET NEUROL, V7, P903, DOI 10.1016/S1474-4422(08)70200-X; Novikov I, 2007, JAMA-J AM MED ASSOC, V297, P2077, DOI 10.1001/jama.297.19.2077-a; O'Connor P, 2009, LANCET NEUROL, V8, P889, DOI 10.1016/S1474-4422(09)70226-1; Panitch H, 2002, NEUROLOGY, V59, P1496, DOI 10.1212/01.WNL.0000034080.43681.DA; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Platform R, 2008, R PLATFORM; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Reder AT, 2010, NEUROLOGY, V74, P1877, DOI 10.1212/WNL.0b013e3181e240d0; Reder AT, 2011, EARLY DISABILI UNPUB; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; SCLAR DA, 1991, CLIN THER, V13, P489; Senn S, 2007, STAT MED, V26, P5529, DOI 10.1002/sim.3133; Siannis F, 2005, BIOSTATISTICS, V6, P77, DOI 10.1093/biostatistics/kxh019; Sikka R, 2005, AM J MANAG CARE, V11, P453; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102	45	34	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e22444	10.1371/journal.pone.0022444	http://dx.doi.org/10.1371/journal.pone.0022444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140424	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100001
J	Jurkowski, TP; Jeltsch, A				Jurkowski, Tomasz P.; Jeltsch, Albert			On the Evolutionary Origin of Eukaryotic DNA Methyltransferases and Dnmt2	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MODIFICATION ENZYMES; MOLECULAR EVOLUTION; MAXIMUM-LIKELIHOOD; PROTEIN SEQUENCES; FISSION YEAST; IN-VIVO; METHYLATION; HOMOLOG; GENES	The Dnmt2 enzymes show strong amino acid sequence similarity with eukaryotic and prokaryotic DNA-(cytosine C5)-methyltransferases. Yet, Dnmt2 enzymes from several species were shown to methylate tRNA-Asp and had been proposed that eukaryotic DNA methyltransferases evolved from a Dnmt2-like tRNA methyltransferase ancestor [Goll et al., 2006, Science, 311, 395-8]. It was the aim of this study to investigate if this hypothesis could be supported by evidence from sequence alignments. We present phylogenetic analyses based on sequence alignments of the methyltransferase catalytic domains of more than 2300 eukaryotic and prokaryotic DNA-(cytosine C5)-methyltransferases and analyzed the distribution of DNA methyltransferases in eukaryotic species. The Dnmt2 homologues were reliably identified by an additional conserved CFT motif next to motif IX. All DNA methyltransferases and Dnmt2 enzymes were clearly separated from other RNA-(cytosine-C5)-methyltransferases. Our sequence alignments and phylogenetic analyses indicate that the last universal eukaryotic ancestor contained at least one member of the Dnmt1, Dnmt2 and Dnmt3 families of enzymes and additional RNA methyltransferases. The similarity of Dnmt2 enzymes with DNA methyltransferases and absence of similarity with RNA methyltransferases combined with their strong RNA methylation activity suggest that the ancestor of Dnmt2 was a DNA methyltransferase and an early Dnmt2 enzyme changed its substrate preference to tRNA. There is no phylogenetic evidence that Dnmt2 was the precursor of eukaryotic Dnmts. Most likely, the eukaryotic Dnmt1 and Dnmt3 families of DNA methyltransferases had an independent origin in the prokaryotic DNA methyltransferase sequence space.	[Jurkowski, Tomasz P.; Jeltsch, Albert] Univ Bremen, Sch Sci & Engn, Bremen, Germany	University of Bremen	Jurkowski, TP (corresponding author), Univ Bremen, Sch Sci & Engn, Campus Ring Bremen, Bremen, Germany.	t.jurkowski@jacobs-university.de; a.jeltsch@jacobs-university.de	Jeltsch, Albert/O-7404-2014	Jeltsch, Albert/0000-0001-6113-9290; Jurkowski, Tomasz/0000-0002-2012-0240	Deutsche Forschungsgemeinschaft [JE 252/8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (JE 252/8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Brack A., 1998, MOL ORIGINS LIFE; Bujnicki JM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-3; Bujnicki JM, 1999, NUCLEIC ACIDS RES, V27, P4501, DOI 10.1093/nar/27.22.4501; Bujnicki JM, 2004, NUCLEIC ACIDS RES, V32, P2453, DOI 10.1093/nar/gkh564; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; Dong AP, 2001, NUCLEIC ACIDS RES, V29, P439, DOI 10.1093/nar/29.2.439; FAUMAN EB, 1999, S ADENOSYLMETHIONINE, P1, DOI DOI 10.1142/9789812813077_0001; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Fisher O, 2004, NUCLEIC ACIDS RES, V32, P287, DOI 10.1093/nar/gkh161; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutierrez A, 2004, NUCLEIC ACIDS RES, V32, P6388, DOI 10.1093/nar/gkh982; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hermann A, 2003, J BIOL CHEM, V278, P31717, DOI 10.1074/jbc.M305448200; Iyer LM, 2011, PROG MOL BIOL TRANSL, V101, P25, DOI 10.1016/B978-0-12-387685-0.00002-0; Jeltsch A, 1996, J MOL EVOL, V42, P91, DOI 10.1007/BF02198833; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Jeltsch A, 2006, TRENDS BIOCHEM SCI, V31, P306, DOI 10.1016/j.tibs.2006.04.005; Jeltsch A, 2010, SCIENCE, V328, P837, DOI 10.1126/science.1190738; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Jurkowski TP, 2008, RNA, V14, P1663, DOI 10.1261/rna.970408; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kuhlmann M, 2005, NUCLEIC ACIDS RES, V33, P6405, DOI 10.1093/nar/gki952; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Liu K, 2003, MOL CELL BIOL, V23, P2709, DOI 10.1128/MCB.23.8.2709-2719.2003; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pei JM, 2003, BIOINFORMATICS, V19, P427, DOI 10.1093/bioinformatics/btg008; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schopf W, 2002, LIFES ORIGIN; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; SCHWARTZ RM, 1979, SCIENCE, V205, P1038, DOI 10.1126/science.205.4410.1038; Sunita S, 2008, J MOL BIOL, V383, P652, DOI 10.1016/j.jmb.2008.08.062; Tang LY, 2003, J BIOL CHEM, V278, P33613, DOI 10.1074/jbc.C300255200; Van den Wyngaert I, 1998, FEBS LETT, V426, P283, DOI 10.1016/S0014-5793(98)00362-7; Vilkaitis G, 2002, NUCLEIC ACIDS RES, V30, P1547, DOI 10.1093/nar/30.7.1547; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; WILKINSON CRM, 1995, NUCLEIC ACIDS RES, V23, P203, DOI 10.1093/nar/23.2.203; Yoder JA, 1998, HUM MOL GENET, V7, P279, DOI 10.1093/hmg/7.2.279; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	50	80	83	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28104	10.1371/journal.pone.0028104	http://dx.doi.org/10.1371/journal.pone.0028104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140515	gold, Green Published, Green Submitted			2022-12-25	WOS:000298168100036
J	Li, CG; Fang, R; Sun, YH; Han, XK; Li, F; Gao, B; Iafrate, AJ; Liu, XY; Pao, W; Chen, HQ; Ji, HB				Li, Chenguang; Fang, Rong; Sun, Yihua; Han, Xiangkun; Li, Fei; Gao, Bin; Iafrate, A. John; Liu, Xin-Yuan; Pao, William; Chen, Haiquan; Ji, Hongbin			Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers	PLOS ONE			English	Article							CANCER; EGFR; DIAGNOSIS; SURVIVAL; FUSION; TRIAL	Purpose: We previously showed that 90% (47 of 52; 95% CI, 0.79 to 0.96) of lung adenocarcinomas from East Asian never-smokers harbored well-known oncogenic mutations in just four genes: EGFR, HER2, ALK, and KRAS. Here, we sought to extend these findings to more samples and identify driver alterations in tumors negative for these mutations. Experimental Design: We have collected and analyzed 202 resected lung adenocarcinomas from never smokers seen at Fudan University Shanghai Cancer Center. Since mutations were mutually exclusive in the first 52 examined, we determined the status of EGFR, KRAS, HER2, ALK, and BRAF in stepwise fashion as previously described. Samples negative for mutations in these 5 genes were subsequently examined for known ROS1 fusions by RT-PCR and direct sequencing. Results: 152 tumors (75.3%) harbored EGFR mutations, 12 (6%) had HER2 mutations, 10 (5%) had ALK fusions all involving EML4 as the 59 partner, 4 (2%) had KRAS mutations, and 2 (1%) harbored ROS1 fusions. No BRAF mutation were detected. Conclusion: The vast majority (176 of 202; 87.1%, 95% CI: 0.82 to 0.91) of lung adenocarcinomas from never smokers harbor mutant kinases sensitive to available TKIs. Interestingly, patients with EGFR mutant patients tend to be older than those without EGFR mutations (58.3 Vs 54.3, P = 0.016) and patient without any known oncogenic driver tend to be diagnosed at a younger age (52.3 Vs 57.9, P = 0.013). Collectively, these data indicate that the majority of never smokers with lung adenocarcinoma could benefit from treatment with a specific tyrosine kinase inhibitor.	[Li, Chenguang; Fang, Rong; Han, Xiangkun; Li, Fei; Gao, Bin; Liu, Xin-Yuan; Ji, Hongbin] Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Li, Chenguang; Sun, Yihua; Chen, Haiquan] Fudan Univ, Dept Thorac Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Li, Chenguang; Sun, Yihua; Chen, Haiquan] Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [Iafrate, A. John] Massachusetts Gen Hosp, Dept Pathol, Ctr Canc, Boston, MA 02114 USA; [Pao, William] Vanderbilt Ingram Canc Ctr, Nashville, TN USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Harvard University; Massachusetts General Hospital; Vanderbilt University	Li, CG (corresponding author), Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	william.pao@vanderbilt.edu; hqchen1@yahoo.com; hbji@sibs.ac.cn	Liu, Xinyuan/HDM-5505-2022	CHEN, Gao Bin/0000-0001-9988-1773	National Basic Research Program of China [2010CB912102, 2012CB910800]; National Natural Science Foundation of China [30871284, 30971461]; Chinese Academy of Sciences [2010KIP504]; Science and Technology Commission of Shanghai Municipality [09JC1416300]; National Cancer Institute (USA) [R01 CA121210]; Specialized Program of Research Excellence in Lung Cancer [CA90949]; Vanderbilt-Ingram Cancer Center [CA68485]; Xcovery; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA121210, P50CA090949] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Cancer Institute (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Specialized Program of Research Excellence in Lung Cancer; Vanderbilt-Ingram Cancer Center; Xcovery; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Basic Research Program of China (2010CB912102; 2012CB910800), the National Natural Science Foundation of China (30871284 and 30971461), the Chinese Academy of Sciences (2010KIP504), and the Science and Technology Commission of Shanghai Municipality (09JC1416300). H.J. is a scholar of the Hundred Talents Program of the Chinese Academy of Sciences. W. P. received funding from the National Cancer Institute (USA): R01 CA121210; the Specialized Program of Research Excellence in Lung Cancer Grant (CA90949), and the Vanderbilt-Ingram Cancer Center Core Grant (CA68485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dr. William Pao has consulted for AstraZeneca and MolecularMD and has received research funding from Xcovery. Dr. A. John Iafrate has consulted for Pfizer and Abbott Molecular. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2010, CHIN MOHOTPSRO; Cappuzzo F, 2006, NEW ENGL J MED, V354, P2619, DOI 10.1056/NEJMc060020; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Choi YH, 2010, J THORAC ONCOL, V5, P1949, DOI 10.1097/JTO.0b013e3181f38816; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Henschke CI, 2006, JAMA-J AM MED ASSOC, V296, P180; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sequist LV, 2010, J CLIN ONCOL, V28, P3076, DOI 10.1200/JCO.2009.27.9414; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Sun YH, 2010, ACTA PHARMACOL SIN, V31, P647, DOI 10.1038/aps.2010.43; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Toh CK, 2006, J CLIN ONCOL, V24, P2245, DOI 10.1200/JCO.2005.04.8033; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wong DW, 2011, CANCER; Yap TA, 2010, J CLIN ONCOL, V28, P3965, DOI 10.1200/JCO.2009.26.7278	20	153	170	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28204	10.1371/journal.pone.0028204	http://dx.doi.org/10.1371/journal.pone.0028204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140546	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168100050
J	Xiang, X; Lee, CY; Li, T; Chen, W; Lou, JZ; Zhu, C				Xiang, Xue; Lee, Cho-yin; Li, Tian; Chen, Wei; Lou, Jizhong; Zhu, Cheng			Structural Basis and Kinetics of Force-Induced Conformational Changes of an alpha A Domain-Containing Integrin	PLOS ONE			English	Article							I-LIKE DOMAIN; CRYSTAL-STRUCTURE; ADHESION; BINDING; LFA-1; CHEMOKINES; DYNAMICS; SUBUNIT; PATHWAY; ARREST	Background: Integrin alpha(L)beta(2) (lymphocyte function-associated antigen, LFA-1) bears force upon binding to its ligand intercellular adhesion molecule 1 (ICAM-1) when a leukocyte adheres to vascular endothelium or an antigen presenting cell (APC) during immune responses. The ligand binding propensity of LFA-1 is related to its conformations, which can be regulated by force. Three conformations of the LFA-1 alpha A domain, determined by the position of its alpha(7)-helix, have been suggested to correspond to three different affinity states for ligand binding. Methodology/Principal Findings: The kinetics of the force-driven transitions between these conformations has not been defined and dynamically coupled to the force-dependent dissociation from ligand. Here we show, by steered molecular dynamics (SMD) simulations, that the alpha A domain was successively transitioned through three distinct conformations upon pulling the C-terminus of its alpha(7)-helix. Based on these sequential transitions, we have constructed a mathematical model to describe the coupling between the alpha A domain conformational changes of LFA-1 and its dissociation from ICAM-1 under force. Using this model to analyze the published data on the force-induced dissociation of single LFA-1/ICAM-1 bonds, we estimated the force-dependent kinetic rates of interstate transition from the short-lived to intermediate-lived and from intermediate-lived to long-lived states. Interestingly, force increased these transition rates; hence activation of LFA-1 was accelerated by pulling it via an engaged ICAM-1. Conclusions/Significance: Our study defines the structural basis for mechanical regulation of the kinetics of LFA-1 alpha A domain conformational changes and relates these simulation results to experimental data of force-induced dissociation of single LFA-1/ICAM-1 bonds by a new mathematical model, thus provided detailed structural and kinetic characterizations for force-stabilization of LFA-1/ICAM-1 interaction.	[Xiang, Xue] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Xiang, Xue; Lee, Cho-yin; Chen, Wei; Lou, Jizhong; Zhu, Cheng] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Xiang, Xue; Lee, Cho-yin; Chen, Wei; Lou, Jizhong; Zhu, Cheng] Emory Univ, Atlanta, GA 30322 USA; [Lee, Cho-yin] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Li, Tian; Lou, Jizhong] Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100080, Peoples R China	Sun Yat Sen University; University System of Georgia; Georgia Institute of Technology; Emory University; National Taiwan University; National Taiwan University Hospital; Chinese Academy of Sciences; Institute of Biophysics, CAS	Xiang, X (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	jlou@ibp.ac.cn; cheng.zhu@bme.gatech.edu			Natural Science Foundations of China [31070827]; Chinese Academy of Sciences; National Institutes of Health (NIH) [AI44902]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044902, R21AI044902] Funding Source: NIH RePORTER	Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Natural Science Foundations of China under 31070827 (to J. L.), by the Knowledge Innovation Program of the Chinese Academy of Sciences (to J. L.) and by a National Institutes of Health (NIH) grant AI44902 (to C.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Bednar B, 1997, CYTOMETRY, V28, P58, DOI 10.1002/(SICI)1097-0320(19970501)28:1<58::AID-CYTO7>3.0.CO;2-D; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Legge GB, 2000, J MOL BIOL, V295, P1251, DOI 10.1006/jmbi.1999.3409; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MULLER B, 1993, J BIOL CHEM, V268, P6800; Neelamegham S, 2000, J IMMUNOL, V164, P3798, DOI 10.4049/jimmunol.164.7.3798; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qu AD, 1996, STRUCTURE, V4, P931, DOI 10.1016/S0969-2126(96)00100-1; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; Rainger GE, 1997, AM J PHYSIOL-HEART C, V272, pH114, DOI 10.1152/ajpheart.1997.272.1.H114; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimaoka M, 2003, IMMUNITY, V19, P391, DOI 10.1016/S1074-7613(03)00238-3; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Welzenbach K, 2002, J BIOL CHEM, V277, P10590, DOI 10.1074/jbc.M110521200; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200	26	21	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27946	10.1371/journal.pone.0027946	http://dx.doi.org/10.1371/journal.pone.0027946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140490	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163400026
J	Talukdar, I; Sen, S; Urbano, R; Thompson, J; Yates, JR; Webster, NJG				Talukdar, Indrani; Sen, Supriya; Urbano, Rodolfo; Thompson, James; Yates, John R., III; Webster, Nicholas J. G.			hnRNP A1 and hnRNP F Modulate the Alternative Splicing of Exon 11 of the Insulin Receptor Gene	PLOS ONE			English	Article							PRE-MESSENGER-RNA; SR PROTEINS; NUCLEOTIDE-SEQUENCES; BINDING SPECIFICITY; RICH PROTEIN; U1 SNRNP; RIBONUCLEOPROTEIN; COMPLEX; IDENTIFICATION; PREDICTION	Exon 11 of the insulin receptor gene (INSR) is alternatively spliced in a developmentally and tissue-specific manner. Linker scanning mutations in a 5' GA-rich enhancer in intron 10 identified AGGGA sequences that are important for enhancer function. Using RNA-affinity purification and mass spectrometry, we identified hnRNP F and hnRNP A1 binding to these AGGGA sites and also to similar motifs at the 3' end of the intron. The hnRNPs have opposite functional effects with hnRNP F promoting and hnRNP A1 inhibiting exon 11 inclusion, and deletion of the GA-rich elements eliminates both effects. We also observed specific binding of hnRNP A1 to the 5' splice site of intron 11. The SR protein SRSF1 (SF2/ASF) co-purified on the GA-rich enhancer and, interestingly, also competes with hnRNP A1 for binding to the splice site. A point mutation - 3U -> C decreases hnRNP A1 binding, increases SRSF1 binding and renders the exon constitutive. Lastly, our data point to a functional interaction between hnRNP F and SRSF1 as a mutant that eliminates SRSF1 binding to exon 11, or a SRSF1 knockdown, which prevents the stimulatory effect of hnRNP F over expression.	[Talukdar, Indrani; Sen, Supriya; Urbano, Rodolfo; Webster, Nicholas J. G.] VA San Diego Healthcare Syst, San Diego, CA USA; [Talukdar, Indrani; Sen, Supriya; Urbano, Rodolfo; Webster, Nicholas J. G.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Talukdar, Indrani; Sen, Supriya; Urbano, Rodolfo; Webster, Nicholas J. G.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Thompson, James; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Talukdar, I (corresponding author), Burnham Inst Med Res, La Jolla, CA USA.	nwebster@ucsd.edu	Webster, Nick/AAI-8410-2021; Sen, Supriya/J-1750-2015	Sen, Supriya/0000-0002-0417-9322; Urbano, Rodolfo/0000-0001-7404-774X	Department of Veterans Affairs; National Institutes of Health National Center for Research Resources [RR11823]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047400] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000130] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work is supported by a Merit Review Award from the Department of Veterans Affairs and the National Institutes of Health National Center for Research Resources (RR11823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bladen CL, 2005, J BIOL CHEM, V280, P5205, DOI 10.1074/jbc.M412758200; Boukis LA, 2004, J BIOL CHEM, V279, P29647, DOI 10.1074/jbc.M313209200; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Buxade M, 2008, J BIOL CHEM, V283, P57, DOI 10.1074/jbc.M705286200; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Crawford JB, 2006, MOL CELL BIOL, V26, P8791, DOI 10.1128/MCB.01677-06; CRISPINO JD, 1994, SCIENCE, V265, P1866, DOI 10.1126/science.8091213; Dominguez C, 2006, NUCLEIC ACIDS RES, V34, P3634, DOI 10.1093/nar/gkl488; Eperon IC, 2000, MOL CELL BIOL, V20, P8303, DOI 10.1128/MCB.20.22.8303-8318.2000; EPERON LP, 1986, NATURE, V324, P280, DOI 10.1038/324280a0; Golovkin M, 1999, J BIOL CHEM, V274, P36428, DOI 10.1074/jbc.274.51.36428; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; Hallay H, 2006, J BIOL CHEM, V281, P37159, DOI 10.1074/jbc.M603864200; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Kosaki A, 1998, J BIOL CHEM, V273, P10331, DOI 10.1074/jbc.273.17.10331; Makarova OV, 2001, EMBO J, V20, P2553, DOI 10.1093/emboj/20.10.2553; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Mauger DM, 2008, MOL CELL BIOL, V28, P5403, DOI 10.1128/MCB.00739-08; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; NAKATA K, 1985, NUCLEIC ACIDS RES, V13, P5327, DOI 10.1093/nar/13.14.5327; NAORA H, 1980, J THEOR BIOL, V85, P83, DOI 10.1016/0022-5193(80)90282-9; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; RIO D C, 1992, Current Opinion in Cell Biology, V4, P444, DOI 10.1016/0955-0674(92)90010-A; ROGERS J, 1980, P NATL ACAD SCI-BIOL, V77, P1877, DOI 10.1073/pnas.77.4.1877; Rooke N, 2003, MOL CELL BIOL, V23, P1874, DOI 10.1128/MCB.23.6.1874-1884.2003; Rosonina E, 2005, MOL CELL BIOL, V25, P6734, DOI 10.1128/MCB.25.15.6734-6746.2005; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114; Sen S, 2009, MOL CELL BIOL, V29, P871, DOI 10.1128/MCB.01709-08; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	36	48	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27869	10.1371/journal.pone.0027869	http://dx.doi.org/10.1371/journal.pone.0027869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132154	Green Published, Green Submitted, gold			2022-12-25	WOS:000298162000046
J	Williams, PT				Williams, Paul T.			Evidence That Obesity Risk Factor Potencies Are Weight Dependent, a Phenomenon That May Explain Accelerated Weight Gain in Western Societies	PLOS ONE			English	Article							BODY-MASS INDEX; PUTATIVE CONTRIBUTORS; WALKING DISTANCE; HEART-DISEASE; ASSOCIATION; EXERCISE; HEALTH; DIET; AGE; PERCENTILES	Background: We have shown that individuals at the highest percentiles of the body mass index (BMI) distribution (i.e., most overweight) experience greater increases in body weight from sedentary lifestyle than those from the lowest percentiles. The purpose of the current analyses was to assess whether recent, accelerated increases in obesity could potentially be due to increased vulnerability to obesity risk factors as the population has become more overweight. Methodology/Principal Findings: Quantile regression was used to compare BMI population percentiles to obesity risk factors (lower education, diets characterized by high-meat/low-fruit content, parental adiposity) in two independent samples of men (N-1 = 3,513, N-2 = 11,365) and women (N-1 = 15,809, N-2 = 10,159). The samples were subsets of the National Walkers' (Study 1) and Runners' (Study 2) Health Studies whose physical activities fell short of nationally recommended activity levels. The data were adjusted for age, race, and any residual effects of physical activity. The regression slopes for BMI vs. education, diet, and family history became progressively stronger from the lowest (e.g., 5(th), 6(th).) to the highest (e.g.,., 94(th), 95(th)) BMI percentiles. Compared to the 10(th) BMI percentile, their effects on the 90(th) BMI percentile were: 1) 2.7- to 8.6-fold greater in women and 2.0- to 2.4-fold greater in men for education; 2) 3.6- to 4.8-fold greater in women and 1.7- to 2.7-fold greater in men for diet; and 3) 2.0- to 2.6-fold greater in women and 1.7-fold greater in men for family history. Conclusions/Significance: Thus we propose risk factors that produce little weight gain in lean individuals may become more potent with increasing adiposity. This leads us to hypothesize that an individual's obesity is itself a major component of their obesogenic environment, and that, the cycle of weight gain and increased sensitivity to obesity risk factors may partly explain recent increases in obesity in western societies.	Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Williams, PT (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	ptwilliams@lbl.gov			National Heart, Lung and Blood Institute [HL094717]; Institute of Aging [AG032004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG032004] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Institute of Aging; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grant HL094717 from the National Heart, Lung and Blood Institute and by grant AG032004 from the Institute of Aging. The research was conducted at the Ernest Orlando Lawrence Berkeley National Laboratory (Department of Energy DE-AC03-76SF00098 to the University of California). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Allison DB, 1996, INT J OBESITY, V20, P990; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Beyerlein A, 2010, INT J OBESITY, V34, P642, DOI 10.1038/ijo.2009.301; Beyerlein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019057; Beyerlein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015739; Beyerlein A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-59; Booth FW, 2007, PHYSIOL GENOMICS, V28, P146, DOI 10.1152/physiolgenomics.00174.2006; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Classen TJ, 2010, ECON HUM BIOL, V8, P30, DOI 10.1016/j.ehb.2009.11.002; Eckel RH, 1997, CIRCULATION, V96, P3248, DOI 10.1161/01.CIR.96.9.3248; Freedman David S, 2007, MedGenMed, V9, P26; Helmchen LA, 2004, ANN HUM BIOL, V31, P174, DOI 10.1080/03014460410001663434; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Institute of Medicine, 2005, DIET REF INT EN CARB, P880; Johnson Richard J, 2010, Trans Am Clin Climatol Assoc, V121, P295; Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Lake A, 2006, J R SOC PROMO HEALTH, V126, P262, DOI 10.1177/1466424006070487; Lee JH, 1997, INT J OBESITY, V21, P935, DOI 10.1038/sj.ijo.0800498; Lofgren P, 2005, J CLIN ENDOCR METAB, V90, P6207, DOI 10.1210/jc.2005-0596; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; McLaren L, 2010, INT J PUBLIC HEALTH, V55, P193, DOI 10.1007/s00038-009-0085-z; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; NEEL JV, 1962, AM J HUM GENET, V14, P353; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; ROCHE AF, 1994, AM J HUM BIOL, V6, P33, DOI 10.1002/ajhb.1310060107; Saris W H M, 2003, Obes Rev, V4, P101, DOI 10.1046/j.1467-789X.2003.00101.x; Smith PK, 2003, ECON HUM BIOL, V1, P145, DOI 10.1016/S1570-677X(02)00032-1; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Summerbell CD, 2009, INT J OBESITY, V33, pS1, DOI 10.1038/ijo.2009.80; Terry MB, 2007, AM J EPIDEMIOL, V166, P5, DOI 10.1093/aje/kwm094; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Williams P. T., 2011, Medicine and Science in Sports & Exercise, V43, P2120, DOI 10.1249/MSS.0b013e31821cd128; Williams PT, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.041822; Williams PT, 2008, MED SCI SPORT EXER, V40, P296, DOI 10.1249/mss.0b013e31815b6475; Williams PT, 2007, ARTERIOSCL THROM VAS, V27, P1811, DOI 10.1161/ATVBAHA.107.141853; Williams PT, 2007, MED SCI SPORT EXER, V39, P801, DOI 10.1249/mss.0b013e31803349b1; Williams PT, 2011, PREV MED, V52, P293, DOI 10.1016/j.ypmed.2011.03.008; Williams PT, 2009, OBESITY, V17, P1428, DOI 10.1038/oby.2008.680; Williams PT, 2005, MED SCI SPORT EXER, V37, P1893, DOI 10.1249/01.mss.0000175860.51204.85; Williams PT, 2005, OBES RES, V13, P1370, DOI 10.1038/oby.2005.166; Williams PT, 2005, MED SCI SPORT EXER, V37, P1329, DOI 10.1249/01.mss.0000174894.05236.45; Williams PT, 2004, INT J OBESITY, V28, P120, DOI 10.1038/sj.ijo.0802480; Williams PT, 2011, OBESITY IN PRESS	49	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27657	10.1371/journal.pone.0027657	http://dx.doi.org/10.1371/journal.pone.0027657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132124	Green Submitted, Green Published, gold			2022-12-25	WOS:000298162000033
J	Mack, AA; Kroboth, S; Rajesh, D; Wang, WB				Mack, Amanda A.; Kroboth, Stacie; Rajesh, Deepika; Wang, Wen Bo			Generation of Induced Pluripotent Stem Cells from CD34+Cells across Blood Drawn from Multiple Donors with Non-Integrating Episomal Vectors	PLOS ONE			English	Article							EFFICIENT NEURAL CONVERSION; PLASMID REPLICON; PERIPHERAL-BLOOD; PROGENITOR CELLS; B-LYMPHOCYTES; IN-VITRO; FIBROBLASTS; INHIBITION; INDUCTION; EXPANSION	The methodology to create induced pluripotent stem cells (iPSCs) affords the opportunity to generate cells specific to the individual providing the host tissue. However, existing methods of reprogramming as well as the types of source tissue have significant limitations that preclude the ability to generate iPSCs in a scalable manner from a readily available tissue source. We present the first study whereby iPSCs are derived in parallel from multiple donors using episomal, non-integrating, oriP/EBNA1-based plasmids from freshly drawn blood. Specifically, successful reprogramming was demonstrated from a single vial of blood or less using cells expressing the early lineage marker CD34 as well as from unpurified peripheral blood mononuclear cells. From these experiments, we also show that proliferation and cell identity play a role in the number of iPSCs per input cell number. Resulting iPSCs were further characterized and deemed free of transfected DNA, integrated transgene DNA, and lack detectable gene rearrangements such as those within the immunoglobulin heavy chain and T cell receptor loci of more differentiated cell types. Furthermore, additional improvements were made to incorporate completely defined media and matrices in an effort to facilitate a scalable transition for the production of clinic-grade iPSCs.	[Mack, Amanda A.; Kroboth, Stacie; Rajesh, Deepika; Wang, Wen Bo] Cellular Dynam Int Inc, Madison, WI 53711 USA		Mack, AA (corresponding author), Cellular Dynam Int Inc, Madison, WI 53711 USA.	amack@cellulardynamics.com		Kroboth, Stacie/0000-0001-8767-4021; Rajesh, Deepika/0000-0002-8820-4328				Brown ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011373; Cashen AF, 2007, BONE MARROW TRANSPL, V39, P577, DOI 10.1038/sj.bmt.1705616; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; Chou B.K., 2011, CELL RES; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hernandez JM, 2005, LEUKEMIA, V19, P1088, DOI 10.1038/sj.leu.2403753; HU K, 2011, BLOOD; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Lindner SE, 2007, PLASMID, V58, P1, DOI 10.1016/j.plasmid.2007.01.003; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nagler A, 2004, EXP HEMATOL, V32, P122, DOI 10.1016/j.exphem.2003.09.007; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Nakano T, 1995, Semin Immunol, V7, P197, DOI 10.1016/1044-5323(95)90047-0; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Patani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007327; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Szilvassy SJ, 2001, BLOOD, V98, P2108, DOI 10.1182/blood.V98.7.2108; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; van den Akker E, 2010, HAEMATOL-HEMATOL J, V95, P1594, DOI 10.3324/haematol.2009.019828; Wada H, 2011, INT IMMUNOL, V23, P65, DOI 10.1093/intimm/dxq458; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yamanaka S, 2010, CELL STEM CELL, V7, P1, DOI 10.1016/j.stem.2010.06.009; YU J, 2009, HUMAN INDUCED PLURIP; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017557	33	62	72	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27956	10.1371/journal.pone.0027956	http://dx.doi.org/10.1371/journal.pone.0027956			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132178	Green Published, Green Submitted, gold			2022-12-25	WOS:000297792400026
J	Wingo, TS; Cutler, DJ; Yarab, N; Kelly, CM; Glass, JD				Wingo, Thomas S.; Cutler, David J.; Yarab, Nicole; Kelly, Crystal M.; Glass, Jonathan D.			The Heritability of Amyotrophic Lateral Sclerosis in a Clinically Ascertained United States Research Registry	PLOS ONE			English	Article							HEXANUCLEOTIDE REPEAT; ALS; POPULATION; EPIDEMIOLOGY; PREVALENCE; MUTATIONS; GENETICS; DISEASES; C9ORF72; TWIN	Background: The genetic basis of amyotrophic highly penetrant mutations in Cu/Zn superoxide dismutase 1 and several other genes that cause apparent Mendelian inheritance of the disease, most ALS occurs in families without another affected individual. However, twin studies suggest that all ALS has a substantial genetic basis. Herein, we estimate the genetic contribution to ALS in a clinically ascertained case series from the United States. Methodology/Principal Findings: We used the database of the Emory ALS Center to ascertain individuals with ALS along with their family histories to determine the concordance among parents and offspring for the disease. We found that concordance for all parent-offspring pairs was low (<2%). With this concordance we found that ALS heritability, or the proportion of the disease explained by genetic factors, is between 40 and 45% for all likely estimates of ALS lifetime prevalence. Conclusions/Significance: We found the lifetime risk of ALS is 1.1% in first-degree relatives of those with ALS. Environmental and genetic factors appear nearly equally important for the development of ALS.	[Wingo, Thomas S.] Atlanta Vet Adm Med Ctr, Atlanta, GA 30312 USA; [Wingo, Thomas S.; Yarab, Nicole; Kelly, Crystal M.; Glass, Jonathan D.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Cutler, David J.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA	Emory University; Emory University	Wingo, TS (corresponding author), Atlanta Vet Adm Med Ctr, Atlanta, GA 30312 USA.	thomas.wingo@emory.edu	Wingo, Thomas/AEM-2481-2022	Wingo, Thomas/0000-0002-7679-6282	Department of Veterans Affairs [CDA1-002-09F]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	TSW is supported by a career development grant by the Department of Veterans Affairs (CDA1-002-09F). This study does not have any specific funding, and the Department of Veteran Affairs had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2010, J NEUROL NEUROSUR PS, V81, P1324, DOI 10.1136/jnnp.2010.207464; Al-Chalabi A, 2011, HUM HERED, V71, P281, DOI 10.1159/000330167; [Anonymous], 2001, NEUROLOGY, V56, P239; Beghi E, 2006, BBA-MOL BASIS DIS, V1762, P1150, DOI 10.1016/j.bbadis.2006.09.008; Chio A, 2008, NEUROLOGY, V70, P533, DOI 10.1212/01.wnl.0000299187.90432.3f; Chio A, 2009, NEUROLOGY, V72, P725, DOI 10.1212/01.wnl.0000343008.26874.d1; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fang F, 2009, ANN NEUROL, V66, P94, DOI 10.1002/ana.21580; Graham AJ, 1997, J NEUROL NEUROSUR PS, V62, P562, DOI 10.1136/jnnp.62.6.562; Hanby MF, 2011, BRAIN; Johnston CA, 2006, J NEUROL, V253, P1642, DOI 10.1007/s00415-006-0195-y; Logroscino G, 2005, J NEUROL NEUROSUR PS, V76, P1094, DOI 10.1136/jnnp.2004.039180; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McGuire V, 1996, NEUROLOGY, V47, P571, DOI 10.1212/WNL.47.2.571; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; MORTON NE, 1959, AM J HUM GENET, V11, P1; Orrell RW, 2001, NEUROLOGY, V57, P9, DOI 10.1212/WNL.57.1.9; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Schymick JC, 2007, HUM MOL GENET, V16, pR233, DOI 10.1093/hmg/ddm215; Traynor BJ, 1999, NEUROLOGY, V52, P504, DOI 10.1212/WNL.52.3.504	21	43	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27985	10.1371/journal.pone.0027985	http://dx.doi.org/10.1371/journal.pone.0027985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132186	Green Published, Green Submitted, gold			2022-12-25	WOS:000297792400029
J	Haridas, V; Xu, ZX; Kitchen, D; Jiang, A; Michels, P; Gutterman, JU				Haridas, Valsala; Xu, Zhi-Xiang; Kitchen, Doug; Jiang, Anna; Michels, Peter; Gutterman, Jordan U.			The Anticancer Plant Triterpenoid, Avicin D, Regulates Glucocorticoid Receptor Signaling: Implications for Cellular Metabolism	PLOS ONE			English	Article							ACACIA-VICTORIAE BENTHAM; FACTOR-KAPPA-B; ACTIVATED PROTEIN-KINASE; INDUCED APOPTOSIS; IN-VIVO; MOLECULAR-MECHANISMS; INDUCE APOPTOSIS; SAPONINS; GENE; STRESS	Avicins, a family of apoptotic triterpene electrophiles, are known to regulate cellular metabolism and energy homeostasis, by targeting the mitochondria. Having evolved from "ancient hopanoids,'' avicins bear a structural resemblance with glucocorticoids (GCs), which are the endogenous regulators of metabolism and energy balance. These structural and functional similarities prompted us to compare the mode of action of avicin D with dexamethasone (Dex), a prototypical GC. Using cold competition assay, we show that Avicin D competes with Dex for binding to the GC receptor (GR), leading to its nuclear translocation. In contrast to Dex, avicin-induced nuclear translocation of GR does not result in transcriptional activation of GC-dependent genes. Instead we observe a decrease in the expression of GC-dependent metabolic proteins such as PEPCK and FASN. However, like Dex, avicin D treatment does induce a transrepressive effect on the pro-inflammatory transcription factor NF-kappa B. While avicin's ability to inhibit NF-kappa B and its downstream targets appear to be GR-dependent, its pro-apoptotic effects were independent of GR expression. Using various deletion mutants of GR, we demonstrate the requirement of both the DNA and ligand binding domains of GR in mediating avicin D's transrepressive effects. Modeling of avicin-GR interaction revealed that avicin molecule binds only to the antagonist confirmation of GR. These findings suggest that avicin D has properties of being a selective GR modulator that separates transactivation from transrepression. Since the gene-activating properties of GR are mainly linked to its metabolic effects, and the negative interference with the activity of transcription factors to its anti-inflammatory and immune suppressive effects, the identification of such a dissociated GR ligand could have great potential for therapeutic use.	[Haridas, Valsala; Xu, Zhi-Xiang; Jiang, Anna; Gutterman, Jordan U.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Kitchen, Doug] Albany Mol Res Inc, Dept Comp Aided Drug Discovery, Albany, NY USA; [Michels, Peter] Albany Mol Res Inc, Dept Metab & Biotransformat, Albany, NY USA	University of Texas System; UTMD Anderson Cancer Center	Haridas, V (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	vharidas@mdanderson.org		Kitchen, Douglas/0000-0001-8988-759X	Clayton Foundation for Research; Welch Foundation	Clayton Foundation for Research; Welch Foundation(The Welch Foundation)	Research was supported by the Clayton Foundation for Research. Additional support was provided by a research grant from the Welch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Albany Molecular Inc. has not provided any funding for the study.	BAMBERGER CM, 1995, J CLIN INVEST, V95, P2435, DOI 10.1172/JCI117943; Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736; Belvisi MG, 2001, J IMMUNOL, V166, P1975, DOI 10.4049/jimmunol.166.3.1975; Brewer JA, 2002, J IMMUNOL, V169, P1837, DOI 10.4049/jimmunol.169.4.1837; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Bosscher K, 2010, BRAIN BEHAV IMMUN, V24, P1035, DOI 10.1016/j.bbi.2010.06.010; De Bosscher K, 2010, J STEROID BIOCHEM, V120, P96, DOI 10.1016/j.jsbmb.2010.02.027; Distelhorst CW, 2002, CELL DEATH DIFFER, V9, P6, DOI 10.1038/sj.cdd.4400969; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Frankfurt O, 2004, CURR OPIN ONCOL, V16, P553, DOI 10.1097/01.cco.0000142072.22226.09; Furst R, 2007, FASEB J, V21, P74, DOI 10.1096/fj.06-6752com; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; Hanausek M, 2001, P NATL ACAD SCI USA, V98, P11551, DOI 10.1073/pnas.191363198; Haridas V, 2005, P NATL ACAD SCI USA, V102, P10088, DOI 10.1073/pnas.0504430102; Haridas V, 2004, J CLIN INVEST, V113, P65, DOI 10.1172/JCI200418699; Haridas V, 2001, P NATL ACAD SCI USA, V98, P5821, DOI 10.1073/pnas.101619098; Haridas V, 2001, P NATL ACAD SCI USA, V98, P11557, DOI 10.1073/pnas.191363498; Haridas V, 2007, MITOCHONDRION, V7, P234, DOI 10.1016/j.mito.2006.12.005; Haridas V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005578; HELMBERG A, 1995, EMBO J, V14, P452, DOI 10.1002/j.1460-2075.1995.tb07021.x; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; Jayatilake GS, 2003, J NAT PROD, V66, P779, DOI 10.1021/np020400v; JOHNSON IS, 1992, SCIENCE, V258, P203; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kordula T, 1996, BIOCHEM J, V313, P1019, DOI 10.1042/bj3131019; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MITSIADES N, 2004, BLOOD, V104, P2403; Mujoo K, 2001, CANCER RES, V61, P5486; Newton R, 2003, BIODRUGS, V17, P113, DOI 10.2165/00063030-200317020-00004; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; OTTEN U, 1979, NATURE, V282, P413, DOI 10.1038/282413a0; Paterson I, 2005, SCIENCE, V310, P451, DOI 10.1126/science.1116364; Polizzi D, 1999, CANCER RES, V59, P1036; Pratt W B, 1996, EXS, V77, P79; Reichardt HM, 2000, Z RHEUMATOL, V59, P1; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Tuckermann JP, 2005, CRIT REV CL LAB SCI, V42, P71, DOI 10.1080/10408360590888983; Vanden Berghe W, 1999, MOL PHARMACOL, V56, P797; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Wesselborg S, 1997, J BIOL CHEM, V272, P12422, DOI 10.1074/jbc.272.19.12422; Xu ZX, 2007, CELL DEATH DIFFER, V14, P1948, DOI 10.1038/sj.cdd.4402207; ZORA JA, 1986, J ALLERGY CLIN IMMUN, V77, P9, DOI 10.1016/0091-6749(86)90315-5	47	15	15	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28037	10.1371/journal.pone.0028037	http://dx.doi.org/10.1371/journal.pone.0028037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132201	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789900042
J	Wingfield, DK; Peckham, SH; Foley, DG; Palacios, DM; Lavaniegos, BE; Durazo, R; Nichols, WJ; Croll, DA; Bograd, SJ				Wingfield, Dana K.; Hoyt Peckham, S.; Foley, David G.; Palacios, Daniel M.; Lavaniegos, Bertha E.; Durazo, Reginaldo; Nichols, Wallace J.; Croll, Donald A.; Bograd, Steven J.			The Making of a Productivity Hotspot in the Coastal Ocean	PLOS ONE			English	Article							CRAB PLEURONCODES-PLANIPES; BAJA-CALIFORNIA; UPWELLING SHADOWS; PACIFIC-OCEAN; EXTINCTION; RETENTION; MOVEMENTS; DECAPODA; SITES	Background: Highly productive hotspots in the ocean often occur where complex physical forcing mechanisms lead to aggregation of primary and secondary producers. Understanding how hotspots persist, however, requires combining knowledge of the spatio-temporal linkages between geomorphology, physical forcing, and biological responses with the physiological requirements and movement of top predators. Methodology/Principal Findings: Here we integrate remotely sensed oceanography, ship surveys, and satellite telemetry to show how local geomorphology interacts with physical forcing to create a region with locally enhanced upwelling and an adjacent upwelling shadow that promotes retentive circulation, enhanced year-round primary production, and prey aggregation. These conditions provide an area within the upwelling shadow where physiologically optimal water temperatures can be found adjacent to a region of enhanced prey availability, resulting in a foraging hotspot for loggerhead sea turtles (Caretta caretta) off the Baja California peninsula, Mexico. Significance/Conclusions: We have identified the set of conditions that lead to a persistent top predator hotspot, which increases our understanding of how highly migratory species exploit productive regions of the ocean. These results will aid in the development of spatially and environmentally explicit management strategies for marine species of conservation concern.	[Wingfield, Dana K.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Hoyt Peckham, S.] Ocean Fdn, Grp Tortuguero AC, La Paz, Baja California, Mexico; [Hoyt Peckham, S.] Duke Univ, Ctr Marine Conservat, Beaufort, NC USA; [Foley, David G.; Palacios, Daniel M.; Bograd, Steven J.] NOAA Fisheries, Div Environm Res, SW Fisheries Sci Ctr, Pacific Grove, CA USA; [Foley, David G.; Palacios, Daniel M.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Lavaniegos, Bertha E.] Ctr Invest Cient & Educ Super Ensenada, Dept Oceanog Biol, Ensenada, Baja California, Mexico; [Durazo, Reginaldo] Univ Autonoma Baja California, Fac Ciencias Marinas, Ensenada, Baja California, Mexico; [Nichols, Wallace J.] Calif Acad Sci, San Francisco, CA 94118 USA; [Nichols, Wallace J.] Ocean Revolut, Davenport, CA USA; [Croll, Donald A.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Duke University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Autonoma de Baja California; California Academy of Sciences; University of California System; University of California Santa Cruz	Wingfield, DK (corresponding author), Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA.	danawing@sfsu.edu	Bograd, Steven/AAA-4824-2021; Palacios, Daniel M./B-9180-2008	Palacios, Daniel M./0000-0001-7069-7913; Chiaradia, Andre/0000-0002-6178-4211	David and Lucile Packard Foundation; Secretaria de medio ambiente y recursos naturales-Consejo nacional de ciencia y technologia (SEMARNAT-CONACYT); University of California Institute for Mexico and the United States (UC-MEXUS); National Marine Fisheries Service (NMFS); PADI Foundation; TE Foundation; Wallace Research Foundation; Earthwatch Institute; Tagging of Pacific Predators (TOPP); Office of Naval Research/National Oceanographic Partnership Program (ONR/NOPP)	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Secretaria de medio ambiente y recursos naturales-Consejo nacional de ciencia y technologia (SEMARNAT-CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of California Institute for Mexico and the United States (UC-MEXUS); National Marine Fisheries Service (NMFS); PADI Foundation; TE Foundation; Wallace Research Foundation; Earthwatch Institute; Tagging of Pacific Predators (TOPP); Office of Naval Research/National Oceanographic Partnership Program (ONR/NOPP)(Office of Naval Research)	Funding was provided by the David and Lucile Packard Foundation, Secretaria de medio ambiente y recursos naturales-Consejo nacional de ciencia y technologia (SEMARNAT-CONACYT), University of California Institute for Mexico and the United States (UC-MEXUS), National Marine Fisheries Service (NMFS), PADI Foundation, T&E Foundation, Wallace Research Foundation, Earthwatch Institute, Tagging of Pacific Predators (TOPP), and the Office of Naval Research/National Oceanographic Partnership Program (ONR/NOPP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ARG CLS, 1989, GUID ARG SYST; AURIOLESGAMBOA D, 1992, CRUSTACEANA, V62, P71, DOI 10.1163/156854092X00064; Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; BLACKBURN M, 1969, BAJA CALIFORNIA FISH, V68, P147; BOYD CM, 1960, BIOL BULL, V118, P17, DOI 10.2307/1539052; BREAKER LC, 2005, MAPPING MONITORING L; Coles WC, 2000, COPEIA, P551, DOI 10.1643/0045-8511(2000)000[0551:SSSTAA]2.0.CO;2; Croll DA, 2005, MAR ECOL PROG SER, V289, P117, DOI 10.3354/meps289117; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; DUNHAM A, 1989, INTERFACES BIOPHYSIC; Etnoyer P, 2006, DEEP-SEA RES PT II, V53, P340, DOI 10.1016/j.dsr2.2006.01.010; Gomez-Gutierrez J, 2000, MAR ECOL PROG SER, V208, P283, DOI 10.3354/meps208283; GRAHAM WM, 1992, MAR BIOL, V114, P561, DOI 10.1007/BF00357253; Graham WM, 1997, CONT SHELF RES, V17, P509, DOI 10.1016/S0278-4343(96)00045-3; Guinet C, 2001, MAR ECOL PROG SER, V219, P251, DOI 10.3354/meps219251; Hatase H, 2010, MAR BIOL, V157, P1337, DOI 10.1007/s00227-010-1413-9; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Lavaniegos BE, 2009, MAR ECOL PROG SER, V394, P137, DOI 10.3354/meps08285; LONGHURST AR, 1967, ECOLOGY, V48, P190, DOI 10.2307/1933100; LONGHURST AR, 2004, OCEANOGRAPHY, V17, P6; McClellan CM, 2010, J EXP MAR BIOL ECOL, V387, P44, DOI 10.1016/j.jembe.2010.02.020; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; NICHOLS WJ, 2003, THESIS U ARIZONA TUC; PECKHAM S, 2008, THESIS U CALIFORNIA; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Powell R., 2000, RES TECHNIQUES ANIMA, P64; Risien CM, 2008, J PHYS OCEANOGR, V38, P2379, DOI 10.1175/2008JPO3881.1; Robinson CJ, 2004, DEEP-SEA RES PT II, V51, P753, DOI 10.1016/j.dsr2.2004.05.018; Roughan M, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2005JC002898; Schaefer KM, 2007, MAR BIOL, V152, P503, DOI 10.1007/s00227-007-0689-x; Shanks AL, 2003, J PLANKTON RES, V25, P1251, DOI 10.1093/plankt/fbg090; Stearns S.C., 1992, pi; Sydeman WJ, 2006, DEEP-SEA RES PT II, V53, P247, DOI 10.1016/j.dsr2.2006.03.001; Tremblay Y, 2006, J EXP BIOL, V209, P128, DOI 10.1242/jeb.01970; VILLANUEVA D, 1991, TORTUGA PERICA CARET; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf SG, 2009, ECOLOGY, V90, P742, DOI 10.1890/07-1267.1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	38	56	57	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27874	10.1371/journal.pone.0027874	http://dx.doi.org/10.1371/journal.pone.0027874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132156	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789900027
J	Dessombz, A; Bazin, D; Dumas, P; Sandt, C; Sule-Suso, J; Daudon, M				Dessombz, Arnaud; Bazin, Dominique; Dumas, Paul; Sandt, Christophe; Sule-Suso, Josep; Daudon, Michel			Shedding Light on the Chemical Diversity of Ectopic Calcifications in Kidney Tissues: Diagnostic and Research Aspects	PLOS ONE			English	Article							INFRARED MICROSCOPY; RENAL-FAILURE; IDENTIFICATION; FOSCARNET; PHOSPHATE; CRYSTALS	In most industrialized countries, different epidemiologic studies show that chronic renal failure is dramatically increasing. Such major public health problem is a consequence of acquired systemic diseases such as type II diabetes, which is now the first cause for end stage renal failure. Furthermore, lithogenic diseases may also induce intratubular crystallization, which may finally result in end-stage renal failure (ESRF). Up to now, such rare diseases are often misdiagnosed. In this study, based on twenty four biopsies, we show that SR mu FTIR (Synchrotron Radiation-mu Fourier transform infrared) spectroscopy constitutes a significant opportunity to characterize such pathological mu calcifications giving not only their chemical composition but also their spatial distribution in the tissues. This experimental approach offers new opportunities to the clinicians to describe at the cell level the physico-chemical processes leading to the formation of the pathological calcifications which lead to ESRF.	[Dessombz, Arnaud; Bazin, Dominique] Univ Paris 11, Lab Phys Solides, Orsay, France; [Dumas, Paul; Sandt, Christophe] Synchrotron SOLEIL, Gif Sur Yvette, France; [Sule-Suso, Josep] Univ Hosp N Staffordshire, Ctr Canc, Stoke On Trent, Staffs, England; [Daudon, Michel] Hop Tenon, AP HP, Serv Explorat Fonct, F-75970 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron; Keele University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Dessombz, A (corresponding author), Univ Paris 11, Lab Phys Solides, Bat 510, Orsay, France.	arnaud.dessombz@u-psud.fr	Sandt, Christophe/ABE-6818-2020; Dessombz, Arnaud/B-7149-2016; , Bazin/C-6306-2014; Sandt, Christophe/M-9806-2014; Soleil, SMIS/I-3166-2014	Sandt, Christophe/0000-0002-6432-2004; Dessombz, Arnaud/0000-0002-6610-4879; , Bazin/0000-0002-5112-9061; Sandt, Christophe/0000-0002-6432-2004; 	physic and chemistry institutes of CNRS (Centre National de la Recherche Scientifique); Agence Nationale de la Recheche [ANR-09-BLAN-0120-02];  [20100039]	physic and chemistry institutes of CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recheche(French National Research Agency (ANR)); 	This work was supported by proposal 20100039 for Synchrotron experiments. This proposal was provided by Synchrotron SOLEIL. It was also supported by the physic and chemistry institutes of CNRS (Centre National de la Recherche Scientifique) and by an Agence Nationale de la Recheche contract (grant number: ANR-09-BLAN-0120-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All the supporters have no commercial interests.	Atkins RC, 2005, KIDNEY INT, V67, pS14, DOI 10.1111/j.1523-1755.2005.09403.x; BEAUFILS H, 1990, LANCET, V336, P755, DOI 10.1016/0140-6736(90)92253-E; Bollee G, 2010, J AM SOC NEPHROL, V21, P679, DOI 10.1681/ASN.2009080808; Bouzidi H, 2011, ANN BIOL CLIN-PARIS, V69, P405, DOI 10.1684/abc.2011.0590; Daudon M, 2010, UROL RES, V38, P459, DOI 10.1007/s00240-010-0320-3; Dumas P, 2006, INFRARED PHYS TECHN, V49, P152, DOI 10.1016/j.infrared.2006.01.030; Eller P, 2004, CLIN NEPHROL, V61, P217; EstepaMaurice L, 1996, AM J CLIN PATHOL, V105, P576; Hassan I, 2001, MAYO CLIN PROC, V76, P758, DOI 10.4065/76.7.758; Iijima M, 1998, J CRYST GROWTH, V193, P182, DOI 10.1016/S0022-0248(98)00455-2; Maurice-Estepa L, 1999, SCAND J UROL NEPHROL, V33, P299, DOI 10.1080/003655999750017365; Maurice-Estepa L, 1998, AM J KIDNEY DIS, V32, P392, DOI 10.1053/ajkd.1998.v32.pm9740154; Meria P, 2010, J UROLOGY, V183, P1412, DOI 10.1016/j.juro.2009.12.016; Parasuraman R, 2010, AM J KIDNEY DIS, V55, P192, DOI 10.1053/j.ajkd.2009.08.012; Perazella MA, 1999, AM J MED, V106, P459, DOI 10.1016/S0002-9343(99)00041-8; Quy-Dao N, 1997, INFRARED RAMAN SPECT	16	49	50	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e28007	10.1371/journal.pone.0028007	http://dx.doi.org/10.1371/journal.pone.0028007			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125652	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789200052
J	Ghafouri, N; Ghafouri, B; Larsson, B; Turkina, MV; Karlsson, L; Fowler, CJ; Gerdle, B				Ghafouri, Nazdar; Ghafouri, Bijar; Larsson, Britt; Turkina, Maria V.; Karlsson, Linn; Fowler, Christopher J.; Gerdle, Bjorn			High Levels of N-Palmitoylethanolamide and N-Stearoylethanolamide in Microdialysate Samples from Myalgic Trapezius Muscle in Women	PLOS ONE			English	Article							WHIPLASH-ASSOCIATED DISORDERS; ACTIVATED-RECEPTOR-ALPHA; FATTY-ACID AMIDE; PAIN; HYPERALGESIA; TRPV1; WORK; ACYLETHANOLAMINE; QUANTIFICATION; FIBROMYALGIA	Background: N-acylethanolamines (NAEs) are endogenous compounds that regulate inflammation and pain. These include the cannabinoid ligand anandamide (AEA) and the peroxisome proliferator-activated receptor-a ligand palmitoylethanolamide (PEA). Little is known as to the levels of NAEs in pain states in human, particularly in the skeletal muscle. The aim of this study was to investigate the levels of these lipid mediators in muscle dialysate from women with chronic neck-/shoulder pain compared to healthy controls. Methods: Eleven women with chronic neck-/shoulder pain and eleven healthy women participated in this study. All participants went through microdialysis procedures in the trapezius muscle. Muscle dialysate samples were collected during four hours and analysed by nano liquid chromatography tandem mass spectrometry (nLC-MS/MS). Results: We were able to detect AEA, PEA, N-stearoylethanolamine (SEA) and 2-arachidonoylglycerol (2-AG) in a single chromatographic run. Of the NAEs studied, PEA and SEA were clearly detectable in the muscle microdialysate samples. The muscle dialysate levels of PEA and SEA were significantly higher in myalgic subjects compared to healthy controls. Conclusion: This study demonstrates that microdialysis in combination with mass spectrometry can be used for analysing NAE's in human muscle tissue regularly over time. Furthermore the significant group differences in the concentration of PEA and SEA in this study might fill an important gap in our knowledge of mechanisms in chronic myalgia in humans. In the long run this expanded understanding of nociceptive and anitinociceptive processes in the muscle may provide a base for ameliorating treatment and rehabilitation of pain.	[Ghafouri, Nazdar; Ghafouri, Bijar; Larsson, Britt; Turkina, Maria V.; Karlsson, Linn; Gerdle, Bjorn] Linkoping Univ, Fac Hlth Sci, Linkoping, Sweden; [Ghafouri, Nazdar; Ghafouri, Bijar; Larsson, Britt; Turkina, Maria V.; Karlsson, Linn; Gerdle, Bjorn] Linkoping Univ, Fac Hlth Sci, Linkoping, Sweden; [Ghafouri, Nazdar; Fowler, Christopher J.] Cty Council Ostergotland, Pain & Rehabil Ctr, Linkoping, Sweden; [Ghafouri, Bijar] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Ghafouri, Bijar] Linkoping Univ, Dept Clin & Expt Med, Fac Hlth Sci, Linkoping, Sweden; [Ghafouri, Bijar] Cty Council Ostergotland, Dept Occupat & Environm Med, Linkoping, Sweden	Linkoping University; Linkoping University; City Council Ostergotland; Umea University; Linkoping University; City Council Ostergotland	Ghafouri, N (corresponding author), Linkoping Univ, Fac Hlth Sci, Linkoping, Sweden.	bjorn.gerdle@liu.se	Ghafouri, Bijar/H-8257-2014; Fowler, Christopher J./M-6313-2019	Fowler, Christopher J./0000-0002-6658-7874; Gerdle, Bjorn/0000-0002-4316-1264	Swedish Council for Working Life and Social Research [2010-0683, 2007-0760]; Swedish Research Council [2010-2893]; IngaBritt and Arne Lundberg foundation	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); IngaBritt and Arne Lundberg foundation	This study was supported by the Swedish Council for Working Life and Social Research (2010-0683, 2007-0760), the Swedish Research Council (2010-2893) and IngaBritt and Arne Lundberg foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmundson GJG, 2009, DEPRESS ANXIETY, V26, P888, DOI 10.1002/da.20600; Borsbo B, 2008, J REHABIL MED, V40, P562, DOI 10.2340/16501977-0207; Buczynski MW, 2010, BRIT J PHARMACOL, V160, P423, DOI 10.1111/j.1476-5381.2010.00787.x; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Carbonare MD, 2008, J NEUROENDOCRINOL, V20, P26, DOI 10.1111/j.1365-2826.2008.01689.x; Costa B, 2008, PAIN, V139, P541, DOI 10.1016/j.pain.2008.06.003; Coutaux A, 2005, JOINT BONE SPINE, V72, P359, DOI 10.1016/j.jbspin.2004.01.010; D'Agostino G, 2009, EUR J PHARMACOL, V613, P54, DOI 10.1016/j.ejphar.2009.04.022; Dersh J, 2001, Spine J, V1, P88, DOI 10.1016/S1529-9430(01)00017-1; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Ernberg M, 1999, LIFE SCI, V65, P313, DOI 10.1016/S0024-3205(99)00250-7; Farquhar-Smith WP, 2002, PAIN, V97, P11, DOI 10.1016/S0304-3959(01)00419-5; Flodgren GM, 2005, EUR J PAIN, V9, P511, DOI 10.1016/j.ejpain.2004.11.004; Fowler CJ, 2009, BRIT J PHARMACOL, V156, P412, DOI 10.1111/j.1476-5381.2008.00029.x; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Gerdle B, 2008, PAIN, V139, P578, DOI 10.1016/j.pain.2008.06.012; Gerdle B, 2008, EUR J PAIN, V12, P82, DOI 10.1016/j.ejpain.2007.03.009; Gerdle B, 2010, J REHABIL MED, V42, P679, DOI 10.2340/16501977-0581; Gibson W, 2006, PAIN, V120, P113, DOI 10.1016/j.pain.2005.10.023; GravenNielsen T, 1997, PAIN, V69, P111, DOI 10.1016/S0304-3959(96)03243-5; Hula N M, 2009, Ukr Biokhim Zh (1999), V81, P107; Jaggar SI, 1998, PAIN, V76, P189, DOI 10.1016/S0304-3959(98)00041-4; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Langley CK, 2008, NEUROIMAGE, V42, P467, DOI 10.1016/j.neuroimage.2008.05.030; Larsson B, 2008, PAIN, V140, P479, DOI 10.1016/j.pain.2008.10.001; Lidgren L, 2008, SPINE, V33, pS1, DOI 10.1097/BRS.0b013e3181643f14; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; LoVerme J, 2006, J PHARMACOL EXP THER, V319, P1051, DOI 10.1124/jpet.106.111385; MEANSCHRISTENSE.AJ, 2008, ANXIETY, V25, P593; Movahed P, 2005, J BIOL CHEM, V280, P38496, DOI 10.1074/jbc.M507429200; Ocanez KLS, 2010, DEPRESS ANXIETY, V27, P760, DOI 10.1002/da.20681; OHLSSON K, 1994, ERGONOMICS, V37, P891, DOI 10.1080/00140139408963698; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Plock N, 2005, EUR J PHARM SCI, V25, P1, DOI 10.1016/j.ejps.2005.01.017; Rosendal L, 2005, PAIN, V119, P201, DOI 10.1016/j.pain.2005.09.026; Rosendal L, 2004, PAIN, V112, P324, DOI 10.1016/j.pain.2004.09.017; SCHELLER D, 1991, J NEUROSCI METH, V40, P31, DOI 10.1016/0165-0270(91)90114-F; Schneider GM, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-29; Shah JP, 2005, J APPL PHYSIOL, V99, P1977, DOI 10.1152/japplphysiol.00419.2005; Sjogaard G, 2010, EUR J APPL PHYSIOL, V108, P657, DOI 10.1007/s00421-009-1268-2; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Staud R, 2009, PAIN, V145, P96, DOI 10.1016/j.pain.2009.05.020; UNGERSTEDT U, 1987, LIFE SCI, V41, P861, DOI 10.1016/0024-3205(87)90181-0	44	32	33	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27257	10.1371/journal.pone.0027257	http://dx.doi.org/10.1371/journal.pone.0027257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125609	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789200009
J	Haas, AF; Nelson, CE; Kelly, LW; Carlson, CA; Rohwer, F; Leichter, JJ; Wyatt, A; Smith, JE				Haas, Andreas F.; Nelson, Craig E.; Kelly, Linda Wegley; Carlson, Craig A.; Rohwer, Forest; Leichter, James J.; Wyatt, Alex; Smith, Jennifer E.			Effects of Coral Reef Benthic Primary Producers on Dissolved Organic Carbon and Microbial Activity	PLOS ONE			English	Article							SCLERACTINIAN CORALS; DIEL FLUCTUATIONS; NUTRIENT FLUXES; MATTER RELEASE; SURFACE-AREA; MACROALGAE; COMPETITION; SEAGRASS; DISEASES; GROWTH	Benthic primary producers in marine ecosystems may significantly alter biogeochemical cycling and microbial processes in their surrounding environment. To examine these interactions, we studied dissolved organic matter release by dominant benthic taxa and subsequent microbial remineralization in the lagoonal reefs of Moorea, French Polynesia. Rates of photosynthesis, respiration, and dissolved organic carbon (DOC) release were assessed for several common benthic reef organisms from the backreef habitat. We assessed microbial community response to dissolved exudates of each benthic producer by measuring bacterioplankton growth, respiration, and DOC drawdown in two-day dark dilution culture incubations. Experiments were conducted for six benthic producers: three species of macroalgae (each representing a different algal phylum: Turbinaria ornata - Ochrophyta; Amansia rhodantha - Rhodophyta; Halimeda opuntia - Chlorophyta), a mixed assemblage of turf algae, a species of crustose coralline algae (Hydrolithon reinboldii) and a dominant hermatypic coral (Porites lobata). Our results show that all five types of algae, but not the coral, exuded significant amounts of labile DOC into their surrounding environment. In general, primary producers with the highest rates of photosynthesis released the most DOC and yielded the greatest bacterioplankton growth; turf algae produced nearly twice as much DOC per unit surface area than the other benthic producers (14.0 +/- 2.8 mu mol h(-1) dm(-2)), stimulating rapid bacterioplankton growth (0.044 +/- 0.002 log10 cells h(-1)) and concomitant oxygen drawdown (0.16 +/- 0.05 mu mol L-1 h(-1) dm(-2)). Our results demonstrate that benthic reef algae can release a significant fraction of their photosynthetically-fixed carbon as DOC, these release rates vary by species, and this DOC is available to and consumed by reef associated microbes. These data provide compelling evidence that benthic primary producers differentially influence reef microbial dynamics and biogeochemical parameters (i.e., DOC and oxygen availability, bacterial abundance and metabolism) in coral reef communities.	[Haas, Andreas F.; Leichter, James J.; Wyatt, Alex; Smith, Jennifer E.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA; [Nelson, Craig E.; Carlson, Craig A.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Kelly, Linda Wegley; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Carlson, Craig A.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California Santa Barbara; California State University System; San Diego State University; University of California System; University of California Santa Barbara	Haas, AF (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA.	ahaas@ucsd.edu	Wyatt, Alex S.J./A-9402-2008; Smith, Jennifer/E-5207-2013; Rohwer, Forest/AAC-5315-2019; Nelson, Craig E/H-3323-2019	Wyatt, Alex S.J./0000-0002-1339-9546; Nelson, Craig E/0000-0003-2525-3496; Rohwer, Forest/0000-0003-1548-5429	National Science Foundation (NSF) [OCE-0927415, OCE-0927411]; Directorate For Geosciences [0927448] Funding Source: National Science Foundation; Division Of Ocean Sciences [0927411] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the National Science Foundation (NSF; http://www.nsf.gov/) award OCE-0927415 to JES and FLR and OCE-0927411 to CAC. Funds were provided to investigate the coupling between DOM, algae, and microbes on coral reef platforms. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2006, MAR ECOL PROG SER, V318, P287, DOI 10.3354/meps318287; ATKINSON MJ, 1984, CORAL REEFS, V3, P13, DOI 10.1007/BF00306136; AZAM F, 1994, MICROBIAL ECOL, V28, P167, DOI 10.1007/BF00166806; BARKO JW, 1981, ECOL MONOGR, V51, P219, DOI 10.2307/2937264; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bertin C, 2003, PLANT SOIL, V256, P67, DOI 10.1023/A:1026290508166; Biber PD, 2004, ECOL MODEL, V175, P25, DOI 10.1016/j.ecolmodel.2003.10.003; BRYLINSKY M, 1977, MAR BIOL, V39, P213, DOI 10.1007/BF00390995; Carlson CA, 2002, AQUAT MICROB ECOL, V30, P19, DOI 10.3354/ame030019; Carlson CA, 2010, DEEP-SEA RES PT II, V57, P1433, DOI 10.1016/j.dsr2.2010.02.013; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; CROSSLAND CJ, 1987, CORAL REEFS, V6, P35, DOI 10.1007/BF00302210; DAHL AL, 1973, MAR BIOL, V23, P239, DOI 10.1007/BF00389331; DAVIES PS, 1984, CORAL REEFS, V2, P181; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; DUBINSKY Z, 1974, OECOLOGIA, V16, P53, DOI 10.1007/BF00345087; DUCKLOW HW, 1986, SCIENCE, V232, P865, DOI 10.1126/science.232.4752.865; Eyre BD, 2002, MAR ECOL PROG SER, V229, P43, DOI 10.3354/meps229043; FERRIER MD, 1991, CORAL REEFS, V10, P183, DOI 10.1007/BF00336772; Ferrier-Pages C, 1998, MAR ECOL PROG SER, V172, P265, DOI 10.3354/meps172265; Ferrier-Pages C, 2000, AQUAT MICROB ECOL, V21, P203, DOI 10.3354/ame021203; Fonseca M. S., 2000, P 4 INT SEAGR BIOL W, V7, P373; FUHRMAN J, 1992, ENVIR SCI R, V43, P361; GALLAGHER JL, 1976, ESTUAR COAST MAR SCI, V4, P467, DOI 10.1016/0302-3524(76)90021-9; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GARRETT P, 1975, NATURE, V253, P349, DOI 10.1038/253349a0; Goldshmid R, 2004, LIMNOL OCEANOGR, V49, P1832, DOI 10.4319/lo.2004.49.5.1832; GONZALES JEA, 1997, CORAL REEFS, V16, P231; GOREAU TF, 1971, BIOL BULL, V141, P247, DOI 10.2307/1540115; Goreau TJ, 1998, REV BIOL TROP, V46, P157; Haas AF, 2010, AQUAT BIOL, V10, P131, DOI 10.3354/ab00271; Haas AF, 2010, J EXP MAR BIOL ECOL, V389, P53, DOI 10.1016/j.jembe.2010.03.018; Haas AF, 2010, MAR ECOL PROG SER, V409, P27, DOI 10.3354/meps08631; Halliwell B., 1999, FREE RADICAL BIO MED, P936; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Hayes RL, 1998, REV BIOL TROP, V46, P173; HERNDL GJ, 1986, MAR BIOL, V90, P363, DOI 10.1007/BF00428560; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hutsch BW, 2002, J PLANT NUTR SOIL SC, V165, P397, DOI 10.1002/1522-2624(200208)165:4<397::AID-JPLN397>3.0.CO;2-C; JOHANNES RE, 1975, TROPICAL MARINE POLL, V12, P13; Jompa J, 2003, MAR ECOL PROG SER, V258, P87, DOI 10.3354/meps258087; Jompa J, 2002, J EXP MAR BIOL ECOL, V271, P25, DOI 10.1016/S0022-0981(02)00040-0; KAPLAN LA, 1982, LIMNOL OCEANOGR, V27, P1091, DOI 10.4319/lo.1982.27.6.1091; Kendrick GA, 2000, ESTUAR COAST SHELF S, V50, P341, DOI 10.1006/ecss.1999.0569; KHAILOV KM, 1969, LIMNOL OCEANOGR, V14, P521, DOI 10.4319/lo.1969.14.4.0521; KINSEY DW, 1967, AUST J MAR FRESH RES, V18, P23, DOI 10.1071/MF9670023; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Kraines S, 1996, LIMNOL OCEANOGR, V41, P1790, DOI 10.4319/lo.1996.41.8.1790; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Kushmaro A, 1996, NATURE, V380, P396, DOI 10.1038/380396a0; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; LEE S, 1987, APPL ENVIRON MICROB, V53, P1298, DOI 10.1128/AEM.53.6.1298-1303.1987; LEWIS SM, 1985, OECOLOGIA, V65, P370, DOI 10.1007/BF00378911; LITTLER MM, 1982, J PHYCOL, V18, P307, DOI 10.1111/j.0022-3646.1982.00307.x; Littler MM, 1984, PROGR PHYCOLOGICAL R, V3, P323; Lobban C.S., 1994, SEAWEED ECOLOGY PHYS; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Mitchell R, 1975, MICROB ECOL, V2, P227, DOI 10.1007/BF02010442; Muscatine, 1990, CORAL REEFS, V25, P1; Nakajima R, 2010, B MAR SCI, V86, P861, DOI 10.5343/bms.2009.1069; Naumann MS, 2010, CORAL REEFS, V29, P649, DOI 10.1007/s00338-010-0612-7; Naumann MS, 2009, CORAL REEFS, V28, P109, DOI 10.1007/s00338-008-0459-3; Neall VE, 2008, PHILOS T R SOC B, V363, P3293, DOI 10.1098/rstb.2008.0119; Nelson CE, 2011, ISME J, V5, P1374, DOI 10.1038/ismej.2011.12; Niggl W, 2010, HYDROBIOLOGIA, V644, P401, DOI 10.1007/s10750-010-0200-4; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; PECKOL P, 1995, J EXP MAR BIOL ECOL, V190, P1, DOI 10.1016/0022-0981(95)00026-N; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Richier S, 2003, BBA-GEN SUBJECTS, V1621, P84, DOI 10.1016/S0304-4165(03)00049-7; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; RUSSO AR, 1990, HYDROBIOLOGIA, V194, P1, DOI 10.1007/BF00012107; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SCHRAMM W, 1984, BOT MAR, V27, P71, DOI 10.1515/botm.1984.27.2.71; SEGEL LA, 1982, B MAR SCI, V32, P919; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; SIMPSON CJ, 1993, CORAL REEFS, V12, P185, DOI 10.1007/BF00334478; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; SMITH SV, 1973, LIMNOL OCEANOGR, V18, P953, DOI 10.4319/lo.1973.18.6.0953; SONDERGAARD M, 1981, OIKOS, V36, P331, DOI 10.2307/3544631; SOROKIN YI, 1990, AUST J MAR FRESH RES, V41, P775; SOROKIN YI, 1973, LIMNOL OCEANOGR, V18, P380, DOI 10.4319/lo.1973.18.3.0380; Tanaka Y, 2008, B MAR SCI, V82, P237; Tanaka Y, 2009, J EXP MAR BIOL ECOL, V377, P101, DOI 10.1016/j.jembe.2009.06.023; TANNER JE, 1995, J EXP MAR BIOL ECOL, V190, P151, DOI 10.1016/0022-0981(95)00027-O; TENORE KR, 1977, LIMNOL OCEANOGR, V22, P936, DOI 10.4319/lo.1977.22.5.0936; Ulstrup KE, 2005, MAR ECOL PROG SER, V286, P125, DOI 10.3354/meps286125; Valiela I., 1984, MARINE ECOLOGICAL PR, DOI 10.1007/978-1-4757-4125-4; Wada S, 2007, J EXP MAR BIOL ECOL, V349, P344, DOI 10.1016/j.jembe.2007.05.024; WANDERS J B W, 1976, Aquatic Botany, V2, P235, DOI 10.1016/0304-3770(76)90023-1; WETZEL RG, 1979, AQUAT BOT, V6, P149, DOI 10.1016/0304-3770(79)90058-5; Wild C, 2005, MAR ECOL PROG SER, V287, P87, DOI 10.3354/meps287087; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; WILD C, 2009, P 11 INT COR REEF S, V1, P1319; Wild C, 2010, MAR ECOL PROG SER, V411, P61, DOI 10.3354/meps08653; WILKINSON C, 2002, STATUS CORAL REEFS W; Zhu BH, 2004, CHINESE SCI BULL, V49, P1923, DOI 10.1360/04wc0195; Ziegler S, 1999, MAR ECOL PROG SER, V180, P149, DOI 10.3354/meps180149	103	154	154	4	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27973	10.1371/journal.pone.0027973	http://dx.doi.org/10.1371/journal.pone.0027973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125645	Green Submitted, gold, Green Published			2022-12-25	WOS:000297789200045
J	Huntgeburth, M; Tiemann, K; Shahverdyan, R; Schluter, KD; Schreckenberg, R; Gross, ML; Modersheim, S; Caglayan, E; Muller-Ehmsen, J; Ghanem, A; Vantler, M; Zimmermann, WH; Bohm, M; Rosenkranz, S				Huntgeburth, Michael; Tiemann, Klaus; Shahverdyan, Robert; Schlueter, Klaus-Dieter; Schreckenberg, Rolf; Gross, Marie-Luise; Moedersheim, Sonja; Caglayan, Evren; Mueller-Ehmsen, Jochen; Ghanem, Alexander; Vantler, Marius; Zimmermann, Wolfram H.; Boehm, Michael; Rosenkranz, Stephan			Transforming Growth Factor beta(1) Oppositely Regulates the Hypertrophic and Contractile Response to beta-Adrenergic Stimulation in the Heart	PLOS ONE			English	Article							MYOCARDIAL ENERGY-METABOLISM; TGF-BETA; UNCOUPLING PROTEINS; GENE-EXPRESSION; TRANSGENIC MICE; CARDIAC-HYPERTROPHY; UP-REGULATION; FIBROSIS; FAILURE; CARDIOMYOCYTES	Background: Neuroendocrine activation and local mediators such as transforming growth factor-beta(1) (TGF-beta(1)) contribute to the pathobiology of cardiac hypertrophy and failure, but the underlying mechanisms are incompletely understood. We aimed to characterize the functional network involving TGF-beta(1), the renin-angiotensin system, and the beta-adrenergic system in the heart. Methods: Transgenic mice overexpressing TGF-beta(1) (TGF-beta(1)-Tg) were treated with a beta-blocker, an AT(1)-receptor antagonist, or a TGF-beta-antagonist (sTGF beta R-Fc), were morphologically characterized. Contractile function was assessed by dobutamine stress echocardiography in vivo and isolated myocytes in vitro. Functional alterations were related to regulators of cardiac energy metabolism. Results: Compared to wild-type controls, TGF-beta(1)-Tg mice displayed an increased heart-to-body-weight ratio involving both fibrosis and myocyte hypertrophy. TGF-beta(1) overexpression increased the hypertrophic responsiveness to beta-adrenergic stimulation. In contrast, the inotropic response to beta-adrenergic stimulation was diminished in TGF-beta(1)-Tg mice, albeit unchanged basal contractility. Treatment with sTGF-beta R-Fc completely prevented the cardiac phenotype in transgenic mice. Chronic beta-blocker treatment also prevented hypertrophy and ANF induction by isoprenaline, and restored the inotropic response to beta-adrenergic stimulation without affecting TGF-beta(1) levels, whereas AT(1)-receptor blockade had no effect. The impaired contractile reserve in TGF-beta(1)-Tg mice was accompanied by an upregulation of mitochondrial uncoupling proteins (UCPs) which was reversed by beta-adrenoceptor blockade. UCP-inhibition restored the contractile response to beta-adrenoceptor stimulation in vitro and in vivo. Finally, cardiac TGF-beta(1) and UCP expression were elevated in heart failure in humans, and UCP - but not TGF-beta(1) - was downregulated by beta-blocker treatment. Conclusions: Our data support the concept that TGF-beta(1) acts downstream of angiotensin II in cardiomyocytes, and furthermore, highlight the critical role of the beta-adrenergic system in TGF-beta(1)-induced cardiac phenotype. Our data indicate for the first time, that TGF-beta(1) directly influences mitochondrial energy metabolism by regulating UCP3 expression. beta-blockers may act beneficially by normalizing regulatory mechanisms of cellular hypertrophy and energy metabolism.	[Huntgeburth, Michael; Shahverdyan, Robert; Caglayan, Evren; Mueller-Ehmsen, Jochen; Vantler, Marius; Rosenkranz, Stephan] Herzzentrum Univ Koln, Innere Med Klin 3, Cologne, Germany; [Tiemann, Klaus] Univ Klinikum Munster, Abt Kardiol & Angiol, Munster, Germany; [Schlueter, Klaus-Dieter; Schreckenberg, Rolf] Univ Giessen, Inst Physiol, Giessen, Germany; [Gross, Marie-Luise; Moedersheim, Sonja] Heidelberg Univ, Inst Pathol, D-6900 Heidelberg, Germany; [Caglayan, Evren; Vantler, Marius; Rosenkranz, Stephan] Univ Cologne, Ctr Mol Med Cologne CMMC, Cologne, Germany; [Ghanem, Alexander] Univ Klinikum Bonn, Med Klin & Poliklin 2, Bonn, Germany; [Zimmermann, Wolfram H.] Univ Gottingen, Abt Pharmakol, Gottingen, Germany; [Boehm, Michael] Univ Saarland, Innere Med Klin 3, Homburg, Germany	University of Cologne; University of Munster; Justus Liebig University Giessen; Ruprecht Karls University Heidelberg; University of Cologne; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen; Saarland University	Huntgeburth, M (corresponding author), Herzzentrum Univ Koln, Innere Med Klin 3, Cologne, Germany.	stephan.rosenkranz@uk-koeln.de	Zimmermann, Wolfram-Hubertus H/I-6838-2012; Böhm, Michael/C-3638-2011; Caglayan, Evren/ABB-8674-2020	Zimmermann, Wolfram-Hubertus H/0000-0003-1190-4040; 	Deutsche Forschungsgemeinschaft [RO1306/2-2, HU1583/2-1, SFB656 C3, KFO 196]; Center for Molecular Medicine Cologne (CMMC) [A6]; Medical Faculty of the University of Cologne; Boehringer-Ingelheim	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Molecular Medicine Cologne (CMMC); Medical Faculty of the University of Cologne; Boehringer-Ingelheim(Boehringer Ingelheim)	This work was supported in part by the Deutsche Forschungsgemeinschaft (RO1306/2-2 to SR and WHZ, HU1583/2-1 to MH, and SFB656 C3 to KT), the Center for Molecular Medicine Cologne (CMMC; project A6, to SR), the Koln Fortune Program of the Medical Faculty of the University of Cologne (to MH), and by a research grant from Boehringer-Ingelheim. MB is funded by the Deutsche Forschungsgemeinschaft (KFO 196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong WF, 1998, J AM SOC ECHOCARDIOG, V11, P97, DOI 10.1016/S0894-7317(98)70132-4; Bohm M, 1999, HEART FAIL REV, V4, P329; BOLUYT MO, 1994, CIRC RES, V75, P23, DOI 10.1161/01.RES.75.1.23; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; BRAND T, 1995, J MOL CELL CARDIOL, V27, P5, DOI 10.1016/S0022-2828(08)80003-X; Brooks WW, 2000, J MOL CELL CARDIOL, V32, P187, DOI 10.1006/jmcc.1999.1065; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Cerqueira MD, 2002, J NUCL CARDIOL, V9, P240, DOI 10.1067/mnc.2002.123122; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Collins KA, 2001, AM J PHYSIOL-HEART C, V280, pH1954, DOI 10.1152/ajpheart.2001.280.5.H1954; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; HUGEL S, 1992, AM J PHYSIOL-HEART C, pH2167; Ishizawa M, 2006, LIFE SCI, V78, P2974, DOI 10.1016/j.lfs.2006.02.029; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Langer M, 2003, PFLUG ARCH EUR J PHY, V447, P289, DOI 10.1007/s00424-003-1187-8; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MATTFELDT T, 1990, J MICROSC-OXFORD, V159, P301, DOI 10.1111/j.1365-2818.1990.tb03036.x; MILLAN FA, 1991, DEVELOPMENT, V111, P131; Murray AJ, 2004, LANCET, V364, P1786, DOI 10.1016/S0140-6736(04)17402-3; Murray AJ, 2008, J MOL CELL CARDIOL, V44, P694, DOI 10.1016/j.yjmcc.2008.01.008; Nagase I, 2001, FEBS LETT, V494, P175, DOI 10.1016/S0014-5793(01)02341-9; Nakajima H, 2000, CIRC RES, V86, P571, DOI 10.1161/01.RES.86.5.571; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Noma T, 2001, FASEB J, V15, P1206, DOI 10.1096/fj.000569fje; PFEFFER JM, 1995, ANNU REV PHYSIOL, V57, P805, DOI 10.1146/annurev.ph.57.030195.004105; Ramsay TG, 2007, COMP BIOCHEM PHYS A, V147, P395, DOI 10.1016/j.cbpa.2007.01.007; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; SAMUEL SK, 1992, EMBO J, V11, P1599, DOI 10.1002/j.1460-2075.1992.tb05205.x; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Schluter KD, 2000, CARDIOVASC RES, V45, P410, DOI 10.1016/S0008-6363(99)00351-X; SCHLUTER KD, 1995, AM J PHYSIOL-CELL PH, V269, pC1311, DOI 10.1152/ajpcell.1995.269.5.C1311; SCHLUTER KD, 2004, METHOD MOL BIOL, V290, P305; Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SIMPSON P, 1983, J CLIN INVEST, V72, P732, DOI 10.1172/JCI111023; TERUEL T, 1995, FEBS LETT, V364, P193, DOI 10.1016/0014-5793(95)00385-M; Tiemann K, 2003, AM J PHYSIOL-HEART C, V284, pH464, DOI 10.1152/ajpheart.00540.2002; Tornig J, 1996, J AM SOC NEPHROL, V7, P667; Yamazaki T, 1999, AM J CARDIOL, V83, p53H; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010	42	37	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e26628	10.1371/journal.pone.0026628	http://dx.doi.org/10.1371/journal.pone.0026628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22125598	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555800006
J	Lahar, N; Lei, NY; Wang, JF; Jabaji, Z; Tung, SC; Joshi, V; Lewis, M; Stelzner, M; Martin, MG; Dunn, JCY				Lahar, Nicholas; Lei, Nan Ye; Wang, Jiafang; Jabaji, Ziyad; Tung, Stephaine C.; Joshi, Vaidehi; Lewis, Michael; Stelzner, Matthias; Martin, Martin G.; Dunn, James C. Y.			Intestinal Subepithelial Myofibroblasts Support in vitro and in vivo Growth of Human Small Intestinal Epithelium	PLOS ONE			English	Article							STEM-CELLS; DIFFERENTIATION; RENEWAL; NICHE	The intestinal crypt-niche interaction is thought to be essential to the function, maintenance, and proliferation of progenitor stem cells found at the bases of intestinal crypts. These stem cells are constantly renewing the intestinal epithelium by sending differentiated cells from the base of the crypts of Lieberkuhn to the villus tips where they slough off into the intestinal lumen. The intestinal niche consists of various cell types, extracellular matrix, and growth factors and surrounds the intestinal progenitor cells. There have recently been advances in the understanding of the interactions that regulate the behavior of the intestinal epithelium and there is great interest in methods for isolating and expanding viable intestinal epithelium. However, there is no method to maintain primary human small intestinal epithelium in culture over a prolonged period of time. Similarly no method has been published that describes isolation and support of human intestinal epithelium in an in vivo model. We describe a technique to isolate and maintain human small intestinal epithelium in vitro from surgical specimens. We also describe a novel method to maintain human intestinal epithelium subcutaneously in a mouse model for a prolonged period of time. Our methods require various growth factors and the intimate interaction between intestinal sub-epithelial myofibroblasts (ISEMFs) and the intestinal epithelial cells to support the epithelial in vitro and in vivo growth. Absence of these myofibroblasts precluded successful maintenance of epithelial cell formation and proliferation beyond just a few days, even in the presence of supportive growth factors. We believe that the methods described here can be used to explore the molecular basis of human intestinal stem cell support, maintenance, and growth.	[Lahar, Nicholas; Lei, Nan Ye; Jabaji, Ziyad; Tung, Stephaine C.; Stelzner, Matthias; Dunn, James C. Y.] Univ Calif Los Angeles, David Geffen Sch Med, Div Gastroenterol & Nutr, Dept Surg, Los Angeles, CA 90095 USA; [Lei, Nan Ye; Joshi, Vaidehi; Dunn, James C. Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Bioengn, Div Gastroenterol & Nutr, Los Angeles, CA 90095 USA; [Wang, Jiafang; Tung, Stephaine C.; Martin, Martin G.] Univ Calif Los Angeles, David Geffen Sch Med, Div Gastroenterol & Nutr, Dept Pediat, Los Angeles, CA 90095 USA; [Lewis, Michael] Univ Calif Los Angeles, Dept Pathol, Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Lahar, N (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Gastroenterol & Nutr, Dept Surg, Los Angeles, CA 90095 USA.	jdunn@mednet.ucla.edu	Martín, María/HDL-9512-2022		National Institute of Diabetes and Digestive and Kidney Diseases, Intestinal Stem Cell Consortium [DK085535-01, DK085535-02S2]; California Institute for Regenerative Medicine (CIRM) [RT2-01985];  [DK083762];  [DK083319]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085535, R01DK083319, R01DK083762] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, Intestinal Stem Cell Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases U01 Intestinal Stem Cell Consortium (DK085535-01 and DK085535-02S2), DK083762, DK083319 and the California Institute for Regenerative Medicine (CIRM) (Grant Number RT2-01985). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of CIRM or any other agency of the State of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Garrison AP, 2009, J PEDIATR GASTR NUTR, V49, P2, DOI 10.1097/MPG.0b013e3181ad3021; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Ishizuya-Oka A, 2008, DIGESTION, V77, P42, DOI 10.1159/000111487; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Mahida YR, 1997, AM J PHYSIOL-GASTR L, V273, pG1341, DOI 10.1152/ajpgi.1997.273.6.G1341; McKaig BC, 1999, AM J PHYSIOL-GASTR L, V276, pG1087, DOI 10.1152/ajpgi.1999.276.5.G1087; MIFFLIN RC, 2011, GASTROINTESTINAL LIV, V300, pG684; Pinchuk I V, 2010, Curr Gastroenterol Rep, V12, P310, DOI 10.1007/s11894-010-0135-y; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Samuel S, 2009, AM J PHYSIOL-CELL PH, V296, pC296, DOI 10.1152/ajpcell.00383.2008; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1; YEUNG TM, 2011, CELLULAR MOL LIFE SC	18	130	135	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e26898	10.1371/journal.pone.0026898	http://dx.doi.org/10.1371/journal.pone.0026898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22125602	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555800010
J	Xue, JLZ; Costopoulos, A; Guichard, F				Xue, Julian Z.; Costopoulos, Andre; Guichard, Frederic			Choosing Fitness-Enhancing Innovations Can Be Detrimental under Fluctuating Environments	PLOS ONE			English	Article							CHANGING ENVIRONMENT; MUTATION-RATES; EVOLUTION; POPULATION; ADAPTATION; FORESIGHT; CLIMATE; SIZE; SELECTION; GROWTH	The ability to predict the consequences of one's behavior in a particular environment is a mechanism for adaptation. In the absence of any cost to this activity, we might expect agents to choose behaviors that maximize their fitness, an example of directed innovation. This is in contrast to blind mutation, where the probability of becoming a new genotype is independent of the fitness of the new genotypes. Here, we show that under environments punctuated by rapid reversals, a system with both genetic and cultural inheritance should not always maximize fitness through directed innovation. This is because populations highly accurate at selecting the fittest innovations tend to over-fit the environment during its stable phase, to the point that a rapid environmental reversal can cause extinction. A less accurate population, on the other hand, can track long term trends in environmental change, keeping closer to the time-average of the environment. We use both analytical and agent-based models to explore when this mechanism is expected to occur.	[Xue, Julian Z.; Guichard, Frederic] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Costopoulos, Andre] McGill Univ, Dept Anthropol, Montreal, PQ, Canada	McGill University; McGill University	Xue, JLZ (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	zhunping.xue@mail.mcgill.ca	Guichard, Frederic/B-6188-2015	Guichard, Frederic/0000-0002-7369-482X	Fonds de recherche sur la societe et la culture Team; European Science Foundation; Social Sciences and Humanities Research Council of Canada; Canadian Institutes of Health Research	Fonds de recherche sur la societe et la culture Team; European Science Foundation(European Science Foundation (ESF)European Commission); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was partially funded by a Fonds de recherche sur la societe et la culture Team grant on hominid dispersals, the European Science Foundation's BOREAS Histories From the North program, Social Sciences and Humanities Research Council of Canada, and Canadian Institutes of Health Research. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Barrett Paul H., 1987, C DARWINS NOTEBOOKS; Bell G, 2010, PHILOS T R SOC B, V365, P87, DOI 10.1098/rstb.2009.0150; Bock J, 2002, HUM NATURE-INT BIOS, V13, P153, DOI 10.1007/s12110-002-1006-5; Boyd R., 2005, ORIGIN EVOLUTION CUL; CHARNOV EL, 1974, IBIS, V116, P217, DOI 10.1111/j.1474-919X.1974.tb00241.x; Darwin Charles, 1876, ORIGIN SPECIES; FISHER S. R. A., 1999, GENETICAL THEORY NAT; Haldane J. B. S., 1990, CAUSES EVOLUTION; Heath DD, 2003, SCIENCE, V299, P1738, DOI 10.1126/science.1079707; Johnson T, 1999, P ROY SOC B-BIOL SCI, V266, P2389, DOI 10.1098/rspb.1999.0936; Jouzel J, 1996, CLIM DYNAM, V12, P513, DOI 10.1007/BF00207935; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KIMURA MOTEE, 1960, JOUR GENET, V57, P21, DOI 10.1007/BF02985336; Lande R, 1996, EVOLUTION, V50, P434, DOI 10.2307/2410812; LEVINS RICHARD, 1968; LEWONTIN RC, 1965, IDEAS MODERN BIOL, V6, P299; LYNCH M, 1977, ECOLOGY, V58, P763, DOI 10.2307/1936212; Malthus T R, 1973, ESSAY PRINCIPLE POPU; Mangel M, 2001, EVOL ECOL RES, V3, P583; Mesoudi A, 2008, BIOL PHILOS, V23, P243, DOI 10.1007/s10539-007-9097-3; Ohtsuki H, 2006, J THEOR BIOL, V243, P86, DOI 10.1016/j.jtbi.2006.06.004; PEASE CM, 1989, ECOLOGY, V70, P1657, DOI 10.2307/1938100; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Richerson P.J, 1988, CULTURE EVOLUTIONARY; Rosenberg Karen, 1995, Evolutionary Anthropology, V4, P161, DOI 10.1002/evan.1360040506; SCHAFFER W, 1974, AM NAT, P783; SLOBODKIN LB, 1964, AM SCI, V52, P342; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Suddendorf T, 2006, SCIENCE, V312, P1006, DOI 10.1126/science.1129217; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Whitebead H, 2007, J THEOR BIOL, V245, P341, DOI 10.1016/j.jtbi.2006.10.001; Whitehead H, 2009, EVOL HUM BEHAV, V30, P261, DOI 10.1016/j.evolhumbehav.2009.02.003; Wright S, 1932, P INT C GENET, V6, P356	35	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e26770	10.1371/journal.pone.0026770	http://dx.doi.org/10.1371/journal.pone.0026770			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22125601	Green Submitted, Green Published, gold			2022-12-25	WOS:000297555800009
J	Kong, D; Piao, YS; Yamashita, S; Oshima, H; Oguma, K; Fushida, S; Fujimura, T; Minamoto, T; Seno, H; Yamada, Y; Satou, K; Ushijima, T; Ishikawa, TO; Oshima, M				Kong, D.; Piao, Y-S; Yamashita, S.; Oshima, H.; Oguma, K.; Fushida, S.; Fujimura, T.; Minamoto, T.; Seno, H.; Yamada, Y.; Satou, K.; Ushijima, T.; Ishikawa, T-O; Oshima, M.			Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells	ONCOGENE			English	Article						miR-7; gastric cancer; inflammation; macrophages	PROSTAGLANDIN E-2 PATHWAY; GROWTH-FACTOR RECEPTOR; ACTIVATED MACROPHAGES; NEURITE OUTGROWTH; DNA METHYLATION; CANCER; MICRORNA-7; TARGETS; INDUCTION; ELEMENT	Inflammation has an important role in cancer development through various mechanisms. It has been shown that dysregulation of microRNAs (miRNAs) that function as oncogenes or tumor suppressors contributes to tumorigenesis. However, the relationship between inflammation and cancer-related miRNA expression in tumorigenesis has not yet been fully understood. Using K19-C2mE and Gan mouse models that develop gastritis and gastritis-associated tumors, respectively, we found that 21 miRNAs were upregulated, and that 29 miRNAs were downregulated in gastric tumors in an inflammation-dependent manner. Among these miRNAs, the expression of miR-7, a possible tumor suppressor, significantly decreased in both gastritis and gastric tumors. Moreover, the expression of miR-7 in human gastric cancer was inversely correlated with the levels of interleukin-1 beta and tumor necrosis factor-alpha, suggesting that miR-7 downregulation is related to the severity of inflammatory responses. In the normal mouse stomach, miR-7 expression was at a basal level in undifferentiated gastric epithelial cells, and was induced during differentiation. Moreover, transfection of a miR-7 precursor into gastric cancer cells suppressed cell proliferation and soft agar colony formation. These results suggest that suppression of miR- 7 expression is important for maintaining the undifferentiated status of gastric epithelial cells, and thus contributes to gastric tumorigenesis. Although epigenetic changes were not found in the CpG islands around miR-7-1 of gastritis and gastric tumor cells, we found that activated macrophage-derived small molecule(s) ( <3kDa) are responsible for miR-7 repression in gastric cancer cells. Furthermore, the miR-7 expression level significantly decreased in the inflamed gastric mucosa of Helicobacter-infected mice, whereas it increased in the stomach of germfree K19-C2mE and Gan mice wherein inflammatory responses were suppressed.	[Kong, D.; Piao, Y-S; Oshima, H.; Oguma, K.; Ishikawa, T-O; Oshima, M.] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 9201192, Japan; [Yamashita, S.; Ushijima, T.] Natl Canc Ctr, Res Inst, Div Epigen, Tokyo 104, Japan; [Fushida, S.; Fujimura, T.] Kanazawa Univ Hosp, Dept Gastroenterol Surg, Kanazawa, Ishikawa, Japan; [Minamoto, T.] Kanazawa Univ, Canc Res Inst, Div Translat & Clin Oncol, Kanazawa, Ishikawa 9201192, Japan; [Seno, H.] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Yamada, Y.; Satou, K.] Kanazawa Univ, Inst Sci & Engn, Fac Elect & Comp Engn, Kanazawa, Ishikawa 9201192, Japan; [Piao, Y-S] Yanbian Univ, Med Coll, Dept Pathophysiol, Yanji 133002, Peoples R China	Kanazawa University; National Cancer Center - Japan; Kanazawa University; Kanazawa University; Kyoto University; Kanazawa University; Yanbian University	Oshima, M (corresponding author), Kanazawa Univ, Canc Res Inst, Div Genet, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	oshimam@kenroku.kanazawa-u.ac.jp	Satou, Kenji/C-3316-2015; Ushijima, Toshikazu/AAP-5742-2021; Oshima, Masanobu/F-9958-2014	Satou, Kenji/0000-0001-5474-7087; Ushijima, Toshikazu/0000-0003-3405-7817; Oshima, Masanobu/0000-0002-3304-0004; Oshima, Hiroko/0000-0001-6855-4008; Seno, Hiroshi/0000-0002-8509-8128	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan; Grants-in-Aid for Scientific Research [22500996, 23659643] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Manami Watanabe for her excellent technical assistance. This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Ministry of Health, Labour and Welfare of Japan.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen HL, 2010, BIOCHEM BIOPH RES CO, V394, P921, DOI 10.1016/j.bbrc.2010.03.076; CHENG H, 1984, GASTROENTEROLOGY, V86, P78; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ichtchenko K, 1999, J BIOL CHEM, V274, P5491, DOI 10.1074/jbc.274.9.5491; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Itadani H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-615; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Korshunova I, 2008, J NEUROSCI RES, V86, P2201, DOI 10.1002/jnr.21678; Nguyen HTT, 2010, J BIOL CHEM, V285, P1479, DOI 10.1074/jbc.M109.057141; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Oshima H, 2004, EMBO J, V23, P1669, DOI 10.1038/sj.emboj.7600170; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Oshima H, 2011, GASTROENTEROLOGY, V140, P596, DOI 10.1053/j.gastro.2010.11.007; Oshima H, 2009, CANCER RES, V69, P2729, DOI 10.1158/0008-5472.CAN-08-4394; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Saydam O, 2011, CANCER RES, V71, P852, DOI 10.1158/0008-5472.CAN-10-1219; Sonkoly E, 2011, MUTAT RES-FUND MOL M, V717, P46, DOI 10.1016/j.mrfmmm.2011.02.002; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Suzuki H, 2010, CARCINOGENESIS, V31, P2066, DOI 10.1093/carcin/bgq203; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wu H, 2010, MOL CELL, V38, P67, DOI 10.1016/j.molcel.2010.02.021; Yamashita S, 2008, CANCER RES, V68, P2112, DOI 10.1158/0008-5472.CAN-07-5282	39	88	92	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	35					3949	3960		10.1038/onc.2011.558	http://dx.doi.org/10.1038/onc.2011.558			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	999VJ	22139078	Green Submitted			2022-12-25	WOS:000308342800004
J	Barrientos, GC; Feng, W; Truong, K; Matthaei, KI; Yang, TZ; Allen, PD; Lopez, JR; Pessah, IN				Barrientos, Genaro C.; Feng, Wei; Kim Truong; Matthaei, Klaus I.; Yang, Tianzhong; Allen, Paul D.; Lopez, Jose R.; Pessah, Isaac N.			Gene Dose Influences Cellular and Calcium Channel Dysregulation in Heterozygous and Homozygous T4826I-RYR1 Malignant Hyperthermia-susceptible Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 RYANODINE RECEPTOR; CENTRAL CORE DISEASE; KNOCK-IN MOUSE; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; RELEASE CHANNEL; COUPLED CALCIUM; CA2+ RELEASE; MG2+ INHIBITION; CARDIAC-MUSCLE	Malignant hyperthermia susceptibility (MHS) is primarily conferred by mutations within ryanodine receptor type 1 (RYR1). Here we address how the MHS mutation T4826I within the S4-S5 linker influences excitation-contraction coupling and resting myoplasmic Ca2+ concentration ([Ca2+](rest)) in flexor digitorum brevis (FDB) and vastus lateralis prepared from heterozygous (Het) and homozygous (Hom) T4826I-RYR1 knock-in mice (Yuen, B. T., Boncompagni, S., Feng, W., Yang, T., Lopez, J. R., Matthaei, K. I., Goth, S. R., Protasi, F., Franzini-Armstrong, C., Allen, P. D., and Pessah, I. N. (2011) FASEB J. doi:22131268). FDB responses to electrical stimuli and acute halothane (0.1%, v/v) exposure showed a rank order of Hom >> Het >> WT. Release of Ca2+ from the sarcoplasmic reticulum and Ca2+ entry contributed to halothane-triggered increases in [Ca2+](rest) in Hom FDBs and elicited pronounced Ca2+ oscillations in similar to 30% of FDBs tested. Genotype contributed significantly elevated [Ca2+](rest) (Hom > Het > WT) measured in vivo using ion-selective microelectrodes. Het and Hom oxygen consumption rates measured in intact myotubes using the Seahorse Bioscience (Billerica, MA) flux analyzer and mitochondrial content measured with MitoTracker were lower than WT, whereas total cellular calpain activity was higher than WT. Muscle membranes did not differ in RYR1 expression nor in Ser(2844) phosphorylation among the genotypes. Single channel analysis showed highly divergent gating behavior with Hom and WT favoring open and closed states, respectively, whereas Het exhibited heterogeneous gating behaviors. [H-3] Ryanodine binding analysis revealed a gene dose influence on binding density and regulation by Ca2+, Mg2+, and temperature. Pronounced abnormalities inherent in T4826I-RYR1 channels confer MHS and promote basal disturbances of excitation-contraction coupling, [Ca2+](rest), and oxygen consumption rates. Considering that both Het and Hom T4826I-RYR1 mice are viable, the remarkable isolated single channel dysfunction mediated through this mutation in S4-S5 cytoplasmic linker must be highly regulated in vivo.	[Barrientos, Genaro C.; Feng, Wei; Kim Truong; Pessah, Isaac N.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; [Matthaei, Klaus I.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia; [Yang, Tianzhong; Allen, Paul D.; Lopez, Jose R.] Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA	University of California System; University of California Davis; Australian National University; John Curtin School of Medical Research; Harvard University; Brigham & Women's Hospital	Pessah, IN (corresponding author), Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, 1 Shields Ave, Davis, CA 95616 USA.	inpessah@ucdavis.edu	Barrientos, Genaro/I-2778-2013; Pessah, Isaac N/K-7985-2017	Pessah, Isaac N/0000-0002-8149-588X	National Institutes of Health [1P01 AR52354, 3R01 AR043140, 1R01 ES014901]; J. B. Johnson Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR052354, R01AR043140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. B. Johnson Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1P01 AR52354 and 3R01 AR043140 (to P. D. A. and I. N. P.) and 1R01 ES014901 (to I. N. P.). This work was also supported by a grant from the J. B. Johnson Foundation.	AIREY JA, 1990, J BIOL CHEM, V265, P14187; Andronache Z, 2009, P NATL ACAD SCI USA, V106, P4531, DOI 10.1073/pnas.0812661106; Bannister RA, 2010, J GEN PHYSIOL, V135, P629, DOI 10.1085/jgp.200910329; Barrientos G, 2009, MOL PHARMACOL, V76, P560, DOI 10.1124/mol.109.057265; Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106; Brady JE, 2009, ANESTH ANALG, V109, P1162, DOI 10.1213/ane.0b013e3181ac1548; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Brown RL, 2000, HUM MOL GENET, V9, P1515, DOI 10.1093/hmg/9.10.1515; Carpenter D, 2009, ANN HUM GENET, V73, P10, DOI 10.1111/j.1469-1809.2008.00482.x; Carpenter D, 2009, MUSCLE NERVE, V40, P633, DOI 10.1002/mus.21397; Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje; Cherednichenko G, 2004, P NATL ACAD SCI USA, V101, P15793, DOI 10.1073/pnas.0403485101; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Eltit JM, 2011, P NATL ACAD SCI USA, V108, P7046, DOI 10.1073/pnas.1018380108; Feng W, 2011, MOL PHARMACOL, V79, P420, DOI 10.1124/mol.110.067959; Gailly P, 2007, J PHYSIOL-LONDON, V582, P1261, DOI 10.1113/jphysiol.2007.132191; Giulivi C, 2011, J BIOL CHEM, V286, P99, DOI 10.1074/jbc.M110.153247; HAIN J, 1994, BIOPHYS J, V67, P1823, DOI 10.1016/S0006-3495(94)80664-2; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Jurkat-Rott K, 2002, J NEUROL, V249, P1493, DOI 10.1007/s00415-002-0871-5; Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200; LAMB GD, 1993, J MUSCLE RES CELL M, V14, P554, DOI 10.1007/BF00141551; Laver DR, 1997, BIOPHYS J, V73, P1913, DOI 10.1016/S0006-3495(97)78222-5; Laver DR, 1997, J MEMBRANE BIOL, V156, P213, DOI 10.1007/s002329900202; Litman RS, 2005, JAMA-J AM MED ASSOC, V293, P2918, DOI 10.1001/jama.293.23.2918; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; LOPEZ J R, 1985, Acta Cientifica Venezolana, V36, P102; Louis CF, 2001, BIOSCIENCE REP, V21, P155, DOI 10.1023/A:1013644107519; Lynch PJ, 1997, ANESTHESIOLOGY, V86, P620, DOI 10.1097/00000542-199703000-00014; MACK MM, 1992, J PHARMACOL EXP THER, V262, P1028; MacLennan DH, 2011, BBA-MOL CELL RES, V1813, P948, DOI 10.1016/j.bbamcr.2010.11.009; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; Meissner G, 2002, FRONT BIOSCI, V7, pD2072, DOI 10.2741/meissner; Monnier N, 2002, ANESTHESIOLOGY, V97, P1067, DOI 10.1097/00000542-200211000-00007; Murayama T, 2007, BIOCHEM J, V402, P349, DOI 10.1042/BJ20061040; Murayama T, 2011, J BIOL CHEM, V286, P35571, DOI 10.1074/jbc.M111.255240; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Owen VJ, 1997, AM J PHYSIOL-CELL PH, V272, pC203, DOI 10.1152/ajpcell.1997.272.1.C203; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Pessah IN, 1997, AM J PHYSIOL-CELL PH, V272, pC601, DOI 10.1152/ajpcell.1997.272.2.C601; PESSAH IN, 1985, BIOCHEM BIOPH RES CO, V128, P449, DOI 10.1016/0006-291X(85)91699-7; PESSAH IN, 1987, MOL PHARMACOL, V31, P232; PESSAH IN, 1991, MOL PHARMACOL, V39, P679; Rando TA, 1997, METHOD CELL BIOL, V52, P261, DOI 10.1016/S0091-679X(08)60382-9; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Robinson RL, 2003, EUR J HUM GENET, V11, P342, DOI 10.1038/sj.ejhg.5200964; Rueffert H, 2001, BRIT J ANAESTH, V87, P240, DOI 10.1093/bja/87.2.240; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; Sonnleitner A, 1997, CELL CALCIUM, V21, P283, DOI 10.1016/S0143-4160(97)90116-0; Stewart SL, 2001, CLIN GENET, V59, P178, DOI 10.1034/j.1399-0004.2001.590306.x; Toppin PJ, 2010, CAN J ANAESTH, V57, P689, DOI 10.1007/s12630-010-9314-4; Vinciguerra M, 2010, ADV EXP MED BIOL, V694, P211; Voss AA, 2008, BIOCHEM BIOPH RES CO, V366, P988, DOI 10.1016/j.bbrc.2007.12.058; Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006; Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200; Yuen B. T., 2011, FASEB J, DOI 22131268; Zhao XL, 2006, J BIOL CHEM, V281, P33477, DOI 10.1074/jbc.M602306200; Zhou J, 2010, MILLERS ANESTHESIA, P1171	63	25	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2863	2876		10.1074/jbc.M111.307926	http://dx.doi.org/10.1074/jbc.M111.307926			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139840	Green Published, hybrid			2022-12-25	WOS:000300292300058
J	Kelkar, DA; Khushoo, A; Yang, ZY; Skach, WR				Kelkar, Devaki A.; Khushoo, Amardeep; Yang, Zhongying; Skach, William R.			Kinetic Analysis of Ribosome-bound Fluorescent Proteins Reveals an Early, Stable, Cotranslational Folding Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NASCENT CHAIN COMPLEXES; IN-VITRO; EXIT TUNNEL; CHROMOPHORE FORMATION; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; ENERGY LANDSCAPE; HELIX FORMATION; VIVO; GFP	Protein folding in cells reflects a delicate interplay between biophysical properties of the nascent polypeptide, the vectorial nature and rate of translation, molecular crowding, and cellular biosynthetic machinery. To better understand how this complex environment affects de novo folding pathways as they occur in the cell, we expressed beta-barrel fluorescent proteins derived from GFP and RFP in an in vitro system that allows direct analysis of cotranslational folding intermediates. Quantitative analysis of ribosome-bound eCFP and mCherry fusion proteins revealed that productive folding exhibits a sharp threshold as the length of polypeptide from the C terminus to the ribosome peptidyltransferase center is increased. Fluorescence spectroscopy, urea denaturation, and limited protease digestion confirmed that sequestration of only 10-15 C-terminal residues within the ribosome exit tunnel effectively prevents stable barrel formation, whereas folding occurs unimpeded when the C terminus is extended beyond the ribosome exit site. Nascent FPs with 10 of the 11 beta-strands outside the ribosome exit tunnel acquire a non-native conformation that is remarkably stable in diverse environments. Upon ribosome release, these structural intermediates fold efficiently with kinetics that are unaffected by the cytosolic crowding or cellular chaperones. Our results indicate that during synthesis, fluorescent protein folding is initiated cotranslationally via rapid formation of a highly stable, on-pathway structural intermediate and that the rate-limiting step of folding involves autonomous incorporation of the 11th beta-strand into the mature barrel structure.	[Kelkar, Devaki A.; Khushoo, Amardeep; Yang, Zhongying; Skach, William R.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Skach, WR (corresponding author), MC L-224,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	skachw@ohsu.edu		Kelkar, Devaki/0000-0002-4442-9680	National Institutes of Health [GM53456, DK51818]; Cystic Fibrosis Foundation Therapeutics [SKACH05X0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053456, R01GM053457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM53456 and DK51818 and Cystic Fibrosis Foundation Therapeutics Grant SKACH05X0.	Andrews BT, 2007, J MOL BIOL, V373, P476, DOI 10.1016/j.jmb.2007.07.071; Andrews BT, 2009, J MOL BIOL, V392, P218, DOI 10.1016/j.jmb.2009.06.072; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bertz M, 2008, ANGEW CHEM INT EDIT, V47, P8192, DOI 10.1002/anie.200802987; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Cabrita LD, 2009, P NATL ACAD SCI USA, V106, P22239, DOI 10.1073/pnas.0903750106; Clark PL, 2004, TRENDS BIOCHEM SCI, V29, P527, DOI 10.1016/j.tibs.2004.08.008; Clark PL, 2001, J BIOL CHEM, V276, P25411, DOI 10.1074/jbc.M008490200; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Daniel CJ, 2008, J BIOL CHEM, V283, P20864, DOI 10.1074/jbc.M803517200; Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004; Eichmann C, 2010, P NATL ACAD SCI USA, V107, P9111, DOI 10.1073/pnas.0914300107; Enoki S, 2004, BIOCHEMISTRY-US, V43, P14238, DOI 10.1021/bi048733+; Etchells SA, 2005, J BIOL CHEM, V280, P28118, DOI 10.1074/jbc.M504110200; Evans MS, 2008, J MOL BIOL, V383, P683, DOI 10.1016/j.jmb.2008.07.035; Evans MS, 2005, NAT METHODS, V2, P757, DOI 10.1038/NMETH790; FEDOROV AN, 1995, P NATL ACAD SCI USA, V92, P1227, DOI 10.1073/pnas.92.4.1227; Fukuda H, 2000, BIOCHEMISTRY-US, V39, P12025, DOI 10.1021/bi000543l; Fulle S, 2009, J MOL BIOL, V387, P502, DOI 10.1016/j.jmb.2009.01.037; Gajewski C, 2011, P NATL ACAD SCI USA, V108, P3240, DOI 10.1073/pnas.1017097108; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; HASEGAWA H, 1992, SCIENCE, V258, P1477, DOI 10.1126/science.1279809; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; Hsu STD, 2009, CHEM SOC REV, V38, P2951, DOI 10.1039/b908170b; Hsu STD, 2009, BIOMOL NMR ASSIGN, V3, P67, DOI 10.1007/s12104-009-9143-y; Huang JR, 2007, J MOL BIOL, V370, P356, DOI 10.1016/j.jmb.2007.04.039; Huang JR, 2008, HFSP J, V2, P378, DOI 10.2976/1.2976660; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Johnson AE, 2005, FEBS LETT, V579, P916, DOI 10.1016/j.febslet.2004.11.046; Kamagata K, 2004, J MOL BIOL, V339, P951, DOI 10.1016/j.jmb.2004.04.015; Kent KP, 2008, J AM CHEM SOC, V130, P9664, DOI 10.1021/ja803782x; Kent KP, 2011, J AM CHEM SOC, V133, P4046, DOI 10.1021/ja110256c; Khushoo A, 2011, MOL CELL, V41, P682, DOI 10.1016/j.molcel.2011.02.027; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Kosolapov A, 2009, NAT STRUCT MOL BIOL, V16, P405, DOI 10.1038/nsmb.1571; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Maggioni MC, 2005, NAT STRUCT MOL BIOL, V12, P258, DOI 10.1038/nsmb897; Mankin AS, 2006, TRENDS BIOCHEM SCI, V31, P11, DOI 10.1016/j.tibs.2005.11.007; Matagne A, 1998, CELL MOL LIFE SCI, V54, P363, DOI 10.1007/s000180050165; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nicola AV, 1999, NAT CELL BIOL, V1, P341, DOI 10.1038/14032; O'Brien EP, 2008, NANO LETT, V8, P3702, DOI 10.1021/nl8019328; O'Brien EP, 2010, J AM CHEM SOC, V132, P16928, DOI 10.1021/ja106530y; Oberdorf Jon, 2002, Methods Mol Med, V70, P295; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Ozkan SB, 2002, PROTEIN SCI, V11, P1958, DOI 10.1110/ps.0207102; PICKING WD, 1992, BIOCHEMISTRY-US, V31, P2368, DOI 10.1021/bi00123a023; POKROVSKAYA ID, 1994, ANAL BIOCHEM, V220, P420, DOI 10.1006/abio.1994.1360; Reeder PJ, 2010, BIOCHEMISTRY-US, V49, P10773, DOI 10.1021/bi100975z; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; Schaffitzel C, 2007, J STRUCT BIOL, V158, P463, DOI 10.1016/j.jsb.2007.01.005; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Sniegowski JA, 2005, BIOCHEM BIOPH RES CO, V332, P657, DOI 10.1016/j.bbrc.2005.04.166; Svetlov MS, 2006, PROTEIN SCI, V15, P242, DOI 10.1110/ps.051752506; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ugrinov KG, 2010, BIOPHYS J, V98, P1312, DOI 10.1016/j.bpj.2009.12.4291; Verkhusha VV, 2004, CHEM BIOL, V11, P845, DOI 10.1016/j.chembiol.2004.04.007; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; WARD WW, 1982, PHOTOCHEM PHOTOBIOL, V35, P803, DOI 10.1111/j.1751-1097.1982.tb02651.x; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Xia K, 2007, P NATL ACAD SCI USA, V104, P17329, DOI 10.1073/pnas.0705417104; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; Ziv G, 2005, P NATL ACAD SCI USA, V102, P18956, DOI 10.1073/pnas.0508234102	75	37	37	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2568	2578		10.1074/jbc.M111.318766	http://dx.doi.org/10.1074/jbc.M111.318766			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22128180	Green Published, hybrid			2022-12-25	WOS:000300292300030
J	Torres-Bugeau, CM; Avila, CL; Raisman-Vozari, R; Papy-Garcia, D; Itri, R; Barbosa, LRS; Cortez, LM; Sim, VL; Chehin, RN				Torres-Bugeau, Clarisa M.; Avila, Cesar L.; Raisman-Vozari, Rita; Papy-Garcia, Dulce; Itri, Rosangela; Barbosa, Leandro R. S.; Cortez, Leonardo M.; Sim, Valerie L.; Chehin, Rosana N.			Characterization of Heparin-induced Glyceraldehyde-3-phosphate Dehydrogenase Early Amyloid-like Oligomers and Their Implication in alpha-Synuclein Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; FILAMENTOUS INCLUSIONS; MOONLIGHTING PROTEINS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; FIBRIL FORMATION; BETA; GLYCOSAMINOGLYCANS; NEURODEGENERATION; FIBRILLOGENESIS	Lewy bodies and Lewy neurites, neuropathological hallmarks of several neurological diseases, are mainly made of filamentous assemblies of alpha-synuclein. However, other macromolecules including Tau, ubiquitin, glyceraldehyde-3-phosphate dehydrogenase, and glycosaminoglycans are routinely found associated with these amyloid deposits. Glyceraldehyde-3-phosphate dehydrogenase is a glycolytic enzyme that can form fibrillar aggregates in the presence of acidic membranes, but its role in Parkinson disease is still unknown. In this work, the ability of heparin to trigger the amyloid aggregation of this protein at physiological conditions of pH and temperature is demonstrated by infrared and fluorescence spectroscopy, dynamic light scattering, small angle x-ray scattering, circular dichroism, and fluorescence microscopy. Aggregation proceeds through the formation of short rod-like oligomers, which elongates in one dimension. Heparan sulfate was also capable of inducing glyceraldehyde-3-phosphate dehydrogenase aggregation, but chondroitin sulfates A, B, and C together with dextran sulfate had a negligible effect. Aided with molecular docking simulations, a putative binding site on the protein is proposed providing a rational explanation for the structural specificity of heparin and heparan sulfate. Finally, it is demonstrated that in vitro the early oligomers present in the glyceraldehyde-3-phosphate dehydrogenase fibrillation pathway promote alpha-synuclein aggregation. Taking into account the toxicity of alpha-synuclein prefibrillar species, the heparin-induced glyceraldehyde-3-phosphate dehydrogenase early oligomers might come in useful as a novel therapeutic strategy in Parkinson disease and other synucleinopathies.	[Torres-Bugeau, Clarisa M.; Avila, Cesar L.; Chehin, Rosana N.] CCT Tucuman, Inst Super Invest Biol, San Miguel De Tucuman, Argentina; [Torres-Bugeau, Clarisa M.; Avila, Cesar L.; Chehin, Rosana N.] Inst Quim Biol Dr Bernabe Bloj CONICET UNT, San Miguel De Tucuman, Argentina; [Raisman-Vozari, Rita] INSERM, CRICM, ICM, UMRS 975, F-91010 Creteil, France; [Papy-Garcia, Dulce] Univ Paris Est Creteil, Lab CRRET EAC CNRS 7149, F-94010 Creteil, France; [Itri, Rosangela; Barbosa, Leandro R. S.] Univ Sao Paulo, Inst Fis, BR-05508900 Sao Paulo, Brazil; [Cortez, Leonardo M.; Sim, Valerie L.] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB T6G 2M8, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universidade de Sao Paulo; University of Alberta	Chehin, RN (corresponding author), INSIBIO, Chacabuco 461, RA-4000 San Miguel De Tucuman, Argentina.	rosana@fbqf.unt.edu.ar	Barbosa, Leandro Ramos Souza/E-6577-2012; Barbosa, Leandro Ramos Souza/GRJ-9680-2022; Barbosa, L. R. S./AAN-7787-2020; Itri, Rosangela/B-4312-2014; Sim, Valerie/C-4137-2013	Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Sim, Valerie/0000-0002-0088-8666; Avila, Cesar Luis/0000-0003-0187-7915; Cortez, Leonardo/0000-0003-4080-8728; Chehin, Rosana/0000-0003-3504-7952; Itri, Rosangela/0000-0001-9311-0804	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 2518]; Consejo Investigaciones de la Universidad Nacional de Tucuman (CIUNT) [26/D439-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo Investigaciones de la Universidad Nacional de Tucuman (CIUNT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Grants PIP 2518 and Consejo Investigaciones de la Universidad Nacional de Tucuman (CIUNT) Grant 26/D439-1.; Recipient of a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) research fellowship.	Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; ARRONDO JLR, 1994, BIOCHEMISTRY-US, V33, P11650, DOI 10.1021/bi00204a029; ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; ARRONDO JLR, 1988, BIOCHIM BIOPHYS ACTA, V952, P261, DOI 10.1016/0167-4838(88)90125-2; Avila CL, 2008, BIOPHYS CHEM, V137, P126, DOI 10.1016/j.bpc.2008.08.003; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BANEULOS S, 1995, J BIOL CHEM, V270, P9192; Barbosa LRS, 2008, J PHYS CHEM B, V112, P4261, DOI 10.1021/jp710332t; Barbosa LRS, 2010, BIOPHYS J, V98, P147, DOI 10.1016/j.bpj.2009.09.056; Bemporad F, 2009, FEBS LETT, V583, P2630, DOI 10.1016/j.febslet.2009.07.013; Bitomsky W, 1999, J AM CHEM SOC, V121, P3004, DOI 10.1021/ja983319g; Bourgault S, 2011, BIOCHEMISTRY-US, V50, P1001, DOI 10.1021/bi101822y; Calero Miguel, 2004, V299, P129; Carrotta R, 2001, PROTEIN SCI, V10, P1312, DOI 10.1110/ps.42501; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; CORBIER C, 1990, BIOCHEMISTRY-US, V29, P7101, DOI 10.1021/bi00482a022; Cortez LM, 2010, FEBS LETT, V584, P625, DOI 10.1016/j.febslet.2009.12.012; Cotman SL, 2000, MOL CELL NEUROSCI, V15, P183, DOI 10.1006/mcne.1999.0816; Cowan-Jacob SW, 2003, ACTA CRYSTALLOGR D, V59, P2218, DOI 10.1107/S0907444903020493; DISCHE Z, 1950, J BIOL CHEM, V184, P517; DURRIEU C, 1987, ARCH BIOCHEM BIOPHYS, V252, P32, DOI 10.1016/0003-9861(87)90005-1; Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Glatter O., 1982, SMALL ANGLE X RAY SC; Guinier A., 1955, SMALL ANGLE SCATTERI; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Valle-Delgado JJ, 2010, FASEB J, V24, P4250, DOI 10.1096/fj.09-153551; Khan S, 2010, J MOL BIOL, V395, P504, DOI 10.1016/j.jmb.2009.10.064; Kragten E, 1998, J BIOL CHEM, V273, P5821, DOI 10.1074/jbc.273.10.5821; Krysmann MJ, 2008, LANGMUIR, V24, P8158, DOI 10.1021/la800942n; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Liu C, 2007, J BIOL CHEM, V282, P14558, DOI 10.1074/jbc.M700422200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maruyama W, 2001, J NEUROCHEM, V78, P727, DOI 10.1046/j.1471-4159.2001.00448.x; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Ortore MG, 2009, J R SOC INTERFACE, V6, pS619, DOI 10.1098/rsif.2009.0163.focus; Papy-Garcia D, 2011, CURR PROTEIN PEPT SC, V12, P258, DOI 10.2174/138920311795860188; PERRY G, 1992, BRAIN RES, V579, P350, DOI 10.1016/0006-8993(92)90074-J; RISEMAN J, 1950, J CHEM PHYS, V18, P512, DOI 10.1063/1.1747672; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; SUGAHARA T, 1995, FEBS LETT, V368, P92, DOI 10.1016/0014-5793(95)00607-B; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Tatton WG, 2000, ADV RES NEURODEGENER, V8, P77; Tong JC, 2010, BRAIN, V133, P172, DOI 10.1093/brain/awp282; Tsuchiya K, 2005, EUR J NEUROSCI, V21, P317, DOI 10.1111/j.1460-9568.2005.03870.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WEBER K, 1969, J BIOL CHEM, V244, P4406; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yamaji R, 2005, BBA-GEN SUBJECTS, V1726, P261, DOI 10.1016/j.bbagen.2005.07.013; ZHANG J, 1992, P NATL ACAD SCI USA, V89, P9382, DOI 10.1073/pnas.89.20.9382; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c	63	16	17	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2398	2409		10.1074/jbc.M111.303503	http://dx.doi.org/10.1074/jbc.M111.303503			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22134915	Green Published, hybrid			2022-12-25	WOS:000300292300015
J	Lee, CYD; Tse, W; Smith, JD; Landreth, GE				Lee, C. Y. Daniel; Tse, Wayne; Smith, Jonathan D.; Landreth, Gary E.			Apolipoprotein E Promotes beta-Amyloid Trafficking and Degradation by Modulating Microglial Cholesterol Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONSET ALZHEIMER-DISEASE; ISOFORM-SPECIFIC BINDING; HIGH-DENSITY-LIPOPROTEIN; TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM; A-I; RAB GTPASES; ENDOCYTIC PATHWAY; ENDOSOME MOTILITY; TRANSPORT PROTEIN	Allelic variation in the apolipoprotein E (APOE) gene is the major risk factor of sporadic Alzheimer disease. ApoE is the primary cholesterol carrier in the brain. Previously, we demonstrated that intracellular degradation of beta-amyloid (A beta) peptides by microglia is dramatically enhanced in the presence of apoE. However, the molecular mechanisms subserving this effect remain unknown. This study reports a mechanistic link between apoE-regulated cholesterol homeostasis and A beta degradation. We demonstrate that promoting intracellular A beta degradation by microglia is a common feature of HDL apolipoproteins, including apoE and apoA-I. This effect was not dependent on the direct interaction of apoE and A beta. Regulation of A beta degradation was achieved by solely manipulating cellular cholesterol levels. The expression and the activity of A beta degrading enzymes, however, were not regulated by cholesterol. We observed that reducing cellular cholesterol levels by apoE resulted in faster delivery of A beta to lysosomes and enhanced degradation. Moreover, apoE facilitated the recycling of Rab7, a small GTPase responsible for recruiting the motor complex to late endosomes/lysosomes. These data indicate that faster endocytic trafficking of A beta-containing vesicles in the presence of apoE resulted from efficient recycling of Rab7 from lysosomes to early endosomes. Thus, apoE-induced intracellular A beta degradation is mediated by the cholesterol efflux function of apoE, which lowers cellular cholesterol levels and subsequently facilitates the intracellular-trafficking of A beta to lysosomes for degradation. These findings demonstrate a direct role of cholesterol in the intracellular A beta degradation.	[Lee, C. Y. Daniel; Tse, Wayne; Landreth, Gary E.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA; [Smith, Jonathan D.] Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	Landreth, GE (corresponding author), Case Western Reserve Univ, Dept Neurosci, 10900 Euclid Ave, Cleveland, OH 44106 USA.	gary.landreth@case.edu	Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X; Tse, Wayne/0000-0001-9868-1593	National Institutes of Health [R01-AG030482]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AG030482 (to G. E. L.).	Aleshkov S, 1997, BIOCHEMISTRY-US, V36, P10571, DOI 10.1021/bi9626362; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chen HT, 2008, BIOPHYS J, V94, P1508, DOI 10.1529/biophysj.106.099366; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Datta G, 2001, J LIPID RES, V42, P1096; Falcone S, 2006, J CELL SCI, V119, P4758, DOI 10.1242/jcs.03238; Falkevall A, 2006, J BIOL CHEM, V281, P29096, DOI 10.1074/jbc.M602532200; Feng B, 2003, P NATL ACAD SCI USA, V100, P10423, DOI 10.1073/pnas.1732494100; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Grehan S, 2001, J NEUROSCI, V21, P812, DOI 10.1523/JNEUROSCI.21-03-00812.2001; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Handattu SP, 2009, NEUROBIOL DIS, V34, P525, DOI 10.1016/j.nbd.2009.03.007; Hara M, 2003, ARTERIOSCL THROM VAS, V23, P269, DOI 10.1161/01.ATV.0000054199.78458.4B; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Holtzman DM, 2004, J MOL NEUROSCI, V23, P247, DOI 10.1385/JMN:23:3:247; Hutt DM, 2000, J BIOL CHEM, V275, P18511, DOI 10.1074/jbc.M909309199; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Kuo YM, 1996, J BIOL CHEM, V271, P4077; LADU MJ, 1994, J BIOL CHEM, V269, P23403; LADU MJ, 1995, J BIOL CHEM, V270, P9039, DOI 10.1074/jbc.270.16.9039; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Lefterov I, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-20; Levin-Allerhand J A, 2002, J Nutr Health Aging, V6, P315; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lund-Katz S, 2010, SUBCELL BIOCHEM, V51, P183, DOI 10.1007/978-90-481-8622-8_7; Ma JY, 1996, NEUROBIOL AGING, V17, P773; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Martins IJ, 2009, J NEUROCHEM, V111, P1275, DOI 10.1111/j.1471-4159.2009.06408.x; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Maxfield FR, 2006, BIOCHEM SOC T, V34, P335, DOI 10.1042/BST0340335; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; Michikawa M, 2000, J NEUROCHEM, V74, P1008, DOI 10.1046/j.1471-4159.2000.0741008.x; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Mukherjee A, 2002, J ALZHEIMERS DIS, V4, P341, DOI 10.3233/JAD-2002-4501; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NASLUND J, 1995, NEURON, V15, P219, DOI 10.1016/0896-6273(95)90079-9; Navab M, 2005, CIRC RES, V97, P1085, DOI 10.1161/01.RES.0000194558.86099.ba; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1325, DOI 10.1161/01.ATV.0000165694.39518.95; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Ou JS, 2005, CIRC RES, V97, P1190, DOI 10.1161/01.RES.0000190634.60042.cb; Petanceska SS, 2002, J MOL NEUROSCI, V19, P155, DOI 10.1007/s12031-002-0026-2; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Remaley AT, 2003, J LIPID RES, V44, P828, DOI 10.1194/jlr.M200475-JLR200; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Rupper A, 2001, MOL BIOL CELL, V12, P2813, DOI 10.1091/mbc.12.9.2813; Sadowski M, 2004, AM J PATHOL, V165, P937, DOI 10.1016/S0002-9440(10)63355-X; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; Soto C, 1996, BIOCHEM J, V314, P701, DOI 10.1042/bj3140701; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Umebayashi K, 2003, CELL STRUCT FUNCT, V28, P443, DOI 10.1247/csf.28.443; Vihervaara T, 2011, CELL MOL LIFE SCI, V68, P537, DOI 10.1007/s00018-010-0470-z; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; WISNIEWSKI T, 1993, BIOCHEM BIOPH RES CO, V192, P359, DOI 10.1006/bbrc.1993.1423; Xu SZ, 1997, J LIPID RES, V38, P1289; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; Zhang M, 2001, P NATL ACAD SCI USA, V98, P4466, DOI 10.1073/pnas.081070898	87	114	123	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2032	2044		10.1074/jbc.M111.295451	http://dx.doi.org/10.1074/jbc.M111.295451			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22130662	hybrid, Green Published			2022-12-25	WOS:000299321000044
J	Silva, AC; Xu, XM; Kim, HS; Fillingham, J; Kislinger, T; Mennella, TA; Keogh, MC				Silva, Andrea C.; Xu, Xiaomeng; Kim, Hyun-Soo; Fillingham, Jeffrey; Kislinger, Thomas; Mennella, Thomas A.; Keogh, Michael-Christopher			The Replication-independent Histone H3-H4 Chaperones HIR, ASF1, and RTT106 Co-operate to Maintain Promoter Fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION ELONGATION; INTRAGENIC TRANSCRIPTION; SPURIOUS TRANSCRIPTION; CRYPTIC TRANSCRIPTION; CHROMATIN-STRUCTURE; EUKARYOTIC GENOME; YEAST; DEPOSITION	RNA polymerase II initiates from low complexity sequences so cells must reliably distinguish "real" from "cryptic" promoters and maintain fidelity to the former. Further, this must be performed under a range of conditions, including those found within inactive and highly transcribed regions. Here, we used genome-scale screening to identify those factors that regulate the use of a specific cryptic promoter and how this is influenced by the degree of transcription over the element. We show that promoter fidelity is most reliant on histone gene transactivators (Spt10, Spt21) and H3-H4 chaperones (Asf1, HIR complex) from the replication-independent deposition pathway. Mutations of Rtt106 that abrogate its interactions with H3-H4 or dsDNA permit extensive cryptic transcription comparable with replication-independent deposition factor deletions. We propose that nucleosome shielding is the primary means to maintain promoter fidelity, and histone replacement is most efficiently mediated in yeast cells by a HIR/Asf1/H3-H4/Rtt106 pathway.	[Silva, Andrea C.; Xu, Xiaomeng; Kim, Hyun-Soo; Keogh, Michael-Christopher] Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA; [Fillingham, Jeffrey] Ryerson Univ, Dept Biol & Chem, Toronto, ON ONB 2K3, Canada; [Kislinger, Thomas] Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Mennella, Thomas A.] Delaware State Univ, Dept Biol Sci, Dover, DE 19901 USA	Yeshiva University; Toronto Metropolitan University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Delaware State University	Keogh, MC (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Chanin 415A,1300 Morris Pk Ave, Bronx, NY 10461 USA.	michael.keogh@einstein.yu.edu	Silva, Andrea Cristina/K-8837-2014; Silva, Andrea/O-8852-2019; Kislinger, Thomas/A-5934-2008	Silva, Andrea Cristina/0000-0001-5248-5511; Kislinger, Thomas/0000-0003-3525-5540; kim, Hyun Soo/0000-0002-1792-1928	National Institutes of Health [T32 GM007491-34, 1R21 ES019966-01]; National Institutes of Health Cancer Center [2P30 CA013330]; NCI; Ryerson University; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health under National Center for Research Resources [2P20 RR016472-11]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ryerson University; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health under National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the National Institutes of Health Grants T32 GM007491-34 and 1R21 ES019966-01 and National Institutes of Health Cancer Center Support Grant 2P30 CA013330 Grant through the NCI (to the Albert Einstein College of Medicine).; Supported by start-up funding from Ryerson University and a Natural Sciences and Engineering Research Council of Canada discovery grant.; Supported by National Institutes of Health Grant 2P20 RR016472-11 under the IDeA Networks of Biomedical Research Excellence program of the National Center for Research Resources.	Agez M, 2007, STRUCTURE, V15, P191, DOI 10.1016/j.str.2007.01.002; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/j.cub.2003.11.027; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; DOLLARD C, 1994, MOL CELL BIOL, V14, P5223, DOI 10.1128/MCB.14.8.5223; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Eriksson PR, 2005, MOL CELL BIOL, V25, P9127, DOI 10.1128/MCB.25.20.9127-9137.2005; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Fillingham J, 2009, MOL CELL, V35, P340, DOI 10.1016/j.molcel.2009.06.023; Galvani A, 2008, MOL CELL BIOL, V28, P3672, DOI 10.1128/MCB.00510-07; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Huang SB, 2007, EMBO J, V26, P2274, DOI 10.1038/sj.emboj.7601670; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Imbeault D, 2008, J BIOL CHEM, V283, P27350, DOI 10.1074/jbc.C800147200; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; Keogh Michael-Christopher, 2004, Methods Mol Biol, V257, P1, DOI 10.1385/1-59259-750-5:001; Kim HS, 2009, NAT STRUCT MOL BIOL, V16, P1286, DOI 10.1038/nsmb.1688; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lambert JP, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.104; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Libuda DE, 2006, NATURE, V443, P1003, DOI 10.1038/nature05205; Liu YW, 2010, J BIOL CHEM, V285, P4251, DOI 10.1074/jbc.M109.055996; Mehta M, 2010, J BIOL CHEM, V285, P39855, DOI 10.1074/jbc.M110.185967; Mousson F, 2007, CHROMOSOMA, V116, P79, DOI 10.1007/s00412-006-0087-z; Nourani A, 2006, MOL CELL BIOL, V26, P1496, DOI 10.1128/MCB.26.4.1496-1509.2006; Osley M. A., 1987, MOL CELL BIOL, V7, P4202; OSLEY MA, 1986, CELL, V45, P537, DOI 10.1016/0092-8674(86)90285-0; OSLEY MA, 1981, CELL, V24, P377, DOI 10.1016/0092-8674(81)90327-5; Pattenden SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012927; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; Sutton A, 2001, GENETICS, V158, P587; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Thebault P, 2011, MOL CELL BIOL, V31, P1288, DOI 10.1128/MCB.01083-10; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Xie LQ, 2011, EMBO J, V30, P1473, DOI 10.1038/emboj.2011.91	63	45	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1709	1718		10.1074/jbc.M111.316489	http://dx.doi.org/10.1074/jbc.M111.316489			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128187	Green Published, hybrid			2022-12-25	WOS:000299321000014
J	McCann, CK; Growdon, WB; Kulkarni-Datar, K; Curley, MD; Friel, AM; Proctor, JL; Sheikh, H; Deyneko, I; Ferguson, JA; Vathipadiekal, V; Birrer, MJ; Borger, DR; Mohapatra, G; Zukerberg, LR; Foster, R; MacDougall, JR; Rueda, BR				McCann, Christopher K.; Growdon, Whitfield B.; Kulkarni-Datar, Kashmira; Curley, Michael D.; Friel, Anne M.; Proctor, Jennifer L.; Sheikh, Hana; Deyneko, Igor; Ferguson, Jeanne A.; Vathipadiekal, Vinod; Birrer, Michael J.; Borger, Darrell R.; Mohapatra, Gayatry; Zukerberg, Lawrence R.; Foster, Rosemary; MacDougall, John R.; Rueda, Bo R.			Inhibition of Hedgehog Signaling Antagonizes Serous Ovarian Cancer Growth in a Primary Xenograft Model	PLOS ONE			English	Article							PROSTATE-CANCER; STEM-CELL; PATHWAY; MEDULLOBLASTOMA; PROLIFERATION; ACTIVATION; PARADIGMS; THERAPY	Background: Recent evidence links aberrant activation of Hedgehog (Hh) signaling with the pathogenesis of several cancers including medulloblastoma, basal cell, small cell lung, pancreatic, prostate and ovarian. This investigation was designed to determine if inhibition of this pathway could inhibit serous ovarian cancer growth. Methodology: We utilized an in vivo pre-clinical model of serous ovarian cancer to characterize the anti-tumor activity of Hh pathway inhibitors cyclopamine and a clinically applicable derivative, IPI-926. Primary human serous ovarian tumor tissue was used to generate tumor xenografts in mice that were subsequently treated with cyclopamine or IPI-926. Principal Findings: Both compounds demonstrated significant anti-tumor activity as single agents. When IPI-926 was used in combination with paclitaxel and carboplatinum (T/C), no synergistic effect was observed, though sustained treatment with IPI-926 after cessation of T/C continued to suppress tumor growth. Hh pathway activity was analyzed by RT-PCR to assess changes in Gli1 transcript levels. A single dose of IPI-926 inhibited mouse stromal Gli1 transcript levels at 24 hours with unchanged human intra-tumor Gli1 levels. Chronic IPI-926 therapy for 21 days, however, inhibited Hh signaling in both mouse stromal and human tumor cells. Expression data from the micro-dissected stroma in human serous ovarian tumors confirmed the presence of Gli1 transcript and a significant association between elevated Gli1 transcript levels and worsened survival. Conclusions/Significance: IPI-926 treatment inhibits serous tumor growth suggesting the Hh signaling pathway contributes to the pathogenesis of ovarian cancer and may hold promise as a novel therapeutic target, especially in the maintenance setting.	[McCann, Christopher K.; Growdon, Whitfield B.; Kulkarni-Datar, Kashmira; Curley, Michael D.; Friel, Anne M.; Foster, Rosemary; Rueda, Bo R.] Massachusetts Gen Hosp, Dept Vincent Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA; [McCann, Christopher K.; Growdon, Whitfield B.; Rueda, Bo R.] Massachusetts Gen Hosp, Div Gynecol Oncol, Dept Vincent Obstet & Gynecol, Boston, MA 02114 USA; [McCann, Christopher K.; Growdon, Whitfield B.; Kulkarni-Datar, Kashmira; Curley, Michael D.; Friel, Anne M.; Vathipadiekal, Vinod; Birrer, Michael J.; Borger, Darrell R.; Mohapatra, Gayatry; Zukerberg, Lawrence R.; Foster, Rosemary; Rueda, Bo R.] Harvard Univ, Sch Med, Boston, MA USA; [Proctor, Jennifer L.; Sheikh, Hana; Deyneko, Igor; Ferguson, Jeanne A.; MacDougall, John R.] Infin Pharmaceut, Cambridge, MA USA; [Vathipadiekal, Vinod; Birrer, Michael J.; Borger, Darrell R.; Mohapatra, Gayatry] Massachusetts Gen Hosp, Div Hematol Oncol, Ctr Canc, Boston, MA 02114 USA; [Zukerberg, Lawrence R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	McCann, CK (corresponding author), Massachusetts Gen Hosp, Dept Vincent Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA.	brueda@partners.org		/0000-0002-8181-6890; Friel, Anne/0000-0001-9876-5332	Ovarian Cancer Research Fund; Advanced Medical Research Foundation; Vincent Memorial Research Funds	Ovarian Cancer Research Fund; Advanced Medical Research Foundation; Vincent Memorial Research Funds	This research was funded by grants from the Ovarian Cancer Research Fund (BRR), Advanced Medical Research Foundation (BRR), and the Vincent Memorial Research Funds (BRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Bhattacharya R, 2008, CLIN CANCER RES, V14, P7659, DOI 10.1158/1078-0432.CCR-08-1414; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Chen XJ, 2007, CANCER SCI, V98, P68, DOI 10.1111/j.1349-7006.2006.00353.x; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Grichnik JM, 2006, J INVEST DERMATOL, V126, P142, DOI 10.1038/sj.jid.5700017; Growdon WB, 2010, EXPERT REV OBSTET GY, V5, P409; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Lou H, 2007, ONCOGENE, V26, P1357, DOI 10.1038/sj.onc.1210200; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Romer J, 2005, CANCER RES, V65, P4975, DOI 10.1158/0008-5472.CAN-05-0481; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sanchez P, 2005, CANCER RES, V65, P2990, DOI 10.1158/0008-5472.CAN-05-0439; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tremblay MR, 2009, J MED CHEM, V52, P4400, DOI 10.1021/jm900305z; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Watkins DN, 2003, CELL CYCLE, V2, P196, DOI 10.4161/cc.2.3.378; Xie JW, 2008, CURR ONCOL REP, V10, P107, DOI 10.1007/s11912-008-0018-7; Yang L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-112; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	27	52	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28077	10.1371/journal.pone.0028077	http://dx.doi.org/10.1371/journal.pone.0028077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140510	Green Published, gold, Green Submitted			2022-12-25	WOS:000298166300025
J	dos Santos, TAT; Portes, JD; Damasceno-Sa, JC; Caldas, LA; de Souza, W; DaMatta, RA; Seabra, SH				Teixeira dos Santos, Thiago Alves; Portes, Juliana de Araujo; Damasceno-Sa, Joao Claudio; Caldas, Lucio Ayres; de Souza, Wanderley; DaMatta, Renato Augusto; Seabra, Sergio Henrique			Phosphatidylserine Exposure by Toxoplasma gondii Is Fundamental to Balance the Immune Response Granting Survival of the Parasite and of the Host	PLOS ONE			English	Article							ACTIVATED MURINE MACROPHAGES; NITRIC-OXIDE SYNTHASE; APOPTOTIC CELLS; MIMICRY; MECHANISM; DYNAMIN; INHIBITION; INFECTION; INVASION; EVASION	Phosphatidylserine (PS) exposure on the cell surface indicates apoptosis, but has also been related to evasion mechanisms of parasites, a concept known as apoptotic mimicry. Toxoplasma gondii mimics apoptotic cells by exposing PS, inducing secretion of TGF-beta1 by infected activated macrophages leading to degradation of inducible nitric oxide (NO) synthase, NO production inhibition and consequently persisting in these cells. Here PS+ and PS- subpopulation of tachyzoites were separated and the entrance mechanism, growth and NO inhibition in murine macrophages, and mice survival and pathology were analyzed. Infection index in resident macrophages was similar for both PS subpopulations but lower when compared to the total T. gondii population. Growth in resident macrophages was higher for the total T. gondii population, intermediate for the PS+ and lower for the PS- subpopulation. Production of NO by activated macrophages was inhibited after infection with the PS+ subpopulation and the total populations of tachyzoites. However, the PS- subpopulation was not able to inhibit NO production. PS+ subpopulation invaded macrophages by active penetration as indicated by tightfitting vacuoles, but the PS- subpopulation entered macrophages by phagocytosis as suggested by loose-fitting vacuoles containing these tachyzoites. The entrance mechanism of both subpopulations was confirmed in a non-professional phagocytic cell line where only the PS+ tachyzoites were found inside these cells in tight-fitting vacuoles. Both subpopulations of T. gondii killed mice faster than the total population. Clear signs of inflammation and no tachyzoites were seen in the peritoneal cavity of mice infected with the PS- subpopulation. Moreover, mice infected with the PS+ subpopulation had no sign of inflammation and the parasite burden was intense. These results show that PS+ and PS- subpopulations of T. gondii are necessary for a successful toxoplasma infection indicating that both subpopulations are required to maintain the balance between inflammation and parasite growth.	[Teixeira dos Santos, Thiago Alves; Portes, Juliana de Araujo; Seabra, Sergio Henrique] Ctr Univ Estadual Zona Oeste UEZO, Lab Tecnol Bioquim & Microscopia LTBM, Colegiado Ciencias Biol & Saude, Rio De Janeiro, Brazil; [Teixeira dos Santos, Thiago Alves; Damasceno-Sa, Joao Claudio; DaMatta, Renato Augusto] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Lab Biol Celular & Tecidual, Ctr Biociencias & Biotecnol, Campos Dos Goytacazes, Brazil; [Portes, Juliana de Araujo; Caldas, Lucio Ayres; de Souza, Wanderley] Univ Fed Rio de Janeiro UFRJ, Lab Ultraestrutura Celular Hertha Meyer, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil	Centro Universitario Estadual da Zona Oeste; Universidade Estadual do Norte Fluminense; Universidade Federal do Rio de Janeiro	dos Santos, TAT (corresponding author), Ctr Univ Estadual Zona Oeste UEZO, Lab Tecnol Bioquim & Microscopia LTBM, Colegiado Ciencias Biol & Saude, Rio De Janeiro, Brazil.	seabra@pq.cnpq.br	DaMatta, Renato/G-8367-2015	DaMatta, Renato/0000-0002-0108-9268; Portes, Juliana de Araujo/0000-0001-5701-0793; Caldas, Lucio Ayres/0000-0002-1187-557X	FAPERJ (Research Support Foundation of Rio de Janeiro); CNPQ (National Research Council of Brazil)	FAPERJ (Research Support Foundation of Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPQ (National Research Council of Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by FAPERJ (Research Support Foundation of Rio de Janeiro) and CNPQ (National Research Council of Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LB, 1990, J IMMUNOL, V144, P2725; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; Barcinski Marcello A, 2003, Kinetoplastid Biol Dis, V2, P6, DOI 10.1186/1475-9292-2-6; Caldas LA, 2009, FEMS MICROBIOL LETT, V301, P103, DOI 10.1111/j.1574-6968.2009.01799.x; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; DaMatta RA, 2007, FEMS MICROBIOL LETT, V266, P29, DOI 10.1111/j.1574-6968.2006.00495.x; de Souza W, 2008, MICRON, V39, P77, DOI 10.1016/j.micron.2006.11.003; de Souza W, 2009, MEM I OSWALDO CRUZ, V104, P149, DOI 10.1590/S0074-02762009000200004; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Guillermo LVC, 2004, POULTRY SCI, V83, P776, DOI 10.1093/ps/83.5.776; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; JONES TC, 1972, J EXP MED, V136, P1157, DOI 10.1084/jem.136.5.1157; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kozmar A, 2010, J INNATE IMMUN, V2, P248, DOI 10.1159/000295790; Luder CGK, 2003, INT J PARASITOL, V33, P833, DOI 10.1016/S0020-7519(03)00092-4; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; MORISAKI JH, 1995, J CELL SCI, V108, P2457; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rozenfeld C, 2005, AM J PATHOL, V167, P1021, DOI 10.1016/S0002-9440(10)61191-1; Seabra SH, 2004, BIOCHEM BIOPH RES CO, V324, P744, DOI 10.1016/j.bbrc.2004.09.114; Seabra SJ, 2002, EXP PARASITOL, V100, P62, DOI 10.1006/expr.2001.4675; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Wanderley JLM, 2006, J IMMUNOL, V176, P1834, DOI 10.4049/jimmunol.176.3.1834; Wanderley JLM, 2010, CELL MOL LIFE SCI, V67, P1653, DOI 10.1007/s00018-010-0291-0	29	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27867	10.1371/journal.pone.0027867	http://dx.doi.org/10.1371/journal.pone.0027867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140476	Green Submitted, gold, Green Published			2022-12-25	WOS:000298166300015
J	Bernstein, J; Long, JS; Veillette, C; Ahn, J				Bernstein, Joseph; Long, Joy S.; Veillette, Christian; Ahn, Jaimo			Crowd Intelligence for the Classification of Fractures and Beyond	PLOS ONE			English	Article							FEMORAL-NECK FRACTURES	Background: Medical diagnosis, like all products of human cognition, is subject to error. We tested the hypothesis that errors of diagnosis in the realm of fracture classification can be reduced by a consensus (group) diagnosis; and that digital imaging and Internet access makes feasible the compilation of a diagnostic consensus in real time. Methods: Twelve orthopaedic surgeons were asked to evaluate 20 hip radiographs demonstrating a femoral neck fracture. The surgeons were asked to determine if the fractures were displaced or not. Because no reference standard is available, the maximal accuracy of the diagnosis of displacement can be inferred from inter-observer reliability: if two readers disagree about displacement, one of them must be wrong. That method was employed here. Additionally, virtual reader groups of 3 and 5 individual members were amalgamated, with the response of those groups defined by majority vote. The purpose of this step was to see if increasing the number of readers would improve accuracy. In a second experiment, to study the feasibility of amassing a reader group on the Internet in real time, 40 volunteers were sent 10 periodic email requests to answer questions and their response times were assessed. Results: The mean kappa coefficient for individual inter-observer reliability for the diagnosis of displacement was 0.69, comparable to prior published values. For 3-member virtual reader groups, inter-observer reliability was 0.77; and for 5-member groups, it was 0.80. In the experiment studying the feasibility of amassing a reader group in real time, the mean response time was 594 minutes. For all cases, a 9-member group (theoretically 99% accurate) was amassed in 135.8 minutes or less. Conclusions: Consensus may improve diagnosis. Amassing a group for this purpose on the Internet is feasible.	[Bernstein, Joseph] Vet Hosp, Dept Orthoped Surg, Philadelphia, PA USA; [Bernstein, Joseph; Long, Joy S.; Ahn, Jaimo] Univ Penn, Sch Med, Dept Orthoped Surg, Philadelphia, PA 19104 USA; [Veillette, Christian] Univ Toronto, Dept Orthoped Surg, Toronto, ON, Canada	University of Pennsylvania; University of Toronto	Bernstein, J (corresponding author), Vet Hosp, Dept Orthoped Surg, Philadelphia, PA USA.	orthodoc@uphs.upenn.edu	Veillette, Christian/AAF-5089-2021		Orthopaedic Trauma Association; Orthopaedic Research and Education Foundation	Orthopaedic Trauma Association; Orthopaedic Research and Education Foundation	This study was funded, in part, by research grants from the Orthopaedic Trauma Association (to JA, JB, CV) and the Orthopaedic Research and Education Foundation (to JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURSTEIN AH, 1993, J BONE JOINT SURG AM, V75A, P1743, DOI 10.2106/00004623-199312000-00001; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Garbuz Donald S, 2002, J Am Acad Orthop Surg, V10, P290; GARDEN RS, 1961, J BONE JOINT SURG BR, V43, P647, DOI 10.1302/0301-620X.43B4.647; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mackay Charles, 1995, EXTRAORDINARY POPULA; Oakes DA, 2003, CLIN ORTHOP RELAT R, P232, DOI 10.1097/01.blo.0000059583.08469.e5; Schmidt Andrew H, 2005, Instr Course Lect, V54, P417; Surowiecki J., 2004, WISDOM CROWDS WHY MA, VXXI, P295; Thomsen NOB, 1996, INT ORTHOP, V20, P326, DOI 10.1007/s002640050087; Totterman A, 2007, ARCH ORTHOP TRAUM SU, V127, P185, DOI 10.1007/s00402-006-0276-5; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; Zlowodzki M, 2005, ARCH ORTHOP TRAUM SU, V125, P503, DOI 10.1007/s00402-005-0022-4	13	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27620	10.1371/journal.pone.0027620	http://dx.doi.org/10.1371/journal.pone.0027620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132118	Green Submitted, gold, Green Published			2022-12-25	WOS:000298162000030
J	Kalinina, O; Zeller, SL; Schmid, B				Kalinina, Olena; Zeller, Simon L.; Schmid, Bernhard			Competitive Performance of Transgenic Wheat Resistant to Powdery Mildew	PLOS ONE			English	Article							GENETICALLY-ENGINEERED ORGANISMS; BARLEY SEED PROTEINS; DISEASE-RESISTANCE; PATHOGEN DEFENSE; ECOLOGICAL COSTS; RISK-ASSESSMENT; FITNESS COSTS; PLANTS; DIVERSITY; ABILITY	Genetically modified (GM) plants offer an ideal model system to study the influence of single genes that confer constitutive resistance to pathogens on the ecological behaviour of plants. We used phytometers to study competitive interactions between GM lines of spring wheat Triticum aestivum carrying such genes and control lines. We hypothesized that competitive performance of GM lines would be reduced due to enhanced transgene expression under pathogen levels typically encountered in the field. The transgenes pm3b from wheat (resistance against powdery mildew Blumeria graminis) or chitinase and glucanase genes from barley (resistance against fungi in general) were introduced with the ubiquitin promoter from maize (pm3b and chitinase genes) or the actin promoter from rice (glucanase gene). Phytometers of 15 transgenic and non-transgenic wheat lines were transplanted as seedlings into plots sown with the same 15 lines as competitive environments and subject to two soil nutrient levels. Pm3b lines had reduced mildew incidence compared with control lines. Chitinase and chitinase/glucanase lines showed the same high resistance to mildew as their control in low-nutrient treatment and slightly lower mildew rates than the control in high-nutrient environment. Pm3b lines were weaker competitors than control lines. This resulted in reduced yield and seed number. The Pm3b line with the highest transgene expression had 53.2% lower yield than the control whereas the Pm3b line which segregated in resistance and had higher mildew rates showed only minor costs under competition. The line expressing both chitinase and glucanase genes also showed reduced yield and seed number under competition compared with its control. Our results suggest that single transgenes conferring constitutive resistance to pathogens can have ecological costs and can weaken plant competitiveness even in the presence of the pathogen. The magnitude of these costs appears related to the degree of expression of the transgenes.	[Kalinina, Olena; Zeller, Simon L.; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland	University of Zurich	Kalinina, O (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	olena.kalinina@ieu.uzh.ch	Kalinina, Olena/H-6275-2011; Kalinina, Olena/J-5986-2019; Schmid, Bernhard/C-8625-2009	Schmid, Bernhard/0000-0002-8430-3214	Swiss National Science Foundation; wheat-cluster.ch [SNF 405940-115607]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); wheat-cluster.ch	This project was supported by the Swiss National Science Foundation and is a part of the wheat-cluster.ch, a sub-unit of the national research programme NRP 59 (SNF 405940-115607). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, ECOLOGY, V81, P1804, DOI 10.1890/0012-9658(2000)081[1804:BACOIP]2.0.CO;2; ALLARD RW, 1969, AM NAT, V103, P621, DOI 10.1086/282630; Alvarez-Alfageme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022690; Ammann K, 2000, Z PFLANZENK PFLANZEN, P19; Andersson HC, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2150; BAINBRIDGE A, 1974, PLANT PATHOL, V23, P160, DOI 10.1111/j.1365-3059.1974.tb01842.x; Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; Baldwin IT, 2000, J CHEM ECOL, V26, P915, DOI 10.1023/A:1005408208826; BALDWIN IT, 1988, J CHEM ECOL, V14, P1113, DOI 10.1007/BF01019339; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bartsch D, 1996, MOL ECOL, V5, P199, DOI 10.1111/j.1365-294X.1996.tb00307.x; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; Bieri S, 2003, MOL BREEDING, V11, P37, DOI 10.1023/A:1022145915983; Brown JKM, 2002, CURR OPIN PLANT BIOL, V5, P339, DOI 10.1016/S1369-5266(02)00270-4; Brunner S, 2011, PLANT BIOTECHNOL J, V9, P897, DOI 10.1111/j.1467-7652.2011.00603.x; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; Chen LY, 2006, AM J BOT, V93, P94, DOI 10.3732/ajb.93.1.94; Chen YX, 2007, PLANT SOIL, V291, P1, DOI 10.1007/s11104-006-9161-9; Clements F.E., 1924, PHYTOMETER METHOD EC; CRAWLEY MJ, 1993, NATURE, V363, P620, DOI 10.1038/363620a0; Crawley MJ, 1992, P 2 INT S BIOS RES F, P43; Dale PJ, 2002, NAT BIOTECHNOL, V20, P567, DOI 10.1038/nbt0602-567; Filipecki M, 2006, J APPL GENET, V47, P277, DOI 10.1007/BF03194637; Fredshavn JR, 1996, FIELD CROP RES, V45, P11, DOI 10.1016/0378-4290(95)00054-2; Fuchs Marc, 2004, Environmental Biosafety Research, V3, P17, DOI 10.1051/ebr:2004004; Gurr SJ, 2005, TRENDS BIOTECHNOL, V23, P275, DOI 10.1016/j.tibtech.2005.04.007; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Heil M, 2000, J ECOL, V88, P645, DOI 10.1046/j.1365-2745.2000.00479.x; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Heil M, 2002, CURR OPIN PLANT BIOL, V5, P345, DOI 10.1016/S1369-5266(02)00267-4; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; LAST FT, 1953, ANN APPL BIOL, V40, P312, DOI 10.1111/j.1744-7348.1953.tb01085.x; Laughlin KD, 2009, ECOL APPL, V19, P1091, DOI 10.1890/08-0105.1; LEAH R, 1991, J BIOL CHEM, V266, P1564; LUBY JJ, 1995, THEOR APPL GENET, V90, P1133, DOI 10.1007/BF00222933; McCullagh P, 1989, GEN LINEAR MODELS; MCGILCHRIST CA, 1965, BIOMETRICS, V21, P975, DOI 10.2307/2528258; MCGRAW JB, 1985, NEW PHYTOL, V100, P233, DOI 10.1111/j.1469-8137.1985.tb02775.x; Melchers LS, 2000, CURR OPIN PLANT BIOL, V3, P147, DOI 10.1016/S1369-5266(99)00055-2; Mwangi PN, 2007, J ECOL, V95, P65, DOI 10.1111/j.1365-2745.2006.01189.x; Pellegrineschi A, 2002, GENOME, V45, P421, DOI 10.1139/G01-154; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Rooke L, 2000, ANN APPL BIOL, V136, P167, DOI 10.1111/j.1744-7348.2000.tb00022.x; SCHMID B, 1994, J ECOL, V82, P165, DOI 10.2307/2261395; SHANER G, 1977, PHYTOPATHOLOGY, V67, P1051, DOI 10.1094/Phyto-67-1051; Smithson JB, 1996, ANN APPL BIOL, V128, P127, DOI 10.1111/j.1744-7348.1996.tb07096.x; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; Somssich IE, 1998, TRENDS PLANT SCI, V3, P86, DOI 10.1016/S1360-1385(98)01199-6; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; TIEDJE JM, 1989, ECOLOGY, V70, P298, DOI 10.2307/1937535; Tollrian Ralph, 1999, P306; Van Dam NM, 2001, FUNCT ECOL, V15, P406, DOI 10.1046/j.1365-2435.2001.00533.x; van Kleunen M, 2003, ECOLOGY, V84, P2816, DOI 10.1890/02-0494; Violle C, 2009, OECOLOGIA, V160, P747, DOI 10.1007/s00442-009-1333-x; von Burg S, 2011, BIOL LETTERS, V7, P387, DOI 10.1098/rsbl.2010.1147; von Burg S, 2010, BASIC APPL ECOL, V11, P257, DOI 10.1016/j.baae.2010.02.003; WILLIAMSON M, 1990, TRENDS ECOL EVOL, V5, P417, DOI 10.1016/0169-5347(90)90028-C; WILLIAMSON M, 1994, MOL ECOL, V3, P75, DOI 10.1111/j.1365-294X.1994.tb00048.x; WILSON SD, 1993, ECOLOGY, V74, P599, DOI 10.2307/1939319; WOLFE MS, 1985, ANNU REV PHYTOPATHOL, V23, P251, DOI 10.1146/annurev.py.23.090185.001343; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zeller SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011405; ZHU Q, 1994, BIO-TECHNOL, V12, P807, DOI 10.1038/nbt0894-807; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	67	13	13	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28091	10.1371/journal.pone.0028091	http://dx.doi.org/10.1371/journal.pone.0028091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132219	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000298162000070
J	Yin, N; Zhang, N; Lal, G; Xu, JN; Yan, MH; Ding, YZ; Bromberg, JS				Yin, Na; Zhang, Nan; Lal, Girdhari; Xu, Jiangnan; Yan, Minhong; Ding, Yaozhong; Bromberg, Jonathan S.			Lymphangiogenesis Is Required for Pancreatic Islet Inflammation and Diabetes	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LYMPHATIC VESSELS; DENDRITIC CELLS; VEGF-C; TYROSINE KINASES; MYELOID CELLS; BONE-MARROW; NOD MICE; RECEPTOR; MACROPHAGES	Lymphangiogenesis is a common phenomenon observed during inflammation and engraftment of transplants, but its precise role in the immune response and underlying mechanisms of regulation remain poorly defined. Here we showed that in response to injury and autoimmunity, lymphangiogenesis occurred around islets and played a key role in the islet inflammation in mice. Vascular endothelial growth factors receptor 3 (VEGFR3) is specifically involved in lymphangiogenesis, and blockade of VEGFR3 potently inhibited lymphangiogenesis in both islets and the draining LN during multiple low-dose streptozotocin (MLDS) induced autoimmune insulitis, which resulted in less T cell infiltration, preservation of islets and prevention of the onset of diabetes. In addition to their well-known conduit function, lymphatic endothelial cells (LEC) also produced chemokines in response to inflammation. These LEC attracted two distinct CX3CR1(hi) and LYVE-1(+) macrophage subsets to the inflamed islets and CX3CR1(hi) cells were influenced by LEC to differentiate into LYVE-1(+) cells closely associated with lymphatic vessels. These observations indicate a linkage among lymphangiogenesis and myeloid cell inflammation during insulitis. Thus, inhibition of lymphangiogenesis holds potential for treating insulitis and autoimmune diabetes.	[Yin, Na; Lal, Girdhari; Xu, Jiangnan; Ding, Yaozhong; Bromberg, Jonathan S.] Univ Maryland, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Lal, Girdhari; Xu, Jiangnan; Ding, Yaozhong; Bromberg, Jonathan S.] Univ Maryland, Dept Surg & Microbiol, Baltimore, MD 21201 USA; [Lal, Girdhari; Xu, Jiangnan; Ding, Yaozhong; Bromberg, Jonathan S.] Univ Maryland, Dept Immunol, Baltimore, MD 21201 USA; [Zhang, Nan] Marshall Univ, Dept Surg, Huntington, WV USA; [Yan, Minhong] Genentech Inc, Div Res, Dept Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Marshall University; Roche Holding; Genentech	Yin, N (corresponding author), Univ Maryland, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.	NYin@som.umaryland.edu; JBromberg@smail.umaryland.edu	Lal, Girdhari/C-1752-2012; Lal, Girdhari/AAU-8179-2021	Lal, Girdhari/0000-0002-3799-3603; Lal, Girdhari/0000-0002-3799-3603	Emerald Foundation; Juvenile Diabetes Research Foundation (JDRF) [S-2007-236, 1-2008-90]; National Institutes of Health (NIH) [AI72039, AI41428]; American Society of Transplant Surgeons-Genentech Laboratories; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI072039, R01AI072039, R21AI041428, R01AI041428] Funding Source: NIH RePORTER	Emerald Foundation; Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Transplant Surgeons-Genentech Laboratories; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Emerald Foundation, Juvenile Diabetes Research Foundation (JDRF) S-2007-236 and 1-2008-90, National Institutes of Health (NIH) AI72039 and AI41428 (all to JSB); and the American Society of Transplant Surgeons-Genentech Laboratories Scientist Scholarship (to NY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Dietrich T, 2010, J IMMUNOL, V184, P535, DOI 10.4049/jimmunol.0903180; Ebos JML, 2007, P NATL ACAD SCI USA, V104, P17069, DOI 10.1073/pnas.0708148104; Edirisinghe I, 2008, FASEB J, V22, P2297, DOI 10.1096/fj.07-099481; El-Chemaly S, 2008, ANN NY ACAD SCI, V1131, P195, DOI 10.1196/annals.1413.017; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Fu FM, 2002, TRANSPLANTATION, V73, P1425, DOI 10.1097/00007890-200205150-00011; Guo RL, 2009, ARTHRITIS RHEUM-US, V60, P2666, DOI 10.1002/art.24764; Hamrah P, 2004, EXP EYE RES, V79, P553, DOI 10.1016/j.exer.2004.06.028; Hamrah P, 2003, AM J PATHOL, V163, P57, DOI 10.1016/S0002-9440(10)63630-9; Hipp MM, 2008, BLOOD, V111, P5610, DOI 10.1182/blood-2007-02-075945; Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Joukov V, 1996, EMBO J, V15, P290; Jun HS, 1999, DIABETES, V48, P34, DOI 10.2337/diabetes.48.1.34; Kallskog O, 2006, AM J TRANSPLANT, V6, P680, DOI 10.1111/j.1600-6143.2006.01234.x; Kang S, 2009, BLOOD, V113, P2605, DOI 10.1182/blood-2008-07-166934; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Leclers D, 2006, ANTICANCER RES, V26, P1885; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Liao S, 2006, J IMMUNOL, V177, P3369, DOI 10.4049/jimmunol.177.5.3369; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Maki T, 2005, TRANSPLANTATION, V79, P1051, DOI 10.1097/01.TP.0000161220.87548.EE; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Martin AP, 2008, DIABETES, V57, P3025, DOI 10.2337/db08-0625; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Mounzer RH, 2010, BLOOD, V116, P2173, DOI 10.1182/blood-2009-12-256065; Niessen K, 2010, BLOOD, V115, P1654, DOI 10.1182/blood-2009-07-235655; Nykanen AI, 2010, CIRCULATION, V121, P1413, DOI 10.1161/CIRCULATIONAHA.109.910703; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Oliver G, 2005, ANNU REV CELL DEV BI, V21, P457, DOI 10.1146/annurev.cellbio.21.012704.132338; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PAIK SG, 1980, P NATL ACAD SCI-BIOL, V77, P6129, DOI 10.1073/pnas.77.10.6129; Pepper MS, 2003, J CELL BIOL, V163, P209, DOI 10.1083/jcb.200308082; Pytowski B, 2005, JNCI-J NATL CANCER I, V97, P14, DOI 10.1093/jnci/dji003; Qu P, 2003, J ANAT, V203, P523, DOI 10.1046/j.1469-7580.2003.00234.x; Regoli M, 2001, ANAT REC, V263, P155, DOI 10.1002/ar.1090; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; Sundar SS, 2007, J CLIN ONCOL, V25, P4298, DOI 10.1200/JCO.2006.07.1092; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Wirzenius M, 2007, J EXP MED, V204, P1431, DOI 10.1084/jem.20062642; Yin N, 2011, TRANSPLANTATION, V92, P25, DOI 10.1097/TP.0b013e31821d2661; Yoon CM, 2008, BLOOD, V112, P1129, DOI 10.1182/blood-2007-11-125203; Zumsteg A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007067	58	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28023	10.1371/journal.pone.0028023	http://dx.doi.org/10.1371/journal.pone.0028023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132197	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000060
J	Zakostelska, Z; Kverka, M; Klimesova, K; Rossmann, P; Mrazek, J; Kopecny, J; Hornova, M; Srutkova, D; Hudcovic, T; Ridl, J; Tlaskalova-Hogenova, H				Zakostelska, Zuzana; Kverka, Miloslav; Klimesova, Klara; Rossmann, Pavel; Mrazek, Jakub; Kopecny, Jan; Hornova, Michaela; Srutkova, Dagmar; Hudcovic, Tomas; Ridl, Jakub; Tlaskalova-Hogenova, Helena			Lysate of Probiotic Lactobacillus casei DN-114 001 Ameliorates Colitis by Strengthening the Gut Barrier Function and Changing the Gut Microenvironment	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LACTIC-ACID BACTERIA; DEXTRAN SULFATE; CROHNS-DISEASE; ULCERATIVE-COLITIS; INTESTINAL INFLAMMATION; COMMENSAL BACTERIA; DOUBLE-BLIND; GERM-FREE; MICROBIOTA	Background: Probiotic bacteria can be used for the prevention and treatment of human inflammatory diseases including inflammatory bowel diseases (IBD). However, the nature of active components and exact mechanisms of this beneficial effects have not been fully elucidated. Our aim was to investigate if lysate of probiotic bacterium L. casei DN-114 001 (Lc) could decrease the severity of intestinal inflammation in a murine model of IBD. Methodology/Principal Findings: The preventive effect of oral administration of Lc significantly reduces the severity of acute dextran sulfate sodium (DSS) colitis in BALB/c but not in SCID mice. In order to analyze how this beneficial effect interferes with well-known phases of intestinal inflammation pathogenesis in vivo and in vitro, we evaluated intestinal permeability using the FITC-labeled dextran method and analysed tight junction proteins expression by immunofluorescence and PCR. We also measured CD4(+)FoxP3(+) regulatory T cells proportion by FACS analysis, microbiota composition by pyrosequencing, and local cytokine production by ELISA. Lc leads to a significant protection against increased intestinal permeability and barrier dysfunction shown by preserved ZO-1 expression. We found that the Lc treatment increases the numbers of CD4(+)FoxP3(+) regulatory T cells in mesenteric lymph nodes (MLN), decreases production of pro-inflammatory cytokines TNF-alpha and IFN-gamma, and anti-inflammatory IL-10 in Peyer's patches and large intestine, and changes the gut microbiota composition. Moreover, Lc treatment prevents lipopolysaccharide-induced TNF-alpha expression in RAW 264.7 cell line by down-regulating the NF-kappa B signaling pathway. Conclusion/Significance: Our study provided evidence that even non-living probiotic bacteria can prevent the development of severe forms of intestinal inflammation by strengthening the integrity of intestinal barrier and modulation of gut microenvironment.	[Zakostelska, Zuzana; Kverka, Miloslav; Klimesova, Klara; Rossmann, Pavel; Hornova, Michaela; Tlaskalova-Hogenova, Helena] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic; [Srutkova, Dagmar; Hudcovic, Tomas] Acad Sci Czech Republ, Inst Microbiol, Novy Hradek, Czech Republic; [Mrazek, Jakub; Kopecny, Jan] Acad Sci Czech Republ, Inst Anim Physiol & Genet, Prague, Czech Republic; [Ridl, Jakub] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Zakostelska, Z (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic.	kverka@biomed.cas.cz	Mrazek, Jakub/B-7764-2017; Hudcovic, Tomas/H-7917-2014; Zákostelská, Zuzana/ABB-9807-2021; Šrůtková, Dagmar/H-8511-2014; Kopecny, Jan/C-3899-2011; Hornova, Michaela/J-8064-2014; Tlaskalová-Hogenová, Helena/J-8008-2014; Mrazek, Jakub/AAS-9861-2020; Zakostelska, Zuzana/D-6518-2012; Kverka, Miloslav/H-2507-2014; Mrazek, Jakub/G-7198-2014; Kostovcikova, Klara/J-6851-2014	Mrazek, Jakub/0000-0003-1907-3333; Hudcovic, Tomas/0000-0002-4761-5040; Šrůtková, Dagmar/0000-0003-0054-5396; Kopecny, Jan/0000-0002-2428-2511; Mrazek, Jakub/0000-0003-1907-3333; Kverka, Miloslav/0000-0002-1335-5252; Mrazek, Jakub/0000-0003-1907-3333; Kostovcikova, Klara/0000-0003-1821-398X; Zakostelska, Zuzana/0000-0002-6695-8188	Danone Institute of Czech Republic [2005-2006, 2010-2011]; Czech Science Foundation [P304/11/1252, 310/08/H077, 305/08/0535, 303/08/0367]; Academy of Sciences of Czech Republic [KJB500200904]; Ministry of Education, Youth and Sports of the Czech Republic [2B06155]; Grant Agency of the Ministry of Health of the Czech Republic [IGA MZ NS10340]; Institutional Research Concept Grant [AV0Z50200510]	Danone Institute of Czech Republic(Danone Nutricia); Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of Czech Republic(Czech Academy of Sciences); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Ministry of Health of the Czech Republic; Institutional Research Concept Grant	This work was supported by grants from Danone Institute of Czech Republic (2005-2006 and 2010-2011), the Czech Science Foundation (P304/11/1252, 310/08/H077, 305/08/0535 and 303/08/0367), http://www.gacr.cz/; the Academy of Sciences of Czech Republic (KJB500200904), http://www.gaav.cz/; the Ministry of Education, Youth and Sports of the Czech Republic (2B06155), http://www.msmt.cz; the Grant Agency of the Ministry of Health of the Czech Republic (IGA MZ NS10340), http://www.mzcr.cz/; and by Institutional Research Concept Grant AV0Z50200510, http://www.isvav.cz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Biswas A, 2011, EUR J IMMUNOL, V41, P182, DOI 10.1002/eji.201040479; Boyer M, 2009, FEMS MICROBIOL ECOL, V70, P1, DOI 10.1111/j.1574-6941.2009.00745.x; CHEN HQ, 2010, AM J PHYSL GASTROINT; Chuang L, 2007, J AGR FOOD CHEM, V55, P11080, DOI 10.1021/jf071786o; Delcenserie V, 2008, CURR ISSUES MOL BIOL, V10, P37; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; Fava F, 2011, WORLD J GASTROENTERO, V17, P557, DOI 10.3748/wjg.v17.i5.557; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Gupta P, 2000, J PEDIATR GASTR NUTR, V31, P453, DOI 10.1097/00005176-200010000-00024; Hanniffy S, 2004, ADV APPL MICROBIOL, V56, P1, DOI 10.1016/S0065-2164(04)56001-X; Hotel ACP., 2001, PREVENTION, V5, P1; Hudcovic T, 2001, FOLIA MICROBIOL, V46, P565, DOI 10.1007/BF02818004; Ingrassia I, 2005, APPL ENVIRON MICROB, V71, P2880, DOI 10.1128/AEM.71.6.2880-2887.2005; Jamuna M, 2004, J GEN APPL MICROBIOL, V50, P79, DOI 10.2323/jgam.50.79; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Kleerebezem M, 2009, ANNU REV MICROBIOL, V63, P269, DOI 10.1146/annurev.micro.091208.073341; Kokesova A, 2006, FOLIA MICROBIOL, V51, P478, DOI 10.1007/BF02931595; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lee JM, 2008, J MICROBIOL BIOTECHN, V18, P1683; Liu ZH, 2011, MOL BIOL REP, V38, P1353, DOI 10.1007/s11033-010-0237-5; Llopis M, 2009, INFLAMM BOWEL DIS, V15, P275, DOI 10.1002/ibd.20736; MacDonald TT, 2000, SCAND J IMMUNOL, V51, P2; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; Matsumoto S, 2005, CLIN EXP IMMUNOL, V140, P417, DOI 10.1111/j.1365-2249.2005.02790.x; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Merenstein D, 2010, EUR J CLIN NUTR, V64, P669, DOI 10.1038/ejcn.2010.65; Mileti E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007056; Mondel M, 2009, MUCOSAL IMMUNOL, V2, P166, DOI 10.1038/mi.2008.77; Mowat Allan McI, 2003, Novartis Found Symp, V252, P291; MUNKHOLM P, 1994, GUT, V35, P68, DOI 10.1136/gut.35.1.68; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Reiff C, 2009, INFLAMM BOWEL DIS, V15, P1721, DOI 10.1002/ibd.20999; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Sheil B, 2007, J NUTR, V137, p819S, DOI 10.1093/jn/137.3.819S; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Sokol H, 2006, INFLAMM BOWEL DIS, V12, P106, DOI 10.1097/01.MIB.0000200323.38139.c6; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Wang Q, 2001, AM J PHYSIOL-REG I, V281, pR1013, DOI 10.1152/ajpregu.2001.281.3.R1013; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Zanvit P, 2010, IMMUNOL LETT, V134, P26, DOI 10.1016/j.imlet.2010.08.006; Zhao Ying, 2003, Methods Mol Biol, V224, P183	56	136	138	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27961	10.1371/journal.pone.0027961	http://dx.doi.org/10.1371/journal.pone.0027961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132181	Green Submitted, gold, Green Published			2022-12-25	WOS:000297792400027
J	Darabos, C; Di Cunto, F; Tomassini, M; Moore, JH; Provero, P; Giacobini, M				Darabos, Christian; Di Cunto, Ferdinando; Tomassini, Marco; Moore, Jason H.; Provero, Paolo; Giacobini, Mario			Additive Functions in Boolean Models of Gene Regulatory Network Modules	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTIONAL NETWORK; EXPRESSION; DYNAMICS	Gene-on-gene regulations are key components of every living organism. Dynamical abstract models of genetic regulatory networks help explain the genome's evolvability and robustness. These properties can be attributed to the structural topology of the graph formed by genes, as vertices, and regulatory interactions, as edges. Moreover, the actual gene interaction of each gene is believed to play a key role in the stability of the structure. With advances in biology, some effort was deployed to develop update functions in Boolean models that include recent knowledge. We combine real-life gene interaction networks with novel update functions in a Boolean model. We use two sub-networks of biological organisms, the yeast cell-cycle and the mouse embryonic stem cell, as topological support for our system. On these structures, we substitute the original random update functions by a novel threshold-based dynamic function in which the promoting and repressing effect of each interaction is considered. We use a third real-life regulatory network, along with its inferred Boolean update functions to validate the proposed update function. Results of this validation hint to increased biological plausibility of the threshold-based function. To investigate the dynamical behavior of this new model, we visualized the phase transition between order and chaos into the critical regime using Derrida plots. We complement the qualitative nature of Derrida plots with an alternative measure, the criticality distance, that also allows to discriminate between regimes in a quantitative way. Simulation on both real-life genetic regulatory networks show that there exists a set of parameters that allows the systems to operate in the critical region. This new model includes experimentally derived biological information and recent discoveries, which makes it potentially useful to guide experimental research. The update function confers additional realism to the model, while reducing the complexity and solution space, thus making it easier to investigate.	[Darabos, Christian; Moore, Jason H.] Dartmouth Med Sch, Computat Genet Lab, Lebanon, NH USA; [Di Cunto, Ferdinando; Provero, Paolo; Giacobini, Mario] Univ Turin, Computat Biol Unit, Ctr Mol Biotechnol, Dept Genet Biol & Biochem, Turin, Italy; [Tomassini, Marco] Univ Lausanne, Dept Informat Syst, Fac Business & Econ, Lausanne, Switzerland; [Giacobini, Mario] Univ Turin, Dept Anim Prod Epidemiol & Ecol, Fac Vet Med, Turin, Italy	Dartmouth College; University of Turin; University of Lausanne; University of Turin	Darabos, C (corresponding author), Dartmouth Med Sch, Computat Genet Lab, Lebanon, NH USA.	christian.darabos@dartmouth.edu	Di Cunto, Ferdinando/K-5575-2016; Tomassini, Marco/D-6312-2013; Provero, Paolo/AAC-1930-2019; Moore, Jason H./AAV-9645-2021	Moore, Jason H./0000-0002-5015-1099; di cunto, ferdinando/0000-0001-9367-6357; Giacobini, Mario/0000-0002-7647-5649	Swiss National Science Foundation [PBLAP2-129416/1]; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica; Italian Association for Cancer Research (AIRC); Compagnia di San Paolo; NIH [AI59694, LM009012, LM010098]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059694] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009012, R01LM010098] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR)); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Compagnia di San Paolo(Compagnia di San Paolo); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	C.D. was supported by the Swiss National Science Foundation, grant PBLAP2-129416/1. M.G. and P.P. were supported by the Ministero dell'Universita e della Ricerca Scientifica e Tecnologica. P.P. acknowledges financial support from the Italian Association for Cancer Research (AIRC). F.D.C. and M.G. acknowledge Compagnia di San Paolo for the financial support offered through the Neuroscience Program. J.H.M. was supported by NIH grants AI59694, LM009012 and LM010098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana M, 2003, PHYSICA D, V185, P45, DOI 10.1016/S0167-2789(03)00174-X; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; Balleza E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002456; BOWER JM, COMPUTATIONAL MODELI; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Conlon EM, 2003, P NATL ACAD SCI USA, V100, P3339, DOI 10.1073/pnas.0630591100; DARABOS C, 2009, SPRINGER LECT NOTES, P89; Darabos C, 2009, J THEOR BIOL, V260, P531, DOI 10.1016/j.jtbi.2009.06.027; Darabos C, 2007, LECT NOTES ARTIF INT, V4648, P976; DERRIDA B, 1986, EUROPHYS LETT, V1, P45, DOI 10.1209/0295-5075/1/2/001; Hassoun MH., 1995, FUNDAMENTALS ARTIFIC, DOI 10.1109/JPROC.1996.503146; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; KAUFFMAN S, 2003, INT J ASTROBIOL, V2, P131, DOI DOI 10.1017/S147355040300154X; Kauffman S.A., 2000, INVESTIGATIONS; Kauffman S. A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Keles S, 2002, BIOINFORMATICS, V18, P1167, DOI 10.1093/bioinformatics/18.9.1167; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; LANGTON CG, 1990, PHYSICA D, V42, P12, DOI 10.1016/0167-2789(90)90064-V; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Mansergh FC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-5; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Shmulevich I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.048701; Smolen P, 2000, B MATH BIOL, V62, P247, DOI 10.1006/bulm.1999.0155; Stoll G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011917; WUENSCHE A, 1989, PAC S BIOC WORLD SCI, P89	33	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e25110	10.1371/journal.pone.0025110	http://dx.doi.org/10.1371/journal.pone.0025110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132067	gold, Green Published, Green Submitted			2022-12-25	WOS:000297789900001
J	Konishi, K; Watanabe, Y; Shen, LL; Guo, Y; Castoro, RJ; Kondo, K; Chung, W; Ahmed, S; Jelinek, J; Boumber, YA; Estecio, MR; Maegawa, S; Kondo, Y; Itoh, F; Imawari, M; Hamilton, SR; Issa, JPJ				Konishi, Kazuo; Watanabe, Yoshiyuki; Shen, Lanlan; Guo, Yi; Castoro, Ryan J.; Kondo, Kimie; Chung, Woonbok; Ahmed, Saira; Jelinek, Jaroslav; Boumber, Yanis A.; Estecio, Marcos R.; Maegawa, Shinji; Kondo, Yutaka; Itoh, Fumio; Imawari, Michio; Hamilton, Stanley R.; Issa, Jean-Pierre J.			DNA Methylation Profiles of Primary Colorectal Carcinoma and Matched Liver Metastasis	PLOS ONE			English	Article							COLON-CANCER; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; MICROSATELLITE INSTABILITY; K-RAS; PROMOTER HYPERMETHYLATION; POOR-PROGNOSIS; PHENOTYPE; GENE; SURVIVAL; INACTIVATION	Background: The contribution of DNA methylation to the metastatic process in colorectal cancers (CRCs) is unclear. Methods: We evaluated the methylation status of 13 genes (MINT1, MINT2, MINT31, MLH1, p16, p14, TIMP3, CDH1, CDH13, THBS1, MGMT, HPP1 and ER alpha) by bisulfite-pyrosequencing in 79 CRCs comprising 36 CRCs without liver metastasis and 43 CRCs with liver metastasis, including 16 paired primary CRCs and liver metastasis. We also performed methylated CpG island amplification microarrays (MCAM) in three paired primary and metastatic cancers. Results: Methylation of p14, TIMP3 and HPP1 in primary CRCs progressively decreased from absence to presence of liver metastasis (13.1% vs. 4.3%; 14.8% vs. 3.7%; 43.9% vs. 35.8%, respectively) (P<.05). When paired primary and metastatic tumors were compared, only MGMT methylation was significantly higher in metastatic cancers (27.4% vs. 13.4%, P=.013), and this difference was due to an increase in methylation density rather than frequency in the majority of cases. MCAM showed an average 7.4% increase in DNA methylated genes in the metastatic samples. The numbers of differentially hypermethylated genes in the liver metastases increased with increasing time between resection of the primary and resection of the liver metastasis. Bisulfite-pyrosequencing validation in 12 paired samples showed that most of these increases were not conserved, and could be explained by differences in methylation density rather than frequency. Conclusions: Most DNA methylation differences between primary CRCs and matched liver metastasis are due to random variation and an increase in DNA methylation density rather than de-novo inactivation and silencing. Thus, DNA methylation changes occur for the most part before progression to liver metastasis.	[Konishi, Kazuo; Watanabe, Yoshiyuki; Shen, Lanlan; Guo, Yi; Castoro, Ryan J.; Kondo, Kimie; Chung, Woonbok; Ahmed, Saira; Jelinek, Jaroslav; Boumber, Yanis A.; Estecio, Marcos R.; Maegawa, Shinji; Issa, Jean-Pierre J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Div Canc Med, Houston, TX 77030 USA; [Hamilton, Stanley R.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Div Pathol & Lab Med, Houston, TX 77030 USA; [Imawari, Michio] Showa Univ, Sch Med, Dept Med, Div Gastroenterol, Tokyo 142, Japan; [Itoh, Fumio] St Marianna Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Kawasaki, Kanagawa, Japan; [Kondo, Yutaka] Aichi Canc Ctr, Div Mol Oncol, Nagoya, Aichi 464, Japan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Showa University; Saint Marianna University; Aichi Cancer Center	Konishi, K (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Div Canc Med, Houston, TX 77030 USA.	konishimd@med.showa-u.ac.jp	Jelinek, Jaroslav/O-6876-2019; Jelinek, Jaroslav/D-2282-2012; Boumber, Yanis/AAP-8901-2021	Jelinek, Jaroslav/0000-0002-2533-0220; Issa, Jean-Pierre/0000-0003-2258-5030; Castoro, Ryan/0000-0002-3242-3775; Boumber, Yanis/0000-0001-5003-248X; Castoro, Ryan/0000-0003-3619-484X; Estecio, Marcos/0000-0002-6874-7413	National Institutes of Health [CA098006, CA105346]; Frederick F. Becker Distinguished University Chair in Cancer Research of the University of Texas; NATIONAL CANCER INSTITUTE [R01CA105346, R01CA098006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick F. Becker Distinguished University Chair in Cancer Research of the University of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health grants CA098006 and CA105346 (J-PI). J-PI is an American Cancer Society Clinical Research Professor supported by a generous gift from the F. M. Kirby Foundation. SH is supported by the Frederick F. Becker Distinguished University Chair in Cancer Research of the University of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja N, 1998, CANCER RES, V58, P5489; Baylin SB, 1998, ADV CANCER RES, V72, P141; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Esteller M, 2000, CANCER RES, V60, P2368; Esteller M, 2001, J CLIN ONCOL, V19, P299, DOI 10.1200/JCO.2001.19.2.299; Hiraga J, 2006, INT J HEMATOL, V84, P248, DOI 10.1532/IJH97.06087; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kohonen-Corish MRJ, 2005, J CLIN ONCOL, V23, P2318, DOI 10.1200/JCO.2005.00.109; Konishi K, 2003, GASTROINTEST ENDOSC, V57, P48, DOI 10.1067/mge.2003.31; Konishi K, 2007, GASTROENTEROLOGY, V132, P1254, DOI 10.1053/j.gastro.2007.01.035; Li Q, 1999, ONCOGENE, V18, P3284, DOI 10.1038/sj.onc.1202663; LINDAHL T, 1982, EMBO J, V1, P1359, DOI 10.1002/j.1460-2075.1982.tb01323.x; Ogino S, 2007, VIRCHOWS ARCH, V450, P529, DOI 10.1007/s00428-007-0398-3; Park TJ, 2001, CANCER, V92, P2760, DOI 10.1002/1097-0142(20011201)92:11<2760::AID-CNCR10123>3.0.CO;2-8; POTTER JD, 1993, EPIDEMIOL REV, V15, P499, DOI 10.1093/oxfordjournals.epirev.a036132; Powe DG, 1997, BRIT J CANCER, V75, P1678, DOI 10.1038/bjc.1997.285; Pulukuri SM, 2007, ONCOGENE, V26, P5229, DOI 10.1038/sj.onc.1210329; RADINSKY R, 1992, In Vivo (Attiki), V6, P325; Rhei E, 1998, CANCER RES, V58, P3193; Shen L, 2003, GASTROENTEROLOGY, V124, P626, DOI 10.1053/gast.2003.50102; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Shen L, 2007, CLIN CANCER RES, V13, P6093, DOI 10.1158/1078-0432.CCR-07-1011; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Suehiro Y, 2008, CLIN CANCER RES, V14, P2560, DOI 10.1158/1078-0432.CCR-07-1802; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Toyooka S, 2002, CANCER RES, V62, P3382; Toyota M, 1999, CANCER RES, V59, P2307; Toyota M, 2000, P NATL ACAD SCI USA, V97, P710, DOI 10.1073/pnas.97.2.710; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; van Rijnsoever M, 2003, CLIN CANCER RES, V9, P2898; Ward RL, 2003, J CLIN ONCOL, V21, P3729, DOI 10.1200/JCO.2003.03.123	40	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27889	10.1371/journal.pone.0027889	http://dx.doi.org/10.1371/journal.pone.0027889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132162	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789900030
J	Klymiuk, N; Bocker, W; Schonitzer, V; Bahr, A; Radic, T; Frohlich, T; Wunsch, A; Kessler, B; Kurome, M; Schilling, E; Herbach, N; Wanke, R; Nagashima, H; Mutschler, W; Arnold, GJ; Schwinzer, R; Schieker, M; Wolf, E				Klymiuk, Nikolai; Boecker, Wolfgang; Schoenitzer, Veronika; Baehr, Andrea; Radic, Tamara; Froehlich, Thomas; Wuensch, Annegret; Kessler, Barbara; Kurome, Mayuko; Schilling, Eleonore; Herbach, Nadja; Wanke, Ruediger; Nagashima, Hiroshi; Mutschler, Wolf; Arnold, Georg J.; Schwinzer, Reinhard; Schieker, Matthias; Wolf, Eckhard			First inducible transgene expression in porcine large animal models	FASEB JOURNAL			English	Article						tet-on system; RANKL; CTLA-4Ig	OSTEOCLAST DIFFERENTIATION; CELLS; PIGS; OSTEOPROTEGERIN; INTERFERENCE; DISRUPTION; LIGAND; WOMEN; BONE; MICE	The purpose of this study was to establish inducible transgene expression in pigs, a model organism with great promise for experimental physiology and translational medicine, using the binary tet-on system. This expression system is activated by doxycycline (dox) via the tet-controlled transactivator (TA). Binding of TA to the transactivator response element (TRE) results in transcription of downstream genes. First, we cloned transgenic founder pigs expressing TA under the control of the CMV enhancer/chicken beta-actin promoter (CAG). Then, cells from CAG-TA transgenic founders were nucleofected with TRE-controlled expression vectors for either porcine cytotoxic T-lymphocyte associated antigen 4-Fc domain of immunoglobulin G1 (CTLA-4Ig) or soluble receptor activator of NF-kappa B ligand (RANKL), and double-transgenic offspring were cloned. Dox administration resulted in a dose-dependent increase in expression of CTLA-4Ig or RANKL, in nucleofected cells and in transgenic pigs, while in the absence of dox, the levels of both proteins were below the detection limit. Inducible transgene expression was reproduced in double-transgenic offspring generated by cloning or breeding. Our strategy revealed the first two examples of inducible transgene expression in pigs. The CAG-TA transgenic pigs generated in this study constitute an interesting basis for future pig models with inducible transgene expression.- Klymiuk, N., Bocker, W., Schonitzer, V., Bahr, A., Radic, T., Frohlich, T., Wunsch, A., Kessler, B., Kurome, M., Schilling, E., Herbach, N., Wanke, R., Nagashima, H., Mutschler, W., Arnold, G. J., Schwinzer, R., Schieker, M., Wolf, E. First inducible transgene expression in porcine large animal models. FASEB J. 26, 1086-1099 (2012). www.fasebj.org	[Klymiuk, Nikolai; Baehr, Andrea; Wuensch, Annegret; Kessler, Barbara; Kurome, Mayuko; Schilling, Eleonore; Wolf, Eckhard] Univ Munich, Chair Mol Anim Breeding & Biotechnol, Munich, Germany; [Klymiuk, Nikolai; Froehlich, Thomas; Arnold, Georg J.; Wolf, Eckhard] Univ Munich, Lab Funct Genome Anal LAFUGA, Gene Ctr, Munich, Germany; [Boecker, Wolfgang; Schoenitzer, Veronika; Radic, Tamara; Mutschler, Wolf; Schieker, Matthias] Univ Munich, Klinikum Innenstadt, Dept Surg, D-8000 Munich, Germany; [Herbach, Nadja; Wanke, Ruediger] Univ Munich, Inst Vet Pathol, Munich, Germany; [Nagashima, Hiroshi] Meiji Univ, Sch Agr, Dept Life Sci, Lab Dev Engn, Kawasaki, Kanagawa, Japan; [Schwinzer, Reinhard] Hannover Med Sch, Transplant Lab, D-30623 Hannover, Germany	University of Munich; University of Munich; University of Munich; University of Munich; Meiji University; Hannover Medical School	Wolf, E (corresponding author), Ludwig Maximilians Univ Munchen, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	ewolf@lmb.uni-muenchen.de	Fröhlich, Thomas/C-6735-2011; Klymiuk, Nikolai/AAB-8345-2022; Schieker, Matthias/AGZ-2030-2022; Schieker, Matthias/J-6511-2015	Fröhlich, Thomas/0000-0002-4709-3211; Klymiuk, Nikolai/0000-0003-3532-1659; Schieker, Matthias/0000-0002-1230-3653; Schieker, Matthias/0000-0002-1230-3653; Nagashima, Hiroshi/0000-0001-9940-8783; Herbach, Nadja/0000-0001-5893-0356; Wolf, Eckhard/0000-0002-0430-9510; Wanke, Rudiger/0000-0002-0153-224X	Deutsche Forschungsgemeinschaft [FOR 535, FOR 793]; Bayerische Forschungsstiftung (FORZebRA); Bundesministerium fur Bildung und Forschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayerische Forschungsstiftung (FORZebRA); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	The authors thank Wiebke Baars, Miwako Kosters, Christian Erdle, and Sigfried Elsner for competent technical assistance. This study was supported by the Deutsche Forschungsgemeinschaft (FOR 535, Xenotransplantation; FOR 793, Mechanisms of Fracture Healing in Osteoporosis), the Bayerische Forschungsstiftung (FORZebRA), and the Bundesministerium fur Bildung und Forschung (Leading Edge Cluster Munich: m<SUP>4</SUP>, Personalized Medicine and Targeted Therapies).	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Besenfelder U, 1997, THERIOGENOLOGY, V47, P1051, DOI 10.1016/S0093-691X(97)00062-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ching S, 2007, J NEUROSCI, V27, P10476, DOI 10.1523/JNEUROSCI.3357-07.2007; Dennison E, 2000, HORM RES, V54, P58, DOI 10.1159/000053299; Frohlich T, 2011, METHODS MOL BIOL, V790, P141, DOI 10.1007/978-1-61779-319-6_11; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Kendler DL, 2010, J BONE MINER RES, V25, P72, DOI 10.1359/jbmr.090716; Kues WA, 2006, FASEB J, V20, P1200, DOI 10.1096/fj.05-5415fje; Kulkarni RN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001027; Kurome M, 2006, TRANSGENIC RES, V15, P229, DOI 10.1007/s11248-006-0004-5; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Larsen CP, 2005, AM J TRANSPLANT, V5, P443, DOI 10.1111/j.1600-6143.2005.00749.x; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Meier C, 2006, CLIN LAB, V52, P1; Mizuno A, 2002, J BONE MINER METAB, V20, P337, DOI 10.1007/s007740200049; Pearce AI, 2007, EUR CELLS MATER, V13, P1; Phelps CJ, 2009, XENOTRANSPLANTATION, V16, P477, DOI 10.1111/j.1399-3089.2009.00533.x; Plege A, 2009, TRANSPLANTATION, V87, P975, DOI 10.1097/TP.0b013e31819c85e8; Renner S, 2010, DIABETES, V59, P1228, DOI 10.2337/db09-0519; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Saunders TL, 2011, METHODS MOL BIOL, V693, P103, DOI 10.1007/978-1-60761-974-1_7; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Uemura H, 2008, J ENDOCRINOL INVEST, V31, P163, DOI 10.1007/BF03345584; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wine JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001130; Yin XJ, 2002, BIOL REPROD, V67, P442, DOI 10.1095/biolreprod67.2.442	30	44	47	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2012	26	3					1086	1099		10.1096/fj.11-185041	http://dx.doi.org/10.1096/fj.11-185041			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22138035	Bronze			2022-12-25	WOS:000300949300013
J	Bubner, P; Dohr, J; Plank, H; Mayrhofer, C; Nidetzky, B				Bubner, Patricia; Dohr, Judith; Plank, Harald; Mayrhofer, Claudia; Nidetzky, Bernd			Cellulases Dig Deep IN SITU OBSERVATION OF THE MESOSCOPIC STRUCTURAL DYNAMICS OF ENZYMATIC CELLULOSE DEGRADATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; X-RAY-SCATTERING; TRICHODERMA-REESEI; CELLOBIOHYDROLASE-I; ENDOGLUCANASE-I; IONIC LIQUIDS; HYDROLYSIS; VISUALIZATION; PRETREATMENT; BIOFUELS	Enzymatic hydrolysis of cellulose is key for the production of second generation biofuels, which represent a long-standing leading area in the field of sustainable energy. Despite the wealth of knowledge about cellulase structure and function, the elusive mechanism by which these enzymes disintegrate the complex structure of their insoluble substrate, which is the gist of cellulose saccharification, is still unclear. We herein present a time-resolved structural characterization of the action of cellulases on a nano-flat cellulose preparation, which enabled us to overcome previous limitations, using atomic force microscopy (AFM). As a first step in substrate disintegration, elongated fissures emerge which develop into coniform cracks as disintegration continues. Detailed data analysis allowed tracing the surface evolution back to the dynamics of crack morphology. This, in turn, reflects the interplay between surface degradation inside and outside of the crack. We observed how small cracks evolved and initially increased in size. At a certain point, the crack diameter stagnated and then started decreasing again. Stagnation corresponds with a decrease in the total amount of surface which is fissured and thus leads to the conclusion that the surface hydrolysis "around" the cracks is proceeding more rapidly than inside the cracks. The mesoscopic view presented here is in good agreement with various mechanistic proposals from the past and allows a novel insight into the structural dynamics occurring on the cellulosic substrate through cellulase action.	[Bubner, Patricia; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Dohr, Judith; Plank, Harald; Mayrhofer, Claudia] Graz Univ Technol, Inst Electron Microscopy, A-8010 Graz, Austria	Graz University of Technology; Graz University of Technology	Nidetzky, B (corresponding author), Graz Univ Technol, Inst Biotechnol & Biochem Engn, Petersgasse 12, A-8010 Graz, Austria.	bernd.nidetzky@tugraz.at		Nidetzky, Bernd/0000-0002-5030-2643	Austrian Science Fund FWF [P 24156-B21]; Austrian Science Fund (FWF) [P 24156] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Grant P 24156-B21 from the Austrian Science Fund FWF (to B. N.).	ABUJA PM, 1988, EUR BIOPHYS J BIOPHY, V15, P339, DOI 10.1007/BF00254721; ABUJA PM, 1988, BIOCHEM BIOPH RES CO, V156, P180, DOI 10.1016/S0006-291X(88)80821-0; Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Bommarius AS, 2008, METAB ENG, V10, P370, DOI 10.1016/j.ymben.2008.06.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cui ST, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1989314; Ding SY, 2008, CURR OPIN BIOTECH, V19, P218, DOI 10.1016/j.copbio.2008.04.008; ESTERBAUER H, 1991, BIORESOURCE TECHNOL, V36, P51, DOI 10.1016/0960-8524(91)90099-6; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HOLTZAPPLE M, 1990, BIOTECHNOL BIOENG, V36, P275, DOI 10.1002/bit.260360310; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Kim SJ, 2010, BIORESOURCE TECHNOL, V101, P8273, DOI 10.1016/j.biortech.2010.06.047; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8; Levine SE, 2010, BIOTECHNOL BIOENG, V107, P37, DOI 10.1002/bit.22789; Liu H, 2009, ENZYME MICROB TECH, V45, P274, DOI 10.1016/j.enzmictec.2009.06.009; Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mansfield SD, 1999, BIOTECHNOL PROGR, V15, P804, DOI 10.1021/bp9900864; NIEVES RA, 1991, APPL ENVIRON MICROB, V57, P3163, DOI 10.1128/AEM.57.11.3163-3170.1991; Nigmatullin R, 2004, COLLOID SURFACE B, V35, P125, DOI 10.1016/j.colsurfb.2004.02.013; Ohtani H, 2008, ANAL SCI, V24, P1335, DOI 10.2116/analsci.24.1335; Penttila PA, 2010, BIOMACROMOLECULES, V11, P1111, DOI 10.1021/bm1001119; Prasad K, 2009, MACROMOL BIOSCI, V9, P376, DOI 10.1002/mabi.200800179; Quirk A, 2010, LANGMUIR, V26, P5007, DOI 10.1021/la9037028; Solomon BD, 2007, BIOMASS BIOENERG, V31, P416, DOI 10.1016/j.biombioe.2007.01.023; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Zhao H, 2009, J BIOTECHNOL, V139, P47, DOI 10.1016/j.jbiotec.2008.08.009	32	44	44	3	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2759	2765		10.1074/jbc.M111.257717	http://dx.doi.org/10.1074/jbc.M111.257717			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22128148	Green Published, hybrid			2022-12-25	WOS:000300292300047
J	Sarfstein, R; Pasmanik-Chor, M; Yeheskel, A; Edry, L; Shomron, N; Warman, N; Wertheimer, E; Maor, S; Shochat, L; Werner, H				Sarfstein, Rive; Pasmanik-Chor, Metsada; Yeheskel, Adva; Edry, Liat; Shomron, Noam; Warman, Naama; Wertheimer, Efrat; Maor, Sharon; Shochat, Lea; Werner, Haim			Insulin-like Growth Factor-I Receptor (IGF-IR) Translocates to Nucleus and Autoregulates IGF-IR Gene Expression in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING RESIDUES; ESTROGEN-RECEPTOR; TUMOR-CELLS; TRANSCRIPTION FACTOR; SEQUENCE; PREDICTION; PROTEINS; PROMOTER; BRCA1; PROLIFERATION	The insulin-like growth factor (IGF) system plays an important role in mammary gland biology as well as in the etiology of breast cancer. The IGF-I receptor (IGF-IR), which mediates the biological actions of IGF-I and IGF-II, has emerged in recent years as a promising therapeutic target. The IGF and estrogen signaling pathways act in a synergistic manner in breast epithelial cells. The present study was aimed at investigating 1) the putative translocation of IGF-IR and the related insulin receptor (IR) to the nucleus in breast cancer cells, 2) the impact of IGF-IR and IR levels on IGF-IR biosynthesis in estrogen receptor (ER)positive and ER-depleted breast cancer cells, and 3) the potential transcription factor role of IGF-IR in the specific context of IGF-IR gene regulation. We describe here a novel mechanism of autoregulation of IGF-IR gene expression by cellular IGF-IR, which is seemingly dependent on ER status. Regulation of the IGF-IR gene by IGF-IR protein is mediated at the level of transcription, as demonstrated by 1) binding assays (DNA affinity chromatography and ChIP) showing specific IGF-IR binding to IGF-IR promoter DNA and 2) transient transfection assays showing transactivation of the IGF-IR promoter by exogenous IGF-IR. The IR is also capable of translocating to the nucleus and binding the IGF-IR promoter in ER-depleted, but not in ER-positive, cells. However, transcription factors IGF-IR and IR display diametrically opposite activities in the context of IGF-IR gene regulation. Thus, whereas IGF-IR stimulated IGF-IR gene expression, IR inhibited IGF-IR promoter activity. In summary, we have identified a novel mechanism of IGF-IR gene autoregulation in breast cancer cells. The clinical implications of these findings and, in particular, the impact of IGF-IR/IR nuclear localization on targeted therapy require further investigation.	[Sarfstein, Rive; Maor, Sharon; Shochat, Lea; Werner, Haim] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Edry, Liat; Shomron, Noam] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Warman, Naama; Wertheimer, Efrat] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Tel Aviv, Israel; [Pasmanik-Chor, Metsada; Yeheskel, Adva] Tel Aviv Univ, George Wise Fac Life Sci, Bioinformat Unit, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Werner, H (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	hwerner@post.tau.ac.il						Abramovitch S, 2003, HORM METAB RES, V35, P758; Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Becker MA, 2011, MOL ENDOCRINOL, V25, P516, DOI 10.1210/me.2010-0373; Belfiore A, 2008, J MAMMARY GLAND BIOL, V13, P381, DOI 10.1007/s10911-008-9099-z; Boutet Emmanuel, 2007, V406, P89; Bruchim I, 2009, EXPERT OPIN THER TAR, V13, P1179, DOI 10.1517/14728220903201702; Cannata D, 2010, ENDOCRINOLOGY, V151, P5751, DOI 10.1210/en.2010-0792; Casa A. J., 2011, BREAST CANC IN PRESS; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; COOKE DW, 1991, BIOCHEM BIOPH RES CO, V177, P1113, DOI 10.1016/0006-291X(91)90654-P; Creighton CJ, 2008, J CLIN ONCOL, V26, P4078, DOI 10.1200/JCO.2007.13.4429; Deng H, 2011, BIOCHEM BIOPH RES CO, V404, P667, DOI 10.1016/j.bbrc.2010.12.038; Happerfield LC, 1997, J PATHOL, V183, P412; HernandezSanchez C, 1997, J BIOL CHEM, V272, P4663, DOI 10.1074/jbc.272.8.4663; Hwang S, 2007, BIOINFORMATICS, V23, P634, DOI 10.1093/bioinformatics/btl672; Idelman G, 2003, J BIOL CHEM, V278, P3474, DOI 10.1074/jbc.M211606200; Jones RA, 2007, ONCOGENE, V26, P1636, DOI 10.1038/sj.onc.1209955; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Maor SB, 2000, MOL GENET METAB, V69, P130, DOI 10.1006/mgme.1999.2958; Maor S, 2007, CANCER LETT, V257, P236, DOI 10.1016/j.canlet.2007.07.019; Maor S, 2006, J ENDOCRINOL, V191, P605, DOI 10.1677/joe.1.07016; Martin MB, 2000, ENDOCRINOLOGY, V141, P4503, DOI 10.1210/en.141.12.4503; Martin MB, 2002, J NUTR, V132, p3799S, DOI 10.1093/jn/132.12.3799S; Oesterreich S, 2001, CANCER RES, V61, P5771; Ofran Y, 2007, BIOINFORMATICS, V23, pI347, DOI 10.1093/bioinformatics/btm174; PEYRAT JP, 1992, BREAST CANCER RES TR, V22, P59, DOI 10.1007/BF01833334; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Rowzee A, 2008, J MAMMARY GLAND BIOL, V13, P361, DOI 10.1007/s10911-008-9102-8; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sarfstein Rive, 2010, Cancers (Basel), V2, P233, DOI 10.3390/cancers2020233; Schnarr B, 2000, INT J CANCER, V89, P506, DOI 10.1002/1097-0215(20001120)89:6<506::AID-IJC7>3.0.CO;2-F; Scotlandi K, 2008, CURR OPIN ONCOL, V20, P419, DOI 10.1097/CCO.0b013e328302edab; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; SELL C, 1993, P NATL ACAD SCI USA, V90, P11217, DOI 10.1073/pnas.90.23.11217; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Sun HZ, 2003, MOL ENDOCRINOL, V17, P472, DOI 10.1210/me.2002-0276; Surmacz E, 2000, J MAMMARY GLAND BIOL, V5, P95, DOI 10.1023/A:1009523501499; Vigneri R, 2010, ACTA DIABETOL, V47, P271, DOI 10.1007/s00592-010-0215-3; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Werner H, 2000, CELL MOL LIFE SCI, V57, P932, DOI 10.1007/PL00000735; WERNER H, 1994, J BIOL CHEM, V269, P12577; WERNER H, 1992, MOL ENDOCRINOL, V6, P1545, DOI 10.1210/me.6.10.1545; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; Werner H, 2006, TRENDS ENDOCRIN MET, V17, P236, DOI 10.1016/j.tem.2006.06.007; Werner Haim, 2009, Pediatr Endocrinol Rev, V7, P2; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Yee D, 2000, J MAMMARY GLAND BIOL, V5, P107, DOI 10.1023/A:1009575518338; Yerushalmi R, 2012, BREAST CANCER RES TR, V132, P131, DOI 10.1007/s10549-011-1529-8; Yuen JSP, 2008, EXPERT OPIN THER TAR, V12, P589, DOI 10.1517/14728222.12.5.589 	54	64	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2766	2776		10.1074/jbc.M111.281782	http://dx.doi.org/10.1074/jbc.M111.281782			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22128190	Green Published, hybrid			2022-12-25	WOS:000300292300048
J	Weiss, N; Hameed, S; Fernandez-Fernandez, JM; Fablet, K; Karmazinova, M; Poillot, C; Proft, J; Chen, LN; Bidaud, I; Monteil, A; Huc-Brandt, S; Lacinova, L; Lory, P; Zamponi, GW; De Waard, M				Weiss, Norbert; Hameed, Shahid; Fernandez-Fernandez, Jose M.; Fablet, Katell; Karmazinova, Maria; Poillot, Cathy; Proft, Juliane; Chen, Lina; Bidaud, Isabelle; Monteil, Arnaud; Huc-Brandt, Sylvaine; Lacinova, Lubica; Lory, Philippe; Zamponi, Gerald W.; De Waard, Michel			A Ca(v)3.2/Syntaxin-1A Signaling Complex Controls T-type Channel Activity and Low-threshold Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-INTERACTION SITE; N-TYPE; CA2+ CHANNELS; CALCIUM-CHANNELS; MOLECULAR DETERMINANTS; NEUROTRANSMITTER RELEASE; SUBCELLULAR-DISTRIBUTION; FUNCTIONAL INTERACTION; ALPHA(1A) SUBUNITS; KINETIC-PROPERTIES	T-type calcium channels represent a key pathway for Ca2+ entry near the resting membrane potential. Increasing evidence supports a unique role of these channels in fast and low-threshold exocytosis in an action potential-independent manner, but the underlying molecular mechanisms have remained unknown. Here, we report the existence of a syntaxin-1A/Ca(v)3.2 T-type calcium channel signaling complex that relies on molecular determinants that are distinct from the synaptic protein interaction site (synprint) found in synaptic high voltage-activated calcium channels. This interaction potently modulated Ca(v)3.2 channel activity, by reducing channel availability. Other members of the T-type calcium channel family were also regulated by syntaxin-1A, but to a smaller extent. Overexpression of Ca(v)3.2 channels in MPC 9/3L-AH chromaffin cells induced low-threshold secretion that could be prevented by uncoupling the channels from syntaxin-1A. Altogether, our findings provide compelling evidence for the existence of a syntaxin-1A/T-type Ca2+ channel signaling complex and provide new insights into the molecular mechanism by which these channels control low-threshold exocytosis.	[De Waard, Michel] INSERM, U836, Grenoble Inst Neurosci, Lab Ion Channels Funct & Pathol, F-38706 La Tronche, France; [Weiss, Norbert; Hameed, Shahid; Chen, Lina; Zamponi, Gerald W.] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Proft, Juliane] Univ Calgary, Dept Clin Neurosci, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Weiss, Norbert; Fablet, Katell; Poillot, Cathy; De Waard, Michel] Univ Grenoble 1, F-38000 Grenoble, France; [Fernandez-Fernandez, Jose M.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol & Channelopathies, Barcelona 08003, Spain; [Karmazinova, Maria; Lacinova, Lubica] Slovak Acad Sci, Biophys Lab, Inst Mol Physiol & Genet, Bratislava 83334, Slovakia; [Bidaud, Isabelle; Monteil, Arnaud; Huc-Brandt, Sylvaine; Lory, Philippe] Inst Genom Fonct, Dept Physiol, F-34094 Montpellier, France; [Bidaud, Isabelle; Monteil, Arnaud; Huc-Brandt, Sylvaine; Lory, Philippe] CNRS, Unite Mixte Rech 5203, F-34396 Montpellier, France; [Bidaud, Isabelle; Monteil, Arnaud; Huc-Brandt, Sylvaine; Lory, Philippe] CNRS, INSERM, U661, F-34094 Montpellier, France; [Bidaud, Isabelle; Monteil, Arnaud; Huc-Brandt, Sylvaine; Lory, Philippe] Univ Montpellier I, Inst Federatif Rech 3, F-34090 Montpellier, France; [Bidaud, Isabelle; Monteil, Arnaud; Huc-Brandt, Sylvaine; Lory, Philippe] Univ Montpellier 2, Inst Federatif Rech 3, F-34090 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Calgary; University of Calgary; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Pompeu Fabra University; Slovak Academy of Sciences; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier	De Waard, M (corresponding author), INSERM, U836, Grenoble Inst Neurosci, Lab Ion Channels Funct & Pathol, Batiment Edmond J Safra,Chemin Fortune Ferrini, F-38706 La Tronche, France.	dewaardm@ujf-grenoble.fr	Brandt, Sylvaine/AAJ-1277-2021; Weiss, Norbert/G-5330-2014; Proft, Juliane/H-6549-2014; Lacinova, Lubica/A-9645-2014; De Waard, Michel/G-7406-2014; Fernández-Fernández, José Manuel M/M-8157-2015; Monteil, Arnaud/G-3113-2012	Brandt, Sylvaine/0000-0002-5582-4643; Weiss, Norbert/0000-0002-0040-1109; Proft, Juliane/0000-0003-0980-8930; Lacinova, Lubica/0000-0001-9207-0978; De Waard, Michel/0000-0002-2782-9615; Fernández-Fernández, José Manuel M/0000-0003-2330-8449; Monteil, Arnaud/0000-0003-1632-7318; Zamponi, Gerald W./0000-0002-0644-9066; LORY, philippe/0000-0002-1638-7604; BIDAUD, Isabelle/0000-0002-1812-1447	Alberta Innovates, Health Solutions (AIHS); Hotchkiss Brain Institute; Spanish Ministry of Science and Innovation; Fondos Europeos de Desarrollo Regional (FEDER) Funds, and Plan E [SAF2009-13182-C03-02]; Fondo de Investigacion Sanitaria [Red HERACLES RD06/0009]; Generalitat de Catalunya [2009SGR1369]; VEGA [2/0195/10]; Canadian Institutes of Health Research;  [ANR-2006-Neuro35];  [ANR-09-MNPS-035]	Alberta Innovates, Health Solutions (AIHS); Hotchkiss Brain Institute; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondos Europeos de Desarrollo Regional (FEDER) Funds, and Plan E; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya); VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ; 	This work was supported in part by fellowships from Alberta Innovates, Health Solutions (AIHS) and from the Hotchkiss Brain Institute (to N. W.), by Spanish Ministry of Science and Innovation, Fondos Europeos de Desarrollo Regional (FEDER) Funds, and Plan E (Grant SAF2009-13182-C03-02), Fondo de Investigacion Sanitaria (Red HERACLES RD06/0009) and Generalitat de Catalunya (Grant 2009SGR1369) (to J. M. F.-F.), by VEGA 2/0195/10 grant (to L. L.), by ANR-2006-Neuro35 and ANR-09-MNPS-035 grants (to P. L.), and by the Canadian Institutes of Health Research (to G. W. Z.).	Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bezprozvanny I, 2000, P NATL ACAD SCI USA, V97, P13943, DOI 10.1073/pnas.220389697; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Carabelli V, 2007, J PHYSIOL-LONDON, V584, P149, DOI 10.1113/jphysiol.2007.132274; COHEN MW, 1991, J NEUROSCI, V11, P1032; Cueni L, 2008, NAT NEUROSCI, V11, P683, DOI 10.1038/nn.2124; Cueni L, 2009, PFLUG ARCH EUR J PHY, V457, P1161, DOI 10.1007/s00424-008-0582-6; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Egger V, 2003, J NEUROSCI, V23, P7551; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Harkins AB, 2004, P NATL ACAD SCI USA, V101, P15219, DOI 10.1073/pnas.0401001101; Harkins AB, 2003, J NEUROPHYSIOL, V90, P2325, DOI 10.1152/jn.00425.2003; HUGUENARD JR, 1992, J NEUROSCI, V12, P3804, DOI 10.1523/jneurosci.12-10-03804.1992; Ivanov AI, 2000, J NEUROSCI, V20, P4930; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; Jarvis SE, 2002, J BIOL CHEM, V277, P44399, DOI 10.1074/jbc.M206902200; Jarvis SE, 2001, TRENDS PHARMACOL SCI, V22, P519, DOI 10.1016/S0165-6147(00)01800-9; Jarvis SE, 2001, J NEUROSCI, V21, P2939, DOI 10.1523/JNEUROSCI.21-09-02939.2001; Joksovic PM, 2005, J PHYSIOL-LONDON, V566, P125, DOI 10.1113/jphysiol.2005.086579; Keith RK, 2007, J NEUROSCI, V27, P265, DOI 10.1523/JNEUROSCI.4213-06.2007; Khosravani H, 2006, PHYSIOL REV, V86, P941, DOI 10.1152/physrev.00002.2006; Kim K, 1997, P NATL ACAD SCI USA, V94, P14782, DOI 10.1073/pnas.94.26.14782; LEVEQUE C, 1994, J BIOL CHEM, V269, P6306; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Pan ZH, 2001, NEURON, V32, P89, DOI 10.1016/S0896-6273(01)00454-8; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; Rettig J, 1997, J NEUROSCI, V17, P6647; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Serra SA, 2010, P NATL ACAD SCI USA, V107, P1672, DOI 10.1073/pnas.0908359107; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Tang AH, 2011, J NEUROSCI, V31, P13546, DOI 10.1523/JNEUROSCI.2781-11.2011; Tscherter A, 2011, J PHYSIOL-LONDON, V589, P1707, DOI 10.1113/jphysiol.2010.203836; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Weber AM, 2010, NAT NEUROSCI, V13, P1348, DOI 10.1038/nn.2657; Weiss N, 2008, PFLUG ARCH EUR J PHY, V457, P315, DOI 10.1007/s00424-008-0541-2; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Wiser O, 1997, FEBS LETT, V404, P203, DOI 10.1016/S0014-5793(97)00130-0; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925; Zamponi GW, 2003, J PHARMACOL SCI, V92, P79; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	50	82	84	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2810	2818		10.1074/jbc.M111.290882	http://dx.doi.org/10.1074/jbc.M111.290882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130660	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000300292300052
J	Fang, Z; Zhang, T; Dizeyi, N; Chen, S; Wang, HY; Swanson, KD; Cai, CM; Balk, SP; Yuan, X				Fang, Zi; Zhang, Tao; Dizeyi, Nishtman; Chen, Sen; Wang, Hongyun; Swanson, Kenneth D.; Cai, Changmeng; Balk, Steven P.; Yuan, Xin			Androgen Receptor Enhances p27 Degradation in Prostate Cancer Cells through Rapid and Selective TORC2 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MTOR COMPLEX 2; KINASE 1 SGK1; MOTIF PHOSPHORYLATION; REGULATES PROTEOLYSIS; CYCLE PROGRESSION; UBIQUITIN LIGASE; NUCLEAR EXPORT; P27(KIP1); AKT; SPECIFICITY	Androgen receptor (AR) plays a central role in prostate cancer (PCa) growth, with androgen deprivation or AR down-regulation causing cell-cycle arrest and accumulation of the p27 cyclin-dependent kinase inhibitor. The molecular basis for this AR regulation of cell-cycle progression remains unclear. Here we demonstrate that androgen can rapidly reduce p27 protein in PCa cells by increasing its proteasome-mediated degradation. This rapid androgen-stimulated p27 degradation was mediated by AKT through the phosphorylation of p27 T157. Significantly, androgen increased TORC2-mediated AKT S473 phosphorylation without affecting the PDK1-mediated AKT T308 phosphorylation or TORC1 activity. The TORC2 activation was further supported by enhanced mTOR/RICTOR association and increased phosphorylation of additional TORC2 substrates, SGK1 and PKC alpha. The androgen-stimulated nuclear translocation of AR was associated with markedly-increased nuclear SIN1, a critical component of TORC2. Finally, the androgen-mediated TORC2/AKT activation targets a subset of AKT substrates including p27 and FOXO1, but not PRAS40. This study reveals a pathway linking AR to a selective activation of TORC2, the subsequent activation of AKT, and phosphorylation of a discrete set of AKT substrates that regulate cellular proliferation and survival. These findings establish that TORC2 can function as a central regulator of growth in response to signals that are distinct from those regulating TORC1, and support efforts to target TORC2 for cancer therapy.	[Fang, Zi; Zhang, Tao; Dizeyi, Nishtman; Chen, Sen; Wang, Hongyun; Swanson, Kenneth D.; Cai, Changmeng; Balk, Steven P.; Yuan, Xin] Harvard Univ, Div Hematol Oncol, Dept Med, Beth Israel Deaconess Med Ctr,Med Sch, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Balk, SP (corresponding author), 330 Brookline Ave,CLS 0443, Boston, MA 02115 USA.	sbalk@bidmc.harvard.edu; xyuan@bidmc.harvard.edu	Cai, Changmeng/AAE-6835-2020	Cai, Changmeng/0000-0002-8701-2586	National Institutes of Health [R01DK079962, R56AI085131]; Dana-Farber/Harvard SPORE in prostate cancer [P50 CA 090381]; Department of Defense [PC020320]; NATIONAL CANCER INSTITUTE [P50CA090381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber/Harvard SPORE in prostate cancer; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants R01DK079962 (to X. Y.) and R56AI085131 (to K. D. S.) from the National Institutes of Health. This work was also supported by Grant P50 CA 090381 from the Dana-Farber/Harvard SPORE in prostate cancer (to S. P. B.) and Grant PC020320 from the Department of Defense (to X. Y.).	Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Chen SY, 2009, J BIOL CHEM, V284, P25576, DOI 10.1074/jbc.M109.043133; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Di Pietro N, 2010, MOL ENDOCRINOL, V24, P370, DOI 10.1210/me.2009-0265; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Kotoshiba S, 2005, J BIOL CHEM, V280, P17694, DOI 10.1074/jbc.M500866200; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lu M, 2010, J AM SOC NEPHROL, V21, P811, DOI 10.1681/ASN.2009111168; Migliaccio A, 2005, CANCER RES, V65, P10585, DOI 10.1158/0008-5472.CAN-05-0912; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nardella C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000189; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Susaki E, 2007, CELL CYCLE, V6, P3015, DOI 10.4161/cc.6.24.5087; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Truica CI, 2000, CANCER RES, V60, P4709; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yuan X, 2006, AM J PATHOL, V169, P682, DOI 10.2353/ajpath.2006.051047; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208	40	54	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2090	2098		10.1074/jbc.M111.323303	http://dx.doi.org/10.1074/jbc.M111.323303			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22139837	Green Published, hybrid			2022-12-25	WOS:000299321000049
J	Parthibane, V; Rajakumari, S; Venkateshwari, V; Iyappan, R; Rajasekharan, R				Parthibane, Velayoudame; Rajakumari, Sona; Venkateshwari, Varadarajan; Iyappan, Ramachandiran; Rajasekharan, Ram			Oleosin Is Bifunctional Enzyme That Has Both Monoacylglycerol Acyltransferase and Phospholipase Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE; DEVELOPING PEANUT COTYLEDONS; SEED OIL BODIES; ENDOPLASMIC-RETICULUM; BRASSICA-NAPUS; ARABIDOPSIS; BIOSYNTHESIS; ACCUMULATION; MEMBRANE; PROTEINS	In plants, fatty oils are generally stored in spherical intracellular organelles referred to as oleosomes that are covered by proteins such as oleosin. Seeds with high oil content have more oleosin than those with low oil content. However, the exact role of oleosin in oil accumulation is thus far unclear. Here, we report the isolation of a catalytically active 14 S multiprotein complex capable of acylating monoacylglycerol from the microsomal membranes of developing peanut cotyledons. Microsomal membranes from immature peanut seeds were solubilized using 8 M urea and 10 mM CHAPS. Using two-dimensional gel electrophoresis and mass spectrometry, we identified 27 proteins in the 14 S complex. The major proteins present in the 14 S complex are conarachin, the major allergen Ara h 1, and other seed storage proteins. We identified oleosin 3 as a part of the 14 S complex, which is capable of acylating monoacylglycerol. The recombinant OLE3 microsomes from Saccharomyces cerevisiae have been shown to have both a monoacylglycerol acyltransferase and a phospholipase A(2) activity. Overexpression of the oleosin 3 (OLE3) gene in S. cerevisiae resulted in an increased accumulation of diacylglycerols and triacylglycerols and decreased phospholipids. These findings provide a direct role for a structural protein (OLE3) in the biosynthesis and mobilization of plant oils.	[Venkateshwari, Varadarajan; Rajasekharan, Ram] CSIR, Cent Inst Med & Aromat Plants, Lucknow 226015, Uttar Pradesh, India; [Parthibane, Velayoudame; Rajakumari, Sona; Iyappan, Ramachandiran; Rajasekharan, Ram] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Indian Institute of Science (IISC) - Bangalore	Rajasekharan, R (corresponding author), CSIR, Cent Inst Med & Aromat Plants, Lucknow 226015, Uttar Pradesh, India.	lipid@biochem.iisc.ernet.in; ram@cimap.res.in	Rajasekharan, Ram/R-2257-2019; Ramachandiran, Iyappan/AAC-4258-2019	Ramachandiran, Iyappan/0000-0002-0271-5478; Ram, Rajasekharan/0000-0002-4114-0654; Varadharajan, Venkateshwari/0000-0002-4557-9840; Rajasekharan, Ram/0000-0002-2124-6013	Council of Scientific and Industrial Research, New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research, New Delhi.	Abell BM, 1997, PLANT CELL, V9, P1481, DOI 10.1105/tpc.9.8.1481; Abell BM, 2004, PLANT J, V37, P461, DOI 10.1111/j.1365-313X.2003.01988.x; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Chuang RLC, 1996, J BIOCHEM-TOKYO, V120, P74, DOI 10.1093/oxfordjournals.jbchem.a021396; Ciambella C, 2005, PROTEOMICS, V5, P746, DOI 10.1002/pmic.200401129; Gangar A, 2001, J BIOL CHEM, V276, P10290, DOI 10.1074/jbc.M009550200; Ghosh AK, 2009, PLANT PHYSIOL, V151, P869, DOI 10.1104/pp.109.144261; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; Hsieh K, 2004, PLANT PHYSIOL, V136, P3427, DOI 10.1104/pp.104.051060; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; Huang CY, 2009, PLANT PHYSIOL, V150, P1192, DOI 10.1104/pp.109.138123; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Kayden H. J., 1967, J CLIN INVEST, V46, P1965; KENNEDY EP, 1961, FED PROC, V20, P934; Kim HU, 2002, J BIOL CHEM, V277, P22677, DOI 10.1074/jbc.M109298200; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; Li M, 2002, J BIOL CHEM, V277, P37888, DOI 10.1074/jbc.M202721200; Maisonneuve S, 2010, PLANT PHYSIOL, V152, P670, DOI 10.1104/pp.109.148247; MURPHY DJ, 1989, J PLANT PHYSIOL, V135, P63, DOI 10.1016/S0176-1617(89)80225-1; Murphy DJ, 1998, PLANT J, V13, P1; Napier JA, 1996, PLANT MOL BIOL, V31, P945, DOI 10.1007/BF00040714; Peng FY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-286; RADETZKY R, 1994, PLANTA, V194, P1, DOI 10.1007/BF00201027; ROSS JHE, 1993, PLANT SCI, V93, P203, DOI 10.1016/0168-9452(93)90050-A; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schmidt MA, 2008, MOL PLANT, V1, P910, DOI 10.1093/mp/ssn049; Shekar S, 2002, PLANT PHYSIOL, V128, P988, DOI 10.1104/pp.010654; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; Stahl U, 2008, FEBS LETT, V582, P305, DOI 10.1016/j.febslet.2007.12.020; Ting JTL, 1996, PLANTA, V199, P158, DOI 10.1007/BF00196892; Tumaney AW, 2001, J BIOL CHEM, V276, P10847, DOI 10.1074/jbc.M100005200; TZEN JTC, 1993, PLANT PHYSIOL, V101, P267, DOI 10.1104/pp.101.1.267; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zheng ZF, 2003, PLANT CELL, V15, P1872, DOI 10.1105/tpc.012427	36	72	89	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1946	1954		10.1074/jbc.M111.309955	http://dx.doi.org/10.1074/jbc.M111.309955			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128159	Green Published, hybrid			2022-12-25	WOS:000299321000035
J	Baldo, B; Weiss, A; Parker, CN; Bibel, M; Paganetti, P; Kaupmann, K				Baldo, Barbara; Weiss, Andreas; Parker, Christian N.; Bibel, Miriam; Paganetti, Paolo; Kaupmann, Klemens			A Screen for Enhancers of Clearance Identifies Huntingtin as a Heat Shock Protein 90 (Hsp90) Client Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT HUNTINGTIN; MOUSE MODEL; SYSTEM IMPAIRMENT; DISEASE; HSP70; NEUROPATHOLOGY; PATHOGENESIS; AGGREGATION; EXPRESSION; CONFORMATION	Mechanisms to reduce the cellular levels of mutant huntingtin (mHtt) provide promising strategies for treating Huntington disease (HD). To identify compounds enhancing the degradation of mHtt, we performed a high throughput screen using a hippocampal HN10 cell line expressing a 573-amino acid mHtt fragment. Several hit structures were identified as heat shock protein 90 (Hsp90) inhibitors. Cell treatment with these compounds reduced levels of mHtt without overt toxic effects as measured by time-resolved Forster resonance energy transfer assays and Western blots. To characterize the mechanism of mHtt degradation, we used the potent and selective Hsp90 inhibitor NVP-AUY922. In HdhQ150 embryonic stem (ES) cells and in ES cell-derived neurons, NVP-AUY922 treatment substantially reduced soluble full-length mHtt levels. In HN10 cells, Hsp90 inhibition by NVP-AUY922 enhanced mHtt clearance in the absence of any detectable Hsp70 induction. Furthermore, inhibition of protein synthesis with cycloheximide or overexpression of dominant negative heat shock factor 1(Hsf1) in HdhQ150 ES cells attenuated Hsp70 induction but did not affect NVP-AUY922-mediated mHtt clearance. Together, these data provided evidence that direct inhibition of Hsp90 chaperone function was crucial for mHtt degradation rather than heat shock response induction and Hsp70 up-regulation. Co-immunoprecipitation experiments revealed a physical interaction of mutant and wild-type Htt with the Hsp90 chaperone. Hsp90 inhibition disrupted the interaction and induced clearance of Htt through the ubiquitin-proteasome system. Our data suggest that Htt is an Hsp90 client protein and that Hsp90 inhibition may provide a means to reduce mHtt in HD.	[Baldo, Barbara; Weiss, Andreas; Bibel, Miriam; Paganetti, Paolo; Kaupmann, Klemens] Novartis Pharma AG, Novartis Inst BioMed Res, Neurosci, CH-4002 Basel, Switzerland; [Parker, Christian N.] Novartis Pharma AG, Novartis Inst BioMed Res, Dev & Mol Pathways, CH-4002 Basel, Switzerland	Novartis; Novartis	Kaupmann, K (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Neurosci, WSJ-355-3-051-11, CH-4002 Basel, Switzerland.	klemens.kaupmann@novartis.com	Paganetti, Paolo/AAF-8039-2020	Paganetti, Paolo/0000-0003-1896-6324; Kaupmann, Klemens/0000-0001-8903-2508	European Community [215618, FP7/2008]	European Community(European Commission)	This work was supported by the European Community's Seventh Framework Programme FP7/2008 under Grant Agreement 215618.	Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bett JS, 2006, HUM MOL GENET, V15, P33, DOI 10.1093/hmg/ddi423; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Brough PA, 2008, J MED CHEM, V51, P196, DOI 10.1021/jm701018h; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Fecke W, 2009, DRUG DISCOV TODAY, V14, P453, DOI 10.1016/j.drudis.2009.02.006; Heldens L, 2010, CELL MOL LIFE SCI, V67, P4035, DOI 10.1007/s00018-010-0430-7; Hunter JM, 2007, J NEUROSCI RES, V85, P1774, DOI 10.1002/jnr.21287; JOHNSON JL, 1995, MOL ENDOCRINOL, V9, P670, DOI 10.1210/me.9.6.670; Kaarniranta K, 2002, MOL BRAIN RES, V101, P136, DOI 10.1016/S0169-328X(02)00179-1; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kamal Adeela, 2004, Discov Med, V4, P277; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lotz GP, 2010, J BIOL CHEM, V285, P38183, DOI 10.1074/jbc.M110.160218; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Ortega Z, 2010, J NEUROSCI, V30, P3675, DOI 10.1523/JNEUROSCI.5673-09.2010; Paganetti P, 2009, CHEMBIOCHEM, V10, P1678, DOI 10.1002/cbic.200900131; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sah DWY, 2011, J CLIN INVEST, V121, P500, DOI 10.1172/JCI45130; Schilb A, 2004, J BIOMOL SCREEN, V9, P569, DOI 10.1177/1087057104265538; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Thomas M, 2006, HUM MOL GENET, V15, P1876, DOI 10.1093/hmg/ddl110; Tokui K, 2009, HUM MOL GENET, V18, P898, DOI 10.1093/hmg/ddn419; Turturici G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/618127; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Weiss A, 2011, ANAL BIOCHEM, V410, P304, DOI 10.1016/j.ab.2010.11.044; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Weiss A, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-11; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	44	70	71	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1406	1414		10.1074/jbc.M111.294801	http://dx.doi.org/10.1074/jbc.M111.294801			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22123826	Green Published, hybrid			2022-12-25	WOS:000299170300054
J	Jost, KL; Rottach, A; Milden, M; Bertulat, B; Becker, A; Wolf, P; Sandoval, J; Petazzi, P; Huertas, D; Esteller, M; Kremmer, E; Leonhardt, H; Cardoso, MC				Jost, K. Laurence; Rottach, Andrea; Milden, Manuela; Bertulat, Bianca; Becker, Annette; Wolf, Patricia; Sandoval, Juan; Petazzi, Paolo; Huertas, Dori; Esteller, Manel; Kremmer, Elisabeth; Leonhardt, Heinrich; Cardoso, M. Cristina			Generation and Characterization of Rat and Mouse Monoclonal Antibodies Specific for MeCP2 and Their Use in X-Inactivation Studies	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; RETT-SYNDROME; METHYLATED DNA; TERMINAL DIFFERENTIATION; HISTONE DEACETYLASE; MUTATIONS; CHROMATIN; CELLS; PURIFICATION; PHENOTYPE	Methyl CpG binding protein 2 (MeCP2) binds DNA, and has a preference for methylated CpGs and, hence, in cells, it accumulates in heterochromatin. Even though it is expressed ubiquitously MeCP2 is particularly important during neuronal maturation. This is underscored by the fact that in Rett syndrome, a neurological disease, 80% of patients carry a mutation in the MECP2 gene. Since the MECP2 gene lies on the X chromosome and is subjected to X chromosome inactivation, affected patients are usually chimeric for wild type and mutant MeCP2. Here, we present the generation and characterization of the first rat monoclonal MeCP2 specific antibodies as well as mouse monoclonal antibodies and a rabbit polyclonal antibody. We demonstrate that our antibodies are suitable for immunoblotting, (chromatin) immunoprecipitation and immunofluorescence of endogenous and ectopically expressed MeCP2. Epitope mapping revealed that most of the MeCP2 monoclonal antibodies recognize the C-terminal domain and one the N-terminal domain of MeCP2. Using slot blot analysis, we determined a high sensitivity of all antibodies, detecting amounts as low as 1 ng of MeCP2 protein. Moreover, the antibodies recognize MeCP2 from different species, including human, mouse, rat and pig. Lastly, we have validated their use by analyzing and quantifying X chromosome inactivation skewing using brain tissue of MeCP2 heterozygous null female mice. The new MeCP2 specific monoclonal antibodies described here perform well in a large variety of immunological applications making them a very valuable set of tools for studies of MeCP2 pathophysiology in situ and in vitro.	[Jost, K. Laurence; Milden, Manuela; Bertulat, Bianca; Becker, Annette; Cardoso, M. Cristina] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [Rottach, Andrea; Wolf, Patricia; Leonhardt, Heinrich] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Sandoval, Juan; Petazzi, Paolo; Huertas, Dori; Esteller, Manel] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program, Barcelona, Spain; [Kremmer, Elisabeth] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Mol Immunol, Munich, Germany	Technical University of Darmstadt; University of Munich; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Jost, KL (corresponding author), Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany.	Cardoso@bio.tu-darmstadt.de	Cardoso, M. Cristina/F-5215-2011; Bertulat, Bianca/F-5330-2012; Esteller, Manel/L-5956-2014; Petazzi, Paolo/H-7707-2013; sandoval, juan/M-4593-2015; Becker, Annette/F-5331-2012; Leonhardt, Heinrich/B-2791-2014	Esteller, Manel/0000-0003-4490-6093; sandoval, juan/0000-0002-5100-973X; Petazzi, Paolo/0000-0002-1036-2895	Deutsche Forschungsgemeinschaft; E-Rare EuroRETT network; European Commission [PITN-GA-2009-238242]; Juan de la Cierva [JCI-2009-04490]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); E-Rare EuroRETT network; European Commission(European CommissionEuropean Commission Joint Research Centre); Juan de la Cierva(Instituto de Salud Carlos III)	This work was funded in part by grants of the Deutsche Forschungsgemeinschaft to H.L. and M.C.C. and the E-Rare EuroRETT network to M.C.C. P.P. has a fellowship from the FP7 DisChrom Project (PITN-GA-2009-238242), which is funded by the European Commission, and J.S. is a Juan de la Cierva researcher (JCI-2009-04490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Amir RE, 2000, AM J MED GENET, V97, P147, DOI 10.1002/1096-8628(200022)97:2<147::AID-AJMG6>3.0.CO;2-O; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; CARDOSO MC, 1993, CELL, V74, P979, DOI 10.1016/0092-8674(93)90721-2; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Gibson JH, 2005, BRAIN DEV-JPN, V27, P266, DOI 10.1016/j.braindev.2004.07.002; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; JONES KW, 1970, NATURE, V225, P912, DOI 10.1038/225912a0; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kudo S, 2003, J MED GENET, V40, P487, DOI 10.1136/jmg.40.7.487; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Prusov AN, 2002, BIOCHEMISTRY-MOSCOW+, V67, P423, DOI 10.1023/A:1015229922183; Rett A, 1966, Wien Med Wochenschr, V116, P723; Rottach A, 2008, HYBRIDOMA, V27, P91, DOI 10.1089/hyb.2007.0555; Rottach A, 2008, HYBRIDOMA, V27, P337, DOI 10.1089/hyb.2008.0031; Roux JC, 2008, NEUROSCI LETT, V447, P82, DOI 10.1016/j.neulet.2008.09.045; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Suetake I, 2011, BIOCHEM J, V437, P141, DOI 10.1042/BJ20110241; Vasiliou SA, 2012, ADDICT BIOL, V17, P156, DOI 10.1111/j.1369-1600.2010.00288.x; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Young JI, 2004, AM J HUM GENET, V74, P511, DOI 10.1086/382228; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172	31	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e26499	10.1371/journal.pone.0026499	http://dx.doi.org/10.1371/journal.pone.0026499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140431	Green Submitted, Green Published, gold			2022-12-25	WOS:000298163400002
J	Nunes, MC; von Gottberg, A; de Gouveia, L; Cohen, C; Kuwanda, L; Karstaedt, AS; Klugman, KP; Madhi, SA				Nunes, Marta C.; von Gottberg, Anne; de Gouveia, Linda; Cohen, Cheryl; Kuwanda, Locadiah; Karstaedt, Alan S.; Klugman, Keith P.; Madhi, Shabir A.			Persistent High Burden of Invasive Pneumococcal Disease in South African HIV-Infected Adults in the Era of an Antiretroviral Treatment Program	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; STREPTOCOCCUS-PNEUMONIAE; TRIMETHOPRIM-SULFAMETHOXAZOLE; POLYSACCHARIDE VACCINE; HAEMOPHILUS-INFLUENZAE; CONTROLLED-TRIAL; UGANDAN ADULTS; UNITED-STATES; COTE-DIVOIRE; THERAPY	Background: Highly active antiretroviral treatment (HAART) programs have been associated with declines in the burden of invasive pneumococcal disease (IPD) in industrialized countries. The aim of this study was to evaluate trends in IPD hospitalizations in HIV-infected adults in Soweto, South Africa, associated with up-scaling of the HAART program from 2003 to 2008. Methods: Laboratory-confirmed IPD cases were identified from 2003 through 2008 through an existing surveillance program. The period 2003-04 was designated as the early-HAART era, 2005-06 as the intermediate-HAART era and 2007-08 as the established-HAART era. The incidence of IPD was compared between the early-HAART and established-HAART eras in HIV-infected and-uninfected individuals. Results: A total of 2,567 IPD cases among individuals older than 18 years were reported from 2003 through 2008. Overall incidence of IPD (per 100,000) did not change during the study period in HIV-infected adults (207.4 cases in the early-HAART and 214.0 cases in the established-HAART era; p = 0.55). IPD incidence, actually increased 1.16-fold (95% CI: 1.01; 1.62) in HIV-infected females between the early-and established-HAART eras (212.1 cases and 246.2 cases, respectively; p = 0.03). The incidence of IPD remained unchanged in HIV-uninfected adults across the three time periods. Conclusion: Despite a stable prevalence of HIV and the increased roll-out of HAART for treatment of AIDS patients in our setting, the burden of IPD has not decreased among HIV-infected adults. The study indicates a need for ongoing monitoring of disease and HAART program effectiveness to reduce opportunistic infections in African adults with HIV/AIDS, as well as the need to consider alternate strategies including pneumococcal conjugate vaccine immunization for the prevention of IPD in HIV-infected adults.	[Nunes, Marta C.; Kuwanda, Locadiah; Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Fac Hlth Sci, Johannesburg, South Africa; [von Gottberg, Anne; de Gouveia, Linda; Klugman, Keith P.; Madhi, Shabir A.] Natl Inst Communicable Dis, Resp & Meningeal Pathogens Reference Unit, Johannesburg, South Africa; [Cohen, Cheryl] Natl Inst Communicable Dis, Epidemiol & Surveillance Unit, Johannesburg, South Africa; [Karstaedt, Alan S.] Univ Witwatersrand, Dept Med, ZA-2001 Johannesburg, South Africa; [Karstaedt, Alan S.] Chris Hani Baragwanath Acad Hosp, Johannesburg, South Africa; [Nunes, Marta C.; Kuwanda, Locadiah; Madhi, Shabir A.] Univ Witwatersrand, Med Res Council Resp & Meningeal Pathogens Res Un, Fac Hlth Sci, Johannesburg, South Africa; [Klugman, Keith P.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Klugman, Keith P.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA	National Research Foundation - South Africa; University of Witwatersrand; National Institute for Communicable Diseases (NICD); National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; Emory University; Rollins School Public Health; Emory University	Nunes, MC (corresponding author), Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Fac Hlth Sci, Johannesburg, South Africa.	shabirm@nicd.ac.za		de Gouveia, Linda/0000-0002-1418-8468; von Gottberg, Anne/0000-0002-0243-7455; Nunes, Marta/0000-0003-3788-878X; Cohen, Cheryl/0000-0003-0376-2302	University of the Witwatersrand; United States Agency for International Development's Antimicrobial Resistance Initiative from the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia [U60/CCU022088]; CDC; National Center for HIV/AIDS; Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U62/PSO022901]; Pfizer; GSK	University of the Witwatersrand; United States Agency for International Development's Antimicrobial Resistance Initiative from the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia(United States Agency for International Development (USAID)); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for HIV/AIDS; Viral Hepatitis, STD, and TB Prevention (NCHHSTP); Pfizer(Pfizer); GSK(GlaxoSmithKline)	MCN had financial support from the University of the Witwatersrand. This study was funded in part in 2003-2006 by the United States Agency for International Development's Antimicrobial Resistance Initiative, transferred via a cooperative agreement (number U60/CCU022088) from the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia. In 2005-2007, the study was also supported by the CDC, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program (GAP) Cooperative Agreement U62/PSO022901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Receipt of research funding (SAM, AvG, KPK) and consultancy from Pfizer (SAM, KPK). Receipt of research funding (SAM, AvG, KPK), consultancies and honoraria from GSK (SAM, KPK). Consultancy for Merck (KPK). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adam MA, 2009, SAMJ S AFR MED J, V99, P661; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; ASSA2003, FULL PROV AIDS DEM M; Barry PM, 2006, AIDS, V20, P437, DOI 10.1097/01.aids.0000206507.54901.84; Bliss SJ, 2008, LANCET INFECT DIS, V8, P67, DOI 10.1016/S1473-3099(07)70242-6; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; Cohen AL, 2010, AIDS, V24, P2253, DOI 10.1097/QAD.0b013e32833d46fd; Everett DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017765; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; Feldman C, 1999, CHEST, V116, P107, DOI 10.1378/chest.116.1.107; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Gill CJ, 2008, B WORLD HEALTH ORGAN, V86, P929, DOI 10.2471/BLT.07.049668; Grau I, 2005, ARCH INTERN MED, V165, P1533, DOI 10.1001/archinte.165.13.1533; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Huebner RE, 1999, S AFR MED J, V89, P924; Jones N, 1998, AIDS, V12, P2177, DOI 10.1097/00002030-199816000-00013; Jordano Q, 2004, CLIN INFECT DIS, V38, P1623, DOI 10.1086/420933; Karstaedt AS, 2001, CLIN INFECT DIS, V33, P610, DOI 10.1086/322589; Kourtis AP, 2010, JAIDS-J ACQ IMM DEF, V55, P128, DOI 10.1097/QAI.0b013e3181e8ed15; Mayanja BN, 2010, TROP MED INT HEALTH, V15, P697, DOI 10.1111/j.1365-3156.2010.02528.x; McEllistrem MC, 2002, J INFECT DIS, V185, P1364, DOI 10.1086/339882; Morrison KE, 2000, J CLIN MICROBIOL, V38, P434; National Department of Health, 2003, OP PLAN COMPR HIV AI; Nunes MC, 2011, AIDS, V25, P453, DOI 10.1097/QAD.0b013e328341b7f1; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pemba L, 2008, J INFECTION, V56, P171, DOI 10.1016/j.jinf.2007.12.003; RADSTROM P, 1994, J CLIN MICROBIOL, V32, P2738; REDD SC, 1990, J INFECT DIS, V162, P1012, DOI 10.1093/infdis/162.5.1012; SHISANA O, 2005, S AFRICAN NATL HIV P; SHISANA O, 2010, S AFRICAN NATL HIV P; STATSSA, MID POP EST 2003 200; Teshale EH, 2008, VACCINE, V26, P5830, DOI 10.1016/j.vaccine.2008.08.032; Watera C, 2004, AIDS, V18, P1210, DOI 10.1097/00002030-200405210-00018; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; Winn W, 2006, INTRO MICROBIOLOGY 2, P68; World Health Organization/UNAIDS, 2001, AFR HEALTH SCI, V1, P30	38	42	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27929	10.1371/journal.pone.0027929	http://dx.doi.org/10.1371/journal.pone.0027929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140487	Green Submitted, gold, Green Published			2022-12-25	WOS:000298163400024
J	Ouyang, YS; Song, Y; Lu, BW				Ouyang, Yingshi; Song, Yan; Lu, Bingwei			dp53 Restrains Ectopic Neural Stem Cell Formation in the Drosophila Brain in a Non-Apoptotic Mechanism Involving Archipelago and Cyclin E	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; ASYMMETRIC DIVISION; TUMOR-SUPPRESSOR; SELF-RENEWAL; FATE SPECIFICATION; S-PHASE; P53; CANCER; NUMB; PROTEIN	Accumulating evidence suggests that tumor-initiating stem cells or cancer stem cells (CSCs) possibly originating from normal stem cells may be the root cause of certain malignancies. How stem cell homeostasis is impaired in tumor tissues is not well understood, although certain tumor suppressors have been implicated. In this study, we use the Drosophila neural stem cells (NSCs) called neuroblasts as a model to study this process. Loss-of-function of Numb, a key cell fate determinant with well-conserved mammalian counterparts, leads to the formation of ectopic neuroblasts and a tumor phenotype in the larval brain. Overexpression of the Drosophila tumor suppressor p53 (dp53) was able to suppress ectopic neuroblast formation caused by numb loss-of-function. This occurred in a non-apoptotic manner and was independent of Dacapo, the fly counterpart of the well-characterized mammalian p53 target p21 involved in cellular senescence. The observation that dp53 affected Edu incorporation into neuroblasts led us to test the hypothesis that dp53 acts through regulation of factors involved in cell cycle progression. Our results show that the inhibitory effect of dp53 on ectopic neuroblast formation was mediated largely through its regulation of Cyclin E (Cyc E). Overexpression of Cyc E was able to abrogate dp539s ability to rescue numb loss-of-function phenotypes. Increasing Cyc E levels by attenuating Archipelago (Ago), a recently identified transcriptional target of dp53 and a negative regulator of Cyc E, had similar effects. Conversely, reducing Cyc E activity by overexpressing Ago blocked ectopic neuroblast formation in numb mutant. Our results reveal an intimate connection between cell cycle progression and NSC self-renewal vs. differentiation control, and indicate that p53-mediated regulation of ectopic NSC self-renewal through the Ago/Cyc E axis becomes particularly important when NSC homeostasis is perturbed as in numb loss-of-function condition. This has important clinical implications.	[Ouyang, Yingshi; Song, Yan; Lu, Bingwei] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University	Ouyang, YS (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	bingwei@stanford.edu		Lu, Bingwei/0000-0002-5807-7014	National Institutes of Health [NS043167]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by National Institutes of Health grant NS043167 to B.L. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertoni M, 1998, ONCOGENE, V16, P321, DOI 10.1038/sj.onc.1201544; Berger C, 2010, DEV BIOL, V337, P415, DOI 10.1016/j.ydbio.2009.11.012; Bhalerao S, 2005, CURR BIOL, V15, P1583, DOI 10.1016/j.cub.2005.07.061; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Buttitta LA, 2010, J CELL BIOL, V189, P981, DOI 10.1083/jcb.200910006; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Casaccia-Bonnefil P, 1999, DEVELOPMENT, V126, P4027; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Fan Y, 2010, CELL DEATH DIFFER, V17, P912, DOI 10.1038/cdd.2009.182; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; GJERSET RA, 1995, IN VITRO CELL DEV-AN, V31, P207; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hede SM, 2011, J ONCOL, V2011, DOI 10.1155/2011/852970; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Januschke J, 2008, ONCOGENE, V27, P6994, DOI 10.1038/onc.2008.349; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; KOFF A, 1991, CELL, V66, P1217, DOI 10.1016/0092-8674(91)90044-Y; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Leung SY, 2000, ONCOGENE, V19, P4079, DOI 10.1038/sj.onc.1203740; Lu WJ, 2010, SCIENCE, V328, P1278, DOI 10.1126/science.1185640; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Mandal S, 2010, J CELL BIOL, V188, P473, DOI 10.1083/jcb.200912024; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Mesquita D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000566; Moberg KH, 2004, CURR BIOL, V14, P965, DOI 10.1016/j.cub.2004.04.040; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Mortimer NT, 2007, DEV BIOL, V312, P560, DOI 10.1016/j.ydbio.2007.10.002; NEWCOMB EW, 1993, BRAIN PATHOL, V3, P229, DOI 10.1111/j.1750-3639.1993.tb00749.x; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Ouyang YS, 2011, DEVELOPMENT, V138, P2185, DOI 10.1242/dev.058347; Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001; Rahman R, 2009, BBA-MOL BASIS DIS, V1792, P280, DOI 10.1016/j.bbadis.2009.01.011; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; RICHARDSON HE, 1993, DEVELOPMENT, V119, P673; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Simon F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000594; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Vanderluit JL, 2007, J CELL BIOL, V178, P129, DOI 10.1083/jcb.200703176; Vanderluit JL, 2004, J CELL BIOL, V166, P853, DOI 10.1083/jcb.200403156; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wells BS, 2006, CURR BIOL, V16, P1606, DOI 10.1016/j.cub.2006.07.046; Weng M, 2010, DEV CELL, V18, P126, DOI 10.1016/j.devcel.2009.12.007; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wodarz A, 2006, CELL, V124, P1121, DOI 10.1016/j.cell.2006.03.004; Yamaguchi M, 1999, ONCOGENE, V18, P6767, DOI 10.1038/sj.onc.1203113; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	67	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28098	10.1371/journal.pone.0028098	http://dx.doi.org/10.1371/journal.pone.0028098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140513	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163400032
J	Aschkenasy, G; Bromberg, Z; Raj, N; Deutschman, CS; Weiss, YG				Aschkenasy, Gabriella; Bromberg, Zohar; Raj, Nichelle; Deutschman, Clifford S.; Weiss, Yoram G.			Enhanced Hsp70 Expression Protects against Acute Lung Injury by Modulating Apoptotic Pathways	PLOS ONE			English	Article							NF-KAPPA-B; MOLECULAR CHAPERONES; PULMONARY EPITHELIUM; CELL-DEATH; IN-VIVO; INHIBITION; STRESS; HEAT-SHOCK-PROTEIN-70; IDENTIFICATION; PHAGOCYTOSIS	The Acute respiratory distress syndrome (ARDS) is a highly lethal inflammatory lung disorder. Apoptosis plays a key role in its pathogenesis. We showed that an adenovirus expressing the 70 kDa heat shock protein Hsp70 (AdHSP) protected against sepsis-induced lung injury. In this study we tested the hypothesis that AdHSP attenuates apoptosis in sepsisinduced lung injury. Sepsis was induced in rats via cecal ligation and double puncture (2CLP). At the time of 2CLP PBS, AdHSP or AdGFP (an adenoviral vector expressing green fluorescent protein) were injected into the tracheas of septic rats. 48 hours later, lungs were isolated. One lung was fixed for TUNEL staining and immunohistochemistry. The other was homogenized to isolate cytosolic and nuclear protein. Immunoblotting, gel filtration and co-immunoprecipitation were performed in these extracts. In separate experiments MLE-12 cells were incubated with medium, AdHSP or AdGFP. Cells were stimulated with TNFa. Cytosolic and nuclear proteins were isolated. These were subjected to immunoblotting, coimmunoprecipitation and a caspase-3 activity assay. TUNEL assay demonstrated that AdHSP reduced alveolar cell apoptosis. This was confirmed by immunohistochemical detection of caspase 3 abundance. In lung isolated from septic animals, immunoblotting, co-immunoprecipitation and gel filtration studies revealed an increase in cytoplasmic complexes containing caspases 3, 8 and 9. AdHSP disrupted these complexes. We propose that Hsp70 impairs apoptotic cellular pathways via interactions with caspases. Disruption of large complexes resulted in stabilization of lower molecular weight complexes, thereby, reducing nuclear caspase-3. Prevention of apoptosis in lung injury may preserve alveolar cells and aid in recovery.	[Aschkenasy, Gabriella; Bromberg, Zohar; Weiss, Yoram G.] Hadassah Hebrew Univ, Dept Anesthesiol & Crit Care Med, Sch Med, Jerusalem, Israel; [Aschkenasy, Gabriella; Bromberg, Zohar; Weiss, Yoram G.] Hadassah Hebrew Univ, Goldyne Savad Inst Gene Therapy, Sch Med, Jerusalem, Israel; [Raj, Nichelle; Deutschman, Clifford S.; Weiss, Yoram G.] Univ Penn, Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Raj, Nichelle; Deutschman, Clifford S.; Weiss, Yoram G.] Univ Penn, Sch Med, Stavropoulos Sepsis Res Program, Philadelphia, PA 19104 USA	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Pennsylvania; University of Pennsylvania	Aschkenasy, G (corresponding author), Hadassah Hebrew Univ, Dept Anesthesiol & Crit Care Med, Sch Med, Jerusalem, Israel.	weiss@hadassah.org.il	Deutschman, Clifford/AAN-2742-2021		Israel Science Foundation [586/03, 529_/08]; Israel Ministry of Health Chief Scientist [5304]; NIH/NIGMS [GM059930-07]; Stavropoulos Sepsis Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059930] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Israel Ministry of Health Chief Scientist; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stavropoulos Sepsis Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the Israel Science Foundation (#586/03 and #529_/08 - YGW), the Israel Ministry of Health Chief Scientist (#5304 -YGW), the NIH/NIGMS (GM059930-07 - CSD) and the Stavropoulos Sepsis Research Program (CSD). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Beere HM, 2001, TRENDS CELL BIOL, V11, P6, DOI 10.1016/S0962-8924(00)01874-2; Beere HM, 2005, J CLIN INVEST, V115, P2633, DOI 10.1172/JCI26471; Bromberg Z, 2008, CRIT CARE MED, V36, P246, DOI 10.1097/01.CCM.0000295473.56522.EF; Brower RG, 2004, NEW ENGL J MED, V351, P327; Chello M, 2007, ANN THORAC SURG, V83, P1374, DOI 10.1016/j.athoracsur.2006.10.065; Chen H, 2008, EUR J PHARMACOL, V581, P306, DOI 10.1016/j.ejphar.2007.11.050; Clarke AR, 1996, CURR OPIN STRUC BIOL, V6, P43, DOI 10.1016/S0959-440X(96)80093-5; Coimbra R, 2006, J TRAUMA, V60, P115, DOI 10.1097/01.ta.0000200075.12489.74; Delettre C, 2006, J BIOL CHEM, V281, P6413, DOI 10.1074/jbc.M509884200; Diamant S, 2003, MOL MICROBIOL, V49, P401, DOI 10.1046/j.1365-2958.2003.03553.x; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Guthmann F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-10; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Li GF, 2011, J BIOL CHEM, V286, P20251, DOI 10.1074/jbc.M110.211771; Li XP, 2004, J APPL PHYSIOL, V97, P1535, DOI 10.1152/japplphysiol.00519.2004; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003; Marshall John C, 2007, Novartis Found Symp, V280, P53; Martin TR, 2003, CRIT CARE MED, V31, pS184, DOI 10.1097/01.CCM.0000057841.33876.B1; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Oyake J, 2006, LIFE SCI, V79, P300, DOI 10.1016/j.lfs.2006.01.013; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pongcharoen S, 2004, CLIN EXP IMMUNOL, V138, P330, DOI 10.1111/j.1365-2249.2004.02612.x; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Selva E, 2007, IMMUNOL CELL BIOL, V85, P257, DOI 10.1038/sj.icb.7100029; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; STEINBERG H, 1982, EXP LUNG RES, V3, P163, DOI 10.3109/01902148209063290; Sun YJ, 2006, J CEREBR BLOOD F MET, V26, P937, DOI 10.1038/sj.jcbfm.9600246; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Twiddy D, 2004, J BIOL CHEM, V279, P19665, DOI 10.1074/jbc.M311388200; Wang ZB, 2005, CELL BIOL INT, V29, P489, DOI 10.1016/j.cellbi.2005.04.001; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Weiss YG, 2000, SHOCK, V13, P19, DOI 10.1097/00024382-200013010-00004; Weiss YG, 2001, ANESTHESIOLOGY, V95, P974, DOI 10.1097/00000542-200110000-00029; Weiss YG, 2002, J CLIN INVEST, V110, P801, DOI 10.1172/JCI200215888; Weiss YG, 2007, CRIT CARE MED, V35, P2128, DOI 10.1097/01.CCM.0000278915.78030.74; Yang B, 2011, J CELL BIOCH    0214; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159	43	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e26956	10.1371/journal.pone.0026956	http://dx.doi.org/10.1371/journal.pone.0026956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132083	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000009
J	Beattie, RL; Lu, ZL; Manis, FR				Beattie, Rachel L.; Lu, Zhong-Lin; Manis, Franklin R.			Dyslexic Adults Can Learn from Repeated Stimulus Presentation but Have Difficulties in Excluding External Noise	PLOS ONE			English	Article							SPEECH-PERCEPTION; DEFICITS; ANCHOR; INSIGHTS	We examined whether the characteristic impairments of dyslexia are due to a deficit in excluding external noise or a deficit in taking advantage of repeated stimulus presentation. We compared non-impaired adults and adults with poor reading performance on a visual letter detection task that varied two aspects: the presence or absence of background visual noise, and a small or large stimulus set. There was no interaction between group and stimulus set size, indicating that the poor readers took advantage of repeated stimulus presentation as well as the non-impaired readers. The poor readers had higher thresholds than non-impaired readers in the presence of high external noise, but not in the absence of external noise. The results support the hypothesis that an external noise exclusion deficit, not a perceptual anchoring deficit, impairs reading for adults.	[Beattie, Rachel L.; Lu, Zhong-Lin; Manis, Franklin R.] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Lu, Zhong-Lin] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA	University of Southern California; University System of Ohio; Ohio State University	Beattie, RL (corresponding author), Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA.	beattie@usc.edu	Beattie, Rachel/B-8574-2013	Beattie, Rachel/0000-0002-9828-4720; Lu, Zhong-Lin/0000-0002-7295-727X	National Institure of Child Health and Human Development [HD29891]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029891] Funding Source: NIH RePORTER	National Institure of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was supported by National Institure of Child Health and Human Development Grant #HD29891 to FM, PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2008, TRENDS COGN SCI, V12, P245, DOI 10.1016/j.tics.2008.05.001; Ahissar M, 2007, TRENDS COGN SCI, V11, P458, DOI 10.1016/j.tics.2007.08.015; Ahissar M, 2006, NAT NEUROSCI, V9, P1558, DOI 10.1038/nn1800; [Anonymous], 1992, GRAY ORAL READING TE; Bailey CE, 2004, J EXP CHILD PSYCHOL, V87, P125, DOI 10.1016/j.jecp.2003.10.004; BANAI K, 2010, ADV NEURAL IN PRESS; Banai K, 2006, CEREB CORTEX, V16, P1718, DOI 10.1093/cercor/bhj107; Besner D., 1991, BASIC PROCESSES READ; Boets B, 2008, BRAIN LANG, V106, P29, DOI 10.1016/j.bandl.2007.12.004; Boets B, 2011, RES DEV DISABIL, V32, P560, DOI 10.1016/j.ridd.2010.12.020; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BROWN JI, 1993, NELSONDENNY READING; Di Filippo G, 2008, DEVELOPMENTAL SCI, V11, pF40, DOI 10.1111/j.1467-7687.2008.00752.x; Faes L, 2007, PERCEPT PSYCHOPHYS, V69, P254, DOI 10.3758/BF03193747; Harm MW, 1999, PSYCHOL REV, V106, P491, DOI 10.1037/0033-295X.106.3.491; HARRIS JD, 1948, AM J PSYCHOL, V61, P309, DOI 10.2307/1417151; KESTEN H, 1958, ANN MATH STAT, V29, P41, DOI 10.1214/aoms/1177706705; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; ROBBINS H, 1951, ANN MATH STAT, V22, P400, DOI 10.1214/aoms/1177729586; Rosen S, 2003, J PHONETICS, V31, P509, DOI 10.1016/S0095-4470(03)00046-9; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; Sperling AJ, 2005, NAT NEUROSCI, V8, P862, DOI 10.1038/nn1474; Sperling AJ, 2006, PSYCHOL SCI, V17, P1047, DOI 10.1111/j.1467-9280.2006.01825.x; STANOVICH KE, 1994, J EDUC PSYCHOL, V86, P24, DOI 10.1037/0022-0663.86.1.24; Torgesen J.K., 1999, COMPREHENSIVE TEST P; TORGESEN JK, 1992, TEST WORD READING EF; TREUTWEIN B, 1995, VISION RES, V35, P2503, DOI 10.1016/0042-6989(95)00016-X; Whitney C, 2005, J RES READ, V28, P274, DOI 10.1111/j.1467-9817.2005.00270.x; Woodcock R. W, 2001, WOODCOCK JOHNSON TES; Ziegler JC, 2008, TRENDS COGN SCI, V12, P244, DOI 10.1016/j.tics.2008.04.001; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x	32	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27893	10.1371/journal.pone.0027893	http://dx.doi.org/10.1371/journal.pone.0027893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KL	22132164	Green Submitted, Green Published, gold			2022-12-25	WOS:000298162000049
J	Kvist, S; Narechania, A; Oceguera-Figueroa, A; Fuks, B; Siddall, ME				Kvist, Sebastian; Narechania, Apurva; Oceguera-Figueroa, Alejandro; Fuks, Bella; Siddall, Mark E.			Phylogenomics of Reichenowia parasitica, an Alphaproteobacterial Endosymbiont of the Freshwater Leech Placobdella parasitica	PLOS ONE			English	Article							SYMBIOTIC NITROGEN-FIXATION; ESCHERICHIA-COLI; RHIZOBIUM-LEGUMINOSARUM; FAMILY GLOSSIPHONIIDAE; PHYLOGENETIC ANALYSIS; TSETSE-FLIES; BACTERIA; EVOLUTION; SEQUENCE; GENOMICS	Although several commensal alphaproteobacteria form close relationships with plant hosts where they aid in (e. g.,) nitrogen fixation and nodulation, only a few inhabit animal hosts. Among these, Reichenowia picta, R. ornata and R. parasitica, are currently the only known mutualistic, alphaproteobacterial endosymbionts to inhabit leeches. These bacteria are harbored in the epithelial cells of the mycetomal structures of their freshwater leech hosts, Placobdella spp., and these structures have no other obvious function than housing bacterial symbionts. However, the function of the bacterial symbionts has remained unclear. Here, we focused both on exploring the genomic makeup of R. parasitica and on performing a robust phylogenetic analysis, based on more data than previous hypotheses, to test its position among related bacteria. We sequenced a combined pool of host and symbiont DNA from 36 pairs of mycetomes and performed an in silico separation of the different DNA pools through subtractive scaffolding. The bacterial contigs were compared to 50 annotated bacterial genomes and the genome of the freshwater leech Helobdella robusta using a BLASTn protocol. Further, amino acid sequences inferred from the contigs were used as queries against the 50 bacterial genomes to establish orthology. A total of 358 orthologous genes were used for the phylogenetic analyses. In part, results suggest that R. parasitica possesses genes coding for proteins related to nitrogen fixation, iron/vitamin B translocation and plasmid survival. Our results also indicate that R. parasitica interacts with its host in part by transmembrane signaling and that several of its genes show orthology across Rhizobiaceae. The phylogenetic analyses support the nesting of R. parasitica within the Rhizobiaceae, as sister to a group containing Agrobacterium and Rhizobium species.	[Kvist, Sebastian] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA; [Kvist, Sebastian; Oceguera-Figueroa, Alejandro; Siddall, Mark E.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Narechania, Apurva; Siddall, Mark E.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Oceguera-Figueroa, Alejandro] CUNY, Grad Ctr, Dept Biol, New York, NY USA; [Fuks, Bella] Long Isl Univ, Brooklyn, NY USA	American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); City University of New York (CUNY) System; Long Island University-Brooklyn Campus	Kvist, S (corresponding author), Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA.	skvist@amnh.org		Kvist, Sebastian/0000-0003-3200-6207	Swedish American Foundation; Helge Ax:sson Johnson's Foundation; National Science Foundation [DEB-0640463]	Swedish American Foundation; Helge Ax:sson Johnson's Foundation; National Science Foundation(National Science Foundation (NSF))	This work was supported by a Swedish American Foundation Fellowship and a Helge Ax:sson Johnson's Foundation Fellowship, as well as a National Science Foundation Grant DEB-0640463. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Ausmees N, 2001, MICROBIOL-UK, V147, P549, DOI 10.1099/00221287-147-3-549; Batut J., 1985, Nitrogen fixation research progress. Proceedings of the 6th International Symposium on Nitrogen Fixation, Corvallis, OR, USA, August 4-10, 1985., P109; BATUT J, 1985, MOL GEN GENET, V199, P232, DOI 10.1007/BF00330264; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Burnett WJ, 1997, APPL ENVIRON MICROB, V63, P1721, DOI 10.1128/AEM.63.5.1721-1724.1997; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Casjens S, 1998, ANNU REV GENET, V32, P339, DOI 10.1146/annurev.genet.32.1.339; Chiu JC, 2006, BIOINFORMATICS, V22, P699, DOI 10.1093/bioinformatics/btk040; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; FISCHER HM, 1994, MICROBIOL REV, V58, P352, DOI 10.1128/MMBR.58.3.352-386.1994; FONTANA R, 1979, J BACTERIOL, V139, P1028, DOI 10.1128/JB.139.3.1028-1038.1979; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Graf J, 2006, TRENDS MICROBIOL, V14, P365, DOI 10.1016/j.tim.2006.06.009; HENNING U, 1972, EUR J BIOCHEM, V26, P570, DOI 10.1111/j.1432-1033.1972.tb01800.x; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P688, DOI 10.4319/lo.1988.33.4_part_2.0688; KAHN D, 1989, J BACTERIOL, V171, P929, DOI 10.1128/jb.171.2.929-939.1989; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kennaway CK, 2009, NUCLEIC ACIDS RES, V37, P762, DOI 10.1093/nar/gkn988; Kikuchi Y, 2002, APPL ENVIRON MICROB, V68, P4637, DOI 10.1128/AEM.68.9.4637-4641.2002; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Lefevre C, 2004, MOL BIOL EVOL, V21, P965, DOI 10.1093/molbev/msh063; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; Light JE, 1999, J PARASITOL, V85, P815, DOI 10.2307/3285816; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Masoudi-Nejad A, 2006, NUCLEIC ACIDS RES, V34, pW459, DOI 10.1093/nar/gkl066; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moreno E, 1998, FEMS MICROBIOL REV, V22, P255, DOI 10.1111/j.1574-6976.1998.tb00370.x; Nekrasov SV, 2007, J MOL BIOL, V365, P284, DOI 10.1016/j.jmb.2006.09.087; NOGGE G, 1976, EXPERIENTIA, V32, P995, DOI 10.1007/BF01933932; NOGGE G, 1981, PARASITOLOGY, V82, P101; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Perkins SL, 2005, APPL ENVIRON MICROB, V71, P5219, DOI 10.1128/AEM.71.9.5219-5224.2005; REICHENOW E, 1922, INTRAZELLULARE SYMBI, V45; REICHENOW E, 1921, ARCH SCHIFFS U TROPE, V25; Rogers GB, 2009, J MED MICROBIOL, V58, P1401, DOI 10.1099/jmm.0.013334-0; ROTHER D, 2001, EUR J BIOCHEM, V268, P6011; RUBINSTEIN B, 1986, PLANT PHYSIOL, V80, P805, DOI 10.1104/pp.80.4.805; Siddall ME, 2011, PARASITOLOGY, V138, P1815, DOI 10.1017/S0031182011000539; Siddall ME, 2010, CLADISTICS, V26, P444, DOI 10.1111/j.1096-0031.2009.00295.x; Siddall ME, 2005, INVERTEBR SYST, V19, P105, DOI 10.1071/IS04034; Siddall ME, 2004, MOL PHYLOGENET EVOL, V30, P178, DOI 10.1016/S1055-7903(03)00184-2; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Spaepen S, 2009, FEMS MICROBIOL LETT, V291, P195, DOI 10.1111/j.1574-6968.2008.01453.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tamames J, 2001, TRENDS GENET, V17, P124, DOI 10.1016/S0168-9525(00)02212-5; Townsend AR, 2003, FRONT ECOL ENVIRON, V1, P240, DOI 10.2307/3868011; van Borm S, 2002, P ROY SOC B-BIOL SCI, V269, P2023, DOI 10.1098/rspb.2002.2101; VANBRUSSEL AAN, 1977, J GEN MICROBIOL, V101, P51, DOI 10.1099/00221287-101-1-51; Weidner S, 2003, CURR OPIN BIOTECH, V14, P200, DOI 10.1016/S0958-1669(03)00022-3	58	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28192	10.1371/journal.pone.0028192	http://dx.doi.org/10.1371/journal.pone.0028192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132238	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000085
J	Barboni, B; Russo, V; Cecconi, S; Curini, V; Colosimo, A; Garofalo, MLA; Capacchietti, G; Di Giacinto, O; Mattioli, M				Barboni, Barbara; Russo, Valentina; Cecconi, Sandra; Curini, Valentina; Colosimo, Alessia; Garofalo, Maria Luigia A.; Capacchietti, Giulia; Di Giacinto, Oriana; Mattioli, Mauro			In Vitro Grown Sheep Preantral Follicles Yield Oocytes with Normal Nuclear-Epigenetic Maturation	PLOS ONE			English	Article							GERMINAL VESICLE GV; STIMULATING-HORMONE; MOUSE OOCYTES; IMPRINTING ESTABLISHMENT; SITU HYBRIDIZATION; TELOMERE THEORY; CELL COMPLEXES; CULTURE-MEDIUM; CHROMATIN; METHYLATION	Background: Assisted reproductive technologies allow to utilize a limited number of fully grown oocytes despite the presence in the ovary of a large pool of meiotically incompetent gametes potentially able to produce live births. In vitro folliculogenesis could be useful to recruit these oocytes by promoting their growth and differentiation. Methodology/Principal Findings: In vitro folliculogenesis was performed starting from sheep preantral (PA) follicles to evaluate oocyte nuclear/epigenetic maturation. Chromatin configuration, quantification of global DNA methylation, and epigenetic remodelling enzymes were evaluated with immunocytochemistry, telomere elongation was assessed with the Q-FISH technique, while the DNA methylation status at the DMRs of maternally IGF2R and BEGAIN, and paternally H19 methylated imprinted genes was determined by bisulfite sequencing and COBRA. Specifically, 70% of PA underwent early antrum (EA) differentiation and supported in culture oocyte global DNA methylation, telomere elongation, TERT and Dnmt3a redistribution thus mimicking the physiological events that involve the oocyte during the transition from secondary to tertiary follicle. Dnmt1 anticipated cytoplasmic translocation in in vitro grown oocytes did not impair global and single gene DNA methylation. Indeed, the in vitro grown oocytes acquired a methylation profile of IGF2R and BEGAIN compatible with the follicle/oocyte stage reached, and maintained an unmethylated status of H19. In addition, the percentage of oocytes displaying a condensed chromatin configuration resulted lower in in vitro grown oocytes, however, their ability to undergo meiosis and early embryo development after IVF and parthenogenetic activation was similar to that recorded in EA follicle in vivo grown oocytes. Conclusions/Significance: In conclusion, the in vitro folliculogenesis was able to support the intracellular/nuclear mechanisms leading the oocytes to acquire a meiotic and developmental competence. Thus, the in vitro culture may increase the availability of fertilizable oocytes in sheep, and become an in vitro translational model to investigate the mechanisms governing nuclear/epigenetic oocyte maturation.	[Barboni, Barbara; Russo, Valentina; Curini, Valentina; Colosimo, Alessia; Garofalo, Maria Luigia A.; Capacchietti, Giulia; Di Giacinto, Oriana; Mattioli, Mauro] Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy; [Cecconi, Sandra] Univ Aquila, Dept Biomed Sci & Technol, I-67100 Laquila, Italy	University of Teramo; University of L'Aquila	Barboni, B (corresponding author), Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy.	vrusso@unite.it	Russo, Valentina/G-8209-2011; Curini, Valentina VC/C-1094-2016	Russo, Valentina/0000-0003-4368-2534; Curini, Valentina VC/0000-0002-2335-3154; CECCONI, Sandra/0000-0003-1931-394X	Tercas Foundation	Tercas Foundation	This work was supported by a Tercas Foundation grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anckaert E, 2010, BIOL REPROD, V83, P377, DOI 10.1095/biolreprod.109.082164; Anckaert E, 2009, BIOL REPROD, V81, P666, DOI 10.1095/biolreprod.109.076810; Anckaert E, 2009, INT J DEV BIOL, V53, P541, DOI 10.1387/ijdb.082619ea; Arney KL, 2001, INT J DEV BIOL, V45, P533; Bao SQ, 2000, BIOL REPROD, V62, P616, DOI 10.1095/biolreprod62.3.616; Barboni B, 1996, REPROD DOMEST ANIM, V31, P589; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Borghol N, 2006, GENOMICS, V87, P417, DOI 10.1016/j.ygeno.2005.10.008; Bouniol-Baly C, 1999, BIOL REPROD, V60, P580, DOI 10.1095/biolreprod60.3.580; Bowdin S, 2007, HUM REPROD, V22, P3237, DOI 10.1093/humrep/dem268; Cecconi S, 1999, BIOL REPROD, V60, P594, DOI 10.1095/biolreprod60.3.594; Cecconi S, 2004, BIOL REPROD, V70, P12, DOI 10.1095/biolreprod.103.016774; Cecconi S, 2008, ENDOCRINOLOGY, V149, P100, DOI 10.1210/en.2007-0874; Colosimo A, 2009, ANIM GENET, V40, P900, DOI 10.1111/j.1365-2052.2009.01939.x; De La Fuente R, 2006, DEV BIOL, V292, P1, DOI 10.1016/j.ydbio.2006.01.008; De La Fuente R, 2004, DEV BIOL, V275, P447, DOI 10.1016/j.ydbio.2004.08.028; Dean Wendy, 2005, Birth Defects Res C Embryo Today, V75, P98, DOI 10.1002/bdrc.20037; delaSena C, 1995, HEREDITAS, V123, P269; Desai N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-119; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gioia L, 2005, REPRODUCTION, V130, P29, DOI 10.1530/rep.1.00550; Hiura H, 2006, GENES CELLS, V11, P353, DOI 10.1111/j.1365-2443.2006.00943.x; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Keefe DL, 2006, CURR OPIN OBSTET GYN, V18, P280, DOI 10.1097/01.gco.0000193019.05686.49; Keefe DL, 2005, AM J OBSTET GYNECOL, V192, P1256, DOI 10.1016/j.ajog.2005.01.036; Kerjean A, 2003, EUR J HUM GENET, V11, P493, DOI 10.1038/sj.ejhg.5200990; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Laprise SL, 2009, MOL REPROD DEV, V76, P1006, DOI 10.1002/mrd.21058; Ledda S, 1999, REPROD NUTR DEV, V39, P503, DOI 10.1051/rnd:19990409; Li YF, 2011, CELL RES, V21, P466, DOI 10.1038/cr.2011.15; Lima-Verde IB, 2010, CELLS TISSUES ORGANS, V191, P240, DOI 10.1159/000231484; Liu L, 2002, DEV BIOL, V249, P74, DOI 10.1006/dbio.2002.0735; Liu Y, 2006, MICROSC RES TECHNIQ, V69, P799, DOI 10.1002/jemt.20349; Lodde V, 2007, MOL REPROD DEV, V74, P740, DOI 10.1002/mrd.20639; Lucidi P, 2001, THERIOGENOLOGY, V55, P1797, DOI 10.1016/S0093-691X(01)00522-2; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Maher ER, 2005, HUM MOL GENET, V14, pR133, DOI 10.1093/hmg/ddi107; Manipalviratn S, 2009, FERTIL STERIL, V91, P305, DOI 10.1016/j.fertnstert.2009.01.002; Mao JD, 2002, BIOL REPROD, V67, P1197, DOI 10.1095/biolreprod67.4.1197; Market-Velker BA, 2010, BIOL REPROD, V83, P938, DOI 10.1095/biolreprod.110.085480; Market-Velker BA, 2010, HUM MOL GENET, V19, P36, DOI 10.1093/hmg/ddp465; Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9; Miracco C, 2002, BRIT J DERMATOL, V146, P399, DOI 10.1046/j.1365-2133.2002.04600.x; MOOR RM, 1977, J REPROD FERTIL, V49, P101, DOI 10.1530/jrf.0.0490101; Newton H, 1999, J REPROD FERTIL, V115, P141, DOI 10.1530/jrf.0.1150141; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Russo V, 2006, J HISTOCHEM CYTOCHEM, V54, P443, DOI 10.1369/jhc.4A6603.2006; Russo V, 2007, MICROSC RES TECHNIQ, V70, P733, DOI 10.1002/jemt.20462; Sato A, 2007, HUM REPROD, V22, P26, DOI 10.1093/humrep/del316; Steele W, 2005, REPROD BIOMED ONLINE, V10, P755, DOI 10.1016/S1472-6483(10)61120-0; Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221; Swales AKE, 2005, REPRODUCTION, V130, P389, DOI 10.1530/rep.1.00395; Tanemura K, 2005, DEV BIOL, V281, P196, DOI 10.1016/j.ydbio.2005.02.025; TINGEN CM, 2011, H REPROD, V141, P809; Van der Auwera I, 2001, HUM REPROD, V16, P1237, DOI 10.1093/humrep/16.6.1237; Webb R., 2004, J ANIM SCI, V82, P63; Willard ST, 2006, ANIM REPROD SCI, V93, P280, DOI 10.1016/j.anireprosci.2005.08.002; Xu M, 2011, BIOL REPROD, V84, P689, DOI 10.1095/biolreprod.110.088674; Xu M, 2009, BIOTECHNOL BIOENG, V103, P378, DOI 10.1002/bit.22250; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; ZUCCOTTI M, 1995, MOL REPROD DEV, V41, P479, DOI 10.1002/mrd.1080410410	62	31	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27550	10.1371/journal.pone.0027550	http://dx.doi.org/10.1371/journal.pone.0027550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132111	gold, Green Published, Green Submitted			2022-12-25	WOS:000297789900013
J	Mason, THE; Chirichella, R; Richards, SA; Stephens, PA; Willis, SG; Apollonio, M				Mason, Tom H. E.; Chirichella, Roberta; Richards, Shane A.; Stephens, Philip A.; Willis, Stephen G.; Apollonio, Marco			Contrasting Life Histories in Neighbouring Populations of a Large Mammal	PLOS ONE			English	Article							DEPENDENT REPRODUCTIVE EFFORT; SEXUAL SIZE DIMORPHISM; TERMINAL INVESTMENT; SENESCENCE; MORTALITY; SELECTION; BEHAVIOR; COSTS; MALES; MOOSE	Background: A fundamental life history question is how individuals should allocate resources to reproduction optimally over time (reproductive allocation). The reproductive restraint hypothesis predicts that reproductive effort (RE; the allocation of resources to current reproduction) should peak at prime-age, whilst the terminal investment hypothesis predicts that individuals should continue to invest more resources in reproduction throughout life, owing to an ever-decreasing residual reproductive value. There is evidence supporting both hypotheses in the scientific literature. Methodology/Principal Findings: We used an uncommonly large, 38 year dataset on Alpine chamois (Rupicapra rupicapra) shot at various times during the rutting period to test these two hypotheses. We assumed that body mass loss in rutting males was strongly related to RE and, using a process-based approach, modelled how male relative mass loss rates varied with age. For different regions of our study area, we provide evidence consistent with different hypotheses for reproductive allocation. In sites where RE declined in older age, this appears to be strongly linked to declining body condition in old males. In this species, terminal investment may only occur in areas with lower rates of body mass senescence. Conclusions/Significance: Our results show that patterns of reproductive allocation may be more plastic than previously thought. It appears that there is a continuum from downturns in RE at old age to terminal investment that can be manifest, even across adjacent populations. Our work identifies uncertainty in the relationship between reproductive restraint and a lack of competitive ability in older life (driven by body mass senescence); both could explain a decline in RE in old age and may be hard to disentangle in empirical data. We discuss a number of environmental and anthropogenic factors which could influence reproductive life histories, underlining that life history patterns should not be generalised across different populations.	[Mason, Tom H. E.; Richards, Shane A.; Stephens, Philip A.; Willis, Stephen G.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Chirichella, Roberta] Adamello Brenta Nat Pk, Strembo, Trento, Italy; [Chirichella, Roberta; Apollonio, Marco] Univ Sassari, Dept Zool & Evolutionary Genet, I-07100 Sassari, Sardinia, Italy	Durham University; University of Sassari	Mason, THE (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	t.h.mason@durham.ac.uk	Willis, Stephen G/F-8503-2015; Mason, Tom Howard Elliott/AAT-2859-2020; Stephens, Philip/B-8397-2008; Mason, Tom/A-9873-2012	Willis, Stephen G/0000-0002-8656-5808; Mason, Tom Howard Elliott/0000-0003-0834-0571; Stephens, Philip/0000-0001-5849-788X; Richards, Shane/0000-0002-9638-5827; CHIRICHELLA, Roberta/0000-0001-6734-5319	Natural Environment Research Council [NE/H524573/1]; Adamello Brenta Nature Park	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Adamello Brenta Nature Park	TM is funded by a Natural Environment Research Council Doctoral Training Grant (NE/H524573/1). RC was funded by the Adamello Brenta Nature Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apollonio M, 2004, NATURWISSENSCHAFTEN, V91, P579, DOI 10.1007/s00114-004-0574-0; Bardsen BJ, 2011, OIKOS, V120, P245, DOI 10.1111/j.1600-0706.2010.18597.x; Berube CH, 1999, ECOLOGY, V80, P2555, DOI 10.1890/0012-9658(1999)080[2555:IDLARS]2.0.CO;2; Billing AM, 2007, BEHAV ECOL, V18, P535, DOI 10.1093/beheco/arm007; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cameron EZ, 2000, BEHAV ECOL SOCIOBIOL, V47, P243, DOI 10.1007/s002650050661; Candolin U, 2000, ANIM BEHAV, V60, P417, DOI 10.1006/anbe.2000.1481; Clutton-Brock T.H., 1988, P325; Clutton-Brock T. H., 1985, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Coltman DW, 2002, P ROY SOC B-BIOL SCI, V269, P165, DOI 10.1098/rspb.2001.1851; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Couturier M., 1938, CHAMOIS; Creighton JC, 2009, AM NAT, V174, P673, DOI 10.1086/605963; Doughty P, 1997, OECOLOGIA, V110, P508, DOI 10.1007/s004420050187; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Ericsson G, 2001, ECOSCIENCE, V8, P157, DOI 10.1080/11956860.2001.11682641; Evans SR, 2011, EVOLUTION, V65, P1623, DOI 10.1111/j.1558-5646.2011.01253.x; Forsyth DM, 2005, ECOLOGY, V86, P2154, DOI 10.1890/03-0738; GENSAC P, 1990, ARCTIC ALPINE RES, V22, P195, DOI 10.2307/1551304; Isaac JL, 2005, BIOL LETTERS, V1, P271, DOI 10.1098/rsbl.2005.0326; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; Knaus W, 1983, GAMSWILD; KRAMER A, 1969, Zeitschrift fuer Tierpsychologie, V26, P889; KREBS JR, 1993, INTRO BEHAV ECOLOGY, P208; Kreyszig E, 2006, ADV ENG MATH; Loison A, 1999, EVOL ECOL RES, V1, P611; Loison A, 1999, ECOGRAPHY, V22, P20, DOI 10.1111/j.1600-0587.1999.tb00451.x; MAHER CR, 1987, BEHAV ECOL SOCIOBIOL, V21, P91, DOI 10.1007/BF02395436; Mainguy J, 2008, BEHAV ECOL SOCIOBIOL, V62, P935, DOI 10.1007/s00265-007-0517-9; McElligott AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P266, DOI 10.1007/s002650000293; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P4061, DOI 10.1098/rspb.2009.0959; Mysterud A, 2005, J ANIM ECOL, V74, P742, DOI 10.1111/j.1365-2656.2005.00965.x; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; PIANKA ER, 1975, AM NAT, V109, P453, DOI 10.1086/283013; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Rughetti M, 2011, J ZOOL, V284, P257, DOI 10.1111/j.1469-7998.2011.00800.x; Schroder W., 1985, BIOL MANAGEMENT MOUN; Singer FJ, 2002, J MAMMAL, V83, P682, DOI 10.1644/1545-1542(2002)083&lt;0682:IOTHAH&gt;2.0.CO;2; Stearns S.C., 1992, pi; Stephens PA, 2009, ECOLOGY, V90, P2057, DOI 10.1890/08-1369.1; Velando A, 2006, P ROY SOC B-BIOL SCI, V273, P1443, DOI 10.1098/rspb.2006.3480; von Hardenberg A, 2000, ETHOLOGY, V106, P617; Williams G. C., 1966, P307; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Willisch CS, 2007, ETHOLOGY, V113, P97, DOI 10.1111/j.1439-0310.2006.01301.x; Yoccoz NG, 2002, P ROY SOC B-BIOL SCI, V269, P1523, DOI 10.1098/rspb.2002.2047	49	27	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e28002	10.1371/journal.pone.0028002	http://dx.doi.org/10.1371/journal.pone.0028002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125651	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000297789200051
J	Carnarius, C; Kreir, M; Krick, M; Methfessel, C; Moehrle, V; Valerius, O; Bruggemann, A; Steinem, C; Fertig, N				Carnarius, Christian; Kreir, Mohamed; Krick, Marcel; Methfessel, Christoph; Moehrle, Volker; Valerius, Oliver; Brueggemann, Andrea; Steinem, Claudia; Fertig, Niels			Green Fluorescent Protein Changes the Conductance of Connexin 43 (Cx43) Hemichannels Reconstituted in Planar Lipid Bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION HEMICHANNELS; ION CHANNELS; METABOLIC INHIBITION; ZONULA OCCLUDENS-1; STRUCTURAL-CHANGES; CARBOXYL-TERMINUS; ATP RELEASE; EXPRESSION; LIPOSOMES; CHIP	In mammalian tissues, connexin 43 (Cx43) is the most prominent member of the connexin family. In a single lipid bilayer, six connexin subunits assemble into a hemichannel (connexon). Direct communication of apposing cells is realized by two adjacent hemichannels, which can form gap junction channels. Here, we established an expression system in Pichia pastoris to recombinantly produce and purify Cx43 as well as Cx43 fused to green fluorescent protein (GFP). Proteins were isolated from crude cell membrane fractions via affinity chromatography. Cx43 and Cx43-GFP hemichannels were reconstituted in giant unilamellar vesicles as proven by fluorescence microscopy, and their electrophysiological behavior was analyzed on the single channel level by planar patch clamping. Cx43 and Cx43-GFP both showed an ohmic behavior and a voltage-dependent open probability. Cx43 hemichannels exhibited one major mean conductance of 224 +/- 26 picosiemens (pS). In addition, a subconductance state at 124 +/- 5 pS was identified. In contrast, the analysis of Cx43-GFP single channels revealed 10 distinct conductance states in the range of 15 to 250 pS, with a larger open probability at 0 mV as compared with Cx43, which suggests that intermolecular interactions between the GFP molecules alter the electrophysiology of the protein.	[Carnarius, Christian; Krick, Marcel; Steinem, Claudia] Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany; [Kreir, Mohamed; Brueggemann, Andrea; Fertig, Niels] Nan Technol GmbH, D-80636 Munich, Germany; [Methfessel, Christoph; Moehrle, Volker] Bayer Technol Serv GmbH, D-51368 Leverkusen, Germany; [Valerius, Oliver] Univ Gottingen, Inst Microbiol & Genet, D-37077 Gottingen, Germany	University of Gottingen; Bayer AG; University of Gottingen	Steinem, C (corresponding author), Univ Gottingen, Inst Organ & Biomol Chem, Tammannstr 2, D-37077 Gottingen, Germany.	csteine@gwdg.de	Steinem, Claudia/K-7534-2018; Steinem, Claudia/O-4801-2019	Steinem, Claudia/0000-0001-8778-9283; Bruggemann, Andrea/0000-0002-7325-6715; Kreir, Mohamed/0000-0001-9159-9554	European Union [019335]; Bundesministerium fur Bildung und Forschung (BMBF) [13N9110, 13N9108]	European Union(European Commission); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the European Union within the framework of the Marie Curie Training Network 019335 "Translocation" and by grants from the Bundesministerium fur Bildung und Forschung (BMBF 13N9110 and 13N9108).	Ahmad S, 1999, BIOCHEM J, V339, P247, DOI 10.1042/0264-6021:3390247; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bao XY, 2004, J BIOL CHEM, V279, P20058, DOI 10.1074/jbc.M311137200; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Bevans CG, 1999, J BIOL CHEM, V274, P3711, DOI 10.1074/jbc.274.6.3711; Bouvier D, 2009, J BIOL CHEM, V284, P34257, DOI 10.1074/jbc.M109.039594; BRIERLEY RA, 1990, ANN NY ACAD SCI, V589, P350, DOI 10.1111/j.1749-6632.1990.tb24257.x; Bruzzone S, 2001, FASEB J, V15, P10; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cottrell GT, 2002, AM J PHYSIOL-CELL PH, V282, pC1469, DOI 10.1152/ajpcell.00484.2001; Cottrell GT, 2001, AM J PHYSIOL-CELL PH, V281, pC1559, DOI 10.1152/ajpcell.2001.281.5.C1559; Essner JJ, 1996, DEV BIOL, V177, P449, DOI 10.1006/dbio.1996.0177; Falk MM, 1997, EMBO J, V16, P2703, DOI 10.1093/emboj/16.10.2703; Fertig N, 2003, RECEPTOR CHANNEL, V9, P29, DOI 10.1080/10606820308256; Fertig N, 2002, BIOPHYS J, V82, P3056, DOI 10.1016/S0006-3495(02)75646-4; Gassmann O, 2009, J STRUCT BIOL, V168, P168, DOI 10.1016/j.jsb.2009.02.004; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gnidehou S, 2011, PROTEIN EXPRES PURIF, V78, P174, DOI 10.1016/j.pep.2011.04.018; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Hunter AW, 2003, CELL COMMUN ADHES, V10, P211, DOI 10.1080/714040429; John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kaneda M, 2009, BIOMATERIALS, V30, P3971, DOI 10.1016/j.biomaterials.2009.04.006; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Kondo RP, 2000, J MOL CELL CARDIOL, V32, P1859, DOI 10.1006/jmcc.2000.1220; Kreir M, 2008, LAB CHIP, V8, P587, DOI 10.1039/b713982a; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Martinac B, 2010, METHODS MOL BIOL, V606, P31, DOI 10.1007/978-1-60761-447-0_4; MAZET JL, 1992, EUR J BIOCHEM, V210, P249, DOI 10.1111/j.1432-1033.1992.tb17415.x; Moritani Y, 2010, FEBS J, V277, P3343, DOI 10.1111/j.1742-4658.2010.07736.x; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; Pantoja R, 2001, BIOPHYS J, V81, P2389, DOI 10.1016/S0006-3495(01)75885-7; Paznekas WA, 2009, HUM MUTAT, V30, P724, DOI 10.1002/humu.20958; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Rochefort GY, 2010, OSTEOPOROSIS INT, V21, P1457, DOI 10.1007/s00198-010-1194-5; Schalper KA, 2010, AM J PHYSIOL-CELL PH, V299, pC1504, DOI 10.1152/ajpcell.00015.2010; Schmidt C, 2000, ANGEW CHEM INT EDIT, V39, P3137, DOI 10.1002/1521-3773(20000901)39:17<3137::AID-ANIE3137>3.0.CO;2-D; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sondermann M, 2006, BBA-BIOMEMBRANES, V1758, P545, DOI 10.1016/j.bbamem.2006.03.023; Song YN, 2009, PHARMAZIE, V64, P291, DOI 10.1691/ph.2009.8814; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; STAUFFER KA, 1991, J CELL BIOL, V115, P141, DOI 10.1083/jcb.115.1.141; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Streicher P, 2009, BBA-BIOMEMBRANES, V1788, P2291, DOI 10.1016/j.bbamem.2009.07.025; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; YEAGER M, 1992, J MOL BIOL, V223, P929, DOI 10.1016/0022-2836(92)90253-G; Yeager M, 1998, J STRUCT BIOL, V121, P231, DOI 10.1006/jsbi.1998.3972	59	13	14	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2877	2886		10.1074/jbc.M111.319871	http://dx.doi.org/10.1074/jbc.M111.319871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139870	Green Published, hybrid			2022-12-25	WOS:000300292300059
J	Chimote, AA; Kuras, Z; Conforti, L				Chimote, Ameet A.; Kuras, Zerrin; Conforti, Laura			Disruption of Kv1.3 Channel Forward Vesicular Trafficking by Hypoxia in Human T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; BREFELDIN-A; POTASSIUM CHANNEL; PLASMA-MEMBRANE; CELL-SURFACE; LIVING CELLS; K+ CHANNEL; CLATHRIN; VESICLE; EXPRESSION	Hypoxia in solid tumors contributes to decreased immunosurveillance via down-regulation of Kv1.3 channels in T lymphocytes and associated T cell function inhibition. However, the mechanisms responsible for Kv1.3 down-regulation are not understood. We hypothesized that chronic hypoxia reduces Kv1.3 surface expression via alterations in membrane trafficking. Chronic hypoxia decreased Kv1.3 surface expression and current density in Jurkat T cells. Inhibition of either protein synthesis or degradation and endocytosis did not prevent this effect. Instead, blockade of clathrin-coated vesicle formation and forward trafficking prevented the Kv1.3 surface expression decrease in hypoxia. Confocal microscopy revealed an increased retention of Kv1.3 in the trans-Golgi during hypoxia. Expression of adaptor protein-1 (AP1), responsible for clathrin-coated vesicle formation at the trans-Golgi, was selectively down-regulated by hypoxia. Furthermore, AP1 down-regulation increased Kv1.3 retention in the trans-Golgi and reduced Kv1.3 currents. Our results indicate that hypoxia disrupts AP1/clathrin-mediated forward trafficking of Kv1.3 from the trans-Golgi to the plasma membrane thus contributing to decreased Kv1.3 surface expression in T lymphocytes.	[Chimote, Ameet A.; Kuras, Zerrin; Conforti, Laura] Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45267 USA; [Conforti, Laura] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Conforti, L (corresponding author), 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	laura.conforti@uc.edu	Chimote, Ameet A/R-5357-2016	Chimote, Ameet/0000-0001-5163-0123	National Institutes of Health [2R01CA095286]; NATIONAL CANCER INSTITUTE [R01CA095286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01CA095286 (to L. C.).	Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Anitei M, 2010, MOL MEMBR BIOL, V27, P443, DOI 10.3109/09687688.2010.522601; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Caldwell CC, 2001, J IMMUNOL, V167, P6140, DOI 10.4049/jimmunol.167.11.6140; CHAKRABARTI R, 1994, J BIOL CHEM, V269, P7926; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Choi WS, 2005, CIRC RES, V97, P363, DOI 10.1161/01.RES.0000179535.06458.f8; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Conforti L, 1997, J PHYSIOL-LONDON, V502, P293, DOI 10.1111/j.1469-7793.1997.293bk.x; Conforti L, 2003, J IMMUNOL, V170, P695, DOI 10.4049/jimmunol.170.2.695; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Doray B, 2001, MOL BIOL CELL, V12, P1925, DOI 10.1091/mbc.12.7.1925; Gonzalez A, 2009, FEBS LETT, V583, P3784, DOI 10.1016/j.febslet.2009.10.050; Gonzalez-Gronow M, 2007, J BIOL CHEM, V282, P32811, DOI 10.1074/jbc.M703342200; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Hansen JS, 2008, BIOCHEM J, V410, P463, DOI 10.1042/BJ20070559; Hartness ME, 2003, J BIOL CHEM, V278, P51422, DOI 10.1074/jbc.M309463200; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Huang BH, 2011, BLOOD, V118, P2918, DOI 10.1182/blood-2011-03-341214; Jansen JA, 2008, BIOCHEM BIOPH RES CO, V367, P687, DOI 10.1016/j.bbrc.2007.12.168; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Kirchhof MG, 2008, J IMMUNOL, V181, P1927, DOI 10.4049/jimmunol.181.3.1927; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kojima H, 2003, CURR PHARM DESIGN, V9, P1827, DOI 10.2174/1381612033454388; Kosolapov A, 2004, NEURON, V44, P295, DOI 10.1016/j.neuron.2004.09.011; Lee I, 2008, ARCH BIOCHEM BIOPHYS, V479, P63, DOI 10.1016/j.abb.2008.08.009; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mattera R, 2011, J BIOL CHEM, V286, P2022, DOI 10.1074/jbc.M110.197178; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Moudgil R, 2006, MICROCIRCULATION, V13, P615, DOI 10.1080/10739680600930222; Nanduri J, 2009, BIOCHEM BIOPH RES CO, V388, P212, DOI 10.1016/j.bbrc.2009.07.149; Nesti E, 2004, MOL BIOL CELL, V15, P4073, DOI 10.1091/mbc.E03-11-0788; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nicolaou SA, 2010, CELL CALCIUM, V47, P19, DOI 10.1016/j.ceca.2009.11.001; Nicolaou SA, 2009, J IMMUNOL, V183, P6296, DOI 10.4049/jimmunol.0900613; O'Neil-Andersen NJ, 2002, CLIN DIAGN LAB IMMUN, V9, P243, DOI 10.1128/CDLI.9.2.243-250.2001; Park JH, 1999, AM J PHYSIOL-CELL PH, V277, pC1066, DOI 10.1152/ajpcell.1999.277.6.C1066; Peers C, 2004, CELL CALCIUM, V36, P341, DOI 10.1016/j.ceca.2004.02.005; Presley JF, 1997, J BIOL CHEM, V272, P13929, DOI 10.1074/jbc.272.21.13929; Progida C, 2010, J CELL SCI, V123, P1480, DOI 10.1242/jcs.051474; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Ren QG, 2009, J MOL NEUROSCI, V38, P57, DOI 10.1007/s12031-008-9161-8; Robbins JR, 2005, J PHYSIOL-LONDON, V564, P131, DOI 10.1113/jphysiol.2004.081893; Roche PA, 1999, IMMUNITY, V11, P391, DOI 10.1016/S1074-7613(00)80114-4; Rodriguez-Boulan E, 2005, BBA-MOL CELL RES, V1744, P455, DOI 10.1016/j.bbamcr.2005.04.007; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Sole L, 2009, J CELL SCI, V122, P3738, DOI 10.1242/jcs.056689; Steele DF, 2007, J PHYSIOL-LONDON, V582, P17, DOI 10.1113/jphysiol.2007.130245; Szigligeti P, 2006, J PHYSIOL-LONDON, V573, P357, DOI 10.1113/jphysiol.2006.109967; Traub LM, 2010, NATURE, V465, P556, DOI 10.1038/465556a; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Vanoye CG, 2010, CHANNELS, V4, P108, DOI 10.4161/chan.4.2.11141; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yoon SO, 2005, CANCER RES, V65, P2761, DOI 10.1158/0008-5472.CAN-04-4122; Yotnda P, 2010, METHODS MOL BIOL, V651, P1, DOI 10.1007/978-1-60761-786-0_1; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2; Zadeh AD, 2008, J PHYSIOL-LONDON, V586, P4793, DOI 10.1113/jphysiol.2008.161570; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	65	27	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2055	2067		10.1074/jbc.M111.274209	http://dx.doi.org/10.1074/jbc.M111.274209			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22134923	hybrid, Green Published			2022-12-25	WOS:000299321000046
J	Pullen, NA; Barnstein, BO; Falanga, YT; Wang, ZQ; Suzuki, R; Tamang, TDL; Khurana, MC; Harry, EA; Draber, P; Bunting, KD; Mizuno, K; Wilson, BS; Ryan, JJ				Pullen, Nicholas A.; Barnstein, Brian O.; Falanga, Yves T.; Wang, Zhengqi; Suzuki, Ryo; Tamang, Tenchee D. Lama; Khurana, Michele C.; Harry, Emily A.; Draber, Petr; Bunting, Kevin D.; Mizuno, Kazuya; Wilson, Bridget S.; Ryan, John J.			Novel Mechanism for Fc epsilon RI-mediated Signal Transducer and Activator of Transcription 5 (STAT5) Tyrosine Phosphorylation and the Selective Influence of STAT5B over Mast Cell Cytokine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLERGIC RESPONSES; PROLIFERATION; EXPRESSION; SURVIVAL; DOMAINS; PATHWAY; ASTHMA; KINASE; GAB2; DEGRANULATION	Previous studies indicate that STAT5 expression is required for mast cell development, survival, and IgE-mediated function. STAT5 tyrosine phosphorylation is swiftly and transiently induced by activation of the high affinity IgE receptor, Fc epsilon RI. However, the mechanism for this mode of activation remains unknown. In this study we observed that STAT5 co-localizes with Fc epsilon RI in antigen-stimulated mast cells. This localization was supported by cholesterol depletion of membranes, which ablated STAT5 tyrosine phosphorylation. Through the use of various pharmacological inhibitors and murine knock-out models, we found that IgE-mediated STAT5 activation is dependent upon Fyn kinase, independent of Syk, PI3K, Akt, Bruton's tyrosine kinase, and JAK2, and enhanced in the context of Lyn kinase deficiency. STAT5 immunoprecipitation revealed that unphosphorylated protein preassociates with Fyn and that this association diminishes significantly during mast cell activation. SHP-1 tyrosine phosphatase deficiency modestly enhanced STAT5 phosphorylation. This effect was more apparent in the absence of Gab2, a scaffolding protein that docks with multiple negative regulators, including SHP-1, SHP-2, and Lyn. Targeting of STAT5A or B with specific siRNA pools revealed that IgE-mediated mast cell cytokine production is selectively dependent upon the STAT5B isoform. Altogether, these data implicate Fyn as the major positive mediator of STAT5 after Fc epsilon RI engagement and demonstrate importantly distinct roles for STAT5A and STAT5B in mast cell function.	[Pullen, Nicholas A.; Barnstein, Brian O.; Falanga, Yves T.; Tamang, Tenchee D. Lama; Khurana, Michele C.; Harry, Emily A.; Ryan, John J.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; [Pullen, Nicholas A.; Barnstein, Brian O.; Falanga, Yves T.; Tamang, Tenchee D. Lama; Khurana, Michele C.; Harry, Emily A.; Ryan, John J.] Virginia Commonwealth Univ, Asthma & Allerg Dis Cooperat Res Ctr, Richmond, VA 23284 USA; [Wang, Zhengqi; Bunting, Kevin D.] Emory Univ, Aflac Canc Ctr Childrens Healthcare Atlanta, Atlanta, GA 30345 USA; [Wang, Zhengqi; Bunting, Kevin D.] Emory Univ, Dept Pediat, Atlanta, GA 30345 USA; [Suzuki, Ryo] NIAMS, Immunogenet Mol Lab, NIH, Bethesda, MD 20892 USA; [Draber, Petr] Acad Sci Czech Republic, Dept Signal Transduct, Inst Mol Genet, Prague 4, Czech Republic; [Mizuno, Kazuya] Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Neurosci, Tokyo 1838526, Japan; [Wilson, Bridget S.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA	Virginia Commonwealth University; Virginia Commonwealth University; Children's Healthcare of Atlanta (CHOA); Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; University of New Mexico; University of New Mexico's Health Sciences Center	Ryan, JJ (corresponding author), Virginia Commonwealth Univ, Dept Biol, 1000 W Cary St, Richmond, VA 23284 USA.	jjryan@vcu.edu	Draber, Petr/E-1119-2018; Pullen, Nicholas/X-3294-2019; Draber, Petr/G-3412-2014	Draber, Petr/0000-0002-3986-2025; Pullen, Nicholas/0000-0002-4014-9278; Draber, Petr/0000-0002-3986-2025	National Institutes of Health [1R01 AI59638, R01DK059380, AI051575, GM065794]; Virginia Commonwealth University [U19A1077435]; Ministry of Education, Youth and Sports of the Czech Republic [1M0506]; Grant Agency of the Czech Republic [P302/10/1759, 301/09/1826]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059638, R01AI051575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM093857, F32GM065794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01 AI59638 (to J. R.), R01DK059380 (to K. D. B.), and AI051575 and GM065794 (to B. S. W.). This work was also supported by Virginia Commonwealth University Allergy Core Grant U19A1077435, Ministry of Education, Youth and Sports of the Czech Republic Project 1M0506 (to P. D.), and Grant Agency of the Czech Republic Grants P302/10/1759 and 301/09/1826 (to P. D.).	Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Barbu EA, 2010, J BIOL CHEM, V285, P15761, DOI 10.1074/jbc.M110.109413; Barnstein BO, 2006, J IMMUNOL, V177, P3421, DOI 10.4049/jimmunol.177.5.3421; Benekli M, 2009, J CLIN ONCOL, V27, P4422, DOI 10.1200/JCO.2008.21.3264; Bunting KD, 2007, FRONT BIOSCI-LANDMRK, V12, P2807, DOI 10.2741/2274; Chaix A, 2011, J BIOL CHEM, V286, P5956, DOI 10.1074/jbc.M110.182642; Field KA, 2000, MOL BIOL CELL, V11, P3661, DOI 10.1091/mbc.11.10.3661; Friedbichler K, 2010, BLOOD, V116, P1548, DOI 10.1182/blood-2009-12-258913; Fuhlbrigge AL, 2002, AM J RESP CRIT CARE, V166, P1044, DOI 10.1164/rccm.2107057; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gibson PG, 2010, LANCET, V376, P803, DOI 10.1016/S0140-6736(10)61087-2; Gomez G, 2005, J IMMUNOL, V175, P7602, DOI 10.4049/jimmunol.175.11.7602; Gotoh A, 1996, BLOOD, V88, P138; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; HAASE P, 1995, J VEG SCI, V6, P575, DOI 10.2307/3236356; Harir N, 2007, BLOOD, V109, P1678, DOI 10.1182/blood-2006-01-029918; Hexner EO, 2008, BLOOD, V111, P5663, DOI 10.1182/blood-2007-04-083402; Ikeda K, 2005, INT ARCH ALLERGY IMM, V137, P45, DOI 10.1159/000085431; Iwaki S, 2007, INT J BIOCHEM CELL B, V39, P868, DOI 10.1016/j.biocel.2006.10.018; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P2325, DOI 10.1073/pnas.0806963106; Kim MS, 2008, TRENDS IMMUNOL, V29, P493, DOI 10.1016/j.it.2008.07.004; Li GQ, 2010, BLOOD, V115, P1416, DOI 10.1182/blood-2009-07-234963; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Morales JK, 2010, GENES IMMUN, V11, P599, DOI 10.1038/gene.2010.35; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; Nakata K, 2011, MOL IMMUNOL, V48, P472, DOI 10.1016/j.molimm.2010.10.001; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Ryan JJ, 1997, EXP HEMATOL, V25, P357; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Setiadi H, 2008, BLOOD, V111, P1989, DOI 10.1182/blood-2007-09-113423; Shelburne CP, 2003, BLOOD, V102, P1290, DOI 10.1182/blood-2002-11-3490; Suzuki R, 2010, J LEUKOCYTE BIOL, V88, P863, DOI 10.1189/jlb.0510253; Wilson Bridget S., 2007, V398, P245, DOI 10.1007/978-1-59745-513-8_17; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574; Xue M, 2007, MOL BIOL CELL, V18, P1410, DOI 10.1091/mbc.E05-11-1073; Yamashita Y, 2007, J IMMUNOL, V179, P740, DOI 10.4049/jimmunol.179.2.740; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Yu WM, 2002, BLOOD, V99, P2351, DOI 10.1182/blood.V99.7.2351; Zhang Y, 2007, BLOOD, V110, P116, DOI 10.1182/blood-2006-11-060707	43	30	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2045	2054		10.1074/jbc.M111.311142	http://dx.doi.org/10.1074/jbc.M111.311142			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22130676	Green Published, hybrid			2022-12-25	WOS:000299321000045
J	Biesold, SE; Ritz, D; Gloza-Rausch, F; Wollny, R; Drexler, JF; Corman, VM; Kalko, EKV; Oppong, S; Drosten, C; Muller, MA				Biesold, Susanne E.; Ritz, Daniel; Gloza-Rausch, Florian; Wollny, Robert; Drexler, Jan Felix; Corman, Victor M.; Kalko, Elisabeth K. V.; Oppong, Samuel; Drosten, Christian; Mueller, Marcel A.			Type I Interferon Reaction to Viral Infection in Interferon-Competent, Immortalized Cell Lines from the African Fruit Bat Eidolon helvum	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PTEROPUS-GIGANTEUS; GENE-EXPRESSION; RESERVOIR HOSTS; VIRUS-INFECTION; SINDBIS VIRUS; MARBURG VIRUS; V-PROTEIN; ASSAY; EVOLUTION	Bats harbor several highly pathogenic zoonotic viruses including Rabies, Marburg, and henipaviruses, without overt clinical symptoms in the animals. It has been suspected that bats might have evolved particularly effective mechanisms to suppress viral replication. Here, we investigated interferon (IFN) response, -induction, -secretion and -signaling in epithelial-like cells of the relevant and abundant African fruit bat species, Eidolon helvum (E. helvum). Immortalized cell lines were generated; their potential to induce and react on IFN was confirmed, and biological assays were adapted to application in bat cell cultures, enabling comparison of landmark IFN properties with that of common mammalian cell lines. E. helvum cells were fully capable of reacting to viral and artificial IFN stimuli. E. helvum cells showed highest IFN mRNA induction, highly productive IFN protein secretion, and evidence of efficient IFN stimulated gene induction. In an Alphavirus infection model, O'nyong-nyong virus exhibited strong IFN induction but evaded the IFN response by translational rather than transcriptional shutoff, similar to other Alphavirus infections. These novel IFN-competent cell lines will allow comparative research on zoonotic, bat-borne viruses in order to model mechanisms of viral maintenance and emergence in bat reservoirs.	[Biesold, Susanne E.; Ritz, Daniel; Gloza-Rausch, Florian; Wollny, Robert; Drexler, Jan Felix; Corman, Victor M.; Drosten, Christian; Mueller, Marcel A.] Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany; [Gloza-Rausch, Florian] Noctalis, Ctr Bat Protect & Informat, Bad Segeberg, Germany; [Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama; [Oppong, Samuel] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana	University of Bonn; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute; Kwame Nkrumah University Science & Technology	Biesold, SE (corresponding author), Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany.	drosten@virology-bonn.de	Drexler, Jan Felix/GMW-5098-2022; Drexler, Jan Felix/C-1004-2014; Corman, Victor M/K-1319-2019; Müller, Marcel A./O-2425-2019	Corman, Victor M/0000-0002-3605-0136; Müller, Marcel A./0000-0003-2242-5117; Zweerink, Susanne/0000-0003-0926-8436; Drexler, Jan Felix/0000-0002-3509-0232	German Ministry of Education [SARS II 01KI1005A]; European Commission [228292, 223498]	German Ministry of Education; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the German Ministry of Education (project code SARS II 01KI1005A) and grants from the European Commission (contracts FP7-EVA number 228292 and FP7-EMPERIE number 223498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT ADT, 1984, J VIROL METHODS, V8, P349, DOI 10.1016/0166-0934(84)90072-7; Beitzel BF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001146; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; BLACKBURN NK, 1982, CENT AFR J MED, V28, P201; BOULGER L. R., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P421, DOI 10.1016/0035-9203(58)90127-5; Breakwell L, 2007, J VIROL, V81, P8677, DOI 10.1128/JVI.02411-06; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; CHAKRAVARTY AK, 1994, LYMPHOLOGY, V27, P97; CORREAGIRON P, 1972, SCIENCE, V175, P546, DOI 10.1126/science.175.4021.546; Cowled C, 2011, DEV COMP IMMUNOL, V35, P7, DOI 10.1016/j.dci.2010.07.006; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Frolova EI, 2002, J VIROL, V76, P11254, DOI 10.1128/JVI.76.22.11254-11264.2002; Hagmaier K, 2007, J GEN VIROL, V88, P956, DOI 10.1099/vir.0.82579-0; Hagmaier K, 2006, J GEN VIROL, V87, P3649, DOI 10.1099/vir.0.82261-0; Heaton PR, 1997, J CLIN MICROBIOL, V35, P2762, DOI 10.1128/JCM.35.11.2762-2766.1997; Herzog P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-138; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Iha K, 2010, J VET MED SCI, V72, P217, DOI 10.1292/jvms.09-0050; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jordan I, 2009, VIRUS RES, V145, P54, DOI 10.1016/j.virusres.2009.06.007; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kuhl A, 2011, J INFECT DIS, V204, pS840, DOI 10.1093/infdis/jir306; Kulasegaran-Shylini R, 2009, VIROLOGY, V387, P211, DOI 10.1016/j.virol.2009.02.027; Kuri T, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-50; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCMURRAY DN, 1982, DEV COMP IMMUNOL, V6, P557, DOI 10.1016/S0145-305X(82)80042-6; MOSCA JD, 1986, MOL CELL BIOL, V6, P2279, DOI 10.1128/MCB.6.6.2279; Muller MA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-6; Panning M, 2007, J INFECT DIS, V196, pS199, DOI 10.1086/520600; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Perler L, 1999, J IMMUNOL METHODS, V222, P189, DOI 10.1016/S0022-1759(98)00198-7; Pfefferle S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-131; Ryman KD, 2008, IMMUNOL REV, V225, P27, DOI 10.1111/j.1600-065X.2008.00670.x; SARKAR SK, 1991, DEV COMP IMMUNOL, V15, P423, DOI 10.1016/0145-305X(91)90034-V; Simmons NB, 2005, SCIENCE, V307, P527, DOI 10.1126/science.1108871; STEWART WE, 1969, J VIROL, V4, P147, DOI 10.1128/JVI.4.2.147-153.1969; Stormer M, 2009, INT J MED MICROBIOL, V299, P291, DOI 10.1016/j.ijmm.2008.08.002; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Vallo P, 2008, ACTA CHIROPTEROL, V10, P193, DOI 10.3161/150811008X414782; Virtue ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022488; Volkova E, 2008, VIROLOGY, V377, P160, DOI 10.1016/j.virol.2008.04.020; Weingartl HM, 2009, VET J, V181, P211, DOI 10.1016/j.tvjl.2008.10.016; White LK, 2011, J VIROL, V85, P606, DOI 10.1128/JVI.00767-10; Zhou P, 2011, J IMMUNOL, V186, P3138, DOI 10.4049/jimmunol.1003115	54	53	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28131	10.1371/journal.pone.0028131	http://dx.doi.org/10.1371/journal.pone.0028131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140523	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168100039
J	Diaz-Rodriguez, E; Alvarez-Fernandez, S; Chen, X; Paiva, B; Lopez-Perez, R; Garcia-Hernandez, JL; Miguel, JFS; Pandiella, A				Diaz-Rodriguez, Elena; Alvarez-Fernandez, Stela; Chen, Xi; Paiva, Bruno; Lopez-Perez, Ricardo; Luis Garcia-Hernandez, Juan; San Miguel, Jesus F.; Pandiella, Atanasio			Deficient Spindle Assembly Checkpoint in Multiple Myeloma	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; MITOTIC CHECKPOINT; KINASE INHIBITOR; TUMOR-SUPPRESSOR; AURORA KINASES; IN-VIVO; ANEUPLOIDY; CANCER; INSTABILITY; MAD2	Multiple myeloma (MM) is a hematological disease characterized by an abnormal accumulation of plasma cells in the bone marrow. These cells have frequent cytogenetic abnormalities including translocations of the immunoglobulin heavy chain gene and chromosomal gains and losses. In fact, a singular characteristic differentiating MM from other hematological malignancies is the presence of a high degree of aneuploidies. As chromosomal abnormalities can be generated by alterations in the spindle assembly checkpoint (SAC), the functionality of such checkpoint was tested in MM. When SAC components were analyzed in MM cell lines, the RNA levels of most of them were conserved. Nevertheless, the protein content of some key constituents was very low in several cell lines, as was the case of MAD2 or CDC20 in RPMI-8226 or RPMI-LR5 cells. The recovery of their cellular content did not substantially affect cell growth, but improved their ability to segregate chromosomes. Finally, SAC functionality was tested by challenging cells with agents disrupting microtubule dynamics. Most of the cell lines analyzed exhibited functional defects in this checkpoint. Based on the data obtained, alterations both in SAC components and their functionality have been detected in MM, pointing to this pathway as a potential target in MM treatment.	[Diaz-Rodriguez, Elena; Alvarez-Fernandez, Stela; Chen, Xi; Paiva, Bruno; Lopez-Perez, Ricardo; Luis Garcia-Hernandez, Juan; San Miguel, Jesus F.; Pandiella, Atanasio] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain; [Paiva, Bruno; Luis Garcia-Hernandez, Juan; San Miguel, Jesus F.] Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca	Diaz-Rodriguez, E (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain.	ediaz@usal.es	Díaz-Rodriguez, Elena/I-4784-2015; Pandiella, Atanasio/O-5180-2014; Paiva, Bruno/AAB-8881-2021; San-Miguel, Jesús F./V-8977-2018	Díaz-Rodriguez, Elena/0000-0002-6240-6327; Pandiella, Atanasio/0000-0002-4704-8971; Paiva, Bruno/0000-0003-1977-3815; San-Miguel, Jesús F./0000-0002-9183-4857; Lopez-Perez, Ricardo/0000-0001-9495-8604	Ministry of Science and Education of Spain [BFU2006-01813/BMC, BFU2009-07728/BMC]; Instituto de Salud Carlos III [RD06/0020/0041]; European Community; Fundacion Ramon Areces; Spanish Association for Cancer Research (AACR)	Ministry of Science and Education of Spain(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Community(European Commission); Fundacion Ramon Areces; Spanish Association for Cancer Research (AACR)	This work was supported by grants from the Ministry of Science and Education of Spain (BFU2006-01813/BMC and BFU2009-07728/BMC) and Instituto de Salud Carlos III (RD06/0020/0041). The Cancer Research Institute, and the work carried out at the authors' laboratory received support from the European Community through the regional development funding program (FEDER), and from the Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We want to thank Dr. M. P. Sacristan for helpful discussion of the project and members of the Pandiella lab for discussion and encouragement. We also want to thank Dr. Pintor-Toro for the generous gift of the anti-PTTG antibody and Dr. Hernando for the MSCV and MSCV-IG-hMAD2 retroviral vectors. E.D-R. is supported by the Spanish Association for Cancer Research (AACR).	Amiel A, 2005, CANCER GENET CYTOGEN, V163, P12, DOI 10.1016/j.cancergencyto.2005.04.007; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Bolanos-Garcia VM, 2011, TRENDS BIOCHEM SCI, V36, P141, DOI 10.1016/j.tibs.2010.08.004; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Carro A, 2010, NUCLEIC ACIDS RES, V38, pW182, DOI 10.1093/nar/gkq441; Carvajal-Vergara X, 2005, BLOOD, V105, P4492, DOI 10.1182/blood-2004-08-2985; Ching WJ, 2009, ENVIRON MOL MUTAGEN, V50, P697, DOI 10.1002/em.20528; Diaz-Rodriguez E, 2008, P NATL ACAD SCI USA, V105, P16719, DOI 10.1073/pnas.0803504105; Diaz-Rodriguez E, 2010, J CELL SCI, V123, P3146, DOI 10.1242/jcs.070516; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Evans RP, 2008, BRIT J HAEMATOL, V140, P295, DOI 10.1111/j.1365-2141.2007.06913.x; Fonseca R, 2003, BLOOD, V101, P4569, DOI 10.1182/blood-2002-10-3017; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Gutierrez NC, 2007, CLIN TRANSL ONCOL, V9, P618, DOI 10.1007/s12094-007-0114-4; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Ho P Joy, 2002, Rev Clin Exp Hematol, V6, P276, DOI 10.1046/j.1468-0734.2002.00081.x; Hose D, 2009, BLOOD, V113, P4331, DOI 10.1182/blood-2008-09-178350; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; KUNG AL, 1990, P NATL ACAD SCI USA, V87, P9553, DOI 10.1073/pnas.87.24.9553; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma MH, 2003, CLIN CANCER RES, V9, P1136; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Negri JM, 2009, BRIT J HAEMATOL, V147, P672, DOI 10.1111/j.1365-2141.2009.07891.x; Ocio EM, 2008, LANCET ONCOL, V9, P1157, DOI 10.1016/S1470-2045(08)70304-8; Pandiella A, 2003, BRIT J HAEMATOL, V123, P858, DOI 10.1046/j.1365-2141.2003.04706.x; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Sawyer JR, 2011, CANCER GENET-NY, V204, P3, DOI 10.1016/j.cancergencyto.2010.11.002; Schliekelman M, 2009, CANCER RES, V69, P45, DOI 10.1158/0008-5472.CAN-07-6330; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Shepard JL, 2007, GENE DEV, V21, P55, DOI 10.1101/gad.1470407; Shi YJ, 2007, BLOOD, V109, P3915, DOI 10.1182/blood-2006-07-037671; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stewart HJ, 2011, EXP HEMATOL, V39, P330, DOI 10.1016/j.exphem.2010.12.006; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Wang XJ, 2010, BRIT J HAEMATOL, V150, P313, DOI 10.1111/j.1365-2141.2010.08248.x; Wassmann K, 2001, CURR OPIN GENET DEV, V11, P83, DOI 10.1016/S0959-437X(00)00161-1; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003	41	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27583	10.1371/journal.pone.0027583	http://dx.doi.org/10.1371/journal.pone.0027583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132115	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000028
J	Ma, N; Huang, ZB; Chen, XH; He, F; Wang, K; Liu, W; Zhao, LF; Xu, XM; Liao, WJ; Ruan, H; Luo, SQ; Zhang, WQ				Ma, Ning; Huang, Zhibin; Chen, Xiaohui; He, Fei; Wang, Kun; Liu, Wei; Zhao, Linfeng; Xu, Xiangmin; Liao, Wangjun; Ruan, Hua; Luo, Shenqiu; Zhang, Wenqing			Characterization of a Weak Allele of Zebrafish cloche Mutant	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; DEFINITIVE HEMATOPOIESIS; AORTIC ENDOTHELIUM; MOUSE EMBRYO; GENE CLOCHE; DIFFERENTIATION; VERTEBRATE; MUTATIONS; PRECURSOR; LINEAGES	Hematopoiesis is a complicated and dynamic process about which the molecular mechanisms remain poorly understood. Danio rerio (zebrafish) is an excellent vertebrate system for studying hematopoiesis and developmental mechanisms. In the previous study, we isolated and identified a cloche(172) (clo(172)) mutant, a novel allele compared to the original cloche (clo) mutant, through using complementation test and initial mapping. Here, according to whole mount in-situ hybridization, we report that the endothelial cells in clo(172) mutant embryos, although initially developed, failed to form the functional vascular system eventually. In addition, further characterization indicates that the clo(172) mutant exhibited weaker defects instead of completely lost in primitive erythroid cells and definitive hematopoietic cells compared with the clo(s5) mutant. In contrast, primitive myeloid cells were totally lost in clo(172) mutant. Furthermore, these reappeared definitive myeloid cells were demonstrated to initiate from the remaining hematopoietic stem cells (HSCs) in clo 172 mutant, confirmed by the dramatic decrease of lyc in clo(172)runx1(w84x) double mutant. Collectively, the clo(172) mutant is a weak allele compared to the clo(s5) mutant, therefore providing a model for studying the early development of hematopoietic and vascular system, as well as an opportunity to further understand the function of the cloche gene.	[Ma, Ning; Huang, Zhibin; Chen, Xiaohui; Wang, Kun; Liu, Wei; Zhao, Linfeng; Luo, Shenqiu; Zhang, Wenqing] So Med Univ, Key Lab Zebrafish Modeling & Drug Screening Human, Guangdong Higher Educ Inst, Dept Cell Biol,Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [He, Fei] Key Lab Shock & Microcirculat Res Guangdong, Guangzhou, Guangdong, Peoples R China; [Xu, Xiangmin] So Med Univ, Dept Med Genet, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [Liao, Wangjun] So Med Univ, Dept Oncol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Ruan, Hua] Southwest Univ, Key Lab Freshwater Fish Reprod & Dev, Minist Educ,Sch Life Sci, State Key Lab Breeding Base Ecoenviroments & Bio, Chongqing, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southwest University - China	Ma, N (corresponding author), So Med Univ, Key Lab Zebrafish Modeling & Drug Screening Human, Guangdong Higher Educ Inst, Dept Cell Biol,Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China.	zzwwqq@smu.edu.cn	zhang, wenqing/GYA-0786-2022		National Basic Research Program of China [2012CB945102]; National Natural Science Foundation of China [31171403, 30671074]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (Grant No.: 2012CB945102) and the National Natural Science Foundation of China (Grant No.: 31171403 and 30671074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, ZEBRAFISH BOOK GUIDE; Baldessari D, 2008, PHARMACOL THERAPEUT, V118, P206, DOI 10.1016/j.pharmthera.2008.02.010; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Bertrand JY, 2007, DEVELOPMENT, V134, P4147, DOI 10.1242/dev.012385; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Chen AT, 2009, J CELL BIOCHEM, V108, P35, DOI 10.1002/jcb.22251; CHEN MJ, 2009, RUNX1 IS REQUIRED EN, P887; Choi K, 1998, DEVELOPMENT, V125, P725; Crowhurst MO, 2002, INT J DEV BIOL, V46, P483; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; de Jong JLO, 2005, ANNU REV GENET, V39, P481, DOI 10.1146/annurev.genet.39.073003.095931; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Driever W, 1996, DEVELOPMENT, V123, P37; Ellertsdottir E, 2010, DEV BIOL, V341, P56, DOI 10.1016/j.ydbio.2009.10.035; Ellett F, 2010, CURR OPIN PHARMACOL, V10, P563, DOI 10.1016/j.coph.2010.05.004; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Galloway JL, 2003, CURR TOP DEV BIOL, V53, P139, DOI 10.1016/S0070-2153(03)53004-6; Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jin H, 2007, BLOOD, V109, P5208, DOI 10.1182/blood-2007-01-069005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Liao W, 1997, DEVELOPMENT, V124, P381; Liao W, 2000, DEVELOPMENT, V127, P4303; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Long QM, 1997, DEVELOPMENT, V124, P4105; Ma Ning, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P458; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Parker L, 1999, DEVELOPMENT, V126, P2643; Roman BL, 2000, BIOESSAYS, V22, P882; Roman BL, 2002, DEVELOPMENT, V129, P3009; Sood R, 2010, BLOOD, V115, P2806, DOI 10.1182/blood-2009-08-236729; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Weber GJ, 2005, BLOOD, V106, P521, DOI 10.1182/blood-2004-11-4541; Weinstein BM, 1996, DEVELOPMENT, V123, P303; Xiong JW, 2008, CIRC RES, V102, P1057, DOI 10.1161/CIRCRESAHA.107.163907	44	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27540	10.1371/journal.pone.0027540	http://dx.doi.org/10.1371/journal.pone.0027540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132109	gold, Green Submitted, Green Published			2022-12-25	WOS:000298162000025
J	Prado, BR; Pozo, C; Valdez-Moreno, M; Hebert, PDN				Prado, Blanca R.; Pozo, Carmen; Valdez-Moreno, Martha; Hebert, Paul D. N.			Beyond the Colours: Discovering Hidden Diversity in the Nymphalidae of the Yucatan Peninsula in Mexico through DNA Barcoding	PLOS ONE			English	Article							SKIPPER BUTTERFLIES; LEPIDOPTERA; SYSTEMATICS; INVENTORY	Background: Recent studies have demonstrated the utility of DNA barcoding in the discovery of overlooked species and in the connection of immature and adult stages. In this study, we use DNA barcoding to examine diversity patterns in 121 species of Nymphalidae from the Yucatan Peninsula in Mexico. Our results suggest the presence of cryptic species in 8 of these 121 taxa. As well, the reference database derived from the analysis of adult specimens allowed the identification of nymphalid caterpillars providing new details on host plant use. Methodology/Principal Findings: We gathered DNA barcode sequences from 857 adult Nymphalidae representing 121 different species. This total includes four species (Adelpha iphiclus, Adelpha malea, Hamadryas iphtime and Taygetis laches) that were initially overlooked because of their close morphological similarity to other species. The barcode results showed that each of the 121 species possessed a diagnostic array of barcode sequences. In addition, there was evidence of cryptic taxa; seven species included two barcode clusters showing more than 2% sequence divergence while one species included three clusters. All 71 nymphalid caterpillars were identified to a species level by their sequence congruence to adult sequences. These caterpillars represented 16 species, and included Hamadryas julitta, an endemic species from the Yucatan Peninsula whose larval stages and host plant (Dalechampia schottii, also endemic to the Yucatan Peninsula) were previously unknown. Conclusions/Significance: This investigation has revealed overlooked species in a well-studied museum collection of nymphalid butterflies and suggests that there is a substantial incidence of cryptic species that await full characterization. The utility of barcoding in the rapid identification of caterpillars also promises to accelerate the assembly of information on life histories, a particularly important advance for hyperdiverse tropical insect assemblages.	[Prado, Blanca R.; Pozo, Carmen; Valdez-Moreno, Martha] Colegio Frontera Sur, Unidad Chetumal, Quintana Roo, Mexico; [Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	El Colegio de la Frontera Sur (ECOSUR); University of Guelph	Prado, BR (corresponding author), Colegio Frontera Sur, Unidad Chetumal, Quintana Roo, Mexico.	cpozo@ecosur.mx	Hebert, Paul DN/C-4161-2013; Pozo, Carmen/GPK-5969-2022	Hebert, Paul DN/0000-0002-3081-6700; Pozo, Carmen/0000-0002-8685-1134	Natural Sciences and Engineering Research Council; Government of Canada through Genome Canada; Ontario Genomics Institute; The Ontario Ministry of Research and Innovation; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [207930]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; The Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding for sequence analysis was provided by a Discovery Grant from Natural Sciences and Engineering Research Council to PH and by a grant from the Government of Canada through Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life Project. The Ontario Ministry of Research and Innovation provided funds for the analysis and curation of the barcode records. This work is part of the MSc thesis of Blanca R. Prado and was supported with a grant provided by the Consejo Nacional de Ciencia y Tecnologia (CONACyT grant 207930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski D, 2010, P ENTOMOL SOC WASH, V112, P183, DOI 10.4289/0013-8797-112.2.183; Burns John M., 2007, Journal of the Lepidopterists' Society, V61, P138; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Butler AG., 1868, CATALOGUE DIURNAL LE; DELAMAZA RF, 1987, MARIPOSAS MEXICANAS; DEVRIES P. J., 1987, BUTTERFLIES COSTA RI, V1; Escalante P, 2010, MITOCHONDR DNA, V21, P30, DOI 10.3109/19401736.2010.535527; Freitas AVL, 2004, SYST BIOL, V53, P363, DOI 10.1080/10635150490445670; GODMAN FD, 1879, LEPIDOPTERA RHOPALOC, V1; Grimaldi David, 2005, pi; Grund R, 2010, ENTOMOL SCI, V13, P134, DOI 10.1111/j.1479-8298.2010.00368.x; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HEPPNER J B, 1991, Tropical Lepidoptera, V2, P1; Hrcek J, 2011, MOL ECOL RESOUR, V11, P786, DOI 10.1111/j.1755-0998.2011.03016.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019874; Janzen DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018123; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; JANZEN DH, DYNAMIC DATABASE INV; JENKINS DW, 1983, B ALLYN MUSEUM, V81, P1, DOI DOI 10.2307/3259456; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LAMAS G, 2004, ATLAS NEOTROPICAL A, V5; Llorente Bousquets Jorge, 1996, P3; LUISMARTINEZ A, 2003, NYMPHALIDAE MEXICO 1; MILLER JC, 2006, 100 CATERPILLARS POR; MILLER JC, 2007, 100 BUTTERFLIES MOTH; PETERSON A, 1962, LEPIDOPTERA PLANT IN, P112; Powell J. A., 2009, MOTHS W N AM; Pozo C, 2003, SOUTHWEST NAT, V48, P505, DOI 10.1894/0038-4909(2003)048<0505:BPAHOC>2.0.CO;2; Scoble M. J., 1995, LEPIDOPTERA FORM FUN; STANCELAND E. M., 2011, INTERACTIVE LISTING; STANDLEY PAUL C., 1930, FIELD MUS NAT HIST PUBL BOT SER, V3, P157; Stehr F.W., 1987, P288; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; *TROP, 2011, MISS BOT GARD; van Velzen Robin, 2007, Proceedings of the Netherlands Entomological Society Meeting, V18, P95; Wahlberg N, 2003, MOL PHYLOGENET EVOL, V28, P473, DOI 10.1016/S1055-7903(03)00052-6; Willmott K. R., 2003, GENUS ADELPHA ITS SY; Wilson John James, 2010, ZooKeys, V46, P41	42	26	30	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27776	10.1371/journal.pone.0027776	http://dx.doi.org/10.1371/journal.pone.0027776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132140	gold, Green Published, Green Submitted			2022-12-25	WOS:000298162000042
J	Schmeink, CE; Melchers, WJG; Siebers, AG; Quint, WGV; Massuger, LFAG; Bekkers, RLM				Schmeink, Channa E.; Melchers, Willem J. G.; Siebers, Albertus G.; Quint, Wim G. V.; Massuger, Leon F. A. G.; Bekkers, Ruud L. M.			Human Papillomavirus Persistence in Young Unscreened Women, a Prospective Cohort Study	PLOS ONE			English	Article							FORMER SOVIET-UNION; NATURAL-HISTORY; CERVICAL-CANCER; HPV INFECTIONS; HORMONAL CONTRACEPTIVES; INDEPENDENT STATES; VIRAL PERSISTENCE; RISK-FACTORS; PREVALENCE; CLEARANCE	Objective: To evaluate hr-HPV persistence and associated risk factors in a prospective cohort of young unscreened women. Additionally, the relation between hr-HPV status and cytology/histology results is examined. Methods and Principal Findings: Two year follow-up of 235 out of 2065 young women (18-29 years), participating in a large, one year epidemiological study, with questionnaires, self-collected cervico-vaginal samples (Vibabrush), and SPF(10)LiPA for HPV detection. Only women hr-HPV positive at sample month 12 were invited for a second year of follow-up. After study follow-up, available cytology/histology data were requested from PALGA (the national network and registry of histo-and cytopathology in The Netherlands). These data were compared with available cytology/histology data of the month 12 hr-HPV negative women from the same cohort. 44.1% of the hr-HPV types detected at study month 12, persisted during follow-up. HPV types 45, 31, 16 and 18 were most likely to persist with percentages of 60.0%, 56.8%, 54.4%, and 50.0%, respectively. Compared to newly detected infections at month 12, infections present since 6 months or baseline had an increased risk to persist (OR 3.09 [95% CI: 1.74-5.51] and OR 4.99 [95% CI: 2.67-9.32], respectively). Other co-factors influencing persistence were, multiple HPV infections, smoking and multiple lifetime sexual partners. The percentage of women with a HSIL/CIN2+ (12.1%) in the persistent HPV group, was not significantly different (p = 0.107) from the 5.3% of the women who cleared the hr-HPV infection, but was significantly (p 0.000) higher than to the 1.6% of women in the hr-HPV negative control group. Conclusion: We showed that HPV genotype, multiple infections, smoking, and multiple lifetime sexual partners are co-factors that increase the risk of hr-HPV persistency. Most importantly, we showed that hr-HPV infections are more likely to persist the longer they have been present and that women with a persistent hr-HPV infection have a high risk of HSIL/CIN2+ development.	[Schmeink, Channa E.; Massuger, Leon F. A. G.; Bekkers, Ruud L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6525 ED Nijmegen, Netherlands; [Melchers, Willem J. G.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Siebers, Albertus G.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Quint, Wim G. V.] DDL Diagnost Lab, Voorburg, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; DDL Diagnostic Laboratory	Schmeink, CE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6525 ED Nijmegen, Netherlands.	c.schmeink@obgyn.umcn.nl	Massuger, Leon F.A.G./H-8072-2014; Bekkers, Ruud/AAU-5319-2020; Siebers, Albert/D-6300-2015; Bekkers, Ruud/M-3866-2014; Melchers, Willem/C-8819-2015	Siebers, Albert/0000-0002-6085-0678; Bekkers, Ruud/0000-0002-4577-8495; Melchers, Willem/0000-0002-5446-2230; Siebers, Albert Siebers/0000-0001-5413-9903	GlaxoSmithKline (GSK) [2702-HPV-109932]	GlaxoSmithKline (GSK)(GlaxoSmithKline)	GlaxoSmithKline (GSK 2702-HPV-109932 to R.L.B., L.F.M.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; BAE J, 2009, GYNECOL ONCOL; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Brink AATP, 2006, BEST PRACT RES CL OB, V20, P253, DOI 10.1016/j.bpobgyn.2005.10.009; Casparie M, 2007, CELL ONCOL, V29, P19; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Castle PE, 2008, AM J EPIDEMIOL, V168, P138, DOI 10.1093/aje/kwn037; Castle PE, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2569; Cuschieri KS, 2005, J CLIN PATHOL, V58, P946, DOI 10.1136/jcp.2004.022863; Dal Bello B, 2009, J MED VIROL, V81, P703, DOI 10.1002/jmv.21429; Franco EL, 2009, ARCH MED RES, V40, P478, DOI 10.1016/j.arcmed.2009.06.003; FUKUCHI E, 2009, SEX TRANSM DIS; Giuliano AR, 2002, J INFECT DIS, V186, P462, DOI 10.1086/341782; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Iftner T, 2010, J MED VIROL, V82, P1928, DOI 10.1002/jmv.21910; Koshiol J, 2008, AM J EPIDEMIOL, V168, P123, DOI 10.1093/aje/kwn036; Kulmala SMA, 2007, CANCER EPIDEM BIOMAR, V16, P17, DOI 10.1158/1055-9965.EPI-06-0649; Lai CH, 2008, INT J CANCER, V123, P1685, DOI 10.1002/ijc.23679; Lenselink CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003743; Louvanto K, 2010, J INFECT DIS, V202, P436, DOI 10.1086/653826; MAUCORTBOULCH D, 2009, INT J CANC; Melchers WJG, 1999, AM J PATHOL, V155, P1473, DOI 10.1016/S0002-9440(10)65462-4; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Munoz N, 2000, J CLIN VIROL, V19, P1, DOI 10.1016/S1386-6532(00)00125-6; MUNOZ N, 2009, BR J CANC; Nielsen A, 2010, J MED VIROL, V82, P616, DOI 10.1002/jmv.21750; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Richardson H, 2003, CANCER EPIDEM BIOMAR, V12, P485; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958; Schmeink CE, 2010, OBSTET GYNECOL, V116, P67, DOI 10.1097/AOG.0b013e3181e238f0; SUNDSTROM K, 2010, CANC EPIDEMIOL BIOMA; Syrjanen K, 2008, EUR J GYNAECOL ONCOL, V29, P114; Syrjanen K, 2009, INT J GYNECOL CANCER, V19, P934, DOI 10.1111/IGC.0b013e3181a834fe; Trottier H, 2008, J INFECT DIS, V197, P1436, DOI 10.1086/587698; van Duin M, 2002, INT J CANCER, V98, P590, DOI 10.1002/ijc.10232; van Hamont D, 2006, J CLIN MICROBIOL, V44, P3122, DOI 10.1128/JCM.00517-06; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050	44	31	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27937	10.1371/journal.pone.0027937	http://dx.doi.org/10.1371/journal.pone.0027937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132173	Green Published, Green Submitted, gold			2022-12-25	WOS:000298162000050
J	Canuet, L; Ishii, R; Pascual-Marqui, RD; Iwase, M; Kurimoto, R; Aoki, Y; Ikeda, S; Takahashi, H; Nakahachi, T; Takeda, M				Canuet, Leonides; Ishii, Ryouhei; Pascual-Marqui, Roberto D.; Iwase, Masao; Kurimoto, Ryu; Aoki, Yasunori; Ikeda, Shunichiro; Takahashi, Hidetoshi; Nakahachi, Takayuki; Takeda, Masatoshi			Resting-State EEG Source Localization and Functional Connectivity in Schizophrenia-Like Psychosis of Epilepsy	PLOS ONE			English	Article							RESOLUTION ELECTROMAGNETIC TOMOGRAPHY; TEMPORAL-LOBE EPILEPSY; WORKING-MEMORY; PREFRONTAL CORTEX; HUMAN BRAIN; ABNORMALITIES; NETWORK; DISCONNECTIVITY; HALLUCINATIONS; CLASSIFICATION	Background: It is unclear whether, like in schizophrenia, psychosis-related disruption in connectivity between certain regions, as an index of intrinsic functional disintegration, occurs in schizophrenia-like psychosis of epilepsy (SLPE). In this study, we sought to determine abnormal patterns of resting-state EEG oscillations and functional connectivity in patients with SLPE, compared with nonpsychotic epilepsy patients, and to assess correlations with psychopathological deficits. Methodology/Principal Findings: Resting EEG was recorded in 21 patients with focal epilepsy and SLPE and in 21 clinically-matched non-psychotic epilepsy controls. Source current density and functional connectivity were determined using eLORETA software. For connectivity analysis, a novel nonlinear connectivity measure called "lagged phase synchronization" was used. We found increased theta oscillations in regions involved in the default mode network (DMN), namely the medial and lateral parietal cortex bilaterally in the psychotic patients relative to their nonpsychotic counterparts. In addition, patients with psychosis had increased beta temporo-prefrontal connectivity in the hemisphere with predominant seizure focus. This functional connectivity in temporo-prefrontal circuits correlated with positive symptoms. Additionally, there was increased interhemispheric phase synchronization between the auditory cortex of the affected temporal lobe and the Broca's area correlating with auditory hallucination scores. Conclusions/Significance: In addition to dysfunction of parietal regions that are part of the DMN, resting-state disrupted connectivity of the medial temporal cortex with prefrontal areas that are either involved in the DMN or implicated in psychopathological dysfunction may be critical to schizophrenia-like psychosis, especially in individuals with temporal lobe epilepsy. This suggests that DMN deficits might be a core neurobiological feature of the disorder, and that abnormalities in theta oscillations and beta phase synchronization represent the underlying neural activity.	[Canuet, Leonides; Ishii, Ryouhei; Iwase, Masao; Kurimoto, Ryu; Aoki, Yasunori; Ikeda, Shunichiro; Takahashi, Hidetoshi; Nakahachi, Takayuki; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat & Clin Neurosci, Suita, Osaka, Japan; [Pascual-Marqui, Roberto D.] Univ Hosp Psychiat, KEY Inst Brain Mind Res, Zurich, Switzerland; [Pascual-Marqui, Roberto D.] Kansai Med Univ, Dept Neuropsychiat, Osaka, Japan	Osaka University; Kansai Medical University	Canuet, L (corresponding author), Osaka Univ, Grad Sch Med, Dept Psychiat & Clin Neurosci, Suita, Osaka, Japan.	ishii@psy.med.osaka-u.ac.jp	Ishii, Ryouhei/A-9929-2008; Pascual-Marqui, Roberto D./A-2012-2008; Canuet, Leonides/B-1655-2008	Ishii, Ryouhei/0000-0002-4245-0953; Pascual-Marqui, Roberto D./0000-0002-5029-4065; Canuet, Leonides/0000-0003-1608-4715				Adachi N, 2008, EPILEPSY RES, V78, P201, DOI 10.1016/j.eplepsyres.2007.12.001; AINE CJ, 1995, CRIT REV NEUROBIOL, V9, P229; Anderer P, 1998, NEUROPSYCHOBIOLOGY, V37, P20, DOI 10.1159/000026472; Bai X, 2011, NEUROLOGY, V76, P1960, DOI 10.1212/WNL.0b013e31821e54de; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Canuet L, 2008, J CLIN NEUROSCI, V15, P1296, DOI 10.1016/j.jocn.2007.03.030; Canuet L, 2011, PSYCHIAT CLIN NEUROS, V65, P183, DOI 10.1111/j.1440-1819.2010.02179.x; Canuet L, 2010, EPILEPSY BEHAV, V17, P109, DOI 10.1016/j.yebeh.2009.11.002; Canuet L, 2009, EPILEPSY RES, V83, P58, DOI 10.1016/j.eplepsyres.2008.09.001; Craddock R., HUM BRAIN M IN PRESS; Dierks T, 2000, CLIN NEUROPHYSIOL, V111, P1817, DOI 10.1016/S1388-2457(00)00427-2; Fingelkurts AA, 2005, NEUROSCI BIOBEHAV R, V28, P827, DOI 10.1016/j.neubiorev.2004.10.009; Fletcher P, 1999, NEUROIMAGE, V9, P337, DOI 10.1006/nimg.1998.0411; Flor-Henry P, 2004, PSYCHIAT RES-NEUROIM, V130, P191, DOI 10.1016/j.pscychresns.2003.08.006; Fluegel D, 2006, EPILEPSIA, V47, P941, DOI 10.1111/j.1528-1167.2006.00527.x; Flugel D, 2006, BIOL PSYCHIAT, V59, P560, DOI 10.1016/j.biopsych.2005.07.023; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Goghari VM, 2010, NEUROSCI BIOBEHAV R, V34, P468, DOI 10.1016/j.neubiorev.2009.09.004; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Ishii R, 2006, EPILEPSY BEHAV, V9, P367, DOI 10.1016/j.yebeh.2006.06.017; Ishii R, 1999, NEUROREPORT, V10, P675, DOI 10.1097/00001756-199903170-00003; Ishii R, 2008, EPILEPSY RES, V81, P228, DOI 10.1016/j.eplepsyres.2008.06.006; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; Johnson MR, 2006, BIOL PSYCHIAT, V60, P11, DOI 10.1016/j.biopsych.2005.11.012; Krishnamoorthy ES, 2007, EPILEPSY BEHAV, V10, P349, DOI 10.1016/j.yebeh.2006.10.002; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Lui S, 2010, ARCH GEN PSYCHIAT, V67, P783, DOI 10.1001/archgenpsychiatry.2010.84; Marsh L, 2001, PSYCHIAT RES-NEUROIM, V108, P1, DOI 10.1016/S0925-4927(01)00115-9; Matsuura M, 2000, EPILEPSY BEHAV, V1, P343, DOI 10.1006/ebeh.2000.0113; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MCGUIRE PK, 1993, LANCET, V342, P703, DOI 10.1016/0140-6736(93)91707-S; Mellers JDC, 1998, BRIT J PSYCHIAT, V173, P69, DOI 10.1192/bjp.173.1.69; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mueser KT, 1997, PSYCHOL ASSESSMENT, V9, P196; Mulert C, 2011, INT J PSYCHOPHYSIOL, V79, P55, DOI 10.1016/j.ijpsycho.2010.08.004; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; Pascual-Marqui RD., 2007, ARXIV 07103341 MATH; Pascual-Marqui RD, 2011, PHILOS T R SOC A, V369, P3768, DOI 10.1098/rsta.2011.0081; Pascual-Marqui Roberto D., 2009, P121; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; PASCUALMARQUI RD, 2007, ARXIV1455STATME; Peled A, 2001, INT J NEUROSCI, V106, P47, DOI 10.3109/00207450109149737; Pettersson-Yeo W, 2011, NEUROSCI BIOBEHAV R, V35, P1110, DOI 10.1016/j.neubiorev.2010.11.004; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Pizzagalli DA, 2004, MOL PSYCHIATR, V9, P393, DOI 10.1038/sj.mp.4001469; Rotarska-Jagiela A, 2010, SCHIZOPHR RES, V117, P21, DOI 10.1016/j.schres.2010.01.001; Sachdev P, 1998, AM J PSYCHIAT, V155, P325, DOI 10.1176/ajp.155.3.325; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Shim G, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-58; SLATER E, 1963, BRIT J PSYCHIAT, V109, P95, DOI 10.1192/bjp.109.458.95; Sponheim SR, 2000, BIOL PSYCHIAT, V48, P1088, DOI 10.1016/S0006-3223(00)00907-0; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Strelets VB, 2002, INT J PSYCHOPHYSIOL, V44, P101, DOI 10.1016/S0167-8760(01)00196-9; Sundram F, 2010, BRIT J PSYCHIAT, V197, P482, DOI 10.1192/bjp.bp.110.080218; Torrey EF, 2007, SCHIZOPHR RES, V97, P215, DOI 10.1016/j.schres.2007.08.023; Uylings HBM, 2005, ANAT EMBRYOL, V210, P423, DOI 10.1007/s00429-005-0042-4; van Elst LT, 2002, BRAIN, V125, P140, DOI 10.1093/brain/awf008; Vitacco D, 2002, HUM BRAIN MAPP, V17, P4, DOI 10.1002/hbm.10038; Walterfang M, 2005, AUST NZ J PSYCHIAT, V39, P746, DOI 10.1080/j.1440-1614.2005.01678.x; Whalley HC, 2005, BRAIN, V128, P2097, DOI 10.1093/brain/awh556; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; Worrell GA, 2000, BRAIN TOPOGR, V12, P273, DOI 10.1023/A:1023407521772; Worsley KJ, 2005, PHILOS T R SOC B, V360, P913, DOI 10.1098/rstb.2005.1637; Zhou Y, 2007, SCHIZOPHR RES, V97, P194, DOI 10.1016/j.schres.2007.05.029; Zumsteg D, 2005, NEUROLOGY, V65, P1657, DOI 10.1212/01.wnl.0000184516.32369.1a; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P2615, DOI 10.1016/j.clinph.2006.07.319; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P1602, DOI 10.1016/j.clinph.2006.04.008; 1989, EPILEPSIA, V30, P389, DOI DOI 10.1111/J.1528-1157.1989.TB05316.X	77	130	130	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27863	10.1371/journal.pone.0027863	http://dx.doi.org/10.1371/journal.pone.0027863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125634	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000297789200034
J	Ito, H; Abe, M; Mifune, M; Oshikiri, K; Antoku, S; Takeuchi, Y; Togane, M				Ito, Hiroyuki; Abe, Mariko; Mifune, Mizuo; Oshikiri, Koshiro; Antoku, Shinichi; Takeuchi, Yuichiro; Togane, Michiko			Hyperuricemia Is Independently Associated with Coronary Heart Disease and Renal Dysfunction in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							SERUM URIC-ACID; URINARY ALBUMIN EXCRETION; MIDDLE-AGED MEN; CARDIOVASCULAR MORTALITY; RISK-FACTOR; METABOLIC SYNDROME; ALL-CAUSE; INSULIN; GLUCOSE; LEVEL	Aims: To investigate the relationship between hyperuricemia (HUA) and the clinical backgrounds in Japanese patients with type 2 diabetes mellitus. Methods: After a cross-sectional study evaluating the association of HUA with the clinical characteristics in 1,213 patients with type 2 diabetes mellitus, the estimated glomerular filtration rate (eGFR) and the incidence of diabetic macroangiopathies was investigated in a prospective observational study in 1,073 patients during a 3.5 year period. HUA was defined by serum uric acid levels >327 mu mol/L or as patients using allopurinol. Results: The frequency of HUA was significantly higher in the diabetic patients (32% in men and 15% in women) than in the normal controls (14% in men and 1% in women). In total, HUA was found in 299 (25%) of the patients during the cross-sectional study. Even after adjusting for sex, drinking status, treatment for diabetes mellitus, body mass index, hypertension, use of diuretics, hyperlipidemia, HbA1c and/or the eGFR, the HUA was independently associated with some diabetic complications. The eGFR was significantly reduced in HUA patients compared to those with normouricemia in the 12 months after observation was started. HUA was also an independent risk factor for coronary heart disease even after adjustment in the Cox proportional hazard model. Conclusions: HUA is a associated with diabetic micro-and macroangiopathies. HUA is a predictor of coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus. However, the influence of HUA is considered to be limited.	[Ito, Hiroyuki; Abe, Mariko; Mifune, Mizuo; Oshikiri, Koshiro; Antoku, Shinichi; Takeuchi, Yuichiro; Togane, Michiko] Edogawa Hosp, Dept Diabet Metab & Kidney Dis, Tokyo, Japan		Ito, H (corresponding author), Edogawa Hosp, Dept Diabet Metab & Kidney Dis, Tokyo, Japan.	ito@edogawa.or.jp		Ito, Hiroyuki/0000-0002-8143-0082				Alderman MH, 1999, HYPERTENSION, V34, P144, DOI 10.1161/01.HYP.34.1.144; Chen JH, 2009, ARTHRIT RHEUM-ARTHR, V61, P225, DOI 10.1002/art.24164; Chien KL, 2008, CLIN CHEM, V54, P310, DOI 10.1373/clinchem.2007.095190; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; *ED COMM TREATM GU, 2007, TREATM GUID DIAB 200; FACCHINI F, 1991, JAMA-J AM MED ASSOC, V266, P3008, DOI 10.1001/jama.266.21.3008; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Fukui M, 2008, METABOLISM, V57, P625, DOI 10.1016/j.metabol.2007.12.005; HERMAN JB, 1982, LANCET, V2, P240; Ioachimescu AG, 2007, DIABETIC MED, V24, P1369, DOI 10.1111/j.1464-5491.2007.02302.x; Ito H, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-18; Ito H, 2010, NEPHROL DIAL TRANSPL, V25, P1161, DOI 10.1093/ndt/gfp579; *JAP SOC GOUT NUCL, 2010, GUID MAN HYP GOUT; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Krishnan E, 2008, ARCH INTERN MED, V168, P1104, DOI 10.1001/archinte.168.10.1104; Lehto S, 1998, STROKE, V29, P635, DOI 10.1161/01.STR.29.3.635; Li Q, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-72; Madero M, 2009, AM J KIDNEY DIS, V53, P796, DOI 10.1053/j.ajkd.2008.12.021; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mazza A, 2007, ACTA DIABETOL, V44, P99, DOI 10.1007/s00592-007-0249-3; Muscelli E, 1996, AM J HYPERTENS, V9, P746, DOI 10.1016/0895-7061(96)00098-2; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; Ong G, 2010, DIABETOLOGIA, V53, P1288, DOI 10.1007/s00125-010-1735-7; RATHMANN W, 1993, DIABETES METAB, V19, P159; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Strasak AM, 2008, INT J CARDIOL, V125, P232, DOI 10.1016/j.ijcard.2007.11.094; Sui XM, 2008, METABOLISM, V57, P845, DOI 10.1016/j.metabol.2008.01.030; ter Maaten JC, 1998, EUR J CLIN INVEST, V28, P279; Tseng CH, 2005, KIDNEY INT, V68, P796, DOI 10.1111/j.1523-1755.2005.00459.x; Tseng CH, 2004, DIABETIC MED, V21, P724, DOI 10.1111/j.1464-5491.2004.01239.x; TUOMILEHTO J, 1988, AM J EPIDEMIOL, V127, P321, DOI 10.1093/oxfordjournals.aje.a114807; Viazzi F, 2011, DIABETES CARE, V34, P126, DOI 10.2337/dc10-0918; Wen CP, 2010, AM J KIDNEY DIS, V56, P273, DOI 10.1053/j.ajkd.2010.01.024; Wiik BP, 2010, AM J HYPERTENS, V23, P845, DOI 10.1038/ajh.2010.89; Yuan HJ, 2011, CHINESE MED J-PEKING, V124, P1443, DOI 10.3760/cma.j.issn.0366-6999.2011.10.001; Zoppini G, 2009, DIABETES CARE, V32, P1716, DOI 10.2337/dc09-0625	42	70	85	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27817	10.1371/journal.pone.0027817	http://dx.doi.org/10.1371/journal.pone.0027817			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125626	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789200026
J	Pouya, A; Satarian, L; Kiani, S; Javan, M; Baharvand, H				Pouya, Alireza; Satarian, Leila; Kiani, Sahar; Javan, Mohammad; Baharvand, Hossein			Human Induced Pluripotent Stem Cells Differentiation into Oligodendrocyte Progenitors and Transplantation in a Rat Model of Optic Chiasm Demyelination	PLOS ONE			English	Article							SPINAL-CORD-INJURY; LYSOLECITHIN-INDUCED DEMYELINATION; LYSOPHOSPHATIDYL CHOLINE; NEURAL PRECURSORS; WHITE-MATTER; GLIAL-CELLS; HIGH-PURITY; EXPRESSION; IDENTIFICATION; RECOVERY	Background: This study aims to differentiate human induced pluripotent stem cells (hiPSCs) into oligodendrocyte precursors and assess their recovery potential in a demyelinated optic chiasm model in rats. Methodology/Principal Findings: We generated a cell population of oligodendrocyte progenitors from hiPSCs by using embryoid body formation in a defined medium supplemented with a combination of factors, positive selection and mechanical enrichment. Real-time polymerase chain reaction and immunofluorescence analyses showed that stage-specific markers, Olig2, Sox10, NG2, PDGFRa, O4, A2B5, GalC, and MBP were expressed following the differentiation procedure, and enrichment of the oligodendrocyte lineage. These results are comparable with the expression of stage-specific markers in human embryonic stem cell-derived oligodendrocyte lineage cells. Transplantation of hiPSC-derived oligodendrocyte progenitors into the lysolecithin-induced demyelinated optic chiasm of the rat model resulted in recovery from symptoms, and integration and differentiation into oligodendrocytes were detected by immunohistofluorescence staining against PLP and MBP, and measurements of the visual evoked potentials. Conclusions/Significance: These results showed that oligodendrocyte progenitors generated efficiently from hiPSCs can be used in future biomedical studies once safety issues have been overcome.	[Pouya, Alireza; Satarian, Leila; Kiani, Sahar; Javan, Mohammad; Baharvand, Hossein] Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, ACECR, Tehran, Iran; [Satarian, Leila; Javan, Mohammad] Tarbiat Modares Univ, Dept Physiol, Fac Med Sci, Tehran, Iran; [Baharvand, Hossein] Univ Sci & Culture, Dept Dev Biol, ACECR, Tehran, Iran	Academic Center for Education, Culture & Research (ACECR); Tarbiat Modares University; Academic Center for Education, Culture & Research (ACECR)	Pouya, A (corresponding author), Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, ACECR, Tehran, Iran.	baharvand@royaninstitute.org	Satarian, Leila/M-3835-2017; Kiani, Sahar/AAO-3557-2020; Javan, Mohammad/C-6758-2008	Satarian, Leila/0000-0002-5068-5031; Kiani, Sahar/0000-0001-7779-9998; Javan, Mohammad/0000-0003-2045-6171	Royan Institute; Iranian Council of Stem Cell Technology	Royan Institute; Iranian Council of Stem Cell Technology	This study was funded by grants from the Royan Institute and the Iranian Council of Stem Cell Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLT G, 1988, ACTA NEUROPATHOL, V75, P456, DOI 10.1007/BF00687132; Baharvand H, 2006, DEV GROWTH DIFFER, V48, P117, DOI 10.1111/j.1440-169x.2006.00851.x; Brolen G, 2010, J BIOTECHNOL, V145, P284, DOI 10.1016/j.jbiotec.2009.11.007; Buchet D, 2009, NEUROSCI LETT, V456, P112, DOI 10.1016/j.neulet.2008.09.086; Bull ND, 2009, INVEST OPHTH VIS SCI, V50, P4244, DOI 10.1167/iovs.08-3239; Cai ZW, 2001, BRAIN RES, V898, P126, DOI 10.1016/S0006-8993(01)02180-1; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cloutier F, 2006, REGEN MED, V1, P469, DOI 10.2217/17460751.1.4.469; CROCKER SJ, 2011, NEUROPATHOL APPL NEU; Czepiel M, 2011, GLIA, V59, P882, DOI 10.1002/glia.21159; DOUSSET V, 1995, AM J NEURORADIOL, V16, P225; Durand B, 2000, BIOESSAYS, V22, P64; Einstein O, 2009, J NEUROSCI, V29, P15694, DOI 10.1523/JNEUROSCI.3364-09.2009; Erceg S, 2010, STEM CELLS, V28, P1541, DOI 10.1002/stem.489; Espinosa-Jeffrey Araceli, 2009, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02d04s10; Faulkner J, 2005, TRANSPL IMMUNOL, V15, P131, DOI 10.1016/j.trim.2005.09.007; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; HALL SM, 1972, J CELL SCI, V10, P535; Hatch Maya N., 2009, V549, P59, DOI 10.1007/978-1-60327-931-4_5; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Hua ZX, 2009, DIFFERENTIATION, V78, P177, DOI 10.1016/j.diff.2009.05.008; HUDNELL HK, 1990, NEUROTOXICOL TERATOL, V12, P391, DOI 10.1016/0892-0362(90)90059-L; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kerr CL, 2010, INT J NEUROSCI, V120, P305, DOI 10.3109/00207450903585290; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martino G, 2010, NAT REV NEUROL, V6, P247, DOI 10.1038/nrneurol.2010.35; Mozafari S, 2010, BRAIN RES, V1351, P50, DOI 10.1016/j.brainres.2010.07.026; NEMATI S, 2010, STEM CELLS DEV; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Onorati M, 2010, MOL CELL NEUROSCI, V43, P287, DOI 10.1016/j.mcn.2009.12.002; Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Tokumoto Y, 2010, J BIOSCI BIOENG, V109, P622, DOI 10.1016/j.jbiosc.2009.11.013; Totonchi M, 2010, INT J DEV BIOL, V54, P877, DOI 10.1387/ijdb.092903mt; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007; Woodruff RH, 1999, NEUROPATH APPL NEURO, V25, P226; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 2001, NAT REV NEUROSCI, V2, P840, DOI 10.1038/35097593; Zhang YW, 2006, STEM CELLS DEV, V15, P943, DOI 10.1089/scd.2006.15.943; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhu H, 2011, NAT REV GENET, V12, P266, DOI 10.1038/nrg2951	56	60	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27925	10.1371/journal.pone.0027925	http://dx.doi.org/10.1371/journal.pone.0027925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125639	Green Published, gold			2022-12-25	WOS:000297789200039
J	Bryant, B; Raikhel, AS				Bryant, Bart; Raikhel, Alexander S.			Programmed Autophagy in the Fat Body of Aedes aegypti Is Required to Maintain Egg Maturation Cycles	PLOS ONE			English	Article							INHIBITS CELL-GROWTH; VITELLOGENIN SECRETION; MONOCLONAL-ANTIBODIES; STEROID REGULATION; NUCLEAR RECEPTORS; JUVENILE-HORMONE; YOLK PROTEIN; MOSQUITO; ECDYSONE; INSULIN	Autophagy plays a pivotal role by allowing cells to recycle cellular components under conditions of stress, starvation, development and cancer. In this work, we have demonstrated that programmed autophagy in the mosquito fat body plays a critical role in maintaining of developmental switches required for normal progression of gonadotrophic cycles. Mosquitoes must feed on vertebrate blood for their egg development, with each gonadotrophic cycle being tightly coupled to a separate blood meal. As a consequence, some mosquito species are vectors of pathogens that cause devastating diseases in humans and domestic animals, most importantly malaria and Dengue fever. Hence, deciphering mechanisms to control egg developmental cycles is of paramount importance for devising novel approaches for mosquito control. Central to egg development is vitellogenesis, the production of yolk protein precursors in the fat body, the tissue analogous to a vertebrate liver, and their subsequent specific accumulation in developing oocytes. During each egg developmental cycle, the fat body undergoes a developmental program that includes previtellogenic build-up of biosynthetic machinery, intense production of yolk protein precursors, and termination of vitellogenesis. The importance of autophagy for termination of vitellogenesis was confirmed by RNA interference (RNAi) depletions of several autophagic genes (ATGs), which inhibited autophagy and resulted in untimely hyper activation of TOR and prolonged production of the major yolk protein precursor, vitellogenin (Vg). RNAi depletion of the ecdysone receptor (EcR) demonstrated its activating role of autophagy. Depletion of the autophagic genes and of EcR led to inhibition of the competence factor, betaFTZ-F1, which is required for ecdysone-mediated developmental transitions. Moreover, autophagy-incompetent female mosquitoes were unable to complete the second reproductive cycle and exhibited retardation and abnormalities in egg maturation. Thus, our study has revealed a novel function of programmed autophagy in maintaining egg maturation cycles in mosquitoes.	[Bryant, Bart; Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Inst Integrat Genome Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Bryant, B (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	alexander.raikhel@ucr.edu			National Institutes of Health [R37 AI244716, RO1 AI59492]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by grants from the National Institutes of Health (R37 AI244716 and RO1 AI59492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Broadus J, 1999, MOL CELL, V3, P143, DOI 10.1016/S1097-2765(00)80305-6; Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105; Brown MR, 1998, J BIOL CHEM, V273, P3967, DOI 10.1074/jbc.273.7.3967; Chen L, 2004, J MOL ENDOCRINOL, V33, P743, DOI 10.1677/jme.1.01531; Cruz J, 2009, FEBS J, V276, P1233, DOI 10.1111/j.1742-4658.2008.06860.x; DEAN RL, 1978, J INSECT PHYSIOL, V24, P439, DOI 10.1016/0022-1910(78)90087-2; Denton D, 2009, CURR BIOL, V19, P1741, DOI 10.1016/j.cub.2009.08.042; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; KOMUVES LG, 1985, CELL TISSUE RES, V240, P215; Lam GT, 1997, DEVELOPMENT, V124, P1757; Lee CY, 2002, DEV BIOL, V250, P101, DOI 10.1006/dbio.2002.0784; Lee CY, 2001, DEVELOPMENT, V128, P1443; Lee SB, 2007, EMBO REP, V8, P360, DOI 10.1038/sj.embor.7400917; Li C, 2000, DEV BIOL, V224, P96, DOI 10.1006/dbio.2000.9792; Martin D, 2001, MOL CELL ENDOCRINOL, V173, P75, DOI 10.1016/S0303-7207(00)00413-5; McPhee CK, 2009, BBA-MOL CELL RES, V1793, P1452, DOI 10.1016/j.bbamcr.2009.02.009; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Neufeld TP, 2010, CURR OPIN CELL BIOL, V22, P157, DOI 10.1016/j.ceb.2009.11.005; Nezis IP, 2010, J CELL BIOL, V190, P523, DOI 10.1083/jcb.201002035; Raikhel Alexander S., 2005, P329; RAIKHEL AS, 1987, TISSUE CELL, V19, P515, DOI 10.1016/0040-8166(87)90045-0; RAIKHEL AS, 1986, J INSECT PHYSIOL, V32, P879, DOI 10.1016/0022-1910(86)90103-4; RAIKHEL AS, 1986, TISSUE CELL, V18, P125, DOI 10.1016/0040-8166(86)90012-1; RAIKHEL AS, 1986, J INSECT PHYSIOL, V32, P597, DOI 10.1016/0022-1910(86)90088-0; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; RAIKHEL AS, 2005, ENDOCRINE CONTROL RE, P433; Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3; Rosenfeldt MT, 2011, CARCINOGENESIS; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; SASS M, 1977, CELL TISSUE RES, V180, P403; SASS M, 1975, ACTA BIOL ACAD SCI H, V26, P189; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Sun GQ, 2005, P NATL ACAD SCI USA, V102, P15506, DOI 10.1073/pnas.0503501102; Tanner EA, 2011, DEVELOPMENT, V138, P327, DOI 10.1242/dev.057943; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wang SF, 1998, J BIOL CHEM, V273, P27531, DOI 10.1074/jbc.273.42.27531; Wen ZM, 2010, MOL CELL ENDOCRINOL, V328, P47, DOI 10.1016/j.mce.2010.07.003; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114; Zhu JS, 2007, MOL CELL ENDOCRINOL, V267, P97, DOI 10.1016/j.mce.2007.01.006; Zhu JS, 2003, P NATL ACAD SCI USA, V100, P13338, DOI 10.1073/pnas.2234416100	54	59	70	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e25502	10.1371/journal.pone.0025502	http://dx.doi.org/10.1371/journal.pone.0025502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22125592	Green Submitted, gold, Green Published			2022-12-25	WOS:000297555800001
J	Cronan, MR; Nakamura, K; Johnson, NL; Granger, DA; Cuevas, BD; Wang, JG; Mackman, N; Scott, JE; Dohlman, HG; Johnson, GL				Cronan, M. R.; Nakamura, K.; Johnson, N. L.; Granger, D. A.; Cuevas, B. D.; Wang, J-G; Mackman, N.; Scott, J. E.; Dohlman, H. G.; Johnson, G. L.			Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis	ONCOGENE			English	Article						MAP3K; metastasis; MAPK network; MEKK2; MLK3	SIGNAL-REGULATED KINASE-5; BREAST-CANCER; PROSTATE-CANCER; TISSUE FACTOR; EXPRESSION; ACTIVATION; ERK5; PROGRESSION; CARCINOMA; APOPTOSIS	Analysis of patient tumors suggests that multiple MAP3 kinases (MAP3Ks) are critical for growth and metastasis of cancer cells. MAP3Ks selectively control the activation of extracellular signal-regulated kinase 1/2 (ERK1/2), Jun N-terminal kinase (JNK), p38 and ERK5 in response to receptor tyrosine kinases and GTPases. We used MDA-MB-231 cells because of their ability to metastasize from the breast fat pad to distant lymph nodes for an orthotopic xenograft model to screen the function of seven MAP3Ks in controlling tumor growth and metastasis. Stable short hairpin RNA (shRNA) knockdown was used to inhibit the expression of each of the seven MAP3Ks, which were selected for their differential regulation of the MAPK network. The screen identified two MAP3Ks, MEKK2 and MLK3, whose shRNA knockdown caused significant inhibition of both tumor growth and metastasis. Neither MEKK2 nor MLK3 have been previously shown to regulate tumor growth and metastasis in vivo. These results demonstrated that MAP3Ks, which differentially activate JNK, p38 and ERK5, are necessary for xenograft tumor growth and metastasis of MDA-MB-231 tumors. The requirement for MAP3Ks signaling through multiple MAPK pathways explains why several members of the MAPK network are activated in cancer. MEKK2 was required for epidermal growth factor receptor and Her2/Neu activation of ERK5, with ERK5 being required for metastasis. Loss of MLK3 expression increased mitotic infidelity and apoptosis in vitro. Knockdown of MEKK2 and MLK3 resulted in increased apoptosis in orthotopic xenografts relative to control tumors in mice, inhibiting both tumor growth and metastasis; MEKK2 and MLK3 represent untargeted kinases in tumor biology for potential therapeutic development. Oncogene (2012) 31, 3889-3900; doi:10.1038/onc.2011.544; published online 5 December 2011	[Cronan, M. R.; Nakamura, K.; Johnson, N. L.; Granger, D. A.; Johnson, G. L.] Univ N Carolina, Dept Pharmacol, Sch Med, Chapel Hill, NC 27599 USA; [Cronan, M. R.; Dohlman, H. G.] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27599 USA; [Cronan, M. R.; Nakamura, K.; Johnson, N. L.; Granger, D. A.; Wang, J-G; Mackman, N.; Dohlman, H. G.; Johnson, G. L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA; [Cuevas, B. D.] Loyola Univ Chicago, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL USA; [Mackman, N.] Univ N Carolina, McAllister Heart Inst, Sch Med, Div Hematol & Oncol,Dept Med, Chapel Hill, NC 27599 USA; [Scott, J. E.] N Carolina Cent Univ, Dept Pharmaceut Sci, Biomfg Res Inst & Technol Enterprise, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Loyola University Chicago; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; North Carolina Central University	Johnson, GL (corresponding author), Univ N Carolina, Dept Pharmacol, Sch Med, Chapel Hill, NC 27599 USA.	glj@med.unc.edu		Cronan, Mark/0000-0002-3760-1649; Dohlman, Henrik/0000-0003-2443-0729; Mackman, Nigel/0000-0002-9170-7700	NIH [GM30324, DK37871, GM059167, U54CA156735, CA120881]; University of North Carolina; RNAi Screening Core; Lentiviral shRNA Core; NATIONAL CANCER INSTITUTE [U54CA156735, K01CA120881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030324, R01GM059167, R01GM030324] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina; RNAi Screening Core; Lentiviral shRNA Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grants GM30324 (GLJ), DK37871 (GLJ), GM059167 (HGD), U54CA156735 (GLJ and JES) and CA120881 (BC) and the University of North Carolina Cancer Research Fund (GLJ). We acknowledge the RNAi Screening Core and Lentiviral shRNA Core for support of this research.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Brancho D, 2005, MOL CELL BIOL, V25, P3670, DOI 10.1128/MCB.25.9.3670-3681.2005; Montero JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005565; Cazares LH, 2009, CLIN CANCER RES, V15, P5541, DOI 10.1158/1078-0432.CCR-08-2892; Cha HJ, 2006, CELL SIGNAL, V18, P93, DOI 10.1016/j.cellsig.2005.03.028; Chang S, 2011, COMPOS MATH, V147, P375, DOI 10.1112/S0010437X1000504X; Chen J, 2010, ONCOGENE, V29, P4399, DOI 10.1038/onc.2010.198; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; Cuevas BD, 2006, ONCOGENE, V25, P4998, DOI 10.1038/sj.onc.1209507; Davidson B, 2006, GYNECOL ONCOL, V102, P453, DOI 10.1016/j.ygyno.2006.01.034; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Guo ZJ, 2002, MOL CELL BIOL, V22, P5761, DOI 10.1128/MCB.22.16.5761-5768.2002; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Jaeschke A, 2007, MOL CELL, V27, P498, DOI 10.1016/j.molcel.2007.07.008; Kasthuri RS, 2009, J CLIN ONCOL, V27, P4834, DOI 10.1200/JCO.2009.22.6324; Kesavan K, 2004, J CELL PHYSIOL, V199, P140, DOI 10.1002/jcp.10457; Khorana AA, 2008, J THROMB HAEMOST, V6, P1983, DOI 10.1111/j.1538-7836.2008.03156.x; Kim KY, 2004, J BIOL CHEM, V279, P29478, DOI 10.1074/jbc.M313947200; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; McCracken SRC, 2008, ONCOGENE, V27, P2978, DOI 10.1038/sj.onc.1210963; Mehta PB, 2003, ONCOGENE, V22, P1381, DOI 10.1038/sj.onc.1206154; Mishra R, 2007, J BIOL CHEM, V282, P30393, DOI 10.1074/jbc.M705895200; Nakamura K, 2010, J BIOL CHEM, V285, P2077, DOI 10.1074/jbc.M109.065102; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rak J, 2010, SEMIN THROMB HEMOST, V36, P888, DOI 10.1055/s-0030-1267043; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Sartorius CA, 2003, BREAST CANCER RES TR, V79, P287, DOI 10.1023/A:1024031731269; Sheridan C, 2008, J BIOL CHEM, V283, P22128, DOI 10.1074/jbc.M800271200; SIDEBOTTOM E, 1983, BRIT J CANCER, V47, P399, DOI 10.1038/bjc.1983.60; Sourvinos G, 1999, ONCOGENE, V18, P4968, DOI 10.1038/sj.onc.1202891; Sticht C, 2008, NEOPLASIA, V10, P462, DOI 10.1593/neo.08164; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Tatake RJ, 2008, BIOCHEM BIOPH RES CO, V377, P120, DOI 10.1016/j.bbrc.2008.09.087; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Waldmeier P, 2006, BIOCHEM PHARMACOL, V72, P1197, DOI 10.1016/j.bcp.2006.06.031; Wang X, 2010, HUM PATHOL, V41, P401, DOI 10.1016/j.humpath.2009.08.018; Wo JY, 2011, J CLIN ONCOL, V29, P2619, DOI 10.1200/JCO.2010.29.5907; Yang QK, 2010, CANCER CELL, V18, P258, DOI 10.1016/j.ccr.2010.08.008; Yu JL, 2005, BLOOD, V105, P1734, DOI 10.1182/blood-2004-05-2042; Zen K, 2009, GENE CHROMOSOME CANC, V48, P109, DOI 10.1002/gcc.20624	44	47	49	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	34					3889	3900		10.1038/onc.2011.544	http://dx.doi.org/10.1038/onc.2011.544			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	994IV	22139075	Green Accepted, Green Submitted			2022-12-25	WOS:000307925000006
J	Kosa, P; Szabo, R; Molinolo, AA; Bugge, TH				Kosa, P.; Szabo, R.; Molinolo, A. A.; Bugge, T. H.			Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis	ONCOGENE			English	Article						inflammatory bowel disease; intestinal barrier; colon carcinogenesis	INFLAMMATORY-BOWEL-DISEASE; SERINE-PROTEASE MATRIPTASE; HEPATOCYTE GROWTH-FACTOR; COLORECTAL-CANCER; ULCERATIVE-COLITIS; MOUSE MODEL; MATRIX METALLOPROTEINASES; PLASMINOGEN ACTIVATION; INTESTINAL HOMEOSTASIS; BARRIER FUNCTION	Colitis-associated colorectal cancers are an etiologically distinct subgroup of colon cancers that occur in individuals suffering from inflammatory bowel disease and arise as a consequence of persistent exposure of hyperproliferative epithelial stem cells to an inflammatory microenvironment. An intrinsic defect in the intestinal epithelial barrier has been proposed to be one of several factors that contribute to the inappropriate immune response to the commensal microbiota that underlies inflammatory bowel disease. Matriptase is a membrane-anchored serine protease encoded by Suppression of Tumorigenicity-14 (ST14) that strengthens the intestinal epithelial barrier by promoting tight junction formation. Here, we show that intestinal epithelial-specific ablation of St14 in mice causes formation of colon adenocarcinoma with very early onset and high penetrance. Neoplastic progression is preceded by a chronic inflammation of the colon that resembles human inflammatory bowel disease and is promoted by the commensal microbiota. This study demonstrates that inflammation-associated colon carcinogenesis can be initiated and promoted solely by an intrinsic intestinal permeability barrier perturbation, establishes St14 as a critical tumor-suppressor gene in the mouse gastrointestinal tract and adds matriptase to the expanding list of pericellular proteases with tumor-suppressive functions. Oncogene (2012) 31, 3679-3695; doi:10.1038/onc.2011.545; published online 5 December 2011	[Bugge, T. H.] Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Bugge, TH (corresponding author), Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, Natl Inst Hlth, 30 Convent Dr,Room 211, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov			NIDCR Intramural Research Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER	NIDCR Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Drs Jerrold M Ward, Robert D Cardiff and Stephen M Hewitt for pathology advice, Drs Vyomesh Patel and Kantima Leelahavanichkul for help with the array analysis, Dr Myrna Mandel for helicobacter testing, as well as Drs Silvio Gutkind and Mary Jo Danton for critically reviewing this manuscript. Histology was performed by Histoserv Inc. (Germantown, MD, USA). This study was supported by the NIDCR Intramural Research Program (THB).	Acuff HB, 2006, CANCER RES, V66, P7968, DOI 10.1158/0008-5472.CAN-05-4279; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Cheng HX, 2009, CANCER RES, V69, P1828, DOI 10.1158/0008-5472.CAN-08-3728; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; de Lau W, 2007, FRONT BIOSCI-LANDMRK, V12, P471, DOI 10.2741/2076; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Engle SJ, 2002, CANCER RES, V62, P6362; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Feng SL, 2005, CLIN DIAGN LAB IMMUN, V12, P531, DOI 10.1128/CDLI.12.4.531-536.2005; Forbs D, 2005, INT J ONCOL, V27, P1061; Garrett WS, 2009, CANCER CELL, V16, P208, DOI 10.1016/j.ccr.2009.07.015; Gaspar C, 2008, AM J PATHOL, V172, P1363, DOI 10.2353/ajpath.2008.070851; Hale LP, 2007, HELICOBACTER, V12, P598, DOI 10.1111/j.1523-5378.2007.00552.x; Hardwick JC, 2008, NAT REV CANCER, V8, P806, DOI 10.1038/nrc2467; Ihara S, 2002, J BIOL CHEM, V277, P16960, DOI 10.1074/jbc.M200673200; Jin XL, 2006, CANCER SCI, V97, P1327, DOI 10.1111/j.1349-7006.2006.00328.x; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lopez-Otin C, 2009, CELL CYCLE, V8, P3657, DOI 10.4161/cc.8.22.9956; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448; McCawley LJ, 2008, AM J PATHOL, V173, P1528, DOI 10.2353/ajpath.2008.080132; McCawley LJ, 2004, CANCER RES, V64, P6965, DOI 10.1158/0008-5472.CAN-04-0910; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Okayasu I, 2002, J GASTROEN HEPATOL, V17, P1078, DOI 10.1046/j.1440-1746.2002.02853.x; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Owen KA, 2010, BIOCHEM J, V426, P219, DOI 10.1042/BJ20091448; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reinheckel T, 2005, J CELL SCI, V118, P3387, DOI 10.1242/jcs.02469; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Riley LK, 1996, J CLIN MICROBIOL, V34, P942, DOI 10.1128/JCM.34.4.942-946.1996; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Sales KU, 2010, NAT GENET, V42, P676, DOI 10.1038/ng.629; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Shah SA, 1998, INFLAMM BOWEL DIS, V4, P196, DOI 10.1097/00054725-199808000-00004; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Suzuki M, 2004, J BIOL CHEM, V279, P14899, DOI 10.1074/jbc.M313130200; Szabo R, 2011, ONCOGENE, V30, P2003, DOI 10.1038/onc.2010.586; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tanimoto H, 2001, TUMOR BIOL, V22, P104, DOI 10.1159/000050604; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zeki SS, 2011, NAT REV GASTRO HEPAT, V8, P90, DOI 10.1038/nrgastro.2010.211; Zhang Y, 1998, CYTOGENET CELL GENET, V83, P56, DOI 10.1159/000015125	75	42	44	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2012	31	32					3679	3695		10.1038/onc.2011.545	http://dx.doi.org/10.1038/onc.2011.545			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	990TF	22139080	Green Accepted			2022-12-25	WOS:000307653800003
J	Khan, MM; Chatterjee, S; Dwivedi, VP; Pandey, NK; Singh, Y; Tousif, S; Bhavesh, NS; Van Kaer, L; Das, J; Das, G				Khan, Mohd Moin; Chatterjee, Samit; Dwivedi, Ved Prakash; Pandey, Nishant Kumar; Singh, Yogesh; Tousif, Sultan; Bhavesh, Neel Sarovar; Van Kaer, Luc; Das, Jyoti; Das, Gobardhan			CD4(+) T Cell-derived Novel Peptide Thp5 Induces Interleukin-4 Production in CD4(+) T Cells to Direct T Helper 2 Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; TH2 DIFFERENTIATION; IN-VIVO; IL-4; EXPRESSION; DYNAMICS; PROGRAM; NMR	The differentiation of naive CD4(+) T cells into T helper 2 (Th2) cells requires production of the cytokine IL-4 in the local microenvironment. It is evident that naive/quiescently activated CD4(+) T cells produce the IL-4 that drives Th2 cell differentiation. Because early production of IL-4 in naive T cells leads to preferential Th2 cell differentiation, this process needs to be tightly regulated so as to avoid catastrophic and misdirected Th2 cell differentiation. Here, we show that Thp5, a novel peptide with structural similarity to vasoactive intestinal peptide, regulates production of early IL-4 in newly activated CD4(+) T cells. Induction of IL-4 in CD4(+) T cells by Thp5 is independent of the transcription factor STAT6 but dependent on ERK1/2 signaling. Furthermore, cytokines (IL-12 and TGF-beta) that promote the differentiation of Th1 or Th17 cells inhibit Thp5 induction, thus suppressing Th2 cell differentiation. We further showed that Thp5 enhances Th2 responses and exacerbates allergic airway inflammation in mice. Taken together, our findings reveal that early activated CD4(+) T cells produce Thp5, which plays a critical role as a molecular switch in the differentiation of Th cells, biasing the response toward the Th2 cell phenotype.	[Das, Jyoti] Natl Inst Malaria Res, Dept Immunol, Sect 8, New Delhi 110077, India; [Khan, Mohd Moin; Chatterjee, Samit; Dwivedi, Ved Prakash; Singh, Yogesh; Tousif, Sultan; Das, Gobardhan] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India; [Pandey, Nishant Kumar; Bhavesh, Neel Sarovar] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi 110067, India; [Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Vanderbilt University	Das, J (corresponding author), Natl Inst Malaria Res, Dept Immunol, Sect 8, New Delhi 110077, India.	jyoti@mrcindia.org; dasgo@icgeb.res.in	Chatterjee, Samit/ABZ-2522-2022; Singh, Yogesh/T-8230-2017; Van Kaer, Luc/H-1033-2015; Bhavesh, Neel Sarovar/F-3127-2015; Khan, Mohd Moin/GYQ-7170-2022	Chatterjee, Samit/0000-0001-8176-3410; Singh, Yogesh/0000-0001-6919-6273; Van Kaer, Luc/0000-0001-5275-2309; Bhavesh, Neel Sarovar/0000-0002-7248-4978; Dwivedi, Ved Prakash/0000-0003-4321-2567; Tousif, Sultan/0000-0001-6174-6541	Wellcome Trust Department of Biotechnology (DBT) alliance; DBT, Government of India; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Wellcome Trust Department of Biotechnology (DBT) alliance(Department of Biotechnology (DBT) IndiaWellcome Trust DBT India Alliance); DBT, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from The Wellcome Trust Department of Biotechnology (DBT) alliance, and by the DBT, Government of India, for the 500 MHz and 700 MHz NMR spectrometers at the International Centre for Genetic Engineering and Biotechnology, New Delhi, and National Institute of Immunology, New Delhi.; Supported by a Department of Biotechnology, Government of India, senior research fellowship.; Supported by a Council of Scientific and Industrial Research senior research fellowship, Government of India.	Chorny A, 2005, P NATL ACAD SCI USA, V102, P13562, DOI 10.1073/pnas.0504484102; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Delgado M, 2005, J LEUKOCYTE BIOL, V78, P1327, DOI 10.1189/jlb.0605299; Delgado M, 2003, TRENDS IMMUNOL, V24, P221, DOI 10.1016/S1471-4906(03)00069-3; FRY DC, 1989, BIOCHEMISTRY-US, V28, P2399, DOI 10.1021/bi00432a010; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Keller R., 2004, COMPUTER AIDED RESON, V1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Noben-Trauth N, 2002, EUR J IMMUNOL, V32, P1428, DOI 10.1002/1521-4141(200205)32:5<1428::AID-IMMU1428>3.0.CO;2-0; Noben-Trauth N, 2000, J IMMUNOL, V165, P3620, DOI 10.4049/jimmunol.165.7.3620; Ono K, 2007, IMMUNOL RES, V38, P319, DOI 10.1007/s12026-007-0011-5; So EY, 2007, MOL IMMUNOL, V44, P3416, DOI 10.1016/j.molimm.2007.02.022; Sokol CL, 2010, CURR OPIN IMMUNOL, V22, P73, DOI 10.1016/j.coi.2010.01.012; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	20	12	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2830	2835		10.1074/jbc.M111.319947	http://dx.doi.org/10.1074/jbc.M111.319947			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130674	Green Published, hybrid			2022-12-25	WOS:000300292300054
J	Scheidt, HA; Morgado, I; Rothemund, S; Huster, D				Scheidt, Holger A.; Morgado, Isabel; Rothemund, Sven; Huster, Daniel			Dynamics of Amyloid beta Fibrils Revealed by Solid-state NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; STRUCTURAL MODEL; POLYMORPHISM; A-BETA(1-40); PEPTIDE; SPECTROSCOPY; DOMAIN	We have investigated the site-specific backbone dynamics of mature amyloid beta (A beta) fibrils using solid-state NMR spectroscopy. Overall, the known beta-sheet segments and the turn linking these two beta-strands exhibit high order parameters between 0.8 and 0.95, suggesting low conformational flexibility. The first approximately eight N-terminal and the last C-terminal residues exhibit lower order parameters between similar to 0.4 and 0.8. Interestingly, the order parameters increase again for the first two residues, Asp(1) and Ala(2), suggesting that the N terminus could carry some structural importance.	[Huster, Daniel] Univ Leipzig, Inst Med Phys & Biophys, D-04107 Leipzig, Germany; [Morgado, Isabel] Univ Halle Wittenberg, Inst Biochem Biotechnol, D-06120 Halle, Germany; [Rothemund, Sven] Univ Leipzig, Interdisciplinary Ctr Clin Res, D-04103 Leipzig, Germany	Leipzig University; Martin Luther University Halle Wittenberg; Leipzig University	Huster, D (corresponding author), Univ Leipzig, Inst Med Phys & Biophys, Hartelstr 16-18, D-04107 Leipzig, Germany.	daniel.huster@medizin.uni-leipzig.de	Morgado, Isabel/J-4798-2013; Scheidt, Holger A./C-1416-2014	Morgado, Isabel/0000-0002-7826-997X; 	Deutsche Forschungsgemeinschaft [Transregio-SFB 102]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Transregio-SFB 102, A6 and a personal grant to I. M.).	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Barre P, 2003, BIOCHEMISTRY-US, V42, P8377, DOI 10.1021/bi034239e; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Buchete NV, 2007, BIOPHYS J, V92, P3032, DOI 10.1529/biophysj.106.100404; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; Fandrich M, 2011, TRENDS BIOCHEM SCI, V36, P338, DOI 10.1016/j.tibs.2011.02.002; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Helmus JJ, 2010, J AM CHEM SOC, V132, P2393, DOI 10.1021/ja909827v; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Huster D, 2005, PROG NUCL MAG RES SP, V46, P79, DOI 10.1016/j.pnmrs.2005.01.001; Huster D, 2001, BIOCHEMISTRY-US, V40, P7662, DOI 10.1021/bi0027231; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Miller Y, 2011, J AM CHEM SOC, V133, P2742, DOI 10.1021/ja1100273; MUNOWITZ MG, 1981, J AM CHEM SOC, V103, P2529, DOI 10.1021/ja00400a007; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Paravastu AK, 2006, BIOPHYS J, V90, P4618, DOI 10.1529/biophysj.105.076927; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Sachse C, 2008, P NATL ACAD SCI USA, V105, P7462, DOI 10.1073/pnas.0712290105; Sackewitz M, 2008, J AM CHEM SOC, V130, P7172, DOI 10.1021/ja800120s; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scheidt HA, 2011, ANGEW CHEM INT EDIT, V50, P2837, DOI 10.1002/anie.201007265; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Tarus B, 2006, J AM CHEM SOC, V128, P16159, DOI 10.1021/ja064872y; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173	30	70	72	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2017	2021		10.1074/jbc.M111.308619	http://dx.doi.org/10.1074/jbc.M111.308619			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22130659	hybrid, Green Published			2022-12-25	WOS:000299321000042
J	Kosaka, N; Iguchi, H; Yoshioka, Y; Hagiwara, K; Takeshita, F; Ochiya, T				Kosaka, Nobuyoshi; Iguchi, Haruhisa; Yoshioka, Yusuke; Hagiwara, Keitaro; Takeshita, Fumitaka; Ochiya, Takahiro			Competitive Interactions of Cancer Cells and Normal Cells via Secretory MicroRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; PROSTATE; PATHWAY	Normal epithelial cells regulate the secretion of autocrine and paracrine factors that prevent aberrant growth of neighboring cells, leading to healthy development and normal metabolism. One reason for tumor initiation is considered to be a failure of this homeostatic cell competitive system. Here we identify tumor-suppressive microRNAs (miRNAs) secreted by normal cells as anti-proliferative signal entities. Culture supernatant of normal epithelial prostate PNT-2 cells attenuated proliferation of PC-3M-luc cells, prostate cancer cells. Global analysis of miRNA expression signature revealed that a variety of tumor-suppressive miRNAs are released from PNT-2 cells. Of these miRNAs, secretory miR-143 could induce growth inhibition exclusively in cancer cells in vitro and in vivo. These results suggest that secretory tumor-suppressive miRNAs can act as a death signal in a cell competitive process. This study provides a novel insight into a tumor initiation mechanism.	[Kosaka, Nobuyoshi; Iguchi, Haruhisa; Yoshioka, Yusuke; Hagiwara, Keitaro; Takeshita, Fumitaka; Ochiya, Takahiro] Natl Canc Ctr, Div Mol & Cellular Med, Chuo Ku, Tokyo 1040045, Japan; [Iguchi, Haruhisa] Dainippon Sumitomo Pharma Co Ltd, Pharmacol Res Labs, Konohana Ku, Osaka 5540022, Japan; [Hagiwara, Keitaro] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	National Cancer Center - Japan; Dainippon Sumitomo Pharmaceutical Company; Tokyo Institute of Technology	Ochiya, T (corresponding author), Natl Canc Ctr, Div Mol & Cellular Med, Chuo Ku, 1-1 Tsukiji,5 Chome, Tokyo 1040045, Japan.	tochiya@ncc.go.jp	Ochiya, Takahiro/AAH-7585-2019		Ministry of Education, Culture, Sports, Science, and Technology; National Institute of Biomedical Innovation; Japan Society for the Promotion of Science through Council for Science and Technology Policy; Grants-in-Aid for Scientific Research [21115008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Japan Society for the Promotion of Science through Council for Science and Technology Policy(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control, a grant-in-aid for Scientific Research on Priority Areas Cancer from the Ministry of Education, Culture, Sports, Science, and Technology, the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and the Japan Society for the Promotion of Science through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)" initiated by the Council for Science and Technology Policy.	Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; Bourhis XFDL, 1997, INT J CANCER, V71, P42, DOI 10.1002/(SICI)1097-0215(19970328)71:1<42::AID-IJC9>3.0.CO;2-3; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Diaz B, 2005, EXP CELL RES, V306, P317, DOI 10.1016/j.yexcr.2005.03.017; Franses JW, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001542; Fujita Y, 2010, J BIOL CHEM, V285, P19076, DOI 10.1074/jbc.M109.079525; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kwak PB, 2010, CANCER SCI, V101, P2309, DOI 10.1111/j.1349-7006.2010.01683.x; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peng XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020341; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Savina A, 2002, J CELL SCI, V115, P2505; Senoo-Matsuda N, 2007, P NATL ACAD SCI USA, V104, P18543, DOI 10.1073/pnas.0709021104; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Xu B, 2011, MOL CELL BIOCHEM, V350, P207, DOI 10.1007/s11010-010-0700-6; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579	26	207	218	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1397	1405		10.1074/jbc.M111.288662	http://dx.doi.org/10.1074/jbc.M111.288662			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22123823	Green Published, hybrid			2022-12-25	WOS:000299170300053
J	Magistroni, V; Mologni, L; Sanselicio, S; Reid, JF; Redaelli, S; Piazza, R; Viltadi, M; Bovo, G; Strada, G; Grasso, M; Gariboldi, M; Gambacorti-Passerini, C				Magistroni, Vera; Mologni, Luca; Sanselicio, Stefano; Reid, James Frances; Redaelli, Sara; Piazza, Rocco; Viltadi, Michela; Bovo, Giorgio; Strada, Guido; Grasso, Marco; Gariboldi, Manuela; Gambacorti-Passerini, Carlo			ERG Deregulation Induces PIM1 Over-Expression and Aneuploidy in Prostate Epithelial Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; EMBRYONIC STEM-CELLS; ETS-RELATED GENE; TRANSCRIPTION FACTOR; FUSION PROTEIN; CANCER CELLS; CHROMOSOMAL TRANSLOCATION; HEMATOPOIETIC-CELLS; EWINGS-SARCOMA; EWS-ERG	The ERG gene belongs to the ETS family of transcription factors and has been found to be involved in atypical chromosomal rearrangements in several cancers. To gain insight into the oncogenic activity of ERG, we compared the gene expression profile of NIH-3T3 cells stably expressing the coding regions of the three main ERG oncogenic fusions: TMPRSS2/ERG (tERG), EWS/ERG and FUS/ERG. We found that all three ERG fusions significantly up-regulate PIM1 expression in the NIH-3T3 cell line. PIM1 is a serine/threonine kinase frequently over-expressed in cancers of haematological and epithelial origin. We show here that tERG expression induces PIM1 in the non-malignant prostate cell line RWPE-1, strengthening the relation between tERG and PIM1 up-regulation in the initial stages of prostate carcinogenesis. Silencing of tERG reversed PIM1 induction. A significant association between ERG and PIM1 expression in clinical prostate carcinoma specimens was found, suggesting that such a mechanism may be relevant in vivo. Chromatin Immunoprecipitation experiments showed that tERG directly binds to PIM1 promoter in the RWPE-1 prostate cell line, suggesting that tERG could be a direct regulator of PIM1 expression. The up-regulation of PIM1 induced by tERG over-expression significantly modified Cyclin B1 levels and increased the percentage of aneuploid cells in the RWPE-1 cell line after taxane-based treatment. Here we provide the first evidence for an ERG-mediated PIM1 up-regulation in prostate cells in vitro and in vivo, suggesting a direct effect of ERG transcriptional activity in the alteration of genetic stability.	[Magistroni, Vera; Mologni, Luca; Sanselicio, Stefano; Redaelli, Sara; Piazza, Rocco; Viltadi, Michela; Gambacorti-Passerini, Carlo] Univ Milano Bicocca, Dept Clin Med, Monza, Italy; [Reid, James Frances; Gariboldi, Manuela] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy; [Reid, James Frances; Gariboldi, Manuela] IFOM Fdn, Unit Mol Genet Canc, Milan, Italy; [Bovo, Giorgio] S Gerardo Hosp, Dept Pathol, Monza, Italy; [Strada, Guido] Bassini ICP Hosp, Div Urol, Milan, Italy; [Grasso, Marco] San Gerardo Hosp, Dept Urol, Monza, Italy; [Gambacorti-Passerini, Carlo] San Gerardo Hosp, Sect Haematol, Monza, Italy	University of Milano-Bicocca; Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; San Gerardo Hospital; San Gerardo Hospital	Magistroni, V (corresponding author), Univ Milano Bicocca, Dept Clin Med, Monza, Italy.	vera.magistroni@unimib.it	Piazza, Rocco/I-3540-2012; Reid, James/G-2496-2010; redaelli, sara/I-5146-2012; Mologni, Luca/AAC-1065-2022; Magistroni, Vera/AAA-5582-2020; Gariboldi, Manuela/K-4744-2016	redaelli, sara/0000-0003-0166-1188; Mologni, Luca/0000-0002-6365-5149; Magistroni, Vera/0000-0002-7334-9401; Reid, James/0000-0001-6997-2850; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Rocco, Piazza/0000-0003-4198-9620; Gariboldi, Manuela/0000-0001-8406-165X	Italian Ministry of Health [RFPS-2006-333974]; Italian Association for Cancer Research (AIRC) [IG-10092]; Progetti di Ricerca di Interesse Nazionale (PRIN) [20084XBENM_004]; CARIPLO Foundation [2009-2667]; Regione Lombardia [ID-16871, ID-14546A]	Italian Ministry of Health; Italian Association for Cancer Research (AIRC); Progetti di Ricerca di Interesse Nazionale (PRIN); CARIPLO Foundation; Regione Lombardia	This work was supported by the Italian Ministry of Health (RFPS-2006-333974); the Italian Association for Cancer Research (AIRC) (IG-10092); Progetti di Ricerca di Interesse Nazionale (PRIN) (20084XBENM_004); CARIPLO Foundation (2009-2667); Regione Lombardia (ID-16871 and ID-14546A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babel I, 2009, MOL CELL PROTEOMICS, V8, P2382, DOI 10.1074/mcp.M800596-MCP200; Bachmann PS, 2010, BLOOD, V116, P3013, DOI 10.1182/blood-2010-05-284968; Baldus CD, 2006, J CLIN ONCOL, V24, P4714, DOI 10.1200/JCO.2006.06.1580; Beier UH, 2007, INT J ONCOL, V30, P1381; Bhattacharya N, 2002, CHROMOSOMA, V111, P80, DOI 10.1007/s00412-002-0192-6; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Carver BS, 2009, NATURE, V457, pE1, DOI 10.1038/nature07738; Chen J, 2009, ONCOGENE, V28, P2581, DOI 10.1038/onc.2009.124; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Chu QJ, 2006, CARCINOGENESIS, V27, P2180, DOI 10.1093/carcin/bgl054; Cibull TL, 2006, J CLIN PATHOL, V59, P285, DOI 10.1136/jcp.2005.027672; Clark J, 2007, ONCOGENE, V26, P2667, DOI 10.1038/sj.onc.1210070; Codrington R, 2005, PLOS BIOL, V3, P1459, DOI 10.1371/journal.pbio.0030242; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Diaz FJ, 2006, DEV BIOL, V299, P91, DOI 10.1016/j.ydbio.2006.07.012; Diecke S, 2008, CELLS TISSUES ORGANS, V188, P52, DOI 10.1159/000121282; GIOVANNINI M, 1994, J CLIN INVEST, V94, P489, DOI 10.1172/JCI117360; Harb JG, 2008, BLOOD, V111, P3760, DOI 10.1182/blood-2007-08-108803; ICHIKAWA H, 1994, CANCER RES, V54, P2865; Ichikawa H, 1999, MOL CELL BIOL, V19, P7639; Kim J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-248; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kong XT, 1997, BLOOD, V90, P1192; Kunderfranco P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010547; Marcucci G, 2005, J CLIN ONCOL, V23, P9234, DOI 10.1200/JCO.2005.03.6137; Mologni L, 2010, CANCER RES, V70, P7253, DOI 10.1158/0008-5472.CAN-10-1108; Mumenthaler SM, 2009, MOL CANCER THER, V8, P2882, DOI 10.1158/1535-7163.MCT-09-0293; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; PANAGOPOULOS I, 1994, GENE CHROMOSOME CANC, V11, P256, DOI 10.1002/gcc.2870110408; Peltola K, 2009, NEOPLASIA, V11, P629, DOI 10.1593/neo.81038; Pereira DS, 1998, P NATL ACAD SCI USA, V95, P8239, DOI 10.1073/pnas.95.14.8239; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Reiser-Erkan C, 2008, CANCER BIOL THER, V7, P1352, DOI 10.4161/cbt.7.9.6418; Roh M, 2005, J BIOL CHEM, V280, P40568, DOI 10.1074/jbc.M509369200; Roh M, 2003, CANCER RES, V63, P8079; Roh M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002572; Sahlberg C, 2007, J DENT RES, V86, P600, DOI 10.1177/154405910708600704; SHIMIZU K, 1993, P NATL ACAD SCI USA, V90, P10280, DOI 10.1073/pnas.90.21.10280; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Valdman A, 2004, PROSTATE, V60, P367, DOI 10.1002/pros.20064; Van Orman JR, 2009, AM J PHYSIOL-HEART C, V297, pH1369, DOI 10.1152/ajpheart.00172.2009; Willems E, 2006, INT J DEV BIOL, V50, P627, DOI 10.1387/ijdb.052130ew; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Yang L, 2000, MOL CELL BIOL, V20, P3345, DOI 10.1128/MCB.20.10.3345-3354.2000; Zemskova M, 2008, J BIOL CHEM, V283, P20635, DOI 10.1074/jbc.M709479200; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106; Zou JH, 2005, MOL CELL BIOL, V25, P6235, DOI 10.1128/MCB.25.14.6235-6246.2005; ZUCMAN J, 1993, EMBO J, V12, P4481, DOI 10.1002/j.1460-2075.1993.tb06137.x	55	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28162	10.1371/journal.pone.0028162	http://dx.doi.org/10.1371/journal.pone.0028162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140532	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168100042
J	Kaushansky, N; de Rosbo, NK; Zilkha-Falb, R; Yosef-Hemo, R; Cohen, L; Ben-Nun, A				Kaushansky, Nathali; de Rosbo, Nicole Kerlero; Zilkha-Falb, Rina; Yosef-Hemo, Reut; Cohen, Lydia; Ben-Nun, Avraham			'Multi-Epitope-Targeted' Immune-Specific Therapy for a Multiple Sclerosis-Like Disease via Engineered Multi-Epitope Protein Is Superior to Peptides	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN BASIC-PROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; OLIGODENDROCYTE-SPECIFIC PROTEIN; T-CELL AUTOIMMUNITY; CLASS-II; H-2(B) MICE; SJL/J MICE; DEMYELINATING DISEASE; ANTIGEN PRESENTATION	Antigen-induced peripheral tolerance is potentially one of the most efficient and specific therapeutic approaches for autoimmune diseases. Although highly effective in animal models, antigen-based strategies have not yet been translated into practicable human therapy, and several clinical trials using a single antigen or peptidic-epitope in multiple sclerosis (MS) yielded disappointing results. In these clinical trials, however, the apparent complexity and dynamics of the pathogenic autoimmunity associated with MS, which result from the multiplicity of potential target antigens and "epitope spread", have not been sufficiently considered. Thus, targeting pathogenic T-cells reactive against a single antigen/epitope is unlikely to be sufficient; to be effective, immunospecific therapy to MS should logically neutralize concomitantly T-cells reactive against as many major target antigens/epitopes as possible. We investigated such "multi-epitope-targeting" approach in murine experimental autoimmune encephalomyelitis (EAE) associated with a single ("classical") or multiple ("complex") anti-myelin autoreactivities, using cocktail of different encephalitogenic peptides vis-a-vis artificial multi-epitope-protein (designated Y-MSPc) encompassing rationally selected MS-relevant epitopes of five major myelin antigens, as "multi-epitope-targeting" agents. Y-MSPc was superior to peptide(s) in concomitantly downregulating pathogenic T-cells reactive against multiple myelin antigens/epitopes, via inducing more effective, longer lasting peripheral regulatory mechanisms (cytokine shift, anergy, and Foxp3+ CTLA4+ regulatory T-cells). Y-MSPc was also consistently more effective than the disease-inducing single peptide or peptide cocktail, not only in suppressing the development of "classical" or "complex EAE" or ameliorating ongoing disease, but most importantly, in reversing chronic EAE. Overall, our data emphasize that a "multi-epitope-targeting" strategy is required for effective immune-specific therapy of organ-specific autoimmune diseases associated with complex and dynamic pathogenic autoimmunity, such as MS; our data further demonstrate that the "multi-epitope-targeting" approach to therapy is optimized through specifically designed multi-epitope-proteins, rather than myelin peptide cocktails, as "multi-epitope-targeting" agents. Such artificial multi-epitope proteins can be tailored to other organ-specific autoimmune diseases.	[Kaushansky, Nathali; de Rosbo, Nicole Kerlero; Zilkha-Falb, Rina; Yosef-Hemo, Reut; Cohen, Lydia; Ben-Nun, Avraham] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Kaushansky, N (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	avraham.ben-nun@weizmann.ac.il	KAUSHANSKY, NATHALI/K-1722-2012; Kerlero de Rosbo, Nicole/I-1134-2018	Kerlero de Rosbo, Nicole/0000-0002-0493-0964	Israel Academy of Science and Humanities (ISF); National Multiple Sclerosis Society of New York; Israel Ministry of Health; Estate of the Late Florence Blau; William Sahm Foundation; Rubin & Gladys Wollowick Foundation; Kirk Center for Childhood Cancer and Immunological Disorders	Israel Academy of Science and Humanities (ISF); National Multiple Sclerosis Society of New York(National Multiple Sclerosis Society); Israel Ministry of Health; Estate of the Late Florence Blau; William Sahm Foundation; Rubin & Gladys Wollowick Foundation; Kirk Center for Childhood Cancer and Immunological Disorders	This work was supported in part by the Israel Academy of Science and Humanities (ISF), the National Multiple Sclerosis Society of New York, the Israel Ministry of Health, the Estate of the Late Florence Blau, the William Sahm Foundation, the Rubin & Gladys Wollowick Foundation, and The Kirk Center for Childhood Cancer and Immunological Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2004, J NEUROL SCI, V223, P13, DOI 10.1016/j.jns.2004.04.014; AMOR S, 1994, J IMMUNOL, V153, P4349; Ben-Nun A, 2006, EUR J IMMUNOL, V36, P478, DOI 10.1002/eji.200535363; BENNUN A, 1983, J IMMUNOL, V130, P1205; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; CAMPBELL B, 1973, ARCH NEUROL-CHICAGO, V29, P10, DOI 10.1001/archneur.1973.00490250028003; Chen CC, 2001, BLOOD, V97, P886, DOI 10.1182/blood.V97.4.886; CLAYTON JP, 1989, J EXP MED, V169, P1681, DOI 10.1084/jem.169.5.1681; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; de Rosbo NK, 1998, J AUTOIMMUN, V11, P287, DOI 10.1006/jaut.1998.0202; de Rosbo NK, 2004, J IMMUNOL, V173, P1426, DOI 10.4049/jimmunol.173.2.1426; Devaux B, 1997, J NEUROIMMUNOL, V75, P169, DOI 10.1016/S0165-5728(97)00019-2; Elliott EA, 1996, J CLIN INVEST, V98, P1602, DOI 10.1172/JCI118954; Ellmerich S, 2004, EUR J IMMUNOL, V34, P1839, DOI 10.1002/eji.200324044; Fritz RB, 1996, J NEUROSCI RES, V45, P471, DOI 10.1002/(SICI)1097-4547(19960815)45:4<471::AID-JNR17>3.0.CO;2-3; GAUR A, 1992, SCIENCE, V258, P1491, DOI 10.1126/science.1279812; GONSETTE RE, 1977, J NEUROL, V216, P27, DOI 10.1007/BF00312812; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; HOWELL MD, 1989, SCIENCE, V246, P668, DOI 10.1126/science.2814489; Huan JY, 2004, J IMMUNOL, V172, P4556, DOI 10.4049/jimmunol.172.7.4556; Jin Y, 2004, HUM IMMUNOL, V65, P93, DOI 10.1016/j.humimm.2003.11.002; Jurynczyk M, 2010, ANN NEUROL, V68, P593, DOI 10.1002/ana.22219; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; Kaushansky N, 2007, EUR J IMMUNOL, V37, P2018, DOI 10.1002/eji.200636965; Kaushansky N, 2006, J IMMUNOL, V177, P7364, DOI 10.4049/jimmunol.177.10.7364; Kaye JF, 2000, J NEUROIMMUNOL, V102, P189, DOI 10.1016/S0165-5728(99)00168-X; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Leadbetter EA, 1998, J IMMUNOL, V161, P504; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; LIDER O, 1988, SCIENCE, V239, P181, DOI 10.1126/science.2447648; Liu E, 2002, J CLIN INVEST, V110, P1021, DOI 10.1172/JCI200215488; MCRAE BL, 1995, J EXP MED, V182, P75, DOI 10.1084/jem.182.1.75; Mendel I, 1996, EUR J IMMUNOL, V26, P2470, DOI 10.1002/eji.1830261030; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; OWHASHI M, 1988, J EXP MED, V168, P2153, DOI 10.1084/jem.168.6.2153; Pathak SS, 2000, TRAFFIC, V1, P561, DOI 10.1034/j.1600-0854.2000.010706.x; Pedotti R, 2001, NAT IMMUNOL, V2, P216, DOI 10.1038/85266; Pedotti Rosetta, 2003, BMC Immunol, V4, P2, DOI 10.1186/1471-2172-4-2; Racke MK, 1996, ANN NEUROL, V39, P46, DOI 10.1002/ana.410390108; Ruiz PJ, 1999, J IMMUNOL, V162, P3336; SAKAI K, 1988, J NEUROIMMUNOL, V19, P21, DOI 10.1016/0165-5728(88)90032-X; SHARMA SD, 1991, P NATL ACAD SCI USA, V88, P11465, DOI 10.1073/pnas.88.24.11465; Simpson D, 2002, CNS DRUGS, V16, P825, DOI 10.2165/00023210-200216120-00004; Smith CE, 2006, J AUTOIMMUN, V27, P218, DOI 10.1016/j.jaut.2006.12.002; Smith CE, 2005, P NATL ACAD SCI USA, V102, P9595, DOI 10.1073/pnas.0504131102; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stevens DB, 1999, J IMMUNOL, V162, P7501; TUOHY VK, 1994, NEUROCHEM RES, V19, P935, DOI 10.1007/BF00968703; Tuohy VK, 1998, IMMUNOL REV, V164, P93, DOI 10.1111/j.1600-065X.1998.tb01211.x; Tuohy VK, 1997, J CLIN INVEST, V99, P1682, DOI 10.1172/JCI119331; URBAN JL, 1988, CELL, V54, P577, DOI 10.1016/0092-8674(88)90079-7; VANDENBARK AA, 1989, NATURE, V341, P541, DOI 10.1038/341541a0; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724; Warren KG, 2006, EUR J NEUROL, V13, P887, DOI 10.1111/j.1468-1331.2006.01533.x; Watts C, 2004, NAT IMMUNOL, V5, P685, DOI 10.1038/ni1088; WRAITH DC, 1989, CELL, V59, P247, DOI 10.1016/0092-8674(89)90287-0; Yu M, 1998, HUM IMMUNOL, V59, P15, DOI 10.1016/S0198-8859(97)00252-8; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0; Zhong MC, 2000, J NEUROIMMUNOL, V105, P39, DOI 10.1016/S0165-5728(00)00186-7; Zhong MC, 2002, J CLIN INVEST, V110, P81, DOI 10.1172/JCI200215692	62	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27860	10.1371/journal.pone.0027860	http://dx.doi.org/10.1371/journal.pone.0027860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140475	Green Published, Green Submitted, gold			2022-12-25	WOS:000298166300014
J	Yuan, CB; Chen, MH; Covey, DF; Johnston, LJ; Treistman, SN				Yuan, Chunbo; Chen, Maohui; Covey, Douglas F.; Johnston, Linda J.; Treistman, Steven N.			Cholesterol Tuning of BK Ethanol Response Is Enantioselective, and Is a Function of Accompanying Lipids	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; CONTENT MODULATES ACTIVATION; ATOMIC-FORCE MICROSCOPY; MEMBRANE CHOLESTEROL; LARGE-CONDUCTANCE; POTASSIUM CHANNELS; ENDOTHELIAL-CELLS; MODEL MEMBRANES; ALCOHOL ACTION; RAFTS	In the search to uncover ethanol's molecular mechanisms, the calcium and voltage activated, large conductance potassium channel (BK) has emerged as an important molecule. We examine how cholesterol content in bilayers of 1,2-dioleoyl-3-phosphatidylethanolamine (DOPE)/sphingomyelin (SPM) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylethanolamine (POPE)/1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylserine (POPS) affect the function and ethanol sensitivity of BK. In addition, we examine how manipulation of cholesterol in biological membranes modulates ethanol's actions on BK. We report that cholesterol levels regulate the change in BK channel open probability elicited by 50 mM ethanol. Low levels of cholesterol (<20%, molar ratio) supports ethanol activation, while high levels of cholesterol leads to ethanol inhibition of BK. To determine if cholesterol affects BK and its sensitivity to ethanol through a direct cholesterol-protein interaction or via an indirect action on the lipid bilayer, we used the synthetic enantiomer of cholesterol (ent-CHS). We found that 20% and 40% ent-CHS had little effect on the ethanol sensitivity of BK, when compared with the same concentration of nat-CHS. We accessed the effects of ent-CHS and nat-CHS on the molecular organization of DOPE/SPM monolayers at the air/water interface. The isotherm data showed that ent-CHS condensed DOPE/SPM monolayer equivalently to nat-CHS at a 20% concentration, but slightly less at a 40% concentration. Atomic force microscopy (AFM) images of DOPE/SPM membranes in the presence of ent-CHS or nat-CHS prepared with LB technique or vesicle deposition showed no significant difference in topographies, supporting the interpretation that the differences in actions of nat-CHS and ent-CHS on BK channel are not likely from a generalized action on bilayers. We conclude that membrane cholesterol influences ethanol's modulation of BK in a complex manner, including an interaction with the channel protein. Finally, our results suggest that an understanding of membrane protein function and modulation is impossible unless protein and surrounding lipid are considered as a functional unit.	[Yuan, Chunbo; Treistman, Steven N.] Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA; [Chen, Maohui; Johnston, Linda J.] Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON, Canada; [Covey, Douglas F.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA	University of Puerto Rico; National Research Council Canada; Washington University (WUSTL)	Yuan, CB (corresponding author), Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA.	steven.treistman@upr.edu		Chen, Maohui/0000-0001-6931-8875; Johnston, Linda/0000-0002-9136-4920	National Institutes of Health [GM47969, AA 018038-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047969, P20GM103642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018038, R01AA017920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by grants from National Institutes of Health GM47969 (DC), and AA 018038-05 (ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addona GH, 1998, BBA-BIOMEMBRANES, V1370, P299, DOI 10.1016/S0005-2736(97)00280-0; Aguayo Luis G., 2002, Current Topics in Medicinal Chemistry, V2, P869, DOI 10.2174/1568026023393426; Ahring PK, 1997, FEBS LETT, V415, P67, DOI 10.1016/S0014-5793(97)01096-X; BOLOTINA V, 1989, PFLUG ARCH EUR J PHY, V415, P262, DOI 10.1007/BF00370875; Brainard AM, 2005, AM J PHYSIOL-CELL PH, V289, pC49, DOI 10.1152/ajpcell.00399.2004; BREGESTOVSKI PD, 1989, BIOMED BIOCHIM ACTA, V48, pS382; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN EM, 1988, BRIT J OBSTET GYNAEC, V95, P286, DOI 10.1111/j.1471-0528.1988.tb06871.x; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; CHANG HM, 1995, J MEMBRANE BIOL, V143, P51; Chu BS, 1998, MOL PHARMACOL, V54, P397, DOI 10.1124/mol.54.2.397; Coban O, 2007, BIOPHYS J, V92, P2842, DOI 10.1529/biophysj.106.088419; Connell RJO, 2006, J MEMBRANE BIOL, V213, P143, DOI 10.1007/s00232-006-0034-1; Cornelius F, 2003, BIOCHEMISTRY-US, V42, P8541, DOI 10.1021/bi034532e; Covey DF, 2009, STEROIDS, V74, P577, DOI 10.1016/j.steroids.2008.11.019; Crowder CM, 2001, J BIOL CHEM, V276, P44369, DOI 10.1074/jbc.C100535200; Crowley JJ, 2005, MOL PHARMACOL, V68, P4, DOI 10.1124/mol.105.012971; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; D'Avanzo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019393; Dopico AM, 1996, MOL PHARMACOL, V49, P40; Finol-Urdaneta RK, 2010, BIOPHYS J, V98, P762, DOI 10.1016/j.bpj.2009.10.053; Fullekrug J, 2004, ANN NY ACAD SCI, V1014, P164, DOI 10.1196/annals.1294.017; Gillis KD, 2000, PFLUG ARCH EUR J PHY, V439, P655, DOI 10.1007/s004240050990; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Jiang X, 2002, J ORG CHEM, V67, P4893, DOI 10.1021/jo025535k; Johnston LJ, 2007, LANGMUIR, V23, P5886, DOI 10.1021/la070108t; Koudinov AR, 2005, PLOS MED, V2, P265, DOI 10.1371/journal.pmed.0020081; Koudinov AR, 2005, J NEUROL SCI, V229, P233, DOI 10.1016/j.jns.2004.11.036; Lam RS, 2004, BBA-BIOMEMBRANES, V1667, P241, DOI 10.1016/j.bbamem.2004.11.004; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; LI CY, 1994, P NATL ACAD SCI USA, V91, P8200, DOI 10.1073/pnas.91.17.8200; Lin MW, 2006, CHINESE J PHYSIOL, V49, P1; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; London E, 2002, CURR OPIN STRUC BIOL, V12, P480, DOI 10.1016/S0959-440X(02)00351-2; Martin G, 2004, J NEUROSCI, V24, P6563, DOI 10.1523/JNEUROSCI.0684-04.2004; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; Pfrieger FW, 2003, BBA-BIOMEMBRANES, V1610, P271, DOI 10.1016/S0005-2736(03)00024-5; Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Romanenko VG, 2009, AM J PHYSIOL-CELL PH, V296, pC878, DOI 10.1152/ajpcell.00438.2008; Shmygol A, 2007, J PHYSIOL-LONDON, V581, P445, DOI 10.1113/jphysiol.2007.129452; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; SUN TY, 1994, BIOCHEMISTRY-US, V33, P9992, DOI 10.1021/bi00199a024; Tajima N, 2010, J BIOL CHEM; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Treistman SN, 2009, TRENDS NEUROSCI, V32, P629, DOI 10.1016/j.tins.2009.08.001; Vial C, 2005, J BIOL CHEM, V280, P30705, DOI 10.1074/jbc.M504256200; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; WEIGHT FF, 1991, ANN NY ACAD SCI, V625, P97, DOI 10.1111/j.1749-6632.1991.tb33833.x; West TA, 2005, CELL PHYSIOL BIOCHEM, V16, P263, DOI 10.1159/000089852; Westover EJ, 2004, J MEMBRANE BIOL, V202, P61, DOI 10.1007/s00232-004-0714-7; Westover EJ, 2003, J BIOL CHEM, V278, P51125, DOI 10.1074/jbc.M304332200; Westover EJ, 2003, STEROIDS, V68, P159, DOI 10.1016/S0039-128X(02)00174-5; Westover EJ, 2006, STEROIDS, V71, P484, DOI 10.1016/j.steroids.2006.01.007; Yuan C, 2002, J MICROSC-OXFORD, V205, P136, DOI 10.1046/j.0022-2720.2001.00982.x; Yuan CB, 2002, BIOPHYS J, V82, P2526, DOI 10.1016/S0006-3495(02)75596-3; Yuan C, 2008, J BIOL CHEM, V283, P5090, DOI 10.1074/jbc.M708214200; Yuan CB, 2007, J BIOL CHEM, V282, P7276, DOI 10.1074/jbc.M607593200	63	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27572	10.1371/journal.pone.0027572	http://dx.doi.org/10.1371/journal.pone.0027572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140451	gold, Green Submitted, Green Published			2022-12-25	WOS:000298166300008
J	Badisco, L; Ott, SR; Rogers, SM; Matheson, T; Knapen, D; Vergauwen, L; Verlinden, H; Marchal, E; Sheehy, MRJ; Burrows, M; Vanden Broeck, J				Badisco, Liesbeth; Ott, Swidbert R.; Rogers, Stephen M.; Matheson, Thomas; Knapen, Dries; Vergauwen, Lucia; Verlinden, Heleen; Marchal, Elisabeth; Sheehy, Matt R. J.; Burrows, Malcolm; Vanden Broeck, Jozef			Microarray-Based Transcriptomic Analysis of Differences between Long-Term Gregarious and Solitarious Desert Locusts	PLOS ONE			English	Article							MATURATION FACTOR-BETA; THAUMATIN-LIKE PROTEINS; HEAT-SHOCK PROTEINS; BEHAVIORAL GREGARIZATION; CHANNEL SUBUNITS; EXPRESSION; GENE; K+; METHYLATION; ANNOTATION	Desert locusts (Schistocerca gregaria) show an extreme form of phenotypic plasticity and can transform between a cryptic solitarious phase and a swarming gregarious phase. The two phases differ extensively in behavior, morphology and physiology but very little is known about the molecular basis of these differences. We used our recently generated Expressed Sequence Tag (EST) database derived from S. gregaria central nervous system (CNS) to design oligonucleotide microarrays and compare the expression of thousands of genes in the CNS of long-term gregarious and solitarious adult desert locusts. This identified 214 differentially expressed genes, of which 40% have been annotated to date. These include genes encoding proteins that are associated with CNS development and modeling, sensory perception, stress response and resistance, and fundamental cellular processes. Our microarray analysis has identified genes whose altered expression may enable locusts of either phase to deal with the different challenges they face. Genes for heat shock proteins and proteins which confer protection from infection were upregulated in gregarious locusts, which may allow them to respond to acute physiological challenges. By contrast the longer-lived solitarious locusts appear to be more strongly protected from the slowly accumulating effects of ageing by an upregulation of genes related to anti-oxidant systems, detoxification and anabolic renewal. Gregarious locusts also had a greater abundance of transcripts for proteins involved in sensory processing and in nervous system development and plasticity. Gregarious locusts live in a more complex sensory environment than solitarious locusts and may require a greater turnover of proteins involved in sensory transduction, and possibly greater neuronal plasticity.	[Badisco, Liesbeth; Verlinden, Heleen; Marchal, Elisabeth; Vanden Broeck, Jozef] Katholieke Univ Leuven, Dept Anim Physiol & Neurobiol, Louvain, Belgium; [Ott, Swidbert R.; Rogers, Stephen M.; Burrows, Malcolm] Univ Cambridge, Dept Zool, Cambridge, England; [Matheson, Thomas; Sheehy, Matt R. J.] Univ Leicester, Dept Biol, Leicester, Leics, England; [Knapen, Dries; Vergauwen, Lucia] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Sheehy, Matt R. J.] Univ Nottingham, Fac Med & Hlth Sci, Nottingham NG7 2RD, England	KU Leuven; University of Cambridge; University of Leicester; University of Antwerp; University of Nottingham	Badisco, L (corresponding author), Katholieke Univ Leuven, Dept Anim Physiol & Neurobiol, Louvain, Belgium.	jozef.vandenbroeck@bio.kuleuven.be	Vergauwen, Lucia/AAP-5933-2021; Verlinden, Heleen/D-1033-2011	Verlinden, Heleen/0000-0001-6721-3973; Ott, Swidbert/0000-0003-4278-2613; Marchal, Elisabeth/0000-0003-1310-4792; Vergauwen, Lucia/0000-0002-6534-7473; Matheson, Thomas/0000-0002-6061-9038; Knapen, Dries/0000-0003-0472-8114; Vanden Broeck, Jozef/0000-0001-7653-0516	K.U. Leuven Research Foundation [GOA/11/002]; Research Foundation of Flanders (FWO-Flanders); Interuniversity Attraction Poles program (Belgian Science Policy) [P6/14]; 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT); Biotechnology and Biological Science Research Council (UK) [BB/H002510/1, BB/D018587/1, BB/H002537/1, BB/D018854/1]; Royal Society (UK); Royal Society; BBSRC [BB/D018587/1, BB/H002510/1, BB/D018854/1, BB/H002537/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D018854/1, BB/H002510/1, BB/D018587/1, BB/H002537/1] Funding Source: researchfish	K.U. Leuven Research Foundation; Research Foundation of Flanders (FWO-Flanders)(FWO); Interuniversity Attraction Poles program (Belgian Science Policy)(Belgian Federal Science Policy Office); 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Biotechnology and Biological Science Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society (UK)(Royal Society of London); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors gratefully acknowledge the K.U. Leuven Research Foundation (GOA/11/002), the Research Foundation of Flanders (FWO-Flanders) and the Interuniversity Attraction Poles program (Belgian Science Policy Grant P6/14). LB, HV and EM have been supported by a scholarship from the 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT) and HV obtained a postdoctoral research fellowship from the K.U. Leuven Research Foundation. This work was also supported by grants from the Biotechnology and Biological Science Research Council (UK) to TM, MRJS, MB, SMR and SRO (BB/H002510/1; BB/D018587/1; BB/H002537/1; BB/D018854/1). SRO is recipient of a University Research Fellowship from the Royal Society (UK). SRO and SMR also obtained a Royal Society Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Anstey ML, 2009, SCIENCE, V323, P627, DOI 10.1126/science.1165939; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badisco L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017274; Baig J, 2010, GENETICS, V184, P731, DOI 10.1534/genetics.109.109967; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berthier K, 2010, ADV INSECT PHYSIOL, V39, P1, DOI 10.1016/S0065-2806(10)39001-1; BOERJAN B, 2011, GEN COMP ENDOCRINOL; Bolanos JP, 2010, IUBMB LIFE, V62, P14, DOI 10.1002/iub.280; BOSCH EP, 1989, J NEUROSCI, V9, P3690; Brandazza A, 2004, FEBS LETT, V572, P3, DOI 10.1016/j.febslet.2004.07.003; Breugelmans B, 2008, INSECT MOL BIOL, V17, P137, DOI 10.1111/j.1365-2583.2008.00793.x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collins RT, 1999, EMBO J, V18, P7029, DOI 10.1093/emboj/18.24.7029; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Djagaeva I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007598; DUGAN LL, 2005, SCI AGING KNOWLEDGE; Engel JE, 1998, J NEUROSCI, V18, P2254; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FEYEREISEN R, 1980, MOL CELL ENDOCRINOL, V20, P157, DOI 10.1016/0303-7207(80)90079-9; Fonseca DB, 2005, P ROY SOC B-BIOL SCI, V272, P1941, DOI 10.1098/rspb.2005.3192; Fuchs E, 2003, J NEUROBIOL, V57, P152, DOI 10.1002/neu.10261; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grenier J, 1999, PLANT J, V19, P473, DOI 10.1046/j.1365-313X.1999.00551.x; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Hardie RC, 2001, J EXP BIOL, V204, P3403; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hoste B, 2002, ENTOMOL EXP APPL, V104, P281, DOI 10.1023/A:1021207518712; Hughes AL, 1999, IMMUNOGENETICS, V49, P106, DOI 10.1007/s002510050469; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Joiner MA, 2007, J NEUROGENET, V21, P45, DOI 10.1080/01677060701247375; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; Knapen D, 2009, TRENDS BIOTECHNOL, V27, P406, DOI 10.1016/j.tibtech.2009.03.007; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee J, 2008, NEUROSCIENCE, V154, P1283, DOI 10.1016/j.neuroscience.2008.04.043; Lee J, 2010, J NEUROSCI, V30, P15821, DOI 10.1523/JNEUROSCI.3448-10.2010; Lester RL, 2005, J INSECT PHYSIOL, V51, P737, DOI 10.1016/j.jinsphys.2005.03.015; LIM R, 1989, P NATL ACAD SCI USA, V86, P3901, DOI 10.1073/pnas.86.10.3901; LIM R, 1990, DEV BIOL, V137, P444, DOI 10.1016/0012-1606(90)90269-O; Liu CH, 2008, NEURON, V59, P778, DOI 10.1016/j.neuron.2008.07.007; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Ma ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-11; Matheson T, 2004, J NEUROPHYSIOL, V91, P1, DOI 10.1152/jn.00795.2003; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Menu-Bouaouiche L, 2003, BIOCHIMIE, V85, P123, DOI 10.1016/S0300-9084(03)00058-0; Mituyama T, 2009, NUCLEIC ACIDS RES, V37, pD89, DOI 10.1093/nar/gkn805; Nakano K, 2010, CYTOSKELETON, V67, P373, DOI 10.1002/cm.20451; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Ott SR, 2010, P ROY SOC B-BIOL SCI, V277, P3087, DOI 10.1098/rspb.2010.0694; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Pener MP, 1998, J INSECT PHYSIOL, V44, P365, DOI 10.1016/S0022-1910(97)00169-8; Rai K, 2007, GENE DEV, V21, P261, DOI 10.1101/gad.1472907; RAMING K, 1993, CELL SIGNAL, V5, P69, DOI 10.1016/0898-6568(93)90009-B; Ranson H, 2005, METHOD ENZYMOL, V401, P226, DOI 10.1016/S0076-6879(05)01014-1; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Roessingh P, 1998, J INSECT PHYSIOL, V44, P883, DOI 10.1016/S0022-1910(98)00070-5; Rogers SM, 2004, J EXP BIOL, V207, P3603, DOI 10.1242/jeb.01183; Rogers SM, 2003, J EXP BIOL, V206, P3991, DOI 10.1242/jeb.00648; Rogers SM, 2007, J NEUROSCI, V27, P4621, DOI 10.1523/JNEUROSCI.4615-06.2007; Rogers SM, 2010, J NEUROPHYSIOL, V103, P779, DOI 10.1152/jn.00855.2009; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Sclep G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-400; Scott JG, 2001, PEST MANAG SCI, V57, P958, DOI 10.1002/ps.354; Seshaiah P, 2001, DEV BIOL, V239, P309, DOI 10.1006/dbio.2001.0429; Simonet G, 2002, COMP BIOCHEM PHYS B, V132, P247, DOI 10.1016/S1096-4959(01)00530-9; Simonet G, 2004, BIOCHEM BIOPH RES CO, V317, P565, DOI 10.1016/j.bbrc.2004.03.078; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sword GA, 2002, P ROY SOC B-BIOL SCI, V269, P1639, DOI 10.1098/rspb.2002.2060; Szymanski M, 2007, NUCLEIC ACIDS RES, V35, pD162, DOI 10.1093/nar/gkl994; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Towner P, 1997, VISION RES, V37, P495, DOI 10.1016/S0042-6989(96)00198-8; Tu CPD, 2005, METHOD ENZYMOL, V401, P204, DOI 10.1016/S0076-6879(05)01013-X; Uvarov B, 1977, GRASSHOPPERS LOCUSTS; UVAROV BP, 1966, GRASSHOPPERS LOCUSTS, P332; Verlinden H, 2009, GEN COMP ENDOCR, V162, P79, DOI 10.1016/j.ygcen.2008.11.016; Wang HS, 2007, INSECT MOL BIOL, V16, P207, DOI 10.1111/j.1365-2583.2006.00715.x; Warbington L, 1996, INVERTEBR NEUROSCI, V2, P51, DOI 10.1007/BF02336660; Wilson K, 2002, P NATL ACAD SCI USA, V99, P5471, DOI 10.1073/pnas.082461999; Winter J, 1999, BIOCHEM BIOPH RES CO, V259, P305, DOI 10.1006/bbrc.1999.0783; Zhou X, 2006, GENE, V376, P47, DOI 10.1016/j.gene.2006.02.002; Zhou XG, 2006, P NATL ACAD SCI USA, V103, P4499, DOI 10.1073/pnas.0508866103	93	29	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28110	10.1371/journal.pone.0028110	http://dx.doi.org/10.1371/journal.pone.0028110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132225	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000075
J	Bokov, AF; Garg, N; Ikeno, Y; Thakur, S; Musi, N; DeFronzo, RA; Zhang, N; Erickson, RC; Gelfond, J; Hubbard, GB; Adamo, ML; Richardson, A				Bokov, Alex F.; Garg, Neha; Ikeno, Yuji; Thakur, Sachin; Musi, Nicolas; DeFronzo, Ralph A.; Zhang, Ning; Erickson, Rebecca C.; Gelfond, Jon; Hubbard, Gene B.; Adamo, Martin L.; Richardson, Arlan			Does Reduced IGF-1R Signaling in Igf1r(+/-) Mice Alter Aging?	PLOS ONE			English	Article							GROWTH-FACTOR-I; FATAL NEOPLASTIC DISEASES; LIFE-SPAN EXTENSION; INSULIN-RECEPTOR; CAENORHABDITIS-ELEGANS; DELAYED OCCURRENCE; DWARF MICE; GENE; LONGEVITY; HORMONE	Mutations in insulin/IGF-1 signaling pathway have been shown to lead to increased longevity in various invertebrate models. Therefore, the effect of the haplo-insufficiency of the IGF-1 receptor (Igf1r(+/-)) on longevity/aging was evaluated in C57Bl/6 mice using rigorous criteria where lifespan and end-of-life pathology were measured under optimal husbandry conditions using large sample sizes. Igf1r(+/-) mice exhibited reductions in IGF-1 receptor levels and the activation of Akt by IGF-1, with no compensatory increases in serum IGF-1 or tissue IGF-1 mRNA levels, indicating that the Igf1r(+/-) mice show reduced IGF-1 signaling. Aged male, but not female Igf1r(+/-) mice were glucose intolerant, and both genders developed insulin resistance as they aged. Female, but not male Igf1r(+/-) mice survived longer than wild type mice after lethal paraquat and diquat exposure, and female Igf1r(+/-) mice also exhibited less diquat-induced liver damage. However, no significant difference between the lifespans of the male Igf1r(+/-) and wild type mice was observed; and the mean lifespan of the Igf1r(+/-) females was increased only slightly (less than 5%) compared to wild type mice. A comprehensive pathological analysis showed no significant difference in end-of-life pathological lesions between the Igf1r(+/-) and wild type mice. These data show that the Igf1r(+/-) mouse is not a model of increased longevity and delayed aging as predicted by invertebrate models with mutations in the insulin/IGF-1 signaling pathway.	[Bokov, Alex F.; Ikeno, Yuji; Musi, Nicolas; Gelfond, Jon; Hubbard, Gene B.; Adamo, Martin L.; Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Bokov, Alex F.; Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Garg, Neha; Thakur, Sachin; Adamo, Martin L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Gelfond, Jon] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Ikeno, Yuji; Hubbard, Gene B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Musi, Nicolas; DeFronzo, Ralph A.; Zhang, Ning] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ikeno, Yuji; Musi, Nicolas; Richardson, Arlan] S Texas Vet Hlth Care Syst, GRECC, San Antonio, TX USA; [Erickson, Rebecca C.] Univ Texas Austin, Coll Nat Sci, Austin, TX 78712 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Austin	Bokov, AF (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.	Richardson@uthscsa.edu	Bokov, Alex/O-9952-2014	Bokov, Alex/0000-0002-0511-9815	National Institutes of Health (NIH) [AGO-21890]; Beeson Career Development Award [AG-030979, DK-80157, DK-089229, DK-24092 RAD, R01AG026012, AG-19316, AG-13319, AG-23843, AG-26557]; Nathan Shock [1P30-AG-13319]; Department of Veteran's Affairs; University of Texas System; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK024092, R01DK089229, R01DK024092, R01DK080157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013319, R01AG026012, T32AG021890, P01AG019316, R01AG023843, R37AG026557, K23AG030979] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beeson Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nathan Shock; Department of Veteran's Affairs(US Department of Veterans Affairs); University of Texas System; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) (http://grants.nih.gov/grants/oer.htm) AGO-21890 to AFB; AG-030979 (Beeson Career Development Award), DK-80157 and DK-089229 to NM; DK-24092 RAD; R01AG026012 to MLA; AG-19316, AG-13319, AG-23843, and AG-26557 to AR; Nathan Shock: 1P30-AG-13319 to AR; Department of Veteran's Affairs: Research Enhancement Award Program, Merit Grant to AR; and University of Texas System's Graduate Programs Initiative: Translational Science Training (TST) Across Disciplines to NG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartke A, 2009, EXP GERONTOL, V44, P372, DOI 10.1016/j.exger.2009.04.001; Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Delahunty KM, 2006, ENDOCRINOLOGY, V147, P3915, DOI 10.1210/en.2006-0277; Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081; Dorai-Raj S., 2009, BINOM BINOMIAL CONFI; Duan CM, 1996, J BIOL CHEM, V271, P4280; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; FOX J, 2010, CAR COMPANION APPL R; FRIEDMAN DB, 1988, GENETICS, V118, P75; Goran B, 2010, EHA EVENT HIST ANAL; HOLM S, 1979, SCAND J STAT, V6, P65; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Ikeno Y, 2005, J GERONTOL A-BIOL, V60, P1510, DOI 10.1093/gerona/60.12.1510; Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291; Ikeno Y, 2009, J GERONTOL A-BIOL, V64, P522, DOI 10.1093/gerona/glp017; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; Koenker R, 2008, J STAT SOFTW, V27, P1; Kraus D., 2008, SURV2SAMPLE 2 SAMPLE; Ladiges W, 2009, AGING CELL, V8, P346, DOI 10.1111/j.1474-9726.2009.00491.x; LEITER EH, 1988, FASEB J, V2, P2807, DOI 10.1096/fasebj.2.12.3044905; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; McCarter R, 2007, J GERONTOL A-BIOL, V62, P1059, DOI 10.1093/gerona/62.10.1059; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Priest NK, 2002, EVOLUTION, V56, P927, DOI 10.1111/j.0014-3820.2002.tb01405.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Riddle DL., 1988, NEMATODE CAENORHABDI, P393; Salmon AB, 2009, FASEB J, V23, P3601, DOI 10.1096/fj.08-127415; Selman C, 2008, SCIENCE, V320, DOI 10.1126/science.1152366; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; SMITH GS, 1973, J NATL CANCER I, V50, P1195, DOI 10.1093/jnci/50.5.1195; Sonntag WE, 1999, J GERONTOL A-BIOL, V54, pB521, DOI 10.1093/gerona/54.12.B521; STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; Valverde AM, 2001, MOL CELL BIOL, V21, P2269, DOI 10.1128/MCB.21.7.2269-2280.2001; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; WEINDRUCH R, 1991, J GERONTOL, V46, pB87, DOI 10.1093/geronj/46.3.B87; Ye P, 1998, ENDOCRINOLOGY, V139, P65, DOI 10.1210/en.139.1.65; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132	51	112	113	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e26891	10.1371/journal.pone.0026891	http://dx.doi.org/10.1371/journal.pone.0026891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132081	gold, Green Published, Green Submitted			2022-12-25	WOS:000298162000007
J	Molnar, I; Kubalakova, M; Simkova, H; Cseh, A; Molnar-Lang, M; Dolezel, J				Molnar, Istvan; Kubalakova, Marie; Simkova, Hana; Cseh, Andras; Molnar-Lang, Marta; Dolezel, Jaroslav			Chromosome Isolation by Flow Sorting in Aegilops umbellulata and Ae. comosa and Their Allotetraploid Hybrids Ae. biuncialis and Ae. geniculata	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; BREAD WHEAT; ADDITION LINES; WILD WHEATS; VICIA-FABA; SHORT ARM; GENOME DIFFERENTIATION; MICROSATELLITE MARKERS; MITOTIC CHROMOSOMES; GENETIC DIVERSITY	This study evaluates the potential of flow cytometry for chromosome sorting in two wild diploid wheats Aegilops umbellulata and Ae. comosa and their natural allotetraploid hybrids Ae. biuncialis and Ae. geniculata. Flow karyotypes obtained after the analysis of DAPI-stained chromosomes were characterized and content of chromosome peaks was determined. Peaks of chromosome 1U could be discriminated in flow karyotypes of Ae. umbellulata and Ae. biuncialis and the chromosome could be sorted with purities exceeding 95%. The remaining chromosomes formed composite peaks and could be sorted in groups of two to four. Twenty four wheat SSR markers were tested for their position on chromosomes of Ae. umbellulata and Ae. comosa using PCR on DNA amplified from flow-sorted chromosomes and genomic DNA of wheat-Ae. geniculata addition lines, respectively. Six SSR markers were located on particular Aegilops chromosomes using sorted chromosomes, thus confirming the usefulness of this approach for physical mapping. The SSR markers are suitable for marker assisted selection of wheat-Aegilops introgression lines. The results obtained in this work provide new opportunities for dissecting genomes of wild relatives of wheat with the aim to assist in alien gene transfer and discovery of novel genes for wheat improvement.	[Molnar, Istvan; Cseh, Andras; Molnar-Lang, Marta] Hungarian Acad Sci, Agr Res Inst, H-2462 Martonvasar, Hungary; [Kubalakova, Marie; Simkova, Hana; Dolezel, Jaroslav] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Olomouc, Czech Republic	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Molnar, I (corresponding author), Hungarian Acad Sci, Agr Res Inst, H-2462 Martonvasar, Hungary.	dolezel@ueb.cas.cz	Cseh, Andras/AAP-3999-2021; Simkova, Hana/F-7734-2014; Dolezel, Jaroslav/B-7716-2008; Kubaláková, Marie/F-8269-2014; Molnar, istvan/L-9779-2019	Cseh, Andras/0000-0002-8681-6654; Simkova, Hana/0000-0003-4159-7619; Dolezel, Jaroslav/0000-0002-6263-0492; Molnar, Istvan/0000-0002-7167-9319	Hungarian National Research Fund [PD83444]; Czech Ministry of Education, Youth and Sport [LC06004, OC08025]; European Regional Development Fund (Operational Programme Research and Development for Innovations) [CZ.1.05/2.1.00/01.0007]	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Czech Ministry of Education, Youth and Sport(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund (Operational Programme Research and Development for Innovations)	This research was supported by the Hungarian National Research Fund (PD83444), Czech Ministry of Education, Youth and Sports (grant awards LC06004 and OC08025), and the European Regional Development Fund (Operational Programme Research and Development for Innovations No. CZ.1.05/2.1.00/01.0007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaeva ED, 2004, PLANT SYST EVOL, V246, P45, DOI 10.1007/s00606-003-0072-4; Badaeva ED, 1996, GENOME, V39, P293, DOI 10.1139/g96-040; Bartos J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-95; Berkman PJ, 2011, PLANT BIOTECHNOL J, V9, P768, DOI 10.1111/j.1467-7652.2010.00587.x; CHEE PW, 1995, GENOME, V38, P290, DOI 10.1139/g95-036; Cifuentes M, 2006, THEOR APPL GENET, V112, P657, DOI 10.1007/s00122-005-0168-z; Cifuentes M, 2009, THEOR APPL GENET, V119, P805, DOI 10.1007/s00122-009-1090-6; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; Contento A, 2005, CYTOGENET GENOME RES, V109, P34, DOI 10.1159/000082379; DOLEZEL J, 1989, BIOL PLANTARUM, V31, P113, DOI 10.1007/BF02907241; Dolezel J, 2004, CHROMOSOME RES, V12, P77, DOI 10.1023/B:CHRO.0000009293.15189.e5; DOLEZEL J, 1992, PLANTA, V188, P93, DOI 10.1007/BF00198944; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; Edwards D, 2010, PLANT BIOTECHNOL J, V8, P2, DOI 10.1111/j.1467-7652.2009.00459.x; Eilam T, 2008, GENOME, V51, P616, DOI 10.1139/G08-043; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Feuillet C, 2008, TRENDS GENET, V24, P24, DOI 10.1016/j.tig.2007.11.001; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Friebe BR, 1999, GENOME, V42, P374, DOI 10.1139/gen-42-3-374; Furuta Y., 1970, WHEAT INF SER, V30, P20; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; HOHMANN U, 1995, THEOR APPL GENET, V91, P611, DOI 10.1007/BF00223287; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Kofler R, 2008, THEOR APPL GENET, V117, P915, DOI 10.1007/s00122-008-0831-2; Kubalakova M, 1997, THEOR APPL GENET, V94, P758, DOI 10.1007/s001220050475; Kubalakova M, 2005, GENETICS, V170, P823, DOI 10.1534/genetics.104.039180; Kubalakova M, 2003, GENOME, V46, P893, DOI [10.1139/g03-054, 10.1139/G03-054]; Kubalakova M, 2002, THEOR APPL GENET, V104, P1362, DOI 10.1007/s00122-002-0888-2; Lelley T, 2000, GENOME, V43, P661, DOI 10.1139/gen-43-4-661; Lysak MA, 1999, CHROMOSOME RES, V7, P431, DOI 10.1023/A:1009293628638; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Mayer KFX, 2009, PLANT PHYSIOL, V151, P496, DOI 10.1104/pp.109.142612; MICKELSONYOUNG L, 1995, THEOR APPL GENET, V90, P1007, DOI 10.1007/BF00222914; Molnar I, 2004, FUNCT PLANT BIOL, V31, P1149, DOI 10.1071/FP03143; Molnar I, 2011, ANN BOT-LONDON, V107, P65, DOI 10.1093/aob/mcq215; Monte JV, 2001, HEREDITAS, V135, P233, DOI 10.1111/j.1601-5223.2001.00233.x; NAGAKI K, 1995, GENOME, V38, P479, DOI 10.1139/g95-063; Nagy ED, 2006, GENOME, V49, P289, DOI 10.1139/G05-109; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; Peil A, 1998, THEOR APPL GENET, V96, P138, DOI 10.1007/s001220050720; Pestsova E, 2000, THEOR APPL GENET, V101, P100, DOI 10.1007/s001220051456; Pozarkova D, 2002, BIOL PLANTARUM, V45, P337, DOI 10.1023/A:1016253214182; Rekika D, 1997, J PLANT PHYSIOL, V150, P734, DOI 10.1016/S0176-1617(97)80291-X; Resta P, 1996, AM J BOT, V83, P1556, DOI 10.2307/2445829; Roder MS, 1998, GENETICS, V149, P2007; Roman B, 2004, THEOR APPL GENET, V108, P1079, DOI 10.1007/s00122-003-1515-6; Sabot F, 2005, MOL GENET GENOMICS, V274, P119, DOI 10.1007/s00438-005-0012-9; Safar J, 2010, CYTOGENET GENOME RES, V129, P211, DOI 10.1159/000313072; Schneider A, 2005, GENOME, V48, P1070, DOI 10.1139/G05-062; Schneider A, 2008, EUPHYTICA, V163, P1, DOI 10.1007/s10681-007-9624-y; Schneider A, 2010, EUPHYTICA, V175, P357, DOI 10.1007/s10681-010-0180-5; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; Simkova H, 2008, BMC GENOMICS, V9, DOI [10.1186/1471-2164-9-237, 10.1186/1471-2164-9-294]; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Sourdille Pierre, 2004, Functional & Integrative Genomics, V4, P12, DOI 10.1007/s10142-004-0106-1; Van Slageren M.W., 1994, WAGENINGEN AGR U PAP, P514; Vrana J, 2000, GENETICS, V156, P2033; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wenzl P, 2010, THEOR APPL GENET, V121, P465, DOI 10.1007/s00122-010-1323-8; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Zaharieva M, 2006, CROP SCI, V46, P512, DOI 10.2135/cropsci2005.0023; ZAHARIEVA M, 2003, ANN WHEAT NEWSLETTER, V49, P75; Zaharieva M, 2002, ANN WHEAT NEWSLETTER, V48, P108; ZELLER FJ, 1983, Z PFLANZENZUCHT, V90, P285; Zhang H, 1998, THEOR APPL GENET, V96, P69, DOI 10.1007/s001220050710	66	34	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27708	10.1371/journal.pone.0027708	http://dx.doi.org/10.1371/journal.pone.0027708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132127	Green Submitted, gold, Green Published			2022-12-25	WOS:000298162000035
J	Narita, K; Nagao, K; Bannai, M; Ichimaru, T; Nakano, S; Murata, T; Higuchi, T; Takahashi, M				Narita, Kazumi; Nagao, Kenji; Bannai, Makoto; Ichimaru, Toru; Nakano, Sayako; Murata, Takuya; Higuchi, Takashi; Takahashi, Michio			Dietary Deficiency of Essential Amino Acids Rapidly Induces Cessation of the Rat Estrous Cycle	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; CALORIC RESTRICTION; ANOREXIA-NERVOSA; LH-SECRETION; IN-VIVO; METABOLISM; SUPPRESSION; ACTIVATION; DEPLETION; PEPTIDE	Reproductive functions are regulated by the sophisticated coordination between the neuronal and endocrine systems and are sustained by a proper nutritional environment. Female reproductive function is vulnerable to effects from dietary restrictions, suggesting a transient adaptation that prioritizes individual survival over reproduction until a possible future opportunity for satiation. This adaptation could also partially explain the existence of amenorrhea in women with anorexia nervosa. Because amino acid nutritional conditions other than caloric restriction uniquely alters amino acid metabolism and affect the hormonal levels of organisms, we hypothesized that the supply of essential amino acids in the diet plays a pivotal role in the maintenance of the female reproductive system. To test this hypothesis, we examined ovulatory cyclicity in female rats under diets that were deficient in threonine, lysine, tryptophan, methionine or valine. Ovulatory cyclicity was monitored by daily cytological evaluations of vaginal smears. After continuous feeding of the deficient diet, a persistent diestrus or anovulatory state was induced most quickly by the valine-deficient diet and most slowly by the lysine-deficient diet. A decline in the systemic insulin-like growth factor 1 level was associated with a dietary amino acid deficiency. Furthermore, a paired group of rats that were fed an isocaloric diet with balanced amino acids maintained normal estrous cyclicity. These disturbances of the estrous cycle by amino acid deficiency were quickly reversed by the consumption of a normal diet. The continuous anovulatory state in this study is not attributable to a decrease in caloric intake but to an imbalance in the dietary amino acid composition. With a shortage of well-balanced amino acid sources, reproduction becomes risky for both the mother and the fetus. It could be viewed as an adaptation to the diet, diverting resources away from reproduction and reallocating them to survival until well-balanced amino acid sources are found.	[Narita, Kazumi; Ichimaru, Toru; Murata, Takuya; Higuchi, Takashi] Univ Fukui, Dept Integrat Physiol, Fac Med Sci, Fukui 910, Japan; [Nagao, Kenji; Bannai, Makoto; Nakano, Sayako; Takahashi, Michio] Ajinomoto Co Inc, Frontier Res Labs, Inst Innovat, Kawasaki, Kanagawa, Japan	University of Fukui; Ajinomoto Co Inc	Narita, K (corresponding author), Univ Fukui, Dept Integrat Physiol, Fac Med Sci, Fukui 910, Japan.	makoto_bannai@ajinomoto.com	Nagao, Kenji/AAE-7377-2021	Nagao, Kenji/0000-0002-0946-1431	Ajinomoto Co., Inc.	Ajinomoto Co., Inc.	This study was funded by Ajinomoto Co., Inc. The funder had no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281; BIGWOOD EJ, 1972, PROTEIN AMINO ACID F; Carew LB, 1997, POULTRY SCI, V76, P1398, DOI 10.1093/ps/76.10.1398; Casanueva FF, 1999, FRONT NEUROENDOCRIN, V20, P317, DOI 10.1006/frne.1999.0187; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; Deligeoroglou E, 2010, ANN NY ACAD SCI, V1205, P23, DOI 10.1111/j.1749-6632.2010.05669.x; Della Torre S, 2011, CELL METAB, V13, P205, DOI 10.1016/j.cmet.2011.01.002; Donato J, 2009, J NEUROSCI, V29, P5240, DOI 10.1523/JNEUROSCI.0405-09.2009; Fernandez-Fernandez R, 2005, ENDOCRINOLOGY, V146, P1403, DOI 10.1210/en.2004-0858; Fernandez-Fernandez R, 2005, NEUROENDOCRINOLOGY, V82, P245, DOI 10.1159/000092753; Fontana L, 2008, AGING CELL, V7, P681, DOI 10.1111/j.1474-9726.2008.00417.x; Furuta M, 2002, NEUROENDOCRINOLOGY, V75, P151, DOI 10.1159/000048232; Gems D, 1998, GENETICS, V150, P129; Genazzani Alessandro D, 2005, Pediatr Endocrinol Rev, V2, P661; Gietzen DW, 2006, TRENDS NEUROSCI, V29, P91, DOI 10.1016/j.tins.2005.12.007; Goto S, 2010, NEUROSCIENCE, V166, P333, DOI 10.1016/j.neuroscience.2009.12.013; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; HOLEHAN AM, 1985, MECH AGEING DEV, V32, P179, DOI 10.1016/0047-6374(85)90078-8; Huang WY, 2008, AM J PHYSIOL-ENDOC M, V295, pE1439, DOI 10.1152/ajpendo.90615.2008; I'Anson H, 2003, HORM BEHAV, V43, P388, DOI 10.1016/S0018-506X(03)00007-2; Inderdeo DS, 1996, BIOL REPROD, V55, P498, DOI 10.1095/biolreprod55.3.498; Jans LAW, 2007, NEUROSCIENCE, V147, P304, DOI 10.1016/j.neuroscience.2007.04.028; KALRA SP, 1992, FRONT NEUROENDOCRIN, V13, P1; KNUTH UA, 1983, ACTA ENDOCRINOL-COP, V104, P402, DOI 10.1530/acta.0.1040402; Lane M, 1997, J REPROD FERTIL, V109, P153, DOI 10.1530/jrf.0.1090153; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Maxwell SRJ, 1998, BASIC RES CARDIOL, V93, P79; McShane TM, 1996, BIOL REPROD, V54, P70, DOI 10.1095/biolreprod54.1.70; Misra M, 2004, PEDIATRICS, V114, P1574, DOI 10.1542/peds.2004-0540; Miyaji K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013808; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Munoz MT, 2002, EUR J ENDOCRINOL, V147, P275, DOI 10.1530/eje.0.1470275; Murahashi K, 1996, ENDOCRINOLOGY, V137, P1171, DOI 10.1210/en.137.4.1171; Nagao K, 2010, AM J PHYSIOL-ENDOC M, V298, pE1170, DOI 10.1152/ajpendo.00763.2009; Nagao K, 2009, AMINO ACIDS, V36, P555, DOI 10.1007/s00726-008-0117-7; NAKAHARA K, 2011, AMINO ACIDS; NELSON JF, 1995, NEUROBIOL AGING, V16, P837, DOI 10.1016/0197-4580(95)00072-M; Noguchi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012057; Noguchi Y, 2008, PHYSIOL GENOMICS, V34, P315, DOI 10.1152/physiolgenomics.00007.2008; Ogata R, 2009, NEUROENDOCRINOLOGY, V90, P364, DOI 10.1159/000257421; Ottinger MA, 2005, MECH AGEING DEV, V126, P967, DOI 10.1016/j.mad.2005.03.017; Pelland AMD, 2009, BIOL REPROD, V81, P1041, DOI 10.1095/biolreprod.109.079046; Rees WD, 2006, J NUTR, V136, p1701S, DOI 10.1093/jn/136.6.1701S; Rudell JB, 2011, J NEUROSCI, V31, P1583, DOI 10.1523/JNEUROSCI.4934-10.2011; Shikata N, 2007, AMINO ACIDS, V33, P113, DOI 10.1007/s00726-006-0412-0; Shikata N, 2010, AMINO ACIDS, V38, P179, DOI 10.1007/s00726-008-0226-3; Takenaka A, 2000, J NUTR, V130, P2910, DOI 10.1093/jn/130.12.2910; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Van Winkle LJ, 2001, BIOL REPROD, V64, P1, DOI 10.1095/biolreprod64.1.1; Vigo E, 2007, ENDOCRINOLOGY, V148, P813, DOI 10.1210/en.2006-0636; Vigo E, 2007, AM J PHYSIOL-ENDOC M, V293, pE1265, DOI 10.1152/ajpendo.00425.2007; Wade GN, 2004, AM J PHYSIOL-REG I, V287, pR1277, DOI 10.1152/ajpregu.00475.2004	53	10	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28136	10.1371/journal.pone.0028136	http://dx.doi.org/10.1371/journal.pone.0028136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132231	Green Submitted, Green Published, gold			2022-12-25	WOS:000298162000080
J	Wu, T; Fu, F; Wang, L				Wu, Te; Fu, Feng; Wang, Long			Moving Away from Nasty Encounters Enhances Cooperation in Ecological Prisoner's Dilemma Game	PLOS ONE			English	Article							EVOLUTIONARY GAMES; RAPID EVOLUTION; EMERGENCE; PROMOTES; INDIVIDUALS	We study the role of migration in the evolution of cooperation. Individuals spatially located on a square lattice play the prisoner's dilemma game. Dissatisfied players, who have been exploited by defectors, tend to terminate interaction with selfish partners by leaving the current habitats, and explore unknown physical niches available surrounding them. The time scale ratio of game interaction to natural selection governs how many game rounds occur before individuals experience strategy updating. Under local migration and strong selection, simulation results demonstrate that cooperation can be stabilized for a wide range of model parameters, and the slower the natural selection, the more favorable for the emergence of cooperation. Besides, how the selection intensity affects cooperators' evolutionary fate is also investigated. We find that increasing it weakens cooperators' viability at different speeds for different time scale ratios. However, cooperation is greatly improved provided that individuals are offered with enough chance to agglomerate, while cooperation can always establish under weak selection but vanishes under very strong selection whenever individuals have less odds to migrate. Whenever the migration range restriction is removed, the parameter area responsible for the emergence of cooperation is, albeit somewhat compressed, still remarkable, validating the effectiveness of collectively migrating in promoting cooperation.	[Wu, Te; Wang, Long] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Ctr Syst & Control, Beijing 100871, Peoples R China; [Fu, Feng] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA	Peking University; Harvard University	Wu, T (corresponding author), Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Ctr Syst & Control, Beijing 100871, Peoples R China.	wute@pku.edu.cn	Fu, Feng/R-3686-2017; Wang, Long/A-7798-2010; Gao, Y./GWZ-3665-2022	Fu, Feng/0000-0001-8252-1990; Wang, Long/0000-0001-5600-8157; 				AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Binmore K., 1994, PLAYING FAIR GAME TH; Brock WA, 2007, P NATL ACAD SCI USA, V104, P15206, DOI 10.1073/pnas.0702096104; Burtsev M, 2006, NATURE, V440, P1041, DOI 10.1038/nature04470; Chen XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051104; Chen X, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051120; Colman AM., 1995, GAME THEORY ITS APPL; Dugatkin LA, 1995, COOPERATION ANIMALS; Fu F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036101; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026117; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Helbing D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012530; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Helbing D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057104; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hendry AP, 2000, SCIENCE, V290, P516, DOI 10.1126/science.290.5491.516; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; McNamara JM, 2004, NATURE, V428, P745, DOI 10.1038/nature02432; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/142; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Roca CP, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.158701; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Smaldino PE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023019; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021901; Traulsen A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238701; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; Woelfing B, 2009, J THEOR BIOL, V257, P689, DOI 10.1016/j.jtbi.2008.12.025; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Wu T, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/30011; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	52	35	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27669	10.1371/journal.pone.0027669	http://dx.doi.org/10.1371/journal.pone.0027669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132125	gold, Green Published, Green Submitted			2022-12-25	WOS:000298162000034
J	Zhou, WY; Dosey, TL; Biechele, T; Moon, RT; Horwitz, MS; Ruohola-Baker, H				Zhou, Wenyu; Dosey, Timothy L.; Biechele, Travis; Moon, Randall T.; Horwitz, Marshall S.; Ruohola-Baker, Hannele			Assessment of Hypoxia Inducible Factor Levels in Cancer Cell Lines upon Hypoxic Induction Using a Novel Reporter Construct	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HIPPEL-LINDAU PROTEIN; IN-VIVO; HUMAN PAPILLOMAVIRUSES; TUMOR ANGIOGENESIS; DEVELOPING MOUSE; GENE-EXPRESSION; HIF-1-ALPHA; DIFFERENTIATION; HSP90	Hypoxia Inducible Factor (HIF) signaling pathway is important for tumor cells with limited oxygen supplies, as it is shown to be involved in the process of proliferation and angiogenesis. Given its pivotal role in cancer biology, robust assays for tracking changes in HIF expression are necessary for understanding its regulation in cancer as well as developing therapies that target HIF signaling. Here we report a novel HIF reporter construct containing tandem repeats of minimum HIF binding sites upstream of eYFP coding sequence. We show that the reporter construct has an excellent signal to background ratio and the reporter activity is HIF dependent and directly correlates with HIF protein levels. By utilizing this new construct, we assayed HIF activity levels in different cancer cell lines cultured in various degrees of hypoxia. This analysis reveals a surprising cancer cell line specific variation of HIF activity in the same level of hypoxia. We further show that in two cervical cancer cell lines, ME180 and HeLa, the different HIF activity levels observed correlate with the levels of hsp90, a cofactor that protects HIF against VHL-independent degradation. This novel HIF reporter construct serves as a tool to rapidly define HIF activity levels and therefore the therapeutic capacity of potential HIF repressors in individual cancers.	[Zhou, Wenyu; Horwitz, Marshall S.; Ruohola-Baker, Hannele] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Dosey, Timothy L.; Ruohola-Baker, Hannele] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Biechele, Travis; Moon, Randall T.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Horwitz, Marshall S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Zhou, Wenyu; Dosey, Timothy L.; Biechele, Travis; Moon, Randall T.; Horwitz, Marshall S.; Ruohola-Baker, Hannele] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zhou, WY (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	hannele@u.washington.edu	Moon, Randall/M-5605-2019; Zhou, Wenyu/I-1278-2014; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Horwitz, Marshall/0000-0002-1683-1680	National Institute of General Medical Sciences [R01GM083867-01, R01GM097372-01, 1P01GM081619]; Breast Cancer Research Program Pilot project grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097372, P01GM081619, R01GM083867] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Breast Cancer Research Program Pilot project grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01GM083867-01, R01GM097372-01, and 1P01GM081619 from the National Institute of General Medical Sciences and a Breast Cancer Research Program Pilot project grant to HR-B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; BARBOSA MS, 1991, J VIROL, V65, P292, DOI 10.1128/JVI.65.1.292-298.1991; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Berchner-Pfannschmidt U, 2008, EUR RESPIR J, V32, P210, DOI 10.1183/09031936.00013408; Biechele TL, 2009, COLD SPRING HARB PRO, V2009; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chiarotto JA, 1999, BRIT J CANCER, V80, P1518, DOI 10.1038/sj.bjc.6690555; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Huh K, 2007, J VIROL, V81, P9737, DOI 10.1128/JVI.00881-07; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Kong XG, 2007, J BIOL CHEM, V282, P15498, DOI 10.1074/jbc.M700704200; Krishnan J, 2008, CIRC RES, V103, P1139, DOI 10.1161/01.RES.0000338613.89841.c1; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; Lin ZH, 2009, CLIN CANCER RES, V15, P570, DOI 10.1158/1078-0432.CCR-08-1813; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Macfarlane CM, 1997, LIFE SCI, V60, P1923, DOI 10.1016/S0024-3205(97)00154-9; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Modarressi A, 2010, J INVEST DERMATOL, V130, P2818, DOI 10.1038/jid.2010.224; Nakamura M, 2009, VIROLOGY, V387, P442, DOI 10.1016/j.virol.2009.02.036; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pilch H, 2001, INT J GYNECOL CANCER, V11, P137, DOI 10.1046/j.1525-1438.2001.01002.x; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Post DE, 2001, GENE THER, V8, P1801, DOI 10.1038/sj.gt.3301605; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; SAHAI A, 1994, J CELL PHYSIOL, V160, P107, DOI 10.1002/jcp.1041600113; Schipani E, 2001, GENE DEV, V15, P2865; Schipani E, 2006, ANN NY ACAD SCI, V1068, P66, DOI 10.1196/annals.1346.009; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Schwock J, 2008, CANCER CHEMOTH PHARM, V61, P669, DOI 10.1007/s00280-007-0522-8; Shibata T, 1998, INT J RADIAT ONCOL, V42, P913, DOI 10.1016/S0360-3016(98)00298-3; Shibata T, 2000, GENE THER, V7, P493, DOI 10.1038/sj.gt.3301124; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Staab A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-213; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Wykoff CC, 2000, CANCER RES, V60, P7075; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06	49	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27460	10.1371/journal.pone.0027460	http://dx.doi.org/10.1371/journal.pone.0027460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132102	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000020
J	Christensen, ASH; Roed, C; Omland, LH; Andersen, PH; Obel, N; Andersen, AB				Christensen, Anne-Sophie Halkjaer; Roed, Casper; Omland, Lars Haukali; Andersen, Peter Henrik; Obel, Niels; Andersen, Ase Bengaard			Long-Term Mortality in Patients with Tuberculous Meningitis: A Danish Nationwide Cohort Study	PLOS ONE			English	Article							HIV-INFECTION; ADULTS; EPIDEMIOLOGY; PREDICTORS; DENMARK	Background: With high short-term mortality and substantial excess morbidity among survivors, tuberculous meningitis (TBM) is the most severe manifestation of extra-pulmonary tuberculosis (TB). The objective of this study was to assess the long-term mortality and causes of death in a TBM patient population compared to the background population. Methods: A nationwide cohort study was conducted enrolling patients notified with TBM in Denmark from 1972-2008 and alive one year after TBM diagnosis. Data was extracted from national registries. From the background population we identified a control cohort of individuals matched on gender and date of birth. Kaplan-Meier survival curves and Cox regression analysis were used to estimate mortality rate ratios (MRR) and analyse causes of death. Findings: A total of 55 TBM patients and 550 individuals from the background population were included in the study. Eighteen patients (32.7%) and 107 population controls (19.5%) died during the observation period. The overall MRR was 1.79 (95% CI: 1.09-2.95) for TBM patients compared to the population control cohort. TBM patients in the age group 31-60 years at time of diagnosis had the highest relative risk of death (MRR 2.68; 95% CI 1.34-5.34). The TBM patients had a higher risk of death due to infectious disease, but not from other causes of death. Conclusion: Adult TBM patients have an almost two-fold increased long-term mortality and the excess mortality stems from infectious disease related causes of death.	[Christensen, Anne-Sophie Halkjaer; Roed, Casper; Omland, Lars Haukali; Obel, Niels] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Andersen, Peter Henrik] Statens Serum Inst, Dept Epidemiol, DK-2300 Copenhagen, Denmark; [Andersen, Ase Bengaard] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark	Rigshospitalet; University of Copenhagen; Statens Serum Institut; University of Southern Denmark; Odense University Hospital	Christensen, ASH (corresponding author), Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark.	annesophiechristensen@gmail.com		Roed, Casper/0000-0001-8987-5230; Omland, Lars Haukali/0000-0002-5338-8948; Obel, Niels/0000-0002-5031-0045	Research Foundation at Copenhagen University Hospital, Rigshospitalet	Research Foundation at Copenhagen University Hospital, Rigshospitalet	The study was funded by the Research Foundation at Copenhagen University Hospital, Rigshospitalet. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN PH, 2001, EPI NEWS WEEK, V43; ANDERSEN PH, 2010, EPI NEWS WEEK, V49; Andersen TF, 1999, DAN MED BULL, V46, P263; Anderson NE, 2010, J CLIN NEUROSCI, V17, P1114, DOI 10.1016/j.jocn.2010.01.006; Bang D, 2010, J INFECTION, V60, P452, DOI 10.1016/j.jinf.2010.03.017; Bang D, 2010, SCAND J INFECT DIS, V42, P288, DOI 10.3109/00365540903456282; Bang D, 2010, DAN MED BULL, V57; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christensen ASH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-47; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Hosoglu S, 2002, INT J TUBERC LUNG D, V6, P64; Juel K, 1999, DAN MED BULL, V46, P354; Kalita J, 2007, EUR J NEUROL, V14, P33, DOI 10.1111/j.1468-1331.2006.01534.x; Karstaedt AS, 1998, QJM-INT J MED, V91, P743, DOI 10.1093/qjmed/91.11.743; Lohse N, 2005, SCAND J INFECT DIS, V37, P338, DOI 10.1080/00365540510031692; MARSHALL G, 1948, LANCET, V254, P582; Padayatchi NI, 2006, PEDIATR INFECT DIS J, V25, P147, DOI 10.1097/01.inf.0000199314.88063.4c; Porkert MT, 1997, AM J MED SCI, V313, P325, DOI 10.1097/00000441-199706000-00002; Poulsen S, 1999, Ugeskr Laeger, V161, P3452; Roed C, 2010, AM J EPIDEMIOL, V172, P309, DOI 10.1093/aje/kwq126; Roed C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009662; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sengoz G, 2008, NEUROSCIENCES, V13, P402; Shaw JET, 2010, MEDICINE, V89, P189, DOI 10.1097/MD.0b013e3181df9070; *STAT DENM, 2009, POP EL POP DENM; Thwaites GE, 2005, J INFECT DIS, V192, P2134, DOI 10.1086/498220; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Verdon R, 1996, CLIN INFECT DIS, V22, P982, DOI 10.1093/clinids/22.6.982; Yechoor VK, 1996, ARCH INTERN MED, V156, P1710, DOI 10.1001/archinte.156.15.1710	29	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27900	10.1371/journal.pone.0027900	http://dx.doi.org/10.1371/journal.pone.0027900			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132165	Green Published, Green Submitted, gold			2022-12-25	WOS:000297792400021
J	Dang, RH; Torigoe, D; Sasaki, N; Agui, T				Dang, Ruihua; Torigoe, Daisuke; Sasaki, Nobuya; Agui, Takashi			QTL Analysis Identifies a Modifier Locus of Aganglionosis in the Rat Model of Hirschsprung Disease Carrying Ednrb(sl) Mutations	PLOS ONE			English	Article							B RECEPTOR GENE; SHAH-WAARDENBURG-SYNDROME; NEURAL CREST DEVELOPMENT; MOUSE MODEL; GERMLINE MUTATIONS; ENDOTHELIN-3 GENE; SOX10(DOM) MOUSE; RET; GDNF; CHROMOSOME-10	Hirschsprung disease (HSCR) exhibits complex genetics with incomplete penetrance and variable severity thought to result as a consequence of multiple gene interactions that modulate the ability of enteric neural crest cells to populate the developing gut. As reported previously, when the same null mutation of the Ednrb gene, Ednrb(sl), was introgressed into the F344 strain, almost 60% of F344-Ednrb(sl/sl) pups did not show any symptoms of aganglionosis, appearing healthy and normally fertile. These findings strongly suggested that the severity of HSCR was affected by strain-specific genetic factor (s). In this study, the genetic basis of such large strain differences in the severity of aganglionosis in the rat model was studied by whole-genome scanning for quantitative trait loci (QTLs) using an intercross of (AGH-Ednrb(sl) x F344-Ednrb(sl)) F-1 with the varying severity of aganglionosis. Genome linkage analysis identified one significant QTL on chromosome 2 for the severity of aganglionosis. Our QTL analyses using rat models of HSCR revealed that multiple genetic factors regulated the severity of aganglionosis. Moreover, a known HSCR susceptibility gene, Gdnf, was found in QTL that suggested a novel non-coding sequence mutation in GDNF that modifies the penetrance and severity of the aganglionosis phenotype in EDNRB-deficient rats. A further identification and analysis of responsible genes located on the identified QTL could lead to the richer understanding of the genetic basis of HSCR development.	[Dang, Ruihua; Torigoe, Daisuke; Sasaki, Nobuya; Agui, Takashi] Hokkaido Univ, Lab Lab Anim Sci & Med, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido 060, Japan	Hokkaido University	Dang, RH (corresponding author), Hokkaido Univ, Lab Lab Anim Sci & Med, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido 060, Japan.	agui@vetmed.hokudai.ac.jp	Sasaki, Nobuya/F-6579-2012					Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Alves MMM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015144; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Amiel J, 1996, HUM MOL GENET, V5, P355, DOI 10.1093/hmg/5.3.355; ANGRIST M, 1993, NAT GENET, V4, P351, DOI 10.1038/ng0893-351; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; ATTIE T, 1995, HUM MOL GENET, V4, P2407, DOI 10.1093/hmg/4.12.2407; Auricchio A, 1996, HUM MOL GENET, V5, P351, DOI 10.1093/hmg/5.3.351; BADNER JA, 1990, AM J HUM GENET, V46, P568; Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; Boardman JP, 2001, J MED GENET, V38, P646, DOI 10.1136/jmg.38.9.646; BORREGO S, 2011, J MOL MED-JMM, V89, P471; Brooks AS, 2005, AM J HUM GENET, V77, P120, DOI 10.1086/431244; Cantrell VA, 2004, HUM MOL GENET, V13, P2289, DOI 10.1093/hmg/ddh243; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; COHEN IT, 1982, J PEDIATR SURG, V17, P632, DOI 10.1016/S0022-3468(82)80124-3; Cozma D, 2002, GENOME RES, V12, P969, DOI 10.1101/gr.210502; Dang RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024086; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Fitze G, 2008, AM J MED GENET A, V146A, P1486, DOI 10.1002/ajmg.a.32300; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; Ivanchuk SM, 1996, HUM MOL GENET, V5, P2023, DOI 10.1093/hmg/5.12.2023; Jiang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021219; Kusafuka T, 1996, HUM MOL GENET, V5, P347, DOI 10.1093/hmg/5.3.347; LUO Y, 1993, HUM MOL GENET, V2, P1803, DOI 10.1093/hmg/2.11.1803; LYONNET S, 1993, NAT GENET, V4, P346, DOI 10.1038/ng0893-346; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCallion AS, 2003, P NATL ACAD SCI USA, V100, P1826, DOI 10.1073/pnas.0337540100; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Nadeau JH, 2003, CURR OPIN GENET DEV, V13, P290, DOI 10.1016/S0959-437X(03)00061-3; Owens SE, 2005, HUM MOL GENET, V14, P1549, DOI 10.1093/hmg/ddi163; Passarge E, 2002, NAT GENET, V31, P11, DOI 10.1038/ng878; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; Sasongko Teguh Haryo, 2007, Kobe J Med Sci, V53, P157; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Skinner MA, 1996, CURR PROB SURG, V33, P394, DOI 10.1016/S0011-3840(96)80009-8; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Southard-Smith EM, 1999, GENOME RES, V9, P215; Syrris P, 1999, AM J MED GENET, V87, P69, DOI 10.1002/(SICI)1096-8628(19991105)87:1<69::AID-AJMG14>3.0.CO;2-R; Tanaka H, 1998, J BIOL CHEM, V273, P11378, DOI 10.1074/jbc.273.18.11378; Yanagisawa H, 1998, DEVELOPMENT, V125, P825	47	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27902	10.1371/journal.pone.0027902	http://dx.doi.org/10.1371/journal.pone.0027902			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132166	Green Published, gold			2022-12-25	WOS:000297792400022
J	Hoffmann, S; Maro, B; Kubiak, JZ; Polanski, Z				Hoffmann, Steffen; Maro, Bernard; Kubiak, Jacek Z.; Polanski, Zbigniew			A Single Bivalent Efficiently Inhibits Cyclin B1 Degradation and Polar Body Extrusion in Mouse Oocytes Indicating Robust SAC during Female Meiosis I	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; CHROMOSOME SEGREGATION; MEIOTIC MATURATION; ANEUPLOIDY; ANAPHASE; SECURIN; ARREST; MAD2; SUSCEPTIBILITY; DESTRUCTION	The Spindle Assembly Checkpoint (SAC) inhibits anaphase until microtubule-to-kinetochore attachments are formed, thus securing correct chromosome separation and preventing aneuploidy. Whereas in mitosis even a single unattached chromosome keeps the SAC active, the high incidence of aneuploidy related to maternal meiotic errors raises a concern about the lower efficiency of SAC in oocytes. Recently it was suggested that in mouse oocytes, contrary to somatic cells, not a single chromosome but a critical mass of chromosomes triggers efficient SAC pointing to the necessity of evaluating the robustness of SAC in oocytes. Two types of errors in chromosome segregation upon meiosis I related to SAC were envisaged: (1) SAC escape, when kinetochores emit SAC-activating signal unable to stop anaphase I; and (2) SAC deceive, when kinetochores do not emit the signal. Using micromanipulations and live imaging of the first polar body extrusion, as well as the dynamics of cyclin B1 degradation, here we show that in mouse oocytes a single bivalent keeps the SAC active. This is the first direct evaluation of SAC efficiency in mouse oocytes, which provides strong evidence that the robustness of SAC in mammalian oocytes is comparable to other cell types. Our data do not contradict the hypothesis of the critical mass of chromosomes necessary for SAC activation, but suggest that the same rule may govern SAC activity also in other cell types. We postulate that the innate susceptibility of oocytes to errors in chromosome segregation during the first meiotic division may not be caused by lower efficiency of SAC itself, but could be linked to high critical chromosome mass necessary to keep SAC active in oocyte of large size.	[Hoffmann, Steffen; Polanski, Zbigniew] Max Planck Inst Immunobiol, Dept Dev Biol, Freiburg, Germany; [Maro, Bernard; Kubiak, Jacek Z.] Univ Rennes 1, UMR 6061, Mitosis & Meiosis Grp, CNRS,IFR GFAS 140, Rennes, France; [Polanski, Zbigniew] Jagiellonian Univ, Inst Zool, Dept Genet & Evolut, PL-30060 Krakow, Poland	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Jagiellonian University	Hoffmann, S (corresponding author), Max Planck Inst Immunobiol, Dept Dev Biol, Stubeweg 51, Freiburg, Germany.	jacek.kubiak@univ-rennes1.fr; zbigniew.polanski@uj.edu.pl	Polański, Zbigniew/AAJ-2435-2021; Maro, Bernard/AAL-2220-2020	Kubiak, Jacek Z./0000-0003-2772-5127	Max Planck Society (Germany); ARC (Association pour la Recherche contre le Cancer)(France)	Max Planck Society (Germany)(Max Planck Society); ARC (Association pour la Recherche contre le Cancer)(France)(Fondation ARC pour la Recherche sur le Cancer)	Max Planck Society (Germany) internal grants to ZP were used for experiments. JZK was supported by ARC (Association pour la Recherche contre le Cancer)(France) for chemicals and travel expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Brunet S, 1998, CURR BIOL, V8, P1231, DOI 10.1016/S0960-9822(07)00516-7; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Chiang T, 2010, CURR BIOL, V20, P1522, DOI 10.1016/j.cub.2010.06.069; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Holland AJ, 2006, J CELL SCI, V119, P3325, DOI 10.1242/jcs.03083; Holt JE, 2009, MOL HUM REPROD, V15, P139, DOI 10.1093/molehr/gap007; Homer HA, 2005, REPRODUCTION, V130, P829, DOI 10.1530/rep.1.00856; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Hupalowska A, 2008, BIOL REPROD, V79, P1102, DOI 10.1095/biolreprod.108.069609; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Kouznetsova A, 2007, NAT GENET, V39, P966, DOI 10.1038/ng2065; KUBIAK JZ, 1993, EMBO J, V12, P3773, DOI 10.1002/j.1460-2075.1993.tb06055.x; Lamb NE, 2004, NEW ENGL J MED, V351, P1931, DOI 10.1056/NEJMp048118; Ledan E, 2001, DEV BIOL, V232, P400, DOI 10.1006/dbio.2001.0188; Lemaire-Adkins R, 1997, J CELL BIOL, V139, P1611, DOI 10.1083/jcb.139.7.1611; Lister LM, 2010, CURR BIOL, V20, P1511, DOI 10.1016/j.cub.2010.08.023; McGulnness BE, 2009, CURR BIOL, V19, P369, DOI 10.1016/j.cub.2009.01.064; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nabti I, 2008, DEV BIOL, V321, P379, DOI 10.1016/j.ydbio.2008.06.036; Nagaoka SI, 2011, CURR BIOL, V21, P651, DOI 10.1016/j.cub.2011.03.003; Niault T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001165; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; Polanski Z, 1998, DEVELOPMENT, V125, P4989; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Tachibana-Konwalski K, 2010, GENE DEV, V24, P2505, DOI 10.1101/gad.605910; TARKOWSKI AK, 1977, J EMBRYOL EXP MORPH, V38, P187; Terret ME, 2003, CURR BIOL, V13, P1797, DOI 10.1016/j.cub.2003.09.032; Tsurumi C, 2004, J CELL BIOL, V167, P1037, DOI 10.1083/jcb.200405165; Vogt E, 2008, MUTAT RES-GEN TOX EN, V651, P14, DOI 10.1016/j.mrgentox.2007.10.015	32	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27143	10.1371/journal.pone.0027143	http://dx.doi.org/10.1371/journal.pone.0027143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125605	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789200005
J	Zhang, J; Wang, JC; Ma, YY; Du, WQ; Zhao, SY; Zhang, ZW; Zhang, XJ; Liu, Y; Xiao, HS; Wang, HY; Jin, L; Liu, J				Zhang, Jun; Wang, Jiucun; Ma, Yanyun; Du, Wenqi; Zhao, Siyang; Zhang, Zuowei; Zhang, Xiaojiao; Liu, Yue; Xiao, Huasheng; Wang, Hongyan; Jin, Li; Liu, Jie			A Novel Splicing Mutation Alters DSPP Transcription and Leads to Dentinogenesis Imperfecta Type II	PLOS ONE			English	Article								Dentinogenesis imperfecta (DGI) type II is an autosomal dominant disease characterized by a serious disorders in teeth. Mutations of dentin sialophosphoprotein (DSPP) gene were revealed to be the causation of DGI type II (DGI-II). In this study, we identified a novel mutation (NG_011595.1:g.8662T>C, c.135+2T>C) lying in the splice donor site of intron 3 of DSPP gene in a Chinese Han DGI-II pedigree. It was found in all affected subjects but not in unaffected ones or other unrelated healthy controls. The function of the mutant DSPP gene, which was predicted online and subsequently confirmed by in vitro splicing analysis, was the loss of splicing of intron 3, leading to the extended length of DSPP mRNA. For the first time, the functional non-splicing of intron was revealed in a novel DSPP mutation and was considered as the causation of DGI-II. It was also indicated that splicing was of key importance to the function of DSPP and this splice donor site might be a sensitive mutation hot spot. Our findings combined with other reports would facilitate the genetic diagnosis of DGI-II, shed light on its gene therapy and help to finally conquer human diseases.	[Zhang, Jun; Du, Wenqi; Zhao, Siyang; Zhang, Zuowei; Zhang, Xiaojiao; Liu, Jie] Fudan Univ, Huashan Hosp, Dept Digest Dis, Shanghai 200433, Peoples R China; [Zhang, Jun; Wang, Jiucun; Ma, Yanyun; Wang, Hongyan; Jin, Li] Fudan Univ, Sch Life Sci, Inst Biomed Sci, Minist Educ,MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Zhang, Jun; Wang, Jiucun; Ma, Yanyun; Wang, Hongyan; Jin, Li] Fudan Univ, Sch Life Sci, Inst Biomed Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Zuowei; Zhang, Xiaojiao; Liu, Jie] Fudan Univ, Inst Biomed Sci, Shanghai Med Sch, Dept Immunol, Shanghai 200433, Peoples R China; [Liu, Yue] Fudan Univ, Huashan Hosp, Dept Stomatol, Shanghai 200433, Peoples R China; [Xiao, Huasheng] Natl Engn Ctr Biochip Shanghai, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Zhang, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Digest Dis, Shanghai 200433, Peoples R China.	jieliu28@hotmail.com	Jin, Li/M-5063-2019; MA, YAN/HHN-2912-2022; Li, Yuan/J-8015-2012; Jin, Li/C-1468-2009; Wang, Jiucun/J-8744-2012	Jin, Li/0000-0002-4546-2415; Wang, Jiucun/0000-0003-2765-0620	Science and Technology Commission of Shanghai Municipality [09JC1403000, 10XD1400800]; National Natural Science Foundation of China [81125001]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from the Science and Technology Commission of Shanghai Municipality (Grant No. 09JC1403000 and 10XD1400800) and the National Natural Science Foundation of China (Grant No. 81125001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bai HH, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-23; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Hartmann L, 2010, AM J HUM GENET, V87, P480, DOI 10.1016/j.ajhg.2010.08.016; Kim JW, 2005, HUM GENET, V116, P186, DOI 10.1007/s00439-004-1223-6; Lee SK, 2009, J DENT RES, V88, P51, DOI 10.1177/0022034508328168; Lee SK, 2008, J ENDODONT, V34, P1470, DOI 10.1016/j.joen.2008.08.027; McKnight DA, 2008, J DENT RES, V87, P1108, DOI 10.1177/154405910808701217; Song YL, 2006, ORAL SURG ORAL MED O, V102, P360, DOI 10.1016/j.tripleo.2005.06.020; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Wang HY, 2009, MUTAT RES-FUND MOL M, V662, P22, DOI 10.1016/j.mrfmmm.2008.11.019; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765; Zhang XQ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-52	13	9	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27982	10.1371/journal.pone.0027982	http://dx.doi.org/10.1371/journal.pone.0027982			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125647	Green Published, gold, Green Submitted			2022-12-25	WOS:000297789200047
J	Zhang, Y; Wang, JT; Guo, WS; Wang, HY; Zhu, SL; Wang, DY; Bai, RY; Li, XL; Yan, DM; Wang, HL; Zhang, Y; Zhu, Z; Tan, XJ; An, HQ; Xu, AQ; Xu, WB				Zhang, Yong; Wang, Jitao; Guo, Wanshen; Wang, Haiyan; Zhu, Shuangli; Wang, Dongyan; Bai, Ruyin; Li, Xingle; Yan, Dongmei; Wang, Huiling; Zhang, Yan; Zhu, Zhen; Tan, Xiaojuan; An, Hongqiu; Xu, Aiqiang; Xu, Wenbo			Emergence and Transmission Pathways of Rapidly Evolving Evolutionary Branch C4a Strains of Human Enterovirus 71 in the Central Plain of China	PLOS ONE			English	Article							VACCINE-DERIVED POLIOVIRUS; MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; SOUTHERN CHINA; HAND; FOOT; TAIWAN; COXSACKIEVIRUS; INFECTION; OUTBREAK	Background: Large-scale outbreaks of hand, foot, and mouth disease (HFMD) occurred repeatedly in the Central Plain of China (Shandong, Anhui, and Henan provinces) from 2007 until now. These epidemics have increased in size and severity each year and are a major public health concern in mainland China. Principal Findings: Phylogenetic analysis was performed and a Bayesian Markov chain Monte Carlo tree was constructed based on the complete VP1 sequences of HEV71 isolates. These analyses showed that the HFMD epidemic in the Central Plain of China was caused by at least 5 chains of HEV71 transmission and that the virus continued to circulate and evolve over the winter seasons between outbreaks. Between 1998 and 2010, there were 2 stages of HEV71 circulation in mainland China, with a shift from evolutionary branch C4b to C4a in 2003-2004. The evolution rate of C4a HEV71 was 4.99x10(-3) substitutions per site per year, faster than the mean of all HEV71 genotypes. The most recent common ancestor estimates for the Chinese clusters dated to October 1994 and November 1993 for the C4a and C4b evolutionary branches, respectively. Compared with all C4a HEV71 strains, a nucleotide substitution in all C4b HEV71 genome (A to C reversion at nt2503 in the VP1 coding region, which caused amino acid substitution of VP1-10: Gln to His) had reverted. Conclusions: The data suggest that C4a HEV71 strains introduced into the Central Plain of China are responsible for the recent outbreaks. The relationships among HEV71 isolates determined from the combined sequence and epidemiological data reveal the underlying seasonal dynamics of HEV71 circulation. At least 5 HEV71 lineages circulated in the Central Plain of China from 2007 to 2009, and the Shandong and Anhui lineages were found to have passed through a genetic bottleneck during the low-transmission winter season.	[Zhang, Yong; Wang, Jitao; Zhu, Shuangli; Wang, Dongyan; Bai, Ruyin; Yan, Dongmei; Wang, Huiling; Zhang, Yan; Zhu, Zhen; Tan, Xiaojuan; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China; [Zhang, Yong; Wang, Jitao; Zhu, Shuangli; Wang, Dongyan; Bai, Ruyin; Yan, Dongmei; Wang, Huiling; Zhang, Yan; Zhu, Zhen; Tan, Xiaojuan; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Wang, Jitao] Taiyuan Ctr Dis Control & Prevent, Taiyuan, Shanxi Province, Peoples R China; [Guo, Wanshen; Li, Xingle] Henan Ctr Dis Control & Prevent, Zhengzhou, Henan Province, Peoples R China; [Wang, Haiyan; Xu, Aiqiang] Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Infect Dis Control & Preven, Jinan, Shandong, Peoples R China; [Bai, Ruyin] Taishan Med Univ, Taishan City, Shandong, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Shandong First Medical University & Shandong Academy of Medical Sciences	Zhang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn		Zhang, Yong/0000-0002-2692-5437	National Natural Science Foundation of China [30900063]; National Key Technology R&D Program of China [2008BAI56B00]; National Program on Key Basic Research Project (973 Program) [2011CB504902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program); National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (project no. 30900063), the National Key Technology R&D Program of China (project no. 2008BAI56B00) and the National Program on Key Basic Research Project (973 Program) (project no. 2011CB504902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bible JM, 2007, REV MED VIROL, V17, P371, DOI 10.1002/rmv.538; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Huang YP, 2008, VIRUS RES, V137, P206, DOI 10.1016/j.virusres.2008.07.015; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lan YC, 2011, SCAND J INFECT DIS, V43, P354, DOI 10.3109/00365548.2010.545995; Lee MS, 2010, PEDIATR INFECT DIS J, V29, P1030, DOI 10.1097/INF.0b013e3181e52945; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; MINOR PD, 1990, CURR TOP MICROBIOL, V161, P121; MINOR PD, 1993, BIOLOGICALS, V21, P357, DOI 10.1006/biol.1993.1096; Oberste MS, 2005, J GEN VIROL, V86, P445, DOI 10.1099/vir.0.80475-0; Oberste MS, 2004, J GEN VIROL, V85, P1597, DOI 10.1099/vir.0.79789-0; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; Ryu WS, 2010, J CLIN MICROBIOL, V48, P2490, DOI 10.1128/JCM.02369-09; Shih ACC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-63; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; Wu Z, 2010, INT J INFECT DIS, V14, pE340, DOI 10.1016/j.ijid.2010.02.377; YANG CF, 1992, VIRUS RES, V24, P277, DOI 10.1016/0168-1702(92)90124-R; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yip CCY, 2010, ARCH VIROL, V155, P1413, DOI 10.1007/s00705-010-0722-0; Zhang Y, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-14; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2010, J GEN VIROL, V91, P421, DOI 10.1099/vir.0.014258-0; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300; Zhu Z, 2010, J CLIN MICROBIOL, V48, P1775, DOI 10.1128/JCM.02055-09	48	67	92	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27895	10.1371/journal.pone.0027895	http://dx.doi.org/10.1371/journal.pone.0027895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125635	gold, Green Submitted, Green Published			2022-12-25	WOS:000297789200035
J	Lee, AYL; Chiba, T; Truong, LN; Cheng, AN; Do, J; Cho, MJ; Chen, LC; Wu, XH				Lee, Alan Yueh-Luen; Chiba, Takuya; Truong, Lan N.; Cheng, An Ning; Do, Johnny; Cho, Michael Jeffrey; Chen, Longchuan; Wu, Xiaohua			Dbf4 Is Direct Downstream Target of Ataxia Telangiectasia Mutated (ATM) and Ataxia Telangiectasia and Rad3-related (ATR) Protein to Regulate Intra-S-phase Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; DNA-DAMAGE CHECKPOINT; HUMAN CDC7-RELATED KINASE; MAMMALIAN-CELLS; EUKARYOTIC CELLS; SCHIZOSACCHAROMYCES-POMBE; PREVENTS REREPLICATION; CHROMOSOME-REPLICATION; ALKYLATION DAMAGE; GENOME INTEGRITY	Dbf4/Cdc7 (Dbf4-dependent kinase (DDK)) is activated at the onset of S-phase, and its kinase activity is required for DNA replication initiation from each origin. We showed that DDK is an important target for the S-phase checkpoint in mammalian cells to suppress replication initiation and to protect replication forks. We demonstrated that ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR) proteins directly phosphorylate Dbf4 in response to ionizing radiation and replication stress. We identified novel ATM/ATR phosphorylation sites on Dbf4 and showed that ATM/ATR-mediated phosphorylation of Dbf4 is critical for the intra-S-phase checkpoint to inhibit DNA replication. The kinase activity of DDK, which is not suppressed upon DNA damage, is required for fork protection under replication stress. We further demonstrated that ATM/ATR-mediated phosphorylation of Dbf4 is important for preventing DNA rereplication upon loss of replication licensing through the activation of the S-phase checkpoint. These studies indicate that DDK is a direct substrate of ATM and ATR to mediate the intra-S-phase checkpoint in mammalian cells.	[Lee, Alan Yueh-Luen; Chiba, Takuya; Truong, Lan N.; Do, Johnny; Cho, Michael Jeffrey; Wu, Xiaohua] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Lee, Alan Yueh-Luen; Cheng, An Ning] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan 35053, Miaoli, Taiwan; [Chiba, Takuya] Nagasaki Univ, Grad Sch Biomed Sci, Dept Invest Pathol, Nagasaki 8528523, Japan; [Cheng, An Ning] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Chen, Longchuan] Vet Adm Med Ctr, Dept Pathol, Long Beach, CA 90822 USA	Scripps Research Institute; National Health Research Institutes - Taiwan; Nagasaki University; National Tsing Hua University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Lee, AYL (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.	alanylee@nhri.org.tw; xiaohwu@scripps.edu	Lee, Alan Yueh-Luen/B-1097-2010	Cho, Michael Jeffrey/0000-0002-4628-303X; Lee, Alan Yueh-Luen/0000-0003-0252-0571	National Institutes of Health [CA102361, GM080677, CA140972, CA102361-07S1, DK007022-30]; National Science Council [NSC 98-2311-B-037-001-MY3]; National Health Research Institutes [CA-100-PP-08]; Department of Health, Taiwan [DOH99-TD-C-111-004]; Takeda Science Foundation; Japan Society for the Promotion of Science [17790269]; NATIONAL CANCER INSTITUTE [R01CA102361, R01CA140972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); Department of Health, Taiwan; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA102361, GM080677, CA140972, and CA102361-07S1 (to X. W.) and Training Grant DK007022-30 (to L. T.). This work was also supported by National Science Council Grant NSC 98-2311-B-037-001-MY3, National Health Research Institutes Grant CA-100-PP-08, and Department of Health Grant DOH99-TD-C-111-004), Taiwan, (to A. Y.-L. L.). This work was also supported by a grant from the Takeda Science Foundation and Grant-in-Aid for Young Scientists (B) 17790269 from the Japan Society for the Promotion of Science (to T. C.).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Brown GW, 1999, P NATL ACAD SCI USA, V96, P8443, DOI 10.1073/pnas.96.15.8443; Cheng LA, 1999, MOL CELL BIOL, V19, P4270; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; Dierov J, 2004, CANCER CELL, V5, P275, DOI 10.1016/S1535-6108(04)00056-X; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; Duncker BP, 2003, MUTAT RES-FUND MOL M, V532, P21, DOI 10.1016/j.mrfmmm.2003.08.007; Fung AD, 2002, MOL CELL BIOL, V22, P4477, DOI 10.1128/MCB.22.13.4477-4490.2002; Furuya K, 2010, MOL CELL, V40, P606, DOI 10.1016/j.molcel.2010.10.026; Guo WY, 2004, J RADIAT RES, V45, P269, DOI 10.1269/jrr.45.269; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heffernan TP, 2007, J BIOL CHEM, V282, P9458, DOI 10.1074/jbc.M611292200; JACKSON AL, 1993, MOL CELL BIOL, V13, P2899, DOI 10.1128/MCB.13.5.2899; Jares P, 2000, EMBO REP, V1, P319, DOI 10.1093/embo-reports/kvd076; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Johnston L H, 2000, Prog Cell Cycle Res, V4, P61; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Kihara M, 2000, J BIOL CHEM, V275, P35051, DOI 10.1074/jbc.M003491200; Kim JM, 2008, ONCOGENE, V27, P3475, DOI 10.1038/sj.onc.1210994; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lee AYL, 2007, J BIOL CHEM, V282, P32243, DOI 10.1074/jbc.M705486200; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lei M, 2001, J CELL SCI, V114, P1447; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; Liu PJ, 2006, J BIOL CHEM, V281, P30631, DOI 10.1074/jbc.M602982200; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Matsumoto S, 2005, J BIOL CHEM, V280, P42536, DOI 10.1074/jbc.M510575200; Matsumoto S, 2010, CELL CYCLE, V9, P4627, DOI 10.4161/cc.9.23.13937; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Pasero P, 1999, GENE DEV, V13, P2159, DOI 10.1101/gad.13.16.2159; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Petersen P, 2006, MOL CELL BIOL, V26, P1997, DOI 10.1128/MCB.26.5.1997-2011.2006; Sato N, 2003, GENES CELLS, V8, P451, DOI 10.1046/j.1365-2443.2003.00647.x; Sclafani RA, 2000, J CELL SCI, V113, P2111; Silva T, 2006, J BIOL CHEM, V281, P11569, DOI 10.1074/jbc.M510278200; Snaith HA, 2000, MOL CELL BIOL, V20, P7922, DOI 10.1128/MCB.20.21.7922-7932.2000; Sommariva E, 2005, MOL CELL BIOL, V25, P2770, DOI 10.1128/MCB.25.7.2770-2784.2005; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Takeda T, 1999, MOL CELL BIOL, V19, P5535; Tenca P, 2007, J BIOL CHEM, V282, P208, DOI 10.1074/jbc.M604457200; Truong LN, 2011, J MOL CELL BIOL, V3, P13, DOI 10.1093/jmcb/mjq052; Tsuji T, 2008, MOL CELL, V32, P862, DOI 10.1016/j.molcel.2008.12.005; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Uno S, 2011, GENES CELLS, V16, P842, DOI 10.1111/j.1365-2443.2011.01535.x; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; YOON HJ, 1993, MOL BIOL CELL, V4, P195, DOI 10.1091/mbc.4.2.195; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	70	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2531	2543		10.1074/jbc.M111.291104	http://dx.doi.org/10.1074/jbc.M111.291104			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22123827	Green Published, hybrid			2022-12-25	WOS:000300292300027
J	Montagna, GN; Buscaglia, CA; Munter, S; Goosmann, C; Frischknecht, F; Brinkmann, V; Matuschewski, K				Montagna, Georgina N.; Buscaglia, Carlos A.; Muenter, Sylvia; Goosmann, Christian; Frischknecht, Friedrich; Brinkmann, Volker; Matuschewski, Kai			Critical Role for Heat Shock Protein 20 (HSP20) in Migration of Malarial Sporozoites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-DEPOLYMERIZING FACTOR; TRAP-LIKE PROTEIN; PLASMODIUM SPOROZOITES; TOXOPLASMA-GONDII; GLIDING MOTILITY; MICROFILAMENT DYNAMICS; ANONYMOUS PROTEIN; CRYSTAL-STRUCTURE; CELL INVASION; MYOSIN-A	Plasmodium sporozoites, single cell eukaryotic pathogens, use their own actin/myosin-based motor machinery for life cycle progression, which includes forward locomotion, penetration of cellular barriers, and invasion of target cells. To display fast gliding motility, the parasite uses a high turnover of actin polymerization and adhesion sites. Paradoxically, only a few classic actin regulatory proteins appear to be encoded in the Plasmodium genome. Small heat shock proteins have been associated with cytoskeleton modulation in various biological processes. In this study, we identify HSP20 as a novel player in Plasmodium motility and provide molecular genetics evidence for a critical role of a small heat shock protein in cell traction and motility. We demonstrate that HSP20 ablation profoundly affects sporozoite-substrate adhesion, which translates into aberrant speed and directionality in vitro. Loss of HSP20 function impairs migration in the host, an important sporozoite trait required to find a blood vessel and reach the liver after being deposited in the skin by the mosquito. Our study also shows that fast locomotion of sporozoites is crucial during natural malaria transmission.	[Matuschewski, Kai] Max Planck Inst Infect Biol, Parasitol Unit, D-10117 Berlin, Germany; [Buscaglia, Carlos A.] Univ Nacl San Martin, Inst Invest Biotecnol IIB INTECH, RA-1650 Buenos Aires, DF, Argentina; [Muenter, Sylvia; Frischknecht, Friedrich] Heidelberg Univ, Sch Med, Dept Infect Dis, D-69120 Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg	Matuschewski, K (corresponding author), Max Planck Inst Infect Biol, Parasitol Unit, D-10117 Berlin, Germany.	matuschewski@mpiib-berlin.mpg.de	Montagna, Georgina/D-1202-2013; Brinkmann, Volker/A-6015-2009	Matuschewski, Kai/0000-0001-6147-8591; Montagna, Georgina/0000-0003-0283-8977; Buscaglia, Carlos/0000-0001-6466-4138; Frischknecht, Friedrich/0000-0002-8332-6668	European Commission (European Virtual Institute) [34]; Max Planck Society; Joachim Siebeneicher Foundation; Chica and Heinz Schaller Foundation; German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung); University of Heidelberg; von Humboldt Foundation; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina); United Nations Children's Fund/United Nations Development Program/World Bank/World Health Organization Special Program for Research and Training in Tropical Diseases	European Commission (European Virtual Institute)(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Joachim Siebeneicher Foundation; Chica and Heinz Schaller Foundation; German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); University of Heidelberg; von Humboldt Foundation(Alexander von Humboldt Foundation); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); United Nations Children's Fund/United Nations Development Program/World Bank/World Health Organization Special Program for Research and Training in Tropical Diseases	This work was supported by the European Commission (European Virtual Institute for Malaria Research Grants 2 and 34 to F. F. and K. M.); the Max Planck Society, the Joachim Siebeneicher Foundation, and the Chica and Heinz Schaller Foundation (to K. M.); the German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BioFuture program) and the Frontier Program of the University of Heidelberg (to F. F.); the von Humboldt Foundation (to G. N. M.); and the Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) and the United Nations Children's Fund/United Nations Development Program/World Bank/World Health Organization Special Program for Research and Training in Tropical Diseases (to C. A. B.).	Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bhanot P, 2005, J BIOL CHEM, V280, P6752, DOI 10.1074/jbc.M411465200; Bosch J, 2007, P NATL ACAD SCI USA, V104, P7015, DOI 10.1073/pnas.0605301104; Buscaglia CA, 2003, MOL BIOL CELL, V14, P4947, DOI 10.1091/mbc.E03-06-0355; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; de Miguel N, 2008, BIOL CELL, V100, P479, DOI 10.1042/BC20080004; Dreiza CM, 2004, FASEB J, V18, P261, DOI 10.1096/fj.04-2911fje; Edwards HV, 2011, CELL SIGNAL, V23, P1447, DOI 10.1016/j.cellsig.2011.05.009; Engelmann S, 2009, EUKARYOT CELL, V8, P640, DOI 10.1128/EC.00347-08; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Frischknecht F, 2004, CELL MICROBIOL, V6, P687, DOI 10.1111/j.1462-5822.2004.00395.x; Ganter M, 2009, MOL MICROBIOL, V74, P1356, DOI 10.1111/j.1365-2958.2009.06828.x; Goosmann C, 2008, METHOD CELL BIOL, V88, P477, DOI 10.1016/S0091-679X(08)00424-X; Gu JR, 1997, MOL CELL BIOL, V17, P4033, DOI 10.1128/MCB.17.7.4033; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000720; Hegge S, 2010, FASEB J, V24, P2222, DOI 10.1096/fj.09-148700; Heiss K, 2008, EUKARYOT CELL, V7, P1062, DOI 10.1128/EC.00089-08; Hliscs M, 2010, J BIOL CHEM, V285, P11572, DOI 10.1074/jbc.M109.054916; Ishino T, 2004, PLOS BIOL, V2, P77, DOI 10.1371/journal.pbio.0020004; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jayabalasingham B, 2010, CELL RES, V20, P1043, DOI 10.1038/cr.2010.88; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kappe SHI, 2003, TRENDS PARASITOL, V19, P135, DOI 10.1016/S1471-4922(03)00007-2; Karolczak-Bayatti M, 2011, J BIOL CHEM, V286, P34346, DOI 10.1074/jbc.M111.278549; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kursula I, 2008, STRUCTURE, V16, P1638, DOI 10.1016/j.str.2008.09.008; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Lacroix C, 2008, TRENDS PARASITOL, V24, P431, DOI 10.1016/j.pt.2008.07.003; LAVOIE JN, 1993, J BIOL CHEM, V268, P3420; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Matuschewski K, 2006, CELL MICROBIOL, V8, P1547, DOI 10.1111/j.1462-5822.2006.00778.x; Mehta S, 2010, J BIOL CHEM, V285, P6835, DOI 10.1074/jbc.M109.068155; MEIS JFGM, 1985, CELL TISSUE RES, V241, P353, DOI 10.1007/BF00217180; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Menard R, 2001, CELL MICROBIOL, V3, P63, DOI 10.1046/j.1462-5822.2001.00097.x; MIRON T, 1988, EUR J BIOCHEM, V178, P543, DOI 10.1111/j.1432-1033.1988.tb14481.x; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Munter S, 2009, CELL HOST MICROBE, V6, P551, DOI 10.1016/j.chom.2009.11.007; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; Rembold CM, 2000, J PHYSIOL-LONDON, V524, P865, DOI 10.1111/j.1469-7793.2000.00865.x; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; Sattler JM, 2011, EUR J CELL BIOL, V90, P966, DOI 10.1016/j.ejcb.2010.11.011; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Schmitz S, 2010, J BIOL CHEM, V285, P36577, DOI 10.1074/jbc.M110.142638; Schuler H, 2006, TRAFFIC, V7, P1433, DOI 10.1111/j.1600-0854.2006.00484.x; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; Schuler H, 2005, FEBS LETT, V579, P655, DOI 10.1016/j.febslet.2004.12.037; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaw MK, 1999, P NATL ACAD SCI USA, V96, P9095, DOI 10.1073/pnas.96.16.9095; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Siden-Kiamos I, 2011, CELL MICROBIOL, V13, P1996, DOI 10.1111/j.1462-5822.2011.01686.x; Steinbuechel M, 2009, CELL MICROBIOL, V11, P279, DOI 10.1111/j.1462-5822.2008.01252.x; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; VANDERBERG JP, 1975, J PARASITOL, V61, P43, DOI 10.2307/3279102; VANDERBERG JP, 1974, J PROTOZOOL, V21, P527, DOI 10.1111/j.1550-7408.1974.tb03693.x; Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458	74	50	53	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2410	2422		10.1074/jbc.M111.302109	http://dx.doi.org/10.1074/jbc.M111.302109			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139844	hybrid, Green Published			2022-12-25	WOS:000300292300016
J	Ohkita, M; Saito, S; Imagawa, T; Takahashi, K; Tominaga, M; Ohta, T				Ohkita, Masashi; Saito, Shigeru; Imagawa, Toshiaki; Takahashi, Kenji; Tominaga, Makoto; Ohta, Toshio			Molecular Cloning and Functional Characterization of Xenopus tropicalis Frog Transient Receptor Potential Vanilloid 1 Reveal Its Functional Evolution for Heat, Acid, and Capsaicin Sensitivities in Terrestrial Vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY SENSORY NEURONS; ION-CHANNEL; PAIN PATHWAY; TRPV1; TEMPERATURE; ACTIVATION; EXPRESSION; RESPONSES; PROTEIN; GENOME	The functional difference of thermosensitive transient receptor potential (TRP) channels in the evolutionary context has attracted attention, but thus far little information is available on the TRP vanilloid 1 (TRPV1) function of amphibians, which diverged earliest from terrestrial vertebrate lineages. In this study we cloned Xenopus tropicalis frog TRPV1 (xtTRPV1), and functional characterization was performed using HeLa cells heterologously expressing xtTRPV1 (xtTRPV1-HeLa) and dorsal root ganglion neurons isolated from X. tropicalis (xtDRG neurons) by measuring changes in the intracellular calcium concentration ([Ca2+](i)). The channel activity was also observed in xtTRPV1-expressing Xenopus oocytes. Furthermore, we tested capsaicin-and heat-induced nocifensive behaviors of the frog X. tropicalis in vivo. At the amino acid level, xtTRPV1 displays similar to 60% sequence identity to other terrestrial vertebrate TRPV1 orthologues. Capsaicin induced [Ca2+](i) increases in xtTRPV1-HeLa and xtDRG neurons and evoked nocifensive behavior in X. tropicalis. However, its sensitivity was extremely low compared with mammalian orthologues. Low extracellular pH and heat activated xtTRPV1-HeLa and xtDRG neurons. Heat also evoked nocifensive behavior. In oocytes expressing xtTRPV1, inward currents were elicited by heat and low extracellular pH. Mutagenesis analysis revealed that two amino acids (tyrosine 523 and alanine 561) were responsible for the low sensitivity to capsaicin. Taken together, our results indicate that xtTRPV1 functions as a polymodal receptor similar to its mammalian orthologues. The present study demonstrates that TRPV1 functions as a heat-and acid-sensitive channel in the ancestor of terrestrial vertebrates. Because it is possible to examine vanilloid and heat sensitivities in vitro and in vivo, X. tropicalis could be the ideal experimental lower vertebrate animal for the study of TRPV1 function.	[Ohkita, Masashi; Takahashi, Kenji; Ohta, Toshio] Tottori Univ, Fac Agr, Dept Vet Pharmacol, Tottori 6808553, Japan; [Saito, Shigeru; Tominaga, Makoto] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 4448787, Japan; [Imagawa, Toshiaki] Hokkaido Univ, Grad Sch Sci, Div Chem,Grad, Sapporo, Hokkaido 0600810, Japan	Tottori University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Hokkaido University	Ohta, T (corresponding author), Tottori Univ, Fac Agr, Dept Vet Pharmacol, Koyama South 4, Tottori 6808553, Japan.	tohta@muses.tottori-u.ac.jp	Saito, Shigeru/B-4698-2015	Saito, Shigeru/0000-0002-6237-8979	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22380160] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bianchi BR, 2006, EUR J PHARMACOL, V537, P20, DOI 10.1016/j.ejphar.2006.03.003; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHERYCROZE S, 1985, N-S ARCH PHARMACOL, V331, P159, DOI 10.1007/BF00634233; Correll CC, 2004, NEUROSCI LETT, V370, P55, DOI 10.1016/j.neulet.2004.07.058; Dowland LK, 2000, J BIOL CHEM, V275, P37765, DOI 10.1074/jbc.M004840200; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Guler AD, 2002, J NEUROSCI, V22, P6408; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kajihara Y, 2010, NEUROSCIENCE, V166, P292, DOI 10.1016/j.neuroscience.2009.12.001; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kashiwagi K, 2010, EXP ANIM TOKYO, V59, P395, DOI 10.1538/expanim.59.395; Khokha MK, 2002, DEV DYNAM, V225, P499, DOI 10.1002/dvdy.10184; Kuffler DP, 2002, J NEUROPHYSIOL, V88, P1843, DOI 10.1152/jn.2002.88.4.1843; McIntyre P, 2001, BRIT J PHARMACOL, V132, P1084, DOI 10.1038/sj.bjp.0703918; Myers BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005741; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ohta T, 2008, J BIOL CHEM, V283, P9377, DOI 10.1074/jbc.M709377200; Ohta T, 2006, J PHYSIOL-LONDON, V576, P809, DOI 10.1113/jphysiol.2006.112250; Phelps PT, 2005, EUR J PHARMACOL, V513, P57, DOI 10.1016/j.ejphar.2005.02.045; PHILIPPI M, 1995, J NEUROSCI RES, V40, P387, DOI 10.1002/jnr.490400313; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Saito S, 2006, PHYSIOL GENOMICS, V27, P219, DOI 10.1152/physiolgenomics.00322.2005; Saito S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002041; Savidge J, 2002, NEUROPHARMACOLOGY, V43, P450, DOI 10.1016/S0028-3908(02)00122-3; Seebacher F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000281; SZALLASI A, 1993, N-S ARCH PHARMACOL, V347, P84; Szolcsanyi J, 2004, NEUROPEPTIDES, V38, P377, DOI 10.1016/j.npep.2004.07.005; Tewksbury JJ, 2001, NATURE, V412, P403, DOI 10.1038/35086653; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; WOOD JN, 1988, J NEUROSCI, V8, P3208; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882	40	30	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2388	2397		10.1074/jbc.M111.305698	http://dx.doi.org/10.1074/jbc.M111.305698			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130664	Green Published, hybrid			2022-12-25	WOS:000300292300014
J	Hinz, J; Lehnhardt, L; Zakrzewski, S; Zhang, G; Ignatova, Z				Hinz, Justyna; Lehnhardt, Lothar; Zakrzewski, Silke; Zhang, Gong; Ignatova, Zoya			Polyglutamine Expansion Alters the Dynamics and Molecular Architecture of Aggregates in Dentatorubropallidoluysian Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; HUNTINGTONS-DISEASE; INTRANUCLEAR INCLUSIONS; PROTEIN AGGREGATION; REPRESSES TRANSCRIPTION; NUCLEAR-LOCALIZATION; SEEDING SPECIFICITY; CELLULAR TOXICITY; GENE-PRODUCT; LIVING CELLS	Preferential accumulation of mutant proteins in the nucleus has been suggested to be the molecular culprit that confers cellular toxicity in the neurodegenerative disorders caused by polyglutamine (polyQ) expansion. Here, we use dynamic imaging approaches, orthogonal cross-seeding, and composition analysis to examine the dynamics and structure of nuclear and cytoplasmic inclusions of atrophin-1, implicated in dentatorubropallidoluysian atrophy, a polyQ-based disease with complex clinical features. Our results reveal a large heterogeneity in the dynamics of the nuclear inclusions compared with the compact and immobile cytoplasmic aggregates. At least two types of inclusions of expanded atrophin-1 with different mobility of the molecular species and ability to exchange with the surrounding monomer pool coexist in the nucleus. Intriguingly, the enrichment of nuclear inclusions with slow dynamics parallels changes in the aggregate core architecture that are dominated by the polyQ stretch. We propose that the observed complexity in the dynamics of the nuclear inclusions provides a molecular explanation for the enhanced cellular toxicity of the nuclear aggregates in polyQ-based neurodegeneration.	[Hinz, Justyna; Lehnhardt, Lothar; Zakrzewski, Silke; Zhang, Gong; Ignatova, Zoya] Univ Potsdam, Inst Biochem & Biol, D-14467 Potsdam, Germany	University of Potsdam	Ignatova, Z (corresponding author), Univ Potsdam, Inst Biochem & Biol, Karl Liebknecht Str 24-25, D-14467 Potsdam, Germany.	ignatova@uni-potsdam.de	Zhang, Gong/Q-7419-2017	Zhang, Gong/0000-0003-0418-3433; Ignatova, Zoya/0000-0002-9478-8825	Deutsche Forschungsgemeinschaft [IG 73/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant IG 73/8-1 (to Z. I.).	Allen TD, 2000, J CELL SCI, V113, P1651; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Bhattacharyya AM, 2005, P NATL ACAD SCI USA, V102, P15400, DOI 10.1073/pnas.0501651102; Bulone D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000111; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Chapple JP, 2008, NEUROSCI LETT, V447, P172, DOI 10.1016/j.neulet.2008.09.075; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hinz J, 2008, BIOCHEMISTRY-US, V47, P4196, DOI 10.1021/bi800002j; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Ignatova Z, 2007, J BIOL CHEM, V282, P36736, DOI 10.1074/jbc.M703682200; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Krol HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001503; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1927, DOI 10.1093/hmg/11.17.1927; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Miyashita T, 1998, BIOCHEM BIOPH RES CO, V249, P96, DOI 10.1006/bbrc.1998.9096; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Nucifora FC, 2003, J BIOL CHEM, V278, P13047, DOI 10.1074/jbc.M211224200; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Okamura-Oho Y, 1999, HUM MOL GENET, V8, P947, DOI 10.1093/hmg/8.6.947; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Romero Pedro, 2004, Appl Bioinformatics, V3, P105, DOI 10.2165/00822942-200403020-00005; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schilling G, 1999, NEURON, V24, P275, DOI 10.1016/S0896-6273(00)80839-9; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shen Y, 2009, CELL MOL LIFE SCI, V66, P437, DOI 10.1007/s00018-008-8403-9; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Stenoien DL, 2002, NAT CELL BIOL, V4, P806, DOI 10.1038/ncb859; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wood JD, 2000, J CELL BIOL, V150, P939, DOI 10.1083/jcb.150.5.939; Yamada M, 2001, AM J PATHOL, V159, P1785, DOI 10.1016/S0002-9440(10)63025-8; Yamada M, 2001, ANN NEUROL, V49, P14, DOI 10.1002/1531-8249(200101)49:1<14::AID-ANA5>3.0.CO;2-X; YAZAWA I, 1995, NAT GENET, V10, P99, DOI 10.1038/ng0595-99	58	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2068	2078		10.1074/jbc.M111.318915	http://dx.doi.org/10.1074/jbc.M111.318915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22134925	Green Published, hybrid			2022-12-25	WOS:000299321000047
J	Roy, G; Placzek, E; Scanlan, TS				Roy, Gouriprasanna; Placzek, Ekaterina; Scanlan, Thomas S.			ApoB-100-containing Lipoproteins Are Major Carriers of 3-Iodothyronamine in Circulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; HUMAN APOLIPOPROTEIN-B; PLASMA-LIPOPROTEINS; THYROXINE-BINDING; THYROID-HORMONE; HEPG2 CELLS; ATHEROSCLEROTIC LESIONS; MASS-SPECTROMETRY; TRANSGENIC MICE; DEFICIENT MICE	3-Iodothyronamine (T(1)AM) is a biogenic amine derivative of thyroid hormone present in tissue and blood of vertebrates. Approximately 99% of the circulating thyroid hormones are bound to plasma proteins, including three major thyroid hormone-binding proteins, and the question arises as to whether circulating T(1)AMis also bound to serum factors. We report here that T(1)AM is largely bound to a single protein component of human serum. Using T(1)AM-affinity chromatography, we isolated this protein, and sequence analysis identified it as apolipoprotein B-100 (apoB-100), the protein component of several low density lipoprotein particles. Consistent with this finding, we demonstrate that >90% of specifically bound T(1)AM in human serum resides in the apoB-100-containing low density lipoprotein fraction. T(1)AM reversibly binds to apoB-100-containing lipoprotein particles with an equilibrium dissociation constant (K-D) of 17nM and a T(1)AM/apoB-100 stoichiometry of 1:1. Competition binding assays demonstrate that this binding site is highly selective for T(1)AM. Intracellular T(1)AM uptake is significantly enhanced by apoB-100-containing lipoprotein particles. Modest enhancements to apoB-100 cellular uptake and secretion by T(1)AM were observed; however, multidose T(1)AM treatment did not affect lipid or lipoprotein inventory in vivo. Thus, it appears that apoB-100 serves as a carrier of circulating T(1)AM and affords a novel mechanism by which T(1)AM gains entry to cells.	[Roy, Gouriprasanna; Placzek, Ekaterina; Scanlan, Thomas S.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA	Oregon Health & Science University	Scanlan, TS (corresponding author), 3181 SW Sam Jackson Pk Rd,L334, Portland, OR 97239 USA.	scanlant@ohsu.edu	Roy, Gouriprasanna/AAV-8533-2021	Roy, Gouriprasanna/0000-0002-0047-3575	National Institutes of Health [DK-52798]; Center [5P30CA-069533, 5P30EY-010572]; Proteomics Shared Resource; Oregon Opportunity; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY010572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091539, R56DK052798, R01DK052798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center; Proteomics Shared Resource; Oregon Opportunity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-52798 (to T. S. S.) and Center Grants 5P30CA-069533 and 5P30EY-010572. This work was also supported by the Proteomics Shared Resource that is generously funded by Oregon Opportunity.	ADELI K, 1990, FEBS LETT, V263, P345, DOI 10.1016/0014-5793(90)81410-P; AVIRAM M, 1988, J BIOL CHEM, V263, P15416; AVIRAM M, 1988, J BIOL CHEM, V263, P16842; Beghin L, 2000, J LIPID RES, V41, P1172; BENVENGA S, 1992, ENDOCRINOLOGY, V131, P2805, DOI 10.1210/en.131.6.2805; Benvenga S, 1998, ENDOCRINOLOGY, V139, P4311, DOI 10.1210/en.139.10.4311; BENVENGA S, 1990, ENDOCRINOLOGY, V127, P2241, DOI 10.1210/endo-127-5-2241; BENVENGA S, 1988, J CLIN ENDOCR METAB, V67, P6, DOI 10.1210/jcem-67-1-6; BENVENGA S, 1990, ENDOCRINOLOGY, V126, P933, DOI 10.1210/endo-126-2-933; Bietrix F, 2006, J BIOL CHEM, V281, P7214, DOI 10.1074/jbc.M508868200; Braulke LJ, 2008, J COMP PHYSIOL B, V178, P167, DOI 10.1007/s00360-007-0208-x; BROUSSEAU T, 1993, CLIN CHEM, V39, P960; CALLOW MJ, 1994, P NATL ACAD SCI USA, V91, P2130, DOI 10.1073/pnas.91.6.2130; Chiellini G, 2007, FASEB J, V21, P1597, DOI 10.1096/fj.06-7474com; Doyle KP, 2007, STROKE, V38, P2569, DOI 10.1161/STROKEAHA.106.480277; Fu T, 2004, J BIOL CHEM, V279, P28662, DOI 10.1074/jbc.M403271200; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Hart ME, 2006, J MED CHEM, V49, P1101, DOI 10.1021/jm0505718; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hoefig CS, 2011, J CLIN ENDOCR METAB, V96, P1864, DOI 10.1210/jc.2010-2680; Ianculescu AG, 2010, MOL BIOSYST, V6, P1403, DOI 10.1039/b926588k; Ianculescu AG, 2009, ENDOCRINOLOGY, V150, P1991, DOI 10.1210/en.2008-1339; Jonas A, 2008, N COMP BIOC, P485, DOI 10.1016/B978-044453219-0.50019-2; Klieverik LP, 2009, J ENDOCRINOL, V201, P377, DOI 10.1677/JOE-09-0043; Lynn EG, 2001, KIDNEY INT, V60, P520, DOI 10.1046/j.1523-1755.2001.060002520.x; Maiyoh GK, 2007, J NUTR, V137, P2185, DOI 10.1093/jn/137.10.2185; Manthey KC, 2005, J NUTR, V135, P978, DOI 10.1093/jn/135.5.978; Miyakawa M, 2006, SYNTHETIC COMMUN, V36, P891, DOI 10.1080/00397910500466074; Piehl S, 2011, ENDOCR REV, V32, P64, DOI 10.1210/er.2009-0040; PURCELLHUYNH DA, 1995, J CLIN INVEST, V95, P2246, DOI 10.1172/JCI117915; Qiu SQ, 1998, J LIPID RES, V39, P1661; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; Robbins J, 1976, Prog Clin Biol Res, V5, P331; Saba A, 2010, ENDOCRINOLOGY, V151, P5063, DOI 10.1210/en.2010-0491; Scanlan TS, 2011, J CLIN ENDOCR METAB, V96, P1674, DOI 10.1210/jc.2011-0688; Scanlan TS, 2009, ENDOCRINOLOGY, V150, P1108, DOI 10.1210/en.2008-1596; Scanlan TS, 2004, NAT MED, V10, P638, DOI 10.1038/nm1051; Schurer H, 2001, BIOORGAN MED CHEM, V9, P2557, DOI 10.1016/S0968-0896(01)00030-X; Schussler G C, 1990, Thyroid, V1, P25, DOI 10.1089/thy.1990.1.25; Schussler GC, 2000, THYROID, V10, P141, DOI 10.1089/thy.2000.10.141; Stahlman M, 2008, J LIPID RES, V49, P481, DOI 10.1194/jlr.D700025-JLR200; Stewart BJ, 2009, BBA-MOL CELL BIOL L, V1791, P772, DOI 10.1016/j.bbalip.2009.04.004; THERIAULT A, 1992, BIOCHEM BIOPH RES CO, V186, P617, DOI 10.1016/0006-291X(92)90791-I; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Wood WJL, 2009, CHEMBIOCHEM, V10, P361, DOI 10.1002/cbic.200800607	45	36	36	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1790	1800		10.1074/jbc.M111.275552	http://dx.doi.org/10.1074/jbc.M111.275552			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128163	Green Published, hybrid			2022-12-25	WOS:000299321000021
J	Albrecht, N; Jatzwauk, L; Slickers, P; Ehricht, R; Monecke, S				Albrecht, Nicole; Jatzwauk, Lutz; Slickers, Peter; Ehricht, Ralf; Monecke, Stefan			Clonal Replacement of Epidemic Methicillin-Resistant Staphylococcus aureus Strains in a German University Hospital over a Period of Eleven Years	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; PANTON-VALENTINE LEUCOCIDIN; CATABOLIC MOBILE ELEMENT; ANTIBIOTIC-RESISTANCE; LEUKOCIDIN GENES; FITNESS COST; RISK-FACTORS; MRSA; SURVEILLANCE; INFECTIONS	Worldwide, methicillin-resistant Staphylococcus aureus (MRSA) pose an increased risk for healthcare- and community-associated infections. Since the first report of MRSA in England in 1961, several distinct clones or strains have emerged. Changes within the MRSA population of whole countries, small regions or of single hospitals have been observed with some clones replacing others. In this study, the clonal replacement of MRSA isolates in a South-eastern German tertiary care hospital between 2000 and 2010 is described based on microarray analyses of 778 isolates and at least 50 MRSA per year. Within these eleven years, four common epidemic strains, CC22-MRSA-IV, CC45-MRSA-IV, CC5/ST228-MRSA-I (including a variant with a truncated SCCmec element) and CC5-MRSA-II were identified. The PVL-negative CC22-MRSA-IV strain (Barnim Epidemic Strain, UK-EMRSA-15) was detected for the first time in 2001 and its abundance increased since then to 58.6% in 2010. CC5-MRSA-II increased from 2% (2000) to about 30% (2003), and since then it fluctuates between 23 and 37% of isolates. CC5/ST228-MRSA-I decreased from about the half of tested isolates (2000) to 2.3% (2010). A similar trend was observed for CC45-MRSA-IV, which decreased drastically down to 3.4% in 2010 after reaching a maximum of 62.0% in 2002. Seventeen other PVL-negative MRSA strains were identified sporadically with no significant trend being observed. Seven PVL-positive MRSA strains were found, but they remained rare during the study period accounting together for 2.7% of isolates.	[Albrecht, Nicole; Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany; [Albrecht, Nicole] Univ Appl Sci, Hsch Lausitz FH, Senftenberg, Germany; [Jatzwauk, Lutz] Dresden Univ Hosp, Dept Hosp Infect Control, Dresden, Germany; [Slickers, Peter; Ehricht, Ralf; Monecke, Stefan] Alere Technol GmbH, Jena, Germany	Technische Universitat Dresden; Brandenburg University of Technology Cottbus; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Alere	Albrecht, N (corresponding author), Tech Univ Dresden, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany.	monecke@rocketmail.com						Adler A, 2010, J CLIN MICROBIOL, V48, P531, DOI 10.1128/JCM.02290-08; Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Amorim ML, 2007, J CLIN MICROBIOL, V45, P2881, DOI 10.1128/JCM.00603-07; Amorim ML, 2002, MICROB DRUG RESIST, V8, P301, DOI 10.1089/10766290260469561; Barbier F, 2011, J ANTIMICROB CHEMOTH, V66, P29, DOI 10.1093/jac/dkq410; Bekkhoucha SN, 2009, EUR J CLIN MICROBIOL, V28, P553, DOI 10.1007/s10096-008-0660-x; Ben Nejma M, 2008, DIAGN MICROBIOL INFE; Campanile F, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-22; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; Conceicao T, 2010, EUR J CLIN MICROBIOL, V29, P543, DOI 10.1007/s10096-010-0892-4; Coombs GW, 2006, EMERG INFECT DIS, V12, P241; Cuevas O, 2007, CLIN MICROBIOL INFEC, V13, P250, DOI 10.1111/j.1469-0691.2006.01672.x; Cuny C, 2006, Euro Surveill, V11, P44; D'Souza N, 2010, J CLIN MICROBIOL, V48, P1806, DOI 10.1128/JCM.01867-09; Deurenberg RH, 2009, EMERG INFECT DIS, V15, P727, DOI 10.3201/eid1505.071618; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P446, DOI 10.1093/jac/dkp448; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P46, DOI 10.1093/jac/dkp386; Enany S, 2010, MICROBIOL RES, V165, P152, DOI 10.1016/j.micres.2009.03.005; Ender M, 2004, ANTIMICROB AGENTS CH, V48, P2295, DOI 10.1128/AAC.48.6.2295-2297.2004; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Grundmann H, 2002, J INFECT DIS, V185, P481, DOI 10.1086/338568; HARTMAN B, 1981, ANTIMICROB AGENTS CH, V19, P726, DOI 10.1128/AAC.19.5.726; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Huggan PJ, 2010, INTERN MED J, V40, P117, DOI 10.1111/j.1445-5994.2009.01910.x; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; HUMPHREYS H, 1990, J HOSP INFECT, V15, P127, DOI 10.1016/0195-6701(90)90121-4; Ito T, 2003, DRUG RESIST UPDATE, V6, P41, DOI 10.1016/S1368-7646(03)00003-7; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Kupfer M, 2009, EPIDEMIOLOGISCHE UNT; Kupfer M, 2010, GMS HYG INFECT CONTR, V5, DOI 10.3205/dgkh000154; Lee SM, 2007, ANTIMICROB AGENTS CH, V51, P1497, DOI 10.1128/AAC.01239-06; Linde H, 2005, EUR J CLIN MICROBIOL, V24, P419, DOI 10.1007/s10096-005-1341-7; Ma XX, 2006, J CLIN MICROBIOL, V44, P4515, DOI 10.1128/JCM.00985-06; Maier J, 2005, EUR J CLIN MICROBIOL, V24, P637, DOI 10.1007/s10096-005-0008-8; Melter O, 1999, J CLIN MICROBIOL, V37, P2798, DOI 10.1128/JCM.37.9.2798-2803.1999; Melter O, 2003, J CLIN MICROBIOL, V41, P4998, DOI 10.1128/JCM.41.11.4998-5005.2003; Miragaia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007722; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2006, CLIN MICROBIOL INFEC, V12, P718, DOI 10.1111/j.1469-0691.2006.01420.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Otter JA, 2009, EUR J CLIN MICROBIOL, V28, P835, DOI 10.1007/s10096-008-0698-9; Panton PN, 1932, LANCET, V1, P506; Rossney AS, 2006, EUR J CLIN MICROBIOL, V25, P79, DOI 10.1007/s10096-006-0091-5; Scicluna EA, 2010, EUR J CLIN MICROBIOL, V29, P163, DOI 10.1007/s10096-009-0834-1; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; Shore AC, 2010, J CLIN MICROBIOL, V48, P1839, DOI 10.1128/JCM.02155-09; Smyth DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008582; Tavares DA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-110; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Tenover FC, 2008, J CLIN MICROBIOL, V46, P2837, DOI 10.1128/JCM.00480-08; Tokajian ST, 2010, EPIDEMIOL INFECT, V138, P707, DOI 10.1017/S0950268810000440; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; Udo EE, 2008, J CLIN MICROBIOL, V46, P3514, DOI 10.1128/JCM.00966-08; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; VANDEVELDE H, 1894, CELLULE, V10, P401; Velazquez-Meza ME, 2004, J CLIN MICROBIOL, V42, P3877, DOI 10.1128/JCM.42.8.3877-3880.2004; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Vourli S, 2005, Euro Surveill, V10, P78; Walther B, 2009, J CLIN MICROBIOL, V47, P704, DOI 10.1128/JCM.01626-08; Witte W, 2000, Euro Surveill, V5, P31; Witte W, 2001, INT J MED MICROBIOL, V290, P677, DOI 10.1016/S1438-4221(01)80006-0; Witte W, 1997, Euro Surveill, V2, P25; WITTE W, 2000, BUNDESGESUNDHEITSBLA, V43, P633; Witte W, 2005, EPIDEMIOLOGISCHES B, P376	72	42	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28189	10.1371/journal.pone.0028189	http://dx.doi.org/10.1371/journal.pone.0028189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140542	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100048
J	Jiang, YS; Zhang, RJ; Sun, P; Tang, GP; Zhang, XH; Wang, X; Guo, XD; Wang, QY; Li, X				Jiang, Yongshuai; Zhang, Ruijie; Sun, Peng; Tang, Guoping; Zhang, Xuehong; Wang, Xing; Guo, Xiaodan; Wang, Qiuyu; Li, Xia			Identifying Highly Conserved and Highly Differentiated Gene Ontology Categories in Human Populations	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; DEMOGRAPHIC HISTORY; TAGSNP TRANSFERABILITY; SIGNAL-TRANSDUCTION; KYOTO ENCYCLOPEDIA; HAPLOTYPE; SELECTION; RECOMBINATION	Detecting and interpreting certain system-level characteristics associated with human population genetic differences is a challenge for human geneticists. In this study, we conducted a population genetic study using the HapMap genotype data to identify certain special Gene Ontology (GO) categories associated with high/low genetic difference among 11 Hapmap populations. Initially, the genetic differences in each gene region among these populations were measured using allele frequency, linkage disequilibrium (LD) pattern, and transferability of tagSNPs. The associations between each GO term and these genetic differences were then identified. The results showed that cellular process, catalytic activity, binding, and some of their sub-terms were associated with high levels of genetic difference, and genes involved in these functional categories displayed, on average, high genetic diversity among different populations. By contrast, multicellular organismal processes, molecular transducer activity, and some of their sub-terms were associated with low levels of genetic difference. In particular, the neurological system process under the multicellular organismal process category had low levels of genetic difference; the neurological function also showed high evolutionary conservation between species in some previous studies. These results may provide a new insight into the understanding of human evolutionary history at the system-level.	[Jiang, Yongshuai; Zhang, Ruijie; Sun, Peng; Tang, Guoping; Zhang, Xuehong; Wang, Xing; Guo, Xiaodan; Wang, Qiuyu; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	Harbin Medical University	Jiang, YS (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	zhangruijie2009@yahoo.com.cn; lixia6@yahoo.com	li, xia/HHZ-7468-2022	Jiang, Yongshuai/0000-0002-7163-6554	National Natural Science Foundation of China [81172842, 30871394, 61170154]; Natural Science Foundation of Heilongjiang Province [F2008-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This work was supported in part by the National Natural Science Foundation of China (Grant nos. 81172842, 30871394, 61170154), Natural Science Foundation of Heilongjiang Province (Grant No. F2008-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], GO DATABASE; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Balaresque PL, 2007, HUM MOL GENET, V16, pR134, DOI 10.1093/hmg/ddm242; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blake J. A., 2008, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0702S23; Bowcock AM, 2007, NATURE, V447, P645, DOI 10.1038/447645a; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; De Bakker Paul I W, 2006, Pac Symp Biocomput, P478, DOI 10.1142/9789812701626_0044; De la Vega FM, 2005, GENOME RES, V15, P454, DOI 10.1101/gr.3241705; Du P, 2009, BIOINFORMATICS, V25, pI63, DOI 10.1093/bioinformatics/btp193; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Huang H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r47; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang HJ, 2005, NUCLEIC ACIDS RES, V33, pD518; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Lopez-Bigas N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r33; Lundmark PE, 2008, EUR J HUM GENET, V16, P1142, DOI 10.1038/ejhg.2008.77; Mahasirimongkol S, 2006, J HUM GENET, V51, P896, DOI 10.1007/s10038-006-0041-1; Marvelle AF, 2007, J HUM GENET, V52, P729, DOI 10.1007/s10038-007-0175-9; Mattson MP, 2002, MECH AGEING DEV, V123, P947, DOI 10.1016/S0047-6374(02)00032-5; Mizutani T, 2001, P NATL ACAD SCI USA, V98, P9026, DOI 10.1073/pnas.161269998; Mueller JC, 2005, AM J HUM GENET, V76, P387, DOI 10.1086/427925; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nakajima T, 2004, AM J HUM GENET, V74, P898, DOI 10.1086/420793; Nejentsev S, 2004, HUM MOL GENET, V13, P1633, DOI 10.1093/hmg/ddh169; Newton-Cheh C., 2009, NAT GENET, V41, P666, DOI [10.1038/ng.361, DOI 10.1038/NG.361]; Peng G, 2009, EUR J HUM GENET; Porst H, 2007, J SEX MED, V4, P372, DOI 10.1111/j.1743-6109.2006.00422.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Ribas G, 2006, HUM GENET, V118, P669, DOI 10.1007/s00439-005-0094-9; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Srivastava S, 2009, BMC P S7, V3, pS21; Walsh EC, 2006, HUM GENET, V119, P92, DOI 10.1007/s00439-005-0090-0; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Weedon MN, 2006, AM J HUM GENET, V79, P991, DOI 10.1086/509517; WELLS J A, 1992, Current Opinion in Biotechnology, V3, P355, DOI 10.1016/0958-1669(92)90163-D; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Xing JC, 2008, GENOMICS, V92, P41, DOI 10.1016/j.ygeno.2008.03.011; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	52	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27871	10.1371/journal.pone.0027871	http://dx.doi.org/10.1371/journal.pone.0027871			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140477	gold, Green Published, Green Submitted			2022-12-25	WOS:000298168100022
J	Ahn, HJ; Kim, KI; Kim, G; Moon, E; Yang, SS; Lee, JS				Ahn, Hak Jun; Kim, Kang Il; Kim, Geunyoung; Moon, Eunpyo; Yang, Sang Sik; Lee, Jong-Soo			Atmospheric-Pressure Plasma Jet Induces Apoptosis Involving Mitochondria via Generation of Free Radicals	PLOS ONE			English	Article							NITRIC-OXIDE; CELL-DEATH; MEMBRANE; PERMEABILIZATION; BCL-2; SKIN	The plasma jet has been proposed as a novel therapeutic method for anticancer treatment. However, its biological effects and mechanism of action remain elusive. Here, we investigated its cell death effects and underlying molecular mechanisms, using air and N2 plasma jets from a micro nozzle array. Treatment with air or N2 plasma jets caused apoptotic death in human cervical cancer HeLa cells, simultaneously with depolarization of mitochondrial membrane potential. In addition, the plasma jets were able to generate reactive oxygen species (ROS), which function as surrogate apoptotic signals by targeting the mitochondrial membrane potential. Antioxidants or caspase inhibitors ameliorated the apoptotic cell death induced by the air and N2 plasma jets, suggesting that the plasma jet may generate ROS as a proapoptotic cue, thus initiating mitochondria-mediated apoptosis. Taken together, our data suggest the potential employment of plasma jets as a novel therapy for cancer.	[Ahn, Hak Jun; Moon, Eunpyo; Lee, Jong-Soo] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, Gyounggi Do, South Korea; [Ahn, Hak Jun; Moon, Eunpyo; Lee, Jong-Soo] Ajou Univ, Dept Life Sci, Suwon 441749, Gyounggi Do, South Korea; [Kim, Kang Il; Kim, Geunyoung; Yang, Sang Sik] Ajou Univ, Dept Elect & Comp Engn, Suwon 441749, Gyounggi Do, South Korea	Ajou University; Ajou University; Ajou University	Ahn, HJ (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, Gyounggi Do, South Korea.	ssyang@ajou.ac.kr; jsjlee@ajou.ac.kr	Kim, Geunyoung/GQR-0665-2022; Kim, Kangil/F-2165-2013	Kim, Kangil/0000-0003-4790-7593	Ministry of Health and Welfare, Korea [1020210]; Korea National Research Foundation [313-2008-2-C00626, 2009-0074556, 2010-0018546]	Ministry of Health and Welfare, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea National Research Foundation(National Research Foundation of Korea)	This work was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Korea (1020210) and grants from the Korea National Research Foundation (313-2008-2-C00626, 2009-0074556, 2010-0018546), for data collection and analysis and preparation of the manuscript.	Ahn HJ, 2006, J CELL BIOCHEM, V99, P807, DOI 10.1002/jcb.20973; Ameisen JC, 2002, CELL DEATH DIFFER, V9, P367, DOI 10.1038/sj.cdd.4400950; Barros LF, 2003, CELL DEATH DIFFER, V10, P687, DOI 10.1038/sj.cdd.4401236; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; Brune B, 2003, CELL DEATH DIFFER, V10, P864, DOI 10.1038/sj.cdd.4401261; Cook SA, 1999, CIRC RES, V85, P940; Deng XT, 2007, J APPL PHYS, V101, DOI 10.1063/1.2717576; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P699, DOI 10.1006/bbrc.1999.1888; Franco R, 2007, J BIOL CHEM, V282, P30452, DOI 10.1074/jbc.M703091200; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Hong YC, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2400078; Jacotot E, 2001, J EXP MED, V193, P509, DOI 10.1084/jem.193.4.509; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kim GC, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/3/032005; Kim GJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3292206; Kim K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3555434; Kim K, 2010, MICROELECTRON ENG, V87, P1177, DOI 10.1016/j.mee.2009.12.045; Kolb JF, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2940325; Lee HJ, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115026; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Ptasinska S, 2010, PHYS CHEM CHEM PHYS, V12, P7779, DOI [10.1039/c001188f, 10.1039/e001188f]; Skulachev VP, 2006, APOPTOSIS, V11, P473, DOI 10.1007/s10495-006-5881-9; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Wang HW, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2975831; Yang J, 2008, FREE RADICAL RES, V42, P492, DOI 10.1080/10715760802112791; Zhang XH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2959735	27	248	251	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28154	10.1371/journal.pone.0028154	http://dx.doi.org/10.1371/journal.pone.0028154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140530	Green Published, gold, Green Submitted			2022-12-25	WOS:000298166300033
J	Carriere, C; Young, AL; Gunn, JR; Longnecker, DS; Korc, M				Carriere, Catherine; Young, Alison L.; Gunn, Jason R.; Longnecker, Daniel S.; Korc, Murray			Acute Pancreatitis Accelerates Initiation and Progression to Pancreatic Cancer in Mice Expressing Oncogenic Kras in the Nestin Cell Lineage	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; ACINAR-CELLS; DUCTAL ADENOCARCINOMA; GROWTH-FACTOR; RAS ACTIVITY; ADULT MICE; K-RAS; MOUSE; REGENERATION; PRECURSORS	Targeting of oncogenic Kras to the pancreatic Nestin-expressing embryonic progenitor cells and subsequently to the adult acinar compartment and Nestin-expressing cells is sufficient for the development of low grade pancreatic intraepithelial neoplasia (PanIN) between 2 and 4 months. The mice die around 6 month-old of unrelated causes, and it is therefore not possible to assess whether the lesions will progress to carcinoma. We now report that two brief episodes of caerulein-induced acute pancreatitis in 2 month-old mice causes rapid PanIN progression and pancreatic ductal adenocarcinoma (PDAC) development by 4 months of age. These events occur with similar frequency as observed in animals where the oncogene is targeted during embryogenesis to all pancreatic cell types. Thus, these data show that oncogenic Kras-driven PanIN originating in a non-ductal compartment can rapidly progress to PDAC when subjected to a brief inflammatory insult.	[Carriere, Catherine; Young, Alison L.; Gunn, Jason R.; Korc, Murray] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA; [Longnecker, Daniel S.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pathol, Hanover, NH 03756 USA; [Korc, Murray] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03756 USA; [Carriere, Catherine; Korc, Murray] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Carriere, C (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA.	Carriere@Dartmouth.edu			National Cancer Institute [CA- R37-075059, CA-127095]; Lustgarten Foundation for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [R37CA075059, R21CA127095] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lustgarten Foundation for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from: The National Cancer Institute: CA- R37-075059 to Murray Korc and CA- 127095 to Catherine Carriere; The Lustgarten Foundation for Pancreatic Cancer Research to Catherine Carriere. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Blaine SA, 2010, DEVELOPMENT, V137, P2289, DOI 10.1242/dev.048421; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carriere C, 2007, P NATL ACAD SCI USA, V104, P4437, DOI 10.1073/pnas.0701117104; Carriere C, 2009, BIOCHEM BIOPH RES CO, V382, P561, DOI 10.1016/j.bbrc.2009.03.068; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Ebert M, 1999, PANCREAS, V18, P240, DOI 10.1097/00006676-199904000-00004; Esni F, 2004, MECH DEVELOP, V121, P15, DOI 10.1016/j.mod.2003.08.010; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2005, METH MOLEC MED, V103, P1; Ishiwata T, 2006, PANCREAS, V32, P360, DOI 10.1097/01.mpa.0000220860.01120.21; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Logsdon CD, 2009, CLIN GASTROENTEROL H, V7, pS40, DOI 10.1016/j.cgh.2009.07.040; Lowenfels AB, 2006, BEST PRACT RES CL GA, V20, P197, DOI 10.1016/j.bpg.2005.10.001; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Neuschwander-Tetri BA, 2000, DIGEST DIS SCI, V45, P665, DOI 10.1023/A:1005423122127; Ray KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016786; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tuveson DA, 2005, COLD SH Q B, V70, P65, DOI 10.1101/sqb.2005.70.040; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; WILLEMER S, 1992, EUR SURG RES, V24, P29, DOI 10.1159/000129237; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	35	48	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27725	10.1371/journal.pone.0027725	http://dx.doi.org/10.1371/journal.pone.0027725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140463	Green Submitted, Green Published, gold			2022-12-25	WOS:000298163400016
J	Dublineau, A; Batejat, C; Pinon, A; Burguiere, AM; Leclercq, I; Manuguerra, JC				Dublineau, Amelie; Batejat, Christophe; Pinon, Anthony; Burguiere, Ana Maria; Leclercq, India; Manuguerra, Jean-Claude			Persistence of the 2009 Pandemic Influenza A (H1N1) Virus in Water and on Non-Porous Surface	PLOS ONE			English	Article							SURVIVAL; TRANSMISSION; INACTIVATION	Knowledge of influenza A virus survival in different environmental conditions is a key element for the implementation of hygiene and personal protection measures by health authorities. As it is dependent on virus isolates even within the same subtype, we studied the survival of the 2009 H1N1 pandemic (H1N1pdm) virus in water and on non-porous surface. The H1N1pdm virus was subjected to various environmental parameters over time and tested for infectivity. In water, at low and medium salinity levels and 4 degrees C, virus survived at least 200 days. Increasing temperature and salinity had a strong negative effect on the survival of the virus which remained infectious no more than 1 day at 35 degrees C and 270 parts per thousand (ppt) of salt. Based on modeled data, the H1N1pdm virus retained its infectivity on smooth non-porous surface for at least 7 days at 35 degrees C and up to 66 days at 4 degrees C. The H1N1pdm virus has thus the ability to persist in water and on glass surface for extended periods of time, even at 35 degrees C. Additional experiments suggest that external viral structures in direct contact with the environment are mostly involved in loss of virus infectivity.	[Dublineau, Amelie; Batejat, Christophe; Burguiere, Ana Maria; Leclercq, India; Manuguerra, Jean-Claude] Inst Pasteur, Lab Urgent Response Biol Threats, Paris, France; [Pinon, Anthony] Inst Pasteur, Microbiol Safety Unit, F-59019 Lille, France; [Leclercq, India] Univ Paris Diderot, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; UDICE-French Research Universities; Universite Paris Cite	Dublineau, A (corresponding author), Inst Pasteur, Lab Urgent Response Biol Threats, Paris, France.	jean-claude.manuguerra@pasteur.fr		Batejat, Christophe/0000-0002-2344-5710; Pinon, Anthony/0000-0001-7048-3085	European Union [SSP-5-B-INFLUENZA 04 405]; BNP-Paribas	European Union(European Commission); BNP-Paribas	This study was supported by the European Union funded RIVERS program (Sixth Framework Program SSP-5-B-INFLUENZA 04 405: Resistance of Influenza Viruses in Environmental Reservoirs and Systems: http://cordis.europa.eu/fp6). The authors are grateful to BNP-Paribas and its foundation (http://mecenat.bnpparibas.com/) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Davidson I, 2010, AVIAN DIS, V54, P725, DOI 10.1637/8736-032509-ResNote.1; De Benedictis P, 2007, ZOONOSES PUBLIC HLTH, V54, P51, DOI 10.1111/j.1863-2378.2007.01029.x; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Graiver DA, 2009, ENVIRON SCI TECHNOL, V43, P4063, DOI 10.1021/es900370x; HINSHAW VS, 1979, INTERVIROLOGY, V11, P66, DOI 10.1159/000149014; Muench H, 1938, AM J HYG, V27; Negovetich NJ, J VIROL; Noyce JO, 2007, APPL ENVIRON MICROB, V73, P2748, DOI 10.1128/AEM.01139-06; Shahid MA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-38; Stallknecht DE, 2009, REV SCI TECH OIE, V28, P59; Stallknecht DE, 2010, AVIAN DIS, V54, P461, DOI 10.1637/8760-033109-Reg.1; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Thomas Y, 2008, APPL ENV MICROBIOL; Tiwari A, 2006, AVIAN DIS, V50, P284, DOI 10.1637/7453-101205R.1; Wood JP, 2010, ENVIRON SCI TECHNOL, V44, P7515, DOI 10.1021/es1016153; Zhou HB, 2011, EMERG INFECT DIS, V17, P1757, DOI 10.3201/eid1709.101916	21	40	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28043	10.1371/journal.pone.0028043	http://dx.doi.org/10.1371/journal.pone.0028043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132205	Green Submitted, Green Published, gold			2022-12-25	WOS:000298162000061
J	Pandey, R; Blanco, J; Udolph, G				Pandey, Rahul; Blanco, Jorge; Udolph, Gerald			The Glucuronyltransferase GlcAT-P Is Required for Stretch Growth of Peripheral Nerves in Drosophila	PLOS ONE			English	Article							HNK-1 CARBOHYDRATE EPITOPE; MYELIN-ASSOCIATED GLYCOPROTEIN; CELL-ADHESION MOLECULES; PROTEIN LINKAGE REGION; NERVOUS-SYSTEM; CYTOSKELETAL DYNAMICS; EXTRACELLULAR-MATRIX; L2/HNK-1 CARBOHYDRATE; MICROTUBULE DYNAMICS; AXON OUTGROWTH	During development, the growth of the animal body is accompanied by a concomitant elongation of the peripheral nerves, which requires the elongation of integrated nerve fibers and the axons projecting therein. Although this process is of fundamental importance to almost all organisms of the animal kingdom, very little is known about the mechanisms regulating this process. Here, we describe the identification and characterization of novel mutant alleles of GlcAT-P, the Drosophila ortholog of the mammalian glucuronyltransferase b3gat1. GlcAT-P mutants reveal shorter larval peripheral nerves and an elongated ventral nerve cord (VNC). We show that GlcAT-P is expressed in a subset of neurons in the central brain hemispheres, in some motoneurons of the ventral nerve cord as well as in central and peripheral nerve glia. We demonstrate that in GlcAT-P mutants the VNC is under tension of shorter peripheral nerves suggesting that the VNC elongates as a consequence of tension imparted by retarded peripheral nerve growth during larval development. We also provide evidence that for growth of peripheral nerve fibers GlcAT-P is critically required in hemocytes; however, glial cells are also important in this process. The glial specific repo gene acts as a modifier of GlcAT-P and loss or reduction of repo function in a GlcAT-P mutant background enhances VNC elongation. We propose a model in which hemocytes are required for aspects of glial cell biology which in turn affects the elongation of peripheral nerves during larval development. Our data also identifies GlcAT-P as a first candidate gene involved in growth of integrated peripheral nerves and therefore establishes Drosophila as an amenable in-vivo model system to study this process at the cellular and molecular level in more detail.	[Pandey, Rahul; Blanco, Jorge; Udolph, Gerald] Inst Med Biol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Pandey, R (corresponding author), Inst Med Biol, Singapore, Singapore.	gerald.udolph@gmail.com			Institute of Medical Biology; NICHD	Institute of Medical Biology(Agency for Science Technology & Research (A*STAR)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the Institute of Medical Biology. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the mansucript.; We thank R. White, J. Casanova, F. Matsuzaki and S. Oka for antibodies and S. Luschnig for flies. The Elav, Repo, Nrt, Antp and AbdB monoclonal antibodies developed by G. M. Rubin, C. Goodman, D. Brower and S. Celniker, respectively, were obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242. The Bloomington Drosophila Stock Center resources contributed to this work and FlyBase provided important information used in this work. We are grateful to C. Lehner, X.H. Yang, B. Reversade and B. Knowles for critical comments on the manuscript.	AKAM M, 1987, DEVELOPMENT, V101, P1; Anzai D, 2009, GLYCOBIOLOGY, V19, P868, DOI 10.1093/glycob/cwp060; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Bannister J, 1996, ACTION PLAN AUSTR CE; Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9; Bernal R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.018301; BOLLENSEN E, 1987, NEUROSCI LETT, V82, P77, DOI 10.1016/0304-3940(87)90174-1; Breloy I, 2008, FEBS LETT, V582, P1593, DOI 10.1016/j.febslet.2008.04.003; Broadie K, 2011, DEV NEUROBIOL; Chang SH, 1998, J NEUROSCI, V18, P821; Chetta J, 2010, CYTOSKELETON, V67, P650, DOI 10.1002/cm.20478; Chou TB, 1996, GENETICS, V144, P1673; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Dagg AI, 1982, GIRAFFE ITS BIOL BEH; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Edenfeld G, 2005, CURR OPIN NEUROBIOL, V15, P34, DOI 10.1016/j.conb.2005.01.007; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; HALTER DA, 1995, DEVELOPMENT, V121, P317; Hummel T, 2000, GENE DEV, V14, P863; Imiya K, 2002, GENE, V296, P29, DOI 10.1016/S0378-1119(02)00840-5; Inoue M, 2007, BRAIN RES, V1179, P1, DOI 10.1016/j.brainres.2007.05.012; Jeffries AR, 2003, MOL PSYCHIATR, V8, P654, DOI 10.1038/sj.mp.4001382; Kakuda S, 2005, GLYCOBIOLOGY, V15, P203, DOI 10.1093/glycob/cwi001; Kakuda S, 2004, PROTEIN EXPRES PURIF, V35, P111, DOI 10.1016/j.pep.2003.12.021; Kim BT, 2003, J BIOL CHEM, V278, P9116, DOI 10.1074/jbc.M209344200; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kizuka Y, 2009, J BIOL CHEM, V284, P9247, DOI 10.1074/jbc.M807517200; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; KNIBIEHLER M, 1987, FEBS LETT, V216, P183, DOI 10.1016/0014-5793(87)80686-5; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; LaJeunesse DR, 2004, BIOTECHNIQUES, V36, P784, DOI 10.2144/04365ST01; Lamoureux P, 2010, DEV NEUROBIOL, V70, P135, DOI 10.1002/dneu.20764; Lee AC, 2008, DEV NEUROBIOL, V68, P1363, DOI 10.1002/dneu.20662; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Lin YR, 2008, DEV DYNAM, V237, P3703, DOI 10.1002/dvdy.21775; MARTINI R, 1992, EUR J NEUROSCI, V4, P628, DOI 10.1111/j.1460-9568.1992.tb00171.x; MCGARRY RC, 1983, NATURE, V306, P376, DOI 10.1038/306376a0; Miller KE, 2006, J CELL BIOL, V173, P373, DOI 10.1083/jcb.200510097; MIRRE C, 1988, DEVELOPMENT, V102, P369; Morita I, 2008, J BIOCHEM, V143, P719, DOI 10.1093/jb/mvm221; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Myers JP, 2011, DEV NEUROBIOL; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; OKA S, 1992, J BIOL CHEM, V267, P22711; Olofsson B, 2005, DEV BIOL, V279, P233, DOI 10.1016/j.ydbio.2004.12.020; Ozoka VC, 2011, J NEUROTRAUMA; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006; Rodrigues F, 2011, CELL MOL LIFE SCI, V68, P55, DOI 10.1007/s00018-010-0512-6; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Sanchez-Soriano N, 2010, DEV NEUROBIOL, V70, P58, DOI 10.1002/dneu.20762; SAUDOU F, 1992, EMBO J, V11, P7, DOI 10.1002/j.1460-2075.1992.tb05021.x; Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Schweitzer J, 2005, DEV DYNAM, V234, P550, DOI 10.1002/dvdy.20525; Seiki T, 1999, BIOCHEM BIOPH RES CO, V255, P182, DOI 10.1006/bbrc.1999.0151; SHASHOUA VE, 1986, J NEUROCHEM, V47, P738; Siddiqui S, 2008, NEURON GLIA BIOL, V4, P271, DOI 10.1017/S1740925X09990020; Smith DH, 2009, PROG NEUROBIOL, V89, P231, DOI 10.1016/j.pneurobio.2009.07.006; STAEHLINGHAMPTON K, 1994, DEV BIOL, V164, P502, DOI 10.1006/dbio.1994.1219; Sun BH, 1999, P NATL ACAD SCI USA, V96, P10438, DOI 10.1073/pnas.96.18.10438; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Udolph G, 2009, DEV BIOL, V336, P156, DOI 10.1016/j.ydbio.2009.09.030; Uusitalo M, 2001, PROG RETIN EYE RES, V20, P1, DOI 10.1016/S1350-9462(00)00018-5; Venken KJT, 2005, NAT REV GENET, V6, P167, DOI 10.1038/nrg1553; Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486; WEISS P, 1941, GROWTH             S, V5, P163; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yu Robert K., 2006, CNS & Neurological Disorders-Drug Targets, V5, P415, DOI 10.2174/187152706777950675; Yuasa Y, 2003, DEVELOPMENT, V130, P2419, DOI 10.1242/dev.00468	78	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28106	10.1371/journal.pone.0028106	http://dx.doi.org/10.1371/journal.pone.0028106			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132223	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000073
J	Sterrenburg, L; Gaszner, B; Boerrigter, J; Santbergen, L; Bramini, M; Elliott, E; Chen, A; Peeters, BWMM; Roubos, EW; Kozicz, T				Sterrenburg, Linda; Gaszner, Balazs; Boerrigter, Jeroen; Santbergen, Lennart; Bramini, Mattia; Elliott, Evan; Chen, Alon; Peeters, Bernard W. M. M.; Roubos, Eric W.; Kozicz, Tamas			Chronic Stress Induces Sex-Specific Alterations in Methylation and Expression of Corticotropin-Releasing Factor Gene in the Rat	PLOS ONE			English	Article							EDINGER-WESTPHAL NUCLEUS; CHRONIC MILD STRESS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MESSENGER-RNA LEVELS; STRIA TERMINALIS; BED NUCLEUS; SOCIAL STRESS; DELTA-FOSB; IMMUNOREACTIVE NEURONS; TYROSINE-HYDROXYLASE	Background: Although the higher prevalence of depression in women than in men is well known, the neuronal basis of this sex difference is largely elusive. Methods: Male and female rats were exposed to chronic variable mild stress (CVMS) after which immediate early gene products, corticotropin-releasing factor (CRF) mRNA and peptide, various epigenetic-associated enzymes and DNA methylation of the Crf gene were determined in the hypothalamic paraventricular nucleus (PVN), oval (BSTov) and fusiform (BSTfu) parts of the bed nucleus of the stria terminalis, and central amygdala (CeA). Results: CVMS induced site-specific changes in Crf gene methylation in all brain centers studied in female rats and in the male BST and CeA, whereas the histone acetyltransferase, CREB-binding protein was increased in the female BST and the histone-deacetylase-5 decreased in the male CeA. These changes were accompanied by an increased amount of c-Fos in the PVN, BSTfu and CeA in males, and of FosB in the PVN of both sexes and in the male BSTov and BSTfu. In the PVN, CVMS increased CRF mRNA in males and CRF peptide decreased in females. Conclusions: The data confirm our hypothesis that chronic stress affects gene expression and CRF transcriptional, translational and secretory activities in the PVN, BSTov, BSTfu and CeA, in a brain center-specific and sex-specific manner. Brain region-specific and sex-specific changes in epigenetic activity and neuronal activation may play, too, an important role in the sex specificity of the stress response and the susceptibility to depression.	[Sterrenburg, Linda; Boerrigter, Jeroen; Santbergen, Lennart; Bramini, Mattia; Peeters, Bernard W. M. M.; Roubos, Eric W.; Kozicz, Tamas] Radboud Univ Nijmegen, Dept Cellular Anim Physiol, Donders Inst Brain Cognit & Behav, Ctr Neurosci, NL-6525 ED Nijmegen, Netherlands; [Gaszner, Balazs] Univ Pecs, Dept Anat, Pecs, Hungary; [Elliott, Evan; Chen, Alon] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Elliott, Evan] Bar Ilan Univ, Fac Med, Safed, Israel	Radboud University Nijmegen; University of Pecs; Weizmann Institute of Science; Bar Ilan University	Sterrenburg, L (corresponding author), Radboud Univ Nijmegen, Dept Cellular Anim Physiol, Donders Inst Brain Cognit & Behav, Ctr Neurosci, NL-6525 ED Nijmegen, Netherlands.	t.kozicz@science.ru.nl	Kozicz, Tamas/N-5154-2014; Kozicz, Tamas/G-3161-2012; Bramini, Mattia/Q-6130-2016; Roubos, Eric W/D-1912-2010; Gaszner, Balázs/AAL-5382-2020	Kozicz, Tamas/0000-0001-6915-4364; Kozicz, Tamas/0000-0001-6915-4364; Bramini, Mattia/0000-0002-0381-9391; Gaszner, Balázs/0000-0003-2830-2732; Chen, Alon/0000-0003-3625-8233; Elliott, Evan/0000-0002-1630-969X	Netherlands Organization for Scientific Research [864.05.008]; MSD (Merck Sharp Dohme); Oss; EU; Hungarian Academy of Sciences; Pecs University [PTE KA-34039/10-8]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); MSD (Merck Sharp Dohme); Oss; EU(European Commission); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Pecs University	This study was supported by grants from the Netherlands Organization for Scientific Research (#864.05.008) to TK, from MSD (Merck Sharp & Dohme), Oss to L. Sterrenburg, and by an EU ERASMUS grant to MB. BG was supported by the "Bolyai Janos" Scholarschip of the Hungarian Academy of Sciences and by the research grant of Pecs University no: PTE KA-34039/10-8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck DS, 1997, J NEUROSCI, V17, P4895; Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001; Bale TL, 2006, HORM BEHAV, V50, P529, DOI 10.1016/j.yhbeh.2006.06.033; Barha C.K., 2010, HIPPOCAMPUS; CAREY MP, 1995, J ENDOCRINOL, V144, P311, DOI 10.1677/joe.0.1440311; CHAPPELL PB, 1986, J NEUROSCI, V6, P2908; Choi DC, 2008, PSYCHONEUROENDOCRINO, V33, P659, DOI 10.1016/j.psyneuen.2008.02.006; Choi DC, 2007, J NEUROSCI, V27, P2025, DOI 10.1523/JNEUROSCI.4301-06.2007; Csaki A, 2000, NEUROSCIENCE, V101, P637, DOI 10.1016/S0306-4522(00)00411-5; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Day HEW, 1999, J COMP NEUROL, V413, P113; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Derks NM, 2008, NEUROSCIENCE, V156, P305, DOI 10.1016/j.neuroscience.2008.07.047; Derks NM, 2007, GEN COMP ENDOCR, V153, P228, DOI 10.1016/j.ygcen.2007.04.009; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; Duncko R, 2001, PSYCHONEUROENDOCRINO, V26, P77, DOI 10.1016/S0306-4530(00)00040-8; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Forray MI, 2004, BRAIN RES REV, V47, P145, DOI 10.1016/j.brainresrev.2004.07.011; Gaszner B, 2009, STRESS, V12, P115, DOI 10.1080/10253890802057221; Gaszner B, 2004, J COMP NEUROL, V480, P170, DOI 10.1002/cne.20343; Gorka Z, 1996, PHARMACOL BIOCHEM BE, V54, P229, DOI 10.1016/0091-3057(95)02173-6; Gorman Jack M, 2006, Gend Med, V3, P93, DOI 10.1016/S1550-8579(06)80199-3; GRAY TS, 1993, ANN NY ACAD SCI, V697, P53, DOI 10.1111/j.1749-6632.1993.tb49922.x; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; HERMAN JP, 1994, J NEUROENDOCRINOL, V6, P433, DOI 10.1111/j.1365-2826.1994.tb00604.x; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Jozsa R, 2005, BIOMED PHARMACOTHER, V59, pS109, DOI 10.1016/S0753-3322(05)80018-6; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; Kim HR, 2007, J IMMUNOL, V178, P5473, DOI 10.4049/jimmunol.178.9.5473; Kim SJ, 2006, NEUROPHARMACOLOGY, V50, P824, DOI 10.1016/j.neuropharm.2005.12.003; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Kozicz T, 2008, PSYCHONEUROENDOCRINO, V33, P741, DOI 10.1016/j.psyneuen.2008.02.012; Kozicz T, 2002, EUR J NEUROSCI, V16, P823, DOI 10.1046/j.1460-9568.2002.02129.x; Kozicz T, 1997, BRAIN RES, V767, P109, DOI 10.1016/S0006-8993(97)00737-3; Kuipers SD, 2006, NEUROPHARMACOLOGY, V50, P428, DOI 10.1016/j.neuropharm.2005.10.006; Lamont Elaine Waddington, 2007, Dialogues Clin Neurosci, V9, P333; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Marcus SM, 2005, J AFFECT DISORDERS, V87, P141, DOI 10.1016/j.jad.2004.09.008; Marin MT, 2007, PHYSIOL BEHAV, V90, P29, DOI 10.1016/j.physbeh.2006.08.021; Martinez M, 1998, EUR J NEUROSCI, V10, P20, DOI 10.1046/j.1460-9568.1998.00011.x; MERCHENTHALER I, 1982, AM J ANAT, V165, P385, DOI 10.1002/aja.1001650404; Morin SM, 1999, NEUROSCIENCE, V92, P281, DOI 10.1016/S0306-4522(98)00732-5; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nestler EJ, 1999, BRAIN RES, V835, P10, DOI 10.1016/S0006-8993(98)01191-3; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Neufeld-Cohen A, 2010, MOL PSYCHIATR, V15, P426, DOI 10.1038/mp.2009.115; Nock MK, 2010, MOL PSYCHIATR, V15, P868, DOI 10.1038/mp.2009.29; Parihar VK, 2011, MOL PSYCHIATR, V16, P171, DOI 10.1038/mp.2009.130; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; RAADSHEER FC, 1995, AM J PSYCHIAT, V152, P1372; RAADSHEER FC, 1994, NEUROENDOCRINOLOGY, V60, P436, DOI 10.1159/000126778; REGEV L, 2010, MOL PSYCHIAT; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Reul JMHM, 2002, CURR OPIN PHARMACOL, V2, P23, DOI 10.1016/S1471-4892(01)00117-5; Rouwette TPH, 2010, J PAIN, V11, P930, DOI 10.1016/j.jpain.2009.12.017; SARACCI R, 1969, LANCET, V1, P416; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Snedecor GW, 1989, STAT METHODS, VEighth, P503; STERRENBURG L, 2011, J NEUROSCI IN PRESS; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; Tafet GE, 2003, PROG NEURO-PSYCHOPH, V27, P893, DOI 10.1016/S0278-5846(03)00162-3; Takkinen S, 2004, AGING MENT HEALTH, V8, P187, DOI 10.1080/13607860410001669714; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VanElzakker M, 2008, LEARN MEMORY, V15, P899, DOI 10.1101/lm.1196508; Verma P, 2010, PHYSIOL BEHAV, V99, P276, DOI 10.1016/j.physbeh.2009.11.002; VIAU V, 1991, ENDOCRINOLOGY, V129, P2503, DOI 10.1210/endo-129-5-2503; Viau V, 2002, J COMP NEUROL, V445, P293, DOI 10.1002/cne.10178; Walker DL, 2008, BRAIN STRUCT FUNCT, V213, P29, DOI 10.1007/s00429-008-0183-3; Walker DL, 2003, EUR J PHARMACOL, V463, P199, DOI 10.1016/S0014-2999(03)01282-2; Westenbroek C, 2003, NEUROSCIENCE, V121, P189, DOI 10.1016/S0306-4522(03)00367-1; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Xu L, 2010, NEUROSCIENCE, V170, P478, DOI 10.1016/j.neuroscience.2010.07.001; Yao M, 2007, ENDOCRINOLOGY, V148, P2518, DOI 10.1210/en.2006-1413; ZHOU JN, 1995, NATURE, V378, P68, DOI 10.1038/378068a0	76	113	115	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28128	10.1371/journal.pone.0028128	http://dx.doi.org/10.1371/journal.pone.0028128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132228	Green Published, gold			2022-12-25	WOS:000298162000077
J	Gu, QQ; Jin, NN; Sheng, HZ; Yin, XM; Zhu, JH				Gu, Qingqing; Jin, Nana; Sheng, Hongzhuan; Yin, Xiaomin; Zhu, Jianhua			Cyclic AMP-Dependent Protein Kinase A Regulates the Alternative Splicing of CaMKII delta	PLOS ONE			English	Article							HEART-FAILURE; BETA(1)-ADRENERGIC RECEPTOR; DIFFERENTIAL EXPRESSION; DILATED CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; TRANSGENIC MICE; PHOSPHORYLATION; ISOFORMS; IDENTIFICATION; INHIBITION	Ca(2+)/calmodulin-dependent protein kinase (CaMK) II delta is predominantly expressed in the heart. There are three isoforms of CaMKII delta resulting from the alternative splicing of exons 14, 15, and 16 of its pre-mRNA, which is regulated by the splicing factor SF2/ASF. Inclusion of exons 15 and 16 or of exon 14 generates delta A or delta B isoform. The exclusion of all three exons gives rise to delta C isoform, which is selectively increased in pressure-overload-induced hypertrophy. Overexpression of either delta B or delta C induces hypertrophy and heart failure, suggesting their specific role in the pathogenesis of hypertrophy and heart failure. It is well known that the beta-adrenergic-cyclic AMP-dependent protein kinase A (PKA) pathway is implicated in heart failure. To determine the role of PKA in the alternative splicing of CaMKII delta, we constructed mini-CaMKII delta genes and used these genes to investigate the regulation of the alternative splicing of CaMKII delta by PKA in cultured cells. We found that PKA promoted the exclusion of exons 14, 15, and 16 of CaMKII delta, resulting in an increase in delta C isoform. PKA interacted with and phosphorylated SF2/ASF, and enhanced SF2/ASF's activity to promote the exclusion of exons 14, 15, and 16 of CaMKII delta, leading to a further increase in the expression of delta C isoform. These findings suggest that abnormality in beta-adrenergic-PKA signaling may contribute to cardiomyopathy and heart failure through dysregulation in the alternative splicing of CaMKII delta exons 14, 15, and 16 and up-regulation of CaMKII delta C.	[Gu, Qingqing; Sheng, Hongzhuan; Zhu, Jianhua] Nantong Univ, Affiliated Hosp, Dept Cardiol, Nantong, Jiangsu, Peoples R China; [Jin, Nana; Yin, Xiaomin] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University	Gu, QQ (corresponding author), Nantong Univ, Affiliated Hosp, Dept Cardiol, Nantong, Jiangsu, Peoples R China.	jhz323@yahoo.com.cn			National Natural Science Foundation of China [30971223, 30971224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (30971223 and 30971224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Bisognano JD, 2000, J MOL CELL CARDIOL, V32, P817, DOI 10.1006/jmcc.2000.1123; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Colomer JM, 2003, MOL ENDOCRINOL, V17, P183, DOI 10.1210/me.2002-0350; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Hoch B, 1999, CIRC RES, V84, P713, DOI 10.1161/01.RES.84.6.713; Kirchhefer U, 1999, CARDIOVASC RES, V42, P254, DOI 10.1016/S0008-6363(98)00296-X; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; PACKER M, 1987, J AM COLL CARDIOL, V10, P837, DOI 10.1016/S0735-1097(87)80278-4; Peng W, 2010, CIRC RES, V106, P102, DOI 10.1161/CIRCRESAHA.109.210914; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Shi JH, 2011, J BIOL CHEM, V286, P14639, DOI 10.1074/jbc.M110.204453; SHUNTOH H, 1992, BIOCHIM BIOPHYS ACTA, V1131, P175, DOI 10.1016/0167-4781(92)90073-9; Tombes RM, 2003, GENE, V322, P17, DOI 10.1016/j.gene.2003.08.023; Wu YJ, 2006, J MOL CELL CARDIOL, V40, P213, DOI 10.1016/j.yjmcc.2005.11.005; Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7; XIAO RP, 1994, P NATL ACAD SCI USA, V91, P9659, DOI 10.1073/pnas.91.20.9659; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yang DM, 2003, CIRC RES, V92, P659, DOI 10.1161/01.RES.0000064566.91495.0C; Zhang L, 2002, BIOCHEM J, V368, P145, DOI 10.1042/BJ20020780; Zhang Q, 2003, EUR J PHARMACOL, V467, P145, DOI 10.1016/S0014-2999(03)01567-X; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhang ZS, 2005, J PHARMACOL EXP THER, V315, P1203, DOI 10.1124/jpet.105.089672; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326	28	7	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e25745	10.1371/journal.pone.0025745	http://dx.doi.org/10.1371/journal.pone.0025745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132070	Green Published, Green Submitted, gold			2022-12-25	WOS:000297792400001
J	Kato, Y; Muramatsu, T; Kato, M; Shibukawa, Y; Shintani, M; Mimura, M				Kato, Yutaka; Muramatsu, Taro; Kato, Motoichiro; Shibukawa, Yoshiyuki; Shintani, Masuro; Mimura, Masaru			Magnetoencephalography Study of Right Parietal Lobe Dysfunction of the Evoked Mirror Neuron System in Antipsychotic-Free Schizophrenia	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SOCIAL COGNITION; PREMOTOR CORTEX; HUMAN BRAIN; EEG; RECOGNITION; ATTENTION; AGENCY; MIND; SYNCHRONIZATION	Introduction: Patients with schizophrenia commonly exhibit deficits of non-verbal communication in social contexts, which may be related to cognitive dysfunction that impairs recognition of biological motion. Although perception of biological motion is known to be mediated by the mirror neuron system, there have been few empirical studies of this system in patients with schizophrenia. Methods: Using magnetoencephalography, we examined whether antipsychotic-free schizophrenia patients displayed mirror neuron system dysfunction during observation of biological motion (jaw movement of another individual). Results: Compared with normal controls, the patients with schizophrenia had fewer components of both the waveform and equivalent current dipole, suggesting aberrant brain activity resulting from dysfunction of the right inferior parietal cortex. They also lacked the changes of alpha band and gamma band oscillation seen in normal controls, and had weaker phase-locking factors and gamma-synchronization predominantly in right parietal cortex. Conclusions: Our findings demonstrate that untreated patients with schizophrenia exhibit aberrant mirror neuron system function based on the right inferior parietal cortex, which is characterized by dysfunction of gamma-synchronization in the right parietal lobe during observation of biological motion.	[Kato, Yutaka; Muramatsu, Taro; Kato, Motoichiro; Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Kato, Yutaka; Kato, Motoichiro; Shibukawa, Yoshiyuki; Shintani, Masuro] Tokyo Dent Coll, Brain Res Lab, Oral Hlth Sci Ctr, Chiba, Japan; [Shibukawa, Yoshiyuki] Tokyo Dent Coll, Dept Physiol, Chiba, Japan	Keio University; Tokyo Dental College; Tokyo Dental College	Kato, Y (corresponding author), Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan.	yutaka-k@db3.so-net.ne.jp	Kato, Yutaka/Q-7706-2019	Kato, Yutaka/0000-0001-7622-5001	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [HRC6A02];  [23120009]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by a grant (HRC6A02) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to M.K. and by a Grant-in-Aid for Scientific Research on Innovative Areas: Prediction and Decision Making (23120009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHONEN AI, 1993, PHYS SCRIPTA, VT49A, P198, DOI 10.1088/0031-8949/1993/T49A/033; Aichhorn M, 2009, J COGNITIVE NEUROSCI, V21, P1179, DOI 10.1162/jocn.2009.21082; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andreasen NC, 2008, SCHIZOPHRENIA BULL, V34, P708, DOI 10.1093/schbul/sbn034; Bauer M, 2006, J NEUROSCI, V26, P490, DOI 10.1523/JNEUROSCI.5228-04.2006; Bernier R, 2007, BRAIN COGNITION, V64, P228, DOI 10.1016/j.bandc.2007.03.004; Breakspear M, 2003, NEUROIMAGE, V20, P466, DOI 10.1016/S1053-8119(03)00332-X; Brunet-Gouet E, 2006, PSYCHIAT RES-NEUROIM, V148, P75, DOI 10.1016/j.pscychresns.2006.05.001; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; DOUGHERTY FE, 1974, J CLIN PSYCHOL, V30, P243, DOI 10.1002/1097-4679(197407)30:3<243::AID-JCLP2270300304>3.0.CO;2-0; Farrer C, 2004, PSYCHIAT RES-NEUROIM, V131, P31, DOI 10.1016/j.pscychresns.2004.02.004; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; First M.B., 1997, STRUCTURAL CLIN INTE; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Ford JM, 2007, AM J PSYCHIAT, V164, P458, DOI 10.1176/appi.ajp.164.3.458; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2002, ATTENTION PERFORM, V19, P334; GASTAUT HJ, 1954, ELECTROEN CLIN NEURO, V6, P433, DOI 10.1016/0013-4694(54)90058-9; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hong LE, 2004, SCHIZOPHR RES, V70, P293, DOI 10.1016/j.schres.2003.12.011; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Kim JJ, 2005, SCHIZOPHR RES, V77, P299, DOI 10.1016/j.schres.2005.04.006; KONIG P, 1995, CURR OPIN NEUROBIOL, V5, P511, DOI 10.1016/0959-4388(95)80013-1; Lee Kwang-Hyuk, 2003, Cogn Neuropsychiatry, V8, P57, DOI 10.1080/713752240; McGuire PK, 1996, BRIT J PSYCHIAT, V169, P148, DOI 10.1192/bjp.169.2.148; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; NURNBERGER JI, 1992, ACTA PSYCHIAT SCAND, V86, P1, DOI 10.1111/j.1600-0447.1992.tb03217.x; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penn DL, 1997, PSYCHOL BULL, V121, P114, DOI 10.1037/0033-2909.121.1.114; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2008, CURR OPIN NEUROBIOL, V18, P179, DOI 10.1016/j.conb.2008.08.001; Rizzolatti G, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P427; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Schurmann M, 2007, BRIT J PSYCHIAT, V191, P178, DOI 10.1192/bjp.bp.106.024604; Shibukawa Y, 2007, PAIN, V128, P180, DOI 10.1016/j.pain.2006.10.006; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; SPENCE SA, 2003, DISORDERS BRAIN MIND, P223; Spencer KM, 2008, BIOL PSYCHIAT, V64, P369, DOI 10.1016/j.biopsych.2008.02.021; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Takahashi H, 2010, SCHIZOPHRENIA BULL, V36, P642, DOI 10.1093/schbul/sbn132; Toomey R, 2002, SCHIZOPHR RES, V53, P83, DOI 10.1016/S0920-9964(01)00177-3; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144	51	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28087	10.1371/journal.pone.0028087	http://dx.doi.org/10.1371/journal.pone.0028087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132217	Green Published, Green Submitted, gold			2022-12-25	WOS:000297792400037
J	Morin, N; Cescut, J; Beopoulos, A; Lelandais, G; Le Berre, V; Uribelarrea, JL; Molina-Jouve, C; Nicaud, JM				Morin, Nicolas; Cescut, Julien; Beopoulos, Athanasios; Lelandais, Gaelle; Le Berre, Veronique; Uribelarrea, Jean-Louis; Molina-Jouve, Carole; Nicaud, Jean-Marc			Transcriptomic Analyses during the Transition from Biomass Production to Lipid Accumulation in the Oleaginous Yeast Yarrowia lipolytica	PLOS ONE			English	Article							RHODOSPORIDIUM-TORULOIDES; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; BIODIESEL PRODUCTION; ACID BIOSYNTHESIS; ENCODING GENE; GATA FACTORS; NITROGEN; METABOLISM; REPRESSION	We previously developed a fermentation protocol for lipid accumulation in the oleaginous yeast Y. lipolytica. This process was used to perform transcriptomic time-course analyses to explore gene expression in Y. lipolytica during the transition from biomass production to lipid accumulation. In this experiment, a biomass concentration of 54.6 g(CDW)/l, with 0.18 g/g(CDW) lipid was obtained in ca. 32 h, with low citric acid production. A transcriptomic profiling was performed on 11 samples throughout the fermentation. Through statistical analyses, 569 genes were highlighted as differentially expressed at one point during the time course of the experiment. These genes were classified into 9 clusters, according to their expression profiles. The combination of macroscopic and transcriptomic profiles highlighted 4 major steps in the culture: (i) a growth phase, (ii) a transition phase, (iii) an early lipid accumulation phase, characterized by an increase in nitrogen metabolism, together with strong repression of protein production and activity; (iv) a late lipid accumulation phase, characterized by the rerouting of carbon fluxes within cells. This study explores the potential of Y. lipolytica as an alternative oil producer, by identifying, at the transcriptomic level, the genes potentially involved in the metabolism of oleaginous species.	[Morin, Nicolas; Beopoulos, Athanasios; Nicaud, Jean-Marc] INRA, Micalis UMR1319, Jouy En Josas, France; [Cescut, Julien; Le Berre, Veronique; Uribelarrea, Jean-Louis; Molina-Jouve, Carole] Univ Toulouse, INSA, UPS, INP,LISBP, Toulouse, France; [Cescut, Julien; Le Berre, Veronique; Uribelarrea, Jean-Louis; Molina-Jouve, Carole] INRA, UMR792, F-31931 Toulouse, France; [Cescut, Julien; Le Berre, Veronique; Uribelarrea, Jean-Louis; Molina-Jouve, Carole] CNRS, UMR5504, Toulouse, France; [Lelandais, Gaelle] Univ Paris 07, INTS, UMR S 665, Paris, France; [Le Berre, Veronique] INSA DGBA 135, Toulouse, France; [Nicaud, Jean-Marc] CNRS, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; UDICE-French Research Universities; Universite Paris Cite; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Morin, N (corresponding author), INRA, Micalis UMR1319, Jouy En Josas, France.	jean-marc.nicaud@grignon.inra.fr	Nicaud, jean marc/G-4204-2016; Anton Leberre, veronique/U-9208-2018; NICAUD, Jean-marc/ABA-9076-2021	Nicaud, jean marc/0000-0002-6679-972X; Molina Jouve, Carole/0000-0003-2097-4120	CALIN French national research program (DGCIS); ANR-PNRB [0701C0089]; EU	CALIN French national research program (DGCIS); ANR-PNRB(French National Research Agency (ANR)); EU(European Commission)	This work was labellized by Aerospace Valley (a non-profit association) and financially supported in part by CALIN French national research program (DGCIS), by the Lipicaero French national research program (ANR-PNRB) No. 0701C0089 and by the EU in the 7th Framework Programme for Research and Technological Development, under ALFA-BIRD (Alternative Fuels and Biofuels for Aircraft Development) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Athenstaedt K, 2006, PROTEOMICS, V6, P1450, DOI 10.1002/pmic.200500339; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Becker B, 1998, MOL MICROBIOL, V29, P151, DOI 10.1046/j.1365-2958.1998.00916.x; BEOPOULOS A, 2011, APPL MICROBIOL BIOTE; Beopoulos A, 2011, APPL MICROBIOL BIOT, V90, P1193, DOI 10.1007/s00253-011-3212-8; Beopoulos A, 2009, PROG LIPID RES, V48, P375, DOI 10.1016/j.plipres.2009.08.005; Beopoulos A, 2008, APPL ENVIRON MICROB, V74, P7779, DOI 10.1128/AEM.01412-08; Beopoulos A, 2009, BIOCHIMIE, V91, P692, DOI 10.1016/j.biochi.2009.02.004; Boczko EM, 2005, P NATL ACAD SCI USA, V102, P5647, DOI 10.1073/pnas.0501339102; Boles E, 2004, TOP CURR GENET, V9, P121; Bras LP, 2007, BIOMOL ENG, V24, P273, DOI 10.1016/j.bioeng.2007.04.003; Cescut J, 2011, J CHROMATOGR A, V1218, P373, DOI 10.1016/j.chroma.2010.12.003; CESCUT J, 2009, THESIS U TOULOUSE FR; Christensen T, 1998, APPL ENVIRON MICROB, V64, P3232; Coffman JA, 1997, J BACTERIOL, V179, P3416, DOI 10.1128/jb.179.11.3416-3429.1997; COOPER AJ, 1992, GENE, V114, P145; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; COSTES P, 2010, Patent No. 2010076432; Daugherty M, 2002, J BIOL CHEM, V277, P21431, DOI 10.1074/jbc.M201708200; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; DUBOIS E, 1978, J MOL BIOL, V122, P383, DOI 10.1016/0022-2836(78)90417-5; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dulermo T, 2011, METAB ENG, V13, P482, DOI 10.1016/j.ymben.2011.05.002; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EVANS CT, 1985, CAN J MICROBIOL, V31, P1000, DOI 10.1139/m85-189; Fickers P, 2005, FEMS YEAST RES, V5, P527, DOI 10.1016/j.femsyr.2004.09.004; Fickers P, 2011, BIOTECHNOL ADV, V29, P632, DOI 10.1016/j.biotechadv.2011.04.005; Finogenova TV, 2005, APPL BIOCHEM MICRO+, V41, P418, DOI 10.1007/s10438-005-0076-7; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; FUKUI S, 1979, TRENDS BIOCHEM SCI, V4, P246, DOI 10.1016/0968-0004(79)90214-7; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; GRANGER LM, 1992, APPL MICROBIOL BIOT, V37, P13; HEDGES D, 1995, MOL CELL BIOL, V15, P1915; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; HOLDSWORTH JE, 1988, J GEN MICROBIOL, V134, P2907; Kingsbury JM, 2006, EUKARYOT CELL, V5, P816, DOI 10.1128/EC.5.5.816-824.2006; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Li YH, 2007, ENZYME MICROB TECH, V41, P312, DOI 10.1016/j.enzmictec.2007.02.008; Liu HW, 2011, FEMS YEAST RES, V11, P42, DOI 10.1111/j.1567-1364.2010.00687.x; Liu HW, 2009, YEAST, V26, P553, DOI 10.1002/yea.1706; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Madzak C, 2004, J BIOTECHNOL, V109, P63, DOI 10.1016/j.jbiotec.2003.10.027; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Mendizabal I, 1998, FEBS LETT, V425, P323, DOI 10.1016/S0014-5793(98)00249-X; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Minami E, 2006, FUEL, V85, P2479, DOI 10.1016/j.fuel.2006.04.017; Mlickova K, 2004, APPL ENVIRON MICROB, V70, P3918, DOI 10.1128/AEM.70.7.3918-3924.2004; Morgunov IG, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1391, DOI 10.1007/s10541-005-0086-3; Nie KL, 2006, J MOL CATAL B-ENZYM, V43, P142, DOI 10.1016/j.molcatb.2006.07.016; Papanikolaou S, 2006, CURR MICROBIOL, V52, P134, DOI 10.1007/s00284-005-0223-7; Papanikolaou S, 2003, CURR MICROBIOL, V46, P398, DOI 10.1007/s00284-002-3907-2; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramadhas AS, 2005, FUEL, V84, P335, DOI 10.1016/j.fuel.2004.09.016; Ratledge C, 2004, BIOCHIMIE, V86, P807, DOI 10.1016/j.biochi.2004.09.017; Ratledge C, 2002, ADV APPL MICROBIOL, V51, P1, DOI 10.1016/S0065-2164(02)51000-5; Ratledge C, 2002, BIOCHEM SOC T, V30, P1047, DOI 10.1042/bst0301047; Ratledge C., 2010, SINGLE CELL OILS, DOI [10.1016/B978-1-893997-73-8.50005-0, DOI 10.1016/B978-1-893997-73-8.50005-0]; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SALTZGABERMULLER J, 1983, J BIOL CHEM, V258, P1465; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spielewoy N, 2010, EUKARYOT CELL, V9, P592, DOI 10.1128/EC.00192-09; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THORPE RF, 1972, J GEN MICROBIOL, V72, P151, DOI 10.1099/00221287-72-1-151; Todd RB, 1997, FUNGAL GENET BIOL, V21, P388, DOI 10.1006/fgbi.1997.0993; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498	72	93	102	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27966	10.1371/journal.pone.0027966	http://dx.doi.org/10.1371/journal.pone.0027966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132183	Green Submitted, Green Published, gold			2022-12-25	WOS:000297792400028
J	Dambuza, I; Keeton, R; Allie, N; Hsu, NJ; Randall, P; Sebesho, B; Fick, L; Quesniaux, VJF; Jacobs, M				Dambuza, Ivy; Keeton, Roanne; Allie, Nasiema; Hsu, Nai-Jen; Randall, Philippa; Sebesho, Boipelo; Fick, Lizette; Quesniaux, Valerie J. F.; Jacobs, Muazzam			Reactivation of M. tuberculosis Infection in Trans-Membrane Tumour Necrosis Factor Mice	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; TNF-DEFICIENT MICE; MYCOBACTERIUM-TUBERCULOSIS; FACTOR-ALPHA; GRANULOMA-FORMATION; LATENT TUBERCULOSIS; INTERFERON-GAMMA; MURINE TUBERCULOSIS; TRANSMEMBRANE TNF; IMMUNE-RESPONSE	Of those individuals who are infected with M. tuberculosis, 90% do not develop active disease and represents a large reservoir of M. tuberculosis with the potential for reactivation of infection. Sustained TNF expression is required for containment of persistent infection and TNF neutralization leads to tuberculosis reactivation. In this study, we investigated the contribution of soluble TNF (solTNF) and transmembrane TNF (Tm-TNF) in immune responses generated against reactivating tuberculosis. In a chemotherapy induced tuberculosis reactivation model, mice were challenged by aerosol inhalation infection with low dose M. tuberculosis for three weeks to establish infection followed chemotherapeutic treatment for six weeks, after which therapy was terminated and tuberculosis reactivation investigated. We demonstrate that complete absence of TNF results in host susceptibility to M. tuberculosis reactivation in the presence of established mycobacteria-specific adaptive immunity with mice displaying unrestricted bacilli growth and diffused granuloma structures compared to WT control mice. Interestingly, bacterial re-emergence is contained in Tm-TNF mice during the initial phases of tuberculosis reactivation, indicating that Tm-TNF sustains immune pressure as in WT mice. However, Tm-TNF mice show susceptibility to long term M. tuberculosis reactivation associated with uncontrolled influx of leukocytes in the lungs and reduced IL-12p70, IFN gamma and IL-10, enlarged granuloma structures, and failure to contain mycobacterial replication relative to WT mice. In conclusion, we demonstrate that both solTNF and Tm-TNF are required for maintaining immune pressure to contain reactivating M. tuberculosis bacilli even after mycobacteria-specific immunity has been established.	[Dambuza, Ivy; Keeton, Roanne; Allie, Nasiema; Hsu, Nai-Jen; Randall, Philippa; Sebesho, Boipelo; Fick, Lizette; Jacobs, Muazzam] Univ Cape Town, Div Immunol, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Quesniaux, Valerie J. F.] CNRS, UMR6218, F-45071 Orleans, France; [Quesniaux, Valerie J. F.] Univ Orleans, Orleans, France; [Jacobs, Muazzam] Natl Hlth Lab Serv, Johannesburg, South Africa	University of Cape Town; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; National Health Laboratory Service	Dambuza, I (corresponding author), Univ Cape Town, Div Immunol, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	Muazzam.Jacobs@uct.ac.za	Keeton, Roanne/AAS-2728-2021; Dambuza, Ivy/M-2484-2019	JACOBS, MUAZZAM/0000-0002-7403-4604; Hsu, Nai-Jen/0000-0002-7718-9839; Keeton, Roanne/0000-0003-4808-9756	National Research Foundation (South Africa); Medical Research Council (South Africa); National Health Laboratory Services (South Africa); University of Cape Town; European Union [028190]	National Research Foundation (South Africa)(National Research Foundation - South Africa); Medical Research Council (South Africa)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health Laboratory Services (South Africa); University of Cape Town; European Union(European Commission)	This study was funded by the National Research Foundation (South Africa), The Medical Research Council (South Africa), The National Health Laboratory Services (South Africa), The University of Cape Town, the European Union (TB REACT Contract no 028190). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnholt J, 2003, CYTOKINE, V23, P76, DOI 10.1016/S1043-4666(03)00201-1; Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994; Allie N, 2008, IMMUNOLOGY, V125, P522, DOI 10.1111/j.1365-2567.2008.02865.x; Anolik JH, 2008, J IMMUNOL, V180, P688, DOI 10.4049/jimmunol.180.2.688; Bean AGD, 1999, J IMMUNOL, V162, P3504; Botha T, 2003, J IMMUNOL, V171, P3110, DOI 10.4049/jimmunol.171.6.3110; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Chakravarty SD, 2008, INFECT IMMUN, V76, P916, DOI 10.1128/IAI.01011-07; CHAN J, 1995, INFECT IMMUN, V63, P736, DOI 10.1128/IAI.63.2.736-740.1995; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; COOPER AM, 1995, IMMUNOLOGY, V84, P423; Dambuza I, 2008, TUBERCULOSIS, V88, P221, DOI 10.1016/j.tube.2007.08.011; Desai SB, 2006, BEST PRACT RES CL RH, V20, P757, DOI 10.1016/j.berh.2006.06.002; Dimakou K, 2004, INT J CLIN PRACT, V58, P1052, DOI 10.1111/j.1742-1241.2004.00061.x; Ehlers S, 2003, ANN RHEUM DIS, V62, P37, DOI 10.1136/ard.62.suppl_2.ii37; Feng CG, 2005, J IMMUNOL, V174, P4185, DOI 10.4049/jimmunol.174.7.4185; Florido M, 2007, J IMMUNOL, V179, P7702, DOI 10.4049/jimmunol.179.11.7702; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 1998, J IMMUNOL, V160, P1796; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Fremond C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-136; Garcia I, 2000, LAB INVEST, V80, P1385, DOI 10.1038/labinvest.3780146; Grell M, 1996, J INFLAMM, V47, P8; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; Iliopoulos A, 2006, INT J TUBERC LUNG D, V10, P588; Jacobs M, 2000, LAB INVEST, V80, P901, DOI 10.1038/labinvest.3780094; Johnson CM, 1998, INFECT IMMUN, V66, P1666, DOI 10.1128/IAI.66.4.1666-1670.1998; Kaneko H, 1999, LAB INVEST, V79, P379; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; KOO MS, PLOS ONE; LIN PL, ARTHRITIS RHEUM, V62, P340; Manabe YC, 2008, TUBERCULOSIS, V88, P187, DOI 10.1016/j.tube.2007.10.006; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; MCCUNE RM, 1966, J EXP MED, V123, P445, DOI 10.1084/jem.123.3.445; Mitoma H, 2004, GASTROENTEROLOGY, V126, P934, DOI 10.1053/j.gastro.2004.01.036; Mitoma H, 2005, GASTROENTEROLOGY, V128, P376, DOI 10.1053/j.gastro.2004.11.060; Mohan VP, 2001, INFECT IMMUN, V69, P1847, DOI 10.1128/IAI.69.3.1847-1855.2001; Olleros ML, 2009, J INFECT DIS, V199, P1053, DOI 10.1086/597204; Olleros ML, 2005, AM J PATHOL, V166, P1109, DOI 10.1016/S0002-9440(10)62331-0; PROBERT L, 1995, EUR J IMMUNOL, V25, P1794, DOI 10.1002/eji.1830250647; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; Saliu OY, 2006, J INFECT DIS, V194, P486, DOI 10.1086/505430; Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852; Scallon B, 2002, J PHARMACOL EXP THER, V301, P418, DOI 10.1124/jpet.301.2.418; Scanga CA, 1999, INFECT IMMUN, V67, P4531, DOI 10.1128/IAI.67.9.4531-4538.1999; Schottelius AJG, 2004, EXP DERMATOL, V13, P193, DOI 10.1111/j.0906-6705.2004.00205.x; Sichletidis L, 2006, INT J TUBERC LUNG D, V10, P1127; Smith S, 2002, INFECT IMMUN, V70, P2082, DOI 10.1128/IAI.70.4.2082-2089.2002; Spohn G, 2007, J IMMUNOL, V178, P7450, DOI 10.4049/jimmunol.178.11.7450; Steed PM, 2003, SCIENCE, V301, P1895, DOI 10.1126/science.1081297; Van Rhijn I, 2008, MICROBES INFECT, V10, P711, DOI 10.1016/j.micinf.2008.04.005; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; *WHO, 2010, GLOB TURC CONTR; Zalevsky J, 2007, J IMMUNOL, V179, P1872, DOI 10.4049/jimmunol.179.3.1872	58	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e25121	10.1371/journal.pone.0025121	http://dx.doi.org/10.1371/journal.pone.0025121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132068	gold, Green Published, Green Submitted			2022-12-25	WOS:000297789900002
J	O'Dwyer, D; Ralton, LD; O'Shea, A; Murray, GI				O'Dwyer, Donna; Ralton, Lynda D.; O'Shea, Aisling; Murray, Graeme I.			The Proteomics of Colorectal Cancer: Identification of a Protein Signature Associated with Prognosis	PLOS ONE			English	Article							MASS-SPECTROMETRY; POOR-PROGNOSIS; COLON-CANCER; EXPRESSION; MARKERS; METASTASIS; BIOMARKERS; CARCINOMA; THERAPY; HSP60	Colorectal cancer is one of the commonest types of cancer and there is requirement for the identification of prognostic biomarkers. In this study protein expression profiles have been established for colorectal cancer and normal colonic mucosa by proteomics using a combination of two dimensional gel electrophoresis with fresh frozen sections of paired Dukes B colorectal cancer and normal colorectal mucosa (n = 28), gel image analysis and high performance liquid chromatography-tandem mass spectrometry. Hierarchical cluster analysis and principal components analysis showed that the protein expression profiles of colorectal cancer and normal colonic mucosa clustered into distinct patterns of protein expression. Forty-five proteins were identified as showing at least 1.5 times increased expression in colorectal cancer and the identity of these proteins was confirmed by liquid chromatography-tandem mass spectrometry. Fifteen proteins that showed increased expression were validated by immunohistochemistry using a well characterised colorectal cancer tissue microarray containing 515 primary colorectal cancer, 224 lymph node metastasis and 50 normal colonic mucosal samples. The proteins that showed the greatest degree of overexpression in primary colorectal cancer compared with normal colonic mucosa were heat shock protein 60 (p < 0.001), S100A9 (p < 0.001) and translationally controlled tumour protein (p, 0.001). Analysis of proteins individually identified 14-3-3 beta as a prognostic biomarker (chi(2) = 6.218, p = 0.013, HR = 0.639, 95% CL 0.448-0.913). Hierarchical cluster analysis identified distinct phenotypes associated with survival and a two-protein signature consisting of 14-3-3b and aldehyde dehydrogenase 1 was identified as showing prognostic significance (chi(2) = 7.306, p = 0.007, HR = 0.504, 95% CL 0.303-0.838) and that remained independently prognostic (p = 0.01, HR = 0.416, 95% CL 0.208-0.829) in a multivariate model.	[O'Dwyer, Donna; Ralton, Lynda D.; O'Shea, Aisling; Murray, Graeme I.] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland	University of Aberdeen	O'Dwyer, D (corresponding author), Univ Aberdeen, Dept Pathol, Aberdeen, Scotland.	g.i.murray@abdn.ac.uk			Association for International Cancer Research; NHS Grampian; University of Aberdeen Development Trust; Scottish Academic Health Sciences Collaboration; Chief Scientist Office of The Scottish Government; Pathological Society; Biotechnology and Biological Sciences Research Council, Scottish Funding Council; University of Aberdeen	Association for International Cancer Research; NHS Grampian; University of Aberdeen Development Trust; Scottish Academic Health Sciences Collaboration; Chief Scientist Office of The Scottish Government; Pathological Society; Biotechnology and Biological Sciences Research Council, Scottish Funding Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Aberdeen	This research was supported by funding from the Association for International Cancer Research (www.aicr.org.uk), NHS Grampian and The University of Aberdeen Development Trust (www.abdn.ac.uk/giving). The development of the colorectal cancer tissue microarray was supported by the Scottish Academic Health Sciences Collaboration funded by the Chief Scientist Office of The Scottish Government (www.cso.scot.nhs.uk/SuppScience/SAHSC.11.html). DO'D was in receipt of an undergraduate research scholarship from The Pathological Society (www.pathsoc.org) to undertake an intercalated BSc Med Sci degree. The Aberdeen Proteome Facility (www.abdn.ac.uk/ims/proteomics/) is funded jointly by Biotechnology and Biological Sciences Research Council, Scottish Funding Council and the University of Aberdeen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cappello F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-139; Cappello F, 2003, EUR J HISTOCHEM, V47, P105; Carpenter B, 2006, BRIT J CANCER, V95, P921, DOI 10.1038/sj.bjc.6603349; Chen DB, 2010, INT J ONCOL, V37, P355, DOI 10.3892/ijo_00000684; Coghlin C, 2006, J PATHOL, V210, P351, DOI 10.1002/path.2056; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Curran S, 2004, CLIN CANCER RES, V10, P8229, DOI 10.1158/1078-0432.CCR-04-0424; Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C; Downie D, 2005, CLIN CANCER RES, V11, P7369, DOI 10.1158/1078-0432.CCR-05-0466; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; Dundas SR, 2005, J PATHOL, V205, P74, DOI 10.1002/path.1672; Friedman DB, 2004, PROTEOMICS, V4, P793, DOI 10.1002/pmic.200300635; Guastadisegni C, 2010, EUR J CANCER, V46, P2788, DOI 10.1016/j.ejca.2010.05.009; He YJ, 2007, PROTEOM CLIN APPL, V1, P336, DOI 10.1002/prca.200600718; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Herrmann K, 2009, NAT CLIN PRACT GASTR, V6, P170, DOI 10.1038/ncpgasthep1366; Hope NR, 2011, HUM PATHOL, V42, P393, DOI 10.1016/j.humpath.2010.08.006; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Jimenez CR, 2010, J PROTEOMICS, V73, P1873, DOI 10.1016/j.jprot.2010.06.004; Komiya Y, 2008, J BIOL CHEM, V283, P18753, DOI 10.1074/jbc.M802530200; Koopman M, 2009, EUR J CANCER, V45, P1935, DOI 10.1016/j.ejca.2009.04.023; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; Kumarakulasingham M, 2005, CLIN CANCER RES, V11, P3758, DOI 10.1158/1078-0432.CCR-04-1848; Lawrie LC, 2001, LANCET ONCOL, V2, P270, DOI 10.1016/S1470-2045(00)00321-1; Lawrie LC, 2004, BRIT J CANCER, V90, P1955, DOI 10.1038/sj.bjc.6601828; Liao CCL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-410; Lievre A, 2010, ONCOGENE, V29, P3033, DOI 10.1038/onc.2010.89; Lyall MS, 2006, CLIN CANCER RES, V12, P1184, DOI 10.1158/1078-0432.CCR-05-1864; Ma YL, 2009, J PROTEOME RES, V8, P4525, DOI 10.1021/pr900365e; McKay JA, 2000, CLIN CANCER RES, V6, P1113; McKay JA, 2002, J PATHOL, V196, P386, DOI 10.1002/path.1053; McLeod HL, 1999, BRIT J CANCER, V79, P191, DOI 10.1038/sj.bjc.6690033; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Murray GI, 2010, HISTOPATHOLOGY, V57, P202, DOI 10.1111/j.1365-2559.2010.03606.x; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Ralton LD, 2010, CURR PROTEOMICS, V7, P212; Ross JS, 2010, AM J CLIN PATHOL, V134, P478, DOI 10.1309/AJCP2Y8KTDPOAORH; Schee K, 2010, AM J PATHOL, V177, P1592, DOI 10.2353/ajpath.2010.100024; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Soreide K, 2009, SURG ONCOL, V18, P31, DOI 10.1016/j.suronc.2008.06.006; Stulik J, 1999, ELECTROPHORESIS, V20, P3638, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3638::AID-ELPS3638>3.0.CO;2-W; Tweedle EM, 2010, GUT, V59, P1501, DOI 10.1136/gut.2009.196626; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wilson PM, 2010, CANCER J, V16, P262, DOI 10.1097/PPO.0b013e3181e07738; Winder T, 2010, CANCER TREAT REV, V36, P550, DOI 10.1016/j.ctrv.2010.03.005; Zhao LA, 2010, FEBS J, V277, P4195, DOI 10.1111/j.1742-4658.2010.07808.x	49	71	71	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27718	10.1371/journal.pone.0027718	http://dx.doi.org/10.1371/journal.pone.0027718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125622	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789200022
J	Zhang, DM; van der Wel, H; Johnson, JM; West, CM				Zhang, Dongmei; van der Wel, Hanke; Johnson, Jennifer M.; West, Christopher M.			Skp1 Prolyl 4-Hydroxylase of Dictyostelium Mediates Glycosylation-independent and -dependent Responses to O-2 without Affecting Skp1 Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLCNAC-TRANSFERASE; MODIFIES SKP1; CYTOPLASM; DIFFERENTIATION; HYDROXYLASE; EXPRESSION; INITIATION; PATHWAYS; BEHAVIOR; GROWTH	Cytoplasmic prolyl 4-hydroxylases (PHDs) have a primary role in O-2 sensing in animals via modification of the transcriptional factor subunit HIF alpha, resulting in its polyubiquitination by the E3(VHL)ubiquitin (Ub) ligase and degradation in the 26 S proteasome. Previously thought to be restricted to animals, a homolog (P4H1) of HIF alpha-type PHDs is expressed in the social amoeba Dictyostelium where it also exhibits characteristics of an O-2 sensor for development. Dictyostelium lacks HIF alpha, and P4H1 modifies a different protein, Skp1, an adaptor of the SCF class of E3-Ub ligases related to the E3(VHL)Ub ligase that targets animal HIF alpha. Normally, the HO-Skp1 product of the P4H1 reaction is capped by a GlcNAc sugar that can be subsequently extended to a pentasaccharide by novel glycosyltransferases. To analyze the role of glycosylation, the Skp1 GlcNAc-transferase locus gnt1 was modified with a missense mutation to block catalysis or a stop codon to truncate the protein. Despite the accumulation of the hydroxylated form of Skp1, Skp1 was not destabilized based on metabolic labeling. However, hydroxylation alone allowed for partial correction of the high O-2 requirement of P4H1-null cells, therefore revealing both glycosylation-independent and glycosylation-dependent roles for hydroxylation. Genetic complementation of the latter function required an enzymatically active form of Gnt1. Because the effect of the gnt1 deficiency depended on P4H1, and Skp1 was the only protein labeled when the GlcNAc-transferase was restored to mutant extracts, Skp1 apparently mediates the cellular functions of both P4H1 and Gnt1. Although Skp1 stability itself is not affected by hydroxylation, its modification may affect the stability of targets of Skp1-dependent Ub ligases.	[West, Christopher M.] Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, OUHSC, Oklahoma City, OK 73104 USA; [Johnson, Jennifer M.; West, Christopher M.] Univ Oklahoma, Oklahoma Ctr Med Glycobiol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Zhang, Dongmei] Fujian Agr & Forestry Univ, Key Lab Biopesticide & Chem Biol, Minist Educ, Fuzhou 350002, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Fujian Agriculture & Forestry University	West, CM (corresponding author), Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, OUHSC, 975 NE 10th St,BRC 417, Oklahoma City, OK 73104 USA.	Cwest2@ouhsc.edu	zhang, dongmei/B-8011-2013	Johnson Hays, Jennifer/0000-0001-5855-7352	National Institutes of Health [R01-GM037539]; Oklahoma Center for Advancement of Science and Technology [HR10-181]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for Advancement of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM037539 ( to C. M. W.). This work was also supported by Grant HR10-181 from the Oklahoma Center for Advancement of Science and Technology.	Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Bonner JT, 2005, MYCOLOGIA, V97, P178, DOI 10.3852/mycologia.97.1.178; Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ennis HL, 2000, P NATL ACAD SCI USA, V97, P3292, DOI 10.1073/pnas.050005097; Ercan A, 2006, J BIOL CHEM, V281, P12713, DOI 10.1074/jbc.M513664200; Ercan A, 2005, GLYCOBIOLOGY, V15, P489, DOI 10.1093/glycob/cwi034; Fey P, 2007, NAT PROTOC, V2, P1307, DOI 10.1038/nprot.2007.178; Funakoshi Y, 2009, BBA-GEN SUBJECTS, V1790, P81, DOI 10.1016/j.bbagen.2008.09.009; Hart G. W., 2009, ESSENTIALS GLYCOBIOL, P249; Heise N, 2009, GLYCOBIOLOGY, V19, P918, DOI 10.1093/glycob/cwp068; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Loenarz C, 2009, ANGEW CHEM INT EDIT, V48, P1784, DOI 10.1002/anie.200805427; Mohanty S, 2001, GENE DEV, V15, P1435, DOI 10.1101/gad.871101; Nelson MK, 2000, DEV BIOL, V224, P42, DOI 10.1006/dbio.2000.9793; NEWELL PC, 1969, J BACTERIOL, V100, P763, DOI 10.1128/JB.100.2.763-768.1969; NEWELL PC, 1982, J GEN MICROBIOL, V128, P1639; SANDONA D, 1995, J BIOL CHEM, V270, P5587, DOI 10.1074/jbc.270.10.5587; Sassi S, 2001, GLYCOBIOLOGY, V11, P283, DOI 10.1093/glycob/11.4.283; SCHINDLER J, 1977, J MOL BIOL, V116, P161, DOI 10.1016/0022-2836(77)90124-3; Singleton CK, 2006, EUKARYOT CELL, V5, P991, DOI 10.1128/EC.00058-06; SMITH E, 1980, J EMBRYOL EXP MORPH, V57, P233; Sucgang R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r20; Tan AM, 2009, BIOPHYS CHEM, V144, P108, DOI 10.1016/j.bpc.2009.07.003; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Teng-umnuay P, 1999, J BIOL CHEM, V274, P36392, DOI 10.1074/jbc.274.51.36392; van der Wel H, 2005, J BIOL CHEM, V280, P14645, DOI 10.1074/jbc.M500600200; van der Wel H, 2002, J BIOL CHEM, V277, P46527, DOI 10.1074/jbc.M208824200; van der Wel H, 2002, J BIOL CHEM, V277, P46328, DOI 10.1074/jbc.M208024200; van der Wel H, 2011, BIOCHEMISTRY-US, V50, P1700, DOI 10.1021/bi101977w; Wang B, 2002, EUKARYOT CELL, V1, P126, DOI 10.1128/EC.1.1.126-136.2002; Wang ZA, 2011, DEV BIOL, V349, P283, DOI 10.1016/j.ydbio.2010.10.013; Wang ZA, 2009, J BIOL CHEM, V284, P28896, DOI 10.1074/jbc.M109.022574; Ward JPT, 2008, BBA-BIOENERGETICS, V1777, P1, DOI 10.1016/j.bbabio.2007.10.010; West CM, 2006, METHOD ENZYMOL, V417, P389, DOI 10.1016/S0076-6879(06)17023-8; West CM, 2007, DEVELOPMENT, V134, P3349, DOI 10.1242/dev.000893; West CM, 2010, BBA-GEN SUBJECTS, V1800, P160, DOI 10.1016/j.bbagen.2009.11.006; West CM, 2004, BBA-GEN SUBJECTS, V1673, P29, DOI 10.1016/j.bbagen.2004.04.007; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027	39	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2006	2016		10.1074/jbc.M111.314021	http://dx.doi.org/10.1074/jbc.M111.314021			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128189	Green Published, hybrid			2022-12-25	WOS:000299321000041
J	Nadiminty, N; Tummala, R; Lou, W; Zhu, YZ; Zhang, J; Chen, XB; White, RWD; Kung, HJ; Evans, CP; Gao, AC				Nadiminty, Nagalakshmi; Tummala, Ramakumar; Lou, Wei; Zhu, Yezi; Zhang, Jin; Chen, Xinbin; White, Ralph W. deVere; Kung, Hsing-Jien; Evans, Christopher P.; Gao, Allen C.			MicroRNA let-7c Suppresses Androgen Receptor Expression and Activity via Regulation of Myc Expression in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAT3 ACTIVATION; PROGRESSION; LIN28; NF-KAPPA-B2/P52; DIFFERENTIATION; ANTIANDROGEN; ONCOGENE; PROFILES; THERAPY; MIRNAS	Castration-resistant prostate cancer continues to rely on androgen receptor (AR) expression. AR plays a central role in the development of prostate cancer and progression to castration resistance during and after androgen deprivation therapy. Here, we identified miR-let-7c as a key regulator of expression of AR. miR-let-7c suppresses AR expression and activity in human prostate cancer cells by targeting its transcription via c-Myc. Suppression of AR by let-7c leads to decreased cell proliferation of human prostate cancer cells. Down-regulation of Let-7c in prostate cancer specimens is inversely correlated with AR expression, whereas the expression of Lin28 (a repressor of let-7) is correlated positively with AR expression. Our study demonstrates that the miRNA let-7c plays an important role in the regulation of androgen signaling in prostate cancer by down-regulating AR expression. These results suggest that reconstitution of miR-let-7c may aid in targeting enhanced and hypersensitive AR in advanced prostate cancer.	[Nadiminty, Nagalakshmi; Gao, Allen C.] Univ Calif Davis, Med Ctr, Dept Urol, Sacramento, CA 95817 USA; [Chen, Xinbin; White, Ralph W. deVere; Kung, Hsing-Jien; Evans, Christopher P.; Gao, Allen C.] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA; [Zhang, Jin] Univ Calif Davis, Comparat Oncol Lab, Sch Vet Med, Sacramento, CA 95817 USA; [Kung, Hsing-Jien] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Nadiminty, N (corresponding author), Univ Calif Davis, Med Ctr, Dept Urol, 4645 2nd Ave,Res 3,Suite 1300, Sacramento, CA 95817 USA.	nnadiminty@ucdavis.edu; acgao@ucdavis.edu	Zhu, Yezi/F-2373-2014; Kung, Hsing-Jien/C-7651-2013; Jackson, Benjamin L/C-4297-2012		National Institutes of Health [CA140468, CA118887, CA109441, DOD PC080538]; NATIONAL CANCER INSTITUTE [R01CA118887, P30CA093373, R01CA081237, R01CA168601, R01CA123227, R01CA140468, R01CA109441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA140468, CA118887, CA109441, and DOD PC080538.	Bonkhoff H, 2010, PROSTATE, V70, P100, DOI 10.1002/pros.21042; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Dhir R, 2002, PROSTATE, V51, P241, DOI 10.1002/pros.10079; Donovan MJ, 2009, J UROLOGY, V182, P125, DOI 10.1016/j.juro.2009.02.135; Gandellini P, 2009, TRENDS MOL MED, V15, P381, DOI 10.1016/j.molmed.2009.07.004; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Koscianska E, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-79; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lamont KR, 2010, ADV CANCER RES, V107, P137, DOI 10.1016/S0065-230X(10)07005-3; Lee SO, 2003, CLIN CANCER RES, V9, P370; Lee SO, 2007, PROSTATE, V67, P764, DOI 10.1002/pros.20553; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nadiminty N, 2006, P NATL ACAD SCI USA, V103, P7264, DOI 10.1073/pnas.0509808103; Nadiminty N, 2010, CANCER RES, V70, P3309, DOI 10.1158/0008-5472.CAN-09-3703; Nadiminty N, 2010, PROSTATE, V70, P276, DOI 10.1002/pros.21062; Ni ZY, 2002, J UROLOGY, V167, P1859, DOI 10.1016/S0022-5347(05)65249-4; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Prasad PD, 2010, CELL TISSUE RES, V339, P337, DOI 10.1007/s00441-009-0902-y; Shi XB, 2008, CELL CYCLE, V7, P1529, DOI 10.4161/cc.7.11.5977; Singh P, 2006, ENDOCR-RELAT CANCER, V13, P653, DOI 10.1677/erc.1.00797; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	39	148	154	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1527	1537		10.1074/jbc.M111.278705	http://dx.doi.org/10.1074/jbc.M111.278705			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128178	hybrid, Green Published			2022-12-25	WOS:000299170300066
J	Moore, MS; Reichard, JD; Murtha, TD; Zahedi, B; Fallier, RM; Kunz, TH				Moore, Marianne S.; Reichard, Jonathan D.; Murtha, Timothy D.; Zahedi, Bita; Fallier, Renee M.; Kunz, Thomas H.			Specific Alterations in Complement Protein Activity of Little Brown Myotis (Myotis lucifugus) Hibernating in White-Nose Syndrome Affected Sites	PLOS ONE			English	Article							IMMUNE-RESPONSE; FUNGAL-INFECTIONS; GROUND-SQUIRRELS; CITELLUS TRIDECEMLINEATUS; HUMORAL IMMUNITY; ADIPOSE-TISSUE; TRADE-OFFS; BODY-FAT; BATS; COST	White-nose syndrome (WNS) is the most devastating condition ever reported for hibernating bats, causing widespread mortality in the northeastern United States. The syndrome is characterized by cutaneous lesions caused by a recently identified psychrophilic and keratinophylic fungus (Geomyces destructans), depleted fat reserves, atypical behavior, and damage to wings; however, the proximate cause of mortality is still uncertain. To assess relative levels of immunocompetence in bats hibernating in WNS-affected sites compared with levels in unaffected bats, we describe blood plasma complement protein activity in hibernating little brown myotis (Myotis lucifugus) based on microbicidal competence assays using Escherichia coli, Staphylococcus aureus and Candida albicans. Blood plasma from bats collected during mid-hibernation at WNS-affected sites had higher bactericidal ability against E. coli and S. aureus, but lower fungicidal ability against C. albicans when compared with blood plasma from bats collected at unaffected sites. Within affected sites during mid-hibernation, we observed no difference in microbicidal ability between bats displaying obvious fungal infections compared to those without. Bactericidal ability against E. coli decreased significantly as hibernation progressed in bats collected from an affected site. Bactericidal ability against E. coli and fungicidal ability against C. albicans were positively correlated with body mass index (BMI) during late hibernation. We also compared complement activity against the three microbes within individuals and found that the ability of blood plasma from hibernating M. lucifugus to lyse microbial cells differed as follows: E. coli > S. aureus > C. albicans. Overall, bats affected by WNS experience both relatively elevated and reduced innate immune responses depending on the microbe tested, although the cause of observed immunological changes remains unknown. Additionally, considerable trade-offs may exist between energy conservation and immunological responses. Relationships between immune activity and torpor, including associated energy expenditure, are likely critical components in the development of WNS.	[Moore, Marianne S.; Reichard, Jonathan D.; Murtha, Timothy D.; Zahedi, Bita; Fallier, Renee M.; Kunz, Thomas H.] Boston Univ, Dept Biol, Ctr Ecol & Conservat Biol, Boston, MA 02215 USA	Boston University	Moore, MS (corresponding author), Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA.	msm035@bucknell.edu		Murtha, Timothy/0000-0001-5427-9340	Bat Conservation International; National Speleological Society; New York Department of Environmental Conservation; United States Fish and Wildlife Service	Bat Conservation International; National Speleological Society; New York Department of Environmental Conservation; United States Fish and Wildlife Service(US Fish & Wildlife Service)	Funding for this study was provided by Bat Conservation International (http://batcon.org/), the National Speleological Society (http://www.caves.org/index.shtml), New York Department of Environmental Conservation (http://www.dec.ny.gov/) and the United States Fish and Wildlife Service (http://www.fws.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; ARDAWI MSM, 1985, ESSAYS BIOCHEM, V21, P1; Barr DP, 1922, ARCH INTERN MED, V29, P608, DOI 10.1001/archinte.1922.00110050055004; Blanco JL, 2008, VET IMMUNOL IMMUNOP, V125, P47, DOI 10.1016/j.vetimm.2008.04.020; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Burton RS, 1999, FUNCT ECOL, V13, P232, DOI 10.1046/j.1365-2435.1999.00302.x; CAHILL JE, 1967, J PARASITOL, V53, P110, DOI 10.2307/3276633; CALDER PC, 1994, BIOCHEM J, V300, P509, DOI 10.1042/bj3000509; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; CHUTE RM, 1960, J PARASITOL, V46, P855, DOI 10.2307/3275550; Chute RM, 1960, J PARASITOLOGY S, V46, P21; Courtin F, 2010, VET PATHOL, V47, P214, DOI 10.1177/0300985809358614; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Demas GE, 2005, P ROY SOC B-BIOL SCI, V272, P1845, DOI 10.1098/rspb.2005.3126; Demas GE, 2003, P ROY SOC B-BIOL SCI, V270, P905, DOI 10.1098/rspb.2003.2341; Demas GE, 2004, HORM BEHAV, V45, P173, DOI 10.1016/j.yhbeh.2003.11.002; Demas GE, 1997, AM J PHYSIOL-REG I, V273, pR1631, DOI 10.1152/ajpregu.1997.273.5.R1631; EMMONS RW, 1966, AM J TROP MED HYG, V15, P428, DOI 10.4269/ajtmh.1966.15.428; Eraud C, 2005, FUNCT ECOL, V19, P110, DOI 10.1111/j.0269-8463.2005.00934.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Galletti G, 1982, ACTA LEPROL, V88, P23; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; JAROSLOW BN, 1972, J EXP ZOOL, V181, P111, DOI 10.1002/jez.1401810112; JAROSLOW BN, 1968, P NATL ACAD SCI USA, V61, P69, DOI 10.1073/pnas.61.1.69; KALABUKHOV N. I., 1958, Journal of Microbiology, Epidemiology and Immunobiology, V29, P1453; Kurtz CC, 2007, DEV COMP IMMUNOL, V31, P415, DOI 10.1016/j.dci.2006.07.003; LARSEN B, 1971, COMP BIOCHEM PHYSIOL, V38, P571, DOI 10.1016/0300-9629(71)90124-1; LEHMANN PF, 1985, VET IMMUNOL IMMUNOP, V10, P33, DOI 10.1016/0165-2427(85)90038-8; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; MANASEK FJ, 1965, J CELL COMPAR PHYSL, V65, P319, DOI 10.1002/jcp.1030650305; Maniero GD, 2002, DEV COMP IMMUNOL, V26, P563, DOI 10.1016/S0145-305X(02)00006-X; Maniero GD, 2000, LIFE IN THE COLD, P493; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Martin LB, 2006, INTEGR COMP BIOL, V46, P1030, DOI 10.1093/icb/icl039; Martinkova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013853; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nicola AM, 2008, CURR OPIN MICROBIOL, V11, P313, DOI 10.1016/j.mib.2008.05.011; Ots I, 2001, P ROY SOC B-BIOL SCI, V268, P1175, DOI 10.1098/rspb.2001.1636; Prendergast BJ, 2002, AM J PHYSIOL-REG I, V282, pR1054, DOI 10.1152/ajpregu.00562.2001; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Reichard JD, 2009, ACTA CHIROPTEROL, V11, P457, DOI 10.3161/150811009X485684; Romani L, 2008, MED MYCOL, V46, P515, DOI 10.1080/13693780801971450; Sadd BM, 2009, EVOL APPL, V2, P113, DOI 10.1111/j.1752-4571.2008.00057.x; Shoman S, 2005, BRIT J HAEMATOL, V129, P569; Speth C, 2004, MYCOSES, V47, P93, DOI 10.1111/j.1439-0507.2004.00979.x; Speth C, 2008, MYCOSES, V51, P477, DOI 10.1111/j.1439-0507.2008.01597.x; Sulkin S E, 1974, Monogr Virol, V8, P1; THOMAS DW, 1990, J MAMMAL, V71, P475, DOI 10.2307/1381967; Tieleman BI, 2005, P ROY SOC B-BIOL SCI, V272, P1715, DOI 10.1098/rspb.2005.3155; Turner Gregory G., 2009, Bat Research News, V50, P47; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; Xu DL, 2010, COMP BIOCHEM PHYS A, V155, P25, DOI 10.1016/j.cbpa.2009.09.003; Zysling DA, 2007, J COMP PHYSIOL B, V177, P339, DOI 10.1007/s00360-006-0133-4	58	44	45	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27430	10.1371/journal.pone.0027430	http://dx.doi.org/10.1371/journal.pone.0027430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140440	Green Published, gold			2022-12-25	WOS:000298168100009
J	Raju, I; Abraham, EC				Raju, Ilangovan; Abraham, Edathara C.			Congenital Cataract Causing Mutants of alpha A-Crystallin/sHSP Form Aggregates and Aggresomes Degraded through Ubiquitin-Proteasome Pathway	PLOS ONE			English	Article							DEGRADATION; MUTATION; CRYAA; CELLS; HDAC6	Background: Mutations of human alpha A-crystallin cause congenital cataract by protein aggregation. How mutations of alpha A-crystallin cause disease pathogenesis through protein aggregation is not well understood. To better understand the cellular events leading to protein aggregation, we transfected cataract causing mutants, R12C, R21L, R21W, R49C, R54C, R116C and R116H, of human alpha A-crystallin in HeLa cells and examined the formation of intracellular protein aggregates and aggresomes by confocal microscopy. Methodology/Principal Findings: YFP-tagged human alpha A-wild-type (alpha A-wt) was sub-cloned and the mutants were generated by site-directed mutagenesis. The alpha A-wt and the mutants were individually transfected or co-transfected with CFP-tagged alpha A-wt or alpha B-wild-type (alpha B-wt) in HeLa cells(Overexpression of these mutants forms multiple small dispersed cytoplasmic aggregates as well as aggresomes(Co-expression of aB-wt with these mutants significantly inhibited protein aggregates where as co-expression with alpha A-wt enhanced protein aggregates which seems to be due to co-aggregation of the mutants with alpha A-wt. Aggresomes were validated by double immunofluorescence by co-localization of gamma-tubulin, a centrosome marker protein with alpha A-crystallin. Furthermore, increased ubiquitination was detected in R21W, R116C and R116H as assessed by western blot analyses. Immunostaining with an ubiquitin antibody revealed that ubiquitin inclusions in the perinuclear regions were evident only in R116C transfected cells(Pulse chase assay, after cycloheximide treatment, suggested that R116C degraded faster than the wild-type control. Conclusions/Significance: Mutants of alpha A-crystallin form aggregates and aggresomes. Co-expression of alpha A-wt with the mutants increased aggregates and co-expression of alpha B-wt with the mutants significantly decreased the aggregates. The mutant, R116C protein degraded faster than wild-type control and increased ubiquitination was evident in R116C expressing cells.	[Raju, Ilangovan; Abraham, Edathara C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Raju, I (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	ecabraham@uams.edu			National Institute of Health from National Eye Institute [5RO1EY001352-15]; NATIONAL EYE INSTITUTE [R01EY011352] Funding Source: NIH RePORTER	National Institute of Health from National Eye Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institute of Health grant 5RO1EY001352-15 from National Eye Institute to ECA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; DEJONG WW, 1975, FEBS LETT, V58, P310, DOI 10.1016/0014-5793(75)80286-9; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Graw J, 2006, GRAEF ARCH CLIN EXP, V244, P912, DOI 10.1007/s00417-005-0234-x; Hansen L, 2007, INVEST OPHTH VIS SCI, V48, P3937, DOI 10.1167/iovs.07-0013; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kore RA, 2010, STRUCTURAL FUNCTIONA; Kumarasamy A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003175; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Raju I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019876; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; Reddy MA, 2004, SURV OPHTHALMOL, V49, P300, DOI 10.1016/j.survophthal.2004.02.013; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Santhiya S, 2006, MOL VIS, V12, P768; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Vanita V, 2006, MOL VIS, V12, P518; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; Xia CH, 2006, INVEST OPHTH VIS SCI, V47, P3004, DOI 10.1167/iovs.06-0178; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200; Zhang HL, 2010, J MOL CELL CARDIOL, V49, P918, DOI 10.1016/j.yjmcc.2010.09.004; Zhang XY, 2007, INVEST OPHTH VIS SCI, V48, P4200, DOI 10.1167/iovs.07-0196; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	33	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28085	10.1371/journal.pone.0028085	http://dx.doi.org/10.1371/journal.pone.0028085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140512	Green Submitted, Green Published, gold			2022-12-25	WOS:000298166300026
J	Sirois, M; Robitaille, L; Allary, R; Shah, M; Woelk, CH; Estaquier, J; Corbeil, J				Sirois, Melissa; Robitaille, Lynda; Allary, Robin; Shah, Mohak; Woelk, Christopher H.; Estaquier, Jerome; Corbeil, Jacques			TRAF6 and IRF7 Control HIV Replication in Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; IMMUNODEFICIENCY-VIRUS TYPE-1; REGULATORY FACTORS 3; TOLL-LIKE RECEPTORS; RIG-I; INTERFERON-ALPHA; TRANSCRIPTION FACTORS; DIFFERENTIAL REGULATION; INDUCED ACTIVATION; POSITIVE FEEDBACK	The innate immune system recognizes virus infection and evokes antiviral responses which include producing type I interferons (IFNs). The induction of IFN provides a crucial mechanism of antiviral defense by upregulating interferon-stimulated genes (ISGs) that restrict viral replication. ISGs inhibit the replication of many viruses by acting at different steps of their viral cycle. Specifically, IFN treatment prior to in vitro human immunodeficiency virus (HIV) infection stops or significantly delays HIV-1 production indicating that potent inhibitory factors are generated. We report that HIV-1 infection of primary human macrophages decreases tumor necrosis factor receptor-associated factor 6 (TRAF6) and virus-induced signaling adaptor (VISA) expression, which are both components of the IFN signaling pathway controlling viral replication. Knocking down the expression of TRAF6 in macrophages increased HIV-1 replication and augmented the expression of IRF7 but not IRF3. Suppressing VISA had no impact on viral replication. Overexpression of IRF7 resulted in enhanced viral replication while knocking down IRF7 expression in macrophages significantly reduced viral output. These findings are the first demonstration that TRAF6 can regulate HIV-1 production and furthermore that expression of IRF7 promotes HIV-1 replication.	[Sirois, Melissa; Robitaille, Lynda; Allary, Robin; Estaquier, Jerome; Corbeil, Jacques] CHUL Res Ctr, Infect Dis Res Ctr, Dept Mol Med, Quebec City, PQ, Canada; [Sirois, Melissa; Robitaille, Lynda; Allary, Robin; Estaquier, Jerome; Corbeil, Jacques] Univ Laval, Quebec City, PQ, Canada; [Shah, Mohak] McGill Univ, Ctr Intelligent Machines, Dept Elect & Comp Engn, Montreal, PQ, Canada; [Woelk, Christopher H.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Estaquier, Jerome] Univ Paris 05, CNRS FRE3235, Paris, France	Laval University; Laval University; McGill University; University of California System; University of California San Diego; UDICE-French Research Universities; Universite Paris Cite	Sirois, M (corresponding author), CHUL Res Ctr, Infect Dis Res Ctr, Dept Mol Med, Quebec City, PQ, Canada.	jacques.corbeil@crchul.ulaval.ca	Corbeil, Jacques/AAW-9739-2020; , ESTAQUIER/AAR-7799-2020	Corbeil, Jacques/0000-0002-9973-2740; , ESTAQUIER/0000-0002-9432-8044; Woelk, Christopher/0000-0002-1977-0502	Canadian Institute of Health Research (CIHR); Center for AIDS Research (CFAR) at the University of California San Diego [AI36214]; Canada Research Chair in Medical Genomics; NIH [AI065242]; UCSD CFAR; CIHR HIV/AIDS; CIHR; Agence Nationale de la Recherche sur le SIDA et les Hepatites; Canada Research Chair; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065242, P30AI036214] Funding Source: NIH RePORTER	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Center for AIDS Research (CFAR) at the University of California San Diego; Canada Research Chair in Medical Genomics(Canada Research Chairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD CFAR; CIHR HIV/AIDS(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Agence Nationale de la Recherche sur le SIDA et les Hepatites(French National Research Agency (ANR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JC acknowledges the support of Canadian Institute of Health Research (CIHR), the Genomics Core at the Center for AIDS Research (CFAR) at the University of California San Diego (AI36214), and the Canada Research Chair in Medical Genomics. CHW is supported by the NIH (AI065242) and a UCSD CFAR developmental award. MSirois is the recipient of a Doctoral Research Award from CIHR HIV/AIDS Research Program. M. Shah acknowledges the support of the CIHR training grant while at CHUL Research Center. JE acknowledges the financial support of Agence Nationale de la Recherche sur le SIDA et les Hepatites and the Canada Research Chair Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Buettner N, 2010, J GEN VIROL, V91, P220, DOI 10.1099/vir.0.015172-0; Campillo-Gimenez L, 2010, J IMMUNOL, V184, P984, DOI 10.4049/jimmunol.0902316; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fortin JF, 1997, J VIROL, V71, P3588, DOI 10.1128/JVI.71.5.3588-3596.1997; Genin P, 2009, MOL CELL BIOL, V29, P3435, DOI 10.1128/MCB.01805-08; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Izmailova E, 2003, NAT MED, V9, P191, DOI 10.1038/nm822; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Konno H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005674; KORNBLUTH RS, 1989, J EXP MED, V169, P1137, DOI 10.1084/jem.169.3.1137; KUNZI MS, 1995, J INFECT DIS, V171, P822, DOI 10.1093/infdis/171.4.822; Laforge M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002087; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; MEYLAN PRA, 1993, VIROLOGY, V193, P138, DOI 10.1006/viro.1993.1110; Muto NF, 1999, J VIROL, V73, P9021, DOI 10.1128/JVI.73.11.9021-9028.1999; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ning S, 2011, GENES IMMUN; Nuovo GJ, 1999, J HISTOCHEM CYTOCHEM, V47, P273, DOI 10.1177/002215549904700301; Oldak M, 2011, J VIROL, V85, P178, DOI 10.1128/JVI.00998-10; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Richman DD, 2001, CURR PROTOC IMMUNOL; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; SAMUEL CE, 1988, PROG NUCLEIC ACID RE, V35, P27, DOI 10.1016/S0079-6603(08)60609-1; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; SCHRODER HC, 1990, FASEB J, V4, P3124, DOI 10.1096/fasebj.4.13.1698680; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sgarbanti M, 2002, J EXP MED, V195, P1359, DOI 10.1084/jem.20010753; Sgarbanti M, 2008, J VIROL, V82, P3632, DOI 10.1128/JVI.00599-07; Shah M, 2011, IEEE ACM T COMPUT BI, V8, P14, DOI 10.1109/TCBB.2009.51; Shah Mohak CJ, 2009, IEEE COMPUTER SOC, V8, P14; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Smith AJ, 2010, J IMMUNOL, V185, P5417, DOI 10.4049/jimmunol.1002197; Song L, 2007, BIOINFORMATICS, V23, pI490, DOI 10.1093/bioinformatics/btm216; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Takeda K, 2003, CELL MICROBIOL, V5, P143, DOI 10.1046/j.1462-5822.2003.00264.x; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200	63	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28125	10.1371/journal.pone.0028125	http://dx.doi.org/10.1371/journal.pone.0028125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140520	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000298163400033
J	Gagnon, AE; Heimpel, GE; Brodeur, J				Gagnon, Annie-Eve; Heimpel, George E.; Brodeur, Jacques			The Ubiquity of Intraguild Predation among Predatory Arthropods	PLOS ONE			English	Article							BIOLOGICAL-CONTROL AGENT; GUT-CONTENT-ANALYSIS; SOYBEAN APHID; GENERALIST PREDATORS; MOLECULAR ANALYSIS; HARMONIA-AXYRIDIS; INSECT PREDATORS; ALTERNATIVE PREY; CANNIBALISM; DENSITY	Intraguild predation (IGP) occurs when one predator species attacks another predator species with which it competes for a shared prey species. Despite the apparent omnipresence of intraguild interactions in natural and managed ecosystems, very few studies have quantified rates of IGP in various taxa under field conditions. We used molecular analyses of gut contents to assess the nature and incidence of IGP among four species of coccinellid predators in soybean fields. Over half of the 368 predator individuals collected in soybean contained the DNA of other coccinellid species indicating that IGP was very common at our field site. Furthermore, 13.2% of the sampled individuals contained two and even three other coccinellid species in their gut. The interaction was reciprocal, as each of the four coccinellid species has the capacity to feed on the others. To our knowledge, this study represents the most convincing field evidence of a high prevalence of IGP among predatory arthropods. The finding has important implications for conservation biology and biological control.	[Gagnon, Annie-Eve] Univ Laval, Dept Phytol, Quebec City, PQ G1K 7P4, Canada; [Heimpel, George E.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Brodeur, Jacques] Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, Montreal, PQ H3C 3J7, Canada	Laval University; University of Minnesota System; University of Minnesota Twin Cities; Universite de Montreal	Gagnon, AE (corresponding author), Univ Laval, Dept Phytol, Quebec City, PQ G1K 7P4, Canada.	jacques.brodeur@umontreal.ca			Fonds Quebecois de Recherche sur la Nature et les Technologies; Canada Research Chair program	Fonds Quebecois de Recherche sur la Nature et les Technologies(FQRNT); Canada Research Chair program(Canada Research Chairs)	This work was funded by the Fonds Quebecois de Recherche sur la Nature et les Technologies and the Canada Research Chair program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi A, 2011, BIOCONTROL, V56, P429, DOI 10.1007/s10526-011-9378-2; Arim M, 2004, ECOL LETT, V7, P557, DOI 10.1111/j.1461-0248.2004.00613.x; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; Borer ET, 2003, ECOL LETT, V6, P929, DOI 10.1046/j.1461-0248.2003.00515.x; Briggs CJ, 2005, ECOL APPL, V15, P1111, DOI 10.1890/04-1776; Camus PA, 2008, MAR ECOL PROG SER, V361, P35, DOI 10.3354/meps07421; Chacon JM, 2008, BIOL CONTROL, V46, P216, DOI 10.1016/j.biocontrol.2008.04.018; Chacon JM, 2010, OECOLOGIA, V164, P213, DOI 10.1007/s00442-010-1611-7; Chapman EG, 2010, MOL ECOL RESOUR, V10, P1023, DOI 10.1111/j.1755-0998.2010.02857.x; Chen Y, 2000, MOL ECOL, V9, P1887, DOI 10.1046/j.1365-294x.2000.01100.x; Donaldson JR, 2007, BIOL CONTROL, V43, P111, DOI 10.1016/j.biocontrol.2007.06.004; EVANS EW, 1992, J KANSAS ENTOMOL SOC, V65, P30; Foltan P, 2005, MOL ECOL, V14, P4147, DOI 10.1111/j.1365-294X.2005.02732.x; Fournier V, 2008, OECOLOGIA, V157, P629, DOI 10.1007/s00442-008-1095-x; Gagnon AE, 2011, MOL ECOL RESOUR, V11, P1022, DOI 10.1111/j.1755-0998.2011.03047.x; Gardiner MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023576; Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718; Greenstone MH, 2011, MOL ECOL RESOUR, V11, P286, DOI 10.1111/j.1755-0998.2010.02922.x; Greenstone MH, 2010, ENTOMOL EXP APPL, V136, P97, DOI 10.1111/j.1570-7458.2010.01006.x; Hall RJ, 2011, ECOLOGY, V92, P352, DOI 10.1890/09-2314.1; Harwood JD, 2008, ENVIRON ENTOMOL, V37, P990, DOI 10.1603/0046-225X(2008)37[990:ASNSAP]2.0.CO;2; Harwood JD, 2007, MOL ECOL, V16, P4390, DOI 10.1111/j.1365-294X.2007.03482.x; Harwood JD, 2009, BIOL INVASIONS, V11, P895, DOI 10.1007/s10530-008-9302-6; Harwood JD, 2005, EUR J ENTOMOL, V102, P335, DOI 10.14411/eje.2005.051; Hautier L, 2008, CHEMOECOLOGY, V18, P191, DOI 10.1007/s00049-008-0405-4; Hironori Y, 1997, ENTOMOPHAGA, V42, P153, DOI 10.1007/BF02769893; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; Holt RD, 2007, ECOLOGY, V88, P2706, DOI 10.1890/06-1525.1; Hoogendoorn M, 2004, ENTOMOL EXP APPL, V111, P19, DOI 10.1111/j.0013-8703.2004.00157.x; Hoogendoorn M, 2001, MOL ECOL, V10, P2059, DOI 10.1046/j.1365-294X.2001.01316.x; IVES AR, 1993, ECOLOGY, V74, P1929, DOI 10.2307/1940836; Kindlmann P, 2006, POPUL ECOL, V48, P317, DOI 10.1007/s10144-006-0006-4; Law YH, 2011, ECOLOGY, V92, P333, DOI 10.1890/10-0156.1; Lucas E, 1998, ECOLOGY, V79, P1084, DOI 10.1890/0012-9658(1998)079[1084:IPAAPC]2.0.CO;2; Lucas E, 2001, ECOLOGY, V82, P3246, DOI 10.1890/0012-9658(2001)082[3246:AFISSC]2.0.CO;2; Lundgren JG, 2009, ECOL APPL, V19, P2157, DOI 10.1890/08-1882.1; Majerus M. E. N, 1994, LADYBIRDS; Messing R, 2006, ENVIRONMENTAL IMPACT OF INVERTEBRATES FOR BIOLOGICAL CONTROL OF ARTHROPODS: METHODS AND RISK ASSESSMENT, P64, DOI 10.1079/9780851990583.0064; Mignault MP, 2006, BIOCONTROL, V51, P89, DOI 10.1007/s10526-005-1517-1; Muller CB, 2002, BIOL CONTROL, V25, P216, DOI 10.1016/S1049-9644(02)00102-0; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; POLIS GA, 1987, ECOLOGY, V68, P332, DOI 10.2307/1939264; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Rhainds M, 2007, CAN ENTOMOL, V139, P728, DOI 10.4039/N06-095; Rosenheim JA, 1999, ECOL APPL, V9, P409, DOI 10.1890/1051-0761(1999)009[0409:IOGPOA]2.0.CO;2; Rosenheim JA, 1998, ANNU REV ENTOMOL, V43, P421, DOI 10.1146/annurev.ento.43.1.421; Rosenheim JA, 2004, ECOLOGY, V85, P3362, DOI 10.1890/03-0825; ROSENHEIM JA, 1995, BIOL CONTROL, V5, P303, DOI 10.1006/bcon.1995.1038; ROSENHEIM JA, 1993, OECOLOGIA, V96, P439, DOI 10.1007/BF00317517; Rosenheim JA, 2006, PROG BIOL CONTROL, V3, P1; Salo P, 2008, J ANIM ECOL, V77, P1092, DOI 10.1111/j.1365-2656.2008.01430.x; Sergio F, 2007, ANIM BEHAV, V74, P1607, DOI 10.1016/j.anbehav.2006.10.022; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Sheppard SK, 2005, MOL ECOL, V14, P4461, DOI 10.1111/j.1365-294X.2005.02742.x; Sigsgaard L, 2002, BIOCONTROL, V47, P151, DOI 10.1023/A:1014577114915; Snyder WE, 2004, OECOLOGIA, V140, P559, DOI 10.1007/s00442-004-1612-5; Snyder WE, 2000, ENVIRON ENTOMOL, V29, P1173, DOI 10.1603/0046-225X-29.6.1173; Sulkava S, 1997, ORNIS FENNICA, V74, P65; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Szendrei Z, 2010, BASIC APPL ECOL, V11, P153, DOI 10.1016/j.baae.2009.10.006; Takizawa T, 2011, ENVIRON ENTOMOL, V40, P8, DOI 10.1603/EN10047; Traugott M, 2008, B ENTOMOL RES, V98, P223, DOI 10.1017/S0007485308005968; van der Hammen T, 2010, OECOLOGIA, V163, P79, DOI 10.1007/s00442-010-1575-7; Vance-Chalcraft HD, 2007, ECOLOGY, V88, P2689, DOI 10.1890/06-1869.1	67	80	84	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28061	10.1371/journal.pone.0028061	http://dx.doi.org/10.1371/journal.pone.0028061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132211	Green Published, Green Submitted, gold			2022-12-25	WOS:000298162000066
J	Wagar, LE; Rosella, L; Crowcroft, N; Lowcock, B; Drohomyrecky, PC; Foisy, J; Gubbay, J; Rebbapragada, A; Winter, AL; Achonu, C; Ward, BJ; Watts, TH				Wagar, Lisa E.; Rosella, Laura; Crowcroft, Natasha; Lowcock, Beth; Drohomyrecky, Paulina C.; Foisy, Julie; Gubbay, Jonathan; Rebbapragada, Anu; Winter, Anne-Luise; Achonu, Camille; Ward, Brian J.; Watts, Tania H.			Humoral and Cell-Mediated Immunity to Pandemic H1N1 Influenza in a Canadian Cohort One Year Post-Pandemic: Implications for Vaccination	PLOS ONE			English	Article							CD8(+) T-CELLS; HEMAGGLUTINATION-INHIBITING ANTIBODY; VIRUS; MEMORY; PROTECTION; INFECTION; LYMPHOCYTES; CHALLENGE; RESPONSES; HUMANS	We evaluated a cohort of Canadian donors for T cell and antibody responses against influenza A/California/7/2009 (pH1N1) at 8-10 months after the 2nd pandemic wave by flow cytometry and microneutralization assays. Memory CD8 T cell responses to pH1N1 were detectable in 58% (61/105) of donors. These responses were largely due to cross-reactive CD8 T cell epitopes as, for those donors tested, similar recall responses were obtained to A/California 2009 and A/PR8 1934 H1N1 Hviruses. Longitudinal analysis of a single infected individual showed only a small and transient increase in neutralizing antibody levels, but a robust CD8 T cell response that rose rapidly post symptom onset, peaking at 3 weeks, followed by a gradual decline to the baseline levels seen in a seroprevalence cohort post-pandemic. The magnitude of the influenzaspecific CD8 T cell memory response at one year post-pandemic was similar in cases and controls as well as in vaccinated and unvaccinated donors, suggesting that any T cell boosting from infection was transient. Pandemic H1-specific antibodies were only detectable in approximately half of vaccinated donors. However, those who were vaccinated within a few months following infection had the highest persisting antibody titers, suggesting that vaccination shortly after influenza infection can boost or sustain antibody levels. For the most part the circulating influenza-specific T cell and serum antibody levels in the population at one year post-pandemic were not different between cases and controls, suggesting that natural infection does not lead to higher long term T cell and antibody responses in donors with pre-existing immunity to influenza. However, based on the responses of one longitudinal donor, it is possible for a small population of pre-existing crossreactive memory CD8 T cells to expand rapidly following infection and this response may aid in viral clearance and contribute to a lessening of disease severity.	[Wagar, Lisa E.; Drohomyrecky, Paulina C.; Watts, Tania H.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Rosella, Laura; Crowcroft, Natasha; Lowcock, Beth; Foisy, Julie; Gubbay, Jonathan; Rebbapragada, Anu; Winter, Anne-Luise; Achonu, Camille] Publ Hlth Ontario, Toronto, ON, Canada; [Rosella, Laura; Crowcroft, Natasha] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Crowcroft, Natasha; Gubbay, Jonathan; Rebbapragada, Anu] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Ward, Brian J.] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada	University of Toronto; University of Toronto; University of Toronto; McGill University	Wagar, LE (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	tania.watts@utoronto.ca	Gubbay, Jonathan/Q-8580-2019	Gubbay, Jonathan/0000-0003-0026-3786; Tripp, Ralph/0000-0002-2924-9956; Wagar, Lisa/0000-0001-5980-3586	Canadian Institutes of Health Research (CIHR) [MOP-74492, TPA-90194]; Public Health Agency of Canada; GlaxoSmithKline Inc.; Hoffmann-La Roche Ltd Inc.	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada; GlaxoSmithKline Inc.(GlaxoSmithKline); Hoffmann-La Roche Ltd Inc.	This research was supported by grants MOP-74492 and TPA-90194 from the Canadian Institutes of Health Research (CIHR) to T.H.W. and by a contract from the Public Health Agency of Canada to N.C. T.H.W. holds the Sanofi Pasteur Chair in Human Immunology at the University of Toronto. L.E.W. was funded by a CIHR doctoral award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Jonathan Gubbay has received grants from GlaxoSmithKline Inc. and Hoffmann-La Roche Ltd Inc. B.J.W. is co-investigator on a CIHR grant with the VP research of GSK; he is on the Scientific advisory board of Medicago and has served on ad hoc advisory committees (clinical and scientific) for all of the major vaccine manufacturers. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Please note: Although the GSK vaccine was mentioned in this study, they did not provide vaccine for the study. The authors did not vaccinate the cohort but asked the participants to report on whether they had received the vaccine, which in the season reported was available through a public vaccine program, using vaccine purchased by the Canadian Government from GSK. Similarly the longitudinal donor in the study who reports 2 vaccinations obtained these vaccines through the public mechanism, not through the study.	Achonu C, 2010, SEROPREVALENCE STUDY; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bodewes R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005538; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Crotty S, 2004, SEMIN IMMUNOL, V16, P197, DOI 10.1016/j.smim.2004.02.008; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hamann D, 1999, INT IMMUNOL, V11, P1027, DOI 10.1093/intimm/11.7.1027; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Louie JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018221; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Mavrouli MD, 2011, VIRAL IMMUNOL, V24, P221, DOI 10.1089/vim.2010.0137; MCMICHAEL AJ, 1981, CLIN EXP IMMUNOL, V43, P276; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Roman F, 2010, VACCINE, V28, P1740, DOI 10.1016/j.vaccine.2009.12.014; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Scheible K, 2011, VACCINE, V29, P2159, DOI 10.1016/j.vaccine.2010.12.073; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; Wagar LE, 2011, PLOS ONE IN PRESS; Wichmann O, 2010, EURO SURVEILL, V15; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, 2010, SER DIAGN INFL MICR; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231	38	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28063	10.1371/journal.pone.0028063	http://dx.doi.org/10.1371/journal.pone.0028063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132212	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000067
J	Sosnoff, JJ; Socie, MJ; Boes, MK; Sandroff, BM; Pula, JH; Suh, Y; Weikert, M; Balantrapu, S; Morrison, S; Motl, RW				Sosnoff, Jacob J.; Socie, Michael J.; Boes, Morgan K.; Sandroff, Brian M.; Pula, John H.; Suh, Yoojin; Weikert, Madeline; Balantrapu, Swathi; Morrison, Steven; Motl, Robert W.			Mobility, Balance and Falls in Persons with Multiple Sclerosis	PLOS ONE			English	Article							ACCIDENTAL FALLS; POSTURAL CONTROL; PEOPLE; RISK; WALK; IMPAIRMENT; TESTS; WOMEN	Background: There is a lack of information concerning the relation between objective measures of gait and balance and fall history in persons with MS (PwMS). This investigation assessed the relation between demographic, clinical, mobility and balance metrics and falls history in persons with multiple sclerosis (MS). Methods: 52 ambulatory persons with MS (PwMS) participated in the investigation. All persons provided demographic information including fall history over the last 12 months. Disease status was assessed with Expanded Disability Status Scale (EDSS). Walking speed, coordination, endurance and postural control were quantified with a multidimensional mobility battery. Results: Over 51% of the participants fell in the previous year with 79% of these people being suffering recurrent falls. Overall, fallers were older, had a greater prevalence of assistive devices use, worse disability, decreased walking endurance, and greater postural sway velocity with eyes closed compared to non-fallers. Additionally, fallers had greater impairment in cerebellar, sensory, pyramidal, and bladder/bowel subscales of the EDSS. Conclusions: The current observations suggest that PwMS who are older, more disabled, utilize an assistive device, have decreased walking coordination and endurance and have diminished balance have fallen in the previous year. This suggests that individuals who meet these criteria need to be carefully monitored for future falls. Future research is needed to determine a prospective model of falls specific to PwMS. Additionally, the utility of interventions aimed at reducing falls and fall risk in PwMS needs to be established.	[Sosnoff, Jacob J.; Sandroff, Brian M.; Suh, Yoojin; Weikert, Madeline; Balantrapu, Swathi; Motl, Robert W.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; [Socie, Michael J.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL USA; [Sosnoff, Jacob J.] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Pula, John H.] Univ Illinois, Coll Med Peoria, Peoria, IL USA; [Morrison, Steven] Old Dominion Univ, Sch Phys Therapy, Norfolk, VA USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Peoria; Old Dominion University	Sosnoff, JJ (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA.	jsosnoff@illinois.edu	Sosnoff, Jacob/P-3397-2019	Sosnoff, Jacob/0000-0002-0286-9207; Boes, Morgan/0000-0002-2832-2306; Sandroff, Brian/0000-0002-2013-7632; Morrison, Steven/0000-0001-7485-0305	Olaf-Saint Francis Foundation	Olaf-Saint Francis Foundation	The research was funded in part with support from the Olaf-Saint Francis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bateni H, 2005, ARCH PHYS MED REHAB, V86, P134, DOI 10.1016/j.apmr.2004.04.023; Brown JS, 2000, J AM GERIATR SOC, V48, P721, DOI 10.1111/j.1532-5415.2000.tb04744.x; Cameron MH, 2008, SOMATOSENS MOT RES, V25, P113, DOI 10.1080/08990220802131127; Cameron MH, 2011, J REHABIL RES DEV, V48, P13, DOI 10.1682/JRRD.2009.12.0192; Cattaneo D, 2007, CLIN REHABIL, V21, P771, DOI 10.1177/0269215507077602; Cattaneo D, 2009, MULT SCLER, V15, P59, DOI 10.1177/1352458508096874; Cattaneo D, 2002, ARCH PHYS MED REHAB, V83, P864, DOI 10.1053/apmr.2002.32825; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Coote S, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-34; Finlayson ML, 2006, ARCH PHYS MED REHAB, V87, P1274, DOI 10.1016/j.apmr.2006.06.002; Finlayson ML, 2010, PHYS MED REH CLIN N, V21, P357, DOI 10.1016/j.pmr.2009.12.003; Gillespie L, 2009, INJURY PREV, V15, P354, DOI 10.1136/ip.2009.023101; Goldman MD, 2008, MULT SCLER J, V14, P383, DOI 10.1177/1352458507082607; HEBERT JR, 2011, PHYS THER; KASSER SL, 2011, ARCH PHYS MED REHABI; Kaufman M, 2000, MULT SCLER, V6, P286, DOI 10.1177/135245850000600411; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kuspinar A, 2010, ARCH PHYS MED REHAB, V91, P1410, DOI 10.1016/j.apmr.2010.06.005; LORD SR, 1993, AUST J PUBLIC HEALTH, V17, P240, DOI 10.1111/j.1753-6405.1993.tb00143.x; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Matsuda PN, 2011, PM&R, V3, P624, DOI 10.1016/j.pmrj.2011.04.015; Morrison S, 2010, DIABETES CARE, V33, P748, DOI 10.2337/dc09-1699; Nieuwenhuis MM, 2006, MULT SCLER J, V12, P495, DOI 10.1191/1352458506ms1293oa; Nilsagard Y, 2009, CLIN REHABIL, V23, P259, DOI 10.1177/0269215508095087; Nilsagard Y, 2007, PHYSIOTHER RES INT, V12, P105, DOI 10.1002/pri.358; Peterson EW, 2008, ARCH PHYS MED REHAB, V89, P1031, DOI 10.1016/j.apmr.2007.10.043; Piirtola M, 2006, GERONTOLOGY, V52, P1, DOI 10.1159/000089820; Prosperini L, 2011, J NEUROL SCI, V304, P55, DOI 10.1016/j.jns.2011.02.014; SOSNOFF J, J NEUROLOGI IN PRESS; Sosnoff JJ, 2011, GAIT POSTURE, V34, P145, DOI 10.1016/j.gaitpost.2011.03.020; Sosnoff JJ, 2010, ARCH PHYS MED REHAB, V91, P93, DOI 10.1016/j.apmr.2009.09.013; Van Emmerik REA, 2010, GAIT POSTURE, V32, P608, DOI 10.1016/j.gaitpost.2010.09.002; Winter D. A., 1993, BIOMECHANICS MOTOR C	33	143	143	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28021	10.1371/journal.pone.0028021	http://dx.doi.org/10.1371/journal.pone.0028021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132196	Green Published, Green Submitted, gold			2022-12-25	WOS:000297792400034
J	Beutler, LR; Eldred, KC; Quintana, A; Keene, CD; Rose, SE; Postupna, N; Montine, TJ; Palmiter, RD				Beutler, Lisa R.; Eldred, Kiara C.; Quintana, Albert; Keene, C. Dirk; Rose, Shannon E.; Postupna, Nadia; Montine, Thomas J.; Palmiter, Richard D.			Severely Impaired Learning and Altered Neuronal Morphology in Mice Lacking NMDA Receptors in Medium Spiny Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; BASAL GANGLIA; DORSOMEDIAL STRIATUM; SYNAPTIC PLASTICITY; NUCLEUS-ACCUMBENS; DEFICIENT MICE; DOPAMINE; EXPRESSION; D1; MEMORY	The striatum is composed predominantly of medium spiny neurons (MSNs) that integrate excitatory, glutamatergic inputs from the cortex and thalamus, and modulatory dopaminergic inputs from the ventral midbrain to influence behavior. Glutamatergic activation of AMPA, NMDA, and metabotropic receptors on MSNs is important for striatal development and function, but the roles of each of these receptor classes remain incompletely understood. Signaling through NMDA-type glutamate receptors (NMDARs) in the striatum has been implicated in various motor and appetitive learning paradigms. In addition, signaling through NMDARs influences neuronal morphology, which could underlie their role in mediating learned behaviors. To study the role of NMDARs on MSNs in learning and in morphological development, we generated mice lacking the essential NR1 subunit, encoded by the Grin1 gene, selectively in MSNs. Although these knockout mice appear normal and display normal 24-hour locomotion, they have severe deficits in motor learning, operant conditioning and active avoidance. In addition, the MSNs from these knockout mice have smaller cell bodies and decreased dendritic length compared to littermate controls. We conclude that NMDAR signaling in MSNs is critical for normal MSN morphology and many forms of learning.	[Beutler, Lisa R.; Palmiter, Richard D.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Beutler, Lisa R.; Eldred, Kiara C.; Quintana, Albert; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Beutler, Lisa R.; Eldred, Kiara C.; Quintana, Albert; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Keene, C. Dirk; Rose, Shannon E.; Postupna, Nadia; Montine, Thomas J.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Beutler, LR (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	palmiter@uw.edu	Quintana, Albert/N-5544-2015; Keene, Christopher D/N-1806-2015	Quintana, Albert/0000-0003-1674-7160; Keene, Christopher/0000-0002-5291-1469; Beutler, Lisa/0000-0002-9489-8098; Eldred, Kiara/0000-0002-4067-8639	Howard Hughes Medical Institute; Udall Center [NS062684]; NIGMS [T32 GM07735]; ARCS Foundation; MCINN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS062684] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Udall Center; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ARCS Foundation; MCINN(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Howard Hughes Medical Institute and grants from the Udall Center (NS062684), NIGMS T32 GM07735, and the ARCS Foundation. A. Q. is a recipient of a MCINN postdoctoral mobility program fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALBIN RL, 1992, NEUROSCIENCE, V46, P35, DOI 10.1016/0306-4522(92)90006-N; Baydyuk M, 2011, P NATL ACAD SCI USA, V108, P1669, DOI 10.1073/pnas.1004744108; Beutler LR, 2011, P NATL ACAD SCI USA, V108, P4206, DOI 10.1073/pnas.1101424108; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Ciccolini F, 2003, J NEUROSCI, V23, P103; Dalley JW, 2005, P NATL ACAD SCI USA, V102, P6189, DOI 10.1073/pnas.0502080102; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Darvas M, 2011, LEARN MEMORY, V18, P136, DOI 10.1101/lm.2041211; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; FACCHINETTI F, 1993, DEV BRAIN RES, V74, P219, DOI 10.1016/0165-3806(93)90007-W; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; Ferreira TL, 2003, BRAIN RES, V987, P17, DOI 10.1016/S0006-8993(03)03217-7; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Herlenius E, 2004, EXP NEUROL, V190, pS8, DOI 10.1016/j.expneurol.2004.03.027; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Jongen-Relo AL, 2003, BEHAV NEUROSCI, V117, P150, DOI 10.1037/0735-7044.117.1.150; Kelley AE, 1997, P NATL ACAD SCI USA, V94, P12174, DOI 10.1073/pnas.94.22.12174; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Massart R, 2009, EUR J NEUROSCI, V30, P397, DOI 10.1111/j.1460-9568.2009.06842.x; MATTSON MP, 1987, J NEUROSCI, V7, P4034; McKee BL, 2010, BEHAV NEUROSCI, V124, P500, DOI 10.1037/a0020270; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Ohtsuka N, 2008, P NATL ACAD SCI USA, V105, P12961, DOI 10.1073/pnas.0806180105; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Parker JG, 2011, J NEUROSCI, V31, P11362, DOI 10.1523/JNEUROSCI.2411-11.2011; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Schenberg EE, 2006, BRAIN RES BULL, V69, P440, DOI 10.1016/j.brainresbull.2006.02.010; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Thomas EA, 1998, J NEUROSCI RES, V52, P118, DOI 10.1002/(SICI)1097-4547(19980401)52:1<118::AID-JNR11>3.0.CO;2-6; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; Zaja-Milatovic S, 2005, NEUROLOGY, V64, P545, DOI 10.1212/01.WNL.0000150591.33787.A4	44	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28168	10.1371/journal.pone.0028168	http://dx.doi.org/10.1371/journal.pone.0028168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132236	gold, Green Submitted, Green Published			2022-12-25	WOS:000297789900050
J	Runker, AE; O'Tuathaigh, C; Dunleavy, M; Morris, DW; Little, GE; Corvin, AP; Gill, M; Henshall, DC; Waddington, JL; Mitchell, KJ				Ruenker, Annette E.; O'Tuathaigh, Colm; Dunleavy, Mark; Morris, Derek W.; Little, Graham E.; Corvin, Aiden P.; Gill, Michael; Henshall, David C.; Waddington, John L.; Mitchell, Kevin J.			Mutation of Semaphorin-6A Disrupts Limbic and Cortical Connectivity and Models Neurodevelopmental Psychopathology	PLOS ONE			English	Article							SCHIZOPHRENIA-SUSCEPTIBILITY LOCUS; LAMINA-RESTRICTED PROJECTION; WHITE-MATTER ABNORMALITIES; BIPOLAR DISORDER; MOLECULAR CHARACTERIZATION; INTERSTITIAL DELETION; RECEPTOR HYPOFUNCTION; MENTAL-RETARDATION; D-AMPHETAMINE; PLXNA2 GENE	Psychiatric disorders such as schizophrenia and autism are characterised by cellular disorganisation and dysconnectivity across the brain and can be caused by mutations in genes that control neurodevelopmental processes. To examine how neurodevelopmental defects can affect brain function and behaviour, we have comprehensively investigated the consequences of mutation of one such gene, Semaphorin-6A, on cellular organisation, axonal projection patterns, behaviour and physiology in mice. These analyses reveal a spectrum of widespread but subtle anatomical defects in Sema6A mutants, notably in limbic and cortical cellular organisation, lamination and connectivity. These mutants display concomitant alterations in the electroencephalogram and hyper-exploratory behaviour, which are characteristic of models of psychosis and reversible by the antipsychotic clozapine. They also show altered social interaction and deficits in object recognition and working memory. Mice with mutations in Sema6A or the interacting genes may thus represent a highly informative model for how neurodevelopmental defects can lead to anatomical dysconnectivity, resulting, either directly or through reactive mechanisms, in dysfunction at the level of neuronal networks with associated behavioural phenotypes of relevance to psychiatric disorders. The biological data presented here also make these genes plausible candidates to explain human linkage findings for schizophrenia and autism.	[Ruenker, Annette E.; Little, Graham E.; Mitchell, Kevin J.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Ruenker, Annette E.; Little, Graham E.; Mitchell, Kevin J.] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [O'Tuathaigh, Colm; Dunleavy, Mark; Henshall, David C.; Waddington, John L.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Morris, Derek W.; Corvin, Aiden P.; Gill, Michael] Trinity Coll Dublin, Neuropsychiat Genet Res Grp, Inst Mol Med, Dublin, Ireland; [Morris, Derek W.; Corvin, Aiden P.; Gill, Michael] Trinity Coll Dublin, Dept Psychiat, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Royal College of Surgeons - Ireland; Trinity College Dublin; Trinity College Dublin	Runker, AE (corresponding author), Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany.	Kevin.Mitchell@tcd.ie	Henshall, David/C-3364-2012; Rünker, Annette/A-4642-2012; Dunleavy, Mark/B-4260-2012; Rünker, Annette/AAB-9179-2021; Morris, Derek/AAW-8343-2021	Dunleavy, Mark/0000-0001-5916-9722; Rünker, Annette/0000-0002-2524-1041; Morris, Derek/0000-0002-3413-570X; O'Tuathaigh, Colm/0000-0003-1365-1606; Mitchell, Kevin/0000-0002-3433-4530; Gill, Michael/0000-0003-0206-5337; Walters, James/0000-0002-6980-4053; Henshall, David/0000-0001-6237-9632; Corvin, Aiden/0000-0001-6717-4089	Science Foundation Ireland [01/F1/B006, 07/IN.1/B969, 09/IN.1/B2614, 07/IN.1/B960, 08/IN1/B1875, 07/RFP/GENF327]; Health Research Board [RP/2007/207, RP/2007/37, PD/2004/16, PD/2007/20]; Government of Ireland; Irish Research Council of Science, Engineering and Technology	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board; Government of Ireland; Irish Research Council of Science, Engineering and Technology(Irish Research Council for Science, Engineering and Technology)	This work was supported by grants from Science Foundation Ireland to KJM (01/F1/B006; 07/IN.1/B969, 09/IN.1/B2614), JLW (07/IN.1/B960), DCH (08/IN1/B1875), and DWM (07/RFP/GENF327), and from the Health Research Board to KJM (RP/2007/207) and DCH (RP/2007/37). AER was supported by a postdoctoral fellowship from the Health Research Board (PD/2004/16). CO was supported by a postdoctoral fellowship from the Health Research Board (PD/2007/20). GEL has been supported by a Government of Ireland Scholarship, awarded by the Irish Research Council of Science, Engineering and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg K, 2008, AM J MED GENET B, V147B, P1238, DOI 10.1002/ajmg.b.30762; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Amann LC, 2010, BRAIN RES BULL, V83, P147, DOI 10.1016/j.brainresbull.2010.04.008; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Andreasen NC, 2008, BIOL PSYCHIAT, V64, P81, DOI 10.1016/j.biopsych.2008.01.003; Arion D, 2010, NEUROBIOL DIS, V37, P738, DOI 10.1016/j.nbd.2009.12.013; Arnold SE, 2000, ANN NY ACAD SCI, V911, P275; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Barch DM, 2008, BIOL PSYCHIAT, V64, P11, DOI 10.1016/j.biopsych.2008.03.003; Bennett RL, 1997, AM J HUM GENET, V61, P1450, DOI 10.1086/301634; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bron R, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-21; Budel S, 2008, SCHIZOPHR RES, V99, P365, DOI 10.1016/j.schres.2007.10.033; Butler PD, 2008, BIOL PSYCHIAT, V64, P40, DOI 10.1016/j.biopsych.2008.03.023; Butler PD, 2007, BRAIN, V130, P417, DOI 10.1093/brain/awl233; Byne W, 2009, ACTA NEUROPATHOL, V117, P347, DOI 10.1007/s00401-008-0404-0; Carpenter WT, 2008, NEUROPSYCHOPHARMACOL, V33, P2061, DOI 10.1038/sj.npp.1301639; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Casanova MF, 2007, BRAIN PATHOL, V17, P422, DOI 10.1111/j.1750-3639.2007.00100.x; Cascella NG, 2009, NEUROSCI RES, V63, P227, DOI 10.1016/j.neures.2009.01.002; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Clark RE, 2010, NEUROPSYCHOLOGIA, V48, P2234, DOI 10.1016/j.neuropsychologia.2010.02.004; Connor CM, 2011, INT J DEV NEUROSCI, V29, P325, DOI 10.1016/j.ijdevneu.2010.07.236; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Croci L, 2006, DEVELOPMENT, V133, P2719, DOI 10.1242/dev.02437; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dorph-Petersen KA, 2007, J COMP NEUROL, V501, P290, DOI 10.1002/cne.21243; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; English JA, 2011, BIOL PSYCHIAT, V69, P163, DOI 10.1016/j.biopsych.2010.06.031; Erbel-Sieler C, 2004, P NATL ACAD SCI USA, V101, P13648, DOI 10.1073/pnas.0405310101; Faulkner RL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-21; FERGER B, 1994, PSYCHOPHARMACOLOGY, V114, P297, DOI 10.1007/BF02244852; Fitzsimmons J, 2009, SCHIZOPHR RES, V107, P39, DOI 10.1016/j.schres.2008.10.022; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Fujii T, 2007, PROG NEURO-PSYCHOPH, V31, P873, DOI 10.1016/j.pnpbp.2007.01.027; Galaburda AM, 2006, NAT NEUROSCI, V9, P1213, DOI 10.1038/nn1772; Garcia-Minaur S, 2005, AM J MED GENET A, V132A, P402, DOI 10.1002/ajmg.a.30421; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Gowen E, 2007, CEREBELLUM, V6, P268, DOI 10.1080/14734220601184821; Grace AA, 2010, NEUROTOX RES, V18, P367, DOI 10.1007/s12640-010-9154-6; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Heng S, 2010, J NEURAL TRANSM, V117, P639, DOI 10.1007/s00702-010-0368-9; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Hussman JP, 2011, MOL AUTISM, V2, DOI [10.1186/2040-2392-2-1, 10.1186/2040-2392-2-18]; Hutsler JJ, 2007, BIOL PSYCHIAT, V61, P449, DOI 10.1016/j.biopsych.2006.01.015; Jang HS, 2009, KOREAN J PHYSIOL PHA, V13, P147, DOI 10.4196/kjpp.2009.13.3.147; Jang YL, 2007, AM J MED GENET B, V144B, P279, DOI 10.1002/ajmg.b.30389; Johnson DMG, 2000, J NEUROSCI, V20, P6974, DOI 10.1523/JNEUROSCI.20-18-06974.2000; Kanaan R, 2009, BRIT J PSYCHIAT, V194, P236, DOI 10.1192/bjp.bp.108.054320; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Karlsgodt KH, 2008, DEV PSYCHOPATHOL, V20, P1297, DOI 10.1017/S095457940800062X; Keller MC, 2006, BEHAV BRAIN SCI, V29, P385, DOI 10.1017/S0140525X06009095; Kendi M, 2008, J AM ACAD CHILD PSY, V47, P826, DOI [10.1097/CHI.Ob013e318172ef36, 10.1097/CHI.0b013e318172ef36]; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Kilpinen H, 2009, HUM MOL GENET, V18, P2912, DOI 10.1093/hmg/ddp229; Kittner H, 2000, PSYCHOPHARMACOLOGY, V150, P123, DOI 10.1007/s002130000403; Kuroki N, 2006, BIOL PSYCHIAT, V60, P22, DOI 10.1016/j.biopsych.2005.09.021; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lipina TV, 2010, GENES BRAIN BEHAV, V9, P777, DOI 10.1111/j.1601-183X.2010.00615.x; Lipina TV, 2011, SYNAPSE, V65, P234, DOI 10.1002/syn.20839; Lipska BK, 2002, NEUROTOX RES, V4, P469, DOI 10.1080/1029842021000022089; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Little GE, 2009, PLOS BIOL, V7, P756, DOI 10.1371/journal.pbio.1000098; Maestrini E, 2010, MOL PSYCHIATR, V15, P954, DOI 10.1038/mp.2009.34; Mah S, 2006, MOL PSYCHIATR, V11, P471, DOI 10.1038/sj.mp.4001785; Mann F, 2007, PROG NEUROBIOL, V82, P57, DOI 10.1016/j.pneurobio.2007.02.011; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; McIntosh AM, 2008, BIOL PSYCHIAT, V64, P1088, DOI 10.1016/j.biopsych.2008.07.026; Minshew NJ, 2007, ARCH NEUROL-CHICAGO, V64, P945, DOI 10.1001/archneur.64.7.945; Mitchell KJ, 2011, CURR OPIN NEUROBIOL, V21, P197, DOI 10.1016/j.conb.2010.08.009; MITCHELL KJ, 2010, PSYCHOL MED, P1; Mitelman SA, 2007, SCHIZOPHR RES, V92, P211, DOI 10.1016/j.schres.2006.12.029; Murray RM, 2008, EUR NEUROPSYCHOPHARM, V18, pS129, DOI 10.1016/j.euroneuro.2008.04.002; O'Donovan MC, 2009, HUM GENET, V126, P3, DOI 10.1007/s00439-009-0703-0; O'Sullivan GJ, 2008, NEUROPHARMACOLOGY, V54, P1051, DOI 10.1016/j.neuropharm.2008.02.011; O'Tuathaigh CM, 2006, NEUROREPORT, V17, P79, DOI 10.1097/01.wnr.0000192738.31029.0a; Ofner L, 2006, J HUM GENET, V51, P141, DOI 10.1007/s10038-005-0333-x; Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004; Patel LS, 2004, J NEUROSCI, V24, P9005, DOI 10.1523/JNEUROSCI.2943-04.2004; Peleg-Raibstein D, 2006, NEUROPHARMACOLOGY, V51, P947, DOI 10.1016/j.neuropharm.2006.06.002; Peleg-Raibstein D, 2009, PSYCHOPHARMACOLOGY, V206, P603, DOI 10.1007/s00213-009-1514-7; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; Perry W, 2009, ARCH GEN PSYCHIAT, V66, P1072, DOI 10.1001/archgenpsychiatry.2009.58; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Pol HEH, 2004, NEUROIMAGE, V21, P27, DOI 10.1016/j.neuroimage.2003.09.026; Porteous D, 2008, CURR OPIN GENET DEV, V18, P229, DOI 10.1016/j.gde.2008.07.005; Qin P, 2005, BMJ-BRIT MED J, V331, P23, DOI 10.1136/bmj.38488.462037.8F; Rametti G, 2009, PSYCHIAT RES-NEUROIM, V171, P166, DOI 10.1016/j.pscychresns.2008.05.003; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Ruenker AE, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-34; Rujescu D, 2006, BIOL PSYCHIAT, V59, P721, DOI 10.1016/j.biopsych.2005.08.029; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Seeman P, 2011, CNS NEUROSCI THER, V17, P118, DOI 10.1111/j.1755-5949.2010.00162.x; Shukla DK, 2011, J CHILD PSYCHOL PSYC, V52, P286, DOI 10.1111/j.1469-7610.2010.02342.x; Shukla DK, 2010, J AM ACAD CHILD PSY, V49, P1269, DOI 10.1016/j.jaac.2010.08.018; Spielewoy C, 2000, BEHAV PHARMACOL, V11, P279, DOI 10.1097/00008877-200006000-00011; Stahl D, 1997, N-S ARCH PHARMACOL, V356, P335, DOI 10.1007/PL00005059; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stober G, 2002, HUM GENET, V111, P323, DOI 10.1007/s00439-002-0805-4; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; Suda S, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-14; Sussmann JE, 2009, BIPOLAR DISORD, V11, P11, DOI 10.1111/j.1399-5618.2008.00646.x; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Takei K, 2008, SCHIZOPHR RES, V103, P52, DOI 10.1016/j.schres.2008.03.008; Takeshita M, 2008, SCHIZOPHR RES, V99, P359, DOI 10.1016/j.schres.2007.11.002; Tawarayama H, 2010, J NEUROSCI, V30, P7049, DOI 10.1523/JNEUROSCI.0073-10.2010; Thomann PA, 2009, PSYCHOL MED, V39, P371, DOI 10.1017/S0033291708003656; van den Buuse M, 2010, SCHIZOPHRENIA BULL, V36, P246, DOI 10.1093/schbul/sbp132; Waddington JL, 2007, PSYCHIAT CLIN N AM, V30, P365, DOI 10.1016/j.psc.2007.04.011; Wall PM, 2002, PSYCHOPHARMACOLOGY, V160, P233, DOI 10.1007/s00213-001-0979-9; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Welham J, 2009, SCHIZOPHRENIA BULL, V35, P603, DOI 10.1093/schbul/sbn084; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Wray NR, 2007, ARCH GEN PSYCHIAT, V64, P318, DOI 10.1001/archpsyc.64.3.318; Yeap S, 2006, ARCH GEN PSYCHIAT, V63, P1180, DOI 10.1001/archpsyc.63.11.1180; Young JW, 2010, CURR TOP BEHAV NEURO, V4, P391, DOI 10.1007/7854_2010_62; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zhou KJ, 2012, SCHIZOPHRENIA BULL, V38, P579, DOI 10.1093/schbul/sbq132; Zhou YA, 2008, SCHIZOPHR RES, V100, P120, DOI 10.1016/j.schres.2007.11.039; Zhuang BQ, 2009, NEURON, V61, P359, DOI 10.1016/j.neuron.2008.12.022	129	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e26488	10.1371/journal.pone.0026488	http://dx.doi.org/10.1371/journal.pone.0026488			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132072	Green Published, gold			2022-12-25	WOS:000297789900003
J	Thayil, SM; Morrison, N; Schechter, N; Rubin, H; Karakousis, PC				Thayil, Seema M.; Morrison, Norman; Schechter, Norman; Rubin, Harvey; Karakousis, Petros C.			The Role of the Novel Exopolyphosphatase MT0516 in Mycobacterium tuberculosis Drug Tolerance and Persistence	PLOS ONE			English	Article							INORGANIC POLYPHOSPHATE; ESCHERICHIA-COLI; STRINGENT RESPONSE; STATIONARY-PHASE; GUINEA-PIGS; SURVIVAL; LATENT; INFECTION; GROWTH; GENES	Inorganic polyphosphate (poly P) has been postulated to play a regulatory role in the transition to bacterial persistence. In bacteria, poly P balance in the cell is maintained by the hydrolysis activity of the exopolyphosphatase PPX. However, the Mycobacterium tuberculosis PPX has not been characterized previously. Here we show that recombinant MT0516 hydrolyzes poly P, and an MT0516-deficient M. tuberculosis mutant exhibits elevated intracellular levels of poly P and increased expression of the genes mprB, sigE, and rel relative to the isogenic wild-type strain, indicating poly P-mediated signaling. Deficiency of MT0516 resulted in decelerated growth during logarithmic-phase in axenic cultures, and tolerance to the cell wall-active drug isoniazid. The MT0516-deficient mutant showed a significant survival defect in activated human macrophages and reduced persistence in the lungs of guinea pigs. We conclude that exopolyphosphatase is required for long-term survival of M. tuberculosis in necrotic lung lesions.	[Thayil, Seema M.; Morrison, Norman; Karakousis, Petros C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Schechter, Norman; Rubin, Harvey] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Karakousis, Petros C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; University of Pennsylvania; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Thayil, SM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	petros@jhmi.edu	Karakousis, Petros Constantine/AAR-7899-2020	Thayil, SEEMA/0000-0002-3111-6861	Bill and Melinda Gates Foundation [42851]; National Institutes of Health [K08AI064229, R01AI083125, R01HL106786]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083125, K08AI064229] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by TB Accelerator grant # 42851 from the Bill and Melinda Gates Foundation and National Institutes of Health grants K08AI064229, R01AI083125, and R01HL106786 to P. C. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Ahmad Z, 2011, ANTIMICROB AGENTS CH; Ahmad Z, 2009, J INFECT DIS, V200, P1136, DOI 10.1086/605605; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Avarbock D, 2000, BIOCHEMISTRY-US, V39, P11640, DOI 10.1021/bi001256k; BLOCH H, 1956, JBACTERIOL, V72, P132; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Fauci AS, 2008, J INFECT DIS, V197, P1493, DOI 10.1086/587904; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gomez JE, 2004, TUBERCULOSIS, P101; HAAPANEN JH, 1959, AM REV RESPIR DIS, V80, P1; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Horsburgh CR, 2011, NEW ENGL J MED, V364, P1441, DOI 10.1056/NEJMcp1005750; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; Karakousis PC, 2009, INFECT DIS-SER, P271, DOI 10.1007/978-1-59745-180-2_24; KEASLING JD, 1993, P NATL ACAD SCI USA, V90, P7029, DOI 10.1073/pnas.90.15.7029; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klinkenberg LG, 2008, J INFECT DIS, V198, P275, DOI 10.1086/589515; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kristensen O, 2008, J MOL BIOL, V375, P1469, DOI 10.1016/j.jmb.2007.11.073; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Lindner SN, 2009, APPL ENVIRON MICROB, V75, P3161, DOI 10.1128/AEM.02705-08; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; MCDERMOTT W, 1959, PUBLIC HEALTH REP, V74, P485, DOI 10.2307/4590490; Nuermberger E, 2004, SEMIN RESP CRIT CARE, V25, P317, DOI 10.1055/s-2004-829504; Opie EL, 1927, ARCH PATHOL LAB MED, V4, P1; POTRYKUS K, 2008, ANN REV MICROBIOL; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Rangarajan ES, 2006, J MOL BIOL, V359, P1249, DOI 10.1016/j.jmb.2006.04.031; Rao N N, 1999, Prog Mol Subcell Biol, V23, P183; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rifat D, 2009, J INFECT DIS, V200, P1126, DOI 10.1086/605700; Sable SB, 2005, INFECT IMMUN, V73, P3547, DOI 10.1128/IAI.73.6.3547-3558.2005; Shi XB, 2004, P NATL ACAD SCI USA, V101, P17061, DOI 10.1073/pnas.0407787101; Shiba T, 1997, P NATL ACAD SCI USA, V94, P11210, DOI 10.1073/pnas.94.21.11210; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; TAKAYAMA K, 1972, ANTIMICROB AGENTS CH, V2, P29, DOI 10.1128/AAC.2.1.29; TOMASZ A, 1970, NATURE, V227, P138, DOI 10.1038/227138a0; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; WAYNE LG, 1994, ANTIMICROB AGENTS CH, V38, P2054, DOI 10.1128/AAC.38.9.2054; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Werner TP, 2005, ARCH MICROBIOL, V184, P129, DOI 10.1007/s00203-005-0031-2; WINDER F G, 1970, Journal of General Microbiology, V63, P41; WINDER FG, 1957, J GEN MICROBIOL, V17, P573, DOI 10.1099/00221287-17-3-573; Xie ZF, 2005, ANTIMICROB AGENTS CH, V49, P4778, DOI 10.1128/AAC.49.11.4778-4780.2005; Zhang QA, 2010, J BIOL CHEM, V285, P34259, DOI 10.1074/jbc.M110.154393; Zhang TY, 2009, AM J RESP CRIT CARE, V180, P1151, DOI 10.1164/rccm.200905-0795OC	58	49	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28076	10.1371/journal.pone.0028076	http://dx.doi.org/10.1371/journal.pone.0028076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132215	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789900046
J	Tong, YQ; Liu, B; Zheng, HY; He, YJ; Gu, J; Li, F; Li, Y				Tong, Yong-Qing; Liu, Bei; Zheng, Hong-Yun; He, Yu-Juan; Gu, Jian; Li, Feng; Li, Yan			BMI-1 Autoantibody as a New Potential Biomarker for Cervical Carcinoma	PLOS ONE			English	Article							POLYCOMB GROUP PROTEINS; HUMAN-PAPILLOMAVIRUS; UNITED-STATES; NASOPHARYNGEAL CARCINOMA; DEVELOPING-COUNTRIES; BREAST-CANCER; C-MYC; GENE; OVEREXPRESSION; EXPRESSION	BMI-1 is overexpressed in a variety of cancers, which can elicit an immune response leading to the induction of autoantibodies. However, BMI-1 autoantibody as a biomarker has seldom been studied with the exception of nasopharyngeal carcinoma. Whether BMI-1 autoantibodies can be used as a biomarker for cervical carcinoma is unclear. In this study, BMI-1 proteins were isolated by screening of a T7 phage cDNA library from mixed cervical carcinoma tissues. We analyzed BMI-1 autoantibody levels in serum samples from 67 patients with cervical carcinoma and 65 controls using ELISA and immunoblot. BMI-1 mRNA or protein levels were over-expressed in cervical carcinoma cell lines. Immunoblot results exhibited increased BMI-1 autoantibody levels in patient sera compared to normal sera. Additionally, the results for antibody affinity assay showed that there was no difference between cervical polyps and normal sera of BMI-1 autoantibody levels, but it was significantly greater in patient sera than that in normal controls (patient 0.827 +/- 0.043 and normal 0.445 +/- 0.023; P<0.001). What's more, the levels of BMI-1 autoantibody increased significantly at stage I (0.672 +/- 0.019) compared to normal sera (P<0.001), and levels of BMI-1 autoantibodies were increased gradually during the tumor progression (stage I 0.672 +/- 0.019; stage II 0.775 +/- 0.019; stage III 0.890 +/- 0.027; stage IV 1.043 +/- 0.041), which were significantly correlated with disease progression of cervical carcer (P<0.001). Statistical analyses using logistic regression and receiver operating characteristics (ROC) curves indicated that the BMI-1 autoantibody level can be used as a biomarker for cervical carcinoma (sensitivity 0.78 and specificity 0.76; AUC = 0.922). In conclusion, measuring BMI-1 autoantibody levels of patients with cervical cancer could have clinical prognostic value as well as a non-tissue specific biomarker for neoplasms expressing BMI-1.	[Tong, Yong-Qing; Zheng, Hong-Yun; Gu, Jian; Li, Feng; Li, Yan] Wuhan Univ, Dept Clin Lab, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China; [Tong, Yong-Qing; Zheng, Hong-Yun; Li, Feng; Li, Yan] Wuhan Univ, Clin Mol Diagnost Ctr, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China; [Liu, Bei; He, Yu-Juan] Wuhan Univ Sci & Technol, Dept Pathol, Affiliated Tianyou Hosp, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University of Science & Technology	Tong, YQ (corresponding author), Wuhan Univ, Dept Clin Lab, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China.	yanlitf@yahoo.com.cn			Fundamental Research Funds for the Central Universities [302275751]; Hubei Provincial Natural Science Foundation of China [2010CDB06903]; National Natural Science Foundation of China [81000771]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Provincial Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work supported by the Fundamental Research Funds for the Central Universities (Grant No. 302275751, www.whu.edu.cn), Hubei Provincial Natural Science Foundation of China (Grant No. 2010CDB06903, www.hbstd.gov.cn), and National Natural Science Foundation of China (Grant No. 81000771, www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bea S, 2001, CANCER RES, V61, P2409; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Breuer RHJ, 2005, LUNG CANCER, V48, P299, DOI 10.1016/j.lungcan.2004.11.026; Carozzi F, 2008, LANCET ONCOL, V9, P937, DOI 10.1016/S1470-2045(08)70208-0; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chmura A, 2009, GINEKOL POL, V80, P361; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Honig A, 2010, ANTICANCER RES, V30, P1559; Insinga RP, 2011, CANCER EPIDEM BIOMAR, V20, P287, DOI 10.1158/1055-9965.EPI-10-0791; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Kalushkova A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011483; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Munoz N, 2000, J CLIN VIROL, V19, P1, DOI 10.1016/S1386-6532(00)00125-6; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P107, DOI 10.1016/j.ijgo.2009.02.009; Puthucode-Easwaran S, 2005, J Obstet Gynaecol, V25, P486; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Reeler A, 2009, ASIAN PAC J CANCER P, V10, P519; Riis MLH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-686; Ronco G, 2010, LANCET ONCOL; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Silva J, 2006, CLIN CANCER RES, V12, P6929, DOI 10.1158/1078-0432.CCR-06-0788; Smith RA, 2007, CA-CANCER J CLIN, V57, P90, DOI 10.3322/canjclin.57.2.90; Smith R, 2008, CA-CANCER J CLIN, V58, P161, DOI 10.3322/CA.2007.0017; Solomon D, 2007, CA-CANCER J CLIN, V57, P105, DOI 10.3322/canjclin.57.2.105; Steele JC, 2006, BRIT J CANCER, V95, P1202, DOI 10.1038/sj.bjc.6603369; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; SUN ZR, 2010, INT J GYNAECOL OBSTE; Tao YP, 1997, DEVELOPMENT, V124, P3587; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Tong YQ, 2008, PROTEOMICS, V8, P3185, DOI 10.1002/pmic.200700651; Tong YQ, 2008, CANCER BIOL THER, V7, P340, DOI 10.4161/cbt.7.3.5422; Villa LL, 2008, LANCET ONCOL, V9, P910, DOI 10.1016/S1470-2045(08)70238-9; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Zhang CL, 2007, HUM PATHOL, V38, P995, DOI 10.1016/j.humpath.2006.10.021; Zhang X, 2010, INT J GYNECOL CANCER, V20, P1597, DOI 10.1111/IGC.0b013e3181fd080e	35	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27804	10.1371/journal.pone.0027804	http://dx.doi.org/10.1371/journal.pone.0027804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132147	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789900023
J	Li, TG; Fu, CX; Di, B; Wu, JB; Yang, ZC; Wang, YL; Li, MX; Lu, JY; Chen, YY; Lu, EJ; Geng, JM; Hu, WS; Dong, ZQ; Li, MF; Zheng, BJ; Cao, KY; Wang, M				Li, Tiegang; Fu, Chuanxi; Di, Biao; Wu, Jibin; Yang, Zhicong; Wang, Yulin; Li, Meixia; Lu, Jianyun; Chen, Yiyun; Lu, Enjie; Geng, Jinmei; Hu, Wensui; Dong, Zhiqiang; Li, Meng-feng; Zheng, Bo-Jian; Cao, Kai-yuan; Wang, Ming			A Two-Year Surveillance of 2009 Pandemic Influenza A (H1N1) in Guangzhou, China: From Pandemic to Seasonal Influenza?	PLOS ONE			English	Article							UNITED-STATES; VIRUS; ENGLAND	In this two-years surveillance of 2009 pandemic influenza A (H1N1) (pH1N1) in Guangzhou, China, we reported here that the scale and duration of pH1N1 outbreaks, severe disease and fatality rates of pH1N1 patients were significantly lower or shorter in the second epidemic year (May 2010-April 2011) than those in the first epidemic year (May 2009-April 2010) (P<0.05), but similar to those of seasonal influenza (P>0.05). Similar to seasonal influenza, pre-existing chronic pulmonary diseases was a risk factor associated with fatal cases of pH1N1 influenza. Different from seasonal influenza, which occurred in spring/summer seasons annually, pH1N1 influenza mainly occurred in autumn/winter seasons in the first epidemic year, but prolonged to winter/spring season in the second epidemic year. The information suggests a tendency that the epidemics of pH1N1 influenza may probably further shift to spring/summer seasons and become a predominant subtype of seasonal influenza in coming years in Guangzhou, China.	[Li, Tiegang; Fu, Chuanxi; Di, Biao; Wu, Jibin; Yang, Zhicong; Wang, Yulin; Li, Meixia; Lu, Jianyun; Chen, Yiyun; Lu, Enjie; Geng, Jinmei; Hu, Wensui; Dong, Zhiqiang; Wang, Ming] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Li, Meng-feng; Cao, Kai-yuan] Sun Yat Sen Univ, Sch Med, Dept Microbiol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Meng-feng; Cao, Kai-yuan] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Bo-Jian] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; University of Hong Kong	Li, TG (corresponding author), Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	caoky@mail.sysu.edu.cn; wangming@gzcdc.org.cn	Lu, Jianyun/AAU-4620-2020; meng, li/GVT-2063-2022; Fu, Chuanxi/K-5462-2016	Lu, Jianyun/0000-0002-1721-1862; 	Science and Information Technology of Guangzhou [2010YIC09]; Ministry of Science and Technology of the People's Republic of China [2009ZX10004-306, 2009ZX10004-213]	Science and Information Technology of Guangzhou; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This study was supported by Science and Information Technology of Guangzhou (grant number 2010YIC09), and the Ministry of Science and Technology of the People's Republic of China (grant number 2009ZX10004-306 and 2009ZX10004-213). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDARANAYAKE D, 2011, EURO SURVEILL, V16; Brammer L, 2011, CLIN INFECT DIS, V52, pS27, DOI 10.1093/cid/ciq009; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P37; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dominguez-Cherit Guillermo, 2010, Curr Infect Dis Rep, V12, P204, DOI 10.1007/s11908-010-0097-0; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; FU C, 2010, HUM VACCIN, V6; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Haddock Robert L, 2010, Hawaii Med J, V69, P50; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; HERSH AL, 2011, PEDIAT INFECT DIS J; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kim HS, 2011, J KOREAN MED SCI, V26, P22, DOI 10.3346/jkms.2011.26.1.22; KIRAKLI C, 2011, RESP CARE; Li TG, 2011, J CLIN VIROL, V50, P235, DOI 10.1016/j.jcv.2010.11.012; Li TieGang, 2008, Disease Surveillance, V23, P478; Lindblade KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015826; Louie JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018221; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nickel KB, 2011, PUBLIC HEALTH REP, V126, P349, DOI 10.1177/003335491112600308; Oh WS, 2011, J KOREAN MED SCI, V26, P499, DOI 10.3346/jkms.2011.26.4.499; Torres JP, 2010, CLIN INFECT DIS, V50, P860, DOI 10.1086/650750; Pebody RG, 2010, EUROSURVEILLANCE, V15; REYES S, 2011, RESP MED; Roll U, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-92; SIMON ML, 2011, GAC SANIT; VAILLANT L, 2009, EURO SURVEILL, V14; Wang M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016809; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; WILKING H, 2010, EURO SURVEILL, V15; Wilson N, 2009, EUROSURVEILLANCE, V14; Yang Zhi-Cong, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P684; Yuan Jun, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P852	36	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e28027	10.1371/journal.pone.0028027	http://dx.doi.org/10.1371/journal.pone.0028027			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125653	Green Published, gold			2022-12-25	WOS:000297789200053
J	Michielsen, AJ; Hogan, AE; Marry, J; Tosetto, M; Cox, F; Hyland, JM; Sheahan, KD; O'Donoghue, DP; Mulcahy, HE; Ryan, EJ; O'Sullivan, JN				Michielsen, Adriana J.; Hogan, Andrew E.; Marry, Joseph; Tosetto, Miriam; Cox, Fionnuala; Hyland, John M.; Sheahan, Kieran D.; O'Donoghue, Diarmuid P.; Mulcahy, Hugh E.; Ryan, Elizabeth J.; O'Sullivan, Jacintha N.			Tumour Tissue Microenvironment Can Inhibit Dendritic Cell Maturation in Colorectal Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; FUNCTIONAL MATURATION; CXC CHEMOKINES; T-CELLS; G-CSF; ANGIOGENESIS; ACTIVATION; MIGRATION; VEGF	Inflammatory mediators in the tumour microenvironment promote tumour growth, vascular development and enable evasion of anti-tumour immune responses, by disabling infiltrating dendritic cells. However, the constituents of the tumour microenvironment that directly influence dendritic cell maturation and function are not well characterised. Our aim was to identify tumour-associated inflammatory mediators which influence the function of dendritic cells. Tumour conditioned media obtained from cultured colorectal tumour explant tissue contained high levels of the chemokines CCL2, CXCL1, CXCL5 in addition to VEGF. Pre-treatment of monocyte derived dendritic cells with this tumour conditioned media inhibited the up-regulation of CD86, CD83, CD54 and HLA-DR in response to LPS, enhancing IL-10 while reducing IL-12p70 secretion. We examined if specific individual components of the tumour conditioned media (CCL2, CXCL1, CXCL5) could modulate dendritic cell maturation or cytokine secretion in response to LPS. VEGF was also assessed as it has a suppressive effect on dendritic cell maturation. Pre-treatment of immature dendritic cells with VEGF inhibited LPS induced upregulation of CD80 and CD54, while CXCL1 inhibited HLA-DR. Interestingly, treatment of dendritic cells with CCL2, CXCL1, CXCL5 or VEGF significantly suppressed their ability to secrete IL-12p70 in response to LPS. In addition, dendritic cells treated with a combination of CXCL1 and VEGF secreted less IL-12p70 in response to LPS compared to pre-treatment with either cytokine alone. In conclusion, tumour conditioned media strongly influences dendritic cell maturation and function.	[Michielsen, Adriana J.; Marry, Joseph; Tosetto, Miriam; Cox, Fionnuala; Hyland, John M.; Sheahan, Kieran D.; O'Donoghue, Diarmuid P.; Mulcahy, Hugh E.] St Vincents Univ Hosp, Ctr Colorectal Dis, Dublin 4, Ireland; [Hogan, Andrew E.] St Vincents Univ Hosp, Obes Grp, Dublin 4, Ireland; [Ryan, Elizabeth J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [O'Sullivan, Jacintha N.] St James Hosp, Inst Mol Med, Trinity Ctr Hlth Sci, Dublin 8, Ireland	University College Dublin; Saint Vincent's University Hospital; University College Dublin; Saint Vincent's University Hospital; Trinity College Dublin; Trinity College Dublin	Michielsen, AJ (corresponding author), St Vincents Univ Hosp, Ctr Colorectal Dis, Elm Pk, Dublin 4, Ireland.	osullij4@tcd.ie	Ryan, Elizabeth/H-9758-2019; Hogan, Andrew/K-1521-2013	Ryan, Elizabeth/0000-0002-5137-1253; O'Sullivan, Jacintha/0000-0001-8622-9858; Hogan, Andrew/0000-0001-5875-230X; mulcahy, hugh/0000-0002-7087-6177	Irish Research Council for Science, Engineering and Technology; Darren Gibbons Foundation	Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and Technology); Darren Gibbons Foundation	This study was funded by the Irish Research Council for Science, Engineering and Technology and the Darren Gibbons Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro C, 2009, BRIT J CANCER, V100, P1111, DOI 10.1038/sj.bjc.6604965; Baier PK, 2005, ANTICANCER RES, V25, P3581; Bechara C, 2007, MED SCI MONITOR, V13, pRA87; Bharadwaj U, 2007, CANCER RES, V67, P5479, DOI 10.1158/0008-5472.CAN-06-3963; Braun MC, 2000, J IMMUNOL, V164, P3009, DOI 10.4049/jimmunol.164.6.3009; Braun MC, 2001, MICROBES INFECT, V3, P99, DOI 10.1016/S1286-4579(00)01357-5; Breloer M, 2008, TRENDS IMMUNOL, V29, P186, DOI 10.1016/j.it.2008.01.009; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; Czerniecki BJ, 2001, CRIT REV IMMUNOL, V21, P157; de la Rosa G, 2003, J LEUKOCYTE BIOL, V73, P639, DOI 10.1189/jlb.1002516; Della Porta M, 2005, ONCOLOGY-BASEL, V68, P276, DOI 10.1159/000086784; Fainaru O, 2009, FASEB J; Feijoo E, 2005, INT J CANCER, V116, P275, DOI 10.1002/ijc.21046; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; *GEN, 2009, AV FULL PRESCR INF; Gorman S, 2009, MUTAT RES-FUND MOL M, V669, P131, DOI 10.1016/j.mrfmmm.2009.06.003; Kikuchi K, 2006, ANTICANCER RES, V26, P1833; Kulbe H, 2004, INT J DEV BIOL, V48, P489, DOI 10.1387/ijdb.041814hk; Liu C, 2011, INT J BIOL SCI, V7, P168, DOI 10.7150/ijbs.7.168; Liu W M, 2010, Br J Cancer, V102, P115, DOI 10.1038/sj.bjc.6605465; Mimura K, 2007, CANCER IMMUNOL IMMUN, V56, P761, DOI 10.1007/s00262-006-0234-7; Minkis K, 2008, CANCER RES, V68, P9441, DOI 10.1158/0008-5472.CAN-08-0900; Nguyen-Jackson H, 2010, BLOOD, V115, P3354, DOI 10.1182/blood-2009-08-240317; Omata N, 2002, J IMMUNOL, V169, P4861, DOI 10.4049/jimmunol.169.9.4861; Osada T, 2008, CANCER IMMUNOL IMMUN, V57, P1115, DOI 10.1007/s00262-007-0441-x; Payne AS, 2002, J INVEST DERMATOL, V118, P915, DOI 10.1046/j.1523-1747.2002.01725.x; Prechtel AT, 2007, ARCH DERMATOL RES, V299, P59, DOI 10.1007/s00403-007-0743-z; Puig-Kroger A, 2001, BLOOD, V98, P2175, DOI 10.1182/blood.V98.7.2175; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shyamala V, 1998, BIOCHEMISTRY-US, V37, P15918, DOI 10.1021/bi9811415; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Sozzani S, 1997, J IMMUNOL, V159, P1993; Strieter RM, 2004, SEMIN CANCER BIOL, V14, P195, DOI 10.1016/j.semcancer.2003.10.006; Tazzyman S, 2009, INT J EXP PATHOL, V90, P222, DOI 10.1111/j.1365-2613.2009.00641.x; Walz A, 1997, J LEUKOCYTE BIOL, V62, P604, DOI 10.1002/jlb.62.5.604; Wilson C, 2008, J PHARMACOL EXP THER, V327, P746, DOI 10.1124/jpet.108.143826; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; Xu SW, 2003, J IMMUNOL, V171, P2251, DOI 10.4049/jimmunol.171.5.2251	40	79	86	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27944	10.1371/journal.pone.0027944	http://dx.doi.org/10.1371/journal.pone.0027944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125641	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000297789200041
J	Pradeep, CR; Zeisel, A; Kostler, WJ; Lauriola, M; Jacob-Hirsch, J; Haibe-Kains, B; Amariglio, N; Ben-Chetrit, N; Emde, A; Solomonov, I; Neufeld, G; Piccart, M; Sagi, I; Sotiriou, C; Rechavi, G; Domany, E; Desmedt, C; Yarden, Y				Pradeep, C-R; Zeisel, A.; Koestler, W. J.; Lauriola, M.; Jacob-Hirsch, J.; Haibe-Kains, B.; Amariglio, N.; Ben-Chetrit, N.; Emde, A.; Solomonov, I.; Neufeld, G.; Piccart, M.; Sagi, I.; Sotiriou, C.; Rechavi, G.; Domany, E.; Desmedt, C.; Yarden, Y.			Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions	ONCOGENE			English	Article						adhesion; breast cancer; EGF; HER2; hypoxia	CARCINOMA IN-SITU; LYSYL OXIDASE; ANOIKIS RESISTANCE; FACTOR-BETA; EXPRESSION; ERBB2; RECEPTOR; SURVIVAL; CELLS; HER2	The HER2/neu oncogene encodes a receptor-like tyrosine kinase whose overexpression in breast cancer predicts poor prognosis and resistance to conventional therapies. However, the mechanisms underlying aggressiveness of HER2 (human epidermal growth factor receptor 2)-overexpressing tumors remain incompletely understood. Because it assists epidermal growth factor (EGF) and neuregulin receptors, we overexpressed HER2 in MCF10A mammary cells and applied growth factors. HER2-overexpressing cells grown in extracellular matrix formed filled spheroids, which protruded outgrowths upon growth factor stimulation. Our transcriptome analyses imply a two-hit model for invasive growth: HER2-induced proliferation and evasion from anoikis generate filled structures, which are morphologically and transcriptionally analogous to preinvasive patients' lesions. In the second hit, EGF escalates signaling and transcriptional responses leading to invasive growth. Consistent with clinical relevance, a gene expression signature based on the HER2/EGF-activated transcriptional program can predict poorer prognosis of a subgroup of HER2-overexpressing patients. In conclusion, the integration of a three-dimensional cellular model and clinical data attributes progression of HER2-overexpressing lesions to EGF-like growth factors acting in the context of the tumor's microenvironment. Oncogene (2012) 31, 3569-3583; doi:10.1038/onc.2011.547; published online 5 December 2011	[Pradeep, C-R; Koestler, W. J.; Lauriola, M.; Ben-Chetrit, N.; Emde, A.; Yarden, Y.] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Zeisel, A.; Domany, E.] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Jacob-Hirsch, J.; Amariglio, N.; Rechavi, G.] Tel Aviv Univ, Chaim Sheba Med Ctr, Dept Pediat Hematooncol & Funct Genom, IL-69978 Tel Aviv, Israel; [Jacob-Hirsch, J.; Amariglio, N.; Rechavi, G.] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Haibe-Kains, B.; Piccart, M.; Sotiriou, C.; Desmedt, C.] Inst Jules Bordet, Translat Res Unit, B-1000 Brussels, Belgium; [Haibe-Kains, B.] Univ Libre Bruxelles, Machine Learning Grp, Brussels, Belgium; [Solomonov, I.; Sagi, I.] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Neufeld, G.] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc Res & Vasc Biol Ctr, IL-31096 Haifa, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Institut Jules Bordet; Universite Libre de Bruxelles; Weizmann Institute of Science; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Yarden, Y (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, Candiotty Bldg,Room 302,1 Hertzl St, IL-76100 Rehovot, Israel.	yosef.yarden@weizmann.ac.il	Neufeld, Gera/F-1524-2019; Desmedt, Christine/P-7438-2017; lauriola, mattia/N-6435-2014; YARDEN, YOSEF/K-1467-2012; Haibe-Kains, Benjamin/D-3702-2011; DOMANY, EYTAN/K-1560-2012	Desmedt, Christine/0000-0002-5223-5579; Haibe-Kains, Benjamin/0000-0002-7684-0079; lauriola, mattia/0000-0002-7966-0065	National Cancer Institute [CA72981]; M.D. Moross Institute for Cancer Research; Kekst Family Institute for Medical Genetics; Women's Health Research Center; Bennett-Pritzker Endowment Fund; Marvelle Koffler Program for Breast Cancer Research; Harry and Jeanette Weinberg Women's Health Research Endowment; Oprah Winfrey Biomedical Research Fund; Arresto Biosciences; European Commission; German Research Foundation; NATIONAL CANCER INSTITUTE [R01CA072981, R37CA072981] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); M.D. Moross Institute for Cancer Research; Kekst Family Institute for Medical Genetics; Women's Health Research Center; Bennett-Pritzker Endowment Fund; Marvelle Koffler Program for Breast Cancer Research; Harry and Jeanette Weinberg Women's Health Research Endowment; Oprah Winfrey Biomedical Research Fund; Arresto Biosciences; European Commission(European CommissionEuropean Commission Joint Research Centre); German Research Foundation(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Carlos Arteaga and Ittai Ben-Porath for reagents and helpful insights. Our laboratories are supported by research grants from the National Cancer Institute (Grant CA72981), the M.D. Moross Institute for Cancer Research, Kekst Family Institute for Medical Genetics, Women's Health Research Center funded by Bennett-Pritzker Endowment Fund, Marvelle Koffler Program for Breast Cancer Research, Harry and Jeanette Weinberg Women's Health Research Endowment, Oprah Winfrey Biomedical Research Fund, Arresto Biosciences, the European Commission, and the German Research Foundation. YY is the incumbent of the Harold and Zelda Goldenberg Professorial Chair. ED is the incumbent of the Henry J Leir Professorial Chair.	Akiri G, 2003, CANCER RES, V63, P1657; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Balleine RL, 2008, CLIN CANCER RES, V14, P8244, DOI 10.1158/1078-0432.CCR-08-0939; Chen DT, 2010, BREAST CANCER RES TR, V119, P335, DOI 10.1007/s10549-009-0344-y; Collins NL, 2005, MOL CELL BIOL, V25, P5282, DOI 10.1128/MCB.25.12.5282-5291.2005; Cox DR, 1972, J R STAT SOC B, V4, P102; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Desmedt C, 2008, EUR J CANCER, V44, P2714, DOI 10.1016/j.ejca.2008.09.011; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Ensslin MA, 2007, P NATL ACAD SCI USA, V104, P2715, DOI 10.1073/pnas.0610296104; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jechlinger M, 2009, GENE DEV, V23, P1677, DOI 10.1101/gad.1801809; Kirschmann DA, 2002, CANCER RES, V62, P4478; Klapper LN, 1999, P NATL ACAD SCI USA, V96, P4995, DOI 10.1073/pnas.96.9.4995; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; LONARDO F, 1990, New Biologist, V2, P992; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Muller WJ, 1996, MOL CELL BIOL, V16, P5726; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Pontier SM, 2010, ONCOGENE, V29, P3374, DOI 10.1038/onc.2010.86; RIESE DJ, 1995, MOL CELL BIOL, V15, P5770; RILKE F, 1991, INT J CANCER, V49, P44, DOI 10.1002/ijc.2910490109; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smigal C, 2006, CA-CANCER J CLIN, V56, P168, DOI 10.3322/canjclin.56.3.168; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tagliabue E, 2003, LANCET, V362, P527, DOI 10.1016/S0140-6736(03)14112-8; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Therneau TM, 2000, MODELING SURVIVAL DA; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; Valabrega G, 2005, ONCOGENE, V24, P3002, DOI 10.1038/sj.onc.1208478; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; Virolle T, 2003, J BIOL CHEM, V278, P11802, DOI 10.1074/jbc.M210279200; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Zhan LX, 2006, CANCER RES, V66, P5201, DOI 10.1158/0008-5472.CAN-05-4081	47	28	28	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	31					3569	3583		10.1038/onc.2011.547	http://dx.doi.org/10.1038/onc.2011.547			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	985EG	22139081	Green Accepted			2022-12-25	WOS:000307245600001
J	Xue, Y; Ha, Y				Xue, Yi; Ha, Ya			Catalytic Mechanism of Rhomboid Protease GlpG Probed by 3,4-Dichloroisocoumarin and Diisopropyl Fluorophosphonate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMEMBRANE PROTEOLYSIS; DROSOPHILA RHOMBOID-1; CRYSTAL-STRUCTURE; SERINE PROTEASES; STRUCTURAL BASIS; FAMILY; REVEALS; TOXOPLASMA; ACTIVATION; PROTEINS	Rhomboid proteases have many important biological functions. Unlike soluble serine proteases such as chymotrypsin, the active site of rhomboid protease, which contains a Ser-His catalytic dyad, is submerged in the membrane and surrounded by membrane-spanning helices. Previous crystallographic analyses of GlpG, a bacterial rhomboid protease, and its complex with isocoumarin have provided insights into the mechanism of the membrane protease. Here, we studied the interaction of GlpG with 3,4-dichloroisocoumarin and diisopropyl fluorophosphonate, both mechanism-based inhibitors for the serine protease, and describe the crystal structure of the covalent adduct between GlpG and diisopropyl fluorophosphonate, which mimics the oxyanion-containing tetrahedral intermediate of the hydrolytic reaction. The crystal structure confirms that the oxyanion is stabilized by the main chain amide of Ser-201 and by the side chains of His-150 and Asn-154. The phosphorylation of the catalytic Ser-201 weakens its interaction with His-254, causing the catalytic histidine to rotate away from the serine. The rotation of His-254 is accompanied by further rearrangement of the side chains of Tyr-205 and Trp-236 within the substrate-binding groove. The formation of the tetrahedral adduct is also accompanied by opening of the L5 cap and movement of transmembrane helix S5 toward S6 in a direction different from that predicted by the lateral gating model. Combining the new structural data with those on the isocoumarin complex sheds further light on the plasticity of the active site of rhomboid membrane protease.	[Xue, Yi; Ha, Ya] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Ha, Y (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	ya.ha@yale.edu			National Institutes of Health [GM082839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM082839 (to Y. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; BENOIT F, 1969, ORG MASS SPECTROM, V2, P591, DOI 10.1002/oms.1210020605; Bondar AN, 2009, STRUCTURE, V17, P395, DOI 10.1016/j.str.2008.12.017; BONE R, 1991, BIOCHEMISTRY-US, V30, P2263, DOI 10.1021/bi00222a032; Brooks CL, 2011, J MOL BIOL, V407, P687, DOI 10.1016/j.jmb.2011.01.046; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Cole LB, 1998, ACTA CRYSTALLOGR D, V54, P711, DOI 10.1107/S0907444997010457; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erez E, 2009, BIOCHEMISTRY-US, V48, P12314, DOI 10.1021/bi901648g; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Ha Y, 2009, SEMIN CELL DEV BIOL, V20, P240, DOI 10.1016/j.semcdb.2008.11.006; HARPER JW, 1985, BIOCHEMISTRY-US, V24, P1831, DOI 10.1021/bi00329a005; Hill RB, 2010, SEMIN CELL DEV BIOL, V21, P582, DOI 10.1016/j.semcdb.2009.12.011; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Larsen NA, 2006, BIOCHEMISTRY-US, V45, P10184, DOI 10.1021/bi060950i; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; Maegawa S, 2007, MOL MICROBIOL, V64, P435, DOI 10.1111/j.1365-2958.2007.05679.x; MAYER U, 1988, GENE DEV, V2, P1496, DOI 10.1101/gad.2.11.1496; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; Opitz C, 2002, EMBO J, V21, P1577, DOI 10.1093/emboj/21.7.1577; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POWERS JC, 1994, METHOD ENZYMOL, V244, P442; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Urban S, 2008, BIOL CHEM, V389, P1107, DOI 10.1515/BC.2008.122; Urban S, 2006, GENE DEV, V20, P3054, DOI 10.1101/gad.1488606; VIJAYALAKSHMI J, 1991, BIOCHEMISTRY-US, V30, P2175, DOI 10.1021/bi00222a022; Vinothkumar KR, 2011, J MOL BIOL, V407, P232, DOI 10.1016/j.jmb.2011.01.029; Vinothkumar KR, 2010, EMBO J, V29, P3797, DOI 10.1038/emboj.2010.243; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Wang YC, 2007, P NATL ACAD SCI USA, V104, P2098, DOI 10.1073/pnas.0611080104; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Wasserman JD, 2000, GENE DEV, V14, P1651; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179	49	48	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3099	3107		10.1074/jbc.M111.310482	http://dx.doi.org/10.1074/jbc.M111.310482			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22130671	hybrid, Green Published			2022-12-25	WOS:000300295100016
J	Gutierrez-Uzquiza, A; Arechederra, M; Bragado, P; Aguirre-Ghiso, JA; Porras, A				Gutierrez-Uzquiza, Alvaro; Arechederra, Maria; Bragado, Paloma; Aguirre-Ghiso, Julio A.; Porras, Almudena			p38 alpha Mediates Cell Survival in Response to Oxidative Stress via Induction of Antioxidant Genes EFFECT ON THE p70S6K PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P38 MAP-KINASES; H2O2-INDUCED APOPTOSIS; SIGNAL-TRANSDUCTION; SENSITIZES CELLS; MESSENGER-RNA; PATHWAY; ACTIVATION; CANCER; MECHANISMS; SENESCENCE	We reveal a novel pro-survival role for mammalian p38 alpha in response to H2O2, which involves an up-regulation of antioxidant defenses. The presence of p38 alpha increases basal and H2O2-induced expression of the antioxidant enzymes: superoxide-dismutase 1 (SOD-1), SOD-2, and catalase through different mechanisms, which protects from reactive oxygen species (ROS) accumulation and prevents cell death. p38 alpha was found to regulate (i) H2O2-induced SOD-2 expression through a direct regulation of transcription mediated by activating transcription factor 2 (ATF-2) and (ii) H2O2-induced catalase expression through regulation of protein stability and mRNA expression and/or stabilization. As a consequence, SOD and catalase activities are higher in WT MEFs. We also found that this p38 alpha-dependent antioxidant response allows WT cells to maintain an efficient activation of the mTOR/p70S6K pathway. Accordingly, the loss of p38 alpha leads to ROS accumulation in response to H2O2, which causes cell death and inactivation of mTOR/p70S6K signaling. This can be rescued by either p38 alpha re-expression or treatment with the antioxidants, N-acetyl cysteine, or exogenously added catalase. Therefore, our results reveal a novel homeostatic role for p38 alpha in response to oxidative stress, where ROS removal is favored by antioxidant enzymes up-regulation, allowing cell survival and mTOR/p70S6K activation.	[Porras, Almudena] Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol 2, Inst Invest Sanitaria Hosp Clin San Carlos, E-28040 Madrid, Spain; [Bragado, Paloma; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Div Hematol & Oncol, Dept Med, New York, NY 10029 USA; [Bragado, Paloma; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Dept Otolaryngol, Tisch Canc Inst, Black Family Stem Cell Inst, New York, NY 10029 USA	Complutense University of Madrid; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Porras, A (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Bioquim & Biol Mol 2, Inst Invest Sanitaria Hosp Clin San Carlos, Ciudad Univ, E-28040 Madrid, Spain.	maporras@farm.ucm.es	Uzquiza, Alvaro Gutierrez/E-4073-2012; Porras, Almudena/N-2121-2015; Arechederra, Maria/F-4373-2016; Bragado Domingo, Paloma/A-8679-2015; Arechederra, María/L-9108-2019	Uzquiza, Alvaro Gutierrez/0000-0002-0446-4131; Porras, Almudena/0000-0002-6495-3308; Arechederra, Maria/0000-0002-4830-1924; Bragado Domingo, Paloma/0000-0002-7642-1245; Arechederra, María/0000-0002-4830-1924; Aguirre-Ghiso, Julio/0000-0002-6694-6507	National Institutes of Health [CA109182, ES017146]; Ministry of Science and Innovation of Spain [FIS-PI070071, SAF-2010-20198-C02-01]; Comunidad de Madrid/Universidad Complutense de Madrid [920384]; Samuel Waxman Cancer Research Foundation; New York Stem Cell Science; Comunidad de Madrid; Ministry of Education, Spain; NATIONAL CANCER INSTITUTE [R01CA109182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid/Universidad Complutense de Madrid(Comunidad de Madrid); Samuel Waxman Cancer Research Foundation; New York Stem Cell Science; Comunidad de Madrid(Comunidad de Madrid); Ministry of Education, Spain(Spanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA109182 and ES017146 (to J. A. A.-G.). This work was also supported by Grants FIS-PI070071 and SAF-2010-20198-C02-01 from Ministry of Science and Innovation of Spain and Grant 920384 from Comunidad de Madrid/Universidad Complutense de Madrid (to A. P.), grants from the Samuel Waxman Cancer Research Foundation Tumor Dormancy Program, and a grant from New York Stem Cell Science (to J. A. A.-G.).; Predoctoral student supported by Comunidad de Madrid.; Ph.D. student supported by Ministry of Education (FPU fellowship), Spain.	Aggeli IKS, 2006, CELL SIGNAL, V18, P1801, DOI 10.1016/j.cellsig.2006.02.001; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Cai WK, 2011, MOL BIOL CELL, V22, P3231, DOI 10.1091/mbc.E11-05-0400; Cao C, 2008, J BIOL CHEM, V283, P28897, DOI 10.1074/jbc.M804144200; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; del Castillo G, 2008, AM J PATHOL, V172, P1238, DOI 10.2353/ajpath.2008.070793; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Ferreiro I, 2010, J BIOL CHEM, V285, P31819, DOI 10.1074/jbc.M110.155846; Frippiat C, 2002, FREE RADICAL BIO MED, V33, P1334, DOI 10.1016/S0891-5849(02)01044-4; Gutierrez-Uzquiza A, 2010, CELL SIGNAL, V22, P533, DOI 10.1016/j.cellsig.2009.11.008; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; Kurata S, 2000, J BIOL CHEM, V275, P23413, DOI 10.1074/jbc.C000308200; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Sen P, 2005, FEBS LETT, V579, P4402, DOI 10.1016/j.febslet.2005.06.081; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Xu QH, 2004, FREE RADICAL BIO MED, V36, P985, DOI 10.1016/j.freeradbiomed.2004.01.009; Zhang XC, 2005, J BIOL CHEM, V280, P8714, DOI 10.1074/jbc.M408092200; Zuluaga S, 2007, CELL SIGNAL, V19, P62, DOI 10.1016/j.cellsig.2006.05.032	33	101	102	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2632	2642		10.1074/jbc.M111.323709	http://dx.doi.org/10.1074/jbc.M111.323709			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139847	hybrid, Green Published			2022-12-25	WOS:000300292300036
J	Willimott, S; Wagner, SD				Willimott, Shaun; Wagner, Simon D.			miR-125b and miR-155 Contribute to BCL2 Repression and Proliferation in Response to CD40 Ligand (CD154) in Human Leukemic B-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; NEOPLASTIC LYMPHOID-TISSUES; ANTIBODY-FORMING-CELLS; GERMINAL CENTER; MESSENGER-RNA; CYCLE ENTRY; TRANSLATION INITIATION; PROTEIN EXPRESSION; UP-REGULATION; INHIBITION	Developmental stage-specific regulation of BCL2 occurs during B-cell maturation and has a role in normal immunity. CD40 signaling promotes proliferation and rescues B-cells from apoptosis, partly through induction of BCL2L1 and BCL2A1 and repression of BCL2. We previously showed that a stromal cell/CD40 ligand (CD154) culture system reproduced this switch in survival protein expression in primary human leukemic B-cells and we employed this model system to investigate BCL2 repression. BCL2 was post-transcriptionally regulated and the repressed BCL2 mRNA was associated with non-polysomal, but dense fractions on sucrose density gradients. Microarrays identified a set of miRNA that were induced by culture conditions and potentially able to bind to the BCL2 3'-UTR. Luciferase reporter assays demonstrated that miR-125b and miR-155 repressed BCL2 mRNA but while stromal cell contact alone was sufficient to induce strongly miR-125b this did not cause BCL2 repression. miR-155, which is the most abundant miRNA under basal conditions, specifically required CD154 for further induction above a threshold to exert its full repressive effects. Anti-miR-125b and anti-miR-155 prevented CD154-mediated repression of BCL2 and reduced CD154-mediated proliferation in the MEC1 B-cell line. We suggest that miR-155 and miR-125b, which are induced by CD154 and stromal cell signals, contribute to regulating proliferation and that BCL2 is one of their target mRNAs.	[Wagner, Simon D.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester LE1 9HN, Leics, England; [Wagner, Simon D.] Univ Leicester, MRC Toxicol Unit, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leicester	Wagner, SD (corresponding author), Univ Leicester, Dept Canc Studies & Mol Med, Lancaster Rd, Leicester LE1 9HN, Leics, England.	sw227@le.ac.uk		Wagner, Simon/0000-0002-8914-0370	Kay Kendall Leukemia Fund	Kay Kendall Leukemia Fund	This work was supported by grants from the Kay Kendall Leukemia Fund.	AKAGI T, 1994, LEUKEMIA LYMPHOMA, V13, P81, DOI 10.3109/10428199409051655; AZZAM ME, 1973, P NATL ACAD SCI USA, V70, P3866, DOI 10.1073/pnas.70.12.3866; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Basso K, 2009, IMMUNITY, V30, P744, DOI 10.1016/j.immuni.2009.03.017; Bousquet M, 2010, P NATL ACAD SCI USA, V107, P21558, DOI 10.1073/pnas.1016611107; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Caligaris-Cappio F, 2003, BRIT J HAEMATOL, V123, P380, DOI 10.1046/j.1365-2141.2003.04679.x; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; CHLEQDESCHAMPS CM, 1993, BLOOD, V81, P293; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Cuni S, 2004, LEUKEMIA, V18, P1391, DOI 10.1038/sj.leu.2403398; Deng XM, 2004, P NATL ACAD SCI USA, V101, P153, DOI 10.1073/pnas.2533920100; Deng XM, 2003, BLOOD, V102, P3179, DOI 10.1182/blood-2003-04-1027; Gururajan M, 2010, INT IMMUNOL, V22, P583, DOI 10.1093/intimm/dxq042; Huang DCS, 1997, EMBO J, V16, P4628, DOI 10.1093/emboj/16.15.4628; Husson H, 2002, BLOOD, V99, P282, DOI 10.1182/blood.V99.1.282; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; KONDO E, 1992, BLOOD, V80, P2044; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mazel S, 1996, J EXP MED, V183, P2219, DOI 10.1084/jem.183.5.2219; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; O'Reilly L. A., 1997, J IMMUNOL; OReilly LA, 1997, INT IMMUNOL, V9, P1291, DOI 10.1093/intimm/9.9.1291; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; SCHENA M, 1992, BLOOD, V79, P2981; SCHMID C, 1994, HISTOPATHOLOGY, V24, P445, DOI 10.1111/j.1365-2559.1994.tb00553.x; Sellmann L, 2010, CANCER GENET CYTOGEN, V203, P149, DOI 10.1016/j.cancergencyto.2010.09.002; Shen YL, 2004, BLOOD, V104, P2936, DOI 10.1182/blood-2004-01-0243; Sherrill KW, 2004, J BIOL CHEM, V279, P29066, DOI 10.1074/jbc.M402727200; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Tarlinton DM, 2000, IMMUNOL TODAY, V21, P436, DOI 10.1016/S0167-5699(00)01687-X; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Wang M, 2008, J PATHOL, V215, P13, DOI 10.1002/path.2333; Willimott S, 2007, BRIT J HAEMATOL, V138, P721, DOI 10.1111/j.1365-2141.2007.06717.x; Winter JN, 1998, BLOOD, V91, P1391, DOI 10.1182/blood.V91.4.1391; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	50	51	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2608	2617		10.1074/jbc.M111.285718	http://dx.doi.org/10.1074/jbc.M111.285718			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139839	hybrid, Green Published			2022-12-25	WOS:000300292300034
J	Xiong, Y; Sheen, J				Xiong, Yan; Sheen, Jen			Rapamycin and Glucose-Target of Rapamycin (TOR) Protein Signaling in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MTOR FUNCTION; ARABIDOPSIS; GROWTH; KINASE; EXPRESSION; GENE; TRANSDUCTION; METABOLISM; COMPLEX; INHIBITION	Target of rapamycin (TOR) kinase is an evolutionarily conserved master regulator that integrates energy, nutrients, growth factors, and stress signals to promote survival and growth in all eukaryotes. The reported land plant resistance to rapamycin and the embryo lethality of the Arabidopsis tor mutants have hindered functional dissection of TOR signaling in plants. We developed sensitive cellular and seedling assays to monitor endogenous Arabidopsis TOR activity based on its conserved S6 kinase (S6K) phosphorylation. Surprisingly, rapamycin effectively inhibits Arabidopsis TOR-S6K1 signaling and retards glucose-mediated root and leaf growth, mimicking estradiol-inducible tor mutants. Rapamycin inhibition is relieved in transgenic plants deficient in Arabidopsis FK506-binding protein 12 (FKP12), whereas FKP12 overexpression dramatically enhances rapamycin sensitivity. The role of Arabidopsis FKP12 is highly specific as overexpression of seven closely related FKP proteins fails to increase rapamycin sensitivity. Rapamycin exerts TOR inhibition by inducing direct interaction between the TOR-FRB (FKP-rapamycin binding) domain and FKP12 in plant cells. We suggest that variable endogenous FKP12 protein levels may underlie the molecular explanation for longstanding enigmatic observations on inconsistent rapamycin resistance in plants and in various mammalian cell lines or diverse animal cell types. Integrative analyses with rapamycin and conditional tor and fkp12 mutants also reveal a central role of glucose-TOR signaling in root hair formation. Our studies demonstrate the power of chemical genetic approaches in the discovery of previously unknown and pivotal functions of glucose-TOR signaling in governing the growth of cotyledons, true leaves, petioles, and primary and secondary roots and root hairs.	[Sheen, Jen] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sheen, J (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	sheen@molbio.mgh.harvard.edu		Xiong, Yan/0000-0003-0676-8267	National Institutes of Health [R01 GM60493]; National Science Foundation [IOS-0843244]; Massachusetts General Hospital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Massachusetts General Hospital(General Electric); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM60493 (to J. S.). This work was also supported by National Science Foundation Grant IOS-0843244 (to J. S.).; Supported by the Massachusetts General Hospital Tosteson postdoctoral fellowship.	Ahn CS, 2011, PLANT CELL, V23, P185, DOI 10.1105/tpc.110.074005; Anderson GH, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-12; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Baena-Gonzalez E, 2008, TRENDS PLANT SCI, V13, P474, DOI 10.1016/j.tplants.2008.06.006; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Brand L, 2006, PLANT PHYSIOL, V141, P1194, DOI 10.1104/pp.106.081299; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Deprost D, 2005, BIOCHEM BIOPH RES CO, V326, P844, DOI 10.1016/j.bbrc.2004.11.117; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; Dobrenel T, 2011, BIOCHEM SOC T, V39, P477, DOI 10.1042/BST0390477; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; He ZY, 2004, PLANT PHYSIOL, V134, P1248, DOI 10.1104/pp.103.031005; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Li JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027364; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Ren MZ, 2011, PLANT PHYSIOL, V155, P1367, DOI 10.1104/pp.110.169045; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Russell RC, 2011, DEVELOPMENT, V138, P3343, DOI 10.1242/dev.058230; Sormani R, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-26; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao WY, 2000, PLANT MOL BIOL, V44, P451, DOI 10.1023/A:1026501430422; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	34	175	190	4	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2836	2842		10.1074/jbc.M111.300749	http://dx.doi.org/10.1074/jbc.M111.300749			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22134914	Green Published, hybrid			2022-12-25	WOS:000300292300055
J	Ingaramo, M; Beckett, D				Ingaramo, Maria; Beckett, Dorothy			Selectivity in Post-translational Biotin Addition to Five Human Carboxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; HUMAN HOLOCARBOXYLASE SYNTHETASE; ESCHERICHIA-COLI; BIOTINYLATION; PROTEINS; SUBUNIT; DOMAIN; CDNA	Human holocarboxylase synthetase (HCS) catalyzes linkage of the vitamin biotin to the biotin carboxyl carrier protein (BCCP) domain of five biotin-dependent carboxylases. In the two-step reaction, the activated intermediate, bio-5'-AMP, is first synthesized from biotin and ATP, followed by covalent linkage of the biotin moiety to a specific lysine residue of each carboxylase BCCP domain. Selectivity in HCS-catalyzed biotinylation to the carboxylases was investigated in single turnover stopped flow and quench flow measurements of biotin transfer to the minimal biotin acceptor BCCP fragments of the carboxylases. The results demonstrate that biotinylation of the BCCP fragments of the mitochondrial carboxylases propionyl-CoA carboxylase, pyruvate carboxylase, and methylcrotonoyl-CoA carboxylase is fast and limited by the bimolecular association rate of the enzyme with substrate. By contrast, biotinylation of the acetyl-CoA carboxylase 1 and 2 (ACC1 and ACC2) fragments, both of which are accessible to HCS in the cytoplasm, is slow and displays a hyperbolic dependence on substrate concentration. The correlation between HCS accessibility to biotin acceptor substrates and the kinetics of biotinylation suggests that mitochondrial carboxylase sequences evolved to produce fast association rates with HCS in order to ensure biotinylation prior to mitochondrial import. In addition, the results are consistent with a role for HCS specificity in dictating biotin distribution among carboxylases.	[Ingaramo, Maria; Beckett, Dorothy] Univ Maryland, Dept Chem & Biochem, Ctr Biol Struct & Org, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Beckett, D (corresponding author), Univ Maryland, Dept Chem & Biochem, Ctr Biol Struct & Org, College Pk, MD 20742 USA.	dbeckett@umd.edu			National Institutes of Health [R01GM46511, S10RR15899]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM46511 and S10RR15899 (to D. B.).	Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; Bailey LM, 2010, ARCH BIOCHEM BIOPHYS, V496, P45, DOI 10.1016/j.abb.2010.01.015; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Chapman-Smith A, 1999, J BIOL CHEM, V274, P1449, DOI 10.1074/jbc.274.3.1449; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Healy S, 2010, BIOCHEMISTRY-US, V49, P4687, DOI 10.1021/bi901612y; Healy S, 2009, PROTEIN SCI, V18, P314, DOI 10.1002/pro.37; Hiratsuka M, 1998, BBA-PROTEIN STRUCT M, V1385, P165, DOI 10.1016/S0167-4838(98)00032-6; Ingaramo M, 2009, J BIOL CHEM, V284, P30862, DOI 10.1074/jbc.M109.046201; Ingaranno M, 2011, J BIOL CHEM, V286, P13071, DOI 10.1074/jbc.M110.183624; Jitrapakdee S, 2003, CURR PROTEIN PEPT SC, V4, P217, DOI 10.2174/1389203033487199; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LANE MD, 1964, J BIOL CHEM, V239, P2865; Lee CK, 2010, FEBS LETT, V584, P675, DOI 10.1016/j.febslet.2009.12.059; LEONDELRIO A, 1995, P NATL ACAD SCI USA, V92, P4626, DOI 10.1073/pnas.92.10.4626; LEONDELRIO A, 1994, J BIOL CHEM, V269, P22964; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nenortas E, 1996, J BIOL CHEM, V271, P7559, DOI 10.1074/jbc.271.13.7559; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SUZUKI Y, 1994, NAT GENET, V8, P122, DOI 10.1038/ng1094-122; TARONI F, 1991, J BIOL CHEM, V266, P13267; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393	24	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1813	1822		10.1074/jbc.M111.275982	http://dx.doi.org/10.1074/jbc.M111.275982			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22123817	Green Published, hybrid			2022-12-25	WOS:000299321000023
J	Li, XZ; Yan, J; Huang, SH; Zhao, L; Wang, J; Chen, ZY				Li, Xue-Zhi; Yan, Jing; Huang, Shu-Hong; Zhao, Ling; Wang, Jue; Chen, Zhe-Yu			Identification of a Key Motif That Determines the Differential Surface Levels of RET and TrkB Tyrosine Kinase Receptors and Controls Depolarization Enhanced RET Surface Insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; DORSAL-ROOT; GDNF FAMILY; PHEOCHROMOCYTOMA CELLS; GANGLION NEURONS; PLASMA-MEMBRANE; NMDA RECEPTORS; AMPA RECEPTORS; DRG NEURONS; TRAFFICKING	The RET tyrosine kinase receptor plays an important role in the development and maintenance of the nervous system. Although the ligand-induced RET signaling pathway has been well described, little is known about the regulation of RET surface expression, which is integral to the cell ability to control the response to ligand stimuli. We found that in dorsal root ganglion (DRG) neurons, which co-express RET and TrkB, the receptor surface levels of RET are significantly higher than that of TrkB. Using a sequence substitution strategy, we identified a key motif (Box1), which is necessary and sufficient for the differential RET and TrkB surface levels. Furthermore, pharmacological and mutagenesis assays revealed that protein kinase C (PKC) and high K+ depolarization increase RET surface levels through phosphorylation of the Thr(675) residue in the Box1 motif. Finally, we found that the phosphorylation status of the Thr(675) residue influences RET mediated response to GDNF stimulation. In all, these findings provide a novel mechanism for the modulation of RET surface expression.	[Li, Xue-Zhi; Yan, Jing; Huang, Shu-Hong; Zhao, Ling; Wang, Jue; Chen, Zhe-Yu] Shandong Univ, Dept Neurobiol, Shandong Prov Key Lab Mental Disorders, Sch Med, Jinan 250012, Shandong, Peoples R China	Shandong University	Chen, ZY (corresponding author), Shandong Univ, Dept Neurobiol, Shandong Prov Key Lab Mental Disorders, Sch Med, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	zheyuchen@sdu.edu.cn	Li, Xuezhi/ABF-6626-2021; Wang, Jue/GVU-0480-2022	Li, Xuezhi/0000-0003-1030-9688	National Natural Science Foundation of China [30725020, 30900717, 31071254, 31130026]; National 973 Basic Research Program of China [2010CB912004, 2012CB911004]; National Natural Science Foundation of China for Innovative Research Group [81021001]; Foundation for Excellent Young Scientists of Shandong Province [BS2010SW022, BS2010SW023]; Research Fund for the Doctoral Program of Higher Education of China [200804221070]; Independent Innovation Foundation of Shandong University (IIFSDU)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); Foundation for Excellent Young Scientists of Shandong Province; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Independent Innovation Foundation of Shandong University (IIFSDU)	This study was supported by National Natural Science Foundation of China (No. 30725020, 30900717, 31071254, 31130026), the National 973 Basic Research Program of China (No. 2010CB912004, 2012CB911004), the State Program of National Natural Science Foundation of China for Innovative Research Group (No. 81021001), the Foundation for Excellent Young Scientists of Shandong Province (BS2010SW022, BS2010SW023), Research Fund for the Doctoral Program of Higher Education of China (200804221070), and Independent Innovation Foundation of Shandong University (IIFSDU).	Achour L, 2008, TRENDS PHARMACOL SCI, V29, P528, DOI 10.1016/j.tips.2008.07.009; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; ASAI N, 1995, MOL CELL BIOL, V15, P1613; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Bouchard JF, 2008, J NEUROCHEM, V107, P398, DOI 10.1111/j.1471-4159.2008.05609.x; Brismar H, 1998, P NATL ACAD SCI USA, V95, P5573, DOI 10.1073/pnas.95.10.5573; Califano D, 1996, P NATL ACAD SCI USA, V93, P7933, DOI 10.1073/pnas.93.15.7933; Chen ZY, 2005, MOL BIOL CELL, V16, P5761, DOI 10.1091/mbc.E05-07-0651; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; Doxakis E, 2000, DEVELOPMENT, V127, P1477; Dupre DJ, 2006, CELL SIGNAL, V18, P1549, DOI 10.1016/j.cellsig.2006.03.009; Fisher CE, 2001, DEVELOPMENT, V128, P4329; Fukuda T, 2002, J BIOL CHEM, V277, P19114, DOI 10.1074/jbc.M200643200; Gomes AR, 2007, TRAFFIC, V8, P259, DOI 10.1111/j.1600-0854.2006.00521.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; HEIN L, 1994, J BIOL CHEM, V269, P27719; Honma Y, 2010, DEVELOPMENT, V137, P2319, DOI 10.1242/dev.046995; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Huang SH, 2009, J BIOL CHEM, V284, P15126, DOI 10.1074/jbc.M809763200; Jijiwa M, 2004, MOL CELL BIOL, V24, P8026, DOI 10.1128/MCB.24.18.8026-8036.2004; Kashiba H, 2003, MOL BRAIN RES, V110, P52, DOI 10.1016/S0169-328X(02)00584-3; Kelly-Spratt KS, 1999, CELL GROWTH DIFFER, V10, P805; Kirchhausen T, 2002, NAT STRUCT BIOL, V9, P241, DOI 10.1038/nsb0402-241; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Kurokawa K, 2001, ONCOGENE, V20, P1929, DOI 10.1038/sj.onc.1204290; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Miyamoto R, 2011, DEV BIOL, V349, P160, DOI 10.1016/j.ydbio.2010.11.002; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; OLAGUE PH, 1980, P NATL ACAD SCI-BIOL, V77, P1701, DOI 10.1073/pnas.77.3.1701; Patten SA, 2009, P NATL ACAD SCI USA, V106, P6796, DOI 10.1073/pnas.0811171106; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Segouffin-Cariou C, 2000, J BIOL CHEM, V275, P3568, DOI 10.1074/jbc.275.5.3568; Tong W, 2006, J BIOL CHEM, V281, P38930, DOI 10.1074/jbc.M607524200; Valdes-Sanchez T, 2010, DEV BIOL, V339, P465, DOI 10.1016/j.ydbio.2010.01.001; WAKADE TD, 1991, J BIOL CHEM, V266, P6424; Zhao L, 2009, J CELL SCI, V122, P3123, DOI 10.1242/jcs.047712	41	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1932	1945		10.1074/jbc.M111.283457	http://dx.doi.org/10.1074/jbc.M111.283457			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128160	Green Published, hybrid			2022-12-25	WOS:000299321000034
J	Mori, K; Haruyama, T; Nagata, K				Mori, Kotaro; Haruyama, Takahiro; Nagata, Kyosuke			Tamiflu-Resistant but HA-Mediated Cell-to-Cell Transmission through Apical Membranes of Cell-Associated Influenza Viruses	PLOS ONE			English	Article							POLARIZED EPITHELIAL-CELLS; RESPIRATORY SYNCYTIAL VIRUS; ION-CHANNEL ACTIVITY; A VIRUS; VIROLOGICAL SYNAPSES; NEURAMINIDASE; ENTRY; HEMAGGLUTININ; SPREAD; RELEASE	The infection of viruses to a neighboring cell is considered to be beneficial in terms of evasion from host anti-virus defense systems. There are two pathways for viral infection to "right next door": one is the virus transmission through cell-cell fusion by forming syncytium without production of progeny virions, and the other is mediated by virions without virus diffusion, generally designated cell-to-cell transmission. Influenza viruses are believed to be transmitted as cell-free virus from infected cells to uninfected cells. Here, we demonstrated that influenza virus can utilize cell-to-cell transmission pathway through apical membranes, by handover of virions on the surface of an infected cell to adjacent host cells. Live cell imaging techniques showed that a recombinant influenza virus, in which the neuraminidase gene was replaced with the green fluorescence protein gene, spreads from an infected cell to adjacent cells forming infected cell clusters. This type of virus spreading requires HA activation by protease treatment. The cell-to-cell transmission was also blocked by amantadine, which inhibits the acidification of endosomes required for uncoating of influenza virus particles in endosomes, indicating that functional hemagglutinin and endosome acidification by M2 ion channel were essential for the cell-to-cell influenza virus transmission. Furthermore, in the cell-to-cell transmission of influenza virus, progeny virions could remain associated with the surface of infected cell even after budding, for the progeny virions to be passed on to adjacent uninfected cells. The evidence that cell-to-cell transmission occurs in influenza virus lead to the caution that local infection proceeds even when treated with neuraminidase inhibitors.	[Mori, Kotaro] Univ Tsukuba, Dept Infect Biol, Fac Med, Tsukuba, Ibaraki, Japan; Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba	Mori, K (corresponding author), Univ Tsukuba, Dept Infect Biol, Fac Med, Tsukuba, Ibaraki, Japan.	knagata@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [20249025]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to KN: #20249025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no additional external funding for this study.	AIR GM, 1989, PROTEINS, V6, P341, DOI 10.1002/prot.340060402; Balfe Peter, 2009, J Hepatol, V51, P609, DOI 10.1016/j.jhep.2009.06.014; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; BLAU DM, 1995, VIROLOGY, V210, P91, DOI 10.1006/viro.1995.1320; Brock SC, 2003, P NATL ACAD SCI USA, V100, P15143, DOI 10.1073/pnas.2434327100; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Carrasco M, 2004, TRAFFIC, V5, P979, DOI 10.1111/j.1600-0854.2004.00237.x; Chodosh J, 2000, VIROLOGY, V266, P387, DOI 10.1006/viro.1999.0082; Cresawn KO, 2007, EMBO J, V26, P3737, DOI 10.1038/sj.emboj.7601813; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Dustin M, 2003, NAT CELL BIOL, V5, P271, DOI 10.1038/ncb0403-271; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fujii Y, 2003, P NATL ACAD SCI USA, V100, P2002, DOI 10.1073/pnas.0437772100; FULLER S, 1984, CELL, V38, P65, DOI 10.1016/0092-8674(84)90527-0; Gubareva LV, 2002, J GEN VIROL, V83, P2683, DOI 10.1099/0022-1317-83-11-2683; Guerriero CJ, 2008, J BIOL CHEM, V283, P18040, DOI 10.1074/jbc.M802048200; GUPTA P, 1989, J VIROL, V63, P2361, DOI 10.1128/JVI.63.5.2361-2365.1989; Guyader M, 2002, J VIROL, V76, P10356, DOI 10.1128/JVI.76.20.10356-10364.2002; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jolly C, 2005, J VIROL, V79, P12088, DOI 10.1128/JVI.79.18.12088-12094.2005; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; Kawaguchi A, 2011, J VIROL, V85, P6197, DOI 10.1128/JVI.00277-11; KIDO H, 1992, J BIOL CHEM, V267, P13573; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; LAZAROWITZ SG, 1975, VIROLOGY, V68, P440, DOI 10.1016/0042-6822(75)90285-8; Lew W, 2000, CURR MED CHEM, V7, P663, DOI 10.2174/0929867003374886; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Nedyalkova MS, 2002, J INFECT DIS, V185, P591, DOI 10.1086/339358; Pais-Correia AM, 2010, NAT MED, V16, P83, DOI 10.1038/nm.2065; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; PHILLIPS DM, 1994, AIDS, V8, P719, DOI 10.1097/00002030-199406000-00001; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; ROBERTS SR, 1995, J VIROL, V69, P2667, DOI 10.1128/JVI.69.4.2667-2673.1995; SATO H, 1992, VIROLOGY, V186, P712, DOI 10.1016/0042-6822(92)90038-Q; Sato M, 2003, BIOL CHEM, V384, P219, DOI 10.1515/BC.2003.024; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Schlie K, 2010, J VIROL, V84, P3178, DOI 10.1128/JVI.02240-09; SHIBATA S, 1993, J VIROL, V67, P3264, DOI 10.1128/JVI.67.6.3264-3273.1993; Shinya K, 2004, J VIROL, V78, P3083, DOI 10.1128/JVI.78.6.3083-3088.2004; SKEHEL JJ, 1975, P NATL ACAD SCI USA, V72, P93, DOI 10.1073/pnas.72.1.93; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; SUGIURA A, 1975, VIROLOGY, V65, P363, DOI 10.1016/0042-6822(75)90042-2; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Takeda M, 2002, J VIROL, V76, P1391, DOI 10.1128/JVI.76.3.1391-1399.2002; Tamm LK, 2002, BIOPOLYMERS, V66, P249, DOI 10.1002/bip.10261; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Tseng CTK, 2005, J VIROL, V79, P9470, DOI 10.1128/JVI.79.15.9470-9479.2005; Watanabe K, 1996, J VIROL, V70, P241, DOI 10.1128/JVI.70.1.241-247.1996; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053	54	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28178	10.1371/journal.pone.0028178	http://dx.doi.org/10.1371/journal.pone.0028178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140536	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168100044
J	Voss, M; Nimtz, M; Leimkuhler, S				Voss, Martin; Nimtz, Manfred; Leimkuehler, Silke			Elucidation of the Dual Role of Mycobacterial MoeZR in Molybdenum Cofactor Biosynthesis and Cysteine Biosynthesis	PLOS ONE			English	Article							ESCHERICHIA-COLI; MOLYBDOPTERIN SYNTHASE; UBIQUITIN ACTIVATION; CRYSTAL-STRUCTURE; SULFUR DONOR; TUBERCULOSIS; PROTEIN; PATHWAY; IDENTIFICATION; SPECIFICITY	The pathway of molybdenum cofactor biosynthesis has been studied in detail by using proteins from Mycobacterium species, which contain several homologs associated with the first steps of Moco biosynthesis. While all Mycobacteria species contain a MoeZR, only some strains have acquired an additional homolog, MoeBR, by horizontal gene transfer. The role of MoeBR and MoeZR was studied in detail for the interaction with the two MoaD-homologs involved in Moco biosynthesis, MoaD1 and MoaD2, in addition to the CysO protein involved in cysteine biosynthesis. We show that both proteins have a role in Moco biosynthesis, while only MoeZR, but not MoeBR, has an additional role in cysteine biosynthesis. MoeZR and MoeBR were able to complement an E. coli moeB mutant strain, but only in conjunction with the Mycobacterial MoaD1 or MoaD2 proteins. Both proteins were able to sulfurate MoaD1 and MoaD2 in vivo, while only MoeZR additionally transferred the sulfur to CysO. Our in vivo studies show that Mycobacteria have acquired several homologs to maintain Moco biosynthesis. MoeZR has a dual role in Moco- and cysteine biosynthesis and is involved in the sulfuration of MoaD and CysO, whereas MoeBR only has a role in Moco biosynthesis, which is not an essential function for Mycobacteria.	[Voss, Martin; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Nimtz, Manfred] Helmholtz Ctr Infect Res, Braunschweig, Germany	University of Potsdam; Helmholtz Association; Helmholtz-Center for Infection Research	Voss, M (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	sleim@uni-potsdam.de		Leimkuhler, Silke/0000-0003-3238-2122	Deutsche Forschungsgemeinschaft [LE1171/5-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant (LE1171/5-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren D, 2008, J BIOL CHEM, V283, P31567, DOI 10.1074/jbc.M804877200; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Burns KE, 2005, J AM CHEM SOC, V127, P11602, DOI 10.1021/ja053476x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cortese MS, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-8; Dahl JU, 2011, J BIOL CHEM, V286, P35801, DOI 10.1074/jbc.M111.282368; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; JONES RW, 1977, BIOCHEM J, V164, P199, DOI 10.1042/bj1640199; Jurgenson CT, 2008, BIOCHEMISTRY-US, V47, P10354, DOI 10.1021/bi800915j; Krepinsky K, 2007, FEBS J, V274, P2778, DOI 10.1111/j.1742-4658.2007.05811.x; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Leimkuhler S, 2011, COORDIN CHEM REV, V255, P1129, DOI 10.1016/j.ccr.2010.12.003; Leimkuhler S, 2001, J BIOL CHEM, V276, P34695, DOI 10.1074/jbc.M102787200; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Marquet A, 2001, CURR OPIN CHEM BIOL, V5, P541, DOI 10.1016/S1367-5931(00)00249-0; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; O'Leary SE, 2008, BIOCHEMISTRY-US, V47, P11606, DOI 10.1021/bi8013664; Rosas-Magallanes V, 2007, INFECT IMMUN, V75, P504, DOI 10.1128/IAI.00058-06; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; SORBO B, 1957, BIOCHIM BIOPHYS ACTA, V23, P412, DOI 10.1016/0006-3002(57)90346-3; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Taylor SV, 1998, J BIOL CHEM, V273, P16555, DOI 10.1074/jbc.273.26.16555; Williams MJ, 2011, J BACTERIOL, V193, P98, DOI 10.1128/JB.00774-10; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172	28	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28170	10.1371/journal.pone.0028170	http://dx.doi.org/10.1371/journal.pone.0028170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140533	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168100043
J	Azare, J; Doane, A; Leslie, K; Chang, Q; Berishaj, M; Nnoli, J; Mark, K; Al-Ahmadie, H; Gerald, W; Hassimi, M; Viale, A; Stracke, M; Lyden, D; Bromberg, J				Azare, Janeen; Doane, Ashley; Leslie, Kenneth; Chang, Qing; Berishaj, Marjan; Nnoli, Jennifer; Mark, Kevin; Al-Ahmadie, Hikmat; Gerald, William; Hassimi, Maryam; Viale, Agnes; Stracke, Mary; Lyden, David; Bromberg, Jacqueline			Stat3 Mediates Expression of Autotaxin in Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MOTILITY-STIMULATING PROTEIN; ACTIVATED SIGNAL TRANSDUCER; CIRCULATING TUMOR-CELLS; HUMAN-MELANOMA CELLS; NF-KAPPA-B; LYSOPHOSPHATIDIC ACID; CARCINOMA CELLS; GENE-EXPRESSION; CONSTITUTIVE ACTIVATION	We determined that signal transducer and activator of transcription 3 (Stat3) is tyrosine phosphorylated in 37% of primary breast tumors and 63% of paired metastatic axillary lymph nodes. Examination of the distribution of tyrosine phosphorylated (pStat3) in primary tumors revealed heterogenous expression within the tumor with the highest levels found in cells on the edge of tumors with relatively lower levels in the central portion of tumors. In order to determine Stat3 target genes that may be involved in migration and metastasis, we identified those genes that were differentially expressed in primary breast cancer samples as a function of pStat3 levels. In addition to known Stat3 transcriptional targets (Twist, Snail, Tenascin-C and IL-8), we identified ENPP2 as a novel Stat3 regulated gene, which encodes autotaxin (ATX), a secreted lysophospholipase which mediates mammary tumorigenesis and cancer cell migration. A positive correlation between nuclear pStat3 and ATX was determined by immunohistochemical analysis of primary breast cancer samples and matched axillary lymph nodes and in several breast cancer derived cell lines. Inhibition of pStat3 or reducing Stat3 expression led to a decrease in ATX levels and cell migration. An association between Stat3 and the ATX promoter, which contains a number of putative Stat3 binding sites, was determined by chromatin immunoprecipitation. These observations suggest that activated Stat3 may regulate the migration of breast cancer cells through the regulation of ATX.	[Azare, Janeen; Leslie, Kenneth; Chang, Qing; Berishaj, Marjan; Nnoli, Jennifer; Mark, Kevin; Bromberg, Jacqueline] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Doane, Ashley; Al-Ahmadie, Hikmat; Gerald, William] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Hassimi, Maryam; Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10021 USA; [Lyden, David] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Stracke, Mary] NCI, Pathol Lab, Div Clin Sci, NIH, Bethesda, MD 20892 USA; [Lyden, David] Weill Cornell Med Coll, Dept Pediat, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University	Azare, J (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	dcl2001@med.cornell.edu; bromberj@mskcc.org	Doane, Ashley Stephen/B-7027-2008; Doane, Ashley Stephen/A-6442-2015; Doane, Ashley/R-4263-2016	Doane, Ashley Stephen/0000-0002-1489-1786; Doane, Ashley Stephen/0000-0002-1489-1786; Doane, Ashley/0000-0002-1489-1786; chang, qing/0000-0002-8290-6687; Al-Ahmadie, Hikmat/0000-0002-2938-6627; Mark, Kevin/0000-0001-5132-031X	National Institutes of Health [R01 CA87637]; Marjorie and Charles Holloway Foundation; Breast Cancer Alliance Award; Sussman Family Fund; Lerner Awards; Cancer Research and Prevention Foundation; Intercultural Cancer Council; National Cancer Institute, CMBB (Comprehensive Minority Biomedical Branch); NATIONAL CANCER INSTITUTE [R01CA087637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marjorie and Charles Holloway Foundation; Breast Cancer Alliance Award; Sussman Family Fund; Lerner Awards; Cancer Research and Prevention Foundation; Intercultural Cancer Council; National Cancer Institute, CMBB (Comprehensive Minority Biomedical Branch); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by grants from the National Institutes of Health (R01 CA87637), Marjorie and Charles Holloway Foundation, Breast Cancer Alliance Award, Sussman Family Fund and Lerner Awards to JB and a Cancer Research and Prevention Foundation and Intercultural Cancer Council Fellowship and a National Cancer Institute, CMBB (Comprehensive Minority Biomedical Branch) Training Award to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JV, 2005, CANCER RES, V65, P5054, DOI 10.1158/0008-5472.CAN-04-4281; Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Black EJ, 2004, ONCOGENE, V23, P2357, DOI 10.1038/sj.onc.1207377; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Clair T, 1997, J BIOL CHEM, V272, P996, DOI 10.1074/jbc.272.2.996; Cooper AB, 2007, J GASTROINTEST SURG, V11, P1628, DOI 10.1007/s11605-007-0322-9; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; de la Iglesia N, 2008, J NEUROSCI, V28, P5870, DOI 10.1523/JNEUROSCI.5385-07.2008; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Gariboldi MB, 2007, CANCER LETT, V258, P181, DOI 10.1016/j.canlet.2007.08.019; Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1; Giganti A, 2008, J BIOL CHEM, V283, P7776, DOI 10.1074/jbc.M708705200; Ginsberg M, 2007, MOL CELL BIOL, V27, P6300, DOI 10.1128/MCB.00613-07; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Gupta GP, 2005, COLD SH Q B, V70, P149, DOI 10.1101/sqb.2005.70.018; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Hsieh FC, 2005, BIOCHEM BIOPH RES CO, V335, P292, DOI 10.1016/j.bbrc.2005.07.075; Jonkers J, 2009, CANCER CELL, V15, P457, DOI 10.1016/j.ccr.2009.05.003; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Kehlen A, 2004, INT J CANCER, V109, P833, DOI 10.1002/ijc.20022; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Kotha A, 2006, MOL CANCER THER, V5, P621, DOI 10.1158/1535-7163.MCT-05-0268; Lee HY, 2002, FEBS LETT, V515, P137, DOI 10.1016/S0014-5793(02)02457-2; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Leslie K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2725; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Montserrat N, 2011, HUM PATHOL, V42, P103, DOI 10.1016/j.humpath.2010.05.019; Muller V, 2005, CLIN CANCER RES, V11, P3678, DOI 10.1158/1078-0432.CCR-04-2469; MURATA J, 1994, J BIOL CHEM, V269, P30479; Nam SW, 2001, CANCER RES, V61, P6938; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Noh JH, 2006, MOL CELL BIOCHEM, V288, P91, DOI 10.1007/s11010-006-9124-8; Oka M, 2010, EXP DERMATOL, V19, pE50, DOI 10.1111/j.1600-0625.2009.00972.x; Pamuklar Z, 2009, J BIOL CHEM, V284, P7385, DOI 10.1074/jbc.M807820200; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ptaszynska MM, 2008, MOL CANCER RES, V6, P352, DOI 10.1158/1541-7786.MCR-07-0143; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Ranger JJ, 2009, CANCER RES, V69, P6823, DOI 10.1158/0008-5472.CAN-09-1684; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Selander KS, 2004, CANCER RES, V64, P6924, DOI 10.1158/0008-5472.CAN-03-2516; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Shen H, 2009, MOL BIOL REP, V36, P653, DOI 10.1007/s11033-008-9225-4; Song J, 2006, BIOCHEM BIOPH RES CO, V340, P175, DOI 10.1016/j.bbrc.2005.11.171; STRACKE M, 1993, SYM SOC EXP BIOL, V47, P197; Stracke ML, 1997, ADV ENZYME REGUL, V37, P135, DOI 10.1016/S0065-2571(96)00017-9; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Turkson J, 2004, MOL CANCER THER, V3, P1533; Turkson J, 2004, MOL CANCER THER, V3, P261; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Walker SR, 2009, MOL CANCER RES, V7, P966, DOI 10.1158/1541-7786.MCR-08-0238; WATSON CJ, 1995, BRIT J CANCER, V71, P840, DOI 10.1038/bjc.1995.162; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yang J, 2006, CANCER RES, V66, P4549, DOI 10.1158/0008-5472.CAN-05-3850; Yang SY, 2002, CLIN EXP METASTAS, V19, P603, DOI 10.1023/A:1020950420196; Yang Y, 1999, AM J RESP CELL MOL, V21, P216, DOI 10.1165/ajrcmb.21.2.3667; Yano Y, 2003, INT J MOL MED, V12, P763; Zhang GX, 1999, CHINESE MED J-PEKING, V112, P330; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	89	55	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27851	10.1371/journal.pone.0027851	http://dx.doi.org/10.1371/journal.pone.0027851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140473	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163400019
J	Cappello, F; Caramori, G; Campanella, C; Vicari, C; Gnemmi, I; Zanini, A; Spanevello, A; Capelli, A; La Rocca, G; Anzalone, R; Bucchieri, F; D'Anna, SE; Ricciardolo, FLM; Brun, P; Balbi, B; Carone, M; Zummo, G; de Macario, EC; Macario, AJL; Di Stefano, A				Cappello, Francesco; Caramori, Gaetano; Campanella, Claudia; Vicari, Chiara; Gnemmi, Isabella; Zanini, Andrea; Spanevello, Antonio; Capelli, Armando; La Rocca, Giampiero; Anzalone, Rita; Bucchieri, Fabio; D'Anna, Silvestro Ennio; Ricciardolo, Fabio L. M.; Brun, Paola; Balbi, Bruno; Carone, Mauro; Zummo, Giovanni; de Macario, Everly Conway; Macario, Alberto J. L.; Di Stefano, Antonino			Convergent Sets of Data from In Vivo and In Vitro Methods Point to an Active Role of Hsp60 in Chronic Obstructive Pulmonary Disease Pathogenesis	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SPINAL-CORD; KAPPA-B; HEAT-SHOCK-PROTEIN-60; STRESS; EXPRESSION; ACTIVATION; SMOKERS; SUPPRESSES	Background: It is increasingly clear that some heat shock proteins (Hsps) play a role in inflammation. Here, we report results showing participation of Hsp60 in the pathogenesis of chronic obstructive pulmonary diseases (COPD), as indicated by data from both in vivo and in vitro analyses. Methods and Results: Bronchial biopsies from patients with stable COPD, smoker controls with normal lung function, and non-smoker controls were studied. We quantified by immunohistochemistry levels of Hsp10, Hsp27, Hsp40, Hsp60, Hsp70, Hsp90, and HSF-1, along with levels of inflammatory markers. Hsp10, Hsp40, and Hsp60 were increased during progression of disease. We found also a positive correlation between the number of neutrophils and Hsp60 levels. Double-immunostaining showed that Hsp60-positive neutrophils were significantly increased in COPD patients. We then investigated in vitro the effect on Hsp60 expression in bronchial epithelial cells (16HBE) caused by oxidative stress, a hallmark of COPD mucosa, which we induced with H2O2. This stressor determined increased levels of Hsp60 through a gene up-regulation mechanism involving NFkB-p65. Release of Hsp60 in the extracellular medium by the bronchial epithelial cells was also increased after H2O2 treatment in the absence of cell death. Conclusions: This is the first report clearly pointing to participation of Hsps, particularly Hsp60, in COPD pathogenesis. Hsp60 induction by NFkB-p65 and its release by epithelial cells after oxidative stress can have a role in maintaining inflammation, e. g., by stimulating neutrophils activity. The data open new scenarios that might help in designing efficacious anti-inflammatory therapies centered on Hsp60 and applicable to COPD.	[Cappello, Francesco; Campanella, Claudia; La Rocca, Giampiero; Anzalone, Rita; Bucchieri, Fabio; Zummo, Giovanni] Univ Palermo, Sez Anat Umana, Dipartimento Biomed Sperimentale & Neurosci Clin, Palermo, Italy; [Cappello, Francesco; Campanella, Claudia; La Rocca, Giampiero; Bucchieri, Fabio; Macario, Alberto J. L.] Ist Euromediterraneo Sci & Tecnol IEMEST, Palermo, Italy; [Caramori, Gaetano] Univ Ferrara, Sez Malattie Apparato Resp, Dipartimento Med Clin & Sperimentale, I-44100 Ferrara, Italy; [Vicari, Chiara; Gnemmi, Isabella; Zanini, Andrea; Spanevello, Antonio; Capelli, Armando; D'Anna, Silvestro Ennio; Balbi, Bruno; Carone, Mauro; Di Stefano, Antonino] IRCCS, Fdn S Maugeri, Veruno, NO, Italy; [Vicari, Chiara; Gnemmi, Isabella; Zanini, Andrea; Spanevello, Antonio; Capelli, Armando; D'Anna, Silvestro Ennio; Balbi, Bruno; Carone, Mauro; Di Stefano, Antonino] IRCCS, Fdn S Maugeri, Tradate, VA, Italy; [Vicari, Chiara; Gnemmi, Isabella; Zanini, Andrea; Spanevello, Antonio; Capelli, Armando; D'Anna, Silvestro Ennio; Balbi, Bruno; Carone, Mauro; Di Stefano, Antonino] IRCCS, Fdn S Maugeri, Cassano, BA, Italy; [Ricciardolo, Fabio L. M.] Univ Turin, Dipartimento Sci Clin & Biol, Turin, Italy; [Brun, Paola] Univ Padua, Dipartimento Istol Microbiol & Biotecnol Med, Padua, Italy; [de Macario, Everly Conway; Macario, Alberto J. L.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [de Macario, Everly Conway; Macario, Alberto J. L.] Inst Marine & Environm Sci IMET, Baltimore, MD USA	University of Palermo; University of Ferrara; Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; University of Turin; University of Padua; University System of Maryland; University of Maryland Baltimore	Cappello, F (corresponding author), Univ Palermo, Sez Anat Umana, Dipartimento Biomed Sperimentale & Neurosci Clin, Palermo, Italy.	francapp@hotmail.com	D'anna, Silvestro ennio/AAC-2738-2020; SPANEVELLO, ANTONIO/AAB-9503-2020; Ricciardolo, F. L. M./K-5330-2018; Brun, Paola/K-5729-2016; Bucchieri, Fabio/F-8877-2012; Di Stefano, Antonino/AAB-8041-2020; La Rocca, Giampiero/G-4730-2012; Caramori, Gaetano/AAS-8611-2020; Carone, Mauro/E-1241-2019; Balbi, Bruno/E-8380-2019; Gnemmi, Isabella IG/F-3098-2019; Cappello, Francesco/F-9153-2012	D'anna, Silvestro ennio/0000-0003-1986-1495; SPANEVELLO, ANTONIO/0000-0002-3595-9903; Ricciardolo, F. L. M./0000-0003-1826-5018; Di Stefano, Antonino/0000-0003-3479-0875; La Rocca, Giampiero/0000-0002-1334-5054; Caramori, Gaetano/0000-0002-9807-327X; Carone, Mauro/0000-0002-5478-8521; Balbi, Bruno/0000-0002-4439-1424; Gnemmi, Isabella IG/0000-0003-0045-6369; Brun, Paola/0000-0002-4204-3549; Capelli, Armando/0000-0002-9505-2350; BUCCHIERI, Fabio/0000-0002-0209-8668; Cappello, Francesco/0000-0001-9288-1148; Anzalone, Rita/0000-0002-3620-2507	"Fondazione 'Salvatore Maugeri' IRCCS'' (Istituto di Ricovero e Cura a Carattere Scientifico), Ricerca Corrente; "Regione Piemonte'', Ricerca Sanitaria Finalizzata; "Istituto Euro-Mediterraneo di Scienza e Tecnologia'' (IEMEST)	"Fondazione 'Salvatore Maugeri' IRCCS'' (Istituto di Ricovero e Cura a Carattere Scientifico), Ricerca Corrente; "Regione Piemonte'', Ricerca Sanitaria Finalizzata(Regione Piemonte); "Istituto Euro-Mediterraneo di Scienza e Tecnologia'' (IEMEST)	This work was supported by the "Fondazione 'Salvatore Maugeri' IRCCS'' (Istituto di Ricovero e Cura a Carattere Scientifico), Ricerca Corrente; the "Regione Piemonte'', Ricerca Sanitaria Finalizzata 2009; the "Istituto Euro-Mediterraneo di Scienza e Tecnologia'' (IEMEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024119; Arrigo AP, 1998, BIOL CHEM, V379, P19; Athanasas-Platsis S, 2003, J NEUROL SCI, V214, P27, DOI 10.1016/S0022-510X(03)00170-9; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Cappello F, 2005, LANCET ONCOL, V6, P816, DOI 10.1016/S1470-2045(05)70393-4; Cappello F, 2006, CANCER-AM CANCER SOC, V107, P2417, DOI 10.1002/cncr.22265; Chen W, 1999, J IMMUNOL, V162, P3212; Chu S, 2011, INT IMMUNOPHARM 0723; Corrao S, 2010, LIFE SCI, V86, P145, DOI 10.1016/j.lfs.2009.11.004; De Maio A, 2011, CELL STRESS CHAPERON, V16, P235, DOI 10.1007/s12192-010-0236-4; Di Stefano A, 2002, EUR RESPIR J, V20, P556, DOI 10.1183/09031936.02.00272002; Di Stefano A, 2009, THORAX, V64, P968, DOI 10.1136/thx.2009.113647; Di Stefano A, 2004, CLIN EXP ALLERGY, V34, P1156, DOI 10.1111/j.1365-2222.2004.02030.x; Goebel U, 2009, BRIT J ANAESTH, V103, P173, DOI 10.1093/bja/aep087; Habich C, 2007, CELL MOL LIFE SCI, V64, P742, DOI 10.1007/s00018-007-6413-7; Hacker S, 2009, CLIN LAB, V55, P31; Henderson B, 2010, CELL STRESS CHAPERON, V15, P123, DOI 10.1007/s12192-009-0137-6; Isajevs S, 2009, EUR RESPIR J, V33, P61, DOI 10.1183/09031936.00145307; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Macario AJL, 2010, ANN NY ACAD SCI, V1197, P85, DOI 10.1111/j.1749-6632.2010.05187.x; Merendino AM, 2006, AM J RESP CELL MOL, V35, P155, DOI 10.1165/rcmb.2005-0433OC; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; Mustafi SB, 2009, CELL STRESS CHAPERON, V14, P579, DOI 10.1007/s12192-009-0109-x; National Institutes of Health National Heart Lung and Blood Institute, NIH PUBL A; Osterloh A, 2009, J LEUKOCYTE BIOL, V86, P423, DOI 10.1189/jlb.0109011; Pespeni M, 2005, J SURG RES, V126, P41, DOI 10.1016/j.jss.2005.01.012; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Ricciardolo FLM, 2005, J ALLERGY CLIN IMMUN, V116, P1028, DOI 10.1016/j.jaci.2005.06.034; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Takuma K, 2002, BRAIN RES, V946, P232, DOI 10.1016/S0006-8993(02)02888-3; Wang Y, 2010, J MOL CELL CARDIOL, V48, P360, DOI 10.1016/j.yjmcc.2009.11.009; Wheeler DS, 2007, FREE RADICAL BIO MED, V42, P1, DOI 10.1016/j.freeradbiomed.2006.08.028; Yoo CG, 2000, J IMMUNOL, V164, P5416, DOI 10.4049/jimmunol.164.10.5416; Yoshikawa T, 2007, AM J RESP CRIT CARE, V175, P473, DOI 10.1164/rccm.200507-1152OC; Younce CW, 2010, BIOCHEM J, V426, P43, DOI 10.1042/BJ20090976; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423; Zhang B, 2003, J NEUROL SCI, V212, P37, DOI 10.1016/S0022-510X(03)00103-5	38	47	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28200	10.1371/journal.pone.0028200	http://dx.doi.org/10.1371/journal.pone.0028200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140545	Green Submitted, gold, Green Published			2022-12-25	WOS:000298163400037
J	Lockwood, S; Voth, DE; Brayton, KA; Beare, PA; Brown, WC; Heinzen, RA; Broschat, SL				Lockwood, Svetlana; Voth, Daniel E.; Brayton, Kelly A.; Beare, Paul A.; Brown, Wendy C.; Heinzen, Robert A.; Broschat, Shira L.			Identification of Anaplasma marginale Type IV Secretion System Effector Proteins	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA; ANKYRIN REPEAT; COXIELLA-BURNETII; HUMAN MACROPHAGES; MEMBRANE VACCINE; DIVERSITY; TRANSLOCATION; INFECTION; GENOME; MECHANISMS	Background: Anaplasma marginale, an obligate intracellular alphaproteobacterium in the order Rickettsiales, is a tick-borne pathogen and the leading cause of anaplasmosis in cattle worldwide. Complete genome sequencing of A. marginale revealed that it has a type IV secretion system (T4SS). The T4SS is one of seven known types of secretion systems utilized by bacteria, with the type III and IV secretion systems particularly prevalent among pathogenic Gram-negative bacteria. The T4SS is predicted to play an important role in the invasion and pathogenesis of A. marginale by translocating effector proteins across its membrane into eukaryotic target cells. However, T4SS effector proteins have not been identified and tested in the laboratory until now. Results: By combining computational methods with phylogenetic analysis and sequence identity searches, we identified a subset of potential T4SS effectors in A. marginale strain St. Maries and chose six for laboratory testing. Four (AM185, AM470, AM705 [AnkA], and AM1141) of these six proteins were translocated in a T4SS-dependent manner using Legionella pneumophila as a reporter system. Conclusions: The algorithm employed to find T4SS effector proteins in A. marginale identified four such proteins that were verified by laboratory testing. L. pneumophila was shown to work as a model system for A. marginale and thus can be used as a screening tool for A. marginale effector proteins. The first T4SS effector proteins for A. marginale have been identified in this work.	[Lockwood, Svetlana; Broschat, Shira L.] Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA; [Voth, Daniel E.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Brayton, Kelly A.; Brown, Wendy C.; Broschat, Shira L.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Brayton, Kelly A.; Brown, Wendy C.; Broschat, Shira L.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Beare, Paul A.; Heinzen, Robert A.] NIAID, Coxiella Pathogenesis Sect, Intracellular Parasites Lab, Rocky Mt Labs,NIH, Hamilton, MT USA	Washington State University; University of Arkansas System; University of Arkansas Medical Sciences; Washington State University; Washington State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lockwood, S (corresponding author), Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA.	shira@eecs.wsu.edu		Lockwood, Svetlana/0000-0002-9401-239X	National Institutes of Health (NIH) National Institutes of Allergy and Infectious Diseases (NIAID) [AI44005, AI053692, R01AI087669]; Carl M. Hansen Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044005, R01AI044005, R01AI053692, R01AI087669] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institutes of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Carl M. Hansen Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH) National Institutes of Allergy and Infectious Diseases (NIAID) grants AI44005 and AI053692 (to KAB and WCB) and R01AI087669 (DEV) and by the Intramural Research Program of the NIH, NIAID (to RAH and PAB). SL was supported in part by the Carl M. Hansen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodor S, 2008, MOL MICROBIOL, V70, P908, DOI 10.1111/j.1365-2958.2008.06453.x; Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Barbet AF, 2000, INFECT IMMUN, V68, P6133, DOI 10.1128/IAI.68.11.6133-6138.2000; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Bruggemann H, 2006, CURR OPIN MICROBIOL, V9, P86, DOI 10.1016/j.mib.2005.12.009; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Carey KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002056; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chen C, 2010, P NATL ACAD SCI USA, V107, P21755, DOI 10.1073/pnas.1010485107; Dark MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-16; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GARCIAGARCIA JC, 2009, INFECT IMMUN; Gillespie JJ, 2010, INFECT IMMUN, V78, P1809, DOI 10.1128/IAI.01384-09; Huang B, 2010, MICROB PATHOGENESIS, V49, P273, DOI 10.1016/j.micpath.2010.06.009; IJDO JW, 2007, CELL MICROBIOL; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x; Lohr CV, 2002, INFECT IMMUN, V70, P6005, DOI 10.1128/IAI.70.11.6005-6012.2002; Lopez JE, 2005, INFECT IMMUN, V73, P8109, DOI 10.1128/IAI.73.12.8109-8118.2005; Lopez JE, 2008, J IMMUNOL METHODS, V332, P129, DOI 10.1016/j.jim.2007.12.018; Lopez JE, 2007, INFECT IMMUN, V75, P2333, DOI 10.1128/IAI.00061-07; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Medini D, 2006, PLOS COMPUT BIOL, V2, P1543, DOI 10.1371/journal.pcbi.0020173; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Niu H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000774; Noh SM, 2008, INFECT IMMUN; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Ohashi N, 2002, INFECT IMMUN, V70, P2128, DOI 10.1128/IAI.70.4.2128-2138.2002; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Ramabu SS, 2010, INFECT IMMUN, V78, P3047, DOI 10.1128/IAI.00300-10; Ramabu SS, 2011, INFECT IMMUN; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; SADOSKY AB, 1993, INFECT IMMUN, V61, P5361, DOI 10.1128/IAI.61.12.5361-5373.1993; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Stich RW, 2004, INFECT IMMUN, V72, P7257, DOI 10.1128/IAI.72.12.7257-7264.2004; Sutten EL, 2010, INFECT IMMUN, V78, P1314, DOI 10.1128/IAI.01207-09; Voth DE, 2011, J BACTERIOL, V193, P1493, DOI 10.1128/JB.01359-10; Voth DE, 2009, J BACTERIOL, V191, P4232, DOI 10.1128/JB.01656-08; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x	51	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27724	10.1371/journal.pone.0027724	http://dx.doi.org/10.1371/journal.pone.0027724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140462	gold, Green Published, Green Submitted			2022-12-25	WOS:000298163400015
J	Dickinson, RE; Fegan, KS; Ren, X; Hillier, SG; Duncan, WC				Dickinson, Rachel E.; Fegan, K. Scott; Ren, Xia; Hillier, Stephen G.; Duncan, W. Colin			Glucocorticoid Regulation of SLIT/ROBO Tumour Suppressor Genes in the Ovarian Surface Epithelium and Ovarian Cancer Cells	PLOS ONE			English	Article							SLIT-ROBO PATHWAY; CHEMOTHERAPY RESISTANCE; CERVICAL-CANCER; EXPRESSION; GROWTH; BREAST; GUIDANCE; RECEPTORS; QUANTIFICATION; INACTIVATION	The three SLIT ligands and their four ROBO receptors have fundamental roles in mammalian development by promoting apoptosis and repulsing aberrant cell migration. SLITs and ROBOs have emerged as candidate tumour suppressor genes whose expression is inhibited in a variety of epithelial tumours. We demonstrated that their expression could be negatively regulated by cortisol in normal ovarian luteal cells. We hypothesised that after ovulation the locally produced cortisol would inhibit SLIT/ROBO expression in the ovarian surface epithelium (OSE) to facilitate its repair and that this regulatory pathway was still present, and could be manipulated, in ovarian epithelial cancer cells. Here we examined the expression and regulation of the SLIT/ROBO pathway in OSE, ovarian cancer epithelial cells and ovarian tumour cell lines. Basal SLIT2, SLIT3, ROBO1, ROBO2 and ROBO4 expression was lower in primary cultures of ovarian cancer epithelial cells when compared to normal OSE (P<0.05) and in poorly differentiated SKOV-3 cells compared to the more differentiated PEO-14 cells (P<0.05). Cortisol reduced the expression of certain SLITs and ROBOs in normal OSE and PEO-14 cells (P<0.05). Furthermore blocking SLIT/ROBO activity reduced apoptosis in both PEO-14 and SKOV-3 tumour cells (P<0.05). Interestingly SLIT/ROBO expression could be increased by reducing the expression of the glucocorticoid receptor using siRNA (P<0.05). Overall our findings indicate that in the post-ovulatory phase one role of cortisol may be to temporarily inhibit SLIT/ROBO expression to facilitate regeneration of the OSE. Therefore this pathway may be a target to develop strategies to manipulate the SLIT/ROBO system in ovarian cancer.	[Dickinson, Rachel E.; Fegan, K. Scott; Ren, Xia; Hillier, Stephen G.; Duncan, W. Colin] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh	Dickinson, RE (corresponding author), Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	W.C.Duncan@ed.ac.uk		Fegan, Kenneth Scott/0000-0003-1604-203X; hillier, stephen/0000-0001-7378-5855	Scottish Funding Council; CSO [SCD/02]; Medical Research Council [G1002033] Funding Source: researchfish; Chief Scientist Office [SCD/02] Funding Source: researchfish; MRC [G1002033] Funding Source: UKRI	Scottish Funding Council; CSO; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	WCD is supported by a Scottish Senior Clinical Fellowship from the Scottish Funding Council and this work was funded by the CSO (SCD/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argento M, 2008, ANTICANCER RES, V28, P3135; Avci ME, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-392; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chebotaev D, 2007, MOL CARCINOGEN, V46, P732, DOI 10.1002/mc.20349; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Dallol A, 2003, CANCER RES, V63, P1054; Dallol A, 2002, CANCER RES, V62, P5874; Dallol A, 2005, CAN META BIO TREAT, V7, P191; Dickinson RE, 2008, ENDOCRINOLOGY, V149, P5024, DOI 10.1210/en.2008-0204; Dickinson RE, 2010, REPRODUCTION, V139, P697, DOI 10.1530/REP-10-0017; Dickinson RE, 2010, REPRODUCTION, V139, P395, DOI 10.1530/REP-09-0182; Duncan WC, 2010, MOL HUM REPROD, V16, P950, DOI 10.1093/molehr/gaq055; Duncan W. C., 2009, Animal Reproduction, V6, P34; El Etreby MF, 2000, PROSTATE, V43, P31, DOI 10.1002/(SICI)1097-0045(20000401)43:1<31::AID-PROS5>3.0.CO;2-#; Gascoyne DM, 2003, J BIOL CHEM, V278, P18022, DOI 10.1074/jbc.M301812200; Goyeneche AA, 2007, CLIN CANCER RES, V13, P3370, DOI 10.1158/1078-0432.CCR-07-0164; Gubbay O, 2005, BRIT J CANCER, V92, P1927, DOI 10.1038/sj.bjc.6602568; Hillier SG, 1998, J REPROD IMMUNOL, V39, P21, DOI 10.1016/S0165-0378(98)00011-4; Hinck L, 2004, DEV CELL, V7, P783, DOI 10.1016/j.devcel.2004.11.002; Jin J, 2009, BIOCHEM BIOPH RES CO, V379, P86, DOI 10.1016/j.bbrc.2008.12.022; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kim HK, 2008, NEOPLASIA, V10, P1411, DOI 10.1593/neo.08804; Latil A, 2003, INT J CANCER, V103, P306, DOI 10.1002/ijc.10821; Leung PCK, 2007, HUM REPROD UPDATE, V13, P143, DOI 10.1093/humupd/dml002; Liao WX, 2010, HISTOL HISTOPATHOL, V25, P1181, DOI 10.14670/HH-25.1181; Ma SL, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.040; Marlow R, 2008, CANCER RES, V68, P7819, DOI 10.1158/0008-5472.CAN-08-1357; Mertsch S, 2008, J NEURO-ONCOL, V87, P1, DOI 10.1007/s11060-007-9484-2; MORRISSEY C, 2004, P AM ASS CANC RES, V45; Myers M, 2007, ENDOCRINOLOGY, V148, P5769, DOI 10.1210/en.2007-0742; Narayan G, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-16; Papacleovoulou G, 2009, MOL HUM REPROD, V15, P379, DOI 10.1093/molehr/gap022; Prasad A, 2004, J BIOL CHEM, V279, P9115, DOI 10.1074/jbc.M308083200; Purdie DM, 2003, INT J CANCER, V104, P228, DOI 10.1002/ijc.10927; Rae MT, 2009, FERTIL STERIL, V92, P703, DOI 10.1016/j.fertnstert.2008.06.040; Rae MT, 2004, J CLIN ENDOCR METAB, V89, P4538, DOI 10.1210/jc.2003-032225; Runnebaum IB, 2005, CLIN CANCER RES, V11, P6325, DOI 10.1158/1078-0432.CCR-05-0182; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Sengupta S, 2000, EMBO J, V19, P6051, DOI 10.1093/emboj/19.22.6051; Singh RK, 2007, HUM GENET, V122, P71, DOI 10.1007/s00439-007-0375-6; Stella MC, 2009, MOL BIOL CELL, V20, P642, DOI 10.1091/mbc.E08-03-0321; Strickland P, 2006, DEVELOPMENT, V133, P823, DOI 10.1242/dev.02261; Sui MH, 2006, INT J CANCER, V119, P712, DOI 10.1002/ijc.21743; van den Driesche S, 2008, REPRODUCTION, V135, P509, DOI 10.1530/REP-07-0427; Yu J, 2010, ONCOGENE, V29, P5370, DOI 10.1038/onc.2010.269; Zhang C, 2006, CANCER BIOL THER, V5, P59, DOI 10.4161/cbt.5.1.2272; Zhang CW, 2006, INT J ONCOL, V29, P1295	47	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27792	10.1371/journal.pone.0027792	http://dx.doi.org/10.1371/journal.pone.0027792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132142	Green Published, Green Submitted, gold			2022-12-25	WOS:000298162000044
J	Lacoue-Labarthe, T; Villanueva, R; Rouleau, C; Oberhansli, F; Teyssie, JL; Jeffree, R; Bustamante, P				Lacoue-Labarthe, Thomas; Villanueva, Roger; Rouleau, Claude; Oberhaensli, Francois; Teyssie, Jean-Louis; Jeffree, Ross; Bustamante, Paco			Radioisotopes Demonstrate the Contrasting Bioaccumulation Capacities of Heavy Metals in Embryonic Stages of Cephalopod Species	PLOS ONE			English	Article							CUTTLEFISH SEPIA-OFFICINALIS; TRACE-ELEMENT ACCUMULATION; SQUID LOLIGO-VULGARIS; OCTOPUS-VULGARIS; NONESSENTIAL ELEMENTS; PORTUGUESE COAST; LIFE-CYCLE; CADMIUM; TISSUES; MOLLUSKS	Cephalopods play a key role in many marine trophic food webs and also constitute alternative fishery resources in the context of the ongoing decline in finfish stocks. Most coastal cephalopod species of commercial importance migrate into shallow waters during the breeding season to lay their eggs, and are consequently subjected to coastal contamination. Eggs of common cuttlefish Sepia officinalis, European squid Loligo vulgaris, common octopus Octopus vulgaris and the sepiolid Rossia macrosoma were exposed during embryonic development to dissolved Ag-110m, Cd-109, Co-60, Mn-54 and Zn-65 in order to determine their metal accumulation efficiencies and distribution among different egg compartments. Cuttlefish eggs, in which hard shells enclose the embryos, showed the lowest concentration factor (CF) values despite a longer duration of exposure. In contrast, octopus eggs, which are only protected by the chorionic membrane, accumulated the most metal. Uptake appears to be linked to the selective retention properties of the egg envelopes with respect to each element. The study also demonstrated that the octopus embryo accumulated Ag-110m directly from the dissolved phase and also indirectly through assimilation of the contaminated yolk. These results raise questions regarding the potential contrasting vulnerability of early life stages of cephalopods to the metallic contamination of coastal waters.	[Lacoue-Labarthe, Thomas; Oberhaensli, Francois; Teyssie, Jean-Louis; Jeffree, Ross] IAEA, Environm Labs, Monaco, Monaco; [Lacoue-Labarthe, Thomas; Bustamante, Paco] Univ La Rochelle, CNRS, UMR 6250, Littoral Environm & Societes LIENSs, La Rochelle, France; [Villanueva, Roger] CSIC, Inst Ciencias Mar, Barcelona, Spain; [Rouleau, Claude] Inst Maurice Lamontagne, Mont Joli, PQ G5H 3Z4, Canada; [Jeffree, Ross] Univ Technol Sydney, Fac Sci, Sydney, NSW 2007, Australia	Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Fisheries & Oceans Canada; University of Technology Sydney	Lacoue-Labarthe, T (corresponding author), IAEA, Environm Labs, Monaco, Monaco.	tlacouel@gmail.com	Bustamante, Paco/G-5833-2011; Lacoue-Labarthe, Thomas/H-4963-2019; Villanueva, Roger/D-6911-2011	Bustamante, Paco/0000-0003-3877-9390; Lacoue-Labarthe, Thomas/0000-0002-4682-8730; Villanueva, Roger/0000-0001-8122-3449	Conseil General de Charente-Maritime (France); Spanish Ministry of Science and Innovation [AGL2009-11546]	Conseil General de Charente-Maritime (France)(Region Nouvelle-Aquitaine); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	TLL was supported by a post-doctoral grant from the Conseil General de Charente-Maritime (France). RV was funded by the research project CALOCEAN (AGL2009-11546) from the Spanish Ministry of Science and Innovation. This work was a contribution to the research programs of the IAEA and LIENSs. Both supported the study design and data collection and allowed publication of this study in PLoS ONE.	BOLETZKY SV, 1973, HELGOLAND WISS MEER, V25, P135, DOI 10.1007/BF01609965; BOLETZKY SV, 1986, AM MALACOL BULL, V4, P217; Bruland K. W., 1983, CHEM OCEANOGR, V8, P157, DOI 10.1016/b978-0-12-588608-6.50009-2.; Bustamante P, 2006, SCI TOTAL ENVIRON, V368, P585, DOI 10.1016/j.scitotenv.2006.01.038; Bustamante P, 2006, VIE MILIEU, V56, P153; Bustamante P, 1998, SCI TOTAL ENVIRON, V220, P71, DOI 10.1016/S0048-9697(98)00250-2; Bustamante P, 2004, MAR ECOL PROG SER, V269, P185, DOI 10.3354/meps269185; Bustamante P, 2002, MAR ENVIRON RES, V53, P227, DOI 10.1016/S0141-1136(01)00108-8; Bustamante P, 2002, MAR ECOL PROG SER, V231, P167, DOI 10.3354/meps231167; Chouvelon T, 2011, MAR ECOL PROG SER, V433, P107, DOI 10.3354/meps09159; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1053, DOI 10.1098/rstb.1996.0093; D'Aniello A, 1990, ITAL J BIOCHEM, V32, p130A; FAO Yearbook, 2007, FAO YB; Hedouin L, 2006, SCI TOTAL ENVIRON, V366, P154, DOI 10.1016/j.scitotenv.2005.10.022; Kojadinovic J, 2011, ECOTOX ENVIRON SAFE, V74, P1238, DOI 10.1016/j.ecoenv.2011.03.015; Lacoue-Labarthe T, 2008, AQUAT TOXICOL, V86, P437, DOI 10.1016/j.aquatox.2007.12.005; Lacoue-Labarthe T, 2011, AQUAT TOXICOL, V105, P166, DOI 10.1016/j.aquatox.2011.05.021; Lacoue-Labarthe T, 2009, SCI TOTAL ENVIRON, V407, P6188, DOI 10.1016/j.scitotenv.2009.09.003; Lacoue-Labarthe T, 2008, MAR POLLUT BULL, V57, P826, DOI 10.1016/j.marpolbul.2008.01.042; Lacoue-Labarthe T, 2010, ICES J MAR SCI, V67, P1517, DOI 10.1093/icesjms/fsq044; Lacoue-Labarthe T, 2010, J EXP MAR BIOL ECOL, V382, P131, DOI 10.1016/j.jembe.2009.10.008; MARTIN JH, 1975, MAR BIOL, V30, P51, DOI 10.1007/BF00393752; Metian M, 2009, MAR ECOL PROG SER, V375, P161, DOI 10.3354/meps07766; MIRAMAND P, 1992, MAR BIOL, V114, P407, DOI 10.1007/BF00350031; Moltschaniwskyj NA, 2007, REV FISH BIOL FISHER, V17, P455, DOI 10.1007/s11160-007-9056-8; Naef A., 1928, CEPHALOPODEN EMBRYOL; Nixon M, 1998, J ZOOL, V245, P407, DOI 10.1017/S0952836998008048; Pierce GJ, 2010, CEPHALOPOD BIOL FISH, P181; Raimundo J, 2004, SCI TOTAL ENVIRON, V325, P71, DOI 10.1016/j.scitotenv.2003.12.001; Rouleau C, 2003, ENVIRON SCI TECHNOL, V37, P3298, DOI 10.1021/es020984n; Seixas S, 2005, SCI TOTAL ENVIRON, V340, P113, DOI 10.1016/j.scitotenv.2004.08.012; Seixas S, 2005, CHEMOSPHERE, V59, P1113, DOI 10.1016/j.chemosphere.2004.11.099; Sen H, 2007, ENVIRON MONIT ASSESS, V133, P371, DOI 10.1007/s10661-006-9591-0; Storelli MM, 2010, FOOD ADDIT CONTAM B, V3, P14, DOI 10.1080/19440040903552390; Storelli MM, 2006, FOOD ADDIT CONTAM A, V23, P25, DOI 10.1080/02652030500242023; Storelli MM, 2005, J FOOD PROTECT, V68, P577, DOI 10.4315/0362-028X-68.3.577; Storelli MM, 1999, FOOD ADDIT CONTAM, V16, P261, DOI 10.1080/026520399284028; Storelli MM, 2001, FOOD ADDIT CONTAM, V18, P303, DOI 10.1080/02652030010021413; von Boletzky S, 1998, OCEANOGR MAR BIOL<D>, V36, P341; Villanueva R, 1997, J EXP MAR BIOL ECOL, V208, P169, DOI 10.1016/S0022-0981(96)02670-6; Villanueva R, 2006, AQUACULTURE, V261, P225, DOI 10.1016/j.aquaculture.2006.07.006; Wang WX, 1997, MAR ECOL PROG SER, V161, P103, DOI 10.3354/meps161103	42	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27653	10.1371/journal.pone.0027653	http://dx.doi.org/10.1371/journal.pone.0027653			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132123	Green Submitted, Green Published, gold			2022-12-25	WOS:000298162000032
J	Walsh, MC; Buzoianu, SG; Gardiner, GE; Rea, MC; Gelencser, E; Janosi, A; Epstein, MM; Ross, RP; Lawlor, PG				Walsh, Maria C.; Buzoianu, Stefan G.; Gardiner, Gillian E.; Rea, Mary C.; Gelencser, Eva; Janosi, Anna; Epstein, Michelle M.; Ross, R. Paul; Lawlor, Peadar G.			Fate of Transgenic DNA from Orally Administered Bt MON810 Maize and Effects on Immune Response and Growth in Pigs	PLOS ONE			English	Article							ENDOGENOUS PLANT DNA; SALMO-SALAR L.; BACILLUS-THURINGIENSIS; ATLANTIC SALMON; CORN; PERFORMANCE; FRAGMENTS; FEED; NUTRITION; PRODUCTS	We assessed the effect of short-term feeding of genetically modified (GM: Bt MON810) maize on immune responses and growth in weanling pigs and determined the fate of the transgenic DNA and protein in-vivo. Pigs were fed a diet containing 38.9% GM or non-GM isogenic parent line maize for 31 days. We observed that IL-12 and IFN gamma production from mitogenic stimulated peripheral blood mononuclear cells decreased (P<0.10) following 31 days of GM maize exposure. While Cry1Ab-specific IgG and IgA were not detected in the plasma of GM maize-fed pigs, the detection of the cry1Ab gene and protein was limited to the gastrointestinal digesta and was not found in the kidneys, liver, spleen, muscle, heart or blood. Feeding GM maize to weanling pigs had no effect on growth performance or body weight. IL-6 and IL-4 production from isolated splenocytes were increased (P<0.05) in response to feeding GM maize while the proportion of CD4(+) T cells in the spleen decreased. In the ileum, the proportion of B cells and macrophages decreased while the proportion of CD4(+) T cells increased in GM maize-fed pigs. IL-8 and IL-4 production from isolated intraepithelial and lamina propria lymphocytes were also increased (P<0.05) in response to feeding GM maize. In conclusion, there was no evidence of cry1Ab gene or protein translocation to the organs and blood of weaning pigs. The growth of pigs was not affected by feeding GM maize. Alterations in immune responses were detected; however, their biologic relevance is questionable.	[Walsh, Maria C.; Buzoianu, Stefan G.; Lawlor, Peadar G.] TEAGASC, Pig Dev Dept, Anim & Grassland Res & Innovat Ctr, Fermoy, Cork, Ireland; [Buzoianu, Stefan G.; Gardiner, Gillian E.] Waterford Inst Technol, Dept Chem & Life Sci, Waterford, Ireland; [Rea, Mary C.; Ross, R. Paul] TEAGASC, Food Res Ctr, Fermoy, Cork, Ireland; [Gelencser, Eva; Janosi, Anna] Cent Food Technol Res Inst, Dept Biol, Budapest, Hungary; [Epstein, Michelle M.] Med Univ Vienna, Div Immunobiol, Inst Immunol, Vienna, Austria	Teagasc; South East Technological University (SETU); Teagasc; Medical University of Vienna	Walsh, MC (corresponding author), TEAGASC, Pig Dev Dept, Anim & Grassland Res & Innovat Ctr, Moorepk, Fermoy, Cork, Ireland.	peadar.lawlor@teagasc.ie	Ross, Paul/A-7584-2015; Stefan, Buzoianu/F-3030-2010; Jánosi, Anna/A-6921-2013; Gelencser, Eva/A-2842-2013	Ross, Paul/0000-0003-4876-8839; Rea, Mary/0000-0003-3782-0232; Epstein, Michelle/0000-0002-4755-0224	European Union [FP7/2007-2013, 211820]; Teagasc Walsh Fellowship programme	European Union(European Commission); Teagasc Walsh Fellowship programme	The research leading to these results received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 211820 and the Teagasc Walsh Fellowship programme and independently of any commercial input, financial or otherwise. The authors have no financial or personal conflict of interest in regard to the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel-Patient K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016346; Alexander TW, 2006, BRIT J NUTR, V96, P997, DOI 10.1017/BJN20061935; Bertoni G, 2005, VET RES COMMUN, V29, P13, DOI 10.1007/s11259-005-0004-6; Bressener G, 2002, J ANIM SCI S2, V80, P128; Chowdhury EH, 2003, J ANIM SCI, V81, P2546; Custodio MG, 2006, CAN J ANIM SCI, V86, P461, DOI 10.4141/A05-082; Deaville ER, 2005, J AGR FOOD CHEM, V53, P10268, DOI 10.1021/jf051652f; EFSA, 2009, EFSA J, P1149; Einspanier R, 2004, EUR FOOD RES TECHNOL, V218, P269, DOI 10.1007/s00217-003-0842-9; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Fischer R, 2002, J ANIM SCI S1, V80, P894; Flachowsky G, 2007, ANIM FEED SCI TECH, V133, P2, DOI 10.1016/j.anifeedsci.2006.08.002; Ganiere P, 2006, J AGR RESOUR ECON, V31, P129; Hug K, 2008, MEDICINA-LITHUANIA, V44, P87, DOI 10.3390/medicina44020012; Hyun Y, 2004, J ANIM SCI, V82, P571; Kirouac M, 2006, APPL ENVIRON MICROB, V72, P506, DOI 10.1128/AEM.72.1.506-515.2006; Malarkey T, 2003, MUTAT RES-REV MUTAT, V544, P217, DOI 10.1016/j.mrrev.2003.06.001; Mazza R, 2005, TRANSGENIC RES, V14, P775, DOI 10.1007/s11248-005-0009-5; MEYER R, 1994, J AOAC INT, V77, P617; Moses V, 1999, BIOTECHNOL ADV, V17, P647, DOI 10.1016/S0734-9750(99)00023-3; Murtaugh MP, 2009, DEV COMP IMMUNOL, V33, P344, DOI 10.1016/j.dci.2008.06.014; Nemeth A, 2004, J AGR FOOD CHEM, V52, P6129, DOI 10.1021/jf049567f; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Paparini Andrea, 2004, Biotechnol Annu Rev, V10, P85, DOI 10.1016/S1387-2656(04)10004-5; Prescott VE, 2005, J AGR FOOD CHEM, V53, P9023, DOI 10.1021/jf050594v; Randhawa GJ, 2011, FOOD CHEM TOXICOL, V49, P356, DOI 10.1016/j.fct.2010.11.008; Reuter T, 2003, EUR FOOD RES TECHNOL, V216, P185, DOI 10.1007/s00217-002-0642-7; Reuter T, 2002, ARCH ANIM NUTR, V56, P319, DOI 10.1080/00039420215628; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Sanden M, 2006, AQUACULT NUTR, V12, P1, DOI 10.1111/j.1365-2095.2006.00367.x; Sanden M, 2005, J FISH DIS, V28, P317, DOI 10.1111/j.1365-2761.2005.00618.x; SAS Institute Inc, 2000, SAS US GUID; Schiavi E, 2010, ALLERGY; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schwarz A, 2004, J BIOL CHEM, V279, P5641, DOI 10.1074/jbc.M309317200; Sharma R, 2006, J AGR FOOD CHEM, V54, P1699, DOI 10.1021/jf052459o; Shimada N, 2006, J VET MED SCI, V68, P1113, DOI 10.1292/jvms.68.1113; Trabalza-Marinucci M, 2008, LIVEST SCI, V113, P178, DOI 10.1016/j.livsci.2007.03.009; Walsh MC, 2008, FEMS MICROBIOL ECOL, V64, P317, DOI 10.1111/j.1574-6941.2008.00454.x; Walsh MC, 2012, BRIT J NUTR, V107, P364, DOI 10.1017/S0007114511003011; Weber TE, 2001, J ANIM SCI, V79, P2542; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yonemochi C, 2010, ANIM SCI J, V81, P94, DOI 10.1111/j.1740-0929.2009.00718.x	43	56	59	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27177	10.1371/journal.pone.0027177	http://dx.doi.org/10.1371/journal.pone.0027177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132091	gold, Green Submitted, Green Published			2022-12-25	WOS:000298162000012
J	Fatakia, SN; Costanzi, S; Chow, CC				Fatakia, Sarosh N.; Costanzi, Stefano; Chow, Carson C.			Molecular Evolution of the Transmembrane Domains of G Protein-Coupled Receptors	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; PHYLOGENETIC ANALYSIS; FUNCTIONAL EVOLUTION; GENE; RHODOPSIN; CRYSTAL; MODELS; REPERTOIRE; SELECTION; MATRICES	G protein-coupled receptors (GPCRs) are a superfamily of integral membrane proteins vital for signaling and are important targets for pharmaceutical intervention in humans. Previously, we identified a group of ten amino acid positions (called key positions), within the seven transmembrane domain (7TM) interhelical region, which had high mutual information with each other and many other positions in the 7TM. Here, we estimated the evolutionary selection pressure at those key positions. We found that the key positions of receptors for small molecule natural ligands were under strong negative selection. Receptors naturally activated by lipids had weaker negative selection in general when compared to small molecule-activated receptors. Selection pressure varied widely in peptide-activated receptors. We used this observation to predict that a subgroup of orphan GPCRs not under strong selection may not possess a natural small-molecule ligand. In the subgroup of MRGX1-type GPCRs, we identified a key position, along with two non-key positions, under statistically significant positive selection.	[Fatakia, Sarosh N.; Costanzi, Stefano; Chow, Carson C.] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Fatakia, SN (corresponding author), NIDDK, Lab Biol Modeling, NIH, Bethesda, MD USA.	carsonc@mail.nih.gov	Costanzi, Stefano/G-8990-2013; Chow, Carson C/A-7970-2009	Costanzi, Stefano/0000-0003-3183-7332; Fatakia, Sarosh/0000-0003-0430-3191	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013026, ZIADK013025] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres AM, 2007, MOL BIOL EVOL, V24, P2707, DOI 10.1093/molbev/msm202; Anisimova M, 2007, HEREDITY, V99, P567, DOI 10.1038/sj.hdy.6801052; [Anonymous], NCBI NUCL DAT; [Anonymous], 2010, NCBI PROT DAT; Archer E, 2003, TRENDS PHARMACOL SCI, V24, P36, DOI 10.1016/S0165-6147(02)00009-3; Ault AD, 2006, PROTEIN ENG DES SEL, V19, P1, DOI 10.1093/protein/gzi069; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Choi SS, 2003, GENOME RES, V13, P2252, DOI 10.1101/gr.1431603; Choi SS, 2006, MOL BIOL EVOL, V23, P2131, DOI 10.1093/molbev/msl086; Fatakia SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004681; FATAKIA SN, 2011, RECENT ADV BIOSTATIS; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Fredriksson R, 2005, ANN NY ACAD SCI, V1040, P89, DOI 10.1196/annals.1327.011; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gibbons A, 2010, SCIENCE, V329, P740, DOI 10.1126/science.329.5993.740; Gloriam DE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-338; Gloriam DEI, 2005, ANN NY ACAD SCI, V1040, P323, DOI 10.1196/annals.1327.052; GONG S, 2009, BIOCH SOC T ENGLAND, P727; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Huzurbazar S, 2010, J MOL BIOL, V396, P1410, DOI 10.1016/j.jmb.2009.11.075; *IUPHAR, IUPHAR 7TM REC DAT; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Karlin S, 1996, J BACTERIOL, V178, P1881, DOI 10.1128/jb.178.7.1881-1894.1996; Koonin EV, 2010, NAT REV GENET, V11, P487, DOI 10.1038/nrg2810; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Mundy NI, 2003, AM J PHYS ANTHROPOL, V121, P67, DOI 10.1002/ajpa.10169; *NBCI, NBCI GEN DAT; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 1987, MOL EVOLUTIONARY GEN; NEI M, 1983, GENETIC POLYMORPHISM; Nei M., 1975, MOL POPULATION GENET; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Ohno S., 1970, EVOLUTION GENE DUPLI; Pal C, 2003, NATURE, V421, P496, DOI 10.1038/421496b; Pal C, 2001, GENETICS, V158, P927; Pal C, 2001, MOL BIOL EVOL, V18, P2323, DOI 10.1093/oxfordjournals.molbev.a003779; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Perez DM, 2005, MOL PHARMACOL, V67, P1383, DOI 10.1124/mol.105.011890; Perez DM, 2003, MOL PHARMACOL, V63, P1202, DOI 10.1124/mol.63.6.1202; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Plakidou-Dymock S, 1998, CURR BIOL, V8, P315, DOI 10.1016/S0960-9822(98)70131-9; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rodriguez GJ, 2010, P NATL ACAD SCI USA, V107, P7787, DOI 10.1073/pnas.0914877107; Rompler H, 2007, MOL INTERV, V7, P17, DOI 10.1124/mi.7.1.5; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schoneberg T, 2007, PURINERG SIGNAL, V3, P255, DOI 10.1007/s11302-007-9064-0; Schoneberg T, 2007, TRENDS PHARMACOL SCI, V28, P117, DOI 10.1016/j.tips.2007.01.001; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Staubert C, 2007, ENDOCRINOLOGY, V148, P4642, DOI 10.1210/en.2007-0138; Staubert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011133; Strotmann R, 2011, MOL CELL ENDOCRINOL, V331, P170, DOI 10.1016/j.mce.2010.07.012; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; TATUSOVA T, NCBI OPEN READEING F; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Vallender EJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-51; Worth CL, 2009, NAT REV MOL CELL BIO, V10, P709, DOI 10.1038/nrm2762; Yang S, 2005, GENE, V352, P30, DOI 10.1016/j.gene.2005.03.001; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YOKOYAMA S, 1989, MOL BIOL EVOL, V6, P186	70	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27813	10.1371/journal.pone.0027813	http://dx.doi.org/10.1371/journal.pone.0027813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132149	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789900024
J	Kim, GL; Wang, XM; Chalmers, JA; Thompson, DR; Dhillon, SS; Koletar, MM; Belsham, DD				Kim, Ginah L.; Wang, Xiaomei; Chalmers, Jennifer A.; Thompson, David R.; Dhillon, Sandeep S.; Koletar, Margaret M.; Belsham, Denise D.			Generation of Immortal Cell Lines from the Adult Pituitary: Role of cAMP on Differentiation of SOX2-Expressing Progenitor Cells to Mature Gonadotropes	PLOS ONE			English	Article							COLONY-FORMING CELLS; NEURONAL DIFFERENTIATION; RAT PITUITARY; STEM-CELLS; MURINE PITUITARY; TRANSGENIC MICE; GNRH RECEPTOR; TUMOR CELLS; HORMONE; POPULATION	The pituitary is a complex endocrine tissue composed of a number of unique cell types distinguished by the expression and secretion of specific hormones, which in turn control critical components of overall physiology. The basic function of these cells is understood; however, the molecular events involved in their hormonal regulation are not yet fully defined. While previously established cell lines have provided much insight into these regulatory mechanisms, the availability of representative cell lines from each cell lineage is limited, and currently none are derived from adult pituitary. We have therefore used retroviral transfer of SV40 T-antigen to mass immortalize primary pituitary cell culture from an adult mouse. We have generated 19 mixed cell cultures that contain cells from pituitary cell lineages, as determined by RT-PCR analysis and immunocytochemistry for specific hormones. Some lines expressed markers associated with multipotent adult progenitor cells or transit-amplifying cells, including SOX2, nestin, S100, and SOX9. The progenitor lines were exposed to an adenylate cyclase activator, forskolin, over 7 days and were induced to differentiate to a more mature gonadotrope cell, expressing significant levels of a-subunit, LH beta, and FSH beta mRNAs. Additionally, clonal populations of differentiated gonadotropes were exposed to 30 nM gonadotropin-releasing hormone and responded appropriately with a significant increase in alpha-subunit and LH beta transcription. Further, exposure of the lines to a pulse paradigm of GnRH, in combination with 17 beta-estradiol and dexamethasone, significantly increased GnRH receptor mRNA levels. This array of adult-derived pituitary cell models will be valuable for both studies of progenitor cell characteristics and modulation, and the molecular analysis of individual pituitary cell lineages.	[Kim, Ginah L.; Wang, Xiaomei; Chalmers, Jennifer A.; Thompson, David R.; Dhillon, Sandeep S.; Koletar, Margaret M.; Belsham, Denise D.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Belsham, Denise D.] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada; [Belsham, Denise D.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Belsham, Denise D.] Toronto Gen Hosp, Div Cellular & Mol Biol, Res Inst, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Kim, GL (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	d.belsham@utoronto.ca			Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council; Canada Foundation for Innovation; Canada Research Chairs Program; OGS	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs Program(Canada Research Chairs); OGS(Ontario Graduate Scholarship)	The authors acknowledge funding from Canadian Institutes for Health Research, Natural Sciences and Engineering Research Council, Canada Foundation for Innovation, and the Canada Research Chairs Program to DDB. GLK was supported by OGS and NSERC post graduate studentships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarid ET, 1996, DEVELOPMENT, V122, P3319; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; BELSHAM DD, 2009, FASEB J; BUONASSISI V, 1962, P NATL ACAD SCI USA, V48, P1184, DOI 10.1073/pnas.48.7.1184; Chen JH, 2005, ENDOCRINOLOGY, V146, P3985, DOI 10.1210/en.2005-0185; Chen JH, 2009, STEM CELLS, V27, P1182, DOI 10.1002/stem.51; COWANSAGE KK, 2009, CURR MOL PHARM; DHILLON SS, 2010, OPEN NEUROENDOCRIN J, V3, P6; Drouin J, 2007, CLIN GENET, V72, P175, DOI 10.1111/j.1399-0004.2007.00877.x; Drouin J, 2006, FRONT HORM RES, V35, P74, DOI 10.1159/000094310; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; FURTH J, 1953, P SOC EXP BIOL MED, V84, P253; Garcia-Lavandeira M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004815; GHARIB SD, 1990, ENDOCR REV, V11, P177, DOI 10.1210/edrv-11-1-177; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Hapgood JP, 2005, J NEUROENDOCRINOL, V17, P619, DOI 10.1111/j.1365-2826.2005.01353.x; HOWARD MK, 1993, J NEUROCHEM, V60, P1783, DOI 10.1111/j.1471-4159.1993.tb13404.x; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; JUDD AM, 1988, ENDOCRINOLOGY, V123, P2341, DOI 10.1210/endo-123-5-2341; Kaiser UB, 1997, ENDOCRINOLOGY, V138, P1224, DOI 10.1210/en.138.3.1224; Krylyshkina O, 2005, ENDOCRINOLOGY, V146, P2376, DOI 10.1210/en.2004-1209; Lepore DA, 2005, EXP CELL RES, V308, P166, DOI 10.1016/j.yexcr.2005.04.023; Lepore DA, 2007, STEM CELLS, V25, P1730, DOI 10.1634/stemcells.2007-0012; Lepore DA, 2006, STEM CELLS, V24, P2382, DOI 10.1634/stemcells.2006-0085; Mayer CM, 2009, FRONT NEUROENDOCRIN, V30, P405, DOI 10.1016/j.yfrne.2009.03.005; Monaghan TK, 2008, J NEUROCHEM, V104, P74, DOI 10.1111/j.1471-4159.2007.05018.x; Obayashi S, 2009, CELL MOL NEUROBIOL, V29, P423, DOI 10.1007/s10571-008-9338-2; Oh JE, 2007, ELECTROPHORESIS, V28, P2009, DOI 10.1002/elps.200600833; Ooi GT, 2004, MOL CELL ENDOCRINOL, V228, P1, DOI 10.1016/j.mce.2004.07.018; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pernasetti F, 2001, ENDOCRINOLOGY, V142, P2284, DOI 10.1210/en.142.6.2284; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; REYMOND MJ, 1984, ACTA ENDOCRINOL-COP, V106, P459, DOI 10.1530/acta.0.1060459; RIDGWAY EC, 1983, ENDOCRINOLOGY, V113, P1587, DOI 10.1210/endo-113-5-1587; Shi GX, 2008, MOL CELL BIOL, V28, P4940, DOI 10.1128/MCB.02193-07; Skaper SD, 2008, CNS NEUROL DISORD-DR, V7, P46, DOI 10.2174/187152708783885174; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; TASHJIAN AH, 1970, J CELL BIOL, V47, P61, DOI 10.1083/jcb.47.1.61; Thomas P, 1996, ENDOCRINOLOGY, V137, P2979, DOI 10.1210/en.137.7.2979; Tremblay RG, 2010, J NEUROSCI METH, V186, P60, DOI 10.1016/j.jneumeth.2009.11.004; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; VANKELECOM H, 2009, GEN COMP ENDOCRINOL; Vankelecom H, 2007, NEUROENDOCRINOLOGY, V85, P110, DOI 10.1159/000100278; WEISS J, 1990, MOL ENDOCRINOL, V4, P557, DOI 10.1210/mend-4-4-557; Weiss S, 2009, CLIN NEUROPATHOL, V28, P309; WINDLE JJ, 1990, MOL ENDOCRINOL, V4, P597, DOI 10.1210/mend-4-4-597; Zahir T, 2009, STEM CELLS DEV, V18, P1423, DOI 10.1089/scd.2008.0412	49	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27799	10.1371/journal.pone.0027799	http://dx.doi.org/10.1371/journal.pone.0027799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132145	Green Submitted, gold, Green Published			2022-12-25	WOS:000297789900021
J	De la Fuente, IM; Cortes, JM; Perez-Pinilla, MB; Ruiz-Rodriguez, V; Veguillas, J				De la Fuente, Ildefonso M.; Cortes, Jesus M.; Perez-Pinilla, Martin B.; Ruiz-Rodriguez, Vicente; Veguillas, Juan			The Metabolic Core and Catalytic Switches Are Fundamental Elements in the Self-Regulation of the Systemic Metabolic Structure of Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; SACCHAROMYCES-CEREVISIAE; AUTONOMOUS OSCILLATIONS; GLUCOSE-METABOLISM; PROTEIN COMPLEXES; KINETIC-MODEL; CYCLE; YEAST; ORGANIZATION; EXPRESSION	Background: Experimental observations and numerical studies with dissipative metabolic networks have shown that cellular enzymatic activity self-organizes spontaneously leading to the emergence of a metabolic core formed by a set of enzymatic reactions which are always active under all environmental conditions, while the rest of catalytic processes are only intermittently active. The reactions of the metabolic core are essential for biomass formation and to assure optimal metabolic performance. The on-off catalytic reactions and the metabolic core are essential elements of a Systemic Metabolic Structure which seems to be a key feature common to all cellular organisms. Methodology/Principal Findings: In order to investigate the functional importance of the metabolic core we have studied different catalytic patterns of a dissipative metabolic network under different external conditions. The emerging biochemical data have been analysed using information-based dynamic tools, such as Pearson's correlation and Transfer Entropy (which measures effective functionality). Our results show that a functional structure of effective connectivity emerges which is dynamical and characterized by significant variations of bio-molecular information flows. Conclusions/Significance: We have quantified essential aspects of the metabolic core functionality. The always active enzymatic reactions form a hub -with a high degree of effective connectivity-exhibiting a wide range of functional information values being able to act either as a source or as a sink of bio-molecular causal interactions. Likewise, we have found that the metabolic core is an essential part of an emergent functional structure characterized by catalytic modules and metabolic switches which allow critical transitions in enzymatic activity. Both, the metabolic core and the catalytic switches in which also intermittently-active enzymes are involved seem to be fundamental elements in the self-regulation of the Systemic Metabolic Structure.	[De la Fuente, Ildefonso M.] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [De la Fuente, Ildefonso M.] Inst Invest Sanitaria Biocruces, Baracaldo, Bizkaia, Spain; [Cortes, Jesus M.; Ruiz-Rodriguez, Vicente] Univ Granada, DECSAI Dept Ciencias Comp & Inteligencia Artifici, Granada, Spain; [Cortes, Jesus M.] Univ Granada, CITIC Ctr Invest Tecnol Informac & Comunicac, Granada, Spain; [Perez-Pinilla, Martin B.] Univ Basque Country, Fac Ciencia & Tecnol, Dept Matemat, Bizkaia, Spain; [Veguillas, Juan] Univ Basque Country, Fac Ciencias & Tecnol, Dept Quim Fis, Bizkaia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Granada; University of Granada; University of Basque Country; University of Basque Country	De la Fuente, IM (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain.	mtpmadei@ehu.es	Cortes, Jesus/D-9949-2012; Pérez-Pinillla, Martín-Blas/K-9042-2017	Cortes, Jesus/0000-0002-9059-8194; Pérez-Pinillla, Martín-Blas/0000-0002-3461-9990; De la Fuente, Ildefonso/0000-0001-6548-7583	Consejo Superior de Investigaciones Cientificas (CSIC) [2010201026]; Ministerio de Ciencia e Innovacion (MICINN); Programa Ramon y Cajal; Campus de Excelencia Internacional CEI BioTIC GENIL [PYR-2010-14]; Junta de Andalucia [P09-FQM-4682]	Consejo Superior de Investigaciones Cientificas (CSIC); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Programa Ramon y Cajal(Spanish Government); Campus de Excelencia Internacional CEI BioTIC GENIL; Junta de Andalucia(Junta de Andalucia)	Consejo Superior de Investigaciones Cientificas (CSIC), grant 2010201026. Ministerio de Ciencia e Innovacion (MICINN). Programa Ramon y Cajal. Campus de Excelencia Internacional CEI BioTIC GENIL, grant PYR-2010-14. Junta de Andalucia, grant P09-FQM-4682. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainscow EK, 2002, J PHYSIOL-LONDON, V544, P429, DOI 10.1113/jphysiol.2002.022434; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Almaas E, 2007, J EXP BIOL, V210, P1548, DOI 10.1242/jeb.003731; Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Aon MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003624; BARIL EF, 1968, J NUTR, V95, P228, DOI 10.1093/jn/95.2.228; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Bier M, 1996, BIOPHYS CHEM, V62, P15, DOI 10.1016/S0301-4622(96)02195-3; BRODSKY VY, 1992, J CELL SCI, V103, P363; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Chiam KH, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061901; CLEGG JS, 1990, ARCH BIOCHEM BIOPHYS, V278, P452, DOI 10.1016/0003-9861(90)90284-6; De la Fuente IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009484; De la Fuente IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007510; De La Fuente IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003100; De La Fuente IM, 1999, B MATH BIOL, V61, P573, DOI 10.1006/bulm.1999.0103; De la Fuente IM, 1999, BIOSYSTEMS, V50, P83, DOI 10.1016/S0303-2647(98)00094-X; de la Fuente IM, 1998, ACTA BIOTHEOR, V46, P37, DOI 10.1023/A:1000899820111; Dekhuijzen AJ, 1996, J NEUROSCI METH, V67, P141, DOI 10.1016/0165-0270(96)00033-7; DelaFuente IM, 1996, BIOSYSTEMS, V39, P87, DOI 10.1016/0303-2647(95)01603-1; delaFuente IM, 1996, BIOPHYS J, V71, P2375, DOI 10.1016/S0006-3495(96)79431-6; DELAFUENTE IM, 1995, BIOSYSTEMS, V35, P1, DOI 10.1016/0303-2647(94)01473-K; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Friston KJ, 1995, HUM BRAIN MAPP, V3, P56, DOI 10.1002/hbm.460030106; FUENTES JM, 1994, ARCH INT PHYSIOL BIO, V102, P237, DOI 10.3109/13813459409003936; Fujita A, 2007, BIOINFORMATICS, V23, P1623, DOI 10.1093/bioinformatics/btm151; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GERSTEIN GL, 1969, SCIENCE, V164, P828, DOI 10.1126/science.164.3881.828; Getty L, 2000, J CLIN INVEST, V106, P421, DOI 10.1172/JCI7815; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; Goldbeter A, 2007, ADV CHEM PHYS, V135, P253; Gonze D, 2004, INT J QUANTUM CHEM, V98, P228, DOI 10.1002/qua.10875; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; Hartig K, 2005, PLANT BIOLOGY, V7, P33, DOI 10.1055/s-2004-830474; He C, 2005, MOL CELL, V20, P117, DOI 10.1016/j.molcel.2005.08.013; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holz GG, 2008, AM J PHYSIOL-CELL PH, V294, pC4, DOI 10.1152/ajpcell.00522.2007; Hungerbuehler AK, 2007, EUKARYOT CELL, V6, P473, DOI 10.1128/EC.00273-06; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jorgensen K, 2005, CURR OPIN PLANT BIOL, V8, P280, DOI 10.1016/j.pbi.2005.03.014; Jovanovic S, 2007, J MOL BIOL, V371, P349, DOI 10.1016/j.jmb.2007.05.081; Jules M, 2005, FEBS J, V272, P1490, DOI 10.1111/j.1742-4658.2005.04588.x; Kass L, 1996, J PHOTOCH PHOTOBIO B, V35, P105, DOI 10.1016/1011-1344(96)07301-0; Kindzelskii AL, 1998, BIOPHYS J, V74, P90, DOI 10.1016/S0006-3495(98)77770-7; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Klevecz RR, 2001, MOL BIOL REP, V28, P73, DOI 10.1023/A:1017909012215; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; LANGE G, 2004, FEBS, V178, P61; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lim HN, 2007, NAT GENET, V39, P269, DOI 10.1038/ng1956; Lloyd D, 2005, TRENDS BIOCHEM SCI, V30, P373, DOI 10.1016/j.tibs.2005.05.005; Lloyd D, 2002, FEBS LETT, V519, P41, DOI 10.1016/S0014-5793(02)02704-7; Lunn JE, 2007, J EXP BOT, V58, P35, DOI 10.1093/jxb/erl134; Marquez S, 2004, FASEB J, V18, P519, DOI 10.1096/fj.03-0417fje; de la Fuente IM, 2010, INT J MOL SCI, V11, P3540, DOI 10.3390/ijms11093540; Mellon D, 1999, J NEUROPHYSIOL, V81, P1231, DOI 10.1152/jn.1999.81.3.1231; Milani M, 2003, BIOCHEM MOL BIOL EDU, V31, P228, DOI 10.1002/bmb.2003.494031040239; Miller P, 2005, PLOS BIOL, V3, P705, DOI 10.1371/journal.pbio.0030107; Mogilevskaya E, 2006, J BIOL PHYS, V32, P245, DOI 10.1007/s10867-006-9015-y; Moller AC, 1998, BIOPHYS CHEM, V72, P63, DOI 10.1016/S0301-4622(98)00123-9; Monge C, 2008, MOL CELL BIOCHEM, V318, P147, DOI 10.1007/s11010-008-9865-7; Monge C, 2009, BIOPHYS J, V96, p241A, DOI 10.1016/j.bpj.2008.12.1188; Mukhopadhyay ND, 2007, BIOINFORMATICS, V23, P442, DOI 10.1093/bioinformatics/btl598; Nakahata Y, 2007, CURR OPIN CELL BIOL, V19, P230, DOI 10.1016/j.ceb.2007.02.016; NEGRUTSKII BS, 1991, P NATL ACAD SCI USA, V88, P4991, DOI 10.1073/pnas.88.11.4991; Nelson L. D., 2004, LEHNINGER PRINCIPLES; Nicolis G., 1977, SELF ORG NONEQUILIBR; Noble D, 2008, EXP PHYSIOL, V93, P16, DOI 10.1113/expphysiol.2007.038695; OESCHBARTLOMOWI.B, 2003, BIOCHEMISTRY-US, V409, P228; OLSEN LF, 1985, Q REV BIOPHYS, V18, P165, DOI 10.1017/S0033583500005175; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P5, DOI 10.1023/B:MCBI.0000009855.14648.2c; Ovadi J, 2000, INT REV CYTOL, V192, P255; Pahle J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-139; Pang CNI, 2008, PROTEOMICS, V8, P425, DOI 10.1002/pmic.200700801; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Perl A, 2002, ANTIOXID REDOX SIGN, V4, P427, DOI 10.1089/15230860260196227; Placantonakis DG, 2001, J PHYSIOL-LONDON, V534, P123, DOI 10.1111/j.1469-7793.2001.t01-1-00123.x; Rengan R, 1999, BIOCHEM BIOPH RES CO, V262, P479, DOI 10.1006/bbrc.1999.1222; Rosenspire AJ, 2001, J CELL SCI, V114, P1515; Saks V, 2006, J PHYSIOL-LONDON, V571, P253, DOI 10.1113/jphysiol.2005.101444; SAKS VA, 2007, MOLECULARSYSTEM BIOE; Saks V, 2009, INT J MOL SCI, V10, P1161, DOI 10.3390/ijms10031161; Sanchez-Armass S, 2006, AM J PHYSIOL-CELL PH, V290, pC524, DOI 10.1152/ajpcell.00290.2005; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shaul O, 1996, P NATL ACAD SCI USA, V93, P4868, DOI 10.1073/pnas.93.10.4868; Smrcinova M, 1998, INT J BIFURCAT CHAOS, V8, P2467, DOI 10.1142/S0218127498001984; Tennessen JM, 2011, CELL METAB, V13, P139, DOI 10.1016/j.cmet.2011.01.005; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tonozuka H, 2001, J BIOCHEM-TOKYO, V130, P589, DOI 10.1093/oxfordjournals.jbchem.a003023; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; TYSON JJ, 1991, P NATL ACAD SCI USA, V88, P7328, DOI 10.1073/pnas.88.16.7328; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; VASSEUR S, 2010, HYPOXIA INDUCED TUMO, V2, P2138; Verkest A, 2005, PLANT PHYSIOL, V139, P1099, DOI 10.1104/pp.105.069906; Wittmann C, 2005, BIOTECHNOL BIOENG, V89, P839, DOI 10.1002/bit.20408; Xu SB, 2008, PLANT PHYSIOL, V148, P908, DOI 10.1104/pp.108.125633; Xu ZJ, 2004, BIOCHEM J, V383, P171, DOI 10.1042/BJ20040967; Yang CR, 2005, J BIOL CHEM, V280, P11224, DOI 10.1074/jbc.M411471200; Yeates TO, 2007, BIOCHEM SOC T, V35, P508, DOI 10.1042/BST0350508	108	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27224	10.1371/journal.pone.0027224	http://dx.doi.org/10.1371/journal.pone.0027224			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125607	Green Published, gold			2022-12-25	WOS:000297789200007
J	Liu, W; Deng, RF; Liu, WP; Wang, ZM; Ye, WH; Wang, LY; Cao, HL; Shen, H				Liu, Wei; Deng, Ru-Fang; Liu, Wen-Ping; Wang, Zhang-Ming; Ye, Wan-Hui; Wang, Lan-Ying; Cao, Hong-Lin; Shen, Hao			Phenotypic Differentiation Is Associated with Gender Plasticity and Its Responsive Delay to Environmental Changes in Alternanthera philoxeroides - Phenotypic Differentiation in Alligator Weed	PLOS ONE			English	Article							SEX-ALLOCATION; EVOLUTION; PLANT; CONSEQUENCES; ADAPTATION; EXPRESSION; ECOTYPES; STRESS; DIOECY; SIZE	Phenotypic plasticity is common in many taxa, and it may increase an organism's fitness in heterogeneous environments. However, in some cases, the frequency of environmental changes can be faster than the ability of the individual to produce new adaptive phenotypes. The importance of such a time delay in terms of individual fitness and species adaptability has not been well studied. Here, we studied gender plasticity of Alternanthera philoxeroides to address this issue through a reciprocal transplant experiment. We observed that the genders of A. philoxeroides were plastic and reversible between monoclinous and pistillody depending on habitats, the offspring maintained the maternal genders in the first year but changed from year 2 to 5, and there was a cubic relationship between the rate of population gender changes and environmental variations. This relationship indicates that the species must overcome a threshold of environmental variations to switch its developmental path ways between the two genders. This threshold and the maternal gender stability cause a significant delay of gender changes in new environments. At the same time, they result in and maintain the two distinct habitat dependent gender phenotypes. We also observed that there was a significant and adaptive life-history differentiation between monoclinous and pistillody individuals and the gender phenotypes were developmentally linked with the life-history traits. Therefore, the gender phenotypes are adaptive. Low seed production, seed germination failure and matching phenotypes to habitats by gender plasticity indicate that the adaptive phenotypic diversity in A. philoxeroides may not be the result of ecological selection, but of gender plasticity. The delay of the adaptive gender phenotype realization in changing environments can maintain the differentiation between gender systems and their associated life-history traits, which may be an important component in evolution of novel traits and taxonomic diversity.	[Liu, Wei; Deng, Ru-Fang; Liu, Wen-Ping; Wang, Zhang-Ming; Ye, Wan-Hui; Wang, Lan-Ying; Cao, Hong-Lin; Shen, Hao] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Liu, Wei; Deng, Ru-Fang; Liu, Wen-Ping; Wang, Lan-Ying] Grad Univ Chinese Acad Sci, Dept Biol, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, W (corresponding author), Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, S China Bot Garden, Guangzhou, Guangdong, Peoples R China.	liuwei@scbg.ac.cn; why@scbg.ac.cn; shenhao@scbg.ac.cn			National Basic Research Program of China (973 Program) [2009CB119204]; National Natural Science Foundation of China [30530160]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by financial support from the National Basic Research Program of China (973 Program: 2009CB119204) and The National Natural Science Foundation of China: (30530160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2004, POPUL ECOL, V46, P13, DOI 10.1007/s10144-003-0168-2; Ashman TL, 2001, INT J PLANT SCI, V162, P327, DOI 10.1086/319571; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Campbell DR, 2000, TRENDS ECOL EVOL, V15, P227, DOI 10.1016/S0169-5347(00)01872-3; Case AL, 2004, EVOL ECOL, V18, P145, DOI 10.1023/B:EVEC.0000021152.34483.77; Chen Z., 1964, ACTA BOT SIN, V12, P133; Dorken ME, 2003, EVOLUTION, V57, P1973, DOI 10.1111/j.0014-3820.2003.tb00378.x; DORN LA, 1991, EVOLUTION, V45, P371, DOI 10.1111/j.1558-5646.1991.tb04411.x; Fusco G, 2010, PHILOS T R SOC B, V365, P547, DOI 10.1098/rstb.2009.0267; FUTUYMA D., 2009, EVOLUTION; Geng YP, 2007, BIOL INVASIONS, V9, P245, DOI 10.1007/s10530-006-9029-1; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gregg KB., 1975, SELBYANA, V1, P101; Hollander J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-333; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; JABLONKA E, 2008, VOGIS HERALD, V12, P242; JINKS JL, 1975, HEREDITY, V34, P401, DOI 10.1038/hdy.1975.49; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; JORGENSEN RA, 1995, SCIENCE, V268, P686, DOI 10.1126/science.268.5211.686; Klimesova J, 2007, PERSPECT PLANT ECOL, V8, P115, DOI 10.1016/j.ppees.2006.10.002; Lewontin R.C., 2000, TRIPLE HELIX GENE OR, P136; LLOYD DG, 1984, LINNEAN, V21, P357; Minelli A., 2008, EVOLVING PATHWAYS KE; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Mitchell CH, 2005, AM J BOT, V92, P1068, DOI 10.3732/ajb.92.7.1068; Mitchell K., 2007, QUANTITATIVE ANAL PO; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Padilla DK, 1996, EVOL ECOL, V10, P105, DOI 10.1007/BF01239351; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; PICKERING CM, 1993, OIKOS, V68, P539, DOI 10.2307/3544923; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Rice SH, 2004, GENETICS, V166, P513, DOI 10.1534/genetics.166.1.513; Schlichting C.D., 2004, PHENOTYPIC PLASTICIT, P191, DOI DOI 10.1002/AJHB.20088; Schlichting CD, 2002, EVOL ECOL, V16, P189, DOI 10.1023/A:1019624425971; SOSA AJ, 2008, S AM BIOL CONTROL LA, P15; Stokes TL, 2002, GENE DEV, V16, P171, DOI 10.1101/gad.952102; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; Underwood N, 1999, AM NAT, V153, P282, DOI 10.1086/303174; VIA S, 1987, GENET RES, V49, P147, DOI 10.1017/S001667230002694X; Vitt P, 2003, AM J BOT, V90, P1729, DOI 10.3732/ajb.90.12.1729; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Weppler T, 2006, J ECOL, V94, P869, DOI 10.1111/j.1365-2745.2006.01134.x; West-Eberhard Mary Jane, 2003, pi; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; Whitman D. W., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P1; WOODWARD DE, 1993, P ROY SOC B-BIOL SCI, V252, P149, DOI 10.1098/rspb.1993.0059; Wright S, 1934, GENETICS, V19, P0471; Ye WH, 2003, WEED RES, V43, P297, DOI 10.1046/j.1365-3180.2003.00346.x	49	4	6	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27238	10.1371/journal.pone.0027238	http://dx.doi.org/10.1371/journal.pone.0027238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125608	gold, Green Submitted, Green Published			2022-12-25	WOS:000297789200008
J	Orfeo, T; Gissel, M; Butenas, S; Undas, A; Brummel-Ziedins, KE; Mann, KG				Orfeo, Thomas; Gissel, Matthew; Butenas, Saulius; Undas, Anetta; Brummel-Ziedins, Kathleen E.; Mann, Kenneth G.			Anticoagulants and the Propagation Phase of Thrombin Generation	PLOS ONE			English	Article							ORAL DIRECT THROMBIN; FACTOR-XA; IN-VITRO; BLOOD-COAGULATION; ANTITHROMBIN-III; TISSUE FACTOR; FACTOR-V; EX-VIVO; INHIBITOR; HEPARIN	The view that clot time-based assays do not provide a sufficient assessment of an individual's hemostatic competence, especially in the context of anticoagulant therapy, has provoked a search for new metrics, with significant focus directed at techniques that define the propagation phase of thrombin generation. Here we use our deterministic mathematical model of tissue-factor initiated thrombin generation in combination with reconstructions using purified protein components to characterize how the interplay between anticoagulant mechanisms and variable composition of the coagulation proteome result in differential regulation of the propagation phase of thrombin generation. Thrombin parameters were extracted from computationally derived thrombin generation profiles generated using coagulation proteome factor data from warfarin-treated individuals (N = 54) and matching groups of control individuals (N = 37). A computational clot time prolongation value (cINR) was devised that correlated with their actual International Normalized Ratio (INR) values, with differences between individual INR and cINR values shown to derive from the insensitivity of the INR to tissue factor pathway inhibitor (TFPI). The analysis suggests that normal range variation in TFPI levels could be an important contributor to the failure of the INR to adequately reflect the anticoagulated state in some individuals. Warfarin-induced changes in thrombin propagation phase parameters were then compared to those induced by unfractionated heparin, fondaparinux, rivaroxaban, and a reversible thrombin inhibitor. Anticoagulants were assessed at concentrations yielding equivalent cINR values, with each anticoagulant evaluated using 32 unique coagulation proteome compositions. The analyses showed that no anticoagulant recapitulated all features of warfarin propagation phase dynamics; differences in propagation phase effects suggest that anticoagulants that selectively target fXa or thrombin may provoke fewer bleeding episodes. More generally, the study shows that computational modeling of the response of core elements of the coagulation proteome to a physiologically relevant tissue factor stimulus may improve the monitoring of a broad range of anticoagulants.	[Orfeo, Thomas; Gissel, Matthew; Butenas, Saulius; Brummel-Ziedins, Kathleen E.; Mann, Kenneth G.] Univ Vermont, Dept Biochem, Colchester, VT USA; [Undas, Anetta] Jagiellonian Univ, Sch Med, Inst Cardiol, Krakow, Poland; [Mann, Kenneth G.] Johnson & Johnson Pharmaceut Res & Dev, Raritan, NJ USA	University of Vermont; Jagiellonian University; Collegium Medicum Jagiellonian University; Johnson & Johnson; Johnson & Johnson USA	Orfeo, T (corresponding author), Univ Vermont, Dept Biochem, Colchester, VT USA.	kenneth.mann@uvm.edu			National Institutes of Health [HL46703]; Johnson Johnson; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant to KGM: PPG HL46703 (Project 1 from NIH) and a grant from Johnson & Johnson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; BAJAJ SP, 1981, PREP BIOCHEM, V11, P397, DOI 10.1080/00327488108065531; Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; Blech S, 2008, DRUG METAB DISPOS, V36, P386, DOI 10.1124/dmd.107.019083; Bonderman D, 2002, BLOOD, V99, P2794, DOI 10.1182/blood.V99.8.2794; Brufatto N, 2001, J BIOL CHEM, V276, P17663, DOI 10.1074/jbc.M011586200; Brummel KE, 2001, CIRCULATION, V104, P2311, DOI 10.1161/hc4401.098492; Brummel-Ziedins K, 2008, J THROMB HAEMOST, V6, P104; Brummel-Ziedins K, 2005, J THROMB HAEMOST, V3, P1472, DOI 10.1111/j.1538-7836.2005.01249.x; Brummel-Ziedins KE, 2009, J THROMB HAEMOST, V7, P181, DOI 10.1111/j.1538-7836.2009.03426.x; Brummel-Ziedins KE, 2005, J THROMB HAEMOST, V3, P2497, DOI 10.1111/j.1538-7836.2005.01584.x; Brummel-Ziedins KE, 2004, J THROMB HAEMOST, V2, P281, DOI 10.1046/j.1538-7933.2003.00576.x; Cawthern KM, 1998, BLOOD, V91, P4581, DOI 10.1182/blood.V91.12.4581.412k12_4581_4592; Chuang YJ, 2001, J BIOL CHEM, V276, P14961, DOI 10.1074/jbc.M011550200; Cote HCF, 1997, J BIOL CHEM, V272, P6194, DOI 10.1074/jbc.272.10.6194; Danforth CM, 2009, MATH MED BIOL, V26, P323, DOI 10.1093/imammb/dqp011; Eriksson BI, 2009, CLIN PHARMACOKINET, V48, P1, DOI 10.2165/0003088-200948010-00001; Fadeeva OA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P734, DOI 10.1134/S0006297910060088; Gerotziafas GT, 2007, J THROMB HAEMOST, V5, P886, DOI 10.1111/j.1538-7836.2007.02429.x; GRIFFITH MJ, 1985, J BIOL CHEM, V260, P2218; Hacquard M, 2011, THROMB RES, V127, P29, DOI 10.1016/j.thromres.2010.07.024; HEMKER HC, 1993, THROMB HAEMOSTASIS, V70, P617; HIBBARD LS, 1982, BIOCHEMISTRY-US, V21, P2285, DOI 10.1021/bi00539a003; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; Hirsh J, 2004, CHEST, V126, p188S, DOI 10.1378/chest.126.3_suppl.188S; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; Klaeffling C, 2006, THER DRUG MONIT, V28, P375, DOI 10.1097/01.ftd.0000196662.35726.0f; Kubitza D, 2007, J CLIN PHARMACOL, V47, P218, DOI 10.1177/0091270006296058; LAWSON JH, 1993, J BIOL CHEM, V268, P767; Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83; Mueck W, 2008, THROMB HAEMOSTASIS, V100, P453, DOI 10.1160/07-12-0714; OKAMOTO S, 1993, METHOD ENZYMOL, V222, P328; OLSON ST, 1992, J BIOL CHEM, V267, P12528; Orfeo T, 2010, J THROMB HAEMOST, V8, P1745, DOI 10.1111/j.1538-7836.2010.03917.x; Orfeo T, 2008, J BIOL CHEM, V283, P9776, DOI 10.1074/jbc.M707435200; Paolucci F, 2002, CLIN PHARMACOKINET, V41, P11, DOI 10.2165/00003088-200241002-00002; Perzborn E, 2005, J THROMB HAEMOST, V3, P514, DOI 10.1111/j.1538-7836.2005.01166.x; Rand MD, 1996, BLOOD, V88, P3432, DOI 10.1182/blood.V88.9.3432.bloodjournal8893432; Rezaie AR, 1998, J BIOL CHEM, V273, P16824, DOI 10.1074/jbc.273.27.16824; REZAIE AR, 1995, J BIOL CHEM, V270, P16176, DOI 10.1074/jbc.270.27.16176; Rezaie AR, 2001, BLOOD, V97, P2308, DOI 10.1182/blood.V97.8.2308; Robert S, 2009, PHARMACOL RES, V59, P160, DOI 10.1016/j.phrs.2008.12.003; Samama MM, 2010, THROMB HAEMOSTASIS, V103, P815, DOI 10.1160/TH09-03-0176; Undas A, 2010, THROMB HAEMOSTASIS, V104, P224, DOI 10.1160/TH10-02-0091; van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758; vantVeer C, 1997, J BIOL CHEM, V272, P4367, DOI 10.1074/jbc.272.7.4367; Wienen W, 2007, THROMB HAEMOSTASIS, V98, P155, DOI 10.1160/TH07-03-0183; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Yeh RW, 2006, AM HEART J, V151, P1131, DOI 10.1016/j.ahj.2005.09.002; YOUNG E, 1994, THROMB HAEMOSTASIS, V71, P300	51	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27852	10.1371/journal.pone.0027852	http://dx.doi.org/10.1371/journal.pone.0027852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125631	Green Published, gold			2022-12-25	WOS:000297789200031
J	Palmieri, D; D'Angelo, D; Valentino, T; De Martino, I; Ferraro, A; Wierinckx, A; Fedele, M; Trouillas, J; Fusco, A				Palmieri, D.; D'Angelo, D.; Valentino, T.; De Martino, I.; Ferraro, A.; Wierinckx, A.; Fedele, M.; Trouillas, J.; Fusco, A.			Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis	ONCOGENE			English	Article						HMGA; pituitary adenoma; microRNA	NATURAL-KILLER-CELL; MOBILITY GROUP A2; GENE-EXPRESSION; PROTEIN-SYNTHESIS; ADENOMAS; TUMORS; MOUSE; OVEREXPRESSION; TRANSFORMATION; PROLIFERATION	Previous studies have demonstrated that high mobility group A proteins have a critical role on the onset of human pituitary adenomas. Indeed, both high mobility group A (HMGA) genes are overexpressed in pituitary adenomas, and consistently transgenic mice overexpressing either the Hmga1 or the Hmga2 gene develop mixed growth hormone/prolactin (GH-PRL)-secreting pituitary adenomas. Trisomy of chromosome 12, where HMGA2 is located, and/or amplification of the HMGA2 gene locus account for the HMGA2 overexpression in most human prolactinomas. Conversely, HMGA1 over-expression is not associated to any rearrangement or amplification of the HMGA1 locus. We have first identified micro RNAs (miRNAs) able to target both HMGA1 and HMGA2 messenger RNAs. Then, all of these miRNAs have been found downregulated in pituitary adenomas of different histotypes, compared with normal pituitary. Interestingly, their downregulation was also observed in nonfunctioning pituitary adenomas where HMGA2 overexpression is not associated to any alteration of the HMGA2 locus. Functional studies show that all these HMGA-targeting miRNAs inhibit the proliferation of the rat pituitary adenoma cell line GH3. Therefore, these results indicate that the downregulation of the miRNAs able to target the HMGA genes could contribute to increase HMGA protein levels in human pituitary adenomas, and then to pituitary tumorigenesis. Oncogene (2012) 31, 3857-3865; doi:10.1038/onc.2011.557; published online 5 December 2011	[Palmieri, D.; D'Angelo, D.; Valentino, T.; De Martino, I.; Ferraro, A.; Fedele, M.; Fusco, A.] Univ Naples Federico II, CNR, Ist Endocrinol & Oncol Sperimentale,Fac Med & Chi, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; [Wierinckx, A.] Univ Lyon, Lyon, France; [Wierinckx, A.] Ctr Rech Cancerol Lyon, INSERM, U1052, Lyon, France; [Trouillas, J.] CNRS, INSERM, U1028, UMR 5292,Lyon Neurosci Res Ctr,Neurooncol & Neuro, Lyon, France; [Trouillas, J.] Univ Lyon 1, F-69365 Lyon, France; [Ferraro, A.; Fusco, A.] SEMM European Sch Mol Med Naples Site, Naples, Italy; [Ferraro, A.; Fusco, A.] NOGEC Naples Oncogen Ctr CEINGE, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Fusco, A (corresponding author), Univ Naples Federico II, CNR, Ist Endocrinol & Oncol Sperimentale,Fac Med & Chi, Dipartimento Biol & Patol Cellulare & Mol, Via Pansini 5, I-80131 Naples, Italy.	alfusco@unina.it	Ferraro, Angelo/A-4172-2014; D'Angelo, Daniela/GVT-9143-2022; Wierinckx, Anne/AAF-5233-2021; Fedele, Monica/C-1417-2015; Ferraro, Angelo/H-3193-2019	Ferraro, Angelo/0000-0002-2044-7569; Wierinckx, Anne/0000-0002-0186-6645; Fedele, Monica/0000-0002-9171-1312; Ferraro, Angelo/0000-0002-2044-7569; Palmieri, Dario/0000-0002-0797-4268; Fusco, Alfredo/0000-0003-3332-5197	Associazione Italiana Ricerca sul Cancro (AIRC); Fondazione Italiana per la Ricerca sul Cancro (FIRC)	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana per la Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from the Associazione Italiana Ricerca sul Cancro (AIRC). DP is recipient of a fellowship from Fondazione Italiana per la Ricerca sul Cancro (FIRC).	ASHAR HR, 1995, CELL, V82, P57; Baldassarre G, 2001, P NATL ACAD SCI USA, V98, P7970, DOI 10.1073/pnas.141224998; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BERLINGIERI MT, 1995, MOL CELL BIOL, V15, P1545; Berlingieri MT, 2002, ONCOGENE, V21, P2971, DOI 10.1038/sj.onc.1205368; Bottoni A, 2005, J CELL PHYSIOL, V204, P280, DOI 10.1002/jcp.20282; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chiappetta G, 1996, ONCOGENE, V13, P2439; Daly AF, 2006, J CLIN ENDOCR METAB, V91, P4769, DOI 10.1210/jc.2006-1668; Daly AF, 2009, BEST PRACT RES CL EN, V23, P543, DOI 10.1016/j.beem.2009.05.008; De Martino I, 2009, ONCOGENE, V28, P1432, DOI 10.1038/onc.2008.495; De Martino I, 2007, ENDOCR-RELAT CANCER, V14, P875, DOI 10.1677/ERC-07-0036; De Martino I, 2009, CANCER RES, V69, P1844, DOI 10.1158/0008-5472.CAN-08-4133; Fedele M, 2005, ONCOGENE, V24, P3427, DOI 10.1038/sj.onc.1208501; Fedele M, 2002, ONCOGENE, V21, P3190, DOI 10.1038/sj.onc.1205428; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Fedele M, 2010, MOL CELL ENDOCRINOL, V326, P19, DOI 10.1016/j.mce.2010.03.019; Fedele M, 2010, BBA-GENE REGUL MECH, V1799, P48, DOI 10.1016/j.bbagrm.2009.11.007; Fernandez A, 2010, CLIN ENDOCRINOL, V72, P377, DOI 10.1111/j.1365-2265.2009.03667.x; Finelli P, 2002, CANCER RES, V62, P2398; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; JOHNSON KR, 1989, MOL CELL BIOL, V9, P2114, DOI 10.1128/MCB.9.5.2114; Kaddar T, 2009, BIOL CELL, V101, P511, DOI 10.1042/BC20080213; KOVACS K, 1986, SEMIN DIAGN PATHOL, V3, P18; Lagana A, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap008; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee S, 2011, CELL MOL LIFE SCI, V68, P325, DOI 10.1007/s00018-010-0457-9; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Monson JP, 2000, ENDOCR-RELAT CANCER, V7, P29, DOI 10.1677/erc.0.0070029; Pierantoni GM, 2005, ENDOCR-RELAT CANCER, V12, P867, DOI 10.1677/erc.1.01049; Pierantoni GM, 2001, ONCOGENE, V20, P6132, DOI 10.1038/sj.onc.1204635; Qian ZR, 2009, MODERN PATHOL, V22, P431, DOI 10.1038/modpathol.2008.202; Scala S, 2000, P NATL ACAD SCI USA, V97, P4256, DOI 10.1073/pnas.070029997; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; THANOS D, 1993, COLD SPRING HARB SYM, V58, P73, DOI 10.1101/SQB.1993.058.01.011; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; Wang EL, 2010, HISTOPATHOLOGY, V56, P501, DOI 10.1111/j.1365-2559.2010.03495.x; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	41	79	82	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2012	31	34					3857	3865		10.1038/onc.2011.557	http://dx.doi.org/10.1038/onc.2011.557			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	994IV	22139073				2022-12-25	WOS:000307925000003
J	Kimura, T; Yeliseev, AA; Vukoti, K; Rhodes, SD; Cheng, KJ; Rice, KC; Gawrisch, K				Kimura, Tomohiro; Yeliseev, Alexei A.; Vukoti, Krishna; Rhodes, Steven D.; Cheng, Kejun; Rice, Kenner C.; Gawrisch, Klaus			Recombinant Cannabinoid Type 2 Receptor in Liposome Model Activates G Protein in Response to Anionic Lipid Constituents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL RECONSTITUTION; CRYSTAL-STRUCTURE; PHASE-TRANSITION; CB2 RECEPTORS; BINDING-SITE; ANNEXIN-V; PHOSPHATIDYLSERINE; EXPRESSION; RHODOPSIN; MEMBRANE	Human cannabinoid type 2 (CB2) receptor expressed in Escherichia coli was purified and successfully reconstituted in the functional form into lipid bilayers composed of POPC, 1-palmitoyl- 2-oleoyl-sn-glycero-3-phosphocholine, 1-palmitoyl-2-oleoyl- sn-glycero-3-phospho-L-serine (POPS), and cholesteryl hemisuccinate (CHS). Reconstitution was performed by detergent removal from the protein/lipid/detergent mixed micelles either on an adsorbent column, or by rapid dilution to below the critical micelle concentration of detergent followed by removal of detergent monomers on a concentrator. Proteoliposomes prepared at a protein/phospholipid/CHS molar ratio of 1/620 - 650/210-220 are free of detergent as shown by H-1 NMR, have a homogeneous protein/lipid ratio shown by isopycnic gradient ultracentrifugation, and are small in size with a mean diameter of 150-200 nm as measured by dynamic light scattering. Functional integrity of the reconstituted receptor was confirmed by quantitative binding of H-2-labeled agonist CP-55,940-d(6) measured by H-2 magic angle spinning NMR, as well as by activation of G protein. The efficiency of G protein activation by agonist-bound CB2 receptor was affected by negative electric surface potentials of proteoliposomes controlled by the content of anionic CHS or POPS. The activation was highest at an anionic lipid content of about 50 mol %. There was no correlation between the efficiency of G protein activation and an increase of hydrocarbon chain order induced by CHS or cholesterol. The results suggest the importance of anionic lipids in regulating signal transduction by CB2 receptor and other class A GPCR. The successful reconstitution of milligram quantities of pure, functional CB2 receptor enables a wide variety of structural studies.	[Kimura, Tomohiro; Yeliseev, Alexei A.; Vukoti, Krishna; Rhodes, Steven D.; Gawrisch, Klaus] NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD 20852 USA; [Cheng, Kejun; Rice, Kenner C.] NIDA, Chem Biol Res Branch, NIH, Bethesda, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Yeliseev, AA (corresponding author), NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD 20852 USA.	yeliseeva@mail.nih.gov; gawrisch@helix.nih.gov	Kimura, Tomohiro/AEJ-1621-2022; Yeliseev, Alexei A/B-3143-2009	Kimura, Tomohiro/0000-0002-4192-7852	National Institutes of Health from the of the NIAAA; NIDA; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000529] Funding Source: NIH RePORTER	National Institutes of Health from the of the NIAAA; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by a National Institutes of Health grant from the Intramural Research Programs of the NIAAA and NIDA.	Appelt U, 2005, CELL DEATH DIFFER, V12, P194, DOI 10.1038/sj.cdd.4401527; Aveyard R., 1973, INTRO PRINCIPLES SUR; Baker M, 2010, NATURE, V465, P823, DOI 10.1038/465823a; Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Bari M, 2005, J NEUROSCI RES, V81, P275, DOI 10.1002/jnr.20546; Bari M, 2008, NEUROPHARMACOLOGY, V54, P45, DOI 10.1016/j.neuropharm.2007.06.030; Bari M, 2006, J IMMUNOL, V177, P4971, DOI 10.4049/jimmunol.177.8.4971; Berger C, 2010, PROTEIN EXPRES PURIF, V70, P236, DOI 10.1016/j.pep.2009.12.011; Cabral GA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000957; Calandra B, 1997, BIOTECHNOL LETT, V19, P425, DOI 10.1023/A:1018383808401; Callahan MK, 2000, CELL DEATH DIFFER, V7, P645, DOI 10.1038/sj.cdd.4400690; CEVC G, 1981, BIOCHEMISTRY-US, V20, P4955, DOI 10.1021/bi00520a023; Chattopadhyay A, 1996, FEBS LETT, V391, P199, DOI 10.1016/0014-5793(96)00733-8; CHEN NR, 1985, BIOCHEM BIOPH RES CO, V127, P220, DOI 10.1016/S0006-291X(85)80147-9; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Choi G, 2005, BBA-BIOMEMBRANES, V1668, P1, DOI 10.1016/j.bbamem.2004.10.011; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; DeGrip WJ, 1998, BIOCHEM J, V330, P667; DEGRIP WJ, 1983, BIOCHIM BIOPHYS ACTA, V734, P168, DOI 10.1016/0005-2736(83)90115-3; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Escriba PV, 1997, P NATL ACAD SCI USA, V94, P11375, DOI 10.1073/pnas.94.21.11375; EYTAN GD, 1982, BIOCHIM BIOPHYS ACTA, V694, P185, DOI 10.1016/0304-4157(82)90024-7; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Grace CRR, 2007, J STRUCT BIOL, V159, P359, DOI 10.1016/j.jsb.2007.04.004; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Hafez IM, 2000, BBA-BIOMEMBRANES, V1463, P107, DOI 10.1016/S0005-2736(99)00186-8; Heerklotz H, 2006, BIOPHYS J, V91, P600, DOI 10.1529/biophysj.106.082669; HERRMANN KW, 1962, J PHYS CHEM-US, V66, P295, DOI 10.1021/j100808a025; HOLTE LL, 1995, BIOPHYS J, V68, P2396, DOI 10.1016/S0006-3495(95)80422-4; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Ibrahim MM, 2003, P NATL ACAD SCI USA, V100, P10529, DOI 10.1073/pnas.1834309100; JACKSON ML, 1982, BIOCHEMISTRY-US, V21, P5601, DOI 10.1021/bi00265a033; JACKSON ML, 1985, BIOCHIM BIOPHYS ACTA, V812, P369, DOI 10.1016/0005-2736(85)90311-6; Kimura T, 2006, BIOCHEMISTRY-US, V45, P15601, DOI 10.1021/bi061641v; Kimura T, 2010, BIOPHYS J, V98, p625A, DOI 10.1016/j.bpj.2009.12.3421; Kimura T, 2009, BIOPHYS J, V96, P4916, DOI 10.1016/j.bpj.2009.03.033; Koenig BW, 2005, BBA-BIOMEMBRANES, V1715, P65, DOI 10.1016/j.bbamem.2005.07.006; Kosloff M, 2008, J BIOL CHEM, V283, P31197, DOI 10.1074/jbc.M803799200; Krepkiy D, 2007, PROTEIN PEPTIDE LETT, V14, P1031, DOI 10.2174/092986607782541051; Krishna AG, 2002, BIOCHEMISTRY-US, V41, P8298, DOI 10.1021/bi025534m; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Messerschmidt A., 2007, XRAY DIFFRACTION BIO; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; MITCHELL DC, 1990, BIOCHEMISTRY-US, V29, P9143, DOI 10.1021/bi00491a007; Mozsolits H, 2002, BIOCHEMISTRY-US, V41, P7830, DOI 10.1021/bi0121813; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; Nebane NM, 2008, BIOCHEMISTRY-US, V47, P13811, DOI 10.1021/bi8007802; Niu SL, 2009, BIOCHEMISTRY-US, V48, P156, DOI 10.1021/bi801835s; Nunez E, 2004, SYNAPSE, V53, P208, DOI 10.1002/syn.20050; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Petrache HI, 2004, BIOPHYS J, V86, P1574, DOI 10.1016/S0006-3495(04)74225-3; Polozov IV, 2006, BIOPHYS J, V90, P2051, DOI 10.1529/biophysj.105.070441; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Roy MT, 1998, J COLLOID INTERF SCI, V206, P512, DOI 10.1006/jcis.1998.5715; Sarnataro D, 2005, FEBS LETT, V579, P6343, DOI 10.1016/j.febslet.2005.10.016; Sarramegna V, 2006, CELL MOL LIFE SCI, V63, P1149, DOI 10.1007/s00018-005-5557-6; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schubert R, 2003, METHOD ENZYMOL, V367, P46; Shoemaker JL, 2005, J PHARMACOL EXP THER, V315, P828, DOI 10.1124/jpet.105.089474; SILVIUS JR, 1992, ANNU REV BIOPH BIOM, V21, P323, DOI 10.1146/annurev.bb.21.060192.001543; Soubias O, 2006, BIOCHEMISTRY-US, V45, P15583, DOI 10.1021/bi061416d; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; THOMAS BF, 1990, J PHARMACOL EXP THER, V255, P624; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANAKEN T, 1986, METHOD ENZYMOL, V125, P27; WATTS A, 1979, BIOCHEMISTRY-US, V18, P5006, DOI 10.1021/bi00589a031; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WILDMAN DE, 1993, P NATL ACAD SCI USA, V90, P794, DOI 10.1073/pnas.90.3.794; Xie XQ, 2005, J BIOL CHEM, V280, P3605, DOI 10.1074/jbc.M410294200; Xie XQ, 2003, PROTEINS, V53, P307, DOI 10.1002/prot.10511; Yeliseev AA, 2005, PROTEIN SCI, V14, P2638, DOI 10.1110/ps.051550305; Yeliseev A, 2007, PROTEIN EXPRES PURIF, V53, P153, DOI 10.1016/j.pep.2006.12.003; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1	79	35	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	2012	287	6					4076	4087		10.1074/jbc.M111.268425	http://dx.doi.org/10.1074/jbc.M111.268425			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	894EX	22134924	hybrid, Green Published			2022-12-25	WOS:000300410900041
J	Fernandez, JA; Skryma, R; Bidaux, G; Magleby, KL; Scholfield, CN; McGeown, JG; Prevarskaya, N; Zholos, AV				Fernandez, Jose A.; Skryma, Roman; Bidaux, Gabriel; Magleby, Karl L.; Scholfield, C. Norman; McGeown, J. Graham; Prevarskaya, Natalia; Zholos, Alexander V.			Short Isoforms of the Cold Receptor TRPM8 Inhibit Channel Gating by Mimicking Heat Action Rather than Chemical Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; KINETIC STRUCTURE; SENSORY NEURONS; SINGLE; TEMPERATURE; ACTIVATION; MENTHOL; VOLTAGE; THERMOSENSATION; IDENTIFICATION	Transient receptor potential (TRP) channels couple various environmental factors to changes in membrane potential, calcium influx, and cell signaling. They also integrate multiple stimuli through their typically polymodal activation. Thus, although the TRPM8 channel has been extensively investigated as the major neuronal cold sensor, it is also regulated by various chemicals, as well as by several short channel isoforms. Mechanistic understanding of such complex regulation is facilitated by quantitative single-channel analysis. We have recently proposed a single-channel mechanism of TRPM8 regulation by voltage and temperature. Using this gating mechanism, we now investigate TRPM8 inhibition in cell-attached patches using HEK293 cells expressing TRPM8 alone or coexpressed with its short sM8-6 isoform. This is compared with inhibition by the chemicals N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)piperazine-1-carboxamide (BCTC) and clotrimazole or by elevated temperature. We found that within the seven-state single-channel gating mechanism, inhibition of TRPM8 by short sM8-6 isoforms closely resembles inhibition by increased temperature. In contrast, inhibition by BCTC and that by clotrimazole share a different set of common features.	[Fernandez, Jose A.; McGeown, J. Graham; Zholos, Alexander V.] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast BT12 6BA, Antrim, North Ireland; [Skryma, Roman; Bidaux, Gabriel; Prevarskaya, Natalia] Lille Univ Sci & Technol, INSERM, U800, Lab Cell Physiol, F-59655 Villeneuve Dascq, France; [Magleby, Karl L.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA; [Scholfield, C. Norman] Naresuan Univ, Fac Pharmaceut Sci, Phitsanulok 65000, Thailand	Queens University Belfast; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; University of Miami; Naresuan University	Fernandez, JA (corresponding author), Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast BT12 6BA, Antrim, North Ireland.	jfernandezgonzalez01@qub.ac.uk; a.zholos@qub.ac.uk	Zholos, Alexander/A-7017-2011; Bidaux, Gabriel/F-1294-2016	Zholos, Alexander/0000-0002-4320-149X; Scholfield, Charles Norman/0000-0001-7288-590X; Prevarskaya, natacha/0000-0003-0316-197X; Fernandez, Jose A/0000-0002-4199-5513; Bidaux, Gabriel/0000-0002-6162-3223	European Social Fund; National Institutes of Health [AR32805]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032805, R37AR032805] Funding Source: NIH RePORTER	European Social Fund(European Social Fund (ESF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the European Social Fund (to A. V. Z., J. G. M., C. N. S., and J. A. F.) and by National Institutes of Health Grant AR32805 (to K. L. M.).	Abeele FV, 2006, J BIOL CHEM, V281, P40174, DOI 10.1074/jbc.M605779200; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Bidaux G, 2012, J BIOL CHEM, V287, P2948, DOI 10.1074/jbc.M111.270256; BLATZ AL, 1986, BIOPHYS J, V49, P967, DOI 10.1016/S0006-3495(86)83725-0; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Chu X, 2005, CELL CALCIUM, V37, P173, DOI 10.1016/j.ceca.2004.08.005; Colquhoun David, 1995, P483; Fernandez JA, 2011, J GEN PHYSIOL, V137, P173, DOI 10.1085/jgp.201010498; Gkika D, 2009, BBA-MOL CELL RES, V1793, P953, DOI 10.1016/j.bbamcr.2008.11.010; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; HAWKES AG, 1992, PHILOS T ROY SOC B, V337, P383, DOI 10.1098/rstb.1992.0116; HORN R, 1983, BIOPHYS J, V43, P207, DOI 10.1016/S0006-3495(83)84341-0; Hui KK, 2003, BIOPHYS J, V84, P2957, DOI 10.1016/S0006-3495(03)70022-8; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; MAGLEBY KL, 1992, P ROY SOC B-BIOL SCI, V249, P133, DOI 10.1098/rspb.1992.0095; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; Malkia A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-62; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Meseguer V, 2008, J NEUROSCI, V28, P576, DOI 10.1523/JNEUROSCI.4772-07.2008; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Patel T, 2007, J AM ACAD DERMATOL, V57, P873, DOI 10.1016/j.jaad.2007.04.008; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rothberg BS, 2000, J GEN PHYSIOL, V116, P75, DOI 10.1085/jgp.116.1.75; Rothberg BS, 1998, J GEN PHYSIOL, V111, P751, DOI 10.1085/jgp.111.6.751; Rothberg BS, 1997, BIOPHYS J, V72, P2524, DOI 10.1016/S0006-3495(97)78897-0; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Studer M, 2010, J PHYSIOL-LONDON, V588, P3743, DOI 10.1113/jphysiol.2010.190611; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Weil A, 2005, MOL PHARMACOL, V68, P518, DOI 10.1124/mol.105.012146; Zholos AV, 2004, J GEN PHYSIOL, V123, P581, DOI 10.1085/jgp.200309002	36	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					2963	2970		10.1074/jbc.M111.272823	http://dx.doi.org/10.1074/jbc.M111.272823			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22128172	Green Published, hybrid			2022-12-25	WOS:000300295100004
J	Iwata, J; Tung, L; Urata, M; Hacia, JG; Pelikan, R; Suzuki, A; Ramenzoni, L; Chaudhry, O; Parada, C; Sanchez-Lara, PA; Chai, Y				Iwata, Jun-ichi; Tung, Lily; Urata, Mark; Hacia, Joseph G.; Pelikan, Richard; Suzuki, Akiko; Ramenzoni, Liza; Chaudhry, Obaid; Parada, Carolina; Sanchez-Lara, Pedro A.; Chai, Yang			Fibroblast Growth Factor 9 (FGF9)-Pituitary Homeobox 2 (PITX2) Pathway Mediates Transforming Growth Factor beta (TGF beta) Signaling to Regulate Cell Proliferation in Palatal Mesenchyme during Mouse Palatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEFT-RIGHT ASYMMETRY; NEURAL CREST CELLS; CRANIOFACIAL DEVELOPMENT; AORTIC-ANEURYSM; MARFAN-SYNDROME; RIEGER-SYNDROME; TOOTH MORPHOGENESIS; DOWN-REGULATION; RECEPTOR ALK5; II RECEPTOR	Cleft palate represents one of the most common congenital birth defects. Transforming growth factor beta (TGF beta) signaling plays crucial functions in regulating craniofacial development, and loss of TGF beta receptor type II in cranial neural crest cells leads to craniofacial malformations, including cleft palate in mice (Tgfbr2(fl/fl); Wnt1-Cre mice). Here we have identified candidate target genes of TGF beta signaling during palatal formation. These target genes were selected based on combining results from gene expression profiles of embryonic day 14.5 palates from Tgfbr2(fl/fl); Wnt1-Cre mice and previously identified cleft palate phenotypes in genetically engineered mouse models. We found that fibroblast growth factor 9 (Fgf9) and transcription factor pituitary homeobox 2 (Pitx2) expressions are significantly down-regulated in the palate of Tgfbr2(fl/fl); Wnt1-Cre mice, and Fgf9 and Pitx2 loss of function mutations result in cleft palate in mice. Pitx2 expression is down-regulated by siRNA knockdown of Fgf9, suggesting that Fgf9 is upstream of Pitx2. We detected decreased expression of both cyclins D1 and D3 in the palates of Tgfbr2(fl/fl); Wnt1-Cre mice, consistent with the defect in cell proliferation. Significantly, exogenous FGF9 restores expression of cyclins D1 and D3 in a Pitx2-dependent manner and rescues the cell proliferation defect in the palatal mesenchyme of Tgfbr2(fl/fl); Wnt1-Cre mice. Our study indicates that a TGF beta-FGF9-PITX2 signaling cascade regulates cranial neural crest cell proliferation during palate formation.	[Iwata, Jun-ichi; Tung, Lily; Urata, Mark; Pelikan, Richard; Suzuki, Akiko; Ramenzoni, Liza; Chaudhry, Obaid; Parada, Carolina; Chai, Yang] Univ So Calif, Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; [Hacia, Joseph G.] Univ So Calif, Dept Biochem & Mol Biol, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90033 USA; [Sanchez-Lara, Pedro A.] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Tung, Lily; Urata, Mark; Chaudhry, Obaid] Univ So Calif, Keck Sch Med, Div Plast & Reconstruct Surg, Los Angeles, CA 90089 USA; [Sanchez-Lara, Pedro A.] Childrens Hosp Los Angeles, Div Med Genet, Los Angeles, CA 90027 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Children's Hospital Los Angeles	Chai, Y (corresponding author), Univ So Calif, Ostrow Sch Dent, Ctr Craniofacial Mol Biol, 2250 Alcazar St,CSA 103, Los Angeles, CA 90033 USA.	ychai@usc.edu	Sanchez, Pedro/HHM-5713-2022; Sanchez-Lara, Pedro A./AAP-5644-2021; Sanchez, Pedro/P-1377-2018; Pelikan, Richard/I-4109-2013	Sanchez, Pedro/0000-0003-1181-7828; Sanchez-Lara, Pedro A./0000-0003-1181-7828; Ramenzoni, Liza L./0000-0002-7732-2118	National Institutes of Health, NIDCR [DE012711, DE014078, DE017007]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014078, R37DE012711, R01DE022503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017007, R01DE012711] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health, NIDCR, Grants DE012711, DE014078, and DE017007 (to Y. C.).	Ai D, 2006, DEV BIOL, V296, P437, DOI 10.1016/j.ydbio.2006.06.009; Bellusci S, 2008, NAT GENET, V40, P822, DOI 10.1038/ng0708-822; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Chai Y, 2003, CRIT REV ORAL BIOL M, V14, P78, DOI 10.1177/154411130301400202; Ciminello Frank S., 2009, Comprehensive Therapy, V35, P37; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Cui XM, 1998, INT J DEV BIOL, V42, P817; Denissova NG, 2000, P NATL ACAD SCI USA, V97, P6397, DOI 10.1073/pnas.090099297; Dorsky RI, 2000, BIOESSAYS, V22, P708, DOI 10.1002/1521-1878(200008)22:8<708::AID-BIES4>3.3.CO;2-E; Dudas M, 2006, DEV BIOL, V296, P298, DOI 10.1016/j.ydbio.2006.05.030; Espinoza HM, 2002, HUM MOL GENET, V11, P743, DOI 10.1093/hmg/11.7.743; Geske MJ, 2008, DEVELOPMENT, V135, P2959, DOI 10.1242/dev.020453; Govindarajan V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-7; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hayashi M, 2008, J BIOL CHEM, V283, P565, DOI 10.1074/jbc.M708154200; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Hosokawa R, 2010, DEV BIOL, V341, P186, DOI 10.1016/j.ydbio.2010.02.030; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Iwao K, 2009, J CLIN INVEST, V119, P1997, DOI 10.1172/JCI38519; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Iwata J, 2010, J BIOL CHEM, V285, P4975, DOI 10.1074/jbc.M109.035105; Kalluri R, 2008, DEV CELL, V15, P1, DOI 10.1016/j.devcel.2008.06.005; Karaman MW, 2003, GENOME RES, V13, P1619, DOI 10.1101/gr.1289803; Kettunen P, 1998, DEV GENET, V22, P374, DOI 10.1002/(SICI)1520-6408(1998)22:4<374::AID-DVG7>3.0.CO;2-3; Kimura N, 2008, J MOL ENDOCRINOL, V40, P75, DOI 10.1677/JME-07-0108; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lindsay EA, 2001, NAT REV GENET, V2, P858, DOI 10.1038/35098574; Liu CY, 2002, DEVELOPMENT, V129, P5081; Liu CY, 2001, DEVELOPMENT, V128, P2039; Liu W, 2003, DEVELOPMENT, V130, P6375, DOI 10.1242/dev.00849; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Martin DM, 2002, AM J MED GENET, V111, P27, DOI 10.1002/ajmg.10473; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; NAKAMURA T, 1995, EXP CELL RES, V216, P422, DOI 10.1006/excr.1995.1053; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; Oka S, 2007, MECH DEVELOP, V124, P409, DOI 10.1016/j.mod.2007.02.003; PELTON RW, 1990, DEV BIOL, V141, P456, DOI 10.1016/0012-1606(90)90401-4; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Sasaki T, 2006, DEVELOPMENT, V133, P371, DOI 10.1242/dev.02200; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Tolarova MM, 1998, AM J MED GENET, V75, P126; Vitelli F, 2002, HUM MOL GENET, V11, P915, DOI 10.1093/hmg/11.8.915; Wang Y., 2009, COLD SPRING HARB PRO; WANG YQ, 1995, MECH DEVELOP, V52, P275, DOI 10.1016/0925-4773(95)00408-S; Wurdak H, 2005, GENE DEV, V19, P530, DOI 10.1101/gad.317405; Xia XQ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-306; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7; Yu WL, 2009, INDIAN J PLAST SURG, V42, pS35, DOI 10.4103/0970-0358.57185; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhao H, 2008, DEV BIOL, V320, P19, DOI 10.1016/j.ydbio.2008.03.045; Zhu T, 2000, J BIOL CHEM, V275, P2103, DOI 10.1074/jbc.275.3.2103	67	49	50	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2353	2363		10.1074/jbc.M111.280974	http://dx.doi.org/10.1074/jbc.M111.280974			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22123828	Green Published, hybrid			2022-12-25	WOS:000300292300011
J	Tep, C; Kim, ML; Opincariu, LI; Limpert, AS; Chan, JR; Appel, B; Carter, BD; Yoon, SO				Tep, Chhavy; Kim, Mi Lyang; Opincariu, Laura I.; Limpert, Allison S.; Chan, Jonah R.; Appel, Bruce; Carter, Bruce D.; Yoon, Sung Ok			Brain-derived Neurotrophic Factor (BDNF) Induces Polarized Signaling of Small GTPase (Rac1) Protein at the Onset of Schwann Cell Myelination through Partitioning-defective 3 (Par3) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P75; MIGRATION; KINASE; PHOSPHORYLATION; ACTIVATION; COMPLEXES; RECEPTOR; BINDING; AXONS	Brain-derived neurotrophic factor (BDNF) was shown to play a role in Schwann cell myelination by recruiting Par3 to the axon-glial interface, but the underlying mechanism has remained unclear. Here we report that Par3 regulates Rac1 activation by BDNF but not by NRG1-Type III in Schwann cells, although both ligands activate Rac1 in vivo. During development, active Rac1 signaling is localized to the axon-glial interface in Schwann cells by a Par3-dependent polarization mechanism. Knockdown of p75 and Par3 individually inhibits Rac1 activation, whereas constitutive activation of Rac1 disturbs the polarized activation of Rac1 in vivo. Polarized Rac1 activation is necessary for myelination as Par3 knockdown attenuates myelination in mouse sciatic nerves as well as in zebrafish. Specifically, Par3 knockdown in zebrafish disrupts proper alignment between the axon and Schwann cells without perturbing Schwann cell migration, suggesting that localized Rac1 activation at the axon-glial interface helps identify the initial wrapping sites. We therefore conclude that polarization of Rac1 activation is critical for myelination.	[Tep, Chhavy; Kim, Mi Lyang; Yoon, Sung Ok] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Tep, Chhavy] Ohio State Univ, Biochem Program, Columbus, OH 43210 USA; [Kim, Mi Lyang] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Opincariu, Laura I.; Appel, Bruce] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO 80045 USA; [Limpert, Allison S.; Carter, Bruce D.] Vanderbilt Univ Sch Med, Dept Biochem, Nashville, TN USA; [Chan, Jonah R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Chan, Jonah R.] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Colorado System; University of Colorado Anschutz Medical Campus; Vanderbilt University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yoon, SO (corresponding author), Ohio State Univ, Dept Mol & Cellular Biochem, 184 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	sung.yoon@osumc.edu	Yoon, Sung Ok/C-5992-2012; Appel, Bruce/X-6418-2019	Appel, Bruce/0000-0003-4500-0672	National Institute of Health [NS039472, P30NS045758, NS062796, NS048249, NS062717]; Muscular Distrophy Association [MDA115761]; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048249, R01NS062717, R01NS039472, P30NS045758, R01NS062796] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Distrophy Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institute of Health grants NS039472 (to S.O.Y.), P30NS045758 (to the Ohio State Neuroscience Center Core), NS062796 (to J.R.C.), NS048249 (to B.D.C.), and NS062717 (to B.A.). This work was also supported by Muscular Distrophy Association Grant MDA115761 (to A.S.L.).	Bentley CA, 2000, J NEUROSCI, V20, P7706; Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Fang LH, 2007, CELL RES, V17, P100, DOI 10.1038/sj.cr.7310145; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Hurd TW, 2003, CURR BIOL, V13, P2082, DOI 10.1016/j.cub.2003.11.020; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Ng BK, 2007, J NEUROSCI, V27, P7597, DOI 10.1523/JNEUROSCI.0563-07.2007; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nodari A, 2007, J CELL BIOL, V177, P1063, DOI 10.1083/jcb.200610014; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Xiao JH, 2009, J NEUROSCI, V29, P4016, DOI 10.1523/JNEUROSCI.3811-08.2009; Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101; Yoon C, 2008, J NEUROSCI, V28, P3738, DOI 10.1523/JNEUROSCI.4439-07.2008	27	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1600	1608		10.1074/jbc.M111.312736	http://dx.doi.org/10.1074/jbc.M111.312736			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128191	hybrid, Green Published			2022-12-25	WOS:000299170300073
J	Yu, X; Liu, Y; Xie, XL; Zheng, XD; Li, SM				Yu, Xia; Liu, Yan; Xie, Xiulan; Zheng, Xiao-Dong; Li, Shu-Ming			Biochemical Characterization of Indole Prenyltransferases FILLING THE LAST GAP OF PRENYLATION POSITIONS BY A 5-DIMETHYLALLYLTRYPTOPHAN SYNTHASE FROM ASPERGILLUS CLAVATUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHETIC GENE-CLUSTER; ASPERGILLUS-FUMIGATUS; 4-DIMETHYLALLYLTRYPTOPHAN SYNTHASE; 7-DIMETHYLALLYLTRYPTOPHAN SYNTHASE; DIMETHYLALLYLTRYPTOPHAN SYNTHASE; DERIVATIVES; ALKALOIDS; PURIFICATION; OVERPRODUCTION; PRENYLATION	The putative prenyltransferase gene ACLA_031240 belonging to the dimethylallyltryptophan synthase superfamily was identified in the genome sequence of Aspergillus clavatus and overexpressed in Escherichia coli. The soluble His-tagged protein EAW08391 was purified to near homogeneity and used for biochemical investigation with diverse aromatic substrates in the presence of different prenyl diphosphates. It has shown that in the presence of dimethylallyl diphosphate (DMAPP), the recombinant enzyme accepted very well simple indole derivatives with L-tryptophan as the best substrate. Product formation was also observed for tryptophan-containing cyclic dipeptides but with much lower conversion yields. In contrast, no product formation was detected in the reaction mixtures of L-tryptophan with geranyl or farnesyl diphosphate. Structure elucidation of the enzyme products by NMR and MS analyses proved unequivocally the highly regiospecific regular prenylation at C-5 of the indole nucleus of the simple indole derivatives. EAW08391 was therefore termed 5-dimethylallyltryptophan synthase, and it filled the last gap in the toolbox of indole prenyltransferases regarding their prenylation positions. K-m values of 5-dimethylallyltryptophan synthase were determined for L-tryptophan and DMAPP at 34 and 76 mu M, respectively. Average turnover number (k(cat)) at 1.1 s(-1) was calculated from kinetic data of L-tryptophan and DMAPP. Catalytic efficiencies of 5-dimethylallyltryptophan synthase for L-tryptophan at 25,588 s(-1).M-1 and for other 11 simple indole derivatives up to 1538 s(-1).M-1 provided evidence for its potential usage as a catalyst for chemoenzymatic synthesis.	[Yu, Xia; Liu, Yan; Li, Shu-Ming] Univ Marburg, Inst Pharmazeut Biol & Biotechnol, D-35037 Marburg, Germany; [Zheng, Xiao-Dong] Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310058, Zhejiang, Peoples R China; [Xie, Xiulan] Univ Marburg, Fachbereich Chem, D-35032 Marburg, Germany	Philipps University Marburg; Zhejiang University; Philipps University Marburg	Li, SM (corresponding author), Univ Marburg, Inst Pharmazeut Biol & Biotechnol, Deutschhausstr 17A, D-35037 Marburg, Germany.	shuming.li@staff.uni-marburg.de			Deutsche Forschungsgemeinschaft [Li844/4-1]; Deutscher Akademischer Austauschdienst, Programme des Projektbezogenen Personenaustauschs; China Scholarship Council for fellowships	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst, Programme des Projektbezogenen Personenaustauschs(Deutscher Akademischer Austausch Dienst (DAAD)); China Scholarship Council for fellowships	This work was supported in part by Deutsche Forschungsgemeinschaft Grant Li844/4-1 (to S.-M.L.) and by the Deutscher Akademischer Austauschdienst within the Programme des Projektbezogenen Personenaustauschs.; Recipient of a Ph.D. scholarship from the China Scholarship Council for fellowships.	ACHENBACH H, 1995, LIEBIGS ANN, P1327; Balibar CJ, 2007, NAT CHEM BIOL, V3, P584, DOI 10.1038/nchembio.2007.20; BELOFSKY GN, 1995, TETRAHEDRON, V51, P3959, DOI 10.1016/0040-4020(95)00138-X; Berger S, 2004, 200 MORE NMR EXPT PR, P1; Cleveland TE, 2009, TRENDS BIOTECHNOL, V27, P151, DOI 10.1016/j.tibtech.2008.11.008; Ding YS, 2008, J BIOL CHEM, V283, P16068, DOI 10.1074/jbc.M801991200; Ding YS, 2010, J AM CHEM SOC, V132, P12733, DOI 10.1021/ja1049302; Edwards DJ, 2004, J AM CHEM SOC, V126, P11432, DOI 10.1021/ja047876g; Fredenhagen A, 1997, J ANTIBIOT, V50, P395, DOI 10.7164/antibiotics.50.395; Fujimoto K, 1999, CHEM PHARM BULL, V47, P1426; Grundmann A, 2005, MICROBIOL-SGM, V151, P2199, DOI 10.1099/mic.0.27962-0; Grundmann A, 2008, CHEMBIOCHEM, V9, P2059, DOI 10.1002/cbic.200800240; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Kremer A, 2008, APPL MICROBIOL BIOT, V79, P951, DOI 10.1007/s00253-008-1505-3; Kremer A, 2007, MICROBIOL-SGM, V153, P3409, DOI 10.1099/mic.0.2007/009019-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li SM, 2010, NAT PROD REP, V27, P57, DOI 10.1039/b909987p; Li SM, 2009, PHYTOCHEMISTRY, V70, P1746, DOI 10.1016/j.phytochem.2009.03.019; Li SM, 2009, APPL MICROBIOL BIOT, V84, P631, DOI 10.1007/s00253-009-2128-z; Liang PH, 2009, BIOCHEMISTRY-US, V48, P6562, DOI 10.1021/bi900371p; Lindel T, 2012, TOP CURR CHEM, V309, P67, DOI 10.1007/128_2011_204; Liu XY, 2009, BIOCHEMISTRY-US, V48, P11032, DOI 10.1021/bi901597j; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Markert A, 2008, PLANT PHYSIOL, V147, P296, DOI 10.1104/pp.108.116699; Nielsen KF, 2003, J CHROMATOGR A, V1002, P111, DOI 10.1016/S0021-9673(03)00490-4; Ooike M, 1997, CAN J CHEM, V75, P625, DOI 10.1139/v97-075; Peters L, 2002, J NAT PROD, V65, P1633, DOI 10.1021/np0105984; Ruiz-Sanchis P, 2011, CHEM-EUR J, V17, P1388, DOI 10.1002/chem.201001451; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Schardl CL, 2006, ALKALOIDS-CHEM BIOL, V63, P45, DOI 10.1016/S1099-4831(06)63002-2; Schultz AW, 2010, J NAT PROD, V73, P373, DOI 10.1021/np9006876; Sings Heather, 2003, Alkaloids Chem Biol, V60, P51, DOI 10.1016/S0099-9598(03)60002-7; Steffan N, 2009, CURR MED CHEM, V16, P218, DOI 10.2174/092986709787002772; Steffan N, 2007, CHEMBIOCHEM, V8, P1298, DOI 10.1002/cbic.200700107; Steffan N, 2009, ARCH MICROBIOL, V191, P461, DOI 10.1007/s00203-009-0467-x; Steiner U, 2011, MYCOLOGIA, V103, P1133, DOI 10.3852/11-031; Takahashi S, 2010, J BACTERIOL, V192, P2839, DOI 10.1128/JB.01557-09; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Uhlig S, 2009, J AGR FOOD CHEM, V57, P11112, DOI 10.1021/jf902208w; Unsold IA, 2006, CHEMBIOCHEM, V7, P158, DOI 10.1002/cbic.200500318; Unsold IA, 2005, MICROBIOL-SGM, V151, P1499, DOI 10.1099/mic.0.27759-0; Wallwey C, 2011, NAT PROD REP, V28, P496, DOI 10.1039/c0np00060d; Wang WL, 2007, J NAT PROD, V70, P1558, DOI 10.1021/np070208z; Williams RM, 2000, TOP CURR CHEM, V209, P97; WOODSIDE AB, 1988, ORG SYNTH, V66, P211; Xu MJ, 2007, TETRAHEDRON, V63, P435, DOI 10.1016/j.tet.2006.10.050; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023; Yin WB, 2010, ORG BIOMOL CHEM, V8, P2430, DOI 10.1039/c000587h; Yin WB, 2009, J BIOL CHEM, V284, P100, DOI 10.1074/jbc.M807606200; Yu X, 2011, CHEMBIOCHEM, V12, P2280, DOI 10.1002/cbic.201100413; Yu X, 2011, APPL MICROBIOL BIOT, V92, P737, DOI 10.1007/s00253-011-3351-y; Zou HX, 2010, ORG BIOMOL CHEM, V8, P3037, DOI 10.1039/c002850a	52	64	65	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1371	1380		10.1074/jbc.M111.317982	http://dx.doi.org/10.1074/jbc.M111.317982			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22123822	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000299170300051
J	Brault, V; Martin, B; Costet, N; Bizot, JC; Herault, Y				Brault, Veronique; Martin, Benoit; Costet, Nathalie; Bizot, Jean-Charles; Herault, Yann			Characterization of PTZ-Induced Seizure Susceptibility in a Down Syndrome Mouse Model That Overexpresses CSTB	PLOS ONE			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; CYSTATIN-B GENE; UNVERRICHT-LUNDBORG-DISEASE; CYSTEINE PROTEINASE-INHIBITORS; RECEPTOR-IONOPHORE COMPLEX; AMYLOID PRECURSOR PROTEIN; HUMAN STEFIN-B; TRANSGENIC MICE; TS65DN MOUSE; MURINE MODEL	Down syndrome (DS) is a complex genetic syndrome characterized by intellectual disability, dysmorphism and variable additional physiological traits. Current research progress has begun to decipher the neural mechanisms underlying cognitive impairment, leading to new therapeutic perspectives. Pentylenetetrazol (PTZ) has recently been found to have positive effects on learning and memory capacities of a DS mouse model and is foreseen to treat DS patients. But PTZ is also known to be a convulsant drug at higher dose and DS persons are more prone to epileptic seizures than the general population. This raises concerns over what long-term effects of treatment might be in the DS population. The cause of increased propensity for epilepsy in the DS population and which Hsa21 gene(s) are implicated remain unknown. Among Hsa21 candidate genes in epilepsy, CSTB, coding for the cystein protease inhibitor cystatin B, is involved in progressive myoclonus epilepsy and ataxia in both mice and human. Thus we aim to evaluate the effect of an increase in Cstb gene dosage on spontaneous epileptic activity and susceptibility to PTZ-induced seizure. To this end we generated a new mouse model trisomic for Cstb by homologous recombination. We verified that increasing copy number of Cstb from Trisomy (Ts) to Tetrasomy (Tt) was driving overexpression of the gene in the brain, we checked transgenic animals for presence of locomotor activity and electroencephalogram (EEG) abnormalities characteristic of myoclonic epilepsy and we tested if those animals were prone to PTZ-induced seizure. Overall, the results of the analysis shows that an increase in Cstb does not induce any spontaneous epileptic activity and neither increase or decrease the propensity of Ts and Tt mice to myoclonic seizures suggesting that Ctsb dosage should not interfere with PTZ-treatment.	[Brault, Veronique; Herault, Yann] Univ Strasbourg, IGBMC, Dept Translat Med & Neurogenet, CNRS UMR7104,Inserm U596, Illkirch Graffenstaden, France; [Martin, Benoit; Costet, Nathalie] INSERM, U642, Rennes, France; [Martin, Benoit; Costet, Nathalie] Univ Rennes 1, Lab Traitement Signal & Image, Rennes, France; [Bizot, Jean-Charles] Key Obs SAS, Orleans, France; [Herault, Yann] CNRS, TAAM, UPS44, F-45071 Orleans, France; [Herault, Yann] CERBM, GIE, Inst Francais Clin Souris, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Brault, V (corresponding author), Univ Strasbourg, IGBMC, Dept Translat Med & Neurogenet, CNRS UMR7104,Inserm U596, Illkirch Graffenstaden, France.	herault@igbmc.fr	Herault, Yann/B-5500-2012	Herault, Yann/0000-0001-7049-6900; Costet, Nathalie/0000-0002-3706-4812; Brault, Veronique/0000-0002-1418-5849	National Centre for Scientific Research (CNRS); INSERM; University of Strasbourg; European commission; AnEUploidy; EUMODIC (EU) [LSHG-CT-2006-037627, LSHG-CT-2006-037811]; Fondation Jerome Lejeune; Fondation pour la Recherche Medicale	National Centre for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Strasbourg; European commission(European CommissionEuropean Commission Joint Research Centre); AnEUploidy; EUMODIC (EU); Fondation Jerome Lejeune; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This study was supported by grants from the National Centre for Scientific Research (CNRS), the INSERM, the University of Strasbourg, the European commission with the AnEUploidy and the EUMODIC projects (EU-FP6 Integrated Project: LSHG-CT-2006-037627; LSHG-CT-2006-037811 respectively), the Fondation Jerome Lejeune and the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; Alakurtti K, 2005, EUR J HUM GENET, V13, P208, DOI 10.1038/sj.ejhg.5201300; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Aylward EH, 1999, AM J PSYCHIAT, V156, P564; Baxter LL, 2000, HUM MOL GENET, V9, P195, DOI 10.1093/hmg/9.2.195; Belichenko PV, 2007, J COMP NEUROL, V504, P329, DOI 10.1002/cne.21433; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Bespalova IN, 1997, AM J MED GENET, V74, P467, DOI 10.1002/(SICI)1096-8628(19970919)74:5<467::AID-AJMG1>3.0.CO;2-L; Bjarnadottir M, 2001, AMYLOID, V8, P1, DOI 10.3109/13506120108993809; Brault V, 2006, PLOS GENET, V2, P911, DOI 10.1371/journal.pgen.0020086; BROMME D, 1991, BIOMED BIOCHIM ACTA, V50, P631; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Ceru S, 2005, MED HYPOTHESES, V64, P955, DOI 10.1016/j.mehy.2004.11.038; Ceru S, 2010, BIOL CELL, V102, P319, DOI 10.1042/BC20090163; Chioza B, 2002, EPILEPSY RES, V52, P107, DOI 10.1016/S0920-1211(02)00195-X; Cipollini E, 2008, BBA-MOL CELL RES, V1783, P312, DOI 10.1016/j.bbamcr.2007.08.007; Clark D, 2003, AM J MED GENET A, V118A, P210, DOI 10.1002/ajmg.a.20007; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; D'amato E, 2000, EUR J NEUROSCI, V12, P1687, DOI 10.1046/j.1460-9568.2000.00058.x; Di Giaimo R, 2002, HUM MOL GENET, V11, P2941, DOI 10.1093/hmg/11.23.2941; Dierssen M, 2003, GENES BRAIN BEHAV, V2, P152, DOI 10.1034/j.1601-183X.2003.00027.x; Dierssen M, 2009, PHYSIOL REV, V89, P887, DOI 10.1152/physrev.00032.2007; ELSON A, 1994, BIOCHEM J, V299, P409, DOI 10.1042/bj2990409; Ema M, 1999, HUM MOL GENET, V8, P1409, DOI 10.1093/hmg/8.8.1409; EPSTEIN CJ, 1987, P NATL ACAD SCI USA, V84, P8044, DOI 10.1073/pnas.84.22.8044; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; FitzPatrick DR, 2002, HUM MOL GENET, V11, P3249, DOI 10.1093/hmg/11.26.3249; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Franceschetti S, 2007, NEUROBIOL DIS, V25, P675, DOI 10.1016/j.nbd.2006.11.006; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gardiner K, 2003, GENE, V318, P137, DOI 10.1016/S0378-1119(03)00769-8; Gardiner KJ, 2010, TRENDS PHARMACOL SCI, V31, P66, DOI 10.1016/j.tips.2009.10.010; Gerlai R, 1996, NEUROBIOL LEARN MEM, V66, P143, DOI 10.1006/nlme.1996.0055; GERLAI R, 1993, BEHAV BRAIN RES, V59, P119, DOI 10.1016/0166-4328(93)90157-L; GREEN GDJ, 1984, BIOCHEM J, V218, P939, DOI 10.1042/bj2180939; Hallmann K, 2000, AM J MED GENET, V96, P8, DOI 10.1002/(SICI)1096-8628(20000207)96:1<8::AID-AJMG3>3.0.CO;2-S; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hodapp RM, 2005, MENT RETARD DEV D R, V11, P340, DOI 10.1002/mrdd.20087; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Insausti AM, 1998, NEUROSCI LETT, V253, P175, DOI 10.1016/S0304-3940(98)00641-7; JARVINEN M, 1982, BIOCHIM BIOPHYS ACTA, V708, P210, DOI 10.1016/0167-4838(82)90222-9; JERALA R, 1988, FEBS LETT, V239, P41, DOI 10.1016/0014-5793(88)80541-6; Joensuu T, 2007, EUR J HUM GENET, V15, P185, DOI 10.1038/sj.ejhg.5201723; Kagitani-Shimono K, 2002, PEDIATR NEUROL, V26, P55, DOI 10.1016/S0887-8994(01)00336-8; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Krasuski JS, 2002, AM J PSYCHIAT, V159, P74, DOI 10.1176/appi.ajp.159.1.74; Kurt MA, 2000, BRAIN RES, V858, P191, DOI 10.1016/S0006-8993(00)01984-3; Lafreniere RG, 1997, NAT GENET, V15, P298, DOI 10.1038/ng0397-298; Lalioti MD, 1997, AM J HUM GENET, V60, P342; Lalioti MD, 1997, NATURE, V386, P847, DOI 10.1038/386847a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyle R, 2004, GENOME RES, V14, P1268, DOI 10.1101/gr.2090904; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Mao R, 2003, GENOMICS, V81, P457, DOI 10.1016/S0888-7543(03)00035-1; MARCELL MM, 1982, AM J MENT DEF, V87, P86; Martinez-Cue C, 1999, NEUROREPORT, V10, P1119, DOI 10.1097/00001756-199904060-00039; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; MCVICKER RW, 1994, BRIT J PSYCHIAT, V164, P528, DOI 10.1192/bjp.164.4.528; Moechars D, 1998, NEUROREPORT, V9, P3561, DOI 10.1097/00001756-199811160-00004; Moller JC, 2001, SEIZURE-EUR J EPILEP, V10, P303, DOI 10.1053/seiz.2000.0500; Moulard B, 2002, HUM GENET, V111, P255, DOI 10.1007/s00439-002-0755-x; Nadel L, 2003, GENES BRAIN BEHAV, V2, P156, DOI 10.1034/j.1601-183X.2003.00026.x; OLSEN RW, 1981, MOL CELL BIOCHEM, V39, P261, DOI 10.1007/BF00232579; Osawa M, 2003, GENOMICS, V81, P78, DOI 10.1016/S0888-7543(02)00010-1; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Pennington BF, 2003, CHILD DEV, V74, P75, DOI 10.1111/1467-8624.00522; Pinter JD, 2001, NEUROLOGY, V56, P972, DOI 10.1212/WNL.56.7.972; PUESCHEL SM, 1991, ARCH NEUROL-CHICAGO, V48, P318, DOI 10.1001/archneur.1991.00530150088024; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAMANJANEYULU R, 1984, EUR J PHARMACOL, V98, P337, DOI 10.1016/0014-2999(84)90282-6; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; RITONJA A, 1985, BIOCHEM BIOPH RES CO, V131, P1187, DOI 10.1016/0006-291X(85)90216-5; Rueda N, 2008, METHOD FIND EXP CLIN, V30, P92; Salehi A, 2007, MENT RETARD DEV D R, V13, P207, DOI 10.1002/mrdd.20164; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Sultan M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r91; Sumarsono SH, 1996, NATURE, V379, P534, DOI 10.1038/379534a0; SYLVESTER PE, 1983, J MENT DEFIC RES, V27, P227; TANGYE SR, 1979, J MENT DEFIC RES, V23, P17; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; VEALL RM, 1974, J MENT DEFIC RES, V18, P99; Vicari S, 2000, J INTELL DISABIL RES, V44, P504; Virtaneva K, 1997, NAT GENET, V15, P393, DOI 10.1038/ng0497-393; Voronov SV, 2008, P NATL ACAD SCI USA, V105, P9415, DOI 10.1073/pnas.0803756105; WILSON WA, 1974, BRAIN RES, V72, P168, DOI 10.1016/0006-8993(74)90662-3; Xiao F, 2009, BRAIN RES, V1255, P180, DOI 10.1016/j.brainres.2008.12.008; Yahya-Graison EA, 2007, AM J HUM GENET, V81, P475, DOI 10.1086/520000; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	94	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27845	10.1371/journal.pone.0027845	http://dx.doi.org/10.1371/journal.pone.0027845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140471	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100020
J	Secka, O; Antonio, M; Berg, DE; Tapgun, M; Bottomley, C; Thomas, V; Walton, R; Corrah, T; Thomas, JE; Adegbola, RA				Secka, Ousman; Antonio, Martin; Berg, Douglas E.; Tapgun, Mary; Bottomley, Christian; Thomas, Vivat; Walton, Robert; Corrah, Tumani; Thomas, Julian E.; Adegbola, Richard A.			Mixed Infection with cagA Positive and cagA Negative Strains of Helicobacter pylori Lowers Disease Burden in The Gambia	PLOS ONE			English	Article							HIGH PREVALENCE; AFRICAN ENIGMA; MULTIPLE STRAINS; BIOPSY SPECIMENS; GASTRIC-CANCER; ICEA GENOTYPES; VACA; ASSOCIATION; DIVERSITY; HOST	Background: The prevalence of Helicobacter pylori including strains with putatively virulent genotypes is high, whereas the H. pylori-associated disease burden is low, in Africa compared to developed countries. In this study, we investigated the prevalence of virulence-related H. pylori genotypes and their association with gastroduodenal diseases in The Gambia. Methods and Findings: DNA extracted from biopsies and H. pylori cultures from 169 subjects with abdominal pain, dyspepsia or other gastroduodenal diseases were tested by PCR for H. pylori. The H. pylori positive samples were further tested for the cagA oncogene and vacA toxin gene. One hundred and twenty one subjects (71.6%) were H. pylori positive. The cagA gene and more toxigenic s1 and m1 alleles of the vacA gene were found in 61.2%, 76.9% and 45.5% respectively of Gambian patients harbouring H. pylori. There was a high prevalence of cagA positive strains in patients with overt gastric diseases than those with non-ulcerative dyspepsia (NUD) (p = 0.05); however, mixed infection by cagA positive and cagA negative strains was more common in patients with NUD compared to patients with gastric disease (24.5% versus 0%; p = 0.002). Conclusion: This study shows that the prevalence of H. pylori is high in dyspeptic patients in The Gambia and that many strains are of the putatively more virulent cagA(+), vacAs1 and vacAm1 genotypes. This study has also shown significantly lower disease burden in Gambians infected with a mixture of cag-positive and cag-negative strains, relative to those containing only cag-positive or only cag-negative strains, which suggests that harbouring both cag-positive and cag-negative strains is protective.	[Secka, Ousman; Antonio, Martin; Tapgun, Mary; Thomas, Vivat; Walton, Robert; Corrah, Tumani; Adegbola, Richard A.] MRC Unit, Fajara, Gambia; [Thomas, Julian E.] Newcastle Univ, Sch Clin Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Bottomley, Christian] London Sch Hyg & Trop Med, MRC, Trop Epidemiol Grp, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; Newcastle University - UK; Washington University (WUSTL); University of London; London School of Hygiene & Tropical Medicine	Secka, O (corresponding author), MRC Unit, Fajara, Gambia.	osecka@mrc.gm		Bottomley, Christian/0000-0002-5241-8412; Walton, Robert/0000-0001-7700-1907	US National Institutes of Health [RO3-AI061308]; Medical Research Council Unit, The Gambia; MRC [MC_U190074190, MC_U190081991, G0700837, MC_U190092710] Funding Source: UKRI; Medical Research Council [G0700837, MC_U190081991, MC_U190092710, MC_U190074190] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI061308] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council Unit, The Gambia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant RO3-AI061308 from the US National Institutes of Health and The Medical Research Council Unit, The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha A, 2005, SCAND J GASTROENTERO, V40, P523, DOI 10.1080/00365520510012280; Ahmed Niyaz, 2005, Ann Clin Microbiol Antimicrob, V4, P1, DOI 10.1186/1476-0711-4-1; Akada JK, 2003, MICROBIOL-SGM, V149, P1901, DOI 10.1099/mic.0.26129-0; Alam SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-194; Berg S, 2006, SCAND J INFECT DIS, V38, P427, DOI 10.1080/00365540500532852; Blaser MJ, 2001, J CLIN INVEST, V107, P767, DOI 10.1172/JCI12672; Boyanova L, 2009, DIAGN MICR INFEC DIS, V64, P374, DOI 10.1016/j.diagmicrobio.2009.04.005; Campbell DI, 2001, HELICOBACTER, V6, P263, DOI 10.1046/j.1083-4389.2001.00047.x; Chen XJ, 2005, CHINESE MED J-PEKING, V118, P460; Figueiredo C, 2001, SCAND J GASTROENTERO, V36, P128, DOI 10.1080/003655201750065861; Graham DY, 2009, J DIGEST DIS, V10, P77, DOI 10.1111/j.1751-2980.2009.00368.x; HOLCOMBE C, 1992, GUT, V33, P429, DOI 10.1136/gut.33.4.429; Jemilohun AC, 2010, PAN AFR MED J, V6; Kim YS, 2009, EUR J GASTROEN HEPAT, V21, P522, DOI 10.1097/MEG.0b013e3283196af0; Kumar S, 2010, J MED MICROBIOL, V59, P32, DOI 10.1099/jmm.0.013763-0; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Matteo MJ, 2007, J MED MICROBIOL, V56, P664, DOI 10.1099/jmm.0.46885-0; Miernyk K, 2011, J CLIN MICROBIOL, V49, P3114, DOI 10.1128/JCM.00469-11; Momynaliev K, 2003, EUR J CLIN MICROBIOL, V22, P573, DOI 10.1007/s10096-003-0987-2; Mukhopadhyay AK, 2000, J BACTERIOL, V182, P3219, DOI 10.1128/JB.182.11.3219-3227.2000; Nguyen LT, 2008, J MED MICROBIOL, V57, P1445, DOI 10.1099/jmm.0.2008/003160-0; OWEN RJ, 1994, FEMS IMMUNOL MED MIC, V9, P307; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Pan ZJ, 1998, J INFECT DIS, V178, P220, DOI 10.1086/515601; Panangala VS, 2009, AQUAC RES, V40, P915, DOI 10.1111/j.1365-2109.2009.02185.x; Park CY, 2003, J CLIN MICROBIOL, V41, P3336, DOI 10.1128/JCM.41.7.3336-3338.2003; Rieder G, 2005, CURR OPIN MICROBIOL, V8, P67, DOI 10.1016/j.mib.2004.12.004; Secka O, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-5; Segal I, 2001, QJM-INT J MED, V94, P561, DOI 10.1093/qjmed/94.10.561; Serge B, 2002, VET RES, V33, P55; Smith SI, 2002, J MED MICROBIOL, V51, P851, DOI 10.1099/0022-1317-51-10-851; Soto G, 2003, J INFECT DIS, V188, P1263, DOI 10.1086/379046; Sugimoto M, 2009, CLIN MICROBIOL INFEC, V15, P835, DOI 10.1111/j.1469-0691.2009.02769.x; Tanih NF, 2010, ACTA TROP, V116, P68, DOI 10.1016/j.actatropica.2010.05.011; TAYLOR NS, 1995, J CLIN MICROBIOL, V33, P918, DOI 10.1128/JCM.33.4.918-923.1995; Tegtmeyer N, 2009, CELL MICROBIOL, V11, P488, DOI 10.1111/j.1462-5822.2008.01269.x; Thomas JE, 1999, PEDIATR RES, V45, P218, DOI 10.1203/00006450-199902000-00010; van Doorn LJ, 1998, GASTROENTEROLOGY, V115, P58, DOI 10.1016/S0016-5085(98)70365-8; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Yamaoka Y, 2008, INTERNAL MED, V47, P1077, DOI 10.2169/internalmedicine.47.0975	40	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27954	10.1371/journal.pone.0027954	http://dx.doi.org/10.1371/journal.pone.0027954			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140492	Green Published, gold, Green Accepted			2022-12-25	WOS:000298166300018
J	Stringer, S; Wray, NR; Kahn, RS; Derks, EM				Stringer, Sven; Wray, Naomi R.; Kahn, Rene S.; Derks, Eske M.			Underestimated Effect Sizes in GWAS: Fundamental Limitations of Single SNP Analysis for Dichotomous Phenotypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INDIVIDUAL GENETIC RISK; LOGISTIC-REGRESSION; STATISTICAL-METHODS; COMPLEX DISEASES; COLLAPSIBILITY; SCHIZOPHRENIA; HERITABILITY; METAANALYSIS; PREDICTION	Complex diseases are often highly heritable. However, for many complex traits only a small proportion of the heritability can be explained by observed genetic variants in traditional genome-wide association (GWA) studies. Moreover, for some of those traits few significant SNPs have been identified. Single SNP association methods test for association at a single SNP, ignoring the effect of other SNPs. We show using a simple multi-locus odds model of complex disease that moderate to large effect sizes of causal variants may be estimated as relatively small effect sizes in single SNP association testing. This underestimation effect is most severe for diseases influenced by numerous risk variants. We relate the underestimation effect to the concept of non-collapsibility found in the statistics literature. As described, continuous phenotypes generated with linear genetic models are not affected by this underestimation effect. Since many GWA studies apply single SNP analysis to dichotomous phenotypes, previously reported results potentially underestimate true effect sizes, thereby impeding identification of true effect SNPs. Therefore, when a multi-locus model of disease risk is assumed, a multi SNP analysis may be more appropriate.	[Stringer, Sven; Kahn, Rene S.; Derks, Eske M.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Wray, Naomi R.] Queensland Inst Med Res, Psychiat Genet Lab, Brisbane, Qld 4006, Australia; [Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	Utrecht University; Utrecht University Medical Center; QIMR Berghofer Medical Research Institute; University of Queensland	Stringer, S (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands.	s.stringer@umcutrecht.nl	Wray, Naomi/C-8639-2015; Derks, Eske M/A-1652-2017	Wray, Naomi/0000-0001-7421-3357; Derks, Eske M/0000-0002-6292-6883	Netherlands Scientific Organization (NWO) [451-08-010]	Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO))	Eske Derks is supported by the Netherlands Scientific Organization (NWO; project number 451-08-010; www.nwo.nl). NWO had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; DeMaris A, 2002, SOCIOL METHOD RES, V31, P27, DOI 10.1177/0049124102031001002; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; GAIL MH, 1984, BIOMETRIKA, V71, P431; Garner C, 2007, GENET EPIDEMIOL, V31, P288, DOI 10.1002/gepi.20209; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Greenland S, 1999, STAT SCI, V14, P29; GUO JH, 1995, J ROY STAT SOC B MET, V57, P263; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hernan M, 2011, INT J EPIDEMIOL, P1; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kraft P, 2008, EPIDEMIOLOGY, V19, P649, DOI 10.1097/EDE.0b013e318181b865; Ku CS, 2010, J HUM GENET, V55, P195, DOI 10.1038/jhg.2010.19; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MCKELVEY RD, 1975, J MATH SOCIOL, V4, P103, DOI 10.1080/0022250X.1975.9989847; NEUHAUS JM, 1993, BIOMETRIKA, V80, P807, DOI 10.2307/2336872; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Robinson LD, 1991, INT STAT REV, V58, P227; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Visscher PM, 2011, MOL PSYCHIATR, P1; Wei YC, 2010, EUR J HUM GENET, V18, P942, DOI 10.1038/ejhg.2010.51; Wray NR, 2008, CURR OPIN GENET DEV, V18, P257, DOI 10.1016/j.gde.2008.07.006; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Wray NR, 2010, MOL PSYCHIATR, V37, P1; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	37	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27964	10.1371/journal.pone.0027964	http://dx.doi.org/10.1371/journal.pone.0027964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140493	Green Submitted, Green Published, gold			2022-12-25	WOS:000298163400027
J	Bull, JJ; Heineman, RH; Wilke, CO				Bull, James J.; Heineman, Richard H.; Wilke, Claus O.			The Phenotype-Fitness Map in Experimental Evolution of Phages	PLOS ONE			English	Article							LIFE-HISTORY; LYSIS TIME; BACTERIOPHAGE; MODEL; OPTIMALITY; VIRUSES; T7	Evolutionary biologists commonly interpret adaptations of organisms by reference to a phenotype-fitness map, a model of how different states of a phenotype affect fitness. Notwithstanding the popularity of this approach, it remains difficult to directly test these mappings, both because the map often describes only a small subset of phenotypes contributing to total fitness and because direct measures of fitness are difficult to obtain and compare to the map. Both limitations can be overcome for bacterial viruses (phages) grown in the experimental condition of unlimited hosts. A complete accounting of fitness requires 3 easily measured phenotypes, and total fitness is also directly measurable for arbitrary genotypes. Yet despite the presumed transparency of this system, directly estimated fitnesses often differ from fitnesses calculated from the phenotype-fitness map. This study attempts to resolve these discrepancies, both by developing a more exact analytical phenotype-fitness map and by exploring the empirical foundations of direct fitness estimates. We derive an equation (the phenotype-fitness map) for exponential phage growth that allows an arbitrary distribution of lysis times and burst sizes. We also show that direct estimates of fitness are, in many cases, plausibly in error because the population has not attained stable age distribution and thus violates the model underlying the phenotype-fitness map. In conjunction with data provided here, the new understanding appears to resolve a discrepancy between the reported fitness of phage T7 and the substantially lower value calculated from its phenotype-fitness map.	[Bull, James J.; Wilke, Claus O.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Computat Biol & Bioinformat, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Bull, JJ (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Computat Biol & Bioinformat, Sect Integrat Biol, Austin, TX 78712 USA.	bull@mail.utexas.edu	Wilke, Claus O./B-4643-2008	Wilke, Claus/0000-0002-7470-9261	National Institutes of Health (NIH) [GM 57756, R01 GM088344]; Miescher Regents Professorship; National Science Foundation (NSF) [EF-0742373, DBI-0939454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057756, R01GM088344] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miescher Regents Professorship; National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) GM 57756 and the Miescher Regents Professorship (to JJB) and National Science Foundation (NSF) Grant EF-0742373, NSF Cooperative Agreement No.\ DBI-0939454, and NIH R01 GM088344 (to COW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon ST, 2001, APPL ENVIRON MICROB, V67, P4233, DOI 10.1128/AEM.67.9.4233-4241.2001; Adams MH, 1959, BACTERIOPHAGES; Alexander HK, 2008, EVOLUTION, V62, P1600, DOI 10.1111/j.1558-5646.2008.00396.x; BOWES JM, 1974, J VIROL, V13, P53, DOI 10.1128/JVI.13.1.53-61.1974; Bull JJ, 2006, J THEOR BIOL, V241, P928, DOI 10.1016/j.jtbi.2006.01.027; Bull JJ, 2010, VIROLOGY, V398, P79, DOI 10.1016/j.virol.2009.11.040; Domingo-Calap P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000742; Ellis EL, 1939, J GEN PHYSIOL, V22, P365, DOI 10.1085/jgp.22.3.365; Endy D, 2000, P NATL ACAD SCI USA, V97, P5375, DOI 10.1073/pnas.090101397; Guyader S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001946; Heineman RH, 2005, J MOL EVOL, V61, P181, DOI 10.1007/s00239-004-0304-4; Heineman RH, 2007, EVOLUTION, V61, P1695, DOI 10.1111/j.1558-5646.2007.00132.x; Patwa Z, 2008, GENETICS, V180, P459, DOI 10.1534/genetics.108.090555; Patwa Z, 2009, J THEOR BIOL, V259, P799, DOI 10.1016/j.jtbi.2009.05.008; Peris JB, 2010, GENETICS, V185, P603, DOI 10.1534/genetics.110.115162; Rokyta DR, 2008, J MOL EVOL, V67, P368, DOI 10.1007/s00239-008-9153-x; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Shao YP, 2008, GENETICS, V180, P471, DOI 10.1534/genetics.108.090100; Springman R, 2010, GENETICS, V184, P221, DOI 10.1534/genetics.109.108803; Wang IN, 1996, EVOL ECOL, V10, P545, DOI 10.1007/BF01237884; Wang IN, 2006, GENETICS, V172, P17, DOI 10.1534/genetics.105.045922	21	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27796	10.1371/journal.pone.0027796	http://dx.doi.org/10.1371/journal.pone.0027796			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132144	gold, Green Submitted, Green Published			2022-12-25	WOS:000297792400015
J	Walchli, B; Loset, GA; Kumari, S; Johansen, JN; Yang, WW; Sandlie, I; Olweus, J				Walchli, Bastien; Loset, Geir Age; Kumari, Shraddha; Johansen, Jorunn Nergard; Yang, Weiwen; Sandlie, Inger; Olweus, Johanna			A Practical Approach to T-Cell Receptor Cloning and Expression	PLOS ONE			English	Article							TCR GENE-THERAPY; DENDRITIC CELLS; ALPHA-CHAIN; REPERTOIRE; LYMPHOCYTES; USAGE; BETA; IDENTIFICATION; VECTORS; CLONES	Although cloning and expression of T-cell Receptors (TcRs) has been performed for almost two decades, these procedures are still challenging. For example, the use of T-cell clones that have undergone limited expansion as starting material to limit the loss of interesting TcRs, must be weighed against the introduction of mutations by excess PCR cycles. The recent interest in using specific TcRs for cancer immunotherapy has, however, increased the demand for practical and robust methods to rapidly clone and express TcRs. Two main technologies for TcR cloning have emerged; the use of a set of primers specifically annealing to all known TcR variable domains, and 5'-RACE amplification. We here present an improved 5'-RACE protocol that represents a fast and reliable way to identify a TcR from 10(5) cells only, making TcR cloning feasible without a priori knowledge of the variable domain sequence. We further present a detailed procedure for the subcloning of TcR alpha and beta chains into an expression system. We show that a recombination-based cloning protocol facilitates simple and rapid transfer of the TcR transgene into different expression systems. The presented comprehensive method can be performed in any laboratory with standard equipment and with a limited amount of starting material. We finally exemplify the straightforwardness and reliability of our procedure by cloning and expressing several MART-1-specific TcRs and demonstrating their functionality.	[Walchli, Bastien; Kumari, Shraddha; Johansen, Jorunn Nergard; Yang, Weiwen; Olweus, Johanna] Oslo Univ Hosp Radiumhosp, Inst Canc Res, Dept Immunol, Oslo, Norway; [Loset, Geir Age; Sandlie, Inger] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Loset, Geir Age; Sandlie, Inger] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Olweus, Johanna] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Walchli, B (corresponding author), Oslo Univ Hosp Radiumhosp, Inst Canc Res, Dept Immunol, Oslo, Norway.	sebastw@rr-research.no; johanna.olweus@medisin.uio.no	Olweus, Johanna/G-8008-2015; Løset, Geir/I-6413-2015	Olweus, Johanna/0000-0002-1898-3100; Løset, Geir/0000-0002-5257-8571; Walchli, Sebastien/0000-0001-5869-1746	Norwegian Research Council; Oslo University Hospital; University of Oslo; Health Region South-East; OA stiftelsen	Norwegian Research Council(Research Council of NorwayEuropean Commission); Oslo University Hospital; University of Oslo; Health Region South-East; OA stiftelsen	This study was financed by the The Norwegian Research Council (JO, SK, JNJ), Oslo University Hospital (JO, WY, SW), The University of Oslo (JO), Health Region South-East (SW) and OA stiftelsen (JO). The authors are grateful to the Groseth, Moen Stjern and Stokke families for inspiration and funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse CA, 2002, INT J CANCER, V99, P7, DOI 10.1002/ijc.10317; Ahmadi M, 2011, BLOOD, V118, P3528, DOI 10.1182/blood-2011-04-346338; BAER R, 1987, CELL, V50, P97, DOI 10.1016/0092-8674(87)90666-0; Birkholz K, 2009, J IMMUNOL METHODS, V346, P45, DOI 10.1016/j.jim.2009.05.001; Boria I, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-50; Carrasco YR, 2001, J EXP MED, V193, P1045, DOI 10.1084/jem.193.9.1045; Coccoris M, 2010, EXPERT OPIN BIOL TH, V10, P547, DOI 10.1517/14712591003614756; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; DEMBIC Z, 1986, NATURE, V320, P232, DOI 10.1038/320232a0; Dietrich PY, 2003, J IMMUNOL, V170, P5103, DOI 10.4049/jimmunol.170.10.5103; Engels B, 2003, HUM GENE THER, V14, P1155, DOI 10.1089/104303403322167993; Ferradini Laurent, 1993, Molecular Immunology, V30, P1143, DOI 10.1016/0161-5890(93)90132-U; GENEVEE C, 1992, EUR J IMMUNOL, V22, P1261, DOI 10.1002/eji.1830220522; Giudicelli V, 2006, NUCLEIC ACIDS RES, V34, pD781, DOI 10.1093/nar/gkj088; Govers C, 2010, TRENDS MOL MED, V16, P77, DOI 10.1016/j.molmed.2009.12.004; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; Kieback E, 2010, EXPERT OPIN BIOL TH, V10, P749, DOI 10.1517/14712591003689998; Leisegang M, 2008, J MOL MED, V86, P573, DOI 10.1007/s00109-008-0317-3; Lissina A, 2009, J IMMUNOL METHODS, V340, P11, DOI 10.1016/j.jim.2008.09.014; MILLS DR, 1979, P NATL ACAD SCI USA, V76, P2232, DOI 10.1073/pnas.76.5.2232; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Moysey R, 2004, ANAL BIOCHEM, V326, P284, DOI 10.1016/j.ab.2003.12.011; Ochi T, 2011, EXPERT OPIN BIOL TH, V11, P699, DOI 10.1517/14712598.2011.566853; Osborn MJ, 2005, MOL THER, V12, P569, DOI 10.1016/j.ymthe.2005.04.013; Ozawa T, 2008, BIOCHEM BIOPH RES CO, V367, P820, DOI 10.1016/j.bbrc.2008.01.011; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PALIARD X, 1991, SCIENCE, V253, P325, DOI 10.1126/science.1857971; ROSENBERG WMC, 1992, EUR J IMMUNOL, V22, P541, DOI 10.1002/eji.1830220237; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Saeboe-Larssen S, 2002, J IMMUNOL METHODS, V259, P191, DOI 10.1016/S0022-1759(01)00506-3; Schmitt TM, 2009, HUM GENE THER, V20, P1240, DOI 10.1089/hum.2009.146; Schumacher TNM, 2002, NAT REV IMMUNOL, V2, P512, DOI 10.1038/nri841; SENSI M, 1995, P NATL ACAD SCI USA, V92, P5674, DOI 10.1073/pnas.92.12.5674; SIU G, 1984, CELL, V37, P393, DOI 10.1016/0092-8674(84)90369-6; Stronen E, 2009, SCAND J IMMUNOL, V69, P319, DOI 10.1111/j.1365-3083.2008.02223.x; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Trautmann L, 2002, EUR J IMMUNOL, V32, P3181, DOI 10.1002/1521-4141(200211)32:11<3181::AID-IMMU3181>3.0.CO;2-2; TSURUTA Y, 1993, J IMMUNOL METHODS, V161, P7, DOI 10.1016/0022-1759(93)90193-B; Uckert W, 2009, CANCER IMMUNOL IMMUN, V58, P809, DOI 10.1007/s00262-008-0649-4; Wilde S, 2009, BLOOD, V114, P2131, DOI 10.1182/blood-2009-03-209387; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Zhao YB, 2005, J IMMUNOL, V174, P4415, DOI 10.4049/jimmunol.174.7.4415	44	32	71	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27930	10.1371/journal.pone.0027930	http://dx.doi.org/10.1371/journal.pone.0027930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132171	Green Published, gold, Green Submitted			2022-12-25	WOS:000297789900035
J	Evers, E; de Vries, H; Spruijt, BM; Sterck, EHM				Evers, Ellen; de Vries, Han; Spruijt, Berry M.; Sterck, Elisabeth H. M.			Better Safe than Sorry - Socio-Spatial Group Structure Emerges from Individual Variation in Fleeing, Avoidance or Velocity in an Agent-Based Model	PLOS ONE			English	Article							BROWN CAPUCHIN MONKEYS; SOCIAL-ORGANIZATION; DOMINANCE RELATIONSHIPS; SPATIAL STRUCTURE; LONG-TERM; RESOURCE DISTRIBUTIONS; CONFLICT-RESOLUTION; JAPANESE MONKEYS; FORAGING GROUPS; GROUP FISSION	In group-living animals, such as primates, the average spatial group structure often reflects the dominance hierarchy, with central dominants and peripheral subordinates. This central-peripheral group structure can arise by self-organization as a result of subordinates fleeing from dominants after losing a fight. However, in real primates, subordinates often avoid interactions with potentially aggressive group members, thereby preventing aggression and subsequent fleeing. Using agent-based modeling, we investigated which spatial and encounter structures emerge when subordinates also avoid known potential aggressors at a distance as compared with the model which only included fleeing after losing a fight (fleeing model). A central-peripheral group structure emerged in most conditions. When avoidance was employed at small or intermediate distances, centrality of dominants emerged similar to the fleeing model, but in a more pronounced way. This result was also found when fleeing after a fight was made independent of dominance rank, i.e. occurred randomly. Employing avoidance at larger distances yielded more spread out groups. This provides a possible explanation of larger group spread in more aggressive species. With avoidance at very large distances, spatially and socially distinct subgroups emerged. We also investigated how encounters were distributed amongst group members. In the fleeing model all individuals encountered all group members equally often, whereas in the avoidance model encounters occurred mostly among similar-ranking individuals. Finally, we also identified a very general and simple mechanism causing a central-peripheral group structure: when individuals merely differed in velocity, faster individuals automatically ended up at the periphery. In summary, a central-peripheral group pattern can easily emerge from individual variation in different movement properties in general, such as fleeing, avoidance or velocity. Moreover, avoidance behavior also affects the encounter structure and can lead to subgroup formation.	[Evers, Ellen; de Vries, Han; Spruijt, Berry M.; Sterck, Elisabeth H. M.] Univ Utrecht, Utrecht, Netherlands	Utrecht University	Evers, E (corresponding author), Univ Utrecht, Utrecht, Netherlands.	E.Evers1@uu.nl	de Vries, Han/B-9359-2011; Sterck, Elisabeth/C-1063-2011	Sterck, Elisabeth/0000-0003-1101-6027	NWO [864.05.009]	NWO(Netherlands Organization for Scientific Research (NWO))	This work was funded by the NWO Cognition and Behaviour program, grant number 864.05.009 (http://www.nwo.nl/projecten.nsf/pages/2300129002_Eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER BK, 1969, FOLIA PRIMATOL, V10, P230, DOI 10.1159/000155202; AURELI F, 1995, AGGRESSIVE BEHAV, V21, P113, DOI 10.1002/1098-2337(1995)21:2<113::AID-AB2480210204>3.0.CO;2-I; Aureli F, 1997, AM J PRIMATOL, V41, P213, DOI 10.1002/(SICI)1098-2345(1997)41:3<213::AID-AJP4>3.0.CO;2-#; Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; AURELI F, 1993, BEHAVIOUR, V124, P1, DOI 10.1163/156853993X00470; AURELI F, 2000, NATURAL CONICT RESOL; Becher MA, 2010, ECOL MODEL, V221, P769, DOI 10.1016/j.ecolmodel.2009.11.016; Bergstrom ML, 2010, BEHAVIOUR, V147, P899, DOI 10.1163/000579510X497283; BERNSTEIN IS, 1985, INT J PRIMATOL, V6, P209; BERNSTEIN IS, 1966, BEHAVIOUR, V26, P91, DOI 10.1163/156853966X00038; BERNSTEIN IS, 1969, ANIM BEHAV, V17, P452, DOI 10.1016/0003-3472(69)90146-8; BRAMBLETT CA, 1982, AM J PRIMATOL, V2, P43, DOI 10.1002/ajp.1350020107; Bryson JJ, 2007, PHILOS T R SOC B, V362, P1685, DOI 10.1098/rstb.2007.2061; BUSSE CD, 1984, INT J PRIMATOL, V5, P247, DOI 10.1007/BF02735760; CHANCE M.R.A, 1956, BRIT JOUR ANIMAL BEHAVIOUR, V4, P1, DOI 10.1016/S0950-5601(56)80010-5; Christman MC, 2005, ANIM BEHAV, V70, P73, DOI 10.1016/j.anbehav.2004.09.018; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; de Vries H, 1998, BEHAV ECOL SOCIOBIOL, V44, P109, DOI 10.1007/s002650050522; de Vries H, 2009, BEHAVIOUR, V146, P843, DOI 10.1163/156853909X412241; DEWAAL FBM, 1989, AM J PRIMATOL, V19, P83, DOI 10.1002/ajp.1350190203; DEWAAL FBM, 1986, Q REV BIOL, V61, P459, DOI 10.1086/415144; Epstein J.M., 1996, GROWING ARTIFICIAL S; Epstein J.M., 2006, GENERATIVE SOCIAL SC; Fisher NI, 1996, STAT ANAL CIRCULAR D; FURUICHI T, 1983, Primates, V24, P445, DOI 10.1007/BF02381678; Hall CL, 1997, ANIM BEHAV, V53, P1069, DOI 10.1006/anbe.1996.0392; Hall K. R. L., 1965, P53; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HAUSFATER G, 1982, SCIENCE, V217, P752, DOI 10.1126/science.217.4561.752; Hemelrijk CK, 2010, ETHOLOGY, V116, P1099, DOI 10.1111/j.1439-0310.2010.01818.x; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; Hemelrijk CK, 2003, BEHAVIOUR, V140, P1247, DOI 10.1163/156853903771980585; Hemelrijk CK, 2002, ETHOLOGY, V108, P655, DOI 10.1046/j.1439-0310.2002.00812.x; Hemelrijk CK, 1999, LECT NOTES ARTIF INT, V1674, P524; Hemelrijk CK, 2000, ANIM BEHAV, V59, P1035, DOI 10.1006/anbe.2000.1400; Hemelrijk CK, 1998, FROM ANIM ANIMAT, P255; Hemelrijk CK, 1998, FROM ANIM ANIMAT, P307; Hildenbrandt H, 2010, BEHAV ECOL, V21, P1349, DOI 10.1093/beheco/arq149; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Hoare DJ, 2000, J FISH BIOL, V57, P1351, DOI 10.1006/jfbi.2000.1446; HOGEWEG P, 1983, BEHAV ECOL SOCIOBIOL, V12, P271, DOI 10.1007/BF00302895; HOGEWEG P, 1979, HETERARCHICAL SELFST, P221; Hogeweg P, 1988, ARTIFICIAL LIFE SFI, P297; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; IMANISHI K, 1960, CURR ANTHROPOL, V1, P393, DOI 10.1086/200134; Isbell LA, 1998, INT J PRIMATOL, V19, P837, DOI 10.1023/A:1020393329574; Itani J, 1954, MONKEYS MT TAKASAKI; JANSON CH, 1990, ANIM BEHAV, V40, P910, DOI 10.1016/S0003-3472(05)80993-5; Jay P., 1965, P197; JENSEN G D, 1974, Primates, V15, P75, DOI 10.1007/BF01749594; Johnson BR, 2009, P ROY SOC B-BIOL SCI, V276, P255, DOI 10.1098/rspb.2008.0793; Judge P. G., 2005, PRIMATE PSYCHOL, P41; JUDSON OP, 1994, TRENDS ECOL EVOL, V9, P9, DOI 10.1016/0169-5347(94)90225-9; KAPLAN JR, 1980, FOLIA PRIMATOL, V34, P196, DOI 10.1159/000155955; Kaufmann J.H., 1967, pUnpaginated; KEVERNE EB, 1978, ANIM BEHAV, V26, P933, DOI 10.1016/0003-3472(78)90157-4; Koski SE, 2007, BEHAVIOUR, V144, P529, DOI 10.1163/156853907780713082; Krause DJ, 2002, LIVING GROUPS; Kutsukake N, 2008, ANIM BEHAV, V75, P1441, DOI 10.1016/j.anbehav.2007.09.018; Lehmann J, 2007, ANIM BEHAV, V74, P1617, DOI 10.1016/j.anbehav.2006.10.025; Lenth R., 2019, Journal of Statistical Software, V60, P1; LOPEZLUJAN AX, 1989, FOLIA PRIMATOL, V52, P102, DOI 10.1159/000156388; LOY J, 1993, INT J PRIMATOL, V14, P879, DOI 10.1007/BF02220257; LUTKENHONER B, 1991, ACTA OTO-LARYNGOL, P52; McBride G., 1971, P53; McNelis Nicole L., 1998, Animal Cognition, V1, P65, DOI 10.1007/s100710050008; METCALFE NB, 1995, P ROY SOC B-BIOL SCI, V259, P207, DOI 10.1098/rspb.1995.0030; MISSAKIAN E A, 1972, Primates, V13, P169, DOI 10.1007/BF01840878; Morgan D, 2000, AM J PRIMATOL, V52, P115, DOI 10.1002/1098-2345(200011)52:3<115::AID-AJP1>3.0.CO;2-Z; MORI A, 1977, Primates, V18, P331, DOI 10.1007/BF02383112; Oosten JE, 2010, BEHAV ECOL SOCIOBIOL, V64, P793, DOI 10.1007/s00265-009-0896-1; Ostner J, 2008, HORM BEHAV, V54, P613, DOI 10.1016/j.yhbeh.2008.05.020; Pannozzo PL, 2007, ETHOLOGY, V113, P881, DOI 10.1111/j.1439-0310.2007.01392.x; PRUDHOMME J, 1991, PRIMATES, V32, P9, DOI 10.1007/BF02381597; Puga-Gonzalez I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000630; Ramos-Fernandez G, 2006, BEHAV ECOL SOCIOBIOL, V60, P536, DOI 10.1007/s00265-006-0197-x; RASMUSSEN DR, 1994, PRIMATES, V35, P393, DOI 10.1007/BF02381949; RHINE RJ, 1989, AM J PRIMATOL, V19, P69, DOI 10.1002/ajp.1350190202; Richter C, 2009, INT J PRIMATOL, V30, P625, DOI 10.1007/s10764-009-9364-z; Robbins MM, 2005, BEHAVIOUR, V142, P779, DOI 10.1163/1568539054729123; ROBINSON JG, 1981, ANIM BEHAV, V29, P1036, DOI 10.1016/S0003-3472(81)80057-7; Romero T, 2007, BEHAVIOUR, V144, P179, DOI 10.1163/156853907779947355; ROWELL TE, 1983, BEHAVIOUR, V86, P31, DOI 10.1163/156853983X00552; SAMUELS A, 1987, ANIM BEHAV, V35, P785, DOI 10.1016/S0003-3472(87)80115-X; Silk JB, 2002, ANNU REV ANTHROPOL, V31, P21, DOI 10.1146/annurev.anthro.31.032902.101743; SILK JB, 1988, AM NAT, V132, P1, DOI 10.1086/284834; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Sommer V, 2002, ANIM BEHAV, V63, P637, DOI 10.1006/anbe.2001.1897; Southwick C.H., 1965, PRIMATES BEHAV FIELD, P111, DOI DOI 10.1016/J.JHEALECO.2003.08.004; Sueur C, 2010, J EXP BIOL, V213, P1338, DOI 10.1242/jeb.039016; Sueur C, 2009, ANIM BEHAV, V78, P1087, DOI 10.1016/j.anbehav.2009.07.029; Sueur C, 2011, J THEOR BIOL, V273, P156, DOI 10.1016/j.jtbi.2010.12.035; SUGIYAMA Y, 1982, FOLIA PRIMATOL, V39, P238, DOI 10.1159/000156080; TEBOEKHORST IJA, 1994, BEHAVIOUR, V130, P229, DOI 10.1163/156853994X00541; Thierry B, 2008, ANIM BEHAV, V75, P847, DOI 10.1016/j.anbehav.2007.07.006; Thierry Bernard, 2000, P106; Van der Post DJ, 2008, ANIM BEHAV, V75, P133, DOI 10.1016/j.anbehav.2007.04.021; van der Post DJ, 2006, BEHAV ECOL SOCIOBIOL, V61, P65, DOI 10.1007/s00265-006-0237-6; van der Post DJ, 2009, BEHAV ECOL SOCIOBIOL, V63, P1643, DOI 10.1007/s00265-009-0771-0; van der Post DJ, 2009, ANIM BEHAV, V78, P155, DOI 10.1016/j.anbehav.2009.04.009; van der Post DJ, 2004, LECT NOTES COMPUT SC, V3305, P492; VEHRENCAMP SL, 1983, ANIM BEHAV, V31, P667, DOI 10.1016/S0003-3472(83)80222-X; VILLA F, 1992, TRENDS ECOL EVOL, V7, P179, DOI 10.1016/0169-5347(92)90069-N; Viscido SV, 2005, ECOL MODEL, V183, P347, DOI 10.1016/j.ecolmodel.2004.08.019; WADA K, 1986, INT J PRIMATOL, V7, P1, DOI 10.1007/BF02692306; WASHBURN SL, 1961, SCI AM, V204, P62, DOI 10.1038/scientificamerican0661-62; Watson SL, 1998, ATHEROSCLEROSIS, V137, P259, DOI 10.1016/S0021-9150(97)00277-3; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; WILENSKI U, 2007, NETLOGO 4 0 3; Wilson E.O., 1975, P1; WOLKENTEN M, 2006, INT J PRIMATOL, V27, P1241; Yamada M., 1966, Primates, V7, P315, DOI 10.1007/BF01730645	112	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e26189	10.1371/journal.pone.0026189	http://dx.doi.org/10.1371/journal.pone.0026189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125595	Green Published, gold			2022-12-25	WOS:000297789200003
J	Rizzato, C; Campa, D; Giese, N; Werner, J; Rachakonda, PS; Kumar, R; Schanne, M; Greenhalf, W; Costello, E; Khaw, KT; Key, TJ; Siddiq, A; Lorenzo-Bermejo, J; Burwinkel, B; Neoptolemos, JP; Buchler, MW; Hoheisel, JD; Bauer, A; Canzian, F				Rizzato, Cosmeri; Campa, Daniele; Giese, Nathalia; Werner, Jens; Rachakonda, P. Sivaramakrishna; Kumar, Rajiv; Schanne, Michaela; Greenhalf, William; Costello, Eithne; Khaw, Kay-tee; Key, Tim J.; Siddiq, Afshan; Lorenzo-Bermejo, Justo; Burwinkel, Barbara; Neoptolemos, John P.; Buechler, Markus W.; Hoheisel, Joerg D.; Bauer, Andrea; Canzian, Federico			Pancreatic Cancer Susceptibility Loci and Their Role in Survival	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; POLYMORPHISMS; ADIPONECTIN; COHORT	Pancreatic cancer has one of the worst mortality rates of all cancers. Little is known about its etiology, particularly regarding inherited risk. The PanScan project, a genome-wide association study, identified several common polymorphisms affecting pancreatic cancer susceptibility. Single nucleotide polymorphisms (SNPs) in ABO, sonic hedgehog (SHH), telomerase reverse transcriptase (TERT), nuclear receptor subfamily 5, group A, member 2 (NR5A2) were found to be associated with pancreatic cancer risk. Moreover the scan identified loci on chromosomes 13q22.1 and 15q14, to which no known genes or other functional elements are mapped. We sought to replicate these observations in two additional, independent populations (from Germany and the UK), and also evaluate the possible impact of these SNPs on patient survival. We genotyped 15 SNPs in 690 cases of pancreatic ductal adenocarcinoma (PDAC) and in 1277 healthy controls. We replicated several associations between SNPs and PDAC risk. Furthermore we found that SNP rs8028529 was weakly associated with a better overall survival (OS) in both populations. We have also found that NR5A2 rs12029406_T allele was associated with a shorter survival in the German population. In conclusion, we found that rs8028529 could be, if these results are replicated, a promising marker for both risk and prognosis for this lethal disease.	[Rizzato, Cosmeri; Campa, Daniele; Rachakonda, P. Sivaramakrishna; Kumar, Rajiv; Schanne, Michaela; Burwinkel, Barbara; Hoheisel, Joerg D.; Bauer, Andrea; Canzian, Federico] German Canc Res Ctr, Heidelberg, Germany; [Giese, Nathalia; Werner, Jens; Buechler, Markus W.] Univ Heidelberg, Clin Gen Visceral & Transplantat Surg, Heidelberg, Germany; [Greenhalf, William; Costello, Eithne; Neoptolemos, John P.] Natl Inst Hlth Res, Pancreas Biomed Res Unit, Liverpool, Merseyside, England; [Greenhalf, William; Costello, Eithne; Neoptolemos, John P.] Natl Inst Hlth Res, Liverpool Expt Canc Med Ctr, Liverpool, Merseyside, England; [Khaw, Kay-tee] Univ Cambridge, Sch Clin Med, Cambridge, England; [Key, Tim J.] Univ Oxford, Canc Epidemiol Unit, Oxford, England; [Siddiq, Afshan] Univ London Imperial Coll Sci Technol & Med, London, England; [Lorenzo-Bermejo, Justo] Univ Heidelberg Hosp, Inst Med Biometry & Informat, Heidelberg, Germany; [Burwinkel, Barbara] Univ Heidelberg, Dept Gynecol & Obstet, Div Mol Biol Breast Canc, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Liverpool; University of Liverpool; University of Cambridge; University of Oxford; Imperial College London; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Rizzato, C (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	f.canzian@dkfz.de	Canzian, Federico/I-2804-2014; Campa, Daniele/K-1617-2016; Khaw, Kay-Tee/AAZ-3209-2021; Neoptolemos, John/HGU-7742-2022; Greenhalf, William/A-2680-2013; Rizzato, Cosmeri/AAI-1261-2020; Kumar, Rajiv/H-6431-2019	Campa, Daniele/0000-0003-3220-9944; Kumar, Rajiv/0000-0002-6093-0395; Neoptolemos, John/0000-0002-6201-7399; Siddiq, Afshan/0000-0002-9110-1434; Bauer, Andrea/0000-0002-7919-0497; Rachakonda, Sivaramakrishna/0000-0002-2319-2821; Canzian, Federico/0000-0002-4261-4583; Costello, Eithne/0000-0002-0104-8992	European Union; German Federal Ministry of Education, Research (BMBF); National Institute for Health Research Liverpool; Pancreatic Biomedical Research Unit; Liverpool Experimental Cancer Medicine Centre; Medical Research Council [G1000143, G0401527] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10126] Funding Source: researchfish	European Union(European Commission); German Federal Ministry of Education, Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Institute for Health Research Liverpool; Pancreatic Biomedical Research Unit; Liverpool Experimental Cancer Medicine Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the European Union as part of the MolDiagPaCa project as well as the German Federal Ministry of Education, Research (BMBF) as part of the PaCaNet project within the NGFNplus program, and the National Institute for Health Research Liverpool, Pancreatic Biomedical Research Unit and the Liverpool Experimental Cancer Medicine Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRD I, 1960, BRIT MED J, V1, P1163, DOI 10.1136/bmj.1.5180.1163; AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Anderson K, 2006, CANC PANCREAS; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Baudis M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-226; Chen CS, 2001, GENE CHROMOSOME CANC, V31, P333, DOI 10.1002/gcc.1152; Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430; Day N, 1999, BRIT J CANCER, V80, P95; Doolan P, 2009, TUMOR BIOL, V30, P200, DOI 10.1159/000239795; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Fox CS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S18; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gast A, 2007, LEUKEMIA, V21, P320, DOI 10.1038/sj.leu.2404474; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Li DH, 2010, CLIN CANCER RES, V16, P4313, DOI 10.1158/1078-0432.CCR-09-1942; Milech N, 2010, LEUKEMIA RES, V34, P358, DOI 10.1016/j.leukres.2009.06.003; Stolzenberg-Solomon RZ, 2008, AM J EPIDEMIOL, V168, P1047, DOI 10.1093/aje/kwn221; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406	23	43	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27921	10.1371/journal.pone.0027921	http://dx.doi.org/10.1371/journal.pone.0027921			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125638	Green Published, gold, Green Submitted			2022-12-25	WOS:000297789200038
J	Schneider, CP; Shukla, D; Trout, BL				Schneider, Curtiss P.; Shukla, Diwakar; Trout, Bernhardt L.			Effects of Solute-Solute Interactions on Protein Stability Studied Using Various Counterions and Dendrimers	PLOS ONE			English	Article							PAMAM DENDRIMERS; ARGININE; AGGREGATION; GUANIDINIUM; SULFATE; STABILIZATION; GENERATION; HYDRATION; MECHANISM; DESIGN	Much work has been performed on understanding the effects of additives on protein thermodynamics and degradation kinetics, in particular addressing the Hofmeister series and other broad empirical phenomena. Little attention, however, has been paid to the effect of additive-additive interactions on proteins. Our group and others have recently shown that such interactions can actually govern protein events, such as aggregation. Here we use dendrimers, which have the advantage that both size and surface chemical groups can be changed and therein studied independently. Dendrimers are a relatively new and broad class of materials which have been demonstrated useful in biological and therapeutic applications, such as drug delivery, perturbing amyloid formation, etc. Guanidinium modified dendrimers pose an interesting case given that guanidinium can form multiple attractive hydrogen bonds with either a protein surface or other components in solution, such as hydrogen bond accepting counterions. Here we present a study which shows that the behavior of such macromolecule species (modified PAMAM dendrimers) is governed by intra-solvent interactions. Attractive guanidiniumanion interactions seem to cause clustering in solution, which inhibits cooperative binding to the protein surface but at the same time, significantly suppresses nonnative aggregation.	[Schneider, Curtiss P.; Shukla, Diwakar; Trout, Bernhardt L.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Schneider, CP (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	trout@mit.edu	Shukla, Diwakar/GRY-2518-2022	Shukla, Diwakar/0000-0003-4079-5381	Singapore-MIT Alliance	Singapore-MIT Alliance	The Singapore-MIT Alliance funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baynes BM, 2005, BIOCHEMISTRY-US, V44, P4919, DOI 10.1021/bi047528r; Baynes BM, 2004, BIOPHYS J, V87, P1631, DOI 10.1529/biophysj.104.042473; Baynes BM, 2003, J PHYS CHEM B, V107, P14058, DOI 10.1021/jp0363996; Boas U, 2004, CHEM SOC REV, V33, P43, DOI 10.1039/b309043b; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CANNON WR, 1994, J PHYS CHEM-US, V98, P6225, DOI 10.1021/j100075a027; Cordes H, 2007, BIOMACROMOLECULES, V8, P3578, DOI 10.1021/bm7006168; Dempsey CE, 2007, J AM CHEM SOC, V129, P15895, DOI 10.1021/ja074719j; DEYOUNG LR, 1993, ACCOUNTS CHEM RES, V26, P614, DOI 10.1021/ar00036a002; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Gajbhiye V, 2009, J PHARM PHARMACOL, V61, P989, DOI 10.1211/jpp/61.08.0002; Ghosh K, 2009, P NATL ACAD SCI USA, V106, P10649, DOI 10.1073/pnas.0903995106; Giehm L, 2008, BIOPOLYMERS, V89, P522, DOI 10.1002/bip.20921; Heegaard PMH, 2007, MACROMOL BIOSCI, V7, P1047, DOI 10.1002/mabi.200700051; Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI [DOI 10.1007/BF01918191, 10.1007/BF01918191]; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klajnert B, 2003, BBA-PROTEINS PROTEOM, V1648, P115, DOI 10.1016/S1570-9639(03)00117-1; Kozer N, 2007, BIOPHYS J, V92, P2139, DOI 10.1529/biophysj.106.097717; Labieniec M, 2009, CENT EUR J BIOL, V4, P434, DOI 10.2478/s11535-009-0056-7; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; MacKerell AD, 2001, COMPUTATIONAL BIOCHEMISTRY AND BIOPHYSICS, P7; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Mason PE, 2005, J PHYS CHEM B, V109, P24185, DOI 10.1021/jp052799c; Mason PE, 2003, P NATL ACAD SCI USA, V100, P4557, DOI 10.1073/pnas.0735920100; Mason PE, 2009, J PHYS CHEM B, V113, P3227, DOI 10.1021/jp8112232; Minton AP, 1997, CURR OPIN BIOTECH, V8, P65, DOI 10.1016/S0958-1669(97)80159-0; MINTON AP, 1998, ENERGETICS BIOL MA B, P127; Okuro K, 2009, J AM CHEM SOC, V131, P1626, DOI 10.1021/ja800491v; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Schneider CP, 2011, J PHYS CHEM B, V115, P7447, DOI 10.1021/jp111920y; Schneider CP, 2009, J PHYS CHEM B, V113, P2050, DOI 10.1021/jp808042w; SHUKLA D, J PHYS CHEM IN PRESS; Shukla D, 2011, J PHYS CHEM B, V115, P1243, DOI 10.1021/jp108586b; Shukla D, 2010, J PHYS CHEM B, V114, P13426, DOI 10.1021/jp108399g; Shukla D, 2009, J PHYS CHEM B, V113, P12546, DOI 10.1021/jp810949t; Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399	37	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27665	10.1371/journal.pone.0027665	http://dx.doi.org/10.1371/journal.pone.0027665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125620	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789200020
J	van der Watt, PJ; Ngarande, E; Leaner, VD				van der Watt, Pauline J.; Ngarande, Ellen; Leaner, Virna D.			Overexpression of Kpn beta 1 and Kpn alpha 2 Importin Proteins in Cancer Derives from Deregulated E2F Activity	PLOS ONE			English	Article							CELL-LINES; CERVICAL-CANCER; BREAST-CANCER; EXPRESSION; GENES; PROLIFERATION; P16(INK4); MELANOMA; SURVIVAL; PATHWAY	The Karyopherin superfamily comprises nuclear transport proteins, involved in the shuttling of certain cargo proteins into and out of the nucleus. Karyopherin beta 1 (Kpn beta 1) and Karyopherin alpha 2 (Kpn alpha 2) are importin proteins, which work in concert to transport their cargo into the nucleus. We previously identified increased expression of Kpn beta 1 and Kpn alpha 2 in cervical tumours compared to normal epithelium and in transformed cells compared to their normal counterparts. This study therefore aimed to identify the transcription regulatory mechanisms associated with high Kpn beta 1 and Kpn alpha 2 levels in cancer cells. Kpn beta 1 (-2013 to + 100) and Kpn alpha 2 (-1900 to + 69) promoter fragments were separately cloned into the reporter vector, pGL3-basic, and luciferase assays revealed both as significantly more active in cancer and transformed cells compared to normal. A series of deletion constructs identified the -637 to -271 Kpn beta 1 and 2180 to 224 Kpn alpha 2 promoter regions as responsible for the differential promoter activity, and a number of highly conserved E2F binding sites were identified within these regions. Mutation analysis confirmed the requirement of E2F sites for promoter activity, and ChIP analysis confirmed E2F2/Dp1 binding to the Kpn beta 1 and Kpn alpha 2 promoters in vivo. Dp1 inhibition resulted in decreased levels of the respective proteins, confirming the role of E2F in the overexpression of Kpn beta 1 and Kpn alpha 2 proteins in cancer. E2F activity is known to be deregulated in cervical cancer cells due to the inhibition of its repressor, Rb, by HPV E7. The inhibition of E7 using siRNA resulted in decreased Kpn beta 1 and Kpn alpha 2 promoter activities, as did the overexpression of Rb. In conclusion, this study is a first to show that elevated Kpn beta 1 and Kpn alpha 2 expression in cancer cells correlates with altered transcriptional regulation associated with deregulated E2F/Rb activities	[van der Watt, Pauline J.; Ngarande, Ellen; Leaner, Virna D.] Univ Cape Town, Div Med Biochem, Fac Hlth Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	University of Cape Town	van der Watt, PJ (corresponding author), Univ Cape Town, Div Med Biochem, Fac Hlth Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	Virna.Leaner@uct.ac.za			University of Cape Town; Carnegie Corporation of New York; CANSA; Medical Research Council (SA); University of Cape Town/Carnegie Corporation of New York	University of Cape Town; Carnegie Corporation of New York; CANSA; Medical Research Council (SA)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cape Town/Carnegie Corporation of New York	This work was supported by grants from the University of Cape Town, the Carnegie Corporation of New York, CANSA, and the Medical Research Council (SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the University of Cape Town/Carnegie Corporation of New York Development grants, CANSA, and the Medical Research Council (SA). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AAGAARD L, 1995, INT J CANCER, V61, P115, DOI 10.1002/ijc.2910610120; Bartkova J, 1996, CANCER RES, V56, P5475; Chen CX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000912; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Dahl E, 2006, CLIN CANCER RES, V12, P3950, DOI 10.1158/1078-0432.CCR-05-2090; Di Fiore B, 1999, J BIOL CHEM, V274, P10339, DOI 10.1074/jbc.274.15.10339; Gluz O, 2008, INT J CANCER, V123, P1433, DOI 10.1002/ijc.23628; HE J, 1995, CANCER RES, V55, P4833; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Jensen JB, 2011, EUR UROL, V59, P841, DOI 10.1016/j.eururo.2011.01.048; Karstensen B, 2006, VIROLOGY, V353, P200, DOI 10.1016/j.virol.2006.05.030; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Lavia P, 1999, BIOESSAYS, V21, P221; Mortezavi A, 2011, CLIN CANCER RES, V17, P1111, DOI 10.1158/1078-0432.CCR-10-0081; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Noetzel E, 2011, ONCOGENE; Sakai M, 2010, ANTICANCER RES, V30, P851; Tang S, 2006, J VIROL, V80, P4249, DOI 10.1128/JVI.80.9.4249-4263.2006; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146; Wang CI, 2011, INT J CANCER, V128, P2364, DOI 10.1002/ijc.25568; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Yasuhara N, 2004, EXP CELL RES, V297, P285, DOI 10.1016/j.yexcr.2004.03.010; Yoshitake K, 2011, ANN SURG ONCOL, V18, P2093, DOI 10.1245/s10434-011-1569-7; Zheng M, 2010, OBSTET GYNECOL, V116, P884, DOI 10.1097/AOG.0b013e3181f104ce	26	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27723	10.1371/journal.pone.0027723	http://dx.doi.org/10.1371/journal.pone.0027723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125623	Green Published, gold, Green Submitted			2022-12-25	WOS:000297789200023
J	Zhong, YF; Wu, YW; Liu, RJ; Li, ZZ; Chen, YB; Evans, T; Chuang, P; Das, B; He, JC				Zhong, Yifei; Wu, Yingwei; Liu, Ruijie; Li, Zhengzhe; Chen, Yibang; Evans, Todd; Chuang, Peter; Das, Bhaskar; He, John Cijiang			Novel Retinoic Acid Receptor Alpha Agonists for Treatment of Kidney Disease	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; IN-VITRO; DESIGN; PODOCYTES; HETEROAROTINOIDS; DERIVATIVES; NEF; DIFFERENTIATION; PROLIFERATION; NEPHROPATHY	Development of pharmacologic agents that protect podocytes from injury is a critical strategy for the treatment of kidney glomerular diseases. Retinoic acid reduces proteinuria and glomerulosclerosis in multiple animal models of kidney diseases. However, clinical studies are limited because of significant side effects of retinoic acid. Animal studies suggest that all trans retinoic acid (ATRA) attenuates proteinuria by protecting podocytes from injury. The physiological actions of ATRA are mediated by binding to all three isoforms of the nuclear retinoic acid receptors (RARs): RAR alpha, RAR beta, and RAR gamma. We have previously shown that ATRA exerts its renal protective effects mainly through the agonism of RAR alpha. Here, we designed and synthesized a novel boron-containing derivative of the RAR alpha-specific agonist Am580. This new derivative, BD4, binds to RAR alpha receptor specifically and is predicted to have less toxicity based on its structure. We confirmed experimentally that BD4 binds to RAR alpha with a higher affinity and exhibits less cellular toxicity than Am580 and ATRA. BD4 induces the expression of podocyte differentiation markers (synaptopodin, nephrin, and WT-1) in cultured podocytes. Finally, we confirmed that BD4 reduces proteinuria and improves kidney injury in HIV-1 transgenic mice, a model for HIV-associated nephropathy (HIVAN). Mice treated with BD4 did not develop any obvious toxicity or side effect. Our data suggest that BD4 is a novel RARa agonist, which could be used as a potential therapy for patients with kidney disease such as HIVAN.	[Zhong, Yifei] Shanghai Jiantao Univ, Ruijin Hosp, Dept Nephrol, Shanghai, Peoples R China; [Zhong, Yifei] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China; [Liu, Ruijie; Li, Zhengzhe; Chuang, Peter; He, John Cijiang] Mt Sinai Sch Med, Dept Med Nephrol, New York, NY USA; [Chen, Yibang; He, John Cijiang] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA; [Evans, Todd; Das, Bhaskar] Weill Cornell Med Coll, Dept Mol Biol Surg, New York, NY USA; [Wu, Yingwei] Tongji Univ, Shanghai E Hosp, Dept Radiol, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cornell University; Tongji University	Zhong, YF (corresponding author), Shanghai Jiantao Univ, Ruijin Hosp, Dept Nephrol, Shanghai, Peoples R China.	bcd2004@med.cornell.edu; cijiang.he@mssm.edu			National Institute of Health [R01DK078897, R01DK088541, P01-DK-56492, 1RC4DK090860, 5K08DK082760]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088541, RC4DK090860, P01DK056492, R01DK078897, K08DK082760] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	JCH is supported by National Institute of Health R01DK078897, National Institute of Health R01DK088541, National Institute of Health P01-DK-56492, and National Institute of Health 1RC4DK090860. PC is supported by National Institute of Health 5K08DK082760. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2004, CHEMBIOCHEM, V5, P483, DOI 10.1002/cbic.200300748; Barisoni L, 1999, J AM SOC NEPHROL, V10, P51; Barisoni L, 2000, KIDNEY INT, V58, P173, DOI 10.1046/j.1523-1755.2000.00152.x; Benbrook DM, 1998, J MED CHEM, V41, P3753, DOI 10.1021/jm980308p; Benbrook DM, 1997, J MED CHEM, V40, P3567, DOI 10.1021/jm970196m; Collins AJ, 2011, AM J KIDNEY DIS, V57, pA8, DOI 10.1053/j.ajkd.2010.10.007; D'Agati V, 2003, SEMIN NEPHROL, V23, P117, DOI 10.1053/snep.2003.50012; Das BC, 2008, BIOORG MED CHEM LETT, V18, P4177, DOI 10.1016/j.bmcl.2008.05.097; Das BC, 2008, BIOORG MED CHEM LETT, V18, P3805, DOI 10.1016/j.bmcl.2008.05.021; Das BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010004; Das BC, 2009, BIOORG MED CHEM LETT, V19, P4204, DOI 10.1016/j.bmcl.2009.05.110; DAWSON MI, 1995, CANCER RES, V55, P4446; de Lema GP, 2004, KIDNEY INT, V66, P1018, DOI 10.1111/j.1523-1755.2004.00850.x; DELESCLUSE C, 1991, MOL PHARMACOL, V40, P556; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Evans TRJ, 1999, BRIT J CANCER, V80, P1, DOI 10.1038/sj.bjc.6690312; Fevig TL, 1996, J MED CHEM, V39, P4988, DOI 10.1021/jm960243v; Han SY, 2004, IMMUNOL CELL BIOL, V82, P568, DOI 10.1111/j.1440-1711.2004.01287.x; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; He JCJ, 2007, J AM SOC NEPHROL, V18, P93, DOI 10.1681/ASN.2006070727; Jubinsky PT, 2011, BIOORG MED CHEM LETT, V21, P3479, DOI 10.1016/j.bmcl.2011.03.050; KOEHLER KA, 1971, BIOCHEMISTRY-US, V10, P2477; Lehrke I, 2002, AM J PHYSIOL-RENAL, V282, pF741, DOI 10.1152/ajprenal.00026.2001; LOOK J, 1995, AM J PHYSIOL-ENDOC M, V269, pE91, DOI 10.1152/ajpendo.1995.269.1.E91; Lu TC, 2008, J BIOL CHEM, V283, P8173, DOI 10.1074/jbc.M708920200; Lucas GM, 2004, AIDS, V18, P541, DOI 10.1097/00002030-200402200-00022; McCullough PA, 2011, AM J KIDNEY DIS, V57, pS1, DOI 10.1053/j.ajkd.2010.11.011; Merlet-Benichou C, 1999, CURR OPIN NEPHROL HY, V8, P39, DOI 10.1097/00041552-199901000-00007; Montesinos P, 2009, BLOOD, V113, P775, DOI 10.1182/blood-2008-07-168617; Moreno-Manzano V, 2003, BRIT J PHARMACOL, V139, P823, DOI 10.1038/sj.bjp.0705311; Ratnam KK, 2011, KIDNEY INT, V79, P624, DOI 10.1038/ki.2010.470; Schaier M, 2001, KIDNEY INT, V60, P2222, DOI 10.1046/j.1523-1755.2001.00056.x; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Sunamoto M, 2003, KIDNEY INT, V64, P1695, DOI 10.1046/j.1523-1755.2003.00283.x; Suzuki A, 2003, J AM SOC NEPHROL, V14, P981, DOI 10.1097/01.ASN.0000057857.66268.8F; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Torregroza I, 2009, CHEM BIOL DRUG DES, V73, P339, DOI 10.1111/j.1747-0285.2009.00782.x; Vaughan MR, 2005, KIDNEY INT, V68, P133, DOI 10.1111/j.1523-1755.2005.00387.x; Vuligonda V, 1999, BIOORG MED CHEM LETT, V9, P2289, DOI 10.1016/S0960-894X(99)00180-8; Wagner J, 2000, J AM SOC NEPHROL, V11, P1479, DOI 10.1681/ASN.V1181479; WAUGH KM, 1985, J MED CHEM, V28, P116, DOI 10.1021/jm00379a021; Wyatt CM, 2007, AM J MED, V120, P488, DOI 10.1016/j.amjmed.2007.01.025; Xu Q, 2004, KIDNEY INT, V66, P2119, DOI 10.1111/j.1523-1755.2004.66002.x; Yang WQ, 2003, MED RES REV, V23, P346, DOI 10.1002/med.10043; Zhong JY, 2005, KIDNEY INT, V68, P1048, DOI 10.1111/j.1523-1755.2005.00497.x	45	28	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27945	10.1371/journal.pone.0027945	http://dx.doi.org/10.1371/journal.pone.0027945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125642	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789200042
J	Plazzo, AP; De Franceschi, N; Da Broi, F; Zonta, F; Sanasi, MF; Filippini, F; Mongillo, M				Plazzo, Anna Pia; De Franceschi, Nicola; Da Broi, Francesca; Zonta, Francesco; Sanasi, Maria Federica; Filippini, Francesco; Mongillo, Marco			Bioinformatic and Mutational Analysis of Channelrhodopsin-2 Protein Cation-conducting Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPTICAL CONTROL; LIGHT; ACTIVATION; WEB	Channelrhodopsin-2 (ChR2) is a light-gated cation channel widely used as a biotechnological tool to control membrane depolarization in various cell types and tissues. Although several ChR2 variants with modified properties have been generated, the structural determinants of the protein function are largely unresolved. We used bioinformatic modeling of the ChR2 structure to identify the putative cationic pathway within the channel, which is formed by a system of inner cavities that are uniquely present in this microbial rhodopsin. Site-directed mutagenesis combined with patch clamp analysis in HeLa cells was used to determine key residues involved in ChR2 conductance and selectivity. Among them, Gln-56 is important for ion conductance, whereas Ser-63, Thr-250, and Asn-258 are previously unrecognized residues involved in ion selectivity and photocurrent kinetics. This study widens the current structural information on ChR2 and can assist in the design of new improved variants for specific biological applications.	[Plazzo, Anna Pia; Da Broi, Francesca; Sanasi, Maria Federica; Mongillo, Marco] Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy; [De Franceschi, Nicola; Filippini, Francesco] Univ Padua, Dept Biol, I-35100 Padua, Italy; [Filippini, Francesco] Univ Padua, Dept Phys, I-35100 Padua, Italy; [Plazzo, Anna Pia; De Franceschi, Nicola; Da Broi, Francesca; Mongillo, Marco] VIMM, I-35129 Padua, Italy	University of Padua; University of Padua; University of Padua; Veneto Institute Molecular Medicine	Mongillo, M (corresponding author), Univ Padua, Dept Biomed Sci, Viale Colombo 3, I-35100 Padua, Italy.	marco.mongillo@unipd.it	Filippini, Francesco/AAH-2897-2021; Zonta, Francesco/GXW-1979-2022; De Franceschi, Nicola/S-8194-2016	Zonta, Francesco/0000-0001-8729-1071; FILIPPINI, FRANCESCO/0000-0001-5672-0726; De Franceschi, Nicola/0000-0002-7221-613X	European Community [HEALTH-F2-2009-241526]	European Community(European Commission)	This work was supported by funding from the European Community Seventh Framework Program FP7/2007-2013 under Grant Agreement HEALTH-F2-2009-241526, EUTrigTreat (to M. M.).	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Beltramello M, 2003, BIOCHEM BIOPH RES CO, V305, P1024, DOI 10.1016/S0006-291X(03)00868-4; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BROWN LS, 1995, BIOCHEMISTRY-US, V34, P12903, DOI 10.1021/bi00039a053; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; DER A, 1991, P NATL ACAD SCI USA, V88, P4751, DOI 10.1073/pnas.88.11.4751; Enamil N, 2006, J MOL BIOL, V358, P675, DOI 10.1016/j.jmb.2006.02.032; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; FOSTER KW, 1984, NATURE, V311, P756, DOI 10.1038/311756a0; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Hegemann P., 2007, CELL SCI REV, V3, P108; Hegemann P, 2011, NAT METHODS, V8, P39, DOI 10.1038/NMETH.F.327; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hofmann B, 2010, LAB CHIP, V10, P2588, DOI 10.1039/c003091k; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Kouyama T, 2010, J MOL BIOL, V396, P564, DOI 10.1016/j.jmb.2009.11.061; LESSEL U, 1994, PROTEIN ENG, V7, P1175, DOI 10.1093/protein/7.10.1175; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lill MA, 2011, J COMPUT AID MOL DES, V25, P13, DOI 10.1007/s10822-010-9395-8; Muller M, 2011, J MOL BIOL, V414, P86, DOI 10.1016/j.jmb.2011.09.049; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Ruffert K, 2011, BIOCHEM BIOPH RES CO, V410, P737, DOI 10.1016/j.bbrc.2011.06.024; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Sugiyama Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P328, DOI 10.1039/b815762f; Tsunoda SP, 2009, PHOTOCHEM PHOTOBIOL, V85, P564, DOI 10.1111/j.1751-1097.2008.00519.x; Wolf S, 2010, ANGEW CHEM INT EDIT, V49, P6889, DOI 10.1002/anie.201001243; Yoshimura K, 2008, J MOL BIOL, V375, P1267, DOI 10.1016/j.jmb.2007.11.039; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	44	28	29	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	2012	287	7					4818	4825		10.1074/jbc.M111.326207	http://dx.doi.org/10.1074/jbc.M111.326207			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	896YX	22139833	hybrid, Green Published			2022-12-25	WOS:000300608500043
J	Fan, E; Fiedler, S; Jacob-Dubuisson, F; Muller, M				Fan, Enguo; Fiedler, Silke; Jacob-Dubuisson, Francoise; Mueller, Matthias			Two-partner Secretion of Gram-negative Bacteria A SINGLE beta-BARREL PROTEIN ENABLES TRANSPORT ACROSS THE OUTER MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERTUSSIS FILAMENTOUS HEMAGGLUTININ; PERIPLASMIC CHAPERONE SKP; ESCHERICHIA-COLI; SIGNAL PEPTIDE; OMP85 FAMILY; AUTOTRANSPORTER; BORDETELLA; DOMAIN; BIOGENESIS; PATHWAY	The mechanisms of protein secretion by pathogenic bacteria remain poorly understood. In Gram-negative bacteria, the two-partner secretion pathway exports large, mostly virulence-related "TpsA" proteins across the outer membrane via their dedicated "TpsB" transporters. TpsB transporters belong to the ubiquitous Omp85 superfamily, whose members are involved in protein translocation across, or integration into, cellular membranes. The filamentous hemagglutinin/FhaC pair of Bordetella pertussis is a model two-partner secretion system. We have reconstituted the TpsB transporter FhaC into proteoliposomes and demonstrate that FhaC is the sole outer membrane protein required for translocation of its cognate TpsA protein. This is the first in vitro system for analyzing protein secretion across the outer membrane of Gram-negative bacteria. Our data also provide clear evidence for the protein translocation function of Omp85 transporters.	[Fan, Enguo; Fiedler, Silke; Mueller, Matthias] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany; [Jacob-Dubuisson, Francoise] Inst Pasteur, Ctr Infect & Immun Lille, CNRS UMR8204, INSERM U1019, F-59019 Lille, France	University of Freiburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Muller, M (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, Stefan Meier Str 17, D-79104 Freiburg, Germany.	matthias.mueller@biochemie.uni-freiburg.de	Jacob-Dubuisson, Françoise/F-1610-2018	Jacob-Dubuisson, Françoise/0000-0002-5102-1704	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 746, Forschergruppe 929]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Sonderforschungsbereich 746 and Forschergruppe 929 from the Deutsche Forschungsgemeinschaft.	Baud C, 2009, MOL MICROBIOL, V74, P315, DOI 10.1111/j.1365-2958.2009.06860.x; Baud C, 2011, MOL MICROBIOL, V80, P1625, DOI 10.1111/j.1365-2958.2011.07672.x; Bennion D, 2010, MOL MICROBIOL, V77, P1153, DOI 10.1111/j.1365-2958.2010.07280.x; Bodelon G, 2009, J BACTERIOL, V191, P5169, DOI 10.1128/JB.00458-09; Brandon LD, 2003, MOL MICROBIOL, V50, P45, DOI 10.1046/j.1365-2958.2003.03674.x; Chevalier N, 2004, J MOL MICROB BIOTECH, V8, P7, DOI 10.1159/000082076; Choi PS, 2010, MOL MICROBIOL, V75, P440, DOI 10.1111/j.1365-2958.2009.06993.x; Clantin B, 2004, P NATL ACAD SCI USA, V101, P6194, DOI 10.1073/pnas.0400291101; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Coutte L, 2001, EMBO J, V20, P5040, DOI 10.1093/emboj/20.18.5040; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; DOMENIGHINI M, 1990, MOL MICROBIOL, V4, P787, DOI 10.1111/j.1365-2958.1990.tb00649.x; Economou A, 2006, MOL MICROBIOL, V62, P308, DOI 10.1111/j.1365-2958.2006.05377.x; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Guedin S, 1998, MOL MICROBIOL, V29, P763, DOI 10.1046/j.1365-2958.1998.00970.x; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Harms N, 2001, J BIOL CHEM, V276, P18804, DOI 10.1074/jbc.M011194200; Hodak H, 2006, MOL MICROBIOL, V61, P368, DOI 10.1111/j.1365-2958.2006.05242.x; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jacob-Dubuisson F, 1999, J BIOL CHEM, V274, P37731, DOI 10.1074/jbc.274.53.37731; Jacob-Dubuisson F, 2004, BBA-MOL CELL RES, V1694, P235, DOI 10.1016/j.bbamcr.2004.03.008; Jacob-Dubuisson F, 2009, BIOL CHEM, V390, P675, DOI 10.1515/BC.2009.099; JacobDubuisson F, 1996, MOL MICROBIOL, V19, P65, DOI 10.1046/j.1365-2958.1996.349883.x; Jain S, 2007, J BACTERIOL, V189, P5393, DOI 10.1128/JB.00228-07; LOCHT C, 1993, MOL MICROBIOL, V9, P653, DOI 10.1111/j.1365-2958.1993.tb01725.x; Marin E, 2010, J BACTERIOL, V192, P5588, DOI 10.1128/JB.00432-10; Meli AC, 2006, J BIOL CHEM, V281, P158, DOI 10.1074/jbc.M508524200; Moser Michael, 2007, V390, P63; Neumann-Haefelin C, 2000, EMBO J, V19, P6419, DOI 10.1093/emboj/19.23.6419; Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; RenauldMongenie G, 1996, J BACTERIOL, V178, P1053, DOI 10.1128/jb.178.4.1053-1060.1996; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Skillman KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/j.1365-2958.2005.04885.x; SkorkoGlonek J, 1997, J BIOL CHEM, V272, P8974; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; van Dalen A, 2002, FEBS LETT, V511, P51, DOI 10.1016/S0014-5793(01)03278-1; van der Does C, 2003, METHOD ENZYMOL, V372, P86; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wagner JK, 2009, J BACTERIOL, V191, P815, DOI 10.1128/JB.00989-08; Werner J, 2005, MOL MICROBIOL, V57, P1450, DOI 10.1111/j.1365-2958.2005.04775.x; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	50	29	30	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2591	2599		10.1074/jbc.M111.293068	http://dx.doi.org/10.1074/jbc.M111.293068			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22134917	Green Published, hybrid			2022-12-25	WOS:000300292300032
J	Asanoma, K; Kubota, K; Chakraborty, D; Renaud, SJ; Wake, N; Fukushima, K; Soares, MJ; Rumi, MAK				Asanoma, Kazuo; Kubota, Kaiyu; Chakraborty, Damayanti; Renaud, Stephen J.; Wake, Norio; Fukushima, Kotaro; Soares, Michael J.; Rumi, M. A. Karim			SATB Homeobox Proteins Regulate Trophoblast Stem Cell Renewal and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX ATTACHMENT REGION; MAR-BINDING PROTEIN; GENE-EXPRESSION; MOUSE EMBRYOS; DNA-BINDING; FATE SPECIFICATION; MULTIPLE GENES; SELF-RENEWAL; TROPHECTODERM; CHROMATIN	The morphogenesis of the hemochorial placenta is dependent upon the precise expansion and differentiation of trophoblast stem (TS) cells. SATB homeobox 1 (SATB1) and SATB2 are related proteins that have been implicated as regulators of some stem cell populations. SATB1 is highly expressed in TS cells, which prompted an investigation of SATB1 and the related SATB2 as regulators of TS cells. SATB1 and SATB2 were highly expressed in rat TS cells maintained in the stem state and rapidly declined following induction of differentiation. SATB proteins were also present within the rat placenta during early stages of its morphogenesis and disappeared as gestation advanced. Silencing Satb1 or Satb2 expression decreased TS cell self-renewal and increased differentiation, whereas ectopic expression of SATB proteins promoted TS cell expansion and blunted differentiation. Eomes, a key transcriptional regulator of TS cells, was identified as a target for SATB proteins. SATB knockdown decreased Eomes transcript levels and promoter activity, whereas SATB ectopic expression increased Eomes transcript levels and promoter activity. Electrophoretic mobility shift assay as well as chromatin immunoprecipitation analyses demonstrated that SATB proteins physically associate with a regulatory site within the Eomes promoter. We conclude that SATB proteins promote TS cell renewal and inhibit differentiation. These actions are mediated in part by regulating the expression of the TS cell stem-associated transcription factor, EOMES.	[Asanoma, Kazuo; Kubota, Kaiyu; Chakraborty, Damayanti; Renaud, Stephen J.; Soares, Michael J.; Rumi, M. A. Karim] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Reprod Hlth & Regenerat Med, Kansas City, KS 66160 USA; [Wake, Norio; Fukushima, Kotaro] Kyushu Univ, Dept Obstet & Gynecol, Grad Sch Med Sci, Fukuoka 8128582, Japan	University of Kansas; University of Kansas Medical Center; Kyushu University	Rumi, MAK (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Reprod Hlth & Regenerat Med, HLSIC 3056,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	mrumi@kumc.edu			National Institutes of Health [HD20676]; American Heart Association; Lalor Foundation; Canadian Institutes of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD020676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Lalor Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD20676.; Recipient of a predoctoral fellowship from the American Heart Association.; Recipient of postdoctoral fellowships from the Lalor Foundation and the Canadian Institutes of Health Research.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Ahlfors H, 2010, BLOOD, V116, P1443, DOI 10.1182/blood-2009-11-252205; Ain R, 2006, METH MOLEC MED, V121, P295; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Alvarez JD, 2000, GENE DEV, V14, P521; Asanoma K, 2011, DEV BIOL, V351, P110, DOI 10.1016/j.ydbio.2010.12.038; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dickinson LA, 1997, J BIOL CHEM, V272, P11463; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Erlebacher A, 2004, DEV BIOL, V275, P158, DOI 10.1016/j.ydbio.2004.07.032; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FARIA TN, 1991, ENDOCRINOLOGY, V129, P2895, DOI 10.1210/endo-129-6-2895; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Georgiades P, 2006, DEVELOPMENT, V133, P1059, DOI 10.1242/dev.02277; Gyorgy AB, 2008, EUR J NEUROSCI, V27, P865, DOI 10.1111/j.1460-9568.2008.06061.x; Hamatani T, 2004, P NATL ACAD SCI USA, V101, P10326, DOI 10.1073/pnas.0402597101; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hemberger M, 2010, EPIGENETICS-US, V5, P24, DOI 10.4161/epi.5.1.10589; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Kent LN, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-97; Keramari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013952; Kidder BL, 2010, GENOME RES, V20, P458, DOI 10.1101/gr.101469.109; Kuckenberg P, 2010, MOL CELL BIOL, V30, P3310, DOI 10.1128/MCB.01215-09; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nakayama Y, 2005, CELL CYCLE, V4, P1099; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Odiatis C, 2010, PLACENTA, V31, P630, DOI 10.1016/j.placenta.2010.05.001; Purbey PK, 2008, NUCLEIC ACIDS RES, V36, P2107, DOI 10.1093/nar/gkm1151; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; Rielland M, 2008, DEV BIOL, V322, P1, DOI 10.1016/j.ydbio.2008.07.017; Roberts RM, 2011, BIOL REPROD, V84, P412, DOI 10.1095/biolreprod.110.088724; Rugg-Gunn PJ, 2010, P NATL ACAD SCI USA, V107, P10783, DOI 10.1073/pnas.0914507107; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Sahgal N, 2006, METH MOLEC MED, V121, P159; Santos J, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-1; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki H, 2010, DEV GROWTH DIFFER, V52, P263, DOI 10.1111/j.1440-169X.2009.01158.x; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Senner CE, 2010, PLACENTA, V31, P944, DOI 10.1016/j.placenta.2010.07.013; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Tremblay GB, 2001, GENE DEV, V15, P833, DOI 10.1101/gad.873401; Wen F, 2007, DEV BIOL, V312, P284, DOI 10.1016/j.ydbio.2007.09.024; Wen J, 2005, BLOOD, V105, P3330, DOI 10.1182/blood-2004-08-2988; Yamasaki K, 2007, NUCLEIC ACIDS RES, V35, P5073, DOI 10.1093/nar/gkm504; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	69	42	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2257	2268		10.1074/jbc.M111.287128	http://dx.doi.org/10.1074/jbc.M111.287128			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22123820	hybrid, Green Published			2022-12-25	WOS:000299321000063
J	Bhuwan, M; Lee, HJ; Peng, HL; Chang, HY				Bhuwan, Manish; Lee, Hui-Ju; Peng, Hwei-Ling; Chang, Hwan-You			Histidine-containing Phosphotransfer Protein-B (HptB) Regulates Swarming Motility through Partner-switching System in Pseudomonas aeruginosa PAO1 Strain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-SIGMA FACTOR; MEDIATED MULTISTEP PHOSPHORELAY; TRANSCRIPTION FACTOR SIGMA(F); BACILLUS-SUBTILIS; FACTOR SPOIIAB; BACTERIAL CHEMOTAXIS; 2-COMPONENT SYSTEMS; PULMONARY INFECTION; SIGNAL-TRANSDUCTION; RESPONSE REGULATOR	The histidine-containing phosphotransfer protein-B (HptB; PA3345) is an intermediate protein involved in transferring a phosphoryl group from multiple sensor kinases to the response regulator PA3346 in Pseudomonas aeruginosa PAO1. The objective of this study was to elucidate the biological significance of the HptB-PA3346 interaction and the regulatory mechanisms thereafter. The transcription profiling analysis of an hptB knock-out mutant showed that the expression of a number of motility-related genes was altered consistent with the non-swarming phenotype observed for the mutant. Domain analysis indicated that the PA3346 C-terminal region (PA3346C) exhibits similar to 30% identity with the anti-sigma factor SpoIIAB of Bacillus subtilis. The presence of Ser/Thr protein kinase activity targeting an anti-sigma antagonist, PA3347, at Ser-56 was confirmed in PA3346C using an in vitro phosphorelay assay. Furthermore, PA3346C and the anti-sigma(28) factor FlgM were found to interact with PA3347 individually both in vivo and in vitro. FlgM displaced PA3346C in binding of PA3347 and was then competitively displaced by sigma(28) from the PA3347-FlgM complex, forming a phosphorylation-dependent partner-switching system. The significance of PA3347 phosphorylation in linking the partner-switching system and swarming motility was established by analyzing the swarming phenotype of the PA3347 knock-out mutant and its complement strains.	[Bhuwan, Manish; Chang, Hwan-You] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu 300, Taiwan; [Lee, Hui-Ju; Peng, Hwei-Ling] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan	National Tsing Hua University; National Yang Ming Chiao Tung University	Chang, HY (corresponding author), Natl Tsing Hua Univ, Inst Mol Med, Hsinchu 300, Taiwan.	hychang@life.nthu.edu.tw						Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; ALPER S, 1994, CELL, V77, P195, DOI 10.1016/0092-8674(94)90312-3; Arora SK, 1998, INFECT IMMUN, V66, P1000, DOI 10.1128/IAI.66.3.1000-1007.1998; Beaton AR, 2002, P NATL ACAD SCI USA, V99, P13154, DOI 10.1073/pnas.192432299; Bordi C, 2010, MOL MICROBIOL, V76, P1427, DOI 10.1111/j.1365-2958.2010.07146.x; Bren A, 1998, J MOL BIOL, V278, P507, DOI 10.1006/jmbi.1998.1730; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Campbell EA, 2002, CELL, V108, P795, DOI 10.1016/S0092-8674(02)00662-1; Chen YT, 2004, J MOL EVOL, V59, P725, DOI 10.1007/s00239-004-2663-2; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; Da Re S, 1999, MOL MICROBIOL, V34, P504, DOI 10.1046/j.1365-2958.1999.01614.x; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; DIEDERICH B, 1994, GENE DEV, V8, P2653, DOI 10.1101/gad.8.21.2653; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Finelli A, 2003, J BACTERIOL, V185, P2700, DOI 10.1128/JB.185.9.2700-2710.2003; Francez-Charlot A, 2009, P NATL ACAD SCI USA, V106, P3467, DOI 10.1073/pnas.0810291106; Frisk A, 2002, J BACTERIOL, V184, P1514, DOI 10.1128/JB.184.6.1514-1521.2002; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Garsin DA, 1998, J MOL BIOL, V284, P569, DOI 10.1006/jmbi.1998.2202; Hsu JL, 2008, J BIOL CHEM, V283, P9933, DOI 10.1074/jbc.M708836200; Hua L, 2006, MOL MICROBIOL, V59, P623, DOI 10.1111/j.1365-2958.2005.04962.x; Kozak NA, 2005, J BACTERIOL, V187, P5665, DOI 10.1128/JB.187.16.5665-5676.2005; Lin CT, 2006, RES MICROBIOL, V157, P169, DOI 10.1016/j.resmic.2005.06.012; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Mariconda S, 2006, MOL MICROBIOL, V60, P1590, DOI 10.1111/j.1365-2958.2006.05208.x; MARTIN PR, 1993, MOL MICROBIOL, V9, P857, DOI 10.1111/j.1365-2958.1993.tb01744.x; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Masuda S, 2004, J MOL BIOL, V340, P941, DOI 10.1016/j.jmb.2004.05.040; Mattoo S, 2004, MOL MICROBIOL, V52, P1201, DOI 10.1111/j.1365-2958.2004.04053.x; MIN KT, 1993, CELL, V74, P735, DOI 10.1016/0092-8674(93)90520-Z; MONTIE TC, 1982, INFECT IMMUN, V38, P1296, DOI 10.1128/IAI.38.3.1296-1298.1982; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Mukhopadhyay S, 1999, J BACTERIOL, V181, P6615, DOI 10.1128/JB.181.21.6615-6622.1999; Petrova OE, 2011, J BACTERIOL, V193, P6614, DOI 10.1128/JB.00305-11; Rodrigue A, 2000, TRENDS MICROBIOL, V8, P498, DOI 10.1016/S0966-842X(00)01833-3; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Savli H, 2003, J MED MICROBIOL, V52, P403, DOI 10.1099/jmm.0.05132-0; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; STARNBACH MN, 1992, MOL MICROBIOL, V6, P459, DOI 10.1111/j.1365-2958.1992.tb01490.x; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Toker AS, 1997, J MOL BIOL, V273, P623, DOI 10.1006/jmbi.1997.1335; TOTTEN PA, 1990, J BACTERIOL, V172, P389, DOI 10.1128/JB.172.1.389-396.1990; Wilderman PJ, 2001, MOL MICROBIOL, V39, P291, DOI 10.1046/j.1365-2958.2001.02282.x; Wilson CG, 2004, NAT METHODS, V1, P255, DOI 10.1038/nmeth1204-255; Wyman C, 1997, SCIENCE, V275, P1658, DOI 10.1126/science.275.5306.1658; Yang XF, 1996, GENE DEV, V10, P2265, DOI 10.1101/gad.10.18.2265; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang CC, 1996, MOL MICROBIOL, V20, P9, DOI 10.1111/j.1365-2958.1996.tb02483.x	52	32	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1903	1914		10.1074/jbc.M111.256586	http://dx.doi.org/10.1074/jbc.M111.256586			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128156	Green Published, hybrid			2022-12-25	WOS:000299321000031
J	Pumroy, RA; Nardozzi, JD; Hart, DJ; Root, MJ; Cingolani, G				Pumroy, Ruth A.; Nardozzi, Jonathan D.; Hart, Darren J.; Root, Michael J.; Cingolani, Gino			Nucleoporin Nup50 Stabilizes Closed Conformation of Armadillo repeat 10 in Importin alpha 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNAL; STRUCTURAL BASIS; CRYSTALLOGRAPHIC ANALYSIS; YEAST NUCLEOPORIN; MOLECULAR-BASIS; PORE COMPLEX; PROTEIN; NUP2P; RECOGNITION; TRANSPORT	The human genome encodes six isoforms of importin alpha that show greater than 60% sequence similarity and remarkable substrate specificity. The isoform importin alpha 5 can bind phosphorylated cargos such as STAT1 and Epstein-Barr Virus Nuclear Antigen 1, as well as the influenza virus polymerase subunit PB2. In this work, we have studied the interaction of the nucleoporin Nup50 with importin alpha 5. We show that the first 47 residues of Nup50 bind to the C terminus of importin alpha 5 like a "clip," stabilizing the closed conformation of ARM 10. In vitro, Nup50 binds with high affinity either to empty importin alpha 5 or to a preassembled complex of importin alpha 5 bound to the C-terminal domain of the import cargo PB2, resulting in a trimeric complex. By contrast, PB2 can only bind with high affinity to importin alpha 5 in the absence of Nup50. This suggests that Nup50 primary function may not be to actively displace the import cargo from importin alpha 5 but rather to prevent cargo rebinding in preparation for recycling. This is the first evidence for a nucleoporin modulating the import reaction by directly altering the three-dimensional structure of an import adaptor.	[Pumroy, Ruth A.; Root, Michael J.; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Nardozzi, Jonathan D.] Brigham & Womens Hosp, Ctr Neurol Dis, Dept Neurol, Boston, MA 02115 USA; [Hart, Darren J.] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; [Hart, Darren J.] UJF EMBL CNRS, Unit Virus Host Cell Interact, UMI3265, F-38042 Grenoble 9, France	Jefferson University; Harvard University; Brigham & Women's Hospital; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Cingolani, G (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu	; Hart, Darren/C-4858-2015	Pumroy, Ruth/0000-0002-6200-6083; Nardozzi, Jonathan/0000-0002-6655-4765; Hart, Darren/0000-0002-3502-2002	National Institutes of Health [GM074846]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074846 (to G. C.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Boivin S, 2011, J BIOL CHEM, V286, P10439, DOI 10.1074/jbc.M110.182964; Booth JW, 1999, J BIOL CHEM, V274, P32360, DOI 10.1074/jbc.274.45.32360; Cingolani G, 2000, FEBS LETT, V484, P291, DOI 10.1016/S0014-5793(00)02154-2; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Darling RJ, 2004, ASSAY DRUG DEV TECHN, V2, P647, DOI 10.1089/adt.2004.2.647; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Forwood JK, 2010, STRUCTURE, V18, P1171, DOI 10.1016/j.str.2010.06.015; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; Gilchrist D, 2003, J BIOL CHEM, V278, P51937, DOI 10.1074/jbc.M307371200; Gilchrist D, 2002, J BIOL CHEM, V277, P18161, DOI 10.1074/jbc.M112306200; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; Hood JK, 2000, J CELL SCI, V113, P1471; Kitamura R, 2006, J VIROL, V80, P1979, DOI 10.1128/JVI.80.4.1979-1991.2006; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Lindsay ME, 2002, CELL, V110, P349, DOI 10.1016/S0092-8674(02)00836-X; Lott K, 2011, J BIOL CHEM, V286, P28160, DOI 10.1074/jbc.M111.228007; Lott K, 2011, BBA-MOL CELL RES, V1813, P1578, DOI 10.1016/j.bbamcr.2010.10.012; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; Mitrousis G, 2008, J BIOL CHEM, V283, P7877, DOI 10.1074/jbc.M709093200; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nardozzi J, 2010, J MOL BIOL, V402, P83, DOI 10.1016/j.jmb.2010.07.013; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Ogawa Y, 2010, MOL BIOL CELL, V21, P630, DOI 10.1091/mbc.E09-05-0374; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Smitherman M, 2000, MOL CELL BIOL, V20, P5631, DOI 10.1128/MCB.20.15.5631-5642.2000; Solsbacher J, 2000, MOL CELL BIOL, V20, P8468, DOI 10.1128/MCB.20.22.8468-8479.2000; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Sun C, 2008, P NATL ACAD SCI USA, V105, P8613, DOI 10.1073/pnas.0710867105; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562	52	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2022	2031		10.1074/jbc.M111.315838	http://dx.doi.org/10.1074/jbc.M111.315838			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22130666	hybrid, Green Published			2022-12-25	WOS:000299321000043
J	Yang, JC; Corsello, TR; Ma, YP				Yang, Jianchang; Corsello, Tyler R.; Ma, Yupo			Stem Cell Gene SALL4 Suppresses Transcription through Recruitment of DNA Methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM; OKIHIRO-SYNDROME; LEUKEMIC-CELLS; SELF-RENEWAL; REPRESSOR; MUTATIONS; COMPLEX; DIFFERENTIATION; PLURIPOTENCY; REGULATOR	The stem cell protein SALL4 plays a vital role in maintaining stem cell identity and governing stem cell self-renewal through transcriptional repression. To explore SALL4-mediated mechanisms involved in transcriptional repression, we investigated DNA modifications underlying its regulatory activities. By a luciferase activity assay, we found that both histone deacetylase inhibitor valproic acid (VPA) and DNA methylation inhibitor 5-azacytidine (5-azaC) specifically reversed the repression effect of SALL4 on its own as well as other Sal gene promoter activities. Cotreatment of VPA with 5-azaC in cells almost completely blocked this repression effect. Further co-immunoprecipitation assay and enzyme activity analysis demonstrated that SALL4 protein directly interacted with different DNA methyltransferases (DNMTs) and purified DNMT enzymatic activities from nuclear extracts. In addition, SALL4 isoforms co-occupied the same regions of its own promoter as DNMT corepressors, and ectopic overexpression of SALL4 led to increased CpG island promoter methylation of silenced genes in various cell types. These included primary hematopoietic stem/progenitor cells, fibroblasts, and NB4 leukemic cells. In NB4 cells, treatment of cells with 5-azaC also caused decreased amounts of methylated alleles of SALL4 and PTEN and dramatically increased their mRNA expression. Our studies identify a new mechanism by which SALL4 represses gene expression through interaction with DNMTs. Furthermore, DNMTs and histone deacetylase repressors synergistically contribute to the regulatory effects of SALL4. These findings provide new insights into stem cell self-renewal mediated by SALL4 via epigenetic machinery.	[Yang, Jianchang] Nevada Canc Inst, Div Canc Biol, Las Vegas, NV 89135 USA; [Corsello, Tyler R.; Ma, Yupo] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Ma, Yupo] Chinese Acad Med Sci, Biopharmaceut Res Ctr, Suzhou 215126, Peoples R China; [Ma, Yupo] Peking Union Med Coll, Suzhou 215126, Peoples R China	University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, JC (corresponding author), Nevada Canc Inst, Div Canc Biol, 1 Breakthrough Way, Las Vegas, NV 89135 USA.	jyang@nvcancer.org			National Institutes of Health [R01HL087948]; American Cancer Society; Leukemia and Lymphoma Society [3366-09]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL087948 (to Y. M.). This work was also supported in part by American Cancer Society-Institutional Research Grant 2011-2012 (to J. Y.) and Leukemia and Lymphoma Society special fellow award 3366-09 (to J. Y.).	Aguila JR, 2011, EXPERT REV HEMATOL, V4, P479, DOI [10.1586/ehm.11.46, 10.1586/EHM.11.46]; Aguila JR, 2011, BLOOD, V118, P576, DOI 10.1182/blood-2011-01-333641; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Borozdin W, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019505; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Habano W, 2007, INT J CANCER, V121, P1487, DOI 10.1002/ijc.22847; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 1996, GENOMICS, V38, P291, DOI 10.1006/geno.1996.0631; Kuhnlein RP, 1996, DEVELOPMENT, V122, P2215; Kundakovic M, 2009, MOL PHARMACOL, V75, P342, DOI 10.1124/mol.108.051763; Laurenzana A, 2009, CANCER RES, V69, P55, DOI 10.1158/0008-5472.CAN-08-0245; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Maier H, 2002, SEMIN IMMUNOL, V14, P415, DOI 10.1016/S1044532302000763; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Yang JC, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-38; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	35	47	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1996	2005		10.1074/jbc.M111.308734	http://dx.doi.org/10.1074/jbc.M111.308734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128185	hybrid, Green Published			2022-12-25	WOS:000299321000040
J	Dembek, M; Reynolds, CB; Fairweather, NF				Dembek, Marcin; Reynolds, Catherine B.; Fairweather, Neil F.			Clostridium difficile Cell Wall Protein CwpV Undergoes Enzyme-independent Intramolecular Autoproteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETION SYSTEMS; GLYCOSYLASPARAGINASE; MECHANISM; IDENTIFICATION; ACTIVATION; PROTEASOME; CLEAVAGE	Clostridium difficile infection is a leading cause of antibiotic-associated diarrhea, placing considerable economic pressure on healthcare systems and resulting in significant morbidity and mortality. The pathogen produces a proteinaceous array on its cell surface known as the S-layer, consisting primarily of the major S-layer protein SlpA and a family of SlpA homologs. CwpV is the largest member of this family and is expressed in a phase-variable manner. The protein is post-translationally processed into two fragments that form a noncovalent, heterodimeric complex. To date, no specific proteases capable of cleaving CwpV have been identified. Using site-directed mutagenesis we show that CwpV undergoes intramolecular autoproteolysis, most likely facilitated by a N-O acyl shift, with Thr-413 acting as the source of a nucleophile driving this rearrangement. We demonstrate that neighboring residues are also important for correct processing of CwpV. Based on protein structural predictions and analogy to the glycosylasparaginase family of proteins, it appears likely that these residues play key roles in determining the correct protein fold and interact directly with Thr-413 to promote nucleophilic attack. Furthermore, using a cell-free protein synthesis assay we show that CwpV maturation requires neither cofactors nor auxiliary enzymes.	[Dembek, Marcin; Reynolds, Catherine B.; Fairweather, Neil F.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London	Fairweather, NF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, S Kensington Campus, London SW7 2AZ, England.	n.fairweather@imperial.ac.uk	Dembek, Marcin/AAA-8852-2021	Dembek, Marcin/0000-0003-2831-3335	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust studentships (to M.D. and C.B.R.).	Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Braunstein M, 2001, J BACTERIOL, V183, P6979, DOI 10.1128/JB.183.24.6979-6990.2001; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Chen Q, 2004, MOL MICROBIOL, V53, P843, DOI 10.1111/j.1365-2958.2004.04116.x; Dang THT, 2010, ACS CHEM BIOL, V5, P279, DOI 10.1021/cb9002859; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Ditzel L, 1998, J MOL BIOL, V279, P1187, DOI 10.1006/jmbi.1998.1818; Emerson JE, 2009, MOL MICROBIOL, V74, P541, DOI 10.1111/j.1365-2958.2009.06812.x; Fagan RP, 2011, J BIOL CHEM, V286, P27483, DOI 10.1074/jbc.M111.263889; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kirby JM, 2009, J BIOL CHEM, V284, P34666, DOI 10.1074/jbc.M109.051177; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Lenz LL, 2002, MOL MICROBIOL, V45, P1043, DOI 10.1046/j.1365-2958.2002.03072.x; Liu Y, 1998, J BIOL CHEM, V273, P9688, DOI 10.1074/jbc.273.16.9688; McFarland LV, 2008, FUTURE MICROBIOL, V3, P563, DOI 10.2217/17460913.3.5.563; Perler FB, 1997, CURR OPIN CHEM BIOL, V1, P292, DOI 10.1016/S1367-5931(97)80065-8; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Qian XF, 2003, STRUCTURE, V11, P997, DOI 10.1016/S0969-2126(03)00150-3; Reynolds CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002024; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Sleytr UB, 2007, FEBS J, V274, P323, DOI 10.1111/j.1742-4658.2006.05606.x; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X; Xu QA, 1999, CELL, V98, P651, DOI 10.1016/S0092-8674(00)80052-5; ZWICKL P, 1994, NAT STRUCT BIOL, V1, P765, DOI 10.1038/nsb1194-765	30	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1538	1544		10.1074/jbc.M111.302463	http://dx.doi.org/10.1074/jbc.M111.302463			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128177	Green Published, hybrid			2022-12-25	WOS:000299170300067
J	Ricks, PM; Cain, KP; Oeltmann, JE; Kammerer, JS; Moonan, PK				Ricks, Philip M.; Cain, Kevin P.; Oeltmann, John E.; Kammerer, J. Steve; Moonan, Patrick K.			Estimating the Burden of Tuberculosis among Foreign-Born Persons Acquired Prior to Entering the US, 2005-2009	PLOS ONE			English	Article							LATENT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; CONTACT INVESTIGATIONS; UNITED-STATES; MOLECULAR EPIDEMIOLOGY; TRANSMISSION; IMMIGRATION; INFECTION; COUNTRIES; OUTCOMES	Background: The true burden of reactivation of remote latent tuberculosis infection (reactivation TB) among foreign-born persons with tuberculosis (TB) within the United States is not known. Our study objectives were to estimate the proportion of foreign-born persons with TB due reactivation TB and to describe characteristics of foreign-born persons with reactivation TB. Methods: We conducted a cross-sectional study of patients with an M. tuberculosis isolate genotyped by the U. S. National TB Genotyping Service, 2005-2009. TB cases were attributed to reactivation TB if they were not a member of a localized cluster of cases. Localized clusters were determined by a spatial scan statistic of cases with isolates with matching TB genotype results. Crude odds ratios and 95% confidence intervals were used to assess relations between reactivation TB and select factors among foreign-born persons. Main Results: Among the 36,860 cases with genotyping and surveillance data reported, 22,151 (60%) were foreign-born. Among foreign-born persons with TB, 18,540 (83.7%) were attributed to reactivation TB. Reactivation TB among foreign-born persons was associated with increasing age at arrival, incidence of TB in the country of origin, and decreased time in the U. S. at the time of TB diagnosis. Conclusions: Four out of five TB cases among foreign-born persons can be attributed to reactivation TB and present the largest challenge to TB elimination in the U. S. TB control strategies among foreign-born persons should focus on finding and treating latent tuberculosis infection prior to or shortly after arrival to the United States and on reducing the burden of LTBI through improvements in global TB control.	[Ricks, Philip M.; Cain, Kevin P.; Oeltmann, John E.; Kammerer, J. Steve; Moonan, Patrick K.] US Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Ricks, PM (corresponding author), US Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA.	pmoonan@cdc.gov	Moonan, Patrick K/F-4307-2014; Moonan, Patrick/AAD-2169-2021	Moonan, Patrick/0000-0002-3550-2065				Abubakar I, 2011, BMJ-BRIT MED J, V29, P343; [Anonymous], 1991, TECHN INSTR MED EX A; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Barniol J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-197; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P287; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P47; Centers for Disease Control and Prevention, 2010, REP TUB US 2009; Centers for Disease Control and Prevention, 2009, CDC IMM REQ TECHN IN; Centers for Disease Control and Prevention U. S. Department of Health and Human Services, 2010, REP VER CAS TUB RVCT; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; Diel R, 2009, CHEST, V135, P1010, DOI 10.1378/chest.08-2048; El Sahly HM, 2001, J INFECT DIS, V183, P461, DOI 10.1086/318079; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; Ghosh S, 2011, INFECT GENE IN PRESS; Gilbert RL, 2009, INT J TUBERC LUNG D, V13, P645; Haddad MB, 2007, AM J PREV MED, V32, P239, DOI 10.1016/j.amepre.2006.10.013; Hernandez-Garduno E, 2002, CAN MED ASSOC J, V167, P349; Hill A, 2010, MODELING IMPACT INTE; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Jereb J, 2003, INT J TUBERC LUNG D, V7, pS384; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Langlois-Klassen D, 2011, EUR RESPIR J, V38, P895, DOI 10.1183/09031936.00196610; Linas BP, 2011, AM J RESP CRIT CARE, V184, P590, DOI 10.1164/rccm.201101-0181OC; Love J, 2009, INT J TUBERC LUNG D, V13, P201; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Menzies D, 2001, AM J RESP CRIT CARE, V164, P914, DOI 10.1164/ajrccm.164.6.2107090b; Oppong JR, 2007, PROF GEOGR, V59, P478, DOI 10.1111/j.1467-9272.2007.00636.x; Oxlade O, 2007, INT J TUBERC LUNG D, V11, P16; Pareek M, 2011, LANCET INFECT DIS, V11, P435, DOI 10.1016/S1473-3099(11)70069-X; Sandegren L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016647; Savine E, 2002, J CLIN MICROBIOL, V40, P4561, DOI 10.1128/JCM.40.12.4561-4566.2002; Schechter M, 2006, AM J RESP CRIT CARE, V173, P922, DOI 10.1164/rccm.200512-1953OC; Schwartzman K, 2005, NEW ENGL J MED, V353, P1008, DOI 10.1056/NEJMsa043194; Sharnprapai S, 2002, EMERG INFECT DIS, V8, P1239; Sterling TR, 2010, PREVENT TB STUDY TB; Stop TB USA Tuberculosis Elimination Plan Committee, 2010, CALL ACT TUB EL PLAN; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Talbot EA, 2000, JAMA-J AM MED ASSOC, V284, P2894, DOI 10.1001/jama.284.22.2894; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Van Loon Frederik P. L., 1995, Morbidity and Mortality Weekly Report, V44, P1; Walter ND, 2008, CLIN INFECT DIS, V46, P103, DOI 10.1086/523733; WHO, 2020, WHO REPORT; World Health Organization, 2011, WHOHTMTB2010411; Zuber PLF, 1997, JAMA-J AM MED ASSOC, V278, P304, DOI 10.1001/jama.278.4.304	47	77	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27405	10.1371/journal.pone.0027405	http://dx.doi.org/10.1371/journal.pone.0027405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140439	Green Published, gold			2022-12-25	WOS:000298166300004
J	Jung, CJ; Iyengar, S; Blahnik, KR; Ajuha, TP; Jiang, JX; Farnham, PJ; Zern, M				Jung, Christine J.; Iyengar, Sushma; Blahnik, Kimberly R.; Ajuha, Tijess P.; Jiang, Joy X.; Farnham, Peggy J.; Zern, Mark			Epigenetic Modulation of miR-122 Facilitates Human Embryonic Stem Cell Self-Renewal and Hepatocellular Carcinoma Proliferation	PLOS ONE			English	Article							PYRUVATE-KINASE M2; EFFICIENT DIFFERENTIATION; MICRORNA GENES; IN-VIVO; LIVER; CANCER; EXPRESSION; TARGET; IDENTIFICATION; HEPATOCYTES	The self-renewal capacity ascribed to hESCs is paralleled in cancer cell proliferation, suggesting that a common network of genes may facilitate the promotion of these traits. However, the molecular mechanisms that are involved in regulating the silencing of these genes as stem cells differentiate into quiescent cellular lineages remain poorly understood. Here, we show that a differentiated cell specific miR-122 exemplifies this regulatory attribute by suppressing the translation of a gene, Pkm2, which is commonly enriched in hESCs and liver cancer cells (HCCs), and facilitates self-renewal and proliferation. Through a series of gene expression analysis, we show that miR-122 expression is highly elevated in quiescent human primary hepatocytes (hPHs) but lost or attenuated in hESCs and HCCs, while an opposing expression pattern is observed for Pkm2. Depleting hESCs and HCCs of Pkm2, or overexpressing miR-122, leads to a common deficiency in self-renewal and proliferation. Likewise, during the differentiation process of hESCs into hepatocytes, a reciprocal expression pattern is observed between miR-122 and Pkm2. An examination of the genomic region upstream of miR-122 uncovered hypermethylation in hESCs and HCCs, while the same region is de-methylated and occupied by a transcription initiating protein, RNA polymerase II (RNAPII), in hPHs. These findings indicate that one possible mechanism by which hESC self-renewal is modulated in quiescent hepatic derivatives of hESCs is through the regulatory activity of a differentiated cell-specific miR-122, and that a failure to properly turn "on" this miRNA is observed in uncontrollably proliferating HCCs.	[Jung, Christine J.; Ajuha, Tijess P.; Zern, Mark] Univ Calif Davis, Med Ctr, Transplant Res Program, Sacramento, CA 95817 USA; [Iyengar, Sushma; Blahnik, Kimberly R.; Farnham, Peggy J.] Univ Calif Davis, Dept Pharmacol, Genome Ctr, Davis, CA 95616 USA; [Jiang, Joy X.] Univ Calif Davis, Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Jung, CJ (corresponding author), Univ Calif Davis, Med Ctr, Transplant Res Program, Sacramento, CA 95817 USA.	cjjung@ucdavis.edu		Farnham, Peggy/0000-0003-4469-7914	California Institute for Regenerative Medicine (CIRM) [TG-00006]; CIRM [RC1-00359-1]	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); CIRM(California Institute for Regenerative Medicine)	This work was supported in part by California Institute for Regenerative Medicine (CIRM) Training Grant (TG-00006) to CJJ and a CIRM Comprehensive Research Grant (RC1-00359-1) to MAZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Ferguson EC, 2008, TRENDS BIOCHEM SCI, V33, P359, DOI 10.1016/j.tibs.2008.05.006; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Gatfield D, 2009, INTEGRATION MICRORNA; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; LAIRD PW, 1994, HUM MOL GENET, V3, P1487, DOI 10.1093/hmg/3.suppl_1.1487; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Morris John P 4th, 2005, Sci STKE, V2005, ppe41, DOI 10.1126/stke.2972005pe41; Ochsner SA, 2007, STEM CELLS, V25, P2476, DOI 10.1634/stemcells.2007-0101; Ohler U, 2006, NUCLEIC ACIDS RES, V34, P5943, DOI 10.1093/nar/gkl608; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; STEINBERG P, 1994, CARCINOGENESIS, V15, P125, DOI 10.1093/carcin/15.1.125; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian YW, 1997, HISTOCHEM CELL BIOL, V107, P243, DOI 10.1007/s004180050109; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	47	56	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27740	10.1371/journal.pone.0027740	http://dx.doi.org/10.1371/journal.pone.0027740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140464	gold, Green Published, Green Submitted			2022-12-25	WOS:000298163400017
J	Ivanisevic, J; Thomas, OP; Pedel, L; Penez, N; Ereskovsky, AV; Culioli, G; Perez, T				Ivanisevic, Julijana; Thomas, Olivier P.; Pedel, Laura; Penez, Nicolas; Ereskovsky, Alexander V.; Culioli, Gerald; Perez, Thierry			Biochemical Trade-Offs: Evidence for Ecologically Linked Secondary Metabolism of the Sponge Oscarella balibaloi	PLOS ONE			English	Article							TEMPORAL VARIATION; CHEMICAL ECOLOGY; MICROBIAL COMMUNITY; SEXUAL REPRODUCTION; NATURAL TOXICITY; GROWTH DYNAMICS; PATTERNS; DEMOSPONGIAE; VARIABILITY; BIOACTIVITY	Secondary metabolite production is assumed to be costly and therefore the resource allocation to their production should be optimized with respect to primary biological functions such as growth or reproduction. Sponges are known to produce a great diversity of secondary metabolites with powerful biological activities that may explain their domination in some hard substrate communities both in terms of diversity and biomass. Oscarella balibaloi (Homoscleromorpha) is a recently described, highly dynamic species, which often overgrows other sessile marine invertebrates. Bioactivity measurements (standardized Microtox assay) and metabolic fingerprints were used as indicators of the baseline variations of the O. balibaloi secondary metabolism, and related to the sponge reproductive effort over two years. The bioactivity showed a significant seasonal variation with the lowest values at the end of spring and in early summer followed by the highest bioactivity in the late summer and autumn. An effect of the seawater temperature was detected, with a significantly higher bioactivity in warm conditions. There was also a tendency of a higher bioactivity when O. balibaloi was found overgrowing other sponge species. Metabolic fingerprints revealed the existence of three principal metabolic phenotypes: phenotype 1 exhibited by a majority of low bioactive, female individuals, whereas phenotypes 2 and 3 correspond to a majority of highly bioactive, non-reproductive individuals. The bioactivity was negatively correlated to the reproductive effort, minimal bioactivities coinciding with the period of embryogenesis and larval development. Our results fit the Optimal Defense Theory with an investment in the reproduction mainly shaping the secondary metabolism variability, and a less pronounced influence of other biotic (species interaction) and abiotic (temperature) factors.	[Ivanisevic, Julijana; Pedel, Laura; Ereskovsky, Alexander V.; Perez, Thierry] Aix Marseille Univ, Univ Mediterranee, Ctr Oceanol Marseille, CNRS UMR DIMAR 6540,Stn Marine Endoume, Marseille, France; [Ivanisevic, Julijana; Thomas, Olivier P.] Univ Nice Sophia Antipolis, Lab Chim Mol Bioact & Aromes, CNRS UMR 6001, Inst Chim Nice, Nice, France; [Penez, Nicolas; Culioli, Gerald] Univ Sud Toulon Var, Lab MAPIEM, EA 4323, La Garde, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Cote d'Azur	Ivanisevic, J (corresponding author), Aix Marseille Univ, Univ Mediterranee, Ctr Oceanol Marseille, CNRS UMR DIMAR 6540,Stn Marine Endoume, Marseille, France.	thierry.perez@univmed.fr	Ereskovsky, Alexander/W-1504-2019; Culioli, Gérald/C-2040-2013; Ivanisevic, Julijana/AAT-3901-2021; Ereskovsky, Alexander/B-3136-2013	Culioli, Gérald/0000-0001-5760-6394; Ivanisevic, Julijana/0000-0001-8267-2705; Ereskovsky, Alexander/0000-0003-1079-7204; THOMAS, Olivier/0000-0002-5708-1409	ECIMAR [ANR-06-BDIV-001-04]; European Marie Curie Mobility program [MIF1-CT-2006-040065]	ECIMAR; European Marie Curie Mobility program(European Commission)	This work was supported by the ECIMAR program (ANR-06-BDIV-001-04) and European Marie Curie Mobility program (MIF1-CT-2006-040065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo DA, 2007, J CHEM ECOL, V33, P1635, DOI 10.1007/s10886-007-9326-x; Baldacconi R, 2007, MAR BIOL, V152, P969, DOI 10.1007/s00227-007-0747-4; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Becerro MA, 2003, OECOLOGIA, V135, P91, DOI 10.1007/s00442-002-1138-7; Becerro MA, 1995, J CHEM ECOL, V21, P1931, DOI 10.1007/BF02033853; Becerro MA, 1997, HYDROBIOLOGIA, V355, P77, DOI 10.1023/A:1003019221354; Becerro MA, 1997, J CHEM ECOL, V23, P1527, DOI 10.1023/B:JOEC.0000006420.04002.2e; Bolser RC, 1996, ECOLOGY, V77, P2269, DOI 10.2307/2265730; Botsford JL, 2002, ATLA-ALTERN LAB ANIM, V30, P539, DOI 10.1177/026119290203000507; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Coma R, 2003, OIKOS, V101, P205, DOI 10.1034/j.1600-0706.2003.12028.x; Cronin G, 2001, CRC MAR SCI, P325; Dewick P.M., 2002, MED NATURAL PRODUCTS, Vsecond, P7; Duckworth AR, 2004, AQUACULTURE, V242, P237, DOI 10.1016/j.aquaculture.2004.08.046; Dworjanyn SA, 2006, OIKOS, V113, P13; Engel S, 2005, MAR ECOL PROG SER, V303, P133, DOI 10.3354/meps303133; Ferretti C, 2009, MAR ECOL-EVOL PERSP, V30, P327, DOI 10.1111/j.1439-0485.2008.00278.x; Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1111/j.1574-6941.2001.tb00888.x; HARVELL CD, 1993, MAR ECOL PROG SER, V93, P165, DOI 10.3354/meps093165; Hentschel U, 2001, FEMS MICROBIOL ECOL, V35, P305, DOI 10.1111/j.1574-6941.2001.tb00816.x; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Ivanisevic J, 2011, SEASONAL VARIABILITY, V37, P537; Ivanisevic J, 2011, METABOLOMICS, V7, P289, DOI 10.1007/s11306-010-0239-2; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; LABOREL J, 1959, CR HEBD ACAD SCI, V248, P2619; Laubier L, 1966, THESIS U PARIS 6 PAR; Leong W, 2010, MAR ECOL PROG SER, V406, P71, DOI 10.3354/meps08541; Lopez-Legentil S, 2006, J CHEM ECOL, V32, P2079, DOI 10.1007/s10886-006-9148-2; Lopez-Legentil S, 2007, MAR BIOL, V151, P293, DOI 10.1007/s00227-006-0472-4; Luter HM, 2007, MAR BIOL RES, V3, P312, DOI 10.1080/17451000701635102; Luter HM, 2010, BIOCHEM SYST ECOL, V38, P146, DOI 10.1016/j.bse.2009.12.024; MAIDA M, 1993, J CHEM ECOL, V19, P2285, DOI 10.1007/BF00979664; Marti R, 2005, SCI MAR, V69, P485; Marti R, 2004, MAR ECOL PROG SER, V282, P73, DOI 10.3354/meps282073; Marti R, 2003, J CHEM ECOL, V29, P1307, DOI 10.1023/A:1024201100811; Mercurio M, 2007, MAR BIOL, V151, P1491, DOI 10.1007/s00227-006-0584-x; Mohamed NM, 2008, APPL ENVIRON MICROB, V74, P1209, DOI 10.1128/AEM.02047-07; Muller WEG, 2004, MAR BIOL, V144, P19, DOI 10.1007/s00227-003-1184-7; Page M, 2005, J CHEM ECOL, V31, P1161, DOI 10.1007/s10886-005-4254-0; Pawlik JR, 2008, MAR ECOL PROG SER, V368, P137, DOI 10.3354/meps07615; Perez T, 2011, MAR ECOL-EVOL PERSP, V32, P174, DOI 10.1111/j.1439-0485.2011.00435.x; Prince EK, 2010, ANAL BIOANAL CHEM, V396, P193, DOI 10.1007/s00216-009-3162-5; Puyana M, 2002, DISS ABSTR INT B, V62, P5576; Sara M, 1973, SPONGIAIRES ANATOMIE, V3, P462; Schmitt S, INT SOC MIC IN PRESS, DOI [10.1038/ismej.2011.116, DOI 10.1038/ISMEJ.2011.116]; Sipkema D, 2005, MAR BIOTECHNOL, V7, P142, DOI 10.1007/s10126-004-0405-5; Steel HC, 2002, APMIS, V110, P158, DOI 10.1034/j.1600-0463.2002.100206.x; Takken W, 2006, WAG UR FRON, V16, P1; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Taylor MW, 2005, ENVIRON MICROBIOL, V7, P419, DOI 10.1111/j.1462-2920.2004.00711.x; Thacker RW, 1998, ECOLOGY, V79, P1740; THOMPSON JE, 1985, MAR BIOL, V88, P23, DOI 10.1007/BF00393039; Turon X, 1996, OECOLOGIA, V108, P351, DOI 10.1007/BF00334661; Turon X, 1998, FUNCT ECOL, V12, P631, DOI 10.1046/j.1365-2435.1998.00225.x; Turon X, 1996, OIKOS, V75, P33, DOI 10.2307/3546318; Turon X, 2009, SCI MAR, V73, P387, DOI 10.3989/scimar.2009.73n2387; Uriz MJ, 1996, J EXP MAR BIOL ECOL, V205, P187, DOI 10.1016/S0022-0981(96)02609-3; URIZ MJ, 1995, MAR ECOL PROG SER, V124, P159, DOI 10.3354/meps124159; Viant MR, 2009, METABOLOMICS, V5, P1, DOI 10.1007/s11306-009-0157-3; Vishnyakov AE, 2009, MAR BIOL, V156, P1625, DOI 10.1007/s00227-009-1198-x; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2011, MAR BIOTECHNOL, V13, P296, DOI 10.1007/s10126-010-9300-4; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Weis B, 1996, BIOCHEM SYST ECOL, V24, P1, DOI 10.1016/0305-1978(95)00101-8; Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5; Wishart DS, 2007, BRIEF BIOINFORM, V8, P279, DOI 10.1093/bib/bbm030; ZABALA M, 1989, Scientia Marina, V53, P3	67	28	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28059	10.1371/journal.pone.0028059	http://dx.doi.org/10.1371/journal.pone.0028059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132209	Green Published, gold			2022-12-25	WOS:000298162000064
J	Poupin, N; Bos, C; Mariotti, F; Huneau, JF; Tome, D; Fouillet, H				Poupin, Nathalie; Bos, Cecile; Mariotti, Francois; Huneau, Jean-Francois; Tome, Daniel; Fouillet, Helene			The Nature of the Dietary Protein Impacts the Tissue-to-Diet N-15 Discrimination Factors in Laboratory Rats	PLOS ONE			English	Article							NITROGEN ISOTOPES; STABLE CARBON; KINETIC FRACTIONATION; FACTORS DELTA-N-15; TEMPORAL VARIATION; HAIR PROTEIN; METABOLISM; DELTA-C-13; BALANCE; ACID	Due to the existence of isotope effects on some metabolic pathways of amino acid and protein metabolism, animal tissues are N-15-enriched relative to their dietary nitrogen sources and this N-15 enrichment varies among different tissues and metabolic pools. The magnitude of the tissue-to-diet discrimination (Delta N-15) has also been shown to depend on dietary factors. Since dietary protein sources affect amino acid and protein metabolism, we hypothesized that they would impact this discrimination factor, with selective effects at the tissue level. To test this hypothesis, we investigated in rats the influence of a milk or soy protein-based diet on Delta N-15 in various nitrogen fractions (urea, protein and non-protein fractions) of blood and tissues, focusing on visceral tissues. Regardless of the diet, the different protein fractions of blood and tissues were generally N-15-enriched relative to their non-protein fraction and to the diet (Delta N-15. 0), with large variations in the Delta N-15 between tissue proteins. Delta N-15 values were markedly lower in tissue proteins of rats fed milk proteins compared to those fed soy proteins, in all sampled tissues except in the intestine, and the amplitude of Delta N-15 differences between diets differed between tissues. Both between-tissue and between-diet Delta N-15 differences are probably related to modulations of the relative orientation of dietary and endogenous amino acids in the different metabolic pathways. More specifically, the smaller Delta N-15 values observed in tissue proteins with milk than soy dietary protein may be due to a slightly more direct channeling of dietary amino acids for tissue protein renewal and to a lower recycling of amino acids through fractionating pathways. In conclusion, the present data indicate that natural Delta N-15 of tissue are sensitive markers of the specific subtle regional modifications of the protein and amino acid metabolism induced by the protein dietary source.	[Poupin, Nathalie; Bos, Cecile; Mariotti, Francois; Huneau, Jean-Francois; Tome, Daniel; Fouillet, Helene] INRA, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France; [Poupin, Nathalie; Bos, Cecile; Mariotti, Francois; Huneau, Jean-Francois; Tome, Daniel; Fouillet, Helene] AgroParisTech, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Poupin, N (corresponding author), INRA, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France.	Helene.Fouillet@agroparistech.fr	Fouillet, Helene/K-7314-2012; Mariotti, François/F-9651-2017	Fouillet, Helene/0000-0003-3932-251X; Mariotti, François/0000-0002-4516-3853; Poupin, Nathalie/0000-0002-3393-1405	French Ministry for Research	French Ministry for Research(Ministry of Research, France)	Nathalie Poupin is supported by a doctoral fellowship from the French Ministry for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 2000, BIOGEOCHEMICAL APPRO, P243; Arneson LS, 2005, CAN J ZOOL, V83, P989, DOI 10.1139/Z05-083; Arneson LS, 2006, CAN J ZOOL, V84, P992, DOI 10.1139/Z06-081; Balter V, 2006, OECOLOGIA, V147, P212, DOI 10.1007/s00442-005-0263-5; Barboza PS, 2006, PHYSIOL BIOCHEM ZOOL, V79, P628, DOI 10.1086/502811; Blakey GE, 1997, J PHARMACOKINET BIOP, V25, P277, DOI 10.1023/A:1025771608474; Boutry C, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-52; Caut S, 2008, FUNCT ECOL, V22, P255, DOI 10.1111/j.1365-2435.2007.01360.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; del Rio CM, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P141; DeMots RL, 2010, CAN J ZOOL, V88, P961, DOI 10.1139/Z10-063; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Deutz NEP, 1998, J NUTR, V128, P2435, DOI 10.1093/jn/128.12.2435; Fouillet H, 2002, J NUTR, V132, p3208S, DOI 10.1093/jn/131.10.3208S; Fouillet H, 2002, J NUTR, V132, P125, DOI 10.1093/jn/132.1.125; Fouillet H, 2009, AM J PHYSIOL-REG I, V297, pR1691, DOI 10.1152/ajpregu.00281.2009; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; GAEBLER OH, 1966, CAN J BIOCHEM CELL B, V44, P1249, DOI 10.1139/o66-142; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Gaye-Siessegger J, 2004, NATURWISSENSCHAFTEN, V91, P90, DOI 10.1007/s00114-003-0496-2; HAYES JM, 2001, FRACTIONATION CARBON, P225; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Kurle CM, 2009, FUNCT ECOL, V23, P733, DOI 10.1111/j.1365-2435.2009.01553.x; Lacroix M, 2004, AM J PHYSIOL-REG I, V287, pR934, DOI 10.1152/ajpregu.00100.2004; Lohrke B, 2001, BRIT J NUTR, V85, P447, DOI 10.1079/BJN2000291; MacAvoy SE, 2005, CAN J ZOOL, V83, P631, DOI 10.1139/Z05-038; MacAvoy SE, 2006, OECOLOGIA, V150, P190, DOI 10.1007/s00442-006-0522-0; MACKO SA, 1986, GEOCHIM COSMOCHIM AC, V50, P2143, DOI 10.1016/0016-7037(86)90068-2; Mekota AM, 2006, RAPID COMMUN MASS SP, V20, P1604, DOI 10.1002/rcm.2477; Morens C, 2000, J NUTR, V130, P2312, DOI 10.1093/jn/130.9.2312; Morens C, 2003, J NUTR, V133, P2733, DOI 10.1093/jn/133.9.2733; Morens C, 2001, AM J PHYSIOL-ENDOC M, V281, pE826, DOI 10.1152/ajpendo.2001.281.4.E826; O'Brien DM, 2009, AM J CLIN NUTR, V89, P913, DOI 10.3945/ajcn.2008.27054; Petzke KJ, 2005, J NUTR, V135, P1515; Petzke KJ, 2006, RAPID COMMUN MASS SP, V20, P2973, DOI 10.1002/rcm.2695; Ponsard S, 1999, RAPID COMMUN MASS SP, V13, P1305; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Schoeller DA, 1999, J ARCHAEOL SCI, V26, P667, DOI 10.1006/jasc.1998.0391; Seila AC, 2005, BIOCHEMISTRY-US, V44, P4018, DOI 10.1021/bi047742f; Sharp PE, 1998, LAB RAT LAB ANIMAL P; Sick H, 1997, Z ERNAHRUNGSWISS, V36, P340, DOI 10.1007/BF01617819; SILFER JA, 1992, CHEM GEOL, V101, P211, DOI 10.1016/0009-2541(92)90003-N; Smith K, 1996, BAILLIERE CLIN ENDOC, V10, P469, DOI 10.1016/S0950-351X(96)80651-3; Sponheimer M, 2003, J ARCHAEOL SCI, V30, P1649, DOI 10.1016/S0305-4403(03)00066-9; STEELE KW, 1978, J AGR SCI-CAMBRIDGE, V90, P7, DOI 10.1017/S002185960004853X; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Waters-Rist AL, 2010, INT J OSTEOARCHAEOL, V20, P172, DOI 10.1002/oa.1017; Waynforth H. B., 1980, EXPT SURG TECHNIQUE; YONEYAMA T, 1983, Radioisotopes, V32, P330	55	47	47	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28046	10.1371/journal.pone.0028046	http://dx.doi.org/10.1371/journal.pone.0028046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132207	Green Published, gold, Green Submitted			2022-12-25	WOS:000297792400036
J	Alhede, M; Kragh, KN; Qvortrup, K; Allesen-Holm, M; van Gennip, M; Christensen, LD; Jensen, PO; Nielsen, AK; Parsek, M; Wozniak, D; Molin, S; Tolker-Nielsen, T; Hoiby, N; Givskov, M; Bjarnsholt, T				Alhede, Morten; Kragh, Kasper Norskov; Qvortrup, Klaus; Allesen-Holm, Marie; van Gennip, Maria; Christensen, Louise D.; Jensen, Peter Ostrup; Nielsen, Anne K.; Parsek, Matt; Wozniak, Dan; Molin, Soren; Tolker-Nielsen, Tim; Hoiby, Niels; Givskov, Michael; Bjarnsholt, Thomas			Phenotypes of Non-Attached Pseudomonas aeruginosa Aggregates Resemble Surface Attached Biofilm	PLOS ONE			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; BACTERIAL BIOFILMS; HOST-DEFENSE; TOBRAMYCIN; MECHANISMS; TOLERANCE; VARIANTS; GENES; PSL; EXOPOLYSACCHARIDE	For a chronic infection to be established, bacteria must be able to cope with hostile conditions such as low iron levels, oxidative stress, and clearance by the host defense, as well as antibiotic treatment. It is generally accepted that biofilm formation facilitates tolerance to these adverse conditions. However, microscopic investigations of samples isolated from sites of chronic infections seem to suggest that some bacteria do not need to be attached to surfaces in order to establish chronic infections. In this study we employed scanning electron microscopy, confocal laser scanning microscopy, RT-PCR as well as traditional culturing techniques to study the properties of Pseudomonas aeruginosa aggregates. We found that non-attached aggregates from stationary-phase cultures have comparable growth rates to surface attached biofilms. The growth rate estimations indicated that, independently of age, both aggregates and flow-cell biofilm had the same slow growth rate as a stationary phase shaking cultures. Internal structures of the aggregates matrix components and their capacity to survive otherwise lethal treatments with antibiotics (referred to as tolerance) and resistance to phagocytes were also found to be strikingly similar to flow-cell biofilms. Our data indicate that the tolerance of both biofilms and non-attached aggregates towards antibiotics is reversible by physical disruption. We provide evidence that the antibiotic tolerance is likely to be dependent on both the physiological states of the aggregates and particular matrix components. Bacterial surface-attachment and subsequent biofilm formation are considered hallmarks of the capacity of microbes to cause persistent infections. We have observed non-attached aggregates in the lungs of cystic fibrosis patients; otitis media; soft tissue fillers and non-healing wounds, and we propose that aggregated cells exhibit enhanced survival in the hostile host environment, compared with non-aggregated bacterial populations.	[Alhede, Morten; Kragh, Kasper Norskov; Allesen-Holm, Marie; van Gennip, Maria; Christensen, Louise D.; Nielsen, Anne K.; Tolker-Nielsen, Tim] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Qvortrup, Klaus] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Parsek, Matt; Givskov, Michael; Bjarnsholt, Thomas] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Jensen, Peter Ostrup; Hoiby, Niels] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Wozniak, Dan; Bjarnsholt, Thomas] Ohio State Univ, Div Infect Dis, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Molin, Soren] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark	University of Copenhagen; University of Copenhagen; University of Washington; University of Washington Seattle; Rigshospitalet; University of Copenhagen; University System of Ohio; Ohio State University; Technical University of Denmark	Alhede, M (corresponding author), Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	tbjarnsholt@sund.ku.dk	Jensen, Peter Ostrup/HGD-7725-2022; Hultqvist, Louise/M-1352-2015; Bjarnsholt, Thomas/ABD-6178-2021; Kragh, Kasper Nørskov/AAZ-8432-2021	Hultqvist, Louise/0000-0003-0256-892X; Kragh, Kasper Nørskov/0000-0002-7662-9118; Bjarnsholt, Thomas/0000-0002-8003-7414; Tolker-Nielsen, Tim/0000-0002-9751-474X; Qvortrup, Klaus/0000-0001-8811-0260; Jensen, Peter Ostrup/0000-0003-1648-7186; Alhede, Maria/0000-0001-6721-2516; Givskov, Michael/0000-0001-5004-8609; Molin, Soren/0000-0002-7973-2639; Hoiby, Niels/0000-0002-1347-725X	Villum Foundation; Novo Nordic Foundation	Villum Foundation(Villum Fonden); Novo Nordic Foundation(Novo Nordisk Foundation)	MG was supported by the Villum Foundation and Novo Nordic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2002, J CLIN MICROBIOL, V40, P4172, DOI 10.1128/JCM.40.11.4172-4179.2002; Aendekerk S, 2005, MICROBIOL-SGM, V151, P1113, DOI 10.1099/mic.0.27631-0; Alhede M, 2009, MICROBIOL-SGM, V155, P3500, DOI 10.1099/mic.0.031443-0; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Barclay ML, 1996, J ANTIMICROB CHEMOTH, V37, P1155, DOI 10.1093/jac/37.6.1155; Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P373, DOI 10.1099/mic.0.27463-0; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Bossier P, 1996, APPL MICROBIOL BIOT, V45, P1, DOI 10.1007/s002530050640; Christensen LH, 2009, DERMATOL SURG, V35, P1612, DOI 10.1111/j.1524-4725.2009.01338.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Herrmann G, 2010, J INFECT DIS, V202, P1585, DOI 10.1086/656788; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Homoe P, 2009, EUR ARCH OTO-RHINO-L, V266, P1533, DOI 10.1007/s00405-009-0940-9; Hoyle B D, 1991, Prog Drug Res, V37, P91; Jackson KD, 2004, J BACTERIOL, V186, P4466, DOI 10.1128/JB.186.14.4466-4475.2004; JENSEN ET, 1993, MICROB PATHOGENESIS, V15, P377, DOI 10.1006/mpat.1993.1087; JENSEN ET, 1992, APMIS, V100, P727, DOI 10.1111/j.1699-0463.1992.tb03991.x; JENSEN ET, 1990, INFECT IMMUN, V58, P2383, DOI 10.1128/IAI.58.7.2383-2385.1990; Jensen PO, 2007, MICROBIOL-SGM, V153, P1329, DOI 10.1099/mic.0.2006/003863-0; Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329; KHARAZMI A, 1991, IMMUNOL LETT, V30, P201, DOI 10.1016/0165-2478(91)90026-7; Kirisits MJ, 2005, APPL ENVIRON MICROB, V71, P4809, DOI 10.1128/AEM.71.8.4809-4821.2005; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Ma LY, 2007, J BACTERIOL, V189, P8353, DOI 10.1128/JB.00620-07; Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Matsukawa M, 2004, J BACTERIOL, V186, P4449, DOI 10.1128/JB.186.14.4449-4456.2004; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Pamp SJ, 2008, MOL MICROBIOL, V68, P223, DOI 10.1111/j.1365-2958.2008.06152.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; QVORTRUP K, 1995, ANN OTO RHINOL LARYN, V104, P120, DOI 10.1177/000348949510400207; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Xu KD, 1998, APPL ENVIRON MICROB, V64, P4035; Yang L, 2008, J BACTERIOL, V190, P2767, DOI 10.1128/JB.01581-07	47	176	178	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27943	10.1371/journal.pone.0027943	http://dx.doi.org/10.1371/journal.pone.0027943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132176	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789900036
J	Ehlers, BK				Ehlers, Bodil K.			Soil Microorganisms Alleviate the Allelochemical Effects of a Thyme Monoterpene on the Performance of an Associated Grass Species	PLOS ONE			English	Article							PLANTS	Background: Plant allelochemicals released into the soil can significantly impact the performance of associated plant species thereby affecting their competitive ability. Soil microbes can potentially affect the interaction between plant and plant chemicals by degrading the allelochemicals. However, most often plant-plant chemical interactions are studied using filter paper bioassays examining the pair-wise interaction between a plant and a plant chemical, not taking into account the potential role of soil microorganisms. Methodology/Principal findings: To explore if the allelopathic effects on a grass by the common thyme monoterpene "carvacrol" are affected by soil microorganisms. Seedlings of the grass Agrostis capillaris originating from 3 different thyme sites were raised in the greenhouse. Seedlings were grown under four different soil treatments in a 2*2 fully factorial experiment. The monoterpene carvacrol was either added to standard greenhouse soil or left out, and soil was either sterilized (no soil microorganisms) or not (soil microorganisms present in soil). The presence of carvacrol in the soil strongly increased mortality of Agrostis plants, and this increase was highest on sterile soil. Plant biomass was reduced on soil amended with carvacrol, but only when the soil was also sterilized. Plants originating from sites where thyme produces essential oils containing mostly carvacrol had higher survival on soil treated with that monoterpene than plants originating from a site where thyme produced different types of terpenes, suggesting an adaptive response to the locally occurring terpene. Conclusions/Significance: The study shows that presence of soil microorganisms can alleviate the negative effect of a common thyme monoterpene on the performance of an associated plant species, emphasizing the role of soil microbes in modulating plant-plant chemical interactions.	Univ So Denmark, Inst Biol, Odense, Denmark	University of Southern Denmark	Ehlers, BK (corresponding author), Univ So Denmark, Inst Biol, Odense, Denmark.	behlers@biology.sdu.dk	Ehlers, Bodil/J-5609-2013	Ehlers, Bodil/0000-0002-4712-5025	Danish National Science Research Foundation	Danish National Science Research Foundation(Danmarks Grundforskningsfond)	The study was financed the Danish National Science Research Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Ehlers BK, 2004, OECOLOGIA, V141, P511, DOI 10.1007/s00442-004-1663-7; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Groendahl E, 2008, J ESSENT OIL RES, V20, P40, DOI 10.1080/10412905.2008.9699417; Grondahl E, 2008, J ECOL, V96, P981, DOI 10.1111/j.1365-2745.2008.01407.x; Inderjit, 1996, BOT REV, V62, P186, DOI 10.1007/BF02857921; Inderjit, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002536; Inderjit, 2005, PLANT SOIL, V274, P227, DOI 10.1007/s11104-004-0159-x; Jensen CG, 2010, OECOLOGIA, V162, P1017, DOI 10.1007/s00442-009-1501-z; KALEMBA D, 2003, CURRENT MED CHEM, V17; Kaur H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004700; LANGENHEIM JH, 1994, J CHEM ECOL, V20, P1223, DOI 10.1007/BF02059809; Lynch Michael, 1998; Paavolainen L, 1998, PLANT SOIL, V205, P147, DOI 10.1023/A:1004335419358; Perry LG, 2007, J CHEM ECOL, V33, P2337, DOI 10.1007/s10886-007-9383-1; SAS Institute, 2008, JMP US GUID; Stahl-Biskup E., 2002, THYME GENUS THYMUS E, P75; TARAYRE M, 1995, OECOLOGIA, V101, P110, DOI 10.1007/BF00328907; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; Vivanco JM, 2004, ECOL LETT, V7, P285, DOI 10.1111/j.1461-0248.2004.00576.x; Vokou D, 2003, J CHEM ECOL, V29, P2281, DOI 10.1023/A:1026274430898; VOKOU D, 1988, PEDOBIOLOGIA, V31, P413; Vokou D, 2002, J CHEM ECOL, V28, P755, DOI 10.1023/A:1015236709767; WHITE CS, 1991, BIOGEOCHEMISTRY, V12, P43, DOI 10.1007/BF00002625; WILT FM, 1993, J CHEM ECOL, V19, P185, DOI 10.1007/BF00993688	27	40	46	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e26321	10.1371/journal.pone.0026321	http://dx.doi.org/10.1371/journal.pone.0026321			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22125596	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555800004
J	Gupta, S; Mishra, K; Surolia, A; Banerjee, K				Gupta, Sakshi; Mishra, Kanchan; Surolia, Avadhesha; Banerjee, Kakoli			Suppressor of Cytokine Signalling-6 Promotes Neurite Outgrowth via JAK2/STAT5-Mediated Signalling Pathway, Involving Negative Feedback Inhibition	PLOS ONE			English	Article							GROWTH-FACTOR-I; NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; NEURONAL DIFFERENTIATION; SOCS PROTEINS; INSULIN-RESISTANCE; TRANSGENIC MICE; IGF-I; RECEPTOR; ACTIVATION	Background: Suppressors of cytokine signalling (SOCS) protein family are key regulators of cellular responses to cytokines and play an important role in the nervous system. The SOCS6 protein, a less extensively studied SOCS family member, has been shown to induce insulin resistance in the retina and promote survival of the retinal neurons. But no reports are available about the role of SOCS6 in neuritogenesis. In this study, we examined the role of SOCS6 in neurite outgrowth and neuronal cell signalling. Methodology/Principal Findings: The effect of SOCS6 in neural stem cells differentiation was studied in neural stem cells and PC12 cell line. Highly elevated levels of SOCS6 were found upon neural cell differentiation both at the mRNA and protein level. Furthermore, SOCS6 over-expression lead to increase in neurite outgrowth and degree of branching, whereas SOCS6 knockdown with specific siRNAs, lead to a significant decrease in neurite initiation and extension. Insulin-like growth factor-1 (IGF-1) stimulation which enhanced neurite outgrowth of neural cells resulted in further enhancement of SOCS6 expression. Jak/Stat (Janus Kinase/Signal Transducer And Activator Of Transcription) pathway was found to be involved in the SOCS6 mediated neurite outgrowth. Bioinformatics study revealed presence of putative Stat binding sites in the SOCS6 promoter region. Transcription factors Stat5a and Stat5b were involved in SOCS6 gene upregulation leading to neuronal differentiation. Following differentiation, SOCS6 was found to form a ternary complex with IGFR (Insulin Like Growth Factor-1 Receptor) and JAK2 which acted in a negative feedback loop to inhibit pStat5 activation. Conclusion/Significance: The current paradigm for the first time states that SOCS6, a SOCS family member, plays an important role in the process of neuronal differentiation. These findings define a novel molecular mechanism for Jak2/Stat5 mediated SOCS6 signalling.	[Gupta, Sakshi; Mishra, Kanchan; Banerjee, Kakoli] Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India; [Surolia, Avadhesha] Natl Inst Immunol, Ctr Mol Med, New Delhi 110067, India; [Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Science (IISC) - Bangalore	Gupta, S (corresponding author), Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India.	surolia@nii.res.in; kakolib@yahoo.com	Mishra, Kanchan/ABC-3566-2020	Mishra, Kanchan/0000-0001-8499-9971	Department of Biotechnology, Government of India; National Institute of Immunology, New Delhi, India; Council of Scientific and Industrial Research, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); National Institute of Immunology, New Delhi, India; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Department of Biotechnology, Government of India and National Institute of Immunology, New Delhi, India. Dr. Gupta was also supported by a Council of Scientific and Industrial Research Fellowship, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic Y, 2001, J NEUROSCI, V21, P7194, DOI 10.1523/JNEUROSCI.21-18-07194.2001; Balasubramaniyan V, 2004, STEM CELLS, V22, P878, DOI 10.1634/stemcells.22-6-878; Bayle J, 2006, FEBS LETT, V580, P2609, DOI 10.1016/j.febslet.2006.03.093; BONDY CA, 1991, J NEUROSCI, V11, P3442; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Brooker GJF, 2000, J NEUROSCI RES, V59, P332, DOI 10.1002/(SICI)1097-4547(20000201)59:3<332::AID-JNR6>3.0.CO;2-2; Byts N, 2008, CELL DEATH DIFFER, V15, P783, DOI 10.1038/cdd.2008.1; Cao F, 2006, J NEUROCHEM, V98, P459, DOI 10.1111/j.1471-4159.2006.03890.x; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dey BR, 1998, J BIOL CHEM, V273, P24095, DOI 10.1074/jbc.273.37.24095; Dey BR, 2000, BIOCHEM BIOPH RES CO, V278, P38, DOI 10.1006/bbrc.2000.3762; DRAGO J, 1991, P NATL ACAD SCI USA, V88, P2199, DOI 10.1073/pnas.88.6.2199; GarciaSegura LM, 1997, J NEUROCYTOL, V26, P479, DOI 10.1023/A:1018581407804; Goldshmit Y, 2004, J BIOL CHEM, V279, P16349, DOI 10.1074/jbc.M312873200; Goldshmit Y, 2004, EUR J NEUROSCI, V20, P2260, DOI 10.1111/j.1460-9568.2004.03698.x; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hansen JA, 1999, MOL ENDOCRINOL, V13, P1832, DOI 10.1210/me.13.11.1832; Himpe E, 2009, BIOFACTORS, V35, P76, DOI 10.1002/biof.20; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Hwang MN, 2007, MOL CELLS, V23, P94; Hwang MN, 2007, BIOCHEM BIOPH RES CO, V354, P184, DOI 10.1016/j.bbrc.2006.12.175; Krebs DL, 2000, J CELL SCI, V113, P2813; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; Kyba M, 2003, P NATL ACAD SCI USA, V100, P11904, DOI 10.1073/pnas.1734140100; Lai RH, 2010, CANCER LETT, V288, P75, DOI 10.1016/j.canlet.2009.06.025; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Lee JY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001639; Li L, 2004, J BIOL CHEM, V279, P34107, DOI 10.1074/jbc.M312672200; Liu JL, 1998, MOL ENDOCRINOL, V12, P1452, DOI 10.1210/me.12.9.1452; Liu XB, 2008, DIABETES, V57, P1651, DOI 10.2337/db07-1761; Markham K, 2007, MOL CELL NEUROSCI, V35, P272, DOI 10.1016/j.mcn.2007.03.001; Masuhara M, 1997, BIOCHEM BIOPH RES CO, V239, P439, DOI 10.1006/bbrc.1997.7484; Mooney RA, 2001, J BIOL CHEM, V276, P25889, DOI 10.1074/jbc.M010579200; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Nakasato M, 2006, BIOL REPROD, V75, P508, DOI 10.1095/biolreprod.105.047860; Narita M, 2006, NEUROPSYCHOPHARMACOL, V31, P2476, DOI 10.1038/sj.npp.1301007; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Ning HX, 2008, DIFFERENTIATION, V76, P488, DOI 10.1111/j.1432-0436.2007.00240.x; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; O'Sullivan LA, 2007, MOL IMMUNOL, V44, P2497, DOI 10.1016/j.molimm.2006.11.025; Piessevaux J, 2006, J BIOL CHEM, V281, P32953, DOI 10.1074/jbc.M600776200; Polizzotto MN, 2000, J COMP NEUROL, V423, P348; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Scott HJ, 2006, BRAIN RES, V1067, P138, DOI 10.1016/j.brainres.2005.10.032; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Shanley DK, 2006, BRAIN RES, V1067, P85, DOI 10.1016/j.brainres.2005.10.008; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Turnley AM, 2005, TRENDS ENDOCRIN MET, V16, P53, DOI 10.1016/j.tem.2005.01.006; Turnley AM, 2001, NEUROREPORT, V12, P3443, DOI 10.1097/00001756-200111160-00013; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wang LH, 1999, J IMMUNOL, V162, P3897; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Yadav A, 2005, J BIOL CHEM, V280, P31830, DOI 10.1074/jbc.M501316200; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Ye Ping, 1996, Developmental Brain Research, V95, P44, DOI 10.1016/0165-3806(96)00492-0; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9; Zhu PX, 2008, FASEB J, V22, P3866, DOI 10.1096/fj.08-105908; Zong CS, 2000, J BIOL CHEM, V275, P15099, DOI 10.1074/jbc.M000089200	62	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2011	6	11							e26674	10.1371/journal.pone.0026674	http://dx.doi.org/10.1371/journal.pone.0026674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HZ	22125600	Green Published, Green Submitted, gold			2022-12-25	WOS:000297555800008
J	Kappo, MA; AB, E; Hassem, F; Atkinson, RA; Faro, A; Muleya, V; Mulaudzi, T; Poole, JO; McKenzie, JM; Chibi, M; Moolman-Smook, JC; Rees, DJG; Pugh, DJR				Kappo, Mautin A.; AB, Eiso; Hassem, Faqeer; Atkinson, R. Andrew; Faro, Andrew; Muleya, Victor; Mulaudzi, Takalani; Poole, John O.; McKenzie, Jean M.; Chibi, Moredreck; Moolman-Smook, Joanna C.; Rees, D. Jasper G.; Pugh, David J. R.			Solution Structure of RING Finger-like Domain of Retinoblastoma-binding Protein-6 (RBBP6) Suggests It Functions as a U-box	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASES; TORSION ANGLE DYNAMICS; MESSENGER-RNA; P2P-R PROTEIN; INDUCED APOPTOSIS; CRYSTAL-STRUCTURE; QUALITY-CONTROL; NMR RELAXATION; P44 SUBUNIT; CHIP	Retinoblastoma-binding protein-6 (RBBP6) plays a facilitating role, through its RING finger-like domain, in the ubiquitination of p53 by Hdm2 that is suggestive of E4-like activity. Although the presence of eight conserved cysteine residues makes it highly probable that the RING finger-like domain coordinates two zinc ions, analysis of the primary sequence suggests an alternative classification as a member of the U-box family, the members of which do not bind zinc ions. We show here that despite binding two zinc ions, the domain adopts a homodimeric structure highly similar to those of a number of U-boxes. Zinc ions could be replaced by cadmium ions without significantly disrupting the structure or the stability of the domain, although the rate of substitution was an order of magnitude slower than any previous measurement, suggesting that the structure is particularly stable, a conclusion supported by the high thermal stability of the domain. A hallmark of U-box-containing proteins is their association with chaperones, with which they cooperate in eliminating irretrievably unfolded proteins by tagging them for degradation by the proteasome. Using a yeast two-hybrid screen, we show that RBBP6 interacts with chaperones Hsp70 and Hsp40 through its N-terminal ubiquitin-like domain. Taken together with the structural similarities to U-box-containing proteins, our data suggest that RBBP6 plays a role in chaperone-mediated ubiquitination and possibly in protein quality control.	[Kappo, Mautin A.; Hassem, Faqeer; Faro, Andrew; Muleya, Victor; Mulaudzi, Takalani; Poole, John O.; Chibi, Moredreck; Rees, D. Jasper G.; Pugh, David J. R.] Univ Western Cape, Dept Biotechnol, ZA-7535 Bellville, South Africa; [AB, Eiso] ZoBio BV, NL-2333 CC Leiden, Netherlands; [Atkinson, R. Andrew] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [McKenzie, Jean M.] Univ Stellenbosch, Cent Analyt Facil, NMR Lab, ZA-7602 Matieland, South Africa; [Moolman-Smook, Joanna C.] Univ Stellenbosch, Fac Hlth Sci, ZA-7505 Tygerberg, South Africa	University of the Western Cape; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Stellenbosch University; Stellenbosch University	Pugh, DJR (corresponding author), Univ Western Cape, Dept Biotechnol, Private Bag X17, ZA-7535 Bellville, South Africa.	dpugh@uwc.ac.za	Muleya, Victor/CAI-0188-2022; Rees, Jasper/D-9672-2011; Atkinson, Robert Andrew/ABE-8068-2020; AB, Eiso/H-8177-2012; Rees, David Jasper Gilbert/AAZ-8073-2020	Muleya, Victor/0000-0003-2315-4953; Rees, Jasper/0000-0003-3321-1325; Atkinson, Robert Andrew/0000-0002-3645-9492; Rees, David Jasper Gilbert/0000-0003-3321-1325; AB, Eiso/0000-0002-5758-0435	National Research Foundation of South Africa; Medical Research Council of South Africa; CNRS; Oppenheimer Memorial Trust	National Research Foundation of South Africa(National Research Foundation - South Africa); Medical Research Council of South Africa(South African Medical Research Council); CNRS(Centre National de la Recherche Scientifique (CNRS)); Oppenheimer Memorial Trust	This work was supported in part by the National Research Foundation of South Africa and the Medical Research Council of South Africa.; Recipient of grants from National Research Foundation of South Africa and the CNRS.; Recipient of sabbatical funding from The Oppenheimer Memorial Trust.	Andersen P, 2004, J BIOL CHEM, V279, P40053, DOI 10.1074/jbc.M405057200; Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; Atkinson RA, 2004, PROG NUCL MAG RES SP, V44, P141, DOI 10.1016/j.pnmrs.2004.01.001; Bombarda E, 2001, J MOL BIOL, V310, P659, DOI 10.1006/jmbi.2001.4770; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Caffrey DR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-381; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chibi M, 2008, J MOL BIOL, V384, P908, DOI 10.1016/j.jmb.2008.09.060; Chou CC, 2003, J BIOL CHEM, V278, P30311, DOI 10.1074/jbc.M304563200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Daragan VA, 1997, PROG NUCL MAG RES SP, V31, P63, DOI 10.1016/S0079-6565(97)00006-X; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dudev T, 2003, J AM CHEM SOC, V125, P3168, DOI 10.1021/ja0209722; Dudev T, 2002, J AM CHEM SOC, V124, P6759, DOI 10.1021/ja012620l; Gao S, 2003, J CELL PHYSIOL, V197, P445, DOI 10.1002/jcp.10381; Gao SZ, 2002, J CELL PHYSIOL, V193, P199, DOI 10.1002/jcp.10163; Gao SZ, 2002, J CELL PHYSIOL, V191, P145, DOI 10.1002/jcp.10084; Goodfellow BJ, 1998, INORG CHIM ACTA, V273, P279, DOI 10.1016/S0020-1693(97)06074-X; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hanzawa H, 2001, J BIOL CHEM, V276, P10185, DOI 10.1074/jbc.M009298200; Harris R. K., 1978, NMR PERIOD TABLE, P263; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hatakeyama S, 2004, GENES CELLS, V9, P533, DOI 10.1111/j.1356-9597.2004.00742.x; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Houben K, 2005, J MOL BIOL, V349, P621, DOI 10.1016/j.jmb.2005.04.007; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones C, 2006, GENETICS, V173, P793, DOI 10.1534/genetics.106.056762; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kellenberger E, 2005, J BIOL CHEM, V280, P20785, DOI 10.1074/jbc.M412999200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li L, 2007, P NATL ACAD SCI USA, V104, P7951, DOI 10.1073/pnas.0701916104; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Nordquist KA, 2010, BIOCHEMISTRY-US, V49, P347, DOI 10.1021/bi901620v; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Pugh DJR, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-1; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Scott RE, 2003, J CELL BIOCHEM, V90, P6, DOI 10.1002/jcb.10618; Scott RE, 2002, ANTICANCER RES, V22, P3837; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Simons A, 1997, ONCOGENE, V14, P145, DOI 10.1038/sj.onc.1200825; Stoilov P, 2002, TRENDS BIOCHEM SCI, V27, P495, DOI 10.1016/S0968-0004(02)02189-8; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; Vitorino M, 2007, J MOL BIOL, V368, P473, DOI 10.1016/j.jmb.2007.02.020; Vo LTA, 2001, MOL CELL BIOL, V21, P8346, DOI 10.1128/MCB.21.24.8346-8356.2001; Wan T, 2004, BLOOD, V103, P1747, DOI 10.1182/blood-2003-08-2828; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Witte MM, 1997, P NATL ACAD SCI USA, V94, P1212, DOI 10.1073/pnas.94.4.1212; Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yoshitake Y, 2004, CLIN CANCER RES, V10, P6437, DOI 10.1158/1078-0432.CCR-04-0841; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711	61	12	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7146	7158		10.1074/jbc.M110.217059	http://dx.doi.org/10.1074/jbc.M110.217059			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22130672	Green Published, hybrid			2022-12-25	WOS:000301060200018
J	Yuen, B; Boncompagni, S; Feng, W; Yang, TZ; Lopez, JR; Matthaei, KI; Goth, SR; Protasi, F; Franzini-Armstrong, C; Allen, PD; Pessah, IN				Yuen, Benjamin; Boncompagni, Simona; Feng, Wei; Yang, Tianzhong; Lopez, Jose R.; Matthaei, Klaus I.; Goth, Samuel R.; Protasi, Feliciano; Franzini-Armstrong, Clara; Allen, Paul D.; Pessah, Isaac N.			Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage	FASEB JOURNAL			English	Article						Ca2+ regulation; ryanodine receptor mutation; anesthesia; heat stress	KNOCK-IN MICE; TYPE-1 RYANODINE RECEPTOR; CALCIUM-RELEASE UNITS; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; CA2+ RELEASE; INTERDOMAIN INTERACTIONS; CONGENITAL MYOPATHY; POSTULATED ROLE; HEAT-STROKE	Mutation T4825I in the type 1 ryanodine receptor (RYR1(T4825I/+)) confers human malignant hyperthermia susceptibility (MHS). We report a knock-in mouse line that expresses the isogenetic mutation T4826I. Heterozygous RYR1(T4826I/+) (Het) or homozygous RYR1(T4826I/T4826I) (Hom) mice are fully viable under typical rearing conditions but exhibit genotype- and sex-dependent susceptibility to environmental conditions that trigger MH. Hom mice maintain higher core temperatures than WT in the home cage, have chronically elevated myoplasmic[Ca2+](rest), and present muscle damage in soleus with a strong sex bias. Mice subjected to heat stress in an enclosed 37 degrees C chamber fail to trigger MH regardless of genotype, whereas heat stress at 41 degrees C invariably triggers fulminant MH in Hom, but not Het, mice within 20 min. WT and Het female mice fail to maintain euthermic body temperature when placed atop a bed whose surface is 37 degrees C during halothane anesthesia (1.75%) and have no hyperthermic response, whereas 100% Hom mice of either sex and 17% of the Het males develop fulminant MH. WT mice placed on a 41 degrees C bed maintain body temperature while being administered halothane, and 40% of the Het females and 100% of the Het males develop fulminant MH within 40 min. Myopathic alterations in soleus were apparent by 12 mo, including abnormally distributed and enlarged mitochondria, deeply infolded sarcolemma, and frequent Z-line streaming regions, which were more severe in males. These data demonstrate that an MHS mutation within the S4-S5 cytoplasmic linker of RYR1 confers genotype- and sex-dependent susceptibility to pharmacological and environmental stressors that trigger fulminant MH and promote myopathy.-Yuen, B., Boncompagni, S., Feng, W., Yang, T., Lopez, J. R., Matthaei, K. I., Goth, S. R., Protasi, F., Franzini-Armstrong, C., Allen, P. D., Pessah, I. N. Mice expressing T4826I-RYR1 are viable but exhibit sex-and genotype-dependent susceptibility to malignant hyperthermia and muscle damage. FASEB J. 26, 1311-1322 (2012). www.fasebj.org	[Yuen, Benjamin; Feng, Wei; Goth, Samuel R.; Pessah, Isaac N.] Univ Calif Davis, Dept Vet Mol Biosci, Davis, CA 95616 USA; [Boncompagni, Simona; Protasi, Feliciano] Univ G DAnnunzio, Ctr Res Aging, Chieti, Italy; [Boncompagni, Simona; Protasi, Feliciano] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Yang, Tianzhong; Lopez, Jose R.; Allen, Paul D.] Brigham & Womens Hosp, Dept Anesthesia, Boston, MA 02115 USA; [Matthaei, Klaus I.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Franzini-Armstrong, Clara] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of California System; University of California Davis; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Harvard University; Brigham & Women's Hospital; Australian National University; John Curtin School of Medical Research; University of Pennsylvania	Pessah, IN (corresponding author), Univ Calif Davis, Dept Mol Biosci, 1 Shield Ave, Davis, CA 95616 USA.	inpessah@ucdavis.edu	Pessah, Isaac N/K-7985-2017	Pessah, Isaac N/0000-0002-8149-588X	U.S. National Institutes of Health [1P01 AR52354-05, 3R01 AR043140-15, 1R01 ES014901]; J. B. Johnson Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043140, P01AR052354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014901] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. B. Johnson Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was supported by U.S. National Institutes of Health grants 1P01 AR52354-05 (to C. F. A., I.N.P., and P. D. A.), 3R01 AR043140-15 (to P. D. A. and I.N.P.), and 1R01 ES014901 (to I.N.P.), and an unrestricted gift grant from the J. B. Johnson Foundation (to I.N.P.).	Andronache Z, 2009, P NATL ACAD SCI USA, V106, P4531, DOI 10.1073/pnas.0812661106; Bannister RA, 2010, J GEN PHYSIOL, V135, P629, DOI 10.1085/jgp.200910329; Boncompagni S, 2006, J GERONTOL A-BIOL, V61, P995, DOI 10.1093/gerona/61.10.995; Boncompagni S, 2010, AGING CELL, V9, P958, DOI 10.1111/j.1474-9726.2010.00623.x; Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Brady JE, 2009, ANESTH ANALG, V109, P1162, DOI 10.1213/ane.0b013e3181ac1548; Brown RL, 2000, HUM MOL GENET, V9, P1515, DOI 10.1093/hmg/9.10.1515; Buck ED, 1997, J BIOL CHEM, V272, P7360, DOI 10.1074/jbc.272.11.7360; Campbell HD, 2002, MOL CELL BIOL, V22, P3518, DOI 10.1128/MCB.22.10.3518-3526.2002; Carpenter D, 2009, BRIT J ANAESTH, V103, P538, DOI 10.1093/bja/aep204; Carpenter D, 2009, MUSCLE NERVE, V40, P633, DOI 10.1002/mus.21397; Carpenter D, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-104; Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Denborough M, 1998, LANCET, V352, P1131, DOI 10.1016/S0140-6736(98)03078-5; Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Eltit JM, 2010, J BIOL CHEM, V285, P13781, DOI 10.1074/jbc.M110.107300; Eltit JM, 2011, P NATL ACAD SCI USA, V108, P7046, DOI 10.1073/pnas.1018380108; Feng W, 2010, BIOPHYS J, V98, p511A, DOI 10.1016/j.bpj.2009.12.2780; Feng W, 2011, MOL PHARMACOL, V79, P420, DOI 10.1124/mol.110.067959; Franzini-Armstrong C, 2005, ANN NY ACAD SCI, V1047, P76, DOI 10.1196/annals.1341.007; Giulivi C, 2011, J BIOL CHEM, V286, P99, DOI 10.1074/jbc.M110.153247; Groom L, 2011, ANESTHESIOLOGY, V115, P938, DOI 10.1097/ALN.0b013e3182320068; Ikemoto N, 2002, FRONT BIOSCI-LANDMRK, V7, pD671, DOI 10.2741/ikemoto; Jurkat-Rott K, 2002, J NEUROL, V249, P1493, DOI 10.1007/s00415-002-0871-5; Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200; KRIPPENDORF BB, 1994, ANAT RECORD, V238, P304, DOI 10.1002/ar.1092380304; Litman RS, 2005, JAMA-J AM MED ASSOC, V293, P2918, DOI 10.1001/jama.293.23.2918; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Loy RE, 2011, J GEN PHYSIOL, V137, P43, DOI 10.1085/jgp.201010523; Lynch PJ, 1997, ANESTHESIOLOGY, V86, P620, DOI 10.1097/00000542-199703000-00014; Monnier N, 2002, ANESTHESIOLOGY, V97, P1067, DOI 10.1097/00000542-200211000-00007; Murayama T, 2005, AM J PHYSIOL-CELL PH, V288, pC1222, DOI 10.1152/ajpcell.00415.2004; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; NEWHAM DJ, 1983, J NEUROL SCI, V61, P109, DOI 10.1016/0022-510X(83)90058-8; Parness J, 2009, ANESTH ANALG, V109, P1054, DOI 10.1213/ane.0b013e3181a7c8e5; Protasi F, 1998, J CELL BIOL, V140, P831, DOI 10.1083/jcb.140.4.831; Protasi F, 2009, J PHYSIOL-LONDON, V587, P3095, DOI 10.1113/jphysiol.2009.171967; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Rueffert H, 2001, BRIT J ANAESTH, V87, P240, DOI 10.1093/bja/87.2.240; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Sato K, 2010, ANESTHESIOLOGY, V112, P1350, DOI 10.1097/ALN.0b013e3181d69283; Shtifman A, 2002, J GEN PHYSIOL, V119, P15, DOI 10.1085/jgp.119.1.15; SZABO P, 1994, DEVELOPMENT, V120, P1651; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Wang RW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194316; Yamamoto T, 2000, J BIOL CHEM, V275, P11618, DOI 10.1074/jbc.275.16.11618; Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhou H, 2007, BRAIN, V130, P2024, DOI 10.1093/brain/awm096; Zhou J, 2010, MILLERS ANESTHESIA, P1171; Zvaritch E, 2009, P NATL ACAD SCI USA, V106, P21813, DOI 10.1073/pnas.0912126106	57	45	46	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2012	26	3					1311	1322		10.1096/fj.11-197582	http://dx.doi.org/10.1096/fj.11-197582			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	901FY	22131268	Green Published			2022-12-25	WOS:000300949300033
J	Beauchef, G; Bigot, N; Kypriotou, M; Renard, E; Poree, B; Widom, R; Dompmartin-Blanchere, A; Oddos, T; Maquart, FX; Demoor, M; Boumediene, K; Galera, P				Beauchef, Gallic; Bigot, Nicolas; Kypriotou, Magdalini; Renard, Emmanuelle; Poree, Benoit; Widom, Russell; Dompmartin-Blanchere, Anne; Oddos, Thierry; Maquart, Francois-Xavier; Demoor, Magali; Boumediene, Karim; Galera, Philippe			The p65 Subunit of NF-kappa B Inhibits COL1A1 Gene Transcription in Human Dermal and Scleroderma Fibroblasts through Its Recruitment on Promoter by Protein Interaction with Transcriptional Activators (c-Krox, Sp1, and Sp3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; HEPATIC STELLATE CELLS; PROCOLLAGEN MESSENGER-RNA; GROWTH-FACTOR BETA(1); I COLLAGEN GENE; TNF-ALPHA; TGF-BETA; REPRESSES TRANSCRIPTION; DEPENDENT MECHANISM; BINDING SITES	Transcriptional mechanisms regulating type I collagen genes expression in physiopathological situations are not completely known. In this study, we have investigated the role of nuclear factor-kappa B (NF-kappa B) transcription factor on type I collagen expression in adult normal human (ANF) and scleroderma (SF) fibroblasts. We demonstrated that NF-kappa B, a master transcription factor playing a major role in immune response/apoptosis, down-regulates COL1A1 expression by a transcriptional control involving the -112/-61 bp sequence. This 51-bp region mediates the action of two zinc fingers, Sp1 (specific protein-1) and Sp3, acting as trans-activators of type I collagen expression in ANF and SF. Knockdown of each one of these trans factors by siRNA confirmed the trans-activating effect of Sp1/Sp3 and the p65 subunit of NF-kappa B trans-inhibiting effect on COL1A1 expression. Despite no existing kappa B consensus sequence in the COL1A1 promoter, we found that Sp1/Sp3/c-Krox and NF-kappa B bind and/or are recruited on the proximal promoter in chromatin immunoprecipitation (ChIP) assays. Attempts to elucidate whether interactions between Sp1/Sp3/c-Krox and p65 are necessary to mediate the NF-kappa B inhibitory effect on COL1A1 in ANF and SF were carried out; in this regard, immunoprecipitation assays revealed that they interact, and this was validated by re-ChIP. Finally, the knockdown of Sp1/Sp3/c-Krox prevents the p65 inhibitory effect on COL1A1 transcription in ANF, whereas only the siRNAs targeting Sp3 and c-Krox provoked the same effect in SF, suggesting that particular interactions are characteristic of the scleroderma phenotype. In conclusion, our findings highlight a new mechanism for COL1A1 transcriptional regulation by NF-kappa B, and these data could allow the development of new antifibrotic strategies.	[Beauchef, Gallic; Bigot, Nicolas; Kypriotou, Magdalini; Renard, Emmanuelle; Poree, Benoit; Demoor, Magali; Boumediene, Karim; Galera, Philippe] Univ Caen Basse Normandie, Lab Matrice Extracellulaire & Pathol, IFR ICORE 146, UFR Med,CHU Niveau 3, F-14032 Caen, France; [Widom, Russell] Boston Univ, Sch Med, Dept Med, Arthrit Ctr, Boston, MA 02118 USA; [Widom, Russell] Boston Vet Affairs Med Ctr, Boston, MA 02118 USA; [Dompmartin-Blanchere, Anne] CHR, Serv Dermatol, F-14032 Caen, France; [Oddos, Thierry] R&D Europe, Johnson & Johnson Consumer France, F-27106 Val De Reuil, France; [Maquart, Francois-Xavier] Univ Reims, Lab Biochim Med & Biol Mol, UMR CNRS URCA 6237, F-51095 Reims, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; Boston University; CHU de Caen NORMANDIE; Johnson & Johnson; Universite de Reims Champagne-Ardenne	Galera, P (corresponding author), Univ Caen Basse Normandie, Lab Matrice Extracellulaire & Pathol, IFR ICORE 146, UFR Med,CHU Niveau 3, Ave Cote Nacre, F-14032 Caen, France.	philippe.galera@unicaen.fr		Bigot, Nicolas/0000-0002-4247-0217; BOUMEDIENE, Karim/0000-0001-6517-8318	Regional Council of Lower Normandy; French Ministry of Regional Development; Johnson & Johnson Consumer France	Regional Council of Lower Normandy(Region Normandie); French Ministry of Regional Development; Johnson & Johnson Consumer France	This work was supported by the Regional Council of Lower Normandy, the French Ministry of Regional Development, and Johnson & Johnson Consumer France.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Aoki T, 2009, ARTERIOSCL THROM VAS, V29, P1080, DOI 10.1161/ATVBAHA.108.180760; Artlett CM, 1998, MATRIX BIOL, V17, P425, DOI 10.1016/S0945-053X(98)90102-0; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Azakie A, 2006, AM J PHYSIOL-HEART C, V291, pH600, DOI 10.1152/ajpheart.01305.2005; Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; Bitzer M, 2000, GENE DEV, V14, P187; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chun JY, 2007, MOL CANCER THER, V6, P2572, DOI 10.1158/1535-7163.MCT-07-0172; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; DeLuca P, 1996, J BIOL CHEM, V271, P8533, DOI 10.1074/jbc.271.15.8533; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Garcia-Trevijano ER, 1999, HEPATOLOGY, V29, P960, DOI 10.1002/hep.510290346; Ghayor C, 2001, J BIOL CHEM, V276, P36881, DOI 10.1074/jbc.M105083200; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GOLDBERG H, 1992, J BIOL CHEM, V267, P19622; Greene Warner C, 2004, Novartis Found Symp, V259, P208; He SH, 2005, MOL BIOL CELL, V16, P4073, DOI 10.1091/mbc.e05-05-0388; Hitraya EG, 1998, ARTHRITIS RHEUM-US, V41, P2048, DOI 10.1002/1529-0131(199811)41:11<2048::AID-ART21>3.0.CO;2-X; Ihn H, 2000, ARTHRITIS RHEUM, V43, P2240, DOI 10.1002/1529-0131(200010)43:10<2240::AID-ANR11>3.0.CO;2-2; Ihn H, 1997, J BIOL CHEM, V272, P24666, DOI 10.1074/jbc.272.39.24666; Ihn H, 1997, NUCLEIC ACIDS RES, V25, P3712, DOI 10.1093/nar/25.18.3712; INAGAKI Y, 1995, J BIOL CHEM, V270, P3353, DOI 10.1074/jbc.270.7.3353; Iraburu MJ, 2000, HEPATOLOGY, V31, P1086, DOI 10.1053/he.2000.5981; JIMENEZ SA, 1994, J BIOL CHEM, V269, P12684; Jimenez SA, 1996, RHEUM DIS CLIN N AM, V22, P647, DOI 10.1016/S0889-857X(05)70294-5; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim JM, 2004, CLIN EXP IMMUNOL, V137, P341, DOI 10.1111/j.1365-2249.2004.02542.x; Kouba DJ, 1999, J IMMUNOL, V162, P4226; Kum YS, 2007, BIOCHEM BIOPH RES CO, V363, P368, DOI 10.1016/j.bbrc.2007.08.176; Kurland JF, 2001, J BIOL CHEM, V276, P45380, DOI 10.1074/jbc.M108294200; Kypriotou M, 2007, J BIOL CHEM, V282, P32000, DOI 10.1074/jbc.M705197200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2006, EXP EYE RES, V83, P560, DOI 10.1016/j.exer.2006.02.008; MAJELLO B, 1995, ONCOGENE, V10, P1841; Majello B, 1997, J BIOL CHEM, V272, P4021, DOI 10.1074/jbc.272.7.4021; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; Mori K, 1996, BIOCHEM J, V319, P811, DOI 10.1042/bj3190811; Okamoto T, 1997, CURR TOP CELL REGUL, V35, P149, DOI 10.1016/S0070-2137(97)80006-4; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; PETERKOFSKY B, 1971, BIOCHEMISTRY-US, V10, P988, DOI 10.1021/bi00782a009; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; RAMIREZ F, 1990, FASEB J, V4, P1616, DOI 10.1096/fasebj.4.6.2180769; Reuter U, 2002, ANN NEUROL, V51, P507, DOI 10.1002/ana.10159; Rippe RA, 1999, DNA CELL BIOL, V18, P751, DOI 10.1089/104454999314890; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; SCHMITZ ML, 1995, J BIOL CHEM, V270, P7219, DOI 10.1074/jbc.270.13.7219; Schreiber J, 2005, SURGERY, V138, P940, DOI 10.1016/j.surg.2005.05.020; SOLISHERRUZO JA, 1988, J BIOL CHEM, V263, P5841; TAMAKI T, 1995, J BIOL CHEM, V270, P4299, DOI 10.1074/jbc.270.9.4299; Tassorelli C, 2005, CEPHALALGIA, V25, P612, DOI 10.1111/j.1468-2982.2005.00915.x; Teunissen BEJ, 2002, BIOCHEM BIOPH RES CO, V292, P71, DOI 10.1006/bbrc.2002.6621; Trojanowska M, 1998, J MOL MED, V76, P266, DOI 10.1007/s001090050216; Udalova IA, 2000, MOL CELL BIOL, V20, P9113, DOI 10.1128/MCB.20.24.9113-9119.2000; URBAN MB, 1991, NEW BIOL, V3, P279; Varela-Rey M, 2002, FEBS LETT, V528, P133, DOI 10.1016/S0014-5793(02)03276-3; Vermes C, 2000, J BONE MINER RES, V15, P1756, DOI 10.1359/jbmr.2000.15.9.1756; Verrecchia F, 2004, CELL SIGNAL, V16, P873, DOI 10.1016/j.cellsig.2004.02.007; Verrecchia F, 2001, J INVEST DERMATOL, V116, P755, DOI 10.1046/j.1523-1747.2001.01326.x; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; Wang J, 2005, J NEUROCHEM, V93, P474, DOI 10.1111/j.1471-4159.2005.03051.x; Yamane K, 2003, J IMMUNOL, V171, P3855, DOI 10.4049/jimmunol.171.7.3855; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262; Zhu NL, 2007, GENE, V393, P70, DOI 10.1016/j.gene.2007.01.016	73	40	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3462	3478		10.1074/jbc.M111.286443	http://dx.doi.org/10.1074/jbc.M111.286443			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22139845	Green Published, hybrid			2022-12-25	WOS:000300295100051
J	Dunn, CA; Su, V; Lau, AF; Lampe, PD				Dunn, Clarence A.; Su, Vivian; Lau, Alan. F.; Lampe, Paul D.			Activation of Akt, Not Connexin 43 Protein Ubiquitination, Regulates Gap Junction Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME-DEPENDENT DEGRADATION; LIVER EPITHELIAL-CELLS; INTERCELLULAR COMMUNICATION; CELLULAR-DISTRIBUTION; DOWN-REGULATION; GROWTH-FACTOR; LIFE-CYCLE; PHOSPHORYLATION; KINASE; INHIBITION	The pore-forming gap junctional protein connexin 43 (Cx43) has a short (1-3 h) half-life in cells in tissue culture and in whole tissues. Although critical for cellular function in all tissues, the process of gap junction turnover is not well understood because treatment of cells with a proteasomal inhibitor results in larger gap junctions but little change in total Cx43 protein whereas lysosomal inhibitors increase total, mostly nonjunctional Cx43. To better understand turnover and identify potential sites of Cx43 ubiquitination, we prepared constructs of Cx43 with different lysines converted to arginines. However, when transfected into cells, a mutant version of Cx43 with all lysines converted to arginines behaved similarly to wild type in the presence of proteasomal and lysosomal inhibitors, indicating that ubiquitination of Cx43 did not appear to be playing a role in gap junction stability. Through the use of inhibitors and dominant negative constructs, we found that Akt (protein kinase B) activity controlled gap junction stability and was necessary to form larger stable gap junctions. Akt activation was increased upon proteasomal inhibition and resulted in phosphorylation of Cx43 at Akt phosphorylation consensus sites. Thus, we conclude that Cx43 ubiquitination is not necessary for the regulation of Cx43 turnover; rather, Akt activity, probably through direct phosphorylation of Cx43, controls gap junction stability. This linkage of a kinase involved in controlling cell survival and growth to gap junction stability may mechanistically explain how gap junctions and Akt play similar regulatory roles.	[Dunn, Clarence A.; Lampe, Paul D.] Fred Hutchinson Canc Res Ctr, Mol Diagnost Program, Seattle, WA 98109 USA; [Su, Vivian; Lau, Alan. F.] Univ Hawaii, Ctr Canc, Canc Biol Program, Honolulu, HI 96813 USA	Fred Hutchinson Cancer Center; Cancer Research Center of Hawaii; University of Hawaii System	Lampe, PD (corresponding author), Fred Hutchinson Canc Res Ctr, Mol Diagnost Program, M5-C800,1100 Fairview Ave N,Box 19024, Seattle, WA 98109 USA.	plampe@fhcrc.org			National Institutes of Health [GM55632-16, CA052098-18]; American Heart Association [11POST5460028]; NATIONAL CANCER INSTITUTE [P30CA015704, R01CA052098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55632-16 (to P. D. L.) and CA052098-18 (to A. F. L.). This work was also supported by American Heart Association Grant 11POST5460028 (to V. S.).	Adachi M, 2003, FEBS LETT, V554, P77, DOI 10.1016/S0014-5793(03)01109-8; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; ATKINSON MM, 1995, J CELL SCI, V108, P3079; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Burghardt RC, 1995, J MEMBRANE BIOL, V148, P243; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; Dai BB, 2010, CANCER RES, V70, P2951, DOI 10.1158/0008-5472.CAN-09-3909; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Girao H, 2003, MOL VIS, V9, P24; Girao H, 2009, EXP CELL RES, V315, P3587, DOI 10.1016/j.yexcr.2009.10.003; Hossain MZ, 1998, J CELL PHYSIOL, V174, P66; Huang T, 2010, CANCER SCI, V101, P713, DOI 10.1111/j.1349-7006.2009.01421.x; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kjenseth A, 2010, CELL SIGNAL, V22, P1267, DOI 10.1016/j.cellsig.2010.03.005; Kwak YD, 2010, J BIOL CHEM, V285, P9847, DOI 10.1074/jbc.M109.091637; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laing JG, 1997, EXP CELL RES, V236, P482, DOI 10.1006/excr.1997.3747; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lampe PD, 2006, J CELL SCI, V119, P3435, DOI 10.1242/jcs.03089; LAMPE PD, 1994, J CELL BIOL, V127, P1895, DOI 10.1083/jcb.127.6.1895; Leithe E, 2006, BIOCHEM J, V393, P59, DOI 10.1042/BJ20050674; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Leithe E, 2009, J CELL SCI, V122, P3883, DOI 10.1242/jcs.053801; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Moreno AP, 2005, BBA-BIOMEMBRANES, V1711, P164, DOI 10.1016/j.bbamem.2005.02.016; Musil Linda S., 2009, P225, DOI 10.1007/978-1-59745-489-6_9; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; MUSIL LS, 1990, J MEMBRANE BIOL, V116, P163, DOI 10.1007/BF01868674; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Richards TS, 2004, J CELL BIOL, V167, P555, DOI 10.1083/jcb.200404142; Rivedal E, 2005, EXP CELL RES, V302, P143, DOI 10.1016/j.yexcr.2004.09.004; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Solan JL, 2003, J CELL SCI, V116, P2203, DOI 10.1242/jcs.00428; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; Su V, 2010, J BIOL CHEM, V285, P40979, DOI 10.1074/jbc.M110.170753; VanSlyke JK, 2005, MOL BIOL CELL, V16, P5247, DOI 10.1091/mbc.E05-05-0415; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	57	80	84	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2600	2607		10.1074/jbc.M111.276261	http://dx.doi.org/10.1074/jbc.M111.276261			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139843	Green Published, hybrid			2022-12-25	WOS:000300292300033
J	Dolic, K; Weinstock-Guttman, B; Marr, K; Valnarov, V; Carl, E; Hagemeier, J; Brooks, C; Kilanowski, C; Hojnacki, D; Ramanathan, M; Zivadinov, R				Dolic, Kresimir; Weinstock-Guttman, Bianca; Marr, Karen; Valnarov, Vesela; Carl, Ellen; Hagemeier, Jesper; Brooks, Christina; Kilanowski, Colleen; Hojnacki, David; Ramanathan, Murali; Zivadinov, Robert			Risk Factors for Chronic Cerebrospinal Venous Insufficiency (CCSVI) in a Large Cohort of Volunteers	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; FISH-OIL; GINKGO-BILOBA; JUGULAR VALVE; THROMBOEMBOLISM; SMOKING; THROMBOSIS; FLOW; EPIDEMIOLOGY; INCOMPETENCE	Background: The role of intra-and extra-cranial venous system impairment in the pathogenesis of various vascular, inflammatory and neurodegenerative neurological disorders, as well as in aging, has not been studied in detail. Nor have risk factors been determined for increased susceptibility of venous pathology in the intra-cranial and extra-cranial veins. The aim of this study was to investigate the association between presence of a newly proposed vascular condition called chronic cerebrospinal venous insufficiency (CCSVI) and environmental factors in a large volunteer control group without known central nervous system pathology. Methods and Findings: The data were collected in a prospective study from 252 subjects who were screened for medical history as part of the entry criteria and participated in the case-control study of CCSVI prevalence in multiple sclerosis (MS) patients, and then were analyzed post-hoc. All participants underwent physical and Doppler sonography examinations, and were assessed with a structured environmental questionnaire. Fullfilment of >= 2 positive venous hemodynamic (VH) criteria on Doppler sonography was considered indicative of CCSVI diagnosis. Risk and protective factors associated with CCSVI were analyzed using logistic regression analysis. Seventy (27.8%) subjects presented with CCSVI diagnosis and 153 (60.7%) presented with one or more VH criteria. The presence of heart disease (p = .001), especially heart murmurs (p = .007), a history of infectious mononucleosis (p = .002), and irritable bowel syndrome (p = .005) were associated with more frequent CCSVI diagnosis. Current or previous smoking (p = .029) showed a trend for association with more frequent CCSVI diagnosis, while use of dietary supplements (p = .018) showed a trend for association with less frequent CCSVI diagnosis. Conclusions: Risk factors for CCSVI differ from established risk factors for peripheral venous diseases. Vascular, infectious and inflammatory factors were associated with higher CCSVI frequency.	[Dolic, Kresimir; Marr, Karen; Valnarov, Vesela; Carl, Ellen; Hagemeier, Jesper; Brooks, Christina; Kilanowski, Colleen; Ramanathan, Murali; Zivadinov, Robert] SUNY Buffalo, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA; [Weinstock-Guttman, Bianca; Hojnacki, David; Zivadinov, Robert] SUNY Buffalo, Dept Neurol, Jacobs Neurol Inst, Buffalo, NY 14260 USA; [Ramanathan, Murali] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Dolic, K (corresponding author), SUNY Buffalo, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA.	rzivadinov@bnac.net	Dolic, Kresimir/D-8350-2017; Zivadinov, Robert/Q-2054-2019; Weinstock-Guttman, Bianca/AAI-4694-2021; Carl, Ellen/AAC-9162-2020	Zivadinov, Robert/0000-0002-7799-1485; Weinstock-Guttman, Bianca/0000-0001-6732-151X; Carl, Ellen/0000-0002-0930-8285	Buffalo Neuroimaging Analysis Center; Baird MS Center; Jacobs Neurological Institute; University of Buffalo; MS Foundation; Jacquemin Foundation; Biogen Idec; Teva Pharmaceutical Industries Ltd.; EMD Serono; Pfizer Inc; Novartis; National Multiple Sclerosis Society (NMSS); National Institutes of Health; Immune Tolerance Network; Teva Neuroscience; Aspreva; Pfizer; National Science Foundation; Questcor Pharmaceuticals; Genzyme; Bracco	Buffalo Neuroimaging Analysis Center; Baird MS Center; Jacobs Neurological Institute; University of Buffalo; MS Foundation; Jacquemin Foundation; Biogen Idec(Biogen); Teva Pharmaceutical Industries Ltd.(Teva Pharmaceutical Industries); EMD Serono; Pfizer Inc(Pfizer); Novartis(Novartis); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Immune Tolerance Network; Teva Neuroscience(Teva Pharmaceutical Industries); Aspreva; Pfizer(Pfizer); National Science Foundation(National Science Foundation (NSF)); Questcor Pharmaceuticals; Genzyme(Sanofi-AventisGenzyme Corporation); Bracco	This study was funded with internal resources of the Buffalo Neuroimaging Analysis Center and Baird MS Center, the Jacobs Neurological Institute, University of Buffalo. In addition, the authors received support from the Direct MS Foundation and the Jacquemin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DH has received speaker honoraria and consultant fees from Biogen Idec, Teva Pharmaceutical Industries Ltd., EMD Serono, Pfizer Inc, and Novartis. BW-G received personal compensation for consulting, speaking and serving on a scientific advisory board for Biogen Idec, Teva Neuroscience and EMD Serono. BW-G also received financial support for research activities from the National Multiple Sclerosis Society (NMSS), National Institutes of Health, Immune Tolerance Network, Teva Neuroscience, Biogen Idec, EMD Serono, and Aspreva. MR served as an editor for the American Association of Pharmaceutical Scientists Journal, receives royalties for publishing The Pharmacy Calculations Workbook [Pinnacle, Summit and Zenith, 2008], and received research support from EMD Serono, Novartis, Pfizer, NMSS, and the National Science Foundation. RZ received personal compensation from Teva Neuroscience, Biogen Idec, EMD Serono and Questcor Pharmaceuticals for speaking and consultant fees. RZ also received financial support for research activities from Biogen Idec, Teva Neuroscience, Genzyme, Bracco, Questcor Pharmaceuticals and EMD Serono. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Arnould T, 1998, J CARDIOVASC PHARM, V31, P456, DOI 10.1097/00005344-199803000-00018; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Baracchini C, 2011, ANN NEUROL, V69, P90, DOI 10.1002/ana.22228; Bronnum-Hansen H, 2004, BRAIN, V127, P844, DOI 10.1093/brain/awh104; Centonze D, 2011, ANN NEUROL; Christiansen CF, 2010, NEUROEPIDEMIOLOGY, V35, P267, DOI 10.1159/000320245; Chuang YM, 2005, EUR NEUROL, V53, P78, DOI 10.1159/000084651; Chung CP, 2007, ULTRASOUND MED BIOL, V33, P1727, DOI 10.1016/j.ultrasmedbio.2007.05.018; Chung CP, 2011, ANN NEUROL, V69, P553, DOI 10.1002/ana.22276; Chung CP, 2010, ULTRASOUND MED BIOL, V36, P1776, DOI 10.1016/j.ultrasmedbio.2010.07.006; Compston A, 1999, PHILOS T R SOC B, V354, P1623, DOI 10.1098/rstb.1999.0507; D'haeseleer M, 2011, LANCET NEUROL, V10, P657, DOI 10.1016/S1474-4422(11)70105-3; Dalpke AH, 2003, J MED VIROL, V71, P408, DOI 10.1002/jmv.10501; De Giorgio Roberto, 2008, Curr Gastroenterol Rep, V10, P385, DOI 10.1007/s11894-008-0073-0; Doepp F, 2008, CEPHALALGIA, V28, P182, DOI 10.1111/j.1468-2982.2007.01484.x; Doepp F, 2008, J CLIN ULTRASOUND, V36, P480, DOI 10.1002/jcu.20470; Doepp F, 2010, ANN NEUROL, V68, P173, DOI 10.1002/ana.22085; Hausmann S, 1997, CURR OPIN IMMUNOL, V9, P831, DOI 10.1016/S0952-7915(97)80186-0; Hawkes CH, 2007, MULT SCLER J, V13, P610, DOI 10.1177/1352458506073501; Hsu HY, 2008, ANN NEUROL, V63, P247, DOI 10.1002/ana.21299; JUNG F, 1990, ARZNEIMITTELFORSCH, V40-1, P589; Khan O, 2010, ANN NEUROL, V67, P286, DOI 10.1002/ana.22001; KIM DN, 1995, ANN NY ACAD SCI, V748, P474; Lee BB, 2010, INT ANGIOL, V29, P95; Lowe GDO, 2004, MATURITAS, V47, P259, DOI 10.1016/j.maturitas.2003.12.009; Marrie RA, 2010, NEUROLOGY, V74, P1041, DOI 10.1212/WNL.0b013e3181d6b125; Mashav N, 2008, THROMB RES, V122, P570, DOI 10.1016/j.thromres.2008.03.005; Mayer CA, 2011, J NEUROL NEUROSUR PS, V82, P436, DOI 10.1136/jnnp.2010.231613; Nedelmann M, 2009, J NEUROL, V256, P964, DOI 10.1007/s00415-009-5056-z; Nielsen NM, 2008, MULT SCLER J, V14, P823, DOI 10.1177/1352458508088936; OLSZEWSKI AJ, 1993, CORONARY ARTERY DIS, V4, P53, DOI 10.1097/00019501-199301000-00007; Phang M, 2011, SEMIN THROMB HEMOST, V37, P199, DOI 10.1055/s-0031-1273084; Pomp ER, 2008, AM J HEMATOL, V83, P97, DOI 10.1002/ajh.21059; PURRMANN J, 1992, J CLIN GASTROENTEROL, V14, P43, DOI 10.1097/00004836-199201000-00011; Rudick RA, 2010, NAT REV NEUROL, V6, P472, DOI 10.1038/nrneurol.2010.117; SACKS FM, 1995, J AM COLL CARDIOL, V25, P1492, DOI 10.1016/0735-1097(95)00095-L; Severinsen MT, 2009, J THROMB HAEMOST, V7, P1297, DOI 10.1111/j.1538-7836.2009.03490.x; Smith PF, 1996, J ETHNOPHARMACOL, V50, P131, DOI 10.1016/0378-8741(96)01379-7; Solem CA, 2004, AM J GASTROENTEROL, V99, P97, DOI 10.1046/j.1572-0241.2003.04026.x; Sorensen HT, 2009, J THROMB HAEMOST, V7, P521, DOI 10.1111/j.1538-7836.2009.03279.x; Sundstrom P, 2008, MULT SCLER J, V14, P1031, DOI 10.1177/1352458508093615; Sundstrom P, 2010, ANN NEUROL, V68, P255, DOI 10.1002/ana.22132; Taylor BV, 1998, CAN J CARDIOL, V14, P1129; Wattjes MP, 2010, J NEUROL NEUROSURG P; YAMAZAKI M, 1991, BLOOD COAGUL FIBRIN, V2, P771, DOI 10.1097/00001721-199112000-00012; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zivadinov R, 2011, NEUROLOGY; Zivadinov R, 2011, RADIOLOGY, V258, P562, DOI 10.1148/radiol.10101387	50	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28062	10.1371/journal.pone.0028062	http://dx.doi.org/10.1371/journal.pone.0028062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140507	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168100033
J	Krawetz, RJ; Taiani, J; Greene, A; Kelly, GM; Rancourt, DE				Krawetz, Roman J.; Taiani, Jaymi; Greene, Alexis; Kelly, Gregory M.; Rancourt, Derrick E.			Inhibition of Rho Kinase Regulates Specification of Early Differentiation Events in P19 Embryonal Carcinoma Stem Cells	PLOS ONE			English	Article							NEURONAL DIFFERENTIATION; BETA-CATENIN; G-ALPHA-13; ACTIVATION; SURVIVAL; PHOSPHORYLATION; DOWNSTREAM; P160(ROCK); APOPTOSIS; PROTEINS	Background: The Rho kinase pathway plays a key role in many early cell/tissue determination events that take place in embryogenesis. Rho and its downstream effector Rho kinase (ROCK) play pivotal roles in cell migration, apoptosis (membrane blebbing), cell proliferation/cell cycle, cell-cell adhesion and gene regulation. We and others have previously demonstrated that inhibition of ROCK blocks endoderm differentiation in embryonal carcinoma stem cells, however, the effect of ROCK inhibition on mesoderm and ectoderm specification has not been fully examined. In this study, the role of ROCK within the specification and differentiation of all three germ layers was examined. Methodology/Principal Findings: P19 cells were treated with the specific ROCK inhibitor Y-27623, and increase in differentiation efficiency into neuro-ectodermal and mesodermal lineages was observed. However, as expected a dramatic decrease in early endodermal markers was observed when ROCK was inhibited. Interestingly, within these ROCK-inhibited RA treated cultures, increased levels of mesodermal or ectodermal markers were not observed, instead it was found that the pluripotent markers SSEA-1 and Oct-4 remained up-regulated similar to that seen in undifferentiated cultures. Using standard and widely accepted methods for reproducible P19 differentiation into all three germ layers, an enhancement of mesoderm and ectoderm differentiation with a concurrent loss of endoderm lineage specification was observed with Y-27632 treatment. Evidence would suggest that this effect is in part mediated through TGF-beta and SMAD signaling as ROCK-inhibited cells displayed aberrant SMAD activation and did not return to a 'ground' state after the inhibition had been removed. Conclusions/Significance: Given this data and the fact that only a partial rescue of normal differentiation capacity occurred when ROCK inhibition was alleviated, the effect of ROCK inhibition on the differentiation capacity of pluripotent cell populations should be further examined to elucidate the role of the Rho-ROCK pathway in early cellular 'fate' decision making processes.	[Krawetz, Roman J.] Univ Calgary, Dept Surg, Calgary, AB, Canada; [Greene, Alexis; Rancourt, Derrick E.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Taiani, Jaymi] Univ Calgary, Fac Med, Dept Med Sci, Calgary, AB, Canada; [Kelly, Gregory M.] Univ Western Ontario, Dept Biol, Mol Genet Unit, London, ON, Canada	University of Calgary; University of Calgary; University of Calgary; Western University (University of Western Ontario)	Krawetz, RJ (corresponding author), Univ Calgary, Dept Surg, Calgary, AB, Canada.	rkrawetz@ucalgary.ca	Kelly, Gregory/AAF-3400-2020	Kelly, Gregory/0000-0001-8612-364X	Canadian Stem Cell Network and Canadian Institutes of Health Research [CIHR7rpar, RMF-8249]; Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research - Skeletal Regenerative Medicine Team (CIHR-SRMT)	Canadian Stem Cell Network and Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research - Skeletal Regenerative Medicine Team (CIHR-SRMT)(Canadian Institutes of Health Research (CIHR))	This research was supported by Canadian Stem Cell Network and Canadian Institutes of Health Research (CIHR7rpar; Regenerative Medicine and Nanomedicine Team Grants (RMF-8249) to DER, and by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to GMK. RJK and JT were supported by a Canadian Institutes of Health Research - Skeletal Regenerative Medicine Team (CIHR-SRMT) fellowship and studentship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Cho HJ, 2007, CELL BIOL INT, V31, P1225, DOI 10.1016/j.cellbi.2007.04.006; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Fujita A, 1997, BIOCHEM J, V328, P769, DOI 10.1042/bj3280769; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001; Hebert M, 2008, J IMMUNOL, V181, P5963, DOI 10.4049/jimmunol.181.9.5963; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kawabata S, 2004, GENES CELLS, V9, P653, DOI 10.1111/j.1356-9597.2004.00749.x; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Krawetz R, 2008, CELL SIGNAL, V20, P506, DOI 10.1016/j.cellsig.2007.11.001; Krawetz R, 2008, CELL SIGNAL, V20, P163, DOI 10.1016/j.cellsig.2007.10.011; Krawetz R, 2006, EXP CELL RES, V312, P3224, DOI 10.1016/j.yexcr.2006.06.016; Krawetz R, 2009, BIOCHEM CELL BIOL, V87, P567, DOI [10.1139/o09-014, 10.1139/O09-014]; Lee YN, 2004, J BIOL CHEM, V279, P54896, DOI 10.1074/jbc.M407581200; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Liu YL, 2009, FASEB J, V23, P2299, DOI 10.1096/fj.08-127910; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Mills E, 2005, CELL COMMUN ADHES, V12, P9, DOI 10.1080/15419060500305948; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; PRUITT SC, 1992, DIFFERENTIATION, V50, P57, DOI 10.1111/j.1432-0436.1992.tb00486.x; Reuters I, 2006, NEPHRON PHYSIOL, V104, P95, DOI 10.1159/000094573; Diez RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014145; Shao MY, 2011, CELL BIOL INT, V35, P105, DOI 10.1042/CBI20100114; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; Shiokawa S, 2002, J CLIN ENDOCR METAB, V87, P5808, DOI 10.1210/jc.2002-020376; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Sivasubramaniyan K, 2010, CURR STEM CELL RES T, V5, P2, DOI 10.2174/157488810790442769; SMITH SC, 1987, J CELL PHYSIOL, V131, P74, DOI 10.1002/jcp.1041310112; Tang K, 2002, BIOCHEM BIOPH RES CO, V293, P167, DOI 10.1016/S0006-291X(02)00215-2; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107	42	14	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e26484	10.1371/journal.pone.0026484	http://dx.doi.org/10.1371/journal.pone.0026484			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140430	Green Submitted, gold, Green Published			2022-12-25	WOS:000298168100006
J	Ehrnhoefer, DE; Skotte, NH; Savill, J; Nguyen, YTN; Ladha, S; Cao, LP; Dullaghan, E; Hayden, MR				Ehrnhoefer, Dagmar E.; Skotte, Niels H.; Savill, Jane; Nguyen, Yen T. N.; Ladha, Safia; Cao, Li-Ping; Dullaghan, Edie; Hayden, Michael R.			A Quantitative Method for the Specific Assessment of Caspase-6 Activity in Cell Culture	PLOS ONE			English	Article							NUCLEAR LAMIN-A; INDUCED APOPTOSIS; AXONAL DEGENERATION; ALZHEIMERS-DISEASE; MUTANT HUNTINGTIN; HUMAN NEURONS; IN-VIVO; CLEAVAGE; ACTIVATION; DEATH	Aberrant activation of caspase-6 has recently emerged as a major contributor to the pathogeneses of neurodegenerative disorders such as Alzheimer's and Huntington disease. Commercially available assays to measure caspase-6 activity commonly use the VEID peptide as a substrate. However these methods are not well suited to specifically assess caspase-6 activity in the presence of other, confounding protease activities, as often encountered in cell and tissue samples. Here we report the development of a method that overcomes this limitation by using a protein substrate, lamin A, which is highly specific for caspase-6 cleavage at amino acid 230. Using a neo-epitope antibody against cleaved lamin A, we developed an electrochemiluminescence-based ELISA assay that is suitable to specifically detect and quantify caspase-6 activity in highly apoptotic cell extracts. The method is more sensitive than VEID-based assays and can be adapted to a high-content imaging platform for high-throughput screening. This method should be useful to screen for and characterize caspase-6 inhibitor compounds and other interventions to decrease intracellular caspase-6 activity for applications in neurodegenerative disorders.	[Ehrnhoefer, Dagmar E.; Skotte, Niels H.; Nguyen, Yen T. N.; Ladha, Safia; Cao, Li-Ping; Hayden, Michael R.] Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut CMMT, CFRI, Vancouver, BC, Canada; [Savill, Jane; Dullaghan, Edie] Ctr Drug Res & Dev CDRD, Vancouver, BC, Canada; [Skotte, Niels H.] Univ Copenhagen, Inst Cellular & Mol Med ICMM, Dept Med Genet, Copenhagen, Denmark	University of British Columbia; University of Copenhagen	Ehrnhoefer, DE (corresponding author), Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut CMMT, CFRI, Vancouver, BC, Canada.	mrh@cmmt.ubc.ca	Hayden, Michael R/D-8581-2011; Skotte, Niels Henning/AFK-2715-2022; Ehrnhoefer, Dagmar/B-7231-2008; Skotte, Niels Henning/AAG-1023-2022; Ehrnhöfer, Dagmar/O-2514-2016	Hayden, Michael R/0000-0001-5159-1419; Ehrnhoefer, Dagmar/0000-0003-3411-5415; Ehrnhöfer, Dagmar/0000-0003-3411-5415; Skotte, Niels Henning/0000-0001-7027-7193	Canadian Institutes of Health Research (CIHR) [MOP-84438]; Cure Huntington Disease Initiative (CHDI); Austrian Science Fund (FWF) [J2797-B09]; Pfizer-CDRD	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cure Huntington Disease Initiative (CHDI); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Pfizer-CDRD	This work was supported by the Canadian Institutes of Health Research (CIHR MOP-84438) and the Cure Huntington Disease Initiative (CHDI) 'TREAT HD' grants to MRH. DEE is a CIHR fellowship awardee and held a postdoctoral fellowship of the Austrian Science Fund (FWF), project no. J2797-B09. MRH is a University Killam Professor and holds a Canada Research Chair in Human Genetics. The authors gratefully acknowledge partial funding by the Pfizer-CDRD Innovation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Pfizer Innovation fund funded part of the work that was done at the Centre for Drug Research and Development (CDRD). The authors do not have any employment or consultant relationships with Pfizer, there are no relevant patents or products. The authors confirm that the funding does not alter their adherence to the PLos ONE policies on sharing data and materials.	Akpan N, 2011, J NEUROSCI, V31, P8894, DOI 10.1523/JNEUROSCI.0698-11.2011; Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Eleouet JF, 2000, J VIROL, V74, P3975, DOI 10.1128/JVI.74.9.3975-3983.2000; Feinstein-Rotkopf Y, 2009, APOPTOSIS, V14, P980, DOI 10.1007/s10495-009-0346-6; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Kalinin AE, 2005, J INVEST DERMATOL, V124, P46, DOI 10.1111/j.0022-202X.2004.23507.x; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; LIN F, 1993, J BIOL CHEM, V268, P16321; Metzler M, 2010, J NEUROSCI, V30, P14318, DOI 10.1523/JNEUROSCI.1589-10.2010; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nyormoi O, 2001, MOL CELL BIOL, V21, P4856, DOI 10.1128/MCB.21.15.4856-4867.2001; Orme M, 2009, APOPTOSIS, V14, P950, DOI 10.1007/s10495-009-0358-2; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Park KJ, 2010, NAT NEUROSCI, V13, P559, DOI 10.1038/nn.2513; Rhyne PW, 2009, BIOANALYSIS, V1, P919, DOI [10.4155/bio.09.80, 10.4155/BIO.09.80]; ROBER RA, 1989, DEVELOPMENT, V105, P365; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Samejima K, 1999, J BIOL CHEM, V274, P4335, DOI 10.1074/jbc.274.7.4335; Schoenmann Z, 2010, J NEUROSCI, V30, P6375, DOI 10.1523/JNEUROSCI.0922-10.2010; Stefanis L, 1999, J NEUROSCI, V19, P6235; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Uribe V, RESCUE EXCITOT UNPUB; van de Craen M, 1999, FEBS LETT, V445, P149, DOI 10.1016/S0014-5793(99)00108-8; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wen LP, 1997, J BIOL CHEM, V272, P26056, DOI 10.1074/jbc.272.41.26056	39	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27680	10.1371/journal.pone.0027680	http://dx.doi.org/10.1371/journal.pone.0027680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140457	gold, Green Submitted, Green Published			2022-12-25	WOS:000298166300009
J	Alvino, CL; Ong, SC; McNeil, KA; Delaine, C; Booker, GW; Wallace, JC; Forbes, BE				Alvino, Clair L.; Ong, Shee Chee; McNeil, Kerrie A.; Delaine, Carlie; Booker, Grant W.; Wallace, John C.; Forbes, Briony E.			Understanding the Mechanism of Insulin and Insulin-Like Growth Factor (IGF) Receptor Activation by IGF-II	PLOS ONE			English	Article							LIGAND-BINDING; NEGATIVE COOPERATIVITY; SIGNAL-TRANSDUCTION; B-ISOFORM; A-ISOFORM; PROTEINS; HORMONE; ANALOGS; CANCER; SITE	Background: Insulin-like growth factor-II (IGF-II) promotes cell proliferation and survival and plays an important role in normal fetal development and placental function. IGF-II binds both the insulin-like growth factor receptor (IGF-1R) and insulin receptor isoform A (IR-A) with high affinity. Interestingly both IGF-II and the IR-A are often upregulated in cancer and IGF-II acts via both receptors to promote cancer proliferation. There is relatively little known about the mechanism of ligand induced activation of the insulin (IR) and IGF-1R. The recently solved IR structure reveals a folded over dimer with two potential ligand binding pockets arising from residues on each receptor half. Site-directed mutagenesis has mapped receptor residues important for ligand binding to two separate sites within the ligand binding pocket and we have recently shown that the IGFs have two separate binding surfaces which interact with the receptor sites 1 and 2. Methodology/Principal Findings: In this study we describe a series of partial IGF-1R and IR agonists generated by mutating Glu12 of IGF-II. By comparing receptor binding affinities, abilities to induce negative cooperativity and potencies in receptor activation, we provide evidence that residue Glu12 bridges the two receptor halves leading to receptor activation. Conclusions/Significance: This study provides novel insight into the mechanism of receptor binding and activation by IGF-II, which may be important for the future development of inhibitors of its action for the treatment of cancer.	[Alvino, Clair L.; Ong, Shee Chee; McNeil, Kerrie A.; Delaine, Carlie; Booker, Grant W.; Wallace, John C.; Forbes, Briony E.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide	Alvino, CL (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	briony.forbes@adelaide.edu.au	, John/AAP-5150-2020; Forbes, Briony/R-1838-2019	Forbes, Briony/0000-0003-4360-9927	National Health and Medical Research Council Australia [ID399169]	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council Australia, ID399169. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvino CL, 2009, J BIOL CHEM, V284, P7656, DOI 10.1074/jbc.M808061200; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; CHRISTOFFERSEN CT, 1994, ENDOCRINOLOGY, V135, P472, DOI 10.1210/en.135.1.472; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; Delaine C, 2007, J BIOL CHEM, V282, P18886, DOI 10.1074/jbc.M700531200; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEMEYTS P, 1994, HORM RES, V42, P152, DOI 10.1159/000184188; DeMeyts P, 1995, ANN NY ACAD SCI, V766, P388, DOI 10.1111/j.1749-6632.1995.tb26688.x; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Denley A, 2003, HORM METAB RES, V35, P778; FRANCIS GL, 1993, BIOCHEM J, V293, P713, DOI 10.1042/bj2930713; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Gallagher EJ, 2010, TRENDS ENDOCRIN MET, V21, P610, DOI 10.1016/j.tem.2010.06.007; Gauguin L, 2008, J BIOL CHEM, V283, P20821, DOI 10.1074/jbc.M802620200; Gicquel C, 2006, HORM RES, V65, P28, DOI 10.1159/000091503; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; Jensen M, 2000, THESIS U COPENHAGEN; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; KING R, 1992, J MOL ENDOCRINOL, V8, P29, DOI 10.1677/jme.0.0080029; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Magee BA, 1999, BIOCHEMISTRY-US, V38, P15863, DOI 10.1021/bi9910070; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; MILNER SJ, 1995, BIOCHEM J, V308, P865, DOI 10.1042/bj3080865; PIETRZKOWSKI Z, 1992, CELL GROWTH DIFFER, V3, P199; Renehan AG, 2008, BEST PRACT RES CL EN, V22, P639, DOI 10.1016/j.beem.2008.08.011; Sacco A, 2009, ENDOCRINOLOGY, V150, P3594, DOI 10.1210/en.2009-0377; Sadick M D, 1999, Dev Biol Stand, V97, P121; Sajid W, 2009, BIOCHEMISTRY-US, V48, P11283, DOI 10.1021/bi901269j; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; Sciacca L, 2003, ENDOCRINOLOGY, V144, P2650, DOI 10.1210/en.2002-0136; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; Surinya KH, 2008, J BIOL CHEM, V283, P5355, DOI 10.1074/jbc.M707054200; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Ulanet DB, 2010, P NATL ACAD SCI USA, V107, P10791, DOI 10.1073/pnas.0914076107; Walenkamp MJE, 2006, HORM RES, V66, P221, DOI 10.1159/000095161; Ward C, 2008, ACTA PHYSIOL, V192, P3, DOI 10.1111/j.1748-1716.2007.01781.x; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Whittaker J, 2002, J BIOL CHEM, V277, P47380, DOI 10.1074/jbc.M208371200; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h	42	48	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27488	10.1371/journal.pone.0027488	http://dx.doi.org/10.1371/journal.pone.0027488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140443	gold, Green Published, Green Submitted			2022-12-25	WOS:000298163400006
J	Ramamoorthy, R; Jiang, SY; Ramachandran, S				Ramamoorthy, Rengasamy; Jiang, Shu-Ye; Ramachandran, Srinivasan			Oryza sativa Cytochrome P450 Family Member OsCYP96B4 Reduces Plant Height in a Transcript Dosage Dependent Manner	PLOS ONE			English	Article							DELLA PROTEIN SLR1; FUNCTIONAL-ANALYSIS; RICE; GIBBERELLIN; ARABIDOPSIS; ENCODES; GENE; ENZYME; CELLS; ELONGATION	Background: Plant cytochromes P450 are involved in a wide range of biosynthetic reactions and play various roles in plant development. However, little is known about the biological functions of the subfamily CYP96 in plants. Methodology/Principal Findings: Here, we report a novel semi-dwarf rice mutant, in which a single copy of transposon dissociator (Ds) was inserted into the gene OsCYP96B4 (Oryza sativa Cytochrome P450 96B4). The mutant exhibits the defects in cell elongation and pollen germination, which can be complemented by the wild type OsCYP96B4 and be rescued by remobilization of the Ds element with the presence of the transposase Activator (Ac). Transgenic plants harboring OsCYP96B4 double-stranded RNA interference construct mimicked the mutant phenotype. The oscyp96b4 mutant phenotype could not be rescued by all the tested phytohormones and it was found that OsCYP96B4 reduced plant height in a transcript dosage dependent manner. Heterologous expression of OsCYP96B4 in Schizosaccharomyces pombe resulted in missegregation and wider cells. Further investigation showed that the mutant exhibited the defects in the metabolism of some lipid molecular species when compared with the wild type. Conclusions/Significance: The oscyp96b4 mutant is a novel rice semi-dwarf mutant. Our data suggest that OsCYP96B4 might be involved in lipid metabolism and regulate cell elongation.	[Ramamoorthy, Rengasamy; Jiang, Shu-Ye; Ramachandran, Srinivasan] Natl Univ Singapore, Temasek Life Sci Lab, Rice Funct Genom Grp, Singapore 117548, Singapore	National University of Singapore	Ramamoorthy, R (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	shuye@tll.org.sg; sri@tll.org.sg	Ramamoorthy, Rengasamy/AAW-8518-2020; Ramamoorthy, Rengasamy/C-2656-2011; Ramamoorthy, Rengasamy/L-3982-2015	Ramamoorthy, Rengasamy/0000-0003-1045-9109; Ramamoorthy, Rengasamy/0000-0003-1045-9109; Jiang, Shu-Ye/0000-0003-4867-2335	Temasek Life Sciences Laboratory in Singapore	Temasek Life Sciences Laboratory in Singapore(National University of Singapore)	This work was supported by Strategic Research Program from Temasek Life Sciences Laboratory in Singapore. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2009, J EXP BOT, V60, P1085, DOI 10.1093/jxb/ern301; Asano K, 2010, P JPN ACAD B-PHYS, V86, P265, DOI 10.2183/pjab.86.265; Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Banerjee J, 2010, BIOCHEM BIOPH RES CO, V394, P178, DOI 10.1016/j.bbrc.2010.02.142; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Benveniste I, 2006, PLANT SCI, V170, P326, DOI 10.1016/j.plantsci.2005.08.028; Benveniste I, 1998, BIOCHEM BIOPH RES CO, V243, P688, DOI 10.1006/bbrc.1998.8156; Dai C, 2010, EMBO J, V29, P1916, DOI 10.1038/emboj.2010.75; Duan H, 2005, PLANT PHYSIOL, V137, P1067, DOI 10.1104/pp.104.055715; Fernandez MGS, 2009, TRENDS PLANT SCI, V14, P454, DOI 10.1016/j.tplants.2009.06.005; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; Hartweck LM, 2008, PLANTA, V229, P1, DOI 10.1007/s00425-008-0830-1; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirano K, 2010, PLANT CELL, V22, P2680, DOI 10.1105/tpc.110.075549; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; Hofer R, 2008, J EXP BOT, V59, P2347, DOI 10.1093/jxb/ern101; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Hong Z, 2002, PLANT J, V32, P495, DOI 10.1046/j.1365-313X.2002.01438.x; Hu J, 2010, PLANT MOL BIOL, V73, P283, DOI 10.1007/s11103-010-9614-7; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; Itoh H, 2001, P NATL ACAD SCI USA, V98, P8909, DOI 10.1073/pnas.141239398; Jiang S, 2005, PLANT MOL BIOL, V57, P835, DOI 10.1007/s11103-005-2859-x; Jiang SY, 2007, PLANT MOL BIOL, V65, P385, DOI 10.1007/s11103-007-9233-0; Jiang SY, 2007, DEV BIOL, V304, P579, DOI 10.1016/j.ydbio.2007.01.008; Kim YS, 2011, PLANTA, V233, P251, DOI 10.1007/s00425-010-1303-x; Kolesnik T, 2004, PLANT J, V37, P301, DOI 10.1046/j.1365-313X.2003.01948.x; Li JM, 2007, TRENDS PLANT SCI, V12, P37, DOI 10.1016/j.tplants.2006.11.002; Li JA, 2011, PLANT CELL, V23, P628, DOI 10.1105/tpc.110.081901; Li WQ, 2010, PLANTA, V232, P1383, DOI 10.1007/s00425-010-1263-1; Luan WJ, 2011, PLANT BIOTECHNOL J, V9, P513, DOI 10.1111/j.1467-7652.2010.00570.x; Mishra NN, 2005, BIOSENS BIOELECTRON, V21, P696, DOI 10.1016/j.bios.2005.01.011; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Ohnishi T, 2006, PLANT CELL, V18, P3275, DOI 10.1105/tpc.106.045443; Oudin A, 1999, PLANT SCI, V149, P105, DOI 10.1016/S0168-9452(99)00144-2; Park JJ, 2010, PLANT MOL BIOL, V74, P91, DOI 10.1007/s11103-010-9656-x; Rupasinghe SG, 2007, PROTEINS, V68, P279, DOI 10.1002/prot.21335; Saitoh S, 1996, J CELL BIOL, V134, P949, DOI 10.1083/jcb.134.4.949; Sakamoto T, 2004, CURR OPIN BIOTECH, V15, P144, DOI 10.1016/j.copbio.2004.02.003; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Scott L, 1996, GENETICS, V142, P237; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Tang WQ, 2010, CURR OPIN PLANT BIOL, V13, P27, DOI 10.1016/j.pbi.2009.10.007; Ueguchi-Tanaka M, 2008, PLANT CELL, V20, P2437, DOI 10.1105/tpc.108.061648; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Wang L, 2009, PLANT J, V57, P498, DOI 10.1111/j.1365-313X.2008.03707.x; Wang M, 2004, PLANT MOL BIOL REP, V22, P409, DOI 10.1007/BF02772683; Wellesen K, 2001, P NATL ACAD SCI USA, V98, P9694, DOI 10.1073/pnas.171285998; Zhang M, 2010, PLANT J, V63, P312, DOI 10.1111/j.1365-313X.2010.04238.x; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97	50	28	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28069	10.1371/journal.pone.0028069	http://dx.doi.org/10.1371/journal.pone.0028069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140509	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163400031
J	Webster, RJ; Carter, KW; Warrington, NM; Loh, AM; Zaloumis, S; Kuijpers, TW; Palmer, LJ; Burgner, DP				Webster, Rebecca J.; Carter, Kim W.; Warrington, Nicole M.; Loh, Angeline M.; Zaloumis, Sophie; Kuijpers, Taco W.; Palmer, Lyle J.; Burgner, David P.			Hospitalisation with Infection, Asthma and Allergy in Kawasaki Disease Patients and Their Families: Genealogical Analysis Using Linked Population Data	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; CORONARY-ARTERY LESIONS; WESTERN-AUSTRALIA; ASSOCIATION; RISK; POLYMORPHISMS; CHILDREN; ALLELES; GENE	Background: Kawasaki disease results from an abnormal immunological response to one or more infectious triggers. We hypothesised that heritable differences in immune responses in Kawasaki disease-affected children and their families would result in different epidemiological patterns of other immune-related conditions. We investigated whether hospitalisation for infection and asthma/allergy were different in Kawasaki disease-affected children and their relatives. Methods/Major Findings: We used Western Australian population-linked health data from live births (1970-2006) to compare patterns of hospital admissions in Kawasaki disease cases, age-and sex-matched controls, and their relatives. There were 295 Kawasaki disease cases and 598 age-and sex-matched controls, with 1,636 and 3,780 relatives, respectively. Compared to controls, cases were more likely to have been admitted at least once with an infection (cases, 150 admissions (50.8%) vs controls, 210 admissions (35.1%); odds ratio (OR) = 1.9, 95% confidence interval (CI) 1.4-2.6, P = 7.2 x 10(-6)), and with asthma/allergy (cases, 49 admissions (16.6%) vs controls, 42 admissions (7.0%); OR = 2.6, 95% CI 1.7-4.2, P = 1.3 x 10(-5)). Cases also had more admissions per person with infection (cases, median 2 admissions, 95% CI 1-5, vs controls, median 1 admission, 95% CI 1-4, P = 1.09 x 10(-5)). The risk of admission with infection was higher in the first degree relatives of Kawasaki disease cases compared to those of controls, but the differences were not significant. Conclusion: Differences in the immune phenotype of children who develop Kawasaki disease may influence the severity of other immune-related conditions, with some similar patterns observed in relatives. These data suggest the influence of shared heritable factors in these families.	[Webster, Rebecca J.; Loh, Angeline M.; Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Perth, WA 6009, Australia; [Carter, Kim W.] Univ Western Australia, UWA Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Div Bioinformat & Biostat, Perth, WA 6009, Australia; [Warrington, Nicole M.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Zaloumis, Sophie] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Hematol Immunol & Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Burgner, David P.] Univ Western Australia, Sch Pediat & Child Hlth, Perth, WA 6009, Australia; [Burgner, David P.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Melbourne; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Western Australia; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Webster, RJ (corresponding author), Univ Western Australia, Ctr Genet Epidemiol & Biostat, Perth, WA 6009, Australia.	david.burgner@mcri.edu.au	Palmer, Lyle John/N-1948-2019; Palmer, Lyle John/K-3196-2014; Zaloumis, Sophie/AAI-4396-2020; Warrington, Nicole/P-4868-2014	Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055; Zaloumis, Sophie/0000-0002-8253-8896; Warrington, Nicole/0000-0003-4195-775X; Burgner, David/0000-0002-8304-4302				Anaya JM, 2006, CLIN DEV IMMUNOL, V13, P185, DOI 10.1080/17402520600876762; Baker AL, 2009, J PEDIATR-US, V154, P592, DOI 10.1016/j.jpeds.2008.10.006; Benseler SM, 2005, PEDIATRICS, V116, pE760, DOI 10.1542/peds.2005-0559; Biezeveld MH, 2006, ARTHRITIS RHEUM-US, V54, P369, DOI 10.1002/art.21529; Biezeveld MH, 2005, CLIN EXP IMMUNOL, V141, P183, DOI 10.1111/j.1365-2249.2005.02829.x; BROSIUS CL, 1988, PEDIATR INFECT DIS J, V7, P863; Burgner D, 2005, INT J INFECT DIS, V9, P185, DOI 10.1016/j.ijid.2005.03.002; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Carville KS, 2007, PEDIATR INFECT DIS J, V26, P210, DOI 10.1097/01.inf.0000254148.09831.7f; Chahal N, 2010, J PEDIATR HEALTH CAR, V24, P250, DOI 10.1016/j.pedhc.2009.07.002; Cheung YF, 2007, ARCH DIS CHILD, V92, P43, DOI 10.1136/adc.2006.096628; Dietert RR, 2010, WORLD J PEDIATR, V6, P111, DOI 10.1007/s12519-010-0026-1; Ding K, 2009, CIRC-CARDIOVASC GENE, V2, P63, DOI 10.1161/CIRCGENETICS.108.816751; ELIXHAUSER A, 2006, CLIN CLASSIFICATIONS; FUJITA Y, 1989, PEDIATRICS, V84, P666; Gee V, 1994, VALIDATION STUDY W A; Glasson EJ, 2008, INT J EPIDEMIOL, V37, P30, DOI 10.1093/ije/dym136; GLODE MP, 1986, PEDIATR INFECT DIS J, V5, P644, DOI 10.1097/00006454-198611000-00009; Gualano RC, 2006, PULM PHARMACOL THER, V19, P18, DOI 10.1016/j.pupt.2005.02.009; Harnden A, 2009, BMJ-BRIT MED J, V338, P1133; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Holman RC, 2005, PEDIATR INFECT DIS J, V24, P429, DOI 10.1097/01.inf.0000160946.05295.91; Ihaka R, 2001, J COMPUTATIONAL GRAP, V5, P299; Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x; Kimura J, 2004, CLIN EXP IMMUNOL, V137, P444, DOI 10.1111/j.1365-2249.2004.02506.x; Kuijpers TW, 1999, J INFECT DIS, V180, P1869, DOI 10.1086/315111; Kuo HC, 2009, PEDIAT ALLERG IMM-UK, V20, P266, DOI 10.1111/j.1399-3038.2008.00779.x; Liew WK, 2011, PEDIAT ALLERGY IMMUN; Mackay IR, 2009, J AUTOIMMUN, V33, P170, DOI 10.1016/j.jaut.2009.09.006; Maier LM, 2009, IMMUNOL REV, V229, P322, DOI 10.1111/j.1600-065X.2009.00777.x; Matsubara T, 1999, CLIN EXP IMMUNOL, V116, P554; Matsuoka S, 1997, EUR J PEDIATR, V156, P30; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; Nielsen NM, 2011, AM J EPIDEMIOL, V173, P990, DOI 10.1093/aje/kwq492; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Read A, 1996, P BRISB WORKSH NOV; Rowley AH, 2011, J INFECT DIS, V203, P1021, DOI 10.1093/infdis/jiq136; Royle JA, 1998, ARCH DIS CHILD, V78, P33, DOI 10.1136/adc.78.1.33; Sato S, 2009, INT J RHEUM DIS, V12, P307, DOI 10.1111/j.1756-185X.2009.01428.x; Selarnet Tierney ES, 2007, J PEDIATR-US, V151, P225, DOI 10.1016/j.jpeds.2007.05.011; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Shikishima Y, 2003, ASIAN PAC J ALLERGY, V21, P139; STANLEY FJ, 1994, PAEDIATR PERINAT EP, V8, P433, DOI 10.1111/j.1365-3016.1994.tb00482.x; Tsai FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016853; Uehara R, 2003, ACTA PAEDIATR, V92, P694, DOI 10.1080/08035320310002768; Worthley DL, 2005, INTERN MED J, V35, P548, DOI 10.1111/j.1445-5994.2005.00908.x	47	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e28004	10.1371/journal.pone.0028004	http://dx.doi.org/10.1371/journal.pone.0028004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140498	Green Published, gold			2022-12-25	WOS:000298163400028
J	Ameis, SH; Fan, J; Rockel, C; Voineskos, AN; Lobaugh, NJ; Soorya, L; Wang, AT; Hollander, E; Anagnostou, E				Ameis, Stephanie H.; Fan, Jin; Rockel, Conrad; Voineskos, Aristotle N.; Lobaugh, Nancy J.; Soorya, Latha; Wang, A. Ting; Hollander, Eric; Anagnostou, Evdokia			Impaired Structural Connectivity of Socio-Emotional Circuits in Autism Spectrum Disorders: A Diffusion Tensor Imaging Study	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; WHITE-MATTER; IN-VIVO; SENTENCE COMPREHENSION; ATYPICAL DEVELOPMENT; SPATIAL-STATISTICS; BRAIN CONNECTIVITY; ASPERGER-SYNDROME; AMYGDALA DAMAGE; TEMPORAL STEM	Background: Abnormal white matter development may disrupt integration within neural circuits, causing particular impairments in higher-order behaviours. In autism spectrum disorders (ASDs), white matter alterations may contribute to characteristic deficits in complex socio-emotional and communication domains. Here, we used diffusion tensor imaging (DTI) and tract based spatial statistics (TBSS) to evaluate white matter microstructure in ASD. Methods/Principal Findings: DTI scans were acquired for 19 children and adolescents with ASD (>8-18 years; mean 12.4 +/- 3.1) and 16 age and IQ matched controls (>8-18 years; mean 12.3 +/- 3.6) on a 3T MRI system. DTI values for fractional anisotropy, mean diffusivity, radial diffusivity and axial diffusivity, were measured. Age by group interactions for global and voxel-wise white matter indices were examined. Voxel-wise analyses comparing ASD with controls in: (i) the full cohort (ii), children only (<= 12 yrs.), and (iii) adolescents only (>12 yrs.) were performed, followed by tract-specific comparisons. Significant age-by-group interactions on global DTI indices were found for all three diffusivity measures, but not for fractional anisotropy. Voxel-wise analyses revealed prominent diffusion measure differences in ASD children but not adolescents, when compared to healthy controls. Widespread increases in mean and radial diffusivity in ASD children were prominent in frontal white matter voxels. Follow-up tract-specific analyses highlighted disruption to pathways integrating frontal, temporal, and occipital structures involved in socio-emotional processing. Conclusions/Significance: Our findings highlight disruption of neural circuitry in ASD, particularly in those white matter tracts that integrate the complex socio-emotional processing that is impaired in this disorder.	[Ameis, Stephanie H.] Univ Toronto, Hosp Sick Children, Dept Psychiat, Toronto, ON M5G 1X8, Canada; [Fan, Jin] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA; [Fan, Jin; Wang, A. Ting] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Fan, Jin; Wang, A. Ting] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Rockel, Conrad] Univ Toronto, Hosp Sick Children, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Voineskos, Aristotle N.] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Lobaugh, Nancy J.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Fac Med, Sunnybrook Res Inst,LC Campbell Cognit Neurol Res, Toronto, ON, Canada; [Lobaugh, Nancy J.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Fac Med, Sunnybrook Res Inst,Brain Sci Res Program, Toronto, ON, Canada; [Soorya, Latha; Anagnostou, Evdokia] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Hollander, Eric] Univ Hosp, Albert Einstein Coll Med, Dept Psychiat, Montefiore Med Ctr, Bronx, NY USA; [Anagnostou, Evdokia] Univ Toronto, Dept Pediat, Bloorview Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); City University of New York (CUNY) System; Queens College NY (CUNY); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Icahn School of Medicine at Mount Sinai; Montefiore Medical Center; State University of New York (SUNY) System; Yeshiva University; Albert Einstein College of Medicine; University of Toronto	Ameis, SH (corresponding author), Univ Toronto, Hosp Sick Children, Dept Psychiat, Toronto, ON M5G 1X8, Canada.	eanagnostou@hollandbloorview.ca	Fan, Jin/A-6716-2009; Ameis, Stephanie H./Q-4822-2018; Fan, Jin/L-2055-2019; Voineskos, Aristotle/J-5014-2013	Fan, Jin/0000-0001-9630-8330; Fan, Jin/0000-0001-9630-8330; Voineskos, Aristotle/0000-0003-0156-0395	NARSAD; Autism Speaks; NIMH [MH083164]; Autism Research Training Program; Canadian Institutes of Health Research (CIHR); Clinician Scientist Award; American Psychiatric Association; Heart and Stroke Foundation Centre for Stroke Recovery; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083164] Funding Source: NIH RePORTER	NARSAD(NARSAD); Autism Speaks; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Autism Research Training Program; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Clinician Scientist Award; American Psychiatric Association; Heart and Stroke Foundation Centre for Stroke Recovery(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NARSAD (PI: Anagnostou), Autism Speaks (PI: Anagnostou), NIMH MH083164 (PI: Fan), the Autism Research Training Program (salary support to SA), funded by the Canadian Institutes of Health Research (CIHR), CIHR for support from the Clinician Scientist Award to AV, and the American Psychiatric Association for support from the Young Minds in Psychiatry Award to AV. NJL received salary support from the Heart and Stroke Foundation Centre for Stroke Recovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1285, DOI 10.1016/S0028-3932(99)00023-8; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Barnea-Goraly N, 2010, ARCH GEN PSYCHIAT, V67, P1052, DOI 10.1001/archgenpsychiatry.2010.123; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Bloemen OJN, 2010, AUTISM RES, V3, P203, DOI 10.1002/aur.146; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Carper RA, 2002, NEUROIMAGE, V16, P1038, DOI 10.1006/nimg.2002.1099; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cheng YW, 2010, NEUROIMAGE, V50, P873, DOI 10.1016/j.neuroimage.2010.01.011; Cheung C, 2009, J CHILD PSYCHOL PSYC, V50, P1102, DOI 10.1111/j.1469-7610.2009.02086.x; Chiang MC, 2009, J NEUROSCI, V29, P2212, DOI 10.1523/JNEUROSCI.4184-08.2009; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Conturo TE, 2008, J INT NEUROPSYCH SOC, V14, P933, DOI 10.1017/S1355617708081381; Courchesne E, 2004, CURR OPIN NEUROL, V17, P489, DOI 10.1097/01.wco.0000137542.14610.b4; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; DeFelipe J, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.004.2010; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Dubischar-Krivec AM, 2009, PSYCHOL MED, V39, P1355, DOI 10.1017/S0033291708004601; Ebisch SJH, 2010, HUM BRAIN MAPP; Faria AV, 2010, NEUROIMAGE, V52, P415, DOI 10.1016/j.neuroimage.2010.04.238; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fields RD, 2008, SCI AM, V298, P54; Fuentes CT, 2009, NEUROLOGY, V73, P1532, DOI 10.1212/WNL.0b013e3181c0d48c; Gao W, 2009, AM J NEURORADIOL, V30, P290, DOI 10.3174/ajnr.A1363; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; Herbert MR, 2003, BRAIN, V126, P1182, DOI 10.1093/brain/awg110; HOLM S, 1979, SCAND J STAT, V6, P65; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kana RK, 2006, BRAIN, V129, P2484, DOI 10.1093/brain/awl164; Ke XY, 2009, BRAIN RES, V1265, P171, DOI 10.1016/j.brainres.2009.02.013; Kier EL, 2004, AM J NEURORADIOL, V25, P677; Klawiter E. C., 2011, NEUROIMAGE; Koshino H, 2005, NEUROIMAGE, V24, P810, DOI 10.1016/j.neuroimage.2004.09.028; Kumar A, 2009, CEREB CORTEX; Lee JE, 2007, NEUROSCI LETT, V424, P127, DOI 10.1016/j.neulet.2007.07.042; Lo YC, 2011, PSYCHIAT RES-NEUROIM, V192, P60, DOI 10.1016/j.pscychresns.2010.09.008; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nation K, 2006, J AUTISM DEV DISORD, V36, P911, DOI 10.1007/s10803-006-0130-1; Odegard TN, 2009, NEUROPSYCHOLOGIA, V47, P1972, DOI 10.1016/j.neuropsychologia.2009.03.009; Pardini M, 2009, EUR J NEUROL, V16, P1185, DOI 10.1111/j.1468-1331.2009.02699.x; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Pelphrey K, 2004, MENT RETARD DEV D R, V10, P259, DOI 10.1002/mrdd.20040; Pelphrey KA, 2008, DEV PSYCHOPATHOL, V20, P1081, DOI 10.1017/S0954579408000515; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; Pierce K, 2008, BIOL PSYCHIAT, V64, P552, DOI 10.1016/j.biopsych.2008.05.013; Poutska L, 2011, WORLD J BIOL PSYCHIA; Pugliese L, 2009, NEUROIMAGE, V47, P427, DOI 10.1016/j.neuroimage.2009.05.014; Radua J, 2010, PSYCHOL MED, V16, P1; Robb RA, 2001, IEEE T MED IMAGING, V20, P854, DOI 10.1109/42.952724; ROBB RA, 1989, IEEE T MED IMAGING, V8, P217, DOI 10.1109/42.34710; ROBB RA, 1989, COMPUT MED IMAG GRAP, V13, P433, DOI 10.1016/0895-6111(89)90285-1; Sahyoun CP, 2010, BRAIN COGNITION, V73, P180, DOI 10.1016/j.bandc.2010.05.002; Sakurai T, 2010, BIOL PSYCHIAT, V67, P887, DOI 10.1016/j.biopsych.2009.08.042; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Shukla DK, 2011, NEUROPSYCHOLOGIA, V49, P1378, DOI 10.1016/j.neuropsychologia.2011.02.022; Shukla DK, 2011, J CHILD PSYCHOL PSYC, V52, P286, DOI 10.1111/j.1469-7610.2010.02342.x; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Thakkar KN, 2008, BRAIN, V131, P2464, DOI 10.1093/brain/awn099; Thomas C, 2011, CORTEX, V47, P863, DOI 10.1016/j.cortex.2010.07.006; van Eimeren L, 2008, NEUROREPORT, V19, P1117, DOI 10.1097/WNR.0b013e328307f5c1; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Weschler D, 2004, WESCHLER INTELLIGENC; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wicker B, 2008, SOC COGN AFFECT NEUR, V3, P135, DOI 10.1093/scan/nsn007; Zikopoulos B, 2010, J NEUROSCI, V30, P14595, DOI 10.1523/JNEUROSCI.2257-10.2010	83	78	80	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28044	10.1371/journal.pone.0028044	http://dx.doi.org/10.1371/journal.pone.0028044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KL	22132206	Green Published, gold			2022-12-25	WOS:000298162000062
J	Frenzel, A; Zirath, H; Vita, M; Albihn, A; Henriksson, MA				Frenzel, Anna; Zirath, Hanna; Vita, Marina; Albihn, Ami; Henriksson, Marie Arsenian			Identification of Cytotoxic Drugs That Selectively Target Tumor Cells with MYC Overexpression	PLOS ONE			English	Article							C-MYC; INDUCED APOPTOSIS; NEUROBLASTOMA-CELLS; N-MYC; SMALL MOLECULES; ADULT BURKITT; INHIBITION; EXPRESSION; THERAPY; CANCER	Expression of MYC is deregulated in a wide range of human cancers, and is often associated with aggressive disease and poorly differentiated tumor cells. Identification of compounds with selectivity for cells overexpressing MYC would hence be beneficial for the treatment of these tumors. For this purpose we used cell lines with conditional MYCN or c-MYC expression, to screen a library of 80 conventional cytotoxic compounds for their ability to reduce tumor cell viability and/or growth in a MYC dependent way. We found that 25% of the studied compounds induced apoptosis and/or inhibited proliferation in a MYC-specific manner. The activities of the majority of these were enhanced both by c-MYC or MYCN over-expression. Interestingly, these compounds were acting on distinct cellular targets, including microtubules (paclitaxel, podophyllotoxin, vinblastine) and topoisomerases (10-hydroxycamptothecin, camptothecin, daunorubicin, doxorubicin, etoposide) as well as DNA, RNA and protein synthesis and turnover (anisomycin, aphidicholin, gliotoxin, MG132, methotrexate, mitomycin C). Our data indicate that MYC overexpression sensitizes cells to disruption of specific pathways and that in most cases c-MYC and MYCN overexpression have similar effects on the responses to cytotoxic compounds. Treatment of the cells with topoisomerase I inhibitors led to down-regulation of MYC protein levels, while doxorubicin and the small molecule MYRA-A was found to disrupt MYC-Max interaction. We conclude that the MYC pathway is only targeted by a subset of conventional cytotoxic drugs currently used in the clinic. Elucidating the mechanisms underlying their specificity towards MYC may be of importance for optimizing treatment of tumors with MYC deregulation. Our data also underscores that MYC is an attractive target for novel therapies and that cellular screenings of chemical libraries can be a powerful tool for identifying compounds with a desired biological activity.	[Frenzel, Anna; Zirath, Hanna; Vita, Marina; Albihn, Ami; Henriksson, Marie Arsenian] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden	Karolinska Institutet	Frenzel, A (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	Marie.Henriksson@ki.se	Henriksson, Marie Arsenian/F-5010-2015	Arsenian Henriksson, Marie/0000-0001-6376-7792; Zirath, Herbert/0000-0002-5721-4793	Swedish Cancer Society; Petrus and Augusta Hedlund Foundation; Ake Olsson Foundation; Swedish Childhood Cancer Foundation; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Petrus and Augusta Hedlund Foundation; Ake Olsson Foundation; Swedish Childhood Cancer Foundation(European Commission); Karolinska Institutet(Karolinska Institutet)	MAH was the recipient of a Senior Investigator Award by the Swedish Cancer Society. This work has been supported by the Swedish Cancer Society, the Petrus and Augusta Hedlund Foundation, the Ake Olsson Foundation, the Swedish Childhood Cancer Foundation and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Albihn A, 2007, INT J CANCER, V121, P1821, DOI 10.1002/ijc.22866; Albihn A, 2006, J CELL BIOCHEM, V98, P1597, DOI 10.1002/jcb.20816; Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Bejarano MT, 2000, EXP CELL RES, V260, P61, DOI 10.1006/excr.2000.4996; Bottone MG, 2003, EXP CELL RES, V290, P49, DOI 10.1016/S0014-4827(03)00312-4; Bourgarel-Rey V, 2000, EUR J CANCER, V36, P1043, DOI 10.1016/S0959-8049(00)00042-3; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Citro G, 1998, CANCER RES, V58, P283; Courapied S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-205; Di Nicola M, 2004, BRIT J HAEMATOL, V126, P815, DOI 10.1111/j.1365-2141.2004.05141.x; Dorjsuren D, 2006, ANTIVIR RES, V69, P9, DOI 10.1016/j.antiviral.2005.09.005; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Felsher Dean W, 2010, Genes Cancer, V1, P597, DOI 10.1177/1947601910377798; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fong A, 2009, PEDIATR HEMAT ONCOL, V26, P539, DOI 10.3109/08880010903121173; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Fulda S, 2000, MED PEDIATR ONCOL, V35, P582, DOI 10.1002/1096-911X(20001201)35:6<582::AID-MPO19>3.0.CO;2-2; Gatti G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005442; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Grassilli E, 2004, J BIOL CHEM, V279, P21318, DOI 10.1074/jbc.M313532200; Guerra L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008924; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Kujawski LA, 2007, CANCER INVEST, V25, P87, DOI 10.1080/07357900701205507; Larsson LG, 2010, EXP CELL RES, V316, P1429, DOI 10.1016/j.yexcr.2010.03.025; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; Lutz W, 1996, ONCOGENE, V13, P803; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mo H, 2006, P NATL ACAD SCI USA, V103, P6344, DOI 10.1073/pnas.0601418103; Mo H, 2006, CELL CYCLE, V5, P2191, DOI 10.4161/cc.5.19.3320; Nesbit CE, 1998, CELL GROWTH DIFFER, V9, P731; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Paffhausen T, 2007, CANCER LETT, V250, P17, DOI 10.1016/j.canlet.2006.09.010; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Prochownik Edward V, 2010, Genes Cancer, V1, P650; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; SKLAR MD, 1991, CANCER RES, V51, P2118; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucie EL, 2001, MOL CELL BIOL, V21, P4725, DOI 10.1128/MCB.21.14.4725-4736.2001; Thomas DA, 2006, CANCER-AM CANCER SOC, V106, P1569, DOI 10.1002/cncr.21776; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Westermark UK, 2011, SEMIN CANCER BIOL, V21, P256, DOI 10.1016/j.semcancer.2011.08.001; Yang D, 2010, P NATL ACAD SCI USA, V107, P13836, DOI 10.1073/pnas.1008366107; YEN YT, 1991, BIOCHEM BIOPH RES CO, V179, P1241, DOI 10.1016/0006-291X(91)91705-H	51	21	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27988	10.1371/journal.pone.0027988	http://dx.doi.org/10.1371/journal.pone.0027988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132187	Green Published, Green Submitted, gold			2022-12-25	WOS:000298162000056
J	Kaushik, S; Sowdhamini, R				Kaushik, Swati; Sowdhamini, Ramanathan			Structural Analysis of Prolyl Oligopeptidases Using Molecular Docking and Dynamics: Insights into Conformational Changes and Ligand Binding	PLOS ONE			English	Article							PROTEIN DATA-BANK; ENDOPEPTIDASE INHIBITOR; FAMILY ENZYMES; CDNA CLONING; ACTIVE-SITE; AGED RATS; IN-VITRO; S 17092; BRAIN; JTP-4819	Prolyl oligopeptidase (POP) is considered as an important pharmaceutical target for the treatment of numerous diseases. Despite enormous studies on various aspects of POPs structure and function still some of the questions are intriguing like conformational dynamics of the protein and interplay between ligand entry/egress. Here, we have used molecular modeling and docking based approaches to unravel questions like differences in ligand binding affinities in three POP species (porcine, human and A. thaliana). Despite high sequence and structural similarity, they possess different affinities for the ligands. Interestingly, human POP was found to be more specific, selective and incapable of binding to a few planar ligands which showed extrapolation of porcine POP in human context is more complicated. Possible routes for substrate entry and product egress were also investigated by detailed analyses of molecular dynamics (MD) simulations for the three proteins. Trajectory analysis of bound and unbound forms of three species showed differences in conformational dynamics, especially variations in beta-propeller pore size, which was found to be hidden by five lysine residues present on blades one and seven. During simulation, beta-propeller pore size was increased by similar to 2 angstrom in porcine ligand-bound form which might act as a passage for smaller product movement as free energy barrier was reduced, while there were no significant changes in human and A. thaliana POPs. We also suggest that these differences in pore size could lead to fundamental differences in mode of product egress among three species. This analysis also showed some functionally important residues which can be used further for in vitro mutagenesis and inhibitor design. This study can help us in better understanding of the etiology of POPs in several neurodegenerative diseases.	[Kaushik, Swati; Sowdhamini, Ramanathan] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Kaushik, S (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	mini@ncbs.res.in	Kaushik, Swati/AAR-6954-2020	Kaushik, Swati/0000-0002-3562-8522	Department of Biotechnology, India; Wellcome Trust (United Kingdom); National Centre for Biological Sciences (Tata Institute of Fundamental Research)	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Wellcome Trust (United Kingdom)(Wellcome Trust); National Centre for Biological Sciences (Tata Institute of Fundamental Research)	Funding provided by the Department of Biotechnology, India; Wellcome Trust (United Kingdom) for previous funding to RS, and National Centre for Biological Sciences (Tata Institute of Fundamental Research) for infrastructural support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARAI H, 1993, CHEM PHARM BULL, V41, P1583; ATACK JR, 1991, EUR J PHARMACOL, V205, P157, DOI 10.1016/0014-2999(91)90814-7; Atta-Ur-Rahman, 2005, NAT PROD RES, V19, P13, DOI 10.1080/14786410310001643885; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Brandt I, 2008, PEPTIDES, V29, P1472, DOI 10.1016/j.peptides.2008.05.005; Cacabelos R, 2000, DRUG TODAY, V36, P415; Cunningham DF, 1997, BBA-PROTEIN STRUCT M, V1343, P160, DOI 10.1016/S0167-4838(97)00134-9; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Fuxreiter M, 2005, PROTEINS, V60, P504, DOI 10.1002/prot.20508; Garcia-Horsman JA, 2007, NEUROPEPTIDES, V41, P1, DOI 10.1016/j.npep.2006.10.004; Goossens F, 1996, EUR J CLIN CHEM CLIN, V34, P17; Haffner CD, 2008, BIOORG MED CHEM LETT, V18, P4360, DOI 10.1016/j.bmcl.2008.06.067; HOLST M, 1993, J COMPUT CHEM, V14, P105, DOI 10.1002/jcc.540140114; Ishino T, 1998, J BIOCHEM-TOKYO, V123, P540; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KANATANI A, 1993, J BIOCHEM, V113, P790, DOI 10.1093/oxfordjournals.jbchem.a124120; Kaszuba K, 2009, SAR QSAR ENVIRON RES, V20, P595, DOI 10.1080/10629360903438198; Kato A, 1997, J PHARMACOL EXP THER, V283, P328; Katsube N, 1999, J PHARMACOL EXP THER, V288, P6; Katsube N, 2000, CNS DRUG REV, V6, P21; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawandi J, 2010, J MED CHEM, V53, P3423, DOI 10.1021/jm901104g; Lee PH, 2009, NUCLEIC ACIDS RES, V37, pW559, DOI 10.1093/nar/gkp359; Li JR, 1996, J NEUROCHEM, V66, P2105; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; MAES M, 1994, BIOL PSYCHIAT, V35, P545, DOI 10.1016/0006-3223(94)90101-5; MAES M, 1995, PSYCHIAT RES, V58, P217, DOI 10.1016/0165-1781(95)02698-V; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Morain P, 2000, BRIT J CLIN PHARMACO, V50, P350, DOI 10.1046/j.1365-2125.2000.00270.x; Morain P, 2002, CNS DRUG REV, V8, P31; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; NAKAJIMA T, 1992, NEUROSCI LETT, V141, P156, DOI 10.1016/0304-3940(92)90884-A; Ohtsuki S, 1997, INSECT BIOCHEM MOLEC, V27, P337, DOI 10.1016/S0965-1748(97)00004-0; Petit A, 2000, BRIT J PHARMACOL, V130, P1613, DOI 10.1038/sj.bjp.0703440; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Portevin B, 1996, J MED CHEM, V39, P2379, DOI 10.1021/jm950858c; Rea D, 2006, CELL BIOCHEM BIOPHYS, V44, P349, DOI 10.1385/CBB:44:3:349; RENNEX D, 1991, BIOCHEMISTRY-US, V30, P2195, DOI 10.1021/bi00222a025; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider JS, 2002, NEUROPSYCHOPHARMACOL, V26, P176, DOI 10.1016/S0893-133X(01)00307-4; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Serrano SMT, 2005, TOXICON, V45, P1115, DOI 10.1016/j.toxicon.2005.02.020; Shan L, 2005, P NATL ACAD SCI USA, V102, P3599, DOI 10.1073/pnas.0408286102; Shinoda M, 1997, BIOCHEM BIOPH RES CO, V235, P641, DOI 10.1006/bbrc.1997.6730; SHIRASAWA Y, 1994, J BIOCHEM-TOKYO, V115, P724, DOI 10.1093/oxfordjournals.jbchem.a124402; Szeltner Z, 2004, J MOL BIOL, V340, P627, DOI 10.1016/j.jmb.2004.05.011; Tarrago T, 2005, J PEPT SCI, V11, P283, DOI 10.1002/psc.676; Tarrago T, 2008, CHEMMEDCHEM, V3, P1558, DOI 10.1002/cmdc.200800152; Tarrago T, 2008, BIOORGAN MED CHEM, V16, P7516, DOI 10.1016/j.bmc.2008.04.067; Tarrago T, 2007, CHEMMEDCHEM, V2, P354, DOI 10.1002/cmdc.200600303; Tarrago T, 2009, FEBS LETT, V583, P3344, DOI 10.1016/j.febslet.2009.09.036; Tenorio-Laranga J, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-23; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOIDE K, 1995, J PHARMACOL EXP THER, V274, P1370; TOIDE K, 1995, J NEUROCHEM, V65, P234; Toide K, 1996, N-S ARCH PHARMACOL, V353, P355, DOI 10.1007/BF00168640; Toide K, 1997, PHARMACOL BIOCHEM BE, V56, P427, DOI 10.1016/S0091-3057(96)00238-9; Toide K, 1997, BEHAV BRAIN RES, V83, P147, DOI 10.1016/S0166-4328(97)86059-7; VANHOOF G, 1994, GENE, V149, P363, DOI 10.1016/0378-1119(94)90177-5; Venalainen JI, 2004, EUR J BIOCHEM, V271, P2705, DOI 10.1111/j.1432-1033.2004.04199.x; Wallen EAA, 2002, BIOORGAN MED CHEM, V10, P2199, DOI 10.1016/S0968-0896(02)00061-5; WALTER R, 1978, BIOCHEMISTRY-US, V17, P4139, DOI 10.1021/bi00613a006; WALTER R, 1971, SCIENCE, V173, P828, DOI 10.1126/science.173.3999.827; Westbrook J, 2002, NUCLEIC ACIDS RES, V30, P245, DOI 10.1093/nar/30.1.245; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WILK S, 1983, J NEUROCHEM, V41, P69, DOI 10.1111/j.1471-4159.1983.tb11815.x; Williams RSB, 2004, CLIN NEUROSCI RES, V4, P233, DOI 10.1016/j.cnr.2004.09.015; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Yoshimoto T, 1997, BIOL PHARM BULL, V20, P1047; YOSHIMOTO T, 1991, AGR BIOL CHEM TOKYO, V55, P37, DOI 10.1080/00021369.1991.10870532	75	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e26251	10.1371/journal.pone.0026251	http://dx.doi.org/10.1371/journal.pone.0026251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132071	Green Submitted, Green Published, gold			2022-12-25	WOS:000298162000003
J	Laarhoven, LM; de Heus, P; van Luijn, J; Duim, B; Wagenaar, JA; van Duijkeren, E				Laarhoven, Laura M.; de Heus, Phebe; van Luijn, Jeanine; Duim, Birgitta; Wagenaar, Jaap A.; van Duijkeren, Engeline			Longitudinal Study on Methicillin-Resistant Staphylococcus pseudintermedius in Households	PLOS ONE			English	Article							CLINICAL-SAMPLES; AUREUS; COLONIZATION; DOGS; EMERGENCE; CARRIAGE; HEALTHY; SCCMEC; SPREAD; MEC	Methicillin-resistant Staphylococcus pseudintermedius (MRSP) is an emerging pathogen in dogs and has been found in Europe, Asia and North America. To date most studies are one-point prevalence studies and therefore little is known about the dynamics of MRSP in dogs and their surrounding. In this longitudinal study MRSP colonization in dogs and the transmission of MRSP to humans, contact animals and the environment was investigated. Sixteen dogs with a recent clinical MRSP infection were included. The index dogs, contact animals, owners and environments were sampled once a month for six months. Samples taken from the nose, perineum and infection site (if present) of the index cases and contact animals, and the nares of the owners were cultured using pre-enrichment. Index cases were found positive for prolonged periods of time, in two cases during all six samplings. In five of the 12 households that were sampled during six months, the index case was intermittently found MRSP-positive. Contact animals and the environment were also found MRSP-positive, most often in combination with a MRSP-positive index dog. In four households positive environmental samples were found while no animals or humans were MRSP-positive, indicating survival of MRSP in the environment for prolonged periods of time. Genotyping revealed that generally similar or indistinguishable MRSP isolates were found in patients, contact animals and environmental samples within the same household. Within two households, however, genetically distinct MRSP isolates were found. These results show that veterinarians should stay alert with (former) MRSP patients, even after repeated MRSP-negative cultures or after the disappearance of the clinical infection. There is a considerable risk of transmission of MRSP to animals in close contact with MRSP patients. Humans were rarely MRSP-positive and never tested MRSP-positive more than once suggesting occasional contamination or rapid elimination of colonization of the owners.	[Laarhoven, Laura M.; de Heus, Phebe; van Luijn, Jeanine; Duim, Birgitta; Wagenaar, Jaap A.; van Duijkeren, Engeline] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Wagenaar, Jaap A.] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [van Duijkeren, Engeline] Natl Inst Publ Hlth & Environm, Lab Zoonoses & Environm Microbiol, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	Laarhoven, LM (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.	Engeline.van.duijkeren@rivm.nl		de Heus, Phebe/0000-0002-3799-2096	Royal Dutch Veterinary Association	Royal Dutch Veterinary Association	This study was supported by a grant from the Royal Dutch Veterinary Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannoehr J, 2007, J BACTERIOL, V189, P8685, DOI 10.1128/JB.01150-07; Bannoehr J, 2009, J CLIN MICROBIOL, V47, P469, DOI 10.1128/JCM.01915-08; Campanile F, 2007, MICROB DRUG RESIST, V13, P7, DOI 10.1089/mdr.2006.9991; Descloux S, 2008, J CLIN MICROBIOL, V46, P1818, DOI 10.1128/JCM.02255-07; Fazakerley J, 2010, VET DERMATOL, V21, P578, DOI 10.1111/j.1365-3164.2010.00894.x; Francois P, 2003, J CLIN MICROBIOL, V41, P254, DOI 10.1128/JCM.41.1.254-260.2003; Gerstadt K, 1999, CLIN INFECT DIS, V29, P218, DOI 10.1086/520168; Graveland H, 2009, VET MICROBIOL, V139, P121, DOI 10.1016/j.vetmic.2009.05.019; Griffeth GC, 2008, VET DERMATOL, V19, P142, DOI 10.1111/j.1365-3164.2008.00663.x; Hanselman BA, 2008, VET MICROBIOL, V126, P277, DOI 10.1016/j.vetmic.2007.06.015; Hanselman BA, 2009, CAN VET J, V50, P954; Kempker R, 2009, AM J MED SCI, V338, P425, DOI 10.1097/MAJ.0b013e3181b0baa9; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Moodley A, 2009, VET MICROBIOL, V135, P320, DOI 10.1016/j.vetmic.2008.09.070; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Nienhoff U, 2011, VET MICROBIOL, V150, P191, DOI 10.1016/j.vetmic.2010.12.018; Paul NC, 2011, ZOONOSES PUBLIC HLTH, V58, P533, DOI 10.1111/j.1863-2378.2011.01398.x; Penna B, 2010, CAN VET J, V51, P738; Penna B, 2010, VET DERMATOL, V21, P292, DOI 10.1111/j.1365-3164.2009.00842.x; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; Ruscher C, 2010, VET MICROBIOL, V144, P340, DOI 10.1016/j.vetmic.2010.01.008; Ruscher C, 2009, VET MICROBIOL, V136, P197, DOI 10.1016/j.vetmic.2008.10.023; Sasaki T, 2007, J CLIN MICROBIOL, V45, P1118, DOI 10.1128/JCM.02193-06; Stegmann R, 2010, J ANTIMICROB CHEMOTH, V65, P2047, DOI 10.1093/jac/dkq241; van Duijkeren E, 2011, VET MICROBIOL, V150, P338, DOI 10.1016/j.vetmic.2011.02.012; Vengust M, 2006, LETT APPL MICROBIOL, V43, P602, DOI 10.1111/j.1472-765X.2006.02018.x; Wagenvoort JHT, 2000, J HOSP INFECT, V45, P231, DOI 10.1053/jhin.2000.0757; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039	29	67	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27788	10.1371/journal.pone.0027788	http://dx.doi.org/10.1371/journal.pone.0027788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132141	Green Submitted, Green Published, gold			2022-12-25	WOS:000298162000043
J	Nakamura, S; Nagata, Y; Tan, L; Takemura, T; Shibata, K; Fujie, M; Fujisawa, S; Tanaka, Y; Toda, M; Makita, R; Tsunekawa, K; Yamada, M; Yamaoka, M; Yamashita, J; Ohnishi, K; Yamashita, M				Nakamura, Satoki; Nagata, Yasuyuki; Tan, Lin; Takemura, Tomonari; Shibata, Kiyoshi; Fujie, Michio; Fujisawa, Shinya; Tanaka, Yasutaka; Toda, Mitsuo; Makita, Reiko; Tsunekawa, Kenji; Yamada, Manabu; Yamaoka, Mayumi; Yamashita, Junko; Ohnishi, Kazunori; Yamashita, Mitsuji			Transcriptional Repression of Cdc25B by IER5 Inhibits the Proliferation of Leukemic Progenitor Cells through NF-YB and p300 in Acute Myeloid Leukemia	PLOS ONE			English	Article							HUMAN LYMPHOBLASTOID-CELLS; GENOTOXIC STRESS; GENE-EXPRESSION; DNA-DAMAGE; GAMMA-RAY; CYCLE; PHOSPHATASES; CANCER; OVEREXPRESSION; CARCINOMAS	The immediately-early response gene 5 (IER5) has been reported to be induced by c-ray irradiation and to play a role in the induction of cell death caused by radiation. We previously identified IER5 as one of the 2,3,4-tribromo-3-methyl-1-phenylphospholane 1-oxide (TMPP)-induced transcriptional responses in AML cells, using microarrays that encompassed the entire human genome. However, the biochemical pathway and mechanisms of IER5 function in regulation of the cell cycle remain unclear. In this study, we investigated the involvement of IER5 in the cell cycle and in cell proliferation of acute myeloid leukemia (AML) cells. We found that the over-expression of IER5 in AML cell lines and in AML-derived ALDH(hi) (High Aldehyde Dehydrogenase activity)/CD34(+) cells inhibited their proliferation compared to control cells, through induction of G2/M cell cycle arrest and a decrease in Cdc25B expression. Moreover, the over-expression of IER5 reduced colony formation of AML-derived ALDH(hi) /CD34(+) cells due to a decrease in Cdc25B expression. In addition, over-expression of Cdc25B restored TMPP inhibitory effects on colony formation in IER5-suppressed AML-derived ALDH(hi) /CD34(+) cells. Furthermore, the IER5 reduced Cdc25B mRNA expression through direct binding to Cdc25B promoter and mediated its transcriptional attenuation through NF-YB and p300 transcriptinal factors. In summary, we found that transcriptional repression mediated by IER5 regulates Cdc25B expression levels via the release of NF-YB and p300 in AML-derived ALDH(hi) /CD34(+) cells, resulting in inhibition of AML progenitor cell proliferation through modulation of cell cycle. Thus, the induction of IER5 expression represents an attractive target for AML therapy.	[Nakamura, Satoki; Nagata, Yasuyuki; Tan, Lin; Takemura, Tomonari; Ohnishi, Kazunori] Hamamatsu Univ Sch Med, Dept Internal Med 3, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Nagata, Yasuyuki; Tan, Lin; Takemura, Tomonari; Ohnishi, Kazunori] Hamamatsu Univ Sch Med, Ctr Canc, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Shibata, Kiyoshi; Fujie, Michio] Hamamatsu Univ Sch Med, Equipment Ctr, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Fujisawa, Shinya] Hamamatsu Med Ctr, Div Hematol, Naka Ku, Hamamatsu, Shizuoka, Japan; [Tanaka, Yasutaka; Toda, Mitsuo; Makita, Reiko; Tsunekawa, Kenji; Yamada, Manabu; Yamaoka, Mayumi; Yamashita, Junko; Yamashita, Mitsuji] Shizuoka Univ, Grad Sch Sci & Technol, Dept Nano Mat, Naka Ku, Hamamatsu, Shizuoka 4328011, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Shizuoka University	Nakamura, S (corresponding author), Hamamatsu Univ Sch Med, Dept Internal Med 3, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan.	satonaka@hama-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [17590987]; Grants-in-Aid for Scientific Research [21650108, 21590621] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for scientific research (#17590987) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aressy B, 2008, ANTI-CANCER AGENT ME, V8, P818, DOI 10.2174/187152008786847756; Bansal P, 2007, CANCER RES, V67, P3356, DOI 10.1158/0008-5472.CAN-06-3685; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Broggini M, 2000, ANTICANCER RES, V20, P4835; Bugler B, 2006, MOL CANCER THER, V5, P1446, DOI 10.1158/1535-7163.MCT-06-0099; Chung KC, 1998, MOL CELL BIOL, V18, P2272, DOI 10.1128/MCB.18.4.2272; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; Dalvai M, 2011, ONCOGENE, V30, P2282, DOI 10.1038/onc.2010.588; Didier C, 2008, ONCOGENE, V27, P3811, DOI 10.1038/sj.onc.1211041; Ding KK, 2009, RADIAT ENVIRON BIOPH, V48, P205, DOI 10.1007/s00411-009-0213-4; Freter RR, 1996, J BIOL CHEM, V271, P17417, DOI 10.1074/jbc.271.29.17417; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Guo JC, 2004, ONCOGENE, V23, P71, DOI 10.1038/sj.onc.1206926; Korner K, 2001, J BIOL CHEM, V276, P9662, DOI 10.1074/jbc.M008696200; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Kudo Y, 1997, JPN J CANCER RES, V88, P947, DOI 10.1111/j.1349-7006.1997.tb00313.x; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Long XH, 2007, INT J MOL MED, V19, P607; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Miyata H, 2000, CLIN CANCER RES, V6, P4859; Nakamura S, 2010, CARCINOGENESIS, V31, P2012, DOI 10.1093/carcin/bgq185; Nakamura S, 2010, INVEST NEW DRUG, V28, P381, DOI 10.1007/s10637-009-9255-3; Ngan ESW, 2003, ONCOGENE, V22, P734, DOI 10.1038/sj.onc.1206121; Nishioka K, 2001, BRIT J CANCER, V85, P412, DOI 10.1054/bjoc.2001.1934; Okada A, 2005, BIRTH DEFECTS RES A, V73, P229, DOI 10.1002/bdra.20131; Rodriguez S, 2005, CANCER GENET CYTOGEN, V157, P140, DOI 10.1016/j.cancergencyto.2004.08.017; Sasaki H, 2001, CANCER LETT, V173, P187, DOI 10.1016/S0304-3835(01)00669-3; Takemasa I, 2000, CANCER RES, V60, P3043; Tsuda H, 2003, ONCOLOGY-BASEL, V65, P159, DOI 10.1159/000072342; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Wang HP, 2006, INT J RADIAT BIOL, V82, P181, DOI 10.1080/09553000600632261; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Williams M, 1999, GENOMICS, V55, P327, DOI 10.1006/geno.1998.5679; Winkles JA, 1998, PROG NUCLEIC ACID RE, V58, P41; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002	37	28	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28011	10.1371/journal.pone.0028011	http://dx.doi.org/10.1371/journal.pone.0028011			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132193	Green Submitted, Green Published, gold			2022-12-25	WOS:000298162000059
J	Noh, JH; Jung, KH; Kim, JK; Eun, JW; Bae, HJ; Xie, HJ; Chang, YG; Kim, MG; Park, WS; Lee, JY; Nam, SW				Noh, Ji Heon; Jung, Kwang Hwa; Kim, Jeong Kyu; Eun, Jung Woo; Bae, Hyun Jin; Xie, Hong Jian; Chang, Young Gyoon; Kim, Min Gyu; Park, Won Sang; Lee, Jung Young; Nam, Suk Woo			Aberrant Regulation of HDAC2 Mediates Proliferation of Hepatocellular Carcinoma Cells by Deregulating Expression of G1/S Cell Cycle Proteins	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; WAF1/CIP1 GENE PROMOTER; HEPATOMA-CELLS; SP1 SITES; CANCER; APOPTOSIS; TRANSCRIPTION; VALPROATE; GROWTH	Histone deacetylase 2 (HDAC2) is crucial for embryonic development, affects cytokine signaling relevant for immune responses and is often significantly overexpressed in solid tumors; but little is known about its role in human hepatocellular carcinoma (HCC). In this study, we showed that targeted-disruption of HDAC2 resulted in reduction of both tumor cell growth and de novo DNA synthesis in Hep3B cells. We then demonstrated that HDAC2 regulated cell cycle and that disruption of HDAC2 caused G1/S arrest in cell cycle. In G1/S transition, targeted-disruption of HDAC2 selectively induced the expression of p16(INK4A) and p21(WAF1/Cip1), and simultaneously suppressed the expression of cyclin D1, CDK4 and CDK2. Consequently, HDAC2 inhibition led to the down-regulation of E2F/DP1 target genes through a reduction in phosphorylation status of pRb protein. In addition, sustained suppression of HDAC2 attenuated in vitro colony formation and in vivo tumor growth in a mouse xenograft model. Further, we found that HDAC2 suppresses p21(WAF1/Cip1) transcriptional activity via Sp1-binding site enriched proximal region of p21(WAF1/Cip1) promoter. In conclusion, we suggest that the aberrant regulation of HDAC2 may play a pivotal role in the development of HCC through its regulation of cell cycle components at the transcription level providing HDAC2 as a relevant target in liver cancer therapy.	[Nam, Suk Woo] Catholic Univ Korea, Dept Pathol, Coll Med, Seoul, South Korea; Catholic Univ Korea, Funct RN Res Ctr, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Noh, JH (corresponding author), Catholic Univ Korea, Dept Pathol, Coll Med, Seoul, South Korea.	swnam@catholic.ac.kr	Eun, Jung Woo/ABB-5127-2020	Eun, Jung Woo/0000-0002-2461-6702	Ministry for Health, Welfare & Family Affairs, the Republic of Korea [A084930]	Ministry for Health, Welfare & Family Affairs, the Republic of Korea	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, the Republic of Korea (A084930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armeanu S, 2005, J HEPATOL, V42, P210, DOI 10.1016/j.jhep.2004.10.020; Batty N, 2009, CANCER LETT, V280, P192, DOI 10.1016/j.canlet.2009.03.013; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; GRANA X, 1995, ONCOGENE, V11, P211; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hrzenjak A, 2006, MOL CANCER THER, V5, P2203, DOI 10.1158/1535-7163.MCT-05-0480; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Huang WF, 2006, BIOCHEM BIOPH RES CO, V339, P165, DOI 10.1016/j.bbrc.2005.11.010; Kaler P, 2008, EXP CELL RES, V314, P1507, DOI 10.1016/j.yexcr.2008.01.010; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Lu YS, 2007, HEPATOLOGY, V46, P1119, DOI 10.1002/hep.21804; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Nam SW, 2005, HEPATOLOGY, V42, P809, DOI 10.1002/hep.20878; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; Noh JH, 2006, MOL CELL TOXICOL, V2, P166; Pathil A, 2006, HEPATOLOGY, V43, P425, DOI 10.1002/hep.21054; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	30	82	86	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28103	10.1371/journal.pone.0028103	http://dx.doi.org/10.1371/journal.pone.0028103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132221	gold, Green Submitted, Green Published			2022-12-25	WOS:000298162000072
J	Martinez-Falcon, AP; Durban, A; Latorre, A; Anton, J; Marcos-Garcia, MDLA				Paola Martinez-Falcon, Ana; Durban, Ana; Latorre, Amparo; Anton, Josefa; de los Angeles Marcos-Garcia, Maria			Bacteria Associated with Copestylum (Diptera, Syrphidae) Larvae and Their Cactus Host Isolatocereus dumortieri	PLOS ONE			English	Article							CACTOPHILIC DROSOPHILA; IMMATURE STAGES; COLUMNAR CACTI; FLY; ECOLOGY; TISSUE; ADULT; FRUIT	We describe the gut bacterial diversity inhabiting two saprophagous syrphids and their breeding substrate (decayed tissues of the columnar cactus Isolatocereus dumortieri). We analyzed the gut microbiota of Copestylum latum (scooping larvae that feed on decayed cactus tissues) and Copestylum limbipenne (whose larvae can also feed on semiliquid tissues) using molecular techniques. DNA was extracted from larval guts and cactus tissues. The V1-V3 region of the 16S rRNA genes was amplified and sequenced. A total of 31079 sequences were obtained. The main findings are: C. limbipenne is dominated by several Enterobacteriaceae, including putative nitrogen-fixing genera and pectinolitic species and some denitrifying species, whereas in C. latum unclassified Gammaproteobacteria predominate. Decayed tissues have a dominant lactic acid bacterial community. The bacterial communities were more similar between larval species than between each larva and its breeding substrate. The results suggest that the gut bacterial community in these insects is not strongly affected by diet and must be dependent on other factors, such as vertical transmission, evolutionary history and host innate immunity.	[Paola Martinez-Falcon, Ana; de los Angeles Marcos-Garcia, Maria] Univ Alicante, Inst Biodiversidad CIBIO, E-03080 Alicante, Spain; [Durban, Ana; Latorre, Amparo] Univ Alicante, Unidad Mixta Inst Cavanilles Biodiversidad & Biol, E-03080 Alicante, Spain; [Anton, Josefa] Univ Alicante, Dept Fisiol Genet & Microbiol, E-03080 Alicante, Spain	Universitat d'Alacant; Universitat d'Alacant; Universitat d'Alacant	Martinez-Falcon, AP (corresponding author), Univ Alicante, Inst Biodiversidad CIBIO, Campus Univ San Vicente del Raspeig, E-03080 Alicante, Spain.	AnaPaola.Martinez@ua.es	Anton, Josefa/L-5283-2014; Latorre, Amparo/E-4997-2015; Marcos García, Maria Angeles/H-7925-2015	Anton, Josefa/0000-0002-5823-493X; Latorre, Amparo/0000-0002-9146-7284; Marcos García, Maria Angeles/0000-0002-2439-2630; Martinez-Falcon, Ana Paola/0000-0003-3307-3989	AECID [A/020305/08]; FOMIX CONACYT-Hidalgo [95828]; SEP-CONACYT [84127]; Ministerio de Ciencia e Inovacion [BFU2009-12895-C02-01]; European Union [E07D401138MX]; CONACYT [207522]; Instituto de Salud Carlos III, Spain	AECID; FOMIX CONACYT-Hidalgo; SEP-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministerio de Ciencia e Inovacion(Spanish Government); European Union(European Commission); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	This research was funded by AECID (project A/020305/08), FOMIX CONACYT-Hidalgo (project 95828) and SEP-CONACYT (project 84127) to M. A. M.-G., and BFU2009-12895-C02-01 from the Ministerio de Ciencia e Inovacion to A. L. We extend our gratitude to the management of the Barranca de Metztitlan Biosphere Reserve for assisting us in this research. We appreciate discussions with Dr. Graham Rotheray and P. E. Cruz-Dominguez. C Aguilar-Miguel and M. C. Garcia-Chavez assisted with fieldwork. A. P. M. acknowledge the scholarship provided by The Alban programme, the European Union Programme of High Level Scholarships for Latin America, No. E07D401138MX and CONACYT program (207522) for doctoral fellowship. A. D. is recipient of a fellowship from the Instituto de Salud Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behar A, 2008, MOL ECOL, V17, P1375, DOI 10.1111/j.1365-294X.2008.03674.x; Ben-Yosef M, 2008, PHYSIOL ENTOMOL, V33, P145, DOI 10.1111/j.1365-3032.2008.00617.x; Bravo-Hollis H., 1978, CACTACEAS MEXICO, V1, P743; Castrezana S, 2001, CAN ENTOMOL, V133, P301, DOI 10.4039/Ent133301-3; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; ETGES WJ, 1989, EVOLUTION, V43, P1316, DOI 10.1111/j.1558-5646.1989.tb02579.x; Euzeby J. P., LIST PROKARYOTIC NAM; Fogleman J. C., 1989, SPECIAL BIOTIC RELAT, P1; FOGLEMAN JC, 1981, P NATL ACAD SCI-BIOL, V78, P4435, DOI 10.1073/pnas.78.7.4435; FOGLEMAN JC, 1989, APPL ENVIRON MICROB, V55, P100, DOI 10.1128/AEM.55.1.100-105.1989; Fogleman JC, 2001, AM ZOOL, V41, P877, DOI 10.1668/0003-1569(2001)041[0877:CIITCM]2.0.CO;2; Fogleman JC, 1989, LIPIDS, V21, P92; FOSTER JLM, 1993, APPL ENVIRON MICROB, V59, P1; Heed WB, 1986, GENETICS BIOL DROS E, V3e, P311; Ishak HD, 2011, BACTERIAL DIVERSITY; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Jimenez-Sierra C, 2004, CACTACEAS SUCULENTAS, V49, P96; Kinoshita K, 2000, J NAT PROD, V63, P701, DOI 10.1021/np9903907; LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649; Lauzon CR, 1998, ENVIRON ENTOMOL, V27, P853, DOI 10.1093/ee/27.4.853; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lindh JM, 2011, ANTON LEEUW INT J G, V99, P711, DOI 10.1007/s10482-010-9546-x; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P72; Marcos-Garcia M, 2001, EUR J ENTOMOL, V98, P375, DOI 10.14411/eje.2001.058; Marcos-Garcia MA, 2002, ANN ENTOMOL SOC AM, V95, P432, DOI 10.1603/0013-8746(2002)095[0432:LCAAIS]2.0.CO;2; Martinez-Falcon AP, 2010, ECOL ENTOMOL, V35, P754, DOI 10.1111/j.1365-2311.2010.01236.x; Martinez-Falcon AP, 2011, ECOL RES, V26, P341, DOI 10.1007/s11284-010-0788-x; Martinez-Falcon AP, 2008, ENTOMOLOGIA MEXICANA, V7, P176; Oksanen J., 2008, VEGAN COMMUNITY ECOL; R Development Core Team R, 2009, R LANG ENV STAT COMP; Rotheray GE, 2007, ZOOL J LINN SOC-LOND, V150, P267, DOI 10.1111/j.1096-3642.2007.00288.x; Rotheray GE, 2009, ZOOL J LINN SOC-LOND, V156, P697, DOI 10.1111/j.1096-3642.2008.00503.x; Sacchetti P, 2008, J APPL ENTOMOL, V132, P682, DOI 10.1111/j.1439-0418.2008.01334.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; STARMER WT, 1982, EVOL BIOL, V14, P269; THOMPSON F C, 1972, Arquivos de Zoologia (Sao Paulo), V23, P73; Toth EM, 2006, MICROB ECOL, V51, P13, DOI 10.1007/s00248-005-0090-6; Zahner V, 2008, CURR MICROBIOL, V57, P564, DOI 10.1007/s00284-008-9243-4	41	9	11	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27443	10.1371/journal.pone.0027443	http://dx.doi.org/10.1371/journal.pone.0027443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132101	Green Published, Green Submitted, gold			2022-12-25	WOS:000298162000019
J	Zhang, SC; Sun, M; Li, T; Wang, QH; Hao, JH; Han, Y; Hu, XJ; Zhou, M; Lin, SX				Zhang, Si-Cai; Sun, Mi; Li, Tang; Wang, Qi-Hai; Hao, Jian-Hua; Han, Yi; Hu, Xiao-Jian; Zhou, Ming; Lin, Sheng-Xiang			Structure Analysis of a New Psychrophilic Marine Protease	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ALKALINE PROTEASE; ENZYMES; METALLOPROTEASE; INSIGHTS	A new psychrophilic marine protease was found from a marine bacterium Flavobacterium YS-80 in the Chinese Yellow Sea. The protease is about 49 kD with an isoelectric point about 4.5. It consists of 480 amino acids and is homologous to a psychrophilic alkaline protease (PAP) from an Antarctic Pseudomonas species. The protein was purified from the natural bacterium fermented and crystallized. Its crystal structure (PDB ID 3U1R) was solved at 2.0 A by Molecular Replacement using a model based on PAP, and was refined to a crystallographic Rwork of 0.16 and an Rfree of 0.21. The marine protease consists of a two domain structure with an N-terminal domain including residues 37-264 and a C-terminal domain including residues 265-480. Similar to PAP, the N-terminal domain is responsible for proteolysis and the C-terminal is for stability. His186, His190, His196 and Tyr226 are ligands for the Zn2+ ion in the catalytic center. The enzyme's Tyr226 is closer to the Zn2+ ion than in PAP and it shows a stronger Zn2+_ Tyr-OH bond. There are eight calcium ions in the marine protease molecule and they have significantly shorter bond distances to their ligands compared to their counterparts in all three crystal forms of PAP. On the other hand, the loops in the marine protease are more compact than in PAP. This makes the total structure stable and less flexible, resulting in higher thermo stability. These properties are consistent with the respective environments of the proteases. The structural analysis of this new marine protease provides new information for the study of psychrophilic proteases and is helpful for elucidating the structure-environment adaptation of these enzymes.	[Zhang, Si-Cai; Li, Tang; Wang, Qi-Hai; Lin, Sheng-Xiang] Chinese Acad Sci, Struct Biol Lab, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Sun, Mi; Hao, Jian-Hua] Chinese Acad Fisheries Sci, Yellow Sea Fishery Res Inst, Qingdao, Shandong, Peoples R China; [Han, Yi; Hu, Xiao-Jian; Zhou, Ming; Lin, Sheng-Xiang] CHUL Res Ctr CHUQ, Lab Oncol & Mol Endocrinol, Quebec City, PQ, Canada; [Han, Yi; Hu, Xiao-Jian; Zhou, Ming; Lin, Sheng-Xiang] Univ Laval, Quebec City, PQ, Canada	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Laval University; Laval University	Zhang, SC (corresponding author), Chinese Acad Sci, Struct Biol Lab, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	sxlin@crchul.ulaval.ca	Li, Tang/Q-5821-2018	Li, Tang/0000-0001-6622-9471; Lin, Sheng-Xiang/0000-0001-9149-375X	IBCB; SIB; Laboratory of Structural Biology with visiting scientists (IBCB, SIBS); CHUL (CHUQ) Research Center, Quebec, Canada; Chinese Science and Technology Ministry [2005DFA30830]	IBCB; SIB; Laboratory of Structural Biology with visiting scientists (IBCB, SIBS); CHUL (CHUQ) Research Center, Quebec, Canada; Chinese Science and Technology Ministry	This study has been financially supported by IBCB, SIBS; a collaborative agreement between the Laboratory of Structural Biology with visiting scientists (IBCB, SIBS) and CHUL (CHUQ) Research Center, Quebec, Canada, and by the international collaborative project "The study of crystallographic structure and function of marine enzymes" (2005DFA30830, Chinese Science and Technology Ministry) between Yellow Sea Fishery Research Institute and CHUL (CHUQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajari N, 1998, STRUCTURE, V6, P1503, DOI 10.1016/S0969-2126(98)00149-X; Aghajari N, 2003, PROTEINS, V50, P636, DOI 10.1002/prot.10264; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; Bentahir M, 2000, J BIOL CHEM, V275, P11147, DOI 10.1074/jbc.275.15.11147; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chessa J-P, 2000, BIOCHIM BIOPHYS ACTA, V36103, P1; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feller G, 1997, CELL MOL LIFE SCI, V53, P830, DOI 10.1007/s000180050103; Feller G, 1996, FEMS MICROBIOL REV, V18, P189, DOI 10.1016/0168-6445(96)00011-3; Gerday C, 1997, BBA-PROTEIN STRUCT M, V1342, P119, DOI 10.1016/S0167-4838(97)00093-9; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Marx JC, 2007, MAR BIOTECHNOL, V9, P293, DOI 10.1007/s10126-006-6103-8; MIYATAKE H, 1995, J BIOCHEM, V118, P474, DOI 10.1093/oxfordjournals.jbchem.a124932; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ravaud S, 2003, J BACTERIOL, V185, P4195, DOI 10.1128/JB.185.14.4195-4203.2003; Russell N J, 1998, Adv Biochem Eng Biotechnol, V61, P1; Russell RJM, 1998, STRUCTURE, V6, P351, DOI 10.1016/S0969-2126(98)00037-9; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wang F, 2010, APPL BIOCHEM BIOTECH, V162, P1497, DOI 10.1007/s12010-010-8927-y; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; [王宇婧 Yu Yujing], 2004, [海洋湖沼通报, Transactions of Oceanology and Limnology], V0, P8	25	13	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e26939	10.1371/journal.pone.0026939	http://dx.doi.org/10.1371/journal.pone.0026939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132082	Green Published, Green Submitted, gold			2022-12-25	WOS:000298162000008
J	Frezzetti, D; Reale, C; Cali, G; Nitsch, L; Fagman, H; Nilsson, O; Scarfo, M; De Vita, G; Di Lauro, R				Frezzetti, Daniela; Reale, Carla; Cali, Gaetano; Nitsch, Lucio; Fagman, Henrik; Nilsson, Ola; Scarfo, Marzia; De Vita, Gabriella; Di Lauro, Roberto			The microRNA-Processing Enzyme Dicer Is Essential for Thyroid Function	PLOS ONE			English	Article							MORPHOGENESIS; DELETION; BIOGENESIS; GENE; TRANSCRIPTION; MECHANISMS; EXPRESSION; DISEASE; MIR-21; TTF-1	Dicer is a type III ribonuclease required for the biogenesis of microRNAs (miRNAs), a class of small non-coding RNAs regulating gene expression at the post-transcriptional level. To explore the functional role of miRNAs in thyroid gland function, we generated a thyrocyte-specific Dicer conditional knockout mouse. Here we show that development and early differentiation of the thyroid gland are not affected by the absence of Dicer, while severe hypothyroidism gradually develops after birth, leading to reduced body weight and shortened life span. Histological and molecular characterization of knockout mice reveals a dramatic loss of the thyroid gland follicular architecture associated with functional aberrations and down-regulation of several differentiation markers. The data presented in this study show for the first time that an intact miRNAs processing machinery is essential for thyroid physiology, suggesting that deregulation of specific miRNAs could be also involved in human thyroid dysfunctions.	[Frezzetti, Daniela; Reale, Carla; Scarfo, Marzia] IRGS Biogem Scarl, Ariano Irpino, Italy; [Frezzetti, Daniela; Nitsch, Lucio; De Vita, Gabriella; Di Lauro, Roberto] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, Naples, Italy; [Cali, Gaetano] Ist Endocrinol & Oncol Sperimentale CNR, Naples, Italy; [Fagman, Henrik; Nilsson, Ola] Univ Gothenburg, Sahlgrenska Canc Ctr, Sahlgrenska Acad, Gothenburg, Sweden; [Fagman, Henrik; Nilsson, Ola] Univ Gothenburg, Dept Pathol, Sahlgrenska Acad, Gothenburg, Sweden	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Gothenburg; University of Gothenburg	Frezzetti, D (corresponding author), IRGS Biogem Scarl, Ariano Irpino, Italy.	gdevita@unina.it; rdilauro@unina.it	De Vita, Gabriella/H-4422-2011; Reale, Carla/AAB-7939-2020; Frezzetti, Daniela/AAI-2410-2019; Di Lauro, Roberto/A-2746-2012	De Vita, Gabriella/0000-0002-7302-1174; Reale, Carla/0000-0001-7682-4784; Frezzetti, Daniela/0000-0002-7500-5506; Di Lauro, Roberto/0000-0001-9493-3036; Fagman, Henrik/0000-0001-5853-6295	EU [LSHG-CT-2006-037900]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 9471-2009]; Assar Gabrielssons Foundation; Magnus Bergvalls Foundation	EU(European Commission); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Assar Gabrielssons Foundation; Magnus Bergvalls Foundation	This work was supported by EU-Project-SIROCCO (URL: http://cordis.europa.eu/fp6/dc/index.cfm), Grant LSHG-CT-2006-037900, and by Associazione Italiana per la Ricerca sul Cancro (AIRC, URL: https://www.direzionescientifica.airc.it), grant IG 9471-2009. HF was supported by the Assar Gabrielssons and Magnus Bergvalls Foundations. Funders supported fellowships costs and consumable costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola E, 2005, ENDOCRINOLOGY, V146, P5038, DOI 10.1210/en.2005-0882; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bouchard M, 2004, GENESIS, V38, P105, DOI 10.1002/gene.20008; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Cali G, 2007, ENDOCRINOLOGY, V148, P2737, DOI 10.1210/en.2006-1344; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; De Felice M, 2004, ENDOCR REV, V25, P722, DOI 10.1210/er.2003-0028; Di Palma T, 2003, J BIOL CHEM, V278, P3395, DOI 10.1074/jbc.M205977200; Fagman H, 2010, MOL CELL ENDOCRINOL, V323, P35, DOI 10.1016/j.mce.2009.12.008; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Frezzetti D, 2011, ONCOGENE, V30, P275, DOI 10.1038/onc.2010.416; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Missero C, 2000, MOL CELL BIOL, V20, P2783, DOI 10.1128/MCB.20.8.2783-2793.2000; Morita S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004212; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Sekine S, 2009, J PATHOL, V219, P365, DOI 10.1002/path.2606; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Zhang L, 2010, STEM CELLS, V28, P1260, DOI 10.1002/stem.455	33	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27648	10.1371/journal.pone.0027648	http://dx.doi.org/10.1371/journal.pone.0027648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132122	Green Submitted, gold, Green Published			2022-12-25	WOS:000297789900015
J	Van der Veer, T; Frings-Dresen, MHW; Sluiter, JK				Van der Veer, Tjeerd; Frings-Dresen, Monique H. W.; Sluiter, Judith K.			Health Behaviors, Care Needs and Attitudes towards Self-Prescription: A Cross-Sectional Survey among Dutch Medical Students	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY; PREVALENCE; SEEKING; HABITS; DOCTORS; RESIDENTS; SMOKING; OBESITY; TOBACCO	Purpose: There is a growing awareness of the potent ways in which the wellbeing of physicians impacts the health of their patients. The purpose of this study was to investigate the health behaviors, care needs and attitudes towards self-prescription of Dutch medical students, and any differences between junior preclinical and senior clinically active students. Methods: All students (n = 2695) of a major Dutch medical school were invited for an online survey. Physical activity, eating habits, alcohol consumption, smoking, Body Mass Index, substance use and amount of sleep per night were inquired, as well as their need for different forms of care and their attitude towards self-prescription. Results: Data of 902 students were used. Physical activity levels (90% sufficient) and smoking prevalence (94% non-smokers) were satisfying. Healthy eating habits (51% insufficient) and alcohol consumption (46% excessive) were worrying. Body Mass Indexes were acceptable (20% unhealthy). We found no significant differences in health behaviors between preclinical and clinically active students. Care needs were significantly lower among clinically active students. (p<0.05) Student acceptance of self-prescription was significantly higher among clinically active students. (p<0.001) Conclusions: Unhealthy behaviors are prevalent among medical students, but are no more prevalent during the clinical study phase. The need for specific forms of care appears lower with study progression. This could be worrying as the acceptance of self-care and self-prescription is higher among senior clinical students. Medical faculties need to address students' unhealthy behaviors and meet their care needs for the benefit of both the future physicians as well as their patients.	[Van der Veer, Tjeerd; Frings-Dresen, Monique H. W.; Sluiter, Judith K.] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Van der Veer, T (corresponding author), Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.sluiter@amc.nl	van der Veer, Tjeerd/N-8975-2019	van der Veer, Tjeerd/0000-0003-3085-603X				Ahmed I, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.06.003; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Angyan L., 2004, Acta Physiologica Hungarica, V91, P157, DOI 10.1556/APhysiol.91.2004.2.7; Barss P, 2008, MED TEACH, V30, pE196, DOI 10.1080/01421590802334267; Boo NY, 2010, SINGAP MED J, V51, P126; Brimstone R, 2007, MED EDUC, V41, P74, DOI 10.1111/j.1365-2929.2006.02649.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cape G, 2006, ADDICTION, V101, P841, DOI 10.1111/j.1360-0443.2006.01476.x; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; *CBS, 2010, PREV UNH BEH; Chew-Graham CA, 2003, MED EDUC, V37, P873, DOI 10.1046/j.1365-2923.2003.01627.x; Chourdakis M, 2010, APPETITE, V55, P722, DOI 10.1016/j.appet.2010.08.013; Compton MT, 2008, J NERV MENT DIS, V196, P891, DOI 10.1097/NMD.0b013e3181924d03; Davidson SK, 2003, MED J AUSTRALIA, V179, P302, DOI 10.5694/j.1326-5377.2003.tb05552.x; Duperly J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-218; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; FLAHERTY JA, 1993, PSYCHIAT CLIN N AM, V16, P189; Frank E, 2004, JAMA-J AM MED ASSOC, V291, P637, DOI 10.1001/jama.291.5.637; Frank E, 2000, ARCH FAM MED, V9, P287, DOI 10.1001/archfami.9.3.287; Frank E, 2006, AM J PREV MED, V31, P499, DOI 10.1016/j.amepre.2006.08.009; Frank E, 2010, CAN J PUBLIC HEALTH, V101, P390, DOI 10.1007/BF03404859; Frank E, 2009, PREV MED, V49, P233, DOI 10.1016/j.ypmed.2009.06.020; Frank E, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2155; Gawlikowska-Sroka A, 2009, EUR J MED RES, V14, P86, DOI 10.1186/2047-783X-14-S4-86; Goebert D, 2009, ACAD MED, V84, P236, DOI 10.1097/ACM.0b013e31819391bb; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Hem E, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-16; Hooper C, 2005, MED EDUC, V39, P588, DOI 10.1111/j.1365-2929.2005.02175.x; Howe Michael, 2010, Prev Cardiol, V13, P180, DOI 10.1111/j.1751-7141.2010.00079.x; Keller S, 2007, ADDICT BEHAV, V32, P505, DOI 10.1016/j.addbeh.2006.05.017; Kumar P, 2000, J Indian Med Assoc, V98, P447; Lobelo F, 2009, BRIT J SPORT MED, V43, P89, DOI 10.1136/bjsm.2008.055426; Nguyen VH, 2008, ASIA-PAC J PUBLIC HE, V20, P16, DOI 10.1177/1010539507308504; Owens J A, 2001, Curr Opin Pulm Med, V7, P411, DOI 10.1097/00063198-200111000-00009; Ozasa K, 2005, MED EDUC, V39, P971, DOI 10.1111/j.1365-2929.2005.02251.x; Payne D, 2002, LANCET, V359, P1220, DOI 10.1016/S0140-6736(02)08264-8; Price Marilyn, 2007, Med Health R I, V90, P178; Richmond R, 2009, DRUG ALCOHOL REV, V28, P463, DOI 10.1111/j.1465-3362.2009.00115.x; Roberts LW, 2000, COMPR PSYCHIAT, V41, P303, DOI 10.1053/comp.2000.0410303; Roberts LW, 2000, ACAD MED, V75, P272, DOI 10.1097/00001888-200003000-00019; Roberts LW, 2001, COMPR PSYCHIAT, V42, P1, DOI 10.1053/comp.2001.19747; Rose AE, 2011, ACAD MED, V86, P1463, DOI 10.1097/ACM.0b013e3182312471; Single EW, 1995, CAN J PUBLIC HEALTH, V86, P402; Tanaka M, 2008, NUTRITION, V24, P985, DOI 10.1016/j.nut.2008.05.003	45	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28038	10.1371/journal.pone.0028038	http://dx.doi.org/10.1371/journal.pone.0028038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	858IO	22132202	gold, Green Published, Green Submitted			2022-12-25	WOS:000297789900043
J	Betts, RJ; Ho, AWS; Kemeny, DM				Betts, Richard J.; Ho, Adrian W. S.; Kemeny, David M.			Partial Depletion of Natural CD4(+)CD25(+) Regulatory T Cells with Anti-CD25 Antibody Does Not Alter the Course of Acute Influenza A Virus Infection	PLOS ONE			English	Article							LUNG INJURY; MICE; EXPANSION; IMMUNOPATHOLOGY; INTERFERON; ANTIGEN; MODEL	Foxp3(+) CD4(+) regulatory T cells represent a T cell subset with well-characterized immunosuppressive effects during immune homeostasis and chronic infections, and there is emerging evidence to suggest these cells temper pulmonary inflammation in response to acute viral infection. Recent studies have demonstrated treatment with PC61 CD25-depleting antibody potentiates inflammation in a murine model of RSV infection, while paradoxically delaying recruitment of CD8(+) T cells to the site of inflammation. The present study therefore sought to examine the role of these cells in a murine model of acute influenza A virus infection through the administration of PC61 CD25-depleting antibody. PC61 antibody is able to partially deplete CD25(+)Foxp3(+) regulatory T cells to a comparable degree as seen within previous work examining RSV, however this does not alter influenza A-virus induced mortality, weight loss, viral clearance and cellularity within the lung. Collectively, these data demonstrate that partial depletion of CD4(+)CD25(+) regulatory T cells with PC61 antibody does not alter the course of influenza A virus infection.	[Betts, Richard J.; Ho, Adrian W. S.; Kemeny, David M.] Natl Univ Singapore, Dept Microbiol, Immunol Programme, Singapore 117548, Singapore	National University of Singapore	Betts, RJ (corresponding author), Natl Univ Singapore, Dept Microbiol, Immunol Programme, Singapore 117548, Singapore.	mickdm@nus.edu.sg		Betts, Richard/0000-0002-7999-2158; Ho, Adrian/0000-0002-6501-5196	Singapore Immunology Network [R182-000-148-305]; HUJ-CREATE	Singapore Immunology Network(Agency for Science Technology & Research (A*STAR)); HUJ-CREATE	This work was supported by Singapore Immunology Network Grant R182-000-148-305 and HUJ-CREATE programme on Cellular and Molecular Mechanisms of Inflammation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes I, 2010, J VIROL, V84, P12564, DOI 10.1128/JVI.01559-10; Beilharz MW, 2007, BIOCHEM BIOPH RES CO, V355, P740, DOI 10.1016/j.bbrc.2007.02.019; Bruder D, 2006, VIRAL IMMUNOL, V19, P147, DOI 10.1089/vim.2006.19.147; Carrigan SO, 2009, IMMUNOBIOLOGY, V214, P211, DOI 10.1016/j.imbio.2008.07.027; Couper KN, 2007, INFECT IMMUN, V75, P5806, DOI 10.1128/IAI.01005-07; Couper KN, 2007, J IMMUNOL, V178, P4136, DOI 10.4049/jimmunol.178.7.4136; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; FULTON RB, J IMMUNOL, V185, P2382; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kotner J, 2007, INFECT IMMUN, V75, P861, DOI 10.1128/IAI.01500-06; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Larkin J, 2008, J IMMUNOL, V180, P2149, DOI 10.4049/jimmunol.180.4.2149; Li XR, 2010, EUR J IMMUNOL, V40, P3325, DOI 10.1002/eji.201041093; Longhi MP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000006; Moskophidis D, 1998, J EXP MED, V188, P223, DOI 10.1084/jem.188.2.223; Nemzek JA, 2000, AM J PHYSIOL-LUNG C, V278, pL512, DOI 10.1152/ajplung.2000.278.3.L512; Tenorio EP, 2011, FEMS IMMUNOL MED MIC, V62, P362, DOI 10.1111/j.1574-695X.2011.00805.x; Powell TJ, 2006, CLIN IMMUNOL, V119, P87, DOI 10.1016/j.clim.2005.11.004; Ruckwardt TJ, 2009, J VIROL, V83, P3019, DOI 10.1128/JVI.00036-09; Tamura SI, 2004, JPN J INFECT DIS, V57, P236; Tripp Ralph A, 2005, Proc Am Thorac Soc, V2, P147, DOI 10.1513/pats.200502-014AW; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Westendorf AM, 2009, GUT, V58, P211, DOI 10.1136/gut.2008.151720; Wohlfert E, 2008, J CLIN IMMUNOL, V28, P707, DOI 10.1007/s10875-008-9248-6; Zelenay S, 2005, P NATL ACAD SCI USA, V102, P4091, DOI 10.1073/pnas.0408679102	28	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27849	10.1371/journal.pone.0027849	http://dx.doi.org/10.1371/journal.pone.0027849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125630	Green Submitted, gold, Green Published			2022-12-25	WOS:000297789200030
J	Bidaux, G; Beck, B; Zholos, A; Gordienko, D; Lemonnier, L; Flourakis, M; Roudbaraki, M; Borowiec, AS; Fernandez, J; Delcourt, P; Lepage, G; Shuba, Y; Skryma, R; Prevarskaya, N				Bidaux, Gabriel; Beck, Benjamin; Zholos, Alexander; Gordienko, Dmitri; Lemonnier, Loic; Flourakis, Matthieu; Roudbaraki, Morad; Borowiec, Anne-Sophie; Fernandez, Jose; Delcourt, Philippe; Lepage, Gilbert; Shuba, Yaroslav; Skryma, Roman; Prevarskaya, Natalia			Regulation of Activity of Transient Receptor Potential Melastatin 8 (TRPM8) Channel by Its Short Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD RECEPTOR; PROSTATE-CANCER; CATION CHANNEL; SPLICE VARIANT; ACTIVATION; REVEALS; IDENTIFICATION; GENE	One important mechanism of the regulation of membrane ion channels involves their nonfunctional isoforms generated by alternative splicing. However, knowledge of such isoforms for the members of the transient receptor potential (TRP) superfamily of ion channels remains quite limited. This study focuses on the TRPM8, which functions as a cold receptor in sensory neurons but is also expressed in tissues not exposed to ambient temperatures, as well as in cancer tissues. We report the cloning from prostate cancer cells of new short splice variants of TRPM8, termed short TRPM8 alpha and short TRPM8 beta. Our results show that both variants are in a closed configuration with the C-terminal tail of the full-length TRPM8 channel, resulting in stabilization of its closed state and thus reducing both its cold sensitivity and activity. Our findings therefore uncover a new mode of regulation of the TRPM8 channel by its splice variants.	[Bidaux, Gabriel; Beck, Benjamin; Zholos, Alexander; Gordienko, Dmitri; Lemonnier, Loic; Flourakis, Matthieu; Roudbaraki, Morad; Borowiec, Anne-Sophie; Delcourt, Philippe; Lepage, Gilbert; Shuba, Yaroslav; Skryma, Roman; Prevarskaya, Natalia] INSERM, U1003, Equipe Labellisee Ligue Natl Canc, F-59655 Villeneuve Dascq, France; [Bidaux, Gabriel; Beck, Benjamin; Zholos, Alexander; Gordienko, Dmitri; Lemonnier, Loic; Flourakis, Matthieu; Roudbaraki, Morad; Borowiec, Anne-Sophie; Delcourt, Philippe; Lepage, Gilbert; Shuba, Yaroslav; Skryma, Roman; Prevarskaya, Natalia] USTL, F-59655 Villeneuve Dascq, France; [Fernandez, Jose] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast BT12 6BA, Antrim, North Ireland	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Queens University Belfast	Bidaux, G (corresponding author), INSERM, U1003, Equipe Labellisee Ligue Natl Canc, F-59655 Villeneuve Dascq, France.	gabriel.bidaux@univ-lille1.fr; natacha.prevarskaya@univ-lille1.fr	Lemonnier, Loic/L-7289-2018; Shuba, Yaroslav/AAT-6758-2021; Zholos, Alexander/A-7017-2011; Bidaux, Gabriel/F-1294-2016	Lemonnier, Loic/0000-0001-6200-5382; Zholos, Alexander/0000-0002-4320-149X; Fernandez, Jose A/0000-0002-4199-5513; Prevarskaya, natacha/0000-0003-0316-197X; Beck, Benjamin/0000-0001-8162-7566; Bidaux, Gabriel/0000-0002-6162-3223; Flourakis, Matthieu/0000-0002-5366-9125; Gordienko, Dmitri (Dmytro)/0000-0002-4118-9976; Morad, Roudbaraki/0000-0001-5751-3323	INSERM; Ministere de l'Education Nationale; Ligue Nationale contre le Cancer; Agence Nationale de Recherche; Association de Recherche sur les Tumeurs de la Prostate; Region Nord-Pas-de-Calais; Derzhavniy Fond Fundamental'nikh Dosliddhzen [F46.2/001]; University of Lille; Fondation pour la Recherche Medicale	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Education Nationale; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de Recherche(French National Research Agency (ANR)); Association de Recherche sur les Tumeurs de la Prostate; Region Nord-Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); Derzhavniy Fond Fundamental'nikh Dosliddhzen; University of Lille; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported in part by grants from INSERM, the Ministere de l'Education Nationale, the Ligue Nationale contre le Cancer, the Agence Nationale de Recherche, the Association de Recherche sur les Tumeurs de la Prostate, and the Region Nord-Pas-de-Calais.; Supported by Derzhavniy Fond Fundamental'nikh Dosliddhzen Grant F46.2/001. Present address: Lab. of Molecular Pharmacology and Biophysics of Cell Signalling, State Key Laboratory of Molecular and Cell Biology, Bogomoletz Institute of Physiology, 01024 Kiev, Ukraine.; Supported by the Visiting Scientist Program of the University of Lille. Present address: International Center of Molecular Physiology, State Key Laboratory of Molecular and Cell Biology, Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, 01024 Kyiv, Ukraine.; Charge de Recherche of the FRS/Fonds de la Recherche Scientifique (FNRS). Supported by the Fondation pour la Recherche Medicale. Present address: Inst. de Recherche Interdisciplinaire en Biologie Humaine et Moleculaire (IRIBHM), 808 route de Lennik, 1070 Brussels, Belgium.	Abeele FV, 2006, J BIOL CHEM, V281, P40174, DOI 10.1074/jbc.M605779200; Andersson DA, 2007, J NEUROSCI, V27, P3347, DOI 10.1523/JNEUROSCI.4846-06.2007; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Chu X, 2005, CELL CALCIUM, V37, P173, DOI 10.1016/j.ceca.2004.08.005; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Fang D, 2000, BIOCHEM BIOPH RES CO, V279, P53, DOI 10.1006/bbrc.2000.3894; Fernandez JA, 2012, J BIOL CHEM, V287, P2963, DOI 10.1074/jbc.M111.272823; Fernandez JA, 2011, J GEN PHYSIOL, V137, P173, DOI 10.1085/jgp.201010498; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Tsavaler L, 2001, CANCER RES, V61, P3760; Vazquez E, 2006, SEMIN CELL DEV BIOL, V17, P607, DOI 10.1016/j.semcdb.2006.11.004; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Werten PJL, 1999, MOL BIOL REP, V26, P201, DOI 10.1023/A:1007046926233; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200	28	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					2948	2962		10.1074/jbc.M111.270256	http://dx.doi.org/10.1074/jbc.M111.270256			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22128173	Green Published, hybrid			2022-12-25	WOS:000300295100003
J	Folli, F; Okada, T; Perego, C; Gunton, J; Liew, CW; Akiyama, M; D'Amico, A; La Rosa, S; Placidi, C; Lupi, R; Marchetti, P; Sesti, G; Hellerstein, M; Perego, L; Kulkarni, RN				Folli, Franco; Okada, Terumasa; Perego, Carla; Gunton, Jenny; Liew, Chong Wee; Akiyama, Masaru; D'Amico, Anna; La Rosa, Stefano; Placidi, Claudia; Lupi, Roberto; Marchetti, Piero; Sesti, Giorgio; Hellerstein, Marc; Perego, Lucia; Kulkarni, Rohit N.			Altered Insulin Receptor Signalling and beta-Cell Cycle Dynamics in Type 2 Diabetes Mellitus	PLOS ONE			English	Article							HUMAN PANCREATIC-ISLETS; IN-VIVO; GENE-EXPRESSION; GROWTH-FACTOR; NUDE-MICE; APOPTOSIS; INHIBITORS; GLUCOSE; TRANSCRIPTION; REPLICATION	Insulin resistance, reduced beta-cell mass, and hyperglucagonemia are consistent features in type 2 diabetes mellitus (T2DM). We used pancreas and islets from humans with T2DM to examine the regulation of insulin signaling and cell-cycle control of islet cells. We observed reduced beta-cell mass and increased alpha-cell mass in the Type 2 diabetic pancreas. Confocal microscopy, real-time PCR and western blotting analyses revealed increased expression of PCNA and down-regulation of p27-Kip1 and altered expression of insulin receptors, insulin receptor substrate-2 and phosphorylated BAD. To investigate the mechanisms underlying these findings, we examined a mouse model of insulin resistance in beta-cells - which also exhibits reduced beta-cell mass, the beta-cell-specific insulin receptor knockout (beta IRKO). Freshly isolated islets and beta-cell lines derived from beta IRKO mice exhibited poor cell-cycle progression, nuclear restriction of FoxO1 and reduced expression of cell-cycle proteins favoring growth arrest. Re-expression of insulin receptors in beta IRKO beta-cells reversed the defects and promoted cell cycle progression and proliferation implying a role for insulin-signaling in beta-cell growth. These data provide evidence that human beta- and alpha-cells can enter the cell-cycle, but proliferation of beta-cells in T2DM fails due to G1-to-S phase arrest secondary to defective insulin signaling. Activation of insulin signaling, FoxO1 and proteins in beta-cell-cycle progression are attractive therapeutic targets to enhance beta-cell regeneration in the treatment of T2DM.	[Folli, Franco] Univ Texas Hlth Sci Ctr San Antonio, Div Diabet, Dept Med, San Antonio, TX 78229 USA; [Okada, Terumasa; Liew, Chong Wee; Akiyama, Masaru; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA; [Okada, Terumasa; Liew, Chong Wee; Akiyama, Masaru; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Perego, Carla; D'Amico, Anna; Perego, Lucia] Univ Milan, Dept Mol Sci Appl Biosyst, Milan, Italy; [Gunton, Jenny] Garvan Inst Med Res, Sydney, NSW, Australia; [La Rosa, Stefano; Placidi, Claudia] Univ Insubria, Dept Pathol, Osped Circolo, Varese, Italy; [La Rosa, Stefano; Placidi, Claudia] Univ Insubria, Dept Human Morphol, Varese, Italy; [Lupi, Roberto; Marchetti, Piero] Univ Pisa, Div Endocrinol, Pisa, Italy; [Sesti, Giorgio] Magna Graecia Univ Catanzaro, Dept Clin & Expt Med, Catanzaro, Italy; [Hellerstein, Marc] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of Texas System; University of Texas Health San Antonio; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; University of Milan; Garvan Institute of Medical Research; Ospedale Circolo & Fondazione Macchi; University of Insubria; University of Insubria; University of Pisa; Magna Graecia University of Catanzaro; University of California System; University of California Berkeley	Folli, F (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Diabet, Dept Med, San Antonio, TX 78229 USA.	folli@uthscsa.edu; Rohit.Kulkarni@joslin.harvard.edu	Marchetti, Piero/J-7439-2013; folli, franco/J-2795-2018; Gunton, Jenny/E-1561-2012; Perego, Carla/L-6147-2015; Sesti, Giorgio/B-1509-2012; Gunton, Jenny E/AAH-7719-2021	Marchetti, Piero/0000-0003-4907-0635; folli, franco/0000-0001-9824-5222; Perego, Carla/0000-0003-3027-1779; Sesti, Giorgio/0000-0002-1618-7688; Liew, Chong Wee/0000-0001-9904-0958	National Institutes of Health (NIH) [RO1 67536, 1-K99 DK090210-01]; National Health and Medical Research Council of Australia; Royal Australian College of Physicians; Ministero della Salute; MIUR; University of Milano, School of Medicine; Sunstar Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067536, K99DK090210] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Royal Australian College of Physicians; Ministero della Salute(Ministry of Health, Italy); MIUR(Ministry of Education, Universities and Research (MIUR)); University of Milano, School of Medicine; Sunstar Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Institutes of Health (NIH) RO1 67536 (RNK). JG was supported by a C.J. Martin Fellowship from the National Health and Medical Research Council of Australia and Royal Australian College of Physicians Servier Award. FF was supported by Ministero della Salute and MIUR. LP was supported by a postdoctoral fellowship from the University of Milano, School of Medicine. CWL was supported by NIH 1-K99 DK090210-01, and MA is supported by a Sunstar Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8; Assmann A, 2009, PEDIATR DIABETES, V10, P14, DOI 10.1111/j.1399-5448.2008.00468.x; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Bonner-Weir S, 2000, J MOL ENDOCRINOL, V24, P297, DOI 10.1677/jme.0.0240297; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chavez AO, 2008, DIABETES, V57, P899, DOI 10.2337/db07-0790; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Cozar-Castellano I, 2005, P NATL ACAD SCI USA, V102, P7781, DOI 10.1073/pnas.0503261102; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Dahl U, 1996, DEVELOPMENT, V122, P2895; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Davalli AM, 2008, CELL TRANSPLANT, V17, P1323, DOI 10.3727/096368908787648137; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Drexler HCA, 2003, CELL CYCLE, V2, P438, DOI 10.4161/cc.2.5.461; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Finzi G, 2005, ULTRASTRUCT PATHOL, V29, P525, DOI 10.1080/01913120500323563; Fox JT, 2011, FEBS LETT, V585, P2780, DOI 10.1016/j.febslet.2011.05.053; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Guardado-Mendoza R, 2009, P NATL ACAD SCI USA, V106, P13992, DOI 10.1073/pnas.0906471106; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Hori Y, 2002, P NATL ACAD SCI USA, V99, P16105, DOI 10.1073/pnas.252618999; Hribal ML, 2003, FASEB J; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Lechner A, 2005, BIOCHEM BIOPH RES CO, V327, P581, DOI 10.1016/j.bbrc.2004.12.043; Leibiger B, 2001, MOL CELL, V7, P559, DOI 10.1016/S1097-2765(01)00203-9; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Liu SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007983; Lupi R, 2006, EUR J ENDOCRINOL, V154, P355, DOI 10.1530/eje.1.02086; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Muller D, 2007, DIABETOLOGIA, V50, P1239, DOI 10.1007/s00125-007-0671-7; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Porzio O, 1999, J CLIN INVEST, V104, P357, DOI 10.1172/JCI5870; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Rhodes CJ, 2000, J MOL ENDOCRINOL, V24, P303, DOI 10.1677/jme.0.0240303; Ritzel RA, 2003, DIABETES, V52, P1701, DOI 10.2337/diabetes.52.7.1701; SADOWSKI HB, 1993, NATURE, V362, P79, DOI 10.1038/362079a0; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sesti G, 2002, ANN MED, V34, P444, DOI 10.1080/078538902321012397; UNGER RH, 1981, NEW ENGL J MED, V304, P1575, DOI 10.1056/NEJM198106253042604; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735	59	61	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28050	10.1371/journal.pone.0028050	http://dx.doi.org/10.1371/journal.pone.0028050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140505	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168100032
J	Nasser, KM; Obiols, AQ; Silverman, SL				Nasser, Keaton M.; Obiols, Alejandro Quinonez; Silverman, Stuart L.			Identifying Individuals at Risk for Fracture in Guatemala	PLOS ONE			English	Article								Introduction: The FRAX calculator combines a set of clinical risk factors with country-specific incidence rates to determine the ten-year absolute risk of major osteoporotic fracture. However, regional or country-specific databases from Central American countries are not available. We compared the use of various FRAX databases and the Pluijm algorithm in determining risk of fracture. Methods: We collected clinical risk factor data needed for the FRAX calculator and Pluijm algorithm of Hispanic women in Guatemala and calculated the FRAX absolute risk measures of major osteoporotic fracture and hip fracture. Subjects were postmenopausal women greater than age 40 with no history of using medication that affect bone. A random sample of 204 women in 34 different regions women in Guatemala City was visited in their homes to complete the surveys. The Pluijm risk score and FRAX risk score using the US Hispanic, Spain, and Mexican databases were calculated. Results: We used the US NOF guidelines for treatment which suggest a treatment threshold for patients with a 10-year hip fracture probability >= 3% or a 10-year major osteoporotic fracture risk >= 20%. The number of patients meeting the suggested threshold limits for treatment using the Spain and Mexico calculators were identical. There was 100% conformity in threshold limits for both hip and major osteoporotic fracture risk. The mean conformity for any fracture risk between US Hispanic and the other two databases was 97.5%. Conformity was 99.0% based on major osteoporotic fracture and 97.5% based on risk of hip fracture. The Pluijm evaluation shows conformity of 87.2% and 83.3%, respectively, when compared to the US Hispanic and Spain/Mexico FRAX thresholds for risk of fracture. Discussion: Although the different FRAX databases provide variations in the absolute risk of fracture, the overall conformity to treatment thresholds amongst the US Hispanic, Spain, and Mexico databases show the database used would have little effect as to the decision to treat. The Pluijm tool conforms to the FRAX thresholds and can be used as well. It does not matter which country-specific calculator or assessment tool is used, as there are a similar number of patients that would meet the intervention threshold.	[Nasser, Keaton M.] Osteoporosis Med Ctr, Beverly Hills, CA 90211 USA; [Obiols, Alejandro Quinonez] Univ Mariano Galvez Guatemala, Guatemala City, Guatemala; [Silverman, Stuart L.] Cedars Sinai UCLA, Los Angeles, CA USA	Cedars Sinai Medical Center	Nasser, KM (corresponding author), Osteoporosis Med Ctr, Beverly Hills, CA 90211 USA.	keatonn@omcresearch.org		Nasser, Keaton/0000-0003-3133-6028	Procter Gamble; Eli Lilly and Co.; Alliance for Better Bone Health	Procter Gamble(Procter & Gamble); Eli Lilly and Co.(Eli Lilly); Alliance for Better Bone Health	Funding for this study was provided by Procter & Gamble. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Stuart Silverman has received grants from Eli Lilly and Co. and Alliance for Better Bone Health. He has received honoraria from Eli Lilly, Roche Pharmaceuticals, and Pfizer, and he has consulted for Warner Chilcott, Roche Pharmaceuticals, Roche Diagnostics, Novartis, Pfizer, and Eli Lilly and Co. Funding for this study was provided by Procter & Gamble. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Kanis JA, 2002, J BONE MINER RES, V17, P1237, DOI 10.1359/jbmr.2002.17.7.1237; National Osteoporosis Foundation, 2013, CLIN GUID PREV TREAT; Pluijm SMF, 2009, J BONE MINER RES, V24, P768, DOI [10.1359/JBMR.081244, 10.1359/jbmr.081244]; Quinonez A, 2010, J CLIN RHEUM S, V16; Silverman Stuart L, 2010, Curr Osteoporos Rep, V8, P192, DOI 10.1007/s11914-010-0032-1; [No title captured]	6	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28042	10.1371/journal.pone.0028042	http://dx.doi.org/10.1371/journal.pone.0028042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140503	gold, Green Published, Green Submitted			2022-12-25	WOS:000298166300023
J	Pichugin, A; Beaujean, N; Vignon, X; Vassetzky, Y				Pichugin, Andrey; Beaujean, Nathalie; Vignon, Xavier; Vassetzky, Yegor			Ring-Like Distribution of Constitutive Heterochromatin in Bovine Senescent Cells	PLOS ONE			English	Article							CELLULAR SENESCENCE; PREMATURE SENESCENCE; IN-VIVO; TUMOR; FOCI; DNA; MOUSE; PML; FIBROBLASTS; PROTEINS	Background: Cells that reach "Hayflick limit" of proliferation, known as senescent cells, possess a particular type of nuclear architecture. Human senescent cells are characterized by the presence of highly condensed senescent associated heterochromatin foci (SAHF) that can be detected both by immunostaining for histone H3 three-methylated at lysine 9 (H3K9me3) and by DAPI counterstaining. Methods: We have studied nuclear architecture in bovine senescent cells using a combination of immunofluorescence and 3D fluorescent in-situ hybridization (FISH). Results: Analysis of heterochromatin distribution in bovine senescent cells using fluorescent in situ hybridization for pericentric chromosomal regions, immunostaining of H3K9me3, centromeric proteins CENP A/ B and DNA methylation showed a lower level of heterochromatin condensation as compared to young cells. No SAHF foci were observed. Instead, we observed fibrous ring-like or ribbon-like heterochromatin patterns that were undetectable with DAPI counterstaining. These heterochromatin fibers were associated with nucleoli. Conclusions: Constitutive heterochromatin in bovine senescent cells is organized in ring-like structures.	[Pichugin, Andrey; Beaujean, Nathalie; Vignon, Xavier] INRA, Grp Biol Dev & Reprod, UMR 1198, Jouy En Josas, France; [Pichugin, Andrey; Beaujean, Nathalie; Vignon, Xavier] ENVA, Grp Biol Dev & Reprod, UMR 1198, Jouy En Josas, France; [Pichugin, Andrey; Vassetzky, Yegor] Univ Paris 11, Ctr Natl Rech Sci, Inst Canc Gustave Roussy, UMR 8126, Villejuif, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Pichugin, A (corresponding author), INRA, Grp Biol Dev & Reprod, UMR 1198, Jouy En Josas, France.	karyolog@gmail.com; vassetzky@igr.fr	Beaujean, Nathalie/C-9883-2011; Pichugin, Andrey Mihaylovich/Q-1759-2016; Vassetzky, Yegor S/C-6447-2008; Vassetzky, Yegor/M-3383-2019	Beaujean, Nathalie/0000-0003-0188-9190; Pichugin, Andrey Mihaylovich/0000-0003-3810-1977; Vassetzky, Yegor S/0000-0003-3101-7043; Vassetzky, Yegor/0000-0003-3101-7043	European Community [MEST-CT-2004-504854, HEALTH-F4-2009-223485]; INRA "Young Team"; Fondation de France and Institut National de Cancer (INCa); Fondation de France	European Community(European Commission); INRA "Young Team"; Fondation de France and Institut National de Cancer (INCa); Fondation de France(Fondation de France)	This research project was supported by a Marie Curie Early Stage Research Training Fellowship of the European Community's Sixth Framework Program under contract number MEST-CT-2004-504854, by the "PluriSys" Collaborative Project from the European Community's under contract number HEALTH-F4-2009-223485, and INRA "Young Team" funding. The research in YV's laboratory was funded by the Fondation de France and Institut National de Cancer (INCa). AP was a recipient of the postdoctoral fellowship from the Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2007, GENE, V397, P84, DOI 10.1016/j.gene.2007.04.020; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Bui LC, 2009, REPRODUCTION, V138, P289, DOI 10.1530/REP-09-0042; Casillas MA, 2003, MOL CELL BIOCHEM, V252, P33, DOI 10.1023/A:1025548623524; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Condemine W, 2007, J CELL SCI, V120, P3219, DOI 10.1242/jcs.007492; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ferbeyre G, 2000, GENE DEV, V14, P2015; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Funayama R, 2006, J CELL BIOL, V175, P869, DOI 10.1083/jcb.200604005; Hayakawa T, 2003, J CELL SCI, V116, P3327, DOI 10.1242/jcs.00635; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V126, P135, DOI 10.1007/s00418-006-0212-3; HORNSBY PJ, 1992, MUTAT RES, V275, P13, DOI 10.1016/0921-8734(92)90004-9; Janderovd-Rossmeislova L, 2007, J STRUCT BIOL, V159, P56, DOI 10.1016/j.jsb.2007.02.008; Kennedy AL, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-16; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Raffetto JD, 1999, AM J SURG, V178, P107, DOI 10.1016/S0002-9610(99)00134-8; SCHNEDL W, 1977, HUM GENET, V36, P299, DOI 10.1007/BF00446280; Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875; Shi W, 2003, BIOL REPROD, V69, P301, DOI 10.1095/biolreprod.102.012112; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682; Ye XF, 2007, MOL CELL BIOL, V27, P2452, DOI 10.1128/MCB.01592-06; You S, 2004, MOL CELLS, V18, P261; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang RG, 2007, MOL CELL BIOL, V27, P949, DOI 10.1128/MCB.01639-06; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06; Zhang WJ, 2008, LIFE SCI, V83, P475, DOI 10.1016/j.lfs.2008.07.015	33	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e26844	10.1371/journal.pone.0026844	http://dx.doi.org/10.1371/journal.pone.0026844			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132080	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000006
J	Barreto, GE; Sun, XY; Xu, LJ; Giffard, RG				Barreto, George E.; Sun, Xiaoyun; Xu, Lijun; Giffard, Rona G.			Astrocyte Proliferation Following Stroke in the Mouse Depends on Distance from the Infarct	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; TRANSIENT CEREBRAL-ISCHEMIA; RAT-BRAIN; CNS INJURY; WALLERIAN DEGENERATION; REACTIVE ASTROCYTES; GLIAL REACTION; OLIGODENDROCYTES; ACTIVATION; CELLS	Reactive gliosis is a hallmark of brain pathology and the injury response, yet the extent to which astrocytes proliferate, and whether this is central to astrogliosis is still controversial. We determined the fraction of mature astrocytes that proliferate in a mouse stroke model using unbiased stereology as a function of distance from the infarct edge. Cumulatively 11.1+/-1.2% of Aldh1l1(+) astrocytes within 400 mu m in the cortical penumbra incorporate BrdU in the first week following stroke, while the overall number of astrocytes does not change. The number of astrocytes proliferating fell sharply with distance with more than half of all proliferating astrocytes found within 100 mu m of the edge of the infarct. Despite extensive cell proliferation primarily of microglia and neutrophils/monocytes in the week following stroke, few mature astrocytes re-enter cell cycle, and these are concentrated close to the infarct boundary.	[Barreto, George E.; Sun, Xiaoyun; Xu, Lijun; Giffard, Rona G.] Stanford Univ, Dept Anesthesia, Sch Med, Stanford, CA 94305 USA; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia	Stanford University; Pontificia Universidad Javeriana	Barreto, GE (corresponding author), Stanford Univ, Dept Anesthesia, Sch Med, Stanford, CA 94305 USA.	rona.giffard@stanford.edu	Barreto, George E./B-5747-2014; Barreto, George E./AAD-7420-2020	Barreto, George E./0000-0002-6644-1971; Barreto, George E./0000-0002-6644-1971; Giffard, Rona/0000-0003-2173-4436	National Institutes of Health (NIH) [RO1 GM49831]; Department of Anesthesia, Stanford University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049831] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Anesthesia, Stanford University(Stanford University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health (NIH) grant RO1 GM49831 to RGG, and in part by support from the Department of Anesthesia, Stanford University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Burns KA, 2009, GLIA, V57, P1115, DOI 10.1002/glia.20835; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CAVANAGH JB, 1970, J ANAT, V106, P471; Dihne M, 2001, BRAIN RES, V902, P178, DOI 10.1016/S0006-8993(01)02378-2; Dingman A, 2006, J NEUROCHEM, V96, P1467, DOI 10.1111/j.1471-4159.2006.03672.x; Dziewulska D, 1997, FOLIA NEUROPATHOL, V35, P99; FERNAUDESPINOSA I, 1993, GLIA, V8, P277, DOI 10.1002/glia.440080408; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hajos F., 1993, Neurobiology (Budapest), V1, P123; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Han RQ, 2009, ANESTH ANALG, V108, P280, DOI 10.1213/ane.0b013e318187ba6b; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; JANECZKO K, 1988, BRAIN RES, V456, P280, DOI 10.1016/0006-8993(88)90229-6; JANECZKO K, 1989, BRAIN RES, V485, P236, DOI 10.1016/0006-8993(89)90566-0; LATOV N, 1979, DEV BIOL, V72, P381, DOI 10.1016/0012-1606(79)90127-1; LINDSAY RM, 1986, ASTROCYTES, P231; Liu Y, 2010, NEUROSCIENCE, V166, P241, DOI 10.1016/j.neuroscience.2009.12.026; LUDWIN SK, 1985, LAB INVEST, V52, P20; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; PETITO CK, 1990, J CEREBR BLOOD F MET, V10, P850, DOI 10.1038/jcbfm.1990.141; Popa-Wagner A, 2007, ACTA NEUROPATHOL, V113, P277, DOI 10.1007/s00401-006-0164-7; Reier PJ, 1986, ASTROCYTES, V3, P263; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; SCHIFFER D, 1986, BRAIN RES, V374, P110, DOI 10.1016/0006-8993(86)90399-9; SCHIFFER D, 1993, INT J DEV NEUROSCI, V11, P269, DOI 10.1016/0736-5748(93)90085-R; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; VAUGHN JE, 1970, J COMP NEUROL, V140, P207, DOI 10.1002/cne.901400205	35	94	98	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27881	10.1371/journal.pone.0027881	http://dx.doi.org/10.1371/journal.pone.0027881			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132159	Green Submitted, gold, Green Published			2022-12-25	WOS:000297789900028
J	Riley, MC; Lee, JE; Lesho, E; Kirkup, BC				Riley, Matthew C.; Lee, James Eric; Lesho, Emil; Kirkup, Benjamin C., Jr.			Optically Mapping Multiple Bacterial Genomes Simultaneously in a Single Run	PLOS ONE			English	Article								Optical mapping of bacterial chromosomes provides an unambiguous low-resolution sequence scaffold of the entire chromosome. In comparison to some techniques, such as pulse field gel electrophoresis, cost and throughput limit the application of this technique outside of genome finishing. We have demonstrated the production of multiple bacterial maps using a single set of consumables; this significantly reduces the time and expense of map production.	[Riley, Matthew C.; Lee, James Eric; Lesho, Emil; Kirkup, Benjamin C., Jr.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [Riley, Matthew C.; Lesho, Emil; Kirkup, Benjamin C., Jr.] USA, Multidrug Resistant Organism Repository & Surveil, Silver Spring, MD USA; [Lesho, Emil; Kirkup, Benjamin C., Jr.] Uniformed Serv Univ Hlth Sci, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Riley, MC (corresponding author), Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.	bckirkup@post.harvard.edu	Kirkup, Benjamin/C-3610-2009	Kirkup, Benjamin/0000-0002-8722-6218	Department of Defense; Division of Bacterial and Rickettsial Diseases	Department of Defense(United States Department of Defense); Division of Bacterial and Rickettsial Diseases	This research was funded entirely by the Department of Defense. No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the assistance of the OpGen technical support staff, the support of our respective departments and the Division of Bacterial and Rickettsial Diseases. Disclaimer: The findings and opinions expressed herein belong to the authors and do not necessarily reflect the official views of the WRAIR, the U.S. Army or the Department of Defense.	Janda J. M., 2005, ENTEROBACTERIA; Latreille P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-321; Nagarajan N, 2008, BIOINFORMATICS, V24, P1229, DOI 10.1093/bioinformatics/btn102; 2011, GENETIC ENG BIOTECHN, V31	4	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27085	10.1371/journal.pone.0027085	http://dx.doi.org/10.1371/journal.pone.0027085			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132087	gold, Green Published, Green Submitted			2022-12-25	WOS:000297789900009
J	Upadhyay, J; Baker, SJ; Chandran, P; Miller, L; Lee, Y; Marek, GJ; Sakoglu, U; Chin, CL; Luo, F; Fox, GB; Day, M				Upadhyay, Jaymin; Baker, Scott J.; Chandran, Prasant; Miller, Loan; Lee, Younglim; Marek, Gerard J.; Sakoglu, Unal; Chin, Chih-Liang; Luo, Feng; Fox, Gerard B.; Day, Mark			Default-Mode-Like Network Activation in Awake Rodents	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; LEARNED HELPLESSNESS; STRIA TERMINALIS; BRAIN NETWORKS; BED NUCLEUS; ANXIETY; RAT; ARCHITECTURE; RECEPTORS; AMYGDALA	During wakefulness and in absence of performing tasks or sensory processing, the default-mode network (DMN), an intrinsic central nervous system (CNS) network, is in an active state. Non-human primate and human CNS imaging studies have identified the DMN in these two species. Clinical imaging studies have shown that the pattern of activity within the DMN is often modulated in various disease states (e. g., Alzheimer's, schizophrenia or chronic pain). However, whether the DMN exists in awake rodents has not been characterized. The current data provides evidence that awake rodents also possess 'DMN-like' functional connectivity, but only subsequent to habituation to what is initially a novel magnetic resonance imaging (MRI) environment as well as physical restraint. Specifically, the habituation process spanned across four separate scanning sessions (Day 2, 4, 6 and 8). At Day 8, significant (p<0.05) functional connectivity was observed amongst structures such as the anterior cingulate (seed region), retrosplenial, parietal, and hippocampal cortices. Prior to habituation (Day 2), functional connectivity was only detected (p<0.05) amongst CNS structures known to mediate anxiety (i.e., anterior cingulate (seed region), posterior hypothalamic area, amygdala and parabracial nucleus). In relating functional connectivity between cingulate-default-mode and cingulate-anxiety structures across Days 2-8, a significant inverse relationship (r = -0.65, p = 0.0004) was observed between these two functional interactions such that increased cingulate-DMN connectivity corresponded to decreased cingulate anxiety network connectivity. This investigation demonstrates that the cingulate is an important component of both the rodent DMN-like and anxiety networks.	[Upadhyay, Jaymin; Baker, Scott J.; Chandran, Prasant; Miller, Loan; Lee, Younglim; Marek, Gerard J.; Sakoglu, Unal; Chin, Chih-Liang; Luo, Feng; Fox, Gerard B.; Day, Mark] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA	Abbott Laboratories	Upadhyay, J (corresponding author), Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA.	jaymin.upadhyay@abbott.com; mark.day@abbott.com	Marek, Gerard/GQO-8288-2022; Sakoglu, Unal/A-6275-2010	Sakoglu, Unal/0000-0003-2056-077X	Abbott Laboratories	Abbott Laboratories(Abbott Laboratories)	Jaymin Upadhyay, Scott J. Baker, Prasant Chandran, Loan Miller, Younglim Lee, Gerard J. Marek, Unal Sakoglu, Chih-Liang Chin, Feng Luo, Gerard B. Fox, and Mark Day are stated as employees of Abbott Laboratories during the time at which this experiment took place and was completed. Each author helped design and perform this experiment. All experimental research was funded by and performed at Abbott Laboratories.	Abrahamson EE, 2001, BRAIN RES, V889, P1, DOI 10.1016/S0006-8993(00)03015-8; Aggleton J. P., 1999, BEHAV BRAIN SCI, V22, P444, DOI DOI 10.1017/S0140525X99422034; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Balaban CD, 2002, PHYSIOL BEHAV, V77, P469, DOI 10.1016/S0031-9384(02)00935-6; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Balkin TJ, 2002, BRAIN, V125, P2308, DOI 10.1093/brain/awf228; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Davis M, 1997, ANN NY ACAD SCI, V821, P305, DOI 10.1111/j.1749-6632.1997.tb48289.x; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Ferris CF, 2006, J NEUROENDOCRINOL, V18, P307, DOI 10.1111/j.1365-2826.2006.01424.x; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kram ML, 2002, PROG NEURO-PSYCHOPH, V26, P639, DOI 10.1016/S0278-5846(01)00222-6; Kram ML, 2000, NEUROSCI RES, V38, P193, DOI 10.1016/S0168-0102(00)00157-7; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Masamoto K, 2009, EUR J NEUROSCI, V30, P242, DOI 10.1111/j.1460-9568.2009.06812.x; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; MCCLEARN GE, 1960, J COMP PHYSIOL PSYCH, V53, P142, DOI 10.1037/h0042766; ONO K, 1985, NEUROSCI LETT, V57, P283, DOI 10.1016/0304-3940(85)90506-3; PANDYA DN, 1981, EXP BRAIN RES, V42, P319, DOI 10.1007/BF00237497; Paxinos G, 2009, RAT BRAIN STEREOTAXI; PORRINO LJ, 1981, J COMP NEUROL, V198, P121, DOI 10.1002/cne.901980111; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; RAICHLE ME, 2001, SCIENCES, V98, P676; Rilling JK, 2007, P NATL ACAD SCI USA, V104, P17146, DOI 10.1073/pnas.0705132104; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; SHEKHAR A, 1990, BRAIN RES, V512, P81, DOI 10.1016/0006-8993(90)91173-E; Sink KS, 2011, J NEUROSCI, V31, P1802, DOI 10.1523/JNEUROSCI.5274-10.2011; Smith DM, 2002, J NEUROSCI, V22, P8212; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Talalaenko A N, 2008, Neurosci Behav Physiol, V38, P115, DOI 10.1007/s11055-008-0016-0; TSANOV M, 2011, NEUROSCIENCE; Vahl TP, 2005, AM J PHYSIOL-ENDOC M, V289, pE823, DOI 10.1152/ajpendo.00122.2005; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001	46	72	74	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27839	10.1371/journal.pone.0027839	http://dx.doi.org/10.1371/journal.pone.0027839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125628	Green Published, Green Submitted, gold			2022-12-25	WOS:000297789200028
J	Krug, U; Zebisch, M; Krauss, M; Strater, N				Krug, Ulrike; Zebisch, Matthias; Krauss, Michel; Straeter, Norbert			Structural Insight into Activation Mechanism of Toxoplasma gondii Nucleoside Triphosphate Diphosphohydrolases by Disulfide Reduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ATP-DIPHOSPHOHYDROLASE; LEISHMANIA-AMAZONENSIS; CONFORMATIONAL-CHANGE; MAXIMUM-LIKELIHOOD; PROTEIN STRUCTURES; CRYSTAL-STRUCTURE; ECTO-ATPASE; HYDROLASE; PURIFICATION	The intracellular parasite Toxoplasma gondii produces two nucleoside triphosphate diphosphohydrolases (NTPDase1 and -3). These tetrameric, cysteine-rich enzymes require activation by reductive cleavage of a hitherto unknown disulfide bond. Despite a 97% sequence identity, both isozymes differ largely in their ability to hydrolyze ATP and ADP. Here, we present crystal structures of inactive NTPDase3 as an apo form and in complex with the product AMP to resolutions of 2.0 and 2.2 angstrom, respectively. We find that the enzyme is present in an open conformation that precludes productive substrate binding and catalysis. The cysteine bridge 258-268 is identified to be responsible for locking of activity. Crystal structures of constitutively active variants of NTPDase1 and -3 generated by mutation of Cys(258)-Cys(268) show that opening of the regulatory cysteine bridge induces a pronounced contraction of the whole tetramer. This is accompanied by a 12 degrees domain closure motion resulting in the correct arrangement of all active site residues. A complex structure of activated NTPDase3 with a non-hydrolyzable ATP analog and the cofactor Mg2+ to a resolution of 2.85 angstrom indicates that catalytic differences between the NTPDases are primarily dictated by differences in positioning of the adenine base caused by substitution of Arg(492) and Glu(493) in NTPDase1 by glycines in NTPDase3.	[Krug, Ulrike; Zebisch, Matthias; Krauss, Michel; Straeter, Norbert] Univ Leipzig, Inst Bioanalyt Chem, Ctr Biotechnol & Biomed, D-04103 Leipzig, Germany	Leipzig University	Strater, N (corresponding author), Univ Leipzig, Inst Bioanalyt Chem, Ctr Biotechnol & Biomed, Deutsch Pl 5, D-04103 Leipzig, Germany.	strater@bbz.uni-leipzig.de	Strater, Norbert/P-4856-2018	Strater, Norbert/0000-0002-2001-0500; Zebisch, Matthias/0000-0003-3126-3885	European Synchrotron Radiation Facility (Grenoble, France); PSF/BESSY (Berlin, Germany)	European Synchrotron Radiation Facility (Grenoble, France); PSF/BESSY (Berlin, Germany)	We thank Michael Johnson (University of Technology, Sydney, Australia) for providing cDNA. Furthermore, we thank the staff of beamlines BL14.1 and BL14.2 at PSF/BESSY (Berlin, Germany) and beamline ID23-2 at the European Synchrotron Radiation Facility (Grenoble, France) for beam time and support.	ASAI T, 1983, J BIOL CHEM, V258, P6816; ASAI T, 1995, J BIOL CHEM, V270, P11391, DOI 10.1074/jbc.270.19.11391; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BENNETT WS, 1978, P NATL ACAD SCI USA, V75, P4848, DOI 10.1073/pnas.75.10.4848; BERMUDES D, 1994, J BIOL CHEM, V269, P29252; Berredo-Pinho M, 2001, ARCH BIOCHEM BIOPHYS, V391, P16, DOI 10.1006/abbi.2001.2384; Bianconi ML, 2007, BIOPHYS CHEM, V126, P59, DOI 10.1016/j.bpc.2006.05.017; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Drosopoulos JHF, 2000, BIOCHEMISTRY-US, V39, P6936, DOI 10.1021/bi992581e; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Grinthal Alison, 2006, Purinergic Signal, V2, P391, DOI 10.1007/s11302-005-5907-8; Handa M, 1996, BIOCHEM BIOPH RES CO, V218, P916, DOI 10.1006/bbrc.1996.0162; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; Ivanenkov VV, 2005, BIOCHEMISTRY-US, V44, P8998, DOI 10.1021/bi047487z; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kikuchi T, 2001, J EUKARYOT MICROBIOL, p195S; Kuettner EB, 2010, J BIOL CHEM, V285, P41019, DOI 10.1074/jbc.M110.185850; Mateo J, 2003, J BIOL CHEM, V278, P39960, DOI 10.1074/jbc.M307854200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; Mosca R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-352; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakaar V, 1998, MOL BIOCHEM PARASIT, V97, P209, DOI 10.1016/S0166-6851(98)00153-4; Nakaar V, 1999, J BIOL CHEM, V274, P5083, DOI 10.1074/jbc.274.8.5083; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pinheiro CM, 2006, EXP PARASITOL, V114, P16, DOI 10.1016/j.exppara.2006.02.007; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Sansom FM, 2007, CELL MICROBIOL, V9, P1922, DOI 10.1111/j.1462-5822.2007.00924.x; Sansom FM, 2008, MICROBIOL MOL BIOL R, V72, P765, DOI 10.1128/MMBR.00013-08; SCHWARTZMAN JD, 1982, EXP PARASITOL, V53, P77, DOI 10.1016/0014-4894(82)90094-7; SIBLEY LD, 1994, EXP PARASITOL, V79, P301, DOI 10.1006/expr.1994.1093; Silverman JA, 1998, J BIOL CHEM, V273, P12352, DOI 10.1074/jbc.273.20.12352; Stommel EW, 1997, EXP PARASITOL, V87, P88, DOI 10.1006/expr.1997.4187; Stommel EW, 2001, EXP BIOL MED, V226, P229, DOI 10.1177/153537020122600311; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vasconcelos EG, 1996, J BIOL CHEM, V271, P22139, DOI 10.1074/jbc.271.36.22139; VASCONCELOS EG, 1993, MOL BIOCHEM PARASIT, V58, P205, DOI 10.1016/0166-6851(93)90042-V; Vivian JP, 2010, STRUCTURE, V18, P228, DOI 10.1016/j.str.2009.11.014; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Yang F, 2001, BIOCHEMISTRY-US, V40, P3943, DOI 10.1021/bi002711f; Zebisch M., 2011, J MOL BIOL IN PRESS; Zebisch M, 2008, P NATL ACAD SCI USA, V105, P6882, DOI 10.1073/pnas.0802535105; Zebisch M, 2007, BIOCHEMISTRY-US, V46, P11945, DOI 10.1021/bi701103y	53	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2012	287	5					3051	3066		10.1074/jbc.M111.294348	http://dx.doi.org/10.1074/jbc.M111.294348			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892OI	22130673	Green Published, hybrid			2022-12-25	WOS:000300295100012
J	Rondas, D; Tomas, A; Soto-Ribeiro, M; Wehrle-Haller, B; Halban, PA				Rondas, Dieter; Tomas, Alejandra; Soto-Ribeiro, Martinho; Wehrle-Haller, Bernhard; Halban, Philippe A.			Novel Mechanistic Link between Focal Adhesion Remodeling and Glucose-stimulated Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; GTPASE-ACTIVATING PROTEIN; SMALL-MOLECULE INHIBITOR; EVANESCENT-WAVE MICROSCOPY; SKELETAL-MUSCLE CELLS; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; RHO-SUBFAMILY; TYROSINE PHOSPHORYLATION; BINDING PROTEINS	Actin cytoskeleton remodeling is well known to be positively involved in glucose-stimulated pancreatic beta cell insulin secretion. We have observed glucose-stimulated focal adhesion remodeling at the beta cell surface and have shown this to be crucial for glucose-stimulated insulin secretion. However, the mechanistic link between such remodeling and the insulin secretory machinery remained unknown and was the major aim of this study. MIN6B1 cells, a previously validated model of primary beta cell function, were used for all experiments. Total internal reflection fluorescence microscopy revealed the glucose-responsive co-localization of focal adhesion kinase (FAK) and paxillin with integrin beta 1 at the basal cell surface after short term stimulation. In addition, blockade of the interaction between beta 1 integrins and the extracellular matrix with an anti-beta 1 integrin antibody (Ha2/5) inhibited short term glucose-induced phosphorylation of FAK (Tyr-397), paxillin (Tyr-118), and ERK1/2 (Thr-202/Tyr-204). Pharmacological inhibition of FAK activity blocked glucose-induced actin cytoskeleton remodeling and glucose-induced disruption of the F-actin/SNAP-25 association at the plasma membrane as well as the distribution of insulin granules to regions in close proximity to the plasma membrane. Furthermore, FAK inhibition also completely blocked short term glucose-induced activation of the Akt/AS160 signaling pathway. In conclusion, these results indicate 1) that glucose-induced activation of FAK, paxillin, and ERK1/2 is mediated by beta 1 integrin intracellular signaling, 2) a mechanism whereby FAK mediates glucose-induced actin cytoskeleton remodeling, hence allowing docking and fusion of insulin granules to the plasma membrane, and 3) a possible functional role for the Akt/AS160 signaling pathway in the FAK-mediated regulation of glucose-stimulated insulin secretion.	[Rondas, Dieter; Halban, Philippe A.] Univ Geneva, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland; [Tomas, Alejandra] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Soto-Ribeiro, Martinho; Wehrle-Haller, Bernhard] Univ Geneva, Dept Cellular Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of Geneva	Rondas, D (corresponding author), Univ Geneva, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	dieter.rondas@unige.ch		Tomas, Alejandra/0000-0002-2290-8453	Swiss National Science Fund [31003A_127276/1]	Swiss National Science Fund(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Science Fund Grant 31003A_127276/1.	Amin RH, 2003, ENDOCRINOLOGY, V144, P4508, DOI 10.1210/en.2003-0106; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Bisht B, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-48; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Bouzakri K, 2008, DIABETES, V57, P1195, DOI 10.2337/db07-1469; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; CURRY DL, 1968, ENDOCRINOLOGY, V83, P572, DOI 10.1210/endo-83-3-572; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; Duncan MD, 1996, J SURG RES, V63, P359, DOI 10.1006/jsre.1996.0276; Elias BC, 2010, CELL ADHES MIGR, V4, P419, DOI 10.4161/cam.4.3.12043; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Geny B, 2010, CELL MICROBIOL, V12, P217, DOI 10.1111/j.1462-5822.2009.01392.x; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gilmore AP, 1996, STRUCTURE, V4, P647, DOI 10.1016/S0969-2126(96)00069-X; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Grodsky G., 1970, ADV METAB DISORD S1, V1, P45; Hammar E, 2004, DIABETES, V53, P2034, DOI 10.2337/diabetes.53.8.2034; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; HOWELL SL, 1979, BIOCHEM J, V178, P367, DOI 10.1042/bj1780367; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Jebailey L, 2004, MOL ENDOCRINOL, V18, P359, DOI 10.1210/me.2003-0294; JeBailey L, 2007, DIABETES, V56, P394, DOI 10.2337/db06-0823; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; Kaido T, 2004, J BIOL CHEM, V279, P53762, DOI 10.1074/jbc.M411202200; Kaido T, 2004, J BIOL CHEM, V279, P17731, DOI 10.1074/jbc.M308425200; Kantengwa S, 1997, EXP CELL RES, V237, P394, DOI 10.1006/excr.1997.3803; Kowluru A, 2003, ENDOCR RES, V29, P363, DOI 10.1081/ERC-120025043; Kowluru A, 1997, BIOCHEM PHARMACOL, V54, P1097, DOI 10.1016/S0006-2952(97)00314-6; Krishnamurthy M, 2011, ENDOCRINOLOGY, V152, P424, DOI 10.1210/en.2010-0877; Leopoldt D, 2001, J CELL PHYSIOL, V188, P106, DOI 10.1002/jcp.1102; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; MALAISSE WJ, 1971, DIABETES, V20, P257, DOI 10.2337/diab.20.5.257; MEGLASSON M D, 1986, Diabetes Metabolism Reviews, V2, P163; Mehta D, 2002, J PHYSIOL-LONDON, V539, P779, DOI 10.1113/jphysiol.2001.013289; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Nagamatsu S, 1996, J BIOL CHEM, V271, P1160, DOI 10.1074/jbc.271.2.1160; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; OCONNOR MDL, 1980, AM J PHYSIOL, V238, pR378, DOI 10.1152/ajpregu.1980.238.5.R378; Ohara-Imaizumi M, 2004, J BIOL CHEM, V279, P8403, DOI 10.1074/jbc.M308954200; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Parnaud G, 2006, DIABETES, V55, P1413, DOI 10.2337/db05-1388; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Randhawa VK, 2008, J BIOL CHEM, V283, P27208, DOI 10.1074/jbc.M804282200; REGAZZI R, 1995, EMBO J, V14, P2723, DOI 10.1002/j.1460-2075.1995.tb07273.x; RICHARDSON A, 1995, BIOESSAYS, V17, P229, DOI 10.1002/bies.950170309; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riopel M, 2011, J PATHOL, V224, P45, DOI 10.1002/path.2849; ROBINSON IM, 1995, P NATL ACAD SCI USA, V92, P2474, DOI 10.1073/pnas.92.7.2474; Rondas D, 2011, DIABETES, V60, P1146, DOI 10.2337/db10-0946; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; SADOUL K, 1995, J CELL BIOL, V128, P1019, DOI 10.1083/jcb.128.6.1019; Saleem S, 2009, J PATHOL, V219, P182, DOI 10.1002/path.2577; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; SATIN LS, 1985, PFLUG ARCH EUR J PHY, V404, P385, DOI 10.1007/BF00585354; SOMERS G, 1979, ENDOCRINOLOGY, V104, P255, DOI 10.1210/endo-104-1-255; Thamilselvan V, 2005, CARCINOGENESIS, V26, P1687, DOI 10.1093/carcin/bgi135; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Toomre D, 2001, TRENDS CELL BIOL, V11, P298, DOI 10.1016/S0962-8924(01)02027-X; Torregrosa-Hetland CJ, 2011, J CELL SCI, V124, P727, DOI 10.1242/jcs.078600; Torregrosa-Hetland CJ, 2010, CELL MOL NEUROBIOL, V30, P1315, DOI 10.1007/s10571-010-9565-1; Tsuboi T, 2006, DIABETES, V55, P1057, DOI 10.2337/diabetes.55.04.06.db05-1577; Tsuboi T, 2003, J BIOL CHEM, V278, P52042, DOI 10.1074/jbc.M307800200; Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3; Veluthakal R, 2009, BIOCHEM PHARMACOL, V77, P101, DOI 10.1016/j.bcp.2008.09.021; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; WANG JL, 1990, BIOCHEM BIOPH RES CO, V171, P424, DOI 10.1016/0006-291X(90)91410-T; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248	81	55	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2423	2436		10.1074/jbc.M111.279885	http://dx.doi.org/10.1074/jbc.M111.279885			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139838	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000300292300017
J	Singh, N; Wiltshire, TD; Thompson, JR; Mer, G; Couch, FJ				Singh, Namit; Wiltshire, Timothy D.; Thompson, James R.; Mer, Georges; Couch, Fergus J.			Molecular Basis for the Association of Microcephalin (MCPH1) Protein with the Cell Division Cycle Protein 27 (Cdc27) Subunit of the Anaphase-promoting Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; STRUCTURAL BASIS; BRCT DOMAIN; PHOSPHOPEPTIDE RECOGNITION; BINDING SPECIFICITIES; BACH1 PHOSPHOPEPTIDE; MITOTIC ENTRY; MDC1; BRIT1/MCPH1; INTEGRITY	Microcephalin (MCPH1), the first gene identified as causative for primary recessive autosomal microcephaly, is aberrantly expressed in autism-like disorders and human malignancy of breast and ovarian origin. MCPH1, the encoded protein product, has been implicated in various cellular processes including the DNA damage checkpoint, DNA repair, and transcription. Although our understanding of the cellular context in which MCPH1 operates continues to develop, a structural understanding of the C-terminal tandem BRCT domains of MCPH1 remains unexplored. Here, we identify cell division cycle protein 27 (Cdc27), a component of the anaphase-promoting complex (APC/C), as a novel interacting partner of MCPH1. We provide in vitro and in vivo evidence that the C-terminal tandem BRCT domains of MCPH1 (C-BRCTs) bind Cdc27 in a phosphorylation-dependent manner. To characterize this interaction further, we determined the structure of MCPH1 C-BRCTs in complex with a phosphorylated Cdc27 peptide (pCdc27) using x-ray crystallography. Based on this structure, we identified single amino acid mutations targeted at the binding interface that disrupted the MCPH1-pCdc27 interaction. Collectively, our data define the biochemical, structural, and cellular determinants of the novel interaction between MCPH1 and Cdc27 and suggest that this interaction may occur within the larger context of MCPH1-APC/C.	[Singh, Namit; Mer, Georges] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Wiltshire, Timothy D.; Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Thompson, James R.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Mer, G (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	mer.georges@mayo.edu	Mer, Georges/AAT-4946-2021	Mer, Georges/0000-0002-1900-1578	National Institutes of Health [CA132878, CA116167]; NATIONAL CANCER INSTITUTE [R01CA116167, R01CA132878, U01CA116167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132878 (to G. M.) and CA116167 (to F. J. C.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Campbell SJ, 2010, STRUCTURE, V18, P167, DOI 10.1016/j.str.2009.12.008; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Coster G, 2007, J BIOL CHEM, V282, P32053, DOI 10.1074/jbc.M705890200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Joo WS, 2002, GENE DEV, V16, P583, DOI 10.1101/gad.959202; Joughin BA, 2005, PROTEIN SCI, V14, P131, DOI 10.1110/ps.04964705; Kilkenny ML, 2008, GENE DEV, V22, P2034, DOI 10.1101/gad.472808; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Leung CCY, 2011, CELL CYCLE, V10, P2461, DOI 10.4161/cc.10.15.16312; Leung CCY, 2011, J BIOL CHEM, V286, P4292, DOI 10.1074/jbc.M110.189555; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nomine Y, 2008, BIOCHEMISTRY-US, V47, P9866, DOI 10.1021/bi702247d; Peng G, 2009, CELL CYCLE, V8, P3071, DOI 10.4161/cc.8.19.9411; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Varma AK, 2005, BIOCHEMISTRY-US, V44, P10941, DOI 10.1021/bi0509651; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Wu XL, 2009, CANCER RES, V69, P5531, DOI 10.1158/0008-5472.CAN-08-4834; Xu C, 2008, J MOL BIOL, V381, P361, DOI 10.1016/j.jmb.2008.05.087; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	43	16	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2854	2862		10.1074/jbc.M111.307868	http://dx.doi.org/10.1074/jbc.M111.307868			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22139841	hybrid, Green Published			2022-12-25	WOS:000300292300057
J	Egger, S; Chaikuad, A; Klimacek, M; Kavanagh, KL; Oppermann, U; Nidetzky, B				Egger, Sigrid; Chaikuad, Apirat; Klimacek, Mario; Kavanagh, Kathryn L.; Oppermann, Udo; Nidetzky, Bernd			Structural and Kinetic Evidence That Catalytic Reaction of Human UDP-glucose 6-Dehydrogenase Involves Covalent Thiohemiacetal and Thioester Enzyme Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URIDINE DIPHOSPHOGLUCOSE DEHYDROGENASE; MECHANISM; INHIBITION; RESIDUES; REVEALS; BINDING; 2ND	Biosynthesis of UDP-glucuronic acid by UDP-glucose 6-dehydrogenase (UGDH) occurs through the four-electron oxidation of the UDP-glucose C6 primary alcohol in two NAD(+)-dependent steps. The catalytic reaction of UGDH is thought to involve a Cys nucleophile that promotes formation of a thiohemiacetal enzyme intermediate in the course of the first oxidation step. The thiohemiacetal undergoes further oxidation into a thioester, and hydrolysis of the thioester completes the catalytic cycle. Herein we present crystallographic and kinetic evidence for the human form of UGDH that clarifies participation of covalent catalysis in the enzymatic mechanism. Substitution of the putative catalytic base for water attack on the thioester (Glu(161)) by an incompetent analog (Gln(161)) gave a UGDH variant (E161Q) in which the hydrolysis step had become completely rate-limiting so that a thioester enzyme intermediate accumulated at steady state. By crystallizing E161Q in the presence of 5 mM UDP-glucose and 2 mM NAD(+), we succeeded in trapping a thiohemiacetal enzyme intermediate and determined its structure at 2.3 angstrom resolution. Cys(276) was covalently modified in the structure, establishing its role as catalytic nucleophile of the reaction. The thiohemiacetal reactive C6 was in a position suitable to become further oxidized by hydride transfer to NAD(+). The proposed catalytic mechanism of human UGDH involves Lys(220) as general base for UDP-glucose alcohol oxidation and for oxyanion stabilization during formation and breakdown of the thiohemiacetal and thioester enzyme intermediates. Water coordinated to Asp(280) deprotonates Cys(276) to function as an aldehyde trap and also provides oxyanion stabilization. Glu(161) is the Bronsted base catalytically promoting the thioester hydrolysis.	[Egger, Sigrid; Klimacek, Mario; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Chaikuad, Apirat; Kavanagh, Kathryn L.; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Oppermann, Udo] Univ Oxford, Botnar Res Ctr, Natl Inst Hlth Res Oxford Biomed Res Unit, Oxford OX3 7LD, England; [Egger, Sigrid; Nidetzky, Bernd] Austrian Ctr Ind Biotechnol, A-8010 Graz, Austria	Graz University of Technology; University of Oxford; University of Oxford; Austrian Centre of Industrial Biotechnology	Nidetzky, B (corresponding author), Graz Univ Technol, Inst Biotechnol & Biochem Engn, Petersgasse 12-1, A-8010 Graz, Austria.	bernd.nidetzky@tugraz.at		Chaikuad, Apirat/0000-0003-1120-2209; Nidetzky, Bernd/0000-0002-5030-2643	Austrian Science Fund (DK Molecular Enzymology) [W901-B05]; Structural Genomics Consortium [1097737]; Wellcome Trust; GlaxoSmithKline; Genome Canada; Canadian Institutes of Health Research; Ontario Innovation Trust; Ontario Research and Development Challenge Fund; Canadian Foundation for Innovation; Vinnova; Swedish Strategic Research Foundation; Knut and Alice Wallenberg Foundation; Karolinska Institute; National Institute for Health Research Oxford Biomedical Research Unit; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Austrian Science Fund (DK Molecular Enzymology)(Austrian Science Fund (FWF)); Structural Genomics Consortium(University of Toronto); Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline(GlaxoSmithKline); Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Innovation Trust; Ontario Research and Development Challenge Fund(General Electric); Canadian Foundation for Innovation(Canada Foundation for Innovation); Vinnova(Vinnova); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institute(Karolinska Institutet); National Institute for Health Research Oxford Biomedical Research Unit; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (DK Molecular Enzymology W901-B05) and the Structural Genomics Consortium registered charity (no. 1097737) funded by the Wellcome Trust, GlaxoSmithKline, Genome Canada, the Canadian Institutes of Health Research, the Ontario Innovation Trust, the Ontario Research and Development Challenge Fund, the Canadian Foundation for Innovation, Vinnova, the Swedish Strategic Research Foundation, the Knut and Alice Wallenberg Foundation, and the Karolinska Institute. This work was also further supported by the National Institute for Health Research Oxford Biomedical Research Unit.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Campbell RE, 1997, J BIOL CHEM, V272, P3416, DOI 10.1074/jbc.272.6.3416; Campbell RE, 1999, J ORG CHEM, V64, P9487, DOI 10.1021/jo991092h; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Chen YY, 2011, J STRUCT BIOL, V175, P300, DOI 10.1016/j.jsb.2011.04.010; Clarkin CE, 2011, MATRIX BIOL, V30, P163, DOI 10.1016/j.matbio.2011.01.002; Clarkin CE, 2011, J CELL PHYSIOL, V226, P749, DOI 10.1002/jcp.22393; D'Ambrosio K, 2006, BIOCHEMISTRY-US, V45, P2978, DOI 10.1021/bi0515117; Easley KE, 2007, BIOCHEMISTRY-US, V46, P369, DOI 10.1021/bi061537d; ECCLESTON ED, 1979, J BIOL CHEM, V254, P1399; Egger S, 2011, J BIOL CHEM, V286, P23877, DOI 10.1074/jbc.M111.234682; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANZEN JS, 1973, BIOCHEM BIOPH RES CO, V50, P517, DOI 10.1016/0006-291X(73)90870-X; FRANZEN JS, 1976, BIOCHEMISTRY-US, V15, P5665, DOI 10.1021/bi00670a036; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ge X, 2004, EUR J BIOCHEM, V271, P14, DOI 10.1046/j.1432-1033.2003.03876.x; Ge X, 1998, J AM CHEM SOC, V120, P6613, DOI 10.1021/ja9805977; Kadirvelraj R, 2011, BIOCHEMISTRY-US, V50, P5780, DOI 10.1021/bi2005637; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Munoz-Clares RA, 2011, CHEM-BIOL INTERACT, V191, P137, DOI 10.1016/j.cbi.2010.12.024; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSESTUEN GL, 1971, J BIOL CHEM, V246, P3828; ORDMAN AB, 1977, BIOCHIM BIOPHYS ACTA, V481, P25, DOI 10.1016/0005-2744(77)90133-4; ORDMAN AB, 1977, J BIOL CHEM, V252, P1320; Rajakannan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025226; RIDLEY WP, 1973, BIOCHEM BIOPH RES CO, V54, P955, DOI 10.1016/0006-291X(73)90787-0; RIDLEY WP, 1975, J BIOL CHEM, V250, P8761; Rocha J, 2011, J BACTERIOL, V193, P3978, DOI 10.1128/JB.01076-10; SCHILLER JG, 1972, CARBOHYD RES, V21, P249, DOI 10.1016/S0008-6215(00)82151-5; Sommer BJ, 2004, J BIOL CHEM, V279, P23590, DOI 10.1074/jbc.M401928200; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581	34	22	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					2119	2129		10.1074/jbc.M111.313015	http://dx.doi.org/10.1074/jbc.M111.313015			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22123821	hybrid, Green Published			2022-12-25	WOS:000299321000052
J	Cheng, C; Gong, XH				Cheng, Catherine; Gong, Xiaohua			Diverse Roles of Eph/ephrin Signaling in the Mouse Lens	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; BETA-CATENIN; N-CADHERIN; CATARACT; EPHA2; GENE; MORPHOGENESIS; EXPRESSION; MUTATIONS; GROWTH	Recent genetic studies show that the Eph/ephrin bidirectional signaling pathway is associated with both congenital and age-related cataracts in mice and humans. We have investigated the molecular mechanisms of cataractogenesis and the roles of ephrin-A5 and EphA2 in the lens. Ephrin-A5 knockout (-/-) mice often display anterior polar cataracts while EphA2(-/-) lenses show very mild cortical or nuclear cataracts at weaning age. The anterior polar cataract of ephrin-A5(-/-) lenses is correlated with multilayers of aberrant cells that express alpha smooth muscle actin, a marker for mesenchymal cells. Only select fiber cells are altered in ephrin-A5(-/-) lenses. Moreover, the disruption of membrane-associated beta-catenin and E-cadherin junctions is observed in ephrin-A5(-/-) lens central epithelial cells. In contrast, EphA2(-/-) lenses display normal monolayer epithelium while disorganization is apparent in all lens fiber cells. Immunostaining of ephrin-A5 proteins, highly expressed in lens epithelial cells, were not colocalized with EphA2 proteins, mainly expressed in lens fiber cells. Besides the previously reported function of ephrin-A5 in lens fiber cells, this work suggests that ephrin-A5 regulates b-catenin signaling and E-cadherin to prevent lens anterior epithelial cells from undergoing the epithelial-to-mesenchymal transition while EphA2 is essential for controlling the organization of lens fiber cells through an unknown mechanism. Ephrin-A5 and EphA2 likely interacting with other members of Eph/ephrin family to play diverse functions in lens epithelial cells and/or fiber cells.	[Cheng, Catherine] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Cheng, C (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	xgong@berkeley.edu			National Eye Institute [EY013849]; NATIONAL EYE INSTITUTE [R01EY013849] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grant EY013849 (X.G.) from the National Eye Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh A, 2004, INVEST OPHTH VIS SCI, V45, P884, DOI 10.1167/iovs.03-0677; Bassnett S, 1999, J CELL SCI, V112, P2155; Bassnett S, 2003, EXP EYE RES, V76, P291, DOI 10.1016/S0014-4835(02)00315-9; Bassnett S, 2009, MOL VIS, V15, P2448; Cain S, 2008, DEV BIOL, V321, P420, DOI 10.1016/j.ydbio.2008.07.002; Cheng C, 2008, EXP EYE RES, V86, P966, DOI 10.1016/j.exer.2008.03.015; Cooper MA, 2008, P NATL ACAD SCI USA, V105, P16620, DOI 10.1073/pnas.0808987105; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Frieden LA, 2010, DEV DYNAM, V239, P3226, DOI 10.1002/dvdy.22458; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Gong XH, 1999, DEV GENET, V24, P27, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<27::AID-DVG4>3.0.CO;2-7; Goodenough D.A., 1992, Seminars in Cell Biology, V3, P49; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Kaul H, 2010, MOL VIS, V16, P511; Kreslova J, 2007, GENESIS, V45, P157, DOI 10.1002/dvg.20277; KUSZAK JR, 1995, EXP EYE RES, V61, P579, DOI 10.1016/S0014-4835(05)80052-1; Leonard M, 2011, DEV BIOL, V349, P363, DOI 10.1016/j.ydbio.2010.10.009; Martinez G, 2009, INVEST OPHTH VIS SCI, V50, P4794, DOI 10.1167/iovs.09-3567; Mathias RT, 1997, PHYSIOL REV, V77, P21, DOI 10.1152/physrev.1997.77.1.21; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Pontoriero GF, 2009, DEV BIOL, V326, P403, DOI 10.1016/j.ydbio.2008.10.011; RUNGE PE, 1992, INVEST OPHTH VIS SCI, V33, P3202; Sandilands A, 2004, EXP EYE RES, V78, P109, DOI 10.1016/j.exer.2003.09.001; Shestopalov VI, 2003, J CELL SCI, V116, P4191, DOI 10.1242/jcs.00738; Shiels A, 2008, MOL VIS, V14, P2042; Simirskii VN, 2006, INVEST OPHTH VIS SCI, V47, P4931, DOI 10.1167/iovs.06-0423; Stephen LJ, 2007, DEV BIOL, V302, P66, DOI 10.1016/j.ydbio.2006.08.058; Straub BK, 2003, J CELL SCI, V116, P4985, DOI 10.1242/jcs.00815; Sugiyama Y, 2010, DEV BIOL, V338, P193, DOI 10.1016/j.ydbio.2009.11.033; Takemoto M, 2002, EUR J NEUROSCI, V16, P1168, DOI 10.1046/j.1460-9568.2002.02166.x; Tan W, 2011, MOL VIS, V17, P1553; Xu L, 2002, EXP EYE RES, V74, P753, DOI 10.1006/exer.2002.1175; Yamamoto N, 2008, MED MOL MORPHOL, V41, P83, DOI 10.1007/s00795-008-0395-x; Zampighi GA, 2000, EXP EYE RES, V71, P415, DOI 10.1006/exer.2000.0895; Zhang TX, 2009, HUM MUTAT, V30, pE603, DOI 10.1002/humu.20995	41	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28147	10.1371/journal.pone.0028147	http://dx.doi.org/10.1371/journal.pone.0028147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140528	gold, Green Submitted, Green Published			2022-12-25	WOS:000298166300031
J	Fialova, L; Bartos, A; Svarcova, J; Malbohan, I				Fialova, Lenka; Bartos, Ales; Svarcova, Jana; Malbohan, Ivan			Increased Intrathecal High-Avidity Anti-Tau Antibodies in Patients with Multiple Sclerosis	PLOS ONE			English	Article							IMMUNOGLOBULIN-G AVIDITY; CEREBROSPINAL-FLUID ANTIBODIES; AXONAL CYTOSKELETAL PROTEINS; NEUROFILAMENT SUBUNIT; VIRUS-INFECTION; SERUM; AUTOANTIBODIES; CELLS; LIGHT; AUTOIMMUNITY	Background: Antibodies against tau protein indicate an interaction between the immune system and the neurocytoskeleton and therefore may reflect axonal injury in multiple sclerosis (MS). Methodology/Principal Findings: The levels and avidities of anti-tau IgG antibodies were measured using ELISA in paired cerebrospinal fluid (CSF) and serum samples obtained from 49 MS patients and 47 controls. Anti-tau antibodies were significantly elevated intrathecally (p < 0.0001) in the MS group. The CSF anti-tau antibody levels were lower in MS patients receiving therapy than those without treatment (p < 0.05). The avidities of anti-tau antibodies were higher in the CSF than in the serum (MS group p < 0.0001; controls p < 0.005). Anti-tau avidities in the CSF were elevated in MS patients in comparison with controls (p < 0.05), but not in serum. Conclusions: MS patients have higher levels of intrathecal anti-tau antibodies. Anti-tau antibodies have different avidities in different compartments with the highest values in the CSF of MS patients.	[Fialova, Lenka; Malbohan, Ivan] Charles Univ Prague, Inst Med Biochem, Fac Med 1, Prague, Czech Republic; [Bartos, Ales] Charles Univ Prague, Dept Neurol, Fac Med 3, Univ Hosp Kralovske Vinohrady, Prague, Czech Republic; [Bartos, Ales; Svarcova, Jana] Prague Psychiat Ctr, Prague, Czech Republic; [Svarcova, Jana; Malbohan, Ivan] Charles Univ Prague, Inst Clin Biochem & Lab Diagnost, Fac Med 1, Gen Teaching Hosp, Prague, Czech Republic	Charles University Prague; Charles University Prague; University Hospital Vinohrady; Charles University Prague; General University Hospital Prague	Fialova, L (corresponding author), Charles Univ Prague, Inst Med Biochem, Fac Med 1, Prague, Czech Republic.	bartos@pcp.lf3.cuni.cz	Bartos, Ales/C-4353-2019; Fialová, Lenka/G-9419-2017; Malbohan, Ivan/K-2807-2017	Bartos, Ales/0000-0002-8020-8252; Fialová, Lenka/0000-0001-8137-7771; Malbohan, Ivan/0000-0003-1714-0192	Ministry of Education, Youth and Sports [0021620816]; Ministry of Health [10369-3]; Czech Academy of Sciences GA AV CR [KAN200520701]	Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Health; Czech Academy of Sciences GA AV CR	The study was supported by research project 0021620816 from the Ministry of Education, Youth and Sports, by grant from the Ministry of Health No 10369-3 and by grant of Czech Academy of Sciences GA AV CR KAN200520701. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartos A, 2007, ACTA NEUROL SCAND, V116, P100, DOI 10.1111/j.1600-0404.2006.00794.x; Bartos A, 2003, J NEUROL, V250, P1420, DOI 10.1007/s00415-003-0202-5; Bartos A, 2007, J NEUROL, V254, P20, DOI 10.1007/s00415-006-0185-0; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Brettschneider J, 2006, MULT SCLER J, V12, P143, DOI 10.1191/135248506ms1263oa; Brettschneider J, 2005, MULT SCLER J, V11, P261, DOI 10.1191/1352458505ms1159oa; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; Cucnik S, 2004, ANN RHEUM DIS, V63, P1478, DOI 10.1136/ard.2003.017939; Cui Z, 2006, KIDNEY INT, V69, P894, DOI 10.1038/sj.ki.5000135; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Ehling R, 2004, MULT SCLER J, V10, P601, DOI 10.1191/1352458504ms1100oa; Fialova L, 2009, FOLIA BIOL-PRAGUE, V55, P23; Flori P, 2004, CLIN DIAGN LAB IMMUN, V11, P669, DOI 10.1128/CDLI.11.4.669-674.2004; Graus F, 2010, J NEUROL, V257, P509, DOI 10.1007/s00415-009-5431-9; HEDMAN K, 1989, J MED VIROL, V27, P293, DOI 10.1002/jmv.1890270407; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Huizinga R, 2008, TRENDS IMMUNOL, V29, P54, DOI 10.1016/j.it.2007.11.002; Huizinga R, 2007, J NEUROPATH EXP NEUR, V66, P295, DOI 10.1097/nen.0b013e318040ad5c; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Matheus S, 2005, J CLIN MICROBIOL, V43, P2793, DOI 10.1128/JCM.43.6.2793-2797.2005; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Milosevic-Jovcic N, 2004, RHEUMATOLOGY, V43, P1190, DOI 10.1093/rheumatology/keh287; Narita M, 1996, CLIN DIAGN LAB IMMUN, V3, P211, DOI 10.1128/CDLI.3.2.211-215.1996; Niebroj-Dobosz I, 2006, FOLIA NEUROPATHOL, V44, P191; Racke MK, 2008, CURR OPIN NEUROL, V21, pS9, DOI 10.1097/01.wco.0000313359.61176.15; Rosenmann H, 2006, NEUROSCI LETT, V410, P90, DOI 10.1016/j.neulet.2006.01.072; Rosenmann H, 2006, ARCH NEUROL-CHICAGO, V63, P1459, DOI 10.1001/archneur.63.10.1459; Semra YK, 2002, J NEUROIMMUNOL, V122, P132, DOI 10.1016/S0165-5728(01)00455-6; Silber E, 2002, NEUROLOGY, V58, P1372, DOI 10.1212/WNL.58.9.1372; Svarcova J, 2008, EUR J NEUROL, V15, P1173, DOI 10.1111/j.1468-1331.2008.02223.x; Terryberry JW, 1998, NEUROBIOL AGING, V19, P205, DOI 10.1016/S0197-4580(98)00049-9; Terzi M, 2007, ACTA NEUROL SCAND, V115, P325, DOI 10.1111/j.1600-0404.2007.00782.x; Villalta D, 2003, LUPUS, V12, P31, DOI 10.1191/0961203303lu277oa; Zamecnik J, 2004, Cesk Patol, V40, P63	36	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27476	10.1371/journal.pone.0027476	http://dx.doi.org/10.1371/journal.pone.0027476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140442	Green Submitted, Green Published, gold			2022-12-25	WOS:000298166300005
J	Richardson, K; Weinberg, A				Richardson, Kelly; Weinberg, Adriana			Dynamics of Regulatory T-Cells during Pregnancy: Effect of HIV Infection and Correlations with Other Immune Parameters	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; ACTIVATION MARKERS; PERIPHERAL-BLOOD; TYPE-1 INFECTION; PRETERM DELIVERY; INCREASED RISK; CUTTING EDGE; VIRAL LOAD; DISEASE	Objectives: Regulatory T cells (Treg) increase in the context of HIV infection and pregnancy. We studied Treg subpopulations in HIV-infected and uninfected women during pregnancy and their relationship with inflammation, activation and cell-mediated immunity (CMI). Design and Methods: Blood obtained from 20 HIV-infected and 18 uninfected women during early and late gestation was used to measure Treg and activated T cells (Tact) by flow cytometry; plasma cytokines and inflammatory markers by ELISA and chemoluminescence; and CMI against varicella-zoster virus (VZV) by lymphocyte proliferation. Results and Conclusions: Compared with uninfected women, HIV-infected participants had higher frequencies of Treg subpopulations in early pregnancy, including CD4+CD25+FoxP3+%, CD8+CD25+FoxP3+%, CD4+TGF beta+% and CD4+IL10+%. In contrast, Treg frequencies were lower during late pregnancy in HIV-infected compared with uninfected women, including CD8+TGF beta+%, CD4+CTLA4+% and CD8+CTLA4+%. VZV-CMI, which was lower in HIV-infected compared with uninfected pregnant women, was inversely correlated with CD4+FoxP3+%, CD8+FoxP3+% and CD8+TGF beta+% in HIV-infected, but not in uninfected pregnant women. beta(2)-microglobulin, neopterin, IL1, IL4, IL8, IL10, IFN gamma and TNFA plasma concentrations as well as Tact were higher in HIV-infected compared with uninfected women throughout pregnancy. In HIV-infected, but not in uninfected women, inflammatory, Th1, Th2 and regulatory cytokines increased with higher Treg%, suggesting that inflammation and regulation have a common pathophysiologic origin in the context of HIV infection. In HIV-infected and more commonly in uninfected pregnant women, higher Treg% correlated with lower Tact%. We conclude that Treg have different dynamics during pregnancy in HIV-infected and uninfected women. Higher levels of inflammatory cytokines and lower Treg% during late pregnancy in HIV-infected women may contribute to their increased incidence of maternal-fetal morbidity.	[Richardson, Kelly; Weinberg, Adriana] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA; [Weinberg, Adriana] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Weinberg, Adriana] Univ Colorado Denver, Dept Pathol, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Richardson, K (corresponding author), Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA.	Adriana.Weinberg@ucdenver.edu			NIH/National Center for Research Resources Colorado CTSI [UL1 RR025780]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER	NIH/National Center for Research Resources Colorado CTSI; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the NIH/National Center for Research Resources Colorado CTSI grant UL1 RR025780. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, BLOOD, V104, P3672, DOI 10.1182/blood-2004-07-2540; Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Adeegbe D, 2006, J IMMUNOL, V176, P7149, DOI 10.4049/jimmunol.176.12.7149; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Blois SM, 2004, J IMMUNOL, V172, P5893, DOI 10.4049/jimmunol.172.10.5893; Boasso A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002961; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; BRETTLE RP, 1995, AIDS, V9, P1177, DOI 10.1097/00002030-199510000-00010; Brooks DG, 2006, J CLIN INVEST, V116, P1675, DOI 10.1172/JCI26856; Burns DN, 1999, J REPROD IMMUNOL, V42, P147, DOI 10.1016/S0165-0378(98)00085-0; Cao W, 2009, AIDS RES HUM RETROV, V25, P183, DOI 10.1089/aid.2008.0140; Chase AJ, 2008, J VIROL, V82, P8307, DOI 10.1128/JVI.00520-08; Chikuma S, 2003, IMMUNOL RES, V28, P241, DOI 10.1385/IR:28:3:241; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Cotter AM, 2006, J INFECT DIS, V193, P1195, DOI 10.1086/503045; Dubicke A, 2010, J REPROD IMMUNOL, V84, P176, DOI 10.1016/j.jri.2009.12.004; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; El-Bastawissi AY, 2000, OBSTET GYNECOL, V95, P1056, DOI 10.1016/S0029-7844(00)00875-9; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Fahey JL, 1998, AIDS, V12, P1581, DOI 10.1097/00002030-199813000-00004; Ford ES, 2010, AIDS, V24, P1509, DOI 10.1097/QAD.0b013e32833ad914; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Georgiou HM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.005; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Goldenberg RL, 2005, AM J OBSTET GYNECOL, V192, pS36, DOI 10.1016/j.ajog.2005.02.015; Gomez-Lopez N, 2010, BIOL REPROD, V82, P809, DOI 10.1095/biolreprod.109.080432; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Hata A, 2002, NEW ENGL J MED, V347, P26, DOI 10.1056/NEJMoa013441; Hebisch G, 2001, ACTA OBSTET GYN SCAN, V80, P840, DOI 10.1034/j.1600-0412.2001.080009840.x; Jain N, 2010, P NATL ACAD SCI USA, V107, P1524, DOI 10.1073/pnas.0910341107; Kalayjian RC, 2010, J INFECT DIS, V201, P1796, DOI 10.1086/652750; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kared H, 2008, AIDS, V22, P2451, DOI 10.1097/QAD.0b013e328319edc0; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Kinter AL, 2007, AIDS RES HUM RETROV, V23, P438, DOI 10.1089/aid.2006.0162; Kolte L, 2011, BLOOD, V117, P1861, DOI 10.1182/blood-2010-07-298992; Kourtis AP, 2006, AIDS, V20, P1823, DOI 10.1097/01.aids.0000244201.11006.1c; Kramer MS, 2010, CYTOKINE, V49, P10, DOI 10.1016/j.cyto.2009.08.014; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; KUMAR RM, 1995, INT J GYNECOL OBSTET, V49, P137, DOI 10.1016/0020-7292(95)02356-H; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; Maier CL, 2011, ARTERIOSCL THROM VAS, V31, P183, DOI 10.1161/ATVBAHA.110.217117; Marzi M, 1996, CLIN EXP IMMUNOL, V106, P127, DOI 10.1046/j.1365-2249.1996.d01-809.x; McClain MA, 2007, J IMMUNOL, V179, P8146, DOI 10.4049/jimmunol.179.12.8146; Mikyas Y, 1997, J REPROD IMMUNOL, V33, P157, DOI 10.1016/S0165-0378(97)00018-1; Montes M, 2011, J INFECT DIS, V203, P496, DOI 10.1093/infdis/jiq073; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Nixon DF, 2005, MICROBES INFECT, V7, P1063, DOI 10.1016/j.micinf.2005.03.026; Patel K, 2010, J INFECT DIS, V201, P1035, DOI 10.1086/651232; RICH KC, 1995, J INFECT DIS, V172, P1221, DOI 10.1093/infdis/172.5.1221; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Santner-Nanan B, 2009, J IMMUNOL, V183, P7023, DOI 10.4049/jimmunol.0901154; Sharma D, 2011, HUM IMMUNOL, V72, P436, DOI 10.1016/j.humimm.2011.02.007; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Tenorio AR, 2008, JAIDS-J ACQ IMM DEF, V48, P577, DOI 10.1097/QAI.0b013e31817bbea5; Tovar-Salazar A, 2010, VIROLOGY, V398, P158, DOI 10.1016/j.virol.2009.11.038; Wang WJ, 2010, HUM REPROD, V25, P2591, DOI 10.1093/humrep/deq198; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Weinberg A, 2010, J ACQUIR IMMUNE DEFI; Weinberg A, 2009, J INFECT DIS, V200, P1068, DOI 10.1086/605611; Weinberg A, 2009, CLIN VACCINE IMMUNOL, V16, P1176, DOI 10.1128/CVI.00342-08; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4	66	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28172	10.1371/journal.pone.0028172	http://dx.doi.org/10.1371/journal.pone.0028172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140535	Green Submitted, Green Published, gold			2022-12-25	WOS:000298166300035
J	Ung, CY; Lam, SH; Zhang, X; Li, H; Ma, J; Zhang, LX; Li, BW; Gong, ZY				Ung, Choong Yong; Lam, Siew Hong; Zhang, Xun; Li, Hu; Ma, Jing; Zhang, Louxin; Li, Baowen; Gong, Zhiyuan			Existence of Inverted Profile in Chemically Responsive Molecular Pathways in the Zebrafish Liver	PLOS ONE			English	Article							HEPATIC GENE-EXPRESSION; DANIO-RERIO; SPOTTED-MICROARRAY; PARA-NITROPHENOL; HUMAN EXPOSURE; AMINO-ACIDS; YIN-YANG; METABOLISM; RATS; TOXICITY	How a living organism maintains its healthy equilibrium in response to endless exposure of potentially harmful chemicals is an important question in current biology. By transcriptomic analysis of zebrafish livers treated by various chemicals, we defined hubs as molecular pathways that are frequently perturbed by chemicals and have high degree of functional connectivity to other pathways. Our network analysis revealed that these hubs were organized into two groups showing inverted functionality with each other. Intriguingly, the inverted activity profiles in these two groups of hubs were observed to associate only with toxicopathological states but not with physiological changes. Furthermore, these inverted profiles were also present in rat, mouse, and human under certain toxicopathological conditions. Thus, toxicopathological-associated anti-correlated profiles in hubs not only indicate their potential use in diagnosis but also development of systems-based therapeutics to modulate gene expression by chemical approach in order to rewire the deregulated activities of hubs back to normal physiology.	[Ung, Choong Yong; Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Queenstown, Singapore; [Ung, Choong Yong; Zhang, Louxin] Natl Univ Singapore, Dept Math, Queenstown, Singapore; [Zhang, Xun; Ma, Jing; Zhang, Louxin; Li, Baowen] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Queenstown, Singapore; [Zhang, Xun; Ma, Jing; Li, Baowen] Natl Univ Singapore, Dept Phys, Queenstown, Singapore; [Zhang, Xun; Ma, Jing; Li, Baowen] Natl Univ Singapore, Ctr Computat Sci & Engn, Queenstown, Singapore; [Li, Hu] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Boston University	Ung, CY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Queenstown, Singapore.	matucy@nus.edu.sg; dbsgzy@nus.edu.sg	Gong, Zhiyuan/H-8794-2012; Ung, Choong Yong/D-4525-2012; Zhang, Louxin/M-4865-2016; Lam, Siew Hong/H-8483-2012; Li, Baowen/G-3003-2011	Gong, Zhiyuan/0000-0002-9660-5260; Zhang, Louxin/0000-0003-0260-824X; Li, Baowen/0000-0002-8728-520X	Environment and Water Industry Grant of Singapore	Environment and Water Industry Grant of Singapore	This work was supported by Environment and Water Industry Grant of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32; Anderson SP, 2002, HEPATOLOGY, V36, P544, DOI 10.1053/jhep.2002.35276; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Chen F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-240; Chowdhury TR, 1999, NATURE, V401, P545, DOI 10.1038/44056; Clarkson TW, 2002, ENVIRON HEALTH PERSP, V110, P11, DOI 10.1289/ehp.02110s111; De Wit M, 2010, GEN COMP ENDOCR, V167, P190, DOI 10.1016/j.ygcen.2010.03.003; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Drew RE, 2008, PHYSIOL GENOMICS, V35, P283, DOI 10.1152/physiolgenomics.90213.2008; Dueber JE, 2004, CURR OPIN STRUC BIOL, V14, P690, DOI 10.1016/j.sbi.2004.10.004; Esteban E, 1996, J EXPO ANAL ENV EPID, V6, P375; Gatfield D, 2007, SCIENCE, V316, P1135, DOI 10.1126/science.1144165; Hamadeh HK, 2002, TOXICOL SCI, V67, P219, DOI 10.1093/toxsci/67.2.219; Hamel FG, 2003, METABOLISM, V52, P810, DOI 10.1016/S0026-0495(03)00094-5; Heinloth AN, 2004, TOXICOL SCI, V80, P193, DOI 10.1093/toxsci/kfh145; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hoffmann JL, 2006, AQUAT TOXICOL, V79, P233, DOI 10.1016/j.aquatox.2006.06.009; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huang QH, 2004, MUTAT RES-FUND MOL M, V549, P147, DOI 10.1016/j.mrfmmm.2003.12.020; Hylander LD, 2006, SCI TOTAL ENVIRON, V368, P352, DOI 10.1016/j.scitotenv.2005.11.029; Ji JF, 2010, J HEPATOL, V53, P974, DOI 10.1016/j.jhep.2010.07.001; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Kummer V, 2008, TOXICOL LETT, V180, P212, DOI 10.1016/j.toxlet.2008.06.862; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lam SH, 2006, PHYSIOL GENOMICS, V27, P351, DOI 10.1152/physiolgenomics.00201.2005; Lam Siew Hong, 2009, V546, P175, DOI 10.1007/978-1-60327-977-2_12; Lam Siew Hong, 2009, V546, P197, DOI 10.1007/978-1-60327-977-2_13; Lam SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000121; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Li CM, 2006, TOXICOL APPL PHARM, V217, P1, DOI 10.1016/j.taap.2006.06.010; Liu XE, 2010, LIVER INT, V30, P1221, DOI 10.1111/j.1478-3231.2010.02279.x; Luch A, 2005, NAT REV CANCER, V5, P113, DOI 10.1038/nrc1546; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Michalak A, 1996, HEPATOLOGY, V24, P908, DOI 10.1002/hep.510240425; Ortiz PA, 2010, J PROTEOME RES, V9, P1268, DOI 10.1021/pr900755q; Ou BX, 2003, FASEB J, V17, P127, DOI 10.1096/fj.02-0527hyp; Pizon AF, 2009, CLIN TOXICOL, V47, P132, DOI 10.1080/15563650801971390; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Robison BD, 2008, COMP BIOCHEM PHYS D, V3, P141, DOI 10.1016/j.cbd.2008.01.001; Ruepp SU, 2002, TOXICOL SCI, V65, P135, DOI 10.1093/toxsci/65.1.135; Sachdeva M, 2009, CELL CYCLE, V8, P1303, DOI 10.4161/cc.8.9.8362; SHAPIRO B, 1967, ANNU REV BIOCHEM, V36, P247, DOI 10.1146/annurev.bi.36.070167.001335; SMITH LW, 1988, DRUG CHEM TOXICOL, V11, P319, DOI 10.3109/01480548809017886; Spicker JS, 2008, TOXICOL SCI, V102, P444, DOI 10.1093/toxsci/kfn001; Strogatz SH, 2001, NONLINEAR DYNAMICS C, P512; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Tugues S, 2005, GASTROENTEROLOGY, V129, P1686, DOI 10.1053/j.gastro.2005.09.006; Ung CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-212; Vanhooren V, 2009, MECH AGEING DEV, V130, P92, DOI 10.1016/j.mad.2008.11.008; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227; Yang MH, 2006, J ENVIRON SCI HEAL C, V24, P183, DOI 10.1080/10590500600936474; Yi CX, 2010, BBA-MOL BASIS DIS, V1802, P416, DOI 10.1016/j.bbadis.2010.01.006; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	56	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e27819	10.1371/journal.pone.0027819	http://dx.doi.org/10.1371/journal.pone.0027819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22140468	Green Published, gold, Green Submitted			2022-12-25	WOS:000298166300011
J	Kumar, V; Sivaraman, J				Kumar, Veerendra; Sivaraman, J.			A Conformational Switch in the Active Site of BT_2972, a Methyltransferase from an Antibiotic Resistant Pathogen B. thetaiotaomicron	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE; CRYSTAL-STRUCTURE; BACTEROIDES-THETAIOTAOMICRON; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; BIOSYNTHESIS; SUBSTRATE; BINDING; TOOL; PROTEINS	Methylation is one of the most common biochemical reactions involved in cellular and metabolic functions and is catalysed by the action of methyltransferases. Bacteroides thetaiotaomicron is an antibiotic-resistant bacterium that confers resistance through methylation, and as yet, there is no report on the structure of methyltransferases from this bacterium. Here, we report the crystal structure of an AdoMet-dependent methyltransferase, BT_2972 and its complex with AdoMet and AdoHcy for B. thetaiotaomicron VPI-5482 strain along with isothermal titration calorimetric assessment of the binding affinities. Comparison of the apo and complexed BT_2972 structures reveals a significant conformational change between open and closed forms of the active site that presumably regulates the association with cofactors and may aid interaction with substrate. Together, our analysis suggests that BT_2972 is a small molecule methyltransferase and might catalyze two O-methylation reaction steps involved in the ubiquinone biosynthesis pathway.	[Kumar, Veerendra; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Kumar, V (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsjayar@nus.edu.sg	Sivaraman, J/H-8028-2012	Kumar, Veerendra/0000-0002-9241-1303; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council of Singapore (BMRC), A*STAR [R154000362305]; National University of Singapore (NUS)	Biomedical Research Council of Singapore (BMRC), A*STAR(Agency for Science Technology & Research (A*STAR)); National University of Singapore (NUS)(National University of Singapore)	The authors are grateful to the Biomedical Research Council of Singapore (BMRC), A*STAR for providing a research grant (R154000362305) to support this study. X-ray diffraction data were measured at beam line X-12B1 of National Synchrotron Radiation Research Centre (NSRRC), Taiwan. VK is a graduate scholar in receipt of a research scholarship from the National University of Singapore (NUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bjursell MK, 2006, J BIOL CHEM, V281, P36269, DOI 10.1074/jbc.M606509200; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bujnicki Janusz M., 1999, In Silico Biology, V1, P175; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gonzalez B, 2004, J MOL BIOL, V338, P771, DOI 10.1016/j.jmb.2004.03.005; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Griffith SC, 2001, J MOL BIOL, V313, P1103, DOI 10.1006/jmbi.2001.5095; HENGEN PN, 1995, TRENDS BIOCHEM SCI, V20, P285, DOI 10.1016/S0968-0004(00)89045-3; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang CC, 2002, J BIOL CHEM, V277, P11559, DOI 10.1074/jbc.M111698200; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; Kumar V, 2011, J STRUCTURA IN PRESS; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim K, 2001, PROTEINS, V45, P397, DOI 10.1002/prot.10004; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; McFerrin MB, 2002, J APPL CRYSTALLOGR, V35, P538, DOI 10.1107/S0021889802009238; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; Miller DJ, 2003, PROTEIN SCI, V12, P1432, DOI 10.1110/ps.0302403; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; Poon WW, 1999, J BIOL CHEM, V274, P21665, DOI 10.1074/jbc.274.31.21665; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tsuji E, 2009, J STRUCT BIOL, V165, P133, DOI 10.1016/j.jsb.2008.11.012; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	33	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27543	10.1371/journal.pone.0027543	http://dx.doi.org/10.1371/journal.pone.0027543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140448	Green Published, gold, Green Submitted			2022-12-25	WOS:000298163400009
J	Flores, GE; Bates, ST; Knights, D; Lauber, CL; Stombaugh, J; Knight, R; Fierer, N				Flores, Gilberto E.; Bates, Scott T.; Knights, Dan; Lauber, Christian L.; Stombaugh, Jesse; Knight, Rob; Fierer, Noah			Microbial Biogeography of Public Restroom Surfaces	PLOS ONE			English	Article							BACTERIAL COMMUNITY; JAPANESE HOUSEHOLDS; COLLEGE-STUDENTS; DIVERSITY; CONTAMINATION; BATHROOMS; INFECTION; PATHOGENS; SEQUENCES; SURVIVAL	We spend the majority of our lives indoors where we are constantly exposed to bacteria residing on surfaces. However, the diversity of these surface-associated communities is largely unknown. We explored the biogeographical patterns exhibited by bacteria across ten surfaces within each of twelve public restrooms. Using high-throughput barcoded pyrosequencing of the 16 S rRNA gene, we identified 19 bacterial phyla across all surfaces. Most sequences belonged to four phyla: Actinobacteria, Bacteriodetes, Firmicutes and Proteobacteria. The communities clustered into three general categories: those found on surfaces associated with toilets, those on the restroom floor, and those found on surfaces routinely touched with hands. On toilet surfaces, gut-associated taxa were more prevalent, suggesting fecal contamination of these surfaces. Floor surfaces were the most diverse of all communities and contained several taxa commonly found in soils. Skin-associated bacteria, especially the Propionibacteriaceae, dominated surfaces routinely touched with our hands. Certain taxa were more common in female than in male restrooms as vagina-associated Lactobacillaceae were widely distributed in female restrooms, likely from urine contamination. Use of the SourceTracker algorithm confirmed many of our taxonomic observations as human skin was the primary source of bacteria on restroom surfaces. Overall, these results demonstrate that restroom surfaces host relatively diverse microbial communities dominated by human-associated bacteria with clear linkages between communities on or in different body sites and those communities found on restroom surfaces. More generally, this work is relevant to the public health field as we show that human-associated microbes are commonly found on restroom surfaces suggesting that bacterial pathogens could readily be transmitted between individuals by the touching of surfaces. Furthermore, we demonstrate that we can use high-throughput analyses of bacterial communities to determine sources of bacteria on indoor surfaces, an approach which could be used to track pathogen transmission and test the efficacy of hygiene practices.	[Flores, Gilberto E.; Bates, Scott T.; Lauber, Christian L.; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Knights, Dan] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Stombaugh, Jesse; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Flores, GE (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	noah.fierer@colorado.edu	Knight, Rob/D-1299-2010	Bates, Scott/0000-0002-6184-4296; Knight, Rob/0000-0002-0975-9019; Flores, Gilberto/0000-0002-3338-611X; Stombaugh, Jesse/0000-0001-9631-0748; FIERER, NOAH/0000-0002-6432-4261	Alfred P. Sloan Foundation; National Institutes of Health; Howard Hughes Medical Institute	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported with funding from the Alfred P. Sloan Foundation and their Indoor Environment program, and in part by the National Institutes of Health and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2008, AM J INFECT CONTROL, V36, P361, DOI 10.1016/j.ajic.2007.09.007; Barker J, 2000, J APPL MICROBIOL, V89, P137, DOI 10.1046/j.1365-2672.2000.01091.x; Barker J, 2005, J APPL MICROBIOL, V99, P339, DOI 10.1111/j.1365-2672.2005.02610.x; Bowers RM, 2011, APPL ENVIRON MICROB, V77, P6350, DOI 10.1128/AEM.05498-11; Brooke JS, 2009, J ENVIRON HEALTH, V71, P17; Bures S, 2000, AM J INFECT CONTROL, V28, P465, DOI 10.1067/mic.2000.107267; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dong QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019709; Drankiewicz D, 2003, AM J INFECT CONTROL, V31, P67, DOI 10.1067/mic.2003.6; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; GERBA CP, 1975, APPL MICROBIOL, V30, P229, DOI 10.1128/AEM.30.2.229-237.1975; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Kelley ST, 2004, APPL ENVIRON MICROB, V70, P4187, DOI 10.1128/AEM.70.7.4187-4192.2004; KNIGHTS D, 2011, NATURE METHODS; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lee L, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-27; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McManus CJ, 2005, J APPL MICROBIOL, V99, P502, DOI 10.1111/j.1365-2672.2005.02651.x; Medrano-Felix A, 2011, J APPL MICROBIOL, V110, P463, DOI 10.1111/j.1365-2672.2010.04901.x; Morawska L, 2006, INDOOR AIR, V16, P335, DOI 10.1111/j.1600-0668.2006.00432.x; Nelson DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014116; NOSKIN GA, 1995, INFECT CONT HOSP EP, V16, P577; Ojima M, 2002, INT J ENVIRON HEAL R, V12, P41, DOI 10.1080/09603120120110040; Ojima M, 2002, J APPL MICROBIOL, V93, P800, DOI 10.1046/j.1365-2672.2002.01746.x; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Rusin P, 1998, J APPL MICROBIOL, V85, P819, DOI 10.1046/j.1365-2672.1998.00598.x; Sinclair RG, 2011, LETT APPL MICROBIOL, V52, P144, DOI 10.1111/j.1472-765X.2010.02978.x; Smith SM, 1996, J MED, V27, P293; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhou X, 2010, INFECT DIS OBSTET GY, V2010	44	180	181	4	169	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28132	10.1371/journal.pone.0028132	http://dx.doi.org/10.1371/journal.pone.0028132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132229	Green Published, Green Submitted, gold			2022-12-25	WOS:000298162000078
J	Voorbij, AMWY; van Steenbeek, FG; Vos-Loohuis, M; Martens, EECP; Hanson-Nilsson, JM; van Oost, BA; Kooistra, HS; Leegwater, PA				Voorbij, Annemarie M. W. Y.; van Steenbeek, Frank G.; Vos-Loohuis, Manon; Martens, Ellen E. C. P.; Hanson-Nilsson, Jeanette M.; van Oost, Bernard A.; Kooistra, Hans S.; Leegwater, Peter A.			A Contracted DNA Repeat in LHX3 Intron 5 Is Associated with Aberrant Splicing and Pituitary Dwarfism in German Shepherd Dogs	PLOS ONE			English	Article							HORMONE DEFICIENCY; MESSENGER-RNA; MINIMAL INTRON; GENE; MUTATIONS; PIT-1; IDENTIFICATION; CANDIDATE; DELETION; LENGTH	Dwarfism in German shepherd dogs is due to combined pituitary hormone deficiency of unknown genetic cause. We localized the recessively inherited defect by a genome wide approach to a region on chromosome 9 with a lod score of 9.8. The region contains LHX3, which codes for a transcription factor essential for pituitary development. Dwarfs have a deletion of one of six 7 bp repeats in intron 5 of LHX3, reducing the intron size to 68 bp. One dwarf was compound heterozygous for the deletion and an insertion of an asparagine residue in the DNA-binding homeodomain of LHX3, suggesting involvement of the gene in the disorder. An exon trapping assay indicated that the shortened intron is not spliced efficiently, probably because it is too small. We applied bisulfite conversion of cytosine to uracil in RNA followed by RT-PCR to analyze the splicing products. The aberrantly spliced RNA molecules resulted from either skipping of exon 5 or retention of intron 5. The same splicing defects were observed in cDNA derived from the pituitary of dwarfs. A survey of similarly mutated introns suggests that there is a minimal distance requirement between the splice donor and branch site of 50 nucleotides. In conclusion, a contraction of a DNA repeat in intron 5 of canine LHX3 leads to deficient splicing and is associated with pituitary dwarfism.	[Voorbij, Annemarie M. W. Y.; van Steenbeek, Frank G.; Vos-Loohuis, Manon; Martens, Ellen E. C. P.; Hanson-Nilsson, Jeanette M.; Kooistra, Hans S.; Leegwater, Peter A.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [van Oost, Bernard A.] Amer Univ Caribbean, Dept Biochem, Cupecoy, St Maarten, Netherlands	Utrecht University	Voorbij, AMWY (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	P.A.J.Leegwater@uu.nl	van Steenbeek, F.G./AFL-0046-2022; Hanson, Jeanette/Q-9283-2018	van Steenbeek, F.G./0000-0001-5460-6540; Hanson, Jeanette/0000-0001-5596-9538; Leegwater, Peter/0000-0002-4100-015X				ANDRESEN E, 1976, NORD VET MED, V28, P481; Auffray C, 2006, EXP CELL RES, V312, P233, DOI 10.1016/j.yexcr.2005.10.014; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bhangoo APS, 2006, J CLIN ENDOCR METAB, V91, P747, DOI 10.1210/jc.2005-2360; Brock JE, 2008, RNA, V14, P2430, DOI 10.1261/rna.1189008; BURN TC, 1995, GENE, V161, P183, DOI 10.1016/0378-1119(95)00223-S; Chi YI, 2005, HUM GENET, V116, P433, DOI 10.1007/s00439-004-1252-1; Chua K, 2001, MOL CELL BIOL, V21, P1509, DOI 10.1128/MCB.21.5.1509-1514.2001; Fofanova O, 1998, J CLIN ENDOCR METAB, V83, P2601; Hamann F, 1999, VET REC, V144, P644, DOI 10.1136/vr.144.23.644; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; HIMMELSPACH M, 1991, MOL CELL BIOL, V11, P1258, DOI 10.1128/MCB.11.3.1258; Hunter C, 2005, MOL BIOL REP, V32, P67, DOI 10.1007/s11033-004-7657-z; Ichikawa S, 2006, J CLIN ENDOCR METAB, V91, P4022, DOI 10.1210/jc.2005-2840; Kooistra HS, 2000, DOMEST ANIM ENDOCRIN, V19, P177, DOI 10.1016/S0739-7240(00)00074-6; Kristrom B, 2009, J CLIN ENDOCR METAB, V94, P1154, DOI 10.1210/jc.2008-0325; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lantinga-van Leeuwen IS, 2000, CYTOGENET CELL GENET, V88, P140, DOI 10.1159/000015507; Leegwater PAJ, 1999, AM J HUM GENET, V65, P728, DOI 10.1086/302548; Leeuwen ISL, 2000, MAMM GENOME, V11, P31, DOI 10.1007/s003350010006; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Lohi H, 2005, SCIENCE, V307, P81, DOI 10.1126/science.1102832; Meij BP, 1996, DOMEST ANIM ENDOCRIN, V13, P465, DOI 10.1016/0739-7240(96)00075-6; Meij BP, 1996, DOMEST ANIM ENDOCRIN, V13, P161, DOI 10.1016/0739-7240(95)00066-6; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Netchine I, 2000, NAT GENET, V25, P182, DOI 10.1038/76041; Nishioka M, 2001, J BIOTECHNOL, V88, P141, DOI 10.1016/S0168-1656(01)00275-9; PellegriniBouiller I, 1996, J CLIN ENDOCR METAB, V81, P2790, DOI 10.1210/jc.81.8.2790; Peral B, 1997, AM J HUM GENET, V60, P1399, DOI 10.1086/515467; PERAL B, 1995, HUM MOL GENET, V4, P569, DOI 10.1093/hmg/4.4.569; Persichetti E, 2009, HUM MUTAT, V30, P978, DOI 10.1002/humu.20959; Pfaeffle RW, 2007, J CLIN ENDOCR METAB, V92, P1909, DOI 10.1210/jc.2006-2177; Pfaffle R, 1996, HORM RES, V45, P25, DOI 10.1159/000184824; Rajab A, 2008, HUM MOL GENET, V17, P2150, DOI 10.1093/hmg/ddn114; RUSKIN B, 1985, CELL, V41, P833, DOI 10.1016/S0092-8674(85)80064-7; Sasaki F, 1998, ANAT RECORD, V251, P143; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Stabej P, 2005, CYTOGENET GENOME RES, V111, P140, DOI 10.1159/000086383; Sultana A, 2007, MOL VIS, V13, P1327; ULFENDAHL PJ, 1985, NUCLEIC ACIDS RES, V13, P6299, DOI 10.1093/nar/13.17.6299; Voorbij AMWY KooistraHS., 2009, J VET CLIN SCI, V2, P4; Wang LL, 2002, AM J HUM GENET, V71, P165, DOI 10.1086/341234; WIERINGA B, 1984, CELL, V37, P915, DOI 10.1016/0092-8674(84)90426-4; Wu W, 1998, NAT GENET, V18, P147, DOI 10.1038/ng0298-147; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	51	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27940	10.1371/journal.pone.0027940	http://dx.doi.org/10.1371/journal.pone.0027940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132174	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000051
J	Waugh, JL; Celver, J; Sharma, M; Dufresne, RL; Terzi, D; Risch, SC; Fairbrother, WG; Neve, RL; Kane, JP; Malloy, MJ; Pullinger, CR; Gu, HF; Tsatsanis, C; Hamilton, SP; Gold, SJ; Zachariou, V; Kovoor, A				Waugh, Jeffrey L.; Celver, Jeremy; Sharma, Meenakshi; Dufresne, Robert L.; Terzi, Dimitra; Risch, S. Craig; Fairbrother, William G.; Neve, Rachael L.; Kane, John P.; Malloy, Mary J.; Pullinger, Clive R.; Gu, Harvest F.; Tsatsanis, Christos; Hamilton, Steven P.; Gold, Stephen J.; Zachariou, Venetia; Kovoor, Abraham			Association between Regulator of G Protein Signaling 9-2 and Body Weight	PLOS ONE			English	Article							RGS PROTEINS; EXTRACELLULAR DOPAMINE; MICE LACKING; EXPRESSION; RAT; RECEPTORS; COCAINE; COMPLEX; REWARD; R9AP	Regulator of G protein signaling 9-2 (RGS9-2) is a protein that is highly enriched in the striatum, a brain region that mediates motivation, movement and reward responses. We identified a naturally occurring 5 nucleotide deletion polymorphism in the human RGS9 gene and found that the mean body mass index (BMI) of individuals with the deletion was significantly higher than those without. A splicing reporter minigene assay demonstrated that the deletion had the potential to significantly decrease the levels of correctly spliced RGS9 gene product. We measured the weights of rats after virally transduced overexpression of RGS9-2 or the structurally related RGS proteins, RGS7, or RGS11, in the nucleus accumbens (NAc) and observed a reduction in body weight after overexpression of RGS9-2 but not RGS7 or 11. Conversely, we found that the RGS9 knockout mice were heavier than their wild-type littermates and had significantly higher percentages of abdominal fat. The constituent adipocytes were found to have a mean cross-sectional area that was more than double that of corresponding cells from wild-type mice. However, food intake and locomotion were not significantly different between the two strains. These studies with humans, rats and mice implicate RGS9-2 as a factor in regulating body weight.	[Waugh, Jeffrey L.; Gold, Stephen J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Celver, Jeremy; Sharma, Meenakshi; Kovoor, Abraham] Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA; [Celver, Jeremy; Kovoor, Abraham] Kovogen LLC, Mystic, CT USA; [Dufresne, Robert L.] Univ Rhode Isl, Dept Pharm Practice, Kingston, RI 02881 USA; [Terzi, Dimitra; Tsatsanis, Christos; Zachariou, Venetia] Univ Crete, Fac Med, Dept Basic Sci, Iraklion, Crete, Greece; [Risch, S. Craig; Hamilton, Steven P.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Fairbrother, William G.] Brown Univ, Dept Mol & Cell Biol & Biochem, Providence, RI 02912 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Kane, John P.; Malloy, Mary J.; Pullinger, Clive R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Kane, John P.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kane, John P.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Pullinger, Clive R.] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA USA; [Gu, Harvest F.] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Rhode Island; University of Rhode Island; University of Crete; University of California System; University of California San Francisco; Brown University; Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Karolinska Institutet; Karolinska University Hospital	Waugh, JL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	abekovoor@uri.edu	Tsatsanis, Christos/AAM-9362-2020; Zachariou, Venetia/L-2726-2016	Tsatsanis, Christos/0000-0003-1214-4151; Waugh, Jeff/0000-0001-7526-1342; Fairbrother, William/0000-0002-6312-5615; Hamilton, Steven/0000-0001-8106-6260	National Institute of Mental Health (NIMH), NIH [R41MH78570]; National Center for Research Resources (NCRR), NIH [P20RR016457-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R41MH078570] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources (NCRR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project described was supported by an R41MH78570 award from the National Institute of Mental Health (NIMH), NIH (to AK, JC and SPH), and a Rhode Island IDeA Network of Biomedical Research Excellence (RI-INBRE) Award, P20RR016457-10, from the National Center for Research Resources (NCRR), NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenes F, 2005, IMMUNOLOGY, V115, P179, DOI 10.1111/j.1365-2567.2005.02146.x; Aissani B, 2006, OBESITY, V14, P1605, DOI 10.1038/oby.2006.185; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; Bodnar RJ, 2004, PEPTIDES, V25, P697, DOI 10.1016/j.peptides.2004.01.006; Bubser M, 2005, EUR J NEUROSCI, V21, P2993, DOI 10.1111/j.1460-9568.2005.04121.x; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; Carlezon WA, 2000, CRIT REV NEUROBIOL, V14, P47; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Celver J, 2010, J NEUROCHEM, V114, P739, DOI 10.1111/j.1471-4159.2010.06805.x; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Cho H, 2008, MOL CELL BIOL, V28, P2590, DOI 10.1128/MCB.01889-07; Cooper TA, 2005, METHODS, V37, P331, DOI 10.1016/j.ymeth.2005.07.015; Coopersmith R, 1999, BIOTECHNIQUES, V27, P1156, DOI 10.2144/99276st01; Gaildrat P, 2010, METHODS MOL BIOL, V653, P249, DOI 10.1007/978-1-60761-759-4_15; Gainetdinov RR, 2007, AM J PHYSIOL-REG I, V293, pR601, DOI 10.1152/ajpregu.00450.2007; Gold SJ, 1997, J NEUROSCI, V17, P8024; Gold SJ, 2007, J NEUROSCI, V27, P14338, DOI 10.1523/JNEUROSCI.4223-07.2007; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Hooks SB, 2008, BIOCHEM PHARMACOL, V75, P76, DOI 10.1016/j.bcp.2007.07.045; Huang XY, 2008, DIABETES, V57, P77, DOI 10.2337/db07-0599; Jayaraman M, 2009, TRENDS PHARMACOL SCI, V30, P17, DOI 10.1016/j.tips.2008.10.002; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; KALIVAS PW, 1990, SYNAPSE, V5, P48, DOI 10.1002/syn.890050104; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; Kiernan J, 2008, HISTOLOGICAL HISTOCH; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Laroche G, 2010, AM J PHYSIOL-CELL PH, V299, pC654, DOI 10.1152/ajpcell.00441.2009; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Masuho I, 2010, J BIOL CHEM, V285, P4781, DOI 10.1074/jbc.M109.058511; Neve RL, 2005, BIOTECHNIQUES, V39, P381, DOI 10.2144/05393PS01; Nunn C, 2011, CELL SIGNAL, V23, P1375, DOI 10.1016/j.cellsig.2011.03.020; Pacey LKK, 2011, MOL CELL NEUROSCI, V46, P563, DOI 10.1016/j.mcn.2010.12.005; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Psifogeorgou K, 2007, J NEUROCHEM, V103, P617, DOI 10.1111/j.1471-4159.2007.04812.x; Psigfogeorgou K, 2011, J NEUROSCI, V31, P5617, DOI 10.1523/JNEUROSCI.4146-10.2011; Pullinger CR, 2008, J LIPID RES, V49, P1846, DOI 10.1194/jlr.P800011-JLR200; Rahman Z, 1999, J NEUROSCI, V19, P2016; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Reid DC, 2009, RNA, V15, P2385, DOI 10.1261/rna.1821809; Rouge-Pont F, 2002, J NEUROSCI, V22, P3293, DOI 10.1523/JNEUROSCI.22-08-03293.2002; Saito Y, 2001, J COMP NEUROL, V435, P26, DOI 10.1002/cne.1191; Sartori M, 2008, METABOLISM, V57, P421, DOI 10.1016/j.metabol.2007.10.021; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Sethakorn N, 2010, CELL SIGNAL, V22, P1274, DOI 10.1016/j.cellsig.2010.03.016; Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674; Soares P, 2011, AM J HUM GENET, V88, P239, DOI 10.1016/j.ajhg.2011.01.009; Song JH, 2007, MOL CELL NEUROSCI, V35, P311, DOI 10.1016/j.mcn.2007.03.006; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Thomas EA, 1998, J NEUROSCI RES, V52, P118, DOI 10.1002/(SICI)1097-4547(19980401)52:1<118::AID-JNR11>3.0.CO;2-6; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; Uhl GR, 2002, MOL PSYCHIATR, V7, P21, DOI 10.1038/sj/mp/4000964; Wang Q, 2011, FASEB J; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhang K, 1999, GENE, V240, P23, DOI 10.1016/S0378-1119(99)00393-5	67	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27984	10.1371/journal.pone.0027984	http://dx.doi.org/10.1371/journal.pone.0027984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132185	Green Published, Green Submitted, gold			2022-12-25	WOS:000298162000055
J	Souza, CEA; Maitra, D; Saed, GM; Diamond, MP; Moura, AA; Pennathur, S; Abu-Soud, HM				Souza, Carlos Eduardo A.; Maitra, Dhiman; Saed, Ghassan M.; Diamond, Michael P.; Moura, Arlindo A.; Pennathur, Subramaniam; Abu-Soud, Husam M.			Hypochlorous Acid-Induced Heme Degradation from Lactoperoxidase as a Novel Mechanism of Free Iron Release and Tissue Injury in Inflammatory Diseases	PLOS ONE			English	Article							HUMAN ATHEROSCLEROTIC LESIONS; HYDROGEN PEROXIDE SYSTEM; CYSTIC-FIBROSIS; NITRIC-OXIDE; HOST-DEFENSE; EOSINOPHIL PEROXIDASE; MAMMALIAN PEROXIDASES; PROTEIN AGGREGATION; HUMAN-NEUTROPHILS; OXIDATIVE STRESS	Lactoperoxidase (LPO) is the major consumer of hydrogen peroxide (H2O2) in the airways through its ability to oxidize thiocyanate (SCN-) to produce hypothiocyanous acid, an antimicrobial agent. In nasal inflammatory diseases, such as cystic fibrosis, both LPO and myeloperoxidase (MPO), another mammalian peroxidase secreted by neutrophils, are known to colocalize. The aim of this study was to assess the interaction of LPO and hypochlorous acid (HOCl), the final product of MPO. Our rapid kinetic measurements revealed that HOCl binds rapidly and reversibly to LPO-Fe(III) to form the LPO-Fe(III)-OCl complex, which in turn decayed irreversibly to LPO Compound II through the formation of Compound I. The decay rate constant of Compound II decreased with increasing HOCl concentration with an inflection point at 100 mu M HOCl, after which the decay rate increased. This point of inflection is the critical concentration of HOCl beyond which HOCl switches its role, from mediating destabilization of LPO Compound II to LPO heme destruction. Lactoperoxidase heme destruction was associated with protein aggregation, free iron release, and formation of a number of fluorescent heme degradation products. Similar results were obtained when LPO-Fe(II)-O-2, Compound III, was exposed to HOCl. Heme destruction can be partially or completely prevented in the presence of SCN-. On the basis of the present results we concluded that a complex bi-directional relationship exists between LPO activity and HOCl levels at sites of inflammation; LPO serve as a catalytic sink for HOCl, while HOCl serves to modulate LPO catalytic activity, bioavailability, and function.	[Souza, Carlos Eduardo A.; Maitra, Dhiman; Saed, Ghassan M.; Diamond, Michael P.; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA; [Moura, Arlindo A.] Univ Fed Ceara, Fortaleza, Ceara, Brazil; [Pennathur, Subramaniam] Univ Michigan, Dept Internal Med, Div Nephrol, Sch Med, Ann Arbor, MI 48109 USA; [Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University; Universidade Federal do Ceara; University of Michigan System; University of Michigan; Wayne State University	Souza, CEA (corresponding author), Wayne State Univ, Sch Med, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48201 USA.	habusoud@med.wayne.edu	Maitra, Dhiman/E-4362-2012; MOURA, ARLINDO A/P-6697-2018	MOURA, ARLINDO A/0000-0002-8271-5733; , dhiman/0000-0002-8775-2963; Diamond, Michael/0000-0001-6353-4489; Maitra, Dhiman/0000-0003-4604-3551	National Institutes of Health [RO1 HL066367, R01HL094230]; Children's Hospital of Michigan; Doris Duke Foundation; Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center [DK089503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066367, R01HL094230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, R24DK082841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Michigan; Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grant RO1 HL066367 and R01HL094230, the Children's Hospital of Michigan, the Doris Duke Foundation Clinical Scientist Development Award and the Molecular Phenotyping Core of the Michigan Nutrition and Obesity Research Center (DK089503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Abu-Soud HM, 2004, BIOCHEMISTRY-US, V43, P11589, DOI 10.1021/bi049541h; Abu-Soud HM, 2001, BIOCHEMISTRY-US, V40, P11866, DOI 10.1021/bi011206v; Adak S, 1997, J BIOL CHEM, V272, P11049; AGBAI O, 1986, J NATL MED ASSOC, V78, P1053; ARUOMA OI, 1987, BIOCHEM J, V248, P973, DOI 10.1042/bj2480973; Ashby MT, 2004, J AM CHEM SOC, V126, P15976, DOI 10.1021/ja0438361; AUNE TM, 1977, EUR J BIOCHEM, V80, P209, DOI 10.1111/j.1432-1033.1977.tb11873.x; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V784, P177, DOI 10.1016/0167-4838(84)90125-0; Bouckenooghe T, 2006, CURR OPIN CLIN NUTR, V9, P728, DOI 10.1097/01.mco.0000247469.26414.55; Brennan ML, 2003, CURR OPIN LIPIDOL, V14, P353, DOI 10.1097/00041433-200308000-00003; CARTER P, 1971, ANAL BIOCHEM, V40, P450, DOI 10.1016/0003-2697(71)90405-2; Chapman ALP, 2003, BIOCHEM J, V375, P33, DOI 10.1042/BJ20030685; CHAU LY, 2000, LIFE SCI B, V24, P151; CHUNG J, 1970, ARCH BIOCHEM BIOPHYS, V141, P73, DOI 10.1016/0003-9861(70)90108-6; Clark RAF, 2008, J INVEST DERMATOL, V128, P2361, DOI 10.1038/jid.2008.257; Conner GE, 2002, AM J RESP CRIT CARE, V166, pS57, DOI 10.1164/rccm.2206018; Conner GE, 2007, FEBS LETT, V581, P271, DOI 10.1016/j.febslet.2006.12.025; Crichton RR, 2002, J INORG BIOCHEM, V91, P9, DOI 10.1016/S0162-0134(02)00461-0; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Defrere S, 2008, MOL HUM REPROD, V14, P377, DOI 10.1093/molehr/gan033; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DULL TJ, 1990, DNA CELL BIOL, V9, P499, DOI 10.1089/dna.1990.9.499; Ekmekci OB, 2004, BIOCHEMISTRY-MOSCOW+, V69, P462, DOI 10.1023/B:BIRY.0000026205.89894.25; El-Chemaly S, 2003, AM J RESP CRIT CARE, V167, P425, DOI 10.1164/rccm.200206-531OC; Everse J., 1991, PEROXIDASES CHEM BIO; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furman CS, 1998, INORG CHEM, V37, P4321, DOI 10.1021/ic980262q; Furtmuller PG, 2005, J INORG BIOCHEM, V99, P1220, DOI 10.1016/j.jinorgbio.2005.02.021; Furtmuller PG, 2004, JPN J INFECT DIS, V57, pS30; Furtmuller PG, 2002, BIOCHEMISTRY-US, V41, P11895, DOI 10.1021/bi026326x; Galijasevic S, 2006, BIOCHEMISTRY-US, V45, P1255, DOI 10.1021/bi051438k; Galijasevic S, 2004, J BIOL CHEM, V279, P39465, DOI 10.1074/jbc.M406003200; Galijasevic S, 2009, FREE RADICAL BIO MED, V47, P431, DOI 10.1016/j.freeradbiomed.2009.05.017; Gerson C, 2000, AM J RESP CELL MOL, V22, P665, DOI 10.1165/ajrcmb.22.6.3980; GOULD NS, RESP RES, V11, P119; Gray RD, 2010, CHEST, V137, P635, DOI 10.1378/chest.09-1047; Heinecke JW, 2010, J CLIN LIPIDOL, V4, P371, DOI 10.1016/j.jacl.2010.08.005; HEINECKE JW, 1993, J BIOL CHEM, V268, P4069; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; HU SH, 1991, J AM CHEM SOC, V113, P7189, DOI 10.1021/ja00019a015; Ihalin R, 2006, ARCH BIOCHEM BIOPHYS, V445, P261, DOI 10.1016/j.abb.2005.07.004; Jantschko W, 2005, ARCH BIOCHEM BIOPHYS, V434, P51, DOI 10.1016/j.abb.2004.10.014; KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502; Kettle AJ, 2007, BIOCHEMISTRY-US, V46, P4888, DOI 10.1021/bi602587k; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JY, 2010, ARCH ORAL BIOL, V55, P607, DOI 10.1016/j.archoralbio.2010.06.001; MAITRA D, FREE RADIC BIOL MED, V51, P374; MAITRA D, FREE RADIC BIOL MED, V51, P364; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; Malle E, 2000, EUR J BIOCHEM, V267, P4495, DOI 10.1046/j.1432-1327.2000.01498.x; Malle E, 2003, KIDNEY INT, V64, P1956, DOI 10.1046/j.1523-1755.2003.00336.x; MARQUEZ LA, 1990, J BIOL CHEM, V265, P5666; Mertz W, 1986, TRACE ELEMENTS HUMAN; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Nagababu E, 2004, ANTIOXID REDOX SIGN, V6, P967, DOI 10.1089/1523086042259823; NAUSEEF WM, 1986, BLOOD, V67, P1504; Newman A. A., 1975, CHEM BIOCH THIOCYANI; Ohshima H, 2003, ARCH BIOCHEM BIOPHYS, V417, P3, DOI 10.1016/S0003-9861(03)00283-2; Ong WY, 2004, ANN NY ACAD SCI, V1012, P51, DOI 10.1196/annals.1306.005; Pattison DI, 2009, CHEM RES TOXICOL, V22, P807, DOI 10.1021/tx800372d; PENNATHUR S, FREE RADIC BIOL MED, V49, P205; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Pullar JM, 2000, IUBMB LIFE, V50, P259, DOI 10.1080/15216540051080958; Reid DW, 2008, AM J PHYSIOL-LUNG C, V295, pL23, DOI 10.1152/ajplung.90299.2008; Reid DW, 2004, EUR RESPIR J, V24, P286, DOI 10.1183/09031936.04.00104803; Schaffer SW, 2009, CAN J PHYSIOL PHARM, V87, P91, DOI 10.1139/Y08-110; Shishehbor Mehdi H, 2004, Curr Atheroscler Rep, V6, P243, DOI 10.1007/s11883-004-0038-1; Singh AK, 2010, J BIOL INORG CHEM, V15, P1099, DOI 10.1007/s00775-010-0669-3; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; Stanley N, 2006, FREE RADICAL BIO MED, V40, P1636, DOI 10.1016/j.freeradbiomed.2005.12.031; SUBRAMANI S, 1992, J MEMBRANE BIOL, V125, P99; Tahboub YR, 2005, J BIOL CHEM, V280, P26129, DOI 10.1074/jbc.M503027200; TENOVUO J, 1991, Proceedings of the Finnish Dental Society, V87, P197; THOMSON E, FREE RADIC BIOL MED, V49, P1354; Trinder D, 2002, GUT, V51, P290, DOI 10.1136/gut.51.2.290; van der Vliet A, 2000, AM J PHYSIOL-LUNG C, V279, pL537, DOI 10.1152/ajplung.2000.279.3.L537; Wang L, 2007, J Burns Wounds, V6, pe5; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Yamaguchi K, 2008, CLIN CANCER RES, V14, P32, DOI 10.1158/1078-0432.CCR-07-1614	86	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27641	10.1371/journal.pone.0027641	http://dx.doi.org/10.1371/journal.pone.0027641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132121	Green Submitted, gold, Green Published			2022-12-25	WOS:000297792400011
J	Tong, HV; Toan, NL; Song, LH; Abou Ouf, E; Boc, CT; Kremsner, PG; Kun, JFJ; Velavan, TP				Tong, Hoang V.; Toan, Nguyen L.; Song, Le H.; Abou Ouf, Eman; Boc, C. -Thomas; Kremsner, Peter G.; Kun, Juergen F. J.; Velavan, T. P.			Ficolin-2 Levels and FCN2 Haplotypes Influence Hepatitis B Infection Outcome in Vietnamese Patients	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; VIRUS-INFECTION; FUNCTIONAL POLYMORPHISMS; GENE POLYMORPHISMS; INNATE IMMUNITY; DISEASE BURDEN; LIVER-DISEASE; ASSOCIATION; VARIANTS; CHILDREN	Human Ficolin-2 (L-ficolins) encoded by FCN2 gene is a soluble serum protein that plays an important role in innate immunity and is mainly expressed in the liver. Ficolin-2 serum levels and FCN2 single nucleotide polymorphisms were associated to several infectious diseases. We initially screened the complete FCN2 gene in 48 healthy individuals of Vietnamese ethnicity. We genotyped a Vietnamese cohort comprising of 423 clinically classified hepatitis B virus patients and 303 controls for functional single nucleotide polymorphisms in the promoter region (-986G>A, -602G>A, -4A>G) and in exon 8 (+6424G>T) by real-time PCR and investigated the contribution of FCN2 genotypes and haplotypes to serum Ficolin-2 levels, viral load and liver enzyme levels. Haplotypes differed significantly between patients and controls (P = 0.002) and the haplotype AGGG was found frequently in controls in comparison to patients with hepatitis B virus and hepatocellular carcinoma (P = 0.0002 and P<0.0001) conferring a protective effect. Ficolin-2 levels differed significantly between patients and controls (p<0.0001). Patients with acute hepatitis B had higher serum Ficolin-2 levels compared to other patient groups and controls. The viral load was observed to be significantly distributed among the haplotypes (P = 0.04) and the AAAG haplotype contributed to higher Ficolin-2 levels and to viral load. Four novel single nucleotide polymorphisms in introns (-941G>T, -310G>A, +2363G>A, +4882G>A) and one synonymous mutation in exon 8 (+6485G>T) was observed. Strong linkage was found between the variant -986G>A and -4A>G. The very first study on Vietnamese cohort associates both Ficolin-2 serum levels and FCN2 haplotypes to hepatitis B virus infection and subsequent disease progression.	[Tong, Hoang V.; Abou Ouf, Eman; Kremsner, Peter G.; Kun, Juergen F. J.; Velavan, T. P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Toan, Nguyen L.] Vietnam Mil Med Univ, Dept Pathophysiol, Hanoi, Vietnam; [Song, Le H.] Tran Hung Dao Hosp, Hanoi, Vietnam; [Boc, C. -Thomas] Univ Tubingen Hosp, Dept Mol Pathol, Tubingen, Germany; [Boc, C. -Thomas] Robert Koch Inst, Berlin, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Robert Koch Institute	Tong, HV (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.	tong.van-hoang@uni-tuebingen.de	Velavan, Thirumalaisamy P/C-1223-2010; van Tong, Hoang/E-9448-2011; Bock, C.-Thomas/A-3518-2012	Velavan, Thirumalaisamy P/0000-0002-9809-9883; van Tong, Hoang/0000-0002-7170-8810; Bock, C.-Thomas/0000-0002-2773-486X	Vietnamese Government	Vietnamese Government	HVT was supported by a Vietnamese Government scholarship. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson APM, 2004, CLIN EXP IMMUNOL, V138, P517, DOI 10.1111/j.1365-2249.2004.02634.x; Chapman SJ, 2007, MOL IMMUNOL, V44, P3267, DOI 10.1016/j.molimm.2006.04.013; Chong WP, 2005, HEPATOLOGY, V42, P1037, DOI 10.1002/hep.20891; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Faik I, 2011, HUM IMMUNOL, V72, P74, DOI 10.1016/j.humimm.2010.10.003; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; He YL, 2006, WORLD J GASTROENTERO, V12, P4788; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Hummelshoj T, 2008, MOL IMMUNOL, V45, P2508, DOI 10.1016/j.molimm.2008.01.003; Hummelshoj T, 2007, MOL IMMUNOL, V44, P401, DOI 10.1016/j.molimm.2006.02.023; Jensen ML, 2007, MOL IMMUNOL, V44, P856, DOI 10.1016/j.molimm.2006.04.002; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kilpatrick DC, 1999, IMMUNOL LETT, V67, P109, DOI 10.1016/S0165-2478(98)00147-3; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Le Y, 1998, FEBS LETT, V425, P367, DOI 10.1016/S0014-5793(98)00267-1; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Liu J, 2009, CELL MOL IMMUNOL, V6, P235, DOI 10.1038/cmi.2009.32; Messias-Reason IJ, 2009, CLIN EXP IMMUNOL, V157, P395, DOI 10.1111/j.1365-2249.2009.03975.x; MESSIASREASON I, 2009, J INFECT DIS, V199, P801; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Nguyen VTT, 2008, LIVER INT, V28, P525, DOI 10.1111/j.1478-3231.2007.01646.x; Qin XB, 2006, CELL MOL IMMUNOL, V3, P333; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Ruskamp JM, 2009, CLIN EXP IMMUNOL, V155, P433, DOI 10.1111/j.1365-2249.2008.03844.x; Song LH, 2006, MUTAT RES-FUND MOL M, V601, P137, DOI 10.1016/j.mrfmmm.2006.06.011; Song LH, 2008, EUR CYTOKINE NETW, V19, P204, DOI 10.1684/ecn.2008.0137; Song LH, 2003, MUTAT RES-FUND MOL M, V522, P119, DOI 10.1016/S0027-5107(02)00284-1; Thio CL, 2005, J VIROL, V79, P9192, DOI 10.1128/JVI.79.14.9192-9196.2005; Toan NL, 2006, HEPATOLOGY, V43, P1375, DOI 10.1002/hep.21188; Truelove AL, 2008, INT J IMMUNOGENET, V35, P255, DOI 10.1111/j.1744-313X.2008.00770.x; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101	32	38	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e28113	10.1371/journal.pone.0028113	http://dx.doi.org/10.1371/journal.pone.0028113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22140517	Green Published, Green Submitted, gold			2022-12-25	WOS:000297792400039
J	Mather, AE; Denwood, MJ; Haydon, DT; Matthews, L; Mellor, DJ; Coia, JE; Brown, DJ; Reid, SWJ				Mather, Alison E.; Denwood, Matthew J.; Haydon, Daniel T.; Matthews, Louise; Mellor, Dominic J.; Coia, John E.; Brown, Derek J.; Reid, Stuart W. J.			The Prevalences of Salmonella Genomic Island 1 Variants in Human and Animal Salmonella Typhimurium DT104 Are Distinguishable Using a Bayesian Approach	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; MULTIDRUG-RESISTANCE REGION; ANTIBIOTIC-RESISTANCE; SEROTYPE TYPHIMURIUM; ANTIMICROBIAL RESISTANCE; UNITED-STATES; FOOD ANIMALS; HEALTH CONSEQUENCES; DRUG-RESISTANCE; INFECTIONS	Throughout the 1990 s, there was an epidemic of multidrug resistant Salmonella Typhimurium DT104 in both animals and humans in Scotland. The use of antimicrobials in agriculture is often cited as a major source of antimicrobial resistance in pathogenic bacteria of humans, suggesting that DT104 in animals and humans should demonstrate similar prevalences of resistance determinants. Until very recently, only the application of molecular methods would allow such a comparison and our understanding has been hindered by the fact that surveillance data are primarily phenotypic in nature. Here, using large scale surveillance datasets and a novel Bayesian approach, we infer and compare the prevalence of Salmonella Genomic Island 1 (SGI1), SGI1 variants, and resistance determinants independent of SGI1 in animal and human DT104 isolates from such phenotypic data. We demonstrate differences in the prevalences of SGI1, SGI1-B, SGI1-C, absence of SGI1, and tetracycline resistance determinants independent of SGI1 between these human and animal populations, a finding that challenges established tenets that DT104 in domestic animals and humans are from the same well-mixed microbial population.	[Mather, Alison E.; Denwood, Matthew J.; Haydon, Daniel T.; Matthews, Louise; Mellor, Dominic J.; Reid, Stuart W. J.] Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Coia, John E.; Brown, Derek J.] Stobhill Gen Hosp, Scottish Salmonella Shigella & Clostridium Diffic, Glasgow G21 3UW, Lanark, Scotland	University of Glasgow	Mather, AE (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	swjreid@rvc.ac.uk	Matthews, Louise/E-2913-2013; Brown, Derek/AAE-5597-2020; Coia, John/AAP-5379-2020	Matthews, Louise/0000-0003-4420-8367; Brown, Derek/0000-0003-3742-8257; Coia, John/0000-0002-4966-8453; Reid, Stuart/0000-0002-6872-9071; Haydon, Daniel/0000-0002-1240-1886	University of Glasgow; Scottish Government's Centre of Excellence in Epidemiology, Population Health and Disease Control (EPIC)	University of Glasgow; Scottish Government's Centre of Excellence in Epidemiology, Population Health and Disease Control (EPIC)	AEM was supported by the William Stewart Fellowship, University of Glasgow, and MJD was supported by the Scottish Government's Centre of Excellence in Epidemiology, Population Health and Disease Control (EPIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo FJ, 2004, J VET MED B, V51, P374, DOI 10.1111/j.1439-0450.2004.00789.x; Angulo FJ, 2000, MICROB DRUG RESIST, V6, P77, DOI 10.1089/mdr.2000.6.77; Besser TE, 2000, EPIDEMIOL INFECT, V124, P193, DOI 10.1017/S0950268899003283; Boyd D, 2002, ANTIMICROB AGENTS CH, V46, P1714, DOI 10.1128/AAC.46.6.1714-1722.2002; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Boyd DA, 2000, FEMS MICROBIOL LETT, V189, P285, DOI 10.1111/j.1574-6968.2000.tb09245.x; Briggs CE, 1999, ANTIMICROB AGENTS CH, V43, P846, DOI 10.1128/AAC.43.4.846; BROWNING LM, 2007, HPS WEEKLY REPORT, V41, P172; CALLOW B R, 1959, J Hyg (Lond), V57, P346; Calvert N, 1998, VET REC, V143, P351, DOI 10.1136/vr.143.13.351; Carattoli A, 2002, ANTIMICROB AGENTS CH, V46, P2821, DOI 10.1128/AAC.46.9.2821-2828.2002; Denwood MJ, 2011, P ROY SOC B-BIOL SCI, V278, P1434, DOI 10.1098/rspb.2010.1719; Fone D L, 1994, Commun Dis Rep CDR Rev, V4, pR136; Glynn MK, 1998, NEW ENGL J MED, V338, P1333, DOI 10.1056/NEJM199805073381901; Greene SK, 2008, FOODBORNE PATHOG DIS, V5, P669, DOI 10.1089/fpd.2008.0111; Guerra B, 2004, MICROB DRUG RESIST, V10, P83, DOI 10.1089/1076629041310136; Helms M, 2005, EMERG INFECT DIS, V11, P859, DOI 10.3201/eid1106.041017; LEMINOR L, 1984, BERGEYS MANUAL SYSTE, V1, P427; Levings RS, 2005, J BACTERIOL, V187, P4401, DOI 10.1128/JB.187.13.4401-4409.2005; Miko A, 2005, J ANTIMICROB CHEMOTH, V56, P1025, DOI 10.1093/jac/dki365; Molbak K, 2004, J VET MED B, V51, P364, DOI 10.1111/j.1439-0450.2004.00788.x; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Nielsen EM, 2009, EMERG INFECT DIS, V15, P101, DOI 10.3201/eid1501.080853; Poppe C, 2002, MICROB DRUG RESIST, V8, P107, DOI 10.1089/107662902760190653; Targant H, 2010, J ANTIMICROB CHEMOTH, V65, P1543, DOI 10.1093/jac/dkq163; Targant H, 2010, FOODBORNE PATHOG DIS, V7, P419, DOI 10.1089/fpd.2009.0414; Threlfall E.J., 1997, Euro Surveill, V2, P81; Threlfall EJ, 2000, J ANTIMICROB CHEMOTH, V46, P7, DOI 10.1093/jac/46.1.7; Threlfall EJ, 2003, MICROB DRUG RESIST, V9, P183, DOI 10.1089/107662903765826787; Threlfall EJ, 1996, LANCET, V347, P1053, DOI 10.1016/S0140-6736(96)90199-3; THRELFALL EJ, 1994, VET REC, V134, P577, DOI 10.1136/vr.134.22.577; Vo ATT, 2007, J ANTIMICROB CHEMOTH, V59, P594, DOI 10.1093/jac/dkl531; Vo ATT, 2006, INT J ANTIMICROB AG, V28, P172, DOI 10.1016/j.ijantimicag.2006.05.027; Wall P G, 1994, Commun Dis Rep CDR Rev, V4, pR130; WALL PG, 1995, VET REC, V136, P591, DOI 10.1136/vr.136.23.591; WARD LR, 1987, EPIDEMIOL INFECT, V99, P291, DOI 10.1017/S0950268800067765; Weill FX, 2006, J CLIN MICROBIOL, V44, P700, DOI 10.1128/JCM.44.3.700-708.2006; Wiesner M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-131; Wright JG, 2005, EMERG INFECT DIS, V11, P1235, DOI 10.3201/eid1108.050111	39	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27220	10.1371/journal.pone.0027220	http://dx.doi.org/10.1371/journal.pone.0027220			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125606	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000297789200006
J	Nobels, I; Spanoghe, P; Haesaert, G; Robbens, J; Blust, R				Nobels, Ingrid; Spanoghe, Pieter; Haesaert, Geert; Robbens, Johan; Blust, Ronny			Toxicity Ranking and Toxic Mode of Action Evaluation of Commonly Used Agricultural Adjuvants on the Basis of Bacterial Gene Expression Profiles	PLOS ONE			English	Article							ENVIRONMENTAL RISK-ASSESSMENT; GLYPHOSATE; ASSAY; INGREDIENTS; MECHANISMS; PESTICIDES; SURFACTANT; TADPOLES; STRESS; PART	The omnipresent group of pesticide adjuvants are often referred to as "inert" ingredients, a rather misleading term since consumers associate this term with "safe". The upcoming new EU regulation concerning the introduction of plant protection products on the market (EC1107/2009) includes for the first time the demand for information on the possible negative effects of not only the active ingredients but also the used adjuvants. This new regulation requires basic toxicological information that allows decisions on the use/ban or preference of use of available adjuvants. In this study we obtained toxicological relevant information through a multiple endpoint reporter assay for a broad selection of commonly used adjuvants including several solvents (e. g. isophorone) and non-ionic surfactants (e. g. ethoxylated alcohols). The used assay allows the toxicity screening in a mechanistic way, with direct measurement of specific toxicological responses (e. g. oxidative stress, DNA damage, membrane damage and general cell lesions). The results show that the selected solvents are less toxic than the surfactants, suggesting that solvents may have a preference of use, but further research on more compounds is needed to confirm this observation. The gene expression profiles of the selected surfactants reveal that a phenol (ethoxylated tristyrylphenol) and an organosilicone surfactant (ethoxylated trisiloxane) show little or no inductions at EC(20) concentrations, making them preferred surfactants for use in different applications. The organosilicone surfactant shows little or no toxicity and good adjuvant properties. However, this study also illustrates possible genotoxicity (induction of the bacterial SOS response) for several surfactants (POEA, AE, tri-EO, EO FA and EO NP) and one solvent (gamma-butyrolactone). Although the number of compounds that were evaluated is rather limited (13), the results show that the used reporter assay is a promising tool to rank commonly used agricultural adjuvants based on toxicity and toxic mode of action data.	[Nobels, Ingrid; Robbens, Johan; Blust, Ronny] Univ Antwerp, Dept Biol, Lab Ecophysiol Biochem & Toxicol, B-2020 Antwerp, Belgium; [Spanoghe, Pieter] Univ Ghent, Dept Crop Protect Chem, B-9000 Ghent, Belgium; [Haesaert, Geert] Univ Coll Ghent, Dept Biosci & Landscape Architecture, Ghent, Belgium; [Haesaert, Geert] Univ Ghent, Dept Plant Prod, B-9000 Ghent, Belgium	University of Antwerp; Ghent University; HOGENT University College of Applied Sciences & Arts; Ghent University	Nobels, I (corresponding author), Univ Antwerp, Dept Biol, Lab Ecophysiol Biochem & Toxicol, B-2020 Antwerp, Belgium.	ingrid.nobels@ua.ac.be	Spanoghe, Pieter/B-9440-2015	Spanoghe, Pieter/0000-0002-8158-4401; Haesaert, Geert/0000-0003-2993-9858	Federal Public Service of Health, Food chain safety and Environment, Belgium [R-04/001]	Federal Public Service of Health, Food chain safety and Environment, Belgium	This study was financially supported by the Federal Public Service of Health, Food chain safety and Environment, Belgium ( acronym: ADDIT, projectnumber R-04/001). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. An official approval of the manuscript from the Belgian Federal Public Service of Health, Food chain safety and Environment was needed to allow publication of the results.	Belanger SE, 2006, ECOTOX ENVIRON SAFE, V64, P1, DOI 10.1016/j.ecoenv.2006.01.009; Bjorklund K, 2009, SCI TOTAL ENVIRON, V407, P4665, DOI 10.1016/j.scitotenv.2009.04.040; Boeije GM, 2006, ECOTOX ENVIRON SAFE, V64, P75, DOI 10.1016/j.ecoenv.2005.08.009; Breitholtz M, 2006, ECOTOX ENVIRON SAFE, V63, P324, DOI 10.1016/j.ecoenv.2005.12.009; Cox C, 2006, ENVIRON HEALTH PERSP, V114, P1803, DOI 10.1289/ehp.9374; Dardenne F, 2007, APPL MICROBIOL BIOT, V75, P223, DOI 10.1007/s00253-006-0808-5; Dardenne F, 2007, ENVIRON SCI TECHNOL, V41, P1790, DOI 10.1021/es062162m; Escher BI, 2002, ENVIRON SCI TECHNOL, V36, P4201, DOI 10.1021/es015848h; FIELD RJ, 1988, PESTIC SCI, V24, P55, DOI 10.1002/ps.2780240106; Foy C. L., 1996, PESTICIDE FORMULATIO; Howe CM, 2004, ENVIRON TOXICOL CHEM, V23, P1928, DOI 10.1897/03-71; Huang GL, 2007, WATER RES, V41, P4630, DOI 10.1016/j.watres.2007.06.034; KROGH KA, 2003, CHEMOSPHERE, V45; Mann RM, 2001, ENVIRON POLLUT, V114, P195, DOI 10.1016/S0269-7491(00)00216-5; Michel B, 2005, PLOS BIOL, V3, P1174, DOI 10.1371/journal.pbio.0030255; Murray RJ, 1997, PROCEEDINGS OF THE FIFTIETH NEW ZEALAND PLANT PROTECTION CONFERENCE, P134; Nobels I, 2010, TOXICOL IN VITRO, V24, P1768, DOI 10.1016/j.tiv.2010.07.002; ORSER CS, 1995, IN VITRO TOXICOL, V8, P71; QUILLARDET P, 1985, MUTAT RES, V147, P65, DOI 10.1016/0165-1161(85)90020-2; Relyea RA, 2005, ARCH ENVIRON CON TOX, V48, P351, DOI 10.1007/s00244-004-0086-0; Schuurmann G, 1997, AQUAT TOXICOL, V38, P277, DOI 10.1016/S0166-445X(96)00842-9; Spanoghe P, 2007, PEST MANAG SCI, V63, P4, DOI 10.1002/ps.1321; Surgan M, 2010, ENVIRON MANAGE, V45, P834, DOI 10.1007/s00267-009-9382-9; Tsui MTK, 2003, CHEMOSPHERE, V52, P1189, DOI 10.1016/S0045-6535(03)00306-0; *US EPA, 2009, NOT PROP RUL PUBL AV; *US EPA, 2002, HPV CHALL PROGR SUBM; Verhaar HJM, 2000, CHEMOSPHERE, V40, P875, DOI 10.1016/S0045-6535(99)00317-3; Vonk JA, 2009, ATLA-ALTERN LAB ANIM, V37, P557, DOI 10.1177/026119290903700512; Weinhold B, 2010, ENVIRON HEALTH PERSP, V118, pA168, DOI 10.1289/ehp.118-a168	29	46	48	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e24139	10.1371/journal.pone.0024139	http://dx.doi.org/10.1371/journal.pone.0024139			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125591	Green Published, gold, Green Submitted			2022-12-25	WOS:000297789200002
J	Garcin, EB; Bornet, O; Elantak, L; Vita, N; Pieulle, L; Guerlesquin, F; Sebban-Kreuzer, C				Garcin, Edwige B.; Bornet, Olivier; Elantak, Latifa; Vita, Nicolas; Pieulle, Laetitia; Guerlesquin, Francoise; Sebban-Kreuzer, Corinne			Structural and Mechanistic Insights into Unusual Thiol Disulfide Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; ACTIVE-SITE; CHEMICAL-SHIFT; PROTEIN; ISOMERASE; DSBA; REDUCTION; GLUTAREDOXINS; MIMICKING; CATALYSIS	Cytoplasmic desulfothioredoxin (Dtrx) from the anaerobe Desulfovibrio vulgaris Hildenborough has been identified as a new member of the thiol disulfide oxidoreductase family. The active site of Dtrx contains a particular consensus sequence, CPHC, never seen in the cytoplasmic thioredoxins and generally found in periplasmic oxidases. Unlike canonical thioredoxins (Trx), Dtrx does not present any disulfide reductase activity, but it presents instead an unusual disulfide isomerase activity. We have used NMR spectroscopy to gain insights into the structure and the catalytic mechanism of this unusual Dtrx. The redox potential of Dtrx (-181 mV) is significantly less reducing than that of canonical Trx. A pH dependence study allowed the determination of the pK(a) of all protonable residues, including the cysteine and histidine residues. Thus, the pKa values for the thiol group of Cys(31) and Cys(34) are 4.8 and 11.3, respectively. The His(33) pK(a) value, experimentally determined for the first time, differs notably as a function of the redox states, 7.2 for the reduced state and 4.6 for the oxidized state. These data suggest an important role for His(33) in the molecular mechanism of Dtrx catalysis that is confirmed by the properties of mutant DtrxH33G protein. The NMR structure of Dtrx shows a different charge repartition compared with canonical Trx. The results presented are likely indicative of the involvement of this protein in the catalysis of substrates specific of the anaerobe cytoplasm of DvH. The study of Dtrx is an important step toward revealing the molecular details of the thiol-disulfide oxidoreductase catalytic mechanism.	[Garcin, Edwige B.; Bornet, Olivier; Elantak, Latifa; Vita, Nicolas; Pieulle, Laetitia; Guerlesquin, Francoise; Sebban-Kreuzer, Corinne] Aix Marseille Univ, CNRS, IFR88, IMR, F-13402 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Sebban-Kreuzer, C (corresponding author), Aix Marseille Univ, CNRS, IFR88, IMR, F-13402 Marseille, France.	Corinne.kreuzer@ifr88.cnrs-mrs.fr	ELANTAK, Latifa/S-7004-2019	garcin, edwige b./0000-0002-0533-6940				Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Bertini I, 2006, J BIOMOL NMR, V36, P111, DOI 10.1007/s10858-006-9068-z; Capitani G, 2001, J MOL BIOL, V311, P1037, DOI 10.1006/jmbi.2001.4913; Carvalho ATP, 2008, J PHYS CHEM B, V112, P2511, DOI 10.1021/jp7104665; Carvalho ATP, 2006, J COMPUT CHEM, V27, P966, DOI 10.1002/jcc.20404; Chambers JE, 2010, J BIOL CHEM, V285, P29200, DOI 10.1074/jbc.M110.156596; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Garcin EB, 2010, BIOMOL NMR ASSIGN, V4, P135, DOI 10.1007/s12104-010-9226-9; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Huber D, 2005, P NATL ACAD SCI USA, V102, P18872, DOI 10.1073/pnas.0509583102; Jeng MF, 1996, BIOCHEMISTRY-US, V35, P1, DOI 10.1021/bi952404n; JENG MF, 1995, BIOCHEMISTRY-US, V34, P10101, DOI 10.1021/bi00032a001; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Keller R. L. J, 2004, CANTINA; Kersteen EA, 2003, ANTIOXID REDOX SIGN, V5, P413, DOI 10.1089/152308603768295159; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Ladenstein R, 2006, FEBS J, V273, P4170, DOI 10.1111/j.1742-4658.2006.05421.x; Lundstrom J., 1993, BIOCHEMISTRY-US, V32, P6649; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Mossner E, 1998, PROTEIN SCI, V7, P1233; Pieulle L, 2011, J BIOL CHEM, V286, P7812, DOI 10.1074/jbc.M110.197988; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Rinaldi FC, 2009, BIOCHEMISTRY-US, V48, P3508, DOI 10.1021/bi801899x; Roos G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000461; Shouldice SR, 2010, MOL MICROBIOL, V75, P13, DOI 10.1111/j.1365-2958.2009.06952.x; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Xu YL, 2008, APPL MICROBIOL BIOT, V81, P79, DOI 10.1007/s00253-008-1644-6	35	3	3	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2012	287	3					1688	1697		10.1074/jbc.M111.288316	http://dx.doi.org/10.1074/jbc.M111.288316			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	879HT	22128175	Green Published, hybrid			2022-12-25	WOS:000299321000012
J	Ho, KK; McGuire, VA; Koo, CY; Muir, KW; de Olano, N; Maifoshie, E; Kelly, DJ; McGovern, UB; Monteiro, LJ; Gomes, AR; Nebreda, AR; Campbell, DG; Arthur, JSC; Lam, EWF				Ho, Ka-Kei; McGuire, Victoria A.; Koo, Chuay-Yeng; Muir, Kyle W.; de Olano, Natalia; Maifoshie, Evie; Kelly, Douglas J.; McGovern, Ursula B.; Monteiro, Lara J.; Gomes, Ana R.; Nebreda, Angel R.; Campbell, David G.; Arthur, J. Simon C.; Lam, Eric W. -F.			Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO3A; BREAST-CANCER CELLS; MAP KINASE; INDUCED ACTIVATION; INDUCED APOPTOSIS; FOXM1 EXPRESSION; GEFITINIB IRESSA; GENE-EXPRESSION; TARGET; STRESS	FOXO3a is a forkhead transcription factor that regulates a multitude of important cellular processes, including proliferation, apoptosis, differentiation, and metabolism. Doxorubicin treatment of MCF-7 breast carcinoma cells results in FOXO3a nuclear relocation and the induction of the stress-activated kinase p38 MAPK. Here, we studied the potential regulation of FOXO3a by p38 in response to doxorubicin. Co-immunoprecipitation studies in MCF-7 cells demonstrated a direct interaction between p38 and FOXO3a. We also showed that p38 can bind and phosphorylate a recombinant FOXO3a directly in vitro. HPLC-coupled phosphopeptide mapping and mass spectrometric analyses identified serine 7 as a major site for p38 phosphorylation. Using a phosphorylated Ser-7 FOXO3a antibody, we demonstrated that FOXO3a is phosphorylated on Ser-7 in response to doxorubicin. Immunofluorescence staining studies showed that upon doxorubicin treatment, the wild-type FOXO3a relocalized to the nucleus, whereas the phosphorylation-defective FOXO3a (Ala-7) mutant remained largely in the cytoplasm. Treatment with SB202190 also inhibits the doxorubicin-induced FOXO3a Ser-7 phosphorylation and nuclear accumulation in MCF-7 cells. In addition, doxorubicin caused the nuclear translocation of FOXO3a in wild-type but not p38-depleted mouse fibroblasts. Together, our results suggest that p38 phosphorylation of FOXO3a on Ser-7 is essential for its nuclear relocalization in response to doxorubicin.	[Ho, Ka-Kei; Koo, Chuay-Yeng; Muir, Kyle W.; de Olano, Natalia; Maifoshie, Evie; Kelly, Douglas J.; McGovern, Ursula B.; Monteiro, Lara J.; Gomes, Ana R.; Lam, Eric W. -F.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London W12 0NN, England; [McGuire, Victoria A.; Campbell, David G.; Arthur, J. Simon C.] Univ Dundee, Med Res Council Prot Phosphorylat Unit, Sch Life Sci, Dundee DD1 5EH, Scotland; [Kelly, Douglas J.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England; [Nebreda, Angel R.] Inst Catalana Recerca & Estudis Avancats, Barcelona 08028, Spain; [Nebreda, Angel R.] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain	Imperial College London; University of Dundee; Imperial College London; ICREA; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Lam, EWF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, MRC Cyclotron Bldg,Hammersmith Hosp Campus,Du Can, London W12 0NN, England.	eric.lam@imperial.ac.uk	Nebreda, Angel Rodriguez/R-9594-2019; Lam, Eric W-F/AAW-8566-2020; Campbell, David G/K-1874-2015; Arthur, J. Simon/B-8058-2010; McGuire, Victoria/AAG-1953-2019; Monteiro, Lara J/AAU-8518-2020	Lam, Eric W-F/0000-0003-1274-3576; Campbell, David G/0000-0003-2278-2149; Arthur, J. Simon/0000-0002-8135-1958; McGuire, Victoria/0000-0002-7808-3278; Muir, Kyle/0000-0002-0294-5679; Koo, Chuay Yeng/0000-0002-9495-0554	Cancer Research UK; Breast Cancer Campaign; Engineering and Physical Sciences Research Council; Imperial College Healthcare NHS Trust-BRC; ICREA Funding Source: Custom; MRC [G1100713, MC_U127081014] Funding Source: UKRI; Cancer Research UK [12011] Funding Source: researchfish; Medical Research Council [MC_U127081014, G1100713] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Breast Cancer Campaign; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Imperial College Healthcare NHS Trust-BRC; ICREA(ICREA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funds from Cancer Research UK (to K.K.H. and E.W.-F.L.), the Breast Cancer Campaign (to E.W.-F.L.), the Engineering and Physical Sciences Research Council (to D.J.K.), and Imperial College Healthcare NHS Trust-BRC Funding (to C.-Y.K.).	Ambrosino C, 2001, BIOL CELL, V93, P47, DOI 10.1016/S0248-4900(01)01124-8; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Boronkai A, 2009, EUR J CELL BIOL, V88, P753, DOI 10.1016/j.ejcb.2009.07.005; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Cai BB, 2008, APOPTOSIS, V13, P803, DOI 10.1007/s10495-008-0218-5; Campbell David G, 2002, J Biomol Tech, V13, P119; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012293; Chiacchiera F, 2010, CELL CYCLE, V9, P1091, DOI 10.4161/cc.9.6.11035; Corrado P, 2009, LEUKEMIA, V23, P405, DOI 10.1038/leu.2008.186; Corre S, 2009, J BIOL CHEM, V284, P18851, DOI 10.1074/jbc.M808605200; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; de Mattos SF, 2004, MOL CELL BIOL, V24, P10058, DOI 10.1128/MCB.24.22.10058-10071.2004; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Deacon K, 2003, MOL BIOL CELL, V14, P2071, DOI 10.1091/mbc.e02-10-0653; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Essafi Abdelkader, 2009, V462, P201, DOI 10.1007/978-1-60327-115-8_13; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hallahan AR, 2003, NAT MED, V9, P1033, DOI 10.1038/nm904; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Haq R, 2002, CANCER RES, V62, P5076; Hildesheim J, 2002, CANCER RES, V62, P7305; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Hong SW, 2011, CANCER BIOL THER, V12, P421, DOI 10.4161/cbt.12.5.15972; Hui RCY, 2008, MOL CELL BIOL, V28, P5886, DOI 10.1128/MCB.01265-07; Hui RCY, 2008, MOL CANCER THER, V7, P670, DOI 10.1158/1535-7163.MCT-07-0397; Kaestner KH, 2000, GENE DEV, V14, P142; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Krol J, 2007, MOL CANCER THER, V6, P3169, DOI 10.1158/1535-7163.MCT-07-0507; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Link W, 2009, J BIOL CHEM, V284, P28392, DOI 10.1074/jbc.M109.038984; Losa JH, 2003, ONCOGENE, V22, P3998, DOI 10.1038/sj.onc.1206608; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Myatt SS, 2011, ANTIOXID REDOX SIGN, V14, P675, DOI 10.1089/ars.2010.3383; Nagai H, 2007, J BIOCHEM MOL BIOL, V40, P1; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Savarese DMF, 1997, J CLIN ONCOL, V15, P2981, DOI 10.1200/JCO.1997.15.8.2981; She QB, 2001, CANCER RES, V61, P1604; Shiota M, 2010, CANCER SCI, V101, P1177, DOI 10.1111/j.1349-7006.2010.01503.x; SINHA BK, 1989, CANCER RES, V49, P3844; St Germain C, 2010, NEOPLASIA, V12, P527, DOI 10.1593/neo.92048; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Tsai K L, 2001, Health Serv Manage Res, V14, P92, DOI 10.1258/0951484011912582; UBEZIO P, 1994, FREE RADICAL BIO MED, V16, P509, DOI 10.1016/0891-5849(94)90129-5; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; Wang XW, 2012, J CELL PHYSIOL, V227, P1168, DOI 10.1002/jcp.22839; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wong ST, 2009, PHARMACOTHERAPY, V29, P954, DOI 10.1592/phco.29.8.954; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2009, CLIN CANCER RES, V15, P752, DOI 10.1158/1078-0432.CCR-08-0124	64	93	95	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1545	1555		10.1074/jbc.M111.284224	http://dx.doi.org/10.1074/jbc.M111.284224			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128155	Green Published, hybrid			2022-12-25	WOS:000299170300068
J	Miroci, H; Schob, C; Kindler, S; Olschlager-Schutt, J; Fehr, S; Jungenitz, T; Schwarzacher, SW; Bagni, C; Mohr, E				Miroci, Hatmone; Schob, Claudia; Kindler, Stefan; Oelschlaeger-Schuett, Janin; Fehr, Susanne; Jungenitz, Tassilo; Schwarzacher, Stephan W.; Bagni, Claudia; Mohr, Evita			Makorin Ring Zinc Finger Protein 1 (MKRN1), a Novel Poly(A)-binding Protein-interacting Protein, Stimulates Translation in Nerve Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A) BINDING-PROTEIN; MESSENGER-RNA LOCALIZATION; SYNAPTIC ACTIVATION CAUSES; LOCAL TRANSLATION; UBIQUITIN LIGASE; STRUCTURAL BASIS; DENTATE GYRUS; EXPRESSION; DENDRITES; DOMAIN	The poly(A)-binding protein (PABP), a key component of different ribonucleoprotein complexes, plays a crucial role in the control of mRNA translation rates, stability, and subcellular targeting. In this study we identify RING zinc finger protein Makorin 1 (MKRN1), a bona fide RNA-binding protein, as a binding partner of PABP that interacts with PABP in an RNA independent manner. In rat brain, a so far uncharacterized short MKRN1 isoform, MKRN1-short, predominates and is detected in forebrain nerve cells. In neuronal dendrites, MKRN1-short co-localizes with PABP in granule-like structures, which are morphological correlates of sites of mRNA metabolism. Moreover, in primary rat neurons MKRN1-short associates with dendritically localized mRNAs. When tethered to a reporter mRNA, MKRN1-short significantly enhances reporter protein synthesis. Furthermore, after induction of synaptic plasticity via electrical stimulation of the perforant path in vivo, MKRN1-short specifically accumulates in the activated dendritic lamina, the middle molecular layer of the hippocampal dentate gyrus. Collectively, these data indicate that in mammalian neurons MKRN1-short interacts with PABP to locally control the translation of dendritic mRNAs at synapses.	[Miroci, Hatmone; Mohr, Evita] Univ Med Ctr Hamburg Eppendorf, Inst Neuroanat, D-20246 Hamburg, Germany; [Schob, Claudia; Kindler, Stefan; Oelschlaeger-Schuett, Janin] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Fehr, Susanne] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, D-20251 Hamburg, Germany; [Jungenitz, Tassilo; Schwarzacher, Stephan W.] Goethe Univ Frankfurt, Dept Clin Neuroanat, D-60590 Frankfurt, Germany; [Bagni, Claudia] Catholic Univ Louvain VIB, Dept Dev Genet, B-3000 Louvain, Belgium; [Bagni, Claudia] Univ Rome, Dipartimento Med Sperimentale & Sci Biochem, I-00133 Rome, Italy	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Goethe University Frankfurt; Flanders Institute for Biotechnology (VIB); Sapienza University Rome	Mohr, E (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Neuroanat, D-20246 Hamburg, Germany.	emohr@uke.uni-hamburg.de		Bagni, Claudia/0000-0002-4419-210X; Jungenitz, Tassilo/0000-0001-7291-8548	Deutsche Forschungsgemeinschaft [DFG/GRK-336, Ki488/2-6, KR1321/4-1]; Fritz Thyssen Stiftung [Az. 10.05.2.185]; National Ataxia Foundation; Werner Otto Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fritz Thyssen Stiftung; National Ataxia Foundation; Werner Otto Stiftung	This work was supported by Grants of the Deutsche Forschungsgemeinschaft DFG/GRK-336 (to E. M.), Ki488/2-6 (to S. K.), and KR1321/4-1 (to S. K)., the Fritz Thyssen Stiftung (Az. 10.05.2.185 (to S. K.), the National Ataxia Foundation (to S. K.), and the Werner Otto Stiftung (to C. S.). This work forms part of the thesis of H. Miroci, Faculty of Biology (University of Hamburg, Germany).	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Arn EA, 2003, DEV CELL, V4, P41, DOI 10.1016/S1534-5807(02)00397-0; Bag J, 1996, EUR J BIOCHEM, V237, P143, DOI 10.1111/j.1432-1033.1996.0143n.x; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Baron-Benhamou Julie, 2004, Methods Mol Biol, V257, P135, DOI 10.1385/1-59259-750-5:135; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Cajigas IJ, 2010, EMBO J, V29, P2746, DOI 10.1038/emboj.2010.173; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Donnelly CJ, 2010, TRAFFIC, V11, P1498, DOI 10.1111/j.1600-0854.2010.01118.x; DRAGUNOW M, 1989, NEUROSCI LETT, V101, P274, DOI 10.1016/0304-3940(89)90545-4; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; FRANKLIN NC, 1985, J MOL BIOL, V181, P75, DOI 10.1016/0022-2836(85)90325-0; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gray TA, 2000, GENOMICS, V66, P76, DOI 10.1006/geno.2000.6199; Gray TA, 2006, P NATL ACAD SCI USA, V103, P12039, DOI 10.1073/pnas.0602216103; Grosset C, 2000, CELL, V103, P29, DOI 10.1016/S0092-8674(00)00102-1; Hirokawa N, 2006, J NEUROSCI, V26, P7139, DOI 10.1523/JNEUROSCI.1821-06.2006; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kahvejian A, 2001, COLD SPRING HARB SYM, V66, P293, DOI 10.1101/sqb.2001.66.293; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Karim MM, 2006, P NATL ACAD SCI USA, V103, P9494, DOI 10.1073/pnas.0603701103; Khaleghpour K, 2001, MOL CELL BIOL, V21, P5200, DOI 10.1128/MCB.21.15.5200-5213.2001; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Kozlov G, 2001, P NATL ACAD SCI USA, V98, P4409, DOI 10.1073/pnas.071024998; Kozlov G, 2004, EMBO J, V23, P272, DOI 10.1038/sj.emboj.7600048; Kozlov G, 2010, J BIOL CHEM, V285, P13599, DOI 10.1074/jbc.M109.089540; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Kulkarni SD, 2011, J BIOL CHEM, V286, P14146, DOI 10.1074/jbc.M110.190553; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lee EW, 2009, EMBO J, V28, P2100, DOI 10.1038/emboj.2009.164; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; MOHR E, 1995, P NATL ACAD SCI USA, V92, P4377, DOI 10.1073/pnas.92.10.4377; Mohr E, 2004, J NEUROENDOCRINOL, V16, P333, DOI 10.1111/j.0953-8194.2004.01176.x; Mohr E, 2001, P NATL ACAD SCI USA, V98, P7072, DOI 10.1073/pnas.111146598; Naarmann IS, 2010, RNA, V16, P2189, DOI 10.1261/rna.2211110; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nelson MR, 2007, J BIOL CHEM, V282, P34031, DOI 10.1074/jbc.M706363200; NETO OPD, 1995, NUCLEIC ACIDS RES, V23, P2198, DOI 10.1093/nar/23.12.2198; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Omwancha J, 2006, ENDOCRINE, V29, P363, DOI 10.1385/ENDO:29:2:363; Patel GP, 2006, FEBS J, V273, P5678, DOI 10.1111/j.1742-4658.2006.05556.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Richter JD, 2010, BIOCHEM SOC T, V38, P1527, DOI 10.1042/BST0381527; Roy G, 2002, MOL CELL BIOL, V22, P3769, DOI 10.1128/MCB.22.11.3769-3782.2002; Schutt J, 2009, J BIOL CHEM, V284, P25479, DOI 10.1074/jbc.M109.042663; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Schwarzacher SW, 2006, GLIA, V53, P704, DOI 10.1002/glia.20329; Skabkina OV, 2003, J BIOL CHEM, V278, P18191, DOI 10.1074/jbc.M209073200; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; Steward O, 1999, J NEUROSCI, V19, P7834; STEWARD O, 1976, SCIENCE, V194, P426, DOI 10.1126/science.982024; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17	64	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2012	287	2					1322	1334		10.1074/jbc.M111.315291	http://dx.doi.org/10.1074/jbc.M111.315291			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	877IE	22128154	Green Published, hybrid			2022-12-25	WOS:000299170300047
J	Dieterich, C; Relman, DA				Dieterich, Christine; Relman, David A.			Modulation of the Host Interferon Response and ISGylation Pathway by B. pertussis Filamentous Hemagglutinin	PLOS ONE			English	Article							ADENYLATE-CYCLASE TOXIN; UBIQUITIN-LIKE PROTEIN; RESPIRATORY EPITHELIAL-CELLS; INNATE ANTIVIRAL RESPONSE; GENE TRANSCRIPT ABUNDANCE; BORDETELLA-PERTUSSIS; EXPRESSION PATTERNS; ISG15 CONJUGATION; PERIPHERAL-BLOOD; BACTERIAL-INFECTION	Bordetella pertussis filamentous hemagglutinin (FHA) is a surface-associated and secreted protein that serves as a crucial adherence factor, and displays immunomodulatory activity in human peripheral blood mononuclear cells (PBMCs). In order to appreciate more fully the role of secreted FHA in pathogenesis, we analyzed FHA-induced changes in genome-wide transcript abundance in human PBMCs. Among the 683 known unique genes with greater than 3-fold change in transcript abundance following FHA treatment, 125 (18.3%) were identified as interferon (IFN)-regulated. Among the latter group were genes encoding several members of the IFN type I response, as well as 3 key components of the ISGylation pathway. Using real-time RT-PCR, we confirmed FHA-associated increases in transcript abundance for the genes encoding ubiquitin-like protein, ISG15, and its specific protease USP18. Western-blot analysis demonstrated the presence of both, free ISG15 and several ISGylated conjugates in FHA-stimulated PBMC lysates, but not in unstimulated cells. Intracellular FACS analysis provided evidence that monocytes and a natural killer-enriched cell population were the primary producers of ISG15 in PBMCs after FHA stimulation. Our data reveal previously-unrecognized effects of B. pertussis FHA on host IFN and ISGylation responses, and suggest previously-unsuspected mechanisms by which FHA may alter the outcome of the host-pathogen interaction.	[Dieterich, Christine; Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Relman, David A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Dieterich, Christine; Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Dieterich, C (corresponding author), Lipopeptide AB, Solna, Sweden.	relman@stanford.edu		Relman, David A./0000-0001-8331-1354	National Institute for Allergy and Infectious Diseases/National Institutes of Health (NIH) [AI54970, AI057188]; NIH; Thomas C. and Joan M. Merigan Endowment; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI057188, R03AI054970, R21AI057188] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Diseases/National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas C. and Joan M. Merigan Endowment; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute for Allergy and Infectious Diseases/National Institutes of Health (NIH) (grants AI54970, AI057188) (to D. R.). D. R. is the recipient of an NIH Director's Pioneer Award, and is supported by the Thomas C. and Joan M. Merigan Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson T, 2001, INFECT IMMUN, V69, P2650, DOI 10.1128/IAI.69.4.2650-2658.2001; Abramson T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003825; Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Andersen JB, 2006, CYTOKINE GROWTH F R, V17, P411, DOI 10.1016/j.cytogfr.2006.10.001; Belcher CE, 2000, P NATL ACAD SCI USA, V97, P13847, DOI 10.1073/pnas.230262797; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Brinig MM, 2006, J BACTERIOL, V188, P2375, DOI 10.1128/JB.188.7.2375-2382.2006; Cheung GYC, 2008, MICROB PATHOGENESIS, V44, P61, DOI 10.1016/j.micpath.2007.08.007; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; Cotter PA, 1998, INFECT IMMUN, V66, P5921, DOI 10.1128/IAI.66.12.5921-5929.1998; Coutte L, 2003, J EXP MED, V197, P735, DOI 10.1084/jem.20021153; Dao CT, 2005, FRONT BIOSCI-LANDMRK, V10, P2701, DOI 10.2741/1730; Dao CT, 2005, FRONT BIOSCI, V10, P2346; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; DCunha J, 1996, J IMMUNOL, V157, P4100; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; DesJardin LE, 2002, MICROBIOL-SGM, V148, P3161, DOI 10.1099/00221287-148-10-3161; DETMERS PA, 1991, J IMMUNOL, V147, P4211; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farizo KM, 2000, INFECT IMMUN, V68, P4049, DOI 10.1128/IAI.68.7.4049-4054.2000; FARRELL PJ, 1979, NATURE, V279, P523, DOI 10.1038/279523a0; FRIEDMAN RL, 1992, INFECT IMMUN, V60, P4578, DOI 10.1128/IAI.60.11.4578-4585.1992; Gao JJ, 2002, J LEUKOCYTE BIOL, V72, P1234; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; HANNAH JH, 1994, INFECT IMMUN, V62, P5010, DOI 10.1128/IAI.62.11.5010-5019.1994; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; Hewlett EL, 2006, MOL MICROBIOL, V59, P447, DOI 10.1111/j.1365-2958.2005.04958.x; HORTON JK, 1992, J IMMUNOL METHODS, V155, P31, DOI 10.1016/0022-1759(92)90268-X; Inatsuka CS, 2005, P NATL ACAD SCI USA, V102, P18578, DOI 10.1073/pnas.0507910102; ISHIBASHI Y, 1994, J EXP MED, V180, P1225, DOI 10.1084/jem.180.4.1225; Ishibashi Y, 2001, MICROB PATHOGENESIS, V30, P279, DOI 10.1006/mpat.2001.0432; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Julio SM, 2009, MOL MICROBIOL, V71, P1574, DOI 10.1111/j.1365-2958.2009.06623.x; KNIGHT E, 1991, J IMMUNOL, V146, P2280; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Liu MJ, 2004, J INTERF CYTOK RES, V24, P647, DOI 10.1089/jir.2004.24.647; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu G, 2006, CELL MOL BIOL, V52, P29, DOI 10.1170/T695; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Manthey CL, 1998, J LEUKOCYTE BIOL, V64, P409, DOI 10.1002/jlb.64.3.409; Martin C, 2010, J BIOL CHEM, V285, P357, DOI 10.1074/jbc.M109.003491; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Mazar J, 2006, MOL MICROBIOL, V62, P641, DOI 10.1111/j.1365-2958.2006.05392.x; McGuirk P, 2000, EUR J IMMUNOL, V30, P415, DOI 10.1002/1521-4141(200002)30:2<415::AID-IMMU415>3.3.CO;2-O; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; MENOZZI FD, 1991, FEMS MICROBIOL LETT, V78, P59; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; Minakawa M, 2008, BIOL PHARM BULL, V31, P2223, DOI 10.1248/bpb.31.2223; Mobberley-Schuman PS, 2005, INFECT IMMUN, V73, P7317, DOI 10.1128/IAI.73.11.7317-7323.2005; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Paccani SR, 2008, INFECT IMMUN, V76, P2822, DOI 10.1128/IAI.00200-08; PIZZA M, 1990, J BIOL CHEM, V265, P17759; PIZZA M, 1989, SCIENCE, V246, P497, DOI 10.1126/science.2683073; Popper SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r261; Popper SJ, 2009, J INFECT DIS, V200, P657, DOI 10.1086/603538; PRASAD SM, 1993, INFECT IMMUN, V61, P2780, DOI 10.1128/IAI.61.7.2780-2785.1993; RECHT M, 1991, J IMMUNOL, V147, P2617; RELMAN D, 1990, CELL, V61, P1375, DOI 10.1016/0092-8674(90)90701-F; RELMAN DA, 1989, P NATL ACAD SCI USA, V86, P2637, DOI 10.1073/pnas.86.8.2637; Rubins KH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r174; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162; Spensieri F, 2006, INFECT IMMUN, V74, P2831, DOI 10.1128/IAI.74.5.2831-2838.2006; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi T, 2006, FEBS LETT, V580, P4521, DOI 10.1016/j.febslet.2006.07.032; Thornton J, 2005, INFECT IMMUN, V73, P6493, DOI 10.1128/IAI.73.10.6493-6498.2005; VADDI K, 1994, J IMMUNOL, V153, P4721; Walduck A, 2004, CURR OPIN MICROBIOL, V7, P33, DOI 10.1016/j.mib.2003.12.010; WEISS AA, 1983, INFECT IMMUN, V42, P33, DOI 10.1128/IAI.42.1.33-41.1983; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Wood N, 2008, PAEDIATR RESPIR REV, V9, P201, DOI 10.1016/j.prrv.2008.05.010; Yeh Sylvia H, 2003, Expert Rev Vaccines, V2, P113, DOI 10.1586/14760584.2.1.113; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2010, P NATL ACAD SCI USA, V107, P2253, DOI 10.1073/pnas.0909144107; Zou WG, 2005, BIOCHEM BIOPH RES CO, V336, P61, DOI 10.1016/j.bbrc.2005.08.038	84	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27535	10.1371/journal.pone.0027535	http://dx.doi.org/10.1371/journal.pone.0027535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140447	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100012
J	Franzosa, EA; Albanese, V; Frydman, J; Xia, Y; McClellan, AJ				Franzosa, Eric A.; Albanese, Veronique; Frydman, Judith; Xia, Yu; McClellan, Amie J.			Heterozygous Yeast Deletion Collection Screens Reveal Essential Targets of Hsp90	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; HEAT-SHOCK PROTEINS; SACCHAROMYCES-CEREVISIAE; ATPASE ACTIVITY; CHAPERONE COMPLEX; CO-CHAPERONE; BINDING; LOCALIZATION; BIOGENESIS; RECEPTOR	Hsp90 is an essential eukaryotic chaperone with a role in folding specific "client" proteins such as kinases and hormone receptors. Previously performed homozygous diploid yeast deletion collection screens uncovered broad requirements for Hsp90 in cellular transport and cell cycle progression. These screens also revealed that the requisite cellular functions of Hsp90 change with growth temperature. We present here for the first time the results of heterozygous deletion collection screens conducted at the hypothermic stress temperature of 15 degrees C. Extensive bioinformatic analyses were performed on the resulting data in combination with data from homozygous and heterozygous screens previously conducted at normal (30 degrees C) and hyperthermic stress (37 degrees C) growth temperatures. Our resulting meta-analysis uncovered extensive connections between Hsp90 and (1) general transcription, (2) ribosome biogenesis and (3) GTP binding proteins. Predictions from bioinformatic analyses were tested experimentally, supporting a role for Hsp90 in ribosome stability. Importantly, the integrated analysis of the 15 degrees C heterozygous deletion pool screen with previously conducted 30 degrees C and 37 degrees C screens allows for essential genetic targets of Hsp90 to emerge. Altogether, these novel contributions enable a more complete picture of essential Hsp90 functions.	[Franzosa, Eric A.; Xia, Yu] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Xia, Yu] Boston Univ, Dept Chem, Boston, MA 02215 USA; [Albanese, Veronique; Frydman, Judith] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [McClellan, Amie J.] Bennington Coll, Div Nat Sci & Math, Bennington, VT USA	Boston University; Boston University; Stanford University	Franzosa, EA (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	amcclellan@bennington.edu	Xia, Yu/W-6150-2019; McClellan, Amie/V-8950-2019	Xia, Yu/0000-0002-5596-5518; , judith/0000-0003-2302-6943; Albanese, Veronique/0000-0002-5947-7415; McClellan, Amie/0000-0002-8033-6748	National Institutes of Health (NIH) [GM56433, GM087654-01, R15]; National Science Foundation IGERT [DGE-0654108]; Pharmaceutical Research and Manufacturers of America Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056433, R15GM087654] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation IGERT(National Science Foundation (NSF)); Pharmaceutical Research and Manufacturers of America Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH; www.nih.gov) grant GM56433 to JF, NIH R15 AREA grant GM087654-01 to AJM, National Science Foundation IGERT (http://www.igert.org/) grant DGE-0654108 to EAF, and Pharmaceutical Research and Manufacturers of America (PhRMA; http://www.phrmafoundation.org/) Foundation Research Starter Grant in Informatics to YX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKNER G, 1992, EUR J CELL BIOL, V58, P356; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Biggiogera M, 1996, EXP CELL RES, V229, P77, DOI 10.1006/excr.1996.0345; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Brachmann CB, 1998, YEAST, V14, P115; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; Chaudhuri TK, 2005, CELL STRESS CHAPERON, V10, P24, DOI 10.1379/CSC-64R1.1; Chen CY, 2006, MOL BIOL CELL, V17, P3494, DOI 10.1091/mbc.E05-12-1096; Dolinski KJ, 1998, MOL CELL BIOL, V18, P7344, DOI 10.1128/MCB.18.12.7344; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Donze O, 1999, MOL CELL BIOL, V19, P8422, DOI 10.1128/mcb.19.12.8422; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Falsone SF, 2005, FEBS LETT, V579, P6350, DOI 10.1016/j.febslet.2005.10.020; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; Giaever G, 2003, TRENDS PHARMACOL SCI, V24, P444, DOI 10.1016/S0165-6147(03)00225-6; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; HANN BC, 1992, NATURE, V356, P532, DOI 10.1038/356532a0; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Karbstein K, 2005, MOL CELL, V20, P633, DOI 10.1016/j.molcel.2005.09.017; Kim TS, 2006, MOL BIOL CELL, V17, P824, DOI 10.1091/mbc.E05-08-0713; King TH, 2001, MOL CELL BIOL, V21, P7731, DOI 10.1128/MCB.21.22.7731-7746.2001; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Langer T, 2003, CELL BIOL INT, V27, P47, DOI 10.1016/S1065-6995(02)00256-1; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Li J, 2011, NAT STRUCT MOL BIOL, V18, P61, DOI 10.1038/nsmb.1965; Li YL, 2009, J BIOL CHEM, V284, P4324, DOI 10.1074/jbc.M804818200; Liu J, 2009, J NEUROSCI, V29, P1480, DOI 10.1523/JNEUROSCI.6202-08.2009; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Louvion JF, 1998, MOL BIOL CELL, V9, P3071, DOI 10.1091/mbc.9.11.3071; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; Marsh JA, 1998, MOL CELL BIOL, V18, P7353, DOI 10.1128/MCB.18.12.7353; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Nathan DF, 1999, P NATL ACAD SCI USA, V96, P1409, DOI 10.1073/pnas.96.4.1409; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Sangster TA, 2003, CELL CYCLE, V2, P166; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; STIRLING CJ, 1992, NATURE, V356, P534, DOI 10.1038/356534a0; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tapia H, 2010, MOL BIOL CELL, V21, P63, DOI 10.1091/mbc.E09-05-0376; Tsaytler PA, 2009, CELL STRESS CHAPERON, V14, P629, DOI 10.1007/s12192-009-0115-z; Uryu K, 2006, AM J PATHOL, V168, P947, DOI 10.2353/ajpath.2006.050770; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Vaughan CK, 2009, FEBS J, V276, P199, DOI 10.1111/j.1742-4658.2008.06773.x; Wegierski T, 2001, RNA, V7, P1254, DOI 10.1017/S1355838201012079; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	78	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28211	10.1371/journal.pone.0028211	http://dx.doi.org/10.1371/journal.pone.0028211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140548	gold, Green Published, Green Submitted			2022-12-25	WOS:000298168100051
J	Lopes dos Santos Santiago, G; Cools, P; Verstraelen, H; Trog, M; Missine, G; El Aila, N; Verhelst, R; Tency, I; Claeys, G; Temmerman, M; Vaneechoutte, M				Lopes dos Santos Santiago, Guido; Cools, Piet; Verstraelen, Hans; Trog, Marijke; Missine, Griet; El Aila, Nabil; Verhelst, Rita; Tency, Inge; Claeys, Geert; Temmerman, Marleen; Vaneechoutte, Mario			Longitudinal Study of the Dynamics of Vaginal Microflora during Two Consecutive Menstrual Cycles	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; GARDNERELLA-VAGINALIS; ATOPOBIUM-VAGINAE; GENITAL-TRACT; RISK-FACTORS; L.-GASSERI; GRAM STAIN; WOMEN; FLORA; IDENTIFICATION	Background: Although the vaginal microflora (VMF) has been well studied, information on the fluctuation of the different bacterial species throughout the menstrual cycle and the information on events preceding the presence of disturbed VMF is still very limited. Documenting the dynamics of the VMF during the menstrual cycle might provide better insights. In this study, we assessed the presence of different Lactobacillus species in relation to the BV associated species during the menstrual cycle, assessed the influence of the menstrual cycle on the different categories of vaginal microflora and assessed possible causes, such as menstruation and sexual intercourse, of VMF disturbance. To our knowledge, this is the first longitudinal study in which swabs and Gram stains were available for each day of two consecutive menstrual cycles, whereby 8 grades of VMF were distinguished by Gram stain analysis, and whereby the swabs were cultured every 7(th) day and identification of the bacterial isolates was carried out with a molecular technique. Methods: Self-collected vaginal swabs were obtained daily from 17 non pregnant, menarchal volunteers, and used for daily Gram staining and weekly culture. Bacterial isolates were identified with tDNA-PCR and 16 S rRNA gene sequencing. Results: Nine women presented with predominantly normal VMF and the 8 others had predominantly disturbed VMF. The overall VMF of each volunteer was characteristic and rather stable. Menses and antimicrobials were the major disturbing factors of the VMF. Disturbances were always accompanied by a rise in Gram positive cocci, which also appeared to be a significant group within the VMF in general. Conclusions: We observed a huge interindividual variability of predominantly stable VMF types. The importance of Gram positive cocci in VMF is underestimated. L. crispatus was the species that was most negatively affected by the menses, whereas the presence of the other lactobacilli was less variable.	[Lopes dos Santos Santiago, Guido; Cools, Piet; Missine, Griet; El Aila, Nabil; Vaneechoutte, Mario] Univ Ghent, Lab Bacteriol Res, Dept Clin Chem Microbiol & Immunol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Verstraelen, Hans; Trog, Marijke; Verhelst, Rita; Tency, Inge; Temmerman, Marleen] Univ Ghent, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, B-9000 Ghent, Belgium; [Claeys, Geert] Ghent Univ Hosp, Lab Clin Biol, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University Hospital	Lopes dos Santos Santiago, G (corresponding author), Univ Ghent, Lab Bacteriol Res, Dept Clin Chem Microbiol & Immunol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.	Guido.LopesdosSantosSantiago@ugent.be	Verstraelen, Hans/AAA-8694-2019; Verstraelen, Hans/A-5602-2008; Verhelst, Rita/A-6195-2008; Vaneechoutte, Mario/A-6189-2009	Verstraelen, Hans/0000-0002-4070-1587; Verhelst, Rita/0000-0002-2716-5599; Vaneechoutte, Mario/0000-0002-4586-203X; Cools, Piet/0000-0003-2980-5307	University of Gent	University of Gent	This research was made possible by a research grant of the Concerted Research Actions of the University of Gent. Guido Lopes dos Santos Santiago is indebted for PhD research funded by a research grant of the Concerted Research Actions of the University of Gent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Matthew, 2004, MedGenMed, V6, P49; Baele M, 2002, J MICROBIOL METH, V50, P263, DOI 10.1016/S0167-7012(02)00035-0; Baele M, 2000, J CLIN MICROBIOL, V38, P4201, DOI 10.1128/JCM.38.11.4201-4207.2000; Baele M, 2009, COLD SPRING HARB PRO, V4; BARTLETT JG, 1977, J INFECT DIS, V136, P271, DOI 10.1093/infdis/136.2.271; Berger BJ, 1995, CLIN INFECT DIS, V21, P1402, DOI 10.1093/clinids/21.6.1402; Brotman RM, 2010, SEX TRANSM INFECT, V86, P297, DOI 10.1136/sti.2009.040592; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Chiaffarino F, 2004, EUR J OBSTET GYN R B, V117, P222, DOI 10.1016/j.ejogrb.2004.05.012; De Backer E, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-115; El Aila NA, 2011, RES MICROBIOL, V162, P506, DOI 10.1016/j.resmic.2011.04.004; El Aila NA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-167; El Aila NA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-153; Eschenbach DA, 2000, CLIN INFECT DIS, V30, P901, DOI 10.1086/313818; ESCHENBACH DA, 1989, J CLIN MICROBIOL, V27, P251, DOI 10.1128/JCM.27.2.251-256.1989; Ferris MJ, 2004, J CLIN MICROBIOL, V42, P5892, DOI [10.1128/JCM.42.12.5892-5894.2004, 10.1128/jcm.42.12.5892-5894.2004]; Forney LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Hay P, 2005, SEX TRANSM INFECT, V81, P100, DOI 10.1136/sti.2003.007161; Hay PE, 1997, INT J STD AIDS, V8, P603, DOI 10.1258/0956462971918850; Hellberg D, 2000, INT J STD AIDS, V11, P603, DOI 10.1258/0956462001916461; Hill DR, 2005, J APPL PHYSIOL, V99, P1582, DOI 10.1152/japplphysiol.01422.2004; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Jin L, 2007, J APPL MICROBIOL, V102, P1107, DOI 10.1111/j.1365-2672.2006.03147.x; JOHNSON SR, 1985, AM J REPROD IM MIC, V9, P1; Jovita MR, 1999, INT J SYST BACTERIOL, V49, P1573, DOI 10.1099/00207713-49-4-1573; Keane FEA, 1997, INT J STD AIDS, V8, P489, DOI 10.1258/0956462971920631; Klebanoff MA, 2010, SEX TRANSM DIS, V37, P94, DOI 10.1097/OLQ.0b013e3181bc063c; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P732, DOI 10.1097/OLQ.0b013e3181fbbc95; Martinez RCR, 2009, CAN J MICROBIOL, V55, P133, DOI [10.1139/w08-102, 10.1139/W08-102]; Mastromarino P, 2009, CLIN MICROBIOL INFEC, V15, P67, DOI 10.1111/j.1469-0691.2008.02112.x; Morison L, 2005, SEX TRANSM INFECT, V81, P242, DOI 10.1136/sti.2004.011684; Nam H, 2007, J MICROBIOL, V45, P515; Nansel TR, 2006, AM J OBSTET GYNECOL, V194, P381, DOI 10.1016/j.ajog.2005.07.047; Priestley CJF, 1997, GENITOURIN MED, V73, P23; Rabe LK, 2003, J CLIN MICROBIOL, V41, P3260, DOI 10.1128/JCM.41.7.3260-3264.2003; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reid G, 1999, APPL ENVIRON MICROB, V65, P3763; Rossi A, 2010, ARCH GYNECOL OBSTET, V281, P1065, DOI 10.1007/s00404-009-1287-6; Schwebke JR, 1999, J INFECT DIS, V180, P1632, DOI 10.1086/315065; Schwebke JR, 1997, SEX TRANSM DIS, V24, P236, DOI 10.1097/00007435-199704000-00009; Skinner CJ, 1996, GENITOURIN MED, V72, P277; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Swidsinski A, 2010, GYNECOL OBSTET INVES, V70, P256, DOI 10.1159/000314015; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Thoma ME, 2011, SEX TRANSM DIS, V38, P111, DOI 10.1097/OLQ.0b013e3181f0bdd0; Vallor AC, 2001, J INFECT DIS, V184, P1431, DOI 10.1086/324445; Verhelst R, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-61; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Verstraelen H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-81; Verstraelen H, 2009, EXPERT REV ANTI-INFE, V7, P1109, DOI [10.1586/eri.09.87, 10.1586/ERI.09.87]; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; WAGNER G, 1982, ANN INTERN MED, V96, P921, DOI 10.7326/0003-4819-96-6-921; Wira CR, 2010, AM J REPROD IMMUNOL, V63, P544, DOI 10.1111/j.1600-0897.2010.00842.x; Witkin SS, 2007, BEST PRACT RES CL OB, V21, P347, DOI 10.1016/j.bpobgyn.2006.12.004; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	58	60	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e28180	10.1371/journal.pone.0028180	http://dx.doi.org/10.1371/journal.pone.0028180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140538	Green Published, Green Submitted, gold			2022-12-25	WOS:000298168100045
J	Sun, L; Yu, F; Ullah, A; Hubrack, S; Daalis, A; Jung, P; Machaca, K				Sun, Lu; Yu, Fang; Ullah, Aman; Hubrack, Satanay; Daalis, Arwa; Jung, Peter; Machaca, Khaled			Endoplasmic Reticulum Remodeling Tunes IP3-Dependent Ca2+ Release Sensitivity	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; INDUCED CALCIUM OSCILLATIONS; XENOPUS OOCYTE MATURATION; SIGNALING DIFFERENTIATION; DEPENDENT REGULATION; MEIOTIC MATURATION; MOUSE OOCYTES; CELL-CYCLE; TRISPHOSPHATE; FERTILIZATION	The activation of vertebrate development at fertilization relies on IP(3-)dependent Ca2+ release, a pathway that is sensitized during oocyte maturation. This sensitization has been shown to correlate with the remodeling of the endoplasmic reticulum into large ER patches, however the mechanisms involved are not clear. Here we show that IP3 receptors within ER patches have a higher sensitivity to IP3 than those in the neighboring reticular ER. The lateral diffusion rate of IP3 receptors in both ER domains is similar, and ER patches dynamically fuse with reticular ER, arguing that IP3 receptors exchange freely between the two ER compartments. These results suggest that increasing the density of IP3 receptors through ER remodeling is sufficient to sensitize IP3-dependent Ca2+ release. Mathematical modeling supports this concept of 'geometric sensitization' of IP3 receptors as a population, and argues that it depends on enhanced Ca2+-dependent cooperativity at sub-threshold IP3 concentrations. This represents a novel mechanism of tuning the sensitivity of IP3 receptors through ER remodeling during meiosis.	[Sun, Lu; Yu, Fang; Hubrack, Satanay; Daalis, Arwa; Machaca, Khaled] Educ City Qatar Fdn, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar; [Ullah, Aman; Jung, Peter] Ohio Univ, Dept Phys & Astron, Athens, OH 45701 USA; [Ullah, Aman; Jung, Peter] Ohio Univ, Quantitat Biol Inst, Athens, OH 45701 USA	Qatar Foundation (QF); Weill Cornell Medical College Qatar; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Sun, L (corresponding author), Educ City Qatar Fdn, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar.	Khm2002@qatar-med.cornell.edu	Machaca, Khaled/AAF-3579-2019; Jung, Peter/D-2934-2014	Machaca, Khaled/0000-0001-6215-2411	Qatar National Research Fund (QNRF) [NPRP08-395-3-088, NPRP08-138-3-050]; Weill Cornell Medical College; Qatar Foundation	Qatar National Research Fund (QNRF)(National Research Foundation of KoreaQatar National Research Fund (QNRF)); Weill Cornell Medical College; Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF))	This work was funded by grants from the Qatar National Research Fund (QNRF) NPRP08-395-3-088 and NPRP08-138-3-050. Additional support for the authors comes from Biomedical Research Program funds at Weill Cornell Medical College, a program funded by Qatar Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bootman M, 1997, J PHYSIOL-LONDON, V499, P307, DOI 10.1113/jphysiol.1997.sp021928; Boulware MJ, 2008, J PHYSIOL-LONDON, V586, P2873, DOI 10.1113/jphysiol.2008.153379; Boulware MJ, 2005, CURR BIOL, V15, P765, DOI 10.1016/j.cub.2005.02.065; Callamaras N, 1998, J PHYSIOL-LONDON, V509, P81, DOI 10.1111/j.1469-7793.1998.081bo.x; CAMPANELLA C, 1984, J EXP ZOOL, V229, P283, DOI 10.1002/jez.1402290214; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; Chalmers M, 2006, BIOCHEM J, V394, P57, DOI 10.1042/BJ20051130; CHIBA K, 1990, DEV BIOL, V140, P300, DOI 10.1016/0012-1606(90)90080-3; Deng MQ, 2000, BIOL REPROD, V62, P873, DOI 10.1095/biolreprod62.4.873; El-Jouni W, 2005, DEV BIOL, V288, P514, DOI 10.1016/j.ydbio.2005.10.034; El-Jouni W, 2008, DEV BIOL, V324, P99, DOI 10.1016/j.ydbio.2008.09.007; FitzHarris G, 2003, MOL BIOL CELL, V14, P288, DOI 10.1091/mbc.E02-07-0431; Gordo AC, 2002, MOL HUM REPROD, V8, P619, DOI 10.1093/molehr/8.7.619; Horner VL, 2008, DEV DYNAM, V237, P527, DOI 10.1002/dvdy.21454; Ionescu L, 2006, J PHYSIOL-LONDON, V573, P645, DOI 10.1113/jphysiol.2006.109504; Ito J, 2008, DEV BIOL, V320, P402, DOI 10.1016/j.ydbio.2008.05.548; JAFFE LA, 1994, DEV BIOL, V164, P579, DOI 10.1006/dbio.1994.1225; JONES KT, 1995, J BIOL CHEM, V270, P6671, DOI 10.1074/jbc.270.12.6671; Kline D, 2000, CURR TOP DEV BIOL, V50, P125, DOI 10.1016/S0070-2153(00)50007-6; Kline D, 1999, DEV BIOL, V215, P431, DOI 10.1006/dbio.1999.9445; Lee B, 2006, DEVELOPMENT, V133, P4355, DOI 10.1242/dev.02624; Levasseur M, 2000, DEVELOPMENT, V127, P631; Lipp P, 1996, PROG BIOPHYS MOL BIO, V65, P265, DOI 10.1016/S0079-6107(96)00014-4; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Machaca K, 2004, DEV BIOL, V275, P170, DOI 10.1016/j.ydbio.2004.08.004; Machaca K, 2002, J CELL BIOL, V156, P75, DOI 10.1083/jcb.200110059; Machaca K, 2000, J BIOL CHEM, V275, P38710, DOI 10.1074/jbc.M007887200; Machaca K, 2007, J CELL PHYSIOL, V213, P331, DOI 10.1002/jcp.21194; Mak DOD, 1998, P NATL ACAD SCI USA, V95, P15821, DOI 10.1073/pnas.95.26.15821; Marchant JS, 1998, BIOCHEMISTRY-US, V37, P11524, DOI 10.1021/bi980808k; McCullough S, 2005, J ANAT, V206, P415, DOI 10.1111/j.1469-7580.2005.00407.x; MEHLMANN LM, 1994, BIOL REPROD, V51, P1088, DOI 10.1095/biolreprod51.6.1088; Mehlmann LM, 1996, DEV BIOL, V180, P489, DOI 10.1006/dbio.1996.0322; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; Parker I, 1996, CELL CALCIUM, V20, P105, DOI 10.1016/S0143-4160(96)90100-1; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112; SHIRAISHI K, 1995, DEV BIOL, V170, P594, DOI 10.1006/dbio.1995.1239; Smith IF, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000466; Smith IF, 2009, SCI SIGNAL, V2, P7; Sneyd J, 2002, P NATL ACAD SCI USA, V99, P2398, DOI 10.1073/pnas.032281999; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Stricker SA, 2003, DEVELOPMENT, V130, P2867, DOI 10.1242/dev.00508; Sun L, 2004, J CELL BIOL, V165, P63, DOI 10.1083/jcb.200309138; Sun L, 2009, J BIOL CHEM, V284, P20184, DOI 10.1074/jbc.M109.004515; Tateishi Y, 2005, J BIOL CHEM, V280, P6816, DOI 10.1074/jbc.M405469200; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Terasaki M, 2001, MOL BIOL CELL, V12, P1103, DOI 10.1091/mbc.12.4.1103; Ullah G, 2007, CELL CALCIUM, V42, P556, DOI 10.1016/j.ceca.2007.01.010; Vais H, 2010, J GEN PHYSIOL, V136, P687, DOI 10.1085/jgp.201010513; Wilson BS, 1998, MOL BIOL CELL, V9, P1465, DOI 10.1091/mbc.9.6.1465; YAO Y, 1995, J PHYSIOL-LONDON, V482, P533, DOI 10.1113/jphysiol.1995.sp020538; Yu F, 2010, J CELL BIOL, V191, P523, DOI 10.1083/jcb.201006022; Yu F, 2009, P NATL ACAD SCI USA, V106, P17401, DOI 10.1073/pnas.0904651106	55	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27928	10.1371/journal.pone.0027928	http://dx.doi.org/10.1371/journal.pone.0027928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22140486	Green Published, gold, Green Submitted			2022-12-25	WOS:000298168100025
J	Caskey, CF; Hlawitschka, M; Qin, SP; Mahakian, LM; Cardiff, RD; Boone, JM; Ferrara, KW				Caskey, Charles F.; Hlawitschka, Mario; Qin, Shengping; Mahakian, Lisa M.; Cardiff, Robert D.; Boone, John M.; Ferrara, Katherine W.			An Open Environment CT-US Fusion for Tissue Segmentation during Interventional Guidance	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; MILD HYPERTHERMIA; ABDOMINAL FAT; ULTRASOUND; CALIBRATION; TRANSDUCER; DELIVERY; SYSTEM	Therapeutic ultrasound (US) can be noninvasively focused to activate drugs, ablate tumors and deliver drugs beyond the blood brain barrier. However, well-controlled guidance of US therapy requires fusion with a navigational modality, such as magnetic resonance imaging (MRI) or X-ray computed tomography (CT). Here, we developed and validated tissue characterization using a fusion between US and CT. The performance of the CT/US fusion was quantified by the calibration error, target registration error and fiducial registration error. Met-1 tumors in the fat pads of 12 female FVB mice provided a model of developing breast cancer with which to evaluate CT-based tissue segmentation. Hounsfield units (HU) within the tumor and surrounding fat pad were quantified, validated with histology and segmented for parametric analysis (fat: -300 to 0 HU, protein-rich: 1 to 300 HU, and bone: HU>300). Our open source CT/US fusion system differentiated soft tissue, bone and fat with a spatial accuracy of similar to 1 mm. Region of interest (ROI) analysis of the tumor and surrounding fat pad using a 1 mm(2) ROI resulted in mean HU of 68 +/- 44 within the tumor and -97 +/- 52 within the fat pad adjacent to the tumor (p<0.005). The tumor area measured by CT and histology was correlated (r(2) = 0.92), while the area designated as fat decreased with increasing tumor size (r(2) = 0.51). Analysis of CT and histology images of the tumor and surrounding fat pad revealed an average percentage of fat of 65.3% vs. 75.2%, 36.5% vs. 48.4%, and 31.6% vs. 38.5% for tumors,75 mm 3, 75150 mm(3) and >150 mm(3), respectively. Further, CT mapped bone-soft tissue interfaces near the acoustic beam during real-time imaging. Combined CT/US is a feasible method for guiding interventions by tracking the acoustic focus within a pre-acquired CT image volume and characterizing tissues proximal to and surrounding the acoustic focus.	[Caskey, Charles F.; Qin, Shengping; Mahakian, Lisa M.; Ferrara, Katherine W.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Hlawitschka, Mario] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Cardiff, Robert D.] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA; [Boone, John M.] Univ Calif Davis, Dept Radiol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Caskey, CF (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	cfcaskey@ucdavis.edu	Hlawitschka, Mario/AAU-8942-2020	Ferrara, Katherine/0000-0002-4976-9107	National Institutes of Health [NIH R01CA103828]; NATIONAL CANCER INSTITUTE [R01CA103828, P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health under grant NIH R01CA103828. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolhassani MD, 2007, J ULTRAS MED, V26, P215, DOI 10.7863/jum.2007.26.2.215; [Anonymous], IMAGE GUIDED THERAPY; Boone JM, 2001, RADIOLOGY, V221, P657, DOI 10.1148/radiol.2213010334; BORKAN GA, 1982, AM J CLIN NUTR, V36, P172, DOI 10.1093/ajcn/36.1.172; Brizel DM, 1996, CANCER RES, V56, P5347; Chivers R C, 1975, Ultrasound Med Biol, V2, P25, DOI 10.1016/0301-5629(75)90038-1; Cleary K, 2004, INT CONGR SER, V1268, P473, DOI 10.1016/j.ics.2004.03.038; DASTOUS FT, 1986, ULTRASOUND MED BIOL, V12, P795, DOI 10.1016/0301-5629(86)90077-3; DEWEY WC, 1977, RADIOLOGY, V123, P463, DOI 10.1148/123.2.463; Dromi S, 2007, CLIN CANCER RES, V13, P2722, DOI 10.1158/1078-0432.CCR-06-2443; Egorov V, 2008, MED ENG PHYS, V30, P206, DOI 10.1016/j.medengphy.2007.02.007; Fitzpatrick JM, 2001, IEEE T MED IMAGING, V20, P917, DOI 10.1109/42.952729; Gering DT, 1999, LECT NOTES COMPUT SC, V1679, P809; GOSS SA, 1978, J ACOUST SOC AM, V64, P423, DOI 10.1121/1.382016; Hill C.R., 2004, PHYS PRINCIPLES MED; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; HYNYNEN K, 1987, INT J HYPERTHER, V3, P21, DOI 10.3109/02656738709140370; Jensen V., 2006, METHOD ESTIMATING DY; Kitada T, 2008, HEPATOL RES, V38, P565, DOI 10.1111/j.1872-034X.2007.00308.x; Kong G, 2000, CANCER RES, V60, P4440; Kruse DE, 2010, IEEE T BIO-MED ENG, V57, P155, DOI 10.1109/TBME.2009.2029703; Lai CY, 2010, IEEE T ULTRASON FERR, V57, P2671, DOI 10.1109/TUFFC.2010.1741; LEFOR AT, 1985, J SURG ONCOL, V28, P297, DOI 10.1002/jso.2930280412; Mercier L, 2005, ULTRASOUND MED BIOL, V31, P449, DOI 10.1016/j.ultrasmedbio.2004.11.015; More, 1977, LEVENBERG MARQUARDT; Needham D, 2000, CANCER RES, V60, P1197; Nelsona TR, 2008, MED PHYS, V35, P1078, DOI 10.1118/1.2839439; Pace DF, 2009, MIDAS J; Pieper S, 2004, IEEE INT S BIOMED IM, V26, P632, DOI DOI 10.1109/ISBI.2004.1398617; Pieper S, 2006, I S BIOMED IMAGING, P698; Prager RW, 1998, ULTRASOUND MED BIOL, V24, P855, DOI 10.1016/S0301-5629(98)00044-1; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Seip R, 1996, IEEE T ULTRASON FERR, V43, P1063, DOI 10.1109/58.542050; Simon C, 1998, IEEE T ULTRASON FERR, V45, P1088, DOI 10.1109/58.710592; SONG CW, 1984, CANCER RES, V44, P4721; Ukimura O, 2008, BJU INT, V101, P707, DOI 10.1111/j.1464-410X.2007.07324.x; unicap, UN API IM ACQ DEV; Wallace MJ, 2009, J VASC INTERV RADIOL, V20, pS523, DOI 10.1016/j.jvir.2009.04.059; Yang K, 2008, MED PHYS, V35, P5317, DOI 10.1118/1.3002411; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283	40	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27372	10.1371/journal.pone.0027372	http://dx.doi.org/10.1371/journal.pone.0027372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132098	Green Published, gold, Green Submitted			2022-12-25	WOS:000298162000016
J	Gutierrez, H; Castillo, A; Monzon, J; Urrutia, AO				Gutierrez, Humberto; Castillo, Atahualpa; Monzon, Jimena; Urrutia, Araxi O.			Protein Amino Acid Composition: A Genomic Signature of Encephalization in Mammals	PLOS ONE			English	Article							BRAIN EVOLUTION; LIFE-HISTORY; GENES; HYPOTHESIS; METABOLISM; SELECTION; COSTS; SIZE	Large brains relative to body size represent an evolutionarily costly adaptation as they are metabolically expensive and demand substantial amounts of time to reach structural and functional maturity thereby exacerbating offspring mortality while delaying reproductive age. In spite of its cost and adaptive impact, no genomic features linked to brain evolution have been found. By conducting a genome-wide analysis in all 37 fully sequenced mammalian genomes, we show that encephalization is significantly correlated with overall protein amino acid composition. This correlation is not a by-product of changes in nucleotide content, lifespan, body size, absolute brain size or genome size; is independent of phylogenetic effects; and is not restricted to brain expressed genes. This is the first report of a relationship between this fundamental and complex trait and changes in protein AA usage, possibly reflecting the high selective demands imposed by the process of encephalization across mammalian lineages.	[Gutierrez, Humberto; Castillo, Atahualpa; Monzon, Jimena] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Urrutia, Araxi O.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Universidad Nacional Autonoma de Mexico; University of Bath	Gutierrez, H (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	hgutierrez@ifc.unam.mx		Monzon-Sandoval, Jimena/0000-0002-4190-2188; Gutierrez, Humberto/0000-0002-5021-8636; Urrutia, Araxi/0000-0001-9011-8675; Castillo Morales, Atahualpa/0000-0001-9733-6923	National University of Mexico	National University of Mexico	This work was carried out with institutional funding from the National University of Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Allen JS, 2005, AM J HUM BIOL, V17, P673, DOI 10.1002/ajhb.20439; Barrickman NL, 2008, J HUM EVOL, V54, P568, DOI 10.1016/j.jhevol.2007.08.012; Barton MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011935; Deaner RO, 2000, BRAIN BEHAV EVOLUT, V55, P44, DOI 10.1159/000006641; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Dunbar RIM, 2007, PHILOS T R SOC B, V362, P649, DOI 10.1098/rstb.2006.2001; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; Gonzalez-Lagos C, 2010, J EVOLUTION BIOL, V23, P1064, DOI 10.1111/j.1420-9101.2010.01976.x; Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104; Herculano-Houzel S, 2011, ANN NY ACAD SCI, V1225, P191, DOI 10.1111/j.1749-6632.2011.05976.x; Isler K, 2006, J HUM EVOL, V51, P228, DOI 10.1016/j.jhevol.2006.03.006; Leonard WR, 2007, ANNU REV NUTR, V27, P311, DOI 10.1146/annurev.nutr.27.061406.093659; Leonard WR, 2003, COMP BIOCHEM PHYS A, V136, P5, DOI 10.1016/S1095-6433(03)00132-6; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Shi P, 2006, TRENDS GENET, V22, P608, DOI 10.1016/j.tig.2006.09.001; Shultz S, 2010, P NATL ACAD SCI USA, V107, P21582, DOI 10.1073/pnas.1005246107; Swire J, 2007, J MOL EVOL, V64, P558, DOI 10.1007/s00239-006-0206-8; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Wang GZ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-263; Weisbecker V, 2010, P NATL ACAD SCI USA, V107, P16216, DOI 10.1073/pnas.0906486107	25	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e27261	10.1371/journal.pone.0027261	http://dx.doi.org/10.1371/journal.pone.0027261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132093	Green Submitted, Green Published, gold			2022-12-25	WOS:000298162000014
J	Jung, JW; Park, SB; Lee, SJ; Seo, MS; Trosko, JE; Kang, KS				Jung, Ji-Won; Park, Sang-Bum; Lee, Soo-Jin; Seo, Min-Soo; Trosko, James E.; Kang, Kyung-Sun			Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem Cells via Inhibition of Estrogen Receptor-Mediated OCT4 Expression	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; CANCER CELLS; DIABETIC-PATIENTS; TRANSCRIPTIONAL ACTIVITY; POU-DOMAIN; IN-VITRO; ER-ALPHA; RISK; CARCINOGENESIS; GROWTH	Metformin, a Type II diabetic treatment drug, which inhibits transcription of gluconeogenesis genes, has recently been shown to lower the risk of some diabetes-related tumors, including breast cancer. Recently, "cancer stem cells" have been demonstrated to sustain the growth of tumors and are resistant to therapy. To test the hypothesis that metformin might be reducing the risk to breast cancers, the human breast carcinoma cell line, MCF-7, grown in 3-dimensional mammospheres which represent human breast cancer stem cell population, were treated with various known and suspected breast cancer chemicals with and without non-cytotoxic concentrations of metformin. Using OCT4 expression as a marker for the cancer stem cells, the number and size were measured in these cells. Results demonstrated that TCDD (100 nM) and bisphenol A (10 mM) increased the number and size of the mammospheres, as did estrogen (10 nM E2). By monitoring a cancer stem cell marker, OCT4, the stimulation by these chemicals was correlated with the increased expression of OCT4. On the other hand, metformin at 1 and 10 mM concentration dramatically reduced the size and number of mammospheres. Results also demonstrated the metformin reduced the expression of OCT4 in E2 & TCDD mammospheres but not in the bisphenol A mammospheres, suggesting different mechanisms of action of the bisphenol A on human breast carcinoma cells. In addition, these results support the use of 3-dimensional human breast cancer stem cells as a means to screen for potential human breast tumor promoters and breast chemopreventive and chemotherapeutic agents.	[Jung, Ji-Won; Park, Sang-Bum; Lee, Soo-Jin; Seo, Min-Soo; Trosko, James E.; Kang, Kyung-Sun] Seoul Natl Univ, Coll Vet Med, Dept Vet Publ Hlth, Adult Stem Cell Res Ctr, Seoul, South Korea; [Trosko, James E.; Kang, Kyung-Sun] Michigan State Univ, Dept Pediat & Human Dev, Coll Human Med, Ctr Integrat Toxicol, E Lansing, MI 48824 USA	Seoul National University (SNU); Michigan State University; Michigan State University College of Human Medicine	Jung, JW (corresponding author), Korea Natl Inst Hlth, Ctr Biomed Sci, Div Intractable Dis, Chungbuk, South Korea.	kangpub@snu.ac.kr	Trosko, James/J-5954-2019; Kang, Kyung-Sun/G-6205-2013	Lee, Soojin/0000-0002-0383-5025	National Research Foundation [NRF-M1AXA002]; Ministry of Education, Science and Technology of Korea; Ministry of Education, Science and Technology; Korea Ministry of Science and Technology; Brain Korea 21 Program for Veterinary Science	National Research Foundation; Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Brain Korea 21 Program for Veterinary Science(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the Global Frontier Project grant (NRF-M1AXA002) of the National Research Foundation funded by the Ministry of Education, Science and Technology of Korea, and the Ministry of Education, Science and Technology. Professor Trosko's contribution at Seoul National University was supported by the Korea Ministry of Science and Technology, "Brain Pool" award. This work was supported by Brain Korea 21 Program for Veterinary Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Azoulay L, 2011, CANCER EPIDEM BIOMAR, V20, P337, DOI 10.1158/1055-9965.EPI-10-0940; Balan G, 2001, J PHARM SCI, V90, P1176, DOI 10.1002/jps.1071; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Bhat HK, 2003, P NATL ACAD SCI USA, V100, P3913, DOI 10.1073/pnas.0437929100; Bosco JLF, 2011, CANCER EPIDEM BIOMAR, V20, P101, DOI 10.1158/1055-9965.EPI-10-0817; Cavalieri E, 2000, J Natl Cancer Inst Monogr, P75; Cavalieri EL, 1997, P NATL ACAD SCI USA, V94, P10937, DOI 10.1073/pnas.94.20.10937; Chang CC, 2001, RADIAT RES, V155, P201, DOI 10.1667/0033-7587(2001)155[0201:AHBECT]2.0.CO;2; Chong CR, 2009, ONCOLOGIST, V14, P1178, DOI 10.1634/theoncologist.2009-0286; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Gonzalez-Angulo AM, 2010, CLIN CANCER RES, V16, P1695, DOI 10.1158/1078-0432.CCR-09-1805; Hansis C, 2001, MOL HUM REPROD, V7, P155, DOI 10.1093/molehr/7.2.155; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hosono K, 2010, CANCER PREV RES, V3, P1077, DOI 10.1158/1940-6207.CAPR-10-0186; Huang MZ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-80; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Itoh Y, 2007, J IMMUNOL, V178, P3059, DOI 10.4049/jimmunol.178.5.3059; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Kang KS, 2011, TOXICOL SCI, V120, pS269, DOI 10.1093/toxsci/kfq370; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Lee IK, 2007, ARCH PHARM RES, V30, P337, DOI 10.1007/BF02977615; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Ogawa T, 2005, CANCER RES, V65, P9771, DOI 10.1158/0008-5472.CAN-05-0227; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; PITOT HC, 1980, CANCER RES, V40, P3616; Pollak M, 2010, CANCER PREV RES, V3, P1060, DOI 10.1158/1940-6207.CAPR-10-0175; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Seifert A, 2009, INT J ONCOL, V35, P417, DOI 10.3892/ijo_00000354; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Trosko JE, 2009, VET PATHOL, V46, P176, DOI 10.1354/vp.46-2-176; Wright JL, 2009, CANCER CAUSE CONTROL, V20, P1617, DOI 10.1007/s10552-009-9407-y; Yang HM, 2005, J CELL BIOCHEM, V96, P821, DOI 10.1002/jcb.20588; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500	47	107	111	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2011	6	11							e28068	10.1371/journal.pone.0028068	http://dx.doi.org/10.1371/journal.pone.0028068			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KL	22132214	gold, Green Published, Green Submitted			2022-12-25	WOS:000298162000068
J	Greatorex, JS; Digard, P; Curran, MD; Moynihan, R; Wensley, H; Wreghitt, T; Varsani, H; Garcia, F; Enstone, J; Nguyen-Van-Tam, JS				Greatorex, Jane S.; Digard, Paul; Curran, Martin D.; Moynihan, Robert; Wensley, Harrison; Wreghitt, Tim; Varsani, Harsha; Garcia, Fayna; Enstone, Joanne; Nguyen-Van-Tam, Jonathan S.			Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control	PLOS ONE			English	Article							A VIRUS; TRANSMISSION PARAMETERS; SURFACES; COPPER; INACTIVATION; SPREAD; AGENTS; RNA	Background: The majority of influenza transmission occurs in homes, schools and workplaces, where many frequently touched communal items are situated. However the importance of transmission via fomites is unclear since few data exist on the survival of virus on commonly touched surfaces. We therefore measured the viability over time of two H1N1 influenza strains applied to a variety of materials commonly found in households and workplaces. Methodology and Principal Findings: Influenza A/PuertoRico/8/34 (PR8) or A/Cambridge/AHO4/2009 (pandemic H1N1) viruses were inoculated onto a wide range of surfaces used in home and work environments, then sampled at set times following incubation at stabilised temperature and humidity. Virus genome was measured by RT-PCR; plaque assay (for PR8) or fluorescent focus formation (for pandemic H1N1) was used to assess the survival of viable virus. Conclusions/Significance: The genome of either virus could be detected on most surfaces 24 h after application with relatively little drop in copy number, with the exception of unsealed wood surfaces. In contrast, virus viability dropped much more rapidly. Live virus was recovered from most surfaces tested four hours after application and from some nonporous materials after nine hours, but had fallen below the level of detection from all surfaces at 24 h. We conclude that influenza A transmission via fomites is possible but unlikely to occur for long periods after surface contamination (unless reinoculation occurs). In situations involving a high probability of influenza transmission, our data suggest a hierarchy of priorities for surface decontamination in the multi-surface environments of home and hospitals.	[Greatorex, Jane S.; Curran, Martin D.; Wreghitt, Tim; Varsani, Harsha; Garcia, Fayna] Addenbrookes Hosp, Hlth Protect Agcy, Cambridge, England; [Digard, Paul; Moynihan, Robert; Wensley, Harrison] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; [Enstone, Joanne; Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Nguyen-Van-Tam, Jonathan S.] Hlth Protect Agcy, Nottingham, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Health Protection Agency; University of Cambridge; University of Cambridge; University of Nottingham; Health Protection Agency	Greatorex, JS (corresponding author), Addenbrookes Hosp, Hlth Protect Agcy, Cambridge, England.	jvt@nottingham.ac.uk	Digard, Paul/B-7717-2008; Nguyen-Van-Tam, Jonathan/I-2162-2019	Digard, Paul/0000-0002-0872-9440; Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Wensley, Harrison/0000-0002-9634-5462	UK Health Protection Agency	UK Health Protection Agency	This study was funded by the UK Health Protection Agency. The funder had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript. Since several authors are employees of the funder, approval to submit for peer-review was obtained via the funder's Manuscript Approval Process.	BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Blachere FM, 2011, J VIROL METHODS, V176, P120, DOI 10.1016/j.jviromet.2011.05.030; Boone SA, 2005, J INFECTION, V51, P103, DOI 10.1016/j.jinf.2004.09.011; Borkow G, 2007, ANTIMICROB AGENTS CH, V51, P2605, DOI 10.1128/AAC.00125-07; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Bright KR, 2010, J SCH NURS, V26, P33, DOI 10.1177/1059840509354383; BUCKLAND FE, 1962, NATURE, V195, P1063, DOI 10.1038/1951063a0; Dellanno C, 2009, AM J INFECT CONTROL, V37, P649, DOI 10.1016/j.ajic.2009.03.012; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Enstone J., 2009, Introduction to pandemic influenza, P57, DOI 10.1079/9781845936259.0057; Greatorex JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008987; Horie M, 2008, ARCH VIROL, V153, P1467, DOI 10.1007/s00705-008-0154-2; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Hutchinson EC, 2008, J VIROL, V82, P11869, DOI 10.1128/JVI.01634-08; Killingley B, 2010, HEALTH TECHNOL ASSES, V14, P237, DOI 10.3310/hta14460-04; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; LONGINI IM, 1984, INT J EPIDEMIOL, V13, P496, DOI 10.1093/ije/13.4.496; LONGINI IM, 1984, INT J EPIDEMIOL, V13, P99, DOI 10.1093/ije/13.1.99; Noyce JO, 2007, APPL ENVIRON MICROB, V73, P2748, DOI 10.1128/AEM.01139-06; Pappas DE, 2010, PEDIATR INFECT DIS J, V29, P102, DOI 10.1097/INF.0b013e3181b6e482; Parker ER, 1944, J LAB CLIN MED, V29, P37; SILVA TY, 1992, PHARM CHEM J, V26, P613; Simmerman JM, 2010, CLIN INFECT DIS, V51, P1053, DOI 10.1086/656581; TAKIMOTO S, 1991, J CLIN MICROBIOL, V29, P470, DOI 10.1128/JCM.29.3.470-474.1991; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Thomas Y, 2008, APPL ENVIRON MICROB, V74, P3002, DOI 10.1128/AEM.00076-08; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Wei Z, 2007, J VIROL METHODS, V144, P122, DOI 10.1016/j.jviromet.2007.04.008	28	58	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2011	6	11							e27932	10.1371/journal.pone.0027932	http://dx.doi.org/10.1371/journal.pone.0027932			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858JH	22132172	Green Published, gold, Green Submitted			2022-12-25	WOS:000297792400023
J	Derganc, J; Bozic, B; Romih, R				Derganc, Jure; Bozic, Bojan; Romih, Rok			Shapes of Discoid Intracellular Compartments with Small Relative Volumes	PLOS ONE			English	Article							URINARY-BLADDER; TRANSITIONAL EPITHELIUM; MEMBRANE CURVATURE; PHOSPHOLIPID-VESICLES; RAT; SEGREGATION; MECHANISMS; MICROSCOPY	A prominent feature of many intracellular compartments is a large membrane surface area relative to their luminal volume, i.e., the small relative volume. In this study we present a theoretical analysis of discoid membrane compartments with a small relative volume and then compare the theoretical results to quantitative morphological assessment of fusiform vesicles in urinary bladder umbrella cells. Specifically, we employ three established extensions of the standard approach to lipid membrane shape calculation and determine the shapes that could be expected according to three scenarios of membrane shaping: membrane adhesion in the central discoid part, curvature driven lateral segregation of membrane constituents, and existence of stiffer membrane regions, e.g., support by protein scaffolds. The main characteristics of each scenario are analyzed. The results indicate that even though all three scenarios can lead to similar shapes, there are values of model parameters that yield qualitatively distinctive shapes. Consequently, a distinctive shape of an intracellular compartment may reveal its membrane shaping mechanism and the membrane structure. The observed shapes of fusiform vesicles fall into two qualitatively different classes, yet they are all consistent with the theoretical results and the current understanding of their structure and function.	[Derganc, Jure; Bozic, Bojan] Univ Ljubljana, Fac Med, Inst Biophys, Ljubljana, Slovenia; [Romih, Rok] Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Derganc, J (corresponding author), Univ Ljubljana, Fac Med, Inst Biophys, Ljubljana, Slovenia.	jure.derganc@mf.uni-lj.si			Slovenian Research Agency [P1-0055, P3_0108]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	JD and BB were supported by Slovenian Research Agency through Grant P1-0055. RR was supported by Slovenian Research Agency through Grant P3_0108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgart T, 2005, BIOPHYS J, V89, P1067, DOI 10.1529/biophysj.104.049692; BOZIC B, 1992, BIOPHYS J, V61, P963, DOI 10.1016/S0006-3495(92)81903-3; Bozic B, 2009, CHEMPHYSCHEM, V10, P2862, DOI 10.1002/cphc.200900209; Das S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011907; Das SL, 2008, J FLUID MECH, V597, P429, DOI 10.1017/S0022112007009846; Derganc J, 2006, TRAFFIC, V7, P85, DOI 10.1111/j.1600-0854.2005.00365.x; Derganc J, 2003, BIOPHYS J, V84, P1486, DOI 10.1016/S0006-3495(03)74961-3; Derganc J, 2007, PHYS BIOL, V4, P317, DOI 10.1088/1478-3975/4/4/008; FAWCETT DW, 1966, CELLS ORGANELLES INC, P116; Heinrich MC, 2010, J PHYS CHEM LETT, V1, P3401, DOI 10.1021/jz101403q; HICKS RM, 1965, J CELL BIOL, V26, P25, DOI 10.1083/jcb.26.1.25; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; JEZERNIK K, 1992, CELL BIOL INT REP, V16, P1219, DOI 10.1016/S0309-1651(06)80038-X; Julicher F, 1996, PHYS REV E, V53, P2670, DOI 10.1103/PhysRevE.53.2670; JULICHER F, 1993, PHYS REV LETT, V70, P2964, DOI 10.1103/PhysRevLett.70.2964; KOSS LG, 1969, LAB INVEST, V21, P154; Kreplak L, 2007, J MOL BIOL, V374, P365, DOI 10.1016/j.jmb.2007.09.040; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; LEWIS SA, 1982, NATURE, V297, P685, DOI 10.1038/297685a0; Majhenc J, 2004, BBA-BIOMEMBRANES, V1664, P257, DOI 10.1016/j.bbamem.2004.06.006; MARKIN VS, 1981, BIOPHYS J, V36, P1, DOI 10.1016/S0006-3495(81)84713-3; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; MIAO L, 1994, PHYS REV E, V49, P5389, DOI 10.1103/PhysRevE.49.5389; MINSKY BD, 1978, J CELL BIOL, V77, P685, DOI 10.1083/jcb.77.3.685; Monaghan P, 1998, J MICROSC-OXFORD, V192, P248, DOI 10.1046/j.1365-2818.1998.00387.x; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; PORTER KR, 1967, PROTOPLASMA, V63, P262, DOI 10.1007/BF01248042; PORTER KR, 1963, INTRO FINE STRUCTURE; SEIFERT U, 1990, PHYS REV A, V42, P4768, DOI 10.1103/PhysRevA.42.4768; Seifert U, 1997, ADV PHYS, V46, P13, DOI 10.1080/00018739700101488; SEIFERT U, 1993, PHYS REV LETT, V70, P1335, DOI 10.1103/PhysRevLett.70.1335; Semrau S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.088101; SEVERS NJ, 1979, J ULTRA MOL STRUCT R, V69, P279, DOI 10.1016/S0022-5320(79)90117-5; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; STAEHELIN LA, 1972, J CELL BIOL, V53, P73, DOI 10.1083/jcb.53.1.73; Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1; SVETINA S, 1989, EUR BIOPHYS J BIOPHY, V17, P101, DOI 10.1007/BF00257107; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; Wintz W, 1996, EUROPHYS LETT, V33, P403, DOI 10.1209/epl/i1996-00353-8; WU XR, 1994, J BIOL CHEM, V269, P13716; WU XR, 1990, J BIOL CHEM, V265, P19170; Zhao YX, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041919; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	44	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e26824	10.1371/journal.pone.0026824	http://dx.doi.org/10.1371/journal.pone.0026824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132079	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789900007
J	Hajduk, P; Sato, H; Puri, P; Murphy, P				Hajduk, Piotr; Sato, Hideaki; Puri, Prem; Murphy, Paula			Abnormal Notochord Branching Is Associated with Foregut Malformations in the Adriamycin Treated Mouse Model	PLOS ONE			English	Article							OPTICAL PROJECTION TOMOGRAPHY; ESOPHAGEAL ATRESIA; TRACHEOESOPHAGEAL FISTULA; LUNG MORPHOGENESIS; SONIC-HEDGEHOG; FLOOR PLATE; RAT MODEL; 3D REPRESENTATION; GENE-EXPRESSION; ENDODERM	Oesophageal atresia (OA) and tracheooesophageal fistula (TOF) are relatively common human congenital malformations of the foregut where the oesophagus does not connect with the stomach and there is an abnormal connection between the stomach and the respiratory tract. They require immediate corrective surgery and have an impact on the future health of the individual. These abnormalities are mimicked by exposure of rat and mouse embryos in utero to the drug adriamycin. The causes of OA/TOF during human development are not known, however a number of mouse mutants where different signalling pathways are directly affected, show similar abnormalities, implicating multiple and complex signalling mechanisms. The similarities in developmental outcome seen in human infants and in the adriamycin treated mouse model underline the potential of this model to unravel the early embryological events and further our understanding of the processes disturbed, leading to such abnormalities. Here we report a systematic study of the foregut and adjacent tissues in embryos treated with adriamycin at E7 and E8 and analysed between E9 and E12, comparing morphology in 3D in 149 specimens. We describe a spectrum of 8 defects, the most common of which is ventral displacement and branching of the notochord (in 94% of embryos at E10) and a close spatial correspondence between the site of notochord branching and defects of the foregut. In addition gene expression analysis shows altered dorso-ventral foregut patterning in the vicinity of notochord branches. This study shows a number of features of the adriamycin mouse model not previously reported, implicates the notochord as a primary site of disturbance in such abnormalities and underlines the importance of the model to further address the mechanistic basis of foregut congenital abnormalities.	[Hajduk, Piotr; Sato, Hideaki; Murphy, Paula] Univ Dublin, Dept Zool, Sch Nat Sci, Trinity Coll, Dublin, Ireland; [Hajduk, Piotr; Sato, Hideaki; Puri, Prem] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland	Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin	Hajduk, P (corresponding author), Univ Dublin, Dept Zool, Sch Nat Sci, Trinity Coll, Dublin, Ireland.	paula.murphy@tcd.ie		Murphy, Paula/0000-0002-8048-6850	National Children's Research Centre, Dublin, Ireland [E/07/3]; Science Foundation Ireland [02/IN1/B267]; Edinburgh Mouse Atlas Project	National Children's Research Centre, Dublin, Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Edinburgh Mouse Atlas Project	This work was funded by the National Children's Research Centre, Dublin, Ireland (grant number E/07/3) and Science Foundation Ireland (Programme Award 02/IN1/B267) to PM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr K. Roddy for technical advice, Dr Colby Tanner for guidance on statistical analysis and The Edinburgh Mouse Atlas Project for computational tools and support. Also Prof. L.Lundh for the plasmids carrying Shh and Foxf1 cDNA clones, Dr L.Magno for the plasmid carrying Nkx2.1 cDNA, and Prof. R. Lovell-Badge for the Sox2 conatining plasmid.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Brunner HG, 2005, CURR OPIN GENET DEV, V15, P341, DOI 10.1016/j.gde.2005.04.010; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; CLARK D, 1999, AM FAM PHYSICIAN, V15, P919; Clark DC, 1999, AM FAM PHYSICIAN, V59, P910; Cleaver O, 2001, DEV BIOL, V234, P1, DOI 10.1006/dbio.2001.0214; Dawrant MJ, 2007, PEDIATR SURG INT, V23, P469, DOI 10.1007/s00383-006-1847-9; Dawrant MJ, 2007, J PEDIATR SURG, V42, P375, DOI 10.1016/j.jpedsurg.2006.10.011; Dawrant MJ, 2007, J PEDIATR SURG, V42, P1652, DOI 10.1016/j.jpedsurg.2007.05.018; DiezPardo JA, 1996, J PEDIATR SURG, V31, P498, DOI 10.1016/S0022-3468(96)90482-0; Dodd J, 1998, SCIENCE, V282, P1654, DOI 10.1126/science.282.5394.1654; Domyan ET, 2011, DEVELOPMENT, V138, P971, DOI 10.1242/dev.053694; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Gillick J, 2008, PEDIATR SURG INT, V24, P113, DOI 10.1007/s00383-007-2035-2; Gross RE, 1953, SURG INFANCY CHILHOO; Hajduk P, 2010, PEDIATR SURG INT, V26, P23, DOI 10.1007/s00383-009-2519-3; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; Ioannides AS, 2010, DEV BIOL, V337, P351, DOI 10.1016/j.ydbio.2009.11.005; Ioannides AS, 2003, J PEDIATR SURG, V38, P29, DOI 10.1053/jpsu.2003.50005; Ioannides AS, 2002, J PEDIATR SURG, V37, P185, DOI 10.1053/jpsu.2002.30252; JURAND A, 1974, J EMBRYOL EXP MORPH, V32, P1; Kaufman M.H, 1999, ATLAS MOUSE DEV; Kim SK, 1997, DEVELOPMENT, V124, P4243; Kluth Dietrich, 2003, Semin Pediatr Surg, V12, P3, DOI 10.1016/S1055-8586(03)70002-X; LAWSON KA, 1986, DEV BIOL, V115, P325, DOI 10.1016/0012-1606(86)90253-8; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Li Y, 2008, DEV BIOL, V322, P145, DOI 10.1016/j.ydbio.2008.07.021; Li Y, 2007, DEV DYNAM, V236, P746, DOI 10.1002/dvdy.21075; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Mahlapuu M, 1998, DEV BIOL, V202, P183, DOI 10.1006/dbio.1998.9010; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Merei J, 1999, PEDIATR SURG INT, V15, P11, DOI 10.1007/s003830050501; Merei JM, 2002, PEDIATR SURG INT, V18, P319, DOI 10.1007/s00383-002-0751-1; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Mortell A, 2005, J PEDIATR SURG, V40, P403, DOI 10.1016/j.jpedsurg.2004.10.056; Oi BQ, 1999, J PEDIATR SURG, V34, P1593, DOI 10.1016/S0022-3468(99)90623-1; Orford J, 2001, J PEDIATR SURG, V36, P985, DOI 10.1053/jpsu.2001.24722; Peterson RS, 1997, CELL GROWTH DIFFER, V8, P69; PLACZEK M, 1995, CURR OPIN GENET DEV, V5, P499, DOI 10.1016/0959-437X(95)90055-L; Possoegel AK, 1999, PEDIATR SURG INT, V15, P201, DOI 10.1007/s003830050555; Qi BQ, 2000, DEV GROWTH DIFFER, V42, P145; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2006, DIFFERENTIATION, V74, P422, DOI 10.1111/j.1432-0436.2006.00096.x; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; Roddy KA, 2009, J ANAT, V214, P374, DOI 10.1111/j.1469-7580.2008.01040.x; Sasaki T, 2001, SURG TODAY, V31, P133, DOI 10.1007/s005950170197; Sharpe J, 2003, J ANAT, V202, P175, DOI 10.1046/j.1469-7580.2003.00155.x; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Spitz L, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-24; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; Stottmann RW, 2001, DEV BIOL, V240, P457, DOI 10.1006/dbio.2001.0479; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; THOMPSON DJ, 1978, TERATOLOGY, V17, P151, DOI 10.1002/tera.1420170207; Tomaselli V, 2003, PEDIATR SURG INT, V19, P40, DOI 10.1007/s00383-002-0887-z; Weaver M, 2000, DEVELOPMENT, V127, P2695; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Williams AK, 2003, J PEDIATR SURG, V38, P173, DOI 10.1053/jpsu.2003.50037; Williams AK, 2001, PEDIATR SURG INT, V17, P21, DOI 10.1007/s003830000440	62	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e27635	10.1371/journal.pone.0027635	http://dx.doi.org/10.1371/journal.pone.0027635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132119	Green Submitted, gold, Green Published			2022-12-25	WOS:000297789900014
J	Kellar, KL; Gehrke, J; Weis, SE; Mahmutovic-Mayhew, A; Davila, B; Zajdowicz, MJ; Scarborough, R; Lobue, PA; Lardizabal, AA; Daley, CL; Reves, RR; Bernardo, J; Campbell, BH; Whitworth, WC; Mazurek, GH				Kellar, Kathryn L.; Gehrke, Jennifer; Weis, Stephen E.; Mahmutovic-Mayhew, Aida; Davila, Blachy; Zajdowicz, Margan J.; Scarborough, Robin; LoBue, Philip A.; Lardizabal, Alfred A.; Daley, Charles L.; Reves, Randall R.; Bernardo, John; Campbell, Brandon H.; Whitworth, William C.; Mazurek, Gerald H.			Multiple Cytokines Are Released When Blood from Patients with Tuberculosis Is Stimulated with Mycobacterium tuberculosis Antigens	PLOS ONE			English	Article							INTERFERON-GAMMA ASSAY; T-CELL RESPONSES; WHOLE-BLOOD; LATENT TUBERCULOSIS; IFN-GAMMA; SKIN-TEST; INDUCIBLE PROTEIN-10; ESAT-6 ANTIGEN; INFECTION; DIAGNOSIS	Background: Mycobacterium tuberculosis (Mtb) infection may cause overt disease or remain latent. Interferon gamma release assays (IGRAs) detect Mtb infection, both latent infection and infection manifesting as overt disease, by measuring whole-blood interferon gamma (IFN-gamma) responses to Mtb antigens such as early secreted antigenic target-6 (ESAT-6), culture filtrate protein 10 (CFP-10), and TB7.7. Due to a lack of adequate diagnostic standards for confirming latent Mtb infection, IGRA sensitivity for detecting Mtb infection has been estimated using patients with culture-confirmed tuberculosis (CCTB) for whom recovery of Mtb confirms the infection. In this study, cytokines in addition to IFN-gamma were assessed for potential to provide robust measures of Mtb infection. Methods: Cytokine responses to ESAT-6, CFP-10, TB7.7, or combinations of these Mtb antigens, for patients with CCTB were compared with responses for subjects at low risk for Mtb infection (controls). Three different multiplexed immunoassays were used to measure concentrations of 9 to 20 different cytokines. Responses were calculated by subtracting background cytokine concentrations from cytokine concentrations in plasma from blood stimulated with Mtb antigens. Results: Two assays demonstrated that ESAT-6, CFP-10, ESAT-6+CFP-10, and ESAT-6+CFP-10+TB7.7 stimulated the release of significantly greater amounts of IFN-gamma, IL-2, IL-8, MCP-1 and MIP-1 beta for CCTB patients than for controls. Responses to combination antigens were, or tended to be, greater than responses to individual antigens. A third assay, using whole blood stimulation with ESAT-6+CFP-10+TB7.7, revealed significantly greater IFN-gamma, IL-2, IL-6, IL-8, IP-10, MCP-1, MIP-1 beta, and TNF-alpha responses among patients compared with controls. One CCTB patient with a falsely negative IFN-gamma response had elevated responses with other cytokines. Conclusions: Multiple cytokines are released when whole blood from patients with CCTB is stimulated with Mtb antigens. Measurement of multiple cytokine responses may improve diagnostic sensitivity for Mtb infection compared with assessment of IFN-gamma alone.	[Kellar, Kathryn L.; Mahmutovic-Mayhew, Aida; Scarborough, Robin] Ctr Dis Control & Prevent, Div Sci Resources, Atlanta, GA 30333 USA; [Gehrke, Jennifer; Davila, Blachy; LoBue, Philip A.; Campbell, Brandon H.; Whitworth, William C.; Mazurek, Gerald H.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Weis, Stephen E.] Univ N Texas, Hlth Sci Ctr, Dept Med, Ft Worth, TX USA; [Weis, Stephen E.] Tarrant Cty Publ Hlth Dept, Ft Worth, TX USA; [Mahmutovic-Mayhew, Aida] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Zajdowicz, Margan J.] USN Hosp, Great Lakes, IL USA; [Lardizabal, Alfred A.] Univ Med & Dent New Jersey, New Jersey Med Sch, Natl TB Ctr, Newark, NJ 07103 USA; [Daley, Charles L.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Reves, Randall R.] Denver Publ Hlth Dept, Denver, CO USA; [Bernardo, John] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of North Texas System; University of North Texas Health Science Center; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Department of Defense; United States Navy; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California San Francisco; Denver Health Medical Center; Boston University	Kellar, KL (corresponding author), Ctr Dis Control & Prevent, Div Sci Resources, Atlanta, GA 30333 USA.	gym6@cdc.gov	Daley, Charles L./AAC-3231-2021	Bernardo, John/0000-0002-3922-0559; Davila Saldana, Blachy/0000-0001-8281-3627	CDC; Department of the Navy; Cellestis Limited	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department of the Navy; Cellestis Limited	This study had no specific support or funding. Plasma samples were from a larger IRB approved project supported by CDC, the Department of the Navy, and Cellestis Limited. Cellestis Limited provided antigens and kits that were used to measure interferon gamma by the commercial ELISA. CDC, the Department of the Navy, and Cellestis, Ltd. reviewed the study design, data collection methods, and analysis plans prior to approval and funding. CDC and the Department of the Navy cleared the manuscript for publication according to established guidelines.	Aagaard C, 2004, J INFECT DIS, V189, P812, DOI 10.1086/381679; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Arend SM, 2000, INFECT IMMUN, V68, P3314, DOI 10.1128/IAI.68.6.3314-3321.2000; Arend SM, 2000, J INFECT DIS, V181, P1850, DOI 10.1086/315448; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Bellamy R, 2003, AM J RESP CRIT CARE, V167, P946, DOI 10.1164/rccm.2301005; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Cannas A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-333; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Desem N, 1998, CLIN DIAGN LAB IMMUN, V5, P531, DOI 10.1128/CDLI.5.4.531-536.1998; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Dlugovitzky D, 1999, SCAND J IMMUNOL, V49, P210, DOI 10.1046/j.1365-3083.1999.00492.x; Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC; Frahm M, 2011, TUBERCULOSIS, V91, P250, DOI 10.1016/j.tube.2011.02.006; GOLETTI D, 2010, J INFECT; Goletti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012577; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; IKEDIOBI UT, 2010, PLOS ONE; Juffermans NP, 1999, INFECT IMMUN, V67, P4295, DOI 10.1128/IAI.67.8.4295-4297.1999; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; Kabeer BSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009051; Kellar KL, 2001, CYTOMETRY, V45, P27, DOI 10.1002/1097-0320(20010901)45:1<27::AID-CYTO1141>3.0.CO;2-I; Kellar KL, 2003, J IMMUNOL METHODS, V279, P277, DOI 10.1016/S0022-1759(03)00248-5; KELLAR KL, 2006, MULTIPLEXED MICROSPH; Khan SS, 2004, CYTOM PART B-CLIN CY, V61B, P35, DOI 10.1002/cyto.b.20021; Krunic N, 2007, J CLIN VIROL, V40, pS39, DOI 10.1016/S1386-6532(07)70009-4; Lopez-Maderuelo D, 2003, AM J RESP CRIT CARE, V167, P970, DOI 10.1164/rccm.200205-438BC; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Mazurek GH, 2007, CLIN INFECT DIS, V45, P826, DOI 10.1086/521106; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740; Mustafa AS, 2003, SCAND J IMMUNOL, V57, P125, DOI 10.1046/j.1365-3083.2003.01204.x; Okamoto M, 2005, J LAB CLIN MED, V145, P88, DOI 10.1016/j.lab.2004.11.013; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pokkali S, 2008, CYTOKINE, V41, P307, DOI 10.1016/j.cyto.2007.12.009; Pollock JM, 1997, J INFECT DIS, V175, P1251, DOI 10.1086/593686; POWELL RI, 2010, PLOS MED; Raby E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002489; Ribeiro-Rodrigues R, 2002, CLIN DIAGN LAB IMMUN, V9, P818, DOI 10.1128/CDLI.9.4.818-823.2002; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Ruhwald Morten, 2009, BMC Res Notes, V2, P19, DOI 10.1186/1756-0500-2-19; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Streeton JA, 1998, INT J TUBERC LUNG D, V2, P443; Strom CM, 2006, J MOL DIAGN, V8, P371, DOI 10.2353/jmoldx.2006.050115; Supriya P, 2008, DIAGN MICR INFEC DIS, V62, P186, DOI 10.1016/j.diagmicrobio.2008.05.011; Ulrichs T, 1998, EUR J IMMUNOL, V28, P3949, DOI 10.1002/(SICI)1521-4141(199812)28:12<3949::AID-IMMU3949>3.0.CO;2-4; Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110; Wang XS, 2009, J IMMUNOL, V182, P3668, DOI 10.4049/jimmunol.0803579; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; WHO, 2009, WHOHTMTB2009411; *WHO, 2005, WHOHTMTB2005349; ZHANG M, 1995, INFECT IMMUN, V63, P3231, DOI 10.1128/IAI.63.8.3231-3234.1995	54	63	68	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e26545	10.1371/journal.pone.0026545	http://dx.doi.org/10.1371/journal.pone.0026545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132075	Green Published, gold			2022-12-25	WOS:000297789900005
J	Sternberg, L; Ellsworth, PFV				Sternberg, Leonel; Ellsworth, Patricia Fernandes Vendramini			Divergent Biochemical Fractionation, Not Convergent Temperature, Explains Cellulose Oxygen Isotope Enrichment across Latitudes	PLOS ONE			English	Article							TREE-RING CELLULOSE; WATER; RATIOS; HYDROGEN; CARBON; EXCHANGE; ALDOLASE	Recent findings based on the oxygen isotope ratios of tree trunk cellulose indicate that the temperature of biomass production in biomes ranging from boreal to subtropical forests converge to an average leaf temperature of 21.4 degrees C. The above conclusion has been drawn under the assumption that biochemically related isotopic fractionations during cellulose synthesis are not affected by temperature. Here we test the above assumption by heterotrophically generating cellulose at different temperatures and measuring the proportion of carbohydrate oxygen that exchange with water during cellulose synthesis and the average biochemical fractionation associated with this exchange. We observed no variation in the proportion of oxygen that exchange with different temperatures, which averaged 0.42 as it has been observed in other studies. On the other hand, the biochemical oxygen isotope fractionation during cellulose synthesis is affected by temperature and can be described by a 2(nd) order polynomial equation. The biochemical fractionation changes little between temperatures of 20 and 30 degrees C averaging 26 parts per thousand but increases at lower temperatures to values of 31 parts per thousand. This temperature sensitive biochemical fractionation explains the pattern of cellulose oxygen isotope ratios of aquatic plants encompassing several latitudes. The observed temperature sensitive biochemical fractionation also indicates that divergent biochemical fractionation and not convergent leaf temperature explains the increase in oxygen isotope enrichment of cellulose across several biomes.	[Sternberg, Leonel; Ellsworth, Patricia Fernandes Vendramini] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA	University of Miami	Sternberg, L (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.	leo@bio.miami.edu			National Science Foundation [ARC-0803352]	National Science Foundation(National Science Foundation (NSF))	Research was partly funded by the National Science Foundation Grant # ARC-0803352. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barbour MM, 2000, PLANT CELL ENVIRON, V23, P473, DOI 10.1046/j.1365-3040.2000.00575.x; Black CC, 1995, PHOTOSYNTH RES, V46, P169, DOI 10.1007/BF00020427; Cernusak LA, 2005, TREE PHYSIOL, V25, P129, DOI 10.1093/treephys/25.2.129; Cernusak LA, 2003, FUNCT PLANT BIOL, V30, P1059, DOI 10.1071/FP03137; Clark I., 1997, ENV ISOTOPES HYDROLO; Corbineau F, 2004, PHYSIOL PLANTARUM, V122, P28, DOI 10.1111/j.1399-3054.2004.00351.x; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P1885, DOI 10.1016/0016-7037(81)90018-1; Helliker BR, 2008, NATURE, V454, P511, DOI 10.1038/nature07031; HILL SA, 1995, PLANT CELL ENVIRON, V18, P931, DOI 10.1111/j.1365-3040.1995.tb00603.x; Hoefs J., 2004, STABLE ISOTOPE GEOCH, V5th; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; LEAVITT SW, 1993, ANAL CHEM, V65, P87, DOI 10.1021/ac00049a017; LUO YH, 1992, J EXP BOT, V43, P47, DOI 10.1093/jxb/43.1.47; MODEL P, 1968, BIOCHEMISTRY-US, V7, P1339, DOI 10.1021/bi00844a014; REYNOLDS SJ, 1971, BIOCHEM J, V122, P285, DOI 10.1042/bj1220285; Roden JS, 2000, GEOCHIM COSMOCHIM AC, V64, P21, DOI 10.1016/S0016-7037(99)00195-7; Sauer PE, 2001, J PALEOLIMNOL, V25, P43, DOI 10.1023/A:1008133523139; STERNBERG LDL, 1988, NATURE, V333, P59, DOI 10.1038/333059a0; STERNBERG LDL, 1986, PLANT PHYSIOL, V82, P423, DOI 10.1104/pp.82.2.423; STERNBERG LDLO, 1983, GEOCHIM COSMOCHIM AC, V47, P2271; Sternberg L, 2006, PLANT CELL ENVIRON, V29, P1881, DOI 10.1111/j.1365-3040.2006.01564.x; Sternberg LDLO, 2009, NEW PHYTOL, V181, P553, DOI 10.1111/j.1469-8137.2008.02661.x; Vendramini PF, 2007, RAPID COMMUN MASS SP, V21, P164, DOI 10.1002/rcm.2826; YAKIR D, 1990, PLANT PHYSIOL, V93, P325, DOI 10.1104/pp.93.1.325; ZHOU YP, 2005, CARBON OXYGEN HYDROG; MOISTURE ISOTOPES BI	26	81	81	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2011	6	11							e28040	10.1371/journal.pone.0028040	http://dx.doi.org/10.1371/journal.pone.0028040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IO	22132203	Green Published, gold			2022-12-25	WOS:000297789900044
J	Depledge, DP; Palser, AL; Watson, SJ; Lai, IYC; Gray, ER; Grant, P; Kanda, RK; Leproust, E; Kellam, P; Breuer, J				Depledge, Daniel P.; Palser, Anne L.; Watson, Simon J.; Lai, Imogen Yi-Chun; Gray, Eleanor R.; Grant, Paul; Kanda, Ravinder K.; Leproust, Emily; Kellam, Paul; Breuer, Judith			Specific Capture and Whole-Genome Sequencing of Viruses from Clinical Samples	PLOS ONE			English	Article							VARICELLA-ZOSTER-VIRUS; EPSTEIN-BARR-VIRUS; COMPLETE DNA-SEQUENCES; VACCINE; IDENTIFICATION; CARCINOMA; GENOTYPES; RECOMBINATION; AMPLIFICATION; VARIABILITY	Whole genome sequencing of viruses directly from clinical samples is integral for understanding the genetics of host-virus interactions. Here, we report the use of sample sparing target enrichment (by hybridisation) for viral nucleic acid separation and deep-sequencing of herpesvirus genomes directly from a range of clinical samples including saliva, blood, virus vesicles, cerebrospinal fluid, and tumour cell lines. We demonstrate the effectiveness of the method by deep-sequencing 13 highly cell-associated human herpesvirus genomes and generating full length genome alignments at high read depth. Moreover, we show the specificity of the method enables the study of viral population structures and their diversity within a range of clinical samples types.	[Depledge, Daniel P.; Lai, Imogen Yi-Chun; Gray, Eleanor R.; Kanda, Ravinder K.; Kellam, Paul; Breuer, Judith] UCL, Div Infect & Immun, London, England; [Palser, Anne L.; Watson, Simon J.; Lai, Imogen Yi-Chun; Kellam, Paul] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Grant, Paul] Univ Coll London Hosp NHS Trust, Dept Virol, London, England; [Leproust, Emily] Agilent Technol, Santa Rosa, CA USA	University of London; University College London; Wellcome Trust Sanger Institute; University College London Hospitals NHS Foundation Trust; University of London; University College London; Agilent Technologies	Depledge, DP (corresponding author), UCL, Div Infect & Immun, London, England.	d.depledge@ucl.ac.uk		Kellam, Paul/0000-0003-3166-4734; Gray, Eleanor/0000-0002-6515-839X; Breuer, Judith/0000-0001-8246-0534; Depledge, Daniel/0000-0002-4292-0599	Medical Research Centre; Wellcome Trust [WT081703MA]; European Community [FP7/2007-2013]; EC [223498]; Medical Research Council Centre for Molecular Medical Virology [G07008]; UCL/UCLH National Institute for Health Research Comprehensive Biomedical Research Centre; Wellcome Trust Sanger Institute; Medical Research Council [G0700814, G0900950] Funding Source: researchfish; MRC [G0700814, G0900950] Funding Source: UKRI	Medical Research Centre; Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); EC(European CommissionEuropean Commission Joint Research Centre); Medical Research Council Centre for Molecular Medical Virology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCL/UCLH National Institute for Health Research Comprehensive Biomedical Research Centre; Wellcome Trust Sanger Institute(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Centre [G0900950], Wellcome Trust [WT081703MA] and the European Community's Seventh Framework Programme [FP7/2007-2013] under the project EMPERIE, EC grant agreement number 223498. DPD is funded by the Medical Research Council Centre for Molecular Medical Virology [G07008], JB and ERG receive funding from the UCL/UCLH National Institute for Health Research Comprehensive Biomedical Research Centre. PK, ALP, SJW and IY-CL are funded by the Wellcome Trust Sanger Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonanni P, 2009, BMC MED, V7, P26, DOI DOI 10.1186/1741-7015-7-26; Bourboulia D, 2004, AIDS, V18, P485, DOI 10.1097/00002030-200402200-00015; Bracho MA, 1998, J GEN VIROL, V79, P2921, DOI 10.1099/0022-1317-79-12-2921; Breuer J, 2007, J INFECT DIS, V196, P801, DOI 10.1086/520520; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cannon JS, 2000, J VIROL, V74, P10187, DOI 10.1128/JVI.74.21.10187-10193.2000; Dargan DJ, 2010, J GEN VIROL, V91, P1535, DOI 10.1099/vir.0.018994-0; DAVISON AJ, 1986, J GEN VIROL, V67, P1759, DOI 10.1099/0022-1317-67-9-1759; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dolan A, 2006, VIROLOGY, V350, P164, DOI 10.1016/j.virol.2006.01.015; Gaidano G, 1996, LEUKEMIA, V10, P1237; Glenn M, 1999, J VIROL, V73, P6953, DOI 10.1128/JVI.73.8.6953-6963.1999; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gomi Y, 2002, J VIROL, V76, P11447, DOI 10.1128/JVI.76.22.11447-11459.2002; Grose C, 2004, J VIROL, V78, P6799, DOI 10.1128/JVI.78.13.6799-6807.2004; Herbeck JT, 2011, J VIROL; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu P, 2011, J VIROL, V85, P11291, DOI 10.1128/JVI.00823-11; Loparev VN, 2009, VIROLOGY, V383, P216, DOI 10.1016/j.virol.2008.10.026; Loparev VN, 2004, J VIROL, V78, P8349, DOI 10.1128/jvi.78.15.8349-8358.2004; Norberg P, 2006, J VIROL, V80, P9569, DOI 10.1128/JVI.00835-06; Peters GA, 2006, J VIROL, V80, P9850, DOI 10.1128/JVI.00715-06; Pugh TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn378; Quinlivan ML, 2007, P NATL ACAD SCI USA, V104, P208, DOI 10.1073/pnas.0605688104; Renzette N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001344; Takayama M, 1996, J CLIN MICROBIOL, V34, P2869, DOI 10.1128/JCM.34.12.2869-2874.1996; Tillieux SL, 2008, J VIROL, V82, P11023, DOI 10.1128/JVI.00777-08; Tyler SD, 2007, VIROLOGY, V359, P447, DOI 10.1016/j.virol.2006.09.037; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zeng MS, 2005, J VIROL, V79, P15323, DOI 10.1128/JVI.79.24.15323-15330.2005	35	150	158	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27805	10.1371/journal.pone.0027805	http://dx.doi.org/10.1371/journal.pone.0027805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125625	Green Published, gold, Green Submitted			2022-12-25	WOS:000297789200025
J	Kowal, MA; Colzato, LS; Hommel, B				Kowal, Mikael A.; Colzato, Lorenza S.; Hommel, Bernhard			Decreased Spontaneous Eye Blink Rates in Chronic Cannabis Users: Evidence for Striatal Cannabinoid-Dopamine Interactions	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; COCAINE; ABUSE; INTEGRATION; RELEASE; NUCLEUS; MONKEYS	Chronic cannabis use has been shown to block long-term depression of GABA-glutamate synapses in the striatum, which is likely to reduce the extent to which endogenous cannabinoids modulate GABA-and glutamate-related neuronal activity. The current study aimed at investigating the effect of this process on striatal dopamine levels by studying the spontaneous eye blink rate (EBR), a clinical marker of dopamine level in the striatum. 25 adult regular cannabis users and 25 non-user controls matched for age, gender, race, and IQ were compared. Results show a significant reduction in EBR in chronic users as compared to non-users, suggesting an indirect detrimental effect of chronic cannabis use on striatal dopaminergic functioning. Additionally, EBR correlated negatively with years of cannabis exposure, monthly peak cannabis consumption, and lifetime cannabis consumption, pointing to a relationship between the degree of impairment of striatal dopaminergic transmission and cannabis consumption history.	[Kowal, Mikael A.] Leiden Univ, Cognit Psychol Unit, Leiden, Netherlands; Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kowal, MA (corresponding author), Leiden Univ, Cognit Psychol Unit, Leiden, Netherlands.	m.a.kowal@fsw.leidenuniv.nl	Hommel, Bernhard/F-8173-2010; Colzato, Lorenza S/H-6296-2013	Hommel, Bernhard/0000-0003-4731-5125; Colzato, Lorenza/0000-0003-1735-1280; Kowal, Mikael/0000-0002-5526-0083				Abdullaev Y, 2010, BEHAV BRAIN RES, V215, P45, DOI 10.1016/j.bbr.2010.06.023; Barbato G, 2000, PSYCHIAT RES, V93, P145, DOI 10.1016/S0165-1781(00)00108-6; Bolla KI, 1998, J NEUROPSYCH CLIN N, V10, P280, DOI 10.1176/jnp.10.3.280; Bossong MG, 2009, NEUROPSYCHOPHARMACOL, V34, P759, DOI 10.1038/npp.2008.138; Colzato LS, 2008, NEUROPSYCHOLOGIA, V46, P1570, DOI 10.1016/j.neuropsychologia.2007.12.014; Colzato LS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003461; Deuschl G, 1998, J NEUROL NEUROSUR PS, V64, P320, DOI 10.1136/jnnp.64.3.320; Dreisbach G, 2005, BEHAV NEUROSCI, V119, P483, DOI 10.1037/0735-7044.119.2.483; Earleywine M., 2002, UNDERSTANDING MARIJU; Fattore L, 2010, EXP NEUROL, V224, P23, DOI 10.1016/j.expneurol.2010.03.020; Fernandez-Ruiz J, 2010, CNS NEUROSCI THER, V16, pe72, DOI 10.1111/j.1755-5949.2010.00144.x; FREED WJ, 1980, BIOL PSYCHIAT, V15, P329; Gerdeman GL, 2003, TRENDS NEUROSCI, V26, P184, DOI 10.1016/S0166-2236(03)00065-1; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hoffman AF, 2003, J NEUROSCI, V23, P4815; KARSON CN, 1983, BRAIN, V106, P643, DOI 10.1093/brain/106.3.643; Kleven MS, 1996, J PHARMACOL EXP THER, V279, P1211; Kuepper R, 2010, SCHIZOPHR RES, V121, P107, DOI 10.1016/j.schres.2010.05.031; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Morgan CJA, 2010, NEUROPSYCHOPHARMACOL, V35, P1879, DOI 10.1038/npp.2010.58; Quik M, 2006, J NEUROSCI, V26, P4681, DOI 10.1523/JNEUROSCI.0215-06.2006; Raven JC, 1988, MANUAL RAVENS PROGR; SHUKLA D, 1985, NEUROLOGY, V35, P286, DOI 10.1212/WNL.35.2.286; Stokes PRA, 2009, NEUROIMAGE, V48, P186, DOI 10.1016/j.neuroimage.2009.06.029; Taylor JR, 1999, EXP NEUROL, V158, P214, DOI 10.1006/exnr.1999.7093	25	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e26662	10.1371/journal.pone.0026662	http://dx.doi.org/10.1371/journal.pone.0026662			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125599	Green Submitted, Green Published, gold			2022-12-25	WOS:000297789200004
J	Zanin, MP; Phillips, L; Mackenzie, KD; Keating, DJ				Zanin, Mark P.; Phillips, Lucy; Mackenzie, Kimberly D.; Keating, Damien J.			Aging Differentially Affects Multiple Aspects of Vesicle Fusion Kinetics	PLOS ONE			English	Article							ADRENAL CHROMAFFIN CELLS; DENSE-CORE VESICLES; KISS-AND-RUN; QUANTAL SIZE; CATECHOLAMINE RELEASE; SECRETORY VESICLES; PORE KINETICS; EXOCYTOSIS; CHOLESTEROL; TRANSMITTER	How fusion pore formation during exocytosis affects the subsequent release of vesicle contents remains incompletely understood. It is unclear if the amount released per vesicle is dependent upon the nature of the developing fusion pore and whether full fusion and transient kiss and run exocytosis are regulated by similar mechanisms. We hypothesise that if consistent relationships exist between these aspects of exocytosis then they will remain constant across any age. Using amperometry in mouse chromaffin cells we measured catecholamine efflux during single exocytotic events at P0, 1 month and 6 months. At all ages we observed full fusion (amperometric spike only), full fusion preceded by fusion pore flickering (pre-spike foot (PSF) signal followed by a spike) and pure "kiss and run" exocytosis (represented by stand alone foot (SAF) signals). We observe age-associated increases in the size of all 3 modes of fusion but these increases occur at different ages. The release probability of PSF signals or full spikes alone doesn't alter across any age in comparison with an age-dependent increase in the incidence of "kiss and run" type events. However, the most striking changes we observe are age-associated changes in the relationship between vesicle size and the membrane bending energy required for exocytosis. Our data illustrates that vesicle size does not regulate release probability, as has been suggested, that membrane elasticity or flexural rigidity change with age and that the mechanisms controlling full fusion may differ from those controlling "kiss and run" fusion.	[Zanin, Mark P.] Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia; Flinders Univ S Australia, Ctr Neurosci, Adelaide, SA 5001, Australia	Flinders University South Australia; Flinders University South Australia	Zanin, MP (corresponding author), Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia.	Damien.Keating@flinders.edu.au		Zanin, Mark/0000-0003-3158-1744; Keating, Damien/0000-0002-0154-8305	Bio Innovation SA Research Fellowship; ARC [FT0990901]	Bio Innovation SA Research Fellowship; ARC(Australian Research Council)	This work was supported by research fellowships to DJK including the Bio Innovation SA Research Fellowship and an ARC Future Fellowship (number FT0990901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Amatore C, 2005, BIOPHYS J, V88, P4411, DOI 10.1529/biophysj.104.053736; Amatore C, 2009, BIOPHYS CHEM, V143, P124, DOI 10.1016/j.bpc.2009.04.007; AVAKIAN EV, 1984, J AUTONOM NERV SYST, V10, P127, DOI 10.1016/0165-1838(84)90051-1; Chauhan NB, 2003, BRAIN RES, V982, P219, DOI 10.1016/S0006-8993(03)03011-7; Chen Z, 1997, BIOPHYS J, V73, P267, DOI 10.1016/S0006-3495(97)78067-6; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Colliver TL, 2001, J NEUROSCI METH, V105, P95, DOI 10.1016/S0165-0270(00)00359-9; COUPLAND RE, 1989, INT J DEV NEUROSCI, V7, P419, DOI 10.1016/0736-5748(89)90003-8; Doreian BW, 2009, MOL BIOL CELL, V20, P3142, DOI 10.1091/mbc.E09-03-0197; Fang QH, 2008, P NATL ACAD SCI USA, V105, P15388, DOI 10.1073/pnas.0805377105; Fernandez-Morales JC, 2009, AM J PHYSIOL-CELL PH, V297, pC407, DOI 10.1152/ajpcell.00086.2009; Gong LW, 2003, J NEUROSCI, V23, P7917; Jacobsson G, 1998, MECH AGEING DEV, V101, P33, DOI 10.1016/S0047-6374(97)00162-0; Martin MG, 2008, MOL BIOL CELL, V19, P2101, DOI 10.1091/mbc.E07-09-0897; Penev P, 2005, J CLIN ENDOCR METAB, V90, P6198, DOI 10.1210/jc.2005-0415; Pothos EN, 2002, J PHYSIOL-LONDON, V542, P453, DOI 10.1113/jphysiol.2002.018630; Richards DA, 2009, J PHYSIOL-LONDON, V587, P5073, DOI 10.1113/jphysiol.2009.175315; Soderoa AO, 2011, NEUROBIOL AGING, V32, P1043, DOI 10.1016/j.neurobiolaging.2010.06.001; Sombers LA, 2004, J NEUROSCI, V24, P303, DOI 10.1523/JNEUROSCI.1119-03.2004; Sombers LA, 2005, J NEUROCHEM, V93, P1122, DOI 10.1111/j.1471-4159.2005.03087.x; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; SVENNERHOLM L, 1991, J NEUROCHEM, V56, P2051, DOI 10.1111/j.1471-4159.1991.tb03466.x; TEITEL DF, 1985, PEDIATR RES, V19, P948, DOI 10.1203/00006450-198509000-00017; Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Wang N, 2010, J NEUROSCI, V30, P3904, DOI 10.1523/JNEUROSCI.4000-09.2010; Wang WC, 2007, BIOPHYS J, V92, P2819, DOI 10.1529/biophysj.106.097923; Xu JH, 1999, J BIOL CHEM, V274, P19095, DOI 10.1074/jbc.274.27.19095; Zhang Q, 2007, P NATL ACAD SCI USA, V104, P17843, DOI 10.1073/pnas.0706906104; Zhang Z, 2010, BIOPHYS J, V98, P2524, DOI 10.1016/j.bpj.2010.02.043; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7	33	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2011	6	11							e27820	10.1371/journal.pone.0027820	http://dx.doi.org/10.1371/journal.pone.0027820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858IH	22125627	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000297789200027
J	Zhang, HY; Zhang, L; Gao, B; Fan, H; Jin, JB; Botella, MA; Jiang, LW; Lin, JX				Zhang, Haiyan; Zhang, Liang; Gao, Bin; Fan, Hai; Jin, Jingbo; Botella, Miguel A.; Jiang, Liwen; Lin, Jinxing			Golgi Apparatus-Localized Synaptotagmin 2 Is Required for Unconventional Secretion in Arabidopsis	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR-1; HYGROMYCIN-B INHIBITION; DYNAMIN-LIKE PROTEIN; BREFELDIN-A; SELECTABLE MARKER; PLASMA-MEMBRANE; PREVACUOLAR COMPARTMENTS; ACID-PHOSPHATASE; TRAFFICKING; ENDOCYTOSIS	Background: Most secretory proteins contain signal peptides that direct their sorting to the ER and secreted via the conventional ER/Golgi transport pathway, while some signal-peptide-lacking proteins have been shown to export through ER/Golgi independent secretory pathways. Hygromycin B is an aminoglycoside antibiotic produced by Streptomyces hygroscopicus that is active against both prokaryotic and eukaryotic cells. The hygromycin phosphotransferase (HYG(R)) can phosphorylate and inactivate the hygromycin B, and has been widely used as a positive selective marker in the construction of transgenic plants. However, the localization and trafficking of HYG(R) in plant cells remain unknown. Synaptotagmins (SYTs) are involved in controlling vesicle endocytosis and exocytosis as calcium sensors in animal cells, while their functions in plant cells are largely unclear. Methodology/Principal Findings: We found Arabidopsis synaptotagmin SYT2 was localized on the Golgi apparatus by immunofluorescence and immunogold labeling. Surprisingly, co-expression of SYT2 and HYG(R) caused hypersensitivity of the transgenic Arabidopsis plants to hygromycin B. HYG(R), which lacks a signal sequence, was present in the cytoplasm as well as in the extracellular space in HYG(R)-GFP transgenic Arabidopsis plants and its secretion is not sensitive to brefeldin A treatment, suggesting it is not secreted via the conventional secretory pathway. Furthermore, we found that HYG(R)-GFP was truncated at carboxyl terminus of HYG(R) shortly after its synthesis, and the cells deficient SYT2 failed to efficiently truncate HYGR-GFP, resulting in HYG(R)-GFP accumulated in prevacuoles/vacuoles, indicating that SYT2 was involved in HYG(R)-GFP trafficking and secretion. Conclusion/Significance: These findings reveal for the first time that SYT2 is localized on the Golgi apparatus and regulates HYG(R)-GFP secretion via the unconventional protein transport from the cytosol to the extracelluar matrix in plant cells.	[Zhang, Haiyan; Zhang, Liang; Gao, Bin; Jin, Jingbo; Lin, Jinxing] Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Mol Environm Physiol, Beijing, Peoples R China; [Zhang, Liang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Gao, Bin; Fan, Hai] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China; [Botella, Miguel A.] Univ Malaga, Dept Biol Mol Bioquim, E-29071 Malaga, Spain; [Jiang, Liwen] Chinese Univ Hong Kong, Dept Biol, Shatin, Hong Kong, Peoples R China; [Jiang, Liwen] Chinese Univ Hong Kong, Mol Biotechnol Program, Shatin, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shandong Normal University; Universidad de Malaga; Chinese University of Hong Kong; Chinese University of Hong Kong	Zhang, HY (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photosynth & Mol Environm Physiol, Beijing, Peoples R China.	linjx@ibcas.ac.cn	JIANG, Liwen/S-6046-2018; Botella, Miguel Ángel/S-3676-2019; Botella, Miguel A/B-5734-2012; Zhang, Haitao/L-7612-2015	JIANG, Liwen/0000-0002-7829-1472; Botella, Miguel Ángel/0000-0002-8867-1831; Botella, Miguel A/0000-0002-8867-1831; Lin, Jinxing/0000-0001-9338-1356; Zhang, Haitao/0000-0003-4879-2951	National Natural Science Foundation of China [90817010, 30770123]; El Ministerio de Cienciae Innovacion [BIO2008-1709]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); El Ministerio de Cienciae Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The National Natural Science Foundation of China, (Granted No. 90817010 and 30770123)(http://www.nsfc.gov.cn/Portal0/default124.htm), and El Ministerio de Cienciae Innovacion (Grant BIO2008-1709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2010, PROTEOMICS, V10, P799, DOI 10.1002/pmic.200900514; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; Borovinskaya MA, 2008, RNA, V14, P1590, DOI 10.1261/rna.1076908; Cabral M, 2010, EUKARYOT CELL, V9, P1009, DOI 10.1128/EC.00337-09; Cheng FY, 2009, PLANTA, V230, P1093, DOI 10.1007/s00425-009-1006-3; Couchy I, 2003, J EXP BOT, V54, P2053, DOI 10.1093/jxb/erg230; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Fukuda M, 2004, J BIOL CHEM, V279, P52677, DOI 10.1074/jbc.M409241200; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Gustavsson N, 2009, BIOSCIENCE REP, V29, P245, DOI 10.1042/BSR20090031; Harlow E., 1988, ANTIBODIES LAB MANUA; Hu ZT, 2008, BIOCHEM BIOPH RES CO, V371, P781, DOI 10.1016/j.bbrc.2008.04.174; Jaillais Y, 2008, PLANT J, V53, P237, DOI 10.1111/j.1365-313X.2007.03338.x; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kaneko TS, 1996, PLANT CELL REP, V15, P409, DOI 10.1007/BF00232065; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Kotzer AM, 2004, J CELL SCI, V117, P6377, DOI 10.1242/jcs.01564; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lee MH, 2002, PLANT PHYSIOL, V129, P1507, DOI 10.1104/pp.003624; Lee OR, 2010, PLANT CELL, V22, P1812, DOI 10.1105/tpc.110.074211; Lu Y, 2007, J FOOD SCI, V72, pM228, DOI 10.1111/j.1750-3841.2007.00437.x; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; McGaha SM, 2007, ANTIMICROB AGENTS CH, V51, P591, DOI 10.1128/AAC.01116-06; Miki B, 2004, J BIOTECHNOL, V107, P193, DOI 10.1016/j.jbiotec.2003.10.011; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Neumann U, 2003, ANN BOT-LONDON, V92, P167, DOI 10.1093/aob/mcg134; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; ORCI L, 1991, CELL, V64, P1183; Ortiz JPA, 1996, PLANT CELL REP, V15, P877, DOI 10.1007/BF00231579; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PARDO JM, 1985, J GEN MICROBIOL, V131, P1289; Park JM, 1997, PLANT PHYSIOL, V115, P763, DOI 10.1104/pp.115.2.763; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Pfeffer SR, 2010, J CELL BIOL, V188, P451, DOI 10.1083/jcb.201001121; Pfeiffer W, 1996, PHYSIOL PLANTARUM, V98, P773, DOI 10.1111/j.1399-3054.1996.tb06684.x; PITTENGER RC, 1953, ANTIBIOT CHEMOTHER, V3, P1268; Robineau S, 2000, P NATL ACAD SCI USA, V97, P9913, DOI 10.1073/pnas.170290597; Robinson DG, 2008, TRENDS PLANT SCI, V13, P405, DOI 10.1016/j.tplants.2008.05.010; Schapire AL, 2009, TRENDS PLANT SCI, V14, P645, DOI 10.1016/j.tplants.2009.09.004; Schapire AL, 2008, PLANT CELL, V20, P3374, DOI 10.1105/tpc.108.063859; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Schotman H, 2008, DEV CELL, V14, P171, DOI 10.1016/j.devcel.2007.12.006; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; Tian LN, 2000, PLANT CELL REP, V19, P358, DOI 10.1007/s002990050740; Tse YC, 2004, PLANT CELL, V16, P672, DOI 10.1105/tpc.019703; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Wang JA, 2010, PLANT CELL, V22, P4009, DOI 10.1105/tpc.110.080697; Wang JQ, 2009, J EXP BOT, V60, P3075, DOI 10.1093/jxb/erp136; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yamazaki T, 2008, PLANT CELL, V20, P3389, DOI 10.1105/tpc.108.062679; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	59	47	51	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e26477	10.1371/journal.pone.0026477	http://dx.doi.org/10.1371/journal.pone.0026477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140429	Green Submitted, Green Published, gold			2022-12-25	WOS:000298163400001
J	Liu, Z; Luo, WR; Zhou, Y; Zhen, Y; Yang, HL; Yu, XL; Ye, YF; Li, X; Wang, H; Jiang, QP; Zhang, YJ; Yao, KT; Fang, WY				Liu, Zhen; Luo, Weiren; Zhou, Ying; Zhen, Yan; Yang, Huiling; Yu, Xiaoli; Ye, Yanfen; Li, Xin; Wang, Hao; Jiang, Qinping; Zhang, Yajie; Yao, Kaitai; Fang, Weiyi			Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							EXPRESSION; GROWTH; PROLIFERATION; KINASE; ATF-2; CELLS; GENE	Background: Recently we identified nasopharyngeal epithelium specific protein 1 (NESG1) as a potential tumor suppressor in nasopharyngeal carcinoma (NPC). The purpose of this study is to investigate the involvement of NESG1 in tumor progression and prognosis of human NPC. Methodology/Principal Findings: NESG1 protein expression in NPC was examined. Survival analysis was performed using Kaplan-Meier method. The effect of NESG1 on cell proliferation, migration, and invasion were also investigated. Results: NESG1 expression was downregulated in atypical hyperplasia and NPC samples compared to normal and squamous nasopharynx tissues. Reduced protein expression was negatively associated with the status of NPC progression. Patients with lower NESG1 expression had a shorter overall survival and disease-free time than did patients with higher NESG1 expression. Multivariate analysis suggested NESG1 expression as an independent prognostic indicator for NPC patient survival. Proliferation, migration, and invasion ability were significantly increased in cell lines following lentiviral-mediated shRNA suppression of NESG1 expression. Microarray analysis indicated that NESG1 participated in multiple pathways, including MAPK signaling and cell cycle regulation. Finally, DNA methylation microarray examination revealed a lack of hypermethylation at the NESG1 promoter, suggesting other mechanisms are involved in suppressing NESG1 expression in NPC. Conclusion: Our studies are the first to demonstrate that decreased NESG1 expression is an unfavorable prognostic factor for NPC.	[Liu, Zhen; Zhang, Yajie] Guangzhou Med Univ, Dept Pathol, Basic Sch, Guangzhou, Guangdong, Peoples R China; [Liu, Zhen; Luo, Weiren; Zhou, Ying; Zhen, Yan; Yu, Xiaoli; Ye, Yanfen; Li, Xin; Wang, Hao; Yao, Kaitai; Fang, Weiyi] So Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Luo, Weiren] Guangdong Med Coll, Dept Pathol, Dongguan, Peoples R China; [Jiang, Qinping] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Yang, Huiling] Guangdong Med Coll, Sch Pharm, Dongguan, Peoples R China	Guangzhou Medical University; Southern Medical University - China; Guangdong Medical University; Guangzhou Medical University; Guangdong Medical University	Liu, Z (corresponding author), Guangzhou Med Univ, Dept Pathol, Basic Sch, Guangzhou, Guangdong, Peoples R China.	fangweiyi1975@yahoo.com.cn	Ren, Jian/D-3270-2011; Xue, Yu/G-5929-2011; Luo, Weiren/AAI-8364-2020; Liu, Zexian/D-1153-2011	Ren, Jian/0000-0002-4161-1292; Xue, Yu/0000-0002-9403-6869; Luo, Weiren/0000-0002-2762-6332; Liu, Zexian/0000-0001-9698-0610	National Nature Science Fund of China [81071632, 30870973]; Natural Science Fund of Guangdong Province [8451051501000314]	National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by National Nature Science Fund of China (NO. 81071632 and NO. 30870973)(http://www.nsfc.gov.cn), Natural Science Fund of Guangdong Province (NO. 8451051501000314) (http://www.gdstc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010493; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; Dong WJ, 2010, INT J CANCER, V127, P1526, DOI 10.1002/ijc.25161; Du ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019137; Fang WY, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-32; Haines E, 2009, MOL CELL BIOL, V29, P2505, DOI 10.1128/MCB.00034-09; Henkens R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-147; Jadeski LC, 2003, INT J CANCER, V106, P496, DOI 10.1002/ijc.11268; Johansen C, 2009, CARCINOGENESIS, V30, P2100, DOI 10.1093/carcin/bgp238; Jonak C, 2011, J DERMATOL SCI, V61, P32, DOI 10.1016/j.jdermsci.2010.10.009; Knippen S, 2009, ANTICANCER RES, V29, P183; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kumar B, 2010, CANCER RES, V70, P832, DOI 10.1158/0008-5472.CAN-09-2918; Langlois B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011584; Li ZK, 1999, GENE, V237, P235, DOI 10.1016/S0378-1119(99)00234-6; Liu Z, 2011, INT J CANCER, V128, P2562, DOI 10.1002/ijc.25595; Lung HL, 2010, INT J CANCER, V127, P304, DOI 10.1002/ijc.25047; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Modi H, 2011, LEUKEMIA, V25, P305, DOI 10.1038/leu.2010.257; Poage GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009651; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Recio JA, 2002, ONCOGENE, V21, P1000, DOI 10.1038/sj.onc.1205150; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Ungefroren H, 2007, INT J CANCER, V120, P1641, DOI 10.1002/ijc.22393; Wang SA, 2011, HISTOPATHOLOGY, V58, P217, DOI 10.1111/j.1365-2559.2010.03739.x; Wu AB, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-38; Zhou YH, 2008, INT J CANCER, V123, P2065, DOI 10.1002/ijc.23727; Zoumpourlis V, 2000, ONCOGENE, V19, P4011, DOI 10.1038/sj.onc.1203732	31	104	112	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27887	10.1371/journal.pone.0027887	http://dx.doi.org/10.1371/journal.pone.0027887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140479	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163400020
J	Liu, ZX; Cao, J; Gao, XJ; Ma, Q; Ren, J; Xue, Y				Liu, Zexian; Cao, Jun; Gao, Xinjiao; Ma, Qian; Ren, Jian; Xue, Yu			GPS-CCD: A Novel Computational Program for the Prediction of Calpain Cleavage Sites	PLOS ONE			English	Article							PHOSPHORYLATION SITES; MEDIATED CLEAVAGE; PEPTIDE LIBRARY; PROTEIN; DATABASE; IDENTIFICATION; APOPTOSIS; SUBSTRATE; AUTOPHAGY; PATHWAY	As one of the most essential post-translational modifications (PTMs) of proteins, proteolysis, especially calpain-mediated cleavage, plays an important role in many biological processes, including cell death/apoptosis, cytoskeletal remodeling, and the cell cycle. Experimental identification of calpain targets with bona fide cleavage sites is fundamental for dissecting the molecular mechanisms and biological roles of calpain cleavage. In contrast to time-consuming and labor-intensive experimental approaches, computational prediction of calpain cleavage sites might more cheaply and readily provide useful information for further experimental investigation. In this work, we constructed a novel software package of GPS-CCD (Calpain Cleavage Detector) for the prediction of calpain cleavage sites, with an accuracy of 89.98%, sensitivity of 60.87% and specificity of 90.07%. With this software, we annotated potential calpain cleavage sites for hundreds of calpain substrates, for which the exact cleavage sites had not been previously determined. In this regard, GPS-CCD 1.0 is considered to be a useful tool for experimentalists. The online service and local packages of GPS-CCD 1.0 were implemented in JAVA and are freely available at: http://ccd.biocuckoo.org/.	[Liu, Zexian; Cao, Jun; Gao, Xinjiao; Ma, Qian] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Liu, Zexian; Cao, Jun; Gao, Xinjiao; Ma, Qian] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Liu, Zexian; Xue, Yu] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Syst Biol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Hubei, Peoples R China; [Ren, Jian] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Huazhong University of Science & Technology; Sun Yat Sen University	Liu, ZX (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.	renjian.sysu@gmail.com; xueyu@mail.hust.edu.cn	Ren, Jian/D-3270-2011; Xue, Yu/G-5929-2011; Luo, Weiren/AAI-8364-2020; Liu, Zexian/D-1153-2011	Ren, Jian/0000-0002-4161-1292; Xue, Yu/0000-0002-9403-6869; Luo, Weiren/0000-0002-2762-6332; Liu, Zexian/0000-0001-9698-0610	National Basic Research Program (973 project) [2010CB945400, 2011CB910400]; National Natural Science Foundation of China [90919001, 31071154, 30900835, 30830036, 91019020, 21075045]; Fundamental Research Funds for the Central Universities [HUST: 2010JC049, 2010ZD018, SYSU: 11lgzd11, 11lgjc09]	National Basic Research Program (973 project)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Basic Research Program (973 project) (2010CB945400, 2011CB910400), National Natural Science Foundation of China (90919001, 31071154, 30900835, 30830036, 91019020, 21075045), and Fundamental Research Funds for the Central Universities (HUST: 2010JC049, 2010ZD018; SYSU: 11lgzd11, 11lgjc09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arrington DD, 2006, AM J PHYSIOL-CELL PH, V291, pC1159, DOI 10.1152/ajpcell.00207.2006; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Boehmerle W, 2007, P NATL ACAD SCI USA, V104, P11103, DOI 10.1073/pnas.0701546104; Bougie JK, 2009, J NEUROCHEM, V109, P1129, DOI 10.1111/j.1471-4159.2009.06045.x; Boyd Sarah E., 2005, Journal of Bioinformatics and Computational Biology, V3, P551, DOI 10.1142/S021972000500117X; Boyd SE, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P372; Chen Q, 2006, J NEUROCHEM, V99, P1133, DOI 10.1111/j.1471-4159.2006.04160.x; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; duVerle David, 2010, V22, P202; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Futai E, 1999, MOL GEN GENET, V260, P559, DOI 10.1007/s004380050929; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hayashi M, 2005, MOL CELL BIOL, V25, P9478, DOI 10.1128/MCB.25.21.9478-9490.2005; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Joy J, 2006, BIOL CHEM, V387, P329, DOI 10.1515/BC.2006.044; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Rawlings ND, 2009, LARGE ACCURATE COLLE; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Squier MKT, 1999, J CELL PHYSIOL, V178, P311, DOI 10.1002/(SICI)1097-4652(199903)178:3<311::AID-JCP5>3.3.CO;2-K; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Thomas DA, 2006, PROTEOMICS, V6, P2112, DOI 10.1002/pmic.200500153; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361; Zhou FF, 2005, FEBS LETT, V579, P3369, DOI 10.1016/j.febslet.2005.04.076	37	104	112	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19001	10.1371/journal.pone.0019001	http://dx.doi.org/10.1371/journal.pone.0019001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	22140479	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400047
J	Chatterjee, M; Hedrich, CM; Rauen, T; Ioannidis, C; Terhorst, C; Tsokos, GC				Chatterjee, Madhumouli; Hedrich, Christian M.; Rauen, Thomas; Ioannidis, Christina; Terhorst, Cox; Tsokos, George C.			CD3-T Cell Receptor Co-stimulation through SLAMF3 and SLAMF6 Receptors Enhances ROR gamma t Recruitment to the IL17A Promoter in Human T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; EFFECTOR FUNCTIONS; NFAT; TH17; DIFFERENTIATION; SAP; DISEASE; IL-17; ACTIVATION; MECHANISMS	Th17 lymphocytes play a key role during immune responses against bacteria and fungi and are involved in the pathophysiology of multiple autoimmune disorders. The co-stimulatory molecules SLAMF3 and SLAMF6 have been implicated in the formation of Th17 phenotypes and IL-17A expression. Increased surface expression of SLAMF3 and SLAMF6 has been linked with disease activity in systemic lupus erythematosus. Here we demonstrate that in human total T lymphocytes the canonical CD28 and the non-canonical SLAMF3/SLAMF6 co-stimulatory pathways cooperate in the recruitment of the transcription factor NFAT1 to the IL17A promoter. Furthermore, the dominance of the SLAMF3/SLAMF6 pathway in inducing IL-17A production can be attributed to an increased nuclear abundance and recruitment of ROR gamma t to the IL17A promoter. Thus, we have identified an additional mechanism that may be central for the specific control of IL17A gene regulation in systemic lupus erythematosus T lymphocytes.	[Chatterjee, Madhumouli; Hedrich, Christian M.; Rauen, Thomas; Ioannidis, Christina; Tsokos, George C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Rheumatol, Sch Med, Boston, MA 02215 USA; [Terhorst, Cox] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Immunol,Med Sch, Boston, MA 02215 USA; [Rauen, Thomas] Rheinisch Westfael Tech Hsch Aachen Univ, Dept Nephrol & Clin Immunol, D-52056 Aachen, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; RWTH Aachen University	Tsokos, GC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Rheumatol, Sch Med, Boston, MA 02215 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013; Szczesny, Bartosz/D-1026-2012; BANERJEE, DIBYENDU/C-6656-2012; Rauen, Thomas/GLR-8682-2022; Chatterjee, Arpita/GPS-9141-2022; Hedrich, Christian/AAD-6855-2019; Hedrich, Christian/AAW-3958-2020; Banerjee, Dibyendu/Y-4652-2019; Mandal, Santi M./AAF-7156-2020	tsokos, george C/0000-0001-9589-2360; Banerjee, Dibyendu/0000-0003-4244-9714; Hedrich, Christian/0000-0002-1295-6179; Hegde, Muralidhar/0000-0001-7333-8123; Gustafsson, Claes/0000-0003-3531-8468; Dixit, Pavana/0000-0003-0811-3942	National Institutes of Health [R01 AI49954, P01 AI065687]; Deutsche Forschungsgemeinschaft [RA1927-1/1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI49954 and P01 AI065687. This work was also supported by Deutsche Forschungsgemeinschaft Grant RA1927-1/1 (to T. R.).	Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Chatterjee M, 2012, J IMMUNOL, V188, P1206, DOI 10.4049/jimmunol.1102773; Chatterjee M, 2011, AUTOIMMUNITY, V44, P211, DOI 10.3109/08916934.2010.530627; Cippa PE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.38; Collins M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-223; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Detre C, 2010, SEMIN IMMUNOPATHOL, V32, P157, DOI 10.1007/s00281-009-0193-0; Dong C, 2011, EXP MOL MED, V43, P1, DOI 10.3858/emm.2011.43.1.007; Garrett-Sinha LA, 2008, CURR OPIN RHEUMATOL, V20, P519, DOI 10.1097/BOR.0b013e328304b6b5; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Graham DB, 2006, J IMMUNOL, V176, P291, DOI 10.4049/jimmunol.176.1.291; Henning G, 2001, EUR J IMMUNOL, V31, P2741, DOI 10.1002/1521-4141(200109)31:9<2741::AID-IMMU2741>3.0.CO;2-6; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Howie D, 2002, BLOOD, V100, P2899, DOI 10.1182/blood-2002-02-0445; Howie D, 2005, J IMMUNOL, V174, P5931, DOI 10.4049/jimmunol.174.10.5931; Kayama H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000514; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Rauen T, 2012, GENES IMMUN, V13, P346, DOI 10.1038/gene.2011.85; Rauen T, 2011, J BIOL CHEM, V286, P43437, DOI 10.1074/jbc.M111.299313; Rudensky AY, 2006, CELL, V126, P253, DOI 10.1016/j.cell.2006.07.005; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Sundrud MS, 2007, CURR OPIN IMMUNOL, V19, P287, DOI 10.1016/j.coi.2007.04.014; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Valdez PA, 2004, J BIOL CHEM, V279, P18662, DOI 10.1074/jbc.M312313200; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Veillette A, 2007, IMMUNITY, V27, P698, DOI 10.1016/j.immuni.2007.11.005; Wilke CM, 2011, TRENDS IMMUNOL, V32, P603, DOI 10.1016/j.it.2011.08.003; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016	36	84	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.415067	http://dx.doi.org/10.1074/jbc.M112.415067			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22130663	hybrid, Green Published			2022-12-25	WOS:000310642200050
J	Mandal, SM; Hegde, ML; Chatterjee, A; Hegde, PM; Szczesny, B; Banerjee, D; Boldogh, I; Gao, R; Falkenberg, M; Gustafsson, CM; Sarkar, PS; Hazra, TK				Mandal, Santi M.; Hegde, Muralidhar L.; Chatterjee, Arpita; Hegde, Pavana M.; Szczesny, Bartosz; Banerjee, Dibyendu; Boldogh, Istvan; Gao, Rui; Falkenberg, Maria; Gustafsson, Claes M.; Sarkar, Partha S.; Hazra, Tapas K.			Role of Human DNA Glycosylase Nei-like 2 (NEIL2) and Single Strand Break Repair Protein Polynucleotide Kinase 3 '-Phosphatase in Maintenance of Mitochondrial Genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; MAMMALIAN-CELLS; OXIDATIVE DAMAGE; OXIDIZED BASES; TRANSCRIPTION FACTORS; IN-VITRO; KAPPA-B; NUCLEAR; IDENTIFICATION; GENE	The repair of reactive oxygen species-induced base lesions and single strand breaks (SSBs) in the nuclear genome via the base excision (BER) and SSB repair (SSBR) pathways, respectively, is well characterize, and important for maintaining genomic integrity. However, the role of mitochondrial (mt) BER and SSBR proteins in mt genome maintenance is not completely clear. Here we show the presence of the oxidized base-specific DNA glycosylase Nei-like 2 (NEIL2) and the DNA end-processing enzyme polynucleotide kinase 3'-phosphatase (PNKP) in purified human mitochondrial extracts (MEs). Confocal microscopy revealed co-localization of PNKP and NEIL2 with the mitochondrion-specific protein cytochrome c oxidase subunit 2 (MT-CO2). Further, chromatin immunoprecipitation analysis showed association of NEIL2 and PNKP with the mitochondrial genes MT-CO2 and MT-CO3 (cytochrome c oxidase subunit 3); importantly, both enzymes also associated with the mitochondrion-specific DNA polymerase gamma. In cell association of NEIL2 and PNKP with polymerase gamma was further confirmed by proximity ligation assays. PNKP-depleted ME showed a significant decrease in both BER and SSBR activities, and PNKP was found to be the major 3'-phosphatase in human ME. Furthermore, individual depletion of NEIL2 and PNKP in human HEK293 cells caused increased levels of oxidized bases and SSBs in the mt genome, respectively. Taken together, these studies demonstrate the critical role of NEIL2 and PNKP in maintenance of the mammalian mitochondrial genome.	[Hazra, Tapas K.] Univ Texas Med Branch, Div Pulm & Crit Care Med, Sealy Ctr Mol Med, Dept Internal Med, Galveston, TX 77555 USA; [Hegde, Muralidhar L.; Hegde, Pavana M.; Szczesny, Bartosz; Banerjee, Dibyendu; Hazra, Tapas K.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Gao, Rui; Sarkar, Partha S.] Univ Texas Med Branch, Dept Neurol & Neurosci & Cell Biol, Galveston, TX 77555 USA; [Falkenberg, Maria; Gustafsson, Claes M.] Univ Gothenburg, Inst Biomed, SE-40530 Gothenburg, Sweden	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Gothenburg	Hazra, TK (corresponding author), Univ Texas Med Branch, Div Pulm & Crit Care Med, Sealy Ctr Mol Med, Dept Internal Med, 6-136 Med Res Bldg,Route 1079, Galveston, TX 77555 USA.	tkhazra@utmb.edu	tsokos, george C/O-3360-2013; Szczesny, Bartosz/D-1026-2012; BANERJEE, DIBYENDU/C-6656-2012; Rauen, Thomas/GLR-8682-2022; Chatterjee, Arpita/GPS-9141-2022; Hedrich, Christian/AAD-6855-2019; Hedrich, Christian/AAW-3958-2020; Banerjee, Dibyendu/Y-4652-2019; Mandal, Santi M./AAF-7156-2020	tsokos, george C/0000-0001-9589-2360; Banerjee, Dibyendu/0000-0003-4244-9714; Hedrich, Christian/0000-0002-1295-6179; Hegde, Muralidhar/0000-0001-7333-8123; Gustafsson, Claes/0000-0003-3531-8468; Dixit, Pavana/0000-0003-0811-3942	National Institutes of Health from the USPHS [CA102271, ES017353, CA81063, ES018948]	National Institutes of Health from the USPHS	This work was supported, in whole or in part, by National Institutes of Health Grants CA102271 and ES017353 (to T. K. H.), CA81063 (to S. M. M.), and ES018948 (to I. B.) from the USPHS.	Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796; BARRY MA, 1993, ARCH BIOCHEM BIOPHYS, V300, P440, DOI 10.1006/abbi.1993.1060; Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Bottero V, 2001, J BIOL CHEM, V276, P21317, DOI 10.1074/jbc.M005850200; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Caldecott KW, 2001, BIOESSAYS, V23, P447, DOI 10.1002/bies.1063; Chattopadhyay R, 2006, NUCLEIC ACIDS RES, V34, P2067, DOI 10.1093/nar/gkl177; Copeland WC, 2010, METHODS, V51, P363, DOI 10.1016/j.ymeth.2010.07.008; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Das BB, 2010, P NATL ACAD SCI USA, V107, P19790, DOI 10.1073/pnas.1009814107; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DODSON ML, 1994, J BIOL CHEM, V269, P32709; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; GILONI L, 1981, J BIOL CHEM, V256, P8608; Gordon DM, 2001, BIOCHEM J, V356, P207, DOI 10.1042/0264-6021:3560207; Hazra IK, 1998, NUCLEIC ACIDS RES, V26, P5116, DOI 10.1093/nar/26.22.5116; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hegde ML, 2010, J BIOL CHEM, V285, P28812, DOI 10.1074/jbc.M110.126664; HENNER WD, 1983, J BIOL CHEM, V258, P5198; Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Johansson H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013678; Kaneko M, 1998, TOXICOL LETT, V99, P15, DOI 10.1016/S0378-4274(98)00132-5; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Kumar D, 2009, J BIOL CHEM, V284, P1853, DOI 10.1074/jbc.M806289200; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mitra S, 2002, FREE RADICAL BIO MED, V33, P15, DOI 10.1016/S0891-5849(02)00819-5; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Patrick ME, 2004, EMERG INFECT DIS, V10, P1; Pohjanpelto P, 1996, EMBO J, V15, P1193, DOI 10.1002/j.1460-2075.1996.tb00458.x; Psarra AMG, 2008, BBA-MOL CELL RES, V1783, P1, DOI 10.1016/j.bbamcr.2007.10.021; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Scovassi AI, 2004, FASEB J, V18, P1487, DOI 10.1096/fj.04-1841rev; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; Sykora P, 2011, P NATL ACAD SCI USA, V108, P7437, DOI 10.1073/pnas.1100084108; Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Taylor RM, 2000, NUCLEIC ACIDS RES, V28, P3558, DOI 10.1093/nar/28.18.3558; Wallace Douglas C, 2002, Methods Mol Biol, V197, P3, DOI 10.1385/1-59259-284-8:003; Wang HX, 2003, J BIOL CHEM, V278, P28686, DOI 10.1074/jbc.M302844200; Weinfeld M, 2011, TRENDS BIOCHEM SCI, V36, P262, DOI 10.1016/j.tibs.2011.01.006; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024	62	84	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2819	2829		10.1074/jbc.M111.272179	http://dx.doi.org/10.1074/jbc.M111.272179			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130663	hybrid, Green Published			2022-12-25	WOS:000300292300053
J	Sun, YC; Yin, J; Cao, HF; Li, CY; Kang, L; Ge, F				Sun, Yucheng; Yin, Jin; Cao, Haifeng; Li, Chuanyou; Kang, Le; Ge, Feng			Elevated CO2 Influences Nematode-Induced Defense Responses of Tomato Genotypes Differing in the JA Pathway	PLOS ONE			English	Article							ATMOSPHERIC CO2; CARBON-DIOXIDE; SIGNALING PATHWAY; NATURAL ENEMIES; JASMONIC ACID; ROOT; RESISTANCE; HERBIVORY; COSTS; BIOSYNTHESIS	Rising atmospheric CO2 concentrations can affect the induced defense of plants against chewing herbivores but little is known about whether elevated CO2 can change the induced defense of plants against parasitic nematodes. This study examined the interactions between the root-knot nematode Meloidogyne incognita and three isogenic tomato (Lycopersicon esculentum) genotypes grown under ambient (390 ppm) and elevated (750 ppm) CO2 in growth chambers. In a previous study with open-top chambers in the field, we reported that elevated CO2 increased the number of nematode-induced root galls in a JA-defense-dominated genotype but not in a wild-type or JA-defense-recessive genotype. In the current study, we tested the hypothesis that elevated CO2 will favor the salicylic acid (SA)-pathway defense but repress the jasmonic acid (JA)-pathway defense of plants against plant-parasitic nematodes. Our data showed that elevated CO2 reduced the JA-pathway defense against M. incognita in the wild-type and in a genotype in which defense is dominated by the JA pathway (a JA-defense-dominated genotype) but up-regulated the SA-pathway defense in the wild type and in a JA-defense-recessive genotype (jasmonate-deficient mutant). Our results suggest that, in terms of defense genes, secondary metabolites, and volatile organic compounds, induced defense of nematode-infected plants could be affected by elevated CO2, and that CO2-induced changes of plant resistance may lead to genotype-specific responses of plants to nematodes under elevated CO2. The changes in resistance against nematodes, however, were small relative to those reported for chewing insects.	[Sun, Yucheng; Yin, Jin; Cao, Haifeng; Kang, Le; Ge, Feng] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest & Rodent, Beijing, Peoples R China; [Li, Chuanyou] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Sun, YC (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest & Rodent, Beijing, Peoples R China.	gef@ioz.ac.cn	Kang, Le/ABD-1116-2022; Li, Chuanyou/ABF-4143-2020; Jiang, Xingyu/U-3976-2018	Kang, Le/0000-0003-4262-2329; Jiang, Xingyu/0000-0002-5008-4703; Sun, Yi/0000-0002-1746-0404; Sun, Yucheng/0000-0003-2353-0218	National Basic Research Program of China (973 Program) [2009CB119200]; National Nature Science Fund of China [30970510, 31000854, 30921063]; Chinese Academy of Science [KSCX3-YW-N-005, 2010-Biols-CAS-0102]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China (973 Program) (No. 2009CB119200), the National Nature Science Fund of China (No. 30970510, 31000854 and 30921063) and the Innovation Program of Chinese Academy of Science (KSCX3-YW-N-005, 2010-Biols-CAS-0102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2003, MOL PLANT PATHOL, V4, P217, DOI [10.1046/j.1364-3703.2003.00170.x, 10.1046/J.1364-3703.2003.00170.X]; Ayres E, 2008, SOIL BIOL BIOCHEM, V40, P978, DOI 10.1016/j.soilbio.2007.11.018; Barbehenn RV, 2004, GLOBAL CHANGE BIOL, V10, P1565, DOI 10.1111/j.1365-2486.2004.00833.x; Bhattarai KK, 2008, MOL PLANT MICROBE IN, V21, P1205, DOI 10.1094/MPMI-21-9-1205; Bidart-Bouzat MG, 2005, OECOLOGIA, V145, P415, DOI 10.1007/s00442-005-0158-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; [陈法军 Chen Fajun], 2004, [昆虫知识, Entomological  Knowledge], V41, P279; Cooper WR, 2005, J CHEM ECOL, V31, P1953, DOI 10.1007/s10886-005-6070-y; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Hamilton JG, 2001, ECOL LETT, V4, P86, DOI 10.1046/j.1461-0248.2001.00192.x; Hartley SE, 2000, GLOBAL CHANGE BIOL, V6, P497, DOI 10.1046/j.1365-2486.2000.00333.x; HOWE GA, 2007, ANNU REV PLANT BIOL, V17, P41; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Kujala TS, 2000, J AGR FOOD CHEM, V48, P5338, DOI 10.1021/jf000523q; Lau JA, 2009, OECOLOGIA, V161, P401, DOI 10.1007/s00442-009-1384-z; Li CR, 2002, PLANT CELL ENVIRON, V25, P369, DOI 10.1046/j.0016-8025.2001.00818.x; Li CY, 2003, PLANT CELL, V15, P1646, DOI 10.1105/tpc.012237; Li CY, 2002, PLANT PHYSIOL, V130, P494, DOI 10.1104/pp.005314; Li PH, 2008, PLANT CELL ENVIRON, V31, P1673, DOI 10.1111/j.1365-3040.2008.01874.x; Loreto F, 2001, GLOBAL CHANGE BIOL, V7, P709, DOI 10.1046/j.1354-1013.2001.00442.x; Melillo MT, 2006, NEW PHYTOL, V170, P501, DOI 10.1111/j.1469-8137.2006.001724.x; Niklaus PA, 2003, GLOBAL CHANGE BIOL, V9, P585, DOI 10.1046/j.1365-2486.2003.00614.x; Soriano IR, 2004, J CHEM ECOL, V30, P1885, DOI 10.1023/B:JOEC.0000045584.56515.11; Stevens MT, 2007, EVOL ECOL, V21, P829, DOI 10.1007/s10682-006-9154-4; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Sun YC, 2010, PLANT CELL ENVIRON, V33, P729, DOI 10.1111/j.1365-3040.2009.02098.x; Sun YC, 2010, AGR ECOSYST ENVIRON, V135, P140, DOI 10.1016/j.agee.2009.09.011; TERRILL TH, 1992, J SCI FOOD AGR, V58, P321, DOI 10.1002/jsfa.2740580306; TISSUE DT, 1995, FUNCT ECOL, V9, P518, DOI 10.2307/2390018; Turlings TCJ, 1998, BIOL CONTROL, V11, P122, DOI 10.1006/bcon.1997.0591; Vasyukova N. I., 2003, Doklady Akademii Nauk, V391, P419; Vuorinen T, 2004, PLANT PHYSIOL, V135, P1984, DOI 10.1104/pp.104.047084; Vuorinen T, 2004, ATMOS ENVIRON, V38, P675, DOI 10.1016/j.atmosenv.2003.10.029; Williamson VM, 1998, ANNU REV PHYTOPATHOL, V36, P277, DOI 10.1146/annurev.phyto.36.1.277; Yeates GW, 2003, BIOL FERT SOILS, V38, P319, DOI 10.1007/s00374-003-0659-5; Yin J, 2009, AGR ECOSYST ENVIRON, V132, P267, DOI 10.1016/j.agee.2009.04.010; Zavala JA, 2008, P NATL ACAD SCI USA, V105, P5129, DOI 10.1073/pnas.0800568105; Zavala JA, 2009, OECOLOGIA, V161, P35, DOI 10.1007/s00442-009-1360-7	42	61	63	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19751	10.1371/journal.pone.0019751	http://dx.doi.org/10.1371/journal.pone.0019751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629688	Green Submitted, Green Published, gold			2022-12-25	WOS:000291005800007
J	Yang, D; Tao, J; Li, L; Kedei, N; Toth, ZE; Czap, A; Velasquez, JF; Mihova, D; Michalowski, AM; Yuspa, SH; Blumberg, PM				Yang, D.; Tao, J.; Li, L.; Kedei, N.; Toth, Z. E.; Czap, A.; Velasquez, J. F.; Mihova, D.; Michalowski, A. M.; Yuspa, S. H.; Blumberg, P. M.			RasGRP3, a Ras activator, contributes to signaling and the tumorigenic phenotype in human melanoma	ONCOGENE			English	Article						Ras activator; Akt; HGF; melanoma; cell transformation; guanine nucleotide exchange factor	POLYMERASE-CHAIN-REACTION; PHORBOL ESTERS; KINASE ACTIVATION; B-RAF; FUNCTIONAL-ANALYSIS; CELL PROLIFERATION; COLORECTAL TUMORS; REGULATED KINASE; BRAF MUTATIONS; PHOSPHORYLATION	RasGRP3, an activator for H-Ras, R-Ras and Ras-associated protein-1/2, has emerged as an important mediator of signaling downstream from receptor coupled phosphoinositide turnover in B and T cells. Here, we report that RasGRP3 showed a high level of expression in multiple human melanoma cell lines as well as in a subset of human melanoma tissue samples. Suppression of endogenous RasGRP3 expression in these melanoma cell lines reduced Ras-GTP formation as well as c-Met expression and Akt phosphorylation downstream from hepatocyte growth factor (HGF) or epidermal growth factor (EGF) stimulation. RasGRP3 suppression also inhibited cell proliferation and reduced both colony formation in soft agar and xenograft tumor growth in immunodeficient mice, demonstrating the importance of RasGRP3 for the transformed phenotype of the melanoma cells. Reciprocally, overexpression of RasGRP3 in human primary melanocytes altered cellular morphology, markedly enhanced cell proliferation and rendered the cells tumorigenic in a mouse xenograft model. Suppression of RasGRP3 expression in these cells inhibited downstream RasGRP3 responses and suppressed cell growth, confirming the functional role of RasGRP3 in the altered behavior of these cells. The identification of the role of RasGRP3 in melanoma highlights its importance, as a Ras activator, in the phosphoinositide signaling pathway in human melanoma and provides a new potential therapeutic target. Oncogene (2011) 30, 4590-4600; doi: 10.1038/onc.2011.166; published online 23 May 2011	[Yang, D.; Tao, J.; Li, L.; Kedei, N.; Czap, A.; Velasquez, J. F.; Mihova, D.; Michalowski, A. M.; Yuspa, S. H.; Blumberg, P. M.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Toth, Z. E.] Semmelweis Univ, Dept Anat Histol & Embryol, Neuromorphol & Neuroendocrine Res Lab, Budapest, Hungary; [Toth, Z. E.] Hungarian Acad Sci, Budapest, Hungary	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Semmelweis University; Hungarian Academy of Sciences	Blumberg, PM (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, Room 4048,Bldg 37,37 Convent Dr MSC 4255, Bethesda, MD 20892 USA.	blumberp@dc37a.nci.nih.gov	Li, Lili/Q-5750-2018; Tao, Qian/T-4743-2018; Chan, Anthony Tak Cheung/R-3940-2018	Li, Lili/0000-0002-0292-5889; Tao, Qian/0000-0001-5383-4808; Chan, Anthony Tak Cheung/0000-0002-6912-8091	NIH, Center for Cancer Research, National Cancer Institute [Z1A BC 005270]; ETT [495/09]; Bolyai fellowship; NATIONAL CANCER INSTITUTE [ZIABC004504, ZIABC005445, ZIABC005270, Z01BC005270] Funding Source: NIH RePORTER	NIH, Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ETT; Bolyai fellowship(Hungarian Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the intramural program of the NIH, Center for Cancer Research, National Cancer Institute (project number Z1A BC 005270) and in part by grant ETT 495/09. ZE Toth is supported by the Bolyai fellowship. We thank Glenn Merlino for helpful comments.	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Aiba Y, 2004, P NATL ACAD SCI USA, V101, P16612, DOI 10.1073/pnas.0407468101; BALL NJ, 1994, J INVEST DERMATOL, V102, P285, DOI 10.1111/1523-1747.ep12371783; Bastian BC, 2003, AM J PATHOL, V163, P1765, DOI 10.1016/S0002-9440(10)63536-5; Bauer J, 2006, DERMATOL THER, V19, P40, DOI 10.1111/j.1529-8019.2005.00055.x; Brodie C, 2004, MOL PHARMACOL, V66, P76, DOI 10.1124/mol.66.1.76; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Eckhart L, 2000, BIOCHEM BIOPH RES CO, V271, P726, DOI 10.1006/bbrc.2000.2716; Furge KA, 2001, P NATL ACAD SCI USA, V98, P10722, DOI 10.1073/pnas.191067898; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; Gawecka JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011269; Guo FF, 2001, J BIOL CHEM, V276, P25568, DOI 10.1074/jbc.M101277200; Haluska Frank G, 2006, Curr Oncol Rep, V8, P400, DOI 10.1007/s11912-006-0065-x; Hingorani SR, 2003, CANCER RES, V63, P5198; Houben Roland, 2004, J Carcinog, V3, P6, DOI 10.1186/1477-3163-3-6; Huang HP, 2008, J AGR FOOD CHEM, V56, P9286, DOI 10.1021/jf8013102; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Ikenoue T, 2004, CANCER RES, V64, P3428, DOI 10.1158/0008-5472.CAN-03-3591; Ikenoue T, 2003, CANCER RES, V63, P8132; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Lorenzo PS, 2000, MOL PHARMACOL, V57, P840; Lorenzo PS, 2001, CANCER RES, V61, P943; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Ohba Y, 2001, EMBO J, V20, P3333, DOI 10.1093/emboj/20.13.3333; Oki-Idouchi CE, 2007, CANCER RES, V67, P276, DOI 10.1158/0008-5472.CAN-06-3080; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Powell MB, 1999, CARCINOGENESIS, V20, P1747, DOI 10.1093/carcin/20.9.1747; Pu YM, 2005, J BIOL CHEM, V280, P27329, DOI 10.1074/jbc.M414132200; Roberts DM, 2004, MOL CELL BIOL, V24, P10515, DOI 10.1128/MCB.24.24.10515-10528.2004; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Satyamoorthy K, 2003, CANCER RES, V63, P756; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Stone JC, 2006, BIOCHEM SOC T, V34, P858, DOI 10.1042/BST0340858; Stope MB, 2004, MOL CELL BIOL, V24, P4664, DOI 10.1128/MCB.24.11.4664-4676.2004; Sumimoto H, 2004, ONCOGENE, V23, P6031, DOI 10.1038/sj.onc.1207812; Sutlovic D, 2005, CROAT MED J, V46, P556; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Takayama H, 1997, P NATL ACAD SCI USA, V94, P701, DOI 10.1073/pnas.94.2.701; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; van Elsas A, 1995, Recent Results Cancer Res, V139, P57; Wang DZ, 2000, ONCOGENE, V19, P4647, DOI 10.1038/sj.onc.1203820; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yang DZ, 2010, CANCER RES, V70, P7905, DOI 10.1158/0008-5472.CAN-09-4729; Zheng H, 2009, CANCER RES, V69, P449, DOI 10.1158/0008-5472.CAN-08-2399; Zheng Y, 2005, BLOOD, V105, P3648, DOI 10.1182/blood-2004-10-3916	54	40	43	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 10	2011	30	45					4590	4600		10.1038/onc.2011.166	http://dx.doi.org/10.1038/onc.2011.166			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	846IO	22139084	Green Accepted			2022-12-25	WOS:000296890700006
